PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Asai, K; Kitaura, J; Kawakami, Y; Yamagata, N; Tsai, M; Carbone, DP; Liu, FT; Galli, SJ; Kawakami, T				Asai, K; Kitaura, J; Kawakami, Y; Yamagata, N; Tsai, M; Carbone, DP; Liu, FT; Galli, SJ; Kawakami, T			Regulation of mast cell survival by IgE	IMMUNITY			English	Article							FC-EPSILON-RI; KIT-LIGAND; IN-VITRO; IMMUNOGLOBULIN-E; GENE-EXPRESSION; RECEPTOR; ANTIBODY; ACTIVATION; BINDING; PROLIFERATION	Mast cells play critical roles in hypersensitivity and in defense against certain parasites. We provide evidence that mouse mast cell survival and growth are promoted by monomeric IgE binding to its high-affinity receptor, Fc epsilon RI. Monomeric IgE does not promote DNA synthesis but suppresses the apoptosis induced by growth factor deprivation. This antiapoptotic effect occurs in parallel with IgE-induced increases in Fc epsilon RI surface expression but requires the continuous presence of IgE. This process does not involve the FasL/Fas death pathway or several Bcl-2 family proteins and induces a distinctly different signal than Fc epsilon RI cross-linking. The ability of IgE to enhance mast cell survival and Fc epsilon RI expression may contribute to amplified allergic reactions.	La Jolla Inst Allergy & Immunol, Div Allergy, San Diego, CA 92121 USA; Vanderbilt Ingram Canc Ctr, Div Hematol & Oncol, Nashville, TN 37232 USA; Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	La Jolla Institute for Immunology; Vanderbilt University; Stanford University; Stanford University; Stanford University	Kawakami, T (corresponding author), La Jolla Inst Allergy & Immunol, Div Allergy, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	toshi_kawakami@liai.org	Liu, FU-TONG/A-5749-2019; Kawakami, Toshiaki/O-1616-2015	Liu, FU-TONG/0000-0002-3354-1001; Tsai, Mindy/0000-0002-8421-4721	NCI NIH HHS [CA72074] Funding Source: Medline; NIAID NIH HHS [AI23990, AI33617, AI41995, AI42244, AI38348] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI041995, R01AI023990, R01AI033617, U19AI042244, R01AI038348, R37AI023990] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEAVEN MA, 1993, IMMUNOL TODAY, V14, P222, DOI 10.1016/0167-5699(93)90167-J; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Chen HX, 1998, J EXP MED, V188, P1657, DOI 10.1084/jem.188.9.1657; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; Galli SJ, 1999, FUNDAMENTAL IMMUNOLO, P1127; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Green DR, 1997, P NATL ACAD SCI USA, V94, P5986, DOI 10.1073/pnas.94.12.5986; Hartmann K, 1997, J IMMUNOL, V159, P4006; Hata D, 1998, J BIOL CHEM, V273, P10979, DOI 10.1074/jbc.273.18.10979; Hsu C, 1996, IMMUNOL LETT, V52, P129, DOI 10.1016/0165-2478(96)02599-0; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; IEMURA A, 1994, AM J PATHOL, V144, P321; ISHIZAKA K, 1966, J IMMUNOL, V97, P75; ISHIZAKA K, 1985, METHOD ENZYMOL, V116, P76; KAWAKAMI T, 1992, J IMMUNOL, V148, P3513; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; KNAUER KA, 1983, ALLERGY PRINCIPLES P, P673; KULCZYCK.A, 1974, J EXP MED, V140, P1676, DOI 10.1084/jem.140.6.1676; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lantz CS, 1997, J IMMUNOL, V158, P2517; LIU FT, 1980, J IMMUNOL, V124, P2728; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; MacGlashan D, 1999, J ALLERGY CLIN IMMUN, V104, P492, DOI 10.1016/S0091-6749(99)70399-4; MacGlashan D, 1998, BLOOD, V91, P1633, DOI 10.1182/blood.V91.5.1633.1633_1633_1643; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; MEKORI YA, 1993, J IMMUNOL, V151, P3775; MEKORI YA, 1998, SIGNAL TRANSDUCTION, P85; NABEL G, 1981, NATURE, V291, P332, DOI 10.1038/291332a0; NAGAO K, 1981, SCIENCE, V212, P333, DOI 10.1126/science.7209531; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; RAZIN E, 1981, P NATL ACAD SCI-BIOL, V78, P2559, DOI 10.1073/pnas.78.4.2559; SCHRADER JW, 1981, P NATL ACAD SCI-BIOL, V78, P323, DOI 10.1073/pnas.78.1.323; TAKIZAWA F, 1992, J EXP MED, V176, P469, DOI 10.1084/jem.176.2.469; TERTIAN G, 1981, J IMMUNOL, V127, P788; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; Xia HZ, 1997, J IMMUNOL, V159, P2911; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1; Yano K, 1997, LAB INVEST, V77, P185; YEE NS, 1994, J EXP MED, V179, P1777, DOI 10.1084/jem.179.6.1777; Yokota T, 1986, LYMPHOKINES, V13, P1	45	263	268	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2001	14	6					791	800		10.1016/S1074-7613(01)00157-1	http://dx.doi.org/10.1016/S1074-7613(01)00157-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420048	Green Submitted, Bronze			2022-12-18	WOS:000169495100014
J	Sage, PT; Paterson, AM; Lovitch, SB; Sharpe, AH				Sage, Peter T.; Paterson, Alison M.; Lovitch, Scott B.; Sharpe, Arlene H.			The Coinhibitory Receptor CTLA-4 Controls B Cell Responses by Modulating T Follicular Helper, T Follicular Regulatory, and T Regulatory Cells	IMMUNITY			English	Article							IN-VIVO; ANTIBODY-RESPONSES; DIFFERENTIATION; GENERATION; INDUCTION; SELECTION; IMMUNITY; INHIBIT; TRANS; ICOS	The receptor CTLA-4 has been implicated in controlling B cell responses, but the mechanisms by which CTLA-4 regulates antibody production are not known. Here we showed deletion of CTLA-4 in adult mice increased Tfh and Tfr cell numbers and augmented B cell responses. In the effector phase, loss of CTLA-4 on Tfh cells resulted in heightened B cell responses, whereas loss of CTLA-4 on Tfr cells resulted in defective suppression of antigen-specific antibody responses. We also found that non-Tfr Treg cells could suppress B cell responses through CTLA-4 and that Treg and/or Tfr cells might downregulate B7-2 on B cells outside germinal centers as a means of suppression. Within the germinal center, however, Tfr cells potently suppress B cells through CTLA-4, but with a mechanism independent of altering B7-1 or B7-2. Thus, we identify multifaceted regulatory roles for CTLA-4 in Tfh, Tfr, and Treg cells, which together control humoral immunity.	[Sage, Peter T.; Paterson, Alison M.; Lovitch, Scott B.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Sage, Peter T.; Paterson, Alison M.; Lovitch, Scott B.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Sage, Peter T.; Paterson, Alison M.; Lovitch, Scott B.; Sharpe, Arlene H.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Lovitch, Scott B.; Sharpe, Arlene H.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Sharpe, AH (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	arlene_sharpe@hms.harvard.edu		Lovitch, Scott/0000-0001-9013-0105; Sharpe, Arlene/0000-0002-9736-2109	National Institutes of Health [5T32HL007627, R37AI38310, P01AI39671]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038310, R01AI038310, P01AI039671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Armet for technical help. This work was supported by the National Institutes of Health through grants 5T32HL007627, R37AI38310, and P01AI39671.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Bour-Jordan H, 2003, NAT IMMUNOL, V4, P182, DOI 10.1038/ni884; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Corse E, 2012, J IMMUNOL, V189, P1123, DOI 10.4049/jimmunol.1200695; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Hams E, 2011, J IMMUNOL, V186, P5648, DOI 10.4049/jimmunol.1003161; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Miyazaki M, 2014, NAT IMMUNOL, V15, P767, DOI 10.1038/ni.2928; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sage PT, 2014, J CLIN INVEST, V124, P5191, DOI 10.1172/JCI76861; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Tang DN, 2013, CANCER IMMUNOL RES, V1, P229, DOI 10.1158/2326-6066.CIR-13-0020; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Walker LSK, 2003, J IMMUNOL, V170, P91, DOI 10.4049/jimmunol.170.1.91; Walker LSK, 2002, J IMMUNOL, V169, P6202, DOI 10.4049/jimmunol.169.11.6202; Walker LSK, 2013, J AUTOIMMUN, V45, P49, DOI 10.1016/j.jaut.2013.06.006; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; Wang CJ, 2012, J IMMUNOL, V189, P1118, DOI 10.4049/jimmunol.1200972; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	39	262	273	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					1026	1039		10.1016/j.immuni.2014.12.005	http://dx.doi.org/10.1016/j.immuni.2014.12.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526313	Bronze, Green Accepted			2022-12-18	WOS:000346654100019
J	Henault, J; Martinez, J; Riggs, JM; Tian, J; Mehta, P; Clarke, L; Sasai, M; Latz, E; Brinkmann, MM; Iwasaki, A; Coyle, AJ; Kolbeck, R; Green, DR; Sanjuan, MA				Henault, Jill; Martinez, Jennifer; Riggs, Jeffrey M.; Tian, Jane; Mehta, Payal; Clarke, Lorraine; Sasai, Miwa; Latz, Eicke; Brinkmann, Melanie M.; Iwasaki, Akiko; Coyle, Anthony J.; Kolbeck, Roland; Green, Douglas R.; Sanjuan, Miguel A.			Noncanonical Autophagy Is Required for Type I Interferon Secretion in Response to DNA-Immune Complexes	IMMUNITY			English	Article							TOLL-LIKE-RECEPTORS; PLASMACYTOID DENDRITIC CELLS; CPG-DNA; PROTEOLYTIC CLEAVAGE; TLR9; ACTIVATION; MICE; INFLAMMATION; RECOGNITION; MATURATION	Toll-like receptor-9 (TLR9) is largely responsible for discriminating self from pathogenic DNA. However, association of host DNA with autoantibodies activates TLR9, inducing the pathogenic secretion of type I interferons (IFNs) from plasmacytoid dendritic cells (pDCs). Here, we found that in response to DNA-containing immune complexes (DNA-IC), but not to soluble ligands, IFN-alpha production depended upon the convergence of the phagocytic and autophagic pathways, a process called microtubule-associated protein 1A/1 B-light chain 3 (LC3)-associated phagocytosis (LAP). LAP was required for TLR9 trafficking into a specialized interferon signaling compartment by a mechanism that involved autophagy-related proteins, but not the conventional autophagic preinitiation complex, or adaptor protein-3 (AP-3). Our findings unveil a new role for nonconventional autophagy in inflammation and provide one mechanism by which anti-DNA autoantibodies, such as those found in several autoimmune disorders, bypass the controls that normally restrict the apportionment of pathogenic DNA and TLR9 to the interferon signaling compartment.	[Martinez, Jennifer; Green, Douglas R.] St Jude Childrens Res Inst, Dept Immunol, Memphis, TN 38105 USA; [Henault, Jill; Riggs, Jeffrey M.; Tian, Jane; Mehta, Payal; Coyle, Anthony J.; Kolbeck, Roland; Sanjuan, Miguel A.] Medimmune Inc, Resp Inflammat & Autoimmun Res Dept, Gaithersburg, MD 20878 USA; [Clarke, Lorraine] Medimmune Inc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Latz, Eicke] Univ Bonn, Biomed Ctr, Inst Innate Immun, Univ Hosp, D-53127 Bonn, Germany; [Brinkmann, Melanie M.] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Sasai, Miwa; Iwasaki, Akiko] Yale Univ, Dept Immunol, Sch Med, New Haven, CT 06520 USA	St Jude Children's Research Hospital; AstraZeneca; Medimmune; AstraZeneca; Medimmune; University of Bonn; Helmholtz Association; Helmholtz-Center for Infection Research; Yale University	Green, DR (corresponding author), St Jude Childrens Res Inst, Dept Immunol, Memphis, TN 38105 USA.	douglas.green@stjude.org; sanjuanm@medimmune.com	Green, Douglas R/N-8083-2018; Iwasaki, Akiko/Z-1591-2019; Latz, Eicke/H-3951-2014; Martinez, Jennifer/C-3740-2019; Sanjuán, Miguel AF/B-7709-2011	Green, Douglas R/0000-0002-7332-1417; Iwasaki, Akiko/0000-0002-7824-9856; Latz, Eicke/0000-0003-1488-5666; Martinez, Jennifer/0000-0002-3060-2518; Sanjuán, Miguel AF/0000-0003-3515-0837; Sasai, Miwa/0000-0001-6440-3958	National Institute of Health [A140646]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646, R01AI064705, R01AI081884] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health grant A140646. We thank Jacques Moisan for manuscript critical review and David Dilillo for his help with Fcer1g mice. The following authors are or were full-time employees of Medlmmune: M.A.S, J.H., J.M.R., A.J.C., J.T., L.C., P.M. and R.K. MedImmune is developing anti-interferon therapies for autoimmune diseases.	Abrahams VM, 2000, ARTHRITIS RHEUM-US, V43, P608, DOI 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gursel I, 2001, J IMMUNOL, V167, P3324, DOI 10.4049/jimmunol.167.6.3324; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Jaumouille V, 2011, CURR OPIN CELL BIOL, V23, P22, DOI 10.1016/j.ceb.2010.10.006; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kasperkovitz PV, 2010, J IMMUNOL, V185, P7614, DOI 10.4049/jimmunol.1002760; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2008, AUTOPHAGY, V4, P61, DOI 10.4161/auto.4846; Kuo CC, 2006, J IMMUNOL, V176, P5943, DOI 10.4049/jimmunol.176.10.5943; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Macfarlane DE, 1998, J IMMUNOL, V160, P1122; Manzel L, 1999, ANTISENSE NUCLEIC A, V9, P459, DOI 10.1089/oli.1.1999.9.459; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sanjuan MA, 2009, IMMUNOL REV, V227, P203, DOI 10.1111/j.1600-065X.2008.00732.x; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Trieu A, 2006, CRIT REV IMMUNOL, V26, P527, DOI 10.1615/CritRevImmunol.v26.i6.50; Trivedi V, 2006, P NATL ACAD SCI USA, V103, P18226, DOI 10.1073/pnas.0609182103; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Williams-Simons L, 1999, TRANSGENIC RES, V8, P253, DOI 10.1023/A:1008994831937; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x	43	262	269	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					986	997		10.1016/j.immuni.2012.09.014	http://dx.doi.org/10.1016/j.immuni.2012.09.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23219390	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000312575000008
J	Allen, IC; Moore, CB; Schneider, M; Lei, Y; Davis, BK; Scull, MA; Gris, D; Roney, KE; Zimmermann, AG; Bowzard, JB; Ranjan, P; Monroe, KM; Pickles, RJ; Sambhara, S; Ting, JPY				Allen, Irving C.; Moore, Chris B.; Schneider, Monika; Lei, Yu; Davis, Beckley K.; Scull, Margaret A.; Gris, Denis; Roney, Kelly E.; Zimmermann, Albert G.; Bowzard, John B.; Ranjan, Priya; Monroe, Kathryn M.; Pickles, Raymond J.; Sambhara, Suryaprakash; Ting, Jenny P. Y.			NLRX1 Protein Attenuates Inflammatory Responses to Infection by Interfering with the RIG-I-MAVS and TRAF6-NF-kappa B Signaling Pathways	IMMUNITY			English	Article							NF-KAPPA-B; ANTIVIRAL RESPONSES; ACTIVATION; NLRC5; RNA; INHIBITION; APOPTOSIS; RECEPTOR; DOMAIN	The nucleotide-binding domain and leucine-rich-repeat-containing (NLR) proteins regulate innate immunity. Although the positive regulatory impact of NLRs is clear, their inhibitory roles are not well defined. We showed that Nlrx1(-/-) mice exhibited increased expression of antiviral signaling molecules IFN-beta, STAT2, OAS1, and IL-6 after influenza virus infection. Consistent with increased inflammation, Nlrx1(-/-) mice exhibited marked morbidity and histopathology. Infection of these mice with an influenza strain that carries a mutated NS-1 protein, which normally prevents IFN induction by interaction with RNA and the intracellular RNA sensor RIG-I, further exacerbated IL-6 and type 1 IFN signaling. NLRX1 also weakened cytokine responses to the 2009 H1N1 pandemic influenza virus in human cells. Mechanistically, Nlrx1 deletion led to constitutive interaction of MAVS and RIG-I. Additionally, an inhibitory function is identified for NLRX1 during LPS activation of macrophages where the MAVS-RIG-I pathway was not involved. NLRX1 interacts with TRAF6 and inhibits NF-kappa B activation. Thus, NLRX1 functions as a checkpoint of overzealous inflammation.	[Allen, Irving C.; Davis, Beckley K.; Gris, Denis; Zimmermann, Albert G.; Ting, Jenny P. Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Schneider, Monika; Scull, Margaret A.; Roney, Kelly E.; Pickles, Raymond J.; Ting, Jenny P. Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Lei, Yu; Ting, Jenny P. Y.] Univ N Carolina, Oral Biol Program, Chapel Hill, NC 27599 USA; [Moore, Chris B.] Glaxosmithkline, Infect Dis, Ctr Excellence Drug Discovery, Res Triangle Pk, NC 27709 USA; [Bowzard, John B.; Ranjan, Priya; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA; [Monroe, Kathryn M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline; Centers for Disease Control & Prevention - USA; University of California System; University of California Berkeley	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jenny_ting@med.unc.edu	Scull, Margaret/K-9963-2019; Gris, Denis/AGA-1192-2022; Sambhara, Suryaprakash/AAC-4428-2021; Gris, Denis/ABE-5229-2021; Lei, Yu Leo/ABF-1293-2020	Gris, Denis/0000-0003-1215-2434; Gris, Denis/0000-0003-1215-2434; Lei, Yu Leo/0000-0002-9868-9824; Scull, Margaret/0000-0002-6860-2468; Allen, Irving/0000-0001-9573-5250	 [U54-AI057157 (SERCEB)];  [U19-AI067798];  [U19-AI077437];  [F32-AI-082895-01];  [T32-AR007416];  [T32-CA009156]; NATIONAL CANCER INSTITUTE [R01CA156330, T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077437, U54AI057157, U19AI067798, F32AI082895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007416] Funding Source: NIH RePORTER	; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors would like to thank W.S. Barclay (Imperial College London) for providing the influenza A/PR/8/34<SUP>mut39</SUP> virus. We would also like to thank J.M. Katz and N.J. Cox of the Influenza Division for their support. This work is supported by U54-AI057157 (SERCEB), U19-AI067798, U19-AI077437 (J.P.Y.T.), F32-AI-082895-01, T32-AR007416, and T32-CA009156 (I.C.A.).	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hayman A, 2007, J VIROL, V81, P2318, DOI 10.1128/JVI.01856-06; Jia YX, 2009, J IMMUNOL, V183, P4241, DOI 10.4049/jimmunol.0901646; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lechner J, 2008, AM J PHYSIOL-CELL PH, V294, pC153, DOI 10.1152/ajpcell.00120.2007; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Neerincx A, 2010, J BIOL CHEM, V285, P26223, DOI 10.1074/jbc.M110.109736; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815	30	262	276	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 24	2011	34	6					854	865		10.1016/j.immuni.2011.03.026	http://dx.doi.org/10.1016/j.immuni.2011.03.026			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21703540	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000292349700007
J	Kwon, H; Thierry-Mieg, D; Thierry-Mieg, J; Kim, HP; Oh, J; Tunyaplin, C; Carotta, S; Donovan, CE; Goldman, ML; Tailor, P; Ozato, K; Levy, DE; Nutt, SL; Calame, K; Leonard, WJ				Kwon, Hyokjoon; Thierry-Mieg, Danielle; Thierry-Mieg, Jean; Kim, Hyoung-Pyo; Oh, Jangsuk; Tunyaplin, Chainarong; Carotta, Sebastian; Donovan, Colleen E.; Goldman, Matthew L.; Tailor, Prafullakumar; Ozato, Keiko; Levy, David E.; Nutt, Stephen L.; Calame, Kathryn; Leonard, Warren J.			Analysis of Interleukin-21-Induced Prdm1 Gene Regulation Reveals Functional Cooperation of STAT3 and IRF4 Transcription Factors	IMMUNITY			English	Article							T-CELL HOMEOSTASIS; REPRESSOR BLIMP-1; IL-2 RECEPTOR; DIFFERENTIATION; LYMPHOCYTES; FAMILY; IMMUNODEFICIENCY; MODULATION; EXPRESSION; EXPANSION	Interleukin-21 (IL-21) is a pleiotropic cytokine that induces expression of transcription factor BLIMP1 (encoded by Prdm1), which regulates plasma cell differentiation and T cell homeostasis. We identified an IL-21 response element downstream of Prdm1 that binds the transcription factors STAT3 and IRF4, which are required for optimal Prdm1 expression. Genome-wide ChIP-Seq mapping of STAT3- and IRF4-binding sites showed that most regions with IL-21-induced STAT3 binding also bound IRF4 in vivo and furthermore revealed that the noncanonical TTCnnnTAA GAS motif critical in Prdm1 was broadly used for STAT3 binding. Comparing genome-wide expression array data to binding sites revealed that most IL-21-regulated genes were associated with combined STAT3-IRF4 sites rather than pure STAT3 sites. Correspondingly, ChIP-Seq analysis of Irf4(-/-) T cells showed greatly diminished STAT3 binding after IL-21 treatment, and lrf4(-/-) mice showed impaired IL-21-induced Tfh cell differentiation in vivo. These results reveal broad cooperative gene regulation by STAT3 and IRF4.	[Kwon, Hyokjoon; Kim, Hyoung-Pyo; Oh, Jangsuk; Donovan, Colleen E.; Goldman, Matthew L.; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Thierry-Mieg, Danielle; Thierry-Mieg, Jean] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Tunyaplin, Chainarong; Calame, Kathryn] Columbia Univ, Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; [Carotta, Sebastian; Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Tailor, Prafullakumar; Ozato, Keiko] NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; [Levy, David E.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Levy, David E.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Columbia University; Walter & Eliza Hall Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); New York University; New York University	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA.		Leonard, Warren/AAA-1397-2022; Levy, David/AAG-6202-2019; Nutt, Stephen L/C-9256-2013; Levy, David/GPS-4945-2022; THIERRY-MIEG, Jean/F-1975-2017; Goldman, Matthew/AAA-2127-2020	Levy, David/0000-0002-7320-7788; Nutt, Stephen L/0000-0002-0020-6637; THIERRY-MIEG, Jean/0000-0002-0396-6789; Thierry-Mieg, Danielle/0000-0001-9568-4211; Kwon, Hyok Joon/0000-0002-3436-0608	Division of Intramural Research, National Heart, Lung. and Blood Institute; National Center for Biotechnology Information, National Library of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005402, ZIAHL005408] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung. and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Biotechnology Information, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank H C Morse III for NFS201 and NFS202 cells, D E Schones for valuable discussions and assistance with handling the Illumina raw ChIP-Seq data and for processing ChIP-Seq data, K Cui and T -Y Roh for help with Solexa sequencing, the NHLBI Affymetrix Core and N Raghavachan, X Xu, and D Liu for help with generating, analyzing. and handling Affymetrix data, and J -X Lin, H Young, K Zhao, and K -T Jeang for valuable discussions and/or critical comments. This work was supported by the Division of Intramural Research, National Heart, Lung. and Blood Institute, and by the National Center for Biotechnology Information, National Library of Medicine W J L is an inventor on patents and patent applications related to IL-21	Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Gabriele L, 2007, CYTOKINE GROWTH F R, V18, P503, DOI 10.1016/j.cytogfr.2007.06.008; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Gupta S, 1999, J EXP MED, V190, P1837, DOI 10.1084/jem.190.12.1837; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kovanen PE, 2008, J BIOL CHEM, V283, P17362, DOI 10.1074/jbc.M709887200; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NUNEVA RI, 2008, IMMUNITY, V29, P138; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Ozaki K, 2000, P NATL ACAD SCI USA, V97, P11439, DOI 10.1073/pnas.200360997; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973	35	262	271	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					941	952		10.1016/j.immuni.2009.10.008	http://dx.doi.org/10.1016/j.immuni.2009.10.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20064451	Green Accepted, Bronze			2022-12-18	WOS:000273616400014
J	Ellies, LG; Tsuboi, S; Petryniak, B; Lowe, JB; Fukuda, M; Marth, JD				Ellies, LG; Tsuboi, S; Petryniak, B; Lowe, JB; Fukuda, M; Marth, JD			Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation	IMMUNITY			English	Article							O-LINKED OLIGOSACCHARIDES; ALPHA(1,3)FUCOSYLTRANSFERASE FUC-TVII; WISKOTT-ALDRICH SYNDROME; P-SELECTIN; DEFICIENT MICE; CELL-SURFACE; BINDING; LEUKEMIA; ANTIGEN; GLYCANS	Mammalian serine/threonine-linked oligosaccharides (O-glycans) are commonly synthesized with the Golgi enzyme core 2 beta-1,6-N-acetylglucosaminyltransferase (C2 GlcNAcT). Core 2 O-glycans have been hypothesized to be essential for mucin production and selectin ligand biosynthesis. We report that mice lacking C2 GlcNAcT exhibit a restricted phenotype with neutrophilia and a partial deficiency of selectin ligands. Loss of core 2 oligosaccharides reduces neutrophil rolling on substrata bearing E-, L-, and P-selectins and neutrophil recruitment to sites of inflammation. However, the diminished presence of L-selectin ligands on lymph node high endothelial venules does not affect lymphocyte homing. These studies indicate that core 2 oligosaccharide biosynthesis segregates the physiologic roles of selectins and reveal a function for the C2 GlcNAcT in myeloid homeostasis and inflammation.	Univ Calif San Diego, Howard Hughes Med Inst, Div Cellular & Mol Med, La Jolla, CA 92093 USA; Burnham Inst, La Jolla, CA 92037 USA; Univ Michigan, Sch Med, Dept Pathol, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Marth, JD (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Div Cellular & Mol Med, La Jolla, CA 92093 USA.				NCI NIH HHS [CA33000] Funding Source: Medline; NIAID NIH HHS [AI33189] Funding Source: Medline; NIDDK NIH HHS [DK48247] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA033000, R37CA033000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI033189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048247] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AIGNER S, 1995, INT IMMUNOL, V7, P1557, DOI 10.1093/intimm/7.10.1557; ALON R, 1995, J IMMUNOL, V154, P5356; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BAUM LG, 1995, J EXP MED, V181, P877, DOI 10.1084/jem.181.3.877; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; BIERHUIZEN MFA, 1994, J BIOL CHEM, V269, P4473; BROCKHAUSEN I, 1991, CANCER RES, V51, P1257; BROCKHAUSEN I, 1995, GLYCOPROTEINS, P210; Cheng H, 1996, CONNECT TISSUE RES, V34, P87, DOI 10.3109/03008209609021494; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Clark RA, 1998, J CELL BIOL, V140, P721, DOI 10.1083/jcb.140.3.721; FOX RI, 1983, J IMMUNOL, V131, P762; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; HIGGINS EA, 1991, J BIOL CHEM, V266, P6280; Hounsell EF, 1996, GLYCOCONJUGATE J, V13, P19, DOI 10.1007/BF01049675; JOHNSON RC, 1995, BLOOD, V86, P1106; JONES AT, 1994, J IMMUNOL, V153, P3426; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KUHNS W, 1993, GLYCOCONJUGATE J, V10, P381, DOI 10.1007/BF00731043; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; LABOW MA, 1995, IMMUNITY, V1, P709; LARKIN M, 1992, J BIOL CHEM, V267, P13661; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; LI FG, 1996, J BIOL CHEM, V271, P2355; Lowe JB, 1997, J CLIN INVEST, V99, P822, DOI 10.1172/JCI119244; Lowe JB, 1997, KIDNEY INT, V51, P1418, DOI 10.1038/ki.1997.194; MAEMURA K, 1992, J BIOL CHEM, V267, P24379; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NORGARD KE, 1993, J BIOL CHEM, V268, P12764; NORGARDSUMNICHT KE, 1993, SCIENCE, V261, P480, DOI 10.1126/science.7687382; PILLER F, 1984, J BIOL CHEM, V259, P3385; PILLER F, 1991, J EXP MED, V173, P1501, DOI 10.1084/jem.173.6.1501; PILLER F, 1988, J BIOL CHEM, V263, P15146; Priatel JJ, 1997, GLYCOBIOLOGY, V7, P45, DOI 10.1093/glycob/7.1.45; ROPP PA, 1991, J BIOL CHEM, V266, P23863; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; SAITOH O, 1991, BLOOD, V77, P1491; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; SCHAEFER HF, 1989, CHIMIA, V43, P1; Sekine M, 1997, J BIOL CHEM, V272, P27246, DOI 10.1074/jbc.272.43.27246; Smith PL, 1996, J BIOL CHEM, V271, P8250, DOI 10.1074/jbc.271.14.8250; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Steegmaier M, 1997, J CELL SCI, V110, P687; STEEGMAIER M, 1995, NATURE, V373, P615, DOI 10.1038/373615a0; Stroud MR, 1996, BIOCHEMISTRY-US, V35, P758, DOI 10.1021/bi951600r; STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559; Subramaniam M, 1996, BLOOD, V87, P1238, DOI 10.1182/blood.V87.4.1238.bloodjournal8741238; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Tsuboi S, 1997, EMBO J, V16, P6364, DOI 10.1093/emboj/16.21.6364; Varki A, 1997, J CLIN INVEST, V99, P158, DOI 10.1172/JCI119142; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; WILLIAMS D, 1980, J BIOL CHEM, V255, P1247; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772	60	262	275	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1998	9	6					881	890		10.1016/S1074-7613(00)80653-6	http://dx.doi.org/10.1016/S1074-7613(00)80653-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881978	Bronze			2022-12-18	WOS:000077836600013
J	Chen, C; Nagy, Z; Prak, EL; Weigert, M				Chen, C; Nagy, Z; Prak, EL; Weigert, M			Immunoglobulin heavy chain gene replacement: A mechanism of receptor editing	IMMUNITY			English	Article							B-CELL LYMPHOMA; TRANSGENIC MICE; JOINING MECHANISM; ESCAPE TOLERANCE; AUTOIMMUNE MICE; BONE-MARROW; LYMPHOCYTES; EXPRESSION; LOCUS; VH	We have generated a site-directed transgenic (sd-tg) mouse model in which the J(H) locus has been replaced with a rearranged VOJ coding for the heavy chain of an anti-DNA antibody. In these mice, B cells expressing the anti-dsDNA specificity are negatively regulated. We observe a novel mechanism for B cell tolerance, receptor editing at the heavy chain locus. In most sd-tg B cells, the inserted anti-DNA V-H gene has been replaced by the upstream endogenous V-H, or D-H, or both genes through recombination with the heptamer embedded at the 3' end of most V-H genes. Three types of recombination events have been identified: V-H-to-VDJ, D-H-to-VDJ, and V-H-to-D-H-VDJ. Analysis of the junctional sequences revealed features of classical V(D)J rearrangement, namely N sequence addition and nucleotide deletion. A conserved nonamer was found 12 bp upstream of the embedded heptamer. This nonamer may represent a novel recombination signal sequence used for V-H editing. The sd-tg model thus provides direct evidence for secondary rearrangement at V-H-D-J(H). This process may play a role in tolerance by editing autoreactive receptors and may also serve to diversify the V-H repertoire.			Chen, C (corresponding author), PRINCETON UNIV, DEPT MOLEC BIOL, PRINCETON, NJ 08544 USA.				NIGMS NIH HHS [GM-20964] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020964, R37GM020964] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN C, 1994, J IMMUNOL, V152, P1970; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Coutinho A, 1992, Int Rev Immunol, V8, P173, DOI 10.3109/08830189209055572; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; IBRAHIM SM, 1995, J IMMUNOL, V155, P3223; Kabat EA, 1991, SEQUENCES PROTEINS I; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; KLEINFIELD RW, 1989, J IMMUNOL, V142, P4475; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LUNING PE, 1994, J EXP MED, V180, P1805; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; RADIC MZ, 1991, J IMMUNOL, V146, P176; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; SAKANO H, 1981, NATURE, V290, P562, DOI 10.1038/290562a0; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STORB U, 1987, ANNU REV IMMUNOL, V5, P151, DOI 10.1146/annurev.iy.05.040187.001055; TAKI S, 1995, EUR J IMMUNOL, V25, P1888, DOI 10.1002/eji.1830250715; TAKI S, 1993, SCIENCE, V262, P1268, DOI 10.1126/science.8235657; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x	32	262	276	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1995	3	6					747	755		10.1016/1074-7613(95)90064-0	http://dx.doi.org/10.1016/1074-7613(95)90064-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777720	Bronze			2022-12-18	WOS:A1995TM02300009
J	VANENDERT, PM; TAMPE, R; MEYER, TH; TISCH, R; BACH, JF; MCDEVITT, HO				VANENDERT, PM; TAMPE, R; MEYER, TH; TISCH, R; BACH, JF; MCDEVITT, HO			A SEQUENTIAL MODEL FOR PEPTIDE BINDING AND TRANSPORT BY THE TRANSPORTERS ASSOCIATED WITH ANTIGEN-PROCESSING	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; TRANSLOCATION; REGION; VARIANTS; GENE	The TAP proteins translocate antigenic peptides into the endoplasmic reticulum. Investigation of the specificity of this process has been complicated by TAP-independent factors that influence the amount of peptide that accumulates in the ER in transport assays. We have developed an overexpression system in which binding of peptides to the TAP substrate-binding site and peptide transport by TAP can be quantified separately. Efficiency of peptide accumulation in the ER parallels affinity for the TAP substrate-binding site, but can be modified by interaction with the glycosylation system within the ER and, probably, peptide efflux. Random peptide mixtures of 9-16 aa display significantly higher affinity for the binding site than mixtures of shorter or longer peptides. Peptide binds to TAP heteromers in the absence of ATP and is released by the binding of ATP, suggesting a model for TAP function.	STANFORD UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305; MAX PLANCK INST BIOCHEM,D-62152 MARTINSRIED,GERMANY	Stanford University; Max Planck Society	VANENDERT, PM (corresponding author), HOP NECKER ENFANTS MALAD,INSERM,U25,161 RUE SEVRES,F-75743 PARIS,FRANCE.		Tampé, Robert/H-2953-2015; van Endert, Peter/R-4606-2017	Tampé, Robert/0000-0002-0403-2160; van Endert, Peter/0000-0003-3782-0750				ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; COLONNA M, 1992, P NATL ACAD SCI USA, V89, P3932, DOI 10.1073/pnas.89.9.3932; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; KLEIJMEER MJ, 1992, NATURE, V357, P342, DOI 10.1038/357342a0; MEYER TH, 1994, IN PRESS FEBS LETT; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; MULLER KM, 1994, J BIOL CHEM, V269, P14032; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; SPIES T, 1992, NATURE, V355, P644, DOI 10.1038/355644a0; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; VANENDERT PM, 1992, P NATL ACAD SCI USA, V89, P11594, DOI 10.1073/pnas.89.23.11594; VANENDERT PM, 1994, DIABETES, V43, P110, DOI 10.2337/diabetes.43.1.110; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; WINTER G, 1980, NUCLEIC ACIDS RES, V8, P1965, DOI 10.1093/nar/8.9.1965	29	262	265	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1994	1	6					491	500		10.1016/1074-7613(94)90091-4	http://dx.doi.org/10.1016/1074-7613(94)90091-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK171	7895159				2022-12-18	WOS:A1994PK17100006
J	Kuswanto, W; Burzyn, D; Panduro, M; Wang, KK; Jang, YC; Wagers, AJ; Benoist, C; Mathis, D				Kuswanto, Wilson; Burzyn, Dalia; Panduro, Marisella; Wang, Kathy K.; Jang, Young Charles; Wagers, Amy J.; Benoist, Christophe; Mathis, Diane			Poor Repair of Skeletal Muscle in Aging Mice Reflects a Defect in Local, Interleukin-33-Dependent Accumulation of Regulatory T Cells	IMMUNITY			English	Article							FIBRO/ADIPOGENIC PROGENITORS; SATELLITE CELLS; IL-33; INFLAMMATION; REGENERATION; ALARMIN; INJURY; MACROPHAGES; POPULATION; MYOGENESIS	Normal repair of skeletal muscle requires local expansion of a special population of Foxp3(+)CD4(+) regulatory T (Treg) cells. Such cells failed to accumulate in acutely injured muscle of old mice, known to undergo ineffectual repair. This defect reflected reduced recruitment of Treg cells to injured muscle, as well as less proliferation and retention therein. Interleukin-33 (IL-33) regulated muscle Treg cell homeostasis in young mice, and its administration to old mice ameliorated their deficits in Treg cell accumulation and muscle regeneration. The major IL-33-expressing cells in skeletal muscle displayed a constellation of markers diagnostic of fibro/adipogenic progenitor cells and were often associated with neural structures, including nerve fibers, nerve bundles, and muscle spindles, which are stretch-sensitive mechanoreceptors important for proprioception. IL-33(+) cells were more frequent after muscle injury and were reduced in old mice. IL-33 is well situated to relay signals between the nervous and immune systems within the muscle context.	[Kuswanto, Wilson; Burzyn, Dalia; Panduro, Marisella; Wang, Kathy K.; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Microbiol & Immunobiol, Boston, MA 02115 USA; [Jang, Young Charles; Wagers, Amy J.] Harvard Univ, Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Jang, Young Charles; Wagers, Amy J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Wagers, Amy J.] Harvard Univ, Sch Med, Paul F Glenn Ctr Biol Aging, Boston, MA 02115 USA; [Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Benoist, Christophe; Mathis, Diane] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Burzyn, Dalia] Jounce Therapeut Inc, Cambridge, MA 02138 USA; [Jang, Young Charles] Georgia Inst Technol, Atlanta, GA 30332 USA	Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University System of Georgia; Georgia Institute of Technology	Mathis, D (corresponding author), Harvard Univ, Sch Med, Microbiol & Immunobiol, Boston, MA 02115 USA.; Mathis, D (corresponding author), Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Mathis, D (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	cbdm@hms.harvard.edu			JPB Foundation; NIH [R01DK092541, R01AG033053, U01HL100402, T32-GM007753, F30AG046045]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK092541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033053, F30AG046045] Funding Source: NIH RePORTER	JPB Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Asinovski, R. Cruse, K. Hattori, D. Jepson, A. Ortiz-Lopez, H. Paik, A. Rhoads, G. Buruzula, and J. LaVecchio for technical support; R. Lee for the ST2-flox mice; E. Estrella, and L. Kunkel for the human samples and for technical advice; and Drs. I. Chiu, A. Magnuson, J. Sanes, and B. Spiegelman for helpful discussions. This work was funded by the JPB Foundation and by NIH grants R01DK092541 to D.M. and R01AG033053 and U01HL100402 to A.J.W., who was also an Early Career Scientist at the Howard Hughes Institute. W.K. was supported by fellowships from the NIH (T32-GM007753 and F30AG046045). Cell sorting was performed under NIH P30DK036836.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chen WY, 2015, P NATL ACAD SCI USA, V112, P7249, DOI 10.1073/pnas.1424236112; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Ishimaru N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008588; Jang YC, 2011, COLD SH Q B, V76, P101, DOI 10.1101/sqb.2011.76.010652; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Maier A, 1997, INT J DEV BIOL, V41, P1; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Matta BM, 2014, J IMMUNOL, V193, P4010, DOI 10.4049/jimmunol.1400481; Mo R, 2003, J IMMUNOL, V170, P895, DOI 10.4049/jimmunol.170.2.895; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nikolich-Zugich J, 2014, J IMMUNOL, V193, P2622, DOI 10.4049/jimmunol.1401174; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Takeoka A, 2014, CELL, V159, P1626, DOI 10.1016/j.cell.2014.11.019; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Villalta SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009925	39	261	270	4	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					355	367		10.1016/j.immuni.2016.01.009	http://dx.doi.org/10.1016/j.immuni.2016.01.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26872699	Green Accepted, Bronze			2022-12-18	WOS:000370294000017
J	Halliley, JL; Tipton, CM; Liesveld, J; Rosenberg, AF; Darce, J; Gregoretti, IV; Popova, L; Kaminiski, D; Fucile, CF; Albizua, I; Kyu, S; Chiang, KY; Bradley, KT; Burack, R; Slifka, M; Hammarlund, E; Wu, H; Zhao, LP; Walsh, EE; Falsey, AR; Randall, TD; Cheung, WC; Sanz, I; Lee, FEH				Halliley, Jessica L.; Tipton, Christopher M.; Liesveld, Jane; Rosenberg, Alexander F.; Darce, Jaime; Gregoretti, Ivan V.; Popova, Lana; Kaminiski, Denise; Fucile, Christopher F.; Albizua, Igor; Kyu, Shuya; Chiang, Kuang-Yueh; Bradley, Kyle T.; Burack, Richard; Slifka, Mark; Hammarlund, Erika; Wu, Hao; Zhao, Liping; Walsh, Edward E.; Falsey, Ann R.; Randall, Troy D.; Cheung, Wan Cheung; Sanz, Inaki; Lee, F. Eun-Hyung			Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow	IMMUNITY			English	Article							MEMORY B-CELLS; HUMAN MONOCLONAL-ANTIBODIES; HUMORAL IMMUNITY; SECRETING CELLS; BLOOD; SURVIVAL; EXPRESSION; CLONING; DIFFERENTIATION; RESPONSIVENESS	Antibody responses to viral infections are sustained for decades by long-lived plasma cells (LLPCs). However, LLPCs have yet to be characterized in humans. Here we used CD19, CD38, and CD138 to identify four PC subsets in human bone marrow (BM). We found that the CD19(-)CD38(hi)CD138(+) subset was morphologically distinct, differentially expressed PC-associated genes, and exclusively contained PCs specific for viral antigens to which the subjects had not been exposed for more than 40 years. Protein sequences of measles-and mumps-specific circulating antibodies were encoded for by CD19(-)CD38(hi)CD138(+) PCs in the BM. Finally, we found that CD19(-)CD38(hi)CD138(+) PCs had a distinct RNA transcriptome signature and human immunoglobulin heavy chain (VH) repertoire that was relatively uncoupled from other BM PC subsets and probably represents the B cell response's "historical record'' of antigenic exposure. Thus, our studies define human LLPCs and provide a mechanism for the life-long maintenance of anti-viral antibodies in the serum.	[Halliley, Jessica L.; Albizua, Igor; Kyu, Shuya; Lee, F. Eun-Hyung] Emory Univ, Div Pulm, Atlanta, GA 30322 USA; [Halliley, Jessica L.; Albizua, Igor; Kyu, Shuya; Lee, F. Eun-Hyung] Emory Univ, Div Allergy, Atlanta, GA 30322 USA; [Halliley, Jessica L.; Albizua, Igor; Kyu, Shuya; Lee, F. Eun-Hyung] Emory Univ, Div Crit Care Med, Atlanta, GA 30322 USA; [Halliley, Jessica L.] Univ Rochester, Med Ctr, Pulm & Crit Care Med, Rochester, NY 14642 USA; [Tipton, Christopher M.; Sanz, Inaki] Emory Univ, Div Rheumatol, Atlanta, GA 30322 USA; [Tipton, Christopher M.; Sanz, Inaki; Lee, F. Eun-Hyung] Emory Univ, Lowance Ctr Human Immunol, Dept Med, Atlanta, GA 30322 USA; [Tipton, Christopher M.; Sanz, Inaki; Lee, F. Eun-Hyung] Emory Univ, Lowance Ctr Human Immunol, Dept Pediat, Atlanta, GA 30322 USA; [Liesveld, Jane] Univ Rochester, Med Ctr, Div Hematol, James P Wilmot Canc Inst, Rochester, NY 14642 USA; [Liesveld, Jane] Univ Rochester, Med Ctr, Div Oncol, James P Wilmot Canc Inst, Rochester, NY 14642 USA; [Rosenberg, Alexander F.; Kaminiski, Denise; Fucile, Christopher F.] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Darce, Jaime; Gregoretti, Ivan V.; Popova, Lana; Cheung, Wan Cheung] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Chiang, Kuang-Yueh] Emory Univ, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA; [Bradley, Kyle T.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Burack, Richard] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA; [Slifka, Mark; Hammarlund, Erika] Oregon Hlth & Sci Univ, Beaverton, OR 97006 USA; [Wu, Hao; Zhao, Liping] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Walsh, Edward E.; Falsey, Ann R.] Univ Rochester, Med Ctr, Div Infect Dis, Rochester, NY 14621 USA; [Walsh, Edward E.; Falsey, Ann R.] Rochester Gen Hosp, Rochester, NY 14621 USA; [Randall, Troy D.] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA	Emory University; Emory University; Emory University; University of Rochester; Emory University; Emory University; Emory University; University of Rochester; University of Rochester; University of Rochester; Emory University; Emory University; University of Rochester; Oregon Health & Science University; Emory University; University of Rochester; Rochester General Hospital; University of Alabama System; University of Alabama Birmingham	Lee, FEH (corresponding author), Emory Univ, Div Pulm, Atlanta, GA 30322 USA.	f.e.lee@emory.edu	Wu, Hao/H-3899-2017	Wu, Hao/0000-0003-1269-7354	NIH [K23 AI67501, R21AI109601, R21AI094218, P01 A1078907, R37AI049660, U01AI045969]; Autoimmunity Center of Excellence [ARRA:AI056390-06S2, HHSN266200500030C (N01-AI50029), AI078907, AI049600]; NIH/NCATS [UL1 TR000454, UO1 AI082196]; Oregon National Primate Research Center [8P51 OD011092-53, R01 AI097357, U19 AI109962]; Genentech; Biogen Pharmaceutical; Takeda Pharmaceutical; GSK; Sanofi Pasteur; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI045969, U19AI110483, R01AI049660, U01AI082196, R21AI094218, P01AI078907, U19AI056390, R01AI097357, K23AI067501, N01AI050029, U19AI109962, R21AI109601, R37AI049660] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autoimmunity Center of Excellence; NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Oregon National Primate Research Center; Genentech(Roche HoldingGenentech); Biogen Pharmaceutical; Takeda Pharmaceutical(Takeda Pharmaceutical Company Ltd); GSK(GlaxoSmithKline); Sanofi Pasteur; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank Jennifer Scantlin, Claudine Nkurunziza, Deanna Maffett, and Julie Kozarsky for human subject recruitment. We also appreciate Edmund Waller, Jeremy Bechelli, Karen Rosell, and the Atlanta Clinical & Translational Science Institute (ACTSI) for their assistance with the bone marrow aspirates; Chelsea Cook, Flow Cytometry Core at URMC, and Wayne Harris at Emory University; and Jennifer Hom, Linda Kippner, and Melissa Kemp for assistance in preparation of the manuscript. This research was supported by NIH grants K23 AI67501, R21AI109601, R21AI094218, P01 A1078907, R37AI049660, and U01AI045969; Autoimmunity Center of Excellence grants ARRA:AI056390-06S2, HHSN266200500030C (N01-AI50029), AI078907, and AI049600; NIH/NCATS grants UL1 TR000454 and UO1 AI082196; and Oregon National Primate Research Center grants 8P51 OD011092-53, R01 AI097357, and U19 AI109962. F.E.-H.L. has research grants with Genentech and is the founder of MicroBplex. I.S. consults for Pfizer and Genentech and has research grants with Biogen and Takeda Pharmaceuticals. A.R.F. consults for AstraZeneca, Medimmune, Sanofi Pasteur, and Wyeth and has research grants from GSK and Sanofi Pasteur. E.E.W. has research grants from GSK and Sanofi Pasteur and consults for Astra Zeneca.	Ahuja A, 2008, P NATL ACAD SCI USA, V105, P4802, DOI 10.1073/pnas.0800555105; Alamyar E., 2012, IMMUNOME RES, V8, P26, DOI [DOI 10.1007/978-1-61779-842-9_32, 10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Avery DT, 2005, J IMMUNOL, V174, P4034, DOI 10.4049/jimmunol.174.7.4034; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P3612, DOI 10.1002/art.22211; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Cheung WC, 2012, NAT BIOTECHNOL, V30, P447, DOI 10.1038/nbt.2167; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Gonzalez-Garcia I, 2008, BLOOD, V111, P741, DOI 10.1182/blood-2007-08-108118; Gonzalez-Garcia I, 2006, J IMMUNOL, V176, P4042, DOI 10.4049/jimmunol.176.7.4042; Halliley JL, 2010, VACCINE, V28, P3582, DOI 10.1016/j.vaccine.2010.02.088; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; HILBERT DM, 1995, J EXP MED, V182, P243, DOI 10.1084/jem.182.1.243; Huggins J, 2007, BLOOD, V109, P1611, DOI 10.1182/blood-2006-03-008441; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Kaminski DA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00076; Kelly DF, 2006, BLOOD, V108, P2642, DOI 10.1182/blood-2006-01-009282; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kyu SY, 2009, J IMMUNOL METHODS, V340, P42, DOI 10.1016/j.jim.2008.09.025; Lee FEH, 2011, J IMMUNOL, V186, P5514, DOI 10.4049/jimmunol.1002932; Liu DS, 2012, J CLIN PATHOL, V65, P823, DOI 10.1136/jclinpath-2012-200881; Macallan DC, 2005, BLOOD, V105, P3633, DOI 10.1182/blood-2004-09-3740; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; MCMILLAN R, 1972, J IMMUNOL, V109, P1386; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; Mei HE, 2015, BLOOD, V125, P1739, DOI 10.1182/blood-2014-02-555169; MILLER FRANKLIN R., 1931, JOUR EXP MED, V54, P333, DOI 10.1084/jem.54.3.333; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Qian Y, 2010, CYTOM PART B-CLIN CY, V78B, pS69, DOI 10.1002/cyto.b.20554; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rawstron AC, 2002, BLOOD, V100, P3095, DOI 10.1182/blood-2001-12-0297; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Sato S, 2012, NAT BIOTECHNOL, V30, P1039, DOI 10.1038/nbt.2406; Skowronski DM, 2008, J INFECT DIS, V197, P490, DOI 10.1086/524146; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tourigny MR, 2002, IMMUNITY, V17, P179, DOI 10.1016/S1074-7613(02)00364-3; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	48	261	266	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					132	145		10.1016/j.immuni.2015.06.016	http://dx.doi.org/10.1016/j.immuni.2015.06.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26187412	Bronze, Green Accepted			2022-12-18	WOS:000360101100016
J	Bleriot, C; Dupuis, T; Jouvion, G; Eberl, G; Disson, O; Lecuit, M				Bleriot, Camille; Dupuis, Theo; Jouvion, Gregory; Eberl, Gerard; Disson, Olivier; Lecuit, Marc			Liver-Resident Macrophage Necroptosis Orchestrates Type 1 Microbicidal Inflammation and Type-2-Mediated Tissue Repair during Bacterial Infection	IMMUNITY			English	Article							LISTERIA-MONOCYTOGENES; BONE-MARROW; CARDIAC MACROPHAGES; LANGERHANS CELLS; KUPFFER CELLS; IN-VIVO; MONOCYTES; RECEPTOR; HETEROGENEITY; PROLIFERATION	Kupffer cells, the phagocytes of fetal origin that line the liver sinusoids, are key contributors of host defense against enteroinvasive bacteria. Here, we found that infection by Listeria monocytogenes induced the early necroptotic death of Kupffer cells, which was followed by monocyte recruitment and an anti-bacterial type 1 inflammatory response. Kupffer cell death also triggered a type 2 response that involved the hepatocyte-derived alarmin interleukin-33 (IL-33) and basophil-derived interleukin-4 (IL-4). This led to the alternative activation of the monocyte-derived macrophages recruited to the liver, which thereby replaced ablated Kupffer cells and restored liver homeostasis. Kupffer cell death is therefore a key signal orchestrating type 1 microbicidal inflammation and type-2-mediated liver repair upon infection. This indicates that beyond the classical dichotomy of type 1 and type 2 responses, these responses can develop sequentially in the context of a bacterial infection and act interdependently, orchestrating liver immune responses and return to homeostasis, respectively.	[Bleriot, Camille; Dupuis, Theo; Disson, Olivier; Lecuit, Marc] Inst Pasteur, Biol Infect Unit, F-75015 Paris, France; [Bleriot, Camille; Dupuis, Theo; Disson, Olivier; Lecuit, Marc] INSERM, U1117, F-75015 Paris, France; [Jouvion, Gregory] Inst Pasteur, Human Histopathol & Anim Models Unit, F-75015 Paris, France; [Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, F-75015 Paris, France; [Lecuit, Marc] Inst Pasteur, French Natl Reference Ctr, F-75015 Paris, France; [Lecuit, Marc] Inst Pasteur, WHO, Collaborating Ctr Listeria, F-75015 Paris, France; [Lecuit, Marc] Paris Descartes Univ, Necker Enfants Malades Univ Hosp, Necker Pasteur Ctr Infectiol, Inst Imagine,Div Infect Dis & Trop Med,Sorbonne P, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Lecuit, M (corresponding author), Inst Pasteur, Biol Infect Unit, F-75015 Paris, France.	marc.lecuit@pasteur.fr	Eberl, Gerard/A-1160-2013; Disson, Olivier/P-9935-2019; Lecuit, Marc/M-4126-2019; Lecuit, Marc/J-4073-2013; Jouvion, Grégory/AAL-2620-2021; Disson, Olivier/H-6359-2016	Disson, Olivier/0000-0002-7791-9782; Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063; BLERIOT, Camille/0000-0002-4298-2888; Eberl, Gerard/0000-0002-1119-5638	Institut Pasteur; Institut National de la Sante et de la Recherche Medicale; Institut Carnot; Fondation pour la Recherche Medicale; Ville de Paris; Fondation BNP Paribas; LabEx IBEID; European Research Council; Listress EU program	Institut Pasteur(European Commission); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Carnot; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ville de Paris; Fondation BNP Paribas; LabEx IBEID; European Research Council(European Research Council (ERC)European Commission); Listress EU program	We thank the members of the Biology of Infection Unit, and in particular Y.H. Tsai. We thank G. Milon and S. Berre for helpful discussions and critical reading of the manuscript. We thank H. Bierne for her contribution in the initial phase of the project and P. Cossart for providing the Lm Delta hly mutant. We thank T. Walzer at ENS Lyon for Ccr2<SUP>-/-</SUP> ice, Ph. Bousso and F. Montalvao for MaFIA-GFP mice and helpful discussions, M. Leite de Moraes for Il4<SUP>-/-</SUP> mice, B. Ryffel for Il1rl1<SUP>-/-</SUP> mice, V. Dixit for Rip3<SUP>-/-</SUP> mice, T. Taniguchi for Irf3<SUP>-/-</SUP> mice, R. Menard for Flk1-gfp mice, and M. Albert and N. Yatim for Casp1<SUP>-/-</SUP> and Ifnar<SUP>-/-</SUP> mice and helpful discussions. We thank S. Novault of the PFC at Institut Pasteur and N. Serafini for their help in the FACS experiments. This work was financed by Institut Pasteur, Institut National de la Sante et de la Recherche Medicale, Institut Carnot, Fondation pour la Recherche Medicale, Ville de Paris, Fondation BNP Paribas, LabEx IBEID, the European Research Council, and Listress EU program.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Carr KD, 2011, EUR J IMMUNOL, V41, P2666, DOI 10.1002/eji.201041363; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Cervantes J, 2008, CELL MICROBIOL, V10, P41, DOI 10.1111/j.1462-5822.2007.01012.x; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Di Paolo NC, 2013, CELL REP, V3, P1840, DOI 10.1016/j.celrep.2013.05.025; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Disson O, 2012, VIRULENCE, V3, P213, DOI 10.4161/viru.19586; Ebe Y, 1999, PATHOL INT, V49, P519, DOI 10.1046/j.1440-1827.1999.00910.x; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Li CW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003918; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Linkermann A, 2012, MOL MED, V18, P577, DOI 10.2119/molmed.2011.00423; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Murray EGD, 1926, J PATHOL BACTERIOL, V29, P407, DOI 10.1002/path.1700290409; Nascimento M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004282; Nikitas G, 2011, J EXP MED, V208, P2263, DOI 10.1084/jem.20110560; NORTH RJ, 1969, J EXP MED, V130, P315, DOI 10.1084/jem.130.2.315; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Obata-Ninomiya K, 2013, J EXP MED, V210, P2583, DOI 10.1084/jem.20130761; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Pirie JH., 1927, S AFR I MED RES, V3, P163; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Sarantis H, 2012, CELL HOST MICROBE, V12, P419, DOI 10.1016/j.chom.2012.09.001; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Shi C, 2010, J IMMUNOL, V184, P6266, DOI 10.4049/jimmunol.0904160; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Sokol CL, 2010, CURR OPIN IMMUNOL, V22, P73, DOI 10.1016/j.coi.2010.01.012; Solodova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018543; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574	67	261	267	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					145	158		10.1016/j.immuni.2014.12.020	http://dx.doi.org/10.1016/j.immuni.2014.12.020			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25577440	Bronze			2022-12-18	WOS:000348197500018
J	Lahaye, X; Satoh, T; Gentili, M; Cerboni, S; Conrad, C; Hurbain, I; El Marjou, A; Lacabaratz, C; Lelievre, JD; Manel, N				Lahaye, Xavier; Satoh, Takeshi; Gentili, Matteo; Cerboni, Silvia; Conrad, Cecile; Hurbain, Ilse; El Marjou, Ahmed; Lacabaratz, Christine; Lelievre, Jean-Daniel; Manel, Nicolas			The Capsids of HIV-1 and HIV-2 Determine Immune Detection of the Viral cDNA by the Innate Sensor cGAS in Dendritic Cells	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; AICARDI-GOUTIERES-SYNDROME; GMP-AMP SYNTHASE; CENTRAL DNA FLAP; INTRACELLULAR DNA; NUCLEAR IMPORT; SAMHD1; PROTEIN; VPX; ENCAPSIDATION	HIV-2 is less pathogenic for humans than HIV-1 and might provide partial cross-protection from HIV-1-induced pathology. Although both viruses replicate in the T cells of infected patients, only HIV-2 replicates efficiently in dendritic cells (DCs) and activates innate immune pathways. How HIV is sensed in DC is unknown. Capsid-mutated HIV-2 revealed that sensing by the host requires viral cDNA synthesis, but not nuclear entry or genome integration. The HIV-1 capsid prevented viral cDNA sensing up to integration, allowing the virus to escape innate recognition. In contrast, DCs sensed capsid-mutated HIV-1 and enhanced stimulation of T cells in the absence of productive infection. Finally, we found that DC sensing of HIV-1 and HIV-2 required the DNA sensor cGAS. Thus, the HIV capsid is a determinant of innate sensing of the viral cDNA by cGAS in dendritic cells. This pathway might potentially be harnessed to develop effective vaccines against HIV-1.	[Lahaye, Xavier; Satoh, Takeshi; Gentili, Matteo; Cerboni, Silvia; Conrad, Cecile; Hurbain, Ilse; El Marjou, Ahmed; Manel, Nicolas] Inst Curie, F-75005 Paris, France; [Lahaye, Xavier; Satoh, Takeshi; Gentili, Matteo; Cerboni, Silvia; Conrad, Cecile; Manel, Nicolas] INSERM U932, F-75005 Paris, France; [Hurbain, Ilse; El Marjou, Ahmed] CNRS UMR144, F-75005 Paris, France; [Lacabaratz, Christine; Lelievre, Jean-Daniel] Univ Paris Est Creteil, Fac Med, Vaccine Res Inst, INSERM U955, F-94010 Creteil, France; [Lelievre, Jean-Daniel] Grp Henri Mondor Albert Chenevier, AP HP, Immunol Clin, F-94010 Creteil, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Manel, N (corresponding author), Inst Curie, 12 Rue Lhomond, F-75005 Paris, France.	nicolas.manel@curie.fr	LAHAYE, Xavier/AAH-7407-2020; Manel, Nicolas/E-2128-2011; , Lelievre/AAB-1398-2020	Manel, Nicolas/0000-0002-1481-4430; LAHAYE, Xavier/0000-0001-7124-1707; Lelievre, Jean-Daniel/0000-0002-8182-3628; Gentili, Matteo/0000-0002-6970-8133; Lacabaratz, Christine/0000-0001-6925-0225	Institut Curie; Institut National de la Sante et de la Recherche Medicale (INSERM); ATIP-Avenir program; Agence Nationale de Recherche sur le SIDA (ANRS); Ville de Paris Emergence program; European FP7 Marie Curie Actions [268311]; European Research Council [309848]; LABEX VRI; LABEX DCBIOL	Institut Curie; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); ATIP-Avenir program; Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Ville de Paris Emergence program; European FP7 Marie Curie Actions; European Research Council(European Research Council (ERC)European Commission); LABEX VRI; LABEX DCBIOL	N.M., T. S. and X. L. designed the study. X. L. and T. S. performed most of the experiments. N.M., S. C., M. G., and C. C. performed some experiments. N.M., T. S., and X. L. wrote the article and prepared figures. I. H. and A. E.-M. provided platform help. C. L. and J.-D.L. contributed to experiments with samples from HIV-1-infected patients. We are grateful to Sandra Pellegrini for the gift of the HL116 cell line. We thank Dan Littman, Philippe Benaroch, and Ana-Maria Lennon for critical reading of the manuscript and Sebastian Amigorena for comments. We thank Olivier Lantz for helpful discussions. We thank Mathieu Maurin, Carolina Martinez, Maxime Touzot, Maximilien Grandclaudon, Isabelle Peguillet, Francois-Xavier Gobert, Laurent Zablocki, Mohamed El Amine Mechalikh, the Institut Pasteur Macromolecules Biophysics and Interactions platform, and the Houdusse laboratory for technical assistance. We thank the PICT-IBiSA electron microscopy facility, the Cytometry facility, the Proteins and Antibody facility, and the BSL3 facility of Institut Curie. This work was supported by Institut Curie, Institut National de la Sante et de la Recherche Medicale (INSERM), ATIP-Avenir program, Agence Nationale de Recherche sur le SIDA (ANRS), Ville de Paris Emergence program, European FP7 Marie Curie Actions (grant 268311), European Research Council (grant 309848), LABEX VRI, and LABEX DCBIOL.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Braud S, 2005, J PROTEOME RES, V4, P2137, DOI 10.1021/pr050230i; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Buseyne F, 2001, NAT MED, V7, P344, DOI 10.1038/85493; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Dvorin JD, 2002, J VIROL, V76, P12087, DOI 10.1128/JVI.76.23.12087-12096.2002; Esbjornsson J, 2012, NEW ENGL J MED, V367, P224, DOI 10.1056/NEJMoa1113244; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Griffin SDC, 2001, J VIROL, V75, P12058, DOI 10.1128/JVI.75.24.12058-12069.2001; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Poeschla E, 1998, J VIROL, V72, P6527, DOI 10.1128/JVI.72.8.6527-6536.1998; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; PUTKONEN P, 1995, NAT MED, V1, P914, DOI 10.1038/nm0995-914; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Riviere L, 2010, J VIROL, V84, P729, DOI 10.1128/JVI.01952-09; Rowland-Jones SL, 2007, NAT IMMUNOL, V8, P329, DOI 10.1038/ni0407-329; Satoh Takeshi, 2013, Methods Mol Biol, V960, P401, DOI 10.1007/978-1-62703-218-6_30; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; UZE G, 1994, J MOL BIOL, V243, P245, DOI 10.1006/jmbi.1994.1651; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yan N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000327; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	36	261	271	3	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1132	1142		10.1016/j.immuni.2013.11.002	http://dx.doi.org/10.1016/j.immuni.2013.11.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24269171	Bronze, Green Submitted			2022-12-18	WOS:000330951000018
J	Compan, V; Baroja-Mazo, A; Lopez-Castejon, G; Gomez, AI; Martinez, CM; Angosto, D; Montero, MT; Herranz, AS; Bazan, E; Reimers, D; Mulero, V; Pelegrin, P				Compan, Vincent; Baroja-Mazo, Alberto; Lopez-Castejon, Gloria; Gomez, Ana I.; Martinez, Carlos M.; Angosto, Diego; Montero, Maria T.; Herranz, Antonio S.; Bazan, Eulalia; Reimers, Diana; Mulero, Victoriano; Pelegrin, Pablo			Cell Volume Regulation Modulates NLRP3 Inflammasome Activation	IMMUNITY			English	Article							NALP3 INFLAMMASOME; P2X(7) RECEPTOR; INTERLEUKIN-1-BETA RELEASE; CONTACT HYPERSENSITIVITY; GILTHEAD SEABREAM; KAINIC ACID; MECHANISM; CASPASE-1; CHANNEL; INJURY	Cell volume regulation is a primitive response to alterations in environmental osmolarity. The NLRP3 inflammasome is a multiprotein complex that senses pathogen- and danger-associated signals. Here, we report that, from fish to mammals, the basic mechanisms of cell swelling and regulatory volume decrease (RVD) are sensed via the NLRP3 inflammasome. We found that a decrease in extracellular osmolarity induced a K+-dependent conformational change of the preassembled NLRP3-inactive inflammasome during cell swelling, followed by activation of the NLRP3 inflammasome and caspase-1, which was controlled by transient receptor potential channels during RVD. Both mechanisms were necessary for interleukin-1 beta processing. Increased extracellular osmolarity prevented caspase-1 activation by different known NLRP3 activators. Collectively, our data identify cell volume regulation as a basic conserved homeostatic mechanism associated with the formation of the NLRP3 inflammasome and reveal a mechanism for NLRP3 inflammasome activation.	[Compan, Vincent; Lopez-Castejon, Gloria; Pelegrin, Pablo] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Baroja-Mazo, Alberto; Gomez, Ana I.; Martinez, Carlos M.; Pelegrin, Pablo] Univ Hosp Virgen Arrixaca, Fdn Formac & Invest Sanitarias Reg Murcia, Ctr Invest Biomed Red Area Temat Enfermedades Hep, Inflammat & Expt Surg Unit,Murcia Biomed Res Inst, Murcia 30120, Spain; [Angosto, Diego; Mulero, Victoriano] Univ Murcia, Fac Biol, Dept Cell Biol & Histol, E-30100 Murcia, Spain; [Montero, Maria T.; Herranz, Antonio S.; Bazan, Eulalia; Reimers, Diana] Hosp Ramon & Cajal, Neurobiol Serv, E-28034 Madrid, Spain	University of Manchester; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; Hospital Universitario Ramon y Cajal	Pelegrin, P (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	pablo.pelegrin@ffis.es	Baroja-Mazo, Alberto/E-6270-2016; Compan, Vincent/M-6977-2017; Reimers, Diana/K-6584-2017; Martinez, Carlos M./E-4986-2016; Pelegrin, Pablo/M-2007-2014; Montero, Teresa/L-7356-2014; Lopez-Castejon, Gloria/F-6985-2015; Angosto, Diego/AAG-1096-2021	Baroja-Mazo, Alberto/0000-0001-5212-5006; Compan, Vincent/0000-0001-6805-1179; Reimers, Diana/0000-0002-2837-099X; Martinez, Carlos M./0000-0003-3307-1326; Pelegrin, Pablo/0000-0002-9688-1804; Montero, Teresa/0000-0002-3408-8675; Lopez-Castejon, Gloria/0000-0002-8585-3381; Montero-Vega, Maria Teresa/0000-0002-0443-8881; Angosto, Diego/0000-0001-5990-4678	Wellcome Trust; Plan Nacional de Investigacion Cientifica, Desarrollo, e Innovacion Tecnologica; Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER) [EMER07/049, PI09/0120]; Fundacion Seneca [11922/PI/09]; Spanish Ministry of Science and Technology [BIO2008-01379, BIO2011-23400]; Fundacion Marcelino Botin	Wellcome Trust(Wellcome Trust); Plan Nacional de Investigacion Cientifica, Desarrollo, e Innovacion Tecnologica; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Fundacion Seneca(Fundacion Seneca); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Marcelino Botin	We thank I. Couillin for Casp1-, Pycard-, and Nlrp3-deficient mice bone marrow, A. Verkhratsky for P2rx7 receptor-deficient mice, E. Latz for immortalized BMDM from C57BL/6 and Pycard- and Nlrp3-deficient mice, and F. Rassendren for TRPV2-shRNA lentivirus. We thank J. Tschopp for NLRP3-Flag, G. Dubyak for ASC-V5, J. Perroy for Luc-YFP, and J.P. Pin for beta-arrestin-YFP expression vectors. We thank O. Fernandez for advice with animal models, L. Martinez-Alarcon for human blood extraction, F. Machado-Linde for collecting human peritoneal lavages, F. Noguera for running Hitachi ion detection system, P.J. Martinez for animal handling, E. Moutin for hippocampal neuron culture, and E. Martin, R. Gaskell, I. Fuentes, and M.G. Banos for both molecular and cellular technical assistance. We would like to thank A. Surprenant and F. Rassendren for helpful discussions and support. We are indebted to R.A. North, D. Brough, L.E. Browne, and O. Stelmashenko for critical revision of the manuscript. V.C. is supported by a grant from the Wellcome Trust. This work was supported by grants from Plan Nacional de Investigacion Cientifica, Desarrollo, e Innovacion Tecnologica 2008-2011 (PN de I+D+I 2008-2011), Instituto de Salud Carlos III, and Fondo Europeo de Desarrollo Regional (FEDER) (EMER07/049 and PI09/0120); Fundacion Seneca (11922/PI/09), managed by Fundacion para Formacion e Investigacion Sanitarias de la Region de Murcia (FFIS); and grants from the Spanish Ministry of Science and Technology (BIO2008-01379 and BIO2011-23400) and Fundacion Marcelino Botin.	Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Banke TG, 2010, AM J PHYSIOL-CELL PH, V298, pC1457, DOI 10.1152/ajpcell.00489.2009; Boudreault F, 2004, J PHYSIOL-LONDON, V561, P499, DOI 10.1113/jphysiol.2004.072306; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; DISE CA, 1980, J BIOL CHEM, V255, P5201; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fukuno N, 2011, BIOCHEM BIOPH RES CO, V408, P202, DOI 10.1016/j.bbrc.2011.02.127; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Hansen JD, 2011, DEV COMP IMMUNOL, V35, P886, DOI 10.1016/j.dci.2011.01.008; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsu YH, 2007, BRAIN, V130, P3124, DOI 10.1093/brain/awm207; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jha S, 2009, J IMMUNOL, V183, P7623, DOI 10.4049/jimmunol.0902425; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; Liedtke W, 2006, J ENDOCRINOL, V191, P515, DOI 10.1677/joe.1.07000; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Lopez-Castejon G, 2008, MOL IMMUNOL, V45, P49, DOI 10.1016/j.molimm.2007.05.015; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; NEWMAN P J, 1988, Arthroscopy, V4, P179; Numata T, 2007, AM J PHYSIOL-CELL PH, V292, pC460, DOI 10.1152/ajpcell.00367.2006; Oliveira RP, 2002, CRIT CARE, V6, P418, DOI 10.1186/cc1541; Oprica M, 2003, J CELL MOL MED, V7, P127, DOI 10.1111/j.1582-4934.2003.tb00211.x; Pelegrin P, 2004, DEV COMP IMMUNOL, V28, P229, DOI 10.1016/j.dci.2003.08.002; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Penner R., 2007, V179, P313; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sanz JM, 2009, J IMMUNOL, V182, P4378, DOI 10.4049/jimmunol.0803612; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Togo T, 2000, MOL BIOL CELL, V11, P4339, DOI 10.1091/mbc.11.12.4339; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Zhang Z, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035001; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	52	261	268	3	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 21	2012	37	3					487	500		10.1016/j.immuni.2012.06.013	http://dx.doi.org/10.1016/j.immuni.2012.06.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22981536	Bronze			2022-12-18	WOS:000309199000013
J	Miller, LS; O'Connell, RM; Gutierrez, MA; Pietras, EM; Shahangian, A; Gross, CE; Thirumala, A; Cheung, AL; Cheng, GH; Modlin, RL				Miller, LS; O'Connell, RM; Gutierrez, MA; Pietras, EM; Shahangian, A; Gross, CE; Thirumala, A; Cheung, AL; Cheng, GH; Modlin, RL			MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus	IMMUNITY			English	Article							TOLL-LIKE RECEPTOR-2; CUTTING EDGE; HOST-DEFENSE; MYD88-DEFICIENT MICE; ENDOTHELIAL-CELLS; EXPRESSION; MECHANISMS; INFECTION; INTERLEUKIN-1; LIPOPROTEINS	MyD88 is an important signaling adaptor for both TLR and IL-1R family members. Here, we evaluated the role of TLR2/MyD88 and IL-1R/MyD88 signaling in host defense against S. aureus by using a cutaneous infection model in conjunction with bioluminescent bacteria. We found that lesions of S. aureus-infected MyD88- and IL-lR-deficient mice were substantially larger with higher bacterial counts compared with wildtype mice. In contrast, TLR2-deficient mice had lesions that were only moderately larger with minimally higher bacterial counts. In addition, MyD88- and IL-1R- but not TLR2-deficient mice had severely decreased recruitment of neutrophils to the site of infection. This neutrophil recruitment was not dependent upon IL-1R/MyD88 signaling by recruited bone marrow-derived cells, suggesting that resident skin cells utilize IL-1R/MyD88 signaling to promote neutrophil recruitment.	Univ Calif Los Angeles, Div Dermatol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Dartmouth College	Cheng, GH (corresponding author), Univ Calif Los Angeles, Div Dermatol, 52-121 CHS 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	genhongc@microbio.ucla.edu; rmodlin@mednet.ucla.edu	Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X; Miller, Lloyd/0000-0002-8332-2210	NATIONAL CANCER INSTITUTE [R01CA087924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056154, R01AI022553, R01AI047868, K08AI062985, R22AI022553, R37AI047868, R01AI052359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040312] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA87924] Funding Source: Medline; NIAID NIH HHS [R01 AI052359, R01 AI056154, R01 AI22553, R01 AI47868, K08 AI62985] Funding Source: Medline; NIAMS NIH HHS [R01 AR40312] Funding Source: Medline; NIGMS NIH HHS [GM 07185] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Doyle SE, 2003, J IMMUNOL, V170, P3565, DOI 10.4049/jimmunol.170.7.3565; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Fitzgerald KA, 2000, MICROBES INFECT, V2, P933, DOI 10.1016/S1286-4579(00)00396-8; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Hultgren OH, 2002, J IMMUNOL, V168, P5207, DOI 10.4049/jimmunol.168.10.5207; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kielian T, 2004, J NEUROPATH EXP NEUR, V63, P381, DOI 10.1093/jnen/63.4.381; Kielian T, 2001, J IMMUNOL, V166, P4634, DOI 10.4049/jimmunol.166.7.4634; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Miller LS, 2005, J IMMUNOL, V174, P6137, DOI 10.4049/jimmunol.174.10.6137; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; Novick R.P., 1990, MOL BIOL STAPHYLOCOC, P1; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; Steen MB, 1999, IN VITRO CELL DEV-AN, V35, P327, DOI 10.1007/s11626-999-0082-9; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Verdrengh M, 2004, MICROBES INFECT, V6, P1268, DOI 10.1016/j.micinf.2004.08.009; ZHANG Y, 1992, SCIENCE, V258, P1957, DOI 10.1126/science.1470922	40	261	265	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2006	24	1					79	91		10.1016/j.immuni.2005.11.011	http://dx.doi.org/10.1016/j.immuni.2005.11.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413925	Bronze			2022-12-18	WOS:000234850200012
J	Shimoda, K; Kato, K; Aoki, K; Matsuda, T; Miyamoto, A; Shibamori, M; Yamashita, M; Numata, A; Takase, K; Kobayashi, S; Shibata, S; Asano, Y; Gondo, H; Sekiguchi, K; Nakayama, K; Nakayama, T; Okamura, T; Okamura, S; Niho, Y; Nakayama, K				Shimoda, K; Kato, K; Aoki, K; Matsuda, T; Miyamoto, A; Shibamori, M; Yamashita, M; Numata, A; Takase, K; Kobayashi, S; Shibata, S; Asano, Y; Gondo, H; Sekiguchi, K; Nakayama, K; Nakayama, T; Okamura, T; Okamura, S; Niho, Y; Nakayama, K			Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; MICE LACKING JAK3; TRANSDUCTION PATHWAY; TARGETED DISRUPTION; CYTOKINE RECEPTORS; ACTIVATION; DEFECTS	Janus kinases (Jaks) play an important role in signal transduction via cytokine receptors. Tyk2 is a Janus kinase, and we developed tyk2-deficient mice to study the requirement for tyk2 in vivo. Tyk2-deficient mice show no overt developmental abnormalities; however, they display a lack of responsiveness to a small amount of IFN alpha, although a high concentration of IFN alpha can fully transduce its signal even in the absence of tyk2. Furthermore, IL-12-induced T cell function is defective in these mice. In contrast, these mice respond normally to IL-6 and IL-10, both of which activate tyk2 in vitro. These observations demonstrate that tyk2 plays only a restricted role in mediating IFN alpha -dependent signaling while being required in mediating IL-12-dependent biological responses.	Kyushu Univ, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, Fac Med, Dept Internal Med 1, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, Med Inst Bioregulat, Lab Embryon & Genet Engn, Higashi Ku, Fukuoka 8128582, Japan; Toyama Med & Pharmaceut Univ, Fac Med, Dept Immunol, Toyama 9300194, Japan; Japan Sci & Technol Corp, JST, CREST, Kawaguchi, Saitama 33200112, Japan; Otsuka Pharmaceut Co Ltd, Inst New Drug Res 3, Tokushima 7710192, Japan; Chiba Univ, Grad Sch Med, Dept Mol Immunol, Chuo Ku, Chiba 2608670, Japan; Kyushu Med Ctr, Dept Hematol, Cyuou Ku, Fukuoka 8108563, Japan; Chihaya Hosp, Higashi Ku, Fukuoka 8130044, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University; University of Toyama; Japan Science & Technology Agency (JST); Otsuka Pharmaceutical; Chiba University	Shimoda, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.		Nakayama, Toshinori/E-1067-2017; Matsuda, Tadashi/A-3835-2012	Nakayama, Toshinori/0000-0002-1434-2007; Matsuda, Tadashi/0000-0002-3089-3757; Kobayashi, Shinji/0000-0001-5783-2631; Numata, Akihiko/0000-0001-6088-8302				DAMELL JE, 1994, SCIENCE, V264, P1415; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Shimoda K, 1997, BLOOD, V90, P597, DOI 10.1182/blood.V90.2.597.597_597_604; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024	18	261	282	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2000	13	4					561	571		10.1016/S1074-7613(00)00055-8	http://dx.doi.org/10.1016/S1074-7613(00)00055-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070174	Bronze			2022-12-18	WOS:000090079100015
J	Hengel, H; Koopmann, JO; Flohr, T; Muranyi, W; Goulmy, E; Hammerling, GJ; Koszinowski, UH; Momburg, F				Hengel, H; Koopmann, JO; Flohr, T; Muranyi, W; Goulmy, E; Hammerling, GJ; Koszinowski, UH; Momburg, F			A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter	IMMUNITY			English	Article; Proceedings Paper	21st International Herpesvirus Workshop	JUL 26-AUG 02, 1996	DE KALB, IL				CLASS-I MOLECULES; CYTOMEGALOVIRUS-INFECTED CELLS; RECOMBINANT VACCINIA VIRUSES; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; HEAVY-CHAINS; SURFACE EXPRESSION; TAP TRANSPORTERS; DOWN-REGULATION; T-LYMPHOCYTES	Human cytomegalovirus inhibits peptide import into the endoplasmic reticulum (ER) by the MHC-encoded TAP peptide transporter. We identified the open reading frame US6 to mediate this effect. Expression of the 21 kDa US6 glycoprotein in human cytomegalovirus-infected cells correlates with the inhibition of peptide transport during infection. The subcellular localization of US6 is ER restricted and is identical with TAP. US6 protein is found in complexes with TAP1/2, MHC class I heavy chain, beta(2)-microglobulin, calnexin, calreticulin, and tapasin. TAP inhibition, however, is independent of the presence of class I heavy chain and tapasin. The results establish a new mechanism for viral immune escape and a novel role for ER-resident proteins to regulate TAP via its luminal face.	DEUTSCH KREBSFORSCHUNGSZENTRUM,ABT MOL IMMUNOL,D-69120 HEIDELBERG,GERMANY; UNIV LEIDEN HOSP,DEPT IMMUNOHAEMATOL,NL-2300 RC LEIDEN,NETHERLANDS; UNIV LEIDEN HOSP,BLOOD BANK,NL-2300 RC LEIDEN,NETHERLANDS	Helmholtz Association; German Cancer Research Center (DKFZ); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Hengel, H (corresponding author), UNIV MUNICH,MAX VON PETTENKOFER INST,LEHRSTUHL VIROL,GENZENTRUM,D-81377 MUNICH,GERMANY.							Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; Androlewicz MJ, 1996, IMMUNITY, V5, P1, DOI 10.1016/S1074-7613(00)80304-0; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12176; BARNES PD, 1992, J GEN VIROL, V73, P2395, DOI 10.1099/0022-1317-73-9-2395; BEERSMA MFC, 1993, J IMMUNOL, V151, P4455; BORYSIEWICZ LK, 1988, J EXP MED, V168, P919, DOI 10.1084/jem.168.3.919; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; DELVAL M, 1992, J EXP MED, V176, P729, DOI 10.1084/jem.176.3.729; DEMARS R, 1985, P NATL ACAD SCI USA, V82, P8183, DOI 10.1073/pnas.82.23.8183; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; GOULMY E, 1984, IMMUNOGENETICS, V20, P13, DOI 10.1007/BF00373443; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; HENGEL H, 1994, J VIROL, V68, P289, DOI 10.1128/JVI.68.1.289-297.1994; Hengel H, 1996, J GEN VIROL, V77, P2287, DOI 10.1099/0022-1317-77-9-2287; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; HO M, 1982, CYTOMEGALOVIRUS BIOL, P171; Hopkins JI, 1996, J MED VIROL, V49, P124; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JONES TR, 1995, J VIROL, V69, P4830, DOI 10.1128/JVI.69.8.4830-4841.1995; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; JONES TR, 1991, J VIROL, V65, P2024, DOI 10.1128/JVI.65.4.2024-2036.1991; KLEIJMEER MJ, 1992, NATURE, V357, P342, DOI 10.1038/357342a0; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; Koopmann JO, 1997, CURR OPIN IMMUNOL, V9, P80, DOI 10.1016/S0952-7915(97)80163-X; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, CURR OPIN IMMUNOL, V6, P32, DOI 10.1016/0952-7915(94)90030-2; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Nijenhuis M, 1996, J IMMUNOL, V156, P2186; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; PARHAM P, 1979, J IMMUNOL, V123, P342; RAJAGOPALAN S, 1994, J EXP MED, V180, P407, DOI 10.1084/jem.180.1.407; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SCHEELE G, 1983, METHOD ENZYMOL, V96, P94; SCHLICHT HJ, 1989, J VIROL, V63, P5399, DOI 10.1128/JVI.63.12.5399-5404.1989; SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; Solheim JC, 1997, J IMMUNOL, V158, P2236; STAM NJ, 1986, J IMMUNOL, V137, P2299; Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; TENNEY DJ, 1991, J VIROL, V65, P6724, DOI 10.1128/JVI.65.12.6724-6734.1991; THALE R, 1995, J VIROL, V69, P6098; TOMAZIN H, 1996, EMBO J, V15, P3256; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; VAUX D, 1990, NATURE, V345, P495, DOI 10.1038/345495a0; VOLKMER H, 1987, J EXP MED, V166, P668, DOI 10.1084/jem.166.3.668; WARREN AP, 1994, J VIROL, V68, P2822, DOI 10.1128/JVI.68.5.2822-2829.1994; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; YAMASHITA Y, 1993, VIROLOGY, V193, P727, DOI 10.1006/viro.1993.1181; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5; York IA, 1996, CHEM BIOL, V3, P331, DOI 10.1016/S1074-5521(96)90115-5; Ziegler H, 1997, IMMUNITY, V6, P57, DOI 10.1016/S1074-7613(00)80242-3	62	261	267	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1997	6	5					623	632		10.1016/S1074-7613(00)80350-7	http://dx.doi.org/10.1016/S1074-7613(00)80350-7			10	Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175840	Bronze, Green Published			2022-12-18	WOS:A1997XB81900013
J	Pisetsky, DS				Pisetsky, DS			Immune activation by bacterial DNA: A new genetic code	IMMUNITY			English	Review							MYCOBACTERIUM-BOVIS BCG; SYSTEMIC LUPUS-ERYTHEMATOSUS; MURINE LYMPHOCYTE-PROLIFERATION; DEOXYRIBONUCLEIC-ACID FRACTION; DEPENDENT PROTEIN-KINASE; NATURAL-KILLER ACTIVITY; ANTI-DSDNA ANTIBODIES; NF-KAPPA-B; NORMAL MICE; SYNTHETIC OLIGONUCLEOTIDES		DUKE UNIV,MED CTR,DIV RHEUMATOL ALLERGY & CLIN IMMUNOL,DURHAM,NC 27705	Duke University	Pisetsky, DS (corresponding author), VET AFFAIRS MED CTR,MED SERV,DURHAM,NC 27705, USA.							Akhtar S, 1992, Trends Cell Biol, V2, P139, DOI 10.1016/0962-8924(92)90100-2; ARNOLD EA, 1972, J CELL BIOL, V53, P737, DOI 10.1083/jcb.53.3.737; Bennett R M, 1993, Antisense Res Dev, V3, P235; BENNETT RM, 1985, J CLIN INVEST, V76, P2182, DOI 10.1172/JCI112226; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BRANDA RF, 1993, BIOCHEM PHARMACOL, V45, P2037, DOI 10.1016/0006-2952(93)90014-N; Cowdery J, 1996, J IMMUNOL, V156, P4570; DIAMOND B, 1992, ANNU REV IMMUNOL, V10, P731, DOI 10.1146/annurev.iy.10.040192.003503; DOERFLER W, 1991, BIOL CHEM H-S, V372, P557; EMLEN W, 1986, ARTHRITIS RHEUM, V29, P1417, DOI 10.1002/art.1780291201; FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004; FREDRIKSEN K, 1993, SCAND J IMMUNOL, V38, P401, DOI 10.1111/j.1365-3083.1993.tb01744.x; GILKESON GS, 1995, J CLIN INVEST, V95, P1398, DOI 10.1172/JCI117793; GILKESON GS, 1993, J IMMUNOL, V151, P1353; GILKESON GS, 1989, J IMMUNOL, V142, P1482; GILKESON GS, 1989, CLIN IMMUNOL IMMUNOP, V51, P362, DOI 10.1016/0090-1229(89)90034-2; GILKESON GS, 1991, CLIN IMMUNOL IMMUNOP, V59, P288, DOI 10.1016/0090-1229(91)90025-6; Halpern MD, 1996, CELL IMMUNOL, V167, P72, DOI 10.1006/cimm.1996.0009; HEFENEIDER SH, 1992, LUPUS, V1, P167, DOI 10.1177/096120339200100308; HERGERSBERG M, 1991, EXPERIENTIA, V47, P1171, DOI 10.1007/BF01918381; HOVANESSIAN AG, 1987, EUR J BIOCHEM, V167, P467, DOI 10.1111/j.1432-1033.1987.tb13360.x; HOVANESSIAN AG, 1989, J INTERFERON RES, V9, P641, DOI 10.1089/jir.1989.9.641; KAROUNOS DG, 1988, J IMMUNOL, V140, P451; KIMURA Y, 1994, J BIOCHEM-TOKYO, V116, P991, DOI 10.1093/oxfordjournals.jbchem.a124658; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; KREIGER M, 1994, ANNU REV BIOCHEM, V63, P601; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; LAMPSON GP, 1967, P NATL ACAD SCI USA, V58, P782, DOI 10.1073/pnas.58.2.782; MACKWORTHYOUNG C, 1988, CRC CR REV IMMUNOL, V8, P147; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; MASHIBA H, 1988, JPN J MED SCI BIOL, V41, P197, DOI 10.7883/yoken1952.41.197; MESSINA JP, 1993, CELL IMMUNOL, V147, P148, DOI 10.1006/cimm.1993.1055; MESSINA JP, 1991, J IMMUNOL, V147, P1759; MOR G, 1995, J IMMUNOL, V155, P2039; PARDOLL DM, 1995, IMMUNITY, V3, P165, DOI 10.1016/1074-7613(95)90085-3; PEARSON AM, 1993, J BIOL CHEM, V268, P3546; PISETSKY DS, 1992, RHEUM DIS CLIN N AM, V18, P437; PISETSKY DS, 1994, LIFE SCI, V54, P101, DOI 10.1016/0024-3205(94)00780-2; PISETSKY DS, 1993, HUM IMMUNOL, V38, P241, DOI 10.1016/0198-8859(93)90550-K; PISETSKY DS, 1993, MOL BIOL REP, V18, P217, DOI 10.1007/BF01674433; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Raz E, 1996, P NATL ACAD SCI USA, V93, P5141, DOI 10.1073/pnas.93.10.5141; RAZ E, 1994, P NATL ACAD SCI USA, V91, P9519, DOI 10.1073/pnas.91.20.9519; ROBERTSON CR, 1992, CLIN IMMUNOL IMMUNOP, V62, P25, DOI 10.1016/0090-1229(92)90019-K; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; Sen D, 1991, CURR OPIN STRUC BIOL, V1, P435, DOI 10.1016/0959-440X(91)90044-T; SHIMADA S, 1985, J NATL CANCER I, V74, P681; SMITH RC, 1990, DEVELOPMENT, V110, P769; STEIN CA, 1993, SCIENCE, V261, P1004, DOI 10.1126/science.8351515; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; TANIGUCHI T, 1989, J INTERFERON RES, V9, P633, DOI 10.1089/jir.1989.9.633; TERADA K, 1991, CLIN EXP IMMUNOL, V85, P66; TOKUNAGA T, 1984, J NATL CANCER I, V72, P955; TOKUNAGA T, 1992, MICROBIOL IMMUNOL, V36, P55, DOI 10.1111/j.1348-0421.1992.tb01642.x; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; VLASSOV VV, 1994, BBA-REV BIOMEMBRANES, V1197, P95, DOI 10.1016/0304-4157(94)90001-9; VOGT W, 1973, EUR J IMMUNOL, V3, P493, DOI 10.1002/eji.1830030808; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; YAKUBOV LA, 1989, P NATL ACAD SCI USA, V86, P6454, DOI 10.1073/pnas.86.17.6454; YAMAMOTO S, 1992, MICROBIOL IMMUNOL, V36, P983, DOI 10.1111/j.1348-0421.1992.tb02102.x; YAMAMOTO S, 1988, JPN J CANCER RES, V79, P866, DOI 10.1111/j.1349-7006.1988.tb00049.x; YAMAMOTO S, 1992, J IMMUNOL, V148, P4072; YAMAMOTO T, 1994, JPN J CANCER RES, V85, P775, DOI 10.1111/j.1349-7006.1994.tb02947.x; Yi AK, 1996, J IMMUNOL, V156, P558; Zhao QY, 1996, BIOCHEM PHARMACOL, V51, P173, DOI 10.1016/0006-2952(95)02177-9	68	261	304	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1996	5	4					303	310		10.1016/S1074-7613(00)80256-3	http://dx.doi.org/10.1016/S1074-7613(00)80256-3			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VP444	8885863	Bronze			2022-12-18	WOS:A1996VP44400002
J	Deenick, EK; Chan, AN; Ma, CS; Gatto, D; Schwartzberg, PL; Brink, R; Tangye, SG				Deenick, Elissa K.; Chan, Anna; Ma, Cindy S.; Gatto, Dominique; Schwartzberg, Pamela L.; Brink, Robert; Tangye, Stuart G.			Follicular Helper T Cell Differentiation Requires Continuous Antigen Presentation that Is Independent of Unique B Cell Signaling	IMMUNITY			English	Article							LINKED LYMPHOPROLIFERATIVE DISEASE; HUMORAL IMMUNE-RESPONSES; INDUCIBLE COSTIMULATOR LIGAND; CXC CHEMOKINE RECEPTOR-5; MICE DEFICIENT; EXPRESSION; IL-21; SAP; CD40; ICOS	Effective humoral immunity depends on the support of B cell responses by T follicular helper (Tfh) cells. Although it has been proposed that Tfh cell differentiation requires T-B interactions, the relative contribution of specific populations of Ag-presenting cells remains unknown. We employed three independent strategies that compromised interactions between CD4(+) T cells and activated B cells in vivo. Whereas the expansion of CD4(+) T cells was relatively unaffected, Tfh cell differentiation was completely blocked in all scenarios. Surprisingly, augmenting antigen presentation by non-B cells rescued Tfh cell differentiation, as determined by surface phenotype, gene expression, and germinal center localization. We conclude that although Ag presentation by responding B cells is typically required for the generation of Tfh cells, this does not result from the provision of a unique B cell-derived signal, but rather because responding B cells rapidly become the primary source of antigen.	[Deenick, Elissa K.; Chan, Anna; Ma, Cindy S.; Gatto, Dominique; Brink, Robert; Tangye, Stuart G.] St Vincents Hosp, Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia; [Deenick, Elissa K.; Ma, Cindy S.; Gatto, Dominique; Brink, Robert; Tangye, Stuart G.] Univ New S Wales, St Vincents Clin Sch, Kensington, NSW 2033, Australia; [Schwartzberg, Pamela L.] NHGRI, NIH, Bethesda, MD 20892 USA	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Deenick, EK (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia.	e.deenick@garvan.org.au; s.tangye@garvan.org.au	S, Cindy/B-2340-2012; Tangye, Stuart G/H-4023-2014; Brink, Robert/B-7910-2010; Deenick, Elissa/AAY-8998-2020	S, Cindy/0000-0001-5387-8413; Tangye, Stuart G/0000-0002-5360-5180; Brink, Robert/0000-0002-9586-3655; Deenick, Elissa/0000-0002-9271-0004	Australian NHMRC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Garvan Flow Facility for cell sorting, T. Chan for the HEL<SUP>4x</SUP>, D. Fulcher, B. Gaspar, and S. Riminton for patient samples, L. Corcoran for the BcI-6 antibody, and T. Phan for critically reviewing this manuscript. This work was funded by grants and fellowships awarded by the Australian NHMRC to E.K.D., C.S.M., D.G., R.B., and S.G.T.	Aicher A, 2000, J IMMUNOL, V164, P4689, DOI 10.4049/jimmunol.164.9.4689; Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bessa J, 2010, J IMMUNOL, V184, P4615, DOI 10.4049/jimmunol.0903949; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fillatreau S, 2003, J EXP MED, V197, P195, DOI 10.1084/jem.20021750; Franchimont D, 2002, J IMMUNOL, V168, P2212, DOI 10.4049/jimmunol.168.5.2212; Hammerbeck CD, 2008, J IMMUNOL, V180, P2107, DOI 10.4049/jimmunol.180.4.2107; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Hron JD, 2004, J EXP MED, V200, P261, DOI 10.1084/jem.20040526; Hu YL, 2009, J IMMUNOL, V182, P1421, DOI 10.4049/jimmunol.182.3.1421; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kamperschroer C, 2008, J IMMUNOL, V181, P3994, DOI 10.4049/jimmunol.181.6.3994; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Ma CS, 2006, J CLIN INVEST, V116, P322, DOI 10.1172/JCI25720; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; Macaulay AE, 1997, J IMMUNOL, V158, P4171; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; SZAKAL AK, 1989, ANNU REV IMMUNOL, V7, P91, DOI 10.1146/annurev.immunol.7.1.91; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Victoratos P, 2009, IMMUNITY, V30, P130, DOI 10.1016/j.immuni.2008.10.019; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yin L, 2003, J MED VIROL, V71, P446, DOI 10.1002/jmv.10504; Yu D, 2009, CURR OPIN IMMUNOL, V21, P619, DOI 10.1016/j.coi.2009.09.013; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	59	260	266	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					241	253		10.1016/j.immuni.2010.07.015	http://dx.doi.org/10.1016/j.immuni.2010.07.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20691615	Green Accepted, Bronze			2022-12-18	WOS:000281654900013
J	Hitotsumatsu, O; Ahmad, RC; Tavares, R; Wang, M; Philpott, D; Turer, EE; Lee, BL; Shiffin, N; Advincula, R; Malynn, BA; Werts, C; Ma, A				Hitotsumatsu, Osamu; Ahmad, Regina-Celeste; Tavares, Rita; Wang, Min; Philpott, Dana; Turer, Emre E.; Lee, Bettina L.; Shiffin, Nataliya; Advincula, Rommel; Malynn, Barbara A.; Werts, Catherine; Ma, Averil			The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals	IMMUNITY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR; MURAMYL DIPEPTIDE; PROTEIN-KINASE; NOD2; ACTIVATION; INNATE; ALPHA; POLYUBIQUITINATION; ASSOCIATION	Muramyl dipeptide (MDP), a product of bacterial cell-wall peptidoglycan, activates innate immune cells by stimulating nucleotide-binding oligomerization domain containing 2 (NOD2) -dependent activation of the transcription factor NF kappa B and transcription of proinflammatory genes. A20 is a ubiquitin-modifying enzyme that restricts tumor necrosis factor (TNF) receptor and Toll-like receptor (TLR) -induced signals. We now show that MDP induces ubiquitylation of receptor-interacting protein 2 (RIP2) in primary macrophages. A20-deficient cells exhibit dramatically amplified responses to MDP, including increased RIP2 ubiquitylation, prolonged NF kappa B signaling, and increased production of proinflammatory cytokines. In addition, in vivo responses to MDP are exaggerated in A20-deficient mice and in chimeric mice bearing A20-deficient hematopoietic cells. These exaggerated responses occur independently of the TLR adaptors MyD88 and TRIF as well as TNF signals. These findings indicate that A20 directly restricts NOD2 induced signals in vitro and in vivo, and provide new insights into how these signals are physiologically restricted.	[Hitotsumatsu, Osamu; Ahmad, Regina-Celeste; Tavares, Rita; Wang, Min; Turer, Emre E.; Lee, Bettina L.; Shiffin, Nataliya; Advincula, Rommel; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, Div Gastroenterol, Program Biomed Sci,UCSF Colitis Ctr, San Francisco, CA 94143 USA; [Philpott, Dana; Werts, Catherine] Inst Pasteur, Grp Immunite Innee Signalisat, Paris, France	University of California System; University of California San Francisco; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, Div Gastroenterol, Program Biomed Sci,UCSF Colitis Ctr, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu	WERTS, Catherine/AAD-5447-2020	WERTS, Catherine/0000-0003-3079-5476; Tavares, Rita/0000-0002-1654-4454	NIDDK NIH HHS [5P30DK026743, P30 DK026743, R01 DK052751] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK052751] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Rosenstiel P, 2006, P NATL ACAD SCI USA, V103, P3280, DOI 10.1073/pnas.0505423103; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wolfert MA, 2002, J BIOL CHEM, V277, P39179, DOI 10.1074/jbc.M204885200; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200	51	260	272	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2008	28	3					381	390		10.1016/j.immuni.2008.02.002	http://dx.doi.org/10.1016/j.immuni.2008.02.002			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18342009	Green Accepted, Bronze			2022-12-18	WOS:000254142500015
J	Zammit, DJ; Cauley, LS; Pham, QM; Lefrancois, L				Zammit, DJ; Cauley, LS; Pham, QM; Lefrancois, L			Dendritic cells maximize the memory CD8 T cell response to infection	IMMUNITY			English	Article							LISTERIA-MONOCYTOGENES INFECTION; INTESTINAL EPITHELIAL-CELLS; IN-VIVO; VIRUS-INFECTION; PROTECTIVE IMMUNITY; CD8-T-CELL MEMORY; VIRAL-INFECTION; CD4-T-CELL HELP; CUTTING EDGE; B-CELLS	Costimulatory signals from dendritic cells (DCs) are required for naive T cells to respond to antigenic stimulation. To what extent DCs reactivate memory T cells during recall responses is not known. Here, an in vivo depletion system has been used to analyze the role of DCs in reactivating CD8 memory T cells during recall responses to three different microbial infections. We show a profound decrease in the numbers of responding memory CD8 T cells in both lymphoid and nonlymphoid tissues during the recall responses to infection with vesicular stomatitis virus, Listeria monocytogenes (Lm), or influenza virus. These data show that interaction with DCs is a major mechanism driving T cell reactivation in vivo, even during a tissue-specific infection of the respiratory tract.	Univ Connecticut, Ctr Hlth, Div Immunol, Farmington, CT 06030 USA	University of Connecticut	Lefrancois, L (corresponding author), Univ Connecticut, Ctr Hlth, Div Immunol, Farmington, CT 06030 USA.	llefranc@neuron.uchc.edu			NIAID NIH HHS [R01 AI041576-10, R01 AI041576, P01 AI056172, AI 56172, AI 41576, P01 AI056172-05] Funding Source: Medline; NIDDK NIH HHS [DK 45260, R01 DK045260-15, R01 DK045260] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056172, R01AI041576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045260] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bertram EM, 2004, J IMMUNOL, V172, P981, DOI 10.4049/jimmunol.172.2.981; Bourgeois C, 2002, EUR J IMMUNOL, V32, P2199, DOI 10.1002/1521-4141(200208)32:8<2199::AID-IMMU2199>3.0.CO;2-L; COLLINS P, 2004, FIELDS VIROLOGY, P1205; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; Dawicki W, 2004, EUR J IMMUNOL, V34, P743, DOI 10.1002/eji.200324278; DiRosa F, 1996, J EXP MED, V183, P2153, DOI 10.1084/jem.183.5.2153; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Hershberg RM, 1997, J CLIN INVEST, V100, P204, DOI 10.1172/JCI119514; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Khanolkar A, 2004, J IMMUNOL, V172, P2834, DOI 10.4049/jimmunol.172.5.2834; Kim SK, 1999, J IMMUNOL, V163, P4125; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lin MY, 2000, MICROBES INFECT, V2, P1025, DOI 10.1016/S1286-4579(00)01257-0; Lin YL, 2003, EUR J IMMUNOL, V33, P2736, DOI 10.1002/eji.200324087; Lund FE, 2002, J IMMUNOL, V169, P5236, DOI 10.4049/jimmunol.169.9.5236; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; Marzo AL, 2002, J IMMUNOL, V168, P4504, DOI 10.4049/jimmunol.168.9.4504; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Roberts AD, 2004, J IMMUNOL, V172, P6533, DOI 10.4049/jimmunol.172.11.6533; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Shedlock DJ, 2003, J IMMUNOL, V170, P2053, DOI 10.4049/jimmunol.170.4.2053; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shen H, 2003, J IMMUNOL, V170, P1443, DOI 10.4049/jimmunol.170.3.1443; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Topham DJ, 2001, J IMMUNOL, V167, P6983, DOI 10.4049/jimmunol.167.12.6983; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; VIDAL K, 1993, J IMMUNOL, V151, P4642; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C	50	260	271	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2005	22	5					561	570		10.1016/j.immuni.2005.03.005	http://dx.doi.org/10.1016/j.immuni.2005.03.005			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894274	Green Accepted, Bronze			2022-12-18	WOS:000229447200006
J	Muppidi, JR; Tschopp, J; Siegel, RM				Muppidi, JR; Tschopp, J; Siegel, RM			Life and death decisions: Secondary complexes and lipid rafts in TNF receptor family signal transduction	IMMUNITY			English	Review							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; MEDIATED APOPTOSIS; CELL-DEATH; INDUCTION; INHIBITION; CD95; RECRUITMENT; ACTIVATION; C-IAP1	Signaling by receptors in the TNF receptor (TNFR) superfamily mediate biological outcomes ranging from inflammation to apoptosis and other forms of programmed cell death. How receptor signaling mediates these divergent responses is just beginning to be understood. Here, we discuss how receptor submembrane localization and the formation of alternate signaling complexes can alter the fate of cells stimulated through TNFRs with a death domain, also known as "death receptors."	NIAMSD, Autoimmun Branch, Immunoregulat Unit, Bethesda, MD 20892 USA; Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland; Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Lausanne; University of Kansas; University of Kansas Medical Center	Siegel, RM (corresponding author), NIAMSD, Autoimmun Branch, Immunoregulat Unit, Bethesda, MD 20892 USA.	rsiegel@nih.gov	Siegel, Richard/C-7592-2009	Siegel, Richard/0000-0001-5953-9893; Muppidi, Jagan/0000-0002-2639-4226	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041134] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Amanullah A, 2003, NATURE, V424, P741, DOI 10.1038/424741b; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Combadiere B, 1998, J EXP MED, V187, P349, DOI 10.1084/jem.187.3.349; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Doan JES, 2004, J IMMUNOL, V172, P7654, DOI 10.4049/jimmunol.172.12.7654; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Eramo A, 2004, EUR J IMMUNOL, V34, P1930, DOI 10.1002/eji.200324786; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hueber AO, 2002, EMBO REP, V3, P190, DOI 10.1093/embo-reports/kvf022; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Ko YG, 1999, J IMMUNOL, V162, P7217; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; MICHAEU O, 2001, MOL CELL BIOL, V21, P599; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	33	260	268	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2004	21	4					461	465		10.1016/j.immuni.2004.10.001	http://dx.doi.org/10.1016/j.immuni.2004.10.001			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485624	Bronze			2022-12-18	WOS:000224744400003
J	Seman, M; Adriouch, S; Scheuplein, F; Krebs, C; Freese, D; Glowacki, G; Deterre, P; Haag, F; Koch-Nolte, F				Seman, M; Adriouch, S; Scheuplein, F; Krebs, C; Freese, D; Glowacki, G; Deterre, P; Haag, F; Koch-Nolte, F			NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor	IMMUNITY			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; EXTRACELLULAR ATP; MOUSE LYMPHOCYTES; IMMUNE-SYSTEM; L-SELECTIN; RECEPTOR; RIBOSYLTRANSFERASE; APOPTOSIS; MYCOBACTERIA; RESPONSES	T cells express a toxin-related ADP-ribosylating ectoenzyme, ART2. Exposure of mature T cells to NAD, the substrate for ADP-ribosylation, induces cell death. ART2-catalyzed ADP-ribosylation activates the cytolytic P2X7 purinoceptor, causing calcium flux, pore formation, phosphatidylserine exposure, shedding of CD62L, cell shrinkage, and propidium iodide uptake. Interestingly, much lower NAD than ATP concentrations are required to activate P2X7. NAD-induced cell death (NICD) operates with endogenous sources of NAD released upon cell lysis. These findings identify P2X7 as a key effector of NICD and demonstrate that P2X7 can be activated by an endogenous ligand other than ATP. Our results delineate an alternative mechanism for inducing T cell death and set an interesting precedent for immunoregulation via crosstalk between NAD-dependent ADP-ribosyltransferases and purinoceptors.	Univ Hamburg Hosp, Inst Immunol, D-20246 Hamburg, Germany; Univ Paris 07, F-75251 Paris, France; Hop La Pitie Salpetriere, F-75634 Paris 13, France; Vaccine Lab, D-18057 Rostock, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Koch-Nolte, F (corresponding author), Univ Hamburg Hosp, Inst Immunol, Martinistr 52, D-20246 Hamburg, Germany.	nolte@uke.uni-hamburg.de	Deterre, Philippe/O-8984-2017; ADRIOUCH, Sahil/G-8999-2012	Deterre, Philippe/0000-0001-9303-0791; ADRIOUCH, Sahil/0000-0002-0265-7773; Scheuplein, Felix/0000-0002-2691-0796; Koch-Nolte, Friedrich/0000-0003-1730-6674; Krebs, Christian F./0000-0003-2739-5578; Haag, Friedrich/0000-0001-6555-3106				ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Ablamunits V, 2001, DIABETOLOGIA, V44, P848; Adriouch S, 2001, J IMMUNOL, V167, P196, DOI 10.4049/jimmunol.167.1.196; Aktories K, 2000, BACTERIAL PROTEIN TO; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Bruzzone S, 2001, FASEB J, V15, P10; Canaday DH, 2002, INFECT IMMUN, V70, P6456, DOI 10.1128/IAI.70.11.6456-6459.2002; Chused TM, 1996, J IMMUNOL, V157, P1371; Chvatchko Y, 1996, IMMUNITY, V5, P275, DOI 10.1016/S1074-7613(00)80322-2; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DIVE C, 1992, BIOCHIM BIOPHYS ACTA, V1133, P275, DOI 10.1016/0167-4889(92)90048-G; DIVIRGILIO F, 1989, J IMMUNOL, V143, P1955; Domenighini M, 1996, MOL MICROBIOL, V21, P667, DOI 10.1046/j.1365-2958.1996.321396.x; Gargett CE, 1997, BRIT J PHARMACOL, V120, P1483, DOI 10.1038/sj.bjp.0701081; Glowacki G, 2002, PROTEIN SCI, V11, P1657, DOI 10.1110/ps.0200602; Goding JW, 1998, IMMUNOL REV, V161, P5, DOI 10.1111/j.1600-065X.1998.tb01567.x; Green DR, 2000, METHOD ENZYMOL, V322, P15; GREINER DL, 1987, J EXP MED, V166, P461, DOI 10.1084/jem.166.2.461; Gu B, 1998, BLOOD, V92, P946; HAAG F, 1997, ADP RIBOSYLATION ANI, V419; Jacobson EL, 1997, METHOD ENZYMOL, V280, P221; Jamieson GP, 1996, J CELL PHYSIOL, V166, P637, DOI 10.1002/(SICI)1097-4652(199603)166:3<637::AID-JCP19>3.0.CO;2-3; Kahl S, 2000, J IMMUNOL, V165, P4463, DOI 10.4049/jimmunol.165.8.4463; Koch-Nolte F, 1999, J IMMUNOL, V163, P6014; KochNolte F, 1996, J BIOL CHEM, V271, P7686, DOI 10.1074/jbc.271.13.7686; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Krebs C, 2003, ANAL BIOCHEM, V314, P108, DOI 10.1016/S0003-2697(02)00640-1; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Liu ZX, 1999, J BIOL CHEM, V274, P17399, DOI 10.1074/jbc.274.25.17399; Liu ZX, 2001, J IMMUNOL, V167, P4942, DOI 10.4049/jimmunol.167.9.4942; LUND AK, 1995, J TRAUMA, V38, P469, DOI 10.1097/00005373-199504000-00001; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mueller-Dieckmann C, 2002, J MOL BIOL, V322, P687, DOI 10.1016/S0022-2836(02)00818-5; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Ohlrogge W, 2002, MOL CELL BIOL, V22, P7535, DOI 10.1128/MCB.22.21.7535-7542.2002; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Okazaki IJ, 1998, J BIOL CHEM, V273, P23617, DOI 10.1074/jbc.273.37.23617; Paone G, 2002, P NATL ACAD SCI USA, V99, P8231, DOI 10.1073/pnas.122238899; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Van Parijs L, 1998, SCIENCE, V280, P243; ZANOVELLO P, 1990, J IMMUNOL, V145, P1545	44	260	266	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2003	19	4					571	582		10.1016/S1074-7613(03)00266-8	http://dx.doi.org/10.1016/S1074-7613(03)00266-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563321	Bronze			2022-12-18	WOS:000186051900013
J	Zhang, DH; Yang, LY; Cohn, L; Parkyn, L; Homer, R; Ray, P; Ray, A				Zhang, DH; Yang, LY; Cohn, L; Parkyn, L; Homer, R; Ray, P; Ray, A			Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA-3; TH2 CELLS; T-CELLS; TH2-SPECIFIC EXPRESSION; AIRWAY INFLAMMATION; GENE-EXPRESSION; MAMMALIAN-CELLS; CUTTING EDGE; IN-VIVO; KAPPA-B	The cytokines IL-4, IL-5, and IL-13, secreted by Th2 cells, have distinct functions in the pathogenesis of asthma. We have previously shown that the transcription factor GATA-3 is expressed in Th2 but not Th1 cells. However, it was unclear whether GATA-3 controls the expression of all Th2 cytokines. Expression of a dominant-negative mutant of GATA-3 in mice in a T cell-specific fashion led to a reduction in the levels of all the Th2 cytokines IL-4, IL-5, and IL-13. Airway eosinophilia, mucus production, and IgE synthesis, all key features of asthma, were severely attenuated in the transgenic mice. Thus, targeting GATA-3 activity alone is sufficient to blunt Th2 responses in vivo, thereby establishing GATA-3 as a potential therapeutic target in the treatment of asthma and allergic diseases.	Yale Univ, Sch Med, Dept Med, Pulm & Crit Care Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; Vet Adm Connecticut Healthcare Syst, Pathol & Lab Med Serv, West Haven, CT 06516 USA	Yale University; Yale University	Ray, A (corresponding author), Yale Univ, Sch Med, Dept Med, Pulm & Crit Care Sect, New Haven, CT 06520 USA.	anuradha.ray@yale.edu	homer, robert/P-3884-2019	homer, robert/0000-0002-2055-5885	NHLBI NIH HHS [P50-HL56389, HL 56843] Funding Source: Medline; NIAID NIH HHS [AI 31137] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056389, R01HL056843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031137] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander J, 1998, J IMMUNOL, V161, P6794; ALLEN JM, 1992, MOL CELL BIOL, V12, P2758, DOI 10.1128/MCB.12.6.2758; BRUSSELLE G, 1995, AM J RESP CELL MOL, V12, P254, DOI 10.1165/ajrcmb.12.3.7873190; Busse WW, 1998, J ALLERGY CLIN IMMUN, V102, pS17, DOI 10.1016/S0091-6749(98)70002-8; COFFMAN RL, 1989, SCIENCE, V245, P308, DOI 10.1126/science.2787531; Cohn L, 1998, J IMMUNOL, V161, P3813; Cohn L, 1999, J IMMUNOL, V162, P6178; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; COHN L, 1999, IN PRESS J EXP MED; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; FRICK WE, 1989, AM REV RESPIR DIS, V139, P1401, DOI 10.1164/ajrccm/139.6.1401; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Gleich GJ, 1997, P NATL ACAD SCI USA, V94, P2101, DOI 10.1073/pnas.94.6.2101; GLEICH GJ, 1988, J ALLERGY CLIN IMMUN, V81, P776, DOI 10.1016/0091-6749(88)90931-1; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Holgate ST, 1997, CIBA F SYMP, V206, P5; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Lee HJ, 1998, J IMMUNOL, V160, P2343; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; MAGGI E, 1994, ANN NY ACAD SCI, V725, P2, DOI 10.1111/j.1749-6632.1994.tb39784.x; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Morel PA, 1998, CRIT REV IMMUNOL, V18, P275, DOI 10.1615/CritRevImmunol.v18.i4.10; Nakamura Y, 1999, J ALLERGY CLIN IMMUN, V103, P215, DOI 10.1016/S0091-6749(99)70493-8; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; ORKIN SH, 1992, BLOOD, V80, P575; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; PEREZ P, 1995, MOL CELL BIOL, V15, P3523; PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z; Range LM, 1998, J PERS INTERPERS LOS, V3, P161, DOI 10.1080/10811449808414438; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ray P, 1997, J CLIN INVEST, V100, P2501, DOI 10.1172/JCI119792; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; SMITH VM, 1995, J BIOL CHEM, V270, P1515, DOI 10.1074/jbc.270.4.1515; SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Umetsu DT, 1997, P SOC EXP BIOL MED, V215, P11; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; YAMAGUCHI Y, 1990, J IMMUNOL, V145, P873; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Youn J, 1998, J EXP MED, V188, P1803, DOI 10.1084/jem.188.10.1803; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	61	260	283	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1999	11	4					473	482		10.1016/S1074-7613(00)80122-3	http://dx.doi.org/10.1016/S1074-7613(00)80122-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249QE	10549629	Bronze			2022-12-18	WOS:000083343100009
J	MILLER, CL; BURKHARDT, AL; LEE, JH; STEALEY, B; LONGNECKER, R; BOLEN, JB; KIEFF, E				MILLER, CL; BURKHARDT, AL; LEE, JH; STEALEY, B; LONGNECKER, R; BOLEN, JB; KIEFF, E			INTEGRAL MEMBRANE-PROTEIN 2 OF EPSTEIN-BARR-VIRUS REGULATES REACTIVATION FROM LATENCY THROUGH DOMINANT-NEGATIVE EFFECTS ON PROTEIN-TYROSINE KINASES	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; GROWTH TRANSFORMATION INVITRO; LYMPHOCYTE-B TRANSFORMATION; BOVINE LEUKEMIA-VIRUS; SIGNAL TRANSDUCTION; SRC FAMILY; CROSS-LINKING; PHOSPHATIDYLINOSITOL 3-KINASE; PROTOONCOGENE PRODUCT; NUCLEOTIDE EXCHANGE	An Epstein-Barr virus-encoded protein, LMP2, blocks the effects of surface immunoglobulin (sig) cross-linking on calcium mobilization and on lytic reactivation of EBV in latently infected and growth-transformed primary human B lymphocytes. In wild-type EBV-transformed cells, LMP2 is constitutively tyrosine phosphorylated and is associated with Lyn and Syk protein-tyrosine kinases (PTKs). Baseline Lyn PTK activity is substantially reduced, and sig cross-linking fails to activate Lyn, Syk, PI3-K, PLC gamma 2, Vav, She, and MAPK. Syk, P13-K, PLC gamma 2, and Vav are constitutively tyrosine phosphorylated, and their tyrosine phosphorylation does not change following sig cross-linking. In contrast, crosslinking sig on cells transformed by LMP2 null mutant EBV recombinants triggers the same protein tyrosine kinase cascade as in noninfected B lymphocytes. These data are consistent with a model in which LMP2 is a constitutive dominant negative modulator of sig receptor signaling through its effects on Lyn, Syk, or regulators of these kinases.	HARVARD UNIV, SCH MED, DEPT MICROBIOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT MOLEC GENET, BOSTON, MA 02115 USA; BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT MOLEC BIOL, PRINCETON, NJ 08543 USA; NORTHWESTERN UNIV, DEPT MICROBIOL & IMMUNOL, CHICAGO, IL 60611 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Bristol-Myers Squibb; Northwestern University	MILLER, CL (corresponding author), HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA.				NATIONAL CANCER INSTITUTE [R01CA062234] Funding Source: NIH RePORTER; NCI NIH HHS [CA62234] Funding Source: Medline; PHS HHS [47006] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALBER G, 1993, CURR BIOL, V3, P333, DOI 10.1016/0960-9822(93)90196-U; BEAUFILS P, 1993, EMBO J, V12, P5105, DOI 10.1002/j.1460-2075.1993.tb06205.x; BOLEN JB, 1993, ONCOGENE, V8, P2025; BROOKS L, 1992, J VIROL, V66, P2689, DOI 10.1128/JVI.66.5.2689-2697.1992; BRUNSWICK M, 1991, P NATL ACAD SCI USA, V88, P1311, DOI 10.1073/pnas.88.4.1311; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; BURKHARDT AL, 1992, J VIROL, V66, P5161, DOI 10.1128/JVI.66.8.5161-5167.1992; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; BURKHARDT AL, 1993, CURRENT PROTOCOLS IM, P1; BUSSON P, 1992, SCIENC, V256, P1196; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; CAMBIER J, 1988, P NATL ACAD SCI USA, V85, P6493, DOI 10.1073/pnas.85.17.6493; CAMBIER JC, 1992, FASEB J, V6, P3207, DOI 10.1096/fasebj.6.13.1397843; CAMPBELL KS, 1990, EMBO J, V9, P441, DOI 10.1002/j.1460-2075.1990.tb08129.x; CAMPBELL MA, 1992, MOL CELL BIOL, V12, P2315, DOI 10.1128/MCB.12.5.2315; CASILLAS A, 1991, J BIOL CHEM, V266, P19088; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; CLARK MR, 1992, J IMMUNOL, V149, P2857; COGGESHALL KM, 1992, P NATL ACAD SCI USA, V89, P5660, DOI 10.1073/pnas.89.12.5660; COHEN JI, 1989, P NATL ACAD SCI USA, V86, P9558, DOI 10.1073/pnas.86.23.9558; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; DAIBATA M, 1990, J IMMUNOL, V144, P4788; DEFRANCO AL, 1993, ANNU REV CELL BIOL, V9, P377, DOI 10.1146/annurev.cellbio.9.1.377; DILWORTH SM, 1994, NATURE, V367, P87, DOI 10.1038/367087a0; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; EISEMAN E, 1992, J BIOL CHEM, V267, P21027; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GOLD MR, 1993, J IMMUNOL, V150, P377; GOLD MR, 1990, NATURE, V345, P810, DOI 10.1038/345810a0; GOLD MR, 1992, J IMMUNOL, V148, P2012; HAMMERSCHMIDT W, 1989, NATURE, V340, P393, DOI 10.1038/340393a0; HARWOOD AE, 1993, J IMMUNOL, V151, P4513; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; HUTCHCROFT JE, 1991, J BIOL CHEM, V266, P14846; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; KENNEY S, 1989, J VIROL, V63, P1729, DOI 10.1128/JVI.63.4.1729-1736.1989; KIM OJ, 1993, J VIROL, V67, P7634, DOI 10.1128/JVI.67.12.7634-7640.1993; KORETZKY GA, 1993, FASEB J, V7, P420, DOI 10.1096/fasebj.7.5.8462784; LAW CL, 1994, J BIOL CHEM, V269, P12310; LAZARUS AH, 1990, J IMMUNOL, V144, P4147; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LI ZH, 1992, BIOCHEM BIOPH RES CO, V187, P1536, DOI 10.1016/0006-291X(92)90477-3; Liebowitz David, 1993, P107; LONGNECKER R, 1991, J VIROL, V65, P3681, DOI 10.1128/JVI.65.7.3681-3692.1991; LONGNECKER R, 1992, J VIROL, V66, P6461, DOI 10.1128/JVI.66.11.6461-6469.1992; LONGNECKER R, 1993, J VIROL, V67, P2006, DOI 10.1128/JVI.67.4.2006-2013.1993; LONGNECKER R, 1993, J VIROL, V67, P5068, DOI 10.1128/JVI.67.8.5068-5074.1993; MANNICK JB, 1991, J VIROL, V65, P6826, DOI 10.1128/JVI.65.12.6826-6837.1991; MARCHINI A, 1991, J VIROL, V65, P5991, DOI 10.1128/JVI.65.11.5991-6000.1991; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; MASON DY, 1991, J IMMUNOL, V147, P2474; MILLER CL, 1994, P NATL ACAD SCI USA, V91, P772, DOI 10.1073/pnas.91.2.772; MILLER G, 1990, VIROLOGY, P1921; MURRAY RJ, 1992, J EXP MED, V176, P157, DOI 10.1084/jem.176.1.157; MUSTELIN T, 1993, TRENDS BIOCHEM SCI, V18, P215, DOI 10.1016/0968-0004(93)90192-P; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; QU LR, 1992, J VIROL, V66, P3715, DOI 10.1128/JVI.66.6.3715-3724.1992; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROBERTSON ES, 1994, J VIROL, V68, P1449, DOI 10.1128/JVI.68.3.1449-1458.1994; ROONEY CM, 1989, J VIROL, V63, P3109, DOI 10.1128/JVI.63.7.3109-3116.1989; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; SAXTON TM, 1994, J IMMUNOL, V153, P623; SINCLAIR AJ, 1991, J VIROL, V65, P2237, DOI 10.1128/JVI.65.5.2237-2244.1991; SMIT L, 1994, J BIOL CHEM, V269, P20209; SWAMINATHAN S, 1991, P NATL ACAD SCI USA, V88, P1546, DOI 10.1073/pnas.88.4.1546; TAKADA K, 1989, J VIROL, V63, P445, DOI 10.1128/JVI.63.1.445-449.1989; TAKADA K, 1984, INT J CANCER, V33, P27, DOI 10.1002/ijc.2910330106; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TAMAKI T, 1992, CANCER RES, V52, P566; TOMKINSON B, 1992, J VIROL, V66, P2893, DOI 10.1128/JVI.66.5.2893-2903.1992; TOMKINSON B, 1993, J VIROL, V67, P2014, DOI 10.1128/JVI.67.4.2014-2025.1993; TORDAI A, 1994, J BIOL CHEM, V269, P7538; TOVEY MG, 1978, NATURE, V276, P270, DOI 10.1038/276270a0; TSGANKOV AY, 1994, J LEUKOCYTE BIOL, V55, P289; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118; YI TL, 1991, MOL CELL BIOL, V11, P2391, DOI 10.1128/MCB.11.5.2391; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	86	260	264	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	1995	2	2					155	166		10.1016/S1074-7613(95)80040-9	http://dx.doi.org/10.1016/S1074-7613(95)80040-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QH132	7895172	Bronze			2022-12-18	WOS:A1995QH13200004
J	McKenzie, ANJ; Spits, H; Eberl, G				McKenzie, Andrew N. J.; Spits, Hergen; Eberl, Gerard			Innate Lymphoid Cells in Inflammation and Immunity	IMMUNITY			English	Review							ROR-GAMMA-T; NATURAL HELPER-CELLS; HOST-DEFENSE; TYPE-2; IL-25; EXPRESSION; RESPONSES; IL-33; INTERLEUKIN-22; T(H)2	Innate lymphoid cells (ILCs) were first described as playing important roles in the development of lymphoid tissues and more recently in the initiation of inflammation at barrier surfaces in response to infection or tissue damage. It has now become apparent that ILCs play more complex roles throughout the duration of immune responses, participating in the transition from innate to adaptive immunity and contributing to chronic inflammation. The proximity of ILCs to epithelial surfaces and their constitutive strategic positioning in other tissues throughout the body ensures that, in spite of their rarity, ILCs are able to regulate immune homeostasis effectively. Dysregulation of ILC function might result in chronic pathologies such as allergies, autoimmunity, and inflammation. A new role for ILCs in the maintenance of metabolic homeostasis has started to emerge, underlining their importance in fundamental physiological processes beyond infection and immunity.	[McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 BK Amsterdam, Netherlands; [Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France	MRC Laboratory Molecular Biology; University of Amsterdam; Academic Medical Center Amsterdam; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	McKenzie, ANJ (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	anm@mrc-lmb.cam.ac.uk	Spits, Hergen/N-2581-2019; Eberl, Gerard/A-1160-2013	Spits, Hergen/0000-0003-3269-8338; Eberl, Gerard/0000-0002-1119-5638	MRC; Wellcome Trust; Medical Research Council [MC_U105178805] Funding Source: researchfish; MRC [MC_U105178805] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	A.N.J.M. is supported by the MRC and Wellcome Trust.	Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Allen JE, 2014, SEMIN IMMUNOL; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Barlow JL, 2011, CLIN EXP ALLERGY, V41, P1447, DOI 10.1111/j.1365-2222.2011.03806.x; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang JE, 2014, J ALLERGY CLIN IMMUN, V133, P899, DOI 10.1016/j.jaci.2013.09.020; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Drake L. Y., 2014, ALLERGY; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Ermann J, 2014, P NATL ACAD SCI USA, V111, pE2559, DOI 10.1073/pnas.1408540111; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Gorski SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003615; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2013, CHEST, V144, P1681, DOI 10.1378/chest.13-0911; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; He R, 2008, P NATL ACAD SCI USA, V105, P11875, DOI 10.1073/pnas.0801532105; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hong J. Y., 2014, J ALLERGY CLIN IMMUN, V134, pe8; Hong JY, 2014, J ALLERGY CLIN IMMUN, V134, P429, DOI 10.1016/j.jaci.2014.04.020; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Hvid M, 2011, J INVEST DERMATOL, V131, P150, DOI 10.1038/jid.2010.277; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Korn LL, 2014, MUCOSAL IMMUNOL, V7, P1045, DOI 10.1038/mi.2013.121; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Li J, 2014, J CLIN INVEST, V124, P3241, DOI 10.1172/JCI73742; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Mair F, 2014, EUR J IMMUNOL, V44, P37, DOI 10.1002/eji.201343653; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Meylan F, 2014, MUCOSAL IMMUNOL, V7, P958, DOI 10.1038/mi.2013.114; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; Philip NH, 2013, IMMUNOL CELL BIOL, V91, P225, DOI 10.1038/icb.2013.2; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Saglani S, 2013, J ALLERGY CLIN IMMUN, V132, P676, DOI 10.1016/j.jaci.2013.04.012; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stanya KJ, 2013, J CLIN INVEST, V123, P261, DOI 10.1172/JCI64941; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2351, DOI 10.1038/jid.2014.146; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Upadhyay V, 2012, NAT IMMUNOL, V13, P947, DOI 10.1038/ni.2403; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Xue L., 2014, J ALLERGY CLIN IMMUN, V133; Yu X, 2014, MUCOSAL IMMUNOL, V7, P730, DOI 10.1038/mi.2013.92; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	104	259	280	0	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					366	374		10.1016/j.immuni.2014.09.006	http://dx.doi.org/10.1016/j.immuni.2014.09.006			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25238094	Bronze			2022-12-18	WOS:000342626500008
J	Kuchen, S; Resch, W; Yamane, A; Kuo, N; Li, ZY; Chakraborty, T; Wei, L; Laurence, A; Yasuda, T; Peng, SY; Hu-Li, J; Lu, K; Dubois, W; Kitamura, Y; Charles, N; Sun, HW; Muljo, S; Schwartzberg, PL; Paul, WE; O'Shea, J; Rajewsky, K; Casellas, R				Kuchen, Stefan; Resch, Wolfgang; Yamane, Arito; Kuo, Nan; Li, Zhiyu; Chakraborty, Tirtha; Wei, Lai; Laurence, Arian; Yasuda, Tomoharu; Peng, Siying; Hu-Li, Jane; Lu, Kristina; Dubois, Wendy; Kitamura, Yoshiaki; Charles, Nicolas; Sun, Hong-wei; Muljo, Stefan; Schwartzberg, Pamela L.; Paul, William E.; O'Shea, John; Rajewsky, Klaus; Casellas, Rafael			Regulation of MicroRNA Expression and Abundance during Lymphopoiesis	IMMUNITY			English	Article							POSTTRANSCRIPTIONAL REGULATION; CELL DIFFERENTIATION; STEM-CELLS; SMALL RNAS; IDENTIFICATION; BIOGENESIS; PATTERNS; DICER; SPECIFICITY; ABSENCE	Although the cellular concentration of miRNAs is critical to their function, how miRNA expression and abundance are regulated during ontogeny is unclear. We applied miRNA-, mRNA-, and ChIP-Seq to characterize the microRNome during lymphopoiesis within the context of the transcriptome and epigenome. We show that lymphocyte-specific miRNAs are either tightly controlled by polycomb group-mediated H3K27me3 or maintained in a semi-activated epigenetic state prior to full expression. Because of miRNA biogenesis, the cellular concentration of mature miRNAs does not typically reflect transcriptional changes. However, we uncover a subset of miRNAs for which abundance is dictated by miRNA gene expression. We confirm that concentration of 5p and 3p miRNA strands depends largely on free energy properties of miRNA duplexes. Unexpectedly, we also find that miRNA strand accumulation can be developmentally regulated. Our data provide a comprehensive map of immunity's microRNome and reveal the underlying epigenetic and transcriptional forces that shape miRNA homeostasis.	[Resch, Wolfgang; Kitamura, Yoshiaki; Charles, Nicolas] NIAMS, Lab Immune Cell Signaling, NIH, Bethesda, MD 20892 USA; [Chakraborty, Tirtha; Yasuda, Tomoharu; Peng, Siying; Rajewsky, Klaus] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Chakraborty, Tirtha; Yasuda, Tomoharu; Peng, Siying; Rajewsky, Klaus] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Hu-Li, Jane; Muljo, Stefan; Paul, William E.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Lu, Kristina; Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Dubois, Wendy] NCI, Genet Lab, NIH, Bethesda, MD 20892 USA; [Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Resch, W (corresponding author), NIAMS, Lab Immune Cell Signaling, NIH, Bethesda, MD 20892 USA.	wresch@mail.nih.gov; casellar@mail.nih.gov	Wei, Lai/D-1088-2014; CHARLES, Nicolas/S-2214-2019; Yasuda, Tomoharu/J-5102-2019; Yamane, Arito/A-2959-2013; CHARLES, Nicolas/P-5430-2014; Muljo, Stefan A/F-5671-2015; Laurence, Arian/A-8770-2009	CHARLES, Nicolas/0000-0002-5416-5834; CHARLES, Nicolas/0000-0002-5416-5834; Muljo, Stefan A/0000-0003-1013-446X; Laurence, Arian/0000-0003-0942-8292; Yasuda, Tomoharu/0000-0001-9997-6852; Resch, Wolfgang/0000-0001-7594-5963; Rajewsky, Klaus/0000-0002-6633-6370; Kuchen, Stefan/0000-0003-4899-8132	NIAMS-NIH; Swiss Foundation for Grants in Biology and Medicine; NATIONAL CANCER INSTITUTE [ZICBC011047] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493, ZIAAI000926, ZIAAI001131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173, ZIAAR041148, ZIAAR041159, ZIAAR041149, ZICAR041181] Funding Source: NIH RePORTER	NIAMS-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Swiss Foundation for Grants in Biology and Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank members of the Casellas lab for discussions; J. Newman and R. Young for mouse ESCs; J. Simone for cell sorting; G. Gutierrez for technical assistance with the genome analyzer; B. Wold for the mRNA-seq protocol; and L. Naldini for the LV-SFFV lentiviral vector. This work was supported in part by the Intramural Research Program of NIAMS-NIH. S. K. was supported by the Swiss Foundation for Grants in Biology and Medicine.	Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Fang W, 1996, IMMUNITY, V4, P291, DOI 10.1016/S1074-7613(00)80437-9; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186	59	259	276	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 25	2010	32	6					828	839		10.1016/j.immuni.2010.05.009	http://dx.doi.org/10.1016/j.immuni.2010.05.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20605486	Bronze, Green Accepted			2022-12-18	WOS:000279365800013
J	Ara, T; Tokoyoda, K; Sugiyama, T; Egawa, T; Kawabata, K; Nagasawa, T				Ara, T; Tokoyoda, K; Sugiyama, T; Egawa, T; Kawabata, K; Nagasawa, T			Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny	IMMUNITY			English	Article							CHEMOKINE RECEPTOR CXCR4; PROGENITOR CELLS; MOLECULAR-CLONING; CD34(+) CELLS; SDF-1; MOBILIZATION; FETAL; MICE; MIGRATION; MOUSE	The physiological role of SDF-1 on hematopoietic stem cells (HSCs) remains elusive. We show that colonization of bone marrow by HSCs in addition to myeloid cells is severely impaired in SDF-1(-/-) embryos by a long-term repopulation assay. Colonization of spleen by HSCs was also affected, but to a lesser extent. Enforced expression of SDF-1 under the control of vascular-specific Tie-2 regulatory sequences could completely rescue the reduction of HSCs but not myeloid cells in SDF-1(-/-) bone marrow. SDF-1 was detected in the vicinity of the vascular endothelial cells in fetal bone marrow. SDF-1 plays a critical role in colonization of bone marrow by HSCs and myeloid cells during ontogeny, and the mechanisms by which SDF-1 functions are distinct between HSCs and myeloid cells.	Kyoto Univ, Dept Med Syst Control, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan; Osaka Med Ctr Maternal & Child Hlth, Dept Immunol, Osaka 5941101, Japan	Kyoto University	Nagasawa, T (corresponding author), Kyoto Univ, Dept Med Syst Control, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	tnagasa@frontier.kyoto-u.ac.jp		Tokoyoda, Koji/0000-0001-6101-4826; Nagasawa, Takashi/0000-0002-1085-0960; Ara, Toshiaki/0000-0003-4005-9122; Sugiyama, Tatsuki/0000-0002-9349-0824				Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Delassus S, 1996, IMMUNITY, V4, P97, DOI 10.1016/S1074-7613(00)80302-7; Egawa T, 2001, IMMUNITY, V15, P323, DOI 10.1016/S1074-7613(01)00185-6; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Friedrich C, 1996, EUR J IMMUNOL, V26, P2773, DOI 10.1002/eji.1830261133; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Hodohara K, 2000, BLOOD, V95, P769, DOI 10.1182/blood.V95.3.769.003a49_769_775; Hsu HC, 2000, BLOOD, V96, P3757, DOI 10.1182/blood.V96.12.3757.h8003757_3757_3762; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; Lataillade JJ, 2000, BLOOD, V95, P756, DOI 10.1182/blood.V95.3.756; Lataillade JJ, 2002, BLOOD, V99, P1117, DOI 10.1182/blood.V99.4.1117; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MICKLEM HS, 1972, J CELL PHYSIOL, V79, P293, DOI 10.1002/jcp.1040790214; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nagasawa T, 1999, Adv Immunol, V71, P211; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagasawa T, 2000, INT J HEMATOL, V72, P408; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Sweeney EA, 2002, BLOOD, V99, P44, DOI 10.1182/blood.V99.1.44; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TANAKA H, 1993, TRENDS POLYM SCI, V1, P361; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wiesmann A, 1999, EXP HEMATOL, V27, P946, DOI 10.1016/S0301-472X(99)00029-6; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	49	259	272	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2003	19	2					257	267		10.1016/S1074-7613(03)00201-2	http://dx.doi.org/10.1016/S1074-7613(03)00201-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932359	Bronze			2022-12-18	WOS:000184929000013
J	Kopf, M; Ruedl, C; Schmitz, N; Gallimore, A; Lefrang, K; Ecabert, B; Odermatt, B; Bachmann, MF				Kopf, M; Ruedl, C; Schmitz, N; Gallimore, A; Lefrang, K; Ecabert, B; Odermatt, B; Bachmann, MF			OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection	IMMUNITY			English	Article							OX40 LIGAND; CD28-DEFICIENT MICE; VIRAL-INFECTION; IMMUNE-RESPONSE; ACTIVATED RAT; TNF RECEPTOR; DIFFERENTIATION; LYMPHOCYTES; EXPRESSION; CYTOKINE	OX40, a member of the TNF receptor superfamily, is expressed on activated T cells and implicated in stimulation of T cells and T-dependent humoral responses. We generated OX40(-/-) mice and found that the formation of extrafollicular plasma cells, germinal centers, and antibody responses was independent of OX40. After infection with LCMV and influenza virus, OX40(-/-) mice retain primary and memory cytotoxic T cell responses with normal expansion and decline of specific CTL. In contrast, CD4(+) T cell proliferation and the number of IFN-gamma-producing CD4(+) T cells were reduced in OX40(-/-) mice. Moreover, the number of CD4(+) T cells infiltrating the lungs of influenza virus-infected OX40(-/-) mice was reduced. These results define a unique role of OX40 in the generation of optimal CD4(+) T cell responses in vivo.	Basel Inst Immunol, CH-4005 Basel, Switzerland; Univ Zurich, Dept Pathol, CH-8091 Zurich, Switzerland; John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England	University of Zurich; University of Oxford	Kopf, M (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.		Kopf, Manfred/B-6907-2009; Ruedl, christiane/A-2219-2011	Kopf, Manfred/0000-0002-0628-7140; Ruedl, christiane/0000-0002-5599-6541; Gallimore, Awen/0000-0001-6675-7004				AlShamkhani A, 1996, EUR J IMMUNOL, V26, P1695, DOI 10.1002/eji.1830260805; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Bachmann M.F., 1997, IMMUNOLOGY METHODS M, P1921; Bachmann MF, 1999, J IMMUNOL METHODS, V225, P105, DOI 10.1016/S0022-1759(99)00034-4; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Bachmann MF, 1997, SCIENCE, V276, P2024, DOI 10.1126/science.276.5321.2024; Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Baker SJ, 1996, ONCOGENE, V12, P1; BATTEGAY M, 1993, J IMMUNOL, V151, P5408; BATTEGAY M, 1994, J IMMUNOL, V151; BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261; CHARAN S, 1986, P NATL ACAD SCI USA, V83, P2604; DeBenedette MA, 1999, J IMMUNOL, V163, P4833; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gause WC, 1997, J IMMUNOL, V158, P4082; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Gravestein LA, 1998, SEMIN IMMUNOL, V10, P423, DOI 10.1006/smim.1998.0144; GRAY D, 1991, INT IMMUNOL, V3, P141, DOI 10.1093/intimm/3.2.141; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Higgins LM, 1999, J IMMUNOL, V162, P486; Imura A, 1996, J EXP MED, V183, P2185, DOI 10.1084/jem.183.5.2185; Kawai K, 1996, TRANSPLANTATION, V61, P352, DOI 10.1097/00007890-199602150-00003; Kawamata S, 1998, J BIOL CHEM, V273, P5808, DOI 10.1074/jbc.273.10.5808; Kopf M, 1996, J EXP MED, V184, P1127, DOI 10.1084/jem.184.3.1127; KOPF M, 1996, PROTOCOLS GENE TARGE, P199; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Ohshima Y, 1998, BLOOD, V92, P3338, DOI 10.1182/blood.V92.9.3338.421k19_3338_3345; Ohshima Y, 1997, J IMMUNOL, V159, P3838; Oxenius A, 1996, J EXP MED, V183, P2209, DOI 10.1084/jem.183.5.2209; PATERSON DJ, 1987, MOL IMMUNOL, V24, P1281, DOI 10.1016/0161-5890(87)90122-2; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Stuber E, 1996, J EXP MED, V183, P979, DOI 10.1084/jem.183.3.979; Takahashi C, 1999, J IMMUNOL, V162, P5037; Tuosto L, 1998, EUR J IMMUNOL, V28, P2131, DOI 10.1002/(SICI)1521-4141(199807)28:07<2131::AID-IMMU2131>3.0.CO;2-Q; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; Watts TH, 1999, CURR OPIN IMMUNOL, V11, P286, DOI 10.1016/S0952-7915(99)80046-6; Weinberg AD, 1998, SEMIN IMMUNOL, V10, P471, DOI 10.1006/smim.1998.0146; Weinberg AD, 1996, NAT MED, V2, P183, DOI 10.1038/nm0296-183; Whitmire JK, 1996, J VIROL, V70, P8375, DOI 10.1128/JVI.70.12.8375-8381.1996; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075	51	259	271	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1999	11	6					699	708		10.1016/S1074-7613(00)80144-2	http://dx.doi.org/10.1016/S1074-7613(00)80144-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626892	Bronze			2022-12-18	WOS:000084612900006
J	Jumaa, H; Wollscheid, B; Mitterer, M; Wienands, J; Reth, M; Nielsen, PJ				Jumaa, H; Wollscheid, B; Mitterer, M; Wienands, J; Reth, M; Nielsen, PJ			Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; T-CELL; PHOSPHOLIPASE C-GAMMA-2; ACTIVATION; SURFACE; APOPTOSIS; MOUSE; CHAIN; REQUIREMENT; MATURATION	During signal transduction through the B cell antigen receptor (BCR), several signaling elements are brought together by the adaptor protein SLP-65. We have investigated the role of SLP-65 in B cell maturation and function in mice deficient for SLP-65. While the mice are viable, B cell development is affected at several stages. SLP-65-deficient mice show increased proportions of pre-B cells in the bone marrow and immature B cells in peripheral lymphoid organs. B1 B cells are lacking. The mice show tower IgM and IgG3 serum titers and poor IgM but normal IgG immune responses. Mutant B cells show reduced Ca2+ mobilization and reduced proliferative responses to B cell mitogens. We conclude that white playing an important role, SLP-65 is not always required for signaling from the BCR.	Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	Max Planck Society	Nielsen, PJ (corresponding author), Max Planck Inst Immunbiol, Stubeweg 51, D-79108 Freiburg, Germany.		Wollscheid, Bernd/E-8909-2010	Wollscheid, Bernd/0000-0002-3923-1610				ALLMAN DM, 1992, J IMMUNOL, V149, P2533; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; Clements JL, 1998, J IMMUNOL, V161, P3880; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Goitsuka R, 1998, J IMMUNOL, V161, P5804; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HAYASHI SI, 1990, J EXP MED, V171, P1683, DOI 10.1084/jem.171.5.1683; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KRAAL G, 1995, AM J PATHOL, V147, P763; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; MacLennan ICM, 1998, CURR OPIN IMMUNOL, V10, P220, DOI 10.1016/S0952-7915(98)80252-5; Norvell A, 1996, J IMMUNOL, V156, P1328; Osmond DG, 1998, IMMUNOL TODAY, V19, P65, DOI 10.1016/S0167-5699(97)01203-6; Pillai S, 1999, IMMUNITY, V10, P493, DOI 10.1016/S1074-7613(00)80049-7; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Rolink A, 1996, IMMUNOL LETT, V54, P157, DOI 10.1016/S0165-2478(96)02666-1; Sater RA, 1998, INT IMMUNOL, V10, P1673, DOI 10.1093/intimm/10.11.1673; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Townsend SE, 1999, IMMUNOL TODAY, V20, P217, DOI 10.1016/S0167-5699(98)01440-6; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; WIENANDS J, 1998, J EXP MED, V18, P1; Wollscheid B, 1999, CURR TOP MICROBIOL, V246, P283; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413	37	259	261	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1999	11	5					547	554		10.1016/S1074-7613(00)80130-2	http://dx.doi.org/10.1016/S1074-7613(00)80130-2			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591180	hybrid			2022-12-18	WOS:000083952200007
J	SWAIN, SL				SWAIN, SL			GENERATION AND IN-VIVO PERSISTENCE OF POLARIZED TH1 AND TH2 MEMORY CELLS	IMMUNITY			English	Article							CD4+ T-CELLS; RECEPTOR TRANSGENIC MICE; INTERFERON-GAMMA; HELPER-CELLS; LYMPHOKINE SECRETION; LYMPHOCYTES-T; B-CELLS; ANTIGEN; IL-4; SUBSETS	In vitro generated CD4 cell lines and effecters often produce either Th1 or Th2 cytokines, but stimulation of resting CD4 cells from animals leads to production mostly of IL-2. To determine whether polarization of CD4 effector cells results in development of polarized memory, I generated antigen-specific Th1 and Th2 effecters in vitro and transferred them to adoptive hosts. The effecters gave rise to long-lived populations of CD4 T cells with the phenotype of resting memory cells. Recovered cells responded vigorously to specific antigen, producing a pattern of cytokines closely related to that of the transferred effecters. Thus, encounter with a peptide antigen and directive cytokines at the initiation of culture can lead to generation of both effector and long-lived memory cell populations that produce restricted patterns of cytokines.	UNIV CALIF SAN DIEGO,CTR CANC,LA JOLLA,CA 92093	University of California System; University of California San Diego	SWAIN, SL (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.				NIAID NIH HHS [R01AI26887, R01AI22125] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026887, R01AI022125] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRADLEY LM, 1993, J IMMUNOL, V150, P3119; BRADLEY LM, 1991, J EXP MED, V174, P547, DOI 10.1084/jem.174.3.547; BRADLEY LM, 1992, J IMMUNOL, V148, P324; BRADLEY LM, 1993, IMMUNOL TODAY, V14, P197, DOI 10.1016/0167-5699(93)90161-D; BUDD RC, 1987, J IMMUNOL, V138, P3583; CEROTTINI JC, 1989, ANNU REV IMMUNOL, V7, P77, DOI 10.1146/annurev.iy.07.040189.000453; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x; CROFT M, 1992, J EXP MED, V176, P1431, DOI 10.1084/jem.176.5.1431; CROFT M, 1991, J IMMUNOL, V146, P4055; CROFT M, 1994, J IMMUNOL, V152, P2675; EHLERS S, 1991, J EXP MED, V173, P25, DOI 10.1084/jem.173.1.25; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; GROSS A, 1993, J IMMUNOL, V150, P2112; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; KAYE J, 1988, NATURE, V336, P580, DOI 10.1038/336580a0; KUHLMAN P, 1991, J IMMUNOL, V146, P1773; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LEE WT, 1991, INT IMMUNOL, V3, P907, DOI 10.1093/intimm/3.9.907; LINTON PJ, 1989, CELL, V59, P1049, DOI 10.1016/0092-8674(89)90761-7; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; OEHEN S, 1992, J EXP MED, V176, P1273, DOI 10.1084/jem.176.5.1273; POWERS GD, 1988, J IMMUNOL, V140, P3352; RIDDELL SR, 1992, SCIENCE, V257, P238; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; SANDERS ME, 1988, J IMMUNOL, V140, P1401; SCOTT P, 1989, IMMUNOL REV, V112, P161, DOI 10.1111/j.1600-065X.1989.tb00557.x; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; SPRENT J, 1991, J EXP MED, V174, P717, DOI 10.1084/jem.174.3.717; SPRENT J, 1994, CELL, V76, P315, DOI 10.1016/0092-8674(94)90338-7; STREET NE, 1990, J IMMUNOL, V144, P1692; Swain S L, 1992, Semin Immunol, V4, P59; SWAIN SL, 1990, J IMMUNOL, V144, P1788; SWAIN SL, 1991, J IMMUNOL, V147, P2991; SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x; SWAIN SL, 1993, CURR BIOL, V3, P115, DOI 10.1016/0960-9822(93)90169-O; SWAIN SL, 1988, J IMMUNOL, V141, P3445; SWAIN SL, 1990, J IMMUNOL, V145, P3796; SWAIN SL, 1992, NEW ADV CYTOKINES, V92, P107; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; WEINBERG AD, 1990, J IMMUNOL, V144, P1800; YAMAMURA M, 1992, SCIENCE, V255, P12, DOI 10.1126/science.1553522	49	259	264	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1994	1	7					543	552		10.1016/1074-7613(94)90044-2	http://dx.doi.org/10.1016/1074-7613(94)90044-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PN127	7600283				2022-12-18	WOS:A1994PN12700003
J	Galani, IE; Triantafyllia, V; Eleminiadou, EE; Koltsida, O; Stavropoulos, A; Manioudaki, M; Thanos, D; Doyle, SE; Kotenko, SV; Thanopoulou, K; Andreakos, E				Galani, Ioanna E.; Triantafyllia, Vasiliki; Eleminiadou, Evridiki-Evangelia; Koltsida, Ourania; Stavropoulos, Athanasios; Manioudaki, Maria; Thanos, Dimitris; Doyle, Sean E.; Kotenko, Sergei V.; Thanopoulou, Kalliopi; Andreakos, Evangelos			Interferon-lambda Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness	IMMUNITY			English	Article							HEPATITIS-C VIRUS; III INTERFERONS; T-CELLS; IFN; IMMUNITY; EXPRESSION; INDUCTION; REVEALS; COMPLEX; IL-29	Lambda interferons (IFN lambda s) or type III IFNs share homology, expression patterns, signaling cascades, and antiviral functions with type I IFNs. This has complicated the unwinding of their unique non-redundant roles. Through the systematic study of influenza virus infection in mice, we herein show that IFN lambda s are the first IFNs produced that act at the epithelial barrier to suppress initial viral spread without activating inflammation. If infection progresses, type I IFNs come into play to enhance viral resistance and induce pro-inflammatory responses essential for confronting infection but causing immunopathology. Central to this are neutrophils which respond to both cytokines to upregulate antimicrobial functions but exhibit pro-inflammatory activation only to type I IFNs. Accordingly, Ifnlr1(-/-) mice display enhanced type I IFN production, neutrophilia, lung injury, and lethality, while therapeutic administration of PEG-IFN lambda potently suppresses these effects. IFN lambda s therefore constitute the front line of antiviral defense in the lung without compromising host fitness.	[Galani, Ioanna E.; Triantafyllia, Vasiliki; Eleminiadou, Evridiki-Evangelia; Koltsida, Ourania; Stavropoulos, Athanasios; Manioudaki, Maria; Thanopoulou, Kalliopi; Andreakos, Evangelos] Acad Athens, Biomed Res Fdn, Lab Immunobiol, Ctr Clin Expt Surg & Translat Res, Athens 11527, Greece; [Thanos, Dimitris] Acad Athens, Biomed Res Fdn, Lab Mol Biol, Ctr Basic Res, Athens 11527, Greece; [Doyle, Sean E.] ZymoGenetics Inc, Seattle, WA 98102 USA; [Kotenko, Sergei V.] State Univ New Jersey, Dept Microbiol Biochem & Mol Genet, Ctr Immunity & Inflammat, Univ Hosp Canc Ctr,New Jersey Med Sch, Newark, NJ 07103 USA	Academy of Athens; Academy of Athens; Zymogenet Inc.; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Andreakos, E (corresponding author), Acad Athens, Biomed Res Fdn, Lab Immunobiol, Ctr Clin Expt Surg & Translat Res, Athens 11527, Greece.	vandreakos@bioacademy.gr	Galani, Ioanna Evdokia/AAM-3546-2021; Thanos, Dimitris/AAE-5720-2019	Galani, Ioanna Evdokia/0000-0002-0965-3863; Stavropoulos, Athanasios/0000-0002-5101-1899; Triantafyllia, Vasiliki/0000-0001-5832-4014	Hellenic Ministry of Education (MIDAS, RESOLVE-ASTHMA); European Commission	Hellenic Ministry of Education (MIDAS, RESOLVE-ASTHMA); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank P. Sideras for advice and A. Gavriil, A. Apostolidou, A. Doulou, A. Kokkalis, G. Panagopoulos, and A. Polyzos for technical assistance. This work was supported by grant awards from the Hellenic Ministry of Education (MIDAS, RESOLVE-ASTHMA) and the European Commission (FP7 Programs PREDICTA, NILTHERA, and TACIT). S.E.D. is an employee and stock holder of Bristol-Myers Squibb. S.V.K. is an inventor of patents related to IFN lambda s licensed for commercial development.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; Dai JH, 2009, BLOOD, V113, P5829, DOI 10.1182/blood-2008-09-179507; Davidson S, 2016, EMBO MOL MED, V8, P1099, DOI 10.15252/emmm.201606413; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101; Galani IE, 2015, J LEUKOCYTE BIOL, V98, P557, DOI 10.1189/jlb.4VMR1114-555R; Galani IE, 2015, ADV EXP MED BIOL, V850, P1, DOI 10.1007/978-3-319-15774-0_1; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Hogan B.L., 2004, CELL, V3, P11; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Lin JD, 2016, PLOS PATHOG, V12, DOI [10.1371/journal.ppat.1005600, 10.1371/journal.ppat.1005726]; Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mendoza JL, 2017, IMMUNITY, V46, P379, DOI 10.1016/j.immuni.2017.02.017; Mennechet FJD, 2006, BLOOD, V107, P4417, DOI 10.1182/blood-2005-10-4129; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Smee DF, 2012, ANTIMICROB AGENTS CH, V56, P6328, DOI 10.1128/AAC.01664-12; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; Zhang X., 2012, J VIRAL HEPATITUS, V19, P843	36	258	277	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					875	+		10.1016/j.immuni.2017.04.025	http://dx.doi.org/10.1016/j.immuni.2017.04.025			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514692	Bronze			2022-12-18	WOS:000401316300021
J	Dorner, BG; Dorner, MB; Zhou, XF; Opitz, C; Mora, A; Guttler, S; Hutloff, A; Mages, HW; Ranke, K; Schaefer, M; Jack, RS; Henn, V; Kroczek, RA				Dorner, Brigitte G.; Dorner, Martin B.; Zhou, Xuefei; Opitz, Corinna; Mora, Ahmed; Guettler, Steffen; Hutloff, Andreas; Mages, Hans W.; Ranke, Katja; Schaefer, Michael; Jack, Robert S.; Henn, Volker; Kroczek, Richard A.			Selective Expression of the Chemokine Receptor XCR1 on Cross-presenting Dendritic Cells Determines Cooperation with CD8(+) T Cells	IMMUNITY			English	Article							IN-VIVO; MOLECULAR-CLONING; BONE-MARROW; LYMPHOTACTIN; ANTIGENS; CYTOKINES; IMMUNITY; SUBSETS; DEC-205; CULTURE	The expression of the chemokine receptor XCR1 and the function of its ligand XCL1 (otherwise referred to as ATAC, lymphotactin, or SCM-1) remained elusive to date. In the present report we demonstrated that XCR1 is exclusively expressed on murine CD8(+) dendritic cells (DCs) and showed that XCL1 is a potent and highly specific chemoattractant for this DC subset. CD8(+) T cells abundantly secreted XCL1 8-36 hr after antigen recognition on CD8(+) DCs in vivo, in a period in which stable T cell-DC interactions are known to occur. Functionally, XCL1 increased the pool of antigen-specific CD8(+) T cells and their capacity to secrete IFN-gamma. Absence of XCL1 impaired the development of cytotoxicity to antigens cross-presented by CD8(+) DCs. The XCL1 - XCR1 axis thus emerges as an integral component in the development of efficient cytotoxic immunity in vivo.	[Dorner, Brigitte G.; Dorner, Martin B.; Zhou, Xuefei; Opitz, Corinna; Mora, Ahmed; Guettler, Steffen; Hutloff, Andreas; Mages, Hans W.; Ranke, Katja; Henn, Volker; Kroczek, Richard A.] Robert Koch Inst, D-13353 Berlin, Germany; [Schaefer, Michael] Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany; [Jack, Robert S.] Ernst Moritz Arndt Univ Greifswald, Inst Immunol, D-17489 Greifswald, Germany	Robert Koch Institute; Ernst Moritz Arndt Universitat Greifswald	Kroczek, RA (corresponding author), Robert Koch Inst, D-13353 Berlin, Germany.	kroczek@rki.de	Dorner, Martin B/C-5703-2013; ZHOU, XUE/F-6129-2013; Hutloff, Andreas/D-1781-2014	Dorner, Martin B/0000-0002-8176-797X; Hutloff, Andreas/0000-0002-0572-8151; Dorner, Brigitte/0000-0002-5100-2546	Deutsche Forschungsgemeinschaft [SFB421]; Wilhelm Sander-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander-Stiftung	The expert technical assistance of E. Kowalczyk and M. Jaensch is gratefully acknowledged, and we thank J. Lohler for histological analysis of Xcl1-deficient mice. We are grateful to M. Lutz for generation of bone marrow-derived DCs. This work was supported by grants from the Deutsche Forschungsgemeinschaft to R.A.K. (SFB421) and in part by the Wilhelm Sander-Stiftung.	ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dorner B, 1997, J BIOL CHEM, V272, P8817, DOI 10.1074/jbc.272.13.8817; Dorner BG, 2004, J IMMUNOL, V172, P3119, DOI 10.4049/jimmunol.172.5.3119; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; KENNEDY J, 1995, J IMMUNOL, V155, P203; LAW LW, 1977, J NATL CANCER I, V59, P1523, DOI 10.1093/jnci/59.5.1523; Lenz JC, 2002, J CELL BIOL, V159, P291, DOI 10.1083/jcb.200203048; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McLellan AD, 2002, BLOOD, V99, P2084, DOI 10.1182/blood.V99.6.2084; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; MULLER S, 1995, EUR J IMMUNOL, V25, P1744, DOI 10.1002/eji.1830250638; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Tewari K, 2006, P NATL ACAD SCI USA, V103, P16388, DOI 10.1073/pnas.0602565103; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; YOSHIDA T, 1995, FEBS LETT, V360, P155, DOI 10.1016/0014-5793(95)00093-O; Yoshida T, 1998, J BIOL CHEM, V273, P16551, DOI 10.1074/jbc.273.26.16551	30	258	273	2	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 20	2009	31	5					823	833		10.1016/j.immuni.2009.08.027	http://dx.doi.org/10.1016/j.immuni.2009.08.027			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19913446	Bronze			2022-12-18	WOS:000272097900016
J	Egen, JG; Rothfuchs, AG; Feng, CG; Winter, N; Sher, A; Germain, RN				Egen, Jackson G.; Rothfuchs, Antonio Gigliotti; Feng, Carl G.; Winter, Nathalie; Sher, Alan; Germain, Ronald N.			Macrophage and T cell dynamics during the development and disintegration of mycobacterial Granulomas	IMMUNITY			English	Article							BACILLUS-CALMETTE-GUERIN; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; BOVIS BCG; IMMUNE-RESPONSE; BLOOD-VESSELS; INFECTION; LYMPHOCYTES; MOTILITY; MICE	Granulomas play a key role in host protection againstmycobacterial pathogens, with their breakdown contributing to exacerbated disease. To better understand the initiation and maintenance of these structures, we employed both high-resolution multiplex static imaging and intravital multiphoton microscopy of Mycobacterium bovis BCG-induced liver granulomas. We found that Kupffer cells directly capture blood-borne bacteria and subsequently nucleate formation of a nascent granuloma by recruiting both uninfected liver-resident macrophages and blood-derived monocytes. Within the mature granuloma, these myeloid cell populations formed a relatively immobile cellular matrix that interacted with a highly dynamic effector T cell population. The efficient recruitment of these T cells was highly dependent on TNF-alpha-derived signals, which also maintained the granuloma structure through preferential effects on uninfected macrophage populations. By characterizing the migration of both innate and adaptive immune cells throughout the process of granuloma development, these studies provide a new perspective on the cellular events involved in mycobacterial containment and escape.	[Egen, Jackson G.; Germain, Ronald N.] NIAID, Natl Inst Hlth, Immunol Lab, Lymphocyte Biol Sect, Bethesda, MD 20892 USA; [Rothfuchs, Antonio Gigliotti; Feng, Carl G.; Sher, Alan] NIAID, Natl Inst Hlth, Parasit Dis Lab, Immunobiol Sect, Bethesda, MD 20892 USA; [Winter, Nathalie] Inst Pasteur, Mycobacterial Genet Unit, F-7724 Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Germain, RN (corresponding author), NIAID, Natl Inst Hlth, Immunol Lab, Lymphocyte Biol Sect, Bethesda, MD 20892 USA.	asher@niaid.nih.gov; rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Rothfuchs, Antonio G/F-5981-2013; Winter, Nathalie/U-2690-2018; Germain, Ronald/ABE-7090-2020	Rothfuchs, Antonio G/0000-0001-6001-7240; Winter, Nathalie/0000-0003-0994-7834; Egen, Jackson/0000-0003-2053-0837; feng, carl/0000-0003-4301-4640	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000545, ZIAAI001034, Z01AI000843] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000545-19] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; BAMDEN MJ, 1998, IMMUNOL CELL BIOL, V76, P34; BENACERRAF B, 1959, J EXP MED, V110, P27, DOI 10.1084/jem.110.1.27; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Co DO, 2006, J IMMUNOL, V177, P8456, DOI 10.4049/jimmunol.177.12.8456; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Faust N, 2000, BLOOD, V96, P719; Feng CG, 2000, J INFECT DIS, V181, P1846, DOI 10.1086/315466; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Gregory SH, 2002, J LEUKOCYTE BIOL, V72, P239; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Hogan LH, 2007, INFECT IMMUN, V75, P1154, DOI 10.1128/IAI.00943-06; Kaufmann SHE, 1995, CIBA F SYMP, V195, P123; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kennedy David W., 1997, Blood, V90, P986; KHALIL A, 1975, BIOMEDICINE, V22, P112; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Klingler K, 1997, INFECT IMMUN, V65, P5272, DOI 10.1128/IAI.65.12.5272-5278.1997; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; LADEL CH, 1995, EUR J IMMUNOL, V25, P838, DOI 10.1002/eji.1830250331; LADEL CH, 1995, EUR J IMMUNOL, V25, P377, DOI 10.1002/eji.1830250211; Lin PL, 2007, J INVEST DERM SYMP P, V12, P22, DOI 10.1038/sj.jidsymp.5650027; Matsunaga K, 2000, PATHOL INT, V50, P206, DOI 10.1046/j.1440-1827.2000.01025.x; MCCUSKEY RS, 1983, INFECT IMMUN, V42, P362, DOI 10.1128/IAI.42.1.362-367.1983; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; PELLETIER M, 1982, J IMMUNOL, V129, P2179; Peters W, 2003, MICROBES INFECT, V5, P151, DOI 10.1016/S1286-4579(02)00082-5; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Sewell DL, 2003, CLIN DIAGN LAB IMMUN, V10, P564, DOI 10.1128/CDLi.10.4.564-572.2003; Slimani H, 2003, BBA-BIOMEMBRANES, V1617, P80, DOI 10.1016/j.bbamem.2003.09.006; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; VANDENBERG TK, 1992, J EXP MED, V176, P647, DOI 10.1084/jem.176.3.647; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706	50	258	264	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2008	28	2					271	284		10.1016/j.immuni.2007.12.010	http://dx.doi.org/10.1016/j.immuni.2007.12.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18261937	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000253275000016
J	Xiao, H; Gulen, MF; Qin, JZ; Yao, JH; Bulek, K; Kish, D; Altuntas, CZ; Wald, D; Ma, CX; Zhou, H; Tuohy, VK; Fairchild, RL; de la Motte, C; Cua, D; Vallance, BA; Li, XX				Xiao, Hui; Gulen, Muhammet Fatih; Qin, Jinzhong; Yao, Jianhong; Bulek, Katarzyna; Kish, Danielle; Altuntas, Cengiz Zubeyir; Wald, David; Ma, Caixia; Zhou, Hang; Tuohy, Vincent K.; Fairchild, Robert L.; de la Motte, Carol; Cua, Daniel; Vallance, Bruce A.; Li, Xiaoxia			The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; DROSOPHILA TOLL; CANCER; GUT; IMMUNITY; FAMILY; PROGRESSION; MICROFLORA; COLITIS; TUMORS	Despite constant contact with the large population of commensal bacteria, the colonic mucosa is normally hyporesponsive to these potentially proinflammatory signals. Here we report that the single immunoglobulin IL-1 receptor-related molecule (SIGIRR), a negative regulator for Toll-IL-1R signaling, plays a critical role in gut homeostasis, intestinal inflammation, and colitis-associated tumorigenesis by maintaining the microbial tolerance of the colonic epithelium. SIGIRR-deficient (Sigirr(-/-)) colonic epithelial cells displayed commensal bacteria-dependent homeostatic defects, as shown by constitutive upregulation of inflammatory genes, increased inflammatory responses to dextran sulfate sodium (DSS) challenge, and increased Azoxymethane (AOM)+ DSS-induced colitis-associated tumorigenesis. Gut epithelium-specific expression of the SIGIRR transgene in the SIGIRR-deficient background reduced the cell survival of the SIGIRR-cleficient colon epithelium, abrogated the hypersensitivity of the Sigirr(-/-) mice to DSS-induced colitis, and reduced AOM+DSS-induced tumorigenesis. Taken together, our results indicate that epithelium-derived SIGIRR is critical in controlling the homeostasis and innate immune responses of the colon to enteric microflora.	Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; Cleveland State Univ, Dept Biol, Cleveland, OH 44115 USA; Univ British Columbia, Div Gastroenterol, Vancouver, BC V6T 1Z4, Canada; British Columbia Childrens Hosp, Vancouver, BC V6T 1Z4, Canada; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; DNAX Res Inc, Palo Alto, CA 94304 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; University of British Columbia; BC Childrens Hospital; University of British Columbia; Case Western Reserve University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Li, XX (corresponding author), Cleveland Clin Fdn, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lix@ccf.org	Bulek, Katarzyna/L-7517-2015	Xiao, Hui/0000-0001-5304-243X; Vallance, Bruce/0000-0003-1345-6747; Gulen, Muhammet/0000-0002-7139-6781	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060632] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI060632] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0308680101; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guda K, 2004, ONCOGENE, V23, P3813, DOI 10.1038/sj.onc.1207489; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Qin JZ, 2005, J BIOL CHEM, V280, P25233, DOI 10.1074/jbc.M501363200; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	31	258	273	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2007	26	4					461	475		10.1016/j.immuni.2007.02.012	http://dx.doi.org/10.1016/j.immuni.2007.02.012			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17398123	Bronze			2022-12-18	WOS:000246126400011
J	Green, EA; Choi, YW; Flavell, RA				Green, EA; Choi, YW; Flavell, RA			Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: Highly potent regulators of diabetes that require TRANCE-RANK signals	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; IMMUNOREGULATORY T-CELLS; CD40-CD40 LIGAND INTERACTIONS; TNF FAMILY-MEMBER; CROSS-PRESENTATION; EFFECTOR FUNCTION; VIRUS-INFECTION; TOLERANCE; INDUCTION; ALPHA	Inflammation can activate self-reactive CD8(+) T cells and induce autoimmunity. Here we show in a CD8(+) T cell-mediated model of type I diabetes that CD4(+)CD25(+) Treg cells prevent P cell destruction following localized inflammation in the islets of Langerhans. These Treg cells accumulate preferentially in the pancreatic lymph nodes and islets but not other lymph nodes or spleen. PLN-derived Treg cells are extremely potent; only 2 x 10(3) cells are needed to prevent diabetes development, and their capacity to regulate is dependent on TNF-related activation induced cytokine-receptor activator of NFkappaB signals. Indeed, blockade of this pathway results in decreased frequency of CD4(+)CD25(+) Treg cells in the PLN, resulting in intra-islet differentiation of CD8(+) T cells into CTLs and rapid progression to diabetes.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Univ Cambridge, Cambridge Inst Med Res, JDRF WT Diabet & Inflammat Lab, Cambridge CB2 2XY, England; Univ Penn, Dept Immunol, Philadelphia, PA 19104 USA	Yale University; University of Cambridge; University of Pennsylvania	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 310 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu						Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Ehl S, 1998, J EXP MED, V187, P763, DOI 10.1084/jem.187.5.763; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; GERSHON RK, 1970, IMMUNOLOGY, V18, P723; Green EA, 2000, J EXP MED, V191, P225, DOI 10.1084/jem.191.2.225; Green EA, 1998, IMMUNITY, V9, P733, DOI 10.1016/S1074-7613(00)80670-6; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; HERRERA PL, 1994, DIABETOLOGIA, V37, P1277; Homann D, 1999, IMMUNITY, V11, P463, DOI 10.1016/S1074-7613(00)80121-1; Josien R, 1999, J IMMUNOL, V162, P2562; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Kurts C, 1998, J EXP MED, V188, P415, DOI 10.1084/jem.188.2.415; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; Kwon B, 1999, CURR OPIN IMMUNOL, V11, P340, DOI 10.1016/S0952-7915(99)80054-5; Merriman TR, 1998, HUM MOL GENET, V7, P517, DOI 10.1093/hmg/7.3.517; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Oxenius A, 1996, J EXP MED, V183, P2209, DOI 10.1084/jem.183.5.2209; PICARELLA DE, 1993, J IMMUNOL, V150, P4136; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Vaidya B, 2000, AM J HUM GENET, V66, P1710, DOI 10.1086/302908; Whitmire JK, 1996, J VIROL, V70, P8375, DOI 10.1128/JVI.70.12.8375-8381.1996; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075	37	258	275	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2002	16	2					183	191		10.1016/S1074-7613(02)00279-0	http://dx.doi.org/10.1016/S1074-7613(02)00279-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869680	Bronze			2022-12-18	WOS:000174039600003
J	Lohoff, M; Ferrick, D; Mittrucker, HW; Duncan, GS; Bischof, S; Rollinghoff, M; Mak, TW				Lohoff, M; Ferrick, D; Mittrucker, HW; Duncan, GS; Bischof, S; Rollinghoff, M; Mak, TW			Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo	IMMUNITY			English	Article							IFN-INDUCIBLE GENES; TRANSCRIPTION FACTOR; LEISHMANIA-MAJOR; PHENOTYPE DEVELOPMENT; IRF-1; CELLS; MICE; GAMMA; MACROPHAGES; BETA	The transcription factor interferon regulatory factor-1 (IRF-1) mediates the effects of IFN. No information exists on its role in lymphokine production. Protection against the intracellular pathogen Leishmania major depends on a Th1 response. Here, we show that CD4(+) T cells from Leishmania-infected mice lacking one (+/-) or both (-/-) alleles of the IRF-1 gene developed a profound, gene dose-dependent decrease in IFN gamma production. IRF-1(-/-) mice showed dramatically exacerbated Leishmaniasis. They produced increased Leishmania-specific IgG1 and IgE, and their CD4(+) T cells produced increased IL-4, characteristics of the nonprotective Th2 response. In eel transfer experiments, IRF-1(-/-) CD4(+) T cells mounted normal Th1 responses. However, the ability of IRF-1(-/-) mice to produce IL-12 was severely compromised. Thus, IRF-1 is a determining factor for Th1 responses.	UNIV TORONTO,AMGEN RES INST,TORONTO,ON M5G 2M9,CANADA; UNIV TORONTO,DEPT IMMUNOL,TORONTO,ON M5G 2M9,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO,ON M5G 2M9,CANADA; UNIV ERLANGEN NURNBERG,INST KLIN MIKROBIOL & IMMUNOL,D-91054 ERLANGEN,GERMANY; UNIV CALIF DAVIS,SCH VET MED,DEPT PATHOL,DAVIS,CA 95616; UNIV CALIF DAVIS,SCH VET MED,DEPT MICROBIOL,DAVIS,CA 95616; UNIV CALIF DAVIS,DEPT IMMUNOL,SCH VET MED,DAVIS,CA 95616	University of Toronto; University of Toronto; University of Toronto; University of Erlangen Nuremberg; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Lohoff, M (corresponding author), UNIV TORONTO,ONTARIO CANC INST,TORONTO,ON M5G 2M9,CANADA.		Duncan, Gordon/AIE-7011-2022					CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Demant P, 1996, SCIENCE, V274, P1392, DOI 10.1126/science.274.5291.1392; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; Gieni RS, 1996, INT IMMUNOL, V8, P1511, DOI 10.1093/intimm/8.10.1511; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; GRADEHANDT G, 1988, IMMUNOL REV, V106, P59, DOI 10.1111/j.1600-065X.1988.tb00773.x; GREEN SJ, 1991, J LEUKOCYTE BIOL, V50, P93, DOI 10.1002/jlb.50.1.93; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HOERAUF A, 1994, INT IMMUNOL, V6, P1117, DOI 10.1093/intimm/6.8.1117; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Hsieh B, 1996, J IMMUNOL, V156, P232; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; KERSTEN TS, 1995, J IMMUNOL, V154, P5320; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; KRAAN TCTMV, 1995, J EXP MED, V181, P775, DOI 10.1084/jem.181.2.775; LEFKOVITS I, 1984, IMMUNOL TODAY, V5, P265, DOI 10.1016/0167-5699(84)90137-3; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LIMA HC, 1985, PARASITOL TODAY, V13, P80; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; PINE R, 1990, MOL CELL BIOL, V10, P2448, DOI 10.1128/MCB.10.6.2448; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; REIS LFL, 1992, EMBO J, V11, P185, DOI 10.1002/j.1460-2075.1992.tb05041.x; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Stenger S, 1996, J EXP MED, V183, P1501, DOI 10.1084/jem.183.4.1501; SWAIN SL, 1990, J IMMUNOL, V145, P3796; SWIHART K, 1995, J EXP MED, V181, P961, DOI 10.1084/jem.181.3.961; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307	40	258	259	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1997	6	6					681	689		10.1016/S1074-7613(00)80444-6	http://dx.doi.org/10.1016/S1074-7613(00)80444-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XG579	9208841	Bronze			2022-12-18	WOS:A1997XG57900004
J	Zaiss, DMW; van Loosdregt, J; Gorlani, A; Bekker, CPJ; Grone, A; Sibilia, M; Henegouwen, PMPVE; Roovers, RC; Coffer, PJ; Sijts, AJAM				Zaiss, Dietmar M. W.; van Loosdregt, Jorg; Gorlani, Andrea; Bekker, Cornelis P. J.; Grone, Andrea; Sibilia, Maria; Henegouwen, Paul M. P. van Bergen En; Roovers, Rob C.; Coffer, Paul J.; Sijts, Alice J. A. M.			Amphiregulin Enhances Regulatory T Cell-Suppressive Function via the Epidermal Growth Factor Receptor	IMMUNITY			English	Article							COLORECTAL-CANCER PATIENTS; MAST-CELLS; EGF RECEPTOR; CETUXIMAB; EXPRESSION; DISEASE; MICE; LYMPHOPENIA; ACTIVATION; RESISTANCE	Epidermal growth factor receptor (EGFR) is known to be critically involved in tissue development and homeostasis as well as in the pathogenesis of cancer. Here we showed that Foxp3(+) regulatory T (Treg) cells express EGFR under inflammatory conditions. Stimulation with the EGF-like growth factor Amphiregulin (AREG) markedly enhanced Treg cell function in vitro, and in a colitis and tumor vaccination model we showed that AREG was critical for efficient Treg cell function in vivo. In addition, mast cell-derived AREG fully restored optimal Treg cell function. These findings reveal EGFR as a component in the regulation of local immune responses and establish a link between mast cells and Treg cells. Targeting of this immune regulatory mechanism may contribute to the therapeutic successes of EGFR-targeting treatments in cancer patients.	[Zaiss, Dietmar M. W.; Gorlani, Andrea; Bekker, Cornelis P. J.; Sijts, Alice J. A. M.] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, NL-3584 CL Utrecht, Netherlands; [Grone, Andrea] Univ Utrecht, Fac Vet Med, Dept Pathobiol, NL-3584 CL Utrecht, Netherlands; [van Loosdregt, Jorg; Bekker, Cornelis P. J.; Coffer, Paul J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, NL-3584 EA Utrecht, Netherlands; [van Loosdregt, Jorg; Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3508 AB Utrecht, Netherlands; [Gorlani, Andrea; Henegouwen, Paul M. P. van Bergen En; Roovers, Rob C.] Univ Utrecht, Fac Sci, Dept Cell Biol, NL-3584 CH Utrecht, Netherlands; [Sibilia, Maria] Med Univ Vienna, Inst Canc Res, A-1090 Vienna, Austria	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Medical University of Vienna	Zaiss, DMW (corresponding author), Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, NL-3584 CL Utrecht, Netherlands.	d.zaiss@uu.nl	van Bergen en Henegouwen, Paul/B-8870-2011; Coffer, Paul/AAF-7970-2020	van Bergen en Henegouwen, Paul/0000-0001-6050-9042; Sijts, Alice/0000-0003-3815-4788; Zaiss, Dietmar M.W./0000-0003-3596-7062; Sibilia, Maria/0000-0001-6129-5613; van Loosdregt, Jorg/0000-0003-1411-3754	University of Utrecht; Wellcome Trust [WT 085733MA]; NIH [AI064576]; Infectious Diseases and Immunology Center Utrecht (IICU); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064576] Funding Source: NIH RePORTER	University of Utrecht; Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Infectious Diseases and Immunology Center Utrecht (IICU); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors' research was supported by a grant from the University of Utrecht to D.M.W.Z., Wellcome Trust grant WT 085733MA and NIH Grant AI064576 to A.J.A.M.S., and a Seed Grant from the Infectious Diseases and Immunology Center Utrecht (IICU) to A.J.A.M.S. and P.J.C. D.M.W.Z. performed the mouse experiments and J.v.L., A. Gorlani, and C.P.J.B. performed the experiments involving human material. A. Gorlani, P. M. P. v. B. e. H., and R. C. R. isolated and expressed the EGFR-blocking nanobody, A. Grone helped with the histological analysis, and M. S. contributed the Egfr<SUP>flox/flox</SUP> mouse strain. D.M.W.Z. and A.J.A.M.S. conceived the experimental approach, directed the experiments, and interpreted the data. D.M.W.Z., P.J.C., and A.J.A.M.S. wrote the manuscript.	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Amini RM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-165; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Chan G, 2009, P NATL ACAD SCI USA, V106, P22369, DOI 10.1073/pnas.0908787106; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cobbold SP, 2006, IMMUNOL REV, V213, P239, DOI 10.1111/j.1600-065X.2006.00428.x; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Ferris RL, 2010, J CLIN ONCOL, V28, P4390, DOI 10.1200/JCO.2009.27.6360; Garrido G, 2007, CANCER IMMUNOL IMMUN, V56, P1701, DOI 10.1007/s00262-007-0313-4; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Guerau-De-Arellano M, 2009, J EXP MED, V206, P1245, DOI 10.1084/jem.20090300; Hershko AY, 2011, IMMUNITY, V35, P562, DOI 10.1016/j.immuni.2011.07.013; Huang B, 2008, BLOOD, V112, P1269, DOI 10.1182/blood-2008-03-147033; Ishikawa N, 2005, CANCER RES, V65, P9176, DOI 10.1158/0008-5472.CAN-05-1556; Jacobs B, 2009, J CLIN ONCOL, V27, P5068, DOI 10.1200/JCO.2008.21.3744; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Ju MJ, 2009, CANCER SCI, V100, P1267, DOI 10.1111/j.1349-7006.2009.01182.x; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Krupica T, 2006, CLIN IMMUNOL, V120, P121, DOI 10.1016/j.clim.2006.04.569; LACHTER J, 1995, DIS COLON RECTUM, V38, P290, DOI 10.1007/BF02055605; Le Campion A, 2009, BLOOD, V114, P1784, DOI 10.1182/blood-2008-12-192120; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Matsumoto K, 2009, INT ARCH ALLERGY IMM, V149, P39, DOI 10.1159/000210652; Matsushita N, 2008, J IMMUNOL METHODS, V333, P167, DOI 10.1016/j.jim.2008.01.012; Mekori YA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00006; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Tinhofer I, 2011, CLIN CANCER RES, V17, P5197, DOI 10.1158/1078-0432.CCR-10-3338; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Tsang JYS, 2006, J LEUKOCYTE BIOL, V80, P145, DOI 10.1189/jlb.0605344; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	47	257	268	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					275	284		10.1016/j.immuni.2012.09.023	http://dx.doi.org/10.1016/j.immuni.2012.09.023			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23333074	Green Accepted, Bronze			2022-12-18	WOS:000330940800010
J	Kool, M; Willart, MAM; van Nimwegen, M; Bergen, I; Pouliot, P; Virchow, JC; Rogers, N; Osorio, F; Reis e Sousa, C; Hammad, H; Lambrecht, BN				Kool, Mirjam; Willart, Monique A. M.; van Nimwegen, Menno; Bergen, Ingrid; Pouliot, Philippe; Virchow, J. Christian; Rogers, Neil; Osorio, Fabiola; Reis e Sousa, Caetano; Hammad, Hamida; Lambrecht, Bart N.			An Unexpected Role for Uric Acid as an Inducer of T Helper 2 Cell Immunity to Inhaled Antigens and Inflammatory Mediator of Allergic Asthma	IMMUNITY			English	Article							HOUSE-DUST MITE; INDUCED NEUTROPHIL ACTIVATION; MONOSODIUM URATE CRYSTALS; HELPER TYPE-2 RESPONSE; CD4(+) T-CELLS; DENDRITIC CELLS; AIRWAY INFLAMMATION; NALP3 INFLAMMASOME; XANTHINE-OXIDASE; ADAPTIVE IMMUNITY	Although deposition of uric acid (UA) crystals is known as the cause of gout, it is unclear whether UA plays a role in other inflammatory diseases. We here have shown that UA is released in the airways of allergen-challenged asthmatic patients and mice, where it was necessary for mounting T helper 2 (Th2) cell immunity, airway eosinophilia, and bronchial hyperreactivity to inhaled harmless proteins and clinically relevant house dust mite allergen. Conversely, administration of UA crystals together with protein antigen was sufficient to promote Th2 cell immunity and features of asthma. The adjuvant effects of UA did not require the inflammasome (NIrp3, Pycard) or the interleukin-1 (Myd88, IL-1r) axis. UA crystals promoted Th2 cell immunity by activating dendritic cells through spleen tyrosine kinase and PI3-kinase delta signaling. These findings provide further molecular insight into Th2 cell development and identify UA as an essential initiator and amplifier of allergic inflammation.	[Kool, Mirjam; Willart, Monique A. M.; Pouliot, Philippe; Lambrecht, Bart N.] Univ Ghent, Dept Resp Dis, Lab Immunoregulat & Mucosal Immunol, B-9000 Ghent, Belgium; [Hammad, Hamida] Univ Ghent, Dynam Imaging Unit, B-9000 Ghent, Belgium; [Kool, Mirjam; van Nimwegen, Menno; Bergen, Ingrid; Lambrecht, Bart N.] Erasmus Univ, Med Ctr, Dept Pulm Med, NL-3015 Rotterdam, Netherlands; [Kool, Mirjam] VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Virchow, J. Christian] Univ Hosp Rostock, Dept Pulm Med, D-18057 Rostock, Germany; [Rogers, Neil; Osorio, Fabiola; Reis e Sousa, Caetano] Canc Res UK, Immunobiol Lab, London Res Inst, Lincolns Inn Fields Labs, London WC2A 3LY, England	Ghent University; Ghent University; Erasmus University Rotterdam; Erasmus MC; Flanders Institute for Biotechnology (VIB); University of Rostock; Cancer Research UK	Hammad, H (corresponding author), Univ Ghent, Dept Resp Dis, Lab Immunoregulat & Mucosal Immunol, B-9000 Ghent, Belgium.	hamida.hammad@ugent.be; bartiambrecht@ugent.be	Lambrecht, Bart N/K-2484-2014; Hammad, Hamida/J-9391-2015; Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014; Osorio, Fabiola/H-4529-2014	Lambrecht, Bart N/0000-0003-4376-6834; Hammad, Hamida/0000-0003-3762-8603; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Osorio, Fabiola/0000-0001-5306-7856; Rogers, Neil/0000-0001-8977-7585	Marie-Curie Intereuropean Fellowship; Flemish Organization for Scientific Research (FWO); European Research Council; Ghent University; NIH [R21]	Marie-Curie Intereuropean Fellowship; Flemish Organization for Scientific Research (FWO)(FWO); European Research Council(European Research Council (ERC)European Commission); Ghent University(Ghent University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	M.K. is a recipient of a Marie-Curie Intereuropean Fellowship. B.N.L. is a recipient of an Odysseus Grant of the Flemish Organization for Scientific Research (FWO), a European Research Council starting grant, a Concerted Research Initiative Grant (GOA) of Ghent University, and a Multidisciplinary Research Platform (MRP) Grant of Ghent University. H.H. and B.N.L. are the recipients of an NIH grant (R21) and a University of Ghent 4-year project grant. We thank B. Ryffel, B. Vanhaesebroeck, T. De Smedt, and J. Tschopp for provision of mice.	AKAIKE T, 1990, J CLIN INVEST, V85, P739, DOI 10.1172/JCI114499; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barrett NA, 2009, IMMUNITY, V31, P425, DOI 10.1016/j.immuni.2009.08.014; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Desaulniers P, 2001, J LEUKOCYTE BIOL, V70, P659; Dodge IL, 2003, J IMMUNOL, V170, P4457, DOI 10.4049/jimmunol.170.9.4457; Ebeling C, 2007, J IMMUNOL, V179, P2910, DOI 10.4049/jimmunol.179.5.2910; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hassoun PM, 1998, AM J RESP CRIT CARE, V158, P299, DOI 10.1164/ajrccm.158.1.9709116; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Imanaka T, 1999, J BIOL CHEM, V274, P11968, DOI 10.1074/jbc.274.17.11968; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kobayashi T, 2010, J IMMUNOL, V184, P6350, DOI 10.4049/jimmunol.0902673; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kuipers H, 2004, J LEUKOCYTE BIOL, V76, P1028, DOI 10.1189/jlb.0604325; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Lommatzsch M, 2006, J ALLERGY CLIN IMMUN, V118, P91, DOI 10.1016/j.jaci.2006.02.034; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Matsubara S, 2006, AM J RESP CELL MOL, V34, P426, DOI 10.1165/rcmb.2005-0298OC; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Papi A, 2008, J BIOL CHEM, V283, P28595, DOI 10.1074/jbc.M805766200; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Popa-Nita O, 2007, J LEUKOCYTE BIOL, V82, P763, DOI 10.1189/jlb.0307174; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Schmitz N, 2003, EUR J IMMUNOL, V33, P991, DOI 10.1002/eji.200323801; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Williams A, 2010, CURR OPIN IMMUNOL, V22, P34, DOI 10.1016/j.coi.2010.01.004; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	55	257	265	2	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					527	540		10.1016/j.immuni.2011.03.015	http://dx.doi.org/10.1016/j.immuni.2011.03.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21474346	Bronze			2022-12-18	WOS:000290367300012
J	Davis, MM				Davis, Mark M.			A Prescription for Human Immunology	IMMUNITY			English	Editorial Material							IMMUNOTHERAPY	Inbred mice have been an extremely successful tool for basic immunology, but much less so as models of disease. Thus, to maximize the use of immunologic approaches to improve human health, we need more strategically directed efforts in human immunology. This would also open up new opportunities for basic research.	[Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mmdavis@stanford.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, R01AI053589] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [U19 AI053589, U19 AI057229, R01 AI053589, U19 AI057229-05S10017] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allantaz F, 2007, CURR OPIN IMMUNOL, V19, P623, DOI 10.1016/j.coi.2007.10.003; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Cohen AC, 2006, J IMMUNOL, V177, P2770, DOI 10.4049/jimmunol.177.5.2770; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Hayday AC, 2008, NAT IMMUNOL, V9, P575, DOI 10.1038/ni0608-575; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; Ostrand-Rosenberg S, 2004, CURR OPIN IMMUNOL, V16, P143, DOI 10.1016/j.coi.2004.01.003; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Schnabel J, 2008, NATURE, V454, P682, DOI 10.1038/454682a; Steinman RM, 2004, SCIENCE, V305, P197, DOI 10.1126/science.1099688; Tenenbaum JD, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-51; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Herrath MG, 2005, J EXP MED, V202, P1159, DOI 10.1084/jem.20051224	15	257	264	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					835	838		10.1016/j.immuni.2008.12.003	http://dx.doi.org/10.1016/j.immuni.2008.12.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19100694	Bronze, Green Accepted			2022-12-18	WOS:000262012400001
J	Yamaguchi, T; Hirota, K; Nagahama, K; Ohkawa, K; Takahashi, T; Nomura, T; Sakaguchi, S				Yamaguchi, Tomoyuki; Hirota, Keiji; Nagahama, Kanji; Ohkawa, Katsuya; Takahashi, Takeshi; Nomura, Takeshi; Sakaguchi, Shimon			Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor	IMMUNITY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; TRANSCRIPTION FACTOR FOXP3; INDUCED TNF RECEPTOR; AUTOIMMUNE-DISEASE; IN-VITRO; DENDRITIC CELLS; CD4(+); INDUCTION; CD25(+); MEMORY	Immune responses can be enhanced or dampened by differential manipulation of Foxp3-expressing CD25(+)CD4(+) natural regulatory T (Treg) cells versus other naive or activated T cells. By searching for a molecule capable of distinguishing these populations, we here found that natural Treg cells constitutively expressed high amounts of folate receptor 4 (FR4). The expression of FR4 and CD25 also separated antigen-stimulated CD4+ non-Treg cells into the FR4(hi)CD25(-) and FR4(lo)CD25(+) populations, which were different in proliferation and cytokine secretion upon restimulation. These distinctions showed that antigenic stimulation activated and expanded antigen-specific natural Treg cells as well as effector and memory T cells. Accordingly, FR4(hi)CD25(+)CD4(+) T cells enriched from alloantigen-stimulated T cells suppressed graft rejection. Administration of FR4 monoclonal antibody specifically reduced Treg cells, provoking effective tumor immunity in tumor-bearing animals, whereas similar treatment of normal young mice elicited autoimmune disease. Thus, specific manipulation of FR4(hi)CD25(+) CD4(+) Treg cells helps control ongoing immune responses.	Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; Kyoto Univ, Fac Med, Ctr Adv Res, Kyoto 6068507, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009	Hirota, Keiji/0000-0002-4737-0661; Yamaguchi, Tomoyuki/0000-0002-4159-5448				ALARCONSEGOVIA D, 1984, J RHEUMATOL, V11, P208; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Elnakat H, 2004, ADV DRUG DELIVER REV, V56, P1067, DOI 10.1016/j.addr.2004.01.001; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; HENZEL WJ, 1993, P NATL ACAD SCI USA, V90, P5011, DOI 10.1073/pnas.90.11.5011; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; ORAVISTO KJ, 1980, EUR UROL, V6, P10; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shimizu J, 1999, J IMMUNOL, V163, P5211; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Spiegelstein O, 2000, GENE, V258, P117, DOI 10.1016/S0378-1119(00)00418-2; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422	44	257	274	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2007	27	1					145	159		10.1016/j.immuni.2007.04.017	http://dx.doi.org/10.1016/j.immuni.2007.04.017			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17613255	Bronze			2022-12-18	WOS:000248398100016
J	Stranges, PB; Watson, J; Cooper, CJ; Choisy-Rossi, CM; Stonebraker, AC; Beighton, RA; Hartig, H; Sundberg, JP; Servick, S; Kaufmann, G; Fink, PJ; Chervonsky, AV				Stranges, Peter B.; Watson, Jessica; Cooper, Cristie J.; Choisy-Rossi, Caroline-Morgane; Stonebraker, Austin C.; Beighton, Ryan A.; Hartig, Heather; Sundberg, John P.; Servick, Stein; Kaufmann, Gunnar; Fink, Pamela J.; Chervonsky, Alexander V.			Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity	IMMUNITY			English	Article							DENDRITIC CELLS; INDUCED APOPTOSIS; CUTTING EDGE; LIGAND GENE; B-CELLS; EXPRESSION; MOUSE; LYMPHOPROLIFERATION; ACTIVATION; EXPANSION	Fas (also known as Apo-1 and CD95) receptor has been suggested to control T cell expansion by triggering T cell-autonomous apoptosis. This paradigm is based on the extensive lymphoproliferation and systemic autoimmunity in mice and humans lacking Fas or its ligand. However, with systemic loss of Fas, it is unclear whether T cell-extrinsic mechanisms contribute to autoimmunity. We found that tissue-specific deletion of Fas in mouse antigen-presenting cells (APCs) was sufficient to cause systemic autoimmunity, implying that normally APCs are destroyed during immune responses via a Fas-mediated mechanism. Fas expression by APCs was increased by exposure to microbial stimuli. Analysis of mice with Fas loss restricted to T cells revealed that Fas indeed controls autoimmune T cells, but not T cells responding to strong antigenic stimulation. Thus, Fas-dependent elimination of APCs is a major regulatory mechanism curbing autoimmune responses and acts in concert with Fas-mediated regulation of chronically activated autoimmune T cells.	Jackson Lab, Bar Harbor, ME 04609 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Jackson Laboratory; University of Chicago; University of Washington; University of Washington Seattle	Chervonsky, AV (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	achervon@bsd.uchicago.edu		Stranges, Peter Benjamin/0000-0003-1377-7321; Chervonsky, Alexander/0000-0001-7547-871X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044130, R01AI072627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053561] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI044130, AI044130, AI072627, R01 AI072627, R01 AI072627-01] Funding Source: Medline; NIDDK NIH HHS [R01 DK053561-05] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arai H, 1997, NAT MED, V3, P843, DOI 10.1038/nm0897-843; Bevan MJ, 2001, NAT IMMUNOL, V2, P381, DOI 10.1038/87676; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Choi EY, 2002, IMMUNITY, V17, P593, DOI 10.1016/S1074-7613(02)00428-4; CRISPE IN, 1994, IMMUNITY, V1, P347; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; CUSTER RP, 1985, AM J PATHOL, V120, P464; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Fields ML, 2001, J IMMUNOL, V167, P2370, DOI 10.4049/jimmunol.167.4.2370; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Fukuyama H, 1998, J IMMUNOL, V160, P3805; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Karray S, 2004, J IMMUNOL, V172, P2118, DOI 10.4049/jimmunol.172.4.2118; LYNCH DH, 1994, IMMUNITY, V1, P131, DOI 10.1016/1074-7613(94)90106-6; Medema JP, 2001, J EXP MED, V194, P657, DOI 10.1084/jem.194.5.657; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Storni T, 2003, J IMMUNOL, V171, P795, DOI 10.4049/jimmunol.171.2.795; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; WARREN RW, 1984, CELL IMMUNOL, V84, P22, DOI 10.1016/0008-8749(84)90073-X; WARREN RW, 1984, CLIN IMMUNOL IMMUNOP, V31, P65, DOI 10.1016/0090-1229(84)90190-9; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wong P, 2003, IMMUNITY, V18, P499, DOI 10.1016/S1074-7613(03)00081-5; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892; Yang JP, 2006, P NATL ACAD SCI USA, V103, P147, DOI 10.1073/pnas.0509054103	43	257	264	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2007	26	5					629	641		10.1016/j.immuni.2007.03.016	http://dx.doi.org/10.1016/j.immuni.2007.03.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17509906	Green Accepted, Bronze			2022-12-18	WOS:000246895900015
J	Laouar, Y; Welte, T; Fu, XY; Flavell, RA				Laouar, Y; Welte, T; Fu, XY; Flavell, RA			STAT3 is required for FIM-dependent dendritic cell differentiation	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; COMMON PRECURSOR POPULATION; BONE-MARROW CULTURES; LIGAND-TREATED MICE; FLT3 LIGAND; IN-VIVO; C-KIT; PROGENITOR CELLS; GENE-EXPRESSION	The signals that control decisions of progenitor commitment involve the interplay of both cytokines and transcription factors. Flt3L has emerged as a potential regulator of dendritic cell (DC) development, but regulation of HSC commitment to the DC lineage remains poorly understood. Our central finding is the identification of STAT3 activation as a checkpoint of Flt3L-regulated DC development. Deletion of STAT3 caused profound deficiency in the DC compartment and abrogated Flt3L effects on DC development. DC derivation by Flt3L revealed a normal HSC pool, a 2- to 3-fold accumulation of CLP/CMP, but absence of common DC precursors as well as their DC progeny in STAT3-deficient mice. The formation of CMP and CLP represents the first decisive lineage commitment step, and in this regard we provide evidence that commitments of CLP/CMP to the DC lineage strictly depend on the interplay of both Flt3L and STAT3 activation.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Fu, XY (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034522] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34522] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Al-Shami A, 1998, J BIOL CHEM, V273, P1058, DOI 10.1074/jbc.273.2.1058; Anjuere F, 2000, BLOOD, V96, P1633, DOI 10.1182/blood.V96.5.1633.h8001633_1633_1637; Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Borge OJ, 1999, BLOOD, V94, P3781, DOI 10.1182/blood.V94.11.3781.423k04_3781_3790; Brasel K, 1996, BLOOD, V88, P2004, DOI 10.1182/blood.V88.6.2004.bloodjournal8862004; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; Foti M, 1999, INT IMMUNOL, V11, P979, DOI 10.1093/intimm/11.6.979; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Lehtonen A, 2002, J LEUKOCYTE BIOL, V71, P511; Manfra DJ, 2003, J IMMUNOL, V170, P2843, DOI 10.4049/jimmunol.170.6.2843; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; Martin P, 2000, BLOOD, V96, P2511, DOI 10.1182/blood.V96.7.2511.h8002511_2511_2519; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; McKenna HJ, 2001, CURR OPIN HEMATOL, V8, P149, DOI 10.1097/00062752-200105000-00004; Merad M, 2000, BLOOD, V96, P1865, DOI 10.1182/blood.V96.5.1865.h8001865_1865_1872; Mizuki M, 2003, BLOOD, V101, P3164, DOI 10.1182/blood-2002-06-1677; Naik S, 2003, BLOOD, V102, P601, DOI 10.1182/blood-2002-10-3186; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Ogawa M, 1998, EXP HEMATOL, V26, P478; OKADA S, 1991, BLOOD, V78, P1706; Panopoulos AD, 2002, J BIOL CHEM, V277, P19001, DOI 10.1074/jbc.M112271200; Pulendran B, 1997, J IMMUNOL, V159, P2222; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; ROSNET O, 1993, CRIT REV ONCOGENESIS, V4, P595; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307, DOI 10.1128/MCB.17.9.5307; Shurin MR, 1997, CELL IMMUNOL, V179, P174, DOI 10.1006/cimm.1997.1152; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; SMALL D, 1994, P NATL ACAD SCI USA, V91, P459, DOI 10.1073/pnas.91.2.459; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Welte T, 1997, EUR J IMMUNOL, V27, P2737, DOI 10.1002/eji.1830271038; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Williams NS, 1999, J IMMUNOL, V163, P2648; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; Zhang SL, 2000, J EXP MED, V192, P719, DOI 10.1084/jem.192.5.719	57	257	261	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2003	19	6					903	912		10.1016/S1074-7613(03)00332-7	http://dx.doi.org/10.1016/S1074-7613(03)00332-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670306	Bronze			2022-12-18	WOS:000187230700014
J	Liao, XC; Littman, DR				Liao, XC; Littman, DR			Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk	IMMUNITY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; TYROSINE KINASE GENE; TRANSGENIC MICE; ANTIGEN RECEPTOR; HEMATOPOIETIC-CELLS; THYMIC SELECTION; PH DOMAIN; EXPRESSION; DNA; IDENTIFICATION	Itk is a T cell protein tyrosine kinase (PTK) that, along with Btk and Tee, belongs to a family of cytoplasmic PTKs with N-terminal pleckstrin homology domains. Btk plays a critical role in B lymphocyte development. To determine whether Itk has an analogous role in T lymphocytes, we used gene targeting to prepare mice lacking expression of Itk. Such animals had decreased numbers of mature thymocytes, an effect most clearly observed in mice expressing T cell receptor (TCR) transgenes. Mature T cells from Itk-deficient mice had reduced proliferative responses to allogeneic MHC stimulation and to anti-TCR cross-linking, but responded normally to stimulation with phorbol ester plus ionomycin or with IL-2. These results provide genetic evidence that Itk is involved in T cell development and also suggest that Itk has an important role in proximal events in TCR-mediated signaling pathways.	UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA; NYU, MED CTR,SKIRBALL INST BIOMOLEC MED, HOWARD HUGHES MED INST,MOLEC PATHOGENESIS PROGRAM, NEW YORK, NY 10016 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; New York University	Liao, XC (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA.							AOKI Y, 1994, P NATL ACAD SCI USA, V91, P10606, DOI 10.1073/pnas.91.22.10606; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CROOKS MEC, 1994, IMMUNITY, V1, P277; DAVIS CB, 1995, IN PRESS IMMUNOL; DESIDERIO S, 1994, CHEM IMMUNOL, V59, P191; DEWEERS M, 1994, J BIOL CHEM, V269, P23857; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; GIBSON S, 1993, BLOOD, V82, P1561; HAGEMANN TL, 1994, HUM MOL GENET, V3, P1743, DOI 10.1093/hmg/3.10.1743; HEYECK SD, 1993, P NATL ACAD SCI USA, V90, P669, DOI 10.1073/pnas.90.2.669; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; KAYE J, 1992, J IMMUNOL, V148, P3342; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MANO H, 1993, ONCOGENE, V8, P417; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOND JJ, 1983, J IMMUNOL, V131, P2107; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; OHTA Y, 1994, P NATL ACAD SCI USA, V91, P9062, DOI 10.1073/pnas.91.19.9062; PEARL ER, 1978, J IMMUNOL, V120, P1169; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; ROBEY EA, 1992, INT IMMUNOL, V4, P969, DOI 10.1093/intimm/4.9.969; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; ROHRER J, 1994, IMMUNOGENETICS, V40, P319, DOI 10.1007/BF01246672; ROTHENBERG EV, 1994, CURR OPIN IMMUNOL, V6, P257, DOI 10.1016/0952-7915(94)90099-X; RUSSELL JH, 1990, J IMMUNOL, V144, P3318; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; SIDERAS P, 1994, J IMMUNOL, V153, P5607; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TANAKA N, 1993, FEBS LETT, V324, P1, DOI 10.1016/0014-5793(93)81520-A; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUKADA S, 1994, CURR OPIN IMMUNOL, V6, P623, DOI 10.1016/0952-7915(94)90151-1; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; YAMADA N, 1993, BIOCHEM BIOPH RES CO, V192, P231, DOI 10.1006/bbrc.1993.1404; YENOFSKY RL, 1990, P NATL ACAD SCI USA, V87, P3435, DOI 10.1073/pnas.87.9.3435	58	257	266	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1995	3	6					757	769		10.1016/1074-7613(95)90065-9	http://dx.doi.org/10.1016/1074-7613(95)90065-9			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777721	hybrid			2022-12-18	WOS:A1995TM02300010
J	DUDLEY, EC; PETRIE, HT; SHAH, LM; OWEN, MJ; HAYDAY, AC				DUDLEY, EC; PETRIE, HT; SHAH, LM; OWEN, MJ; HAYDAY, AC			T-CELL RECEPTOR-BETA CHAIN GENE REARRANGEMENT AND SELECTION DURING THYMOCYTE DEVELOPMENT IN ADULT MICE	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; IMMATURE THYMOCYTES; ANTIGEN RECEPTOR; ZETA-CHAIN; ALPHA-BETA; INTERLEUKIN-2 RECEPTOR; SURFACE EXPRESSION; ALLELIC EXCLUSION; MURINE THYMOCYTES; MUTANT MICE	The identification is made in normal mice of the stages in T cell development at which the rearranged beta chain of the T cell receptor (TCR) is utilized to promote T cell maturation, independent of the TCR alpha chain. In addition, evidence is provided that utilization of beta chains in T cell progenitors does not preclude differentiation to TCR gamma delta(+) T cells. This is consistent with the view that an initial consequence of beta chain expression by early thymocytes is clonal expansion, increasing the size of the pool of useful precursors. This allows the proposal to be made that allelic exclusion may be a byproduct of cell cycle regulation during early thymocyte differentiation, which may in turn explain why the efficiency of allelic exclusion varies at different TCR or immunoglobulin loci.	MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021; IMPERIAL CANC RES FUND,LABS,LONDON WC2A 3PX,ENGLAND; YALE UNIV,IMMUNOBIOL SECT,NEW HAVEN,CT 06511	Memorial Sloan Kettering Cancer Center; Cancer Research UK; Yale University	DUDLEY, EC (corresponding author), YALE UNIV,DEPT BIOL,POB 6666,NEW HAVEN,CT 06511, USA.							ANDERSON SJ, 1993, NATURE, V365, P552, DOI 10.1038/365552a0; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; BOYER PD, 1989, J IMMUNOL, V142, P4121; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CRISPE IN, 1987, NATURE, V329, P336, DOI 10.1038/329336a0; DAVODEAU F, 1993, SCIENCE, V260, P1800, DOI 10.1126/science.8390096; ELLIOTT JF, 1988, NATURE, V331, P627; EWING T, 1988, EUR J IMMUNOL, V18, P261, DOI 10.1002/eji.1830180213; FEDDERSEN RM, 1990, J IMMUNOL, V144, P1088; FELLER W, 1950, PROBABILITY THEORY I; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GROETTRUP M, 1992, EMBO J, V11, P2735, DOI 10.1002/j.1460-2075.1992.tb05339.x; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; GROETTRUP M, 1993, IMMUNOL TODAY, V14, P610, DOI 10.1016/0167-5699(93)90201-U; Hartwell LH, 1981, MOL BIOL YEAST SACCH, P97; HAYDAY AC, 1992, ENCY IMMUNOLOGY, P1428; KISHI H, 1991, EMBO J, V10, P93, DOI 10.1002/j.1460-2075.1991.tb07924.x; LESLEY J, 1990, CELL IMMUNOL, V128, P63, DOI 10.1016/0008-8749(90)90007-E; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; MAK TW, 1992, ENCY IMMUNOLOGY, P1425; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; Maniatis T., 1982, MOL CLONING; MCVAY LD, 1991, EMBO J, V10, P83, DOI 10.1002/j.1460-2075.1991.tb07923.x; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NIKOLICZUGIC J, 1989, EUR J IMMUNOL, V19, P649, DOI 10.1002/eji.1830190412; NIKOLICZUGIC J, 1989, EUR J IMMUNOL, V19, P1957, DOI 10.1002/eji.1830191030; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; OHNO H, 1993, EMBO J, V12, P4357, DOI 10.1002/j.1460-2075.1993.tb06120.x; OSSENDORP F, 1992, J IMMUNOL, V148, P3714; OWEN MJ, 1993, CURR BIOL, V3, P780, DOI 10.1016/0960-9822(93)90031-I; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PALMER DB, 1993, IMMUNOL TODAY, V14, P460, DOI 10.1016/0167-5699(93)90249-K; PEARSE M, 1989, P NATL ACAD SCI USA, V86, P1614, DOI 10.1073/pnas.86.5.1614; PENIT C, 1988, J IMMUNOL, V140, P3315; PENIT C, 1989, J IMMUNOL, V142, P3369; PETRIE HT, 1990, J EXP MED, V172, P1583, DOI 10.1084/jem.172.6.1583; PETRIE HT, 1990, EUR J IMMUNOL, V20, P2813, DOI 10.1002/eji.1830201243; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; RAULET DH, 1985, NATURE, V314, P103, DOI 10.1038/314103a0; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; RISCH NJ, 1992, SCIENCE, V255, P717, DOI 10.1126/science.1738844; ROTHENBERG EV, 1992, ADV IMMUNOL, V51, P85, DOI 10.1016/S0065-2776(08)60487-3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOLLAY R, 1988, IMMUNOL REV, V104, P81, DOI 10.1111/j.1600-065X.1988.tb00760.x; SCOLLAY R, 1985, J IMMUNOL, V134, P3632; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; TONEGUZZO F, 1988, BIOTECHNIQUES, V6, P460; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VONBOEHMER H, 1988, P NATL ACAD SCI USA, V85, P9729, DOI 10.1073/pnas.85.24.9729; WEAVER D, 1985, CELL, V42, P117, DOI 10.1016/S0092-8674(85)80107-0; WILSON A, 1988, J IMMUNOL, V140, P1461; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0	64	257	258	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1994	1	2					83	93		10.1016/1074-7613(94)90102-3	http://dx.doi.org/10.1016/1074-7613(94)90102-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK162	7534200				2022-12-18	WOS:A1994PK16200001
J	Osorio, F; Sousa, GRE				Osorio, Fabiola; Reis e Sousa, Gaetano			Myeloid C-type Lectin Receptors in Pathogen Recognition and Host Defense	IMMUNITY			English	Review							BETA-GLUCAN RECEPTOR; TOLL-LIKE RECEPTORS; CHRONIC MUCOCUTANEOUS CANDIDIASIS; PLASMACYTOID DENDRITIC CELLS; INNATE IMMUNE-RESPONSES; HUMAN PERIPHERAL-BLOOD; ADAPTER PROTEIN CARD9; SYK TYROSINE KINASE; HYPER-IGE SYNDROME; ACTIVATING RECEPTOR	C-type lectin receptors (CLRs) comprise a heterogeneous group of transmembrane proteins. Many of them are expressed in myeloid cells and signal in response to pathogen-derived or self ligands to initiate or regulate cell activation. Here, we review the properties of myeloid CLRs, highlighting how their signaling function is coordinated with that of other innate receptor families to control immunity to infection.	[Osorio, Fabiola; Reis e Sousa, Gaetano] Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3LY, England	Cancer Research UK	Sousa, GRE (corresponding author), Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	caetano@cancer.org.uk	Osorio, Fabiola/H-4529-2014; Reis e Sousa, Caetano/O-1657-2014; Reis e Sousa, Caetano/ABD-7322-2021	Osorio, Fabiola/0000-0001-5306-7856; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119	Cancer Research UK; UCL	Cancer Research UK(Cancer Research UK); UCL	We are grateful to S. LeibundGut-Landmann, D. Sancho, and C. Johansson for critical review of the manuscript. Work in the C.R.S. laboratory is funded by Cancer Research UK and a prize from Fondation Bettencourt-Schueller. F.O. was funded by a Cancer Research UK and a UCL Overseas Research Studies (ORS) studentship.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Bi LK, 2010, J BIOL CHEM, V285, P25969, DOI 10.1074/jbc.M110.131300; Bonkobara M, 2001, J IMMUNOL, V167, P6893, DOI 10.4049/jimmunol.167.12.6893; Bourgeois C, 2011, J IMMUNOL, V186, P3104, DOI 10.4049/jimmunol.1002599; Bozza S, 2008, J IMMUNOL, V180, P4022, DOI 10.4049/jimmunol.180.6.4022; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Bugarcic A, 2008, GLYCOBIOLOGY, V18, P679, DOI 10.1093/glycob/cwn046; Cambi A, 2008, J BIOL CHEM, V283, P20590, DOI 10.1074/jbc.M709334200; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Caminschi I, 2009, EUR J IMMUNOL, V39, P931, DOI 10.1002/eji.200839035; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chai LYA, 2011, J INFECT DIS, V203, P736, DOI 10.1093/infdis/jiq102; Chaipan C, 2006, J VIROL, V80, P8951, DOI 10.1128/JVI.00136-06; Chen CH, 2006, BLOOD, V107, P1459, DOI 10.1182/blood-2005-08-3264; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cunha C, 2010, BLOOD, V116, P5394, DOI 10.1182/blood-2010-04-279307; De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Forsyth CB, 1998, J IMMUNOL, V161, P6198; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Greenblatt MB, 2010, J EXP MED, V207, P923, DOI 10.1084/jem.20092531; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hernanz-Falcon P, 2009, EUR J IMMUNOL, V39, P507, DOI 10.1002/eji.200838687; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Inui M, 2009, P NATL ACAD SCI USA, V106, P4816, DOI 10.1073/pnas.0900463106; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Joffre OP, 2010, EUR J IMMUNOL, V40, P1255, DOI 10.1002/eji.201040419; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Kaden SA, 2009, J IMMUNOL, V183, P5069, DOI 10.4049/jimmunol.0900908; Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153; Kanazawa N, 2003, J BIOL CHEM, V278, P32645, DOI 10.1074/jbc.M304226200; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Lee SJ, 2003, INFECT IMMUN, V71, P437, DOI 10.1128/IAI.71.1.437-445.2003; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Meyer-Wentrup F, 2007, J IMMUNOL, V178, P154, DOI 10.4049/jimmunol.178.1.154; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Riboldi E, 2009, IMMUNOBIOLOGY, V214, P868, DOI 10.1016/j.imbio.2009.06.016; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rock J, 2007, EUR J IMMUNOL, V37, P3564, DOI 10.1002/eji.200737711; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463, DOI 10.4049/jimmunol.179.6.3463; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Shah VB, 2009, MOL IMMUNOL, V46, P1845, DOI 10.1016/j.molimm.2009.01.014; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Tanne A, 2009, J EXP MED, V206, P2205, DOI 10.1084/jem.20090188; Tassi I, 2009, EUR J IMMUNOL, V39, P1369, DOI 10.1002/eji.200839313; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; Villamon E, 2004, EUR CYTOKINE NETW, V15, P263; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016; Zhou MH, 2008, IMMUNOL LETT, V118, P72, DOI 10.1016/j.imlet.2008.03.004	132	256	271	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 27	2011	34	5					651	664		10.1016/j.immuni.2011.05.001	http://dx.doi.org/10.1016/j.immuni.2011.05.001			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21616435	Bronze			2022-12-18	WOS:000291456500003
J	Jones, RG; Thompson, CB				Jones, Russell G.; Thompson, Craig B.			Revving the engine: signal transduction fuels T cell activation	IMMUNITY			English	Article							ATP-CITRATE LYASE; PROTEIN-KINASE; LYMPHOCYTE-T; GROWTH; METABOLISM; AKT; SURVIVAL; PROLIFERATION; INHIBITION; GLYCOLYSIS	For initiation of an immune response, resting T cells must reprogram their metabolism. Continuing the "From the Field" series (see Editorial [2007] 26,131), Jones and Thompson draw attention to the importance of metabolism during T cell activation and consider how this process is regulated by receptor-mediated signal transduction.	Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Thompson, CB (corresponding author), Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	craig@mail.med.upenn.edu	Jones, Russell Graham/ABD-5261-2021; Jones, Russell/AAC-2861-2022	Jones, Russell Graham/0000-0003-2250-4675; 				Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CHAUDHRI G, 1986, J IMMUNOL, V137, P2646; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; GOTTESDIENER KM, 1988, MOL CELL BIOL, V8, P3809, DOI 10.1128/MCB.8.9.3809; GRIFFITHS M, 1990, IMMUNOL CELL BIOL, V68, P405, DOI 10.1038/icb.1990.54; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jones RG, 2007, IMMUNITY, V27, P268, DOI 10.1016/j.immuni.2007.05.023; KAY JE, 1991, IMMUNOLOGY, V72, P544; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	28	256	273	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2007	27	2					173	178		10.1016/j.immuni.2007.07.008	http://dx.doi.org/10.1016/j.immuni.2007.07.008			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17723208	Bronze			2022-12-18	WOS:000249056300001
J	Laffargue, M; Calvez, R; Finan, P; Trifilieff, A; Barbier, M; Altruda, F; Hirsch, E; Wymann, MP				Laffargue, M; Calvez, R; Finan, P; Trifilieff, A; Barbier, M; Altruda, F; Hirsch, E; Wymann, MP			Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function	IMMUNITY			English	Article							AFFINITY IGE RECEPTOR; FC-EPSILON-RI; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; INOSITOL PHOSPHATASE SHIP; A(3) ADENOSINE RECEPTOR; TUMOR-NECROSIS-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; RBL-2H3 CELLS; NEUTROPHIL RECRUITMENT; TARGETED DISRUPTION	Mast cells are key regulators in allergy and inflammation, and release histamine upon clustering of their IgE receptors. Here we demonstrate that murine mast cell responses are exacerbated in vitro and in vivo by autocrine signals through G protein-coupled receptors (GPCRs) and require functional phosphoinositide 3-kinase gamma (PI3Kgamma). Adenosine, acting through the A(3) adenosine receptor (A(3)AR) as well as other agonists of G(alpha1)-coupled GPCRs, transiently increased Ptdlns(3,4,5)P-3 exclusively via PI3Kgamma. PI3Kgamma-derived Ptdlns(3,415)P-3 was instrumental for initiating a sustained influx of external Ca2+ and degranulation. Mice lacking PI3Kgamma did not form edema after intradermal injection of adenosine and when challenged by passive systemic anaphylaxis. PI3Kgamma thus relays inflammatory signals through various G(1)-coupled receptors and is central to mast cell function.	Univ Fribourg, Inst Biochem, Dept Med, CH-1700 Fribourg, Switzerland; Novartis Resp Res Ctr, Horsham RH12 5AB, W Sussex, England; Univ Turin, Dipartimento Genet Biol & Biochim, I-10126 Turin, Italy	University of Fribourg; Novartis; University of Turin	Wymann, MP (corresponding author), Univ Fribourg, Inst Biochem, Dept Med, Rue du Musee 5, CH-1700 Fribourg, Switzerland.	matthias.wymann@unifr.ch	Hirsch, Emilio/F-4848-2013; Laffargue, Muriel/AAE-7849-2021; Wymann, Matthias P/C-3227-2008	Hirsch, Emilio/0000-0002-9073-6024; Wymann, Matthias P/0000-0003-3349-4281; Calvez, Ronan/0000-0001-5762-1244; Laffargue, Muriel/0000-0003-1833-639X				ALAM R, 1994, J IMMUNOL, V152, P1298; ALAM R, 1992, J EXP MED, V176, P781, DOI 10.1084/jem.176.3.781; Alam R, 1996, AM J RESP CRIT CARE, V153, P1398, DOI 10.1164/ajrccm.153.4.8616572; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Barkley R., 1995, ADHD REPORT, V3, P5; Barnes PJ, 1998, PHARMACOL REV, V50, P515; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; BRUNNER T, 1993, J EXP MED, V177, P605, DOI 10.1084/jem.177.3.605; Ching TT, 2001, J BIOL CHEM, V276, P14814, DOI 10.1074/jbc.M009851200; CONTI P, 1995, IMMUNOLOGY, V86, P434; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Forsythe P, 1999, INFLAMM RES, V48, P301, DOI 10.1007/s000110050464; Gao ZH, 2001, MOL PHARMACOL, V59, P76, DOI 10.1124/mol.59.1.76; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; GOMPERTS BD, 1983, NATURE, V306, P64, DOI 10.1038/306064a0; Gordon JR, 2000, J ALLERGY CLIN IMMUN, V106, P110; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Huber M, 1998, EMBO J, V17, P7311, DOI 10.1093/emboj/17.24.7311; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; HUGHES PJ, 1984, BIOCHEM PHARMACOL, V33, P3847, DOI 10.1016/0006-2952(84)90050-9; Kimura T, 1997, J BIOL CHEM, V272, P13991, DOI 10.1074/jbc.272.21.13991; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Lloyd HGE, 1998, PULM PHARMACOL THER, V11, P41, DOI 10.1006/pupt.1998.0113; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Luster AD, 1997, J LEUKOCYTE BIOL, V62, P620, DOI 10.1002/jlb.62.5.620; MARQUARDT DL, 1986, AM REV RESPIR DIS, V133, P1105; MARQUARDT DL, 1988, BIOCHEM PHARMACOL, V37, P4019, DOI 10.1016/0006-2952(88)90088-3; MARQUARDT DL, 1978, J IMMUNOL, V120, P871; Marquardt DL, 1996, J IMMUNOL, V156, P1942; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MOLLER A, 1993, J IMMUNOL, V151, P3261; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Osborne MA, 1996, J BIOL CHEM, V271, P29271, DOI 10.1074/jbc.271.46.29271; Owen C, 2001, PULM PHARMACOL THER, V14, P193, DOI 10.1006/pupt.2001.0281; OZAWA K, 1993, J BIOL CHEM, V268, P1749; PALMER TM, 1995, J BIOL CHEM, V270, P16895, DOI 10.1074/jbc.270.28.16895; PEACHELL PT, 1991, J PHARMACOL EXP THER, V256, P717; Proudfoot AEI, 2000, IMMUNOL REV, V177, P246, DOI 10.1034/j.1600-065X.2000.17721.x; RAMKUMAR V, 1993, J BIOL CHEM, V268, P16887; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; SELVAN RS, 1994, J BIOL CHEM, V269, P13893; Smith AJ, 2001, J BIOL CHEM, V276, P17213, DOI 10.1074/jbc.M100417200; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Tigani B, 2000, EUR J PHARMACOL, V406, P469, DOI 10.1016/S0014-2999(00)00705-6; Tilley SL, 2000, J CLIN INVEST, V105, P361, DOI 10.1172/JCI8253; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; YANO H, 1993, J BIOL CHEM, V268, P25846; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZHANG Y, 1995, INFLAMMATION, V19, P119, DOI 10.1007/BF01534385; Zhong HY, 2001, J PHARMACOL EXP THER, V298, P433; ZHOU QY, 1992, P NATL ACAD SCI USA, V89, P7432, DOI 10.1073/pnas.89.16.7432	60	256	283	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2002	16	3					441	451		10.1016/S1074-7613(02)00282-0	http://dx.doi.org/10.1016/S1074-7613(02)00282-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911828	Bronze			2022-12-18	WOS:000174572800012
J	Ranger, AM; Hodge, MR; Gravallese, EM; Oukka, M; Davidson, L; Alt, FW; de la Brousse, FC; Hoey, T; Grusby, M; Glimcher, LH				Ranger, AM; Hodge, MR; Gravallese, EM; Oukka, M; Davidson, L; Alt, FW; de la Brousse, FC; Hoey, T; Grusby, M; Glimcher, LH			Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; T-CELL ACTIVATION; NUCLEAR FACTOR; CYCLOSPORINE-A; EXHIBIT DEFECTS; GENE-EXPRESSION; GM-CSF; PROMOTER; IDENTIFICATION; INTERLEUKIN-4	The NF-AT family of transcription factors activates early immune response genes such as cytokines. In the adult, NF-ATc is expressed exclusively in the lymphoid system and is induced upon lymphocyte activation. NF-ATc null mutant mice die in utero of cardiac failure, precluding analysis of the role of NF-ATc in lymphocyte activation. By using BAG-e-deficient blastocyst complementation, we now demonstrate that young, highly chimeric mice lacking NF-ATc have impaired repopulation of both thymus and peripheral lymphoid organs. Furthermore, NF-ATc deficiency impaired T lymphocyte activation and secretion of IL-4. B lymphocytes displayed reduced proliferation and a selective loss of IL-4-driven immunoglobulin isotypes both in vivo and in vitro. Our data demonstrate that NF-ATc is essential for the optimal generation and function of mature T and B lineage cells, with an especially profound effect on IL-4-driven responses.	Harvard Univ, Sch Publ Hlth, Dept Canc Biol, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Tularik Inc, San Francisco, CA 94080 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Canc Biol, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu			NIAID NIH HHS [AI/AG37833] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI037833] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CHOI MSK, 1994, IMMUNITY, V1, P179, DOI 10.1016/1074-7613(94)90096-5; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COCKERILL PN, 1995, MOL CELL BIOL, V15, P2071; CRABTREE G, 1989, SCIENCE, V249, P355; DELPRETE GF, 1991, J CLIN INVEST, V88, P346, DOI 10.1172/JCI115300; DOIMETSCH RE, 1997, NATURE, V386, P855; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Gerondakis S, 1996, P NATL ACAD SCI USA, V93, P3405, DOI 10.1073/pnas.93.8.3405; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Himes SR, 1996, IMMUNITY, V5, P479, DOI 10.1016/S1074-7613(00)80503-8; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; KUBO M, 1994, INT IMMUNOL, V6, P179, DOI 10.1093/intimm/6.2.179; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; MARKOWITZ JS, 1993, J IMMUNOL, V150, P1223; MASUDA ES, 1993, MOL CELL BIOL, V13, P7399, DOI 10.1128/MCB.13.12.7399; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MIYATAKE S, 1991, MOL CELL BIOL, V11, P5894, DOI 10.1128/MCB.11.12.5894; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Park JC, 1996, J BIOL CHEM, V271, P20914, DOI 10.1074/jbc.271.34.20914; RANGER AM, 1997, IN PRESS NATURE; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; ROONEY JW, 1995, IMMUNITY, V2, P545; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; Timmerman LA, 1997, J IMMUNOL, V159, P2735; VENKATARAMAN L, 1994, IMMUNITY, V1, P189, DOI 10.1016/1074-7613(94)90097-3; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; Wang WH, 1997, IMMUNITY, V6, P165, DOI 10.1016/S1074-7613(00)80423-9; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892	44	256	258	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1998	8	1					125	134		10.1016/S1074-7613(00)80465-3	http://dx.doi.org/10.1016/S1074-7613(00)80465-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462518	Bronze			2022-12-18	WOS:000071765700013
J	Chen, AI; McAdam, AJ; Buhlmann, JE; Scott, S; Lupher, ML; Greenfield, EA; Baum, PR; Fanslow, WC; Calderhead, DM; Freeman, GJ; Sharpe, AH				Chen, AI; McAdam, AJ; Buhlmann, JE; Scott, S; Lupher, ML; Greenfield, EA; Baum, PR; Fanslow, WC; Calderhead, DM; Freeman, GJ; Sharpe, AH			Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions	IMMUNITY			English	Article							DELAYED-TYPE HYPERSENSITIVITY; VASCULAR ENDOTHELIAL-CELLS; CONTACT HYPERSENSITIVITY; OX40 LIGAND; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; INTERFERON-GAMMA; OX-40 LIGAND; MURINE; SENSITIVITY	The tumor necrosis factor family molecule Ox40-ligand (Ox40L) has been identified as a potential costimulatory molecule and also has been implicated in T cell homing and B cell activation. To ascertain the essential functions of Ox40L, we generated and characterized Ox40L-deficient mice. Mice lacking Ox40L exhibit an impaired contact hypersensitivity response, a dendritic cell-dependent T cell-mediated response, due to defects in T cell priming and cytokine production. In contrast, Ox40L-deficient mice do not have defects in T cell homing or humoral immune responses. In vitro, Ox40L-deficient dendritic cells are defective in costimulating T cell cytokine production. Thus, Ox40L has a critical costimulatory function in vitro and in vivo for dendritic cell:T cell interactions.	Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Adult Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Immunex Res & Dev Corp, Seattle, WA 98101 USA; Dartmouth Med Sch, Lebanon, NH 03756 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Dartmouth College	Sharpe, AH (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, 75 Francis St, Boston, MA 02115 USA.		Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI041584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NIAID NIH HHS [AI/GF41584] Funding Source: Medline; NIAMS NIH HHS [AR42689] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; Bretscher PA, 1999, P NATL ACAD SCI USA, V96, P185, DOI 10.1073/pnas.96.1.185; CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; CHER DJ, 1987, J IMMUNOL, V138, P3688; COLLIGAN JE, 1994, CURRENT PROTOCOLS IM; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; GOCINSKI BL, 1990, J IMMUNOL, V144, P4121; GODFREY WR, 1994, J EXP MED, V180, P757, DOI 10.1084/jem.180.2.757; GRABBE S, 1995, J IMMUNOL, V155, P4207; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Gramaglia I, 1998, J IMMUNOL, V161, P6510; HASBOLD J, 1994, EUR J IMMUNOL, V24, P1835, DOI 10.1002/eji.1830240817; Higgins LM, 1999, J IMMUNOL, V162, P486; Imura A, 1996, J EXP MED, V183, P2185, DOI 10.1084/jem.183.5.2185; Imura A, 1997, BLOOD, V89, P2951, DOI 10.1182/blood.V89.8.2951; Kaleeba JAR, 1998, INT IMMUNOL, V10, P453, DOI 10.1093/intimm/10.4.453; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kondo S, 1996, J INVEST DERMATOL, V106, P993, DOI 10.1111/1523-1747.ep12338505; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; LEFKOVITS I, 1997, IMMUNOLOGY METHODS M; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; MIURA S, 1991, MOL CELL BIOL, V11, P1313, DOI 10.1128/MCB.11.3.1313; Ohshima Y, 1998, BLOOD, V92, P3338, DOI 10.1182/blood.V92.9.3338.421k19_3338_3345; Ohshima Y, 1997, J IMMUNOL, V159, P3838; PATERSON DJ, 1987, MOL IMMUNOL, V24, P1281, DOI 10.1016/0161-5890(87)90122-2; Rauschmayr-Kopp T, 1998, EUR J IMMUNOL, V28, P4221, DOI 10.1002/(SICI)1521-4141(199812)28:12<4221::AID-IMMU4221>3.0.CO;2-M; Schweitzer AN, 1998, J IMMUNOL, V161, P2762; SIMON JC, 1994, PHOTODERMATOL PHOTO, V10, P206; STREILEIN JW, 1980, J INVEST DERMATOL, V74, P319, DOI 10.1111/1523-1747.ep12543557; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Stuber E, 1996, J EXP MED, V183, P979, DOI 10.1084/jem.183.3.979; Tang Dean G, 1996, Pathol Oncol Res, V2, P117; THOMSON JA, 1993, IMMUNOLOGY, V78, P185; TITUS RG, 1981, J IMMUNOL METHODS, V45, P65, DOI 10.1016/0022-1759(81)90094-6; TOEWS GB, 1980, J IMMUNOL, V124, P445; Vogel LA, 1998, SEMIN IMMUNOL, V10, P435, DOI 10.1006/smim.1998.0145; Weinberg AD, 1996, NAT MED, V2, P183, DOI 10.1038/nm0296-183; Weinberg AD, 1999, J IMMUNOL, V162, P1818; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001	45	255	274	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1999	11	6					689	698		10.1016/S1074-7613(00)80143-0	http://dx.doi.org/10.1016/S1074-7613(00)80143-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626891	Bronze			2022-12-18	WOS:000084612900005
J	LINETTE, GP; GRUSBY, MJ; HEDRICK, SM; HANSEN, TH; GLIMCHER, LH; KORSMEYER, SJ				LINETTE, GP; GRUSBY, MJ; HEDRICK, SM; HANSEN, TH; GLIMCHER, LH; KORSMEYER, SJ			BCL-2 IS UP-REGULATED AT THE CD4(+)CD8(+) STAGE DURING POSITIVE SELECTION AND PROMOTES THYMOCYTE DIFFERENTIATION AT SEVERAL CONTROL POINTS	IMMUNITY			English	Article							T-CELL DEVELOPMENT; DEFICIENT MICE; ANTIGEN RECEPTOR; LYMPHOCYTES-B; IN-VIVO; DEATH; EXPRESSION; APOPTOSIS; PROTEIN; GENE	In vivo thymocyte maturation models were used to investigate the differentiation role of Bcl-2. In alpha/beta T cell receptor (TCR) class II-restricted transgenic mice, Bcl-2 was upregulated at the CD4(+)CD8(+) stage during positive selection. The lck(pr)-bcl2 transgene was bred onto MHC classes I--/- and II-/-, MHC(-/-), and alpha/beta TCR backgrounds to determine whether Bcl-2 promoted thymocyte maturation in the absence of coreceptor-MHC interaction. Bcl-2 rescued CD8(+) thymocytes in class I--/- and alpha/beta TCR mice; however, they were not exported to the periphery. Bcl-2 had no effect an CD4 lineage maturation in class II-/- mice. No single-positive thymocytes accumulate in MHC(-/-) mice despite overexpressed Bcl-2. Thus, Bcl-2 enables selection of certain TCRs on class II molecules and their differentiation along the CD8 pathway; however, Bcl-2 did not substitute for positive selection. In RAG-1(-/-) mice, Bcl-2 promoted differentiation to the CD4(+)CD8(+) stage. Bcl-2 can promote thymocyte maturation at several control points.	ST LOUIS UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,CTR CANC,LA JOLLA,CA 92093	Saint Louis University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego	LINETTE, GP (corresponding author), ST LOUIS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MED & PATHOL,ST LOUIS,MO 63110, USA.		Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031541, R01AI021569, R37AI021569, U01AI031541] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL07088] Funding Source: Medline; NIAID NIH HHS [AI-31541, AI-21569] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLOMGREN H, 1971, CELL IMMUNOL, V1, P545; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GRATIOTDEANS J, 1993, J IMMUNOL, V151, P83; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUGO P, 1991, EUR J IMMUNOL, V21, P835, DOI 10.1002/eji.1830210346; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KAYE J, 1992, J IMMUNOL, V148, P3342; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KRAFT DL, 1993, J EXP MED, V178, P265, DOI 10.1084/jem.178.1.265; LEBRUN DP, 1993, AM J PATHOL, V142, P743; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MERRY DE, 1994, DEVELOPMENT, V120, P301; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; PEZELLA F, 1990, AM J PATHOL, V137, P2115; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SHORTMAN K, 1992, CURR OPIN IMMUNOL, V4, P140, DOI 10.1016/0952-7915(92)90003-W; SMITH JD, 1993, J EXP MED, V178, P2035, DOI 10.1084/jem.178.6.2035; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1994, NATURE, V368, P457, DOI 10.1038/368457a0; TAO W, 1994, J EXP MED, V179, P145, DOI 10.1084/jem.179.1.145; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; VAUX DL, 1993, P NATL ACAD SCI USA, V90, P786, DOI 10.1073/pnas.90.3.786; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VEIS DJ, 1993, J IMMUNOL, V151, P2546; VEISNOVAK D, 1994, IN PRESS AM J PATHOL; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WILDIN RS, 1991, J EXP MED, V173, P383, DOI 10.1084/jem.173.2.383; WILLIAMS GT, 1993, CELL, V74, P777, DOI 10.1016/0092-8674(93)90457-2; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	46	255	255	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1994	1	3					197	205		10.1016/1074-7613(94)90098-1	http://dx.doi.org/10.1016/1074-7613(94)90098-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK165	7889408				2022-12-18	WOS:A1994PK16500004
J	Blattner, C; Lee, JH; Sliepen, K; Derking, R; Falkowska, E; de la Pena, AT; Cupo, A; Julien, JP; van Gils, M; Lee, PS; Peng, WJ; Paulson, JC; Poignard, P; Burton, DR; Moore, JP; Sanders, RW; Wilson, IA; Ward, AB				Blattner, Claudia; Lee, Jeong Hyun; Sliepen, Kwinten; Derking, Ronald; Falkowska, Emilia; de la Pena, Alba Torrents; Cupo, Albert; Julien, Jean-Philippe; van Gils, Marit; Lee, Peter S.; Peng, Wenjie; Paulson, James C.; Poignard, Pascal; Burton, Dennis R.; Moore, John P.; Sanders, Rogier W.; Wilson, Ian A.; Ward, Andrew B.			Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers	IMMUNITY			English	Article							BROADLY NEUTRALIZING ANTIBODIES; POTENT NEUTRALIZATION; RECOGNITION; IDENTIFICATION; COMBINATION; REFINEMENT; BINDING; SITE; GP41	All previously characterized broadly neutralizing antibodies to the HIV-1 envelope glycoprotein (Env) target one of four major sites of vulnerability. Here, we define and structurally characterize a unique epitope on Env that is recognized by a recently discovered family of human monoclonal antibodies (PGT151-PGT158). The PGT151 epitope is comprised of residues and glycans at the interface of gp41 and gp120 within a single protomer and glycans from both subunits of a second protomer and represents a neutralizing epitope that is dependent on both gp120 and gp41. Because PGT151 binds only to properly formed, cleaved trimers, this distinctive property, and its ability to stabilize Env trimers, has enabled the successful purification of mature, cleaved Env trimers from the cell surface as a complex with PGT151. Here we compare the structural and functional properties of membrane-extracted Env trimers from several clades with those of the soluble, cleaved SOSIP gp140 trimer.	[Blattner, Claudia; Lee, Jeong Hyun; Julien, Jean-Philippe; Lee, Peter S.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol Scrip, La Jolla, CA 92037 USA; [Blattner, Claudia; Lee, Jeong Hyun; Falkowska, Emilia; Julien, Jean-Philippe; Poignard, Pascal; Burton, Dennis R.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Lee, Jeong Hyun; Julien, Jean-Philippe; Burton, Dennis R.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Sliepen, Kwinten; Derking, Ronald; de la Pena, Alba Torrents; van Gils, Marit; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Falkowska, Emilia; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Cupo, Albert; Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Peng, Wenjie; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Peng, Wenjie; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Burton, Dennis R.] MIT, Ragon Inst MGH, Cambridge, MA 02129 USA; [Burton, Dennis R.] Harvard, Cambridge, MA 02129 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; Scripps Research Institute; Cornell University; Scripps Research Institute; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol Scrip, La Jolla, CA 92037 USA.	wilson@scripps.edu; abward@scripps.edu	Ward, Andrew B/F-9203-2014; poignard, pascal/AAB-4613-2020; Paulson, James/AAG-3565-2019; Ward, Andrew/ABD-7728-2021; poignard, pascal/N-6678-2013; van Gils, Marit J./H-4791-2019	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; van Gils, Marit J./0000-0003-3422-8161; Poignard, Pascal/0000-0002-0021-7192; Julien, Jean-Philippe/0000-0001-7602-3995; Peng, Wenjie/0000-0001-5093-7115; Lee, Jeong Hyun/0000-0001-7371-845X	International AIDS Vaccine Initiative Neutralizing Antibody Center, Scripps CHAVI-ID [UM1 AI100663]; NIH grants HIVRAD [P01 AI082362, R01 AI084817]; University of California, San Diego Center for AIDS Research, an NIH [P30 AI036214]; NIAID; NCI; NIMH; NIDA; NICHD; NHLBI; NIA; Aids Fonds Netherlands grant [2011032]; Vidi grant from the Netherlands Organization for Scientific Research; European Research Council; German Academic Exchange Service (DAAD) Research fellowship; California HIV/AIDS Research Program; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan; Biomedical Technology Research Center program of the National Institute of General Medical Sciences [GM103310]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084817, UM1AI100663, P01AI082362, P30AI036214, R56AI084817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative Neutralizing Antibody Center, Scripps CHAVI-ID; NIH grants HIVRAD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego Center for AIDS Research, an NIH; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Aids Fonds Netherlands grant; Vidi grant from the Netherlands Organization for Scientific Research; European Research Council(European Research Council (ERC)European Commission); German Academic Exchange Service (DAAD) Research fellowship(Deutscher Akademischer Austausch Dienst (DAAD)); California HIV/AIDS Research Program; US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan; Biomedical Technology Research Center program of the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Hua, A. Irimia, L. Kong, H. Tien, M. Deller, and M. Hong for technical assistance and valuable discussions and J. Voss for providing expression plasmids. This work was supported by the International AIDS Vaccine Initiative Neutralizing Antibody Center, Scripps CHAVI-ID (UM1 AI100663), NIH grants HIVRAD P01 AI082362 and R01 AI084817, the University of California, San Diego Center for AIDS Research, an NIH-funded program (P30 AI036214) (supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA), Aids Fonds Netherlands grant #2011032, a Vidi grant from the Netherlands Organization for Scientific Research (R.W.S.), a Starting Investigator Grant from the European Research Council (R.W.S.), a German Academic Exchange Service (DAAD) Research fellowship (C.B.), and a Dissertation Fellowship from the California HIV/AIDS Research Program (J.H.L). Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357, and beamline 08ID-1 at the Canadian Light Source was supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. EM work was conducted at the National Resource for Automated Molecular Microscopy at The Scripps Research Institute (TSRI), which is supported by the Biomedical Technology Research Center program (GM103310) of the National Institute of General Medical Sciences. Images were generated with the UCSF Chimera package. This is manuscript 26044 from TSRI.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Go EP, 2009, J PROTEOME RES, V8, P4231, DOI 10.1021/pr9002728; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Khayat R, 2013, J VIROL, V87, P9865, DOI 10.1128/JVI.01222-13; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2004, AIDS RES HUM RETROV, V20, P742, DOI 10.1089/0889222041524544; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Scheres SHW, 2005, BIOINFORMATICS, V21, P243, DOI 10.1093/bioinformatics/bti1140; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Yoshioka C, 2007, J STRUCT BIOL, V159, P335, DOI 10.1016/j.jsb.2007.03.005; Zhang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044241; Zhang MY, 2004, ANTIVIR RES, V61, P161, DOI 10.1016/j.antiviral.2003.09.009; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	51	254	270	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					669	680		10.1016/j.immuni.2014.04.008	http://dx.doi.org/10.1016/j.immuni.2014.04.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24768348	Green Accepted, Bronze			2022-12-18	WOS:000336026100007
J	Gehrke, N; Mertens, C; Zillinger, T; Wenzel, J; Bald, T; Zahn, S; Tuting, T; Hartmann, G; Barchet, W				Gehrke, Nadine; Mertens, Christina; Zillinger, Thomas; Wenzel, Joerg; Bald, Tobias; Zahn, Sabine; Tueting, Thomas; Hartmann, Gunther; Barchet, Winfried			Oxidative Damage of DNA Confers Resistance to Cytosolic Nuclease TREX1 Degradation and Potentiates STING-Dependent Immune Sensing	IMMUNITY			English	Article							CYCLIC GMP-AMP; SELF-DNA; REACTIVE OXYGEN; BACTERIAL-DNA; STRANDED-RNA; CPG MOTIFS; RECOGNITION; LUPUS; RECEPTORS; ACID	Immune sensing of DNA is critical for antiviral immunity but can also trigger autoimmune diseases such as lupus erythematosus (LE). Here we have provided evidence for the involvement of a damage-associated DNA modification in the detection of cytosolic DNA. The oxidized base 8-hydroxyguanosine (8-OHG), a marker of oxidative damage in DNA, potentiated cytosolic immune recognition by decreasing its susceptibility to 3' repair exonuclease 1 (TREX1)-mediated degradation. Oxidizative modifications arose physiologically in pathogen DNA during lysosomal reactive oxygen species (ROS) exposure, as well as in neutrophil extracellular trap (NET) DNA during the oxidative burst. 8-OHG was also abundant in UV-exposed skin lesions of LE patients and colocalized with type I interferon (IFN). Injection of oxidized DNA in the skin of lupus-prone mice induced lesions that closely matched respective lesions in patients. Thus, oxidized DNA represents a prototypic damage-associated molecular pattern (DAMP) with important implications for infection, sterile inflammation, and autoimmunity.	[Gehrke, Nadine; Mertens, Christina; Zillinger, Thomas; Hartmann, Gunther; Barchet, Winfried] Univ Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Wenzel, Joerg; Bald, Tobias; Zahn, Sabine; Tueting, Thomas] Univ Bonn, Dept Dermatol & Allergol, Lab Expt Dermatol, D-53127 Bonn, Germany	University of Bonn; University of Bonn	Barchet, W (corresponding author), Univ Bonn, Inst Clin Chem & Clin Pharmacol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	winfried.barchet@ukb.uni-bonn.de	Wenzel, Jörg/AAX-2644-2020; Hartmann, Gunther/P-7492-2017; Zillinger, Thomas/AAD-7320-2020; Bald, Tobias/H-9525-2018; Tüting, Thomas/AAJ-3610-2021	Wenzel, Jörg/0000-0002-4744-5993; Hartmann, Gunther/0000-0003-1021-2018; Zillinger, Thomas/0000-0002-0866-4835; Bald, Tobias/0000-0003-0061-235X; Tüting, Thomas/0000-0001-7146-0934; Barchet, Winfried/0000-0002-6745-6606	Deutsche Forschungsgemeinschaft [BA3544/1-1, WE4428-1/2, SFB670, SFB704]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Stasch for expert technical assistance and E. Latz, T. Cavlar, E. Bartok, M. Schlee, and C. Coch for helpful discussion and critical reading of the manuscript. This work was supported by Deutsche Forschungsgemeinschaft grants BA3544/1-1 (W. B.), WE4428-1/2 (J.W., T. T.), SFB670 (G. H.), and SFB704 (W. B., T. T., G. H.). W. B., T. T., and G. H. are members of the DFG-funded Excellence Cluster ImmunoSensation.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Ahmed NU, 1999, BRIT J DERMATOL, V140, P226, DOI 10.1111/j.1365-2133.1999.02653.x; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amanna IJ, 2012, NAT MED, V18, P974, DOI 10.1038/nm.2763; Atianand MK, 2013, J IMMUNOL, V190, P1911, DOI 10.4049/jimmunol.1203162; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Chamilos G, 2012, BLOOD, V120, P3699, DOI 10.1182/blood-2012-01-401364; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Cooke MS, 1997, FREE RADICAL BIO MED, V22, P151, DOI 10.1016/S0891-5849(96)00283-3; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gilliet M, 2008, CURR OPIN IMMUNOL, V20, P401, DOI 10.1016/j.coi.2008.06.008; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jurk M, 2006, CHEMMEDCHEM, V1, P1007, DOI 10.1002/cmdc.200600064; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kuechle MK, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2100; Kurien BT, 2008, AUTOIMMUN REV, V7, P567, DOI 10.1016/j.autrev.2008.04.019; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Leung DW, 2012, CURR OPIN STRUC BIOL, V22, P297, DOI 10.1016/j.sbi.2012.03.011; LUNEC J, 1994, FEBS LETT, V348, P131, DOI 10.1016/0014-5793(94)00583-4; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Morel L, 2010, NAT REV RHEUMATOL, V6, P348, DOI 10.1038/nrrheum.2010.63; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pisetsky DS, 2012, CLIN IMMUNOL, V144, P32, DOI 10.1016/j.clim.2012.04.006; Prokopowicz ZM, 2010, J IMMUNOL, V184, P824, DOI 10.4049/jimmunol.0902606; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Vallin H, 1999, J IMMUNOL, V163, P6306; Walling HW, 2009, AM J CLIN DERMATOL, V10, P365, DOI 10.2165/11310780-000000000-00000; Wen ZK, 2007, RHEUMATOLOGY, V46, P1796, DOI 10.1093/rheumatology/kem275; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yoshida H, 2011, FREE RADICAL BIO MED, V51, P424, DOI 10.1016/j.freeradbiomed.2011.04.035; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	65	254	269	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					482	495		10.1016/j.immuni.2013.08.004	http://dx.doi.org/10.1016/j.immuni.2013.08.004			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	23993650	Bronze			2022-12-18	WOS:000330949600012
J	Carrasco, YR; Fleire, SJ; Cameron, T; Dustin, ML; Batista, FD				Carrasco, YR; Fleire, SJ; Cameron, T; Dustin, ML; Batista, FD			LFA-1/ICAM-1 interaction lowers the threshold of B cell activation by facilitating B cell adhesion and synapse formation	IMMUNITY			English	Article							FOLLICULAR DENDRITIC CELLS; PEPTIDE-MHC COMPLEXES; RESPONSES IN-VIVO; IMMUNOLOGICAL SYNAPSE; ANTIGEN RECEPTOR; T-CELLS; LYMPHOCYTES-B; ENDOTHELIAL-CELLS; AFFINITY; LFA-1	The integrin LFA-1 and its ligand ICAM-1 mediate B cell adhesion, but their role in membrane-bound antigen recognition is still unknown. Here, using planar lipid bilayers and cells expressing ICAM-1 fused to green fluorescence protein, we found that the engagement of B cell receptor (BCR) promotes B cell adhesion by an LFA-1-mediated mechanism. LFA-1 is recruited to form a mature B cell synapse segregating into a ring around the BCR. This distribution is maintained over a wide range of BCR/antigen affinities (10(6) M-1 to 10(11) M-1). Furthermore, the LFA-1 binding to ICAM-1 reduces the level of antigen required to form the synapse and trigger a B cell. Thus, LFA-1/ICAM-1 interaction lowers the threshold for B cell activation by promoting B cell adhesion and synapse formation.	Canc Res UK, London Res Inst, Lymphocyte Interact Lab, Lincolns Inn Fields Lab, London WC2A 3PX, England; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA	Cancer Research UK; New York University	Batista, FD (corresponding author), Canc Res UK, London Res Inst, Lymphocyte Interact Lab, Lincolns Inn Fields Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	facundo.batista@cancer.org.uk	Carrasco, Yolanda/X-2629-2019; Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; Carrasco, Yolanda R./0000-0003-2148-1926				Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Carman CV, 2003, J IMMUNOL, V171, P6135, DOI 10.4049/jimmunol.171.11.6135; COYNE KE, 1993, J BIOL CHEM, V268, P6689; DANG LH, 1991, J IMMUNOL, V146, P3273; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; KOOPMAN G, 1991, J EXP MED, V173, P1297, DOI 10.1084/jem.173.6.1297; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Kushnir N, 1998, J IMMUNOL, V160, P1774; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; Lanoue A, 2002, EUR J IMMUNOL, V32, P348, DOI 10.1002/1521-4141(200202)32:2<348::AID-IMMU348>3.0.CO;2-5; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lee SJE, 2002, TRENDS IMMUNOL, V23, P492, DOI 10.1016/S1471-4906(02)02285-8; Lee SJE, 2002, TRENDS IMMUNOL, V23, P500, DOI 10.1016/S1471-4906(02)02325-6; Lernmark A, 2001, J CLIN INVEST, V108, P1091, DOI 10.1172/JCI200114234; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; MOLLER G, 1987, IMMUNOL REV, V96, P1; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Reth M, 2001, TRENDS IMMUNOL, V22, P356, DOI 10.1016/S1471-4906(01)01964-0; Reth M, 2000, IMMUNOL REV, V176, P10; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; SCHWARZ FP, 1995, EUR J BIOCHEM, V228, P388; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; Szakal A K, 1988, Adv Exp Med Biol, V237, P197; Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Wagle NM, 2000, CURR TOP MICROBIOL, V245, P101; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wykes M, 1998, J IMMUNOL, V161, P1313	62	254	265	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					589	599		10.1016/S1074-7613(04)00105-0	http://dx.doi.org/10.1016/S1074-7613(04)00105-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142527	Bronze			2022-12-18	WOS:000221631900009
J	O'Riordan, M; Grosschedl, R				O'Riordan, M; Grosschedl, R			Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A	IMMUNITY			English	Article							LYMPHOCYTES-B; FACTOR BSAP; DNA-BINDING; HEAVY-CHAIN; RAG-1-DEFICIENT MICE; GENE-TRANSCRIPTION; TRANSGENIC MICE; IGH LOCUS; EXPRESSION; PROTEINS	The transcription factors EBF and E2A are required at a similar step in early B cell differentiation. EBF and E2A synergistically upregulate transcription of endogenous B cell-specific genes in a non-B cell line. Here, we examine a genetic collaboration between these factors in regulating B lymphopoiesis. We find that Ebf(+/-)E2a(+/-) mice display a marked defect in pro-B cell differentiation at a stage later than observed in the single homozygous mutant mice. Pro-B cells from Ebf(+/-)E2a(+/-) mice show reduced expression of lymphoid-specific transcripts, including Pax5, Rag1, Rag2, and mb-1. We also show that EBF directly binds and activates the Pax5 promoter. Together, these data show collaboration between EBF and E2A and provide insight into the hierarchy of transcription factors that regulate B lymphocyte differentiation.	Univ Calif San Francisco, Dept Microbiol & Immunol, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Grosschedl, R (corresponding author), Univ Munich, Inst Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	rgross@lmb.uni-muenchen.de	O'Riordan, Mary/D-8227-2011	O'Riordan, Mary/0000-0001-6014-4637				ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Busslinger M, 1996, P NATL ACAD SCI USA, V93, P6129, DOI 10.1073/pnas.93.12.6129; Busslinger Meinrad, 1998, P83; CHEN JZ, 1994, CURR OPIN IMMUNOL, V6, P313, DOI 10.1016/0952-7915(94)90107-4; Choi JK, 1996, EMBO J, V15, P5014, DOI 10.1002/j.1460-2075.1996.tb00881.x; Crozatier M, 1996, CURR BIOL, V6, P707, DOI 10.1016/S0960-9822(09)00452-7; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HAGMAN J, 1991, EMBO J, V10, P3409, DOI 10.1002/j.1460-2075.1991.tb04905.x; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; Hardy RR, 1995, ANN NY ACAD SCI, V764, P19; Henikoff S, 1996, BIOESSAYS, V18, P401, DOI 10.1002/bies.950180510; HERNANDEZMUNAIN C, 1995, MOL CELL BIOL, V15, P3090; JACOBS Y, 1994, MOL CELL BIOL, V14, P4087, DOI 10.1128/MCB.14.6.4087; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; KUDO A, 1987, EMBO J, V6, P103, DOI 10.1002/j.1460-2075.1987.tb04725.x; KUDO A, 1987, EMBO J, V6, P4242; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MURRE C, 1991, MOL CELL BIOL, V11, P1156, DOI 10.1128/MCB.11.2.1156; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Reya T, 1998, CURR OPIN IMMUNOL, V10, P158, DOI 10.1016/S0952-7915(98)80244-6; ROLINK A, 1993, ADV IMMUNOL, V53, P123, DOI 10.1016/S0065-2776(08)60499-X; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Tian JY, 1997, EUR J IMMUNOL, V27, P750, DOI 10.1002/eji.1830270325; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; WAKATSUKI Y, 1994, J EXP MED, V179, P1099, DOI 10.1084/jem.179.4.1099; Wallin JJ, 1998, SCIENCE, V279, P1961, DOI 10.1126/science.279.5358.1961; Wang H, 1998, P NATL ACAD SCI USA, V95, P6831, DOI 10.1073/pnas.95.12.6831; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; WASSERMAN R, 1995, J IMMUNOL, V155, P644; Wehr R, 1996, INT J DEV BIOL, V40, P369; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	59	254	255	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1999	11	1					21	31		10.1016/S1074-7613(00)80078-3	http://dx.doi.org/10.1016/S1074-7613(00)80078-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220ND	10435576	Bronze			2022-12-18	WOS:000081671300003
J	Zaiss, MM; Rapin, A; Lebon, L; Dubey, LK; Mosconi, I; Sarter, K; Piersigilli, A; Menin, L; Walker, AW; Rougemont, J; Paerewijck, O; Geldhof, P; McCoy, KD; Macpherson, AJ; Croese, J; Giacomin, PR; Loukas, A; Junt, T; Marsland, BJ; Harris, NL				Zaiss, Mario M.; Rapin, Alexis; Lebon, Luc; Dubey, Lalit Kumar; Mosconi, Ilaria; Sarter, Kerstin; Piersigilli, Alessandra; Menin, Laure; Walker, Alan W.; Rougemont, Jacques; Paerewijck, Oonagh; Geldhof, Peter; McCoy, Kathleen D.; Macpherson, Andrew J.; Croese, John; Giacomin, Paul R.; Loukas, Alex; Junt, Tobias; Marsland, Benjamin J.; Harris, Nicola L.			The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation	IMMUNITY			English	Article							REGULATORY T-CELLS; HELIGMOSOMOIDES-POLYGYRUS; AIRWAY INFLAMMATION; GUT MICROBIOTA; IMMUNE REGULATION; TYPE-2 IMMUNITY; EARLY-LIFE; INFECTION; DISEASE; METABOLITES	Intestinal helminths are potent regulators of their host's immune system and can ameliorate inflammatory diseases such as allergic asthma. In the present study we have assessed whether this anti-inflammatory activity was purely intrinsic to helminths, or whether it also involved crosstalk with the local microbiota. We report that chronic infection with the murine helminth Heligmosomoides polygyrus bakeri (Hpb) altered the intestinal habitat, allowing increased short chain fatty acid (SCFA) production. Transfer of the Hpb-modified microbiota alone was sufficient to mediate protection against allergic asthma. The helminth-induced anti-inflammatory cytokine secretion and regulatory T cell suppressor activity that mediated the protection required the G protein-coupled receptor (GPR)-41. A similar alteration in the metabolic potential of intestinal bacterial communities was observed with diverse parasitic and host species, suggesting that this represents an evolutionary conserved mechanism of host-microbe-helminth interactions.	[Zaiss, Mario M.; Rapin, Alexis; Lebon, Luc; Dubey, Lalit Kumar; Mosconi, Ilaria; Piersigilli, Alessandra; Harris, Nicola L.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Sarter, Kerstin] Univ Geneva, Fac Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Piersigilli, Alessandra] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, CH-3012 Bern, Switzerland; [Menin, Laure] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Walker, Alan W.] Wellcome Trust Sanger Inst, Pathogen Genom Grp, Hinxton CB10 1SA, Cambs, England; [Walker, Alan W.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Microbiol Grp, Aberdeen AB21 9SB, Scotland; [Rougemont, Jacques] Ecole Polytech Fed Lausanne, Bioinformat & Biostat Core Facil, CH-1015 Lausanne, Switzerland; [Rougemont, Jacques] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Paerewijck, Oonagh; Geldhof, Peter] Univ Ghent, Dept Virol Parasitol & Immunol, B-9820 Merelbeke, Belgium; [McCoy, Kathleen D.; Macpherson, Andrew J.] Univ Hosp Bern, Maurice Muller Labs DKF, CH-3010 Bern, Switzerland; [Croese, John] Prince Charles Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4032, Australia; [Croese, John; Giacomin, Paul R.; Loukas, Alex] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld 4870, Australia; [Junt, Tobias] Novartis Pharma AG, CH-4056 Basel, Switzerland; [Marsland, Benjamin J.] Univ Lausanne, CHUV, Fac Biol & Med, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Bern; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Wellcome Trust Sanger Institute; University of Aberdeen; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Ghent University; University of Bern; University Hospital of Bern; Prince Charles Hospital; James Cook University; Novartis; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Harris, NL (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland.	nicola.harris@epfl.ch	harris, nicola/E-5342-2019; Dubey, Lalit Kumar/M-8590-2019; McCoy, Kathy/ABD-5814-2021; Paerewijck, Oonagh/AAN-9982-2020; Zaiss, Mario M./ABE-7125-2021; Junt, Tobias/AAE-4389-2021; Walker, Alan W./AAE-8102-2019; Loukas, Alex/B-7355-2014	harris, nicola/0000-0003-2922-0210; Dubey, Lalit Kumar/0000-0001-8746-7292; Zaiss, Mario M./0000-0003-3844-1664; Walker, Alan W./0000-0001-5099-8495; Loukas, Alex/0000-0002-0896-8441; Rapin, Alexis/0000-0003-3448-5459; Giacomin, Paul/0000-0002-6326-6792	European Research Council under the European Union's Seventh Framework Programme (FP)/ERC [310948]; Wellcome Trust [WT 098051]	European Research Council under the European Union's Seventh Framework Programme (FP)/ERC(European Research Council (ERC)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Manuel Kulagin for technical help, Pierre Bonnaventure for portal vein blood sampling, Francisco Sepulveda for technical assistance in GSMS acquisition, and Dorothee Hahne (Metabolomics Australia, University of Western Australia) for human samples SCFA isolation, acquisition, and analysis. We also thank Cristina Cartoni (Phenotyping Unit, EPFL) for Milliplex analysis, Jessica Dessimoz and her team from the Histology Core Facility (EPFL), Miguel Garcia and his team from the Flow Cytometry Core Facility (EPFL), and staff from the EPFL CPG animal house for excellent animal care. The computations were partially performed at the Vital-IT Center for high-performance computing of the SIB Swiss Institute of Bioinformatics (http://www.vital-it.ch). The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. 310948. Funding for A.W.W. and a subset of the 16S rRNA gene sequencing was provided by the Wellcome Trust (grant number WT 098051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Collison LW, 2011, METHODS MOL BIOL, V707, P21, DOI 10.1007/978-1-61737-979-6_2; Cooper PJ, 2003, J ALLERGY CLIN IMMUN, V111, P995, DOI 10.1067/mai.2003.1348; Correale J, 2011, MULT SCLER J, V17, P1162, DOI 10.1177/1352458511418027; Cotta M, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P1002, DOI 10.1007/0-387-30744-3_35; Croese J, 2015, J ALLERGY CLIN IMMUN, V135, P508, DOI 10.1016/j.jaci.2014.07.022; Daveson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017366; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dorrestein PC, 2014, IMMUNITY, V40, P824, DOI 10.1016/j.immuni.2014.05.015; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Hang L, 2013, J IMMUNOL, V191, P1927, DOI 10.4049/jimmunol.1201457; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Johnston Chris, 2015, Lancet, V385 Suppl 1, pS50, DOI 10.1016/S0140-6736(15)60365-8; Khan AR, 2013, INT J PARASITOL, V43, P293, DOI 10.1016/j.ijpara.2012.12.002; Leonardi-Bee J, 2006, AM J RESP CRIT CARE, V174, P514, DOI 10.1164/rccm.200603-331OC; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maizels RM, 2005, CURR OPIN IMMUNOL, V17, P656, DOI 10.1016/j.coi.2005.09.001; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; McSorley HJ, 2012, EUR J IMMUNOL, V42, P2667, DOI 10.1002/eji.201142161; Mishra PK, 2013, MUCOSAL IMMUNOL, V6, P297, DOI 10.1038/mi.2012.71; Mosconi I, 2015, INFECT IMMUN, V83, P3657, DOI 10.1128/IAI.00266-15; Osada Y, 2013, EXP PARASITOL, V135, P388, DOI 10.1016/j.exppara.2013.08.003; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Reynolds LA, 2014, GUT MICROBES, V5, P522, DOI 10.4161/gmic.32155; Salinas-Carmona MC, 2009, AUTOIMMUNITY, V42, P25, DOI 10.1080/08916930802228290; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Tielens AGM, 2010, INT J PARASITOL, V40, P387, DOI 10.1016/j.ijpara.2009.12.006; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Weinstock JV, 2006, ANN NY ACAD SCI, V1072, P356, DOI 10.1196/annals.1326.033; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Wjst M, 2007, PLOS MED, V4, P203, DOI 10.1371/journal.pmed.0040072; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470; Zeissig S, 2014, NAT IMMUNOL, V15, P307, DOI 10.1038/ni.2847	47	253	261	6	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					998	1010		10.1016/j.immuni.2015.09.012	http://dx.doi.org/10.1016/j.immuni.2015.09.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26522986	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000366846000019
J	Ohnmacht, C; Schwartz, C; Panzer, M; Schiedewitz, I; Naumann, R; Voehringer, D				Ohnmacht, Caspar; Schwartz, Christian; Panzer, Marc; Schiedewitz, Isabel; Naumann, Ronald; Voehringer, David			Basophils Orchestrate Chronic Allergic Dermatitis and Protective Immunity against Helminths	IMMUNITY			English	Article							T-CELLS; DENDRITIC CELLS; TYPE-2 IMMUNITY; IL-4 PRODUCTION; IN-VIVO; EFFECTOR FUNCTION; TRANSGENIC MICE; HOMEOSTASIS; RECRUITMENT; EXPRESSION	Basophils are associated with T helper 2 (Th2) cell-polarized immune responses such as allergic disorders or helminth infections. To directly address the role of basophils for type 2 immunity, we generated transgenic mice with constitutive and selective deletion of basophils. Differentiation and accumulation of Th2 cells, induction of eosinophilia, and increase in serum IgE or IgG1 induced by allergens or by infection with the helminth Nippostrongylus brasiliensis appeared to be basophil independent. Further, basophils were not required for passive IgE- or IgG1-mediated systemic anaphylaxis. However, basophils were essential for IgE-meditated chronic allergic dermatitis and for protection against secondary infection with N. brasiliensis. These results demonstrate that basophils play an important role for protective immunity against helminths and orchestrate chronic allergic inflammation, whereas primary Th2 cell responses can operate efficiently in the absence of this cell type.	[Ohnmacht, Caspar; Schwartz, Christian; Panzer, Marc; Schiedewitz, Isabel; Voehringer, David] Univ Munich, Inst Immunol, D-80336 Munich, Germany; [Naumann, Ronald] MPI Mol Cell Biol & Genet, Transgen Core Facil, D-01307 Dresden, Germany	University of Munich	Voehringer, D (corresponding author), Univ Munich, Inst Immunol, D-80336 Munich, Germany.	david.voehringer@med.uni-muenchen.de	Voehringer, David/K-2776-2019; Ohnmacht, Caspar/M-8033-2013; Schwartz, Christian/K-3716-2015	Schwartz, Christian/0000-0002-7084-268X	Deutsche Forschungsgemeinschaft [Vo944/2]; European Research Council [241506-PAS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We thank S. Wirth for technical assistance; R. Obst, S. Huber, and A. Seidl for helpful comments; T. Brocker for support; W. Mertl and A. Bol for animal husbandry; N. G. Copeland for reagents; Z. Eshhar for the IgG1-anti-DNP; H. Fehling for providing the ROSAtdRFP mice; and A. Oxenius for providing Smarts mice. This work was supported by an Emmy Noether grant from the Deutsche Forschungsgemeinschaft (Vo944/2) and by a starting grant from the European Research Council (241506-PAS).	Arinobu Yojiro, 2009, Allergology International, V58, P21, DOI 10.2332/allergolint.08-RAI-0067; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; DVORAK HF, 1970, J EXP MED, V132, P558, DOI 10.1084/jem.132.3.558; Harris NL, 1999, EUR J IMMUNOL, V29, P311, DOI 10.1002/(SICI)1521-4141(199901)29:01&lt;311::AID-IMMU311&gt;3.0.CO;2-B; Hotez PJ, 2003, INT J PARASITOL, V33, P1245, DOI 10.1016/S0020-7519(03)00158-9; KATONA IM, 1988, J IMMUNOL, V140, P3206; Khodoun MV, 2004, J EXP MED, V200, P857, DOI 10.1084/jem.20040598; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu ZG, 2005, J IMMUNOL, V174, P2242, DOI 10.4049/jimmunol.174.4.2242; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; LYON MF, 1982, GENET RES, V39, P315, DOI 10.1017/S001667230002098X; Macfarlane AJ, 2000, J ALLERGY CLIN IMMUN, V105, P99, DOI 10.1016/S0091-6749(00)90184-2; Mccoy KD, 2008, CELL HOST MICROBE, V4, P362, DOI 10.1016/j.chom.2008.08.014; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Mukai Kaori, 2009, Allergology International, V58, P11, DOI 10.2332/allergolint.08-RAI-0059; Nouri-Aria KT, 2001, J ALLERGY CLIN IMMUN, V108, P205, DOI 10.1067/mai.2001.117175; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Ohnmacht C, 2010, J IMMUNOL, V184, P344, DOI 10.4049/jimmunol.0901841; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Ohnmacht C, 2009, BLOOD, V113, P2816, DOI 10.1182/blood-2008-05-154773; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Pesce JT, 2008, J IMMUNOL, V180, P464, DOI 10.4049/jimmunol.180.1.464; Poorafshar M, 2000, EUR J IMMUNOL, V30, P2660, DOI 10.1002/1521-4141(200009)30:9<2660::AID-IMMU2660>3.0.CO;2-I; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; URBAN JF, 1992, IMMUNOL REV, V127, P205, DOI 10.1111/j.1600-065X.1992.tb01415.x; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Voehringer D, 2009, TRENDS PARASITOL, V25, P551, DOI 10.1016/j.pt.2009.09.004; WESTON SA, 1990, J IMMUNOL METHODS, V133, P87, DOI 10.1016/0022-1759(90)90322-M; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zimmermann N, 2003, J ALLERGY CLIN IMMUN, V111, P227, DOI 10.1067/mai.2003.139	44	253	256	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 24	2010	33	3					364	374		10.1016/j.immuni.2010.08.011	http://dx.doi.org/10.1016/j.immuni.2010.08.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20817571	Bronze			2022-12-18	WOS:000282798500011
J	Sarris, M; Andersen, KG; Randow, F; Mayr, L; Betz, AG				Sarris, Milka; Andersen, Kristian G.; Randow, Felix; Mayr, Luzia; Betz, Alexander G.			Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition	IMMUNITY			English	Article							ENDOTHELIAL GROWTH-FACTOR; KAPPA-B ACTIVATION; IN-VIVO; IMMUNOLOGICAL SYNAPSE; TOLERANCE; RECEPTOR; AUTOIMMUNITY; LYMPHOCYTES; MICE; MICROCLUSTERS	The interaction of T cells with dendritic cells (DCs) determines whether an immune response is launched or not. Recognition of antigen leads to formation of immunological synapses at the interface between the cells. The length of interaction is likely to determine the functional outcome, because it limits the number of MHC class II-peptide complexes that can be recruited into the synapse. Here, we show that regulatory T (Treg) cells and naive helper T (Th) cells interact differently with DCs in the absence of proinflammatory stimuli. Although differences in T cell receptor repertoire might contribute, Foxp3-induced phenotypic differences play a major role. We found that Neuropilin-1 (Nrp-1), which is expressed by most Treg cells but not naive Th cells, promoted prolonged interactions with immature DCs (iDCs), resulting in higher sensitivity to limiting amounts of antigen. This is likely to give Treg cells an advantage over naive Th cells, with the same specificity leading to a "default" suppression of immune responses in the absence of "danger signals."	[Sarris, Milka; Andersen, Kristian G.; Randow, Felix; Mayr, Luzia; Betz, Alexander G.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Betz, AG (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	betz@mrc-Imb.cam.ac.uk	Andersen, Kristian/D-5006-2009; Betz, Alexander/GQQ-2221-2022	Andersen, Kristian/0000-0001-6431-5982; 	Medical Research Council [MC_U105170648, MC_U105184296] Funding Source: Medline; MRC [MC_U105170648, MC_U105184296] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Gerber DA, 1998, TRANSPLANT P, V30, P1573, DOI 10.1016/S0041-1345(98)00361-3; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Oyama T, 1998, J IMMUNOL, V160, P1224; Rothoeft T, 2006, EUR J IMMUNOL, V36, P3105, DOI 10.1002/eji.200636145; Rovere-Querini P, 2005, AUTOIMMUN REV, V4, P555, DOI 10.1016/j.autrev.2005.04.013; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SALKAGUCHI S, 2005, NAT IMMUNOL, V6, P345; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tarbell KV, 2006, SEMIN IMMUNOL, V18, P93, DOI 10.1016/j.smim.2006.01.009; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wan H, 2005, CELL MOL IMMUNOL, V2, P28; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	42	253	274	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2008	28	3					402	413		10.1016/j.immuni.2008.01.012	http://dx.doi.org/10.1016/j.immuni.2008.01.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18328743	hybrid, Green Published			2022-12-18	WOS:000254142500017
J	Delogu, A; Schebesta, A; Sun, Q; Aschenbrenner, K; Perlot, T; Busslinger, M				Delogu, A; Schebesta, A; Sun, Q; Aschenbrenner, K; Perlot, T; Busslinger, M			Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells	IMMUNITY			English	Article							GERMINAL CENTER FORMATION; HEMATOPOIETIC STEM-CELLS; LINEAGE COMMITMENT; GROWTH-FACTOR; BONE-MARROW; IN-VIVO; J-CHAIN; MICE; EXPRESSION; DIFFERENTIATION	The transcription factor Pax5 represses lineage-inappropriate genes and activates B cell-specific genes in B lymphocytes. By identifying 110 Pax5-repressed genes, we now demonstrate that Pax5 downregulates diverse biological activities including receptor signaling, cell adhesion, migration, transcriptional control, and cellular metabolism at B cell commitment. The T lymphoid or myeloid expression of these genes demonstrates that Pax5(-/-) pro-B cells and common lymphoid progenitors display lymphoid and myeloid promiscuity of gene expression. These lineage-inappropriate genes require continuous Pax5 activity for their repression, as they are reactivated in committed pro-B cells and mature B cells following conditional Pax5 deletion. Pax5-repressed genes are also reexpressed in plasma cells, which depend for normal function on Cd28 and Ccr2 reactivation. The loss of Pax5 during terminal differentiation thus contributes to the plasma cell transcription program. Finally, ectopic expression of the Pax5-repressed chemokine gene Ccl3 in B cells results in increased osteoclast formation and bone loss, demonstrating that Pax5-mediated gene repression is essential for normal homeostasis of hematopoietic development.	VIenna Bioctrviebio, Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Busslinger, M (corresponding author), VIenna Bioctrviebio, Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	busslinger@imp.univie.ac.at	Delogu, Alessio/F-5033-2010; Busslinger, Meinrad J./J-1249-2016	Delogu, Alessio/0000-0002-4414-4714; Busslinger, Meinrad J./0000-0002-9111-9351				Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Broome CS, 2000, BRIT J HAEMATOL, V108, P140; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Feldweg AM, 2003, EUR J IMMUNOL, V33, P2262, DOI 10.1002/eji.200323978; Ferguson SE, 1996, J IMMUNOL, V156, P4576; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Harrington C., 2001, POLICY POLITICS NURS, V2, P117; Heavey B, 2003, EMBO J, V22, P3887, DOI 10.1093/emboj/cdg380; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Horowitz MC, 2004, J IMMUNOL, V173, P6583, DOI 10.4049/jimmunol.173.11.6583; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; HUANG RP, 1993, DEV BIOL, V155, P307, DOI 10.1006/dbio.1993.1030; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; NILES MJ, 1995, P NATL ACAD SCI USA, V92, P2884, DOI 10.1073/pnas.92.7.2884; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Oyajobi BO, 2003, BLOOD, V102, P311, DOI 10.1182/blood-2002-12-3905; Rantakokko J, 1996, FEBS LETT, V393, P307, DOI 10.1016/0014-5793(96)00907-6; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Tagoh H, 2004, EMBO J, V23, P4275, DOI 10.1038/sj.emboj.7600421; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Tang Y, 2003, SCIENCE, V299, P574, DOI 10.1126/science.1075994; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Trifilo MJ, 2003, J VIROL, V77, P4004, DOI 10.1128/JVI.77.7.4004-4014.2003; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yoder J, 2001, SCIENCE, V291, P1987, DOI 10.1126/science.1057176; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413	56	253	261	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2006	24	3					269	281		10.1016/j.immuni.2006.01.012	http://dx.doi.org/10.1016/j.immuni.2006.01.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546096	Bronze			2022-12-18	WOS:000236504500008
J	Fischer, AM; Katayama, CD; Pages, G; Pouyssegur, J; Hedrick, SM				Fischer, AM; Katayama, CD; Pages, G; Pouyssegur, J; Hedrick, SM			The role of Erk1 and Erk2 in multiple stages of T cell development	IMMUNITY			English	Article							ACTIVATED PROTEIN-KINASE; CD8 LINEAGE COMMITMENT; THYMOCYTE POSITIVE SELECTION; NEGATIVE SELECTION; SIGNALING PATHWAYS; ALPHA-BETA; STOCHASTIC MECHANISM; GENE-EXPRESSION; IN-VITRO; RECEPTOR	Activation of extracellular-signal-regulated protein kinase (Erk) is central to growth-factor-receptor-mediated signaling including that originating from the T cell antigen receptor. It integrates cytoplasmic signals to effect changes in transcription associated with differentiation, proliferation, and survival. In this report, we present an analysis of mice with targeted deletions in Erk1 and Erk2 to assess the relationship between Erk activity and cell-cycle progression, thymocyte development, and lineage commitment. These studies show that Erk is selectively retained during beta selection-driven proliferation, and yet Erk1/2 are not required to complete differentiation to CD4(+)CD8(+) preselection stage of development. Erk activity is essential for the process of positive selection, and it differentially affects CD4 and CID8 T cell maturation; yet, diminished expression itself is not sufficient to alter lineage commitment.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; CNRS, UMR 6543, Inst Signaling Dev Biol & Canc Res, Ctr Antoine Lacassagne, F-06189 Nice, France	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne	Hedrick, SM (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	shedrick@ucsd.edu	Pages, Gilles/N-7135-2017; Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021372, R37AI021372] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21372-21] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi S, 2002, CELL IMMUNOL, V215, P45, DOI 10.1016/S0008-8749(02)00012-6; Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Aliahmad P, 2004, J EXP MED, V199, P1089, DOI 10.1084/jem.20040051; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Bommhardt U, 2000, J IMMUNOL, V164, P2326, DOI 10.4049/jimmunol.164.5.2326; Bommhardt U, 1999, J IMMUNOL, V163, P715; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Costello PS, 2004, NAT IMMUNOL, V5, P289, DOI 10.1038/ni1038; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; GUIDOS CJ, 1990, J EXP MED, V172, P835, DOI 10.1084/jem.172.3.835; Hashimoto K, 1996, J EXP MED, V184, P931, DOI 10.1084/jem.184.3.931; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kaye J, 2000, IMMUNOL RES, V21, P71, DOI 10.1385/IR:21:2-3:71; KAYNE PS, 1995, CURR OPIN GENET DEV, V5, P38, DOI 10.1016/S0959-437X(95)90051-9; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Laky K, 2005, CURR OPIN IMMUNOL, V17, P116, DOI 10.1016/j.coi.2005.02.004; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Mariathasan S, 2000, EUR J IMMUNOL, V30, P1060, DOI 10.1002/(SICI)1521-4141(200004)30:4<1060::AID-IMMU1060>3.0.CO;2-2; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; Mertsching E, 2002, INT IMMUNOL, V14, P1039, DOI 10.1093/intimm/dxf067; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Nishida T, 2004, J IMMUNOL, V172, P6634, DOI 10.4049/jimmunol.172.11.6634; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Paget WJ, 1999, SOZ PRAVENTIV MED, V44, P1, DOI 10.1007/BF01624804; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; ROBEY E, 1994, J EXP MED, V179, P1997, DOI 10.1084/jem.179.6.1997; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; Shao H, 1999, J IMMUNOL, V163, P603; Sharp LL, 1999, J IMMUNOL, V163, P6598; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Shores EW, 1997, J EXP MED, V185, P893, DOI 10.1084/jem.185.5.893; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Suzuki H, 1997, J EXP MED, V186, P17, DOI 10.1084/jem.186.1.17; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Taniuchi I, 2004, ADV IMMUNOL, V83, P55; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Villunger A, 2004, P NATL ACAD SCI USA, V101, P7052, DOI 10.1073/pnas.0305757101; Walter SA, 2000, MOL BIOL CELL, V11, P887, DOI 10.1091/mbc.11.3.887; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; Wen BG, 2004, P NATL ACAD SCI USA, V101, P5604, DOI 10.1073/pnas.0306907101; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Wilkinson B, 2001, CELL IMMUNOL, V211, P86, DOI 10.1006/cimm.2001.1827; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zamoyska R, 2004, CURR OPIN IMMUNOL, V16, P191, DOI 10.1016/j.coi.2004.01.001; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	75	253	258	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2005	23	4					431	443		10.1016/j.immuni.2005.08.013	http://dx.doi.org/10.1016/j.immuni.2005.08.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	980EC	16226508	Bronze			2022-12-18	WOS:000232995800011
J	Jun, JE; Wilson, LE; Vinuesa, CG; Lesage, S; Blery, M; Miosge, LA; Cook, MC; Kucharska, EM; Hara, H; Penninger, JM; Domashenz, H; Hong, NA; Glynne, RJ; Nelms, KA; Goodnow, CC				Jun, JE; Wilson, LE; Vinuesa, CG; Lesage, S; Blery, M; Miosge, LA; Cook, MC; Kucharska, EM; Hara, H; Penninger, JM; Domashenz, H; Hong, NA; Glynne, RJ; Nelms, KA; Goodnow, CC			Identifying the MAGUK protein CARMA-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis	IMMUNITY			English	Article							NF-KAPPA-B; BRUTONS TYROSINE KINASE; RECEPTOR-INDUCED ACTIVATION; T-CELL-RECEPTOR; C-REL; PHOSPHOLIPASE C-GAMMA-2; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; SELF-TOLERANCE; COILED COILS	In a genome-wide ENU mouse mutagenesis screen a recessive mouse mutation, unmodulated, was isolated with profound defects in humoral immune responses, selective deficits in B cell activation by antigen receptors and T cell costimulation by CD28, and gradual development of atopic dermatitis with hyper-IgE. Mutant B cells are specifically defective in forming connections between antigen receptors and two key signaling pathways for immunogenic responses, NF-kappaB and JNK, but signal normally to calcium, NFAT, and ERK. The mutation alters a conserved leucine in the coiled-coil domain of CARMA-1/CARD11, a member of the MAGUK protein family implicated in organizing multimolecular signaling complexes. These results define Carma-1 as a key regulator of the plasticity in antigen receptor signaling that underpins opposing mechanisms of immunity and tolerance.	Australian Natl Univ, John Curtin Sch Med Res, Australian Canc Res Fdn, Genet Lab, Canberra, ACT 2601, Australia; Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, Canberra, ACT 2601, Australia; Phenomix Australia, Acton, ACT 2601, Australia; Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Toronto, Ontario Canc Inst, Hlth Network, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; Phenomix Corp, La Jolla, CA 92037 USA	Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Goodnow, CC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Australian Canc Res Fdn, Genet Lab, Canberra, ACT 2601, Australia.	chris.goodnow@anu.edu.au	Vinuesa, Carola G/B-1108-2010; Penninger, Josef M/I-6860-2013; Cook, matthew/F-4151-2019; Goodnow, Christopher C/V-8108-2018	Vinuesa, Carola G/0000-0001-9799-0298; Penninger, Josef M/0000-0002-8194-3777; Cook, matthew/0000-0002-3331-9363; Goodnow, Christopher C/0000-0001-5296-6155; BLERY, Mathieu/0000-0003-4738-6038; Miosge, Lisa/0000-0001-8317-3377; Lesage, Sylvie/0000-0002-0968-2795				ALKALAY I, 1995, MOL CELL BIOL, V15, P1294; Aronica MA, 1999, J IMMUNOL, V163, P5116; Bajpai UD, 2000, J EXP MED, V191, P1735, DOI 10.1084/jem.191.10.1735; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Dorado B, 1998, EUR J IMMUNOL, V28, P2234, DOI 10.1002/(SICI)1521-4141(199807)28:07<2234::AID-IMMU2234>3.0.CO;2-2; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Guerder S, 2001, J IMMUNOL, V166, P4399, DOI 10.4049/jimmunol.166.7.4399; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; HITOTSUMACHI S, 1985, P NATL ACAD SCI USA, V82, P6619, DOI 10.1073/pnas.82.19.6619; Jenkins R., 1987, POWDER DIFFR, V2, P84; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; LASALLE JM, 1992, J EXP MED, V176, P177, DOI 10.1084/jem.176.1.177; Lederer JA, 1996, J IMMUNOL, V156, P56; Leitenberg D, 1999, SEMIN IMMUNOL, V11, P283, DOI 10.1006/smim.1999.0184; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Miosge LA, 2002, J EXP MED, V196, P1113, DOI 10.1084/jem.20020959; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; Petro JB, 2001, J BIOL CHEM, V276, P1715, DOI 10.1074/jbc.M009137200; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Reth M, 2001, TRENDS IMMUNOL, V22, P356, DOI 10.1016/S1471-4906(01)01964-0; Richards JD, 2001, J IMMUNOL, V166, P3855, DOI 10.4049/jimmunol.166.6.3855; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; RUST S, 1993, NUCLEIC ACIDS RES, V21, P3623, DOI 10.1093/nar/21.16.3623; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Seetharaman R, 1999, J IMMUNOL, V163, P1577; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Sperling AI, 1996, J IMMUNOL, V157, P3909; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sundstedt A, 1996, P NATL ACAD SCI USA, V93, P979, DOI 10.1073/pnas.93.3.979; Tan JEL, 2001, J BIOL CHEM, V276, P20055, DOI 10.1074/jbc.M010800200; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; VENKATARAMAN L, 1995, J EXP MED, V181, P1091, DOI 10.1084/jem.181.3.1091; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wong SC, 2002, J BIOL CHEM, V277, P30707, DOI 10.1074/jbc.M202460200; Yablonski D, 2001, ADV IMMUNOL, V79, P93, DOI 10.1016/S0065-2776(01)79003-7; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8	70	253	256	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2003	18	6					751	762		10.1016/S1074-7613(03)00141-9	http://dx.doi.org/10.1016/S1074-7613(03)00141-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818157	Bronze			2022-12-18	WOS:000183767700006
J	Lee, DU; Agarwal, S; Rao, A				Lee, DU; Agarwal, S; Rao, A			Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene	IMMUNITY			English	Article							T-CELL DIFFERENTIATION; DNA CYTOSINE-5 METHYLTRANSFERASES; REPRESS TRANSCRIPTION; HISTONE DEACETYLASE; HELPER CELL; METHYLATION; EXPRESSION; BINDING; COMPLEX; LOCUS	The relation of CpG methylation to gene silencing is well established, but the contribution of DNA demethylation to gene expression during cell differentiation remains unclear. We show that the IL-4 locus undergoes a complex series of methylation and demethylation steps during T helper cell differentiation. The 5' region of the iL-4 locus is hypermethylated in naive T cells and becomes specifically demethylated in Th2 cells, whereas a highly conserved DNase 1-hypersensitive region at the 3' end shows the converse behavior, being hypomethylated in naive T cells and becoming methylated during Th1 differentiation. 5' demethylation is not required for chromatin remodeling or primary transcription of the IL-4 gene but is strongly associated with efficient, high-level induction of IL-4 transcripts by differentiated Th2 cells.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Rao, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.				NCI NIH HHS [CA42471, CA09141] Funding Source: Medline; NIAID NIH HHS [AI44432] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009141, R01CA042471, R37CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; AGARWAL S, 1999, THESIS HARVARD U CAM; Ahmadzadeh M, 2001, J IMMUNOL, V166, P926, DOI 10.4049/jimmunol.166.2.926; Avni O, 2000, CURR OPIN IMMUNOL, V12, P654, DOI 10.1016/S0952-7915(00)00158-8; Bergman Y, 1998, BIOL CHEM, V379, P401; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bonifer C, 1997, J BIOL CHEM, V272, P26075, DOI 10.1074/jbc.272.42.26075; Cedar H, 1999, NATURE, V397, P568, DOI 10.1038/17492; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; Hsieh CL, 1999, MOL CELL BIOL, V19, P46; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Hural JA, 2000, J IMMUNOL, V165, P3239, DOI 10.4049/jimmunol.165.6.3239; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Kress C, 2001, FEBS LETT, V494, P135, DOI 10.1016/S0014-5793(01)02328-6; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Reiner SL, 2001, CURR OPIN IMMUNOL, V13, P351, DOI 10.1016/S0952-7915(00)00226-0; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Singal R, 1997, P NATL ACAD SCI USA, V94, P13724, DOI 10.1073/pnas.94.25.13724; Smith SS, 2000, J MOL BIOL, V302, P1, DOI 10.1006/jmbi.2000.4046; SOLOMON MJ, 1987, MOL CELL BIOL, V7, P3822, DOI 10.1128/MCB.7.10.3822; Stewart FJ, 1998, BIOL CHEM, V379, P611; SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Turker MS, 1999, SEMIN CANCER BIOL, V9, P329, DOI 10.1006/scbi.1999.0133; Villey I, 1997, EUR J IMMUNOL, V27, P1619, DOI 10.1002/eji.1830270705; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Wolffe AP, 1999, P NATL ACAD SCI USA, V96, P5894, DOI 10.1073/pnas.96.11.5894; WOLFFE AP, 1986, CELL, V47, P217, DOI 10.1016/0092-8674(86)90444-7; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892	52	253	265	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2002	16	5					649	660		10.1016/S1074-7613(02)00314-X	http://dx.doi.org/10.1016/S1074-7613(02)00314-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	555YJ	12049717	Bronze			2022-12-18	WOS:000175820400004
J	Lehner, PJ; Surman, MJ; Cresswell, P				Lehner, PJ; Surman, MJ; Cresswell, P			Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220	IMMUNITY			English	Article							HLA-CLASS-I; ENDOPLASMIC-RETICULUM; PEPTIDE TRANSPORTERS; TAP; MOLECULES; BINDING; COMPLEX; ANTIGENS; DM; INHIBITOR	Tapasin forms a bridge between TAP (transporters associated with antigen processing) and MHC class I molecules and plays a critical role in class I assembly. In its absence, TAP and class I do not associate, and class I cell surface expression is reduced. We now identify two independent functions for tapasin. Tapasin increases TAP levels and allows more peptide to be translocated to the endoplasmic reticulum. Furthermore, when expressed in the tapasin-negative .220 cell line, recombinant soluble tapasin retains its association with class I and restores class I cell surface expression and function, even though it no longer binds TAP or increases TAP levels. This finding suggests that the association of tapasin with class I is sufficient to facilitate loading and assembly of class I molecules.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA.	peter.cresswell@yale.edu		Lehner, Paul Joseph/0000-0001-9383-1054				Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; CARRENO BM, 1995, J IMMUNOL, V155, P4726; Chang SA, 1996, MOL IMMUNOL, V33, P1165, DOI 10.1016/S0161-5890(96)00082-X; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; HOWARD JC, 1995, CURR OPIN IMMUNOL, V7, P69, DOI 10.1016/0952-7915(95)80031-X; Hughes EA, 1996, J EXP MED, V183, P1569, DOI 10.1084/jem.183.4.1569; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; LEE N, 1995, IMMUNITY, V3, P591, DOI 10.1016/1074-7613(95)90130-2; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Li SL, 1997, P NATL ACAD SCI USA, V94, P8708, DOI 10.1073/pnas.94.16.8708; LUTZ PM, 1987, IMMUNOGENETICS, V25, P228, DOI 10.1007/BF00404692; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Neisig A, 1996, J IMMUNOL, V156, P3196; Nijenhuis M, 1996, J IMMUNOL, V157, P5467; Noessner Elfriede, 1995, Journal of Experimental Medicine, V181, P327; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; PARHAM P, 1979, J IMMUNOL, V123, P342; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROWE M, 1995, EUR J IMMUNOL, V25, P1374, DOI 10.1002/eji.1830250536; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Sadasivan BK, 1995, COLD SPRING HARB SYM, V60, P267, DOI 10.1101/SQB.1995.060.01.031; SCOTT JE, 1995, J IMMUNOL, V155, P143; Sijts AJAM, 1997, J EXP MED, V185, P1403, DOI 10.1084/jem.185.8.1403; Solheim JC, 1997, J IMMUNOL, V158, P2236; STAM NJ, 1986, J IMMUNOL, V137, P2299; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; SUTTON J, 1993, EUR J IMMUNOL, V23, P447, DOI 10.1002/eji.1830230222; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0	47	253	255	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1998	8	2					221	231		10.1016/S1074-7613(00)80474-4	http://dx.doi.org/10.1016/S1074-7613(00)80474-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9492003	hybrid			2022-12-18	WOS:000072201800009
J	CALNAN, BJ; SZYCHOWSKI, S; CHAN, FKM; CADO, D; WINOTO, A				CALNAN, BJ; SZYCHOWSKI, S; CHAN, FKM; CADO, D; WINOTO, A			A ROLE FOR THE ORPHAN STEROID-RECEPTOR NUR77 IN APOPTOSIS ACCOMPANYING ANTIGEN-INDUCED NEGATIVE SELECTION	IMMUNITY			English	Article							NERVE GROWTH-FACTOR; T-CELLS; NGFI-B; DNA-BINDING; GENE; EXPRESSION; THYMOCYTES; MICE; ACTIVATION; DOMAINS	The transcription factor Nur77, an orphan member of the nuclear hormone receptor superfamily, is highly expressed during T cell receptor-signaled apoptosis, suggesting a possible role for Nur77 in negative selection. We examined this by generating two sets of transgenic mice, In one set of mice, a dominant-negative Nur77 mutant is constitutively expressed and the other in which wild-type Nur77 protein is constitutively expressed in developing thymocytes. We report that inhibition of endogenous Nur77 by the dominant-negative mutant perturbed T cell development and inhibited antigen-induced negative selection in F5 T cell receptor transgenic mice, Constitutive expression of wild-type Nur77 protein induced apoptosis in developing thymocytes, resulting in a decreased number of thymocytes and mature T cells. Together, these data support a role for Nur77 in the downstream signaling events in antigen-induced negative selection.	UNIV CALIF BERKELEY,CANC RES LAB,BERKELEY,CA 94720	University of California System; University of California Berkeley	CALNAN, BJ (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,DIV IMMUNOL,469 LIFE SCI ADDIT,BERKELEY,CA 94720, USA.		Chan, Francis/ABB-1895-2021; Chan, Francis Ka-Ming/E-9647-2014	Chan, Francis Ka-Ming/0000-0002-4803-8353	NATIONAL CANCER INSTITUTE [R01CA066236] Funding Source: NIH RePORTER; NCI NIH HHS [CA66236] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN JM, 1992, MOL CELL BIOL, V12, P2758, DOI 10.1128/MCB.12.6.2758; BENDELAC A, 1991, NATURE, V353, P68, DOI 10.1038/353068a0; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CRISPE IN, 1994, IMMUNITY, V1, P347; CRISPE IN, 1987, J IMMUNOL, V138, P2013; CROMPTON T, 1994, EUR J IMMUNOL, V24, P1903, DOI 10.1002/eji.1830240828; DAVIS IJ, 1993, MOL ENDOCRINOL, V7, P953, DOI 10.1210/me.7.8.953; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KOTZIN BL, 1988, J EXP MED, V168, P2221, DOI 10.1084/jem.168.6.2221; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; MATTHIAS P, 1989, NUCLEIC ACIDS RES, V17, P6418, DOI 10.1093/nar/17.15.6418; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; PAULSEN RE, 1992, J BIOL CHEM, V267, P16491; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SINGER PA, 1989, J EXP MED, V170, P1869, DOI 10.1084/jem.170.6.1869; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WILSON A, 1988, CELL IMMUNOL, V117, P312, DOI 10.1016/0008-8749(88)90121-9; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; WILSON TE, 1993, P NATL ACAD SCI USA, V90, P9186, DOI 10.1073/pnas.90.19.9186; WOODLAND D, 1990, SCIENCE, V247, P964, DOI 10.1126/science.1968289; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; YOON JK, 1993, J BIOL CHEM, V268, P9148; ZHOU T, 1991, J IMMUNOL, V147, P466	43	253	257	0	6	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1995	3	3					273	282						10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX645	7552993				2022-12-18	WOS:A1995RX64500003
J	Filipello, F; Morini, R; Corradini, I; Zerbi, V; Canzi, A; Michalski, B; Erreni, M; Markicevic, M; Starvaggi-Cucuzza, C; Otero, K; Piccio, L; Cignarella, F; Perrucci, F; Tamborini, M; Genua, M; Rajendran, L; Menna, E; Vetrano, S; Fahnestock, M; Paolicelli, RC; Matteoli, M				Filipello, Fabia; Morini, Raffaella; Corradini, Irene; Zerbi, Valerio; Canzi, Alice; Michalski, Bernadeta; Erreni, Marco; Markicevic, Marija; Starvaggi-Cucuzza, Chiara; Otero, Karel; Piccio, Laura; Cignarella, Francesca; Perrucci, Fabio; Tamborini, Matteo; Genua, Marco; Rajendran, Lawrence; Menna, Elisabetta; Vetrano, Stefania; Fahnestock, Margaret; Paolicelli, Rosa Chiara; Matteoli, Michela			The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity	IMMUNITY			English	Article							MYELOID CELLS-2 TREM2; RESTING-STATE FMRI; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; MOTION ARTIFACTS; NEURAL CIRCUITS; SOCIAL-BEHAVIOR; MOUSE-BRAIN; IN-VIVO	The triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial innate immune receptor associated with a lethal form of early, progressive dementia, Nasu-Hakola disease, and with an increased risk of Alzheimer's disease. Microglial defects in phagocytosis of toxic aggregates or apoptotic membranes were proposed to be at the origin of the pathological processes in the presence of Trem2 inactivating mutations. Here, we show that TREM2 is essential for microglia-mediated synaptic refinement during the early stages of brain development. The absence of Trem2 resulted in impaired synapse elimination, accompanied by enhanced excitatory neurotransmission and reduced long-range functional connectivity. Trem2(-/-) mice displayed repetitive behavior and altered sociability. TREM2 protein levels were also negatively correlated with the severity of symptoms in humans affected by autism. These data unveil the role of TREM2 in neuronal circuit sculpting and provide the evidence for the receptor's involvement in neurodevelopmental diseases.	[Filipello, Fabia; Canzi, Alice; Vetrano, Stefania] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini, I-20090 Milan, Italy; [Morini, Raffaella; Corradini, Irene; Starvaggi-Cucuzza, Chiara; Perrucci, Fabio; Tamborini, Matteo; Menna, Elisabetta; Matteoli, Michela] Humanitas Clin & Res Ctr, Lab Pharmacol & Brain Pathol, Via Manzoni 56, I-20089 Milan, Italy; [Corradini, Irene; Matteoli, Michela] IN CNR, I-20129 Milan, Italy; [Zerbi, Valerio; Markicevic, Marija] Swiss Fed Inst Technol, HEST, Neural Control Movement Lab, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Michalski, Bernadeta; Fahnestock, Margaret] McMaster Univ, Dept Psychiat & Behav Neurosci, HSC-4N80, Hamilton, ON, Canada; [Erreni, Marco] Humanitas Clin & Res Ctr, Dept Immunol & Inflammat, Via Manzoni 56, I-20089 Milan, Italy; [Otero, Karel] Biogen Inc, Dept Neuroimmunol Acute Neurol & Pain, 115 Broadway, Cambridge, MA USA; [Piccio, Laura; Cignarella, Francesca] Washington Univ, Dept Neurol, St Louis, MO USA; [Rajendran, Lawrence; Paolicelli, Rosa Chiara] Univ Zurich, IREM, Syst & Cell Biol Neurodegenerat, Schlieren, Switzerland; [Filipello, Fabia] Washington Univ, Dept Neurol, St Louis, MO USA	Humanitas University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Swiss Federal Institutes of Technology Domain; ETH Zurich; McMaster University; Biogen; Washington University (WUSTL); Washington University (WUSTL)	Matteoli, M (corresponding author), Humanitas Clin & Res Ctr, Lab Pharmacol & Brain Pathol, Via Manzoni 56, I-20089 Milan, Italy.; Matteoli, M (corresponding author), IN CNR, I-20129 Milan, Italy.	michela.matteoli@hunimed.eu	Fahnestock, Margaret/I-3578-2017; Erreni, Marco/K-2522-2016; Zerbi, Valerio/K-3405-2018; tamborini, matteo/ABI-7245-2020; Filipello, Fabia/AAO-9663-2021; Piccio, Laura/AAE-1706-2020; Matteoli, Michela/K-4526-2018; Menna, Elisabetta/ABH-9628-2020; morini, raffaella/K-9370-2016; Genua, Marco/J-4159-2018; Corradini, Irene/J-5320-2018	Fahnestock, Margaret/0000-0002-6815-0529; Erreni, Marco/0000-0002-1922-0818; tamborini, matteo/0000-0002-2236-2956; Piccio, Laura/0000-0002-8760-109X; Matteoli, Michela/0000-0002-3569-7843; Menna, Elisabetta/0000-0003-2062-0154; morini, raffaella/0000-0002-4403-6932; Genua, Marco/0000-0002-0764-8163; canzi, alice/0000-0001-7020-156X; Cignarella, Francesca/0000-0003-0342-5699; Paolicelli, Rosa Chiara/0000-0001-6851-0849; Perrucci, Fabio/0000-0001-6810-471X; Corradini, Irene/0000-0001-7128-9209; vetrano, stefania/0000-0001-9825-2000; Starvaggi Cucuzza, Chiara/0000-0002-9088-7658; Zerbi, Valerio/0000-0001-7984-9565	Ontario Mental Health Foundation; Fondazione Umberto Veronesi fellowship; Fondazione Giancarla Vollaro Fellowship; ETH Career Seed Grant [SEED-42 16-1]; SNSF AMBIZIONE [PZ00P3_173984 / 1]; ETH Research Grant [ETH-38 16-2]; Synapsis Foundation - Alzheimer Research Switzerland ARS; Ministero della Salute from regione Lombardia [GR-2011-02347377]; Cariplo from regione Lombardia [2015-0594]; "AMANDA'' from regione Lombardia [CUP_B42F16000440005]; MRC [UKDRI-6006] Funding Source: UKRI	Ontario Mental Health Foundation; Fondazione Umberto Veronesi fellowship(Fondazione Umberto Veronesi); Fondazione Giancarla Vollaro Fellowship; ETH Career Seed Grant; SNSF AMBIZIONE; ETH Research Grant; Synapsis Foundation - Alzheimer Research Switzerland ARS; Ministero della Salute from regione Lombardia; Cariplo from regione Lombardia; "AMANDA'' from regione Lombardia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank F. Colombo (FACS facility, Humanitas Research Institute) for assistance with flow cytometry and E. Ghirardini and I. Spera for help in performing some experiments. Work in the lab is supported by Ministero della Salute GR-2011-02347377, Cariplo 2015-0594 and "AMANDA'' CUP_B42F16000440005 from regione Lombardia to M. Matteoli, and Fondazione Vodafone (E. M. and M. Matteoli). M. F. is supported by the Ontario Mental Health Foundation. F. F. was supported by a Fondazione Umberto Veronesi fellowship; M.T. is supported by a Fondazione Giancarla Vollaro Fellowship. V.Z. is supported by ETH Career Seed Grant SEED-42 16-1 and by the SNSF AMBIZIONE PZ00P3_173984 / 1. M. Markicevic was supported by ETH Research Grant ETH-38 16-2. R.C.P. is supported by the Synapsis Foundation - Alzheimer Research Switzerland ARS.	Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bernardinelli Y, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00123; Biesemann C, 2014, EMBO J, V33, P157, DOI 10.1002/embj.201386120; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Braun N, 2000, EUR J NEUROSCI, V12, P4357, DOI 10.1046/j.1460-9568.2000.01342.x; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Corradini I, 2014, CEREB CORTEX, V24, P364, DOI 10.1093/cercor/bhs316; Correale C, 2013, GASTROENTEROLOGY, V144, P346, DOI [10.1053/j.gastro.2012.10.040, 10.1053/j.gastro.2012.12.016]; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Grandjean J, 2017, J NEUROSCI, V37, P8092, DOI 10.1523/JNEUROSCI.0438-17.2017; Grandjean J, 2014, NEUROIMAGE, V102, P838, DOI 10.1016/j.neuroimage.2014.08.043; Greco B, 2013, BEHAV BRAIN RES, V251, P65, DOI 10.1016/j.bbr.2012.12.015; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Haberl MG, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500775; Hamerman JA, 2016, IMMUNOL REV, V269, P212, DOI 10.1111/imr.12381; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Ji K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056293; Jinno S, 2007, GLIA, V55, P1334, DOI 10.1002/glia.20552; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kiialainen A, 2005, NEUROBIOL DIS, V18, P314, DOI 10.1016/j.nbd.2004.09.007; Kim HJ, 2017, MOL PSYCHIATR, V22, P1576, DOI 10.1038/mp.2016.103; Kim H, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0087-y; Kleinberger G, 2017, EMBO J, V36, P1837, DOI 10.15252/embj.201796516; Kober DL, 2016, ELIFE, V5, DOI 10.7554/eLife.20391; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Lee Jae-Kyung, 2013, Methods Mol Biol, V1041, P17, DOI 10.1007/978-1-62703-520-0_3; Liska A, 2018, CEREB CORTEX, V28, P1141, DOI 10.1093/cercor/bhx022; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; Menna E, 2013, EMBO J, V32, P1730, DOI 10.1038/emboj.2013.107; Miyamoto A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12540; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Nicolini C, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0184-4; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Patel AX, 2014, NEUROIMAGE, V95, P287, DOI 10.1016/j.neuroimage.2014.03.012; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Riccomagno MM, 2015, ANNU REV CELL DEV BI, V31, P779, DOI 10.1146/annurev-cellbio-100913-013038; Schafer Dorothy P, 2014, J Vis Exp, DOI 10.3791/51482; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Schreiner MJ, 2014, SOC COGN AFFECT NEUR, V9, P1261, DOI 10.1093/scan/nst114; Sethi SS, 2017, CHAOS, V27, DOI 10.1063/1.4979281; Silverman JL, 2010, NEUROPSYCHOPHARMACOL, V35, P976, DOI 10.1038/npp.2009.201; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Ulrich JD, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-20; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Yeh FL, 2017, TRENDS MOL MED, V23, P512, DOI 10.1016/j.molmed.2017.03.008; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V92, P252, DOI 10.1016/j.neuron.2016.09.016; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zerbi V, 2015, NEUROIMAGE, V123, P11, DOI 10.1016/j.neuroimage.2015.07.090; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182; Zwiers MP, 2010, NEUROIMAGE, V53, P565, DOI 10.1016/j.neuroimage.2010.06.014	85	252	256	10	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					979	+		10.1016/j.immuni.2018.04.016	http://dx.doi.org/10.1016/j.immuni.2018.04.016			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29752066	Bronze			2022-12-18	WOS:000432488600017
J	Blanc, M; Hsieh, WY; Robertson, KA; Kropp, KA; Forster, T; Shui, GH; Lacaze, P; Watterson, S; Griffiths, SJ; Spann, NJ; Meljon, A; Talbot, S; Krishnan, K; Covey, DF; Wenk, MR; Craigon, M; Ruzsics, Z; Haas, J; Angulo, A; Griffiths, WJ; Glass, CK; Wang, YQ; Ghazal, P				Blanc, Mathieu; Hsieh, Wei Yuan; Robertson, Kevin A.; Kropp, Kai A.; Forster, Thorsten; Shui, Guanghou; Lacaze, Paul; Watterson, Steven; Griffiths, Samantha J.; Spann, Nathanael J.; Meljon, Anna; Talbot, Simon; Krishnan, Kathiresan; Covey, Douglas F.; Wenk, Markus R.; Craigon, Marie; Ruzsics, Zsolts; Haas, Juergen; Angulo, Ana; Griffiths, William J.; Glass, Christopher K.; Wang, Yuqin; Ghazal, Peter			The Transcription Factor STAT-1 Couples Macrophage Synthesis of 25-Hydroxycholesterol to the Interferon Antiviral Response	IMMUNITY			English	Article							STEROL-REGULATED TRANSPORT; FATTY-ACID SYNTHESIS; ENDOPLASMIC-RETICULUM; CYTOMEGALOVIRUS-INFECTION; CHOLESTEROL-SYNTHESIS; CELL-MIGRATION; IN-VIVO; BINDING; PROTEIN; PRENYLATION	Recent studies suggest that the sterol metabolic network participates in the interferon (IFN) antiviral response. However, the molecular mechanisms linking IFN with the sterol network and the identity of sterol mediators remain unknown. Here we report a cellular antiviral role for macrophage production of 25-hydroxycholesterol (cholest-5-en-3 beta,25-diol, 25HC) as a component of the sterol metabolic network linked to the IFN response via Stat1. By utilizing quantitative metabolome profiling of all naturally occurring oxysterols upon infection or IFN-stimulation, we reveal 25HC as the only macrophage-synthesized and -secreted oxysterol. We show that 25HC can act at multiple levels as a potent paracrine inhibitor of viral infection for a broad range of viruses. We also demonstrate, using transcriptional regulatory-network analyses, genetic interventions and chromatin immunoprecipitation experiments that Stat1 directly coupled Ch25h regulation to IFN in macrophages. Our studies describe a physiological role for 25HC as a sterol-lipid effector of an innate immune pathway.	[Blanc, Mathieu; Hsieh, Wei Yuan; Robertson, Kevin A.; Kropp, Kai A.; Forster, Thorsten; Lacaze, Paul; Watterson, Steven; Griffiths, Samantha J.; Talbot, Simon; Craigon, Marie; Haas, Juergen; Ghazal, Peter] Univ Edinburgh, Div Pathway Med & Edinburgh Infect Dis, Edinburgh EH16 4SB, Midlothian, Scotland; [Robertson, Kevin A.; Watterson, Steven; Ghazal, Peter] Univ Edinburgh, SynthSys Synthet & Syst Biol, Edinburgh EH9 3JD, Midlothian, Scotland; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biol Sci, Singapore 117597, Singapore; [Spann, Nathanael J.; Glass, Christopher K.] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Meljon, Anna; Griffiths, William J.; Wang, Yuqin] Swansea Univ, Coll Med, Inst Mass Spectrometry, Swansea SA2 8PP, W Glam, Wales; [Krishnan, Kathiresan; Covey, Douglas F.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63011 USA; [Ruzsics, Zsolts] Univ Munich, Max Von Pettenkofer Inst, Genzentrum, D-81377 Munich, Germany; [Angulo, Ana] Inst Invest Biomed August Pi & Sunyer, Fac Med, Barcelona 08036, Spain	University of Edinburgh; University of Edinburgh; National University of Singapore; National University of Singapore; University of California System; University of California San Diego; Swansea University; Washington University (WUSTL); University of Munich; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Ghazal, P (corresponding author), Univ Edinburgh, Div Pathway Med & Edinburgh Infect Dis, Edinburgh EH16 4SB, Midlothian, Scotland.	p.ghazal@ed.ac.uk	Forster, Thorsten/F-4483-2017; Griffiths, William/N-4641-2016; Watterson, Steven/AAG-7891-2020; Ruzsics, Zsolt/D-6284-2014; Glass, Christopher/AAI-3933-2021; Wenk, Markus Rene/D-1441-2014	Forster, Thorsten/0000-0002-4483-3069; Griffiths, William/0000-0002-4129-6616; Glass, Christopher/0000-0003-4344-3592; Ghazal, Peter/0000-0003-0035-2228; Kropp, Kai Alexander/0000-0001-8505-3440; Watterson, Steven/0000-0002-2750-6410; wang, yuqin/0000-0002-3063-3066; Lacaze, Paul/0000-0002-0902-6798; Angulo, Ana/0000-0002-5792-1164; Shui, Guanghou/0000-0002-1621-9643	Wellcome Trust [WT066784]; BBSRC [BB/C5157712, BB/C5113561, BB/I0017351, BB/H0010181]; EPSRC [SynthSys BB/D019621/1]; University of Edinburgh Alumni Fund; BBSRC studentships; BHF studentship [FS/05/022]; SNRF [2007-04]; BRCS [R-183-000-211-305]; NMRC [R-183-000-224-213]; Spanish Ministry of Science and Innovation [SAF 2011-25155]; NIH [HL67773]; Biotechnology and Biological Sciences Research Council [BB/C515771/2, BB/C511356/1, BB/I001735/1, BB/K019112/1, BB/H001018/1, BB/D019621/1] Funding Source: researchfish; BBSRC [BB/K019112/1, BB/H001018/1, BB/I001735/1, BB/D019621/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Edinburgh Alumni Fund; BBSRC studentships(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BHF studentship; SNRF; BRCS; NMRC(National Medical Research Council, Singapore); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Wellcome Trust (WT066784), the BBSRC and EPSRC (SynthSys BB/D019621/1), the University of Edinburgh Alumni Fund, and reagent support from RNAi Global Initiative to P.G.; BBSRC studentships to P.L. and A.M.; BHF studentship (FS/05/022) to M.B.; SNRF award (CRPNo. 2007-04), BRCS (R-183-000-211-305) and NMRC (R-183-000-224-213) to M.R.W.; BBSRC (BB/C5157712, BB/C5113561, BB/I0017351) to W.J.G. and (BB/H0010181) to Y.W.; Spanish Ministry of Science and Innovation (SAF 2011-25155) to A.A.; NIH grant (HL67773) to D.F.C. We are grateful to David Russell for LY295427 and LY306039, Birgit Strobl and Matthias Muller for Ifnar<SUP>-/-</SUP> and Stat1<SUP>-/-</SUP> M phi, Sam Pattie for help with viral infections, and Daniel S. Ory for advice.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Amet T, 2008, MICROBES INFECT, V10, P471, DOI 10.1016/j.micinf.2008.01.009; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Bordier BB, 2003, J CLIN INVEST, V112, P407, DOI 10.1172/JCI200317704; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Clark PJ, 2012, HEPATOLOGY, V56, P49, DOI 10.1002/hep.25631; Clase AC, 2003, J VIROL, V77, P12285, DOI 10.1128/JVI.77.22.12285-12298.2003; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Deraeve C, 2012, J AM CHEM SOC, V134, P7384, DOI 10.1021/ja211305j; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; GLENN JS, 1992, SCIENCE, V256, P1331, DOI 10.1126/science.1598578; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Gower TL, 2001, ANTIMICROB AGENTS CH, V45, P1231, DOI 10.1128/AAC.45.4.1231-1237.2001; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Janowski BA, 2001, J BIOL CHEM, V276, P45408, DOI 10.1074/jbc.M108348200; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202; Potena L, 2004, CIRCULATION, V109, P532, DOI 10.1161/01.CIR.0000109485.79183.81; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rodwell V W, 1976, Adv Lipid Res, V14, P1; Rusinol AE, 2004, J BIOL CHEM, V279, P1392, DOI 10.1074/jbc.M308619200; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Spencer CM, 2011, J VIROL, V85, P5814, DOI 10.1128/JVI.02630-10; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Taylor HE, 2011, J VIROL, V85, P7699, DOI 10.1128/JVI.00337-11; VESTAL DJ, 1995, J LEUKOCYTE BIOL, V58, P607, DOI 10.1002/jlb.58.5.607; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015; Yu YJ, 2012, J VIROL, V86, P2942, DOI 10.1128/JVI.06467-11	41	252	259	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					106	118		10.1016/j.immuni.2012.11.004	http://dx.doi.org/10.1016/j.immuni.2012.11.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23273843	hybrid, Green Published			2022-12-18	WOS:000314195500013
J	Hou, B; Reizis, B; DeFranco, AL				Hou, Baidong; Reizis, Boris; DeFranco, Anthony L.			Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms	IMMUNITY			English	Article							IFN-GAMMA; T-CELLS; MICE; EXPRESSION; INTERFERONS; RESPONSES; MURINE	Toll-like receptors (TLRs) play prominent roles in initiating immune responses to infection, but their roles in particular cell types in vivo are not established. Here we report the generation of mice selectively lacking the crucial TLR-signaling adaptor MyD88 in dendritic cells (DCs). In these mice, the early production of inflammatory cytokines, especially IL-12, was substantially reduced after TLR stimulation. Whereas the innate interferon-gamma response of natural killer cells and of natural killer T cells and the Th1 polarization of antigen-specific CD4(+) T cells were severely compromised after treatment with a soluble TLR9 ligand, they were largely intact after administration of an aggregated TLR9 ligand. These results demonstrate that the physical form of a TLR ligand affects which cells can respond to it and that DCs and other innate immune cells can respond via TLRs and collaborate in promoting Th1 adaptive immune responses to an aggregated stimulus.	[Hou, Baidong; DeFranco, Anthony L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA	University of California System; University of California San Francisco; Columbia University	DeFranco, AL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	anthony.defranco@ucsf.edu		Reizis, Boris/0000-0003-1140-7853; Hou, Baidong/0000-0002-0892-0181	Academic Senate of UCSF; Sandler Foundation; NIH [R01 AI072058, AI067804]; Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072058, R21AI067804] Funding Source: NIH RePORTER	Academic Senate of UCSF; Sandler Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Killeen, V. Nguyen, and A. Kuroda for assistance in creating the Myo88<SUP>fl</SUP> allele; W. Hazenbos for providing the Vav-Cre mice; S. Watson, J. Jarjoura, and C. McArthur for assistance with cell purification by flow cytometry; L. Kuzmich and J. Lyandres for assistance with the mouse colonies; Y. Xu for helping with RT-PCR; L. Lee for providing low LPS flagellin; A. Abbas, J. Bluestone, Z. Hua, L. Lanier, and R. Locksley for helpful discussions; A. Gross for comments; and C. Lowell and L. Fong for critical reading of the manuscript. This research was supported by awards from the Academic Senate of UCSF and from the Sandler Foundation to A.L.D., and by the NIH (R01 AI072058). B.H. is a recipient of an Arthritis Foundation Postdoctoral Fellowship. B.R. is supported by an award from the Sandler Foundation and by the NIH (AI067804).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BAMDEN MJ, 1998, IMMUNOL CELL BIOL, V76, P34; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Freudenberg MA, 2002, J IMMUNOL, V169, P1665, DOI 10.4049/jimmunol.169.4.1665; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Heath WR, 2005, NAT IMMUNOL, V6, P125, DOI 10.1038/ni0205-125; Hoebe K, 2004, J ENDOTOXIN RES, V10, P130, DOI 10.1179/096805104225004031; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NAKANISHI K, 2001, IMMUNITY, V21, P733; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SKELLY RR, 1979, INFECT IMMUN, V23, P287, DOI 10.1128/IAI.23.2.287-293.1979; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997	36	252	258	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2008	29	2					272	282		10.1016/j.immuni.2008.05.016	http://dx.doi.org/10.1016/j.immuni.2008.05.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18656388	Bronze, Green Accepted			2022-12-18	WOS:000258610800015
J	Griewank, K; Borowski, C; Rietdijk, S; Wang, NH; Julien, A; Wei, DG; Mamchak, AA; Terhorst, C; Bendelac, A				Griewank, Klaus; Borowski, Christine; Rietdijk, Svend; Wang, Ninghai; Julien, Aimee; Wei, Datsen G.; Mamchak, Alusha A.; Terhorst, Cox; Bendelac, Albert			Homotypic interactions mediated by slamf1 and slamf6 receptors control NKT cell lineage development	IMMUNITY			English	Article							CONTROLS T-CELL; LINKED LYMPHOPROLIFERATIVE DISEASE; CUTTING EDGE; POSITIVE SELECTION; CORTICAL THYMOCYTES; HUMORAL IMMUNITY; FAMILY RECEPTORS; DEFICIENT MICE; GENE-PRODUCT; MUTANT MICE	Commitment to the T and natural killer T (NKT) cell lineages is determined during alpha beta T cell receptor (TCR)-mediated interactions of common precursors with ligand-expressing cells in the thymus. Whereas mainstream thymocyte precursors recognize major histocompatibility complex (MHC) ligands expressed by stromal cells, NKT cell precursors interact with CD1d ligands expressed by cortical thymocytes. Here, we demonstrated that such homotypic T-T interactions generated "second signals" mediated by the cooperative engagement of the homophilic receptors Slamf1 (SLAM) and Slamf6 (Ly108) and the downstream recruitment of the adaptor SLAM-associated protein (SAP) and the Src kinase Fyn, which are essential for the lineage expansion and differentiation of the NKT cell lineage. These receptor interactions were required during TCR engagement and therefore only occurred when selecting ligands were presented by thymocytes rather than epithelial cells, which do not express Slamf6 or Slamf1. Thus, the topography of NKT cell ligand recognition determines the availability of a cosignaling pathway that is essential for NKT cell lineage development.	Univ Chicago, Howard Hughes Med Inst, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA; Harvard Univ, Med Sch, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02215 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of Chicago; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Francisco	Bendelac, A (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu	Griewank, Klaus G/A-9097-2017; Rietdijk, Svend/AAH-7519-2021	Griewank, Klaus G/0000-0003-3899-9449; Julien/0000-0001-6877-8108	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI038339, R01 AI038339-12A2] Funding Source: Medline; NIDDK NIH HHS [DK073339, R01 DK073339] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073339] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Borowski C, 2005, J EXP MED, V201, P833, DOI 10.1084/jem.20050339; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Carnaud C, 1999, J IMMUNOL, V163, P4647; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Choi EY, 2005, IMMUNITY, V23, P387, DOI 10.1016/j.immuni.2005.09.005; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Cole DN, 2000, US FOR SERV RMRS-P, V1, P1; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Eberl G, 1999, J IMMUNOL, V163, P4091; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Gadue P, 2004, J IMMUNOL, V172, P6093, DOI 10.4049/jimmunol.172.10.6093; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Graham DB, 2006, J IMMUNOL, V176, P291, DOI 10.4049/jimmunol.176.1.291; Gu CP, 2006, P NATL ACAD SCI USA, V103, P14447, DOI 10.1073/pnas.0606624103; Hermiston ML, 2002, J CLIN INVEST, V109, P9; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Horai R, 2007, IMMUNITY, V27, P775, DOI 10.1016/j.immuni.2007.09.012; Howie D, 2002, BLOOD, V99, P957, DOI 10.1182/blood.V99.3.957; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jordan MA, 2007, J IMMUNOL, V178, P1618, DOI 10.4049/jimmunol.178.3.1618; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Li W, 2007, IMMUNITY, V27, P763, DOI 10.1016/j.immuni.2007.10.008; Li WL, 2005, MICROSYST TECHNOL, V11, P23, DOI 10.1007/s00542-004-0462-8; Locksley RM, 2002, NAT IMMUNOL, V3, P705, DOI 10.1038/ni0802-705; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; McNab FW, 2005, J IMMUNOL, V175, P3762, DOI 10.4049/jimmunol.175.6.3762; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Roark JH, 1998, J IMMUNOL, V160, P3121; Rocha-Campos AC, 2006, DIABETES, V55, P1163, DOI 10.2337/diabetes.55.04.06.db05-0908; Romero X, 2005, J IMMUNOL, V174, P7033, DOI 10.4049/jimmunol.174.11.7033; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schumann J, 2006, J IMMUNOL, V176, P2064, DOI 10.4049/jimmunol.176.4.2064; Schumann J, 2005, J IMMUNOL, V175, P7303, DOI 10.4049/jimmunol.175.11.7303; Simarro M, 2004, INT IMMUNOL, V16, P727, DOI 10.1093/intimm/dxh074; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; Vaidya SV, 2005, J IMMUNOL, V174, P800, DOI 10.4049/jimmunol.174.2.800; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Wei DG, 2006, J EXP MED, V203, P1197, DOI 10.1084/jem.20060418; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	67	252	259	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2007	27	5					751	762		10.1016/j.immuni.2007.08.020	http://dx.doi.org/10.1016/j.immuni.2007.08.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	18031695	Green Accepted, Bronze			2022-12-18	WOS:000251269000009
J	Nutt, SL; Kee, BL				Nutt, Stephen L.; Kee, Barbara L.			The transcriptional regulation of B cell lineage commitment	IMMUNITY			English	Review							HEMATOPOIETIC PROGENITOR CELLS; INTERLEUKIN-7 RECEPTOR-ALPHA; DNA-BINDING PROTEINS; STEM-CELLS; LYMPHOID PROGENITOR; GENE-EXPRESSION; DENDRITIC CELLS; TARGETED DISRUPTION; UP-REGULATION; IKAROS GENE	The expression of lineage-associated genes, as well as the survival and expansion of committed B cell progenitors, is controlled by multiple transcriptional regulators and growth-factor receptors. Whereas certain DNA-binding proteins, such as lkaros and PU.1, are required primarily for the formation of more primitive lymphoid progenitors, other factors such as E2A and EBF1 have more direct roles in specifying the B cell-specific gene-expression program. Further, Pax5 functions to promote B cell commitment by repressing lineage-inappropriate gene expression and reinforcing B cell-specific gene expression. In this review, we focus on recent studies that have revealed that instead of a simple transcriptional hierarchy, efficient B cell commitment and differentiation requires the combinatorial activity of multiple transcription factors in a complex gene regulatory network.	Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Chicago, Dept Pathol, Committee Immunol, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Committee Canc Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Committee Dev Biol, Chicago, IL 60637 USA	Walter & Eliza Hall Institute; University of Chicago; University of Chicago; University of Chicago	Nutt, SL (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.	nutt@wehi.edu.au; bkee@bsd.uchicago.edu	Nutt, Stephen L/C-9256-2013	Nutt, Stephen L/0000-0002-0020-6637	NCI NIH HHS [R01 CA099978] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA099978] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Back J, 2005, EXP HEMATOL, V33, P395, DOI 10.1016/j.exphem.2004.12.010; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Borghesi L, 2005, J EXP MED, V202, P1669, DOI 10.1084/jem.20051190; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Ceredig R, 2006, BLOOD, V108, P1216, DOI 10.1182/blood-2005-10-006643; Clark MR, 2005, CURR TOP MICROBIOL, V290, P87; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Dakic A, 2007, TRENDS IMMUNOL, V28, P108, DOI 10.1016/j.it.2007.01.006; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Fuxa M, 2007, J IMMUNOL, V178, P3031, DOI 10.4049/jimmunol.178.5.3031; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gounari F, 2002, NAT IMMUNOL, V3, P489, DOI 10.1038/ni778; Hagman J, 2005, TRENDS IMMUNOL, V26, P455, DOI 10.1016/j.it.2005.07.001; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Harman BC, 2006, BLOOD, V108, P878, DOI 10.1182/blood-2005-11-4545; Hirokawa S, 2003, EUR J IMMUNOL, V33, P1824, DOI 10.1002/eji.200323974; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; HOUSTON IB, 2007, IN PRESS EXP HEMATOL; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kang JS, 2004, CURR OPIN IMMUNOL, V16, P180, DOI 10.1016/j.coi.2004.02.002; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kee BL, 2005, J IMMUNOL, V175, P4518, DOI 10.4049/jimmunol.175.7.4518; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Lazorchak AS, 2006, J IMMUNOL, V177, P2495, DOI 10.4049/jimmunol.177.4.2495; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Martensson A, 2001, EUR J IMMUNOL, V31, P3165, DOI 10.1002/1521-4141(200111)31:11<3165::AID-IMMU3165>3.0.CO;2-N; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Ng SYM, 2007, CURR OPIN IMMUNOL, V19, P116, DOI 10.1016/j.coi.2007.02.014; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; O'Neill DW, 2000, MOL CELL BIOL, V20, P7572, DOI 10.1128/MCB.20.20.7572-7582.2000; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Polli M, 2005, BLOOD, V106, P2083, DOI 10.1182/blood-2005-01-0283; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Sabbattini P, 2005, SEMIN IMMUNOL, V17, P121, DOI 10.1016/j.smim.2005.01.004; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; Schwarz BA, 2007, J IMMUNOL, V178, P2008, DOI 10.4049/jimmunol.178.4.2008; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Tagoh H, 2006, EMBO J, V25, P1070, DOI 10.1038/sj.emboj.7600997; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Traver D, 2004, ADV IMMUNOL, V83, P1; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Xue HH, 2007, IMMUNITY, V26, P421, DOI 10.1016/j.immuni.2007.03.010; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Ye M, 2005, J EXP MED, V202, P1411, DOI 10.1084/jem.20051089; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhang Z, 2003, EMBO J, V22, P4759, DOI 10.1093/emboj/cdg464; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898	104	252	260	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2007	26	6					715	725		10.1016/j.immuni.2007.05.010	http://dx.doi.org/10.1016/j.immuni.2007.05.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17582344	Bronze			2022-12-18	WOS:000247646900006
J	Evrard, M; Kwok, IWH; Chong, SZ; Teng, KWW; Becht, E; Chen, JM; Sieow, JL; Penny, HL; Ching, GC; Devi, S; Adrover, JPM; Li, JLY; Liong, KH; Tan, L; Poon, Z; Foo, S; Chua, JW; Su, IH; Balabanian, K; Bachelerie, F; Biswas, SK; Larbi, A; Hwang, WYK; Madan, V; Koeffler, HP; Wong, SC; Newell, EW; Hidalgo, A; Ginhoux, F; Ng, LG				Evrard, Maximilien; Kwok, Immanuel W. H.; Chong, Shu Zhen; Teng, Karen W. W.; Becht, Etienne; Chen, Jinmiao; Sieow, Je Lin; Penny, Hweixian Leong; Ching, Goh Chi; Devi, Sapna; Adrover, Jose Maria; Li, Jackson L. Y.; Liong, Ka Hang; Tan, Leonard; Poon, Zhiyong; Foo, Shihui; Chua, Jia Wang; Su, I-Hsin; Balabanian, Karl; Bachelerie, Francois; Biswas, Subhra K.; Larbi, Anis; Hwang, William Y. K.; Madan, Vikas; Koeffler, H. Phillip; Wong, Siew Cheng; Newell, Evan W.; Hidalgo, Andres; Ginhoux, Florent; Ng, Lai Guan			Developmental Analysis of Bone Marrow Neutrophils Reveals Populations Specialized in Expansion, Trafficking, and Effector Functions	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTORS; MYELOID CELLS; IMMUNE-RESPONSES; C/EBP-EPSILON; HALF-LIVES; IN-VITRO; CANCER; INFLAMMATION; MACROPHAGES	Neutrophils are specialized innate cells that require constant replenishment from proliferative bone marrow (BM) precursors as a result of their short half-life. Although it is established that neutrophils are derived from the granulocyte-macrophage progenitor (GMP), the differentiation pathways from GMP to functional mature neutrophils are poorly defined. Using mass cytometry (CyTOF) and cell-cycle-based analysis, we identified three neutrophil subsets within the BM: a committed proliferative neutrophil precursor (preNeu) which differentiates into non-proliferating immature neutrophils and mature neutrophils. Transcriptomic profiling and functional analysis revealed that preNeu require the C/EBP epsilon transcription factor for their generation from the GMP, and their proliferative program is substituted by a gain of migratory and effector function as they mature. preNeus expand under microbial and tumoral stress, and immature neutrophils are recruited to the periphery of tumor-bearing mice. In summary, our study identifies specialized BM granulocytic populations that ensure supply under homeostasis and stress responses.	[Evrard, Maximilien; Kwok, Immanuel W. H.; Chong, Shu Zhen; Teng, Karen W. W.; Becht, Etienne; Chen, Jinmiao; Sieow, Je Lin; Penny, Hweixian Leong; Ching, Goh Chi; Devi, Sapna; Li, Jackson L. Y.; Liong, Ka Hang; Tan, Leonard; Foo, Shihui; Chua, Jia Wang; Biswas, Subhra K.; Larbi, Anis; Wong, Siew Cheng; Newell, Evan W.; Ginhoux, Florent; Ng, Lai Guan] Agcy Sci Technol & Res, Singapore Immunol Network, Biopolis 138648, Singapore; [Kwok, Immanuel W. H.; Su, I-Hsin; Ng, Lai Guan] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Adrover, Jose Maria; Li, Jackson L. Y.; Hidalgo, Andres] Fdn Ctr Nacl Invest Cardiovasc, Area Cell & Dev Biol, Madrid 28029, Spain; [Poon, Zhiyong; Hwang, William Y. K.] Singapore Gen Hosp, Dept Hematol, Singapore 169856, Singapore; [Balabanian, Karl; Bachelerie, Francois] Univ Paris Saclay, Univ Paris Sud, Inflammat Chemokines & Immunopathol, INSERM,Fac Med,UMR 996, F-92140 Clamart, France; [Madan, Vikas; Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Koeffler, H. Phillip] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA; [Koeffler, H. Phillip] Natl Univ Singapore Hosp, Natl Univ Canc Inst Singapore, Dept Hematol Oncol, Singapore 119074, Singapore; [Hidalgo, Andres] LMU, Inst Cardiovasc Prevent, D-80336 Munich, Germany; [Evrard, Maximilien] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Singapore General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; National University of Singapore; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore; University of Munich; University of Melbourne	Evrard, M; Ng, LG (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Biopolis 138648, Singapore.; Ng, LG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.; Evrard, M (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.	maximilien.evrard@unimelb.edu.au; ng_lai_guan@immunol.a-star.edu.sg	Su, I-hsin/A-2207-2011; Adrover, Jose M/G-9741-2017; Hwang, William/AAX-8452-2021; Kwok, Immanuel/GXH-0537-2022; Ng, Lai Guan/E-5673-2011; Hwang, William/AAT-3079-2021; Larbi, Anis/ABE-5868-2020; Balabanian, Karl/I-2990-2016; Balabanian, Karl/S-6250-2019; Chen, Jinmiao/ABE-5601-2021; Newell, Evan W/F-9711-2012; Evrard, Maximilien/L-3886-2019; Tan, Leonard/GXG-9931-2022; BACHELERIE, FRANCOISE/F-8823-2013; Ng, Lai Guan/N-6980-2019; Hidalgo, Andrés/L-5643-2014	Su, I-hsin/0000-0002-5894-9580; Adrover, Jose M/0000-0002-1395-5477; Kwok, Immanuel/0000-0003-1523-1621; Ng, Lai Guan/0000-0003-1905-3586; Hwang, William/0000-0003-0143-6263; Balabanian, Karl/0000-0002-0534-3198; Balabanian, Karl/0000-0002-0534-3198; Newell, Evan W/0000-0002-2889-243X; Evrard, Maximilien/0000-0002-2105-1160; BACHELERIE, FRANCOISE/0000-0002-0399-3277; Ng, Lai Guan/0000-0003-1905-3586; Hidalgo, Andrés/0000-0001-5513-555X; Becht, Etienne/0000-0003-1859-9202; Devi, Sapna/0000-0003-4714-6018; Chong, Shu Zhen/0000-0002-2682-912X; Tan, Leonard/0000-0002-6923-1021	SIgN core funding, A*STAR (Agency for Science, Technology and Research), Singapore	SIgN core funding, A*STAR (Agency for Science, Technology and Research), Singapore	We thank all members of L.G.N laboratory, the SIgN (Singapore Immunology Network) flow-cytometry team, the SIgN functional genomics team for their assistance with transcriptomics, and the SIgN mouse core facility for their technical help and support. This research was funded by SIgN core funding, A*STAR (Agency for Science, Technology and Research), Singapore.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012; Anthony BA, 2014, TRENDS IMMUNOL, V35, P32, DOI 10.1016/j.it.2013.10.002; Balabanian K, 2012, BLOOD, V119, P5722, DOI 10.1182/blood-2012-01-403378; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bjerregaard MD, 2003, BLOOD, V101, P4322, DOI 10.1182/blood-2002-03-0835; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Chong SZ, 2016, J EXP MED, V213, P2293, DOI 10.1084/jem.20160800; Chua RYR, 2013, IMMUNOLOGY, V139, P30, DOI 10.1111/imm.12051; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; Faust N, 2000, BLOOD, V96, P719; Fiedler K, 2012, AM J BLOOD RES, V2, P57; Ford AM, 1996, P NATL ACAD SCI USA, V93, P10838, DOI 10.1073/pnas.93.20.10838; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Garay T, 2013, EXP CELL RES, V319, P3094, DOI 10.1016/j.yexcr.2013.08.018; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gombart AF, 2003, BLOOD, V101, P3265, DOI 10.1182/blood-2002-04-1039; Hahsler M, 2008, J STAT SOFTW, V25, P1; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Kim HK, 2006, BLOOD, V108, P812, DOI 10.1182/blood-2005-10-4162; Kohler A, 2011, BLOOD, V117, P4349, DOI 10.1182/blood-2010-09-308387; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kyme P, 2012, J CLIN INVEST, V122, P3316, DOI 10.1172/JCI62070; Lahoz-Beneytez J, 2016, BLOOD, V127, P3431, DOI 10.1182/blood-2016-03-700336; Li JL, 2016, J INVEST DERMATOL, V136, P416, DOI 10.1038/JID.2015.410; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Reber LL, 2017, J EXP MED, V214, P1249, DOI 10.1084/jem.20161238; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rubinstein MP, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-75; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Silvestre-Roig C, 2016, BLOOD, V127, P2173, DOI 10.1182/blood-2016-01-688887; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Tak T, 2013, J LEUKOCYTE BIOL, V94, P595, DOI 10.1189/jlb.1112571; Tomura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073801; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weber GF, 2015, SCIENCE, V347, P1260, DOI 10.1126/science.aaa4268; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Yanez A, 2015, BLOOD, V125, P1452, DOI 10.1182/blood-2014-09-600833; Yang XD, 2011, NAT MED, V17, P87, DOI 10.1038/nm.2278; Yo M, 2015, BIOCHEM BIOPH RES CO, V457, P7, DOI 10.1016/j.bbrc.2014.12.074; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zambirinis CP, 2015, J EXP MED, V212, P2077, DOI 10.1084/jem.20142162	54	251	254	8	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					364	+		10.1016/j.immuni.2018.02.002	http://dx.doi.org/10.1016/j.immuni.2018.02.002			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466759	Green Accepted, Bronze			2022-12-18	WOS:000425507800020
J	Wing, JB; Ise, W; Kurosaki, T; Sakaguchi, S				Wing, James Badger; Ise, Wataru; Kurosaki, Tomohiro; Sakaguchi, Shimon			Regulatory T Cells Control Antigen-Specific Expansion of Tfh Cell Number and Humoral Immune Responses via the Coreceptor CTLA-4	IMMUNITY			English	Article							CUTTING EDGE; DENDRITIC CELLS; BLOCKADE; FOXP3; ENTEROPATHY; EXPRESSION; INFECTION; POLYENDOCRINOPATHY; DYSREGULATION; AUTOIMMUNITY	CD4(+)Foxp3-expressing Treg cells, which constitutively express the inhibitory coreceptor CTLA-4, are indispensable for immune homeostasis. We determined the roles of Treg cells and T follicular regulatory (Tfr) cells in the control of humoral immune responses. Depletion of Treg cells, blocking of CTLA-4 or a Treg cell specific reduction in CTLA-4 expression, resulted in an increase in the formation of antigen-specific Tfh cells, germinal center (GC), and plasma and memory B cells after vaccination. In the absence of Treg cell-expressed CTLA-4, large numbers of Tfr cells were present but were unable to restrain Tfh cell and GC formation. Temporary Treg cell depletion during primary immunization was sufficient to enhance secondary immune responses. Treg cells directly inhibited, via CTLA-4, Bcell expression of CD80 and CD86, which was essential for Tfh cell formation. Thus, Treg and Tfr cells control Tfh cell and germinal center development, via CTLA-4-dependent regulation of CD80 and CD86 expression.	[Wing, James Badger; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Expt Immunol Lab, Suita, Osaka 5650871, Japan; [Ise, Wataru; Kurosaki, Tomohiro] Osaka Univ, Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Suita, Osaka 5650871, Japan; [Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan	Osaka University; Osaka University; Kyoto University	Sakaguchi, S (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Expt Immunol Lab, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	shimon@ifrec.osaka-u.ac.jp	Kurosaki, Tomohiro/D-1306-2009; Wing, James Badger/H-6256-2019; Sakaguchi, Shimon/C-9535-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Wing, James Badger/0000-0002-3462-1003; 	Japan Society for the Promotion of Science young scientist B grant [25860356]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20002007, 26253030]; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology in Japan; CREST grant	Japan Society for the Promotion of Science young scientist B grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST grant	J.B.W. is the recipient of a Japan Society for the Promotion of Science young scientist B grant (25860356), S.S. is the recipient of Grants-in-Aid for Specially Promoted Research (20002007) and for Scientific Research (A) (26253030) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency; W.I. and T.K. were supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology in Japan and by a CREST grant to T.K. We would like to thank M. Jenkins for kindly providing 2W1S:I-A<SUP>b</SUP> tetramer, T. Sparwasser for provision of the DEREG mouse strain, M. Kubo for provision of hCD2-IL-4 reporter mice, J. Allison for provision of the 9D9 hybridoma, H. Nishikawa, D. Sugiyama, H. Hume and D. Adgeebe for helpful discussions, and H. Run for technical support.	Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Boudewijns M, 2005, J LEUKOCYTE BIOL, V78, P1060, DOI 10.1189/jlb.1004562; Bour-Jordan H, 2003, NAT IMMUNOL, V4, P182, DOI 10.1038/ni884; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Corse E, 2012, J IMMUNOL, V189, P1123, DOI 10.4049/jimmunol.1200695; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Eddahri F, 2006, EUR J IMMUNOL, V36, P855, DOI 10.1002/eji.200535500; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Good-Jacobson KL, 2012, J IMMUNOL, V188, P4217, DOI 10.4049/jimmunol.1102885; Harada Y, 2012, IMMUNITY, V36, P188, DOI 10.1016/j.immuni.2012.02.002; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Keler T, 2003, J IMMUNOL, V171, P6251, DOI 10.4049/jimmunol.171.11.6251; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Kirman J, 1999, INFECT IMMUN, V67, P3786, DOI 10.1128/IAI.67.8.3786-3792.1999; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Leon B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4495; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Ludwig-Portugall I, 2008, J IMMUNOL, V181, P4447, DOI 10.4049/jimmunol.181.7.4447; Ludwig-Portugall I, 2009, EUR J IMMUNOL, V39, P225, DOI 10.1002/eji.200838699; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; McCoy K, 1997, J EXP MED, V186, P183, DOI 10.1084/jem.186.2.183; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Pace L, 2012, SCIENCE, V338, P532, DOI 10.1126/science.1227049; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salek-Ardakani S, 2011, J IMMUNOL, V186, P5294, DOI 10.4049/jimmunol.1100406; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Tian L, 2011, BLOOD, V118, P1845, DOI 10.1182/blood-2011-04-346056; Vaeth M, 2014, J EXP MED, V211, P545, DOI 10.1084/jem.20130604; Vendetti S, 2010, IMMUNOL CELL BIOL, V88, P698, DOI 10.1038/icb.2010.76; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Walker LSK, 2003, J IMMUNOL, V170, P91, DOI 10.4049/jimmunol.170.1.91; Wang CJ, 2012, J IMMUNOL, V189, P1118, DOI 10.4049/jimmunol.1200972; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wing JB, 2014, INT IMMUNOL, V26, P61, DOI 10.1093/intimm/dxt060; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Yamaguchi T, 2011, SEMIN IMMUNOL, V23, P424, DOI 10.1016/j.smim.2011.10.002	55	251	261	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					1013	1025		10.1016/j.immuni.2014.12.006	http://dx.doi.org/10.1016/j.immuni.2014.12.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526312	Bronze			2022-12-18	WOS:000346654100018
J	Nika, K; Soldani, C; Salek, M; Paster, W; Gray, A; Etzensperger, R; Fugger, L; Polzella, P; Cerundolo, V; Dushek, O; Hofer, T; Viola, A; Acuto, O				Nika, Konstantina; Soldani, Cristiana; Salek, Mogjiborahman; Paster, Wolfgang; Gray, Adrian; Etzensperger, Ruth; Fugger, Lars; Polzella, Paolo; Cerundolo, Vincenzo; Dushek, Omer; Hoefer, Thomas; Viola, Antonella; Acuto, Oreste			Constitutively Active Lck Kinase in T Cells Drives Antigen Receptor Signal Transduction	IMMUNITY			English	Article							SRC-FAMILY KINASES; PROTEIN-TYROSINE KINASE; CD4 RECEPTOR; LIPID RAFTS; ACTIVATION; REVEALS; BINDING; MOLECULES; DOMAINS; SURFACE	T cell antigen receptor (TCR) and coreceptor ligation is thought to initiate signal transduction by inducing activation of the kinase Lck. Here we showed that catalytically active Lck was present in unstimulated naive T cells and thymocytes and was readily detectable in these cells in lymphoid organs. In naive T cells up to similar to 40% of total Lck was constitutively activated, part of which was also phosphorylated on the C-terminal inhibitory site. Formation of activated Lck was independent of TCR and coreceptors but required Lck catalytic activity and its maintenance relied on monitoring by the HSP90-CDC37 chaperone complex to avoid degradation. The amount of activated Lck did not change after TCR and coreceptor engagement; however it determined the extent of TCR-zeta phosphorylation. Our findings suggest a dynamic regulation of Lck activity that can be promptly utilized to initiate T cell activation and have implications for signaling by other immune receptors.	[Nika, Konstantina; Salek, Mogjiborahman; Paster, Wolfgang; Gray, Adrian; Acuto, Oreste] Univ Oxford, Sir William Dunn Sch Pathol, T Cell Signaling Lab, Oxford OX1 3RE, England; [Soldani, Cristiana; Viola, Antonella] Ist Clin Humanitas IRCCS, I-20089 Milan, Italy; [Etzensperger, Ruth; Fugger, Lars] Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DU, England; [Polzella, Paolo; Cerundolo, Vincenzo] Univ Oxford, Tumour Immunol Grp, MRC Human Immunol Unit, Oxford OX3 9DU, England; [Dushek, Omer] Univ Oxford, Ctr Math Biol, Oxford OX1 3RE, England; [Hoefer, Thomas] German Canc Res Ctr, Res Grp Modeling Biol Syst, D-69120 Heidelberg, Germany; [Viola, Antonella] Univ Milan, Dept Translat Med, I-20089 Milan, Italy	University of Oxford; IRCCS Humanitas Research Hospital; University of Oxford; University of Oxford; University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); University of Milan	Acuto, O (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, T Cell Signaling Lab, S Parks Rd, Oxford OX1 3RE, England.	oreste.acuto@path.ox.ac.uk	Agatea, Lisa/L-8267-2016; Höfer, Thomas/G-5665-2013; Viola, Antonella/A-4321-2015	Höfer, Thomas/0000-0003-3560-8780; Nika, Konstantina/0000-0002-9620-0263; Paster, Wolfgang/0000-0002-5537-2886; Cerundolo, Vincenzo/0000-0003-0040-3793; Salek, Mogjiborahman/0000-0002-6664-4752; Viola, Antonella/0000-0002-0125-9271; Soldani, Cristiana/0000-0001-5041-9588	Wellcome Trust [GR076558MA]; EU [201106]; Austrian Science Fund (FWF); Cancer Research UK [C399/A2291]; UK Medical Research Council; Natural Sciences and Engineering Research Council of Canada; MRC [MC_U137884181, G1000800, G0800500] Funding Source: UKRI; Medical Research Council [G1000800e, G0800500, MC_U137884181, G1000800] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Grant number GR076558MA to O.A. and EU-FP7 "Sybilla" n<SUP>o</SUP>201106 to O.A., A.V., L.F., and T.H. W.P. was supported by the Erwin Schrodinger Fellowship from the Austrian Science Fund (FWF). V.C. and P.P. were supported by Cancer Research UK (C399/A2291) and EU-FP6 "Immunanomap Grant." L.F and R.E were also supported by UK Medical Research Council and EU FP6 "NeuroPromise." O.D. was supported by the Natural Sciences and Engineering Research Council of Canada. We thank W.-D. Lehmann for the generous gift of a peptide; A. van der Merwe, T. Harder, and F. Michel for helpful discussions; D. Prellino for initial help with the mathematical model; and V. Geoghegan for reading the manuscript.	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Baker BM, 2001, IMMUNITY, V14, P681, DOI 10.1016/S1074-7613(01)00160-1; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cherry RJ, 1998, J CELL BIOL, V140, P71, DOI 10.1083/jcb.140.1.71; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Filipp D, 2003, J EXP MED, V197, P1221, DOI 10.1084/jem.20022112; Fischer UB, 2007, P NATL ACAD SCI USA, V104, P7181, DOI 10.1073/pnas.0608299104; Friese MA, 2008, NAT MED, V14, P1227, DOI 10.1038/nm.1881; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Giannini A, 2004, MOL CELL BIOL, V24, P5667, DOI 10.1128/MCB.24.13.5667-5676.2004; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; He HT, 2008, EMBO REP, V9, P525, DOI 10.1038/embor.2008.78; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Kabouridis PS, 2003, BIOCHEM J, V371, P907, DOI 10.1042/BJ20021578; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Marti F, 2006, J EXP MED, V203, P281, DOI 10.1084/jem.20051637; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Shimada Y, 2005, FEBS J, V272, P5454, DOI 10.1111/j.1742-4658.2005.04938.x; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6	42	251	257	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 25	2010	32	6					766	777		10.1016/j.immuni.2010.05.011	http://dx.doi.org/10.1016/j.immuni.2010.05.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20541955	Green Published, hybrid			2022-12-18	WOS:000279365800008
J	Banchereau, J; Pascual, V; Palucka, AK				Banchereau, J; Pascual, V; Palucka, AK			Autoimmunity through cytokine-induced dendritic cell activation	IMMUNITY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TUMOR-NECROSIS-FACTOR; COLONY-STIMULATING-FACTOR; SKEWS MONOCYTE DIFFERENTIATION; ALPHA-PRODUCING CELLS; REGULATORY T-CELLS; CD34(+) HEMATOPOIETIC PROGENITORS; CORD-BLOOD DIFFERENTIATE; SOLUBLE CD40 LIGAND; NAIVE B-LYMPHOCYTES	We propose a model where autoimmunity can be viewed as a dynamic system driven by opposite vectors IFN-alpha/beta and TNF. These cytokines drive differentiation of distinct types of DCs, TNF-DCs, or lFN-DCs, which present different antigens leading to distinct autoimmune responses. When balanced, both cytokines synergize in protective immunity. When one of the cytokines prevails, autoimmunity occurs, Type I interferons (IFN-alpha/beta) playing a major role in systemic lupus erythematosus (SLE) and TNF playing a major role in rheumatoid arthritis. This model complements the Type 1/Type 2 paradigm. Therefore, immunity can be viewed as a dynamic system driven by two sets of opposite vectors: IFN-alpha/beta/TNF and IFN-gamma/IL-4.	Baylor Inst Immunol Res, Dallas, TX 75204 USA	Baylor Scott & White Health	Banchereau, J (corresponding author), Baylor Inst Immunol Res, 3434 Live Oak, Dallas, TX 75204 USA.	jacquesb@baylorhealth.edu; virginip@baylorhealth.edu; virginip@baylorhealth.edu	Pascual, Virginia/ABD-3099-2020		NATIONAL CANCER INSTITUTE [R01CA089440, P01CA084512, R01CA078846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005412, U19AI057234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046589] Funding Source: NIH RePORTER; NCI NIH HHS [R0-1-CA89440, R0-1-CA78846, P0-1-CA84512] Funding Source: Medline; NIAID NIH HHS [U19 AI057234, N01-AI-05412] Funding Source: Medline; NIAMS NIH HHS [R0-1-AR46589] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Bauer JJ, 2001, NARRAT INQ, V11, P123, DOI 10.1075/ni.11.1.06bau; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Bave U, 2001, J AUTOIMMUN, V17, P71, DOI 10.1006/jaut.2001.0519; Bellone M, 1997, J IMMUNOL, V159, P5391; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Benoist C, 2002, NATURE, V420, P875, DOI 10.1038/nature01324; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blomberg S, 2001, LUPUS, V10, P484, DOI 10.1191/096120301678416042; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Braun D, 2003, J AUTOIMMUN, V20, P15, DOI 10.1016/S0896-8411(02)00109-9; Brocker T, 1999, J LEUKOCYTE BIOL, V66, P331, DOI 10.1002/jlb.66.2.331; Casciola-Rosen L, 1999, J EXP MED, V190, P815, DOI 10.1084/jem.190.6.815; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Caux C, 1997, BLOOD, V90, P1458, DOI 10.1182/blood.V90.4.1458.1458_1458_1470; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Cederblad B, 1998, J AUTOIMMUN, V11, P465, DOI 10.1006/jaut.1998.0215; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chabot S, 1997, J CLIN INVEST, V100, P604, DOI 10.1172/JCI119571; Chomarat P, 2003, J IMMUNOL, V171, P2262, DOI 10.4049/jimmunol.171.5.2262; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Cobbold S, 1998, CURR OPIN IMMUNOL, V10, P518, DOI 10.1016/S0952-7915(98)80217-3; Davas EM, 1999, CLIN RHEUMATOL, V18, P17, DOI 10.1007/s100670050045; DesaiMehta A, 1996, J CLIN INVEST, V97, P2063, DOI 10.1172/JCI118643; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dubois B, 1998, J IMMUNOL, V161, P2223; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; Ehlers S, 2003, ANN RHEUM DIS, V62, P37, DOI 10.1136/ard.62.suppl_2.ii37; FADOK VA, 1992, J IMMUNOL, V148, P2207; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Finkelman FD, 1996, J IMMUNOL, V157, P1406; Fujimoto Y, 2002, CELL, V108, P755, DOI 10.1016/S0092-8674(02)00673-6; Galinski W, 1996, NATO ASI SER SER I, V40, P183; Gattorno M, 1998, J RHEUMATOL, V25, P361; Gill MA, 2002, HUM IMMUNOL, V63, P1172, DOI 10.1016/S0198-8859(02)00756-5; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gottlieb AB, 2003, J AM ACAD DERMATOL, V49, pS112, DOI 10.1016/S0190-9622(03)01143-5; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JACOB CO, 1988, NATURE, V331, P356, DOI 10.1038/331356a0; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kalia R, 1999, COMPUT SCI ENG, V1, P2; Kaplan MJ, 2004, J IMMUNOL, V172, P3652, DOI 10.4049/jimmunol.172.6.3652; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kono DH, 2003, AUTOIMMUNITY, V36, P503, DOI 10.1080/08916930310001624665; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Luft T, 1998, J IMMUNOL, V161, P1947; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MacLennan ICM, 2002, IMMUNITY, V17, P235, DOI 10.1016/S1074-7613(02)00398-9; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; Mohty M, 2003, J IMMUNOL, V171, P3385, DOI 10.4049/jimmunol.171.7.3385; Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Palucka K, 2002, CURR OPIN IMMUNOL, V14, P420, DOI 10.1016/S0952-7915(02)00365-5; Paquette RL, 1998, J LEUKOCYTE BIOL, V64, P358, DOI 10.1002/jlb.64.3.358; PETERS JH, 1993, ADV EXP MED BIOL, V329, P275; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; PUGH CW, 1982, ADV EXP MED BIOL, V149, P781; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; REIMOLD AM, 2002, ALLERGY, V1, P377; ROMAGNANI S, 1995, J CLIN IMMUNOL, V15, P121, DOI 10.1007/BF01543103; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; RONNBLOM LE, 1991, ANN INTERN MED, V115, P178, DOI 10.7326/0003-4819-115-3-178; Rothuizen LE, 1999, J NEUROIMMUNOL, V99, P131, DOI 10.1016/S0165-5728(99)00029-6; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; SELMAJ K, 1991, J CLIN INVEST, V87, P949, DOI 10.1172/JCI115102; Shevach EM, 2001, ADV EXP MED BIOL, V490, P21; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; Shodell M, 2003, LUPUS, V12, P222, DOI 10.1191/0961203303lu362xx; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sobel ES, 2002, J IMMUNOL, V169, P2694, DOI 10.4049/jimmunol.169.5.2694; Sprent J, 2002, IMMUNOL REV, V185, P126, DOI 10.1034/j.1600-065X.2002.18512.x; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Tsokos GC, 2003, TRENDS IMMUNOL, V24, P259, DOI 10.1016/S1471-4906(03)00100-5; Turley SJ, 2002, CURR OPIN IMMUNOL, V14, P765, DOI 10.1016/S0952-7915(02)00399-0; Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J; Vallin H, 1999, CLIN EXP IMMUNOL, V115, P196; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Vieira PL, 2000, J IMMUNOL, V164, P4507, DOI 10.4049/jimmunol.164.9.4507; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; VONWUSSOW P, 1988, RHEUMATOL INT, V8, P225, DOI 10.1007/BF00269199; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wykes M, 1998, J IMMUNOL, V161, P1313; Yu M, 1996, J NEUROIMMUNOL, V64, P91, DOI 10.1016/0165-5728(95)00160-3	137	251	279	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					539	550		10.1016/S1074-7613(04)00108-6	http://dx.doi.org/10.1016/S1074-7613(04)00108-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142523	Bronze			2022-12-18	WOS:000221631900005
J	Homeister, JW; Thall, AD; Petryniak, B; Maly, P; Rogers, CE; Smith, PL; Kelly, RJ; Gersten, KM; Askari, SW; Cheng, GY; Smithson, G; Marks, RM; Misra, AK; Hindsgaul, O; von Andrian, UH; Lowe, JB				Homeister, JW; Thall, AD; Petryniak, B; Maly, P; Rogers, CE; Smith, PL; Kelly, RJ; Gersten, KM; Askari, SW; Cheng, GY; Smithson, G; Marks, RM; Misra, AK; Hindsgaul, O; von Andrian, UH; Lowe, JB			The alpha(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing	IMMUNITY			English	Article							P-SELECTIN; GLYCOPROTEIN LIGAND-1; DEFICIENT MICE; FUCOSYL-TRANSFERASE; ELAM-1 LIGAND; CELL-LINES; IN-VIVO; ADHESION; EXPRESSION; BINDING	E-, P-, and L-selectin counterreceptor activities, leukocyte trafficking, and lymphocyte homing are controlled prominently but incompletely by alpha (1,3)fucosyltransferase FucT-VII-dependent fucosylation. Molecular determinants for FucT-VII-independent leukocyte trafficking are not defined, and evidence for contributions by or requirements for other FucTs in leukocyte recruitment is contradictory and incomplete. We show here that inflammation-dependent leukocyte recruitment retained in FucT-VII deficiency is extinguished in FucT-1V(-/-)/FucT-VII-/- mice. Double deficiency yields an extreme leukocytosis characterized by decreased neutrophil turnover and increased neutrophil production. FucT-IV also contributes to HEV-born L-selectin ligands, since lymphocyte homing retained in FucT-VII-/- mice is revoked in FucT-IV-/-/FucT-VII-/- mice. These observations reveal essential FucT-IV-dependent contributions to E-, P-, and L-selectin ligand synthesis and to the control of leukocyte recruitment and lymphocyte homing.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Burnham Inst, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Sanford Burnham Prebys Medical Discovery Institute	Lowe, JB (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.		von Andrian, Ulrich H/A-5775-2008; Malý, Petr/H-5962-2014	Malý, Petr/0000-0001-8118-0581	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949, R01HL054936] Funding Source: NIH RePORTER; NCI NIH HHS [1PO1CA711932] Funding Source: Medline; NHLBI NIH HHS [1RO1 HL54936, 1PO1 HL56949] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Catalina MD, 1999, BLOOD, V93, P580, DOI 10.1182/blood.V93.2.580.402k16_580_589; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GERSTEN KM, 1995, J BIOL CHEM, V270, P25047, DOI 10.1074/jbc.270.42.25047; GOELZ S, 1994, J BIOL CHEM, V269, P1033; GOELZ SE, 1990, CELL, V63, P1349, DOI 10.1016/0092-8674(90)90430-M; Hemmerich S, 2000, GLYCOBIOLOGY, V10, P849, DOI 10.1093/glycob/10.9.849; Homeister JW, 1998, BLOOD, V92, P2345, DOI 10.1182/blood.V92.7.2345.2345_2345_2352; Huang MC, 2000, J BIOL CHEM, V275, P31353, DOI 10.1074/jbc.M005449200; JOHNSON RC, 1995, BLOOD, V86, P1106; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; LEBOW MA, 1994, IMMUNITY, V1, P709; Levesque JP, 1999, IMMUNITY, V11, P369, DOI 10.1016/S1074-7613(00)80112-0; LEY K, 1991, CIRC RES, V69, P1034, DOI 10.1161/01.RES.69.4.1034; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; LORD BI, 1991, BLOOD, V77, P2154; Lowe JB, 1997, KIDNEY INT, V51, P1418, DOI 10.1038/ki.1997.194; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; Misra AK, 2000, BIOORG MED CHEM LETT, V10, P1505, DOI 10.1016/S0960-894X(00)00207-9; Niemela R, 1998, J BIOL CHEM, V273, P4021, DOI 10.1074/jbc.273.7.4021; Puri KD, 1997, J IMMUNOL, V158, P405; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Singer MS, 1996, J IMMUNOL METHODS, V196, P153, DOI 10.1016/0022-1759(96)00106-8; Snapp KR, 1997, BLOOD, V89, P896, DOI 10.1182/blood.V89.3.896; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Torii T, 2000, GLYCOBIOLOGY, V10, P203, DOI 10.1093/glycob/10.2.203; van der Merwe PA, 1999, CURR BIOL, V9, pR419; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Wagers AJ, 1997, J IMMUNOL, V159, P1917; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732	35	251	259	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2001	15	1					115	126		10.1016/S1074-7613(01)00166-2	http://dx.doi.org/10.1016/S1074-7613(01)00166-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485743	Bronze			2022-12-18	WOS:000170153300012
J	Khakoo, SI; Rajalingam, R; Shum, BP; Weidenbach, K; Flodin, L; Muir, DG; Canavez, F; Cooper, SL; Valiante, NM; Lanier, LL; Parham, P				Khakoo, SI; Rajalingam, R; Shum, BP; Weidenbach, K; Flodin, L; Muir, DG; Canavez, F; Cooper, SL; Valiante, NM; Lanier, LL; Parham, P			Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; HLA-B MOLECULES; INHIBITORY RECEPTORS; GENOMIC ORGANIZATION; FUNCTIONAL TRANSFER; MULTIGENE FAMILY; DIRECT BINDING; GENE-COMPLEX; RECOGNITION; CD94/NKG2A	That NK cell receptors engage fast-evolving MHC class I ligands suggests that they, too, evolve rapidly. To test this hypothesis, the structure and class I specificity of chimpanzee KIR and CD94:NKG2 receptors were determined and compared to their human counterparts. The KIR families are divergent, with only three KIR conserved between chimpanzees and humans. By contrast, CD94:NKG2 receptors are conserved. Whereas receptors for polymorphic class I are divergent, those for nonpolymorphic class I are conserved. Although chimpanzee and human NK cells exhibit identical receptor specificities for MHC-C, they are mediated by nonorthologous KIR. These results demonstrate the rapid evolution of NK cell receptor systems and imply that "catching up" with class I is not the only force driving this evolution.	Stanford Univ, Dept Struct Biol & Microbiol, Stanford, CA 94305 USA; Stanford Univ, Dept Immunol, Stanford, CA 94305 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94306 USA	Stanford University; Stanford University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Parham, P (corresponding author), Stanford Univ, Dept Struct Biol & Microbiol, Stanford, CA 94305 USA.		Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952; Khakoo, Salim/0000-0002-4057-9091	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031168, R01AI022039] Funding Source: NIH RePORTER; NIAID NIH HHS [AI31168, AI22039] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ArnaizVillena A, 1997, IMMUNOGENETICS, V46, P251, DOI 10.1007/s002510050271; BAKER E, 1995, CHROMOSOME RES, V3, P511; Barten R, 1999, IMMUNOGENETICS, V49, P731, DOI 10.1007/s002510050675; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Boyington JC, 1999, IMMUNITY, V10, P75, DOI 10.1016/S1074-7613(00)80008-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brown MG, 2000, MAJOR HISTOCOMPATIBILITY COMPLEX, P287; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; CLARK EA, 1981, J IMMUNOL, V126, P969; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Cooper S, 1998, IMMUNOGENETICS, V47, P212, DOI 10.1007/s002510050350; Dohring C, 1996, J IMMUNOL, V156, P3098; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1977, AM NAT, V111, P223, DOI 10.1086/283157; GUMPERZ JE, 1995, NATURE, V378, P245, DOI 10.1038/378245a0; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LAWLOR DA, 1990, IMMUNOL REV, V113, P147, DOI 10.1111/j.1600-065X.1990.tb00040.x; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Martin AM, 2000, IMMUNOGENETICS, V51, P268, DOI 10.1007/s002510050620; MORETTA A, 1995, J EXP MED, V182, P875, DOI 10.1084/jem.182.3.875; MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Pende D, 1996, J EXP MED, V184, P505, DOI 10.1084/jem.184.2.505; Phillips JH, 1996, IMMUNITY, V5, P163, DOI 10.1016/S1074-7613(00)80492-6; Ponte M, 1999, P NATL ACAD SCI USA, V96, P5674, DOI 10.1073/pnas.96.10.5674; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Renedo M, 1997, IMMUNOGENETICS, V46, P307, DOI 10.1007/s002510050276; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Selvakumar A, 1997, TISSUE ANTIGENS, V49, P564, DOI 10.1111/j.1399-0039.1997.tb02803.x; SIBLEY CG, 1990, J MOL EVOL, V30, P202, DOI 10.1007/BF02099992; Steffens U, 1998, TISSUE ANTIGENS, V51, P398; SWOFFORD DL, 1999, PAUP PHYLOGENETIC AN; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Valiante NM, 1997, IMMUNOL REV, V155, P155, DOI 10.1111/j.1600-065X.1997.tb00948.x; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Vilches C, 2000, J IMMUNOL, V164, P5797, DOI 10.4049/jimmunol.164.11.5797; VILCHES C, 2000, IN PRESS IMMUNOGENET; Wagtmann N, 1997, CURR BIOL, V7, P615, DOI 10.1016/S0960-9822(06)00263-6; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Westgaard IH, 1998, EUR J IMMUNOL, V28, P1839, DOI 10.1002/(SICI)1521-4141(199806)28:06<1839::AID-IMMU1839>3.0.CO;2-E; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Wilson MJ, 1997, TISSUE ANTIGENS, V49, P574, DOI 10.1111/j.1399-0039.1997.tb02804.x; Winter CC, 1998, J IMMUNOL, V161, P571; YOKOYAMA WM, 1990, J IMMUNOL, V145, P2353	53	251	258	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2000	12	6					687	698		10.1016/S1074-7613(00)80219-8	http://dx.doi.org/10.1016/S1074-7613(00)80219-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894168	Bronze			2022-12-18	WOS:000087937300010
J	Binstadt, BA; Brumbaugh, KM; Dick, CJ; Scharenberg, AM; Williams, BL; Colonna, M; Lanier, LL; Kinet, JP; Abraham, RT; Leibson, PJ				Binstadt, BA; Brumbaugh, KM; Dick, CJ; Scharenberg, AM; Williams, BL; Colonna, M; Lanier, LL; Kinet, JP; Abraham, RT; Leibson, PJ			Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; COMPLEX CLASS-I; POLYMORPHIC HLA-B; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; PHOSPHOLIPASE-C; T-LYMPHOCYTES; MOLECULES; PHOSPHORYLATION; CLONES	Recognition of major histocompatibility (MHC) class I complexes on target cells by killer cell inhibitory receptors (KIR) blocks natural killer (NK) and T cell cytotoxic function. The inhibitory effect of KIR ligation requires the phosphotyrosine-dependent association of KIR with the cytoplasmic SH2-containing protein tyrosine phosphatase SHP-1. Using a somatic genetic model, we first define a requirement for the Src family protein tyrosine kinase (PTK) Lck in mediating KIR tyrosine phosphorylation. We then investigate how KIR ligation interrupts PTK-dependent NK cell activation signals, Specifically, we show that KIR ligation inhibits the Fc receptor (FcR)-induced tyrosine phosphorylation of the FcR-associated zeta signaling chain, the PTK ZAP-70, and phospholipase C gamma. Overexpression of catalytically inactive SHP-1 (acting as a dominant negative) restores the tyrosine phosphorylation of these signaling events and reverses KIR-mediated inhibition of NK cell cytotoxic function, These results suggest sequential roles for Lck and SHP-1 in the inhibition of PTK following MHC recognition by NK cells.	MAYO CLIN & MAYO FDN, DEPT IMMUNOL, ROCHESTER, MN 55905 USA; BETH ISRAEL HOSP, LAB ALLERGY & IMMUNOL, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02215 USA; BASEL INST IMMUNOL, CH-4005 BASEL, SWITZERLAND; DNAX RES INST MOL & CELLULAR BIOL INC, DEPT HUMAN IMMUNOL, PALO ALTO, CA 94304 USA	Mayo Clinic; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.			Lanier, Lewis L/E-2139-2014; Binstadt, Bryce/N-1305-2013	Lanier, Lewis L/0000-0003-1308-3952; Binstadt, Bryce/0000-0003-3127-3856; Colonna, Marco/0000-0001-5222-4987	NATIONAL CANCER INSTITUTE [R01CA047752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047286] Funding Source: NIH RePORTER; NCI NIH HHS [CA47752] Funding Source: Medline; NIGMS NIH HHS [GM47286] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; AZZONI L, 1992, J EXP MED, V176, P1745, DOI 10.1084/jem.176.6.1745; BONNEMA JD, 1994, J EXP MED, V180, P1427, DOI 10.1084/jem.180.4.1427; BOTTINO C, 1994, EUR J IMMUNOL, V24, P2527, DOI 10.1002/eji.1830241040; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Campbell KS, 1996, J EXP MED, V184, P93, DOI 10.1084/jem.184.1.93; CHAMBERS WH, 1989, J EXP MED, V169, P1373, DOI 10.1084/jem.169.4.1373; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; CONE JC, 1993, EUR J IMMUNOL, V23, P2488; DAndrea A, 1996, J EXP MED, V184, P789, DOI 10.1084/jem.184.2.789; DANDREA A, 1995, J IMMUNOL, V155, P2306; Dohring C, 1996, J IMMUNOL, V156, P3098; EINSPAHR KJ, 1991, P NATL ACAD SCI USA, V88, P6279, DOI 10.1073/pnas.88.14.6279; FARGNOLI J, 1995, J BIOL CHEM, V270, P26533, DOI 10.1074/jbc.270.44.26533; Fry AM, 1996, J EXP MED, V184, P295, DOI 10.1084/jem.184.1.295; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; KAUFMAN DS, 1995, P NATL ACAD SCI USA, V92, P6484, DOI 10.1073/pnas.92.14.6484; LANIER LL, 1995, J IMMUNOL, V154, P3320; Lanier LL, 1996, IMMUNOL TODAY, V17, P86, DOI 10.1016/0167-5699(96)80585-8; LANIER LL, 1993, CYTOTOXIC CELLS RECO, P84; LEIBSON PJ, 1995, IMMUNITY, V3, P5, DOI 10.1016/1074-7613(95)90153-1; Leibson PJ, 1995, NAT IMMUN, V14, P117; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1996, IMMUNOL TODAY, V17, P100, DOI 10.1016/0167-5699(96)80590-1; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MINGARI MC, 1995, INT IMMUNOL, V7, P697, DOI 10.1093/intimm/7.4.697; MORETTA A, 1991, J EXP MED, V174, P1393, DOI 10.1084/jem.174.6.1393; MORETTA L, 1994, ADV IMMUNOL, V55, P341; Olcese L, 1996, J IMMUNOL, V156, P4531; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; ORLOFF DG, 1989, J BIOL CHEM, V264, P14812; OSHEA JJ, 1992, J IMMUNOL, V148, P2497; OSHEA JJ, 1991, P NATL ACAD SCI USA, V88, P350, DOI 10.1073/pnas.88.2.350; PERUSSIA B, 1984, J IMMUNOL, V132, P1410; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; PIGNATA C, 1993, J IMMUNOL, V151, P6794; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; SALCEDO TW, 1993, J EXP MED, V177, P1475, DOI 10.1084/jem.177.5.1475; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TING AT, 1992, J EXP MED, V176, P1751, DOI 10.1084/jem.176.6.1751; TING AT, 1995, J BIOL CHEM, V270, P16415, DOI 10.1074/jbc.270.27.16415; TING AT, 1991, J IMMUNOL, V147, P3122; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; TRINCHIERI G, 1994, J EXP MED, V180, P417, DOI 10.1084/jem.180.2.417; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VITALE M, 1995, P NATL ACAD SCI USA, V92, P3536, DOI 10.1073/pnas.92.8.3536; VIVIER E, 1991, J IMMUNOL, V146, P206; VIVIER E, 1993, EUR J IMMUNOL, V23, P1872, DOI 10.1002/eji.1830230821; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WINDEBANK KP, 1988, J IMMUNOL, V141, P3951; YOKOYAMA WM, 1995, P NATL ACAD SCI USA, V92, P3081, DOI 10.1073/pnas.92.8.3081; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	57	251	253	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1996	5	6					629	638		10.1016/S1074-7613(00)80276-9	http://dx.doi.org/10.1016/S1074-7613(00)80276-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986721	Bronze			2022-12-18	WOS:A1996WA65100012
J	Kamanaka, M; Yu, P; Yasui, T; Yoshida, K; Kawabe, T; Horii, T; Kishimoto, T; Kikutani, H				Kamanaka, M; Yu, P; Yasui, T; Yoshida, K; Kawabe, T; Horii, T; Kishimoto, T; Kikutani, H			Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity	IMMUNITY			English	Article							X-LINKED IMMUNODEFICIENCY; HYPER-IGM SYNDROME; INTERFERON-GAMMA; T-CELLS; MURINE LEISHMANIASIS; IFN-GAMMA; DENDRITIC CELLS; LIGAND; MICE; INTERLEUKIN-4	CD40-deficient mice are susceptible to Leishmania major infection while their wild-type littermates can resolve the infection. Upon stimulation with L. major antigens, draining lymph node T cells of the mutant mice and the susceptible mice, BALB/c, secrete comparable amounts of IL-4. The mutant mice produce less IFN gamma than wild-type mice. The expression of IL-12 p40 mRNA was significantly lower in L. major antigen-stimulated cells of mutant mice than those of wild-type or BALB/c mice. In normal mice, engagement of CD40 activates macrophages to a leishmanicidal state in vitro in the presence of IFN gamma. The results suggest that the CD40-CD40 ligand interaction plays an important role in two critical steps of cell-mediated immunity to L. major infection: the generation of a Th1 response and activation of macrophages to a leishmanicidal state.	OSAKA UNIV,MICROBIAL DIS RES INST,SUITA,OSAKA 565,JAPAN; OSAKA UNIV,SCH MED,DEPT MED 3,SUITA,OSAKA 565,JAPAN	Osaka University; Osaka University	Kamanaka, M (corresponding author), OSAKA UNIV,INST MOLEC & CELLULAR BIOL,SUITA,OSAKA 565,JAPAN.		Kikutani, Hitoshi/C-9525-2009; Kishimoto, Tadamitsu/C-8470-2009; Kawabe, Tsutomu/I-6277-2014	Yu, Philipp/0000-0003-2629-6690; Kawabe, Tsutomu/0000-0002-9319-9930; Horii, Toshihiro/0000-0002-3000-2045				ALDERSON MR, 1993, J EXP MED, V178, P669, DOI 10.1084/jem.178.2.669; ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BELOSEVIC M, 1989, J IMMUNOL, V143, P266; BOOM WH, 1990, INFECT IMMUN, V58, P3863, DOI 10.1128/IAI.58.12.3863-3870.1990; BOUABOULA M, 1992, J BIOL CHEM, V267, P21830; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; CAUX C, 1994, J EXP MED, V180, P1841, DOI 10.1084/jem.180.5.1841; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; DURIE FH, 1994, J CLIN INVEST, V94, P1333, DOI 10.1172/JCI117453; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; HART DNJ, 1988, J EXP MED, V168, P157, DOI 10.1084/jem.168.1.157; HART DNJ, 1993, IMMUNOLOGY, V79, P616; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; HEINZEL FP, 1991, P NATL ACAD SCI USA, V88, P7011, DOI 10.1073/pnas.88.16.7011; HOLADAY BJ, 1991, J IMMUNOL, V147, P1653; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LARSEN CP, 1994, J IMMUNOL, V152, P5208; LIEW FY, 1993, ADV PARASIT, V32, P161, DOI 10.1016/S0065-308X(08)60208-0; LIEW FY, 1990, J IMMUNOL, V144, P4794; MANETTI R, 1994, J EXP MED, V179, P1273, DOI 10.1084/jem.179.4.1273; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; MULLER I, 1989, ANNU REV IMMUNOL, V7, P561, DOI 10.1146/annurev.iy.07.040189.003021; NORTARANGELO LD, 1992, IMMUNODEF REV, V3, P101; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; SHIRE D, 1993, EUR CYTOKINE NETW, V4, P161; SHRIEVER F, 1989, J EXP MED, V169, P2043; SHU U, 1995, EUR J IMMUNOL, V25, P1125, DOI 10.1002/eji.1830250442; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; TASWELL C, 1981, J IMMUNOL, V126, P1614; TIAN LC, 1995, EUR J IMMUNOL, V25, P306, DOI 10.1002/eji.1830250152; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; TOBIN JF, 1993, J IMMUNOL, V150, P5059; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; VARKILA K, 1993, EUR J IMMUNOL, V23, P262, DOI 10.1002/eji.1830230141; WAGNER DH, 1994, EUR J IMMUNOL, V24, P3148, DOI 10.1002/eji.1830241235; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; WU CY, 1993, J IMMUNOL, V151, P1938; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; 1990, TECHNICAL REPORT SR, V793, P144	53	251	252	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1996	4	3					275	281		10.1016/S1074-7613(00)80435-5	http://dx.doi.org/10.1016/S1074-7613(00)80435-5			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624817	Bronze			2022-12-18	WOS:A1996UC01800008
J	Liu, YJ; Malisan, F; deBouteiller, O; Guret, C; Lebecque, S; Banchereau, J; Mills, FC; Max, EE; MartinezValdez, H				Liu, YJ; Malisan, F; deBouteiller, O; Guret, C; Lebecque, S; Banchereau, J; Mills, FC; Max, EE; MartinezValdez, H			Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation	IMMUNITY			English	Article							CONSTANT REGION GENE; PRIMARY IMMUNE-RESPONSE; CENTER B-CELLS; CIRCULAR DNA; RECOMBINATION; EXPRESSION; ANTIGEN; MATURATION; (4-HYDROXY-3-NITROPHENYL)ACETYL; INTERLEUKIN-4	Human tonsillar B cells were separated into naive IgD(+)CD38(-)CD23(-) (Bm1) and IgD(+)CD38(-)CD23(+) (Bm2), germinal center IgD(-)CD38(+)CD23(-) centroblasts (Bm3) and IgD(-)CD38(+)CD77(-) centrocytes (Bm4), and memory IgD(-)CD38(-) (Bm5) subsets. Previous IgV(H) sequence analysis concluded that the triggering of somatic mutations occurs during the transition from Bm2 subset into the Bm3 subset. To determine the initiation of isotype switching, sterile transcript expression was analyzed by amplification, cloning, and sequencing. A selective sterile I gamma, I alpha, and I epsilon expression was observed at centrocyte (Bm4) stage, suggesting that isotype switch is triggered within germinal centers, after somatic mutation is initiated within centroblasts (Bm3). Finally, the high level of 5'S gamma-S mu 3' DNA switching circles observed in germinal center B cells indicates that within human tonsils, germinal center is a major location for isotype switching.	US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892	US Food & Drug Administration (FDA)	Liu, YJ (corresponding author), SCHERING PLOUGH CORP,LAB IMMUNOL RES,F-69571 DARDILLY,FRANCE.			lebecque, serge/0000-0003-4006-8061; MALISAN, FLORENCE/0000-0002-0213-9407				APEL M, 1990, INT IMMUNOL, V2, P813, DOI 10.1093/intimm/2.9.813; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BUTCH AW, 1993, J IMMUNOL, V150, P39; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; FEUILLARD J, 1995, INT IMMUNOL, V7, P121, DOI 10.1093/intimm/7.1.121; FLANAGAN JG, 1984, CELL, V36, P681, DOI 10.1016/0092-8674(84)90348-9; FLANAGAN JG, 1982, EMBO J, V1, P655, DOI 10.1002/j.1460-2075.1982.tb01223.x; GAUCHAT JF, 1990, J EXP MED, V172, P463, DOI 10.1084/jem.172.2.463; HARDIE DL, 1993, EUR J IMMUNOL, V23, P997, DOI 10.1002/eji.1830230502; HARRIMAN W, 1993, ANNU REV IMMUNOL, V11, P361, DOI 10.1146/annurev.iy.11.040193.002045; HOLTON TA, 1990, NUCLEIC ACIDS RES, P1156; HUCK S, 1986, NUCLEIC ACIDS RES, V14, P1779, DOI 10.1093/nar/14.4.1779; ISLAM KB, 1994, CLIN EXP IMMUNOL, V95, P3; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; KLEIN U, 1994, J EXP MED, V180, P1383, DOI 10.1084/jem.180.4.1383; KRAAL G, 1982, NATURE, V298, P377, DOI 10.1038/298377a0; Kroese F G, 1990, Curr Top Pathol, V84 ( Pt 1), P103; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; LEDERMAN S, 1992, J IMMUNOL, V149, P3817; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LIU YJ, 1992, IMMUNOL TODAY, V13, P17, DOI 10.1016/0167-5699(92)90199-H; LIU YJ, 1995, IMMUNITY, V2, P238; LIU YJ, 1989, NATURE, V342, P923; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MAIZELS N, 1985, CELL, V43, P715, DOI 10.1016/0092-8674(85)90244-2; MAIZELS N, 1988, MOL IMMUNOL, V25, P1277, DOI 10.1016/0161-5890(88)90042-9; MARTINEZVALDEZ H, 1996, IN PRESS J EXP MED; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; MILLS GB, 1990, J BIOL CHEM, V265, P3561; NILSSON L, 1991, INT IMMUNOL, V3, P1107, DOI 10.1093/intimm/3.11.1107; NOSSAL GJV, 1968, J EXP MED, V127, P277, DOI 10.1084/jem.127.2.277; OBATA M, 1981, P NATL ACAD SCI-BIOL, V78, P2437, DOI 10.1073/pnas.78.4.2437; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; RADBRUCH A, 1986, P NATL ACAD SCI USA, V83, P3954, DOI 10.1073/pnas.83.11.3954; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LAB MANU; SHAN H, 1990, J EXP MED, V172, P531, DOI 10.1084/jem.172.2.531; SHIMIZU A, 1991, J EXP MED, V173, P1385, DOI 10.1084/jem.173.6.1385; Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; THORBECKE GJ, 1994, FASEB J, V8, P832, DOI 10.1096/fasebj.8.11.8070632; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; WYSOCKI L, 1986, P NATL ACAD SCI USA, V83, P1847, DOI 10.1073/pnas.83.6.1847; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; YAOITA Y, 1982, NATURE, V297, P697, DOI 10.1038/297697a0; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x; ZHANG K, 1994, J IMMUNOL, V152, P3427	61	251	257	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1996	4	3					241	250		10.1016/S1074-7613(00)80432-X	http://dx.doi.org/10.1016/S1074-7613(00)80432-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624814	Bronze			2022-12-18	WOS:A1996UC01800005
J	Li, JY; Byme, KT; Yan, FX; Yamazoe, T; Chen, ZY; Baslan, T; Richman, LP; Lin, JH; Sun, YH; Rech, AJ; Balli, D; Hay, CA; Sela, Y; Merrell, AJ; Liudahl, SM; Gordon, N; Norgard, RJ; Yuan, S; Yu, SX; Chao, T; Ye, S; Eisinger-Mathason, TSK; Faryabi, RB; Tobias, JW; Lowe, SW; Coussens, LM; Wherry, EJ; Vonderheide, RH; Stangert, BZ				Li, Jinyang; Byme, Katelyn T.; Yan, Fangxue; Yamazoe, Taiji; Chen, Zeyu; Baslan, Timour; Richman, Lee P.; Lin, Jeffrey H.; Sun, Yu H.; Rech, Andrew J.; Balli, David; Hay, Ceire A.; Sela, Yogev; Merrell, Allyson J.; Liudahl, Shannon M.; Gordon, Naomi; Norgard, Robert J.; Yuan, Salina; Yu, Sixiang; Chao, Timothy; Ye, Shuai; Eisinger-Mathason, T. S. Karin; Faryabi, Robert B.; Tobias, John W.; Lowe, Scott W.; Coussens, Lisa M.; Wherry, E. John; Vonderheide, Robert H.; Stangert, Ben Z.			Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy	IMMUNITY			English	Article							DENDRITIC CELLS; MDSC INFILTRATION; PREDICTS RESPONSE; PD-1; CANCER; BLOCKADE; INFLAMMATION; TRAFFICKING; RESISTANCE; SURVIVAL	The biological and functional heterogeneity between tumors-both across and within cancer types-poses a challenge for immunotherapy. To understand the factors underlying tumor immune heterogeneity and immunotherapy sensitivity, we established a library of congenic tumor cell clones from an autochthonous mouse model of pancreatic adenocarcinoma. These clones generated tumors that recapitulated T cell-inflamed and non-T-cell-inflamed tumor microenvironments upon implantation in immunocompetent mice, with distinct patterns of infiltration by immune cell subsets. Co-injecting tumor cell clones revealed the non-T-cell-inflamed phenotype is dominant and that both quantitative and qualitative features of intratumoral CD8(+) T cells determine response to therapy. Transcriptomic and epigenetic analyses revealed tumor-cell-intrinsic production of the chemokine CXCL1 as a determinant of the non-T-cell-inflamed microenvironment, and ablation of CXCL1 promoted T cell infiltration and sensitivity to a combination immunotherapy regimen. Thus, tumor cell-intrinsic factors shape the tumor immune microenvironment and influence the outcome of immunotherapy.	[Li, Jinyang; Yan, Fangxue; Yamazoe, Taiji; Richman, Lee P.; Lin, Jeffrey H.; Rech, Andrew J.; Balli, David; Sela, Yogev; Merrell, Allyson J.; Gordon, Naomi; Norgard, Robert J.; Yuan, Salina; Yu, Sixiang; Chao, Timothy; Ye, Shuai; Eisinger-Mathason, T. S. Karin; Faryabi, Robert B.; Vonderheide, Robert H.; Stangert, Ben Z.] Univ Penn, Abramson Family Canc Res Inst, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Byme, Katelyn T.; Hay, Ceire A.; Vonderheide, Robert H.; Stangert, Ben Z.] Univ Penn, Dept Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Stangert, Ben Z.] Univ Penn, Dept Cell & Dev Biol, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Wherry, E. John; Vonderheide, Robert H.; Stangert, Ben Z.] Univ Penn, Abramson Canc Ctr, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Byme, Katelyn T.; Rech, Andrew J.; Wherry, E. John; Vonderheide, Robert H.; Stangert, Ben Z.] Univ Penn, Parker Inst Canc Immunotherapy, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Chen, Zeyu; Faryabi, Robert B.; Wherry, E. John; Vonderheide, Robert H.] Univ Penn, Inst Immunol, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Faryabi, Robert B.] Univ Penn, Dept Pathol & Lab Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Tobias, John W.] Univ Penn, Penn Genom Anal Core, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Baslan, Timour; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 415 East 68th St, New York, NY 10065 USA; [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 415 East 68th St, New York, NY 10065 USA; [Sun, Yu H.] Univ Rochester, Med Ctr, Dept Urol, Ctr RNA Biol,Dept Biochem & Biophys, Rochester, NY 14642 USA; [Liudahl, Shannon M.; Coussens, Lisa M.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Rochester; Oregon Health & Science University	Vonderheide, RH; Stangert, BZ (corresponding author), Univ Penn, Abramson Family Canc Res Inst, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Byme, KT; Vonderheide, RH; Stangert, BZ (corresponding author), Univ Penn, Dept Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Stangert, BZ (corresponding author), Univ Penn, Dept Cell & Dev Biol, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Vonderheide, RH; Stangert, BZ (corresponding author), Univ Penn, Abramson Canc Ctr, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Byme, KT; Vonderheide, RH; Stangert, BZ (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Vonderheide, RH (corresponding author), Univ Penn, Inst Immunol, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	byrnek@upenn.edu; rhv@upenn.edu; bstanger@upenn.edu	Faryabi, Robert/AAN-5512-2020; Sun, Yu H./ABD-9245-2020; Wherry, John/ABI-1280-2020; Coussens, Lisa/ABH-9834-2020; Chen, Zeyu/HGE-0239-2022; Yu, Sixiang/AFM-0114-2022	Faryabi, Robert/0000-0002-7931-2175; Sun, Yu H./0000-0003-0333-2898; Byrne, Katelyn/0000-0002-2459-9041; Liudahl, Shannon/0000-0002-8587-8204; Richman, Lee/0000-0002-4601-5190; Yan, Fangxue Yumi/0000-0002-3107-426X; Li, Jinyang/0000-0001-8125-6603; Yuan, Salina/0000-0002-7503-7081; Chao, Timothy/0000-0003-0082-5013	NIH [R01-CA169123, 1S10OD012312]; Parker Institute for Cancer Immunotherapy; William C. and Joyce C. O'Neil Charitable Trust; Memorial Sloan Kettering Single Cell Sequencing Initiative; Penn Center for Molecular Studies in Digestive and Liver Diseases [P30-DK050306]; ACC Core Grant [P30-CA016520]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; William C. and Joyce C. O'Neil Charitable Trust; Memorial Sloan Kettering Single Cell Sequencing Initiative; Penn Center for Molecular Studies in Digestive and Liver Diseases; ACC Core Grant	We thank all members of the Stanger and Vonderheide laboratories for discussions and Jianping Wang and Chenghua Yang for technical help. This work was supported by grants from the NIH (R01-CA169123 to B.Z.S. and R.H.V.), the Parker Institute for Cancer Immunotherapy (R.H.V. and K.T.B.), the William C. and Joyce C. O'Neil Charitable Trust, Memorial Sloan Kettering Single Cell Sequencing Initiative (T.B.), the Penn Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306), and the ACC Core Grant (P30-CA016520). Computational and bioinformatic analysis was performed on the Penn Medicine Academic Computing Services High-Performance Computing (Penn HPC) environment with support from NIH 1S10OD012312.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Bailey P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35848; Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462; Balli D, 2017, CLIN CANCER RES, V23, P3129, DOI 10.1158/1078-0432.CCR-16-2128; Baslan T, 2015, GENOME RES, V25, P714, DOI 10.1101/gr.188060.114; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Byrne KT, 2016, CELL REP, V15, P2719, DOI 10.1016/j.celrep.2016.05.058; Callari M, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0425-1; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Chao T, 2016, CANCER IMMUNOL RES, V4, P968, DOI 10.1158/2326-6066.CIR-16-0188; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Daud AI, 2016, J CLIN INVEST, V126, P3447, DOI 10.1172/JCI87324; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Desch A. N., 2011, J EXP MED, V208; Evans RA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88328; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Fritsch EF, 2014, CANCER IMMUNOL RES, V2, P522, DOI 10.1158/2326-6066.CIR-13-0227; Goel S, 2017, NATURE, V548, P471, DOI 10.1038/nature23465; Gunderson AJ, 2016, CANCER DISCOV, V6, P270, DOI 10.1158/2159-8290.CD-15-0827; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Kim S., 2017, BIORXIV; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Kumar V, 2017, CANCER CELL, V32, P654, DOI 10.1016/j.ccell.2017.10.005; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Natale CA, 2018, ELIFE, V7, DOI 10.7554/eLife.31770; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rech AJ, 2018, CANCER IMMUNOL RES, V6, P276, DOI 10.1158/2326-6066.CIR-17-0559; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sedlazeck FJ, 2013, BIOINFORMATICS, V29, P2790, DOI 10.1093/bioinformatics/btt468; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2016, P NATL ACAD SCI USA, V113, pE7759, DOI 10.1073/pnas.1609376113; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Stromnes IM, 2017, CANCER IMMUNOL RES, V5, P978, DOI 10.1158/2326-6066.CIR-16-0322; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wang GC, 2016, CANCER DISCOV, V6, P80, DOI 10.1158/2159-8290.CD-15-0224; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Welte T, 2016, NAT CELL BIOL, V18, P632, DOI 10.1038/ncb3355; Winograd R, 2015, CANCER IMMUNOL RES, V3, P399, DOI 10.1158/2326-6066.CIR-14-0215; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654	59	250	254	8	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					178	+		10.1016/j.immuni.2018.06.006	http://dx.doi.org/10.1016/j.immuni.2018.06.006			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	29958801	Green Accepted, Bronze			2022-12-18	WOS:000438949100020
J	Ochiai, K; Maienschein-Cline, M; Simonetti, G; Chen, JJ; Rosenthal, R; Brink, R; Chong, AS; Klein, U; Dinner, AR; Singh, H; Sciammas, R				Ochiai, Kyoko; Maienschein-Cline, Mark; Simonetti, Giorgia; Chen, Jianjun; Rosenthal, Rebecca; Brink, Robert; Chong, Anita S.; Klein, Ulf; Dinner, Aaron R.; Singh, Harinder; Sciammas, Roger			Transcriptional Regulation of Germinal Center B and Plasma Cell Fates by Dynamical Control of IRF4	IMMUNITY			English	Article							GRADED EXPRESSION; LYMPHOCYTE; NETWORK; REQUIREMENT; MEMORY	The transcription factor IRF4 regulates immunoglobulin class switch recombination and plasma cell differentiation. Its differing concentrations appear to regulate mutually antagonistic programs of B and plasma cell gene expression. We show IRF4 to be also required for generation of germinal center (GC) B cells. Its transient expression in vivo induced the expression of key GC genes including Bcl6 and Aicda. In contrast, sustained and higher concentrations of IRF4 promoted the generation of plasma cells while antagonizing the GC fate. IRF4 cobound with the transcription factors PU.1 or BATF to Ets or AP-1 composite motifs, associated with genes involved in B cell activation and the GC response. At higher concentrations, IRF4 binding shifted to interferon sequence response motifs; these enriched for genes involved in plasma cell differentiation. Our results support a model of "kinetic control'' in which signaling-induced dynamics of IRF4 in activated B cells control their cell-fate outcomes.	[Ochiai, Kyoko; Singh, Harinder] Univ Chicago, Dept Mol Genet, Chicago, IL 60637 USA; [Ochiai, Kyoko; Singh, Harinder] Univ Chicago, Dept Cell Biol, Chicago, IL 60637 USA; [Maienschein-Cline, Mark; Dinner, Aaron R.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Chen, Jianjun; Rosenthal, Rebecca; Chong, Anita S.; Sciammas, Roger] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Simonetti, Giorgia; Klein, Ulf] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Dept Pathol, New York, NY 10032 USA; [Simonetti, Giorgia; Klein, Ulf] Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; [Simonetti, Giorgia; Klein, Ulf] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA; [Brink, Robert] Garvan Inst Med Res, Immunol Res Program, Darlinghurst, NSW 2010, Australia; [Singh, Harinder] Genentech Inc, Discovery Immunol, San Francisco, CA 94080 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Columbia University; Columbia University; Columbia University; Garvan Institute of Medical Research; Roche Holding; Genentech	Singh, H (corresponding author), Univ Chicago, Dept Mol Genet, Chicago, IL 60637 USA.	singh.harinder@gene.com; rsciamma@uchicago.edu	Brink, Robert/B-7910-2010; Simonetti, Giorgia/AAB-3071-2021	Brink, Robert/0000-0002-9586-3655; Simonetti, Giorgia/0000-0001-6954-969X	Howard Hughes Medical Institute; US Department of Energy (DOE) Computational Science Graduate Fellowship Program; CLL Global Research Foundation; National Institutes of Health [P50, GM081892]; National Kidney Foundation; IL Division; Illinois Department of Public Health, Juvenile Diabetes and Islet Transplantation Research Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US Department of Energy (DOE) Computational Science Graduate Fellowship Program(United States Department of Energy (DOE)); CLL Global Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; IL Division; Illinois Department of Public Health, Juvenile Diabetes and Islet Transplantation Research Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q. Wang and J. Harakh for animal husbandry and injections. We thank the UC Flow Cytometry Core Facility and the Bendelac laboratory for assistance with cell sorting and analysis, respectively. We are grateful to K. Michelini and J. Zekos for operating the Illumina Genome Analyzer II at the University of Chicago (supported by the Howard Hughes Medical Institute). Research was supported by the US Department of Energy (DOE) Computational Science Graduate Fellowship Program (M. M.-C.), CLL Global Research Foundation (U. K.), the National Institutes of Health (P50, GM081892 to A. R. D. and H. S.), the National Kidney Foundation, IL Division and the Illinois Department of Public Health, Juvenile Diabetes and Islet Transplantation Research Grant (R.S.).	Alinikula J, 2011, EUR J IMMUNOL, V41, P2404, DOI 10.1002/eji.201141553; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Corcoran LM, 2005, J EXP MED, V201, P1385, DOI 10.1084/jem.20042325; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; Garrett-Sinha LA, 2001, BLOOD, V97, P2908, DOI 10.1182/blood.V97.9.2908; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Maienschein-Cline M, 2012, BIOINFORMATICS, V28, P206, DOI 10.1093/bioinformatics/btr628; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2005, J IMMUNOL, V174, P4567, DOI 10.4049/jimmunol.174.8.4567; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sciammas R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.25; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032	28	250	251	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					918	929		10.1016/j.immuni.2013.04.009	http://dx.doi.org/10.1016/j.immuni.2013.04.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23684984	Bronze, Green Accepted			2022-12-18	WOS:000330942500011
J	Feyerabend, TB; Weiser, A; Tietz, A; Stassen, M; Harris, N; Kopf, M; Radermacher, P; Moller, P; Benoist, C; Mathis, D; Fehling, HJ; Rodewald, HR				Feyerabend, Thorsten B.; Weiser, Anne; Tietz, Annette; Stassen, Michael; Harris, Nicola; Kopf, Manfred; Radermacher, Peter; Moeller, Peter; Benoist, Christophe; Mathis, Diane; Fehling, Hans Joerg; Rodewald, Hans-Reimer			Cre-Mediated Cell Ablation Contests Mast Cell Contribution in Models of Antibody- and T Cell-Mediated Autoimmunity	IMMUNITY			English	Article							IN-VIVO; C-KIT; CARBOXYPEPTIDASE-A; MURINE MODEL; W-SH; MICE; RECEPTOR; DISEASE; EXPRESSION; DEFICIENCY	Immunological functions of mast cells remain poorly understood. Studies in Kit mutant mice suggest key roles for mast cells in certain antibody- and T cell-mediated autoimmune diseases. However, Kit mutations affect multiple cell types of both immune and nonimmune origin. Here, we show that targeted insertion of Cre-recombinase into the mast cell carboxypeptidase A3 locus deleted mast cells in connective and mucosal tissues by a genotoxic Trp53-dependent mechanism. Ore-mediated mast cell eradication (Ore-Master) mice had, with the exception of a lack of mast cells and reduced basophils, a normal immune system. Ore-Master mice were refractory to IgE-mediated anaphylaxis, and this defect was rescued by mast cell reconstitution. This mast cell-deficient strain was fully susceptible to antibody-induced autoimmune arthritis and to experimental autoimmune encephalomyelitis. Differences comparing Kit mutant mast cell deficiency models to selectively mast cell-deficient mice call for a systematic re-evaluation of immunological functions of mast cells beyond allergy.	[Feyerabend, Thorsten B.; Weiser, Anne; Rodewald, Hans-Reimer] Deutsch Krebsforschungszentrum DKFZ, Div Cellular Immunol, D-69120 Heidelberg, Germany; [Feyerabend, Thorsten B.; Weiser, Anne; Tietz, Annette; Fehling, Hans Joerg; Rodewald, Hans-Reimer] Univ Ulm, Inst Immunol, D-89081 Ulm, Germany; [Radermacher, Peter] Univ Ulm, Anesthesiol Clin, D-89081 Ulm, Germany; [Moeller, Peter] Univ Ulm, Inst Pathol, D-89081 Ulm, Germany; [Stassen, Michael] Johannes Gutenberg Univ Mainz, Inst Immunol, D-55131 Mainz, Germany; [Harris, Nicola] Ecole Polytech Fed Lausanne, Swiss Vaccine Res Inst, CH-1015 Lausanne, Switzerland; [Harris, Nicola] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Kopf, Manfred] Swiss Fed Inst Technol, Inst Integrat Biol, CH-8952 Zurich, Switzerland; [Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Ulm University; Ulm University; Johannes Gutenberg University of Mainz; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; Harvard Medical School	Rodewald, HR (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Div Cellular Immunol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	hr.rodewald@dkfz.de	harris, nicola/E-5342-2019; Kopf, Manfred/B-6907-2009	harris, nicola/0000-0003-2922-0210; Kopf, Manfred/0000-0002-0628-7140	ERC [233074]; DFG [754-2-3]; SFB 938-project; Medical Faculty Ulm [ETH 0-20400-07, R01 AR055271]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055271] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); SFB 938-project; Medical Faculty Ulm; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank C. Blum for blastocyst injections; C. Haber, N. Maltry, and S. Schafer for technical assistance; S. Henze, T. Schmidt, and O. Heil (DKFZ Microarray Core Facility) for mRNA analyses; A. Benner (DKFZ Biostatistics) for statistical analyses; M. Feuerer and M. Teichert for heat maps; K. Greulich-Bode for karyotype analysis; M. Reth for discussions on genotoxity: M. Gurish for advice on progenitor isolation; A. Roers for sharing unpublished data; and V. Martins and S. Schlenner for comments on the manuscript. This work was supported by the ERC (Advanced Grant 233074), DFG (754-2-3), and SFB 938-project L to H.-R.R., a grant for A.W. from the Medical Faculty Ulm, awarded to T.B.F., ETH 0-20400-07 to M.K., and R01 AR055271 to C.B. and D.M. T.B.F. and H-RH. filed a patent on Cre-driven mast cell eradication.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Albuszies G, 2005, CRIT CARE MED, V33, P2332, DOI 10.1097/01.CCM.0000182817.20977.E9; Aoki H, 2009, DEVELOPMENT, V136, P2511, DOI 10.1242/dev.037168; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Bennett JL, 2009, J IMMUNOL, V182, P5507, DOI 10.4049/jimmunol.0801485; Benoist C, 2002, NATURE, V420, P875, DOI 10.1038/nature01324; Berrozpe G, 1999, BLOOD, V94, P2658, DOI 10.1182/blood.V94.8.2658.420k23_2658_2666; BESMER P, 1993, DEVELOPMENT, P125; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; de Vries VC, 2010, CURR OPIN IMMUNOL, V22, P643, DOI 10.1016/j.coi.2010.08.015; Di Santo JP, 1998, CURR OPIN IMMUNOL, V10, P196, DOI 10.1016/S0952-7915(98)80249-5; Dietrich N, 2010, P NATL ACAD SCI USA, V107, P8748, DOI 10.1073/pnas.0912551107; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; FLEISCHMAN RA, 1993, TRENDS GENET, V9, P285, DOI 10.1016/0168-9525(93)90015-A; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Frossi B, 2010, TRENDS IMMUNOL, V31, P97, DOI 10.1016/j.it.2009.12.007; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; GORDON JR, 1990, BLOOD, V75, P1637; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Jacobs JP, 2010, ARTHRITIS RHEUM-US, V62, P1921, DOI 10.1002/art.27470; KALINER MA, 1979, NEW ENGL J MED, V301, P498, DOI 10.1056/NEJM197908303010910; KITAMURA Y, 1978, BLOOD, V52, P447; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Kovanen PT, 2009, CURR ATHEROSCLER REP, V11, P214, DOI 10.1007/s11883-009-0033-7; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Mancardi DA, 2011, J IMMUNOL, V186, P1899, DOI 10.4049/jimmunol.1003642; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Musch W, 2008, GENESIS, V46, P163, DOI 10.1002/dvg.20378; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Peters EMJ, 2002, J HISTOCHEM CYTOCHEM, V50, P751, DOI 10.1177/002215540205000602; REYNOLDS DS, 1989, J BIOL CHEM, V264, P20094; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Sayed BA, 2008, ANNU REV IMMUNOL, V26, P705, DOI 10.1146/annurev.immunol.26.021607.090320; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tsai M, 2005, CHEM IMMUNOL ALLERGY, V87, P179, DOI 10.1159/000087644; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Waskow C, 2007, BLOOD, V109, P5363, DOI 10.1182/blood-2006-08-039131; Waskow C, 2009, NAT METHODS, V6, P267, DOI [10.1038/NMETH.1309, 10.1038/nmeth.1309]; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391	58	250	251	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					832	844		10.1016/j.immuni.2011.09.015	http://dx.doi.org/10.1016/j.immuni.2011.09.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22101159	Bronze			2022-12-18	WOS:000297390800021
J	Kabashima, K; Banks, TA; Ansel, KM; Lu, TT; Ware, CF; Cyster, JG				Kabashima, K; Banks, TA; Ansel, KM; Lu, TT; Ware, CF; Cyster, JG			Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells	IMMUNITY			English	Article							FOLLICULAR STROMAL CELLS; TUMOR-NECROSIS-FACTOR; BONE-MARROW; ALPHA-BETA; T-CELLS; IN-VIVO; LANGERHANS CELLS; FAMILY-MEMBER; LIFE-SPAN; MOUSE	The factors regulating dendritic cell (DC) development and homeostasis are incompletely understood. Here, we demonstrate that DCs express the lymphotoxin (LT)-beta receptor (LT beta R) and that in mice lacking the LT beta R in hematopoietic cells, spleen, and lymph node, CD8(-) DC numbers are reduced. B cells are a key source of LT alpha 1 beta 2 for splenic DC homeostasis, and transgenic overexpression of LT alpha 1 beta 2 on B cells leads to expansion of the CD8- DC compartment. Furthermore, we find that about 5% of splenic DCs are undergoing cell division, and the number of dividing CD8- DCs is disproportionately reduced in the absence of the LT beta R. In parabiosis experiments, splenic DCs were only partially replaced by circulating precursors over a 6 week period. We conclude that LT alpha 1 beta 2 acts on DCs or DC precursors to promote DC homeostasis, and we suggest that DC proliferation is an important pathway for locally maintaining these cells in the steady state.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; La Jolla Institute for Immunology	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	cyster@itsa.ucsf.edu	; Kabashima, Kenji/G-2521-2014	Lu, Theresa/0000-0002-5707-8744; Kabashima, Kenji/0000-0002-0773-0554	NCI NIH HHS [CA69381] Funding Source: Medline; NIAID NIH HHS [AI45073, AI48073, AI33068] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033068, R01AI033068, R01AI148073, R01AI048073, R01AI045073] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abe K, 2003, BLOOD, V101, P1477, DOI 10.1182/blood.V101.4.1477; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Ardavin C, 2003, NAT REV IMMUNOL, V3, P582, DOI 10.1038/nri1127; Berger DP, 1999, VIROLOGY, V260, P136, DOI 10.1006/viro.1999.9811; Browning JL, 1997, J IMMUNOL, V159, P3288; Browning JL, 2002, J IMMUNOL, V168, P5079, DOI 10.4049/jimmunol.168.10.5079; Castglioni P, 2002, SCAND J IMMUNOL, V56, P219, DOI 10.1046/j.1365-3083.2002.01144.x; Crowley MT, 1999, J IMMUNOL, V163, P4894; Cyster JG, 2000, IMMUNOL REV, V176, P181; CZERNIELEWSKI JM, 1987, J INVEST DERMATOL, V88, P17, DOI 10.1111/1523-1747.ep12464659; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; del Hoyo GM, 2002, BLOOD, V99, P999, DOI 10.1182/blood.V99.3.999; Diao J, 2004, J IMMUNOL, V173, P1826, DOI 10.4049/jimmunol.173.3.1826; Ehlers S, 2003, J IMMUNOL, V170, P5210, DOI 10.4049/jimmunol.170.10.5210; FORCE WR, 1995, J IMMUNOL, V155, P5280; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Gommerman JL, 2003, J CLIN INVEST, V112, P755, DOI 10.1172/JCI200318648; Goto Y, 2003, AM J PHYSIOL-CELL PH, V285, pC253, DOI 10.1152/ajpcell.00035.2003; Gramaglia I, 1999, J IMMUNOL, V162, P1333; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kumaraguru U, 2001, J IMMUNOL, V166, P1066, DOI 10.4049/jimmunol.166.2.1066; Leon B, 2004, BLOOD, V103, P2668, DOI 10.1182/blood-2003-01-0286; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Mackay F, 1997, J IMMUNOL, V159, P3299; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Morel Y, 2001, J IMMUNOL, V167, P2479, DOI 10.4049/jimmunol.167.5.2479; Murphy M, 1998, CELL DEATH DIFFER, V5, P497, DOI 10.1038/sj.cdd.4400374; Naik S, 2003, BLOOD, V102, P601, DOI 10.1182/blood-2002-10-3186; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Ohshima Y, 1999, J IMMUNOL, V162, P3790; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Shortman K, 2004, NAT IMMUNOL, V5, P1105, DOI 10.1038/ni1104-1105; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Stopfer P, 2004, J IMMUNOL, V172, P7459, DOI 10.4049/jimmunol.172.12.7459; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Wang J, 2002, EUR J IMMUNOL, V32, P1969, DOI 10.1002/1521-4141(200207)32:7<1969::AID-IMMU1969>3.0.CO;2-M; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; Wilson HL, 2000, P NATL ACAD SCI USA, V97, P4784, DOI 10.1073/pnas.080278897; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wu Q, 1999, J EXP MED, V190, P629, DOI 10.1084/jem.190.5.629; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130	57	250	255	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2005	22	4					439	450		10.1016/j.immuni.2005.02.007	http://dx.doi.org/10.1016/j.immuni.2005.02.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	923KU	15845449	Bronze			2022-12-18	WOS:000228909600006
J	Martinvalet, D; Zhu, PC; Lieberman, J				Martinvalet, D; Zhu, PC; Lieberman, J			Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis	IMMUNITY			English	Article							CYTOCHROME-C RELEASE; SERINE-PROTEASE OMI/HTRA2; FAS-MEDIATED APOPTOSIS; CELL-DEATH; PERMEABILITY TRANSITION; SUPEROXIDE-DISMUTASE; DNA FRAGMENTATION; ENDONUCLEASE-G; ACTIVATION; INDUCTION	Granzyme A (GzmA) triggers cell death with apoptotic features by targeting the endoplasmic reticulum-associated SET complex, which contains the GzmA-activated DNase NM23-H1, its inhibitor SET, and Ape1. The SET complex was postulated to translocate to the nucleus in response to oxidative stress and participate in its repair. Because mitochondrial damage is important in apoptosis, we investigated whether GzmA damages mitochondria. GzmA induces a rapid increase in reactive oxygen species and mitochondrial transmembrane potential loss, but does not cleave bid or cause apoptogenic factor release. The mitochondrial effect is direct, does not require cytosol, and is insensitive to bcl-2 and caspase inhibition. SET complex nuclear translocation, which occurs within minutes of peroxide or GzmA treatment, is dependent on superoxide generation since superoxide scavengers block it. Superoxide scavengers also block apoptosis by CTLs expressing GzmA and/or GzmB. Therefore, mitochondrial damage is an essential first step in killer cell granule-mediated pathways of apoptosis.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Lieberman, Judy/A-2717-2015		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045587, R01AI045587] Funding Source: NIH RePORTER; NIAID NIH HHS [AI45587] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Aronis A, 2003, CELL DEATH DIFFER, V10, P335, DOI 10.1038/sj.cdd.4401150; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Beresford PJ, 1997, P NATL ACAD SCI USA, V94, P9285, DOI 10.1073/pnas.94.17.9285; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; CHANG DJ, 1992, BIOCHEM BIOPH RES CO, V188, P538, DOI 10.1016/0006-291X(92)91089-9; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Friedman RS, 2000, J VIROL, V74, P9987, DOI 10.1128/JVI.74.21.9987-9993.2000; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Heibein JA, 1999, J IMMUNOL, V163, P4683; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Jans DA, 1998, J CELL SCI, V111, P2645; Johnson H, 2003, BLOOD, V101, P3093, DOI 10.1182/blood-2002-08-2485; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krippner A, 1996, J BIOL CHEM, V271, P21629, DOI 10.1074/jbc.271.35.21629; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lieberman J, 2003, CURR OPIN IMMUNOL, V15, P553, DOI 10.1016/S0952-7915(03)00108-0; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Ma DQ, 2002, J BIOL CHEM, V277, P1560, DOI 10.1074/jbc.M108359200; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Malassagne B, 2001, GASTROENTEROLOGY, V121, P1451, DOI 10.1053/gast.2001.29590; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; SANDSTROM PA, 1994, J LEUKOCYTE BIOL, V55, P221, DOI 10.1002/jlb.55.2.221; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shi LF, 2000, METHOD ENZYMOL, V322, P125; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Susin SA, 2000, METHOD ENZYMOL, V322, P205; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; TORIGOE T, 1994, CANCER RES, V54, P4851; van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944; van Loo G, 2002, CELL DEATH DIFFER, V9, P20, DOI 10.1038/sj.cdd.4400970; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zamzami N, 1996, FEBS LETT, V384, P53, DOI 10.1016/0014-5793(96)00280-3; Zhang D, 2001, P NATL ACAD SCI USA, V98, P5746, DOI 10.1073/pnas.101329598; Zhang D, 2001, J BIOL CHEM, V276, P3683, DOI 10.1074/jbc.M005390200	58	250	258	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2005	22	3					355	370		10.1016/j.immuni.2005.02.004	http://dx.doi.org/10.1016/j.immuni.2005.02.004			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP	15780992	Bronze			2022-12-18	WOS:000228105700010
J	vanOers, NSC; LowinKropf, B; Finlay, D; Connolly, K; Weiss, A				vanOers, NSC; LowinKropf, B; Finlay, D; Connolly, K; Weiss, A			alpha beta T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases	IMMUNITY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; THYMOCYTE DEVELOPMENT; MUTANT MICE; NEGATIVE SELECTION; THYMIC SELECTION; ANTIGEN RECEPTOR; DEFICIENT MICE; TCR-ZETA; EXPRESSION; ZAP-70	Two families of protein tyrosine kinases (PTKs), the Src and Syk/ZAP-70 families, are required for T cell development. Lck is the major Src family member required for thymopoiesis, since there is a severe deficit of CD4(+)CD8(+) thymocytes and mature T cells in its absence. However, some peripheral T cells are evident in these mice, suggesting that additional PTKs may contribute to T cell development. Here we show that the combined disruption of Lck and Fyn (lck(-/-)fyn(-/-)) completely arrests alpha beta T cell development at the CD4(-)CD8(-) stage. The development of V gamma 3(+) dendritic epidermal T cells is also severely impaired, but natural killer cell development and cytolytic activity is unaffected in lck(-/-)fyn(-/-) mice. These findings reveal the potential for redundant functions mediated by Src family PTKs while emphasizing crucial roles for Lck and Fyn in T cell development.	UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT DERMATOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco			Van+Oers, Nicolai/ABA-2437-2021	van Oers, Nicolai/0000-0002-6545-8405	NIGMS NIH HHS [GM-39553] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039553] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON SJ, 1995, IMMUNOL TODAY, V16, P99, DOI 10.1016/0167-5699(95)80096-4; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; BERGSTRESSER PR, 1980, J INVEST DERMATOL, V74, P77, DOI 10.1111/1523-1747.ep12519909; BIONDI A, 1991, EUR J IMMUNOL, V21, P843, DOI 10.1002/eji.1830210348; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1994, J IMMUNOL, V152, P4758; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; EISEMAN E, 1990, CANCER CELL-MON REV, V2, P303; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, J IMMUNOL, V150, P4244; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; KAWAI K, 1995, J EXP MED, V181, P345, DOI 10.1084/jem.181.1.345; LEVELT CN, 1995, IMMUNITY, V3, P215, DOI 10.1016/1074-7613(95)90091-8; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; OLSZOWY MW, 1995, J IMMUNOL, V155, P4236; PENNINGER J, 1993, SCIENCE, V260, P358, DOI 10.1126/science.8469988; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SECKINGER P, 1994, J IMMUNOL, V153, P97; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; VANOERS NSC, 1995, J EXP MED, V182, P1585, DOI 10.1084/jem.182.5.1585; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Vicari AP, 1996, IMMUNOL TODAY, V17, P71, DOI 10.1016/0167-5699(96)80582-2; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEN T, 1995, EUR J IMMUNOL, V25, P3155, DOI 10.1002/eji.1830251125; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355	45	250	251	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1996	5	5					429	436		10.1016/S1074-7613(00)80499-9	http://dx.doi.org/10.1016/S1074-7613(00)80499-9			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VV658	8934570	Bronze			2022-12-18	WOS:A1996VV65800004
J	Bailey-Bucktrout, SL; Martinez-Llordella, M; Zhou, XY; Anthony, B; Rosenthal, W; Luche, H; Fehling, HJ; Bluestone, JA				Bailey-Bucktrout, Samantha L.; Martinez-Llordella, Marc; Zhou, Xuyu; Anthony, Bryan; Rosenthal, Wendy; Luche, Herve; Fehling, Hans J.; Bluestone, Jeffrey A.			Self-antigen-Driven Activation Induces Instability of Regulatory T Cells during an Inflammatory Autoimmune Response	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; VERSUS-HOST-DISEASE; IN-VIVO; REG-CELLS; EXPRESSION; RECEPTOR; LINEAGE; DIFFERENTIATION; STABILITY; MEMORY	Stable Foxp3 expression is crucial for regulatory T (Treg) cell function. We observed that antigen-driven activation and inflammation in the CNS promoted Foxp3 instability selectively in the autoreactive Treg cells that expressed high amounts of Foxp3 before experimental autoimmune encephalitis induction. Treg cells with a demethylated Treg-cell-specific demethylated region in the Foxp3 locus downregulated Foxp3 transcription in the inflamed CNS during the induction phase of the response. Stable Foxp3 expression returned at the population level with the resolution of inflammation or was rescued by IL-2-anti-IL-2 complex treatment during the antigen priming phase. Thus, a subset of fully committed self-antigen-specific Treg cells lost Foxp3 expression during an inflammatory autoimmune response and might be involved in inadequate control of autoimmunity. These results have important implications for Treg cell therapies and give insights into the dynamics of the Treg cell network during autoreactive CD4(+) T cell effector responses in vivo.	[Bailey-Bucktrout, Samantha L.; Martinez-Llordella, Marc; Rosenthal, Wendy; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Zhou, Xuyu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100864, Peoples R China; [Anthony, Bryan] Washington Univ, St Louis, MO 63104 USA; [Luche, Herve; Fehling, Hans J.] Univ Clin Ulm, Inst Immunol, D-8901 Ulm, Germany	University of California System; University of California San Francisco; Chinese Academy of Sciences; Institute of Microbiology, CAS; Washington University (WUSTL); Ulm University	Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	jeff.bluestone@ucsf.edu	LUCHE, Herve/GLT-1401-2022; Zhou, Xuyu/L-7422-2019	Zhou, Xuyu/0000-0002-6626-0898; LUCHE, Herve/0000-0003-4309-8338	NIH [R01 AI50834, RO1 AI46643, P01 AI35297, P30DK63720]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI102011, P01AI035297, R01AI050834, R01AI046643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Lee, S. Jiang, and J. Paw for technical assistance; D. Fuentes for animal husbandry; Alexander Rudensky for the Foxp3-YFP-Cre mice; the National Institutes of Health (NIH) Emory Tetramer Facility for providing I-Ab tetramers; and A. Abbas, Q. Tang, H. Bour-Jordan, M. Anderson, and members of the Bluestone laboratory for discussions. This work was supported by the NIH (R01 AI50834, RO1 AI46643, P01 AI35297, P30DK63720).	Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Bailey-Bucktrout SL, 2011, TRENDS IMMUNOL, V32, P301, DOI 10.1016/j.it.2011.04.002; Barron L, 2010, J IMMUNOL, V185, P6426, DOI 10.4049/jimmunol.0903940; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Laurence A, 2012, IMMUNITY, V37, P209, DOI 10.1016/j.immuni.2012.05.027; Long SA, 2012, DIABETES, V61, P2340, DOI 10.2337/db12-0049; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Vanderlugt CL, 2000, J IMMUNOL, V164, P670, DOI 10.4049/jimmunol.164.2.670; VanValkenburgh J, 2011, J EXP MED, V208, P2069, DOI 10.1084/jem.20102683; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	54	249	254	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					949	962		10.1016/j.immuni.2013.10.016	http://dx.doi.org/10.1016/j.immuni.2013.10.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24238343	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000330950600016
J	Zhou, TQ; Zhu, J; Wu, XL; Moquin, S; Zhang, BS; Acharya, P; Georgiev, IS; Altae-Tran, HR; Chuang, GY; Joyce, MG; Do Kwon, Y; Longo, NS; Louder, MK; Luongo, T; McKee, K; Schramm, CA; Skinner, J; Yang, YP; Yang, ZJ; Zhang, ZH; Zheng, AQ; Bonsignori, M; Haynes, BF; Scheid, JF; Nussenzweig, MC; Simek, M; Burton, DR; Koff, WC; Mullikin, JC; Connors, M; Shapiro, L; Nabel, GJ; Mascola, JR; Kwong, PD				Zhou, Tongqing; Zhu, Jiang; Wu, Xueling; Moquin, Stephanie; Zhang, Baoshan; Acharya, Priyamvada; Georgiev, Ivelin S.; Altae-Tran, Han R.; Chuang, Gwo-Yu; Joyce, M. Gordon; Do Kwon, Young; Longo, Nancy S.; Louder, Mark K.; Luongo, Timothy; McKee, Krisha; Schramm, Chaim A.; Skinner, Jeff; Yang, Yongping; Yang, Zhongjia; Zhang, Zhenhai; Zheng, Anqi; Bonsignori, Mattia; Haynes, Barton F.; Scheid, Johannes F.; Nussenzweig, Michel C.; Simek, Melissa; Burton, Dennis R.; Koff, Wayne C.; Mullikin, James C.; Connors, Mark; Shapiro, Lawrence; Nabel, Gary J.; Mascola, John R.; Kwong, Peter D.		NISC Comparative Sequencing Progra	Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies	IMMUNITY			English	Article							VACCINE EFFICACY; CD4-BINDING SITE; BINDING-SITE; VIRUS; BROAD; ENVELOPE; PROTEIN; PROTECTION; EVOLUTION; SEQUENCE	Antibodies of the VRC01 class neutralize HIV-1, arise in diverse HIV-1-infected donors, and are potential templates for an effective HIV-1 vaccine. However, the stochastic processes that generate repertoires in each individual of >10(12) antibodies make elicitation of specific antibodies uncertain. Here we determine the ontogeny of the VRC01 class by crystallography and next-generation sequencing. Despite antibody-sequence differences exceeding 50%, antibody-gp120 cocrystal structures reveal VRC01-class recognition to be remarkably similar. B cell transcripts indicate that VRC01-class antibodies require few specific genetic elements, suggesting that naive-B cells with VRC01-class features are generated regularly by recombination. Virtually all of these fail to mature, however, with only a few-likely one-ancestor B cell expanding to form a VRC01-class lineage in each donor. Developmental similarities in multiple donors thus reveal the generation of VRC01-class antibodies to be reproducible in principle, thereby providing a framework for attempts to elicit similar antibodies in the general population.	[Zhou, Tongqing; Zhu, Jiang; Wu, Xueling; Moquin, Stephanie; Zhang, Baoshan; Acharya, Priyamvada; Georgiev, Ivelin S.; Altae-Tran, Han R.; Chuang, Gwo-Yu; Joyce, M. Gordon; Do Kwon, Young; Longo, Nancy S.; Louder, Mark K.; Luongo, Timothy; McKee, Krisha; Yang, Yongping; Yang, Zhongjia; Zheng, Anqi; Shapiro, Lawrence; Nabel, Gary J.; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Skinner, Jeff] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20892 USA; [Connors, Mark] NIAID, Lab Immunoregulat, NIH, Bethesda, MD 20892 USA; [Mullikin, James C.; NISC Comparative Sequencing Progra] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Schramm, Chaim A.; Zhang, Zhenhai; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Bonsignori, Mattia; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Bonsignori, Mattia; Haynes, Barton F.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Scheid, Johannes F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Simek, Melissa; Koff, Wayne C.] Int AIDS Vaccine Initiat, New York, NY 10038 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Design, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Columbia University; Duke University; Duke University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; International AIDS Vaccine Initiative; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jmascola@nih.gov; pdkwong@nih.gov	Bonsignori, Mattia/AAE-7678-2019; Zhang, Zhenhai/GRX-5887-2022; Shapiro, Lawrence/AAE-7172-2019; Zhou, Tongqing/A-6880-2010; Luongo, Timothy/AAY-1073-2020; Nussenzweig, Michel/AAE-7292-2019; Mascola, John/AAI-7193-2021; Do Kwon, Young/A-6957-2010	Bonsignori, Mattia/0000-0003-2973-2101; Zhang, Zhenhai/0000-0002-4310-0525; Zhou, Tongqing/0000-0002-3935-4637; Do Kwon, Young/0000-0002-1188-7458; Skinner, Jeff/0000-0001-5697-0442; Moquin, Stephanie/0000-0002-8696-4315; Acharya, Priyamvada/0000-0002-0089-277X; Luongo, Timothy/0000-0001-7621-7992	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute, National Institutes of Health; International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; Center for HIV/AIDS Vaccine Immunology Grant from the National Institutes from Health [AI 5U19 AI 067854-06]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005111, T32AI070084, ZIAAI005095, U19AI067854, ZIAAI005022, ZICAI005112, ZIAAI001090] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; Center for HIV/AIDS Vaccine Immunology Grant from the National Institutes from Health; US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Coleman, M. Park, B. Schmidt, and A. Young for 454 pyrosequencing at the NIH Intramural Sequencing Center (NISC), J. Stuckey for assistance with figures, and the study participants and research staff at each of the Protocol G clinical centers, the Protocol G team members, the IAVI Human Immunology Laboratory and the Protocol G clinical investigators, including George Miiro, Anton Pozniak, Dale McPhee, Olivier Manigart, Etienne Karita, Andre Inwoley, Walter Jaoko, Jack DeHovitz, Linda-Gail Bekker, Punnee Pitisuttithum, Robert Paris, Jennifer Serwanga, and Susan Allen. We also thank Anthony West and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions or comments on the manuscript. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases and the National Human Genome Research Institute, National Institutes of Health, and by grants from the International AIDS Vaccine Initiative's Neutralizing Antibody Consortium and by the Center for HIV/AIDS Vaccine Immunology Grant AI 5U19 AI 067854-06 from the National Institutes from Health. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feeney AJ, 2000, IMMUNOL REV, V175, P59, DOI 10.1111/j.1600-065X.2000.imr017508.x; Gilbert PB, 2011, J INFECT DIS, V203, P969, DOI 10.1093/infdis/jiq152; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Kabat EA, 1991, SEQUENCES PROTEINS I; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul W., 1999, FUNDAMENTAL IMMUNOLO; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Shu Y, 2007, VACCINE, V25, P1398, DOI 10.1016/j.vaccine.2006.10.046; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	34	249	253	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					245	258		10.1016/j.immuni.2013.04.012	http://dx.doi.org/10.1016/j.immuni.2013.04.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23911655	Green Accepted, Bronze			2022-12-18	WOS:000330948800008
J	Lloyd, CM; Hawrylowicz, CM				Lloyd, Clare M.; Hawrylowicz, Catherine M.			Regulatory T Cells in Asthma	IMMUNITY			English	Review							INDUCED AIRWAY HYPERREACTIVITY; VITAMIN-D SUPPLEMENTATION; TGF-BETA; IMMUNE DYSREGULATION; INHALED ANTIGEN; ALLERGIC-ASTHMA; DENDRITIC CELLS; IN-VIVO; PEPTIDE IMMUNOTHERAPY; ALVEOLAR MACROPHAGES	Asthma is characterized by T helper cell 2 (Th2) type inflammation, leading to airway hyperresponsiveness and tissue remodeling. Th2 cell-driven inflammation is likely to represent an abnormal response to harmless airborne particles. These reactions are normally suppressed by regulatory T cells, which maintain airway tolerance. The anti-inflammatory cytokine IL-10 is likely to play a central role. The role of the cytokine transforming growth factor beta (TGF-beta) is more complex, with evidence for immune suppression and remodeling in the airways. In asthmatic individuals there is a breakdown in these regulatory mechanisms. There is emerging evidence that early life events, including exposure to allergen and infections, are critical in programming effective regulatory pathways to maintain pulmonary homeostasis. In this review we examine the clinical and experimental evidence for T regulatory cell function in the lung and discuss the events that might influence the functioning of these cells. Ultimately, the ability to enhance regulatory function in affected individuals may represent an effective treatment for asthma.	[Lloyd, Clare M.] Univ London Imperial Coll Sci Technol & Med, MRC, London SW7 2AZ, England; [Lloyd, Clare M.] Univ London Imperial Coll Sci Technol & Med, Asthma UK Ctr Allerg Mech Asthma, NHLI, London SW7 2AZ, England; [Hawrylowicz, Catherine M.] Kings Coll London, MRC, London SE1 9RT, England; [Hawrylowicz, Catherine M.] Kings Coll London, Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England	Imperial College London; Imperial College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Lloyd, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, London SW7 2AZ, England.	c.lloyd@imperial.ac.uk; catherine.hawrylowicz@kcl.ac.uk	Hawrylowicz, Catherine/Q-8483-2017	Hawrylowicz, Catherine/0000-0002-2337-7463; Lloyd, Clare/0000-0001-8977-6726	Medical Research Council [G0400503B] Funding Source: researchfish; Wellcome Trust [087618, 057704] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Akdis M, 2007, J ALLERGY CLIN IMMUN, V119, P780, DOI 10.1016/j.jaci.2007.01.022; Ali FR, 2004, AM J RESP CRIT CARE, V169, P20, DOI 10.1164/rccm.200305-690OC; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Barrett NA, 2009, IMMUNITY, V31, P425, DOI 10.1016/j.immuni.2009.08.014; Blumenthal RL, 2001, J ALLERGY CLIN IMMUN, V107, P258, DOI 10.1067/mai.2001.112845; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Deniz G, 2008, J IMMUNOL, V180, P850, DOI 10.4049/jimmunol.180.2.850; Doherty T, 2007, CURR OPIN IMMUNOL, V19, P676, DOI 10.1016/j.coi.2007.07.017; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fattouh R, 2008, AM J RESP CRIT CARE, V177, P593, DOI 10.1164/rccm.200706-958OC; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gereke M, 2009, AM J RESP CRIT CARE, V179, P344, DOI 10.1164/rccm.200804-592OC; Gerhold K, 2006, J ALLERGY CLIN IMMUN, V118, P666, DOI 10.1016/j.jaci.2006.05.022; Goswami S, 2009, NAT IMMUNOL, V10, P496, DOI 10.1038/ni.1719; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Haddeland U, 2005, PEDIAT ALLERG IMM-UK, V16, P104, DOI 10.1111/j.1399-3038.2005.00250.x; Hansen G, 2000, J CLIN INVEST, V105, P61, DOI 10.1172/JCI7589; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Haselden BM, 1999, J EXP MED, V189, P1885, DOI 10.1084/jem.189.12.1885; Hawrylowicz C, 2002, J ALLERGY CLIN IMMUN, V109, P369, DOI 10.1067/mai.2002.121455; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; HOLT PG, 1981, IMMUNOLOGY, V42, P409; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Joetham A, 2007, J IMMUNOL, V178, P1433, DOI 10.4049/jimmunol.178.3.1433; John M, 1998, AM J RESP CRIT CARE, V157, P256, DOI 10.1164/ajrccm.157.1.9703079; Karagiannidis C, 2006, J ALLERGY CLIN IMMUN, V117, P111, DOI 10.1016/j.jaci.2005.09.017; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Kariyawasam HH, 2008, AM J RESP CRIT CARE, V177, P1074, DOI 10.1164/rccm.200709-1376OC; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Kearley J, 2008, J ALLERGY CLIN IMMUN, V122, P617, DOI 10.1016/j.jaci.2008.05.048; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Larche M, 2007, J ALLERGY CLIN IMMUN, V119, P906, DOI 10.1016/j.jaci.2007.02.015; Leech MD, 2007, J IMMUNOL, V179, P7050, DOI 10.4049/jimmunol.179.10.7050; Leggat JA, 2008, J ALLERGY CLIN IMMUN, V122, P1014, DOI 10.1016/j.jaci.2008.08.011; LELLEM A, 2001, J EXP MED, V194, P847; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lim S, 1998, LANCET, V352, P113, DOI 10.1016/S0140-6736(98)85018-6; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Lloyd CM, 2007, CURR ALLERGY ASTHM R, V7, P231, DOI 10.1007/s11882-007-0077-0; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Mahon BD, 2003, J NEUROIMMUNOL, V134, P128, DOI 10.1016/S0165-5728(02)00396-X; Makinde T, 2007, IMMUNOL CELL BIOL, V85, P348, DOI 10.1038/sj.icb.7100044; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Miller RL, 2008, J CLIN INVEST, V118, P3265, DOI 10.1172/JCI37171; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Nakao A, 2000, J EXP MED, V192, P151, DOI 10.1084/jem.192.2.151; Novak N, 2001, J IMMUNOL, V167, P797, DOI 10.4049/jimmunol.167.2.797; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Oh JW, 2002, J ALLERGY CLIN IMMUN, V110, P460, DOI 10.1067/mai.2002.127512; Ostroukhova M, 2004, J CLIN INVEST, V114, P28, DOI 10.1172/JC1200420509; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Pereira-Santos MC, 2008, CLIN EXP ALLERGY, V38, P291, DOI 10.1111/j.1365-2222.2007.02887.x; Polte T, 2008, J ALLERGY CLIN IMMUN, V122, P1022, DOI 10.1016/j.jaci.2008.09.014; PROVOOST S, 2009, ALLERGY IN PRESS, DOI DOI 10.1111/J.1398-9995.2009.02056.X; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Rao A, 2007, BLOOD, V109, P383, DOI 10.1182/blood-2006-05-025072; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Roifman CM, 2000, PEDIATR RES, V48, P6, DOI 10.1203/00006450-200007000-00004; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Ryanna K, 2009, ALLERGY, V64, P335, DOI 10.1111/j.1398-9995.2009.01972.x; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Schaub B, 2008, J ALLERGY CLIN IMMUN, V121, P1491, DOI 10.1016/j.jaci.2008.04.010; Scherf W, 2005, EUR J IMMUNOL, V35, P198, DOI 10.1002/eji.200425209; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Seidel MG, 2009, BLOOD, V113, P5689, DOI 10.1182/blood-2009-02-206359; Semitekolou M, 2009, J EXP MED, V206, P1769, DOI 10.1084/jem.20082603; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sly PD, 2008, LANCET, V372, P1100, DOI 10.1016/S0140-6736(08)61451-8; Smith M, 2008, J ALLERGY CLIN IMMUN, V121, P1460, DOI 10.1016/j.jaci.2008.03.025; Stampfli MR, 1999, AM J RESP CELL MOL, V21, P586; Stelmach I, 2002, CLIN EXP ALLERGY, V32, P264, DOI 10.1046/j.1365-2222.2002.01286.x; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Szefler SJ, 2005, AM J RESP CRIT CARE, V171, P672, DOI 10.1164/rccm.2501001; Taher YA, 2008, J IMMUNOL, V180, P5211, DOI 10.4049/jimmunol.180.8.5211; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; Till SJ, 2004, J ALLERGY CLIN IMMUN, V113, P1025, DOI 10.1016/j.jaci.2004.03.024; Torgerson TR, 2007, J ALLERGY CLIN IMMUN, V120, P744, DOI 10.1016/j.jaci.2007.08.044; Urry Z, 2009, J CLIN INVEST, V119, P387, DOI 10.1172/JCI32354; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; Verhoef A, 2005, PLOS MED, V2, P253, DOI 10.1371/journal.pmed.0020078; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Willers SM, 2008, AM J RESP CRIT CARE, V178, P124, DOI 10.1164/rccm.200710-1544OC; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; ZUANYAMORIM C, 1995, J CLIN INVEST, V95, P2644, DOI 10.1172/JCI117966	117	249	267	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					438	449		10.1016/j.immuni.2009.08.007	http://dx.doi.org/10.1016/j.immuni.2009.08.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19766086	Green Accepted, Bronze			2022-12-18	WOS:000270525900009
J	Saraiva, M; Christensen, JR; Veldhoen, M; Murphy, TL; Murphy, KM; O'Garra, A				Saraiva, Margarida; Christensen, Jillian R.; Veldhoen, Marc; Murphy, Theresa L.; Murphy, Kenneth M.; O'Garra, Anne			Interleukin-10 Production by Th1 Cells Requires Interleukin-12-Induced STAT4 Transcription Factor and ERK MAP Kinase Activation by High Antigen Dose	IMMUNITY			English	Article							REGULATORY T-CELLS; IL-10 GENE-EXPRESSION; PROTOONCOGENE C-MAF; INTERFERON-GAMMA; DENDRITIC CELLS; IFN-GAMMA; IMMUNE-SYSTEM; TGF-BETA; RECEPTOR; DIFFERENTIATION	CD4(+) T cells producing interleukin-10 (IL-10) and interferon-gamma (IFN-gamma) are reported in chronic infections. However, the signals that direct the development of IL-10-producing T helper 1 (Th1) cells are undefined. We showed that development of IL-10-producing Th1 cells required high T cell receptor (TCR) ligation, sustained ERK1 and ERK2 MAP kinases phosphorylation, and IL-12-induced STAT4 transcription factor activation. Repeated TCR triggering led to enhanced IL-10 production by Th1 cells, and continued IL-12 action and high-dose TCR signaling were required for the development and maintenance of IL-10-producing Th1 cells. Although Th1, Th2, and Th17 cells require the activation of distinct STATs for their differentiation, activation of ERK1 and ERK2 was a common requirement for production of IL-10 by all Th cell subsets. IL-10 expression also correlated with c-maf expression. Despite having distinct functions in protection against pathogens, all Th cells share the important task of controlling overexuberant immune responses by means of IL-10 production.	[Saraiva, Margarida; Christensen, Jillian R.; O'Garra, Anne] MRC Natl Inst Med Res, Div Immunoregulat, London NW7 1AA, England; [Veldhoen, Marc] MRC Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England; [Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Ctr Immunol, Howard Hughes Med Inst, St Louis, MO 63110 USA	MRC National Institute for Medical Research; MRC National Institute for Medical Research; Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	O'Garra, A (corresponding author), MRC Natl Inst Med Res, Div Immunoregulat, Ridgeway, London NW7 1AA, England.	aogarra@nimr.mrc.ac.uk	Veldhoen, Marc/AAJ-2759-2020; Veldhoen, Marc/AAM-5357-2021; Saraiva, Margarida/E-8781-2011	Veldhoen, Marc/0000-0002-1478-9562; Saraiva, Margarida/0000-0002-8180-1293; O'Garra, Anne/0000-0001-9845-6134	Medical Research Council, UK; Howard Hughes Medical Institute; Medical Research Council [MC_U117565642] Funding Source: researchfish; MRC [MC_U117565642] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Atkins, A. Rae, G. Preece, and N. Biboum for assistance in flow cytometry and M. Holman for the help with the in vivo experiments. We also thank the National Institute for Medical Research (NIMR) Biological Services for their animal husbandry and breeding. We specially thank G. Trincheri (National Cancer Institute, National Institutes of Health, USA), F. Barrat (Dynavax, CA, USA), B. Stockinger, S. Ley, and G. Kassiotis (NIMR, Mill Hill, UK) for critically reading the manuscript and offering helpful advice. We thank P. Cohen and N. Shpiro, University of Dundee, for their generosity in providing MAP kinase PD184352 and CT99021 inhibitor reagents, as well as advice on their use, and thank P. Cohen also for providing critical advice. This work was supported by the Medical Research Council, UK, (M.S., J.R.C., M.V., and A.O.G.) and Howard Hughes Medical Institute (K.M.M. and T.L.M.).	Agrawal A, 2006, J IMMUNOL, V176, P5788, DOI 10.4049/jimmunol.176.10.5788; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; ASSENMACHER M, 1994, EUR J IMMUNOL, V24, P1097, DOI 10.1002/eji.1830240513; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Castro AG, 2000, J EXP MED, V192, P1529, DOI 10.1084/jem.192.10.1529; Chang HD, 2007, EUR J IMMUNOL, V37, P807, DOI 10.1002/eji.200636385; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; DEL PG, 1993, J IMMUNOL, V150, P353; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Glimcher LH, 2000, GENE DEV, V14, P1693; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hacker H, 1999, EMBO J, V18, P6973, DOI 10.1093/emboj/18.24.6973; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jeannin P, 1996, J IMMUNOL, V156, P3159; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Meyaard L, 1996, J IMMUNOL, V156, P2776; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pohl-Koppe A, 1998, J IMMUNOL, V160, P1804; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schiott A, 2000, IMMUNOL LETT, V72, P183, DOI 10.1016/S0165-2478(00)00184-X; Shaw MH, 2006, J IMMUNOL, V176, P7263, DOI 10.4049/jimmunol.176.12.7263; Shoemaker J, 2006, J IMMUNOL, V176, P3470, DOI 10.4049/jimmunol.176.6.3470; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Wang ZY, 2005, J IMMUNOL, V174, P2098, DOI 10.4049/jimmunol.174.4.2098; Windhagen A, 1996, J IMMUNOL, V157, P1127; Witsch EJ, 2002, EUR J IMMUNOL, V32, P2680, DOI 10.1002/1521-4141(200209)32:9<2680::AID-IMMU2680>3.0.CO;2-6; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304	56	249	259	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					209	219		10.1016/j.immuni.2009.05.012	http://dx.doi.org/10.1016/j.immuni.2009.05.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19646904	Green Published, hybrid			2022-12-18	WOS:000269338600008
J	Sasaki, Y; Derudder, E; Hobeika, E; Pelanda, R; Reth, M; Rajewsky, K; Schmidt-Supprian, M				Sasaki, Yoshiteru; Derudder, Emmanuel; Hobeika, Elias; Pelanda, Roberta; Reth, Michael; Rajewsky, Klaus; Schmidt-Supprian, Marc			Canonical NF-kappa B activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation	IMMUNITY			English	Article							LYMPHOCYTE DEVELOPMENT; MARGINAL ZONE; TRANSCRIPTION FACTORS; HEMATOPOIETIC-CELLS; CD19 FUNCTION; SURVIVAL; MATURE; EXPRESSION; MICE; PATHWAY	The maintenance of mature B cells hinges on signals emitted from the BAFF-R cell-surface receptor, but the nature of these signals is incompletely understood. Inhibition of canonical NF-kappa B transcription factor activity through ablation of the essential scaffold protein NEW arrests B cell development at the same stage as BAFF-R deficiency. Correspondingly, activation of this pathway by constitutively active I kappa B Kinase2 renders B cell survival independent of BAFF-R:BAFF interactions and prevents proapoptotic PKC8 nuclear translocation. In addition, canonical NF-kappa B activity mediates differentiation and proper localization of follicular and marginal zone B cells in the absence of BAFF-R, but not CD19. By replacing BAFF-R signals, constitutive canonical NF-kappa B signaling, a hallmark of various B cell lymphomas, causes accumulation of resting B cells and promotes their proliferation and survival upon activation, but does not per se induce lymphomagenesis. Therefore, canonical NF-kappa B activity can substitute for BAFF-R signals in B cell development and pathogenesis.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Max Planck Society	Sasaki, Y (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	sasaki@cbr.med.harvard.edu; rajewsky@cbr.med.harvard.edu; supprian@cbr.med.harvard.edu	hobeika, elias/AAV-6663-2021; Schmidt-Supprian, Marc/F-5893-2011	Schmidt-Supprian, Marc/0000-0002-8543-6166; Rajewsky, Klaus/0000-0002-6633-6370; Derudder, Emmanuel/0000-0003-1421-4045	NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057947, R37AI054636] Funding Source: NIH RePORTER; NCI NIH HHS [CA92625] Funding Source: Medline; NIAID NIH HHS [AI057947, AI054636] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amanna IJ, 2003, J IMMUNOL, V170, P4593, DOI 10.4049/jimmunol.170.9.4593; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Craxton A, 2005, J EXP MED, V202, P1363, DOI 10.1084/jem.20051283; Donahue AC, 2004, SEMIN CELL DEV BIOL, V15, P183, DOI 10.1016/j.semcdb.2003.12.024; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Gerondakis S, 2003, SEMIN IMMUNOL, V15, P159, DOI 10.1016/S1044-5323(03)00036-8; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kern C, 2004, BLOOD, V103, P679, DOI 10.1182/blood-2003-02-0540; Kim S, 2003, P NATL ACAD SCI USA, V100, P1203, DOI 10.1073/pnas.0337707100; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Morrison MD, 2005, J BIOL CHEM, V280, P10018, DOI 10.1074/jbc.M413634200; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Novak AJ, 2004, BLOOD, V104, P2247, DOI 10.1182/blood-2004-02-0762; Otero DC, 2003, J IMMUNOL, V170, P73, DOI 10.4049/jimmunol.170.1.73; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Pelletier M, 2003, J BIOL CHEM, V278, P33127, DOI 10.1074/jbc.M305754200; Rahman ZSM, 2004, J IMMUNOL, V173, P6179, DOI 10.4049/jimmunol.173.10.6179; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rosenwald A, 2003, LEUKEMIA LYMPHOMA, V44, pS41, DOI 10.1080/10428190310001623775; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; Tardivel A, 2004, EUR J IMMUNOL, V34, P509, DOI 10.1002/eji.200324692; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tinnell SB, 1998, INT IMMUNOL, V10, P1529, DOI 10.1093/intimm/10.10.1529; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	46	249	274	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					729	739		10.1016/j.immuni.2006.04.005	http://dx.doi.org/10.1016/j.immuni.2006.04.005			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782029	Bronze			2022-12-18	WOS:000238592200011
J	Howell, MD; Gallo, RL; Boguniewicz, M; Jones, JF; Wong, C; Streib, JE; Leung, DYM				Howell, MD; Gallo, RL; Boguniewicz, M; Jones, JF; Wong, C; Streib, JE; Leung, DYM			Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus	IMMUNITY			English	Article							ANTIMICROBIAL PEPTIDES; EXPRESSION; SMALLPOX; LL-37; IL-4	Atopic dermatitis (AD) is associated with eczema vaccinatum (EV), a disseminated viral skin infection that follows inoculation with vaccinia virus (VV). This study examined whether AD skin can control VV replication, and the role of IL-4 and IL-13 in modulating the human cathelicidin LL-37, an antimicrobial peptide that kills VV. AD skin exhibited increased VV replication and decreased LL-37 expression compared to normal or psoriasis skin. IL-4/IL-13 enhanced VV replication while downregulating LL-37 in VV-stimulated keratinocytes. Neutralizing IL-4/IL-13 in AD skin augmented LL-37 and inhibited VV replication. Cathelicidins were induced via toll-like receptor-3 and were inhibited by IL-4/IL-13 through STAT-6. Skin from cathelicidin-deficient mice exhibited reduced ability to control VV replication. Exogenous LL-37 controlled vaccinia viral replication in infected keratinocytes and AD skin explants. The current study demonstrates that Th2 cytokines enhance VV replication in AD skin by subverting the innate immune response against VV in a STAT-6-dependent manner.	Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Dept Pediat,Div Allergy & Immunol, Denver, CO 80206 USA; Univ Calif San Diego, VA San Diego Hlth Care Syst, Dept Med & Pediat, Div Dermatol, San Diego, CA 92161 USA; Ctr Dis Control & Prevent, Viral Exanthems & Herpesvirus Branch, Atlanta, GA 30333 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Centers for Disease Control & Prevention - USA	Leung, DYM (corresponding author), Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Dept Pediat,Div Allergy & Immunol, 4200 E 9th Ave, Denver, CO 80206 USA.	leungd@njc.org	Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI040029, R01AI052453, R37AI052453, T32AI007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR051634, R01AR041256, R01AR045676] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00051] Funding Source: Medline; NIAID NIH HHS [T32 AI07365, N01 AI40029, AI052453, N01 AI40030] Funding Source: Medline; NIAMS NIH HHS [AR41256, AR45676, 5R21AR051634] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AMEGADZIE BY, 1991, J BIOL CHEM, V266, P13712; Bicknell WJ, 2002, NEW ENGL J MED, V346, P1323, DOI 10.1056/NEJMsb020357; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Drazen JM, 2002, NEW ENGL J MED, V346, P1262, DOI 10.1056/NEJM2e020038; Erdag G, 2002, ANN SURG, V235, P113, DOI 10.1097/00000658-200201000-00015; Fauci AS, 2002, NEW ENGL J MED, V346, P1319, DOI 10.1056/NEJM200204253461711; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; HAMID Q, 1994, J CLIN INVEST, V94, P870, DOI 10.1172/JCI117408; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; Lane HC, 2001, NAT MED, V7, P1271, DOI 10.1038/nm1201-1271; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Pestonjamasp VK, 2001, PEPTIDES, V22, P1643, DOI 10.1016/S0196-9781(01)00499-5; SCHMELZ M, 1994, J VIROL, V68, P130, DOI 10.1128/JVI.68.1.130-147.1994; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Takeda K, 1996, J IMMUNOL, V157, P3220; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; Tukey J. W., 1977, EXPLORATORY DATA ANA; van den Broek M, 2000, J IMMUNOL, V164, P371, DOI 10.4049/jimmunol.164.1.371; WHO, 1980, WKLY EPIDEMIOL REC, V55, P148; YUWEN H, 1993, VIROLOGY, V195, P732, DOI 10.1006/viro.1993.1424	28	249	257	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2006	24	3					341	348		10.1016/j.immuni.2006.02.006	http://dx.doi.org/10.1016/j.immuni.2006.02.006			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546102	Bronze			2022-12-18	WOS:000236504500014
J	Maeda, S; Chang, LF; Li, ZW; Luo, JL; Leffert, H; Karin, M				Maeda, S; Chang, LF; Li, ZW; Luo, JL; Leffert, H; Karin, M			IKK beta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNF alpha	IMMUNITY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; LIVER-INJURY; MICE LACKING; RECEPTOR 1; EMBRYONIC LETHALITY; JNK ACTIVATION; KINASE; DEGENERATION; HEPATOCYTES	IkappaB kinase beta (IKKbeta) is required for NF-kappaB activation and suppression of TNFalpha-mediated liver apoptosis. To investigate how IKKbeta suppresses apoptosis, we generated hepatocyte-specific Ikkbeta knockout mice, IkkbetaDelta(hep), which exhibit little residual NF-kappaB activity but are healthy with normal liver function. Unexpectedly, Ikkbeta(Deltahep),P mice are slightly more sensitive than controls to LPS-induced liver apoptosis but are highly susceptible to liver destruction following concanavalin A (ConA)-induced T cell activation. Unlike LPS, a potent inducer of circulating TNFalpha, ConA exerts cytotoxic effects through cell-bound TNFalpha, which activates type 1 and 2 TNF receptors (TNFR). While TNFR2 does not contribute to NF-kappaB activation, it is important for ConA-induced JNK activation, which is augmented by the absence of IKKbeta. Using JNK-deficient mice we show,that JNK is required for ConA-induced liver damage. Thus, the antiapoptotic function of IKKbeta, which is most-critical in situations that involve cell-bound TNFalpha, is mediated partially through attenuation of JNK activity.	Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Genet Mol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu		Luo, Jun-Li/0000-0002-7625-4766	NIAID NIH HHS [AI43477] Funding Source: Medline; NIEHS NIH HHS [ES10337, ES06376] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337, R01ES006376] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BIRD GLA, 1990, ANN INTERN MED, V112, P917, DOI 10.7326/0003-4819-112-12-917; Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387, DOI 10.1152/ajpgi.1998.275.3.G387; Chaisson ML, 2002, J CLIN INVEST, V110, P193, DOI 10.1172/JCI200215295; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; DECKER K, 1974, REV PHYSIOL BIOCH P, V71, P77, DOI 10.1007/BFb0027661; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; EISSNER G, 1995, BLOOD, V86, P4184, DOI 10.1182/blood.V86.11.4184.bloodjournal86114184; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; GANTNER F, 1995, HEPATOLOGY, V21, P190, DOI 10.1016/0270-9139(95)90428-X; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GONZALEZAMARO R, 1994, J EXP MED, V179, P841, DOI 10.1084/jem.179.3.841; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Haefner B, 2002, DRUG DISCOV TODAY, V7, P653, DOI 10.1016/S1359-6446(02)02309-7; Hatano E, 2001, GASTROENTEROLOGY, V120, P1251, DOI 10.1053/gast.2001.23239; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kusters S, 1997, EUR J IMMUNOL, V27, P2870, DOI 10.1002/eji.1830271119; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Leffert H L, 1979, Methods Enzymol, V58, P536; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liu P, 2002, J HEPATOL, V37, P63, DOI 10.1016/S0168-8278(02)00064-8; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; MUTO Y, 1988, LANCET, V2, P72; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202; Okuda K, 2000, J HEPATOL, V32, P225, DOI 10.1016/S0168-8278(00)80428-6; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Solorzano CC, 1997, J IMMUNOL, V158, P414; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Trautwein C, 1998, GASTROENTEROLOGY, V114, P1035, DOI 10.1016/S0016-5085(98)70324-5; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Xu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1058, DOI 10.1152/ajpcell.1998.275.4.C1058; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	60	249	264	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2003	19	5					725	737		10.1016/S1074-7613(03)00301-7	http://dx.doi.org/10.1016/S1074-7613(03)00301-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614859	Bronze			2022-12-18	WOS:000186672200012
J	Priatel, JJ; Chui, D; Hiraoka, N; Simmons, CJT; Richardson, KB; Page, DM; Fukuda, M; Varki, NM; Marth, JD				Priatel, JJ; Chui, D; Hiraoka, N; Simmons, CJT; Richardson, KB; Page, DM; Fukuda, M; Varki, NM; Marth, JD			The ST3Gal-I sialyltransferase controls CD8(+) T lymphocyte homeostasis by modulating O-glycan biosynthesis	IMMUNITY			English	Article							TISSUE-SPECIFIC EXPRESSION; PEANUT AGGLUTININ; CELL ACTIVATION; LYMPHOBLASTOID-CELLS; MOLECULAR-CLONING; THYMOCYTES; APOPTOSIS; BINDING; LECTIN; CD43	T lymphocyte activation evokes distinct changes in cell surface O-glycans. CD8(+) T cells undergo an elimination of sialic acid on core 10-glycans and an induction of core 2 O-glycans until either apoptotic death or differentiation into memory cells, We find that the ST3Gal-I sialyltransferase is required for core 10-glycan sialylation and its deficiency induces core 2 O-glycan biosynthesis. Apoptosis ensues with the loss of peripheral CD8(+) T cells in the absence of immune stimulation. Cell surface ligation of the ST3Gal-I substrate CD43 recapitulates this phenotype by a caspase 3-independent mechanism. Control of core 10-glycan sialylation in T lymphocytes by ST3Gal-I comprises a homeostatic mechanism that eliminates CD8(+) T cells by apoptosis while facilitating the production of viable CD8(+) memory T cells.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Burnham Inst, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Marth, JD (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	jmarth@ucsd.edu		Priatel, John/0000-0001-8794-6306	NATIONAL CANCER INSTITUTE [R37CA033000] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NCI NIH HHS [R37CA33000] Funding Source: Medline; NHLBI NIH HHS [P01HL 57345] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BAUM LG, 1995, J EXP MED, V181, P877, DOI 10.1084/jem.181.3.877; Brown TJ, 1996, J BIOL CHEM, V271, P27686, DOI 10.1074/jbc.271.44.27686; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CASABO LG, 1994, J IMMUNOL, V152, P397; CHERVENAK R, 1982, THYMUS, V4, P61; CHUI D, 1994, EMBO J, V13, P798, DOI 10.1002/j.1460-2075.1994.tb06322.x; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Cooper DNW, 1999, GLYCOBIOLOGY, V9, P979, DOI 10.1093/glycob/9.10.979; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; DESPONT JP, 1975, CELL IMMUNOL, V17, P487, DOI 10.1016/S0008-8749(75)80052-9; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Ellies LG, 1996, BLOOD, V88, P1725, DOI 10.1182/blood.V88.5.1725.bloodjournal8851725; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; FIGUEROA F, 1982, J IMMUNOL, V129, P2089; Galvan M, 1998, J IMMUNOL, V161, P641; GILLESPIE W, 1993, J BIOL CHEM, V268, P3801; GILLESPIE W, 1992, J BIOL CHEM, V267, P21004; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; HARRINGTON LE, 2000, IN PRESS J EXP MED; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; JONES AT, 1994, J IMMUNOL, V153, P3426; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KABIR A, 1983, CELL STRUCT FUNCT, V8, P29, DOI 10.1247/csf.8.29; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; LEE YC, 1993, EUR J BIOCHEM, V216, P377, DOI 10.1111/j.1432-1033.1993.tb18155.x; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; Lowe JB., 1999, ESSENTIALS GLYCOBIOL, P211; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MANJUNATH N, 1995, NATURE, V377, P535, DOI 10.1038/377535a0; MANSOUR MH, 1995, ZOOL SCI, V12, P79, DOI 10.2108/zsj.12.79; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; PAULSON JC, 1989, J BIOL CHEM, V264, P10931; PEREIRA MEA, 1976, CARBOHYD RES, V51, P107; PETERS J, 1981, GENET RES, V38, P47, DOI 10.1017/S0016672300020395; PILLER F, 1988, J BIOL CHEM, V263, P15146; RAEDLER A, 1981, CELL TISSUE RES, V218, P219; REISNER Y, 1979, P NATL ACAD SCI USA, V76, P447, DOI 10.1073/pnas.76.1.447; REISNER Y, 1976, CELL IMMUNOL, V25, P129, DOI 10.1016/0008-8749(76)90103-9; ROSE ML, 1981, IMMUNOLOGY, V42, P583; SASAKI R, 1982, CLIN EXP IMMUNOL, V47, P381; SATO M, 1992, J BIOCHEM-TOKYO, V111, P331, DOI 10.1093/oxfordjournals.jbchem.a123758; SCHAEFER HF, 1989, CHIMIA, V43, P1; Skrincosky D, 1997, J BIOL CHEM, V272, P22695, DOI 10.1074/jbc.272.36.22695; Thompson, 1999, FUNDAMENTAL IMMUNOLO, P813; TOPOROWICZ A, 1986, CELL IMMUNOL, V100, P10, DOI 10.1016/0008-8749(86)90002-X; UNI Z, 1991, POULTRY SCI, V70, P1516, DOI 10.3382/ps.0701516; WANG WC, 1988, J BIOL CHEM, V263, P4576; Wu WY, 1996, J EXP MED, V184, P759, DOI 10.1084/jem.184.2.759	57	249	254	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2000	12	3					273	283		10.1016/S1074-7613(00)80180-6	http://dx.doi.org/10.1016/S1074-7613(00)80180-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	301DC	10755614	Bronze			2022-12-18	WOS:000086292100005
J	Turner, M; Mee, PJ; Walters, AE; Quinn, ME; Mellor, AL; Zamoyska, R; Tybulewicz, VLJ				Turner, M; Mee, PJ; Walters, AE; Quinn, ME; Mellor, AL; Zamoyska, R; Tybulewicz, VLJ			A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes	IMMUNITY			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; JNK/SAPK SIGNALING PATHWAY; CELL-CYCLE PROGRESSION; T-CELL; THYMIC SELECTION; CD4(+)CD8(+) THYMOCYTES; CD4+8+ THYMOCYTES; RECEPTOR; PROTEIN; PROTOONCOGENE	The T cell repertoire is shaped by positive and negative selection of thymocytes that express low levels of T cell receptor (TCR) and both CD4 and CD8. TCR-mediated signals that determine these selection processes are only partly understood. Vav, a GDP-GTP exchange factor for Rho-family proteins, is tyrosine phosphorylated following TCR stimulation, suggesting that it may transduce TCR signals. We now demonstrate that mice lacking Vav are viable and display a profound defect in the positive selection of both class I-and class Ii-restricted T cells. In contrast, Vav is not essential for negative selection, though in its absence negative selection is much less effective. Vav may influence the efficiency of TCR-induced selection events by regulating the intracellular calcium flux of thymocytes.	NATL INST MED RES,LONDON NW7 1AA,ENGLAND	MRC National Institute for Medical Research			Turner, Martin/N-9976-2014	Turner, Martin/0000-0002-3801-9896; Tybulewicz, Victor/0000-0003-2439-0798; Zamoyska, Rose/0000-0001-9816-2638				ABEROLAILA J, 1996, J EXP MED, V184, P9; ABEROLAILA J, 1995, NATURE, V373, P620; ADAMS JM, 1992, ONCOGENE, V7, P611; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOGUSKI MS, 1992, NATURE, V358, P113, DOI 10.1038/358113a0; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Costello PS, 1996, ONCOGENE, V13, P2595; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Douek DC, 1996, INT IMMUNOL, V8, P1413, DOI 10.1093/intimm/8.9.1413; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; FOY TM, 1995, J EXP MED, V182, P1377, DOI 10.1084/jem.182.5.1377; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Hashimoto K, 1996, J EXP MED, V184, P931, DOI 10.1084/jem.184.3.931; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HELMANFINKEL T, 1987, NATURE, V330, P179; HELMANFINKEL T, 1989, CELL, V58, P1047; HOLSINGER LJ, 1995, P NATL ACAD SCI USA, V92, P9810, DOI 10.1073/pnas.92.21.9810; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Kane LP, 1996, J IMMUNOL, V156, P4594; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MMALISSEN B, 1996, CURR OPIN IMMUNOL, V8, P383; NAKAYAMA T, 1992, SCIENCE, V257, P96, DOI 10.1126/science.1621102; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; OHASHI PS, 1990, NATURE, V346, P861, DOI 10.1038/346861a0; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Penninger JM, 1996, J IMMUNOL, V157, P5359; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Saijo K, 1997, J EXP MED, V185, P351, DOI 10.1084/jem.185.2.351; Schuebel KE, 1996, ONCOGENE, V13, P363; SIMPSON E, 1993, IMMUNOL REV, V131, P93, DOI 10.1111/j.1600-065X.1993.tb01532.x; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; SPONAAS AM, 1994, INT IMMUNOL, V6, P277, DOI 10.1093/intimm/6.2.277; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; Takahama Y, 1996, J IMMUNOL, V157, P1508; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Teramoto H, 1997, J BIOL CHEM, V272, P10751; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; VASQUEZ NJ, 1994, IMMUNITY, V1, P45, DOI 10.1016/1074-7613(94)90008-6; Wallace VA, 1997, J IMMUNOL, V158, P3205; WANG CR, 1995, J EXP MED, V181, P927, DOI 10.1084/jem.181.3.927; WENG WK, 1994, J BIOL CHEM, V269, P32514; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; WILLIAMS O, 1997, IMMUNOL TODAY, V13, P121; WU J, 1995, MOL CELL BIOL, V15, P4337; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; ZMUIDZINAS A, 1995, EMBO J, V14, P1	68	249	253	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1997	7	4					451	460		10.1016/S1074-7613(00)80367-2	http://dx.doi.org/10.1016/S1074-7613(00)80367-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354466	Bronze			2022-12-18	WOS:A1997YD59300002
J	Pestal, K; Funk, CC; Snyder, JM; Price, ND; Treuting, PM; Stetson, DB				Pestal, Kathleen; Funk, Cory C.; Snyder, Jessica M.; Price, Nathan D.; Treuting, Piper M.; Stetson, Daniel B.			Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development	IMMUNITY			English	Article							AICARDI-GOUTIERES SYNDROME; RESTRICTION FACTOR; ADENOSINE-DEAMINASE; MICE LACKING; RIG-I; GENE; MUTATIONS; DISEASE; SAMHD1; IFIH1	Mutations in ADAR, which encodes the ADAR1 RNA-editing enzyme, cause Aicardi-Goutieres syndrome (AGS), a severe autoimmune disease associated with an aberrant type I interferon response. How ADAR1 prevents autoimmunity remains incompletely defined. Here, we demonstrate that ADAR1 is a specific and essential negative regulator of the MDA5-MAVS RNA sensing pathway. Moreover, we uncovered a MDA5-MAVS-independent function for ADAR1 in the development of multiple organs. We showed that the p150 isoform of ADAR1 uniquely regulated the MDA5 pathway, whereas both the p150 and p110 isoforms contributed to development. Abrupt deletion of ADAR1 in adult mice revealed that both of these functions were required throughout life. Our findings delineate genetically separable roles for both ADAR1 isoforms in vivo, with implications for the human diseases caused by ADAR mutations.	[Pestal, Kathleen; Stetson, Daniel B.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Funk, Cory C.; Price, Nathan D.] Univ Washington, Sch Med, Inst Syst Biol, Seattle, WA 98195 USA; [Snyder, Jessica M.; Treuting, Piper M.] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stetson, DB (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	stetson@uw.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519; Pestal, Kathleen/0000-0001-6886-804X; Price, Nathan/0000-0002-4157-0267	NIH [AI084914, T32GM007270]; Lupus Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Stuart Orkin for providing mice with the Adar conditional allele; to Ming R. Loo and Michael Gale, Jr., for providing Mavs<SUP>-/-</SUP>, Ifih1<SUP>-/-</SUP>, and Ddx58<SUP>-/-</SUP> mice; to Shizuo Akira for the Ddx58<SUP>-/-</SUP> mice; to Marco Colonna for the Ifih1<SUP>-/-</SUP> mice; to Glen Barber for Tmem173<SUP>-/-</SUP> mice; to M.B.A. Oldstone for Adar p150<SUP>+/-</SUP> gametes; to Yanick Crow for helpful insights; to Stephanie Cambier for bioinformatics analysis; to Brian Johnson, Kerrie Allen, and the staff of UW Histology and Imaging Core for their technical expertise; and to members of the D.B.S. and M. Bevan labs for helpful discussions. D.B.S. is a scholar of the Rita Allen Foundation and a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease. This work was supported by grants from the NIH (AI084914 to D.B.S. and N.D.P.; T32GM007270 to K.P.) and the Lupus Research Institute (D.B.S.).	Ablasser A, 2014, J IMMUNOL, V192, P5993, DOI 10.4049/jimmunol.1400737; AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Frank MG, 2002, NEUROPSYCHOPHARMACOL, V27, P869, DOI 10.1016/S0893-133X(02)00353-6; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Hayashi M, 2013, J DERMATOL, V40, P336, DOI 10.1111/j.1346-8138.2012.01661.x; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Livingston JH, 2014, J MED GENET, V51, P76, DOI 10.1136/jmedgenet-2013-102038; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Schwartz T, 1999, SCIENCE, V284, P1841, DOI 10.1126/science.284.5421.1841; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sutherland A, 2007, J CLIN ENDOCR METAB, V92, P3338, DOI 10.1210/jc.2007-0173; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vitali P, 2010, NAT STRUCT MOL BIOL, V17, P1043, DOI 10.1038/nsmb.1864; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Yang SY, 2014, J IMMUNOL, V193, P3436, DOI 10.4049/jimmunol.1401136; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	50	248	253	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					933	944		10.1016/j.immuni.2015.11.001	http://dx.doi.org/10.1016/j.immuni.2015.11.001			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26588779	Green Accepted, Bronze			2022-12-18	WOS:000366846000014
J	Zhang, N; Bevan, MJ				Zhang, Nu; Bevan, Michael J.			Transforming Growth Factor-beta Signaling Controls the Formation and Maintenance of Gut-Resident Memory T Cells by Regulating Migration and Retention	IMMUNITY			English	Article							TGF-BETA; INTRAEPITHELIAL LYMPHOCYTES; VIRAL PERSISTENCE; DENDRITIC CELLS; E-CADHERIN; RM CELLS; TISSUE; EXPRESSION; INFECTION; INTEGRINS	Tissue-resident memory T (Trm) cells represent a population of memory CD8(+) T cells that can act as first responders to local infection. The mechanisms regulating the formation and maintenance of intestinal Trm cells remain elusive. Here we showed that transforming growth factor-beta (TGF-beta) controlled both stages of gut Trm cell differentiation through different mechanisms. During the formation phase of Trm cells, TGF-beta signaling inhibited the migration of effector CD8(+) T cells from the spleen to the gut by dampening the expression of integrin alpha 4 beta 7. During the maintenance phase, TGF-beta was required for the retention of intestinal Trm cells at least in part through the induction of integrins alpha E beta 7 and alpha 1, as well as CD69. Thus, the cytokine acts to control cytotoxic T cell differentiation in lymphoid and peripheral organs.	[Zhang, Nu; Bevan, Michael J.] Univ Washington, Dept Immunol, Seattle, WA 98109 USA; [Zhang, Nu; Bevan, Michael J.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98109 USA.	mbevan@uw.edu		Zhang, Nu/0000-0001-9695-210X	NIAID NIH HHS [R01 AI019335] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Boettler T, 2012, VIRAL IMMUNOL, V25, P232, DOI 10.1089/vim.2011.0079; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; CHOY MY, 1990, J PATHOL, V160, P35, DOI 10.1002/path.1711600109; Clevers H, 2013, CELL, V152, P1198, DOI 10.1016/j.cell.2013.02.030; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Garidou L, 2012, J VIROL, V86, P7060, DOI 10.1128/JVI.00164-12; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hale JS, 2010, J IMMUNOL, V184, P5964, DOI 10.4049/jimmunol.1000876; HAMANN A, 1994, J IMMUNOL, V152, P3282; Hawke S, 1998, J EXP MED, V187, P1575, DOI 10.1084/jem.187.10.1575; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Ishigame H, 2013, J IMMUNOL, V190, P6340, DOI 10.4049/jimmunol.1300397; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; KILSHAW PJ, 1990, EUR J IMMUNOL, V20, P2201, DOI 10.1002/eji.1830201008; Kim SK, 1997, J IMMUNOL, V159, P4295; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Laouar Y, 2008, P NATL ACAD SCI USA, V105, P10865, DOI 10.1073/pnas.0805058105; Lauterbach H, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-53; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meharra EJ, 2000, CELL IMMUNOL, V201, P1, DOI 10.1006/cimm.2000.1630; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Roberts AI, 1999, IMMUNOLOGY, V97, P679; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sandoval F., 2013, SCI TRANSL MED, V5; Sanjabi S, 2010, J IMMUNOL METHODS, V353, P111, DOI 10.1016/j.jim.2009.12.008; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schon MP, 1999, J IMMUNOL, V162, P6641; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Tang VA, 2010, J REPROD IMMUNOL, V87, P39, DOI 10.1016/j.jri.2010.06.155; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725; Zhang N, 2012, NAT IMMUNOL, V13, P667, DOI 10.1038/ni.2319	54	248	254	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					687	696		10.1016/j.immuni.2013.08.019	http://dx.doi.org/10.1016/j.immuni.2013.08.019			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24076049	Bronze, Green Accepted			2022-12-18	WOS:000330950000010
J	Li, ST; Wang, LY; Berman, M; Kong, YY; Dorf, ME				Li, Shitao; Wang, Lingyan; Berman, Michael; Kong, Young-Yun; Dorf, Martin E.			Mapping a Dynamic Innate Immunity Protein Interaction Network Regulating Type I Interferon Production	IMMUNITY			English	Article							E3 UBIQUITIN LIGASE; NF-KAPPA-B; TANK-BINDING KINASE-1; RIG-I; ANTIVIRAL RESPONSE; ADAPTER PROTEIN; CYTOSOLIC DNA; CELL-DEATH; MIND BOMB-1; IKK-EPSILON	To systematically investigate innate immune signaling networks regulating production of type I interferon, we analyzed protein complexes formed after microbial recognition. Fifty-eight baits were associated with 260 interacting proteins forming a human innate immunity interactome for type I interferon (HI5) of 401 unique interactions; 21% of interactions were modulated by RNA, DNA, or LPS. Overexpression and depletion analyses identified 22 unique genes that regulated NF-kappa B and ISRE reporter activity, viral replication, or virus-induced interferon production. Detailed mechanistic analysis defined a role for mind bomb (MIB) E3 ligases in K63-linked ubiquitination of TBK1, a kinase that phosphorylates IRF transcription factors controlling interferon production. Mib genes selectively controlled responses to cytosolic RNA. MIB deficiency reduced antiviral activity, establishing the role of MIB proteins as positive regulators of antiviral responses. The HI5 provides a dynamic physical and regulatory network that serves as a resource for mechanistic analysis of innate immune signaling.	[Li, Shitao; Wang, Lingyan; Berman, Michael; Dorf, Martin E.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Kong, Young-Yun] Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea	Harvard University; Harvard Medical School; Seoul National University (SNU)	Li, ST (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	lishitao@hotmail.com; dorf@hms.harvard.edu		Li, Shitao/0000-0002-1398-8519	NIH [NS057162, AI089829]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089829, R56AI089829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057162] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS057162 and AI089829. We thank J. Peng (Emory) for MIB1 antibody, J. Hiscott (McGill) for IRF3(5D), and the services of the Taplin Mass Spectrometry Facility (Harvard). Because of space limitations we list the donors of plasmids in the Supplemental Tables.	Abdullah JM, 2001, BLOOD CELL MOL DIS, V27, P320, DOI 10.1006/bcmd.2001.0390; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Akhouayri O, 2005, MOL CELL BIOL, V25, P3452, DOI 10.1128/MCB.25.9.3452-3460.2005; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Colie S, 2010, AUTOPHAGY, V6, P426, DOI 10.4161/auto.6.3.11529; Ferran MC, 1997, J VIROL, V71, P371, DOI 10.1128/JVI.71.1.371-377.1997; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Huang SMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006871; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nogami S, 2004, BIOCHEM BIOPH RES CO, V319, P936, DOI 10.1016/j.bbrc.2004.05.073; Oka T, 2008, MOL BIOL CELL, V19, P2597, DOI 10.1091/mbc.E07-12-1205; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Song R, 2008, J EXP MED, V205, P2525, DOI 10.1084/jem.20081344; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Wu JI, 2007, GENESIS, V45, P722, DOI 10.1002/dvg.20349; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yanagisawa H, 2003, CELL DEATH DIFFER, V10, P798, DOI 10.1038/sj.cdd.4401246; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida K, 2005, GENES CELLS, V10, P465, DOI 10.1111/j.1365-2443.2005.00848.x; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	55	248	255	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 23	2011	35	3					426	440		10.1016/j.immuni.2011.06.014	http://dx.doi.org/10.1016/j.immuni.2011.06.014			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21903422	Green Accepted, Bronze			2022-12-18	WOS:000295748100013
J	Palucka, K; Banchereau, J; Mellman, I				Palucka, Karolina; Banchereau, Jacques; Mellman, Ira			Designing Vaccines Based on Biology of Human Dendritic Cell Subsets	IMMUNITY			English	Review							CD4(+) T-CELLS; YELLOW-FEVER VACCINE; EPIDERMAL LANGERHANS CELLS; INTERFERON-PRODUCING CELLS; STEADY-STATE; NKT CELLS; ANTIGEN PRESENTATION; CROSS-PRESENTATION; REGULATORY-CELLS; CUTTING EDGE	The effective vaccines developed against a variety of infectious agents, including polio, measles, and hepatitis B, represent major achievements in medicine These vaccines, usually composed of microbial antigens, are often associated with an adjuvant that activates dendritic cells (DCs) Many infectious diseases are still in need of an effective vaccine including HIV, malaria, hepatitis C, and tuberculosis In some cases, the induction of cellular rather than humoral responses may be more important because the goal is to control and eliminate the existing infection rather than to prevent it Our increased understanding of the mechanisms of antigen presentation, particularly with the description of DC subsets with distinct functions, as well as their plasticity in responding to extrinsic signals, represent opportunities to develop novel vaccines In addition, we foresee that this increased knowledge will permit us to design vaccines that will reprogram the immune system to intervene therapeutically in cancer, allergy, and autoimmunity	[Palucka, Karolina; Banchereau, Jacques] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Palucka, Karolina] Baylor Univ, Med Ctr, Sammons Canc Ctr, Dallas, TX 75246 USA; [Palucka, Karolina; Banchereau, Jacques] Mt Sinai Sch Med, Dept Gene & Cell Med, Inst Immunol, New York, NY 10029 USA; [Palucka, Karolina; Banchereau, Jacques] Mt Sinai Sch Med, Dept Med, Inst Immunol, New York, NY 10029 USA; [Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA	Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Roche Holding; Genentech	Palucka, K (corresponding author), Baylor Inst Immunol Res, 3434 Live Oak Ave, Dallas, TX 75204 USA.		Mellman, Ira/ABG-5896-2020		NIH [P01 CA084514, U19 AIO57234, R01 CA089440, CA078846]; Dana Foundation; Susan Komen Foundation; Baylor Health Care System; Baylor Health Care System Foundation; ANRS; NATIONAL CANCER INSTITUTE [P01CA084512, R01CA078846, R01CA140602, R01CA089440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); Baylor Health Care System; Baylor Health Care System Foundation; ANRS(ANRSFrench National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dedicated to patients and volunteers who participated in our studies and clinical trials at BIIR and Genentech We thank former and current members of BIIR Genentech and Yale Medical School for their contributions in particular H Ueno J Fay S Oh V Pascual L Roberts G Zurawski L Delamarre and S Trombetta Supported by the NIH (P01 CA084514 U19 AIO57234 R01 CA089440 and CA078846) the Dana Foundation the Susan Komen Foundation the Baylor Health Care System the Baylor Health Care System Foundation the ANRS and the INSERM K P holds the Michael A Ramsay Chair for Cancer Immunology Research J B holds the Caruth Chair for Transplant Immunology Research We also thank A Bruce (Genentech) for excellent assistance with artwork J B is an employee of Roche and I M is an employee of Genentech and a stockholder of Roche	Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Alvarez D, 2005, J IMMUNOL, V174, P1664, DOI 10.4049/jimmunol.174.3.1664; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Arima K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000567; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Birkholz K, 2010, BLOOD, V116, P2277, DOI 10.1182/blood-2010-02-268425; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2008, NAT IMMUNOL, V9, P1099, DOI 10.1038/ni1008-1099; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Celluzzi CM, 1997, J INVEST DERMATOL, V108, P716, DOI 10.1111/1523-1747.ep12292095; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Cheng PY, 2010, IMMUNOL REV, V234, P105, DOI 10.1111/j.0105-2896.2009.00871.x; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; DARNELL RB, 1994, CURRENT DIAGNOSIS NE, P137; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dullaers M, 2009, IMMUNITY, V30, P120, DOI 10.1016/j.immuni.2008.11.008; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Finn OJ, 2003, NAT REV IMMUNOL, V3, P630, DOI 10.1038/nri1150; Flacher V, 2009, CANCER IMMUNOL IMMUN, V58, P1137, DOI 10.1007/s00262-008-0563-9; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Fukaura H, 1996, J CLIN INVEST, V98, P70, DOI 10.1172/JCI118779; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Higano CS, 2009, CANCER-AM CANCER SOC, V115, P3670, DOI 10.1002/cncr.24429; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Ito T, 2006, P NATL ACAD SCI USA, V103, P13138, DOI 10.1073/pnas.0603107103; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Klechevsky E, 2010, BLOOD, V116, P1685, DOI 10.1182/blood-2010-01-264960; Klechevsky E, 2009, HUM IMMUNOL, V70, P281, DOI 10.1016/j.humimm.2009.02.004; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Leslie DS, 2002, J EXP MED, V196, P1575, DOI 10.1084/jem.20021515; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; McCurley N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011949; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; Mohamadzadeh M, 2008, EXPERT REV VACCINES, V7, P163, DOI 10.1586/14760584.7.2.163; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; Nagorsen D, 2003, CLIN CANCER RES, V9, P4296; Palucka AK, 2007, IMMUNOL REV, V220, P129, DOI 10.1111/j.1600-065X.2007.00575.x; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Paquette RL, 1998, J LEUKOCYTE BIOL, V64, P358, DOI 10.1002/jlb.64.3.358; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Parmiani G, 2007, J IMMUNOL, V178, P1975, DOI 10.4049/jimmunol.178.4.1975; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Pialoux G, 2001, AIDS, V15, P1239, DOI 10.1097/00002030-200107060-00005; PILON TS, 2010, J IMMUNOL, V184, P3442; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shaw J, 2010, BLOOD, V115, P3051, DOI 10.1182/blood-2009-08-239145; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Smyth MJ, 2002, CURR OPIN IMMUNOL, V14, P165, DOI 10.1016/S0952-7915(02)00316-3; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stoitzner P, 2006, P NATL ACAD SCI USA, V103, P7783, DOI 10.1073/pnas.0509307103; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009; van der Aar AMG, 2007, J IMMUNOL, V178, P1986, DOI 10.4049/jimmunol.178.4.1986; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Welters MJP, 2010, P NATL ACAD SCI USA, V107, P11895, DOI 10.1073/pnas.1006500107; Wykes M, 1998, J IMMUNOL, V161, P1313; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Yewdell JW, 2010, CURR OPIN IMMUNOL, V22, P402, DOI 10.1016/j.coi.2010.04.002; ZAPATA GF, 2007, J IMMUNOL, V178, P6130	135	248	257	2	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					464	478		10.1016/j.immuni.2010.10.007	http://dx.doi.org/10.1016/j.immuni.2010.10.007			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029958	Green Accepted, Bronze			2022-12-18	WOS:000284300200004
J	Tamura, T; Nagamura-Inoue, T; Shmeltzer, Z; Kuwata, T; Ozato, K				Tamura, T; Nagamura-Inoue, T; Shmeltzer, Z; Kuwata, T; Ozato, K			ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages	IMMUNITY			English	Article							SEQUENCE-BINDING-PROTEIN; TRANSCRIPTION FACTOR; IFN-GAMMA; REGULATORY FACTORS; DEFICIENT MICE; NITRIC-OXIDE; EXPRESSION; ACTIVATION; INDUCTION; PU.1	During hematopoiesis, myeloid progenitor cells give rise to granulocytes and macrophages. To study the role for ICSBP, a hematopoietic cell-specific transcription factor in myeloid cell development, the gene was introduced into myeloid progenitor cells established from ICSBP-/- mice. ICSBP retrovirus-transduced cells differentiated into mature macrophages with phagocytic activity, which coincided with the induction of specific target DNA binding activity. Similar to macrophages in vivo, ICSBP-transduced cells were growth arrested, expressed many macrophage-specific genes, and responded to macrophage activation signals. Contrary to this, ICSBP transduction led to repression of granulocyte-specific genes and inhibited G-CSF-mediated granulocytic differentiation in these and other myeloid progenitor cells. Together, ICSBP has a key role in the myeloid cell lineage selection and macrophage maturation.	NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ozato, K (corresponding author), NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA.	ozatok@mail.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001310] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amigorena S, 1999, IMMUNOL REV, V172, P279, DOI 10.1111/j.1600-065X.1999.tb01372.x; Anderson KL, 1999, BLOOD, V94, P2310, DOI 10.1182/blood.V94.7.2310.419k34_2310_2318; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Contursi C, 2000, P NATL ACAD SCI USA, V97, P91, DOI 10.1073/pnas.97.1.91; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Eklund EA, 1999, J IMMUNOL, V163, P6095; Fehr T, 1997, J EXP MED, V185, P921, DOI 10.1084/jem.185.5.921; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Gabriele L, 1999, J EXP MED, V190, P411, DOI 10.1084/jem.190.3.411; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; HAWLEY RG, 1994, GENE THER, V1, P136; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hume DA, 1997, MOL REPROD DEV, V46, P46; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; Kantakamalakul W, 1999, J IMMUNOL, V162, P7417; Kuwata T, 2000, BLOOD, V95, P3349, DOI 10.1182/blood.V95.11.3349; Lee SL, 1996, MOL CELL BIOL, V16, P4566; Lloberas J, 1999, IMMUNOL TODAY, V20, P184, DOI 10.1016/S0167-5699(99)01442-5; LUBBERT M, 1991, BLOOD, V77, P909; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Marecki S, 1999, J IMMUNOL, V163, P2713; Meraro D, 1999, J IMMUNOL, V163, P6468; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MORRIS L, 1991, DEVELOPMENT, V112, P517; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; NAGAMURAINOUE T, 2000, IN PRESS INT REV IMM; Nelson N, 1996, J IMMUNOL, V156, P3711; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; Ortiz MA, 1999, P NATL ACAD SCI USA, V96, P2740, DOI 10.1073/pnas.96.6.2740; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; POLITIS AD, 1994, J IMMUNOL, V152, P2270; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; SchartonKersten T, 1997, J EXP MED, V186, P1523, DOI 10.1084/jem.186.9.1523; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; SHARF R, 1995, J BIOL CHEM, V270, P13063, DOI 10.1074/jbc.270.22.13063; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; STANLEY ER, 1985, METHOD ENZYMOL, V116, P564; STEINMAN RA, 1994, BLOOD, V83, P119; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Trinchieri G, 1998, Int Rev Immunol, V16, P365, DOI 10.3109/08830189809043002; Unanue Emil R., 1993, P111; VALTIERI M, 1987, J IMMUNOL, V138, P3829; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Wu CY, 1999, J IMMUNOL, V162, P807; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187	52	248	250	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2000	13	2					155	165		10.1016/S1074-7613(00)00016-9	http://dx.doi.org/10.1016/S1074-7613(00)00016-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	350ZT	10981959	Bronze			2022-12-18	WOS:000089132100001
J	Joshi, NS; Akama-Garren, EH; Lu, YS; Lee, DY; Chang, GP; Li, A; DuPage, M; Tammela, T; Kerper, NR; Farago, AF; Robbins, R; Crowley, DM; Bronson, RT; Jacks, T				Joshi, Nikhil S.; Akama-Garren, Elliot H.; Lu, Yisi; Lee, Da-Yae; Chang, Gregory P.; Li, Amy; DuPage, Michel; Tammela, Tuomas; Kerper, Natanya R.; Farago, Anna F.; Robbins, Rebecca; Crowley, Denise M.; Bronson, Roderick T.; Jacks, Tyler			Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses	IMMUNITY			English	Article							LONG-TERM SURVIVAL; MOUSE MODELS; LUNG-CANCER; EXPRESSION; DIFFERENTIATION; DEPLETION; IMMUNITY	Infiltration of regulatory T (Treg) cells into many tumor types correlates with poor patient prognoses. However, mechanisms of intratumoral Treg cell function remain to be elucidated. We investigated Treg cell function in a genetically engineered mouse model of lung adenocarcinoma and found that Treg cells suppressed anti-tumor responses in tumor-associated tertiary lymphoid structures (TA-TLSs). TA-TLSs have been described in human lung cancers, but their function remains to be determined. TLSs in this model were spatially associated with > 90% of tumors and facilitated interactions between T cells and tumor-antigen-presenting dendritic cells (DCs). Costimulatory ligand expression by DCs and T cell proliferation rates increased in TA-TLSs upon Treg cell depletion, leading to tumor destruction. Thus, we propose that Treg cells in TA-TLSs can inhibit endogenous immune responses against tumors, and targeting these cells might provide therapeutic benefit for cancer patients.	[Joshi, Nikhil S.; Akama-Garren, Elliot H.; Lu, Yisi; Lee, Da-Yae; Chang, Gregory P.; Li, Amy; DuPage, Michel; Tammela, Tuomas; Kerper, Natanya R.; Farago, Anna F.; Robbins, Rebecca; Crowley, Denise M.; Jacks, Tyler] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Joshi, Nikhil S.; Akama-Garren, Elliot H.; Lu, Yisi; Lee, Da-Yae; Chang, Gregory P.; Li, Amy; DuPage, Michel; Tammela, Tuomas; Kerper, Natanya R.; Farago, Anna F.; Robbins, Rebecca; Crowley, Denise M.; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02142 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Bronson, Roderick T.] Tufts Univ, Dept Pathol, Sch Med & Vet Med, North Grafton, MA 01536 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Tufts University	Jacks, T (corresponding author), MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.	tjacks@mit.edu		/0000-0003-3675-6961; Lu, Yisi/0000-0002-7960-5445; Joshi, Nikhil/0000-0002-7045-7837; Akama-Garren, Elliot/0000-0002-1690-2055	NCI Cancer Center Support Grant [P30-CA14051]; Howard Hughes Medical Institute; NIH [1 U54 CA126515-01, R01-CA185020-01, T32 GM007753]; Damon Runyon Cancer Foundation; Margaret A. Cunningham Immune Mechanisms in Cancer Research Fellowship Award; Lung Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P30CA014051, U54CA126515, R01CA185020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Foundation; Margaret A. Cunningham Immune Mechanisms in Cancer Research Fellowship Award; Lung Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Professor Alexander Rudensky (Memorial Sloan-Kettering Cancer Center) for the generous gift of Foxp3<SUP>DTR-GFP</SUP> mice and T.J. lab members for reviewing the manuscript. We also thank the Swanson Biotechnology Center: Kathleen Cormier in the Hope Babette Tang (1983) Histology Facility, Eliza Vasile and Jeff Wyckoff in the Microscopy Facility, Scott Malstrom in the Animal Imaging & Preclinical Testing Core Facility, Glenn Paradis in the Flow Cytometry Facility, and the KI Media Facility. This work was supported by NCI Cancer Center Support Grant P30-CA14051 and grants from the Howard Hughes Medical Institute (T.J.); NIH grants 1 U54 CA126515-01 (T.J.), R01-CA185020-01 (T.J.), and T32 GM007753 (A.L.); the Damon Runyon Cancer Foundation (N.S.J.); the Margaret A. Cunningham Immune Mechanisms in Cancer Research Fellowship Award (N.S.J.); and the Lung Cancer Research Foundation (N.S.J.). T.J. is a Howard Hughes Medical Institute Investigator and a Daniel K. Ludwig Scholar. This paper is dedicated to Professor Herman Eisen and to Officer Sean Collier for his caring service to the MIT community and for his sacrifice.	Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Beyersdorf N, 2007, EUR J IMMUNOL, V37, P3445, DOI 10.1002/eji.200737126; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; de Chaisemartin L, 2011, CANCER RES, V71, P6391, DOI 10.1158/0008-5472.CAN-11-0952; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; DuPage M, 2013, CURR OPIN IMMUNOL, V25, P192, DOI 10.1016/j.coi.2013.02.005; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Goc J, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26836; Hayes SA, 2014, SEMIN CELL DEV BIOL, V27, P118, DOI 10.1016/j.semcdb.2014.04.002; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.3322/caac.20105]; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kwon MC, 2013, MOL ONCOL, V7, P165, DOI 10.1016/j.molonc.2013.02.010; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; McDermott D, 2014, CANCER TREAT REV, V40, P1056, DOI 10.1016/j.ctrv.2014.06.012; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006; Pace L, 2012, SCIENCE, V338, P532, DOI 10.1126/science.1227049; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Raez LE, 2005, CLIN MED RES, V3, P221, DOI 10.3121/cmr.3.4.221; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; Rao S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4056; Ribas A, 2013, J CLIN ONCOL, V31, P616, DOI 10.1200/JCO.2012.44.6112; Robbins SH, 2005, EUR J IMMUNOL, V35, P757, DOI 10.1002/eji.200425797; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Teng MWL, 2010, CANCER RES, V70, P7800, DOI 10.1158/0008-5472.CAN-10-1681; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	48	247	255	4	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					579	590		10.1016/j.immuni.2015.08.006	http://dx.doi.org/10.1016/j.immuni.2015.08.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26341400	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000361575300010
J	Hall, AO; Beiting, DP; Tato, C; John, B; Oldenhove, G; Lombana, CG; Pritchard, GH; Silver, JS; Bouladoux, N; Stumhofer, JS; Harris, TH; Grainger, J; Wojno, EDT; Wagage, S; Roos, DS; Scott, P; Turka, LA; Cherry, S; Reiner, SL; Cua, D; Belkaid, Y; Elloso, MM; Hunter, CA				Hall, Aisling O'Hara; Beiting, Daniel P.; Tato, Cristina; John, Beena; Oldenhove, Guillaume; Lombana, Claudia Gonzalez; Pritchard, Gretchen Harms; Silver, Jonathan S.; Bouladoux, Nicolas; Stumhofer, Jason S.; Harris, Tajie H.; Grainger, John; Wojno, Ella D. Tait; Wagage, Sagie; Roos, David S.; Scott, Philip; Turka, Laurence A.; Cherry, Sara; Reiner, Steven L.; Cua, Daniel; Belkaid, Yasmine; Elloso, M. Merle; Hunter, Christopher A.			The Cytokines Interleukin 27 and Interferon-gamma Promote Distinct Treg Cell Populations Required to Limit Infection-Induced Pathology	IMMUNITY			English	Article							REGULATORY T-CELLS; IFN-GAMMA; EXPRESSION; BET; INDUCTION; HOMEOSTASIS; ACTIVATION; DEPLETION; RESPONSES; EFFECTOR	Interferon-gamma (IFN-gamma) promotes a population of T-bet(+) CXCR3(+) regulatory T (Treg) cells that limit T helper 1 (Th1) cell-mediated pathology. Our studies demonstrate that interleukin-27 (IL-27) also promoted expression of T-bet and CXCR3 in Treg cells. During infection with Toxoplasma gondii, a similar population emerged that limited T cell responses and was dependent on IFN-gamma in the periphery but on IL-27 at mucosa! sites. Transfer of Treg cells ameliorated the infection-induced pathology observed in Il27(-/-) mice, and this was dependent on their ability to produce IL-10. Microarray analysis revealed that Treg cells exposed to either IFN-gamma or IL-27 have distinct transcriptional profiles. Thus, IFN-gamma and IL-27 have different roles in Treg cell biology and IL-27 is a key cytokine that promotes the development of Treg cells specialized to control Th1 cell-mediated immunity at local sites of inflammation.	[Hall, Aisling O'Hara; John, Beena; Lombana, Claudia Gonzalez; Pritchard, Gretchen Harms; Silver, Jonathan S.; Stumhofer, Jason S.; Harris, Tajie H.; Wojno, Ella D. Tait; Wagage, Sagie; Scott, Philip; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Beiting, Daniel P.; Roos, David S.; Cherry, Sara; Cua, Daniel] Univ Penn, Penn Genome Frontiers Inst, Dept Biol, Philadelphia, PA 19104 USA; [Tato, Cristina; Belkaid, Yasmine] DNAX Discovery Res, Merck Res Labs, Palo Alto, CA 94304 USA; [Reiner, Steven L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Oldenhove, Guillaume; Bouladoux, Nicolas; Grainger, John] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Turka, Laurence A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Transplant Inst, Boston, MA 02215 USA	University of Pennsylvania; University of Pennsylvania; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu	Beiting, Daniel/AAG-6275-2019	Roos, David Siker/0000-0001-6725-4089; Grainger, John/0000-0002-4052-5923; Hall, Aisling/0000-0001-8198-3245; Tato, Cristina M./0000-0002-0614-756X; Harris, Tajie/0000-0002-1355-2109; cherry, sara/0000-0003-3956-6610; Tait Wojno, Elia/0000-0003-2822-296X; Bouladoux, Nicolas/0000-0003-1593-671X; Belkaid, Yasmine/0000-0001-9962-3571	state of Pennsylvania, NIH [AI 071302, AI084882, R21-AI090234-01, R37-AI28724, AI055428]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042334, T32AI007532, P01AI043620, T32AI055400, R21AI090234, R01AI061699, R37AI028724, R01AI071302, T32AI055428] Funding Source: NIH RePORTER	state of Pennsylvania, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the state of Pennsylvania, NIH grants AI 071302 and AI084882 (C.A.H.), R21-AI090234-01 (B.J.), R37-AI28724 (D.S.R.), and AI055428 (A.O.H.). We thank K.A. Platt at Lexicon Pharmaceuticals, Inc. for the generation of the Il27<SUP>-/-</SUP>mice. We thank I. Brodsky and D. Campbell for helpful discussions.	Aliberti J, 2002, J EXP MED, V196, P1253, DOI 10.1084/jem.20021183; Apostolou I, 2008, J CLIN IMMUNOL, V28, P619, DOI 10.1007/s10875-008-9254-8; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Bhadra R, 2011, P NATL ACAD SCI USA, V108, P9196, DOI 10.1073/pnas.1015298108; Buzoni-Gatel D, 2001, GASTROENTEROLOGY, V120, P914, DOI 10.1053/gast.2001.22432a; Caretto D, 2010, J IMMUNOL, V184, P30, DOI 10.4049/jimmunol.0903412; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Couper KN, 2009, J IMMUNOL, V182, P3985, DOI 10.4049/jimmunol.0803053; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esposito M, 2010, J IMMUNOL, V185, P7467, DOI 10.4049/jimmunol.1001519; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fujimoto M, 2011, J IMMUNOL, V186, P32, DOI 10.4049/jimmunol.0903314; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hall AO, 2012, ADV IMMUNOL, V115, P1, DOI 10.1016/B978-0-12-394299-9.00001-1; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Jaakkola I, 2003, J IMMUNOL, V170, P1283, DOI 10.4049/jimmunol.170.3.1283; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Narayanan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010636; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Yoshida H, 2008, IMMUNOL REV, V226, P234, DOI 10.1111/j.1600-065X.2008.00710.x; Zheng SG, 2006, INT IMMUNOL, V18, P279, DOI 10.1093/intimm/dxh368; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	50	247	261	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 21	2012	37	3					511	523		10.1016/j.immuni.2012.06.014	http://dx.doi.org/10.1016/j.immuni.2012.06.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22981537	Green Accepted, Bronze			2022-12-18	WOS:000309199000015
J	Ogasawara, K; Hamerman, JA; Ehrlich, LR; Bour-Jordan, H; Santamaria, P; Bluestone, JA; Lanier, LL				Ogasawara, K; Hamerman, JA; Ehrlich, LR; Bour-Jordan, H; Santamaria, P; Bluestone, JA; Lanier, LL			NKG2D blockade prevents autoimmune diabetes in NOD mice	IMMUNITY			English	Article							T-CELLS; INSULITIS; RECEPTOR; LIGANDS; MOUSE; IMMUNORECEPTOR; PROGRESSION; MODULATION; EXPRESSION; ACTIVATION	NKG2D is an activating receptor on CD8(+) T cells and NK cells that has been implicated in immunity against tumors and microbial pathogens. Here we show that RAE-1 is present in prediabetic pancreas islets of NOD mice and that autoreactive CD8(+) T cells infiltrating the pancreas express NKG2D. Treatment with a nondepleting anti-NKG2D monoclonal antibody (mAb) during the prediabetic stage completely prevented disease by impairing the expansion and function of autoreactive CD8(+) T cells. These findings demonstrate that NKG2D is essential for disease progression and suggest a new therapeutic target for autoimmune type I diabetes.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calgary, Fac Med, Julia McFarlane Diabet Res Ctr, Calgary, AB T2N 4N1, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Calgary	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, HSW 1114,Box 0540,513 Parnassus Ave, San Francisco, CA 94143 USA.	lanier@itsa.ucsf.edu	Lanier, Lewis L/E-2139-2014; Santamaria, Pere/ABF-6823-2021; Ogasawara, Kouetsu/G-9892-2011	Lanier, Lewis L/0000-0003-1308-3952; Ehrlich, Lauren/0000-0002-1697-1755	NATIONAL CANCER INSTITUTE [R01CA089189] Funding Source: NIH RePORTER; NCI NIH HHS [CA89189] Funding Source: Medline; NIDDK NIH HHS [P60 DK63720] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Balasa B, 1997, J IMMUNOL, V159, P4620; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 1998, J IMMUNOL, V161, P97; Cerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Guo ZG, 1998, TRANSPLANTATION, V65, P1310, DOI 10.1097/00007890-199805270-00005; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; KATZ J, 1993, EUR J IMMUNOL, V23, P3358, DOI 10.1002/eji.1830231244; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Liblau RS, 2002, IMMUNITY, V17, P1, DOI 10.1016/S1074-7613(02)00338-2; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; NAGATA M, 1994, J IMMUNOL, V152, P2042; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Serra P, 2002, P NATL ACAD SCI USA, V99, P15566, DOI 10.1073/pnas.242321099; Serreze DV, 2001, CURR DIRECT AUTOIMMU, V4, P31; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Trudeau JD, 2003, J CLIN INVEST, V111, P217, DOI 10.1172/JCI200316409; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	34	247	267	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2004	20	6					757	767		10.1016/j.immuni.2004.05.008	http://dx.doi.org/10.1016/j.immuni.2004.05.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY	15189740	Bronze			2022-12-18	WOS:000222205300011
J	Pai, SY; Truitt, ML; Ting, CN; Leiden, JM; Glimcher, LH; Ho, IC				Pai, SY; Truitt, ML; Ting, CN; Leiden, JM; Glimcher, LH; Ho, IC			Critical roles for transcription factor GATA-3 in thymocyte development	IMMUNITY			English	Article							T-CELL DEVELOPMENT; ADAPTER PROTEIN SLP-76; RECEPTOR-ALPHA-GENE; LINEAGE COMMITMENT; NEGATIVE SELECTION; MICE LACKING; TCR SIGNALS; EXPRESSION; BETA; DIFFERENTIATION	The transcription factor GATA-3 is expressed at every stage of thymic development, but its role in thymocyte differentiation is unknown. The fact that RAG chimeric animals lacking GATA-3 cannot generate early thymocytes from common lymphoid progenitors has thus far precluded investigation of the function of GATA-3 in the thymus. To address this, we generated mice deficient in GATA-3 at early and late stages of thymic differentiation. Our studies revealed that GATA-3 is involved in beta selection and is indispensable for single-positive CD4 thymocyte development. Thus, our data demonstrate that the coordinated and regulated expression of GATA-3 at each stage of thymic development is critical for the generation of mature T cells.	Dana Farber Canc Inst, Dept Pediat Hematol & Oncol, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Ctr Prevent Cardiovasc Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Div Infect Dis & Immunol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Ho, IC (corresponding author), Dana Farber Canc Inst, Dept Pediat Hematol & Oncol, Boston, MA 02115 USA.		Pai, Sung-Yun/AAH-7762-2019	Pai, Sung-Yun/0000-0002-0158-8147	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050601, R01AI029673] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI50601, R01 AI029673] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Borowski C, 2002, CURR OPIN IMMUNOL, V14, P200, DOI 10.1016/S0952-7915(02)00322-9; Chen L, 1997, J I ENERGY, V70, P2; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fujimoto Y, 2002, CELL, V108, P755, DOI 10.1016/S0092-8674(02)00673-6; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; HENDERSON AJ, 1994, MOL CELL BIOL, V14, P4286, DOI 10.1128/MCB.14.6.4286; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; JOULIN V, 1991, EMBO J, V10, P1809, DOI 10.1002/j.1460-2075.1991.tb07706.x; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; LANDRY DB, 1993, J EXP MED, V178, P941, DOI 10.1084/jem.178.3.941; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Sharp LL, 1999, J IMMUNOL, V163, P6598; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Sprent J, 2002, IMMUNOL REV, V185, P126, DOI 10.1034/j.1600-065X.2002.18512.x; Staal FJT, 2003, CURR OPIN IMMUNOL, V15, P204, DOI 10.1016/S0952-7915(03)00003-7; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Thien CBF, 2003, J EXP MED, V197, P503, DOI 10.1084/jem.20021498; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	43	247	260	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2003	19	6					863	875		10.1016/S1074-7613(03)00328-5	http://dx.doi.org/10.1016/S1074-7613(03)00328-5			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670303	Bronze			2022-12-18	WOS:000187230700011
J	Shrikant, P; Khoruts, A; Mescher, MF				Shrikant, P; Khoruts, A; Mescher, MF			CTLA-4 blockade reverses CD8(+) T cell tolerance to tumor by a CD4(+) T cell-and IL-2-dependent mechanism	IMMUNITY			English	Article							THYMOMA-BEARING MICE; ANTITUMOR IMMUNITY; IN-VIVO; DENDRITIC CELLS; VIRAL-INFECTION; SOLUBLE-PROTEIN; RESPONSES; INDUCTION; ANTIGEN; LYMPHOCYTES	A tumor-specific CD8(+) T cell response was studied using adoptive transfer of OT-I TCR transgenic cells. Upon i.p. challenge with E.G7 tumor, OT-1 cells undergo CD4(+) T cell-independent expansion at the tumor site and develop lytic function. Before tumor elimination, however, they leave the peritoneal cavity (PC) and appear in the LN and spleen where they exhibit "split anergy" and cannot further proliferate to antigen. Administering anti-CTLA-4 mAb early caused sustained OT-1 expansion in the PC, and late administration caused the OT-1 cells to return to the PC and further expand; in both cases, tumor was controlled. These effects required CD4(+) T cells and IL-2 and appear to result from reversal of the nonresponsive state of the CD8(+) T cells.	Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mescher, MF (corresponding author), Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.		Mescher, Matthew/B-8068-2009		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035296, R01AI034824] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34824, AI35296] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Brossart P, 1997, J IMMUNOL, V158, P3270; Chambers CA, 1998, EUR J IMMUNOL, V28, P3137, DOI 10.1002/(SICI)1521-4141(199810)28:10<3137::AID-IMMU3137>3.0.CO;2-X; Chambers CA, 1996, IMMUNOL REV, V153, P27, DOI 10.1111/j.1600-065X.1996.tb00919.x; Chaux P, 1999, J EXP MED, V189, P767, DOI 10.1084/jem.189.5.767; D'Souza S, 1998, INT J CANCER, V78, P699, DOI 10.1002/(SICI)1097-0215(19981209)78:6<699::AID-IJC6>3.0.CO;2-U; Deeths MJ, 1999, J IMMUNOL, V163, P102; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; FENTON RG, 1993, JNCI-J NATL CANCER I, V85, P1294, DOI 10.1093/jnci/85.16.1294; GREENBERG PD, 1981, J EXP MED, V154, P952, DOI 10.1084/jem.154.3.952; Halder T, 1997, CANCER RES, V57, P3238; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Hurwitz AA, 1998, P NATL ACAD SCI USA, V95, P10067, DOI 10.1073/pnas.95.17.10067; Jantzer P, 1998, CANCER RES, V58, P3078; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Kwon ED, 1997, P NATL ACAD SCI USA, V94, P8099, DOI 10.1073/pnas.94.15.8099; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Manici S, 1999, J EXP MED, V189, P871, DOI 10.1084/jem.189.5.871; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McCoy KD, 1999, J EXP MED, V189, P1157, DOI 10.1084/jem.189.7.1157; MINEV BR, 1994, CANCER RES, V54, P4155; Mokyr MB, 1998, CANCER RES, V58, P5301; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; NEWMAN MJ, 1992, J IMMUNOL, V148, P2357; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; OTTEN GR, 1991, SCIENCE, V251, P1228, DOI 10.1126/science.1900952; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Pieper R, 1999, J EXP MED, V189, P757, DOI 10.1084/jem.189.5.757; Porgador A, 1996, J IMMUNOL, V156, P2918; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; Shrikant P, 1999, J IMMUNOL, V162, P2858; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Stevenson PG, 1998, P NATL ACAD SCI USA, V95, P15565, DOI 10.1073/pnas.95.26.15565; Topalian SL, 1996, J EXP MED, V183, P1965, DOI 10.1084/jem.183.5.1965; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Yang YF, 1997, CANCER RES, V57, P4036; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; ZHOU F, 1992, CANCER RES, V52, P6287	45	247	256	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1999	11	4					483	493		10.1016/S1074-7613(00)80123-5	http://dx.doi.org/10.1016/S1074-7613(00)80123-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249QE	10549630	Bronze			2022-12-18	WOS:000083343100010
J	Zhou, RH; To, KKW; Wong, YC; Liu, L; Zhou, B; Li, X; Huang, HD; Mo, YF; Luk, TY; Lau, TTK; Yeung, P; Chan, WM; Wu, AKL; Lung, KC; Tsang, OTY; Leung, WS; Hung, IFN; Yuen, KY; Chen, ZW				Zhou, Runhong; To, Kelvin Kai-Wang; Wong, Yik-Chun; Liu, Li; Zhou, Biao; Li, Xin; Huang, Haode; Mo, Yufei; Luk, Tsz-Yat; Lau, Thomas Tsz-Kan; Yeung, Pauline; Chan, Wai-Ming; Wu, Alan Ka-Lun; Lung, Kwok-Cheung; Tsang, Owen Tak-Yin; Leung, Wai-Shing; Hung, Ivan Fan-Ngai; Yuen, Kwok-Yung; Chen, Zhiwei			Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses	IMMUNITY			English	Article							ACUTE RESPIRATORY SYNDROME; NEUTRALIZING ANTIBODY-RESPONSE; SARS-CORONAVIRUS; PNEUMONIA; GLYCOPROTEIN; PROTECTION; COVID-19; DISEASE	The SARS-CoV-2 pandemic has resulted in millions of infections, yet the role of host immune responses in early COVID-19 pathogenesis remains unclear, By investigating 17 acute and 24 convalescent patients, we found that acute SARS-CoV-2 infection resulted in broad immune cell reduction including T, natural killer, monocyte, and dendritic cells (DCs). DCs were significantly reduced with functional impairment, and ratios of conventional DCs to plasmacytoid DCs were increased among acute severe patients. Besides lymphocytopenia, although neutralizing antibodies were rapidly and abundantly generated in patients, there were delayed receptor binding domain (RBD)- and nucleocapsid protein (NP)-specific T cell responses during the first 3 weeks after symptoms onset. Moreover, acute RBD- and NP-specific T cell responses included relatively more CD4 T cells than CD8 T cells. Our findings provided evidence that impaired DCs, together with timely inverted strong antibody but weak CD8 T cell responses, could contribute to acute COVID-19 pathogenesis and have implications for vaccine development.	[Zhou, Runhong; Wong, Yik-Chun; Liu, Li; Zhou, Biao; Li, Xin; Huang, Haode; Mo, Yufei; Luk, Tsz-Yat; Lau, Thomas Tsz-Kan; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Hong Kong, Peoples R China; [Zhou, Runhong; To, Kelvin Kai-Wang; Wong, Yik-Chun; Liu, Li; Zhou, Biao; Mo, Yufei; Yuen, Kwok-Yung; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Dept Microbiol, Hong Kong, Peoples R China; [Yeung, Pauline] Univ Hong Kong, Queen Mary Hosp, Dept Intens Care, Hong Kong, Peoples R China; [Chan, Wai-Ming] Queen Mary Hosp, Dept Adult Intens Care, Hong Kong, Peoples R China; [Wu, Alan Ka-Lun] Pamela Youde Nethersole Eastern Hosp, Dept Microbiol, Hong Kong, Peoples R China; [Lung, Kwok-Cheung] Pamela Youde Nethersole Eastern Hosp, Dept Med, Hong Kong, Peoples R China; [Tsang, Owen Tak-Yin; Leung, Wai-Shing] Princess Margaret Hosp, Dept Med, Hong Kong, Peoples R China; [Hung, Ivan Fan-Ngai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; Pamela Youde Nethersole Eastern Hospital; University of Hong Kong	Chen, ZW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Hong Kong, Peoples R China.; Yuen, KY; Chen, ZW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Dept Microbiol, Hong Kong, Peoples R China.	kyyuen@hku.hk; zchenai@hku.hk	Liu, Li/ABA-8315-2020; Hung, Ivan FN/ABD-5916-2021	Liu, Li/0000-0003-2566-7357; Hung, Ivan FN/0000-0002-1556-2538	Hong Kong Research Grants Council, University Development Fund [T11706/18-N]; Li Ka Shing Faculty of Medicine Matching Fund from HKU; Health and Medical Research Fund [COVID190123]; Food and Health Bureau, The Government of the Hong Kong Special Administrative Region; National Program on Key Research Project of China [2020YFA0707500, 2020YFA0707504]; Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Diseases and Research Capability on Antimicrobial Resistance for Department of Health of the Hong Kong Special Administrative Region Government; Research Grants Council, Hong Kong Special Administrative Region [T11/707/15]; Sanming Project of Medicine in Shenzhen, China [SZSM201911014]; Health Commission of Guangdong Province, China	Hong Kong Research Grants Council, University Development Fund(Hong Kong Research Grants Council); Li Ka Shing Faculty of Medicine Matching Fund from HKU; Health and Medical Research Fund; Food and Health Bureau, The Government of the Hong Kong Special Administrative Region; National Program on Key Research Project of China; Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Diseases and Research Capability on Antimicrobial Resistance for Department of Health of the Hong Kong Special Administrative Region Government; Research Grants Council, Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Sanming Project of Medicine in Shenzhen, China; Health Commission of Guangdong Province, China	This work was partly supported by Theme-Based Research Scheme (T11706/18-N to Z.C.) of the Hong Kong Research Grants Council, University Development Fund, and Li Ka Shing Faculty of Medicine Matching Fund from HKU to AIDS Institute. We thank Dr. Xu Aiming for providing purified NP protein. We also thank Serena J. Chen and Lok-Yan Yim for editorial work. Funding supports to K.Y. include the donations of the Shaw Foundation Hong Kong, Richard Yu and Carol Yu, May Tam Mak Mei Yin, Michael Seak-Kan Tong, Respiratory Viral Research Foundation Limited, Hui Ming, Hui Hoy and Chow Sin Lan Charity Fund Limited, Chan Yin Chuen Memorial Charitable Foundation, Marina Man-Wai Lee, the Hong Kong Hainan Commercial Association South China Microbiology Research Fund, the Jessie & George Ho Charitable Foundation, Perfect Shape Medical Limited, and Kai Chong Tong; funding from the Health and Medical Research Fund (grant no. COVID190123), the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region; the National Program on Key Research Project of China (grant no. 2020YFA0707500 and 2020YFA0707504); the Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Diseases and Research Capability on Antimicrobial Resistance for Department of Health of the Hong Kong Special Administrative Region Government; the Theme-Based Research Scheme (T11/707/15) of the Research Grants Council, Hong Kong Special Administrative Region; Sanming Project of Medicine in Shenzhen, China (No. SZSM201911014); and the High Level-Hospital Program, Health Commission of Guangdong Province, China. The funding sources had no role in study design, data collection, analysis, interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Chan JFW, 2020, J CLIN MICROBIOL, V58, DOI [10.1128/JCM.00310-20, 10.1128/JCM.00310-20.]; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chen HB, 2005, J IMMUNOL, V175, P591, DOI 10.4049/jimmunol.175.1.591; Chen J, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.004; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chiappelli F, 2020, BIOINFORMATION, V16, P219, DOI [10.6026/97320630016222, 10.6026/97320630016219]; Chu H, 2020, CLIN INFECT DIS, V71, P1400, DOI 10.1093/cid/ciaa410; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gutzmer R, 2004, J IMMUNOL, V173, P1023, DOI 10.4049/jimmunol.173.2.1023; Ho MS, 2005, EMERG INFECT DIS, V11, P1730, DOI 10.3201/eid1111.040659; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4; Jiang HW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17488-8; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Li CKF, 2008, J IMMUNOL, V181, P5490, DOI 10.4049/jimmunol.181.8.5490; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liu L, 2016, MUCOSAL IMMUNOL, V9, P1089, DOI 10.1038/mi.2015.127; Liu L, 2020, EMERG MICROBES INFEC, V9, P1664, DOI 10.1080/22221751.2020.1791738; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Lv YB, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-61; Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Schuler-Thurner B, 2002, J EXP MED, V195, P1279, DOI 10.1084/jem.20012100; Shin HS, 2019, CLIN INFECT DIS, V68, P984, DOI 10.1093/cid/ciy595; Tan W, 2020, VIRAL KINETICS ANTIB, DOI 10.1101/2020.03.24.20042382; Temperton NJ, 2005, EMERG INFECT DIS, V11, P411, DOI 10.3201/eid1103.040906; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Tseng CTK, 2005, J IMMUNOL, V174, P7977, DOI 10.4049/jimmunol.174.12.7977; Waldrop SL, 1998, J IMMUNOL, V161, P5284; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang P.H., 2020, INCREASING HOST CELL, DOI 10.1101/2020.02.24.963348; Wang YD, 2004, J VIROL, V78, P5612, DOI 10.1128/JVI.78.11.5612-5618.2004; Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001; Wu XL, 2018, J CLIN INVEST, V128, P2239, DOI 10.1172/JCI96764; XU B, 2020, J INFECTION, V81, pE51, DOI 10.1016/j.jinf.2020.04.012; Xu XJ, 2004, CELL MOL IMMUNOL, V1, P119; Yi CE, 2005, J VIROL, V79, P11638, DOI 10.1128/JVI.79.18.11638-11646.2005; Zhang LQ, 2006, J MED VIROL, V78, P1, DOI 10.1002/jmv.20499; Zhang Zheng, 2004, Zhonghua Yi Xue Za Zhi, V84, P22; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10; Zheng YL, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104366; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	54	246	248	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					864	+		10.1016/j.immuni.2020.07.026	http://dx.doi.org/10.1016/j.immuni.2020.07.026			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	32791036	Bronze, Green Published			2022-12-18	WOS:000581062800017
J	Kryczek, I; Lin, YW; Nagarsheth, N; Peng, DJ; Zhao, LL; Zhao, ED; Vatan, L; Szeliga, W; Dou, YL; Owens, S; Zgodzinski, W; Majewski, M; Wallner, G; Fang, JY; Huang, E; Zou, WP				Kryczek, Ilona; Lin, Yanwei; Nagarsheth, Nisha; Peng, Dongjun; Zhao, Lili; Zhao, Ende; Vatan, Linda; Szeliga, Wojciech; Dou, Yali; Owens, Scott; Zgodzinski, Witold; Majewski, Marek; Wallner, Grzegorz; Fang, Jingyuan; Huang, Emina; Zou, Weiping			IL-22(+)CD4(+) T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L	IMMUNITY			English	Article							NF-KAPPA-B; COLON-CANCER; OVARIAN-CARCINOMA; INTERLEUKIN 22; IMMUNE CELLS; HOST-DEFENSE; HISTONE H3; IL-22; INFLAMMATION; EXPRESSION	Little is known about how the immune system impacts human colorectal cancer invasiveness and stemness. Here we detected interleukin-22 (IL-22) in patient colorectal cancer tissues that was produced predominantly by CD4(+) T cells. In a mouse model, migration of these cells into the colon cancer microenvironment required the chemokine receptor CCR6 and its ligand CCL20. IL-22 acted on cancer cells to promote activation of the transcription factor STAT3 and expression of the histone 3 lysine 79 (H3K79) methytransferase DOT1L. The DOT1L complex induced the core stem cell genes NANOG, SOX2, and Pou5F1, resulting in increased cancer stemness and tumorigenic potential. Furthermore, high DOT1L expression and H3K79me2 in colorectal cancer tissues was a predictor of poor patient survival. Thus, IL-22(+) cells promote colon cancer stemness via regulation of stemness genes that negatively affects patient outcome. Efforts to target this network might be a strategy in treating colorectal cancer patients.	[Kryczek, Ilona; Lin, Yanwei; Nagarsheth, Nisha; Peng, Dongjun; Zhao, Ende; Vatan, Linda; Szeliga, Wojciech; Zou, Weiping] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Lin, Yanwei; Fang, Jingyuan] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Gastroenterol & Hepatol, Shanghai 200001, Peoples R China; [Nagarsheth, Nisha] Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Zhao, Lili] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; [Dou, Yali; Owens, Scott] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Zgodzinski, Witold; Majewski, Marek; Wallner, Grzegorz] Med Univ Lublin, Dept Gen Surg 2, PL-20081 Lublin, Poland; [Huang, Emina] Univ Florida, Dept Surg, Gainesville, FL 32610 USA; [Zou, Weiping] Univ Michigan, Sch Med, Grad Program Tumor Biol, Ann Arbor, MI 48109 USA; [Zou, Weiping] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Shanghai Jiao Tong University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Medical University of Lublin; State University System of Florida; University of Florida; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zou, WP (corresponding author), Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA.	wzou@med.umich.edu	Zhao, Ende/B-9851-2013	Zhao, Ende/0000-0002-1355-6919; Wallner, Grzegorz/0000-0002-0486-0484; Zgodzinski, Witold/0000-0003-3838-5789; Nagarsheth, Nisha/0000-0002-9508-1530; Huang, Emina/0000-0003-2495-4370	National Institutes of Health [CA123088, CA099985, CA156685, CA171306, CA142808, CA157663]; NATIONAL CANCER INSTITUTE [R01CA099985, R01CA152470, R01CA171306, R01CA156685, R01CA142808, R01CA157663, R01CA123088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported (in part) by the National Institutes of Health grants (CA123088, CA099985, CA156685, and CA171306 for W.Z.; CA142808 and CA157663 for E. H.). We thank Wolf-Herve Fridman and Jay Hess for their intellectual support and valuable discussions and Deborah Postiff, Michelle Vinco, and Jackline Barikdar in the Tissue Procurement Core for their technical assistance. We are grateful for Weisheng Wu and Yongsheng Bai in the Bioinformatic Core for their help.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang MJ, 2010, CANCER RES, V70, P10234, DOI 10.1158/0008-5472.CAN-10-3294; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Cui TX, 2013, IMMUNITY, V39, P611, DOI 10.1016/j.immuni.2013.08.025; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Hutchins AP, 2013, NUCLEIC ACIDS RES, V41, P2155, DOI 10.1093/nar/gks1300; Jo SY, 2011, BLOOD, V117, P4759, DOI 10.1182/blood-2010-12-327668; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kryczek I, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002949; Kryczek I, 2012, INT J CANCER, V130, P29, DOI 10.1002/ijc.25967; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li L, 2006, J BIOL CHEM, V281, P33172, DOI 10.1074/jbc.M606940200; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Matthews JR, 2011, CELL DEATH DIFFER, V18, P1934, DOI 10.1038/cdd.2011.77; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Thompson CL, 2010, CANCER CAUSE CONTROL, V21, P1165, DOI 10.1007/s10552-010-9542-5; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200; Yang E, 2003, J BIOL CHEM, V278, P15794, DOI 10.1074/jbc.M213073200; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu WY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2304; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	59	246	262	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					772	784		10.1016/j.immuni.2014.03.010	http://dx.doi.org/10.1016/j.immuni.2014.03.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24816405	Green Accepted, Bronze			2022-12-18	WOS:000336026100015
J	Powell, N; Walker, AW; Stolarczyk, E; Canavan, JB; Gokmen, MR; Marks, E; Jackson, I; Hashim, A; Curtis, MA; Jenner, RG; Howard, JK; Parkhill, J; MacDonald, TT; Lord, GM				Powell, Nick; Walker, Alan W.; Stolarczyk, Emilie; Canavan, James B.; Goekmen, M. Refik; Marks, Ellen; Jackson, Ian; Hashim, Ahmed; Curtis, Michael A.; Jenner, Richard G.; Howard, Jane K.; Parkhill, Julian; MacDonald, Thomas T.; Lord, Graham M.			The Transcription Factor T-bet Regulates Intestinal Inflammation Mediated by Interleukin-7 Receptor(+) Innate Lymphoid Cells	IMMUNITY			English	Article							COLITIS; IL-7; DEFICIENCY; TYPHLITIS; DATABASE; MUCOSAL; ADULT; LOCI	Mice lacking the transcription factor T-bet in the innate immune system develop microbiota-dependent colitis. Here, we show that interleukin-17A (IL-17A)-producing IL-7R alpha(+) innate lymphoid cells (ILCs) were potent promoters of disease in Tbx21(-/-)Rag2(-/-) ulcerative colitis (TRUC) mice. TNF-alpha produced by CD103(-)CD11b(+) dendritic cells synergized with IL-23 to drive IL-17A production by ILCs, demonstrating a previously unrecognized layer of cellular crosstalk between dendritic cells and ILCs. We have identified Helicobacter typhlonius as a key disease trigger driving excess TNF-a alpha production and promoting colitis in TRUC mice. Crucially, T-bet also suppressed the expression of IL-7R, a key molecule involved in controlling intestinal ILC homeostasis. The importance of IL-7R signaling in TRUC disease was highlighted by the dramatic reduction in intestinal ILCs and attenuated colitis following IL-7R blockade. Taken together, these data demonstrate the mechanism by which T-bet regulates the complex interplay between mucosal dendritic cells, ILCs, and the intestinal microbiota.	[Powell, Nick; Stolarczyk, Emilie; Canavan, James B.; Goekmen, M. Refik; Marks, Ellen; Jackson, Ian; Howard, Jane K.; Lord, Graham M.] Kings Coll London, Div Transplantat Immunol & Mucosal Biol, Dept Expt Immunobiol, London SE1 9RT, England; [Powell, Nick; Canavan, James B.; Marks, Ellen; Hashim, Ahmed; Curtis, Michael A.; MacDonald, Thomas T.] Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Immunol & Infect Dis, London E1 2AT, England; [Powell, Nick; Canavan, James B.; Marks, Ellen; Jackson, Ian; Lord, Graham M.] Guys & St Thomas Natl Hlth Serv Fdn Trust, Biomed Res Ctr, Natl Inst Hlth Res, London SE1 9RT, England; [Walker, Alan W.; Parkhill, Julian] Wellcome Trust Sanger Inst, Pathogen Genom Grp, Cambridge CB10 1SA, England; [Stolarczyk, Emilie; Howard, Jane K.] Kings Coll London, Div Diabet & Nutr Sci, London SE1 9NH, England; [Jenner, Richard G.] UCL, UCL Canc Inst, London WC1E 6BT, England; [Jenner, Richard G.] UCL, Div Infect & Immun, London WC1E 6BT, England	University of London; King's College London; University of London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; Wellcome Trust Sanger Institute; University of London; King's College London; University of London; University College London; University of London; University College London	Lord, GM (corresponding author), Kings Coll London, Div Transplantat Immunol & Mucosal Biol, Dept Expt Immunobiol, London SE1 9RT, England.	graham.lord@kcl.ac.uk	Powell, Nicholas/F-3498-2014; Parkhill, Julian/G-4703-2011; Walker, Alan W/E-8055-2011; Abraham, Sabu/E-1144-2019; Walker, Alan W./AAE-8102-2019; Jenner, Richard/J-8683-2012	Parkhill, Julian/0000-0002-7069-5958; Abraham, Sabu/0000-0002-0916-5827; Walker, Alan W./0000-0001-5099-8495; Jenner, Richard/0000-0002-2946-6811; Powell, Nick/0000-0003-3231-6950; Hashim, Ahmed/0000-0001-5079-3203; Gokmen, Refik/0000-0001-7388-217X; Howard, Jane/0000-0003-2754-8300; Lord, Graham/0000-0003-2069-4743	Medical Research Council [G0802068]; Wellcome Trust [WT088747MA, WT076964]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's; St Thomas' National Health Service (NHS) Foundation Trust and King's College London; MRC [G0600081, MR/K002996/1, G0802068, MR/J011118/1] Funding Source: UKRI; Medical Research Council [MR/J006742/1, MR/K002996/1, G0600081, MR/J011118/1] Funding Source: researchfish; National Institute for Health Research [DRF-2009-02-22, CL-2010-17-010] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's(National Institute for Health Research (NIHR)); St Thomas' National Health Service (NHS) Foundation Trust and King's College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by grants awarded by the Medical Research Council (G.M.L., T.T.M., grant number G0802068) and the Wellcome Trust (N.P., G.M.L., T.T.M., grant number WT088747MA). Funding for A.W. and J.P. and for 16S rRNA gene sequencing was provided by the Wellcome Trust (grant number WT076964). We are grateful to L. Glimcher, Harvard University, for the kind gift of TRUC mice and to C. Evagora and support staff at the Pathology core at Queen Mary University of London. Research was also supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beckwith CS, 1997, J CLIN MICROBIOL, V35, P1620, DOI 10.1128/JCM.35.6.1620-1623.1997; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chassaing B, 2011, J CLIN INVEST, V121, P966, DOI 10.1172/JCI44632; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Feng SL, 2005, CLIN DIAGN LAB IMMUN, V12, P531, DOI 10.1128/CDLI.12.4.531-536.2005; Fox JG, 1999, INFECT IMMUN, V67, P1757; Franklin CL, 2001, J CLIN MICROBIOL, V39, P3920, DOI 10.1128/JCM.39.11.3920-3926.2001; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kim MY, 2005, J IMMUNOL, V174, P6686, DOI 10.4049/jimmunol.174.11.6686; Kim TW, 2006, WORLD J GASTROENTERO, V12, P302, DOI 10.3748/wjg.v12.i2.302; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Li XT, 1998, INFECT IMMUN, V66, P5477, DOI 10.1128/IAI.66.11.5477-5484.1998; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Powell N, 2010, MUCOSAL IMMUNOL, V3, P567, DOI 10.1038/mi.2010.53; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reinisch W, 2010, INFLAMM BOWEL DIS, V16, P233, DOI 10.1002/ibd.21038; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmutz S, 2009, J IMMUNOL, V183, P2217, DOI 10.4049/jimmunol.0802911; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Veiga P, 2010, P NATL ACAD SCI USA, V107, P18132, DOI 10.1073/pnas.1011737107; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352	42	246	252	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 19	2012	37	4					674	684		10.1016/j.immuni.2012.09.008	http://dx.doi.org/10.1016/j.immuni.2012.09.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23063332	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000310185400012
J	Starossom, SC; Mascanfroni, ID; Imitola, J; Cao, L; Raddassi, K; Hernandez, SF; Bassil, R; Croci, DO; Cerliani, JP; Delacour, D; Wang, Y; Elyaman, W; Khoury, SJ; Rabinovich, GA				Starossom, Sarah C.; Mascanfroni, Ivan D.; Imitola, Jaime; Cao, Li; Raddassi, Khadir; Hernandez, Silvia F.; Bassil, Ribal; Croci, Diego O.; Cerliani, Juan P.; Delacour, Delphine; Wang, Yue; Elyaman, Wassim; Khoury, Samia J.; Rabinovich, Gabriel A.			Galectin-1 Deactivates Classically Activated Microglia and Protects from Inflammation-Induced Neurodegeneration	IMMUNITY			English	Article							NITRIC-OXIDE PRODUCTION; MULTIPLE-SCLEROSIS; NEURONAL DYSFUNCTION; T-CELLS; INHIBITION; EFFECTOR; IMMUNITY; INNATE; DIFFERENTIATION; IDENTIFICATION	Inflammation-mediated neurodegeneration occurs in the acute and the chronic phases of multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Classically activated (M1) microglia are key players mediating this process. Here, we identified Galectin-1 (Gal1), an endogenous glycan-binding protein, as a pivotal regulator of M1 microglial activation that targets the activation of p38MAPK-, CREB-, and NF-kappa B-dependent signaling pathways and hierarchically suppresses downstream proinflammatory mediators, such as iNOS, TNF, and CCL2. Gal1 bound to core 2 O-glycans on CD45, favoring retention of this glycoprotein on the microglial cell surface and augmenting its phosphatase activity and inhibitory function. Gal1 was highly expressed in the acute phase of EAE, and its targeted deletion resulted in pronounced inflammation-induced neurodegeneration. Adoptive transfer of Gal1-secreting astrocytes or administration of recombinant Gal1 suppressed EAE through mechanisms involving microglial deactivation. Thus, Gal1-glycan interactions are essential in tempering microglial activation, brain inflammation, and neurodegeneration, with critical therapeutic implications for MS.	[Starossom, Sarah C.; Imitola, Jaime; Cao, Li; Raddassi, Khadir; Bassil, Ribal; Wang, Yue; Elyaman, Wassim; Khoury, Samia J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Mascanfroni, Ivan D.; Hernandez, Silvia F.; Croci, Diego O.; Cerliani, Juan P.; Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn CONICET, Lab Inmunopatol, Inst Biol & Med Expt IBYME, RA-1428 Buenos Aires, DF, Argentina; [Cao, Li] Second Mil Med Univ, Inst Neurosci, Dept Neurobiol, Shanghai 200433, Peoples R China; [Delacour, Delphine] Paris Diderot Univ, Inst Jacques Monod, Dept Dev Biol, CNRS 7592, F-75205 Paris, France; [Khoury, Samia J.] Amer Univ Beirut, Abu Haidar Neurosci Inst, Beirut 11072020, Lebanon; [Rabinovich, Gabriel A.] Univ Buenos Aires, Lab Glicom Func, Dept Quim Biol, Fac Ciencias Exactas & Nat, RA-1428 Buenos Aires, DF, Argentina	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Naval Medical University; UDICE-French Research Universities; Universite Paris Cite; American University of Beirut; University of Buenos Aires	Khoury, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	skhoury@rics.bwh.harvard.edu; gabyrabi@gmail.com	Croci, Diego/AAJ-5709-2021; Elyaman, Wassim/AAJ-1562-2021; imitola, jaime/J-8478-2015	Croci, Diego/0000-0002-8623-0645; Delacour, Delphine/0000-0001-8202-4425; Starossom, Sarah/0000-0001-7935-9910; khoury, samia/0000-0003-3198-6063; Elyaman, Wassim/0000-0001-7238-374X	National Multiple Sclerosis Society [RG4530, RG3945]; NIH [AI071448, AI058680]; German National Academic Foundation; Argentinian Agency for Promotion of Science and Technology; Mizutani Foundation for Glycoscience; University of Buenos Aires; Argentinian National Research Council; Fundacion SALES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI058680, R01AI043496, R01AI071448, R01AI058680] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German National Academic Foundation; Argentinian Agency for Promotion of Science and Technology(ANPCyT); Mizutani Foundation for Glycoscience; University of Buenos Aires(University of Buenos Aires); Argentinian National Research Council; Fundacion SALES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Poirer for Lgals1<SUP>-/-</SUP> mice, J. Stupirski and C. Leishman for technical assistance, and B. Waksman, B. Zhu, and M. Rubinstein for helpful discussions. This study was supported by grants from the National Multiple Sclerosis Society (RG4530 to G.A.R. and RG3945 to S.J.K.) and NIH (AI071448, AI058680 to S.J.K.), a European Recovery Program project scholarship and a doctoral fellowship of the German National Academic Foundation (to S.C.S.), the Argentinian Agency for Promotion of Science and Technology (to G.A.R.), the Mizutani Foundation for Glycoscience (to G.A.R.), the University of Buenos Aires (to G.A.R.), the Argentinian National Research Council (to G.A.R.), and Fundacion SALES (to G.A.R.). We thank the Ferioli and Ostry families for donations.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cedeno-Laurent F, 2012, J IMMUNOL, V188, P3127, DOI 10.4049/jimmunol.1103433; Cui YQ, 2010, CLIN EXP PHARMACOL P, V37, P422, DOI 10.1111/j.1440-1681.2009.05314.x; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Jeon SB, 2010, J IMMUNOL, V185, P7037, DOI 10.4049/jimmunol.1000154; Jiang HR, 2009, J IMMUNOL, V182, P1167, DOI 10.4049/jimmunol.182.2.1167; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kawanokuchi J, 2008, J NEUROIMMUNOL, V194, P54, DOI 10.1016/j.jneuroim.2007.11.006; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Mirzoeva S, 1999, BRAIN RES, V844, P126, DOI 10.1016/S0006-8993(99)01911-3; Norling LV, 2008, FASEB J, V22, P682, DOI 10.1096/fj.07-9268com; OFFNER H, 1990, J NEUROIMMUNOL, V28, P177, DOI 10.1016/0165-5728(90)90032-I; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pasquini LA, 2011, CELL DEATH DIFFER, V18, P1746, DOI 10.1038/cdd.2011.40; Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; Rasmussen S, 2007, BRAIN, V130, P2816, DOI 10.1093/brain/awm219; Rotshenker S, 2008, GLIA, V56, P1607, DOI 10.1002/glia.20713; Salemi J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-3; Sasaki T, 2004, GLYCOBIOLOGY, V14, P357, DOI 10.1093/glycob/cwh043; Stancic M, 2012, GLIA, V60, P919, DOI 10.1002/glia.22324; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Toscano MA, 2006, J IMMUNOL, V176, P6323, DOI 10.4049/jimmunol.176.10.6323; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tsuboi S, 2011, EMBO J, V30, P3173, DOI 10.1038/emboj.2011.215; van der Leij J, 2007, MOL IMMUNOL, V44, P506, DOI 10.1016/j.molimm.2006.02.011; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; Walther M, 2000, J NEUROSCI RES, V61, P430, DOI 10.1002/1097-4547(20000815)61:4<430::AID-JNR9>3.0.CO;2-3; Wang Y, 2008, ANN NEUROL, V64, P417, DOI 10.1002/ana.21457; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Wei Q, 2007, J NEUROCHEM, V101, P1214, DOI 10.1111/j.1471-4159.2007.04488.x; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Xing B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-4; Zamvil SS, 2003, NEURON, V38, P685, DOI 10.1016/S0896-6273(03)00326-X; Zhang F, 2010, J PHARMACOL EXP THER, V333, P822, DOI 10.1124/jpet.110.165829	49	246	252	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 24	2012	37	2					249	263		10.1016/j.immuni.2012.05.023	http://dx.doi.org/10.1016/j.immuni.2012.05.023			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22884314	Green Accepted, Bronze			2022-12-18	WOS:000308261800010
J	Sumen, C; Mempel, TR; Mazo, IB; von Andrian, UH				Sumen, C; Mempel, TR; Mazo, IB; von Andrian, UH			Intravital microscopy: Visualizing immunity in context	IMMUNITY			English	Review							CD8-ALPHA(+) DENDRITIC CELLS; HEMATOPOIETIC STEM-CELLS; MEMORY T-CELLS; BONE-MARROW; IN-VIVO; LYMPH-NODES; IMMUNOLOGICAL SYNAPSE; ENDOTHELIAL SELECTINS; ANTIGEN PRESENTATION; HUMORAL IMMUNITY	Recent advances in photonics, particularly multi-photon microscopy (MPM) and new molecular and genetic tools are empowering immunologists to answer long-standing unresolved questions in living animals. Using intravital microscopy (IVM) investigators are dissecting the cellular and molecular underpinnings controlling immune cell motility and interactions in tissues. Recent IVM work showed that T cell responses to antigen in lymph nodes are different from those observed in vitro and appear dictated by factors uniquely relevant to intact organs. Other IVM models, particularly in the bone marrow, reveal how different anatomic contexts regulate leukocyte development, immunity, and inflammation. This article will discuss the current state of the field and outline how IVM can generate new discoveries and serve as a "reality check" for areas of research that were formerly the exclusive domain of in vitro experimentation.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	uva@cbr.med.harvard.edu	von Andrian, Ulrich H/A-5775-2008		NHLBI NIH HHS [HL62524, HL56949, HL54936] Funding Source: Medline; NIAID NIH HHS [AI061663] Funding Source: Medline; NIAMS NIH HHS [AR042689] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054936, P01HL056949, R01HL062524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abo T, 2000, IMMUNOL REV, V174, P135, DOI 10.1034/j.1600-0528.2002.017415.x; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; ATHERTON A, 1972, J PHYSIOL-LONDON, V222, P447, DOI 10.1113/jphysiol.1972.sp009808; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Barrett T A, 1995, Semin Immunol, V7, P299, DOI 10.1016/1044-5323(95)90011-X; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; BRANEMARK PI, 1959, VITAL MICROSCOPY BON; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; Cohnheim J., 1889, LECT GEN PATHOLOGY H; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; DAVIGNON D, 1981, J IMMUNOL, V127, P590; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Di Rosa F, 2003, IMMUNOLOGY, V108, P296, DOI 10.1046/j.1365-2567.2003.01593.x; Di Rosa F, 2002, EUR J IMMUNOL, V32, P1873; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Ellyard JI, 2004, BLOOD, V103, P3805, DOI 10.1182/blood-2003-09-3109; Enghofer M, 1995, EXP CLIN ENDOCR DIAB, V103, P99, DOI 10.1055/s-0029-1211403; FALKVOLL KH, 1984, EXP CELL BIOL, V52, P260; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Feuerer M, 2001, NAT MED, V7, P452, DOI 10.1038/86523; Feuerer M, 2001, INT J CANCER, V92, P96, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1152>3.0.CO;2-Q; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Fujimori H, 2002, GASTROENTEROLOGY, V122, P734, DOI 10.1053/gast.2002.31899; Funakoshi N, 2000, MICROVASC RES, V59, P361, DOI 10.1006/mvre.2000.2238; Germain RN, 2002, ADV EXP MED BIOL, V512, P97; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grayson MH, 2003, AM J PHYSIOL-HEART C, V284, pH2213, DOI 10.1152/ajpheart.00999.2002; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; HENDRIKS HR, 1987, EUR J IMMUNOL, V17, P1691, DOI 10.1002/eji.1830171203; HERMANS MHA, 1989, J IMMUNOL, V142, P67; Hideshima T, 2003, IMMUNOL REV, V194, P164, DOI 10.1034/j.1600-065X.2003.00053.x; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; HORNY HP, 1989, BRIT J HAEMATOL, V71, P313; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778; John B, 2004, J IMMUNOL, V172, P5222, DOI 10.4049/jimmunol.172.9.5222; Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556; Jones TR, 2003, J CLIN INVEST, V112, P1714, DOI 10.1172/JCI19391; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Kuroda MJ, 2000, BLOOD, V96, P1474, DOI 10.1182/blood.V96.4.1474.h8001474_1474_1479; Lakkis FG, 2000, NAT MED, V6, P686, DOI 10.1038/76267; Lawler C, 2003, AM J PHYSIOL-LUNG C, V285, pL269, DOI 10.1152/ajplung.00424.2002; LAWRENCE MB, 1995, EUR J IMMUNOL, V25, P1025, DOI 10.1002/eji.1830250425; LAWRENCE MB, 1987, BLOOD, V70, P1284; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; LEUNIG M, 1992, CANCER RES, V52, P6553; LORD BI, 1975, BLOOD, V46, P65; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Maheshwari G, 1998, MICROSC RES TECHNIQ, V43, P358, DOI 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-D; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Massberg S, 1998, BLOOD, V92, P507, DOI 10.1182/blood.V92.2.507; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mazo IB, 2002, BLOOD, V99, P4182, DOI 10.1182/blood.V99.11.4182; MCCUSKEY RS, 1971, BLOOD-J HEMATOL, V38, P87, DOI 10.1182/blood.V38.1.87.87; MEBIUS RE, 1991, J CELL BIOL, V115, P85, DOI 10.1083/jcb.115.1.85; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nakagawa K, 1996, CANCER RES, V56, P507; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; O'Connor BP, 2003, IMMUNOL REV, V194, P61, DOI 10.1034/j.1600-065X.2003.00055.x; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; OSMOND DG, 1986, IMMUNOL REV, V93, P103, DOI 10.1111/j.1600-065X.1986.tb01504.x; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Pannarale L, 1997, ANAT RECORD, V247, P462, DOI 10.1002/(SICI)1097-0185(199704)247:4<462::AID-AR4>3.0.CO;2-T; Paramithiotis E, 1997, P NATL ACAD SCI USA, V94, P208, DOI 10.1073/pnas.94.1.208; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Price PW, 1999, EUR J IMMUNOL, V29, P1051, DOI 10.1002/(SICI)1521-4141(199903)29:03<1051::AID-IMMU1051>3.0.CO;2-Y; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; REUS WF, 1984, BRIT J PLAST SURG, V37, P213, DOI 10.1016/0007-1226(84)90011-0; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schirrmacher V, 2003, TRENDS MOL MED, V9, P526, DOI 10.1016/j.molmed.2003.10.001; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Shinkura R, 1996, INT IMMUNOL, V8, P1067, DOI 10.1093/intimm/8.7.1067; Shohet S. B., 1998, Cellular and Molecular Biology Letters, V3, P413; Sikora L, 2003, AM J PATHOL, V162, P2019, DOI 10.1016/S0002-9440(10)64334-9; Slifka MK, 1997, BLOOD, V90, P2103, DOI 10.1182/blood.V90.5.2103; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; SLIGH JE, 1993, P NATL ACAD SCI USA, V90, P8529, DOI 10.1073/pnas.90.18.8529; Smith AL, 1999, J EXP MED, V189, P593, DOI 10.1084/jem.189.3.593; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tripp RA, 1997, J IMMUNOL, V158, P3716; VAJKOCZY P, 1994, TRANSPLANT P, V26, P687; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Veihelmann A, 1998, RES EXP MED, V198, P43, DOI 10.1007/s004330050088; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Wagner R., 1839, ERLAUTERUNGSTAFELN P; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Wei SH, 2003, IMMUNOL REV, V195, P136, DOI 10.1034/j.1600-065X.2003.00076.x; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Werr J, 1998, J EXP MED, V187, P2091, DOI 10.1084/jem.187.12.2091; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	146	246	249	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2004	21	3					315	329		10.1016/S1074-7613(04)00237-7	http://dx.doi.org/10.1016/S1074-7613(04)00237-7			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357943	Bronze			2022-12-18	WOS:000224034900003
J	Reits, E; Griekspoor, A; Neijssen, J; Groothuis, T; Jalink, K; van Veelen, P; Janssen, H; Calafat, J; Drijfhout, JW; Neefjes, J				Reits, E; Griekspoor, A; Neijssen, J; Groothuis, T; Jalink, K; van Veelen, P; Janssen, H; Calafat, J; Drijfhout, JW; Neefjes, J			Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I	IMMUNITY			English	Article							NEWLY SYNTHESIZED PROTEINS; LIVING CELLS; ENDOPLASMIC-RETICULUM; LEUCINE AMINOPEPTIDASE; MEMBRANE-PROTEIN; MOLECULES; MOBILITY; PROTEASOME; BINDING; DYNAMICS	Antigenic peptides generated by the proteasome have to survive a peptidase-containing environment for presentation by MHC class I molecules. We have visualized the fate and dynamics of intracellular peptides in living cells. We show that peptides are distributed over two different but interconnected compartments, the cytoplasm and the nucleus, and diffuse rapidly through and between these compartments. Since TAP is excluded from the nuclear face of the nuclear envelope, nuclear peptides have to leave the nucleus to contact TAP. Thereby, these peptides encounter cytosolic peptidases that degrade peptides within seconds unless bound to chromatin. Since peptide degradation is far more efficient than translocation, many peptides will be lost for antigen presentation by MHC class I molecules.	Netherlands Canc Inst, Dept Tumor Biol & Cell Biol, NL-1066 CX Amsterdam, Netherlands; Leiden Univ, Ctr Med, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands	Netherlands Cancer Institute; Leiden University; Leiden University - Excl LUMC	Neefjes, J (corresponding author), Netherlands Canc Inst, Dept Tumor Biol & Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.		Drijfhout, Jan Wouter/ABA-6318-2021; Neefjes, Jacques J.C./H-8780-2017	Drijfhout, Jan Wouter/0000-0003-4808-5296; Neefjes, Jacques J.C./0000-0001-6763-2211; Groothuis, Tom/0000-0002-1751-4783; Neijssen, Joost/0000-0001-6697-4324; Griekspoor, Alexander/0000-0003-0144-4335; van Veelen, Peter/0000-0002-7898-9408; Jalink, Kees/0000-0001-7019-3440				ArrioDupont M, 1997, BIOPHYS J, V73, P2667, DOI 10.1016/S0006-3495(97)78295-X; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Benham AM, 1997, J IMMUNOL, V159, P5896; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Binder RJ, 2001, J BIOL CHEM, V276, P17163, DOI 10.1074/jbc.M011547200; BURLEY SK, 1992, J MOL BIOL, V224, P113, DOI 10.1016/0022-2836(92)90580-D; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fruci D, 2001, IMMUNITY, V15, P467, DOI 10.1016/S1074-7613(01)00203-5; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Gromme M, 1997, EUR J IMMUNOL, V27, P898, DOI 10.1002/eji.1830270415; GURDON JB, 1976, J EMBRYOL EXP MORPH, V36, P523; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Meyvis TKL, 1999, PHARM RES-DORDR, V16, P1153, DOI 10.1023/A:1011924909138; Mo XY, 1999, J IMMUNOL, V163, P5851; Montoya M, 1999, J IMMUNOL, V163, P1914; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Spee P, 1999, BIOCHEMISTRY-US, V38, P10559, DOI 10.1021/bi990321r; Takeda S, 1996, BIOCHEMISTRY-US, V35, P4636, DOI 10.1021/bi952903o; VILLANUEVA MS, 1994, IMMUNITY, V1, P479, DOI 10.1016/1074-7613(94)90090-6; WALLNER BP, 1993, TRANSPLANTATION, V64, P1460; Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X	38	246	250	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2003	18	1					97	108		10.1016/S1074-7613(02)00511-3	http://dx.doi.org/10.1016/S1074-7613(02)00511-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530979	Bronze			2022-12-18	WOS:000180860600010
J	Sousa, CRE				Sousa, CRE			Dendritic cells as sensors of infection	IMMUNITY			English	Review							REQUIRES; SIGNAL; IL-12		Imperial Canc Res Fund, Immunobiol Lab, London WC2A 3PX, England	Cancer Research UK	Sousa, CRE (corresponding author), Imperial Canc Res Fund, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.		Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Manickasingham SP, 2001, IMMUNOLOGY, V102, P381, DOI 10.1046/j.1365-2567.2001.01219.x; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Schnurr M, 2000, J IMMUNOL, V165, P4704, DOI 10.4049/jimmunol.165.8.4704; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5	18	246	262	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2001	14	5					495	498						4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371351				2022-12-18	WOS:000168880900001
J	Wang, JH; Avitahl, N; Cariappa, A; Friedrich, C; Ikeda, T; Renold, A; Andrikopoulos, K; Liang, LB; Pillai, S; Morgan, BA; Georgopoulos, K				Wang, JH; Avitahl, N; Cariappa, A; Friedrich, C; Ikeda, T; Renold, A; Andrikopoulos, K; Liang, LB; Pillai, S; Morgan, BA; Georgopoulos, K			Aiolos regulates B cell activation and maturation to effector state	IMMUNITY			English	Article							ANTIGEN RECEPTOR; IKAROS GENE; CD22-DEFICIENT MICE; DNA-REPLICATION; DEFICIENT MICE; BONE-MARROW; IG-BETA; IN-VIVO; IMMUNOGLOBULIN; FC-GAMMA-RIIB1	Aiolos encodes a zinc finger DNA-binding protein that is highly expressed in mature B cells and is homologous to Ikaros. In the periphery of mice homozygous for an Aiolos-null mutation, B cells exhibit an activated cell surface phenotype and undergo augmented antigen receptor (BCR)-mediated in vitro proliferative responses, even at limiting amounts of stimulant. In vivo, T cell-dependent B cell responses, including the formation of germinal centers and elevated serum IgG and IgE, are detected in Aiolos-deficient mice in the absence of immunization. Auto-antibodies and development of B cell lymphomas are frequently seen among aging Aiolos mutants. In sharp contrast to conventional B cells, B cells of the peritoneum, of the marginal zone, and the recirculating bone marrow population are greatly reduced.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Georgopoulos, K (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	Katia_Georgopoulos@CBRC.MGH.Harvar			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042254] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI042254, R01 AI42254-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; COLLINS JT, 1993, INT IMMUNOL, V5, P885, DOI 10.1093/intimm/5.8.885; DAmbrosio D, 1996, IMMUNOL LETT, V54, P77, DOI 10.1016/S0165-2478(96)02653-3; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; DUNN J, 1995, PROF ENG, V8, P8; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; GEORGOPOULOS K, 1998, SEMINARS IMMUNOLOGY; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; HAN SH, 1995, J IMMUNOL, V155, P556; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARDY RR, 1994, IMMUNOL REV, V137, P92; HEINTZ N H, 1992, Current Opinion in Cell Biology, V4, P459, DOI 10.1016/0955-0674(92)90012-2; Hippen KL, 1997, IMMUNITY, V7, P49, DOI 10.1016/S1074-7613(00)80509-9; Hozak Pavel, 1994, Trends in Cell Biology, V4, P48, DOI 10.1016/0962-8924(94)90009-4; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; Kelley CM, 1998, CURR BIOL, V8, P508, DOI 10.1016/S0960-9822(98)70202-7; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Klinman NR, 1996, IMMUNITY, V5, P189, DOI 10.1016/S1074-7613(00)80314-3; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; MANDLER R, 1993, J IMMUNOL, V150, P407; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; MURAKAMI M, 1995, IMMUNOL TODAY, V16, P534, DOI 10.1016/0167-5699(95)80047-6; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; PARRY SL, 1994, J IMMUNOL, V152, P2821; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; TORRES RM, 1996, SCIENCE, V272, P1802; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; WARREN WD, 1995, J IMMUNOL, V155, P5637; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1	39	246	258	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1998	9	4					543	553		10.1016/S1074-7613(00)80637-8	http://dx.doi.org/10.1016/S1074-7613(00)80637-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806640	Bronze			2022-12-18	WOS:000076680700012
J	Friedrich, M; Pohin, M; Powrie, F				Friedrich, Matthias; Pohin, Mathilde; Powrie, Fiona			Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease	IMMUNITY			English	Review							INNATE LYMPHOID-CELLS; CHRONIC INTESTINAL INFLAMMATION; SEVERE CROHNS-DISEASE; ANTIINTERFERON-GAMMA ANTIBODY; GENOME-WIDE ASSOCIATION; GROWTH-FACTOR-BETA; CD4(+) T-CELLS; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; ULCERATIVE-COLITIS	Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract. Cytokine-targeted therapies have transformed the treatment of IBD, providing control of symptoms and longer relapse-free periods. However, many patients fail to respond, highlighting the need for therapies tailored to the underlying cell and molecular disease drivers. Here we discuss the progression of IBD from the perspective of remodeling of cytokine networks. We place well-established and under-studied cytokine modules in the context of cellular interactions, their dynamic regulation in early and late stages of disease (i.e., fibrosis), and their current and potential use in the clinic. Examining how particular cytokine networks drive distinct features and phases of IBD will shed light on the etiology of IBD and provide a basis for more effective treatments.	[Friedrich, Matthias; Pohin, Mathilde; Powrie, Fiona] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Roosevelt Dr, Oxford OX3 7FY, England; [Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Expt Med Div, Nuffield Dept Med,Translat Gastroenterol Unit, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Powrie, F (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Roosevelt Dr, Oxford OX3 7FY, England.; Powrie, F (corresponding author), Univ Oxford, John Radcliffe Hosp, Expt Med Div, Nuffield Dept Med,Translat Gastroenterol Unit, Oxford OX3 9DU, England.	fiona.powrie@kennedy.ox.ac.uk		POHIN, Mathilde/0000-0003-2809-9498	Wellcome Trust UK [212240/Z/18/Z]; BBSRC [BB/1005609/1]; Leona M. and Harry B. Helmsley Charitable Trust; Kennedy Trust for Rheumatology Research; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC); Oxford-UCB prize fellowship scheme; Roche Postdoctoral Fellowship scheme; BBSRC [BB/I005609/1] Funding Source: UKRI	Wellcome Trust UK(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leona M. and Harry B. Helmsley Charitable Trust; Kennedy Trust for Rheumatology Research; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); Oxford-UCB prize fellowship scheme; Roche Postdoctoral Fellowship scheme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We apologize to all those whose work we could not cite due to space limitations. The authors M.F. and M.P. are listed in alphabetical order and contributed equally to the manuscript. We thank Holm Uhlig, Luke Jostins, Elizabeth Thompson, Elizabeth Mann, and Emily Thornton for helpful discussion and critical review of the manuscript. This work was supported by the Wellcome Trust UK (212240/Z/18/Z), the BBSRC (BB/1005609/1), the Leona M. and Harry B. Helmsley Charitable Trust, the Kennedy Trust for Rheumatology Research, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). M.F. received support from the Oxford-UCB prize fellowship scheme and M.P. from the Roche Postdoctoral Fellowship scheme.	Abraham C, 2017, GASTROENTEROLOGY, V152, P374, DOI 10.1053/j.gastro.2016.10.018; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Arnold IC, 2016, MUCOSAL IMMUNOL, V9, P352, DOI 10.1038/mi.2015.65; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Atreya R, 2011, GASTROENTEROLOGY, V141, P2026, DOI 10.1053/j.gastro.2011.08.032; Bamias G, 2005, GASTROENTEROLOGY, V128, P654, DOI 10.1053/j.gastro.2004.11.053; Ben-Horin S, 2014, NAT REV GASTRO HEPAT, V11, P243, DOI 10.1038/nrgastro.2013.253; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Bootz F, 2016, INFLAMM BOWEL DIS, V22, P2098, DOI 10.1097/MIB.0000000000000851; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Buettner M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00342; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Canavan JB, 2016, GUT, V65, P584, DOI 10.1136/gutjnl-2014-306919; Canna SW, 2017, J ALLERGY CLIN IMMUN, V139, P1698, DOI 10.1016/j.jaci.2016.10.022; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Chuang LS, 2016, GASTROENTEROLOGY, V151, P710, DOI 10.1053/j.gastro.2016.06.045; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Colombel JF, 2001, GUT, V49, P42, DOI 10.1136/gut.49.1.42; Danese S, 2019, GUT, V68, P40, DOI 10.1136/gutjnl-2017-314562; Danese S, 2015, GUT, V64, P243, DOI 10.1136/gutjnl-2014-308004; Danne C, 2017, CELL HOST MICROBE, V22, P733, DOI 10.1016/j.chom.2017.11.002; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; DERKX B, 1993, LANCET, V342, P173, DOI 10.1016/0140-6736(93)91375-V; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; DISANTO JP, 1994, P NATL ACAD SCI USA, V91, P9466, DOI 10.1073/pnas.91.20.9466; Disson O, 2018, J EXP MED, V215, P2936, DOI 10.1084/jem.20181210; Dohi T, 2000, GASTROENTEROLOGY, V119, P724, DOI 10.1053/gast.2000.16500; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Feagan BG, 2016, NEW ENGL J MED, V375, P1946, DOI 10.1056/NEJMoa1602773; Feagan BG, 2018, GASTROENTEROLOGY, V154, P61, DOI 10.1053/j.gastro.2017.08.035; Feagan BG, 2017, LANCET, V389, P1699, DOI 10.1016/S0140-6736(17)30570-6; Fichtner-Feigl S, 2008, MUCOSAL IMMUNOL, V1, pS24, DOI 10.1038/mi.2008.41; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Fung TC, 2016, IMMUNITY, V44, P634, DOI 10.1016/j.immuni.2016.02.019; Gabrysova L, 2018, NAT IMMUNOL, V19, P497, DOI 10.1038/s41590-018-0083-5; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Geremia A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01296; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Griseri T, 2015, IMMUNITY, V43, P187, DOI 10.1016/j.immuni.2015.07.008; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Grizotte-Lake M, 2018, IMMUNITY, V49, P1103, DOI 10.1016/j.immuni.2018.11.018; Guerra I, 2014, CLIN EXP GASTROENTER, V7, P359, DOI 10.2147/CEG.S45297; Han XN, 2009, GASTROENTEROLOGY, V136, P1261, DOI 10.1053/j.gastro.2008.12.046; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Herrlinger KR, 2013, J CROHNS COLITIS, V7, P636, DOI 10.1016/j.crohns.2012.09.016; Hommes DW, 2006, GUT, V55, P1131, DOI 10.1136/gut.2005.079392; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kole A, 2013, J IMMUNOL, V191, P2771, DOI 10.4049/jimmunol.1301093; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kotlarz D, 2018, NAT GENET, V50, P344, DOI 10.1038/s41588-018-0063-6; Kotredes KP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00410; Kugathasan S, 2017, LANCET, V389, P1710, DOI 10.1016/S0140-6736(17)30317-3; Kuhn KA, 2018, MUCOSAL IMMUNOL, V11, P357, DOI 10.1038/mi.2017.55; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Levin AD, 2016, J CROHNS COLITIS, V10, P989, DOI 10.1093/ecco-jcc/jjw053; Levy M, 2013, PEDIATRICS, V132, pE779, DOI 10.1542/peds.2012-3344; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lopetuso LR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00181; Macpherson AJ, 2018, ANNU REV IMMUNOL, V36, P359, DOI 10.1146/annurev-immunol-042617-053238; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mathur R, 2019, MUCOSAL IMMUNOL, V12, P612, DOI 10.1038/s41385-019-0146-4; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mencarelli A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03495-3; Mizoguchi A, 1999, GASTROENTEROLOGY, V116, P320, DOI 10.1016/S0016-5085(99)70128-9; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Monteleone G, 2015, NEW ENGL J MED, V372, P1104, DOI 10.1056/NEJMoa1407250; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Neurath M, 2017, NAT REV GASTRO HEPAT, V14, P688, DOI 10.1038/nrgastro.2017.138; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Ngo VL, 2018, P NATL ACAD SCI USA, V115, pE5076, DOI 10.1073/pnas.1718902115; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pearson C, 2016, ELIFE, V5, DOI 10.7554/eLife.10066; Pickard JM, 2017, IMMUNOL REV, V279, P70, DOI 10.1111/imr.12567; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Pott J, 2018, CELL HOST MICROBE, V23, P191, DOI 10.1016/j.chom.2017.12.017; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Reinisch W, 2006, GUT, V55, P1138, DOI 10.1136/gut.2005.079434; Reinisch W, 2015, GUT, V64, P894, DOI 10.1136/gutjnl-2014-308337; Reinisch W, 2010, INFLAMM BOWEL DIS, V16, P233, DOI 10.1002/ibd.21038; Rieder F, 2017, GASTROENTEROLOGY, V152, P340, DOI 10.1053/j.gastro.2016.09.047; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Salzer E, 2014, J ALLERGY CLIN IMMUN, V133, P1651, DOI 10.1016/j.jaci.2014.02.034; Sandborn W. J., 2014, CLIN GASTROENTEROL H, V12; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; Sands BE, 2017, GASTROENTEROLOGY, V153, P77, DOI 10.1053/j.gastro.2017.03.049; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Scheibe K., 2018, GASTROENTEROLOGY, V156; Scheibe K, 2017, GUT, V66, P823, DOI 10.1136/gutjnl-2015-310374; Schiering C, 2017, NATURE, V542, P242, DOI 10.1038/nature21080; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schmitt H, 2019, GUT, V68, P814, DOI 10.1136/gutjnl-2017-315671; Schreiber S, 2000, GASTROENTEROLOGY, V119, P1461, DOI 10.1053/gast.2000.20196; Sedhom MAK, 2013, GUT, V62, P1714, DOI 10.1136/gutjnl-2011-301785; Shih VFS, 2014, P NATL ACAD SCI USA, V111, P13942, DOI 10.1073/pnas.1323852111; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Smillie C. S., 2018, BIORXIV, DOI [10.1101/455451, DOI 10.1101/455451]; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Spadaccini M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061276; Spangler JB, 2015, IMMUNITY, V42, P815, DOI 10.1016/j.immuni.2015.04.015; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stockinger B, 2017, NAT REV IMMUNOL, V17, P535, DOI 10.1038/nri.2017.50; Su LC, 2018, AUTOIMMUN REV, V17, P665, DOI 10.1016/j.autrev.2018.01.017; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Targan SR, 2016, AM J GASTROENTEROL, V111, P1599, DOI 10.1038/ajg.2016.298; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Uhlig HH, 2018, ANNU REV IMMUNOL, V36, P755, DOI 10.1146/annurev-immunol-042617-053055; Vallance BA, 2005, AM J PHYSIOL-GASTR L, V289, pG116, DOI 10.1152/ajpgi.00051.2005; Vannella KM, 2017, ANNU REV PHYSIOL, V79, P593, DOI 10.1146/annurev-physiol-022516-034356; Vermeire S, 2017, LANCET, V389, P266, DOI 10.1016/S0140-6736(16)32537-5; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Wirtz S, 2011, GASTROENTEROLOGY, V141, P1875, DOI 10.1053/j.gastro.2011.07.040; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhou L, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1605; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110	176	245	256	19	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					992	1006		10.1016/j.immuni.2019.03.017	http://dx.doi.org/10.1016/j.immuni.2019.03.017			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995511	Green Submitted, Bronze			2022-12-18	WOS:000464660800015
J	Bertrand, MJM; Doiron, K; Labbe, K; Korneluk, RG; Barker, PA; Saleh, M				Bertrand, Mathieu J. M.; Doiron, Karine; Labbe, Katherine; Korneluk, Robert G.; Barker, Philip A.; Saleh, Maya			Cellular Inhibitors of Apoptosis cIAP1 and cIAP2 Are Required for Innate Immunity Signaling by the Pattern Recognition Receptors NOD1 and NOD2	IMMUNITY			English	Article							NF-KAPPA-B; PROTEIN; KINASE; C-IAP1; POLYUBIQUITINATION; ACTIVATION; TOLERANCE; CHEMOKINE; RESPONSES; TAK1	Cellular inhibitor of apoptosis proteins (cIAPs) block apoptosis, but their physiological functions are still under investigation. Here, we report that cIAP1 and cIAP2 are E3 ubiquitin ligases that are required for receptor-interacting protein 2 (RIP2) ubiquitination and for nucleotide-binding and oligomerization (NOD) signaling. Macrophages derived from Birc2(-/-) or Birc3(-/-) mice, or colonocytes depleted of cIAP1 or cIAP2 by RNAi, were defective in NOD signaling and displayed sharp attenuation of cytokine and chemokine production. This blunted response was observed in vivo when Birc2(-/-) and Birc3(-/-) mice were challenged with NOD agonists. Defects in NOD2 signaling are associated with Crohn's disease, and muramyl dipeptide (MDP) activation of NOD2 signaling protects mice from experimental colitis. Here, we show that administration of MDP protected wild-type but not Ripk2(-/-) or Birc3(-/-) mice from colitis, confirming the role of the cIAPs in NOD2 signaling in vivo. This discovery provides therapeutic opportunities in the treatment of NOD-dependent immunologic and inflammatory diseases.	[Bertrand, Mathieu J. M.; Barker, Philip A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Doiron, Karine; Labbe, Katherine; Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ H3G 0B1, Canada; [Korneluk, Robert G.] Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada	McGill University; McGill University; University of Ottawa; Children's Hospital of Eastern Ontario	Barker, PA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	phil.barker@mcgill.ca; maya.saleh@mcgill.ca	Bertrand, Mathieu/C-2376-2009; Bertrand, Mathieu J/P-6465-2016; Bertrand, Mathieu JM/AAD-2653-2019	Bertrand, Mathieu J/0000-0001-9000-0626; Bertrand, Mathieu JM/0000-0001-9000-0626	Canadian Institute of Health Research [MOP62827, MOP82801]; Jean Timmins Costello Foundation Fellowship	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Jean Timmins Costello Foundation Fellowship	This work was supported by grants from the Canadian Institute of Health Research to P.A.B. (MOP62827) and to M.S. (MOP82801). P.A.B. is a William Dawson Scholar of McGill University and a Chercheur National of the Fonds de la Recherche en Sante Quebec. M.S. is a CIHR New Investigator. M.B. was supported by a Jean Timmins Costello Foundation Fellowship. P.A.B. is a founder of Aegera Therapeutics and a member of its scientific advisory board; we thank T. Mak (University of Toronto), and R. Flavell for providing Birc2<SUP>-/-</SUP> and Ripk2<SUP>-/-</SUP> mice breeder pairs.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Abell AN, 2005, MOL CELL BIOL, V25, P8948, DOI 10.1128/MCB.25.20.8948-8959.2005; Bauler LD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000142; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Berube J, 2009, CELL SIGNAL, V21, P448, DOI 10.1016/j.cellsig.2008.12.001; Chen CM, 2004, J BIOL CHEM, V279, P25876, DOI 10.1074/jbc.M400682200; Chi HB, 2005, P NATL ACAD SCI USA, V102, P3846, DOI 10.1073/pnas.0500026102; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Gesellchen V, 2005, EMBO REP, V6, P979, DOI 10.1038/sj.embor.7400530; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kleino A, 2005, EMBO J, V24, P3423, DOI 10.1038/sj.emboj.7600807; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kullberg BJ, 2008, IMMUNOLOGY, V123, P600, DOI 10.1111/j.1365-2567.2007.02735.x; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; Lysenko ES, 2007, PLOS PATHOG, V3, P1073, DOI 10.1371/journal.ppat.0030118; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Park JH, 2007, J IMMUNOL, V179, P514, DOI 10.4049/jimmunol.179.1.514; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Sirard JC, 2007, PLOS PATHOG, V3, P1829, DOI 10.1371/journal.ppat.0030152; Takada H, 2002, J ENDOTOXIN RES, V8, P337, DOI 10.1179/096805102125000669; Tattoli I, 2007, SEMIN IMMUNOPATHOL, V29, P289, DOI 10.1007/s00281-007-0083-2; Valanne S, 2007, DEV COMP IMMUNOL, V31, P991, DOI 10.1016/j.dci.2007.01.004; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JCI33145, 10.1172/JC133145]; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhou R, 2005, J BIOL CHEM, V280, P34048, DOI 10.1074/jbc.M506655200	48	245	255	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2009	30	6					789	801		10.1016/j.immuni.2009.04.011	http://dx.doi.org/10.1016/j.immuni.2009.04.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19464198	Bronze			2022-12-18	WOS:000267270700008
J	Chessman, D; Kostenko, L; Lethborg, T; Purcell, AW; Williamson, NA; Chen, Z; Kjer-Nielsen, L; Mifsud, NA; Tait, BD; Holdsworth, R; Almeida, CA; Nolan, D; Macdonalds, WA; Archbold, JK; Kellerher, AD; Marriott, D; Mallal, S; Bharadwaj, M; Rossjohn, J; McCluskey, J				Chessman, Diana; Kostenko, Lyudmila; Lethborg, Tessa; Purcell, Anthony W.; Williamson, Nicholas A.; Chen, Zhenjun; Kjer-Nielsen, Lars; Mifsud, Nicole A.; Tait, Brian D.; Holdsworth, Rhonda; Almeida, Coral Ann; Nolan, David; Macdonalds, Whitney A.; Archbold, Julia K.; Kellerher, Anthony D.; Marriott, Debbie; Mallal, Simon; Bharadwaj, Mandvi; Rossjohn, Jamie; McCluskey, James			Human leukocyte antigen class I-restricted activation of CD8(+) T cells provides the immunogenetic basis of a systemic drug hypersensitivity	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; HLA-B REGION; ABACAVIR HYPERSENSITIVITY; GENETIC-VARIATIONS; BERYLLIUM DISEASE; HLA-B27 SUBTYPES; CELIAC-DISEASE; RESPONSES; HLA-B-ASTERISK-5701; RECOGNITION	The basis for strong immunogenetic associations between particular human leukocyte antigen (HLA) class I allotypes and inflammatory conditions like Behcet's disease (HLA-B51) and ankylosing spondylitis (HLA-B27) remain mysterious. Recently, however, even stronger HLA associations are reported in drug hypersensitivities to the reverse-transcriptase inhibitor abacavir (HLA-B57), the gout prophylactic allopurinol (HLA-B58), and the antiepileptic, carbamazepine (HI-A-B*1502), providing a defined disease trigger and suggesting a general mechanism for these associations. We show that systemic reactions to abacavir were driven by drug-specific activation of cytokine-producing, cytotoxic CD8(+) T cells. Recognition of abacavir required the transporter associated with antigen presentation and tapasin, was fixation sensitive, and was uniquely restricted by HLA-B*5701 and not closely related HLA allotypes with polymorphisms in the antigen-binding cleft. Hence, the strong association of HLA-B*5701 with abacavir hypersensitivity reflects specificity through creation of a unique ligand as well as HLA-restricted antigen presentation, suggesting a basis for the strong HLA class I-association with certain inflammatory disorders.	[Macdonalds, Whitney A.; Archbold, Julia K.; Rossjohn, Jamie] Monash Univ, Prot Crystallog Unit, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Chessman, Diana; Kostenko, Lyudmila; Lethborg, Tessa; Chen, Zhenjun; Kjer-Nielsen, Lars; Mifsud, Nicole A.; Bharadwaj, Mandvi; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Purcell, Anthony W.; Williamson, Nicholas A.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Tait, Brian D.; Holdsworth, Rhonda] Australian Red Cross Blood Serv, Victorian Transplantat & Immunogenet Serv, S Melbourne, Vic 3205, Australia; [Almeida, Coral Ann; Nolan, David] Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; [Kellerher, Anthony D.] St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia; [Marriott, Debbie] Natl Ctr HIV Epidemiol & Clin Res UNSW, Sydney, NSW, Australia	Monash University; University of Melbourne; University of Melbourne; Australian Red Cross Blood Service; Royal Perth Hospital; University of Western Australia; St Vincents Hospital Sydney; University of New South Wales Sydney; Kirby Institute	Rossjohn, J (corresponding author), Monash Univ, Prot Crystallog Unit, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia.	jamie.rossjohn@med.monash.edu.au; jamesm1@unimelb.edu.au	McCluskey, James/A-1291-2007; Purcell, Anthony/AAH-1942-2019; Bharadwaj, Mandvi/C-4446-2014; Williamson, Nicholas A/O-9812-2016; Rossjohn, Jamie/F-9032-2013; Mallal, Simon Alexander/HDM-9561-2022; Archbold, Julia/N-2884-2013	McCluskey, James/0000-0002-8597-815X; Purcell, Anthony/0000-0003-0532-8331; Williamson, Nicholas A/0000-0002-2173-3452; Rossjohn, Jamie/0000-0002-2020-7522; Mallal, Simon Alexander/0000-0002-7036-1309; Archbold, Julia/0000-0002-7768-4784; Mifsud, Nicole/0000-0001-8647-2102; Kostenko, Lyudmila/0000-0002-8466-7966				Barber LD, 1997, J IMMUNOL, V158, P1660; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chen WS, 1996, J IMMUNOL, V157, P1000; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; Cutrell AG, 2004, ANN PHARMACOTHER, V38, P2171, DOI 10.1345/aph.1E202; Duraiswamy J, 2003, J VIROL, V77, P7401, DOI 10.1128/JVI.77.13.7401-7410.2003; Gamerdinger K, 2003, J EXP MED, V197, P1345, DOI 10.1084/jem.20030121; Gillespie GMA, 2006, J IMMUNOL, V177, P3893, DOI 10.4049/jimmunol.177.6.3893; Gomez P, 2006, EUR J IMMUNOL, V36, P1867, DOI 10.1002/eji.200635896; HAURUM JS, 1994, J EXP MED, V180, P739, DOI 10.1084/jem.180.2.739; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; Hughes AR, 2004, PHARMACOGENOMICS, V5, P203, DOI 10.1517/phgs.5.2.203.27481; Hughes DA, 2004, PHARMACOGENETICS, V14, P335, DOI 10.1097/00008571-200406000-00002; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; King D, 2005, J ALLERGY CLIN IMMUN, V115, P1081, DOI 10.1016/j.jaci.2004.12.1140; Kubo H, 1998, IMMUNOGENETICS, V47, P256, DOI 10.1007/s002510050355; Lombardi G, 2001, J IMMUNOL, V166, P3549, DOI 10.4049/jimmunol.166.5.3549; Lu L, 2003, J EXP MED, V197, P567, DOI 10.1084/jem.20021762; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; MARGULIES DH, 2008, MAJOR HISTOCOMPATIBI; Martin AM, 2004, P NATL ACAD SCI USA, V101, P4180, DOI 10.1073/pnas.0307067101; Martin AM, 2007, AIDS, V21, P1233, DOI 10.1097/QAD.0b013e3280119579; McCluskey J, 2004, CURR OPIN IMMUNOL, V16, P651, DOI 10.1016/j.coi.2004.07.016; Mifsud NA, 2008, AM J TRANSPLANT, V8, P121, DOI 10.1111/j.1600-6143.2007.02044.x; MIZUSHIMA Y, 1985, J NATL CANCER I, V74, P1269; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Phillips EJ, 2005, AIDS, V19, P979, DOI 10.1097/01.aids.0000171414.99409.fb; Phillips EJ, 2002, AIDS, V16, P2223, DOI 10.1097/00002030-200211080-00017; Purcell AW, 1998, J IMMUNOL, V160, P1085; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; Ray AS, 2002, BIOCHEMISTRY-US, V41, P5150, DOI 10.1021/bi0121858; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; SHIMIZU Y, 1988, P NATL ACAD SCI USA, V85, P227, DOI 10.1073/pnas.85.1.227; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Stewart-Jones GBE, 2005, J IMMUNOL, V175, P2459, DOI 10.4049/jimmunol.175.4.2459; Sun HY, 2007, J ANTIMICROB CHEMOTH, V60, P599, DOI 10.1093/jac/dkm243; Williams A, 2002, TISSUE ANTIGENS, V59, P3, DOI 10.1034/j.1399-0039.2002.590103.x; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Yu XG, 2007, J VIROL, V81, P1619, DOI 10.1128/JVI.01580-06; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941; Zernich D, 2004, J EXP MED, V200, P13, DOI 10.1084/jem.20031680	47	245	255	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2008	28	6					822	832		10.1016/j.immuni.2008.04.020	http://dx.doi.org/10.1016/j.immuni.2008.04.020			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18549801	Bronze			2022-12-18	WOS:000256760200013
J	von Strandmann, EP; Simhadri, VR; von Tresckow, B; Sasse, S; Reiners, KS; Hansen, HP; Rothe, A; Boll, B; Simhadri, VL; Borchmann, P; McKinnon, PJ; Hallek, M; Engert, A				von Strandmann, Elke Pogge; Simhadri, Venkateswara Rao; von Tresckow, Bastian; Sasse, Stephanie; Reiners, Katrin S.; Hansen, Hinrich P.; Rothe, Achim; Boell, Boris; Simhadri, Vijaya Lakshmi; Borchmann, Peter; McKinnon, Peter J.; Hallek, Michael; Engert, Andreas			Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells	IMMUNITY			English	Article							DC MATURATION; NK CELLS; CLASS-I; LIGANDS; NKG2D; HSP70; SCYTHE; RECOGNITION; ACTIVATION; INHIBITION	The activity of natural killer (NK) cells is regulated by surface receptors, which direct target cell recognition. NKp30 (Natural Cytotoxicity Receptor 3) induces target cell lysis and is also crucial for the interaction with dendritic cells. So far, the cellular ligands for NKp30 have remained elusive. Here we show that the nuclear factor HILA-B-associated transcript 3 (BAT3) was released from tumor cells, bound directly to NKp30, and engaged NKp30 on NK cells. BAT3 triggered NKp30-mediated cytotoxicity and was necessary for tumor rejection in a multiple myeloma model. These data identify BAT3 as a cellular ligand for NKp30. We propose a concept for target cell recognition by NK cells beyond "missing self" and "induced self," mediated through a tumor cell-derived extracellular factor.	[von Strandmann, Elke Pogge; Simhadri, Venkateswara Rao; von Tresckow, Bastian; Sasse, Stephanie; Reiners, Katrin S.; Hansen, Hinrich P.; Rothe, Achim; Boell, Boris; Simhadri, Vijaya Lakshmi; Borchmann, Peter; Hallek, Michael; Engert, Andreas] Univ Hosp Cologne, Dept Internal Med 1, D-50924 Cologne, Germany; [McKinnon, Peter J.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	University of Cologne; St Jude Children's Research Hospital	von Strandmann, EP (corresponding author), Univ Hosp Cologne, Dept Internal Med 1, Kerpener Str 62, D-50924 Cologne, Germany.	elke.pogge@uk-koeln.de	Hallek, Michael/Y-3191-2019; sasse, stephanie/AAV-3317-2020	Hallek, Michael/0000-0002-7425-4455; sasse, stephanie/0000-0002-1080-4606; Reiners, Katrin/0000-0002-5908-8823				Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Borchmann P, 2003, BLOOD, V102, P3737, DOI 10.1182/blood-2003-02-0515; Bottino C, 2005, TRENDS IMMUNOL, V26, P221, DOI 10.1016/j.it.2005.02.007; Carbone E, 2005, BLOOD, V105, P251, DOI 10.1182/blood-2004-04-1422; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Friese MA, 2003, CANCER RES, V63, P8996; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Gehrmann M, 2005, CELL DEATH DIFFER, V12, P38, DOI 10.1038/sj.cdd.4401510; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hanna J, 2004, J CLIN INVEST, V114, P1612, DOI 10.1172/JCI200422787; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Krynetski EY, 2003, CANCER RES, V63, P100; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; MORETTA L, 2007, IN PRESS CELL DEATH; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; North J, 2007, J IMMUNOL, V178, P85, DOI 10.4049/jimmunol.178.1.85; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Radons J, 2005, EXERC IMMUNOL REV, V11, P17; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Takahashi A, 1997, BRAIN RES PROTOC, V1, P70, DOI 10.1016/S1385-299X(96)00013-X; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Von Strandmann EP, 2000, MECH DEVELOP, V91, P53, DOI 10.1016/S0925-4773(99)00269-5; Walzer T, 2005, EXPERT OPIN BIOL TH, V5, pS49, DOI 10.1517/14712598.5.1.S49; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200	45	245	251	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2007	27	6					965	974		10.1016/j.immuni.2007.10.010	http://dx.doi.org/10.1016/j.immuni.2007.10.010			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18055229	Bronze			2022-12-18	WOS:000251907300015
J	Scotet, E; Martinez, LO; Grant, E; Barbaras, R; Jeno, P; Guiraud, M; Monsarrat, B; Saulquin, X; Maillet, S; Esteve, JP; Lopez, F; Perret, B; Collet, X; Bonneville, M; Champagne, E				Scotet, E; Martinez, LO; Grant, E; Barbaras, R; Jeno, P; Guiraud, M; Monsarrat, B; Saulquin, X; Maillet, S; Esteve, JP; Lopez, F; Perret, B; Collet, X; Bonneville, M; Champagne, E			Tumor recognition following V gamma 9V delta 2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I	IMMUNITY			English	Article							NONPEPTIDIC MYCOBACTERIAL LIGANDS; KILLER INHIBITORY RECEPTORS; ATP SYNTHASE; ANTIGEN RECOGNITION; INNATE IMMUNITY; LYMPHOMA; PURIFICATION; REQUIREMENTS; CYTOTOXICITY; LYMPHOCYTES	Vgamma9Vdelta2 T lymphocytes, a major gammadelta T lymphocyte subset in humans, display cytolytic activity against various tumor cells upon recognition of yet uncharacterized structures. Here, we show that an entity related to the mitochondrial F1-ATPase is expressed on tumor cell surface and promotes tumor recognition by Vgamma9Vdelta2 T cells. When immobilized, purified F1-ATPase induces selective activation of this lymphocyte subset. The Vgamma9Vdelta2 T cell receptors (TCR) and the F1-ATPase also bind a delipidated form of apolipoprotein A-I (apo A-I), as demonstrated by surface plasmon resonance. Moreover, the presence of apo A-I in the culture medium is required for optimal activation of Vgamma9Vdelta2 T cells by tumors expressing F1-ATPase. This study thus describes an unanticipated tumor recognition mechanism by Vgamma9Vdelta2 lymphocytes and a possible link between gammadelta T cell immunity and lipid metabolism.	CHU Purpan, CPTP, U563, IFR30,INSERM, F-31024 Toulouse 3, France; Inst Biol, INSERM, U601, F-44035 Nantes 01, France; Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; INSERM, IFR 31, F-31403 Toulouse, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Basel; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bonneville, M (corresponding author), CHU Purpan, CPTP, U563, IFR30,INSERM, F-31024 Toulouse 3, France.	bonnevil@nantes.inserm.fr; eric.champagne@toulouse.inserm.fr	Martinez, Laurent O./ABD-6880-2020; Champagne, Eric/M-1543-2014; SAULQUIN, Xavier/L-2886-2015; Collet, Xavier/M-6938-2017; SCOTET, Emmanuel/AAC-9971-2019; Martinez, Laurent O/B-8343-2015; SCOTET, Emmanuel/L-2576-2015	Martinez, Laurent O./0000-0002-0985-3152; Champagne, Eric/0000-0002-8852-0734; SCOTET, Emmanuel/0000-0001-8010-9556; Martinez, Laurent O/0000-0002-0985-3152; SCOTET, Emmanuel/0000-0001-8010-9556; Saulquin, Xavier/0000-0002-5209-7030; Allain, Sophie/0000-0003-2241-5736; Bertrand, PERRET/0000-0001-7568-445X				Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Brossay L, 1998, J IMMUNOL, V161, P5124; BUKOWSKI JF, 1994, J IMMUNOL, V153, P5133; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200; Collet X, 1997, J LIPID RES, V38, P634; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DAVODEAU F, 1993, SCIENCE, V260, P1800, DOI 10.1126/science.8390096; DELIBERO G, 1991, J EXP MED, V173, P1311, DOI 10.1084/jem.173.6.1311; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; Fisch P, 1997, EUR J IMMUNOL, V27, P3368, DOI 10.1002/eji.1830271236; FISCH P, 1990, SCIENCE, V250, P1269, DOI 10.1126/science.1978758; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Halary F, 1997, EUR J IMMUNOL, V27, P2812, DOI 10.1002/eji.1830271111; HARLOW E, 1988, ANTIBODIES LABORATOR, P312; LANG F, 1995, J IMMUNOL, V154, P5986; LUTTER R, 1993, BIOCHEM J, V295, P799, DOI 10.1042/bj2950799; MAHLEY RW, 1989, ARTERIOSCLER, V9, P114; MALKOVSKA V, 1994, CLIN EXP IMMUNOL, V96, P158; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; MEZDOUR H, 1987, J CHROMATOGR-BIOMED, V414, P35, DOI 10.1016/0378-4347(87)80022-1; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551; Ramsburg E, 2003, J EXP MED, V198, P1403, DOI 10.1084/jem.20030050; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Stanic AK, 2003, J IMMUNOL, V171, P4539, DOI 10.4049/jimmunol.171.9.4539; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236	39	245	259	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2005	22	1					71	80		10.1016/j.immuni.2004.11.012	http://dx.doi.org/10.1016/j.immuni.2004.11.012			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664160	Green Submitted, Bronze			2022-12-18	WOS:000226682900008
J	Bruhns, P; Samuelsson, A; Pollard, JW; Ravetch, JV				Bruhns, P; Samuelsson, A; Pollard, JW; Ravetch, JV			Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease	IMMUNITY			English	Article							GAMMA-RIII CD16; RHEUMATOID-ARTHRITIS; FC-RECEPTOR; INTRAVENOUS IMMUNOGLOBULINS; SYNOVIAL FIBROBLASTS; ARTHUS REACTION; AUTOANTIBODIES; EXPRESSION; CELLS; IDENTIFICATION	The ability of IVIG to induce expression of FcgammaRIIB and thereby prevent antibody-induced inflammation has been used as a probe to dissect the effector cell components in the KRNxNOD (K/BxN) arthritis model. IVIG protection resulted from the induction of FcgammaRIIB on infiltrating macrophages but not neutrophils, indicating a critical role for macrophage activation in this disease model. Disease induction but not IVIG protection was observed in CSF-1-deficient mice (op/op) in K/BxN arthritis, thus defining different macrophage subsets in these processes. These results suggest a two-step model for IVIG protection in which CSF-1-dependent macrophages act as innate "sensors" for the Fc fragment of IVIG, leading to the induction of FcgammaRIIB on CSF-1-independent "effector" macrophages thereby raising the threshold required for FcgammaRIII activation and preventing autoantibody-triggered inflammation.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol & Obstet & Gynecol & Womens H, Bronx, NY 10461 USA	Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Bruhns, Pierre/F-5567-2013; Ravetch, Jeffrey/Z-1596-2019	Bruhns, Pierre/0000-0002-4709-8936; Ravetch, Jeffrey/0000-0003-2024-9041				Bischof RJ, 2000, CLIN EXP IMMUNOL, V119, P361; Blom AB, 2000, ARTHRITIS RES, V2, P489, DOI 10.1186/ar131; Bussel JB, 2000, SEMIN HEMATOL, V37, P261, DOI 10.1053/shem.2000.8957; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; Corr M, 2002, J IMMUNOL, V169, P6604, DOI 10.4049/jimmunol.169.11.6604; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Dalakas Marinos C., 2001, Current Opinion in Pharmacology, V1, P300, DOI 10.1016/S1471-4892(01)00053-4; Davis RS, 2001, P NATL ACAD SCI USA, V98, P9772, DOI 10.1073/pnas.171308498; Delire M, 1994, Acta Univ Carol Med (Praha), V40, P95; Edwards JCW, 1997, CLIN EXP IMMUNOL, V108, P401, DOI 10.1046/j.1365-2249.1997.3941286.x; Feldmann M, 2001, NAT IMMUNOL, V2, P771, DOI 10.1038/ni0901-771; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kawaji H, 1995, Nihon Ika Daigaku Zasshi, V62, P260; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; MARKS SC, 1984, METAB BONE DIS RELAT, V5, P183, DOI 10.1016/0221-8747(84)90027-4; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; MIZUTANI H, 1993, BLOOD, V82, P837; MUSCAT C, 1995, ANN RHEUM DIS, V54, P382, DOI 10.1136/ard.54.5.382; Napoli D C, 2001, Curr Allergy Asthma Rep, V1, P329, DOI 10.1007/s11882-001-0044-0; Nieto A, 2000, ARTHRITIS RHEUM, V43, P735, DOI 10.1002/1529-0131(200004)43:4<735::AID-ANR3>3.0.CO;2-Q; Pyne D, 2002, RHEUMATOLOGY, V41, P367, DOI 10.1093/rheumatology/41.4.367; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; RITCHLIN C, 1994, SCAND J IMMUNOL, V40, P292, DOI 10.1111/j.1365-3083.1994.tb03465.x; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; SCHMITZ PE, 1986, BONE, V7, P473, DOI 10.1016/8756-3282(86)90006-2; SEITZ M, 1994, BRIT J RHEUMATOL, V33, P613; Sylvestre DL, 1996, IMMUNITY, V5, P387, DOI 10.1016/S1074-7613(00)80264-2; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; WEINSHANK RL, 1988, J EXP MED, V167, P1909, DOI 10.1084/jem.167.6.1909; WIKTORJEDRZEJCZAK W, 1982, J EXP MED, V156, P1516, DOI 10.1084/jem.156.5.1516; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; WITMERPACK MD, 1993, J CELL SCI, V104, P1021	40	245	252	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2003	18	4					573	581		10.1016/S1074-7613(03)00080-3	http://dx.doi.org/10.1016/S1074-7613(03)00080-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	669LZ	12705859	Bronze			2022-12-18	WOS:000182353900012
J	Slansky, JE; Rattis, FM; Boyd, LF; Fahmy, T; Jaffee, EM; Schneck, JP; Margulies, DH; Pardoll, DM				Slansky, JE; Rattis, FM; Boyd, LF; Fahmy, T; Jaffee, EM; Schneck, JP; Margulies, DH; Pardoll, DM			Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex	IMMUNITY			English	Article							T-CELL-RECEPTOR; SURFACE-PLASMON RESONANCE; TUMOR REJECTION ANTIGEN; CLASS-I MOLECULE; 3-DIMENSIONAL STRUCTURE; MHC/PEPTIDE COMPLEXES; BINDING-SPECIFICITY; DENDRITIC CELLS; HIGH-AFFINITY; LOW AVIDITY	T cell responsiveness to an epitope is affected both by its affinity for the presenting MHC molecule and the affinity of the MHC-peptide complex for TCR. One limitation of cancer immunotherapy is that natural tumor antigens elicit relatively weak T cell responses, in part because high-affinity T cells are rendered tolerant to these antigens. We report here that amino acid substitutions in a natural MHC class I-restricted tumor antigen that increase the stability of the MHC-peptide-TCR complex are significantly more potent as tumor vaccines. The improved immunity results from enhanced in vivo expansion of T cells specific for the natural tumor epitope. These results indicate peptides that stabilize the MHC-peptide-TCR complex may provide superior antitumor immunity through enhanced stimulation of specific T cells.	Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; NIAID, Mol Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Dept Pathol & Med, Div Immunopathol, Baltimore, MD 21205 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University	Pardoll, DM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA.			Jaffee, Elizabeth/0000-0003-3841-6549; Margulies, David/0000-0001-8530-7375	NCI NIH HHS [CA57842, CA76669] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA076669, R01CA057842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000394, ZIAAI000622, Z01AI000622, Z01AI000394] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALEXANDERMILLER M, 1994, INT IMMUNOL, V6, P1699, DOI 10.1093/intimm/6.11.1699; ALRAMADI BK, 1995, J IMMUNOL, V155, P662; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bakker ABH, 1997, INT J CANCER, V70, P302, DOI 10.1002/(SICI)1097-0215(19970127)70:3<302::AID-IJC10>3.0.CO;2-H; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BOEHNCKE WH, 1993, J IMMUNOL, V150, P331; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; BOYD LF, 1992, P NATL ACAD SCI USA, V89, P2242, DOI 10.1073/pnas.89.6.2242; BRONTE V, 1995, J IMMUNOL, V154, P5282; Chen LP, 1999, CURR OPIN IMMUNOL, V11, P219, DOI 10.1016/S0952-7915(99)80037-5; CHEN WS, 1994, J EXP MED, V180, P1471, DOI 10.1084/jem.180.4.1471; CHUNG S, 1994, P NATL ACAD SCI USA, V91, P12654, DOI 10.1073/pnas.91.26.12654; CORR M, 1992, J EXP MED, V176, P1681, DOI 10.1084/jem.176.6.1681; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; DALPORTO J, 1993, P NATL ACAD SCI USA, V90, P6671, DOI 10.1073/pnas.90.14.6671; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DePlaen E, 1997, METHODS, V12, P125, DOI 10.1006/meth.1997.0462; Dyall R, 1998, J EXP MED, V188, P1553, DOI 10.1084/jem.188.9.1553; Gervois N, 1996, J EXP MED, V183, P2403, DOI 10.1084/jem.183.5.2403; Gilboa E, 1999, IMMUNITY, V11, P263, DOI 10.1016/S1074-7613(00)80101-6; Goldstein J, 1997, EUR J IMMUNOL, V27, P871, DOI 10.1002/eji.1830270411; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; GRISWOLD DP, 1975, CANCER, V36, P2441, DOI 10.1002/1097-0142(197512)36:6<2441::AID-CNCR2820360627>3.0.CO;2-P; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; INABA K, 1998, CURRENT PROTOCOLS IM; Jaffee EM, 1996, CURR OPIN IMMUNOL, V8, P622, DOI 10.1016/S0952-7915(96)80077-X; KHILKO SN, 1993, J BIOL CHEM, V268, P15425; KHILKO SN, 1995, J IMMUNOL METHODS, V183, P77, DOI 10.1016/0022-1759(95)00033-7; KRULSBEEK AM, 1993, CURRENT PROTOCOLS IM; KURUCZ I, 1993, P NATL ACAD SCI USA, V90, P3830, DOI 10.1073/pnas.90.9.3830; Lebowitz MS, 1999, CELL IMMUNOL, V192, P175, DOI 10.1006/cimm.1999.1441; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Li HM, 1998, J MOL BIOL, V283, P179, DOI 10.1006/jmbi.1998.2091; LURQUIN C, 1989, CELL, V58, P293, DOI 10.1016/0092-8674(89)90844-1; Manning TC, 1999, IMMUNOL TODAY, V20, P417, DOI 10.1016/S0167-5699(99)01508-X; Margulies David H., 1993, Journal of Molecular Recognition, V6, P59, DOI 10.1002/jmr.300060204; Margulies DH, 1996, CURR OPIN IMMUNOL, V8, P262, DOI 10.1016/S0952-7915(96)80066-5; MARRACK P, 1993, IMMUNOL REV, V131, P79, DOI 10.1111/j.1600-065X.1993.tb01531.x; MAYORDOMO JI, 1995, NAT MED, V1, P1297, DOI 10.1038/nm1295-1297; Morgan DJ, 1998, J IMMUNOL, V160, P643; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; OHerrin SM, 1997, J EXP MED, V186, P1333, DOI 10.1084/jem.186.8.1333; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Pardoll DM, 2000, CLIN IMMUNOL, V95, pS44, DOI 10.1006/clim.1999.4819; PARKER KC, 1994, J IMMUNOL, V152, P163; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Plaksin D, 1997, J IMMUNOL, V158, P2218; Robbins PF, 1996, CURR OPIN IMMUNOL, V8, P628, DOI 10.1016/S0952-7915(96)80078-1; Robinson RA, 1996, J IMMUNOL, V156, P4266; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SCHNECK JP, 1999, CURRENT PROTOCOLS IM; Shields MJ, 1998, J IMMUNOL, V160, P2297; SOLINGER AM, 1979, J EXP MED, V150, P830, DOI 10.1084/jem.150.4.830; Valmori D, 1999, INT IMMUNOL, V11, P1971, DOI 10.1093/intimm/11.12.1971; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	59	245	271	2	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2000	13	4					529	538		10.1016/S1074-7613(00)00052-2	http://dx.doi.org/10.1016/S1074-7613(00)00052-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070171	Bronze			2022-12-18	WOS:000090079100012
J	Takakura, N; Huang, XL; Naruse, T; Hamaguchi, I; Dumont, DJ; Yancopoulos, GD; Suda, T				Takakura, N; Huang, XL; Naruse, T; Hamaguchi, I; Dumont, DJ; Yancopoulos, GD; Suda, T			Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis	IMMUNITY			English	Article							BLOOD-VESSEL FORMATION; MURINE YOLK-SAC; STEM-CELLS; TYROSINE KINASE; MESODERMAL CELLS; C-KIT; MOUSE; EXPRESSION; TEK; VASCULOGENESIS	We have investigated the function of TIE2/TEK receptor tyrosine kinase in the development of definitive hematopoiesis. In the vitelline artery at 9.5 days post-coitum (d.p.c.), TIE2(+) hematopoietic cells aggregated and adhered to TIE2(+) endothelial cells. Soluble TIE2-Fc chimeric protein inhibited the development of hematopoiesis and angiogenesis in the para-aortic splanchnopleural mesoderm (P-Sp) explant culture, and TIE2-deficient mice showed severely impaired definitive hematopoiesis. An in vitro study revealed that Angiopoietin-1 but not Angiopoietin-2 promoted the adhesion to fibronectin (FN) through integrins in TIE2-transfected cells and primary TIE2+ cells sorted from 9.5 d.p.c. P-Sp. Adhesion of TIE2+ cells induced by Angiopoietin-1 enhanced the proliferation of hematopoietic progenitor cells.	Kumamoto Univ, Sch Med, Dept Cell Differentat, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; Sunnybrook & Womens Coll, Hlth Sci Ctr, Div Canc Biol, Toronto, ON M4N 3M5, Canada; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Kumamoto University; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Regeneron	Suda, T (corresponding author), Kumamoto Univ, Sch Med, Dept Cell Differentat, Inst Mol Embryol & Genet, 2-2-1 Honjo, Kumamoto 8600811, Japan.		Suda, Toshio/H-6761-2013	Suda, Toshio/0000-0001-7540-1771				Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DUMONT DJ, 1992, ONCOGENE, V7, P1471; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MIWA Y, 1991, DEVELOPMENT, V111, P543; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takakura N, 1997, J HISTOCHEM CYTOCHEM, V45, P883, DOI 10.1177/002215549704500613; Takakura N, 1996, J EXP MED, V184, P2301, DOI 10.1084/jem.184.6.2301; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Wood HB, 1997, BLOOD, V90, P2300; WU XY, 1994, HYBRIDOMA, V13, P409, DOI 10.1089/hyb.1994.13.409; Yano M, 1997, BLOOD, V89, P4317, DOI 10.1182/blood.V89.12.4317; Yoder MC, 1997, P NATL ACAD SCI USA, V94, P6776, DOI 10.1073/pnas.94.13.6776; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6	34	245	249	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1998	9	5					677	686		10.1016/S1074-7613(00)80665-2	http://dx.doi.org/10.1016/S1074-7613(00)80665-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846489	Bronze			2022-12-18	WOS:000077298300010
J	Fernandez-Ruiz, D; Ng, WY; Holz, LE; Ma, JZ; Zaid, A; Wong, YC; Lau, LS; Mollard, V; Cozijnsen, A; Collins, N; Li, J; Davey, GM; Kato, Y; Devi, S; Skandari, R; Pauley, M; Manton, JH; Godfrey, DI; Braun, A; Tay, SS; Tan, PS; Bowen, DG; Koch-Nolte, F; Rissiek, B; Carbone, FR; Crabb, BS; Lahoud, M; Cockburn, IA; Mueller, SN; Bertolino, P; McFadden, GI; Caminschi, I; Heath, WR				Fernandez-Ruiz, Daniel; Ng, Wei Yi; Holz, Lauren E.; Ma, Joel Z.; Zaid, Ali; Wong, Yik Chun; Lau, Lei Shong; Mollard, Vanessa; Cozijnsen, Anton; Collins, Nicholas; Li, Jessica; Davey, Gayle M.; Kato, Yu; Devi, Sapna; Skandari, Roghieh; Pauley, Michael; Manton, Jonathan H.; Godfrey, Dale I.; Braun, Asolina; Tay, Szun Szun; Tan, Peck Szee; Bowen, David G.; Koch-Nolte, Friedrich; Rissiek, Bjoern; Carbone, Francis R.; Crabb, Brendan S.; Lahoud, Mireille; Cockburn, Ian A.; Mueller, Scott N.; Bertolino, Patrick; McFadden, Geoffrey I.; Caminschi, Irina; Heath, William R.			Liver-Resident Memory CD8(+) T Cells Form a Front-Line Defense against Malaria Liver-Stage Infection	IMMUNITY			English	Article							DENDRITIC CELLS; RM CELLS; TISSUE; PROTECTION; IMMUNITY; IMMUNIZATION; STRATEGY; ANTIGEN; HERPES	In recent years, various intervention strategies have reduced malaria morbidity and mortality, but further improvements probably depend upon development of a broadly protective vaccine. To better understand immune requirement for protection, we examined liver-stage immunity after vaccination with irradiated sporozoites, an effective though logistically difficult vaccine. We identified a population of memory CD8(+) T cells that expressed the gene signature of tissueresident memory T (Trm) cells and remained permanently within the liver, where they patrolled the sinusoids. Exploring the requirements for liver Trm cell induction, we showed that by combining dendritic cell-targeted priming with liver inflammation and antigen recognition on hepatocytes, high frequencies of Trm cells could be induced and these cells were essential for protection against malaria sporozoite challenge. Our study highlights the immune potential of liver Trmcells and provides approaches for their selective transfer, expansion, ordepletion, whichmay be harnessed to control liver infections or autoimmunity.	[Fernandez-Ruiz, Daniel; Ng, Wei Yi; Holz, Lauren E.; Ma, Joel Z.; Zaid, Ali; Lau, Lei Shong; Collins, Nicholas; Li, Jessica; Davey, Gayle M.; Kato, Yu; Devi, Sapna; Godfrey, Dale I.; Braun, Asolina; Carbone, Francis R.; Mueller, Scott N.; Heath, William R.] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Ng, Wei Yi; Li, Jessica; Tan, Peck Szee; Crabb, Brendan S.; Lahoud, Mireille; Caminschi, Irina] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia; [Mollard, Vanessa; Cozijnsen, Anton; McFadden, Geoffrey I.] Univ Melbourne, Sch BioSci, Parkville, Vic 3010, Australia; [Holz, Lauren E.; Zaid, Ali; Davey, Gayle M.; Devi, Sapna; Godfrey, Dale I.; Mueller, Scott N.; Heath, William R.] Univ Melbourne, ARC Ctr Excellence Adv Mol Imaging, Parkville, Vic 3010, Australia; [Skandari, Roghieh; Pauley, Michael; Manton, Jonathan H.] Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic 3010, Australia; [Wong, Yik Chun; Tay, Szun Szun; Bowen, David G.; Bertolino, Patrick] Univ Sydney, Liver Immunol Program, Centenary Inst, Locked Bag 6, Sydney, NSW 2042, Australia; [Wong, Yik Chun; Tay, Szun Szun; Bowen, David G.; Bertolino, Patrick] Univ Sydney, AW Morrow Gastroenterol & Liver Ctr, Locked Bag 6, Sydney, NSW 2042, Australia; [Wong, Yik Chun; Tay, Szun Szun; Bowen, David G.; Bertolino, Patrick] Royal Prince Alfred Hosp, Locked Bag 6, Sydney, NSW 2042, Australia; [Koch-Nolte, Friedrich; Rissiek, Bjoern] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Martinistr 52, D-20246 Hamburg, Germany; [Tan, Peck Szee; Lahoud, Mireille; Caminschi, Irina] Monash Univ, Infect & Immun Program, Monash Biomed Discovery Inst, Clayton, Vic 3168, Australia; [Tan, Peck Szee; Lahoud, Mireille; Caminschi, Irina] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia; [Cockburn, Ian A.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT 2601, Australia	University of Melbourne; Burnet Institute; University of Melbourne; University of Melbourne; University of Melbourne; University of Sydney; Centenary Institute; University of Sydney; University of Sydney; University of Hamburg; University Medical Center Hamburg-Eppendorf; Monash University; Monash University; Australian National University; John Curtin School of Medical Research	Heath, WR (corresponding author), Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.; Caminschi, I (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia.; Heath, WR (corresponding author), Univ Melbourne, ARC Ctr Excellence Adv Mol Imaging, Parkville, Vic 3010, Australia.; Caminschi, I (corresponding author), Monash Univ, Infect & Immun Program, Monash Biomed Discovery Inst, Clayton, Vic 3168, Australia.; Caminschi, I (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia.	irina.caminschi@monash.edu.au; wrheath@unimelb.edu.au	Ruiz, Daniel Fernández/N-2304-2014; Rissiek, Björn/J-4252-2019; McFadden, Geoffrey McFadden I/F-7667-2014; Carbone, Francis/ABF-2141-2020; Mueller, Scott/B-1918-2012; Lahoud, Mireille/F-1299-2013	Ruiz, Daniel Fernández/0000-0002-4040-9121; Rissiek, Björn/0000-0001-5327-5479; McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Kato, Yu/0000-0003-4743-1775; Cockburn, Ian/0000-0001-8220-9294; Braun, Asolina/0000-0002-2646-5362; Holz, Lauren/0000-0003-4897-0981; Mueller, Scott/0000-0002-3838-3989; Lahoud, Mireille/0000-0001-8472-6201; Zaid, Ali/0000-0002-2528-2783; Tay, Szun S/0000-0003-0186-8154; Devi, Sapna/0000-0003-4714-6018; Godfrey, Dale/0000-0002-3009-5472; Bowen, David/0000-0002-7965-5581; Bertolino, Patrick/0000-0001-8244-7057; Heath, William/0000-0001-9670-259X; Koch-Nolte, Friedrich/0000-0003-1730-6674; Ma, Joel/0000-0002-0448-6744; Caminschi, Irina/0000-0002-9027-2098	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank members of the F.R.C. and W.R.H. laboratories for discussion and the staff of the Peter Doherty Institute animal facility for animal husbandry. We also thank the Melbourne Brain Centre and ImmunoID Flow Cytometry Facilities for technical assistance. This work was supported by the National Health and Medical Research Council of Australia and the Australian Research Council.	Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Butler NS, 2012, TRENDS IMMUNOL, V33, P247, DOI 10.1016/j.it.2012.02.001; Cabrera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070842; Cockburn IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000877; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Lahoud MH, 2011, J IMMUNOL, V187, P842, DOI 10.4049/jimmunol.1101176; Lau LS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004135; Louis C., 1997, MOL BIOL INSECT DIS, P2, DOI DOI 10.1126/science.1241800; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Melloul E, 2014, J SURG RES, V187, P458, DOI 10.1016/j.jss.2013.11.1079; Nganou-Makamdop K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036508; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Ramakrishnan Chandra, 2013, Methods Mol Biol, V923, P51; Rissiek B, 2014, J LEUKOCYTE BIOL, V95, P543, DOI 10.1189/jlb.0713407; RODRIGUES M, 1993, IMMUNOLOGY, V80, P1; Samulowitz U, 2010, OLIGONUCLEOTIDES, V20, P93, DOI 10.1089/oli.2009.0210; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Tay SS, 2014, J IMMUNOL, V193, P2087, DOI 10.4049/jimmunol.1400037; Thomas SY, 2011, J EXP MED, V208, P1179, DOI 10.1084/jem.20102630; Tse SW, 2013, GENES IMMUN, V14, P302, DOI 10.1038/gene.2013.20; Tse SW, 2014, J INFECT DIS, V210, P1508, DOI 10.1093/infdis/jiu281; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111	42	244	247	3	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					889	902		10.1016/j.immuni.2016.08.011	http://dx.doi.org/10.1016/j.immuni.2016.08.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27692609	Bronze			2022-12-18	WOS:000389473200019
J	Sanchez, MJ; Holmes, A; Miles, C; Dzierzak, E				Sanchez, MJ; Holmes, A; Miles, C; Dzierzak, E			Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo	IMMUNITY			English	Article							CD34+ MARROW-CELLS; C-KIT RECEPTOR; PROGENITOR CELLS; BONE-MARROW; YOLK-SAC; PARAAORTIC SPLANCHNOPLEURA; REPOPULATING ABILITY; VONWILLEBRAND-FACTOR; LYMPHOCYTE-B; IN-VITRO	At day 10 in mouse gestation, the intraembryonic aorta-gonads-mesonephros (AGM) region generates the first definitive hematopoietic stem cells (HSCs) of the adult blood system. By 11 days postcoitum, the liver contains such HSCs. While HSCs of the adult bone marrow and late-stage fetal liver have been extensively characterized for cell surface markers, there has been no phenotypic description of the first HSCs during embryo development. We report here the temporal cell surface phenotype of HSCs from the AGM region and early fetal liver and show that all HSCs reside in the c-kit(+) population. c-kit(+) HSCs from AGM and liver are mainly CD34(+) and in the AGM are in both Mac-1(+) and Mac-1 fractions. These results demonstrate that during mouse ontogeny the first definitive HSCs are similar in cell surface phenotype to the HSCs of adult bone marrow but that spatial localization and developmental time are critical factors in the phenotypic assessment of this functional cell population.	NATL INST MED RES, LONDON NW7 1AA, ENGLAND	MRC National Institute for Medical Research			Sanchez, Maria Jose/P-4716-2016	Sanchez, Maria Jose/0000-0003-3464-6224				ANDREWS RG, 1992, BLOOD, V80, P1693; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BERENSON RJ, 1988, J CLIN INVEST, V81, P951, DOI 10.1172/JCI113409; BERENSON RJ, 1991, BLOOD, V77, P1717; Broudy VC, 1996, BLOOD, V88, P75; CORBI AL, 1988, J BIOL CHEM, V263, P12403; Diacovo TG, 1996, BLOOD, V88, P146; Dieterlen-Lievre F, 1993, SEMIN DEV BIOL, V4, P325; DZIERZAK E, 1995, TRENDS GENET, V11, P359, DOI 10.1016/S0168-9525(00)89107-6; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; Healy L, 1995, P NATL ACAD SCI USA, V92, P12240, DOI 10.1073/pnas.92.26.12240; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; JORDAN CT, 1995, EXP HEMATOL, V23, P1011; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; KATZ FE, 1985, LEUKEMIA RES, V9, P191, DOI 10.1016/0145-2126(85)90082-7; KESHET E, 1991, EMBO J, V10, P2425, DOI 10.1002/j.1460-2075.1991.tb07782.x; KRAUSE DS, 1994, BLOOD, V84, P691; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; MEDVINSKY A, 1993, SEMIN DEV BIOL, V4, P333; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; OGAWA M, 1993, DEVELOPMENT, V117, P1089; OKADA S, 1991, BLOOD, V78, P1706; ONISHI M, 1993, BLOOD, V81, P3217; ORLIC D, 1993, BLOOD, V82, P762, DOI 10.1182/blood.V82.3.762.bloodjournal823762; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PALACIOS R, 1992, DEVELOPMENT, V115, P1133; PYTELA R, 1988, EMBO J, V7, P1371, DOI 10.1002/j.1460-2075.1988.tb02953.x; Rebel VI, 1996, EXP HEMATOL, V24, P638; RICH IN, 1995, BLOOD, V86, P463, DOI 10.1182/blood.V86.2.463.bloodjournal862463; RUSSELL ELIZABETH S., 1966, P351; SLIEKER WAT, 1993, INT IMMUNOL, V5, P1093, DOI 10.1093/intimm/5.9.1093; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SZILVASSY SJ, 1993, BLOOD, V81, P2310; SZILVASSY SJ, 1989, BLOOD, V74, P930; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; TOLES JF, 1989, P NATL ACAD SCI USA, V86, P7456, DOI 10.1073/pnas.86.19.7456; TREVISAN M, 1995, J EXP MED, V181, P93, DOI 10.1084/jem.181.1.93; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; VANDERLOO JCM, 1995, EXP HEMATOL, V23, P1002; WEISSMANN I, 1978, COLD SPRING HARB SYM, V5, P33; WINEMAN JP, 1992, BLOOD, V80, P1717; YODER MC, 1995, BLOOD, V85, pA592; YOUNG PE, 1995, BLOOD, V85, P96, DOI 10.1182/blood.V85.1.96.bloodjournal85196; ZEGER DL, 1990, IMMUNOGENETICS, V31, P191; ZEIGLER FC, 1994, BLOOD, V84, P2422, DOI 10.1182/blood.V84.8.2422.bloodjournal8482422	49	244	249	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1996	5	6					513	525		10.1016/S1074-7613(00)80267-8	http://dx.doi.org/10.1016/S1074-7613(00)80267-8			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986712	Bronze			2022-12-18	WOS:A1996WA65100003
J	de Diego, RP; Sancho-Shimizu, V; Lorenzo, L; Puel, A; Plancoulaine, S; Picard, C; Herman, M; Cardon, A; Durandy, A; Bustamante, J; Vallabhapurapu, S; Bravo, J; Warnatz, K; Chaix, Y; Cascarrigny, F; Lebon, P; Rozenberg, F; Karin, M; Tardieu, M; Al-Muhsen, S; Jouanguy, E; Zhang, SY; Abel, L; Casanova, JL				de Diego, Rebeca Perez; Sancho-Shimizu, Vanessa; Lorenzo, Lazaro; Puel, Anne; Plancoulaine, Sabine; Picard, Capucine; Herman, Melina; Cardon, Annabelle; Durandy, Anne; Bustamante, Jacinta; Vallabhapurapu, Sivakumar; Bravo, Jeronimo; Warnatz, Klaus; Chaix, Yves; Cascarrigny, Francoise; Lebon, Pierre; Rozenberg, Flore; Karin, Michael; Tardieu, Marc; Al-Muhsen, Saleh; Jouanguy, Emmanuelle; Zhang, Shen-Ying; Abel, Laurent; Casanova, Jean-Laurent			Human TRAF3 Adaptor Molecule Deficiency Leads to Impaired Toll-like Receptor 3 Response and Susceptibility to Herpes Simplex Encephalitis	IMMUNITY			English	Article							PYOGENIC BACTERIAL-INFECTIONS; KAPPA-B ACTIVATION; MULTIPLE-MYELOMA; STAT1 DEFICIENCY; SURVIVAL SIGNALS; BAFF-R; CELLS; CD40; NIK; IMMUNODEFICIENCIES	Tumor necrosis factor (TNF) receptor-associated factor 3 (TRAF3) functions downstream of multiple TNF receptors and receptors that induce interferon-alpha (IFN-alpha), IFN-beta, and IFN-lambda production, including Toll-like receptor 3 (TLR3), which is deficient in some patients with herpes simplex virus-1 encephalitis (HSE). Mice lacking TRAF3 die in the neonatal period, preventing direct investigation of the role of TRAF3 in immune responses and host defenses in vivo. Here, we report autosomal dominant, human TRAF3 deficiency in a young adult with a history of HSE in childhood. The TRAF3 mutant allele is loss-of-expression, loss-of-function, dominant-negative and associated with impaired, but not abolished, TRAF3-dependent responses upon stimulation of both TNF receptors and receptors that induce IFN production. TRAF3 deficiency is associated with a clinical phenotype limited to HSE resulting from the impairment of TLR3-dependent induction of IFN. Thus, TLR3-mediated immunity against primary infection by HSV-1 in the central nervous system is critically dependent on TRAF3.	[de Diego, Rebeca Perez; Sancho-Shimizu, Vanessa; Lorenzo, Lazaro; Puel, Anne; Plancoulaine, Sabine; Picard, Capucine; Herman, Melina; Cardon, Annabelle; Bustamante, Jacinta; Jouanguy, Emmanuelle; Zhang, Shen-Ying; Abel, Laurent; Casanova, Jean-Laurent] Necker Med Sch, INSERM, Necker Branch, Lab Human Genet Infect Dis,U980, F-75015 Paris, France; [de Diego, Rebeca Perez; Sancho-Shimizu, Vanessa; Lorenzo, Lazaro; Puel, Anne; Plancoulaine, Sabine; Picard, Capucine; Herman, Melina; Cardon, Annabelle; Bustamante, Jacinta; Jouanguy, Emmanuelle; Zhang, Shen-Ying; Abel, Laurent; Casanova, Jean-Laurent] Univ Paris 05, F-75015 Paris, France; [de Diego, Rebeca Perez; Sancho-Shimizu, Vanessa; Lorenzo, Lazaro; Puel, Anne; Plancoulaine, Sabine; Herman, Melina; Cardon, Annabelle; Bustamante, Jacinta; Jouanguy, Emmanuelle; Zhang, Shen-Ying; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Picard, Capucine; Durandy, Anne] Hop Necker Enfants Malad, AP HP, Study Ctr Primary Immunodeficiencies, F-75015 Paris, France; [Vallabhapurapu, Sivakumar; Karin, Michael] Univ Calif San Diego, Ctr Canc, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, San Diego, CA 93093 USA; [Vallabhapurapu, Sivakumar; Karin, Michael] Univ Calif San Diego, Ctr Canc, Dept Pathol, San Diego, CA 93093 USA; [Bravo, Jeronimo] CSIC, IBV, Inst Biomed Valencia, Signal Transduct Unit, Valencia 46010, Spain; [Warnatz, Klaus] Univ Clin Freiburg, Div Clin Immunol & Rheumatol, D-79106 Freiburg, Germany; [Chaix, Yves] Toulouse Hosp, F-31059 Toulouse, France; [Cascarrigny, Francoise] Montauban Hosp, Serv Pediat, F-82013 Montauban, France; [Lebon, Pierre; Rozenberg, Flore] Univ Paris 05, Cochin St Vincent de Paul Hosp, F-75014 Paris, France; [Tardieu, Marc] Univ Paris Sud, Bicetre Hosp, F-94270 Le Kremlin Bicetre, France; [Al-Muhsen, Saleh; Casanova, Jean-Laurent] King Saud Univ, Coll Med, Dept Pediat, Prince Naif Ctr Immunol Res, Riyadh 11451, Saudi Arabia; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Pediat Hematol Immunol Unit, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Diego; University of California System; University of California San Diego; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); University of Freiburg; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; King Saud University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), Necker Med Sch, INSERM, Necker Branch, Lab Human Genet Infect Dis,U980, F-75015 Paris, France.	jean-laurent.casanova@inserm.fr	Abel, Laurent/H-8888-2017; PLANCOULAINE, Sabine/E-2824-2017; Al-muhsen, saleh/E-9315-2014; Bravo, Jeronimo/K-9103-2014; Zhang, Shen-Ying/I-2685-2017; Lorenzo, Lazaro/H-7902-2017; Jouanguy, Emmanuelle/H-7901-2017; Durandy, Anne/H-7475-2017; Picard, Capucine/H-3914-2017; Puel, Anne/H-7305-2017; Casanova, Jean-Laurent/I-3418-2017; Bustamante, Jacinta/H-7877-2017; Warnatz, Klaus/AAD-3464-2022; Rozenberg, Flore/O-8854-2017	Abel, Laurent/0000-0001-7016-6493; PLANCOULAINE, Sabine/0000-0003-0725-8306; Al-muhsen, saleh/0000-0003-3698-9968; Bravo, Jeronimo/0000-0001-6695-2846; Zhang, Shen-Ying/0000-0002-9449-3672; Lorenzo, Lazaro/0000-0001-6648-8684; Jouanguy, Emmanuelle/0000-0002-7358-9157; Durandy, Anne/0000-0001-7706-8466; Picard, Capucine/0000-0001-8788-5056; Puel, Anne/0000-0003-2603-0323; Bustamante, Jacinta/0000-0002-3439-2482; Casanova, Jean-Laurent/0000-0002-7782-4169; Casadio, Melina/0000-0003-2389-2243; Perez de Diego, Rebeca/0000-0001-8426-8765	AXA; Schlumberger Foundation; BNP-Paribas Foundation; Groupement d'Interet Scientifique Maladies Rares; Action Concertee Incitative de Microbiologie; March of Dimes; Agence Nationale pour la Recherche; Eppley Foundation; National Institute of Allergy and Infectious Diseases [1R01AI088364]; Thrasher Research Fund; Jeffrey Modell Foundation; Talecris Biotherapeutics; St. Giles Foundation; Rockefeller University Center for Clinical and Translational Science [5UL1RR024143]; Rockefeller University; European Union; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088364] Funding Source: NIH RePORTER	AXA; Schlumberger Foundation(Schlumberger); BNP-Paribas Foundation; Groupement d'Interet Scientifique Maladies Rares; Action Concertee Incitative de Microbiologie; March of Dimes(March of Dimes); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Eppley Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Thrasher Research Fund; Jeffrey Modell Foundation; Talecris Biotherapeutics; St. Giles Foundation; Rockefeller University Center for Clinical and Translational Science; Rockefeller University; European Union(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of the Laboratory of Human Genetics of Infectious Diseases and J. Keats, R. Miller, L. Zitvogel, S. Matikainen, C. Reis e Sousa, S. Plebani, and D.W. Leaman for reagents. We thank the patient and her family for their participation in this study, which was supported by the AXA Research fund, the Schlumberger Foundation, the BNP-Paribas Foundation, the Groupement d'Interet Scientifique Maladies Rares, the Action Concertee Incitative de Microbiologie, the March of Dimes, the Agence Nationale pour la Recherche, the Eppley Foundation, the National Institute of Allergy and Infectious Diseases grant number 1R01AI088364, the Thrasher Research Fund, the Jeffrey Modell Foundation and Talecris Biotherapeutics, the St. Giles Foundation, the Rockefeller University Center for Clinical and Translational Science grant number 5UL1RR024143, and the Rockefeller University. P.R. is supported by a European Union FP6 grant. J.-L.C. was an international scholar of the Howard Hughes Medical Institute until 2008.	Abel L, 2010, J PEDIATR-US, V157, P623, DOI 10.1016/j.jpeds.2010.04.020; ALCAIS A, 2010, ANN NY ACAD IN PRESS; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bishop GA, 2007, IMMUNOL RES, V39, P22, DOI 10.1007/s12026-007-0068-1; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Chen MC, 2003, J BIOL CHEM, V278, P16073, DOI 10.1074/jbc.M208661200; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; De Tiege X, 2008, EUR J PAEDIATR NEURO, V12, P72, DOI 10.1016/j.ejpn.2007.07.007; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Giraffa G, 2000, J MICROBIOL METH, V42, P175, DOI 10.1016/S0167-7012(00)00172-X; Graham JP, 2009, J IMMUNOL, V183, P2966, DOI 10.4049/jimmunol.0900442; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; He JQ, 2007, ADV EXP MED BIOL, V597, P48; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hoebe K, 2006, TRENDS MOL MED, V12, P187, DOI 10.1016/j.molmed.2006.03.008; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kuai J, 2003, J BIOL CHEM, V278, P14363, DOI 10.1074/jbc.M208672200; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pellat-Deceunynck C, 1999, CLIN CANCER RES, V5, P705; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pullen SS, 1999, BIOCHEMISTRY-US, V38, P10168, DOI 10.1021/bi9909905; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Xu LG, 2002, J IMMUNOL, V169, P6883, DOI 10.4049/jimmunol.169.12.6883; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	41	243	244	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 24	2010	33	3					400	411		10.1016/j.immuni.2010.08.014	http://dx.doi.org/10.1016/j.immuni.2010.08.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20832341	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000282798500014
J	Chou, RC; Kim, ND; Sadik, CD; Seung, E; Lan, YN; Byrne, MH; Haribabu, B; Iwakura, Y; Luster, AD				Chou, Richard C.; Kim, Nancy D.; Sadik, Christian D.; Seung, Edward; Lan, Yinan; Byrne, Michael H.; Haribabu, Bodduluri; Iwakura, Yoichiro; Luster, Andrew D.			Lipid-Cytokine-Chemokine Cascade Drives Neutrophil Recruitment in a Murine Model of Inflammatory Arthritis	IMMUNITY			English	Article							INFL AMMATORY ARTHRITIS; T-CELL TRAFFICKING; RHEUMATOID-ARTHRITIS; THERAPEUTIC TARGETS; MEDIATED ARTHRITIS; LEUKOTRIENE B-4; RECEPTOR BLT1; MAST-CELLS; MICE; DISEASE	A large and diverse array of chemoattractants control leukocyte trafficking, but how these apparently redundant signals collaborate in vivo is still largely unknown. We previously demonstrated an absolute requirement for the lipid chemoattractant leukotriene B-4 (LTB4) and its receptor BLT1 for neutrophil recruitment into the joint in autoantibody-induced arthritis. We now demonstrate that BLT1 is required for neutrophils to deliver IL-1 into the joint to initiate arthritis. IL-1-expressing neutrophils amplify arthritis through the production of neutrophil-active chemokines from synovial tissue cells. CCR1 and CXCR2, two neutrophil chemokine receptors, operate nonredundantly to sequentially control the later phase of neutrophil recruitment into the joint and mediate all neutrophil chemokine activity in the model. Thus, we have uncovered a complex sequential relationship involving unique contributions from the lipid mediator LTB4, the cytokine IL-1, and CCR1 and CXCR2 chemokine ligands that are all absolutely required for effective neutrophil recruitment into the joint.	[Chou, Richard C.; Kim, Nancy D.; Sadik, Christian D.; Seung, Edward; Lan, Yinan; Byrne, Michael H.; Luster, Andrew D.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Div Rheumat Allerg, Boston, MA 02114 USA; [Haribabu, Bodduluri] Univ Louisville Hlth Sci, James Graham Brown Canc Ctr, Tumor Immunobiol Program, Louisville, KY 40202 USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Louisville; University of Tokyo	Luster, AD (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Div Rheumat Allerg, Boston, MA 02114 USA.	aluster@mgh.harvard.edu	Sadik, Christian David/G-9593-2014; Luster, Andrew/ABE-6504-2020; Bodduluri, Haribabu/A-2584-2010; Sadik, Christian/E-8404-2012; Iwakura, Yoichiro/E-5457-2011	Sadik, Christian David/0000-0001-6701-048X; Luster, Andrew/0000-0001-9679-7912; Bodduluri, Haribabu/0000-0002-8261-3294; Iwakura, Yoichiro/0000-0002-9934-5775	National Institutes of Health [R01AI050892, K08 AR054094]; Abbott; Deutsche Forschungsgemeinschaft [Sa1960/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott(Abbott Laboratories); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Studies were supported by National Institutes of Health R01AI050892 (A.D.L.) and K08 AR054094 (N.D.K.), Abbott Scholar Award in Rheumatology Research (R.C.C.), and Deutsche Forschungsgemeinschaft Sa1960/1-1 (C.D.S.).	CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; FIRESTEIN GS, 1990, J IMMUNOL, V144, P3347; Fitzgerald AA, 2005, ARTHRITIS RHEUM-US, V52, P1794, DOI 10.1002/art.21061; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; GOLDMAN DW, 1984, J EXP MED, V159, P1027, DOI 10.1084/jem.159.4.1027; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Luster AD, 2004, NAT REV IMMUNOL, V4, P711, DOI 10.1038/nri1438; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Medoff BD, 2009, J IMMUNOL, V182, P623, DOI 10.4049/jimmunol.182.1.623; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Snir O, 2010, ARTHRITIS RHEUM-US, V62, P44, DOI 10.1002/art.25036; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391	29	243	249	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					266	278		10.1016/j.immuni.2010.07.018	http://dx.doi.org/10.1016/j.immuni.2010.07.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20727790	Bronze, Green Accepted			2022-12-18	WOS:000281654900015
J	Hegazy, AN; Peine, M; Helmstetter, C; Panse, I; Frohlich, A; Bergthaler, A; Flatz, L; Pinschewer, DD; Radbruch, A; Lohning, M				Hegazy, Ahmed N.; Peine, Michael; Helmstetter, Caroline; Panse, Isabel; Froehlich, Anja; Bergthaler, Andreas; Flatz, Lukas; Pinschewer, Daniel D.; Radbruch, Andreas; Loehning, Max			Interferons Direct Th2 Cell Reprogramming to Generate a Stable GATA-3(+)T-bet(+) Cell Subset with Combined Th2 and Th1 Cell Functions	IMMUNITY			English	Article							CD4(+) T-CELLS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; TRANSCRIPTION FACTOR GATA-3; VIRAL-INFECTION; LINEAGE COMMITMENT; HELPER LYMPHOCYTES; FATE DETERMINATION; STAT4 ACTIVATION; T(H)1 CELLS; IFN-ALPHA	Current T cell differentiation models invoke separate T helper 2 (Th2) and Th1 cell lineages governed by the lineage-specifying transcription factors GATA-3 and T-bet. However, knowledge on the plasticity of Th2 cell lineage commitment is limited. Here we show that infection with Th1 cell-promoting lymphocytic choriomeningitis virus (LCMV) reprogrammed otherwise stably committed GATA-3(+) Th2 cells to adopt a GATA-3(+)T-bet(+) and interleukin-4(+)interferon-gamma(+) "Th2+1" phenotype that was maintained in vivo for months. Th2 cell reprogramming required T cell receptor stimulation, concerted type I and type 11 interferon and interleukin-12 signals, and T-bet. LCMV-triggered T-bet induction in adoptively transferred virus-specific Th2 cells was crucial to prevent viral persistence and fatal immunopathology. Thus, functional reprogramming of unfavorably differentiated Th2 cells may facilitate the establishment of protective immune responses. Stable coexpression of GATA-3 and T-bet provides a molecular concept for the long-term coexistence of Th2 and Th1 cell lineage characteristics in single memory T cells.	[Hegazy, Ahmed N.; Peine, Michael; Helmstetter, Caroline; Panse, Isabel; Froehlich, Anja; Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany; [Hegazy, Ahmed N.; Peine, Michael; Helmstetter, Caroline; Panse, Isabel; Froehlich, Anja; Radbruch, Andreas; Loehning, Max] German Rheumatism Res Ctr DRFZ, Leibniz Inst, D-10117 Berlin, Germany; [Bergthaler, Andreas] Inst Syst Biol, Seattle, WA 98103 USA; [Flatz, Lukas] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Pinschewer, Daniel D.] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Institute for Systems Biology (ISB); National Institutes of Health (NIH) - USA; University of Geneva	Lohning, M (corresponding author), Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany.	loehning@drfz.de	Bergthaler, Andreas/ABG-5047-2020; Löhning, Max/AAL-2967-2021	Bergthaler, Andreas/0000-0003-0597-1976; Löhning, Max/0000-0001-6382-7281; Hegazy, Ahmed N./0000-0002-2946-8251; Peine, Caroline/0000-0001-6267-3452; Pinschewer, Daniel/0000-0002-1594-3189; Radbruch, Andreas/0000-0001-5753-0000	German Research Foundation [SFB650, SFB618, GRK1121]; German Federal Ministry of Education and Research (FORSYS); Volkswagen Foundation; Swiss National Science Foundation; International Max Planck Research School for Infectious Diseases and Immunology	German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research (FORSYS)(Federal Ministry of Education & Research (BMBF)); Volkswagen Foundation(Volkswagen); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); International Max Planck Research School for Infectious Diseases and Immunology	We are grateful to R.M. Zinkernagel and H. Hengartner for advice and long-term support and to A. Hamann, T. Hofer, K.M. Murphy, W.E. Paul, and J. Zhu for helpful discussions. We thank S. Ebel, T. Geske, H. Hecker-Kia, and H. Schliemann for expert technical assistance. This work was supported by the German Research Foundation (SFB650 and SFB618), the German Federal Ministry of Education and Research (FORSYS), the Volkswagen Foundation, and the Swiss National Science Foundation. A.N.H. is a fellow of GRK1121 of the German Research Foundation. M.P. and C.H. are fellows of the International Max Planck Research School for Infectious Diseases and Immunology. M.L. is a Lichtenberg fellow funded by the Volkswagen Foundation.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Berenson LS, 2006, J IMMUNOL, V177, P5195, DOI 10.4049/jimmunol.177.8.5195; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Glimcher LH, 2000, GENE DEV, V14, P1693; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; HuLi J, 1997, P NATL ACAD SCI USA, V94, P3189, DOI 10.1073/pnas.94.7.3189; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; King C, 2001, NAT MED, V7, P206, DOI 10.1038/84659; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Levanon D, 2007, NAT IMMUNOL, V8, P145; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; Lohning M, 2002, ADV IMMUNOL, V80, P115, DOI 10.1016/S0065-2776(02)80014-1; Mariani L, 2004, PROG BIOPHYS MOL BIO, V86, P45, DOI 10.1016/j.pbiomolbio.2004.02.007; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; PEREZ VL, 1995, INT IMMUNOL, V7, P869, DOI 10.1093/intimm/7.5.869; PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088; Ramos HJ, 2007, J IMMUNOL, V179, P3792, DOI 10.4049/jimmunol.179.6.3792; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Varga SM, 2000, J VIROL, V74, P4429, DOI 10.1128/JVI.74.9.4429-4432.2000; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; ZINKERNAGEL RM, 1986, J EXP MED, V164, P1075, DOI 10.1084/jem.164.4.1075	51	243	253	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 29	2010	32	1					116	128		10.1016/j.immuni.2009.12.004	http://dx.doi.org/10.1016/j.immuni.2009.12.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20079668	Bronze			2022-12-18	WOS:000274119900016
J	Zhang, X; Majlessi, L; Deriaud, E; Leclerc, C; Lo-Man, R				Zhang, Xiaoming; Majlessi, Laleh; Deriaud, Edith; Leclerc, Claude; Lo-Man, Richard			Coactivation of Syk Kinase and MyD88 Adaptor Protein Pathways by Bacteria Promotes Regulatory Properties of Neutrophils	IMMUNITY			English	Article							C-TYPE LECTIN; INNATE IMMUNE RECOGNITION; ACTIVATING RECEPTOR; MYELOID CELLS; AMPLIFIES INFLAMMATION; DEPENDENT MECHANISM; DENDRITIC CELLS; DECTIN-1; RESPONSES; MINCLE	Neutrophils are one of the first lines of defense against microbial pathogens and are rapidly recruited at the infection site upon inflammatory conditions. We show here that after bacterial stimulation, and in contrast to monocytes and macrophages, murine neutrophils contributed poorly to inflammatory responses; however, they secreted high amounts of the anti-inflammatory cytokine IL-10 in a DAP12 adaptor-Syk kinase and MyD88 adaptor-dependent manner. Cotriggering of TLR-MyD88- and C-type lectin receptor (CLR)-Syk-dependent pathways led to a quick and sustained phosphorylation of p38 MAP and Akt kinases in neutrophils. In vivo, both Gram-negative bacteria and mycobacteria induced the recruitment of neutrophils secreting IL-10. In acute mycobacterial infection, neutrophil-derived IL-10 controlled the inflammatory response of dendritic, cells, monocytes and macrophages in the lung. During a chronic infection, neutrophil depletion promoted inflammation and decreased the mycobacterial burden. Therefore, neutrophils can have a previously unsuspected regulatory role during acute and chronic microbial infections.	[Zhang, Xiaoming; Majlessi, Laleh; Deriaud, Edith; Leclerc, Claude; Lo-Man, Richard] Inst Pasteur, Unite Regulat Immunitaire & Vaccinol, F-75724 Paris 15, France; [Zhang, Xiaoming; Majlessi, Laleh; Deriaud, Edith; Leclerc, Claude; Lo-Man, Richard] INSERM, U883, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lo-Man, R (corresponding author), Inst Pasteur, Unite Regulat Immunitaire & Vaccinol, 25 Rue Dr Roux, F-75724 Paris 15, France.	richard.lo-man@pasteur.fr			European Commission [Cellprom-NMP4-CT-2004-500039]; Institut Pasteur [PTR260]; Agence Nationale de la Recherche; Ligue du Cancer	European Commission(European CommissionEuropean Commission Joint Research Centre); Institut Pasteur(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue du Cancer	We are grateful to E. Vivier and M. Dalod for DAP12 <SUP>K Delta Y75</SUP> mice, and to P. Bruhns for Fcer1g<SUP>-/-</SUP> mice. We thank O. Granet for A. fumigatus, G. Sellge for S. flexneri, R. Brosch for M. smegmatis, and C. Fayolle for NIMP-R14 mAb. X, Z, was supported by the European Commission (Cellprom-NMP4-CT-2004-500039) and by Institut Pasteur (PTR260). This work was supported by a grant from Agence Nationale de la Recherche (MIME 2006) and by the Ligue du Cancer.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Bennouna S, 2005, J IMMUNOL, V174, P4845, DOI 10.4049/jimmunol.174.8.4845; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; Bliss SK, 2000, J IMMUNOL, V165, P4515, DOI 10.4049/jimmunol.165.8.4515; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Kanazawa N, 2003, J BIOL CHEM, V278, P32645, DOI 10.1074/jbc.M304226200; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; LOPEZ AF, 1984, BRIT J HAEMATOL, V57, P489, DOI 10.1111/j.1365-2141.1984.tb02923.x; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Pengal RA, 2006, MOL IMMUNOL, V43, P1557, DOI 10.1016/j.molimm.2005.09.022; Piskin G, 2005, ARCH DERMATOL RES, V296, P339, DOI 10.1007/s00403-004-0522-z; Ricevuti G, 1997, ANN NY ACAD SCI, V832, P426, DOI 10.1111/j.1749-6632.1997.tb46269.x; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Romani L, 1997, J IMMUNOL, V158, P2356; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schmielau J, 2001, CANCER RES, V61, P4756; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711	47	243	245	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2009	31	5					761	771		10.1016/j.immuni.2009.09.016	http://dx.doi.org/10.1016/j.immuni.2009.09.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19913447	Bronze			2022-12-18	WOS:000272097900011
J	Clay, H; Volkman, HE; Ramakrishnan, L				Clay, Hilary; Volkman, Hannah E.; Ramakrishnan, Lalita			Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death	IMMUNITY			English	Article							CASPASE-INDEPENDENT PATHWAY; ANTI-TNF THERAPY; FACTOR-ALPHA; GRANULOMA-FORMATION; TUBERCULOSIS INFECTION; IMMUNE-RESPONSE; DEFICIENT MICE; CELL-DEATH; INFLAMMATORY RESPONSE; LATENT TUBERCULOSIS	Tumor necrosis factor (TNF), a key effector in controlling tuberculosis, is thought to exert protection by directing formation of granulomas, organized aggregates of macrophages and other immune cells. Loss of TNF signaling causes progression of tuberculosis in humans, and the increased mortality of Mycobacterium tuberculosis-infected mice is associated with disorganized necrotic granulomas, although the precise roles of TNF signaling preceding this endpoint remain undefined. We monitored transparent Mycobacterium marinum-infected zebrafish live to conduct a stepwise dissection of how TNF signaling operates in mycobacterial pathogenesis. We found that loss of TNF signaling caused increased mortality even when only innate immunity was operant. In the absence of TNF, intracellular bacterial growth and granuloma formation were accelerated and was followed by necrotic death of overladen macrophages and granuloma breakdown. Thus, TNF is not required for tuberculous granuloma formation, but maintains granuloma integrity indirectly by restricting mycobacterial growth within macrophages and preventing their necrosis.	[Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Clay, Hilary; Volkman, Hannah E.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	lalitar@u.washington.edu		Ramakrishnan, Lalita/0000-0003-0692-5533	National Institutes of Health [RO1 AI036396, RO1 AI54503]; Burroughs Wellcome Fund Award; National Institute of General Medical Sciences [T32 GM07270]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054503, R01AI036396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Award(Burroughs Wellcome Fund); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Lesley, K. Urdahl, and P. Edelstein for invaluable discussions and review of the manuscript, F. Fang and T. Richardson for advice and help with the nitric oxide studies, D. Tobin for first identifying the cording phenotype as a measure of extracellular bacterial growth in vivo, P. Edelstein for advice and help on statistical analyses of the data, M. Davis for help with video assembly, and L.Swaim and H. Wiedenhoft for managing the zebrafish facility. This work was funded by National Institutes of Health grants RO1 AI036396 and RO1 AI54503 and a Burroughs Wellcome Fund Award to L.R. H.C. was funded in part by PHS NRSA T32 GM07270 from the National Institute of General Medical Sciences. H.E.V. was funded in part by an American Heart Association predoctoral fellowship.	Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6; Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; APPELBERG R, 1994, INFECT IMMUN, V62, P3962, DOI 10.1128/IAI.62.9.3962-3971.1994; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; BATES JM, 2007, CELL HOST M IN PRESS; Bean AGD, 1999, J IMMUNOL, V162, P3504; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Benini J, 1999, J PATHOL, V189, P127, DOI 10.1002/(SICI)1096-9896(199909)189:1<127::AID-PATH398>3.0.CO;2-S; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Botha T, 2003, J IMMUNOL, V171, P3110, DOI 10.4049/jimmunol.171.6.3110; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Chakravarty SD, 2008, INFECT IMMUN, V76, P916, DOI 10.1128/IAI.01011-07; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Clay H, 2005, ZEBRAFISH, V2, P105, DOI 10.1089/zeb.2005.2.105; Cosma CL, 2006, INFECT IMMUN, V74, P3125, DOI 10.1128/IAI.02061-05; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Criscione LG, 2002, CURR OPIN RHEUMATOL, V14, P204, DOI 10.1097/00002281-200205000-00002; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; DARZINS E, 1956, DIS CHEST, V30, P642, DOI 10.1378/chest.30.6.642; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; DING AH, 1988, J IMMUNOL, V141, P2407; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; DUBOS R J, 1956, Am Rev Tuberc, V74, P667; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Ehlers S, 1999, INFECT IMMUN, V67, P3571, DOI 10.1128/IAI.67.7.3571-3579.1999; Ehlers S, 2000, J IMMUNOL, V165, P483, DOI 10.4049/jimmunol.165.1.483; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; FLESCH IEA, 1990, INFECT IMMUN, V58, P2675, DOI 10.1128/IAI.58.8.2675-2677.1990; FLESCH IEA, 1994, INT IMMUNOL, V6, P693, DOI 10.1093/intimm/6.5.693; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Fratazzi C, 1999, J LEUKOCYTE BIOL, V66, P763, DOI 10.1002/jlb.66.5.763; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Gomez-Reino JJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P756, DOI 10.1002/art.22768; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hernandez RE, 2004, DEVELOPMENT, V131, P4511, DOI 10.1242/dev.01297; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Huerta S, 2007, J SURG RES, V139, P143, DOI 10.1016/j.jss.2006.07.034; Iliopoulos A, 2006, INT J TUBERC LUNG D, V10, P588; Kaku T, 2007, FEMS MICROBIOL LETT, V274, P189, DOI 10.1111/j.1574-6968.2007.00838.x; Kaneko H, 1999, LAB INVEST, V79, P379; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Keane J, 2005, RHEUMATOLOGY, V44, P714, DOI 10.1093/rheumatology/keh567; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; KOCH R, 1882, AETIOLOGY TUBERCULOS; Kwon O. Jung, 1997, Journal of Korean Medical Science, V12, P481; Lange C, 2007, NAT CLIN PRACT RHEUM, V3, P528, DOI 10.1038/ncprheum0571; Lawn SD, 2002, MICROBES INFECT, V4, P635, DOI 10.1016/S1286-4579(02)01582-4; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lin PL, 2007, J INVEST DERM SYMP P, V12, P22, DOI 10.1038/sj.jidsymp.5650027; Liu N, 2003, EMBO J, V22, P5313, DOI 10.1093/emboj/cdg510; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; Menendez A, 2007, CURR OPIN IMMUNOL, V19, P385, DOI 10.1016/j.coi.2007.06.008; MIDDLEBROOK G, 1947, J EXP MED, V86, P175, DOI 10.1084/jem.86.2.175; Miyakawa Y, 1996, INFECT IMMUN, V64, P926, DOI 10.1128/IAI.64.3.926-932.1996; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; O'Sullivan MP, 2007, INFECT IMMUN, V75, P1984, DOI 10.1128/IAI.01107-06; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Pressley ME, 2005, DEV COMP IMMUNOL, V29, P501, DOI 10.1016/j.dci.2004.10.007; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rojo I, 2007, FISH SHELLFISH IMMUN, V23, P1285, DOI 10.1016/j.fsi.2007.07.002; Shin DH, 2000, NEUROSCI LETT, V292, P220, DOI 10.1016/S0304-3940(00)01407-5; Smith S, 2002, INFECT IMMUN, V70, P2082, DOI 10.1128/IAI.70.4.2082-2089.2002; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Taylor JC, 2003, RHEUMATOLOGY, V42, P901, DOI 10.1093/rheumatology/keg158; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tosh K, 2006, P NATL ACAD SCI USA, V103, P10364, DOI 10.1073/pnas.0603340103; Traver D, 2003, ADV IMMUNOL, V81, P253; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Vidal CG, 2005, CLIN INFECT DIS, V40, P756, DOI 10.1086/427941; Vlachaki E, 2005, RESP MED, V99, P648, DOI 10.1016/j.rmed.2004.10.006; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Wagner TE, 2002, AM J MED, V112, P67, DOI 10.1016/S0002-9343(01)01035-X; Zganiacz A, 2004, J CLIN INVEST, V113, P401, DOI 10.1172/JCI200418991	87	243	254	6	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2008	29	2					283	294		10.1016/j.immuni.2008.06.011	http://dx.doi.org/10.1016/j.immuni.2008.06.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18691913	Bronze, Green Accepted			2022-12-18	WOS:000258610800016
J	Price, DA; West, SM; Betts, MR; Ruff, LE; Brenchley, JM; Ambrozak, DR; Edghill-Smith, Y; Kuroda, MJ; Bogdan, D; Kunstman, K; Letvin, NL; Franchini, G; Wolinsky, SM; Koup, RA; Douek, DC				Price, DA; West, SM; Betts, MR; Ruff, LE; Brenchley, JM; Ambrozak, DR; Edghill-Smith, Y; Kuroda, MJ; Bogdan, D; Kunstman, K; Letvin, NL; Franchini, G; Wolinsky, SM; Koup, RA; Douek, DC			T cell receptor recognition motifs govern immune escape patterns in acute SIV infection	IMMUNITY			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; ORIGINAL ANTIGENIC SIN; MAJOR HISTOCOMPATIBILITY COMPLEX; LYMPHOCYTE ESCAPE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; RHESUS-MONKEYS; VIRAL ESCAPE; ALPHA-CHAIN; ACUTE-PHASE	Escape from adaptive T cell immunity through transmutation of viral antigenic structure is a cardinal feature in the pathogenesis of SIV/HIV infection and a major obstacle to antiretroviral vaccine development. However, the molecular determinants of this phenomenon at the T cell receptor (TCR)-antigen interface are unknown. Here, we show that mutational escape is intimately linked to the structural configuration of constituent TCR clonotypes within virus-specific CD8(+) T cell populations. Analysis of 3416 SIV-specific TCR sequences revealed that polyclonal T cell populations characterized by highly conserved TCRB CDR3 motifs were rendered ineffectual by single residue mutations in the cognate viral epitope. Conversely, diverse clono-typic repertoires without discernible motifs were not associated with viral escape. Thus, fundamental differences in the mode of antigen engagement direct the pattern of adaptive viral evolution. These findings have profound implications for the development of vaccines that elicit T cell immunity to combat pathogens with unstable genomes.	NIAID, Human Immunol Sect, NIH, Bethesda, MD 20892 USA; NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NCI, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Northwestern University; Feinberg School of Medicine	Douek, DC (corresponding author), NIAID, Human Immunol Sect, NIH, Bethesda, MD 20892 USA.	ddouek@nih.gov	Brenchley, Jason/AAC-5085-2019; Price, David A/C-7876-2013; Wolinsky, Steven/B-2893-2012	Price, David A/0000-0001-9416-2737; Brenchley, Jason/0000-0001-8357-2984; Wolinsky, Steven/0000-0002-9625-6697				Achour A, 2002, IMMUNITY, V17, P757, DOI 10.1016/S1074-7613(02)00478-8; Allen TM, 2002, J VIROL, V76, P4108, DOI 10.1128/JVI.76.8.4108-4112.2002; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Arden Bernhard, 1995, Immunogenetics, V42, P455; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Charini WA, 2001, J IMMUNOL, V167, P4996, DOI 10.4049/jimmunol.167.9.4996; CHEN ZW, 1995, J EXP MED, V182, P21, DOI 10.1084/jem.182.1.21; Chen ZW, 2001, J IMMUNOL, V166, P4525, DOI 10.4049/jimmunol.166.7.4525; Chen ZW, 2000, J IMMUNOL, V164, P6474, DOI 10.4049/jimmunol.164.12.6474; CIBOTTI R, 1994, J EXP MED, V180, P861, DOI 10.1084/jem.180.3.861; Ciurea A, 2001, J EXP MED, V193, P297, DOI 10.1084/jem.193.3.297; Denkberg G, 2002, J IMMUNOL, V169, P4399, DOI 10.4049/jimmunol.169.8.4399; Desrosiers RC, 2004, NAT MED, V10, P221, DOI 10.1038/nm0304-221; Douek DC, 2002, J IMMUNOL, V168, P3099, DOI 10.4049/jimmunol.168.6.3099; Friedrich TC, 2004, J VIROL, V78, P10064, DOI 10.1128/JVI.78.18.10064-10073.2004; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Gavin MA, 1995, IMMUNITY, V3, P793, DOI 10.1016/1074-7613(95)90068-3; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; Kedl RM, 2003, CURR OPIN IMMUNOL, V15, P120, DOI 10.1016/S0952-7915(02)00009-2; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; MCADAM S, 1995, J IMMUNOL, V155, P2729; McMichael A, 1998, CELL, V93, P673, DOI 10.1016/S0092-8674(00)81428-2; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; Nacsa J, 2003, VIROLOGY, V305, P210, DOI 10.1006/viro.2002.1753; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Peyerl FW, 2003, J VIROL, V77, P12572, DOI 10.1128/JVI.77.23.12572-12578.2003; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Reid SW, 1996, J EXP MED, V184, P2279, DOI 10.1084/jem.184.6.2279; Singh RAK, 2002, J IMMUNOL, V169, P6779, DOI 10.4049/jimmunol.169.12.6779; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; THIEL C, 1995, HUM IMMUNOL, V43, P85, DOI 10.1016/0198-8859(94)00149-K; Tissot AC, 2000, J MOL BIOL, V302, P873, DOI 10.1006/jmbi.2000.4501; Tryniszewska E, 2002, J IMMUNOL, V169, P5347, DOI 10.4049/jimmunol.169.9.5347; Velloso LM, 2004, J IMMUNOL, V172, P5504, DOI 10.4049/jimmunol.172.9.5504; Wagner R, 1999, J IMMUNOL, V162, P3727; Yang OO, 2003, J IMMUNOL, V171, P3718, DOI 10.4049/jimmunol.171.7.3718; Yang OO, 2003, J EXP MED, V197, P1365, DOI 10.1084/jem.20022138; Yu XG, 2002, J VIROL, V76, P8690, DOI 10.1128/JVI.76.17.8690-8701.2002	56	243	245	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2004	21	6					793	803		10.1016/j.immuni.2004.10.010	http://dx.doi.org/10.1016/j.immuni.2004.10.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589168	Bronze			2022-12-18	WOS:000225901600007
J	Sly, LM; Rauh, MJ; Kalesnikoff, J; Song, CH; Krystal, G				Sly, LM; Rauh, MJ; Kalesnikoff, J; Song, CH; Krystal, G			LPS-induced upregulation of SHIP is essential for endotoxin tolerance	IMMUNITY			English	Article							TOLL-LIKE RECEPTOR; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; PHOSPHATIDYLINOSITOL 3-KINASE; INOSITOL PHOSPHATASE; NEGATIVE REGULATION; ADAPTER MOLECULE; MAST-CELLS; LIPOPOLYSACCHARIDE; PROTEIN	An initial exposure to lipopolysaccharide (LPS) induces a transient state of hyporesponsiveness to a subsequent challenge with LPS. The mechanism underlying this phenomenon, termed endotoxin tolerance, remains poorly understood despite a recent resurgence of interest in this area. We demonstrate herein that SHIP-/- bone marrow-derived macrophages (BMmphis) and mast cells (BMMCs) do not display endotoxin tolerance. Moreover, an initial LPS treatment of wild-type BMmphis or BMMCs increases the level of SHIP, but not SHIP2 or PTEN, and this increase is critical for the hypo responsiveness to subsequent LPS stimulation. Interestingly, this increase in SHIP protein is mediated by the LPS-induced production of autocrine-acting TGFbeta and neutralizing antibodies to TGFbeta block LPS-induced endotoxin tolerance. In vivo studies with SHIP+/+ and SHIP-/- mice confirm these in vitro findings and show a correlation between the duration of endotoxin tolerance and elevated SHIP levels.	British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency	Krystal, G (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	gkrystal@bccrc.ca		Rauh, Michael/0000-0002-8346-5537; Sly, Laura/0000-0002-1673-467X; Krystal, Gerald/0000-0002-1961-6281				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bourgin C, 2002, MOL CELL BIOL, V22, P3744, DOI 10.1128/MCB.22.11.3744-3756.2002; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Brauweiler A, 2001, J IMMUNOL, V167, P204, DOI 10.4049/jimmunol.167.1.204; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Crespo A, 2000, BIOCHEM J, V349, P99, DOI 10.1042/0264-6021:3490099; Damen JE, 1998, BLOOD, V92, P1199, DOI 10.1182/blood.V92.4.1199.416k16_1199_1205; Diaz-Guerra MJM, 1999, J IMMUNOL, V162, P6184; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hattori Y, 2003, EUR J PHARMACOL, V481, P153, DOI 10.1016/j.ejphar.2003.09.034; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Imler JL, 2003, NAT IMMUNOL, V4, P105, DOI 10.1038/ni0203-105; Jung YD, 1999, PHARMACOL RES, V40, P423, DOI 10.1006/phrs.1999.0533; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737, DOI 10.4049/jimmunol.168.9.4737; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kleinbongard P, 2002, METHOD ENZYMOL, V359, P158; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Malaviya R, 2002, CLIN REV ALLERG IMMU, V22, P189, DOI 10.1385/CRIAI:22:2:189; Masuda A, 2002, J IMMUNOL, V169, P3801, DOI 10.4049/jimmunol.169.7.3801; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Neumann D, 2002, EUR J IMMUNOL, V32, P3689, DOI 10.1002/1521-4141(200212)32:12<3689::AID-IMMU3689>3.0.CO;2-X; O'Neill LAJ, 2003, NAT IMMUNOL, V4, P299, DOI 10.1038/ni0403-299; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pahan K, 1999, J BIOL CHEM, V274, P7528, DOI 10.1074/jbc.274.11.7528; Park YC, 1997, BIOCHEM BIOPH RES CO, V240, P692, DOI 10.1006/bbrc.1997.7722; Pender BS, 1996, EUR CYTOKINE NETW, V7, P137; Pengal RA, 2003, J BIOL CHEM, V278, P22657, DOI 10.1074/jbc.M302907200; Perrella MA, 1996, P NATL ACAD SCI USA, V93, P2054, DOI 10.1073/pnas.93.5.2054; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887; Rhee SH, 2003, J BIOL CHEM, V278, P22506, DOI 10.1074/jbc.M208633200; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Scheid MP, 2002, J BIOL CHEM, V277, P9027, DOI 10.1074/jbc.M106755200; Shegogue D, 2004, J BIOL CHEM, V279, P23166, DOI 10.1074/jbc.M401238200; Shnyra A, 1998, J IMMUNOL, V160, P3729; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Valderrama-Carvajal H, 2002, NAT CELL BIOL, V4, P963, DOI 10.1038/ncb885; Weinstein SL, 2000, J LEUKOCYTE BIOL, V67, P405, DOI 10.1002/jlb.67.3.405; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yeo SJ, 2003, J IMMUNOL, V170, P1052, DOI 10.4049/jimmunol.170.2.1052; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	61	243	255	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					227	239		10.1016/j.immuni.2004.07.010	http://dx.doi.org/10.1016/j.immuni.2004.07.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308103	Bronze			2022-12-18	WOS:000223441900011
J	Maekawa, Y; Tsukumo, S; Chiba, S; Hirai, H; Hayashi, Y; Okada, H; Kishihara, K; Yasutomo, K				Maekawa, Y; Tsukumo, S; Chiba, S; Hirai, H; Hayashi, Y; Okada, H; Kishihara, K; Yasutomo, K			Delta1-Notch3 interactions bias the functional differentiation of activated CD4(+) T cells	IMMUNITY			English	Article							LINEAGE COMMITMENT; EXPERIMENTAL LEISHMANIASIS; IMMUNE-SYSTEM; CUTTING EDGE; NOTCH; JAGGED1; EXPRESSION; RECEPTORS; DELTA1; NAIVE	Following activation by antigen, naive CD4(+) T helper precursor cells execute distinct genetic programs that result in their differentiation toward the type 1 or type 2 helper T cell (Th1 or Th2) phenotype. Although the differentiation and function of these Th subsets has been well studied, little is known about the contribution to these differentiation events of cell surface receptors other than those for soluble cytokines, such as IL-12 or IL-4. Here, we provide direct evidence that the Delta1 interaction with Notch3 on CD4(+) T cells transduces signals, promoting development toward the Th1 phenotype. The positive role of Notch signaling in effector cell differentiation was dose dependent, with high levels of stimulation resulting in reduced T cell activation. Our data revealed a clear contribution of Notch pathways to Th1 versus Th2 fate decisions, while also providing insight into another mechanism for inhibition of CD4(+) T cell activation.	Univ Tokushima, Sch Med, Dept Immunol & Parasitol, Tokushima 7708503, Japan; Univ Tokyo, Grad Sch Med, Dept Hematol Oncol, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Cell Therapy Transplantat Med, Tokyo 1138655, Japan	Tokushima University; University of Tokyo; University of Tokyo	Yasutomo, K (corresponding author), Univ Tokushima, Sch Med, Dept Immunol & Parasitol, Tokushima 7708503, Japan.	yasutomo@basic.med.tokushima-u.ac.jp		Yasutomo, Koji/0000-0003-0411-2037; Maekawa, Yoichi/0000-0002-3879-5713				Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Anderson AC, 2001, CURR OPIN GENET DEV, V11, P554, DOI 10.1016/S0959-437X(00)00232-X; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bajenoff M, 2002, J IMMUNOL, V168, P1723, DOI 10.4049/jimmunol.168.4.1723; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Glimcher Laurie H., 2001, Journal of Clinical Investigation, V108, pS25; Glimcher LH, 2000, GENE DEV, V14, P1693; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Hoyne GF, 2000, INT IMMUNOL, V12, P177, DOI 10.1093/intimm/12.2.177; Hoyne GF, 2001, IMMUNOL REV, V182, P215, DOI 10.1034/j.1600-065X.2001.1820118.x; Izon DJ, 2002, CURR OPIN IMMUNOL, V14, P192, DOI 10.1016/S0952-7915(02)00321-7; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; MacDonald HR, 2001, TRENDS IMMUNOL, V22, P155; Maekawa Y, 1998, J IMMUNOL, V161, P2120; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Ng WF, 2001, BLOOD, V98, P2736, DOI 10.1182/blood.V98.9.2736; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 2002, IMMUNOL REV, V187, P65, DOI 10.1034/j.1600-065X.2002.18706.x; Reiner SL, 1999, IMMUNITY, V11, P1, DOI 10.1016/S1074-7613(00)80076-X; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; REINER SL, 1993, SCIENCE, V259, P1457, DOI 10.1126/science.8451641; Reiner SL, 2001, CURR OPIN IMMUNOL, V13, P351, DOI 10.1016/S0952-7915(00)00226-0; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Shimizu K, 2002, EMBO J, V21, P294, DOI 10.1093/emboj/21.3.294; Shimizu K, 2000, BIOCHEM BIOPH RES CO, V276, P385, DOI 10.1006/bbrc.2000.3469; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; von Boehmer H, 2001, J EXP MED, V194, pF43, DOI 10.1084/jem.194.7.F43; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yamaguchi E, 2002, IMMUNOL LETT, V81, P59, DOI 10.1016/S0165-2478(01)00326-1; Yamashita M, 2000, J EXP MED, V191, P1869, DOI 10.1084/jem.191.11.1869; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	46	243	257	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2003	19	4					549	559		10.1016/S1074-7613(03)00270-X	http://dx.doi.org/10.1016/S1074-7613(03)00270-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563319	Bronze			2022-12-18	WOS:000186051900011
J	Park, H; Wahl, MI; Afar, DEH; Turck, CW; Rawlings, DJ; Tam, C; Scharenberg, AM; Kinet, JP; Witte, ON				Park, H; Wahl, MI; Afar, DEH; Turck, CW; Rawlings, DJ; Tam, C; Scharenberg, AM; Kinet, JP; Witte, ON			Regulation of Btk function by a major autophosphorylation site within the SH3 domain	IMMUNITY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; TYROSINE KINASE-ACTIVITY; C-ABL; PROTEIN-PHOSPHORYLATION; SRC; P60C-SRC; FAMILY; ACTIVATION; EXPRESSION; DELETION	Bruton's tyrosine kinase (Btk) plays a crucial role in B cell development. Overexpression of Btk with a Src family kinase increases tyrosine phosphorylation and catalytic activity of Btk. This occurs by transphosphorylation at Y551 in the Btk catalytic domain and the enhancement of Btk autophosphorylation at a second site. A gain-of-function mutant called Btk* containing E41 to K change within the pleckstrin homology domain induces fibroblast transformation. Btk* enhances the transphosphorylation of Y551 by endogenous Src family tyrosine kinases and autophosphorylation at the second site. We mapped the major Btk autophosphorylation site to Y223 within the SH3 domain. Mutation of Y223 to F blocks Btk autophosphorylation and dramatically potentiates the transforming activity of Btk* in fibroblasts. The location of Y223 in a potential ligand-binding pocket suggests that autophosphorylation regulates SH3-mediated signaling by Btk.	UNIV CALIF LOS ANGELES, CEDARS SINAI MED GENET TRAINING PROGRAM, LOS ANGELES, CA 90048 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT MED, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA; BETH ISRAEL HOSP, LAB ALLERGY & IMMUNOL, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02215 USA; HOWARD HUGHES MED INST, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, INST MOLEC BIOL, LOS ANGELES, CA 90095 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Park, H (corresponding author), UNIV CALIF LOS ANGELES, DEPT MICROBIOL & MOLEC GENET, LOS ANGELES, CA 90095 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K11AR001912] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR01912] Funding Source: Medline; NIGMS NIH HHS [GM08243] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AOKI Y, 1994, P NATL ACAD SCI USA, V91, P10606, DOI 10.1073/pnas.91.22.10606; APPLEBY MW, 1995, J EXP MED, V182, P811, DOI 10.1084/jem.182.3.811; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; CORY GOC, 1995, J EXP MED, V182, P611, DOI 10.1084/jem.182.2.611; COUSSENS PM, 1985, MOL CELL BIOL, V5, P2753, DOI 10.1128/MCB.5.10.2753; DEWEERS M, 1994, HUM MOL GENET, V3, P161, DOI 10.1093/hmg/3.1.161; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; GOUDREAU N, 1994, NAT STRUCT BIOL, V1, P898, DOI 10.1038/nsb1294-898; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; HIRAI H, 1990, MOL CELL BIOL, V10, P1307, DOI 10.1128/MCB.10.4.1307; IBA H, 1985, MOL CELL BIOL, V5, P1058, DOI 10.1128/MCB.5.5.1058; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; JACKSON PK, 1993, ONCOGENE, V8, P1943; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; KAZLAUSKAS A, 1994, CURR OPIN GENET DEV, V4, P5, DOI 10.1016/0959-437X(94)90085-X; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KINNON C, 1993, IMMUNOL TODAY, V14, P554, DOI 10.1016/0167-5699(93)90187-P; KNUDSEN BS, 1995, EMBO J, V14, P2191, DOI 10.1002/j.1460-2075.1995.tb07213.x; KOHDA D, 1993, CELL, V72, P953, DOI 10.1016/0092-8674(93)90583-C; KONOPKA JB, 1985, MOL CELL BIOL, V5, P3116, DOI 10.1128/MCB.5.11.3116; KOYAMA S, 1993, CELL, V72, P945, DOI 10.1016/0092-8674(93)90582-B; LEVY JB, 1986, P NATL ACAD SCI USA, V83, P4228, DOI 10.1073/pnas.83.12.4228; LI TJ, 1995, IMMUNITY, V2, P451, DOI 10.1016/1074-7613(95)90026-8; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; LUO KX, 1991, METHOD ENZYMOL, V201, P149; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522; MATSUDA T, 1995, BLOOD, V85, P627, DOI 10.1182/blood.V85.3.627.bloodjournal853627; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; NOBLE MEM, 1993, EMBO J, V12, P2617, DOI 10.1002/j.1460-2075.1993.tb05922.x; OKADA M, 1993, J BIOL CHEM, V268, P18070; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; Rawlings D J, 1995, Semin Immunol, V7, P237, DOI 10.1006/smim.1995.0028; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; SATO S, 1994, J EXP MED, V180, P2101, DOI 10.1084/jem.180.6.2101; SEIDELDUGAN C, 1992, MOL CELL BIOL, V12, P1835, DOI 10.1128/MCB.12.4.1835; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TERASAWA H, 1994, NAT STRUCT BIOL, V1, P891, DOI 10.1038/nsb1294-891; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; WICKER LS, 1986, CURR TOP MICROBIOL, V124, P87; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	57	243	249	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1996	4	5					515	525		10.1016/S1074-7613(00)80417-3	http://dx.doi.org/10.1016/S1074-7613(00)80417-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UM678	8630736	Bronze			2022-12-18	WOS:A1996UM67800010
J	GREENLUND, AC; MORALES, MO; VIVIANO, BL; YAN, H; KROLEWSKI, J; SCHREIBER, RD				GREENLUND, AC; MORALES, MO; VIVIANO, BL; YAN, H; KROLEWSKI, J; SCHREIBER, RD			STAT RECRUITMENT BY TYROSINE-PHOSPHORYLATED CYTOKINE RECEPTORS - AN ORDERED REVERSIBLE AFFINITY-DRIVEN PROCESS	IMMUNITY			English	Article							GAMMA SIGNAL-TRANSDUCTION; INTERFERON-GAMMA; TRANSCRIPTION FACTOR; IFN-GAMMA; ACTIVATION; PROTEIN; SH2; DOMAINS; BINDING; 91-KDA	Herein, we demonstrate that purified Stat1 binds to its tyrosine-phosphorylated docking site on the IFN gamma receptor alpha chain in a direct, specific, and reversible manner. Using surface plasmon resonance, we determine the affinity(K-D = 137 nM) and specificity of the interaction and define the minimum affinity needed for receptor-mediated Stat1 activation. In addition, we quantitate the relative ability of purified Stat1 to interact with tyrosine-phosphorylated binding sites on other Stat proteins. Finally, we describe experiments that Imply that the unidirectional release of activated Stat1 from the IFN gamma receptor reflects the preference of free tyrosine-phosphorylated Stat1 monomers to form high avidity reciprocal homodimers rather than reassociating with the receptor binding site. Our results demonstrate that IFN gamma-induced Stat1 activation is an ordered and affinity-driven process and we propose that this process may serve as a paradigm for Stat activation by other cytokine receptors.	WASHINGTON UNIV, SCH MED, DEPT PATHOL, ST LOUIS, MO 63110 USA; COLUMBIA UNIV, COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA	Washington University (WUSTL); Columbia University	GREENLUND, AC (corresponding author), WASHINGTON UNIV, SCH MED, CTR IMMUNOL, ST LOUIS, MO 63110 USA.		Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013	Schreiber, Robert D/0000-0001-6311-0432; Schreiber, Robert/0000-0003-1590-2341	NATIONAL CANCER INSTITUTE [R37CA043059, R01CA043059] Funding Source: NIH RePORTER; NCI NIH HHS [CA43059] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DIGHE AS, 1993, J BIOL CHEM, V268, P10645; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; EARL PL, 1994, CURRENT PROTOCOLS MO; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; FARRAR MA, 1992, P NATL ACAD SCI USA, V89, P11706, DOI 10.1073/pnas.89.24.11706; FOUNTOULAKIS M, 1992, EUR J BIOCHEM, V208, P781, DOI 10.1111/j.1432-1033.1992.tb17248.x; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8; GREENLUND AC, 1993, J BIOL CHEM, V268, P18103; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; IGARASHI K, 1994, J BIOL CHEM, V269, P14333; IGARASHI K, 1993, MOL CELL BIOL, V13, P1634, DOI 10.1128/MCB.13.3.1634; IMPROTA T, 1994, P NATL ACAD SCI USA, V91, P4776, DOI 10.1073/pnas.91.11.4776; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; PANAYOTOU G, 1993, MOL CELL BIOL, V13, P3567, DOI 10.1128/MCB.13.6.3567; PEARSE RN, 1993, P NATL ACAD SCI USA, V90, P4314, DOI 10.1073/pnas.90.9.4314; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; SCHREIBER RD, 1994, GUIDEBOOK CYTOKINES, P120; SHEEHAN KCF, 1995, J EXP MED, V181, P607, DOI 10.1084/jem.181.2.607; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	39	243	245	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1995	2	6					677	687		10.1016/1074-7613(95)90012-8	http://dx.doi.org/10.1016/1074-7613(95)90012-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7796299	hybrid			2022-12-18	WOS:A1995RE53800013
J	Stemberger, C; Huster, KM; Koffler, M; Anderl, F; Schiemann, M; Wagner, H; Busch, DH				Stemberger, Christian; Huster, Katharina M.; Koffler, Martina; Anderl, Florian; Schiemann, Matthias; Wagner, Hermann; Busch, Dirk H.			A single naive CD8(+) T cell precursor can develop into diverse effector and memory subsets	IMMUNITY			English	Article							SELECTIVE EXPRESSION; CUTTING EDGE; GENERATION; POPULATIONS; RECEPTOR; DIFFERENTIATION; HOMEOSTASIS; DIVISION	Upon first antigen encounter, naive CD8(+) T cells get activated, clonally expand, and can develop into very distinct subsets, such as short-living effector cells or different memory subpopulations. The origin of subset diversification is currently unknown, but qualitative and quantitative differences in early signals received by individual precursor cells have been suggested as a major determinant. We show that transfer of a single antigen-specific naive T cell into a normal recipient mouse allowed recovery of clonally expanded daughter cells upon immunization. With this experimental approach, we conclusively demonstrated that a wide range of diversity could develop out of a single precursor cell, including different types of effector and memory T cells. Interestingly, single-cell-derived subset diversification resembled that of polyclonal T cell responses in the same individual mouse, although differentiation patterns differed between immunization strategies. These data implicate that subset diversification is both shaped and synchronized during the expansion phase.	[Stemberger, Christian; Huster, Katharina M.; Koffler, Martina; Anderl, Florian; Schiemann, Matthias; Wagner, Hermann; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Stemberger, Christian; Huster, Katharina M.; Schiemann, Matthias; Busch, Dirk H.] Natl Res Ctr Environm & Hlth, GSF, Clin Cooperat Grp Antigen Specif Immunotherapy &, Neuherberg, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Busch, DH (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany.	dirk.busch@lrz.tum.de						Bachmann MF, 2006, EUR J IMMUNOL, V36, P842, DOI 10.1002/eji.200535730; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Baron V, 2003, IMMUNITY, V18, P193, DOI 10.1016/S1074-7613(03)00020-7; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bouneauld C, 2005, J EXP MED, V201, P579, DOI 10.1084/jem.20040876; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Huster KM, 2006, CURR OPIN IMMUNOL, V18, P458, DOI 10.1016/j.coi.2006.05.008; Huster KM, 2006, EUR J IMMUNOL, V36, P1453, DOI 10.1002/eji.200635874; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Knabel M, 2002, NAT MED, V8, P631, DOI 10.1038/nm0602-631; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schiemann M, 2003, EUR J IMMUNOL, V33, P2875, DOI 10.1002/eji.200324224; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548	33	242	245	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2007	27	6					985	997		10.1016/j.immuni.2007.10.012	http://dx.doi.org/10.1016/j.immuni.2007.10.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18082432	Bronze			2022-12-18	WOS:000251907300017
J	Lee, GR; Kim, ST; Spilianakis, CG; Fields, PE; Flavell, RA				Lee, GR; Kim, ST; Spilianakis, CG; Fields, PE; Flavell, RA			T helper cell differentiation: Regulation by cis elements and epigenetics	IMMUNITY			English	Review							LOCUS-CONTROL REGION; CYTOKINE GENE-EXPRESSION; BETA-GLOBIN LOCUS; RANGE INTRACHROMOSOMAL INTERACTIONS; I-HYPERSENSITIVE SITE; IFN-GAMMA; DNA METHYLATION; TRANSCRIPTION FACTOR; HISTONE ACETYLATION; CUTTING EDGE	Cytokine loci undergo changes in chromatin structure when naive CD4(+) T cells differentiate into Th1 or Th2 cells and have also been examined for regulatory sequences underlying such changes and their functional correlates. Studies have shown that distal regulatory elements control the Ifng and Th2 cytokine loci and are primary targets for tissue-specific transcription factors, serving as centers for epigenetic changes that mark heritable traits in effector cells. Reports of intra- and, remarkably, interchromosomal interactions between these regulatory elements shed light on the mechanisms by which they regulate gene expression, revealing an extraordinary new picture that conceptually extends our views on how genes are regulated from two to three dimensions. Here, we summarize these recent findings on the role of regulatory elements and their mechanisms of action, which are of broad significance for gene regulation, not only of the immune system but also of many, if not all, coregulated genes.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Spilianakis, Charalampos G/C-9893-2011	Spilianakis, Charalampos G/0000-0003-0921-1923; Fields, Patrick/0000-0002-6797-4139	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056389, P01HL056389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56389] Funding Source: Medline; NIAID NIH HHS [T32 AI-07019] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Baarends WM, 1999, DEV BIOL, V207, P322, DOI 10.1006/dbio.1998.9155; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; BUSSLINGER M, 1983, CELL, V34, P197, DOI 10.1016/0092-8674(83)90150-2; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; Dekker J, 2003, TRENDS BIOCHEM SCI, V28, P277, DOI 10.1016/S0968-0004(03)00089-6; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; El-Osta A, 2000, GENE EXPRESSION, V9, P63; FARRAR WL, 1985, J IMMUNOL, V135, P1551; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; FRASER P, 1999, CURR OPIN CELL BIOL, P361; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Graunke DM, 1999, NUCLEIC ACIDS RES, V27, P3881, DOI 10.1093/nar/27.19.3881; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Grosveld F, 1999, CURR OPIN GENET DEV, V9, P152, DOI 10.1016/S0959-437X(99)80023-9; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; HENKEL G, 1992, J IMMUNOL, V149, P3239; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; LANG G, 1991, NUCLEIC ACIDS RES, V19, P5851, DOI 10.1093/nar/19.21.5851; Lee CC, 2003, PHOTOCH PHOTOBIO SCI, V2, P145, DOI 10.1039/b207598a; Lee CY, 2001, J SCHED, V4, P3, DOI 10.1002/1099-1425(200101/02)4:1<3::AID-JOS57>3.0.CO;2-D; Lee DU, 2004, P NATL ACAD SCI USA, V101, P16010, DOI 10.1073/pnas.0407031101; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Li QL, 1999, GENOMICS, V61, P183, DOI 10.1006/geno.1999.5954; Li QL, 1999, TRENDS GENET, V15, P403, DOI 10.1016/S0168-9525(99)01780-1; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; LJUNGMAN M, 1995, NUCLEIC ACIDS RES, V23, P1782, DOI 10.1093/nar/23.10.1782; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Morinobu A, 2004, J BIOL CHEM, V279, P40640, DOI 10.1074/jbc.M407576200; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Okamura H, 2001, CURR OPIN CELL BIOL, V13, P239, DOI 10.1016/S0955-0674(00)00203-9; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Santangelo S, 2002, J IMMUNOL, V169, P1893, DOI 10.4049/jimmunol.169.4.1893; Santoso B, 2000, J BIOL CHEM, V275, P1952, DOI 10.1074/jbc.275.3.1952; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Soutto M, 2002, J IMMUNOL, V169, P6664, DOI 10.4049/jimmunol.169.12.6664; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Takemoto N, 2002, J IMMUNOL, V169, P4103, DOI 10.4049/jimmunol.169.8.4103; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Tykocinski LO, 2005, J BIOL CHEM, V280, P28177, DOI 10.1074/jbc.M502038200; Valapour M, 2002, J ALLERGY CLIN IMMUN, V109, P238, DOI 10.1067/mai.2002.121145; VANDERPLOEG LHT, 1980, CELL, V19, P947, DOI 10.1016/0092-8674(80)90086-0; Wang XY, 1997, NUCLEIC ACIDS RES, V25, P3478, DOI 10.1093/nar/25.17.3478; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Wilson CB, 2005, SEMIN IMMUNOL, V17, P105, DOI 10.1016/j.smim.2005.01.005; Winders BR, 2004, J IMMUNOL, V173, P7377, DOI 10.4049/jimmunol.173.12.7377; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yano S, 2003, J IMMUNOL, V171, P2510, DOI 10.4049/jimmunol.171.5.2510; YOUNG HA, 1989, J IMMUNOL, V143, P2389; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	87	242	252	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2006	24	4					369	379		10.1016/j.immuni.2006.03.007	http://dx.doi.org/10.1016/j.immuni.2006.03.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618596	Bronze			2022-12-18	WOS:000237153000007
J	Probst, HC; Lagnel, J; Kollias, G; van den Broek, M				Probst, HC; Lagnel, J; Kollias, G; van den Broek, M			Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8(+) T cell tolerance	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SITE-SPECIFIC RECOMBINATION; TUMOR-NECROSIS-FACTOR; IN-VIVO; PRECURSOR FREQUENCY; CROSS-PRESENTATION; ANTIGEN; RESPONSES; CD40; EXPRESSION	Dendritic cells (DC) are inducers of immune responses par excellence. They also seem responsible for the induction of peripheral T cell tolerance. To investigate these opposite functions of DC, we generated a Cre/LoxP-based system that allows inducible antigen presentation by DC in vivo. This enables us to study the immunogical consequences of antigen presentation by resting versus mature DC without adoptively transferring DC and with physiological numbers of endogenous, naive responder T cells. We found that presentation of LCMV-derived CTL epitopes by resting DC resulted in antigen-specific tolerance, which could not be broken by subsequent infection with LCMV. On the other hand, antigen presentation by activated DC primed endogenous CTL to expand and to develop protective effector function.	Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Inst Immunol, Biomed Res Ctr Alexander Fleming, Vari 16672, Greece	University of Zurich	van den Broek, M (corresponding author), Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland.		Kollias, George/A-7079-2012; van den Broek, Maries/L-6532-2019; van den Broek, Maries/G-4128-2016	Kollias, George/0000-0003-1867-3150; van den Broek, Maries/0000-0002-9489-3692; PROBST, Hans Christian/0000-0002-7926-0651				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Dhodapkar MV, 2002, BLOOD, V100, P174, DOI 10.1182/blood.V100.1.174; Dhodapkar MV, 1999, J CLIN INVEST, V104, P173, DOI 10.1172/JCI6909; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Diehl L, 1999, NAT MED, V5, P774, DOI 10.1038/10495; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Guermonprez P, 2002, EUR J IMMUNOL, V32, P3071, DOI 10.1002/1521-4141(200211)32:11<3071::AID-IMMU3071>3.0.CO;2-A; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; HULEATT JW, 1995, J IMMUNOL, V154, P5684; INABA K, 1993, J EXP MED, V178, P479, DOI 10.1084/jem.178.2.479; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; King C, 2001, NAT MED, V7, P206, DOI 10.1038/84659; Kreuwel HTC, 2002, IMMUNITY, V17, P73, DOI 10.1016/S1074-7613(02)00337-0; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Legge KL, 2002, J EXP MED, V196, P217, DOI 10.1084/jem.20011061; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Ludin B, 1996, GENE, V173, P107, DOI 10.1016/0378-1119(95)00899-3; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Morgan DJ, 1999, J IMMUNOL, V163, P723; Morgan DJ, 1996, J IMMUNOL, V157, P978; Oukka M, 1996, J IMMUNOL, V156, P968; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Probst HC, 2002, J IMMUNOL, V168, P5387, DOI 10.4049/jimmunol.168.11.5387; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Ruedl C, 1999, J EXP MED, V189, P1875, DOI 10.1084/jem.189.12.1875; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Schoissengeier J, 1998, GLASGOW MATH J, V40, P393, DOI 10.1017/S0017089500032742; Schuurhuis DH, 2000, J EXP MED, V192, P145, DOI 10.1084/jem.192.1.145; Sotomayor EM, 1999, NAT MED, V5, P780, DOI 10.1038/10503; vanderMost RG, 1996, J IMMUNOL, V157, P5543; Wang J, 2001, J POROUS MAT, V8, P167, DOI 10.1023/A:1009611329483	49	242	255	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2003	18	5					713	720		10.1016/S1074-7613(03)00120-1	http://dx.doi.org/10.1016/S1074-7613(03)00120-1			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753747	Green Accepted, Bronze			2022-12-18	WOS:000182962200015
J	Grohmann, U; Belladonna, ML; Bianchi, R; Orabona, C; Ayroldi, E; Fioretti, MC; Puccetti, P				Grohmann, U; Belladonna, ML; Bianchi, R; Orabona, C; Ayroldi, E; Fioretti, MC; Puccetti, P			IL-12 acts directly on DC to promote nuclear localization of NF-kappa B and primes DC for IL-12 production	IMMUNITY			English	Article							CD4+ T-CELLS; DENDRITIC CELLS; TH1 CELLS; IN-VIVO; INTERLEUKIN-12; RECEPTOR; CYTOKINE; ANTIGEN; EXPRESSION; PEPTIDE	We analyzed the expression of an IL-12 receptor by fresh dendritic cells (DC) and a DC line. Using RT-PCR, RNAse protection, and electrophoretic mobility shift assay analysis, we found that DC possess an IL-12 receptor with beta 1 subunit (downstream box 1)-related differences from that on T cells. IL-12 signaling through this receptor involved members of the NF-kappa B but not STAT family. The unique properties of the IL-12 receptor on DC, characterized by a single class of binding sites with a K-d of about 325 pM, may underlie rather unique effects, such as IFN gamma-independent augmentation of class II antigen expression and priming for LPS-induced production of IL-12.	Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; Univ Perugia, Dept Pharmacol, I-06100 Perugia, Italy	University of Perugia; University of Perugia	Puccetti, P (corresponding author), Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy.		Grohmann, Ursula/T-6545-2019; Orabona, Ciriana/L-8725-2015	Orabona, Ciriana/0000-0003-3113-0572; Ayroldi, Emira/0000-0002-9073-7297; Puccetti, Paolo/0000-0001-6674-2128; Bianchi, Roberta/0000-0001-5914-4701; Belladonna, Maria Laura/0000-0001-6522-0870; Grohmann, Ursula/0000-0001-7952-1850				BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Bianchi R, 1996, J IMMUNOL, V157, P1589; Brunda M J, 1995, Important Adv Oncol, P3; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; CHIZZONITE R, 1992, J IMMUNOL, V148, P3117; CHUA AO, 1995, J IMMUNOL, V155, P4286; Coligan JE., 1994, CURRENT PROTOCOLS IM; FREUND YR, 1990, J EXP MED, V171, P1285; GATELY MK, 1992, CELL IMMUNOL, V143, P127, DOI 10.1016/0008-8749(92)90011-D; GILMAN M, 1996, CURRENT PROTOCOLS MO; GROHMANN U, 1995, EUR J IMMUNOL, V25, P2797, DOI 10.1002/eji.1830251013; Grohmann U, 1998, CRIT REV IMMUNOL, V18, P87, DOI 10.1615/CritRevImmunol.v18.i1-2.100; GROHMANN U, 1995, J IMMUNOL, V154, P4630; Grohmann U, 1997, J IMMUNOL, V158, P3593; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kato T, 1997, CELL IMMUNOL, V181, P59, DOI 10.1006/cimm.1997.1196; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; LAMER AC, 1993, SCIENCE, V261, P1730; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; MOSES H, 1992, J IMMUNOL, V148, P3643; MUNSON PJ, 1983, METHOD ENZYMOL, V92, P543; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; MUSSO T, 1994, J LEUKOCYTE BIOL, V56, P21, DOI 10.1002/jlb.56.1.21; PAGLIA P, 1993, J EXP MED, V178, P1893, DOI 10.1084/jem.178.6.1893; Peters JH, 1996, IMMUNOL TODAY, V17, P273, DOI 10.1016/0167-5699(96)80544-5; Pettit AR, 1997, J IMMUNOL, V159, P3681; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Prieschl EE, 1996, J IMMUNOL, V157, P2645; Romani L, 1997, CLIN MICROBIOL REV, V10, P611, DOI 10.1128/CMR.10.4.611; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCOTT P, 1993, SCIENCE, V260, P496, DOI 10.1126/science.8097337; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; SHOWE L, 1995, RES IMMUNOL, V146, P439; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1986, HDB EXPT IMMUNOLOGY; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; TING JPY, 1993, CURR OPIN IMMUNOL, V5, P8, DOI 10.1016/0952-7915(93)90074-3; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Vogel LA, 1996, INT IMMUNOL, V8, P1955, DOI 10.1093/intimm/8.12.1955; Wu CY, 1997, J IMMUNOL, V159, P1658; Zitvogel L, 1995, RES IMMUNOL, V146, P628, DOI 10.1016/0923-2494(96)83041-0	48	242	250	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1998	9	3					315	323		10.1016/S1074-7613(00)80614-7	http://dx.doi.org/10.1016/S1074-7613(00)80614-7			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768751	Bronze			2022-12-18	WOS:000076202300004
J	Rennert, PD; James, D; Mackay, F; Browning, JL; Hochman, PS				Rennert, PD; James, D; Mackay, F; Browning, JL; Hochman, PS			Lymph node genesis is induced by signaling through the lymphotoxin beta receptor	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA-DEFICIENT MICE; MONOCLONAL-ANTIBODIES; ORGANS; MONOCYTOGENES; FOLLICLES; RESISTANT; INFECTION; IMMUNE	We investigated lymphotoxin (LT) and TNF function in lymph node genesis and cellular organization by manipulating LT beta-R and TNF-R signaling. Lymph nodes developed in LT alpha(-/-) mice treated in utero with agonist anti-LT beta-R monoclonal antibody. Thus, LT beta-R signaling mediates lymph node genesis. Surprisingly, mucosal lymph nodes that can develop independently of LT alpha beta/LT beta-R interaction were generated. Normal mice treated in utero with LT beta-R-Ig and TNF-R55-Ig or anti-TNF lacked all lymph nodes, indicating that TNF signaling contributes to lymph node genesis. Lymph nodes generated in LT alpha(-/-) mice had disrupted cellular organization. Therefore, LT beta-R signaling during gestation is not sufficient to establish normal cellular microarchitecture. We conclude that LT and TNF play critical roles in the genesis and cellular organization of lymph nodes.	Biogen Inc, Dept Immunol & Inflammat, Cambridge, MA 02142 USA	Biogen	Rennert, PD (corresponding author), Biogen Inc, Dept Immunol & Inflammat, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	Paul_Rennert@Biogen.com	Mackay, Fabienne/B-7440-2008	Mackay, Fabienne/0000-0002-6074-2693; Browning, Jeffrey/0000-0001-9168-5233				Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93; Alexopoulou Lena, 1998, Journal of Interferon and Cytokine Research, V18, pA87; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; BANKS TA, 1995, J IMMUNOL, V155, P1685; Browning JL, 1997, J IMMUNOL, V159, P3288; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; BROWNING JL, 1995, J IMMUNOL, V154, P33; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Ettinger R, 1998, INT IMMUNOL, V10, P727, DOI 10.1093/intimm/10.6.727; Fadeel B, 1997, INT IMMUNOL, V9, P201, DOI 10.1093/intimm/9.2.201; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fu YX, 1997, P NATL ACAD SCI USA, V94, P5739, DOI 10.1073/pnas.94.11.5739; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; GOODNOW CC, 1997, CURR BIOL, V7, P219; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; HIGUCHI M, 1994, J IMMUNOL, V152, P3550; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; LEDBETTER JA, 1995, CIRC SHOCK, V44, P67; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Liu YJ, 1996, J EXP MED, V184, P1207, DOI 10.1084/jem.184.4.1207; Mackay F, 1997, J IMMUNOL, V159, P3299; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; MACKAY F, 1998, IN PRESS NATURE; Matsumoto M, 1997, IMMUNOL REV, V156, P137, DOI 10.1111/j.1600-065X.1997.tb00965.x; Matsumoto M, 1997, J EXP MED, V186, P1997, DOI 10.1084/jem.186.12.1997; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; MORPHIS LG, 1970, NATURE, V228, P573, DOI 10.1038/228573a0; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pinckard JK, 1997, J BIOL CHEM, V272, P10784; Rennert PD, 1997, INT IMMUNOL, V9, P1627, DOI 10.1093/intimm/9.11.1627; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; TIAN ZG, 1995, CANCER RES, V55, P5335; Tkachuk M, 1998, J EXP MED, V187, P469, DOI 10.1084/jem.187.4.469; vonBoehmer H, 1997, P NATL ACAD SCI USA, V94, P8926, DOI 10.1073/pnas.94.17.8926; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; Yoshie O, 1997, J LEUKOCYTE BIOL, V62, P634, DOI 10.1002/jlb.62.5.634	47	242	245	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	1998	9	1					71	79		10.1016/S1074-7613(00)80589-0	http://dx.doi.org/10.1016/S1074-7613(00)80589-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697837	Bronze			2022-12-18	WOS:000075066600007
J	Deckert, M; TartareDeckert, S; Couture, C; Mustelin, T; Altman, A				Deckert, M; TartareDeckert, S; Couture, C; Mustelin, T; Altman, A			Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product	IMMUNITY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; B-CELL DEVELOPMENT; T-CELL; TYROSINE KINASE; ANTIGEN RECEPTORS; SH2 DOMAIN; SIGNAL-TRANSDUCTION; 2-HYBRID SYSTEM; ZAP-70; PHOSPHORYLATION	Syk family kinases are essential for lymphocyte development and activation. Therefore the identification of their direct effecters is of critical importance. Here, we report that Syk interacts in the yeast two-hybrid system with Vav, a proto-oncogene product exclusively expressed in hematopoietic cells. This interaction was direct, required the catalytic activity of Syk, the SH2 domain of Vav, and tyrosine residues in the linker domain of Syk. Vav also associated with Syk and Zap in antigen receptor-stimulated B or T cells, respectively. Functionally, Vav was phosphorylated by Syk family kinases both in vivo and in vitro. Furthermore, Syk and Vav cooperated to activate NF-AT synergistically, These results indicate that the interaction between Syk family kinases and Vav plays an important role in coupling immune recognition receptors to signaling pathways involved in lymphokine production.	LA JOLLA INST ALLERGY & IMMUNOL, DIV CELL BIOL, SAN DIEGO, CA 92121 USA; FAC MED NICE, INSERM, U145, F-06107 NICE 2, FRANCE	La Jolla Institute for Immunology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur			Deckert, Marcel/M-4998-2016; Deckert, Marcel/T-3566-2019; TARTARE-DECKERT, Sophie/P-6057-2015	Deckert, Marcel/0000-0003-2094-559X; TARTARE-DECKERT, Sophie/0000-0001-8680-5720; Mustelin, Tomas/0000-0001-5912-8840	NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050819] Funding Source: NIH RePORTER; NCI NIH HHS [CA35299] Funding Source: Medline; NIAID NIH HHS [AI35603] Funding Source: Medline; NIGMS NIH HHS [GM50819] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; BonnefoyBerard N, 1996, STEM CELLS, V14, P250, DOI 10.1002/stem.140250; BRUNATI AM, 1995, FEBS LETT, V367, P149, DOI 10.1016/0014-5793(95)00555-N; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; COUTURE C, 1994, MOL CELL BIOL, V14, P5249, DOI 10.1128/MCB.14.8.5249; Couture C, 1996, J BIOL CHEM, V271, P24294, DOI 10.1074/jbc.271.39.24294; DEFRANCO AL, 1995, CURR OPIN CELL BIOL, V7, P163, DOI 10.1016/0955-0674(95)80024-7; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GUPTA S, 1994, J BIOL CHEM, V269, P17349; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P12; HOLSINGER LJ, 1995, P NATL ACAD SCI USA, V92, P9810, DOI 10.1073/pnas.92.21.9810; Isakov N, 1996, J BIOL CHEM, V271, P15753, DOI 10.1074/jbc.271.26.15753; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; KATZAV S, 1993, ONCOGENE, V8, P1757; KATZAV S, 1994, J BIOL CHEM, V269, P32579; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; Law CL, 1996, MOL CELL BIOL, V16, P1305; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; Motto DG, 1996, J EXP MED, V183, P1937, DOI 10.1084/jem.183.4.1937; MUSTELIN T, 1994, SRC FAMILY TYROSINE, P1; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RIVERA VM, 1995, MOL CELL BIOL, V15, P1582; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SILLMAN AL, 1995, J BIOL CHEM, V270, P11806, DOI 10.1074/jbc.270.20.11806; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TARTAREDECKERT S, 1995, J BIOL CHEM, V270, P23456, DOI 10.1074/jbc.270.40.23456; TartareDeckert S, 1996, ENDOCRINOLOGY, V137, P1019, DOI 10.1210/en.137.3.1019; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; VOTJEK AB, 1993, CELL, V74, P205; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WU J, 1995, MOL CELL BIOL, V15, P4337; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	52	242	247	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1996	5	6					591	604		10.1016/S1074-7613(00)80273-3	http://dx.doi.org/10.1016/S1074-7613(00)80273-3			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986718	Bronze			2022-12-18	WOS:A1996WA65100009
J	NISHINAKAMURA, R; NAKAYAMA, N; HIRABAYASHI, Y; INOUE, T; AUD, D; MCNEIL, T; AZUMA, S; YOSHIDA, S; TOYODA, Y; ARAI, K; MIYAJIMA, A; MURRAY, R				NISHINAKAMURA, R; NAKAYAMA, N; HIRABAYASHI, Y; INOUE, T; AUD, D; MCNEIL, T; AZUMA, S; YOSHIDA, S; TOYODA, Y; ARAI, K; MIYAJIMA, A; MURRAY, R			MICE DEFICIENT FOR THE IL-3/GM-CSF/IL-5 BETA-C RECEPTOR EXHIBIT LUNG PATHOLOGY AND IMPAIRED IMMUNE-RESPONSE, WHILE BETA-IL3 RECEPTOR-DEFICIENT MICE ARE NORMAL	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; CELL-REPLACING FACTOR; GM-CSF; INTERLEUKIN-3 RECEPTOR; IL-3 RECEPTOR; GENE FAMILY; GRANULOCYTE; CLONING; BINDING; DIFFERENTIATION	The receptors for IL-3, GM-CSF, and IL-5 share a common beta subunit (beta c), and mice have an additional IL-3 beta subunit (beta(IL3)) We have independently generated mice carrying null mutations of each molecule, beta c mutant bone marrow showed no response to GM-CSF or IL-5, whereas IL-3 stimulation of beta c or beta(IL3) mutant bone marrow was normal. beta c mutant mice showed lung pathology consisting of lymphocytic infiltration and areas resembling alveolar proteinosis, and also exhibited low basal numbers of eosinophils. Infection of beta c mutant mice by Nippostrongylus brasiliensis resulted in the absence of blood and lung eosinophilia. Animals repopulated with beta c mutant bone marrow cells showed slower leukocyte recovery and reduced eosinophil numbers, These data define the role of beta c in vivo, and show a phenotype that is likely to be the cumulative effect of loss of GM-CSF and IL-5 stimulation.	UNIV TOKYO, INST MED SCI, TOKYO 108, JAPAN; YOKOHAMA CITY UNIV, SCH MED, DEPT PATHOL 1, YOKOHAMA, KANAGAWA 236, JAPAN; UNIV TOKYO, FAC MED, DEPT INTERNAL MED 1, TOKYO 113, JAPAN	University of Tokyo; Yokohama City University; University of Tokyo	NISHINAKAMURA, R (corresponding author), DNAX RES INST MOLEC & CELLULAR BIOL INC, 901 CALIF AVE, PALO ALTO, CA 94304 USA.		Nakayama, Naoki/B-3297-2009	Nakayama, Naoki/0000-0002-6315-4387; Yoshida, Shosei/0000-0001-8861-1866				ANTMAN KS, 1988, NEW ENGL J MED, V319, P593, DOI 10.1056/NEJM198809083191001; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; BILYK N, 1993, J EXP MED, V177, P1773, DOI 10.1084/jem.177.6.1773; BOND MW, 1987, J IMMUNOL, V139, P3691; COFFMAN RL, 1986, J IMMUNOL, V136, P949; COFFMAN RL, 1989, SCIENCE, V245, P308, DOI 10.1126/science.2787531; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; FINKELMAN FD, 1988, J IMMUNOL, V141, P2335; GORMAN DM, 1992, J BIOL CHEM, V267, P15842; GORMAN DM, 1990, P NATL ACAD SCI USA, V87, P5459, DOI 10.1073/pnas.87.14.5459; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; HITOSHI Y, 1990, J IMMUNOL, V144, P4218; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Isfort RJ, 1990, GROWTH FACTORS, V2, P213, DOI 10.3109/08977199009071507; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; KANAKURA Y, 1990, BLOOD, V76, P706; KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LOPEZ AF, 1990, J CELL PHYSIOL, V145, P69, DOI 10.1002/jcp.1041450111; LOPEZ AF, 1991, J BIOL CHEM, V266, P24741; METCALF D, 1991, SCIENCE, V254, P529, DOI 10.1126/science.1948028; MUI ALF, 1992, J BIOL CHEM, V267, P16523; NAKAHATA T, 1982, J CELL PHYSIOL, V111, P239, DOI 10.1002/jcp.1041110304; NEMUNAITIS J, 1988, BLOOD, V72, P834; OGOROCHI T, 1992, BLOOD, V79, P895; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; SEELENTAG WK, 1987, EMBO J, V6, P2261, DOI 10.1002/j.1460-2075.1987.tb02499.x; SMITH SM, 1990, AM J RESP CELL MOL, V2, P59, DOI 10.1165/ajrcmb/2.1.59; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; TAKATSU K, 1988, IMMUNOL REV, V102, P107, DOI 10.1111/j.1600-065X.1988.tb00743.x; TAKETAZU F, 1991, J CELL PHYSIOL, V146, P251, DOI 10.1002/jcp.1041460209; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; THORENS B, 1987, CELL, V42, P889; URBAN JF, 1992, IMMUNOL REV, V127, P205, DOI 10.1111/j.1600-065X.1992.tb01415.x; WETZEL GD, 1989, EUR J IMMUNOL, V19, P1701, DOI 10.1002/eji.1830190926; WRIGHT JR, 1991, ANNU REV PHYSIOL, V53, P395, DOI 10.1146/annurev.physiol.53.1.395; YAMAGUCHI Y, 1988, J EXP MED, V167, P43, DOI 10.1084/jem.167.1.43; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737; ZUCALI JR, 1987, BLOOD, V69, P33	42	242	246	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1995	2	3					211	222		10.1016/1074-7613(95)90046-2	http://dx.doi.org/10.1016/1074-7613(95)90046-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QP276	7697542	Bronze			2022-12-18	WOS:A1995QP27600001
J	Tussiwand, R; Everts, B; Grajales-Reyes, GE; Kretzer, NM; Iwata, A; Bagaitkar, J; Wu, XD; Wong, R; Anderson, DA; Murphy, TL; Pearce, EJ; Murphy, KM				Tussiwand, Roxane; Everts, Bart; Grajales-Reyes, Gary E.; Kretzer, Nicole M.; Iwata, Arifumi; Bagaitkar, Juhi; Wu, Xiaodi; Wong, Rachel; Anderson, David A.; Murphy, Theresa L.; Pearce, Edward J.; Murphy, Kenneth M.			Klf4 Expression in Conventional Dendritic Cells Is Required for T Helper 2 Cell Responses	IMMUNITY			English	Article							SCHISTOSOMA-MANSONI; SIGNALING CONTROLS; LANGERHANS CELLS; TRANSGENIC MICE; IL-4 PRODUCTION; STEM-CELLS; DIFFERENTIATION; ACTIVATION; INFECTION; IMMUNITY	The two major lineages of classical dendritic cells (cDCs) express and require either IRF8 or IRF4 transcription factors for their development and function. IRF8-dependent cDCs promote anti-viral and T-helper 1 (Th1) cell responses, whereas IRF4-expressing cDCs have been implicated in controlling both Th2 and Th17 cell responses. Here, we have provided evidence that Kruppel-like factor 4 (Klf4) is required in IRF4-expressing cDCs to promote Th2, but not Th17, cell responses in vivo. Conditional Klf4 deletion within cDCs impaired Th2 cell responses during Schistosoma mansoni infection, Schistosoma egg antigen (SEA) immunization, and house dust mite (HDM) challenge without affecting cytotoxic T lymphocyte (CTL), Th1 cell, or Th17 cell responses to herpes simplex virus, Toxoplasma gondii, and Citrobacter rodentium infections. Further, Klf4 deletion reduced IRF4 expression in pre-cDCs and resulted in selective loss of IRF4-expressing cDCs subsets in several tissues. These results indicate that Klf4 guides a transcriptional program promoting IRF4-expressing cDCs heterogeneity.	[Tussiwand, Roxane; Everts, Bart; Grajales-Reyes, Gary E.; Kretzer, Nicole M.; Iwata, Arifumi; Wu, Xiaodi; Wong, Rachel; Anderson, David A.; Murphy, Theresa L.; Pearce, Edward J.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Tussiwand, Roxane] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Everts, Bart] Leiden Univ, Med Ctr, Dept Parasitol, NL-2333 Leiden, Netherlands; [Bagaitkar, Juhi] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); University of Basel; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid Ave, St Louis, MO 63110 USA.	r.tussiwand@unibas.ch; kmurphy@wustl.edu	Everts, Bart/H-6986-2016	Everts, Bart/0000-0002-3764-5131; Wong, Rachel/0000-0001-7837-2881; Tussiwand, Roxane/0000-0002-1712-868X; Anderson, David/0000-0001-9286-5789	Howard Hughes Medical Institute; NIH [AI32573]; VENI from Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032573, R01AI032573] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VENI from Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute (K.M.M.). NIH grant AI32573 to E.J.P. B.E. was supported by a VENI grant from the Netherlands Organization for Scientific Research. We thank Susan Gilfillan and Marco Colonna for Il34 <SUP>/</SUP> mice (Wang et al., 2012). We thank Victor Cortez for help in processing LP tissues.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bar-On L, 2010, METHODS MOL BIOL, V595, P429, DOI 10.1007/978-1-60761-421-0_28; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Brunet LR, 1997, J IMMUNOL, V159, P777; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chu DK, 2014, J EXP MED, V211, P1657, DOI 10.1084/jem.20131800; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Connor LM, 2014, J IMMUNOL, V193, P2709, DOI 10.4049/jimmunol.1400374; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kane CM, 2008, INFECT IMMUN, V76, P5754, DOI 10.1128/IAI.00497-08; Katz JP, 2002, DEVELOPMENT, V129, P2619; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mollah SA, 2014, J INVEST DERMATOL, V134, P1265, DOI 10.1038/jid.2013.515; Murphy KM, 2013, ADV IMMUNOL, V120, P239, DOI 10.1016/B978-0-12-417028-5.00009-0; Naik SH, 2010, METHODS MOL BIOL, V595, P177, DOI 10.1007/978-1-60761-421-0_11; Ochiai S, 2014, J IMMUNOL, V193, P2504, DOI 10.4049/jimmunol.1400536; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Park CS, 2012, J LEUKOCYTE BIOL, V91, P739, DOI 10.1189/jlb.0811413; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Pearce EJ, 1996, INT IMMUNOL, V8, P435, DOI 10.1093/intimm/8.4.435; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Robinson DS, 2000, CHEM IMMUNOL, V78, P50; Sabin EA, 1996, J EXP MED, V184, P1871, DOI 10.1084/jem.184.5.1871; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Terry RL, 2014, CELL IMMUNOL, V291, P16, DOI 10.1016/j.cellimm.2014.02.008; Torti N, 2011, EUR J IMMUNOL, V41, P2612, DOI 10.1002/eji.201041075; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Yoshida T, 2014, J ATHEROSCLER THROMB, V21, P402; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008; Zhou Q, 2014, J IMMUNOL, V193, P496, DOI 10.4049/jimmunol.1303138	85	241	241	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					916	928		10.1016/j.immuni.2015.04.017	http://dx.doi.org/10.1016/j.immuni.2015.04.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992862	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000354827400017
J	Elinav, E; Strowig, T; Henao-Mejia, J; Flavell, RA				Elinav, Eran; Strowig, Till; Henao-Mejia, Jorge; Flavell, Richard A.			Regulation of the Antimicrobial Response by NLR Proteins	IMMUNITY			English	Review							NF-KAPPA-B; NOD-LIKE RECEPTORS; INNATE IMMUNE-RESPONSE; FAMILY-MEMBER NLRC5; CASPASE-1 ACTIVATION; HOST-DEFENSE; PATTERN-RECOGNITION; MURAMYL DIPEPTIDE; INFLAMMASOME RECOGNITION; AIM2 INFLAMMASOME	Nucleotide-binding, oligomerization domain (NOD)-like receptor (NLR) proteins are a family of innate immune receptors that play a pivotal role in microbial sensing, leading to the initiation of antimicrobial immune responses. Dysregulation of the function of multiple NLR family members has been linked, both in mice and humans, to a propensity for infection and autoinflammatory disease. Despite our increased understanding of NLR function and interactions, many aspects related to mechanisms of sensing, downstream signaling, and in vivo functions remain elusive. In this review, we focus on key members of the NLR family, describing their activation by diverse microbes, downstream effector functions, and interactions with each other and with other innate sensor protein families. Also discussed is the role of microbial sensing by NLR receptors leading to activation of the adaptive immune arm that collaborates in the antimicrobial defense.	[Elinav, Eran; Strowig, Till; Henao-Mejia, Jorge; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110; Strowig, Till/0000-0003-0185-1459	Cancer Research Institute; American Physicians for Medicine in Israel; Leukemia and Lymphoma Society; Howard Hughes Medical Institute	Cancer Research Institute; American Physicians for Medicine in Israel; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank H. Elinav and C.A. Thaiss for their valuable critique of this manuscript. E.E. is supported by Cancer Research Institute (2010-2012) and is a recipient of the Claire and Emmanuel G. Rosenblatt award from the American Physicians for Medicine in Israel (2010). J.H.M. is supported by a Leukemia and Lymphoma Society Postdoctoral Fellowship. This work was supported in part by the Howard Hughes Medical Institute (R.A.F.). We dedicate this review to the memory of Jurg Tschopp, a colleague and pioneer in the field of innate immunology, whose contribution to the study of NLRs is immeasurable.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Appenrodt B, 2010, HEPATOLOGY, V51, P1327, DOI 10.1002/hep.23440; Archer KA, 2010, INFECT IMMUN, V78, P2477, DOI 10.1128/IAI.00243-10; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Berrington WR, 2010, J INFECT DIS, V201, P1422, DOI 10.1086/651559; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Borzutzky A, 2010, CLIN IMMUNOL, V134, P251, DOI 10.1016/j.clim.2009.05.005; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Coers J, 2007, CELL MICROBIOL, V9, P2344, DOI 10.1111/j.1462-5822.2007.00963.x; Coulombe F, 2009, J EXP MED, V206, P1709, DOI 10.1084/jem.20081779; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Davis BK, 2011, J IMMUNOL, V186, P1333, DOI 10.4049/jimmunol.1003111; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Gregory SM, 2011, SCIENCE, V331, P330, DOI 10.1126/science.1199478; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Hasegawa M, 2011, J IMMUNOL, V186, P4872, DOI 10.4049/jimmunol.1003761; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hoffman HM, 2011, J BIOL CHEM, V286, P10889, DOI 10.1074/jbc.R110.135491; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Huang MTH, 2009, J IMMUNOL, V182, P2395, DOI 10.4049/jimmunol.0800909; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ji S, 2009, INFECT IMMUN, V77, P1044, DOI 10.1128/IAI.00449-08; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Kumar H, 2011, J IMMUNOL, V186, P994, DOI 10.4049/jimmunol.1002094; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McGonagle D, 2007, ANN RHEUM DIS, V66, P1683, DOI 10.1136/ard.2007.073759; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Morris AE, 2009, AM J PHYSIOL-LUNG C, V297, pL1112, DOI 10.1152/ajplung.00155.2009; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Neerincx A, 2010, J BIOL CHEM, V285, P26223, DOI 10.1074/jbc.M110.109736; Nischalke HD, 2011, J HEPATOL, V55, P1010, DOI 10.1016/j.jhep.2011.02.022; Nour AM, 2011, J BIOL CHEM, V286, P17921, DOI 10.1074/jbc.M110.210575; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Penack O, 2009, J EXP MED, V206, P2101, DOI 10.1084/jem.20090623; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Petterson T, 2011, J LEUKOCYTE BIOL, V89, P177, DOI 10.1189/jlb.0210061; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rajan JV, 2011, J VIROL, V85, P4167, DOI 10.1128/JVI.01687-10; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Reimer T, 2010, EUR J IMMUNOL, V40, P764, DOI 10.1002/eji.200939996; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Silva GK, 2010, J IMMUNOL, V184, P1148, DOI 10.4049/jimmunol.0902254; Strominger JL, 2007, NAT IMMUNOL, V8, P1269, DOI 10.1038/ni1207-1269; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Sutterwala FS, 2007, J LEUKOCYTE BIOL, V82, P259, DOI 10.1189/jlb.1206755; Sutterwala FS, 2009, CLIN IMMUNOL, V130, P2, DOI 10.1016/j.clim.2008.08.011; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Watanabe T, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/476482; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Werts C, 2007, EUR J IMMUNOL, V37, P2499, DOI 10.1002/eji.200737069; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zurawek M, 2010, HUM IMMUNOL, V71, P530, DOI 10.1016/j.humimm.2010.02.004	139	241	260	3	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 27	2011	34	5					665	679		10.1016/j.immuni.2011.05.007	http://dx.doi.org/10.1016/j.immuni.2011.05.007			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21616436	Bronze			2022-12-18	WOS:000291456500004
J	Colonna, M				Colonna, Marco			Interleukin-22-Producing Natural Killer Cells and Lymphoid Tissue Inducer-like Cells in Mucosal Immunity	IMMUNITY			English	Review							ROR-GAMMA-T; ARYL-HYDROCARBON RECEPTOR; PROINFLAMMATORY GENE-EXPRESSION; INFLAMMATORY-BOWEL-DISEASE; HOST-DEFENSE; NK CELLS; TRANSCRIPTIONAL REGULATION; AUTOIMMUNE INFLAMMATION; INTESTINAL INFLAMMATION; EPITHELIAL-CELLS	Blood, lymphoid tissues, and placenta contain diverse subpopulations of natural killer (NK) cells that possess distinct immune functions. Recent studies have shown that human and mouse gut-associated lymphoid tissues harbor a unique NK cell subset that specializes in production of interleukin (IL)-22. This cytokine plays a role in host defense of mucosal barriers, although dysregulated secretion may cause autoimmune disease. In parallel, human fetal lymphoid tissue inducer (LTi) cells and mouse adult LTi-like cells in secondary lymphoid tissues were found to release IL-22, as well as IL-17, a proinflammatory cytokine that mediates host defense against extracellular pathogens. Here, we compare these recently identified immune cells, reviewing what is known about their anatomical location, differentiation requirements, function, and potential involvement in host defense and autoimmunity. Finally, we discuss the challenges faced in furthering our understanding of the developmental relationships and role of NK and LTi-like cells in mucosal immune responses.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu		Colonna, Marco/0000-0001-5222-4987				Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; Chinen H, 2007, GASTROENTEROLOGY, V133, P559, DOI 10.1053/j.gastro.2007.05.017; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Croy BA, 2003, REPRODUCTION, V126, P149, DOI 10.1530/rep.0.1260149; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Di Santo JP, 2008, EUR J IMMUNOL, V38, P2948, DOI 10.1002/eji.200838830; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Gasser S, 2006, SEMIN CANCER BIOL, V16, P344, DOI 10.1016/j.semcancer.2006.07.004; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Hor S, 2004, J BIOL CHEM, V279, P33343, DOI 10.1074/jbc.M405000200; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kotenko SV, 2002, CYTOKINE GROWTH F R, V13, P223, DOI 10.1016/S1359-6101(02)00012-6; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Manaster I, 2008, PLACENTA, V29, pS60, DOI 10.1016/j.placenta.2007.10.006; McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Munz C, 2008, EUR J IMMUNOL, V38, P2946, DOI 10.1002/eji.200838849; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P577, DOI 10.1016/j.intimp.2004.01.007; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; Quinton LJ, 2008, AM J RESP CELL MOL, V38, P699, DOI 10.1165/rcmb.2007-0365OC; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Scalzo AA, 2008, CURR TOP MICROBIOL, V321, P101; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vondenhoff MFR, 2007, EUR J IMMUNOL, V37, pS46, DOI 10.1002/eji.200737528; Weaver CT, 2007, CURR BIOL, V17, pR61, DOI 10.1016/j.cub.2006.12.015; Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	83	240	247	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 17	2009	31	1					15	23		10.1016/j.immuni.2009.06.008	http://dx.doi.org/10.1016/j.immuni.2009.06.008			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19604490	Bronze			2022-12-18	WOS:000268219900008
J	Michallet, MC; Meylan, E; Ermolaeva, MA; Vazquez, J; Rebsamen, M; Curran, J; Poeck, H; Bscheider, M; Hartmann, G; Koenig, M; Kalinke, U; Pasparakis, M; Tschopp, J				Michallet, Marie-Cecile; Meylan, Etienne; Ermolaeva, Maria A.; Vazquez, Jessica; Rebsamen, Manuele; Curran, Joseph; Poeck, Hendrik; Bscheider, Michael; Hartmann, Gunther; Koenig, Martin; Kalinke, Ulrich; Pasparakis, Manolis; Tschopp, Juerg			TRADD protein is an essential component of the RIG-like helicase antiviral pathway	IMMUNITY			English	Article							NF-KAPPA-B; HEPATITIS-C-VIRUS; NECROSIS-FACTOR RECEPTOR; DOUBLE-STRANDED-RNA; INNATE IMMUNE-RESPONSES; MEDIATED APOPTOSIS; CELL-DEATH; SIGNAL-TRANSDUCTION; ADAPTER PROTEIN; ACTIVATION	Upon detection of viral RNA, the helicases RIG-I and/or MDA5 trigger, via their adaptor Cardif (also known as IPS-1, MAVS, or VISA), the activation of the transcription factors NF-kappa B and IRF3, which collaborate to induce an antiviral type I interferon (IFN) response. FADD and RIP1, known as mediators of death-receptor signaling, are implicated in this antiviral pathway; however, the link between death-receptor and antiviral signaling is not known. Here we showed that TRADD, a crucial adaptor of tumor necrosis factor receptor (TNFRI), was important in RIG-like helicase (RLH)-mediated signal transduction. TRADD is recruited to Cardif and orchestrated complex formation with the E3 ubiquitin ligase TRAF3 and TANK and with FADD and RIP1, leading to the activation of IRF3 and NF-kappa B. Loss of TRADD prevented Card if-dependent activation of IFN-beta, reduced the production of IFN-beta in response to RNA viruses, and enhanced vesicular stomatitis virus replication. Thus, TRADD is not only an essential component of proinflammatory TNFRI signaling, but is also required for RLH-Cardif-dependent antiviral immune responses.	[Michallet, Marie-Cecile; Meylan, Etienne; Vazquez, Jessica; Rebsamen, Manuele; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Ermolaeva, Maria A.; Pasparakis, Manolis] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Curran, Joseph] Univ Geneva, Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Poeck, Hendrik; Hartmann, Gunther] Univ Bonn, Inst Clin Biochem & Pharmacol, D-53127 Bonn, Germany; [Bscheider, Michael] Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80336 Munich, Germany; [Koenig, Martin; Kalinke, Ulrich] Paul Ehrlich Inst, Fed Agcy Sera & Vaccines, D-63225 Langen, Germany	University of Lausanne; University of Cologne; University of Geneva; University of Bonn; University of Munich; Paul Ehrlich Institute	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Rebsamen, Manuele/A-7980-2011; Pasparakis, Manolis/N-4350-2019; Hartmann, Gunther/P-7492-2017; Pasparakis, Manolis/H-9292-2017	Rebsamen, Manuele/0000-0001-6172-4211; Pasparakis, Manolis/0000-0002-9870-0966; Hartmann, Gunther/0000-0003-1021-2018; Pasparakis, Manolis/0000-0002-9870-0966; Kalinke, Ulrich/0000-0003-0503-9564; Meylan, Etienne/0000-0002-0899-2230				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Li CL, 2002, STRUCTURE, V10, P403, DOI 10.1016/S0969-2126(02)00733-5; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Majumder M, 2002, VIROLOGY, V294, P94, DOI 10.1006/viro.2001.1309; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miyasaka Y, 2003, J INFECT DIS, V188, P1537, DOI 10.1086/379253; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thome M, 1999, J BIOL CHEM, V274, P9962, DOI 10.1074/jbc.274.15.9962; THORNE M, 1998, CURR BIOL, V8, P885; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zhu NL, 2001, VIROLOGY, V283, P178, DOI 10.1006/viro.2001.0896	51	240	245	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY	2008	28	5					651	661		10.1016/j.immuni.2008.03.013	http://dx.doi.org/10.1016/j.immuni.2008.03.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18439848	Bronze			2022-12-18	WOS:000256003900012
J	Fritz, JH; Le Bourhis, L; Sellge, G; Magalhaes, JG; Fsihi, H; Kufer, TA; Collins, C; Viala, J; Ferrero, RL; Girardin, SE; Philpott, DJ				Fritz, Jorg H.; Le Bourhis, Lionel; Sellge, Gernot; Magalhaes, Joao Gamelas; Fsihi, Hafida; Kufer, Thomas A.; Collins, Cathy; Viala, Jerome; Ferrero, Richard L.; Girardin, Stephen E.; Philpott, Dana J.			Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; COLONY-STIMULATING FACTOR; DENDRITIC CELLS; HELICOBACTER-PYLORI; INFLAMMATORY DISEASE; ANTIBODY-RESPONSES; EPITHELIAL-CELLS; LRR PROTEINS; T-CELLS	Recent evidence has suggested that signals other than those from Toll-like receptors (TLRs) could contribute to the elicitation of antigen-specific immunity. Therefore, we examined the role of the Nod-like receptor (NLR) family member, Nod1, in the generation of adaptive immune responses. Our findings show that innate immune sensing of peptidoglycan by Nod1 is key for priming antigen-specific T cell immunity and subsequent antibody responses in vivo. Nod1 stimulation alone was sufficient to drive antigen-specific immunity with a predominant Th2 polarization profile. In conjunction with TLR stimulation, however, Nod1 triggering was required to instruct the onset of Th1 and Th2 as well as Th17 immune pathways. Cells outside of the hematopoietic lineage provided the early signals necessary to orchestrate the development of Nod1-dependent immune responses. These findings highlight Nod1 as a key innate immune trigger in the local tissue microenvironment that drives the development of adaptive immunity.	Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris 15, France; INSERM, U786, F-75724 Paris 15, France; Inst Pasteur, Unite Rech Mycol Mol, F-75724 Paris 15, France; Hop Robert Debre, AP HP, Dept Paediat Gastroenterol & Nutr, F-75935 Paris 19, France; Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	University of Toronto; University of Toronto; University of Toronto; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Monash University	Philpott, DJ (corresponding author), Univ Toronto, Dept Immunol, 1 Kings Coll Circle,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	dana.philpott@utoronto.ca	Magalhaes, Joao/AAK-2686-2020; FSIHI, Hafida/H-9852-2014; Kufer, Thomas A/I-5146-2015; Ferrero, Richard/U-1332-2017	Kufer, Thomas A/0000-0003-4563-0412; Ferrero, Richard/0000-0001-6817-6211; Le Bourhis, Lionel/0000-0002-7524-3539				Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Dabbagh K, 2003, CURR OPIN INFECT DIS, V16, P199, DOI 10.1097/00001432-200306000-00003; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; FALLON PG, 2006, J EXP MED, V203, P1105, DOI DOI 10.1084/JEM.20051615; Ferrero RL, 2005, MOL IMMUNOL, V42, P879, DOI 10.1016/j.molimm.2004.12.001; Ferrero RL, 1998, INFECT IMMUN, V66, P1349, DOI 10.1128/IAI.66.4.1349-1355.1998; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Fritz JH, 2004, VACCINE, V22, P3274, DOI 10.1016/j.vaccine.2004.03.007; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Johnson GB, 2003, TRENDS IMMUNOL, V24, P19, DOI 10.1016/S1471-4906(02)00014-5; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LEE CK, 1995, J INFECT DIS, V172, P161, DOI 10.1093/infdis/172.1.161; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lukacs NW, 1997, AM J PATHOL, V150, P1861; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Stetson DB, 2004, ADV IMMUNOL, V83, P163; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; van Heel DA, 2005, EUR J IMMUNOL, V35, P2471, DOI 10.1002/eji.200526296; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034; Wickelgren I, 2006, SCIENCE, V314, P1859, DOI 10.1126/science.314.5807.1859a; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	55	240	257	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2007	26	4					445	459		10.1016/j.immuni.2007.03.009	http://dx.doi.org/10.1016/j.immuni.2007.03.009			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17433730	Bronze			2022-12-18	WOS:000246126400010
J	ROONEY, JW; HOEY, T; GLIMCHER, LH				ROONEY, JW; HOEY, T; GLIMCHER, LH			COORDINATE AND COOPERATIVE ROLES FOR NF-AT AND AP-1 IN THE REGULATION OF THE MURINE IL-4 GENE	IMMUNITY			English	Article							ACTIVATED T-CELLS; CYCLOSPORINE-A; NUCLEAR FACTOR; LYMPHOCYTES-T; 2-STIMULUS REQUIREMENT; INTERLEUKIN-4 GENE; RNA-POLYMERASE; EXPRESSION; JUN; TRANSCRIPTION	The transcription factor NF-AT plays an essential role in the inducible transcription of several cytokine genes during T cell activation. The distal NF-AT site of the murine IL-2 promoter binds both NF-AT and AP-1 proteins, and thus represents a composite regulatory site that integrates Ca2+- and PKC-dependent signaling pathways in T cell activation. However, the individual contributions of the NF-AT and AP-1 components to promoter activity via this composite site have not been resolved, owing to the absence of a clearly defined AP-1 binding site, which, when mutated abolishes AP-1 binding. We describe here an apparently analogous NF-AT/AP-1 composite site in the murine IL-4 promoter, which can be mutated to selectively block the recruitment of each component. We show that the cooperative and coordinate involvement of both NF-AT and AP-1 is necessary for full activity of the NF-AT/AP-1 composite site, and, ultimately, the entire IL-4 promoter.	TULARIK INC, San Francisco, CA 94080 USA; HARVARD UNIV, SCH PUBL HLTH, DEPT CANC BIOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	ROONEY, JW (corresponding author), HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA.							ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BOHMANN D, 1989, CELL, V59, P709, DOI 10.1016/0092-8674(89)90017-2; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HECHT TT, 1983, J IMMUNOL, V131, P1049; HODGE MR, 1995, IN PRESS J IMMUNOL; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1993, J IMMUNOL, V151, P837; JAIN JN, 1994, MOL CELL BIOL, V14, P1566, DOI 10.1128/MCB.14.3.1566; JAMIESON C, 1991, J IMMUNOL, V147, P416; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; KUBO M, 1994, INT IMMUNOL, V6, P179, DOI 10.1093/intimm/6.2.179; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P423, DOI 10.1016/0968-0004(91)90168-U; MINER JN, 1992, GENE DEV, V6, P2491, DOI 10.1101/gad.6.12b.2491; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; RAO A, 1991, CRIT REV IMMUNOL, V10, P495; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; SAKURAI M, 1989, TISSUE ANTIGENS, V34, P64, DOI 10.1111/j.1399-0039.1989.tb01718.x; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; TODD MD, 1993, J EXP MED, V177, P1663, DOI 10.1084/jem.177.6.1663; ULLMAN KS, 1993, GENE DEV, V7, P188, DOI 10.1101/gad.7.2.188; ULLMAN KS, 1991, SCIENCE, V254, P558, DOI 10.1126/science.1683003; WEISS A, 1984, J IMMUNOL, V133, P123; WISKOCIL R, 1985, J IMMUNOL, V134, P1599	41	240	243	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1995	2	5					473	483		10.1016/1074-7613(95)90028-4	http://dx.doi.org/10.1016/1074-7613(95)90028-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QZ430	7749982	Bronze			2022-12-18	WOS:A1995QZ43000005
J	Brydges, SD; Mueller, JL; McGeough, MD; Pena, CA; Misaghi, A; Gandhi, C; Putnam, CD; Boyle, DL; Firestein, GS; Horner, AA; Soroosh, P; Watford, WT; O'Shea, JJ; Kastner, DL; Hoffman, HM				Brydges, Susannah D.; Mueller, James L.; McGeough, Matthew D.; Pena, Carla A.; Misaghi, Amirhossein; Gandhi, Chhavi; Putnam, Chris D.; Boyle, David L.; Firestein, Gary S.; Horner, Anthony A.; Soroosh, Pejman; Watford, Wendy T.; O'Shea, John J.; Kastner, Daniel L.; Hoffman, Hal M.			Inflammasome-Mediated Disease Animal Models Reveal Roles for Innate but Not Adaptive Immunity	IMMUNITY			English	Article							COLD AUTOINFLAMMATORY SYNDROME; INTERLEUKIN-1 RECEPTOR ANTAGONIST; MUCKLE-WELLS-SYNDROME; CIAS1 MUTATIONS; NALP3 INFLAMMASOME; ACTIVATION; MICE; CELL; PROTEIN; PYRIN	NLRP3 nucleates the inflammasome, a protein complex responsible for cleavage of prointerleukin-1 beta (IL-1 beta) to its active form. Mutations in the NLRP3 gene cause the autoinflammatory disease spectrum cryopyrin-associated periodic syndromes (CAPS). The central role of IL-1 beta in CAPS is supported by the response to IL-1-targeted therapy. We developed two Nlrp3 mutant knockin mouse strains to model CAPS to examine the role of other inflammatory mediators and adaptive immune responses in an innate immune-driven disease. These mice had systemic inflammation and poor growth, similar to some human CAPS patients, and demonstrated early mortality, primarily mediated by myeloid cells. Mating these mutant mice to various gene mutant backgrounds showed that the mouse disease phenotype required an intact inflammasome, was only partially dependent on IL-1 beta, and was independent of T cells. These data suggest that CAPS are true inflammasome-mediated diseases and provide insight for more common inflammatory disorders.	[Brydges, Susannah D.; Gandhi, Chhavi; Boyle, David L.; Firestein, Gary S.; Horner, Anthony A.; Hoffman, Hal M.] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA; [Mueller, James L.; McGeough, Matthew D.; Pena, Carla A.; Hoffman, Hal M.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Misaghi, Amirhossein; Putnam, Chris D.; Firestein, Gary S.; Horner, Anthony A.; Hoffman, Hal M.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Watford, Wendy T.; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Brydges, Susannah D.; Kastner, Daniel L.] NIAMSD, Genet & Genom Branch, NIH, Bethesda, MD 20892 USA; [Mueller, James L.; Putnam, Chris D.; Hoffman, Hal M.] Ludwig Inst Canc Res, San Diego Branch, La Jolla, CA 92093 USA; [Soroosh, Pejman] La Jolla Inst Allergy & Immunol, Div Mol Immunol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Ludwig Institute for Cancer Research; La Jolla Institute for Immunology	Hoffman, HM (corresponding author), Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA.	hahoffman@ucsd.edu	Soroosh, Pejman/AAD-8386-2021	Watford, Wendy/0000-0003-4261-5399; Putnam, Christopher/0000-0002-6145-1265	NIH [R01-AI52430]; NIAMS; Regeneron and Novartis Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI061108, R01AI052430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041123, ZIAAR041159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Regeneron and Novartis Pharmaceuticals(Regeneron); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors would like to thank R. Goldbach-Mansky for providing blood samples from CAPS patients, J. Hillman for luminex analysis, N. Ng and S. Lee for FACS analysis, and J.Y. Cho and S. Aceves for immunohistochemistry support. We also appreciate helpful advice from D. Cleveland, A. Silk, M. McAlonis-Downes, R. Kolodner, A. Laurence, M. Croft, T. Doherty, and D. Broide. The UCSD Cancer Center mouse transgenic and embryonic stem cell core (E. Kothari) and histology core (N. Varki) provided support, and the Ludwig Institute of Cancer Research San Diego branch provided DNA sequencing support. This work was funded by NIH R01-AI52430 and NIAMS. H.M.H. has received consultant fees from Regeneron and Novartis Pharmaceuticals.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; BAMDEN MJ, 1998, IMMUNOL CELL BIOL, V76, P34; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; Chen Z, 2008, IMMUNOL RES, V41, P87, DOI 10.1007/s12026-007-8014-9; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dode C, 2002, AM J HUM GENET, V70, P1498, DOI 10.1086/340786; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hoffman HM, 2003, HUM GENET, V112, P209, DOI 10.1007/s00439-002-0860-x; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2008, J LEUKOCYTE BIOL, V83, P507, DOI 10.1189/jlb.0607362; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Ni K, 1997, IMMUNOL CELL BIOL, V75, P223, DOI 10.1038/icb.1997.35; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pain R H, 1987, Symp Soc Exp Biol, V41, P21; Rosengren S, 2007, J ALLERGY CLIN IMMUN, V119, P991, DOI 10.1016/j.jaci.2006.12.649; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Thieringer HA, 1998, BIOESSAYS, V20, P49; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029	45	239	243	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2009	30	6					875	887		10.1016/j.immuni.2009.05.005	http://dx.doi.org/10.1016/j.immuni.2009.05.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19501000	Green Accepted, Bronze			2022-12-18	WOS:000267270700014
J	Wang, YH; Ito, T; Wang, YH; Homey, B; Watanabe, N; Martin, R; Barnes, CJ; McIntyre, BW; Gilliet, M; Kumar, R; Yao, ZB; Liu, YJ				Wang, Yul-Hsi; Ito, Tomoki; Wang, Yi-Hong; Homey, Bernhard; Watanabe, Norihiko; Martin, Rachel; Barnes, Christopher J.; McIntyre, Bradley W.; Gilliet, Michel; Kumar, Rakesh; Yao, Zhengbin; Liu, Yong-Jun			Maintenance and polarization of human T(H)2 central memory T cells lymphopoietin-activated by thymic stromal dendritic cells	IMMUNITY			English	Article							LEYDEN CRYSTAL PROTEIN; IN-VIVO; ATOPIC-DERMATITIS; ALLERGIC-ASTHMA; OX40 LIGAND; TH2 CELLS; EXPRESSION; INFLAMMATION; SKIN; SUBSETS	The identity of T(H)2 memory cells and the mechanism regulating their maintenance during allergic inflammation remain elusive. We report that circulated human CD4(+) T cells expressing the prostaglandin D2 receptor (CRTH2) are T(H)2 central memory T cells, characterized by their phenotype, T(H)2 cytokine production, gene-expression profile, and the ability to respond to allergens. Only dendritic cells (DCs) activated by thymic stromal lymphopoietin (TSLP) can induce a robust expansion of CRTH2(+)CD4(+) T(H)2 memory cells, while maintaining their central memory phenotype and T(H)2 commitments. CRTH2(+)CD4(+) T(H)2 memory cells activated by TSLP-DCs undergo further T(H)2 polarization and express cystatin A, Charcot-Leydon crystal protein, and prostaglandin D2 synthase, implying their broader roles in allergic inflammation. Infiltrated CRTH2(+)CD4(+) T(H)2 effector memory T cells in skin lesion of atopic dermatitis were associated with activated DCs, suggesting that TSLP-DCs play important roles not only in T(H)2 priming, but also in the maintenance and further polarization of T(H)2 central memory cells in allergic diseases.	Univ Texas, MD Anderson Canc Ctr, Grad Sch Biomed Sci, Ctr Canc Immunol Res,Dept Immunol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany; Tanox Biosyst Inc, Houston, TX 77025 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Heinrich Heine University Dusseldorf	Liu, YJ (corresponding author), Univ Texas, MD Anderson Canc Ctr, Grad Sch Biomed Sci, Ctr Canc Immunol Res,Dept Immunol, Houston, TX 77030 USA.	yjliu@mdanderson.org	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803				ACKERMAN SJ, 1993, J IMMUNOL, V150, P456; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fink JR, 2001, EXP HEMATOL, V29, P490, DOI 10.1016/S0301-472X(01)00619-1; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; GOLIGHTLY LM, 1992, J LEUKOCYTE BIOL, V51, P386, DOI 10.1002/jlb.51.4.386; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Holt PG, 1999, NATURE, V402, pB12; Hoshino A, 2003, EUR J IMMUNOL, V33, P861, DOI 10.1002/eji.200323455; Imura A, 1996, J EXP MED, V183, P2185, DOI 10.1084/jem.183.5.2185; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; John RJ, 2000, CLIN EXP ALLERGY, V30, P784, DOI 10.1046/j.1365-2222.2000.00840.x; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Lambrecht BN, 2001, INT ARCH ALLERGY IMM, V124, P432, DOI 10.1159/000053778; Lawson BR, 2004, J EXP MED, V199, P547, DOI 10.1084/jem.20031685; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Mojtabavi N, 2002, J IMMUNOL, V169, P4788, DOI 10.4049/jimmunol.169.9.4788; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Muller K, 2003, INFECT IMMUN, V71, P6178, DOI 10.1128/IAI.71.11.6178-6183.2003; Nagata K, 1999, J IMMUNOL, V162, P1278; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; POPE M, 1995, J INVEST DERMATOL, V104, P11, DOI 10.1111/1523-1747.ep12613452; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Ritz SA, 2004, CLIN EXP IMMUNOL, V138, P213, DOI 10.1111/j.1365-2249.2004.02618.x; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; vanReijsen FC, 1997, J INVEST DERMATOL, V108, P530, DOI 10.1111/1523-1747.ep12291799; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	45	239	260	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					827	838		10.1016/j.immuni.2006.03.019	http://dx.doi.org/10.1016/j.immuni.2006.03.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782037	Bronze			2022-12-18	WOS:000238592200019
J	Park, JM; Greten, FR; Wong, A; Westrick, RJ; Arthur, JSC; Otsu, K; Hoffmann, A; Montminy, M; Karin, M				Park, JM; Greten, FR; Wong, A; Westrick, RJ; Arthur, JSC; Otsu, K; Hoffmann, A; Montminy, M; Karin, M			Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis - CREB and NF-kappa B as key regulators	IMMUNITY			English	Article							P38 MAP KINASE; STRESS-INDUCED PHOSPHORYLATION; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR; INFLAMMATORY GENES; CELL-SURVIVAL; MICE LACKING; ACTIVATION; TYPE-2; DEATH	Certain microbes evade host innate immunity by killing activated macrophages with the help of virulence factors that target prosurvival pathways. For instance, infection of macrophages with the TLR4-activating bacterium Bacillus anthracis triggers an apoptotic response due to inhibition of p38 MAP kinase activation by the bacterial-produced lethal toxin. Other pathogens induce macrophage apoptosis by preventing activation of NF-kappa B, which depends on I kappa B kinase beta (IKK beta). To better understand how p38 and NF-kappa B maintain macrophage survival, we searched for target genes whose products prevent TLR4-induced apoptosis and a p38-dependent transcription factor required for their induction. Here we describe key roles for transcription factor CREB, a target for p38 signaling, and the plasminogen activator 2 (PAI-2) gene, a target for CREB, in maintenance of macrophage survival.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Tech Univ Munich, Klinikum Rechts Isar, Dept Med, D-81675 Munich, Germany; Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Dundee, Prot Phosphorylat Unit, MRC, Dundee DD1 5EH, Scotland; Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Osaka 5650871, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; Technical University of Munich; Salk Institute; University of Michigan System; University of Michigan; University of Dundee; Osaka University	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Greten, Florian R/AAF-5196-2020; Arthur, J. Simon/B-8058-2010	Greten, Florian R/0000-0002-3928-6080; Arthur, J. Simon/0000-0002-8135-1958	NIAID NIH HHS [R01 AI 061712] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061712] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Antalis TM, 1998, J EXP MED, V187, P1799, DOI 10.1084/jem.187.11.1799; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; CUNNINGHAM K, 1998, BIOCHEMISTRY-US, V37, P15737; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; GAN HX, 1995, J IMMUNOL, V155, P1304; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hatakeyama S, 1998, INT IMMUNOL, V10, P631, DOI 10.1093/intimm/10.5.631; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Katsikis J, 2000, THROMB HAEMOSTASIS, V84, P468; KUMAR S, 1991, J BIOL CHEM, V266, P20960; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liu N, 2004, NAT IMMUNOL, V5, P919, DOI 10.1038/ni1107; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Nishihara H, 2004, J BIOL CHEM, V279, P26176, DOI 10.1074/jbc.M313346200; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Yu CT, 2001, J IMMUNOL, V166, P284, DOI 10.4049/jimmunol.166.1.284	57	239	252	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2005	23	3					319	329		10.1016/j.immuni.2005.08.010	http://dx.doi.org/10.1016/j.immuni.2005.08.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	971KJ	16169504	Bronze			2022-12-18	WOS:000232382500010
J	Ioan-Facsinay, A; de Kimpe, SJ; Hellwig, SMM; van Lent, PL; Hofhuis, FMA; van Ojik, HH; Sedlik, C; da Silveira, SA; Gerber, J; de Jong, YF; Roozendaal, R; Aarden, LA; van den Berg, WB; Saito, T; Mosser, D; Amigorena, S; Izui, S; van Ommen, GJB; van Vugt, M; van de Winkel, JGJ; Verbeek, JS				Ioan-Facsinay, A; de Kimpe, SJ; Hellwig, SMM; van Lent, PL; Hofhuis, FMA; van Ojik, HH; Sedlik, C; da Silveira, SA; Gerber, J; de Jong, YF; Roozendaal, R; Aarden, LA; van den Berg, WB; Saito, T; Mosser, D; Amigorena, S; Izui, S; van Ommen, GJB; van Vugt, M; van de Winkel, JGJ; Verbeek, JS			Fc-gamma RI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection	IMMUNITY			English	Article							RECEPTOR-TYPE-I; DEFICIENT MICE; BORDETELLA-PERTUSSIS; HEMOLYTIC-ANEMIA; CELLS; IMMUNITY; MOUSE; CHAIN; AUTOANTIBODY; CYTOTOXICITY	The high-affinity receptor for IgG, FcgammaRI, shares its capacity to bind IgG2a immune complexes (IgG2a-IC) with the low-affinity receptor FcgammaRIII and complement factors, hampering the definition of its biological role. Moreover, in vivo, FcgammaRI is occupied by monomeric IgG2a, reducing its accessibility to newly formed IgG2a-IC. By using a variety of FcgammaR(-/-) mice, we demonstrate that in the absence of FcgammaRI, the IgG2a-IC-induced cellular processes of phagocytosis, cytokine release, cellular cytotoxicity, and antigen presentation are impaired. FcgammaRI(-/-) mice showed impaired hypersensitivity responses, strongly reduced cartilage destruction in an arthritis model, and impaired protection from a bacterial infection. We conclude that FcgammaRI contributes substantially to a variety of IgG2a-IC-dependent immune functions and immunopathological responses.	Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 AL Leiden, Netherlands; Utrecht Inst Pharmaceut Sci, Dept Pharmacol & Pathophysiol, NL-3584 CA Utrecht, Netherlands; GenMab, NL-3508 AD Utrecht, Netherlands; Univ Nijmegen, Med Ctr St Radboud, Dept Rheumatol, NL-6525 GA Nijmegen, Netherlands; Univ Utrecht, Med Ctr, Dept Immunol, NL-3584 EU Utrecht, Netherlands; Univ Utrecht, Med Ctr, Dept Immunol, Lab Immunotherapy, NL-3584 EA Utrecht, Netherlands; Univ Utrecht, Med Ctr, Dept Internal Med & Oncol, NL-3584 CX Utrecht, Netherlands; Inst Curie, INSERM, U520, Sect Rech, F-75005 Paris, France; Ctr Med Univ Geneva, Dept Pathol, CH-1211 Geneva 4, Switzerland; Univ Maryland, College Pk, MD 20742 USA; CLB, Dept Autoimmune Dis, NL-1066 CX Amsterdam, Netherlands; Chiba Univ, Grad Sch Med, Dept Mol Genet, Chiba 2608670, Japan	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Genmab; Radboud University Nijmegen; Utrecht University; Utrecht University; Utrecht University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Geneva; University System of Maryland; University of Maryland College Park; Chiba University	Verbeek, JS (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 AL Leiden, Netherlands.		van den Berg, W.B./H-8010-2014; van Lent, Peter/A-4047-2014; Mosser, David M/I-6697-2016; Saito, Takashi/C-9684-2009; van Lent, Peter/A-4269-2014	Mosser, David M/0000-0002-9503-4187; Saito, Takashi/0000-0001-9495-3547; SEDLIK, Christine/0000-0001-8502-0905; Amigorena, Sebastian/0000-0001-8583-8416				Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Davis RS, 2001, P NATL ACAD SCI USA, V98, P9772, DOI 10.1073/pnas.171308498; Ely P, 1996, BLOOD, V87, P3813, DOI 10.1182/blood.V87.9.3813.bloodjournal8793813; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; Gavin AL, 1998, J IMMUNOL, V160, P20; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Han YM, 2001, J IMMUNOL, V167, P1550, DOI 10.4049/jimmunol.167.3.1550; Hazenbos WLW, 1998, J IMMUNOL, V161, P3026; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Hellwig SMM, 1999, FEMS IMMUNOL MED MIC, V26, P203, DOI 10.1111/j.1574-695X.1999.tb01391.x; Honeychurch J, 2000, BLOOD, V96, P3544, DOI 10.1182/blood.V96.10.3544.h8003544_3544_3552; Keler T, 1997, CANCER RES, V57, P4008; MARTIN TR, 1993, J IMMUNOL, V151, P367; Meite M, 2000, J VIROL, V74, P6045, DOI 10.1128/JVI.74.13.6045-6049.2000; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; Nagel J, 1985, Dev Biol Stand, V61, P325; PARK SY, 1995, EUR J IMMUNOL, V25, P2107, DOI 10.1002/eji.1830250746; PETERSON VM, 1994, J IMMUNOL, V153, P2321; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; SHIBATA T, 1990, INT IMMUNOL, V2, P1133, DOI 10.1093/intimm/2.12.1133; SINGER II, 1995, J CLIN INVEST, V95, P2178, DOI 10.1172/JCI117907; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Ting LM, 1999, J IMMUNOL, V163, P3898; UNKELESS JC, 1975, J EXP MED, V142, P1520, DOI 10.1084/jem.142.6.1520; VALERIUS T, 1993, BLOOD, V82, P931; van Lent PLEM, 2000, ARTHRITIS RHEUM-US, V43, P740, DOI 10.1002/1529-0131(200004)43:4<740::AID-ANR4>3.0.CO;2-0; Verbeek JS, 1997, RES IMMUNOL, V148, P466, DOI 10.1016/S0923-2494(97)82673-9	36	239	246	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2002	16	3					391	402		10.1016/S1074-7613(02)00294-7	http://dx.doi.org/10.1016/S1074-7613(02)00294-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911824	Bronze			2022-12-18	WOS:000174572800008
J	Voll, RE; Jimi, E; Phillips, RJ; Barber, DF; Rincon, M; Hayday, AC; Flavell, RA; Ghosh, S				Voll, RE; Jimi, E; Phillips, RJ; Barber, DF; Rincon, M; Hayday, AC; Flavell, RA; Ghosh, S			NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development	IMMUNITY			English	Article							DEVELOPMENT IN-VIVO; THYMOCYTE DEVELOPMENT; ALPHA-BETA; ALLELIC EXCLUSION; TRANSCRIPTION FACTORS; RAG-1-DEFICIENT MICE; LINEAGE COMMITMENT; EXPRESSION; APOPTOSIS; CHAIN	Activation of the transcription factor NF-kappaB and pre-T cell receptor (pre-TCR) expression is tightly correlated during thymocyte development. inhibition of NF-kappaB in isolated thymocytes in vitro results in spontaneous apoptosis of cells expressing the pre-TCR, whereas inhibition of NF-kappaB in transgenic mice through expression of a mutated, superrepressor form of I kappaB alpha leads to a loss of beta -selected thymocytes. In contrast, the forced activation of NF-kappaB through expression of a dominant-active I kappaB kinase allows differentiation to proceed to the CD4(+)CD8(+) stage in a Rag1(-/-) mouse that cannot assemble the pre-TCR. Therefore, signals emanating from the pre-TCR are mediated at least in part by NF-kappaB, which provides a selective survival signal for developing thymocytes with productive beta chain rearrangements.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Ghosh, S (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.		Barber, Domingo F./G-1257-2010	Barber, Domingo F./0000-0001-8824-5405	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033443, R37AI033443] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 33443] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Akashi K, 1998, IMMUNOL REV, V165, P13, DOI 10.1111/j.1600-065X.1998.tb01226.x; ANDERSON SJ, 1994, ADV IMMUNOL, V56, P151, DOI 10.1016/S0065-2776(08)60451-4; Bakker TR, 1999, INT J CANCER, V80, P320; Barber DF, 1998, J IMMUNOL, V161, P11; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Berger MA, 1997, J EXP MED, V186, P1461, DOI 10.1084/jem.186.9.1461; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Chen L, 1997, J I ENERGY, V70, P2; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Esslinger CW, 1997, J IMMUNOL, V158, P5075; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; IVANOV V, 1992, INT IMMUNOL, V4, P729, DOI 10.1093/intimm/4.7.729; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; Kasibhatla S, 1999, J BIOL CHEM, V274, P987, DOI 10.1074/jbc.274.2.987; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OReilly LA, 1997, INT IMMUNOL, V9, P1291, DOI 10.1093/intimm/9.9.1291; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; OShea CC, 1997, IMMUNITY, V7, P591, DOI 10.1016/S1074-7613(00)80380-5; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Schwarz EM, 1996, MOL CELL BIOL, V16, P3554; SEN J, 1995, J IMMUNOL, V154, P3213; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; von Boehmer H, 1998, IMMUNOL REV, V165, P111; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; WEIH F, 1994, ONCOGENE, V9, P3289; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; ZUNIGAPFLUCKER JC, 1993, J EXP MED, V178, P1139, DOI 10.1084/jem.178.4.1139	47	239	243	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2000	13	5					677	689		10.1016/S1074-7613(00)00067-4	http://dx.doi.org/10.1016/S1074-7613(00)00067-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114380	Bronze			2022-12-18	WOS:000165598500010
J	Kiani, A; Rao, A; Aramburu, J				Kiani, A; Rao, A; Aramburu, J			Manipulating immune responses with immunosuppressive agents that target NFAT	IMMUNITY			English	Review							ACTIVATED T-CELLS; TRANSCRIPTION FACTOR NFAT1; SEVERE COMBINED IMMUNODEFICIENCY; SMOOTH-MUSCLE CELLS; ATP-DEFICIENT MICE; CYCLOSPORINE-A; NUCLEAR FACTOR; GENE-EXPRESSION; KAPPA-B; GROWTH-FACTOR		Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Tech Univ Dresden, Med Klin 1, Klinikum Carl Gustav Carus, D-01307 Dresden, Germany; Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Technische Universitat Dresden; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Rao, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu	Aramburu, J/G-8991-2014	Aramburu, J/0000-0001-9279-9523				Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Avdonin PV, 1999, KIDNEY INT, V55, P2407, DOI 10.1046/j.1523-1755.1999.00481.x; Avots A, 1999, IMMUNITY, V10, P515, DOI 10.1016/S1074-7613(00)80051-5; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Berland R, 1998, J IMMUNOL, V161, P277; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Boss V, 1998, J BIOL CHEM, V273, P19664, DOI 10.1074/jbc.273.31.19664; BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110; CASTIGLI E, 1993, P NATL ACAD SCI USA, V90, P4728, DOI 10.1073/pnas.90.10.4728; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chow CW, 1999, MOL CELL BIOL, V19, P2300; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; COCKERILL GW, 1995, BLOOD, V86, P2689; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Cron RQ, 1999, J IMMUNOL, V162, P860; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; DUMONT FJ, 1992, J EXP MED, V176, P751, DOI 10.1084/jem.176.3.751; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Ferrari D, 1999, J BIOL CHEM, V274, P13205, DOI 10.1074/jbc.274.19.13205; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Furstenau U, 1999, J BIOL CHEM, V274, P5851, DOI 10.1074/jbc.274.9.5851; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Gudmundsdottir H, 1999, J AM SOC NEPHROL, V10, P1356; Gummert JF, 1999, J AM SOC NEPHROL, V10, P1366; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HO AM, 1994, J BIOL CHEM, V269, P28181; Ho IC, 1998, P NATL ACAD SCI USA, V95, P15537, DOI 10.1073/pnas.95.26.15537; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Hughes JR, 1999, TRANSPLANTATION, V68, P583, DOI 10.1097/00007890-199908270-00025; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Khanna A, 1999, TRANSPLANTATION, V67, P614, DOI 10.1097/00007890-199902270-00021; Khanna AK, 1999, TRANSPLANTATION, V67, P882, DOI 10.1097/00007890-199903270-00016; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; Klemm JD, 1997, CURR BIOL, V7, P638, DOI 10.1016/S0960-9822(06)00290-9; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; LEDEIST F, 1995, BLOOD, V85, P1053, DOI 10.1182/blood.V85.4.1053.bloodjournal8541053; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; LI B, 1991, J EXP MED, V174, P1259, DOI 10.1084/jem.174.5.1259; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; LIU J, J IMMUNOL, V4755, P99; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Loh C, 1996, MOL CELL BIOL, V16, P3945; LONDON, 1995, LANCET, V346, P714; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; LoRusso A, 1996, BRIT J PHARMACOL, V118, P885; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; Mages HW, 1998, MOL CELL BIOL, V18, P7157, DOI 10.1128/MCB.18.12.7157; Marienfeld R, 1997, EUR J IMMUNOL, V27, P1601, DOI 10.1002/eji.1830270703; Mayer AD, 1997, TRANSPLANTATION, V64, P436, DOI 10.1097/00007890-199708150-00012; Meyer KB, 1998, EUR J IMMUNOL, V28, P1467, DOI 10.1002/(SICI)1521-4141(199805)28:05<1467::AID-IMMU1467>3.0.CO;2-9; Ming XF, 1998, EMBO J, V17, P6039, DOI 10.1093/emboj/17.20.6039; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; MYERS BD, 1986, KIDNEY INT, V30, P964, DOI 10.1038/ki.1986.280; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; PARK JC, 1995, J BIOL CHEM, V270, P20653, DOI 10.1074/jbc.270.35.20653; Pascual M, 1998, IMMUNOL TODAY, V19, P514, DOI 10.1016/S0167-5699(98)01324-3; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; PENN I, 1987, TRANSPLANTATION, V43, P32, DOI 10.1097/00007890-198701000-00008; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RENOIR JM, 1995, P NATL ACAD SCI USA, V92, P4977, DOI 10.1073/pnas.92.11.4977; RUTHERFORD SL, 1994, CELL, V79, P1129, DOI 10.1016/0092-8674(94)90003-5; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Schuh K, 1998, J EXP MED, V188, P1369, DOI 10.1084/jem.188.7.1369; Schuh K, 1998, EUR J IMMUNOL, V28, P2456, DOI 10.1002/(SICI)1521-4141(199808)28:08<2456::AID-IMMU2456>3.0.CO;2-9; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Shin GT, 1998, TRANSPLANTATION, V65, P313, DOI 10.1097/00007890-199802150-00003; SIGAL NH, 1991, J EXP MED, V173, P619, DOI 10.1084/jem.173.3.619; Snyder SH, 1998, TRENDS PHARMACOL SCI, V19, P21, DOI 10.1016/S0165-6147(97)01146-2; Sugimoto T, 1997, J BIOL CHEM, V272, P29415, DOI 10.1074/jbc.272.47.29415; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Suthanthiran M, 1996, AM J KIDNEY DIS, V28, P159, DOI 10.1016/S0272-6386(96)90297-8; Symes A, 1998, J NEUROSCI RES, V52, P93, DOI 10.1002/(SICI)1097-4547(19980401)52:1<93::AID-JNR9>3.3.CO;2-U; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Viola JPB, 1998, BLOOD, V91, P2223, DOI 10.1182/blood.V91.7.2223.2223_2223_2230; Viola JPB, 1999, J CLIN IMMUNOL, V19, P98, DOI 10.1023/A:1020502516196; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zhu JY, 1999, NATURE, V398, P256, DOI 10.1038/18473; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	117	239	248	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2000	12	4					359	372		10.1016/S1074-7613(00)80188-0	http://dx.doi.org/10.1016/S1074-7613(00)80188-0			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	309FH	10795734	Bronze			2022-12-18	WOS:000086757300001
J	PARDOLL, DM; BECKERLEG, AM				PARDOLL, DM; BECKERLEG, AM			EXPOSING THE IMMUNOLOGY OF NAKED DNA VACCINES	IMMUNITY			English	Article							DIRECT GENE-TRANSFER; IMMUNODEFICIENCY-VIRUS TYPE-1; IMMUNE-RESPONSES; PLASMID DNA; MUSCLE INVIVO; INTRAMUSCULAR INJECTION; IMMUNIZATION; INFLUENZA; PROTECTION; MICE				PARDOLL, DM (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205, USA.							BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; COX GJM, 1993, J VIROL, V67, P5664, DOI 10.1128/JVI.67.9.5664-5667.1993; DAVIS HL, 1993, HUM MOL GENET, V2, P1847, DOI 10.1093/hmg/2.11.1847; DAVIS HL, 1993, HUM GENE THER, V4, P151, DOI 10.1089/hum.1993.4.2-151; EISENBRAUN MD, 1993, DNA CELL BIOL, V12, P791, DOI 10.1089/dna.1993.12.791; FYNAN EF, 1993, DNA CELL BIOL, V12, P785, DOI 10.1089/dna.1993.12.785; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; ITO Y, 1960, VIROLOGY, V12, P596, DOI 10.1016/0042-6822(60)90182-3; JIAO SS, 1992, HUM GENE THER, V3, P21, DOI 10.1089/hum.1992.3.1-21; KOVACSOVICSBANK.M, 1995, SCIENCE, V267, P243; MALONE RW, 1994, J BIOL CHEM, V269, P29903; MANTHORPE M, 1993, HUM GENE THER, V4, P419, DOI 10.1089/hum.1993.4.4-419; MONTGOMERY DL, 1993, DNA CELL BIOL, V12, P777, DOI 10.1089/dna.1993.12.777; PRIGOZY T, 1993, SOMAT CELL MOLEC GEN, V19, P111, DOI 10.1007/BF01233527; RAZ E, 1994, P NATL ACAD SCI USA, V91, P9519, DOI 10.1073/pnas.91.20.9519; ROBINSON HL, 1993, VACCINE, V11, P957, DOI 10.1016/0264-410X(93)90385-B; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; VITADELLO M, 1994, HUM GENE THER, V5, P11, DOI 10.1089/hum.1994.5.1-11; WANG B, 1993, DNA CELL BIOL, V12, P799, DOI 10.1089/dna.1993.12.799; WANG B, 1993, P NATL ACAD SCI USA, V90, P4156, DOI 10.1073/pnas.90.9.4156; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; WOLFF JA, 1991, BIOTECHNIQUES, V11, P474; XIANG ZQ, 1995, IMMUNITY, V2, P129, DOI 10.1016/S1074-7613(95)80001-8; XIANG ZQ, 1994, VIROLOGY, V199, P132, DOI 10.1006/viro.1994.1105; YANKAUCKAS MA, 1993, DNA CELL BIOL, V12, P771, DOI 10.1089/dna.1993.12.771	27	239	278	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1995	3	2					165	169		10.1016/1074-7613(95)90085-3	http://dx.doi.org/10.1016/1074-7613(95)90085-3			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RR339	7648389	Bronze			2022-12-18	WOS:A1995RR33900001
J	JENKINS, MK				JENKINS, MK			THE UPS AND DOWNS OF T-CELL COSTIMULATION	IMMUNITY			English	Review							RECEPTOR OCCUPANCY; ANTIGEN; CD28				JENKINS, MK (corresponding author), UNIV MINNESOTA,SCH MED,DEPT MICROBIOL,MINNEAPOLIS,MN 55455, USA.		Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655				FRASER JD, 1993, IMMUNOL TODAY, V14, P357, DOI 10.1016/0167-5699(93)90236-E; GREEN JM, 1994, IMMUNITY, V1; INABA K, 1994, IN PRESS J EXP MED; JENKINS MK, 1990, J IMMUNOL, V144, P1585; JOHNSON JG, 1994, J IMMUNOL, V152, P429; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; LINSLEY PS, 1993, J IMMUNOL, V150, P3161; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; RONCHESE F, 1994, J EXP MED, V179, P809, DOI 10.1084/jem.179.3.809; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SOTHNA MP, 1994, IMMUNITY, V1, P415; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X	17	239	279	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1994	1	6					443	446		10.1016/1074-7613(94)90086-8	http://dx.doi.org/10.1016/1074-7613(94)90086-8			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK171	7534615				2022-12-18	WOS:A1994PK17100001
J	Vargas, FA; Furness, AJS; Solomon, I; Joshi, K; Mekkaoui, L; Lesko, MH; Rota, EM; Dahan, R; Georgiou, A; Sledzinska, A; Ben Aissa, A; Franz, D; Sunderland, MW; Wong, YNS; Henry, JY; O'Brien, T; Nicol, D; Challacombe, B; Beers, SA; Turajlic, S; Gore, M; Larkin, J; Swanton, C; Chester, KA; Pule, M; Ravetch, JV; Marafioti, T; Peggs, KS; Quezada, SA				Vargas, Frederick Arce; Furness, Andrew J. S.; Solomon, Isabelle; Joshi, Kroopa; Mekkaoui, Leila; Lesko, Marta H.; Rota, Enrique Miranda; Dahan, Rony; Georgiou, Andrew; Sledzinska, Anna; Ben Aissa, Assma; Franz, Dafne; Sunderland, Mariana Werner; Wong, Yien Ning Sophia; Henry, Jake Y.; O'Brien, Tim; Nicol, David; Challacombe, Ben; Beers, Stephen A.; Turajlic, Samra; Gore, Martin; Larkin, James; Swanton, Charles; Chester, Kerry A.; Pule, Martin; Ravetch, Jeffrey V.; Marafioti, Teresa; Peggs, Karl S.; Quezada, Sergio A.		Melanoma TRACERx Consortium; Renal TRACERx Consortium; Lung TRACERx Consortium	Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors	IMMUNITY			English	Article							LYMPHOCYTE-ASSOCIATED ANTIGEN-4; ANTITUMOR-ACTIVITY; MONOCLONAL-ANTIBODY; GAMMA-RS; EFFECTOR; CANCER; COMBINATION; VACCINE; MECHANISMS; AUTOIMMUNE	CD25 is expressed at high levels on regulatory T (Treg) cells and was initially proposed as a target for cancer immunotherapy. However, anti-CD25 antibodies have displayed limited activity against established tumors. We demonstrated that CD25 expression is largely restricted to tumor-infiltrating Treg cells in mice and humans. While existing anti-CD25 antibodies were observed to deplete Treg cells in the periphery, upregulation of the inhibitory Fc gamma receptor (Fc gamma R) IIb at the tumor site prevented intra-tumoral Treg cell depletion, which may underlie the lack of anti-tumor activity previously observed in pre-clinical models. Use of an anti-CD25 antibody with enhanced binding to activating Fc gamma Rs led to effective depletion of tumor-infiltrating Treg cells, increased effector to Treg cell ratios, and improved control of established tumors. Combination with anti-programmed cell death protein-1 antibodies promoted complete tumor rejection, demonstrating the relevance of CD25 as a therapeutic target and promising substrate for future combination approaches in immune-oncology.	[Vargas, Frederick Arce; Furness, Andrew J. S.; Solomon, Isabelle; Joshi, Kroopa; Lesko, Marta H.; Georgiou, Andrew; Sledzinska, Anna; Ben Aissa, Assma; Franz, Dafne; Sunderland, Mariana Werner; Wong, Yien Ning Sophia; Henry, Jake Y.; Peggs, Karl S.; Quezada, Sergio A.] UCL, Inst Canc, Canc Immunol Unit, London WC1E 6DD, England; [Vargas, Frederick Arce; Furness, Andrew J. S.; Solomon, Isabelle; Joshi, Kroopa; Lesko, Marta H.; Georgiou, Andrew; Sledzinska, Anna; Ben Aissa, Assma; Franz, Dafne; Sunderland, Mariana Werner; Wong, Yien Ning Sophia; Henry, Jake Y.; Pule, Martin; Peggs, Karl S.; Quezada, Sergio A.] UCL Canc Inst, Res Dept Haematol, London WC1E 6DD, England; [Furness, Andrew J. S.; Joshi, Kroopa; Nicol, David; Turajlic, Samra; Gore, Martin; Larkin, James] Royal Marsden NHS Fdn Trust, London SW3 6JJ, England; [Mekkaoui, Leila; Rota, Enrique Miranda; Chester, Kerry A.] UCL Canc Inst, Res Dept Oncol, London WC1E 6DD, England; [Dahan, Rony; Ravetch, Jeffrey V.] Rockefeller Univ, Leonard Wagner Lab Mol Genet & Immunol, New York, NY 10065 USA; [O'Brien, Tim; Challacombe, Ben] Guys & St Thomas NHS Fdn Trust, London SE1 9RT, England; [Beers, Stephen A.] Univ Southampton, Fac Med, Antibody & Vaccine Grp, Canc Sci Unit, Southampton SO17 1BJ, Hants, England; [Turajlic, Samra; Swanton, Charles] Francis Crick Inst, London NW1 1AT, England; [Swanton, Charles] UCL Canc Inst, Translat Canc Therapeut Lab, London WC1E 6DD, England; [Marafioti, Teresa] Univ Coll London Hosp, Dept Cellular Pathol, London NW1 2BU, England	University of London; University College London; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; University College London; Rockefeller University; Guy's & St Thomas' NHS Foundation Trust; University of Southampton; Francis Crick Institute; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Peggs, KS; Quezada, SA (corresponding author), UCL, Inst Canc, Canc Immunol Unit, London WC1E 6DD, England.; Peggs, KS; Quezada, SA (corresponding author), UCL Canc Inst, Res Dept Haematol, London WC1E 6DD, England.	k.peggs@ucl.ac.uk; s.quezada@ucl.ac.uk	Challacombe, Ben/AAM-9505-2020; Aerts, Hugo/ABF-2821-2020; Ravetch, Jeffrey/Z-1596-2019; Miranda, Enrique/AAD-4621-2020; Nicol, David L/M-6809-2016; Marafioti, Teresa/AAA-4652-2019; McGranahan, Nicholas/ABD-6561-2021; Marafioti, Teresa/B-4493-2009; Herrero, Javier/H-6971-2019; Quezada, Sergio/ABF-6466-2020; Smith, Myles JF/B-7803-2009; Chester, Kerry/AAE-2856-2020; Blackhall, Fiona/N-2186-2015; Ottensmeier, Christian/E-8131-2012	Challacombe, Ben/0000-0001-8631-0314; Aerts, Hugo/0000-0002-2122-2003; Ravetch, Jeffrey/0000-0003-2024-9041; Miranda, Enrique/0000-0003-3361-3957; Nicol, David L/0000-0002-5623-7467; Marafioti, Teresa/0000-0003-1223-6275; McGranahan, Nicholas/0000-0001-9537-4045; Marafioti, Teresa/0000-0003-1223-6275; Herrero, Javier/0000-0001-7313-717X; Quezada, Sergio/0000-0002-9763-1700; Smith, Myles JF/0000-0002-3254-4817; Chemi, Francesca/0000-0002-6652-5243; Larkin, James/0000-0001-5569-9523; Navani, Neal/0000-0002-6412-7516; Rothwell, Dominic/0000-0002-8757-3893; Lowe, Helen/0000-0001-8630-378X; Middleton, Gary/0000-0001-5695-3474; Mitter, Richard/0000-0002-1279-3760; Spain, Lavinia/0000-0002-9356-8812; Beers, Stephen/0000-0002-3765-3342; Escudero, Mickael/0000-0002-1336-815X; Nicol, David/0000-0003-0107-6990; Ben Aissa, Assma/0000-0002-8190-9683; Johnson, Diana/0000-0003-0479-1228; Birkbak, Nicolai/0000-0003-1613-9587; Le Quesne, John/0000-0003-3552-7446; Blackhall, Fiona/0000-0001-8716-3395; Shaw, Jacqui/0000-0003-4227-503X; Crosbie, Phil/0000-0001-8941-4813; Hynds, Robert/0000-0002-2170-8791; Dive, Caroline/0000-0002-1726-8850; Pule, Martin/0000-0002-8347-9867; Edwards, John/0000-0002-7935-5327; Strauss, Dirk/0000-0003-2413-0697; Lee, Siow Ming/0000-0002-1741-6235; Swanton, Charles/0000-0002-4299-3018; Xu, Hang/0000-0002-5847-655X; Edwards, Alison/0000-0002-9603-2618; De Sousa, Paulo/0000-0003-3011-4116; Thakrar, Ricky/0000-0001-9793-2223; Ottensmeier, Christian/0000-0003-3619-1657; Shackcloth, Michael/0000-0002-6494-9907; Oukrif, Dahmane/0000-0001-8645-158X; Solomon, Isabelle/0000-0003-3114-3760; Henry, Jake/0000-0003-0435-3308; turajlic, samra/0000-0001-8846-136X; Stone, Richard/0000-0001-8059-3800; Laycock, Joanne Louise/0000-0003-3005-1442; Janes, Sam/0000-0002-6634-5939; Mekkaoui, Leila/0000-0001-8640-840X; Hiley, Crispin/0000-0002-5869-0775; naidu, babu/0000-0003-1576-230X; Horswell, Stuart/0000-0003-2787-1933; Dahan, Rony/0000-0002-8420-7601	Cancer Research Institute; CRUK [C36463/A20764, C11496/A17786]; NIHR BTRU for Stem Cells and Immunotherapies [167097]; CRUK-UCL Centre [C416/A18088]; CRUK's Lung Cancer Centre of Excellence [C5759/A20465]; CRUK; Engineering and Physical Sciences Research Council at King's College London and UCL [C1519/A16463]; Cancer Immunotherapy Accelerator Award (CITA-CRUK) [C33499/A20265]; Sam Keen Foundation/RMH NIHR Biomedical Research Centre, Bloodwise [08022/P4664]; Department of Health; Cancer Research UK [19740, 18176, 20275, 17891, 20764, 22795, 20537, 23464, 15953, 20465, 20613, 15954, 12100, 19278, 15951, 20276, 22246, 16463] Funding Source: researchfish; Medical Research Council [MR/P024351/1] Funding Source: researchfish; National Institute for Health Research [CL-2015-17-002] Funding Source: researchfish; Versus Arthritis [20265, 18892] Funding Source: researchfish; The Francis Crick Institute [C50947/A18176, 10002] Funding Source: researchfish; MRC [MR/P024351/1] Funding Source: UKRI	Cancer Research Institute; CRUK(Cancer Research UK); NIHR BTRU for Stem Cells and Immunotherapies; CRUK-UCL Centre; CRUK's Lung Cancer Centre of Excellence; CRUK(Cancer Research UK); Engineering and Physical Sciences Research Council at King's College London and UCL; Cancer Immunotherapy Accelerator Award (CITA-CRUK); Sam Keen Foundation/RMH NIHR Biomedical Research Centre, Bloodwise; Department of Health; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Josep Linares for his technical expertise. S.A.Q. is a Cancer Research U.K. (CRUK) Senior Fellow (C36463/A22246) and is funded by a Cancer Research Institute Investigator Award and a CRUK Biotherapeutic Program Grant (C36463/A20764). K.S.P. receives funding from the NIHR BTRU for Stem Cells and Immunotherapies (167097), of which he is the Scientific Director. None of the animal work described was funded by NIHR. This work was undertaken at UCL Hospitals/UCL with support from the CRUK-UCL Centre (C416/A18088), CRUK's Lung Cancer Centre of Excellence (C5759/A20465), the CRUK and Engineering and Physical Sciences Research Council at King's College London and UCL (C1519/A16463), the Cancer Immunotherapy Accelerator Award (CITA-CRUK) (C33499/A20265), CRUK's Lung TRACERx study (led by C. Swanton) (C11496/A17786), the Sam Keen Foundation/RMH NIHR Biomedical Research Centre, Bloodwise (formerly Leukaemia and Lymphoma Research) (08022/P4664), the Department of Health, and CRUK funding schemes for National Institute for Health Research Biomedical Research Centres and Experimental Cancer Medicine Centres.	Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Bulliard Y, 2014, IMMUNOL CELL BIOL, V92, P475, DOI 10.1038/icb.2014.26; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Coe D, 2010, CANCER IMMUNOL IMMUN, V59, P1367, DOI 10.1007/s00262-010-0866-5; Dahan R, 2015, CANCER CELL, V28, P285, DOI 10.1016/j.ccell.2015.08.004; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Elpek KG, 2007, J IMMUNOL, V178, P6840, DOI 10.4049/jimmunol.178.11.6840; Goding SR, 2013, J IMMUNOL, V190, P4899, DOI 10.4049/jimmunol.1300271; Golgher D, 2002, EUR J IMMUNOL, V32, P3267, DOI 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1; Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105; Jacobs JFM, 2010, CLIN CANCER RES, V16, P5067, DOI 10.1158/1078-0432.CCR-10-1757; Jones Emma, 2002, Cancer Immun, V2, P1; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Luke JJ, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0140-2; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Onizuka S, 1999, CANCER RES, V59, P3128; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Quezada SA, 2008, J EXP MED, V205, P2125, DOI 10.1084/jem.20080099; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Rech AJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003330; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Shang B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15179; Shimizu J, 1999, J IMMUNOL, V163, P5211; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; van Elsas A, 2001, J EXP MED, V194, P481, DOI 10.1084/jem.194.4.481	30	238	249	3	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					577	586		10.1016/j.immuni.2017.03.013	http://dx.doi.org/10.1016/j.immuni.2017.03.013			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28410988	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000399451100011
J	Rabinovich, GA; Croci, DO				Rabinovich, Gabriel A.; Croci, Diego O.			Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer	IMMUNITY			English	Review							C-TYPE LECTIN; T-CELL APOPTOSIS; GALECTIN-8 INDUCES APOPTOSIS; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; CLASS-I; IMMUNE TOLERANCE; INNATE IMMUNITY; O-GLYCANS; DC-SIGN	Numerous regulatory programs have been identified that contribute to the restoration of homeostasis at the conclusion of immune responses and to safeguarding against the detrimental effects of chronic inflammation and autoimmune pathology. Malignant cells may usurp these pathways to create immunosuppressive networks that thwart antitumor responses. Herein we review the role of endogenous lectins (C-type lectins, siglecs, and galectins) and specific N- and O-glycans generated by the coordinated action of glycosyltransferases and glycosidases that together promote regulatory signals that control immune cell homeostasis. We also discuss the mechanisms by which glycan-dependent regulatory programs integrate into canonical circuits that amplify or silence immune responses related to autoimmunity and neoplastic disease.	[Rabinovich, Gabriel A.; Croci, Diego O.] Consejo Nacl Invest Cient & Tecn, IBYME, Lab Inmunopatol, RA-1033 Buenos Aires, DF, Argentina; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Rabinovich, GA (corresponding author), Consejo Nacl Invest Cient & Tecn, IBYME, Lab Inmunopatol, C1428, RA-1033 Buenos Aires, DF, Argentina.	gabyrabi@gmail.com	Croci, Diego/AAJ-5709-2021	Croci, Diego/0000-0002-8623-0645	National Multiple Sclerosis Society (USA); Mizutani Foundation for Glycoscience (Japan); Prostate Action (UK); National Agency for Promotion of Science and Technology (Argentina); University of Buenos Aires (Argentina); National Council of Scientific and Technical Investigations (CONICET, Argentina); Fundacion Sales (Argentina)	National Multiple Sclerosis Society (USA)(National Multiple Sclerosis Society); Mizutani Foundation for Glycoscience (Japan); Prostate Action (UK); National Agency for Promotion of Science and Technology (Argentina)(ANPCyT); University of Buenos Aires (Argentina)(University of Buenos Aires); National Council of Scientific and Technical Investigations (CONICET, Argentina); Fundacion Sales (Argentina)	We thank H. Rosenberg and J. Geffner for critical reading of the manuscript and all members of G.A.R.'s lab for discussion. Research in authors' laboratory is supported by grants from the National Multiple Sclerosis Society (USA), Mizutani Foundation for Glycoscience (Japan), Prostate Action (UK), National Agency for Promotion of Science and Technology (Argentina), University of Buenos Aires (Argentina), National Council of Scientific and Technical Investigations (CONICET, Argentina), and Fundacion Sales (Argentina).	Acosta-Rodriguez EV, 2004, J IMMUNOL, V172, P493, DOI 10.4049/jimmunol.172.1.493; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Antonopoulos A., 2012, J BIOL CHEM IN PRESS; Arikawa T, 2010, EUR J IMMUNOL, V40, P548, DOI 10.1002/eji.200939886; Banh A, 2011, CANCER RES, V71, P4423, DOI 10.1158/0008-5472.CAN-10-4157; Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Bax M, 2011, INFECT IMMUN, V79, P2681, DOI 10.1128/IAI.00009-11; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Bluestone JA, 2010, NAT REV IMMUNOL, V10, P797, DOI 10.1038/nri2869; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Cedeno-Laurent F., 2012, J IMMUNOL IN PRESS; Chavele KM, 2010, J CLIN INVEST, V120, P1469, DOI 10.1172/JCI41560; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen HY, 2009, P NATL ACAD SCI USA, V106, P14496, DOI 10.1073/pnas.0903497106; Chen HL, 2009, J BIOL CHEM, V284, P32454, DOI 10.1074/jbc.M109.023630; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Cummings R.D., 2009, ESSENTIALS GLYCOBIOL, P387; Dam TK, 2010, GLYCOBIOLOGY, V20, P1061, DOI 10.1093/glycob/cwq084; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Duong BH, 2010, J EXP MED, V207, P173, DOI 10.1084/jem.20091873; Earl LA, 2011, GLYCOBIOLOGY, V21, P6, DOI 10.1093/glycob/cwq144; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Espeli M, 2009, BLOOD, V113, P5878, DOI 10.1182/blood-2009-01-198465; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Fukumori T, 2003, CANCER RES, V63, P8302; Fulcher JA, 2009, J BIOL CHEM, V284, P26860, DOI 10.1074/jbc.M109.037507; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; Grigorian A, 2011, J BIOL CHEM, V286, P40133, DOI 10.1074/jbc.M111.277814; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Hokama A, 2004, IMMUNITY, V20, P681, DOI 10.1016/j.immuni.2004.05.009; Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x; Ideo H, 2011, J BIOL CHEM, V286, P11346, DOI 10.1074/jbc.M110.195925; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Ingrassia L, 2006, CURR MED CHEM, V13, P3513, DOI 10.2174/092986706779026219; Jellusova J, 2010, J IMMUNOL, V184, P3618, DOI 10.4049/jimmunol.0902711; Jiang HR, 2009, J IMMUNOL, V182, P1167, DOI 10.4049/jimmunol.182.2.1167; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Juszczynski P, 2007, P NATL ACAD SCI USA, V104, P13134, DOI 10.1073/pnas.0706017104; Karlsson A, 2009, GLYCOBIOLOGY, V19, P16, DOI 10.1093/glycob/cwn104; Kel J, 2007, AM J PATHOL, V170, P272, DOI 10.2353/ajpath.2007.060335; Kopcow HD, 2008, P NATL ACAD SCI USA, V105, P18472, DOI 10.1073/pnas.0809233105; Kreisman LSC, 2011, J BIOL CHEM, V286, P8810, DOI 10.1074/jbc.M110.206011; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Kuo PL, 2011, J IMMUNOL, V186, P1521, DOI 10.4049/jimmunol.1002940; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Li YR, 2011, MOL IMMUNOL, V48, P670, DOI 10.1016/j.molimm.2010.11.011; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181; Liu SD, 2009, J IMMUNOL, V182, P5283, DOI 10.4049/jimmunol.0803811; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Loser K, 2009, J IMMUNOL, V182, P5419, DOI 10.4049/jimmunol.0802308; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Matarrese P, 2005, J BIOL CHEM, V280, P6969, DOI 10.1074/jbc.M409752200; Meesmann HM, 2010, J CELL SCI, V123, P3347, DOI 10.1242/jcs.066696; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Mobergslien A, 2012, J LEUKOCYTE BIOL, V91, P461, DOI 10.1189/jlb.0711361; Motran CC, 2008, EUR J IMMUNOL, V38, P3015, DOI 10.1002/eji.200838295; Mourcin F, 2011, BLOOD, V117, P6552, DOI 10.1182/blood-2010-12-323113; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Nonaka M, 2008, J IMMUNOL, V180, P3347, DOI 10.4049/jimmunol.180.5.3347; Norambuena A, 2009, J BIOL CHEM, V284, P12670, DOI 10.1074/jbc.M808949200; Norling LV, 2008, FASEB J, V22, P682, DOI 10.1096/fj.07-9268com; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Paclik D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002629; Pang MB, 2009, J IMMUNOL, V182, P7001, DOI 10.4049/jimmunol.0804329; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Redelinghuys P, 2011, J BIOL CHEM, V286, P34522, DOI 10.1074/jbc.M111.243410; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Sabatte J, 2011, J IMMUNOL, V187, P5299, DOI 10.4049/jimmunol.1101889; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Seite JF, 2010, BLOOD, V116, P1698, DOI 10.1182/blood-2009-12-261461; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Singh SK, 2011, INT J CANCER, V128, P1371, DOI 10.1002/ijc.25458; Singh SK, 2011, EUR J IMMUNOL, V41, P916, DOI 10.1002/eji.201040762; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; Stanley P, 2009, IMMUNOL REV, V230, P201, DOI 10.1111/j.1600-065X.2009.00791.x; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Stowell SR, 2009, MOL BIOL CELL, V20, P1408, DOI 10.1091/mbc.E08-07-0786; Su EW, 2011, GLYCOBIOLOGY, V21, P1258, DOI 10.1093/glycob/cwq214; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Tang D, 2012, INT J CANCER, V130, P2337, DOI 10.1002/ijc.26290; Than NG, 2008, P NATL ACAD SCI USA, V105, P15819, DOI 10.1073/pnas.0807606105; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Toscano MA, 2006, J IMMUNOL, V176, P6323, DOI 10.4049/jimmunol.176.10.6323; Tribulatti MV, 2007, GLYCOBIOLOGY, V17, P1404, DOI 10.1093/glycob/cwm104; Tsuboi S, 2011, EMBO J, V30, P3173, DOI 10.1038/emboj.2011.215; Van Dyken SJ, 2007, MOL CELL BIOL, V27, P1096, DOI 10.1128/MCB.01750-06; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; Varki A, 2011, GLYCOBIOLOGY, V21, P1121, DOI 10.1093/glycob/cwr087; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Wang F, 2009, IMMUNOBIOLOGY, V214, P342, DOI 10.1016/j.imbio.2008.10.007; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Wu GS, 2011, DIABETES, V60, P2341, DOI 10.2337/db10-1309; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhou YF, 2010, NAT MED, V16, P1128, DOI 10.1038/nm.2201; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	126	238	244	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 23	2012	36	3					322	335		10.1016/j.immuni.2012.03.004	http://dx.doi.org/10.1016/j.immuni.2012.03.004			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22444630	Bronze, Green Published			2022-12-18	WOS:000302048400006
J	Kurata, H; Lee, HJ; O'Garra, A; Arai, N				Kurata, H; Lee, HJ; O'Garra, A; Arai, N			Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells	IMMUNITY			English	Article							T-CELLS; GENE-EXPRESSION; IL-4 RECEPTOR; FACTOR GATA-3; CUTTING EDGE; IFN-GAMMA; PROTEINS; DIFFERENTIATION; T-HELPER-1; RESPONSES	Stat6 is critical for IL-4-mediated Th2 cell development, but its molecular mechanism remains unclear. Here we constructed Stat6:ER, a Stat6-estrogen receptor fusion protein that can be activated by 4-hydroxytamoxifen, independently of IL-4 and endogenous state. Retrovirus-mediated introduction of Stat6:ER into developing Th1 cells induced Th2-specific cytokines and suppressed IFN gamma production in a 4-HT-dependent manner and in the absence of IL-4. It also induced GATA-3 and c-maf expression and downregulated IL-12R beta 2 chain expression. Its decreased ability to induce the Th2 phenotype with progressing Th1 cell commitment correlated with a decreased induction of GATA-3 and c-maf. This study indicates that state functions upstream of GATA-3 and c-Maf to induce Th2 development.	DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA 94304 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Arai, N (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, 901 Calif Ave, Palo Alto, CA 94304 USA.			O'Garra, Anne/0000-0001-9845-6134				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 1998, CURR OPIN IMMUNOL, V10, P345, DOI 10.1016/S0952-7915(98)80174-X; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Ferber IA, 1999, CLIN IMMUNOL, V91, P134, DOI 10.1006/clim.1999.4718; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; HO LC, 1996, CELL, V85, P973; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huang H, 1998, J EXP MED, V187, P1305, DOI 10.1084/jem.187.8.1305; Huang H, 1997, J IMMUNOL, V159, P3731; Kamogawa Y, 1998, J IMMUNOL, V161, P1074; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1998, MOL CELL BIOL, V18, P1996, DOI 10.1128/MCB.18.4.1996; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; Kotanides H, 1996, J BIOL CHEM, V271, P25555, DOI 10.1074/jbc.271.41.25555; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lederer JA, 1996, J EXP MED, V184, P397, DOI 10.1084/jem.184.2.397; Lee HJ, 1998, J IMMUNOL, V160, P2343; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lu BF, 1997, J IMMUNOL, V159, P1255; MIKITA T, 1996, MOL CELL BIOL, V16, P581; Moriggl R, 1997, MOL CELL BIOL, V17, P3663, DOI 10.1128/MCB.17.7.3663; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Murphy KM, 1999, CURR TOP MICROBIOL, V238, P13; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nakamura T, 1997, J IMMUNOL, V158, P2648; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Onishi M, 1996, EXP HEMATOL, V24, P324; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; PRITCHARD CA, 1995, MOL CELL BIOL, V15, P6430; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; Range LM, 1998, J PERS INTERPERS LOS, V3, P161, DOI 10.1080/10811449808414438; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Ryan JJ, 1996, IMMUNITY, V4, P123, DOI 10.1016/S1074-7613(00)80677-9; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; SWAIN SL, 1990, J IMMUNOL, V145, P3796; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Wang HY, 1996, IMMUNITY, V4, P113, DOI 10.1016/S1074-7613(00)80676-7; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Zamorano J, 1998, J IMMUNOL, V161, P859; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	58	238	241	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1999	11	6					677	688		10.1016/S1074-7613(00)80142-9	http://dx.doi.org/10.1016/S1074-7613(00)80142-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626890	Bronze			2022-12-18	WOS:000084612900004
J	Moran, M; Miceli, MC				Moran, M; Miceli, MC			Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: A role for lipid rafts in T cell activation	IMMUNITY			English	Article							PROTEIN TYROSINE KINASES; RECEPTOR ZETA-CHAIN; ACTIN CYTOSKELETON; ANCHORED PROTEINS; MEMBRANE DOMAINS; SURFACE MOLECULES; HUMAN-LYMPHOCYTES; CD2 ANTIGEN; CHOLESTEROL; CAVEOLAE	GPI-linked proteins coassociate with intracellular tyrosine kinases in "lipid rafts" proposed to function as platforms for signal transduction and cytoskeletal reorganization. TCR activation requires both tyrosine kinase signals and cytoskeletal reorganization. How receptor engagement initiates cytoskeletal changes remains poorly understood. We investigated the consequences of recruiting GPI-linked CD48 and associated rafts to the site of T cell:APC contact by stimulating T cells with APCs that express the CD48 ligand CD2. We demonstrate that CD2:CD48 interactions enhance TCR-mediated functions. CD48/TCR coengagement qualitatively and quantitatively enhances lipid raft-dependent 5 association with the actin cytoskeleton and 5 tyrosine phosphorylation. This implicates lipid rafts as sites where receptor-induced signals and cytoskeletal reorganization are integrated and reveals a novel component of accessory molecule function.	Univ Calif Los Angeles, Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Miceli, MC (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.				NCI NIH HHS [R29 CA-65979-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA065979] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; ALTEVOGT P, 1989, EUR J IMMUNOL, V19, P1509, DOI 10.1002/eji.1830190826; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; BROWN D, 1993, CURR OPIN IMMUNOL, V5, P349, DOI 10.1016/0952-7915(93)90052-T; CAPLAN S, 1995, P NATL ACAD SCI USA, V92, P4768, DOI 10.1073/pnas.92.11.4768; Cerny J, 1996, EUR J IMMUNOL, V26, P2335, DOI 10.1002/eji.1830261010; Chung CD, 1997, J IMMUNOL, V159, P1758; CINEK T, 1992, J IMMUNOL, V149, P2262; Deckert M, 1996, J CELL BIOL, V133, P791, DOI 10.1083/jcb.133.4.791; DECKERT M, 1995, EUR J IMMUNOL, V25, P1815, DOI 10.1002/eji.1830250704; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; GEPPERT TD, 1991, J IMMUNOL, V146, P3298; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; KATO K, 1992, J EXP MED, V176, P1241, DOI 10.1084/jem.176.5.1241; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; LaFace DM, 1997, J IMMUNOL, V158, P2057; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; MASCHEK BJ, 1993, J IMMUNOL, V150, P3198; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; NEL AE, 1995, J BIOL CHEM, V270, P18428, DOI 10.1074/jbc.270.31.18428; NEUMEISTERKERSH E, 1998, SCIENCE, V281, P572; REINHERZ EL, 1980, CELL, V19, P821, DOI 10.1016/0092-8674(80)90072-0; REISER H, 1990, J IMMUNOL, V145, P2077; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Romagnoli P, 1997, J IMMUNOL, V158, P5757; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; SCHUBERT J, 1995, CLIN EXP IMMUNOL, V102, P199; SEWELL WA, 1987, EUR J IMMUNOL, V17, P1015, DOI 10.1002/eji.1830170718; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; YAGITA H, 1989, P NATL ACAD SCI USA, V86, P645, DOI 10.1073/pnas.86.2.645; YEH ETH, 1988, CELL, V52, P665, DOI 10.1016/0092-8674(88)90404-7; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	42	238	258	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1998	9	6					787	796		10.1016/S1074-7613(00)80644-5	http://dx.doi.org/10.1016/S1074-7613(00)80644-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881969	Bronze			2022-12-18	WOS:000077836600004
J	Bomsel, M; Heyman, M; Hocini, H; Lagaye, S; Belec, L; Dupont, C; Desgranges, C				Bomsel, M; Heyman, M; Hocini, H; Lagaye, S; Belec, L; Dupont, C; Desgranges, C			Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COWS MILK ALLERGY; MONOCLONAL-ANTIBODIES; POLYMERIC IGA; SECRETORY IGA; MDCK CELLS; RECEPTOR; GP41; IMMUNIZATION; TRANSMISSION	Human immunodeficiency virus, generated during contact between HIV-infected cells and the apical surface of an epithelial cell, can cross a tight epithelial barrier by transcytosis. We show that transcytosis of primary HIV isolates is blocked by dimeric IgA or IgM against HIV envelope proteins. Neutralization occurs intracellularly within the apical recycling endosome, and immune complexes are specifically recycled to the mucosal surface. One epitope involved in neutralization is a conserved sequence of the gp41 HIV envelope protein subunit. Finally, transcytosis also occurs across functional human mucosal tissue in a process inhibited by a serosal internalization of IgM against the HIV envelope protein. These results suggest that induction of mucosal immunity to HIV envelope proteins may impair the transcytotic route of HIV mucosal transmission.	ICGM, INSERM, U332, F-75014 Paris, France; Fac Necker Enfants Malad, INSERM, CJF 98X, F-75730 Paris, France; Hop Broussais, INSERM, U430, F-75014 Paris, France; Inst Pasteur, F-75015 Paris, France; Hop St Vincent de Paul, F-74014 Paris, France; INSERM, U271, F-69424 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bomsel, M (corresponding author), ICGM, INSERM, U332, F-75014 Paris, France.	bomsel@lovelace.infobiogen.fr	Bomsel, Morgane/GSN-1948-2022	Bomsel, Morgane/0000-0002-9577-7474				ABRAHAMSON DR, 1981, J CELL BIOL, V91, P270, DOI 10.1083/jcb.91.1.270; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; BALL JM, 1995, IN VITRO CELL DEV-AN, V31, P196; BELEC L, 1995, CLIN EXP IMMUNOL, V101, P100; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; Brandtzaeg P, 1997, Behring Inst Mitt, P1; BRANDTZAEG P, 1997, REPROD IMMUNOL, V36, P23; BROWN WR, 1976, GASTROENTEROLOGY, V71, P985; BUKAWA H, 1995, NAT MED, V1, P681, DOI 10.1038/nm0795-681; Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104; Calarota S, 1996, AIDS RES HUM RETROV, V12, P705, DOI 10.1089/aid.1996.12.705; CastelloBranco LRR, 1996, MEM I OSWALDO CRUZ, V91, P363, DOI 10.1590/S0074-02761996000300021; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; Denning GM, 1996, J IMMUNOL, V156, P4807; EBERSOLD A, 1992, RES VIROLOGY, V143, P179, DOI 10.1016/S0923-2516(06)80102-0; Fantini J, 1997, AIDS, V11, P1663; FRAISIER C, 1995, RES VIROLOGY, V146, P201, DOI 10.1016/0923-2516(96)80580-2; FRAISIER C, 1994, J IMMUNOL METHODS, V176, P9, DOI 10.1016/0022-1759(94)90346-8; Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045; HEYMAN M, 1988, PEDIATR RES, V24, P197, DOI 10.1203/00006450-198808000-00012; Hocini H, 1997, AIDS RES HUM RETROV, V13, P1179, DOI 10.1089/aid.1997.13.1179; Lehner T, 1996, NAT MED, V2, P767, DOI 10.1038/nm0796-767; LIMET JN, 1985, EUR J BIOCHEM, V146, P539, DOI 10.1111/j.1432-1033.1985.tb08685.x; MAZANEC MB, 1993, IMMUNOL TODAY, V14, P430, DOI 10.1016/0167-5699(93)90245-G; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MOSTOV K, 1996, IN PRESS HDB MUCOSAL; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; NICOLOSI A, 1994, J ACQ IMMUN DEF SYND, V7, P296; Odorizzi G, 1996, J CELL BIOL, V135, P139, DOI 10.1083/jcb.135.1.139; Olivotto M, 1996, BIOESSAYS, V18, P495, DOI 10.1002/bies.950180612; Ortega D, 1998, J CELL SCI, V111, P261; PHILLIPS DM, 1994, AIDS, V8, P719, DOI 10.1097/00002030-199406000-00001; Purtscher M, 1996, AIDS, V10, P587, DOI 10.1097/00002030-199606000-00003; SAIDI D, 1995, CR ACAD SCI III-VIE, V318, P683; SCARLATTI G, 1991, AIDS, V5, P1173, DOI 10.1097/00002030-199110000-00003; SONG WX, 1994, P NATL ACAD SCI USA, V91, P163, DOI 10.1073/pnas.91.1.163; SONG WX, 1994, J BIOL CHEM, V269, P29474; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; TAMER CM, 1995, J IMMUNOL, V155, P707; TURPIN E, 1998, BIOCHIM BIOPHYS ACTA, V1402, P114; VANDEPERRE P, 1994, AIDS RES HUM RETROV, V10, P517, DOI 10.1089/aid.1994.10.517; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039	45	238	248	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1998	9	2					277	287		10.1016/S1074-7613(00)80610-X	http://dx.doi.org/10.1016/S1074-7613(00)80610-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729048	Bronze			2022-12-18	WOS:000075610300014
J	Meadows, L; Wang, W; denHaan, JMM; Blokland, E; Reinhardus, C; Drijfhout, JW; Shabanowitz, J; Pierce, R; Agulnik, AI; Bishop, CE; Hunt, DF; Goulmy, E; Engelhard, VH				Meadows, L; Wang, W; denHaan, JMM; Blokland, E; Reinhardus, C; Drijfhout, JW; Shabanowitz, J; Pierce, R; Agulnik, AI; Bishop, CE; Hunt, DF; Goulmy, E; Engelhard, VH			The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition	IMMUNITY			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; ESCAPES X-INACTIVATION; MHC MOLECULE HLA-A2.1; PEPTIDE-BINDING; LYMPHOCYTE-T; MASS-SPECTROMETRY; HYA LOCUS; LONG ARM; IDENTIFICATION; CHROMOSOME	A peptide recognized by two cytotoxic T cell clones specific for the human minor histocompatibility antigen H-Y and restricted by HLA-A*0201 was identified. This peptide originates from SMCY, as do two other H-Y epitopes, supporting the importance of this protein as a major source of H-Y determinants in mice and humans. In naturally processed peptides, T cells only recognize posttranslationally altered forms of this peptide that have undergone modification of a cysteine residue in the seventh position. One of these modifications involves attachment of a second cysteine residue via a disulfide bond. This modification has profound effects on T cell recognition and also occurs In other class I MHC-associated peptides, supporting its general importance as an immunological determinant.	UNIV VIRGINIA,DEPT CHEM,CHARLOTTESVILLE,VA 22901; UNIV VIRGINIA,DEPT MICROBIOL,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,BEIRNE CARTER CTR IMMUNOL RES,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,DEPT PATHOL,CHARLOTTESVILLE,VA 22908; LEIDEN UNIV HOSP,DEPT IMMUNOHAEMATOL,NL-2333 AA LEIDEN,NETHERLANDS; LEIDEN UNIV HOSP,BLOOD BANK,NL-2333 AA LEIDEN,NETHERLANDS; BAYLOR COLL MED,DEPT OBSTET & GYNECOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT HUMAN & MOL GENET,HOUSTON,TX 77030	University of Virginia; University of Virginia; University of Virginia; University of Virginia; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Baylor College of Medicine; Baylor College of Medicine			Agoulnik, Alexander/AAK-3213-2020; den Haan, Joke MM/A-4281-2010; Drijfhout, Jan Wouter/ABA-6318-2021; Hunt, Donald F/I-6936-2012	Agoulnik, Alexander/0000-0001-6587-6845; den Haan, Joke MM/0000-0002-4421-6917; Drijfhout, Jan Wouter/0000-0003-4808-5296; Hunt, Donald F/0000-0003-2815-6368; Engelhard, Victor/0000-0002-1741-0925	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033993, R37AI020963, R01AI033993, R01AI020963] Funding Source: NIH RePORTER; NIAID NIH HHS [AI0746, AI20963, AI33993] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGULNIK AI, 1994, HUM MOL GENET, V3, P873, DOI 10.1093/hmg/3.6.873; AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; CANTRELL MA, 1992, GENOMICS, V13, P1255, DOI 10.1016/0888-7543(92)90043-R; CHEN Y, 1994, J IMMUNOL, V152, P2874; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; DAMARO J, 1995, HUM IMMUNOL, V43, P13, DOI 10.1016/0198-8859(94)00153-H; DEBUEGER M, 1992, EUR J IMMUNOL, V22, P875, DOI 10.1002/eji.1830220338; DEBUEGER M, 1992, J IMMUNOL, V149, P1788; DEBUEGER M, 1993, EUR J IMMUNOL, V23, P614, DOI 10.1002/eji.1830230305; DENHAAN JMM, 1995, SCIENCE, V268, P1476, DOI 10.1126/science.7539551; DRIJFHOUT JW, 1995, HUM IMMUNOL, V43, P1, DOI 10.1016/0198-8859(94)00151-F; EICHWALD EJ, 1955, TRANSPLAN B, V2, P148; ENGELHARD VH, 1994, CURR OPIN IMMUNOL, V6, P13, DOI 10.1016/0952-7915(94)90028-0; GOULMY E, 1976, LANCET, V2, P1206; GOULMY E, 1977, NATURE, V266, P544, DOI 10.1038/266544a0; Goulmy E, 1996, CURR OPIN IMMUNOL, V8, P75, DOI 10.1016/S0952-7915(96)80108-7; GOULMY E, 1988, TRANSPLANT REV, V2, P29, DOI DOI 10.1016/S0955-470X(88)80005-3; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Gulden PH, 1996, IMMUNITY, V5, P73, DOI 10.1016/S1074-7613(00)80311-8; HENDERSON RA, 1993, P NATL ACAD SCI USA, V90, P10275, DOI 10.1073/pnas.90.21.10275; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; HUNT DF, 1986, P NATL ACAD SCI USA, V83, P6233, DOI 10.1073/pnas.83.17.6233; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; KING TR, 1994, GENOMICS, V24, P159, DOI 10.1006/geno.1994.1593; MICHAELSSON E, 1994, J EXP MED, V180, P745, DOI 10.1084/jem.180.2.745; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MORRISON LA, 1986, J EXP MED, V163, P903, DOI 10.1084/jem.163.4.903; O'Reilly Amanda, 1992, Human Molecular Genetics, V1, P379, DOI 10.1093/hmg/1.6.379; ROTZSCHKE O, 1990, SCIENCE, V249, P283, DOI 10.1126/science.1695760; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; SETTE A, 1994, MOL IMMUNOL, V31, P813, DOI 10.1016/0161-5890(94)90019-1; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; Veronese FD, 1996, J EXP MED, V183, P2509, DOI 10.1084/jem.183.6.2509; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; WOLFEL T, 1994, EUR J IMMUNOL, V24, P759, DOI 10.1002/eji.1830240340; WU JS, 1994, NAT GENET, V7, P491, DOI 10.1038/ng0894-491; WU JS, 1994, HUM MOL GENET, V3, P153, DOI 10.1093/hmg/3.1.153	40	238	244	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1997	6	3					273	281		10.1016/S1074-7613(00)80330-1	http://dx.doi.org/10.1016/S1074-7613(00)80330-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075928	Green Published, Bronze			2022-12-18	WOS:A1997XC61800007
J	Laidlaw, BJ; Zhang, NZ; Marshall, HD; Staron, MM; Guan, TX; Hu, YH; Cauley, LS; Craft, J; Kaech, SM				Laidlaw, Brian J.; Zhang, Nianzhi; Marshall, Heather D.; Staron, Mathew M.; Guan, Tianxia; Hu, Yinghong; Cauley, Linda S.; Craft, Joe; Kaech, Susan M.			CD4(+) T Cell Help Guides Formation of CD103(+) Lung-Resident Memory CD8(+) T Cells during Influenza Viral Infection	IMMUNITY			English	Article							CROSS-PROTECTIVE IMMUNITY; VIRUS-INFECTION; CUTTING EDGE; NONLYMPHOID TISSUE; UNITED-STATES; A VIRUS; DIFFERENTIATION; EXPRESSION; MICE; BET	Tissue-resident memory T (Trm) cells provide enhanced protection against infection at mucosal sites. Here we found that CD4(+) T cells are important for the formation of functional lung-resident CD8(+) T cells after influenza virus infection. In the absence of CD4(+) T cells, CD8(+) T cells displayed reduced expression of CD103 (Itgae), were mislocalized away from airway epithelia, and demonstrated an impaired ability to recruit CD8(+) T cells to the lung airways upon heterosubtypic challenge. CD4(+) T cellderived interferon-gamma was necessary for generating lung-resident CD103(+) CD8(+) Trm cells. Furthermore, expression of the transcription factor T-bet was increased in "unhelped" lung Trm cells, and a reduction in T-bet rescued CD103 expression in the absence of CD4(+) T cell help. Thus, CD4(+) T cell-dependent signals are important to limit expression of T-bet and allow for the development of CD103(+) CD8(+) Trm cells in the lung airways following respiratory infection.	[Laidlaw, Brian J.; Zhang, Nianzhi; Marshall, Heather D.; Staron, Mathew M.; Guan, Tianxia; Craft, Joe; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Craft, Joe] Yale Univ, Sch Med, Dept Internal Med Rheumatol, New Haven, CT 06520 USA; [Zhang, Nianzhi] China Agr Univ, Dept Microbiol & Immunol, Coll Vet Med, Beijing 100094, Peoples R China; [Hu, Yinghong; Cauley, Linda S.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA; [Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; China Agricultural University; University of Connecticut; Howard Hughes Medical Institute	Craft, J (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	joseph.craft@yale.edu; susan.kaech@yale.edu	Guan, Tianxia/B-5559-2017; Hu, Yinghong/P-6305-2017	Guan, Tianxia/0000-0001-6187-5431; Hu, Yinghong/0000-0001-9714-8957	NIH [RO1AI066232, R01AI074699, R01AR40072, P30AR053495, R21AR063942, T32AI07019, F31AG07777]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066232, T32AI007019, R37AI066232, R01AI074699, P01AI056172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040072, R37AR040072, R21AR063942, P30AR053495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG047777] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to acknowledge all members of the Kaech and Craft laboratories for helpful discussions and critical reading of the manuscript. This work was supported by grants from the NIH (RO1AI066232 [S.M.K.], R01AI074699 [S.M.K.], R01AR40072 [J.C.], P30AR053495 [J.C.], R21AR063942 [J.C.], T32AI07019 [B.J.L.]), F31AG07777 [B.J.L.], and the Howard Hughes Medical Institute [S.M.K., B.J.L.]).	Anderson KG, 2012, J IMMUNOL, V189, P2702, DOI 10.4049/jimmunol.1201682; Ballesteros-Tato A, 2013, J EXP MED, V210, P1591, DOI 10.1084/jem.20130097; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Epstein SL, 2010, EXPERT REV VACCINES, V9, P1325, DOI [10.1586/erv.10.123, 10.1586/ERV.10.123]; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Kumamoto Y, 2011, P NATL ACAD SCI USA, V108, P8749, DOI 10.1073/pnas.1100567108; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; Mokrani M, 2014, J IMMUNOL, V192, P2471, DOI 10.4049/jimmunol.1302192; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Piet B, 2011, J CLIN INVEST, V121, P2254, DOI 10.1172/JCI44675; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Slutter B, 2013, J IMMUNOL, V190, P3854, DOI 10.4049/jimmunol.1202790; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun K, 2011, J IMMUNOL, V186, P987, DOI 10.4049/jimmunol.1002664; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019	47	237	244	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					633	645		10.1016/j.immuni.2014.09.007	http://dx.doi.org/10.1016/j.immuni.2014.09.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25308332	Green Accepted, Bronze			2022-12-18	WOS:000345504300016
J	Carroll, MC; Isenman, DE				Carroll, Michael C.; Isenman, David E.			Regulation of Humoral Immunity by Complement	IMMUNITY			English	Review							FOLLICULAR DENDRITIC CELLS; SUBCAPSULAR SINUS MACROPHAGES; EPSTEIN-BARR-VIRUS; RECEPTOR 2; B-CELLS; CRYSTAL-STRUCTURE; GERMINAL-CENTERS; BINDING PROTEIN; ANTIGEN; C3D	The complement system of innate immunity is important in regulating humoral immunity largely through the complement receptor CR2, which forms a coreceptor on B cells during antigen-induced activation. However, CR2 also retains antigens on follicular dendritic cells (FDCs). Display of antigen on FDCs is critical for clonal selection and affinity maturation of activated B cells. This review will discuss the role of complement in adaptive immunity in general with a focus on the interplay between CR2-associated antigen on B cells with CR2 expressed on FDCs. This latter interaction provides an opportunity for memory B cells to sample antigen over prolonged periods. The cocrystal structure of CR2 with its ligand C3d provides insight into how the complement system regulates access of antigen by B cells with implications for therapeutic manipulations to modulate aberrant B cell responses in the case of autoimmunity.	[Carroll, Michael C.] Harvard Univ, Childrens Hosp, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Carroll, Michael C.] Harvard Univ, Childrens Hosp, Sch Med, Program Mol & Cellular Med, Boston, MA 02115 USA; [Carroll, Michael C.] Harvard Univ, Dept Pediat, Sch Med, Boston, MA 02115 USA; [Isenman, David E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Isenman, David E.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Toronto; University of Toronto	Carroll, MC (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	carroll@idi.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039246] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI039246] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alcorlo M, 2011, P NATL ACAD SCI USA, V108, P13236, DOI 10.1073/pnas.1106746108; Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567; Barrault DV, 2005, J IMMUNOL METHODS, V304, P158, DOI 10.1016/j.jim.2005.07.013; Boes M, 1998, J IMMUNOL, V160, P4776; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; CAREL JC, 1990, J BIOL CHEM, V265, P12293; Carroll M C, 2000, Adv Immunol, V74, P61; Carroll MC, 2004, MOL IMMUNOL, V41, P141, DOI 10.1016/j.molimm.2004.03.017; Cherukuri A, 2001, J IMMUNOL, V167, P163, DOI 10.4049/jimmunol.167.1.163; Clark EA, 2011, MOL IMMUNOL, V48, P452, DOI 10.1016/j.molimm.2010.09.017; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; Cyster JG, 2000, IMMUNOL REV, V176, P181; Degn SE, 2007, IMMUNOBIOLOGY, V212, P301, DOI 10.1016/j.imbio.2006.12.004; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; El Shikh ME, 2006, EUR J IMMUNOL, V36, P2715, DOI 10.1002/eji.200636122; Fang YF, 1998, J IMMUNOL, V160, P5273; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Fischer MB, 1996, J IMMUNOL, V157, P549; Fischer MB, 1998, SCIENCE, V280, P582, DOI 10.1126/science.280.5363.582; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Gommerman JL, 2002, J CLIN INVEST, V110, P1359, DOI 10.1172/JCI200215975; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Gonzalez SF, 2011, ANNU REV IMMUNOL, V29, P215, DOI 10.1146/annurev-immunol-031210-101255; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Gonzalez SF, 2008, VACCINE, V26, pI86, DOI 10.1016/j.vaccine.2008.11.057; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; GUSTAVSSON S, 1995, J IMMUNOL, V154, P6524; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; HANNA MG, 1968, J IMMUNOL, V101, P949; Isenman DE, 2010, J IMMUNOL, V184, P1946, DOI 10.4049/jimmunol.0902919; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; KALLI KR, 1991, J IMMUNOL, V147, P590; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; McCloskey ML, 2011, J EXP MED, V208, P135, DOI 10.1084/jem.20100354; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Nielsen CH, 2002, J LEUKOCYTE BIOL, V72, P249; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; NOSSAL GJV, 1968, J EXP MED, V127, P277, DOI 10.1084/jem.127.2.277; Pekkarinen PT, 2011, IMMUNOBIOLOGY, V216, P737, DOI 10.1016/j.imbio.2010.10.004; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rickert RC, 2005, CURR OPIN IMMUNOL, V17, P237, DOI 10.1016/j.coi.2005.03.001; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Szakal A K, 1988, Adv Exp Med Biol, V237, P197; SZAKAL AK, 1989, ANNU REV IMMUNOL, V7, P91, DOI 10.1146/annurev.immunol.7.1.91; Szakonyi G, 2001, SCIENCE, V292, P1725, DOI 10.1126/science.1059118; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Upadhyay A, 2008, J BIOL CHEM, V283, P22113, DOI 10.1074/jbc.M802636200; van den Elsen JMH, 2011, SCIENCE, V332, P608, DOI 10.1126/science.1201954; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Wang LS, 2004, J VIROL, V78, P1616, DOI 10.1128/JVI.78.4.1616-1622.2004; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Wang XL, 2004, J REPROD IMMUNOL, V63, P97, DOI 10.1016/j.jri.2004.04.004; Weaver DJ, 2010, EUR J IMMUNOL, V40, P710, DOI 10.1002/eji.200939333; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041	73	237	241	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 24	2012	37	2					199	207		10.1016/j.immuni.2012.08.002	http://dx.doi.org/10.1016/j.immuni.2012.08.002			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22921118	Green Accepted, Bronze			2022-12-18	WOS:000308261800006
J	Pacholczyk, R; Ignatowicz, H; Kraj, P; Ignatowicz, L				Pacholczyk, Rafal; Ignatowicz, Hanna; Kraj, Piotr; Ignatowicz, Leszek			Origin and T cell receptor diversity of Foxo3(+)CD4(+)CD25(+) T cells	IMMUNITY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; REGULATORY CELLS; THYMIC SELECTION; BETA; SPECIFICITY; REPERTOIRES; INDUCTION; PEPTIDES; INCREASE; COMPLEX	Foxp3(+)CD4(+)CD25(+) regulatory T cells can differentiate from Foxp3(-)CD4(+) medullary thymocytes and Foxp3(-)CD4(+) naive T cells. However, the impact of these two processes on size and composition of the peripheral repertoire of regulatory T cells is unclear. Here we followed the fate of individual Foxp3(+)CD4(+)CD25(+) thymocytes and T cells in vivo in T cell receptor (TCR) transgenic mice that express a restricted but polyclonal repertoire of TCRs. By utilizing high-throughput single-cell analysis, we showed that Foxp3(+)CD4(+) peripheral T cells were derived from thymic precursors that expressed a different TCRs than Foxp3(-)CD4(+) medullary thymocytes and Foxp3(-)CD4(+) T cells. Furthermore, the diversity of TCRs on Foxp3(+)CD4(+) regulatory T cells exceeded the diversity of TCRs on Foxp3(-)CD4(+) naive T cells, even in mice that lack expression of tissue-specific antigens. Our results imply that higher TCR diversity on Foxp3(+) regulatory T cells helps these cells to match the specificities of autoreactive and naive T cells.	Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Ignatowicz, L (corresponding author), Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	lignatowicz@mcg.edu			NATIONAL CANCER INSTITUTE [R01CA107349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041145] Funding Source: NIH RePORTER; NCI NIH HHS [1 R01 CA107349-01A1] Funding Source: Medline; NIAID NIH HHS [AI041145-07A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Baron V, 2003, IMMUNITY, V18, P193, DOI 10.1016/S1074-7613(03)00020-7; Barton GM, 2002, P NATL ACAD SCI USA, V99, P6937, DOI 10.1073/pnas.102645699; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cong YZ, 2002, J IMMUNOL, V169, P6112, DOI 10.4049/jimmunol.169.11.6112; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Dyson PJ, 1999, EUR J IMMUNOL, V29, P1456, DOI 10.1002/(SICI)1521-4141(199905)29:05<1456::AID-IMMU1456>3.0.CO;2-D; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fujishima M, 2005, IMMUNOL LETT, V99, P193, DOI 10.1016/j.imlet.2005.02.011; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kasow KA, 2004, J IMMUNOL, V172, P6123, DOI 10.4049/jimmunol.172.10.6123; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kraj P, 2001, J IMMUNOL, V166, P2251, DOI 10.4049/jimmunol.166.4.2251; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; LEE SM, 1994, BIOMETRICS, V50, P88, DOI 10.2307/2533199; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Pacholczyk R, 2002, J IMMUNOL, V168, P613, DOI 10.4049/jimmunol.168.2.613; Pacholczyk R, 2001, J IMMUNOL, V166, P2357, DOI 10.4049/jimmunol.166.4.2357; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; Schwartz RH, 2005, NAT IMMUNOL, V6, P327, DOI 10.1038/ni1184; Seddon B, 1999, J EXP MED, V189, P279, DOI 10.1084/jem.189.2.279; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Taylor PA, 2001, J EXP MED, V193, P1311, DOI 10.1084/jem.193.11.1311; Thompson C, 2004, CURR OPIN PHARMACOL, V4, P408, DOI 10.1016/j.coph.2004.05.001; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	47	237	244	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2006	25	2					249	259		10.1016/j.immuni.2006.05.016	http://dx.doi.org/10.1016/j.immuni.2006.05.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16879995	Bronze			2022-12-18	WOS:000240047500011
J	Trowsdale, J				Trowsdale, J			Genetic and functional relationships between MHC and NK receptor genes	IMMUNITY			English	Review							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; INHIBITORY RECEPTOR; CELL-RECEPTOR; ANTIGEN PRESENTATION; MULTIGENE FAMILIES; CRYSTAL-STRUCTURE; HLA; EVOLUTION; RECOGNITION	HLA class I and NK receptors are encoded within dense clusters of immune loci. The MHC, at 6p21.3, and the complex containing the KIR loci, at 19q13.4, both feature variation in the number of genes, as well as sequence polymorphism. In addition to T cell receptors, several variable class I-related molecules interact with polymorphic NK receptors. Some of the lectin-related NK receptor genes, at 12p13.1, also have ligands belonging to the extended class I family. The expanding clusters of class I-related sequences and. their receptors, some of which evolved recently, reveal further complexity in immune recognition of disease.	Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Cambridge	Trowsdale, J (corresponding author), Univ Cambridge, Dept Pathol, Div Immunol, Tennis Court Rd, Cambridge CB2 1QP, England.	jt233@mole.bio.cam.ac.uk						Allcock RJN, 2000, IMMUNOL TODAY, V21, P328, DOI 10.1016/S0167-5699(00)01654-6; Amadou C, 1999, IMMUNOGENETICS, V49, P362, DOI 10.1007/s002510050507; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Barten R, 2001, TRENDS IMMUNOL, V22, P52, DOI 10.1016/S1471-4906(00)01802-0; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Beck S, 2000, ANNU REV GENOM HUM G, V1, P117, DOI 10.1146/annurev.genom.1.1.117; Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Borges L, 1999, CURR TOP MICROBIOL, V244, P123; Borges L, 1997, J IMMUNOL, V159, P5192; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brown MG, 2000, MAJOR HISTOCOMPATIBILITY COMPLEX, P287; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Brown P, 2001, NATURE, V410, P1018, DOI 10.1038/35074279; Campbell KS, 1999, INT J BIOCHEM CELL B, V31, P631, DOI 10.1016/S1357-2725(99)00022-9; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Carrington M, 1999, IMMUNOL REV, V167, P245, DOI 10.1111/j.1600-065X.1999.tb01397.x; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; DELARBRE C, 1992, IMMUNOGENETICS, V37, P29; Dennis G, 2000, P NATL ACAD SCI USA, V97, P13245, DOI 10.1073/pnas.230442897; Depatie C, 1997, GENOMICS, V39, P154, DOI 10.1006/geno.1996.4498; Du Pasquier L, 2000, MAJOR HISTOCOMPATIBILITY COMPLEX, P53; Edwards JCW, 2000, IMMUNOL TODAY, V21, P256, DOI 10.1016/S0167-5699(00)01625-X; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; Gallardo MH, 1999, NATURE, V401, P341, DOI 10.1038/43815; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; GERMAIN RN, 1985, CELL, V43, P233, DOI 10.1016/0092-8674(85)90028-5; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Gruen JR, 1997, BLOOD, V90, P4252; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hill AVS, 1999, NATURE, V398, P668, DOI 10.1038/19431; Horton R, 1998, J MOL BIOL, V282, P71, DOI 10.1006/jmbi.1998.2018; Isakov N, 1998, ADV IMMUNOL, V69, P183, DOI 10.1016/S0065-2776(08)60608-2; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Karre K, 1997, IMMUNOL REV, V155, P5, DOI 10.1111/j.1600-065X.1997.tb00935.x; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Khakoo SI, 2000, IMMUNITY, V12, P687, DOI 10.1016/S1074-7613(00)80219-8; King A, 2000, PLACENTA, V21, pS81, DOI 10.1053/plac.1999.0520; Kubagawa H, 1999, CURR TOP MICROBIOL, V244, P137; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Lehner PJ, 1998, CURR BIOL, V8, pR605, DOI 10.1016/S0960-9822(98)70387-2; Lepin EJM, 2000, EUR J IMMUNOL, V30, P3552, DOI 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Little A M, 1999, Rev Immunogenet, V1, P105; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Parham P, 1994, Semin Immunol, V6, P373, DOI 10.1006/smim.1994.1047; PARHAM P, 1999, IMMUNOL REV, P379; PARHAM P, 1997, IMMUNOL REV, V155; Pichon L, 1996, GENOMICS, V32, P236, DOI 10.1006/geno.1996.0110; Rajalingam R, 2001, J EXP MED, V193, P135, DOI 10.1084/jem.193.1.135; Shiina T, 1999, P NATL ACAD SCI USA, V96, P13282, DOI 10.1073/pnas.96.23.13282; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Takei F, 1997, IMMUNOL REV, V155, P67, DOI 10.1111/j.1600-065X.1997.tb00940.x; TROWSDALE J, 1995, IMMUNOGENETICS, V41, P1, DOI 10.1007/BF00188427; Ugolini S, 2001, NAT IMMUNOL, V2, P430, DOI 10.1038/87740; Ugolini S, 2001, NAT IMMUNOL, V2, P198, DOI 10.1038/85246; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; Vely F, 1997, J IMMUNOL, V159, P2075; Vilches C, 2000, J IMMUNOL, V165, P6416, DOI 10.4049/jimmunol.165.11.6416; Volpi EV, 2000, J CELL SCI, V113, P1565; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159; Yokoyama WM, 2000, NAT IMMUNOL, V1, P95, DOI 10.1038/77878	86	237	251	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2001	15	3			SI		363	374		10.1016/S1074-7613(01)00197-2	http://dx.doi.org/10.1016/S1074-7613(01)00197-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567627	Bronze			2022-12-18	WOS:000171211800004
J	Khan, IA; MacLean, JA; Lee, FS; Casciotti, L; DeHaan, E; Schwartzman, JD; Luster, AD				Khan, IA; MacLean, JA; Lee, FS; Casciotti, L; DeHaan, E; Schwartzman, JD; Luster, AD			IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection	IMMUNITY			English	Article							SECONDARY LYMPHOID ORGANS; IFN-GAMMA; CHEMOKINE RECEPTOR; DIFFERENTIAL EXPRESSION; MULTIPLE-SCLEROSIS; INTERFERON-GAMMA; GENE-EXPRESSION; MICE; LYMPHOCYTES; IMMUNITY	The generation of an adaptive immune response against intracellular pathogens requires the recruitment of effector T cells to sites of infection. Here we show that the chemokine IP-10, a specific chemoattractant for activated T cells, controls this process in mice naturally infected with Toxoplasma gondii. Neutralization of IP-10 in infected mice inhibited the massive influx of T cells into tissues and impaired antigen-specific T cell effector functions. This resulted in >1000-fold increase in tissue parasite burden and a marked increase in mortality compared to control antibody-treated mice. These observations suggest that IP-10 may play a broader role in the localization and function of effector T cells at sites of Th1 inflammation.	Harvard Univ, Massachusetts Gen Hosp, AIDS Res Ctr, Sch Med,Allergy & Immunol Unit,Infect Dis Unit, Boston, MA 02114 USA; Dartmouth Med Ctr, Dept Med, Hanover, NH 03755 USA; Dartmouth Med Ctr, Dept Pathol, Hanover, NH 03755 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Dartmouth College; Dartmouth College	Luster, AD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, AIDS Res Ctr, Sch Med,Allergy & Immunol Unit,Infect Dis Unit, Boston, MA 02114 USA.		Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912	NCI NIH HHS [CA69212] Funding Source: Medline; NIAID NIH HHS [AI33325, AI46999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046999, R21AI033325, R01AI033325, R29AI033325] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agostini C, 1998, J IMMUNOL, V161, P6413; Amichay D, 1996, J IMMUNOL, V157, P4511; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Asensio VC, 1997, J VIROL, V71, P7832, DOI 10.1128/JVI.71.10.7832-7840.1997; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Cerwenka A, 1999, J EXP MED, V189, P423, DOI 10.1084/jem.189.2.423; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; DeckertSchluter M, 1996, LAB INVEST, V75, P827; DECOSTER A, 1988, CLIN EXP IMMUNOL, V73, P376; Denkers EY, 1997, J IMMUNOL, V159, P1903; Ely KH, 1999, J IMMUNOL, V162, P5449; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; FRENKEL JK, 1988, PARASITOL TODAY, V4, P273, DOI 10.1016/0169-4758(88)90018-X; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; GOTTLIEB AB, 1988, J EXP MED, V168, P941, DOI 10.1084/jem.168.3.941; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; HAKIM FT, 1991, J IMMUNOL, V147, P2310; INNES EA, 1995, PARASITE IMMUNOL, V17, P151, DOI 10.1111/j.1365-3024.1995.tb01017.x; JOHNSON LL, 1992, INFECT IMMUN, V60, P3719, DOI 10.1128/IAI.60.9.3719-3724.1992; KHAN IA, 1991, J IMMUNOL, V147, P3501; Khan IA, 1996, J IMMUNOL, V157, P2103; KHAN IA, 1990, J CLIN INVEST, V85, P1879, DOI 10.1172/JCI114649; KHAN IA, 1994, J IMMUNOL, V152, P1856; Kirisits MJ, 2000, INT J PARASITOL, V30, P149, DOI 10.1016/S0020-7519(00)00009-6; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; LUFT BJ, 1984, JAMA-J AM MED ASSOC, V252, P913, DOI 10.1001/jama.252.7.913; Luster AD, 1998, P ASSOC AM PHYSICIAN, V110, P183; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; MCCABE RE, 1984, J INFECT DIS, V150, P961, DOI 10.1093/infdis/150.6.961; MEYER M, 2000, IN PRESS CYTOGENET C; Neter J., 1985, APPL LINEAR STAT MOD; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Shields PL, 1999, J IMMUNOL, V163, P6236; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; SUZUKI Y, 1988, J IMMUNOL, V140, P3943; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; TASWELL C, 1981, J IMMUNOL, V126, P1614; WATANABE H, 1992, J IMMUNOL METHODS, V146, P145, DOI 10.1016/0022-1759(92)90223-G; WONG P, 1994, MOL CELL BIOL, V14, P914, DOI 10.1128/MCB.14.2.914	48	237	250	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2000	12	5					483	494		10.1016/S1074-7613(00)80200-9	http://dx.doi.org/10.1016/S1074-7613(00)80200-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843381	Bronze			2022-12-18	WOS:000087356400004
J	Pelanda, R; Schwers, S; Sonoda, E; Torres, RM; Nemazee, D; Rajewsky, K				Pelanda, R; Schwers, S; Sonoda, E; Torres, RM; Nemazee, D; Rajewsky, K			Receptor editing in a transgenic mouse model: Site, efficiency, and role in B cell tolerance and antibody diversification	IMMUNITY			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; MURINE LEUKEMIA-VIRUS; KAPPA-GENE REARRANGEMENT; REACTIVE LYMPHOCYTES-B; BONE-MARROW; LIGHT-CHAIN; CLONAL SELECTION; MICE; RECOMBINATION; EXPRESSION	Mice carrying transgenic rearranged V region genes in their IgH and Ig kappa loci to encode an autoreactive specificity direct the emerging autoreactive progenitors into a pre-B cell compartment, in which their receptors are edited by secondary V kappa-J kappa rearrangements and RS recombination. Editing is an efficient process, because the mutant mice generate normal numbers of B cells. In a similar nonautoreactive transgenic strain, neither a pre-B cell compartment nor receptor editing was seen. Thus, the pre-B cell compartment may have evolved to edit the receptors of autoreactive cells and later been generally exploited for efficient antibody diversification through the invention of the pre-B cell receptor, mimicking an autoreactive antibody to direct the bulk of the progenitors into that compartment.	Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80206 USA; Natl Jewish Ctr Immunol & Resp Med, Dept Pediat, Div Basic Sci, Denver, CO 80206 USA	University of Cologne; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	Pelanda, R (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-50931 Cologne, Germany.	pelanda@immunbio.mpg.de		Rajewsky, Klaus/0000-0002-6633-6370	NIAID NIH HHS [R01 AI033608] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033608] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; COFFMAN RL, 1983, IMMUNOL REV, V69, P5, DOI 10.1111/j.1600-065X.1983.tb00446.x; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; ERA T, 1991, EMBO J, V10, P337, DOI 10.1002/j.1460-2075.1991.tb07954.x; FEDDERSEN RM, 1990, MOL CELL BIOL, V10, P569, DOI 10.1128/MCB.10.2.569; FEDDERSEN RM, 1985, P NATL ACAD SCI USA, V82, P4793, DOI 10.1073/pnas.82.14.4793; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Grutzmann R., 1981, THESIS U COLOGNE COL; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HARADA K, 1991, J EXP MED, V173, P409, DOI 10.1084/jem.173.2.409; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; HUBER C, 1992, EUR J IMMUNOL, V22, P1561, DOI 10.1002/eji.1830220632; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; Klinman NR, 1996, IMMUNITY, V5, P189, DOI 10.1016/S1074-7613(00)80314-3; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; LEWIS S, 1982, CELL, V30, P807, DOI 10.1016/0092-8674(82)90285-9; Monroe JG, 1996, J IMMUNOL, V156, P2657; MOORE MW, 1985, P NATL ACAD SCI USA, V82, P6211, DOI 10.1073/pnas.82.18.6211; MULLER B, 1988, J EXP MED, V168, P2131, DOI 10.1084/jem.168.6.2131; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; OZATO K, 1980, J IMMUNOL, V124, P533; PELANDA, 1996, UNPUB; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; PERSIANI DM, 1987, J EXP MED, V165, P1655, DOI 10.1084/jem.165.6.1655; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; REICHMANFRIED M, 1990, P NATL ACAD SCI USA, V87, P2730, DOI 10.1073/pnas.87.7.2730; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; RETH M, 1979, EUR J IMMUNOL, V9, P1004, DOI 10.1002/eji.1830091216; Rolink A, 1996, Int Rev Immunol, V13, P341, DOI 10.3109/08830189609061757; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; SHAPIRO MA, 1987, J IMMUNOL, V139, P3834; SHIMIZU T, 1991, J EXP MED, V173, P1065, DOI 10.1084/jem.173.5.1065; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; TAKI S, 1993, SCIENCE, V262, P1268, DOI 10.1126/science.8235657; Texido G, 1996, EUR J IMMUNOL, V26, P1966, DOI 10.1002/eji.1830260843; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; Torres RM, 1997, LAB PROTOCOLS CONDIT; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043	63	237	239	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1997	7	6					765	775		10.1016/S1074-7613(00)80395-7	http://dx.doi.org/10.1016/S1074-7613(00)80395-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430222	Bronze			2022-12-18	WOS:000071351300004
J	Kumar, V; Cheng, PY; Condamine, T; Mony, S; Languino, LR; McCaffrey, JC; Hockstein, N; Guarino, M; Masters, G; Penman, E; Denstman, F; Xu, XW; Altieri, DC; Du, H; Yan, C; Gabrilovich, DI				Kumar, Vinit; Cheng, Pingyan; Condamine, Thomas; Mony, Sridevi; Languino, Lucia R.; McCaffrey, Judith C.; Hockstein, Neil; Guarino, Michael; Masters, Gregory; Penman, Emily; Denstman, Fred; Xu, Xiaowei; Altieri, Dario C.; Du, Hong; Yan, Cong; Gabrilovich, Dmitry I.			CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation	IMMUNITY			English	Article							SUPPRESSOR-CELLS; ANTITUMOR IMMUNITY; DENDRITIC CELLS; CANCER-CELLS; ACTIVATION; MODEL; EXPRESSION; SUNITINIB; MONOCYTES; MELANOMA	Recruitment of monocytic myeloid-derived suppressor cells (MDSCs) and differentiation of tumor-associated macrophages (TAMs) are the major factors contributing to tumor progression and metastasis. We demonstrated that differentiation of TAMs in tumor site from monocytic precursors was controlled by downregulation of the activity of the transcription factor STAT3. Decreased STAT3 activity was caused by hypoxia and affected all myeloid cells but was not observed in tumor cells. Upregulation of CD45 tyrosine phosphatase activity in MDSCs exposed to hypoxia in tumor site was responsible for downregulation of STAT3. This effect was mediated by the disruption of CD45 protein dimerization regulated by sialic acid. Thus, STAT3 has a unique function in the tumor environment in controlling the differentiation of MDSC into TAM, and its regulatory pathway could be a potential target for therapy.	[Kumar, Vinit; Condamine, Thomas; Mony, Sridevi; Altieri, Dario C.; Gabrilovich, Dmitry I.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Cheng, Pingyan; McCaffrey, Judith C.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Languino, Lucia R.] Thomas Jefferson Univ, Philadelphia, PA 19110 USA; [Hockstein, Neil; Guarino, Michael; Masters, Gregory; Penman, Emily; Denstman, Fred] Christiana Care Hlth Syst, Helen F Graham Canc Ctr & Res Inst, Newark, DE 19713 USA; [Xu, Xiaowei] Univ Penn, Philadelphia, PA 19104 USA; [Du, Hong; Yan, Cong] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	The Wistar Institute; H Lee Moffitt Cancer Center & Research Institute; Jefferson University; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; University of Pennsylvania; Indiana University System; Indiana University Bloomington	Gabrilovich, DI (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	dgabrilovich@wistar.org	Kumar, Vinit/GQP-7755-2022; Gabrilovich, Dmitry/ABE-7122-2020	Languino, Lucia/0000-0001-9011-7031	NIH [CA177646, CA100062]; Wistar/Penn SPORE grant [P50-CA174523]; Prostate Cancer Foundation; animal and flow cytometry core facilities of The Wistar Institute; NATIONAL CANCER INSTITUTE [R01CA190027, R01CA078810, R01CA152099, R01CA177646, R01CA100062, R01CA138759, P30CA010815, P01CA140043, P50CA174523, P01CA114046] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wistar/Penn SPORE grant; Prostate Cancer Foundation; animal and flow cytometry core facilities of The Wistar Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants CA177646 and CA100062 to DIG and in part by Wistar/Penn SPORE grant P50-CA174523 to DIG and XX and Challenge Award from the Prostate Cancer Foundation to D.C.A., L.R.L., and D.I.G. This work was supported by animal and flow cytometry core facilities of The Wistar Institute.	Abad C, 2014, J LEUKOCYTE BIOL, V95, P357, DOI 10.1189/jlb.1012531; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bharadwaj U, 2007, CANCER RES, V67, P5479, DOI 10.1158/0008-5472.CAN-06-3963; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Hasita H, 2010, CANCER SCI, V101, P1913, DOI 10.1111/j.1349-7006.2010.01614.x; Herrmann A, 2010, CANCER RES, V70, P7455, DOI 10.1158/0008-5472.CAN-10-0736; Holmes N, 2006, IMMUNOLOGY, V117, P145, DOI 10.1111/j.1365-2567.2005.02265.x; Kato M, 1998, ONCOGENE, V17, P1885, DOI 10.1038/sj.onc.1202077; Ko JS, 2010, CANCER RES, V70, P3526, DOI 10.1158/0008-5472.CAN-09-3278; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Meyer C, 2011, P NATL ACAD SCI USA, V108, P17111, DOI 10.1073/pnas.1108121108; Nefedova Y, 2005, CANCER RES, V65, P9525, DOI 10.1158/0008-5472.CAN-05-0529; Nefedova Y, 2005, J IMMUNOL, V175, P4338, DOI 10.4049/jimmunol.175.7.4338; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Rebe Cedric, 2013, JAKSTAT, V2, pe23010, DOI 10.4161/jkst.23010; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shand FHW, 2014, P NATL ACAD SCI USA, V111, P7771, DOI 10.1073/pnas.1402914111; Shim SH, 2009, INT J MOL MED, V23, P805, DOI 10.3892/ijmm_00000196; Solito S, 2011, J LEUKOCYTE BIOL, V90, P31, DOI 10.1189/jlb.0111021; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Sun ZK, 2006, IMMUNOBIOLOGY, V211, P199, DOI 10.1016/j.imbio.2005.11.004; Trikha P, 2014, BBA-REV CANCER, V1846, P55, DOI 10.1016/j.bbcan.2014.04.003; Tu SP, 2012, CANCER PREV RES, V5, P205, DOI 10.1158/1940-6207.CAPR-11-0247; Vasquez-Dunddel D, 2013, J CLIN INVEST, V123, P1580, DOI 10.1172/JCI60083; Wu LT, 2009, MOL IMMUNOL, V46, P2167, DOI 10.1016/j.molimm.2009.04.032; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yin J, 2006, CANCER RES, V66, P2937, DOI 10.1158/0008-5472.CAN-05-2615; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	38	236	241	6	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					303	315		10.1016/j.immuni.2016.01.014	http://dx.doi.org/10.1016/j.immuni.2016.01.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885857	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000370294000013
J	Chalmin, F; Mignot, G; Bruchard, M; Chevriaux, A; Vegran, F; Hichami, A; Ladoire, S; Derangere, V; Vincent, J; Masson, D; Robson, SC; Eberl, G; Pallandre, JR; Borg, C; Ryffel, B; Apetoh, L; Rebe, C; Ghiringhelli, F				Chalmin, Fanny; Mignot, Gregoire; Bruchard, Melanie; Chevriaux, Angelique; Vegran, Frederique; Hichami, Aziz; Ladoire, Sylvain; Derangere, Valentin; Vincent, Julie; Masson, David; Robson, Simon C.; Eberl, Gerard; Pallandre, Jean Rene; Borg, Christophe; Ryffel, Bernhard; Apetoh, Lionel; Rebe, Cedric; Ghiringhelli, Francois			Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; EFFECTOR T-CELLS; ROR-GAMMA-T; TGF-BETA; SIGNALING PATHWAY; T(H)17 CELLS; GENERATION; IL-17; ADENOSINE; CANCER	Although Th17 cells are known to promote tissue inflammation and autoimmunity, their role during cancer progression remains elusive. Here, we showed that in vitro Th17 cells generated with the cytokines IL-6 and TGF-beta expressed CD39 and CD73 ectonucleotidases, leading to adenosine release and the subsequent suppression of CD4(+) and CD8(+) T cell effector functions. The IL-6-mediated activation of the transcription factor Stat3 and the TGF-beta-driven downregulation of Gfi-1 transcription factor were both essential for the expression of ectonucleotidases during Th17 cell differentiation. Stat3 supported whereas Gfi-1 repressed CD39 and CD73 expression by binding to their promoters. Accordingly, Th17 cells differentiated with IL-1 beta, IL-6, and IL-23 but without TGF-beta did not express ectonucleotidases and were not imnnunosuppressive. Finally, adoptive transfer of Th17 cells induced by TGF-beta and IL-6 promoted tumor growth in a CD39-dependent manner. Thus, ectonucleotidase expression supports the immunosuppressive fate of Th17 cells in cancer.	[Chalmin, Fanny; Mignot, Gregoire; Bruchard, Melanie; Chevriaux, Angelique; Vegran, Frederique; Hichami, Aziz; Ladoire, Sylvain; Derangere, Valentin; Vincent, Julie; Masson, David; Apetoh, Lionel; Rebe, Cedric; Ghiringhelli, Francois] INSERM, U866, F-21000 Dijon, France; [Chalmin, Fanny; Mignot, Gregoire; Bruchard, Melanie; Chevriaux, Angelique; Vegran, Frederique; Hichami, Aziz; Ladoire, Sylvain; Derangere, Valentin; Vincent, Julie; Apetoh, Lionel; Rebe, Cedric; Ghiringhelli, Francois] INSERM AVENIR Team, F-21000 Dijon, France; [Chalmin, Fanny; Bruchard, Melanie; Hichami, Aziz; Ladoire, Sylvain; Derangere, Valentin; Vincent, Julie; Masson, David; Ghiringhelli, Francois] Univ Burgundy, Fac Med, F-21000 Dijon, France; [Chevriaux, Angelique; Ladoire, Sylvain; Derangere, Valentin; Apetoh, Lionel; Rebe, Cedric; Ghiringhelli, Francois] Ctr Georges Francois Leclerc, F-21000 Dijon, France; [Robson, Simon C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med & Surg,Liver Ctr, Boston, MA 02115 USA; [Robson, Simon C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med & Surg,Transplantat Inst, Boston, MA 02115 USA; [Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France; [Eberl, Gerard] Inst Pasteur, Dept Biotechnol, CNRS, URA1961, F-75724 Paris, France; [Pallandre, Jean Rene; Borg, Christophe] INSERM U645 EFS Bourgogne Franche Comte, F-25000 Besancon, France; [Ryffel, Bernhard] CNRS, UMR6218, F-45000 Orleans, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Ghiringhelli, F (corresponding author), INSERM, U866, F-21000 Dijon, France.	fghiringhelli@cgfl.fr	Bruchard, Melanie/E-6508-2017; VEGRAN, Frederique/O-9986-2018; Apetoh, Lionel/AIC-2384-2022; Masson, David/R-6633-2019; REBE, Cédric/AAD-4316-2019; VEGRAN, Frédérique/H-4792-2017; Apetoh, Lionel/G-3310-2014; Robson, Simon C./AAA-8537-2021; Mignot, Grégoire/R-4976-2017; MASSON, David/R-4557-2017; Eberl, Gerard/A-1160-2013; MASSON, David/AAC-8896-2022	Bruchard, Melanie/0000-0003-0004-2887; VEGRAN, Frederique/0000-0002-4377-1441; Apetoh, Lionel/0000-0002-2774-438X; REBE, Cédric/0000-0001-8831-145X; Apetoh, Lionel/0000-0002-2774-438X; Mignot, Grégoire/0000-0002-0682-0152; MASSON, David/0000-0003-1692-0699; MASSON, David/0000-0003-1692-0699; LADOIRE, Sylvain/0000-0002-0331-9194; hichami, aziz/0000-0003-4331-5152; ghiringhelli, francois/0000-0002-5465-8305; Eberl, Gerard/0000-0002-1119-5638; Chalmin, Fanny/0000-0002-0855-9453	INSERM-Region-Bourgogne; Ligue Nationale contre le Cancer; Fondation de France; Institut National du Cancer; Association pour la recherche sur le cancer; Fondation pour la recherche Medicale; Ligue contre le cancer (Comite Grand Est); Agence Nationale de la Recherche [ANR-10-PDOC-014-01]; NATIONAL CANCER INSTITUTE [R21CA164970] Funding Source: NIH RePORTER	INSERM-Region-Bourgogne(Region Bourgogne-Franche-Comte); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France); Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la recherche Medicale(Fondation pour la Recherche Medicale); Ligue contre le cancer (Comite Grand Est); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Authors are supported by the INSERM-Region-Bourgogne (F.C.), the Ligue Nationale contre le Cancer (F.G., F.V.), the Fondation de France (F.G.), Institut National du Cancer (F.G.), Association pour la recherche sur le cancer (F.G., G.M.), Fondation pour la recherche Medicale (F.G.), Ligue contre le cancer (Comite Grand Est), and Agence Nationale de la Recherche (ANR-10-PDOC-014-01) (L.A.). F.C., G.M., and C.R. performed in vitro and in vivo experiments; M.B., A.C., F.V., A.H., S.L., V.D., J.V., and J.R.P. performed in vitro experiments; D.M., C.B., S.C.R., G.E., and B.R. provided essential reagents and advice to perform the study; and L.A., C.R., and F.G. supervised the study and wrote the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Chen Z, 2008, IMMUNOL RES, V41, P87, DOI 10.1007/s12026-007-8014-9; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Duhant X, 2002, J IMMUNOL, V169, P15, DOI 10.4049/jimmunol.169.1.15; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Feng LL, 2011, NEOPLASIA, V13, P206, DOI 10.1593/neo.101332; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Korpal M, 2010, EUR J CANCER, V46, P1232, DOI 10.1016/j.ejca.2010.02.040; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Regateiro FS, 2011, EUR J IMMUNOL, V41, P2955, DOI 10.1002/eji.201141512; Sfanos KS, 2008, CLIN CANCER RES, V14, P3254, DOI 10.1158/1078-0432.CCR-07-5164; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Yamaguchi T, 2006, SEMIN CANCER BIOL, V16, P115, DOI 10.1016/j.semcancer.2005.11.005; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2009, J EXP MED, V206, P329, DOI 10.1084/jem.20081666; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	42	236	240	2	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 23	2012	36	3					362	373		10.1016/j.immuni.2011.12.019	http://dx.doi.org/10.1016/j.immuni.2011.12.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22406269	Bronze			2022-12-18	WOS:000302048400009
J	Mukai, K; Matsuoka, K; Taya, C; Suzuki, H; Yokozeki, H; Nishioka, K; Hirokawa, K; Etori, M; Yamashita, M; Kubota, T; Minegishi, Y; Yonekawa, H; Karasuyama, H				Mukai, K; Matsuoka, K; Taya, C; Suzuki, H; Yokozeki, H; Nishioka, K; Hirokawa, K; Etori, M; Yamashita, M; Kubota, T; Minegishi, Y; Yonekawa, H; Karasuyama, H			Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells	IMMUNITY			English	Article							FC-EPSILON-RI; HIGH-AFFINITY RECEPTOR; IMMUNOGLOBULIN-E; TRANSGENIC MICE; EXPRESSION; ANTIBODY; ASTHMA; IL-4; HYPERSENSITIVITY; OMALIZUMAB	The recruitment of basophils into the sites of allergic inflammation is often observed. However, no definitive evidence has been provided that basophils are crucially involved in the pathogenesis of chronic allergic disorders. Here, we show that basophils are responsible for the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. A single subcutaneous injection of multivalent antigens elicited not only immediate and late-phase ear swelling but also delayed-onset ear swelling with massive eosinophil infiltration in mice sensitized with antigen-specific IgE. Mast cells were essential for the immediate and late-phase ear swelling but dispensable for the delayed one. T cells were also dispensable for the latter. Transfer of FC epsilon RI-expressing basophils into Fc epsilon RI-deficient mice restored the development of the delayed-onset allergic inflammation. These findings indicate a novel mechanism of development of chronic allergic inflammation that is induced by basophils through the interaction of antigen, IgE, and Fc epsilon RI.	Tokyo Med & Dent Univ, Grad Sch, Dept Immune Regulat, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Med & Dent Univ, Grad Sch, Dept Dermatol, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Med & Dent Univ, Grad Sch, Dept Pathol & Immunol, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Bunkyo Ku, Tokyo 1138613, Japan; Tokyo Metropolitan Inst Med Sci, Electron Microscopy Lab, Bunkyo Ku, Tokyo 1138613, Japan; Sankyo Co Ltd, Biol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Daiichi Sankyo Company Limited	Karasuyama, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Immune Regulat, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	karasuyama.mbch@tmd.ac.jp	Karasuyama, Hajime/A-7966-2011	Karasuyama, Hajime/0000-0003-0689-0836				Bieber T, 1997, IMMUNOL TODAY, V18, P311, DOI 10.1016/S0167-5699(97)01046-3; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; BROWN SJ, 1982, J IMMUNOL, V129, P790; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Dvorak AM, 2000, BLOOD, V96, P1616, DOI 10.1182/blood.V96.4.1616.h8001608e_1616_1617; DVORAK HF, 1971, J IMMUNOL, V107, P138; Falcone FH, 2000, BLOOD, V96, P4028; FUJIWARA H, 1994, P NATL ACAD SCI USA, V91, P6835, DOI 10.1073/pnas.91.15.6835; GAGA M, 1991, J IMMUNOL, V147, P816; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Genovese A, 2003, J IMMUNOL, V170, P1854, DOI 10.4049/jimmunol.170.4.1854; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Gounni AS, 2001, FASEB J, V15, P940, DOI 10.1096/fj.00-0378com; GRAZIANO FM, 1983, J IMMUNOL, V131, P2675; HAYNES JD, 1978, J IMMUNOL, V120, P886; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Holgate ST, 2004, CLIN EXP ALLERGY, V34, P632, DOI 10.1111/j.1365-2222.2004.1916.x; HULTSCH T, 1990, J IMMUNOL, V144, P2659; Jones TD, 1934, NEW ENGL J MED, V210, P120, DOI 10.1056/NEJM193401182100302; Joseph M, 1997, EUR J IMMUNOL, V27, P2212, DOI 10.1002/eji.1830270914; Kubo S, 2003, J IMMUNOL, V170, P775, DOI 10.4049/jimmunol.170.2.775; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Li L, 1999, J IMMUNOL, V162, P2477; Marone G, 2005, TRENDS IMMUNOL, V26, P25, DOI 10.1016/j.it.2004.10.010; Matsuoka K, 1999, INT IMMUNOL, V11, P987, DOI 10.1093/intimm/11.6.987; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mochizuki M, 1998, J IMMUNOL, V160, P60; Oettgen HC, 2001, J ALLERGY CLIN IMMUN, V107, P429, DOI 10.1067/mai.2001.113759; Oettgen HC, 1999, J CLIN INVEST, V104, P829, DOI 10.1172/JCI8205; Plath KES, 2003, CLIN EXP ALLERGY, V33, P342, DOI 10.1046/j.1365-2222.2003.01610.x; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Sato E, 2003, J ALLERGY CLIN IMMUN, V111, P143, DOI 10.1067/mai.2003.9; Schafer T, 1999, J ALLERGY CLIN IMMUN, V104, P1280, DOI 10.1016/S0091-6749(99)70025-4; Schramm G, 2001, CLIN EXP ALLERGY, V31, P331, DOI 10.1046/j.1365-2222.2001.01049.x; Schroeder JT, 2001, ADV IMMUNOL, V77, P93, DOI 10.1016/S0065-2776(01)77015-0; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; von Bubnoff D, 2003, CLIN EXP DERMATOL, V28, P184, DOI 10.1046/j.1365-2230.2003.01209.x; Wedemeyer J, 2000, BRIT MED BULL, V56, P936, DOI 10.1258/0007142001903616; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	51	236	256	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2005	23	2					191	202		10.1016/j.immuni.2005.06.011	http://dx.doi.org/10.1016/j.immuni.2005.06.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	962HM	16111637	Bronze			2022-12-18	WOS:000231721700009
J	Anandasabapathy, N; Ford, GS; Bloom, D; Holness, C; Paragas, V; Seroogy, C; Skrenta, H; Hollenhorst, M; Fathman, CG; Soares, L				Anandasabapathy, N; Ford, GS; Bloom, D; Holness, C; Paragas, V; Seroogy, C; Skrenta, H; Hollenhorst, M; Fathman, CG; Soares, L			GRAIL: An E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4(+) T cells	IMMUNITY			English	Article							ALDRICH-SYNDROME PROTEIN; CLATHRIN-ASSOCIATED PROTEIN; INDEPENDENT ENDOCYTOSIS; CBL-B; RECEPTOR; INDUCTION; ANTIGEN; ACTIVATION; MOLECULES; KINASE	T cell anergy may serve to limit autoreactive T cell responses. We examined early changes in gene expression after antigen-TCR signaling in the presence (activation) or absence (anergy) of B7 costimulation. Induced expression of GRAIL (gene related to anergy in lymphocytes) was observed in anergic CD4(+) T cells. GRAIL is a type I transmembrane protein that localizes to the endocytic pathway and bears homology to RING zinc-finger proteins. Ubiquitination studies in vitro support GRAIL function as an E3 ubiquitin ligase. Expression of GRAIL in retrovirally transduced T cell hybridomas dramatically limits activation-induced IL-2 and IL-4 production. Additional studies suggest that GRAIL E3 ubiquitin ligase activity and intact endocytic trafficking are critical for cytokine transcriptional regulation. Expression of GRAIL after an anergizing stimulus may result in ubiquitin-mediated regulation of proteins essential for mitogenic cytokine expression, thus positioning GRAIL as a key player in the induction of the anergic phenotype.	Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University	Fathman, CG (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA.	cfathman@stanford.edu	Hollenhorst, Marie/ABA-8636-2020	Hollenhorst, Marie/0000-0002-2237-6645; Anandasabapathy, Niroshana/0000-0002-0473-8358	NATIONAL CANCER INSTITUTE [R01CA085774, R01CA065237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI049903] Funding Source: NIH RePORTER; NCI NIH HHS [CA09302, CA65237, CA85774] Funding Source: Medline; NIAID NIH HHS [AI49903] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alcover A, 2000, CRIT REV IMMUNOL, V20, P325; Antonia SJ, 1998, CRIT REV ONCOGENESIS, V9, P35; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Baker SJ, 2000, GENE, V248, P33, DOI 10.1016/S0378-1119(00)00109-8; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Borchers AGM, 2002, DEV BIOL, V251, P395, DOI 10.1006/dbio.2002.0814; BOUCHARD ML, 1993, GENE, V125, P205, DOI 10.1016/0378-1119(93)90330-6; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Bradshaw JD, 1997, BIOCHEMISTRY-US, V36, P15975, DOI 10.1021/bi971762i; Budd DC, 1999, J BIOL CHEM, V274, P12355, DOI 10.1074/jbc.274.18.12355; Cao XF, 2000, PLANT CELL, V12, P493, DOI 10.1105/tpc.12.4.493; Cavalli V, 2001, FEBS LETT, V498, P190, DOI 10.1016/S0014-5793(01)02484-X; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; CHIANG YJ, 2002, NATURE, V403, P216; Chuang E, 1997, J IMMUNOL, V159, P144; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; DeSilva DR, 1996, J EXP MED, V183, P2017, DOI 10.1084/jem.183.5.2017; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Edwards DA, 1996, P NATL ACAD SCI USA, V93, P1786, DOI 10.1073/pnas.93.5.1786; Eisenbraun MD, 2000, J IMMUNOL, V164, P6105, DOI 10.4049/jimmunol.164.12.6105; Ermann J, 2001, J IMMUNOL, V167, P4271, DOI 10.4049/jimmunol.167.8.4271; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; Girgis L, 1999, J EXP MED, V189, P265, DOI 10.1084/jem.189.2.265; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; HANSEN SH, 1993, J CELL BIOL, V123, P89, DOI 10.1083/jcb.123.1.89; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Huang HK, 2000, J BIOL CHEM, V275, P26661; JENKINS MK, 1990, J IMMUNOL, V144, P16; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Lee CHJ, 1996, J NEUROSCI, V16, P6784; Luo XM, 2001, TRENDS BIOCHEM SCI, V26, P147, DOI 10.1016/S0968-0004(00)01768-0; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; MUELLER DL, 1989, J IMMUNOL, V142, P2617; Nakajima A, 2001, J CLIN INVEST, V107, P1293, DOI 10.1172/JCI12037; QUILL H, 1987, J IMMUNOL, V138, P3704; Raab M, 2001, IMMUNITY, V15, P921, DOI 10.1016/S1074-7613(01)00248-5; RICHIEEHRLICH LI, 2002, IMMUNITY, V17, P809; RIDGWAY WM, 1994, CURR OPIN IMMUNOL, V6, P946, DOI 10.1016/0952-7915(94)90018-3; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; RUBERTI G, 1992, J EXP MED, V175, P157, DOI 10.1084/jem.175.1.157; SALMERON A, 1995, J IMMUNOL, V154, P1675; SEDER RA, 1994, J EXP MED, V179, P299, DOI 10.1084/jem.179.1.299; Sheff DR, 2002, MOL BIOL CELL, V13, P262, DOI 10.1091/mbc.01-07-0320; Silvin C, 2001, J BIOL CHEM, V276, P21450, DOI 10.1074/jbc.M010729200; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Spencer ML, 2002, J BIOL CHEM, V277, P20160, DOI 10.1074/jbc.M201092200; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Telander DG, 1999, J IMMUNOL, V162, P1460; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329	62	236	249	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2003	18	4					535	547		10.1016/S1074-7613(03)00084-0	http://dx.doi.org/10.1016/S1074-7613(03)00084-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	669LZ	12705856	Bronze			2022-12-18	WOS:000182353900009
J	Vicari, AP; Figueroa, DJ; Hedrick, JA; Foster, JS; Singh, KP; Menon, S; Copeland, NG; Gilbert, DJ; Jenkins, NA; Bacon, KB; Zlotnik, A				Vicari, AP; Figueroa, DJ; Hedrick, JA; Foster, JS; Singh, KP; Menon, S; Copeland, NG; Gilbert, DJ; Jenkins, NA; Bacon, KB; Zlotnik, A			TECK: A novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development	IMMUNITY			English	Article							LUNG ALLERGIC INFLAMMATION; SIGNAL SEQUENCE TRAP; MOLECULAR-CLONING; ENDOTHELIAL-CELLS; LINKAGE MAP; TNF-ALPHA; B-CELLS; GM-CSF; MOUSE; PROTEIN	A novel CC chemokine was identified in the thymus of mouse and human and was designated TECK (thymus-expressed chemokine). TECK has weak homology to other CC chemokines and maps to mouse chromosome 8. Besides the thymus, mRNA encoding TECK was detected at substantial levels in the small intestine and at low levels in the liver. The source of TECK in the thymus was determined to be thymic dendritic cells; in contrast, bone marrow-derived dendritic cells do not express TECK. The murine TECK recombinant protein showed chemotactic activity for activated macrophages, dendritic cells, and thymocytes. We conclude that TECK represents a novel thymic dendritic cell-specific CC chemokine that is possibly involved in T cell development.	NCI,FREDERICK CANC RES & DEV CTR,MAMMALIAN GENET LAB,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Vicari, AP (corresponding author), DNAX RES INST MOL & CELLULAR BIOL INC,901 CALIF AVE,PALO ALTO,CA 94304, USA.		Zlotnik, Albert/C-3791-2011					Abo T, 1994, Int Rev Immunol, V11, P61, DOI 10.3109/08830189409061717; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BAZAN F, 1997, NATURE, V385, P640; BEALL CJ, 1992, J BIOL CHEM, V267, P3455; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; CECI JD, 1990, GENOMICS, V6, P72, DOI 10.1016/0888-7543(90)90449-5; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; GarciaZepeda EA, 1996, J IMMUNOL, V157, P5613; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Gonzalo JA, 1996, IMMUNITY, V4, P1, DOI 10.1016/S1074-7613(00)80293-9; Green EL, 1981, GENETICS PROBABILITY, P77; GROVE M, 1990, NUCLEIC ACIDS RES, V18, P5561, DOI 10.1093/nar/18.18.5561; Hedrick JA, 1996, CURR OPIN IMMUNOL, V8, P343, DOI 10.1016/S0952-7915(96)80123-3; Hedrick JA, 1997, J IMMUNOL, V158, P1533; HIESHIMA K, 1997, J BIOL CHEM, V272, P6846; Imai T, 1996, J BIOL CHEM, V271, P21514, DOI 10.1074/jbc.271.35.21514; INABA M, 1991, J EXP MED, V173, P549, DOI 10.1084/jem.173.3.549; JANEWAY CA, 1994, IMMUNITY, V1, P3, DOI 10.1016/1074-7613(94)90003-5; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; Jia GQ, 1996, J EXP MED, V184, P1939, DOI 10.1084/jem.184.5.1939; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; LUSTINARASIMHAN M, 1995, J BIOL CHEM, V270, P2716, DOI 10.1074/jbc.270.6.2716; MACATONIA SE, 1993, J IMMUNOL, V150, P3755; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; MARFAINGKOKA A, 1995, J IMMUNOL, V154, P1870; MARQUEZ C, 1995, J EXP MED, V181, P475, DOI 10.1084/jem.181.2.475; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Patel VP, 1997, J EXP MED, V185, P1163, DOI 10.1084/jem.185.7.1163; POUSSIER P, 1994, ANNU REV IMMUNOL, V12, P521, DOI 10.1146/annurev.immunol.12.1.521; ROLLINS BJ, 1991, AM J PATHOL, V138, P1315; Rossi DL, 1997, J IMMUNOL, V158, P1033; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X; SCHALL TJ, 1992, EUR J IMMUNOL, V22, P1477, DOI 10.1002/eji.1830220621; SCHALL TJ, 1994, CYTOKINE HDB, P419; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shortman K, 1995, ADV EXP MED BIOL, V378, P21; SOZZANI S, 1995, J IMMUNOL, V155, P3292; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; THIRION S, 1994, BIOCHEM BIOPH RES CO, V201, P493, DOI 10.1006/bbrc.1994.1729; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365	57	236	259	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1997	7	2					291	301		10.1016/S1074-7613(00)80531-2	http://dx.doi.org/10.1016/S1074-7613(00)80531-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285413	Bronze			2022-12-18	WOS:A1997XT49200012
J	Deng, MH; Tang, YT; Li, WB; Wang, XY; Zhang, R; Zhang, XY; Zhao, X; Liu, J; Tang, C; Liu, ZH; Huang, YZ; Peng, HG; Xiao, LH; Tang, DL; Scott, MJ; Wang, QD; Liu, J; Xiao, XZ; Watkins, S; Li, JH; Yang, H; Wang, HC; Chen, FP; Tracey, KJ; Billiar, TR; Lu, B				Deng, Meihong; Tang, Yiting; Li, Wenbo; Wang, Xiangyu; Zhang, Rui; Zhang, Xianying; Zhao, Xin; Liu, Jian; Tang, Cheng; Liu, Zhonghua; Huang, Yongzhuo; Peng, Huige; Xiao, Lehui; Tang, Daolin; Scott, Melanie J.; Wang, Qingde; Liu, Jing; Xiao, Xianzhong; Watkins, Simon; Li, Jianhua; Yang, Huan; Wang, Haichao; Chen, Fangping; Tracey, Kevin J.; Billiar, Timothy R.; Lu, Ben			The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis	IMMUNITY			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; GROUP BOX 1; GASDERMIN D; ALARMIN HMGB1; RELEASE; LIPOPOLYSACCHARIDE; RECEPTOR; LPS; PYROPTOSIS; BINDING	Caspase-11, a cytosolic endotoxin (lipopolysaccharide: LPS) receptor, mediates pyroptosis, a lytic form of cell death. Caspase-11-dependent pyroptosis mediates lethality in endotoxemia, but it is unclear how LPS is delivered into the cytosol for the activation of caspase-11. Here we discovered that hepatocyte-released high mobility group box 1 (HMGB1) was required for caspase-11-dependent pyroptosis and lethality in endotoxemia and bacterial sepsis. Mechanistically, hepatocyte-released HMGB1 bound LPS and targeted its internalization into the lysosomes of macrophages and endothelial cells via the receptor for advanced glycation end-products (RAGE). Subsequently, HMGB1 permeabilized the phospholipid bilayer in the acidic environment of lysosomes. This resulted in LPS leakage into the cytosol and caspase-11 activation. Depletion of hepatocyte HMGB1, inhibition of hepatocyte HMGB1 release, neutralizing extracellular HMGB1, or RAGE deficiency prevented caspase-11-dependent pyroptosis and death in endotoxemia and bacterial sepsis. These findings indicate that HMGB1 interacts with LPS to mediate caspase-11-dependent pyroptosis in lethal sepsis.	[Li, Wenbo; Wang, Xiangyu; Zhang, Rui; Zhang, Xianying; Zhao, Xin; Liu, Jian; Liu, Jing; Chen, Fangping; Lu, Ben] Cent S Univ, Xiangya Hosp 3, Dept Hematol, Changsha 410000, Hunan, Peoples R China; [Li, Wenbo; Wang, Xiangyu; Zhang, Rui; Zhang, Xianying; Zhao, Xin; Liu, Jian; Liu, Jing; Chen, Fangping; Lu, Ben] Cent S Univ, Xiangya Hosp 3, Key Lab Nonresolving Inflammat & Canc Hunan Prov, Changsha 410000, Hunan, Peoples R China; [Deng, Meihong; Tang, Daolin; Scott, Melanie J.; Wang, Qingde; Billiar, Timothy R.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA; [Tang, Yiting] Cent S Univ, Sch Basic Med Sci, Dept Physiol, Changsha 410000, Hunan, Peoples R China; [Li, Wenbo; Wang, Xiangyu; Zhang, Rui; Zhang, Xianying; Zhao, Xin; Liu, Jian; Lu, Ben] Cent S Univ, Sch Biol Sci & Technol, Key Lab Med Genet, Changsha 410000, Hunan, Peoples R China; [Wang, Xiangyu; Zhang, Rui; Zhang, Xianying; Zhao, Xin; Liu, Jian; Xiao, Xianzhong; Lu, Ben] Cent S Univ, Key Lab Sepsis Translat Med Hunan, Changsha 410000, Hunan, Peoples R China; [Tang, Cheng; Liu, Zhonghua] Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China; [Huang, Yongzhuo; Peng, Huige] Chinese Acad Sci, Shanghai Inst Mat Med, 501 Hai Ke Rd, Shanghai 201203, Peoples R China; [Xiao, Lehui] Nankai Univ, Coll Chem, Tianjin 300073, Peoples R China; [Watkins, Simon] Univ Pittsburgh, Sch Med, Ctr Biol Imaging, Pittsburgh, PA 15213 USA; [Li, Jianhua; Yang, Huan; Tracey, Kevin J.] Northwell Hlth, Feinstein Inst Med Res, Lab Biomed Sci, 350 Community Dr, Manhasset, NY 11030 USA; [Wang, Haichao] Northwell Hlth, North Shore Univ Hosp, Dept Emergency Med, 350 Community Dr, Manhasset, NY 11030 USA	Central South University; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Central South University; Central South University; Hunan Normal University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Nankai University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwell Health; Northwell Health; North Shore University Hospital	Lu, B (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Hematol, Changsha 410000, Hunan, Peoples R China.; Lu, B (corresponding author), Cent S Univ, Xiangya Hosp 3, Key Lab Nonresolving Inflammat & Canc Hunan Prov, Changsha 410000, Hunan, Peoples R China.; Billiar, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA.; Lu, B (corresponding author), Cent S Univ, Sch Biol Sci & Technol, Key Lab Med Genet, Changsha 410000, Hunan, Peoples R China.; Lu, B (corresponding author), Cent S Univ, Key Lab Sepsis Translat Med Hunan, Changsha 410000, Hunan, Peoples R China.	billiartr@upmc.edu; xybenlu@csu.edu.cn	Tang, Daolin/B-2905-2010; Li, Jing/GYU-5036-2022; Watkins, Simon/ABG-2590-2021; xiao, xiang/GWU-6035-2022; LI, JIAN/GRY-2197-2022; Huang, Yongzhuo/A-4688-2013; Wang, Haichao/AAU-2237-2021; li, wenbo/AAF-3106-2019; Tang, Daolin/ABD-5062-2021; Li, Jin/GYQ-5363-2022; Lu, Ben/AAN-1068-2021; li, jian/GSE-0245-2022; Xiao, Xiao/GQP-7793-2022	Watkins, Simon/0000-0003-4092-1552; Huang, Yongzhuo/0000-0001-7067-8915; Wang, Haichao/0000-0002-0211-9000; li, wenbo/0000-0002-6282-5353; Tang, Daolin/0000-0002-1903-6180; Lu, Ben/0000-0002-8597-0406; tang, cheng/0000-0002-5848-2458; Tracey, Kevin J/0000-0003-1884-6314	National key scientific project [2015CB910700]; National Natural Science Foundation of China [81422027, 81470345, 81400149, 81571879]; Innovation-driven scientific project of CSU; Outstanding young investigator fund of Hunan province; NIH [RO1GM50441, R01GM063075, R21AG052912, R01 GM102146, R01GM115366]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115366, R35GM127027, R01GM102146, R01GM050441, R35GM118182, R01GM063075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG052912] Funding Source: NIH RePORTER	National key scientific project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation-driven scientific project of CSU; Outstanding young investigator fund of Hunan province; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank R. Zhou, A. Bierhaus, and J. Hai for sharing key mouse strains (Nlrp3<SUP>-/-</SUP>, Ager<SUP>-/-</SUP>, Asc<SUP>-/-</SUP>, and Gsdmd<SUP>-/-</SUP> mice). We thank P. Loughran and H. Liao for their excellent technical support. We thank F. Liu, R. Meng, L. Gu, D. Wang, Y. Lu, and Q. Xue for managing mouse colonies and research assistance. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by National key scientific project 2015CB910700 (B.L.), National Natural Science Foundation of China (Nos. 81422027 and 81470345 (B.L.), No. 81400149 (Y.T.), and No. 81571879 (T.R.B.), Innovation-driven scientific project of CSU (B.L.), Outstanding young investigator fund of Hunan province (B. L.), and NIH grants RO1GM50441 (T.R.B.), R01GM063075 (H.W.), No. R21AG052912 (Q.W.), No. R01 GM102146 (M.J.S.), and No. R01GM115366 (D.T.).	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Deng MH, 2013, J IMMUNOL, V190, P5152, DOI 10.4049/jimmunol.1300496; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Frank MG, 2016, BRAIN BEHAV IMMUN, V55, P215, DOI 10.1016/j.bbi.2015.10.009; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huebener P, 2015, J CLIN INVEST, V125, P539, DOI 10.1172/JCI76887; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kim JH, 2009, J IMMUNOL, V182, P2458, DOI 10.4049/jimmunol.0801364; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Moyes DL, 2016, NATURE, V532, P64, DOI 10.1038/nature17625; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Ronco C, 2010, CONTRIB NEPHROL, V167, P25, DOI 10.1159/000315916; Rouhiainen A, 2007, J LEUKOCYTE BIOL, V81, P49, DOI 10.1189/jlb.0306200; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Thompson DB, 2012, CHEM BIOL, V19, P831, DOI 10.1016/j.chembiol.2012.06.014; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Valdes-Ferrer SI, 2013, J INTERN MED, V274, P381, DOI 10.1111/joim.12104; Vanaja SK, 2016, CELL, V165, P1106, DOI 10.1016/j.cell.2016.04.015; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wautier JL, 1996, J CLIN INVEST, V97, P238, DOI 10.1172/JCI118397; Wendt TM, 2003, AM J PATHOL, V162, P1123, DOI 10.1016/S0002-9440(10)63909-0; Xu J, 2014, CELL DEATH DIFFER, V21, P1229, DOI 10.1038/cdd.2014.40; Yanai H, 2013, P NATL ACAD SCI USA, V110, P20699, DOI 10.1073/pnas.1320808110; Yang H, 2015, J EXP MED, V212, P5, DOI 10.1084/jem.20141318; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Youn JH, 2011, EUR J IMMUNOL, V41, P2753, DOI 10.1002/eji.201141391; Zhang LY, 2016, J BIOL CHEM, V291, P15093, DOI 10.1074/jbc.M116.717942	49	235	250	19	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					740	+		10.1016/j.immuni.2018.08.016	http://dx.doi.org/10.1016/j.immuni.2018.08.016			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30314759	Green Accepted, Bronze			2022-12-18	WOS:000447386700018
J	Bronner, DN; Abuaita, BH; Chen, XY; Fitzgerald, KA; Nunez, G; He, YQ; Yin, XM; O'Riordan, MXD				Bronner, Denise N.; Abuaita, Basel H.; Chen, Xiaoyun; Fitzgerald, Katherine A.; Nunez, Gabriel; He, Yongqun; Yin, Xiao-Ming; O'Riordan, Mary X. D.			Endoplasmic Reticulum Stress Activates the Inflammasome via NLRP3-and Caspase-2-Driven Mitochondrial Damage	IMMUNITY			English	Article							THIOREDOXIN-INTERACTING PROTEIN; ER STRESS; CELL-DEATH; MESSENGER-RNA; LISTERIA-MONOCYTOGENES; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS; BRUCELLA-ABORTUS; CYTOCHROME-C; SECRETION	Endoplasmic reticulum (ER) stress is observed in many human diseases, often associated with inflammation. ER stress can trigger inflammation through nucleotide-binding domain and leucine-rich repeat containing (NLRP3) inflammasome, which might stimulate inflammasome formation by association with damaged mitochondria. How ER stress triggers mitochondrial dysfunction and inflammasome activation is ill defined. Here we have used an infection model to show that the IRE1 alpha ER stress sensor regulates regulated mitochondrial dysfunction through an NLRP3-mediated feed-forward loop, independently of ASC. IRE1 alpha activation increased mitochondrial reactive oxygen species, promoting NLRP3 association with mitochondria. NLRP3 was required for ER stress-induced cleavage of caspase-2 and the pro-apoptotic factor, Bid, leading to subsequent release of mitochondrial contents. Caspase-2 and Bid were necessary for activation of the canonical inflammasome by infection-associated or general ER stress. These data identify an NLRP3-caspase2- dependent mechanism that relays ER stress to the mitochondria to promote inflammation, integrating cellular stress and innate immunity.	[Bronner, Denise N.; Abuaita, Basel H.; He, Yongqun; O'Riordan, Mary X. D.] Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA; [Chen, Xiaoyun; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Div Infect Dis & Immunol, Dept Med, Sch Med, Worcester, MA 01605 USA; [Nunez, Gabriel] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA; [Nunez, Gabriel; He, Yongqun; O'Riordan, Mary X. D.] Univ Michigan, Ctr Comprehens Canc, Sch Med, Ann Arbor, MI 48109 USA; [He, Yongqun] Univ Michigan, Unit Lab Anim Med, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Indiana University System; Indiana University Bloomington; University of Massachusetts System; University of Massachusetts Worcester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	O'Riordan, MXD (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA.	oriordan@umich.edu	Nuñez, Gabriel/A-7160-2014; Fitzgerald, Katherine/ABE-6317-2020	He, Yongqun/0000-0001-9189-9661; O'Riordan, Mary/0000-0001-6014-4637; Abuaita, Basel/0000-0001-6492-2707; Fitzgerald, Kate/0000-0003-3175-609X	University of Michigan Rackham Graduate School; UM Genetics Training Program [GM007544]; UM Lung Immunopathology Training Program [HL007517]; American Heart Association; NIH [AI101777, AI083713, AI063331, AR059688, AA021751]; University of Michigan Medical School Unit for Laboratory Animal Medicine and Endowment for Basic Science; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI063331, R21AI101777, R01AI083713, R56AI063331, R01AI063331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021751] Funding Source: NIH RePORTER	University of Michigan Rackham Graduate School(University of Michigan System); UM Genetics Training Program; UM Lung Immunopathology Training Program; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Medical School Unit for Laboratory Animal Medicine and Endowment for Basic Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We acknowledge members of the M.X.D.O. laboratory for helpful discussions. We thank Drs. D. Monack and V. Carruthers for critical review of the manuscript. We are grateful to Dr. M. Swanson, Dr. V. Rathinam, Dr. Yuan He, and Dr. D. Ron for providing critical reagents and experimental guidance. We thank the staff of the UM Unit for Laboratory Animal Medicine. The University of Michigan Vector Core provided the TRC shRNA plasmids for Ern1 silencing. We acknowledge financial support from the University of Michigan Rackham Graduate School (Y.H. and D.N.B.), the UM Genetics Training Program (D.N.B., GM007544), the UM Lung Immunopathology Training Program (B.H.A., HL007517), and the American Heart Association (B.H.A.). This research was supported by funding from the NIH to M.X.D.O. (AI101777), K.A.F. (AI083713), G.N. (AI063331, AR059688), X.-M.Y. (AA021751), and the University of Michigan Medical School Unit for Laboratory Animal Medicine and Endowment for Basic Science (Y.H.). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Bronner DN, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00083; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Escames G, 2012, HUM GENET, V131, P161, DOI 10.1007/s00439-011-1057-y; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Gomes MTR, 2013, J IMMUNOL, V190, P3629, DOI 10.4049/jimmunol.1202817; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hao LY, 2013, CURR OPIN GASTROEN, V29, P363, DOI 10.1097/MOG.0b013e32836157a4; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Horng T, 2014, TRENDS IMMUNOL, V35, P253, DOI 10.1016/j.it.2014.02.007; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Korytowski W, 2011, J BIOL CHEM, V286, P26334, DOI 10.1074/jbc.M110.188516; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Li XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043512; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; OLDEN K, 1978, CELL, V13, P461, DOI 10.1016/0092-8674(78)90320-3; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pillich H, 2012, CELL MICROBIOL, V14, P949, DOI 10.1111/j.1462-5822.2012.01769.x; Qiu Q, 2013, EMBO J, V32, P2477, DOI 10.1038/emboj.2013.183; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Sandow JJ, 2014, CELL DEATH DIFFER, V21, P475, DOI 10.1038/cdd.2013.168; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; SCHRODER K, 2010, BIOCHIM BIOPHYS ACTA, V1788, P2022; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; TAN MS, 2013, MOL NEUROBIOL; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wynosky-Dolfi MA, 2014, J EXP MED, V211, P653, DOI 10.1084/jem.20130627; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; ZENG YC, 1995, EUR J BIOCHEM, V233, P458, DOI 10.1111/j.1432-1033.1995.458_2.x; Zhang QH, 2013, AUTOPHAGY, V9, P451, DOI 10.4161/auto.23691; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	59	235	239	3	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					451	462		10.1016/j.immuni.2015.08.008	http://dx.doi.org/10.1016/j.immuni.2015.08.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26341399	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000361575300008
J	Reynolds, JM; Pappu, BP; Peng, J; Martinez, GJ; Zhang, YL; Chung, Y; Ma, L; Yang, XXO; Nurieva, RI; Tian, Q; Dong, C				Reynolds, Joseph M.; Pappu, Bhanu P.; Peng, Juan; Martinez, Gustavo J.; Zhang, Yongliang; Chung, Yeonseok; Ma, Li; Yang, Xuexian O.; Nurieva, Roza I.; Tian, Qiang; Dong, Chen			Toll-like Receptor 2 Signaling in CD4(+) T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease	IMMUNITY			English	Article							TLR2 ENGAGEMENT; CELLS; LINEAGE; GAMMA; TUBERCULOSIS; INFLAMMATION; GENERATION; SYSTEM; EAE	Toll-like receptors (TLRs) have previously been shown to play critical roles in the activation of innate immunity. Here, we describe that T cell expression of TLR2 regulates T helper 17 (Th17) cell responses. Stimulation with TLR2 agonists promoted Th17 differentiation in vitro and led to more robust proliferation and Th17 cytokine production. Using the experimental autoimmune encephalomyelitis (EAE) model, we found that TLR2 regulated Th17 cell-mediated autoimmunity in vivo and that loss of TLR2 in CD4(+) T cells dramatically ameliorated EAE. This study thus reveals a critical role of a TLR in the direct regulation of adaptive immune response and pathogenesis of autoimmune diseases.	[Reynolds, Joseph M.; Pappu, Bhanu P.; Peng, Juan; Martinez, Gustavo J.; Zhang, Yongliang; Chung, Yeonseok; Yang, Xuexian O.; Nurieva, Roza I.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Reynolds, Joseph M.; Pappu, Bhanu P.; Peng, Juan; Martinez, Gustavo J.; Zhang, Yongliang; Chung, Yeonseok; Yang, Xuexian O.; Nurieva, Roza I.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX 77054 USA; [Martinez, Gustavo J.; Dong, Chen] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Ma, Li; Tian, Qiang] Inst Syst Biol, Seattle, WA 98103 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Institute for Systems Biology (ISB)	Dong, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA.	cdong@mdanderson.org	Yang, Xuexian/Y-2472-2019; dong, chen/B-3181-2009	Yang, Xuexian/0000-0001-6816-7024; dong, chen/0000-0002-0084-9130; Martinez, Gustavo/0000-0003-0178-3329; Chung, Yeonseok/0000-0001-5780-4841; Reynolds, Joseph/0000-0003-3490-0544	National Institutes of Health (NIH); National Cancer Institute (NCI); M.D. Anderson Cancer Center; American Heart Association (AHA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI071130, R01AI083761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772, RC2AR059010] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); M.D. Anderson Cancer Center; American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the flow cytometry core facility at the M.D. Anderson Cancer Center and the entire Dong lab for their help and suggestions. This work is supported by research grants from the National Institutes of Health (NIH to C.D. and R.I.N.). J.M.R. is a recipient of a T32 training grant from the National Cancer Institute (NCI). B.P.P. received an Odyssey Fellowship from the M.D. Anderson Cancer Center. G.J.M. was a Schissler Foundation M.D. Anderson Cancer Center Fellow in cancer research. R.I.N. was a recipient of a Scientist Development Grant from the American Heart Association (AHA). C.D. is a Leukemia & Lymphoma Society Scholar and a Trust Fellow of the M.D. Anderson Cancer Center.	Blink SE, 2009, CURR MOL MED, V9, P15, DOI 10.2174/156652409787314516; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Glimcher LH, 2000, GENE DEV, V14, P1693; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; MacLeod H., 2007, SCI STKE SIGNAL TRAN, V2007, DOI [10.1126/stke.4022007pe48, DOI 10.1126/STKE.4022007PE48]; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mercier BC, 2009, J IMMUNOL, V182, P1860, DOI 10.4049/jimmunol.0801167; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Peng MY, 2008, CELL MOL IMMUNOL, V5, P203, DOI 10.1038/cmi.2008.25; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Schumann RR, 2007, EUR J IMMUNOL, V37, P2059, DOI 10.1002/eji.200737604; Stenzel W, 2008, AM J PATHOL, V172, P132, DOI 10.2353/ajpath.2008.070567; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	33	235	246	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 28	2010	32	5					692	702		10.1016/j.immuni.2010.04.010	http://dx.doi.org/10.1016/j.immuni.2010.04.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20434372	Green Accepted, Bronze			2022-12-18	WOS:000278280500014
J	Xu, YK; Harder, KW; Huntington, ND; Hibbs, ML; Tarlinton, DM				Xu, YK; Harder, KW; Huntington, ND; Hibbs, ML; Tarlinton, DM			Lyn tyrosine kinase: Accentuating the positive and the negative	IMMUNITY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; FC-GAMMA-RIIB; CELL ANTIGEN RECEPTOR; SRC-FAMILY KINASES; B-CELLS; DEFICIENT MICE; AUTOIMMUNE-DISEASE; PIR-B; SIGNAL-TRANSDUCTION; MEMBRANE IMMUNOGLOBULIN	Lyn, one of several Src-family tyrosine kinases in immune cells, is noted for its ability to negatively regulate signaling pathways through phosphorylation of inhibitory receptors, enzymes, and adaptors. Somewhat paradoxically, it is also a key mediator in several pathways of B cell activation, such as CD19 and CD180. Whether Lyn functions to promote or inhibit immune cell activation depends on the stimulus and the developmental state, meaning that the consequences of Lyn activity are context dependent. The importance of regulating Lyn activity is exemplified by the pathological conditions that develop in both lyn(-/-) and lyn gain-of-function mice (lyn(up/up)), including lethal antibody-mediated autoimmune diseases and myeloid neoplasia. Here, we review the outcomes of altered Lyn activity within the framework of B cell development and differentiation and the circumstances that appear to dictate the outcome.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute; Ludwig Institute for Cancer Research	Tarlinton, DM (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	tarlinton@wehi.edu.au	Hibbs, Margaret L/D-7013-2011; Huntington, NICHOLAS/AAV-4704-2020	Hibbs, Margaret L/0000-0002-3751-6751; Huntington, NICHOLAS/0000-0002-5267-7211; Tarlinton, David/0000-0001-9928-686X				Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Ashwell JD, 1999, IMMUNOL TODAY, V20, P412, DOI 10.1016/S0167-5699(99)01505-4; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CHALUPNY NJ, 1995, EUR J IMMUNOL, V25, P2978, DOI 10.1002/eji.1830251040; Chan VWF, 1998, CURR BIOL, V8, P545, DOI 10.1016/S0960-9822(98)70223-4; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Chang KM, 1998, MICROSYST TECHNOL, V5, P93, DOI 10.1007/s005420050148; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; Fujimoto M, 2000, IMMUNITY, V13, P47, DOI 10.1016/S1074-7613(00)00007-8; Gauld SB, 2004, ONCOGENE, V23, P8001, DOI 10.1038/sj.onc.1208075; Harder KW, 2001, IMMUNITY, V15, P603, DOI 10.1016/S1074-7613(01)00208-4; Harder KW, 2004, BLOOD, V104, P3901, DOI 10.1182/blood-2003-12-4396; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hasegawa M, 2001, J IMMUNOL, V167, P2469, DOI 10.4049/jimmunol.167.5.2469; HATA A, 1994, MOL CELL BIOL, V14, P7306, DOI 10.1128/MCB.14.11.7306; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; HIBBS ML, 1995, GENE, V156, P175, DOI 10.1016/0378-1119(95)00022-X; Hibbs ML, 2002, J EXP MED, V196, P1593, DOI 10.1084/jem.20020515; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Ho LH, 1999, P NATL ACAD SCI USA, V96, P15086, DOI 10.1073/pnas.96.26.15086; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Horikawa K, 1999, INT IMMUNOL, V11, P1441, DOI 10.1093/intimm/11.9.1441; Hucka S, 2001, AUTOIMMUNITY, V33, P213, DOI 10.3109/08916930109008048; Janas ML, 1999, J IMMUNOL, V163, P4192; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Kyogoku C, 2002, ARTHRITIS RHEUM, V46, P1242, DOI 10.1002/art.10257; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; Liossis SNC, 2001, J INVEST MED, V49, P157, DOI 10.2310/6650.2001.34042; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Malek SN, 1998, P NATL ACAD SCI USA, V95, P7351, DOI 10.1073/pnas.95.13.7351; Meade J, 2004, EUR J IMMUNOL, V34, P1102, DOI 10.1002/eji.200324309; Meade J, 2002, EUR J IMMUNOL, V32, P1029, DOI 10.1002/1521-4141(200204)32:4<1029::AID-IMMU1029>3.0.CO;2-M; Nath SK, 2004, CURR OPIN IMMUNOL, V16, P794, DOI 10.1016/j.coi.2004.09.007; NEET K, 1995, MOL CELL BIOL, V15, P4908; Nishizumi H, 1998, J EXP MED, V187, P1343, DOI 10.1084/jem.187.8.1343; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; Ochi H, 2000, INT IMMUNOL, V12, P1417, DOI 10.1093/intimm/12.10.1417; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Otsuka J, 2004, ARTHRITIS RHEUM-US, V50, P871, DOI 10.1002/art.20192; PHILLIPS NE, 1984, J IMMUNOL, V132, P627; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Pritchard NR, 2000, CURR BIOL, V10, P227, DOI 10.1016/S0960-9822(00)00344-4; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Robson JD, 2004, MOL CELL BIOL, V24, P2332, DOI 10.1128/MCB.24.6.2332-2343.2004; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; Sato S, 2000, J IMMUNOL, V165, P6635, DOI 10.4049/jimmunol.165.11.6635; Satterthwaite AB, 1998, J EXP MED, V188, P833, DOI 10.1084/jem.188.5.833; Sawabe T, 2003, GENES IMMUN, V4, P122, DOI 10.1038/sj.gene.6363932; Schweighoffer E, 2003, IMMUNITY, V18, P523, DOI 10.1016/S1074-7613(03)00082-7; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Sen G, 1999, EUR J IMMUNOL, V29, P3319; Seo SJ, 2001, J IMMUNOL, V166, P3710, DOI 10.4049/jimmunol.166.6.3710; Smith BP, 1998, EXP APPL ACAROL, V22, P187, DOI 10.1023/A:1006010230247; STANLEY E, 1991, MOL CELL BIOL, V11, P3399, DOI 10.1128/MCB.11.7.3399; Su KH, 2004, J IMMUNOL, V172, P7186, DOI 10.4049/jimmunol.172.11.7186; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takeshita H, 1998, INT IMMUNOL, V10, P435, DOI 10.1093/intimm/10.4.435; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Tamir I, 1998, ONCOGENE, V17, P1353, DOI 10.1038/sj.onc.1202187; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; Tooze RM, 1997, IMMUNITY, V7, P59, DOI 10.1016/S1074-7613(00)80510-5; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; TORRES RM, 1996, SCIENCE, V272, P1802; Tridandapani S, 1998, MOL IMMUNOL, V35, P1135, DOI 10.1016/S0161-5890(98)00097-2; Tsao BP, 2003, TRENDS IMMUNOL, V24, P595, DOI 10.1016/j.it.2003.09.006; Turner M, 1997, J EXP MED, V186, P2013, DOI 10.1084/jem.186.12.2013; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; VANNOESEL CJM, 1993, INT IMMUNOL, V5, P699; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wang Y, 2002, IMMUNITY, V17, P501, DOI 10.1016/S1074-7613(02)00426-0; Whyburn LR, 2003, J IMMUNOL, V171, P1850, DOI 10.4049/jimmunol.171.4.1850; Xu YK, 2002, J IMMUNOL, V169, P6910, DOI 10.4049/jimmunol.169.12.6910; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; Yamanashi Y, 2000, GENE DEV, V14, P11; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; YAMANASHI Y, 1989, P NATL ACAD SCI USA, V86, P6538, DOI 10.1073/pnas.86.17.6538; YAMANASHI Y, 1993, P NATL ACAD SCI USA, V90, P3631, DOI 10.1073/pnas.90.8.3631; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yamashita Y, 1998, J IMMUNOL, V161, P4042; Yankee TM, 1999, J IMMUNOL, V163, P5827; Yasue T, 1997, P NATL ACAD SCI USA, V94, P10307, DOI 10.1073/pnas.94.19.10307; Yazawa N, 2003, BLOOD, V102, P1374, DOI 10.1182/blood-2002-11-3573; YI TL, 1991, MOL CELL BIOL, V11, P2391, DOI 10.1128/MCB.11.5.2391; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187	108	235	244	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2005	22	1					9	18		10.1016/j.immuni.2004.12.004	http://dx.doi.org/10.1016/j.immuni.2004.12.004			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664155	Bronze			2022-12-18	WOS:000226682900003
J	Pimentel-Muinos, FX; Seed, B				Pimentel-Muinos, FX; Seed, B			Regulated commitment of TNF receptor signaling: A molecular switch for death or activation	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; LYMPHOTOXIN-BETA-RECEPTOR; CELL-DEATH; INDUCED APOPTOSIS; T-CELLS; LYMPHOCYTES-T; MICE LACKING; FACTOR-ALPHA; KINASE RIP	Tumor necrosis factor receptor (TNFR) superfamily members can induce a context-dependent apoptosis or cell activation. However, the mechanisms by which these opposing programs are selected remain unclear. We show that in T cells, TNFR2 (TNFRSF1B) signaling is dramatically affected by the intracellular mediator RIP, a protein Ser/Thr kinase required for NF-kappa B activation by TNFR1 (TNFRSF1A). In the presence of RIP, TNFRP triggers cell death, whereas in the absence of RIP, TNFR2 activates NF-kappa B. RIP is induced during IL2-driven T cell proliferation, and its inhibition reduces susceptibility to TNF-dependent apoptosis. Evidence that signaling outputs are shaped by intracellular constraints helps reconcile conflicting views of TNFR1 and TNFRP as apoptotic mediators.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Seed, B (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.		Pimentel-Muinos, Felipe/K-4557-2014	Pimentel-Muinos, Felipe/0000-0002-0258-2855	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI027849, R01AI027849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043039] Funding Source: NIH RePORTER; NIAID NIH HHS [AI27849] Funding Source: Medline; NIDDK NIH HHS [DK43039] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; Alexander-Miller MA, 1998, J EXP MED, V188, P1391, DOI 10.1084/jem.188.8.1391; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ausubel F., 1992, MOL REPROD DEV, DOI DOI 10.1002/MRD.1080010210; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Declercq W, 1998, J IMMUNOL, V161, P390; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; Force WR, 1997, J BIOL CHEM, V272, P30835, DOI 10.1074/jbc.272.49.30835; GEHR G, 1992, J IMMUNOL, V149, P911; GOODWIN RG, 1993, CELL, V73, P447, DOI 10.1016/0092-8674(93)90133-B; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Grell M, 1998, EUR J IMMUNOL, V28, P257, DOI 10.1002/(SICI)1521-4141(199801)28:01<257::AID-IMMU257>3.0.CO;2-G; GRELL M, 1993, LYMPHOKINE CYTOK RES, V12, P143; Haridas V, 1998, J IMMUNOL, V160, P3152; HELLER RA, 1992, CELL, V70, P47; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506; Hess S, 1996, J EXP MED, V183, P159, DOI 10.1084/jem.183.1.159; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lee YT, 1996, FUSION TECHNOL, V30, P669, DOI 10.13182/FST96-A11963013; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mackay F, 1996, J BIOL CHEM, V271, P24934, DOI 10.1074/jbc.271.40.24934; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; Nakajima H, 1997, J IMMUNOL, V159, P4737; Ponton A, 1996, J BIOL CHEM, V271, P8991, DOI 10.1074/jbc.271.15.8991; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SARIN A, 1995, J IMMUNOL, V155, P3716; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1993, CELL, V73, P213, DOI 10.1016/0092-8674(93)90222-C; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TARTAGLIA LA, 1993, J IMMUNOL, V151, P4637; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VANDENABEELE P, 1995, J IMMUNOL, V154, P2904; VANDENABEELE P, 1992, J EXP MED, V176, P1015, DOI 10.1084/jem.176.4.1015; Varfolomeev EE, 1996, J EXP MED, V183, P1271, DOI 10.1084/jem.183.3.1271; WALLACH D, 1984, J IMMUNOL, V132, P2464; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; WARE CF, 1991, J IMMUNOL, V147, P4229; Weiss T, 1997, J IMMUNOL, V158, P2398; Winoto A, 1997, CURR OPIN IMMUNOL, V9, P365, DOI 10.1016/S0952-7915(97)80083-0; YOKOTA S, 1988, J IMMUNOL, V140, P531; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	70	235	242	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1999	11	6					783	793		10.1016/S1074-7613(00)80152-1	http://dx.doi.org/10.1016/S1074-7613(00)80152-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626900	Bronze			2022-12-18	WOS:000084612900014
J	SYKULEV, Y; BRUNMARK, A; JACKSON, M; COHEN, RJ; PETERSON, PA; EISEN, HN				SYKULEV, Y; BRUNMARK, A; JACKSON, M; COHEN, RJ; PETERSON, PA; EISEN, HN			KINETICS AND AFFINITY OF REACTIONS BETWEEN AN ANTIGEN-SPECIFIC T-CELL RECEPTOR AND PEPTIDE-MHC COMPLEXES	IMMUNITY			English	Article							DROSOPHILA-MELANOGASTER CELLS; POSITIVE SELECTION; LYMPHOCYTES-T; MOLECULES; THYMUS; RECOGNITION; BINDING; CLONE; DETERMINANT; ASSOCIATION	We show here that the net rate of accumulation of complexes formed by the antigen-specific receptor of T cells (TCR) of a T cell clone with its natural ligand, an octapeptide in association with L(d), a class I protein of the major histocompatibility complex (MHC), approaches the maximal value determined by the affinity of the TCR for this peptide-MHC ligand in 1-2 min, which is well within the lifetime of transient T cell-target cell conjugates. Consistent with this finding, we also found that the widely divergent affinity values (equilibrium constants) of this TCR for six related peptide-MHC complexes correlate well with the extent of specific lysis of target cells bearing various level of these complexes.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA; HARVARD UNIV, MIT, HLTH SCI & TECHNOL PROGRAM, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT); Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT)	SYKULEV, Y (corresponding author), MIT, CTR CANC RES, CAMBRIDGE, MA 02139 USA.				NATIONAL CANCER INSTITUTE [R35CA042504, R01CA060686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034247] Funding Source: NIH RePORTER; NCI NIH HHS [R35-CA42504, CA60686] Funding Source: Medline; NIAID NIH HHS [AI34247] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; CARBONE FR, 1992, INT IMMUNOL, V4, P861, DOI 10.1093/intimm/4.8.861; CHALUPNY NJ, 1991, EMBO J, V10, P1201, DOI 10.1002/j.1460-2075.1991.tb08061.x; CHANG TW, 1979, P NATL ACAD SCI USA, V76, P2917, DOI 10.1073/pnas.76.6.2917; CORR M, 1992, J EXP MED, V176, P1681, DOI 10.1084/jem.176.6.1681; DAVIS MM, 1990, ANNU REV BIOCHEM, V59, P475, DOI 10.1146/annurev.biochem.59.1.475; DAVIS MM, 1993, CURR OPIN IMMUNOL, V5, P45, DOI 10.1016/0952-7915(93)90079-8; DAY ED, 1990, ADV IMMUNOCHEMISTRY, P281; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KLOTZ IM, 1982, SCIENCE, V217, P1247, DOI 10.1126/science.6287580; KOCKS C, 1989, ANNU REV IMMUNOL, V7, P537, DOI 10.1146/annurev.iy.07.040189.002541; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P7922, DOI 10.1073/pnas.81.24.7922; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MULLER R, 1983, METHOD ENZYMOL, V92, P589; NISONOFF A, 1959, J AM CHEM SOC, V81, P1418, DOI 10.1021/ja01515a033; POENIE M, 1987, EMBO J, V6, P2223, DOI 10.1002/j.1460-2075.1987.tb02494.x; REDDEHASE MJ, 1989, NATURE, V337, P651, DOI 10.1038/337651a0; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SU MWC, 1993, J IMMUNOL, V151, P658; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; UDAKA K, 1993, P NATL ACAD SCI USA, V90, P11272, DOI 10.1073/pnas.90.23.11272; VANBLEEK GM, 1990, NATURE, V348, P213; VELICK SF, 1960, P NATL ACAD SCI USA, V46, P1470, DOI 10.1073/pnas.46.11.1470; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; WEIGERT MG, 1970, NATURE, V228, P1054; WILLIAMS AF, 1992, NATURE, V356, P746, DOI 10.1038/356746a0; ZHOU XZ, 1992, J IMMUNOL METHODS, V153, P193, DOI 10.1016/0022-1759(92)90322-K	40	235	239	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1994	1	1					15	22		10.1016/1074-7613(94)90005-1	http://dx.doi.org/10.1016/1074-7613(94)90005-1			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK154	7889394				2022-12-18	WOS:A1994PK15400003
J	Shalova, IN; Lim, JY; Chittezhath, M; Zinkernagel, AS; Beasley, F; Hernandez-Jimenez, E; Toledano, V; Cubillos-Zapata, C; Rapisarda, A; Chen, JM; Duan, KB; Yang, H; Poidinger, M; Melillo, G; Nizet, V; Arnalich, F; Lopez-Collazo, E; Biswas, SK				Shalova, Irina N.; Lim, Jyue Yuan; Chittezhath, Manesh; Zinkernagel, Annelies S.; Beasley, Federico; Hernandez-Jimenez, Enrique; Toledano, Victor; Cubillos-Zapata, Carolina; Rapisarda, Annamaria; Chen, Jinmiao; Duan, Kaibo; Yang, Henry; Poidinger, Michael; Melillo, Giovanni; Nizet, Victor; Arnalich, Francisco; Lopez-Collazo, Eduardo; Biswas, Subhra K.			Human Monocytes Undergo Functional Re-programming during Sepsis Mediated by Hypoxia-Inducible Factor-1 alpha	IMMUNITY			English	Article							MOUSE MACROPHAGES; GENE-EXPRESSION; SEPTIC SHOCK; KAPPA-B; IRAK-M; HIF-1-ALPHA; IMMUNOSUPPRESSION; POLARIZATION; TOLERANCE; CELLS	Sepsis is characterized by a dysregulated inflammatory response to infection. Despite studies in mice, the cellular and molecular basis of human sepsis remains unclear and effective therapies are lacking. Blood monocytes serve as the first line of host defense and are equipped to recognize and respond to infection by triggering an immune-inflammatory response. However, the response of these cells in human sepsis and their contribution to sepsis pathogenesis is poorly understood. To investigate this, we performed a transcriptomic, functional, and mechanistic analysis of blood monocytes from patients during sepsis and after recovery. Our results revealed the functional plasticity of monocytes during human sepsis, wherein they transited from a pro-inflammatory to an immunosuppressive phenotype, while enhancing protective functions like phagocytosis, anti-microbial activity, and tissue remodeling. Mechanistically, hypoxia inducible factor-1 alpha (HIF1 alpha) mediated this functional re-programming of monocytes, revealing a potential mechanism for their therapeutic targeting to regulate human sepsis.	[Shalova, Irina N.; Lim, Jyue Yuan; Chittezhath, Manesh; Chen, Jinmiao; Duan, Kaibo; Yang, Henry; Poidinger, Michael; Biswas, Subhra K.] Biopolis, Agcy Sci Technol & Res, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Zinkernagel, Annelies S.; Beasley, Federico; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Hernandez-Jimenez, Enrique; Toledano, Victor; Cubillos-Zapata, Carolina; Lopez-Collazo, Eduardo] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Hernandez-Jimenez, Enrique; Toledano, Victor; Cubillos-Zapata, Carolina; Lopez-Collazo, Eduardo] La Paz Hosp, IdiPAZ, Tumor Immunol Lab, Madrid 28046, Spain; [Rapisarda, Annamaria; Melillo, Giovanni] La Paz Hosp, IdiPAZ, Innate Immun Grp, Madrid 28046, Spain; [Rapisarda, Annamaria; Melillo, Giovanni] NCI, Dev Therapeut Program, Tumor Hypoxia Lab, Sci Applicat Int Corp Frederick Inc, Frederick, MD 21701 USA; [Arnalich, Francisco] La Paz Hosp, Dept Internal Med, Madrid 28046, Spain	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of California System; University of California San Diego; University of California System; University of California San Diego; Hospital Universitario La Paz; Hospital Universitario La Paz; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Hospital Universitario La Paz	Biswas, SK (corresponding author), Biopolis, Agcy Sci Technol & Res, Singapore Immunol Network SIgN, 04-06 Immunos Bldg,8A Biomed Grove, Singapore 138648, Singapore.	subhra_biswas@immunol.a-star.edu.sg	Chen, Jinmiao/ABE-5601-2021; Zinkernagel, Annelies S/F-1780-2017; Arnalich, Francisco/AAF-5924-2021; Zapata, Carolina Cubillos/H-3058-2017; Arnalich, Francisco/K-7723-2014; Arnalich, Francisco/J-8184-2017; Nizet, Victor/AAF-3190-2019	Zinkernagel, Annelies S/0000-0003-4700-1118; Arnalich, Francisco/0000-0003-2943-0373; Zapata, Carolina Cubillos/0000-0002-1948-4514; Poidinger, Michael/0000-0002-1047-2277; Hernandez Jimenez, Enrique/0000-0002-8232-8151; Nizet, Victor/0000-0003-3847-0422	SIgN; A*STAR; Fondos de Investigacion Sanitaria [PI11/00350]; Health Sciences Authority, Singapore	SIgN; A*STAR(Agency for Science Technology & Research (A*STAR)); Fondos de Investigacion Sanitaria(Instituto de Salud Carlos III); Health Sciences Authority, Singapore	S.K.B. thanks core funding of SIgN, A*STAR, and E.L.-C. thanks Fondos de Investigacion Sanitaria (PI11/00350) for the funding this research. We thank the Health Sciences Authority, Singapore, for their kind support with the blood supply. We are grateful to Ms. Josephine Lum and Dr. Francesca Zolezzi for their kind help with the transcriptomics. We also thank the Flow Cytometry and Immunomonitoring Platforms (SIgN). We thank Dr. John Common and Professor Birgitte Lane (Institute of Medical Biology, A*STAR) for their help in providing human fibroblasts for wound healing assay. Dr. Neil McCarthy of Insight Editing London edited the manuscript. G.M. is presently an employee of AstraZeneca and has no conflict of interest related to this work.	Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Bosco MC, 2006, J IMMUNOL, V177, P1941, DOI 10.4049/jimmunol.177.3.1941; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Huang Y, 2003, LEUKEMIA, V17, P2065, DOI 10.1038/sj.leu.2403141; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lopez-Collazo E, 2006, CURR OPIN INFECT DIS, V19, P237, DOI 10.1097/01.qco.0000224817.35105.7d; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Pachot A, 2006, IMMUNOL LETT, V106, P63, DOI 10.1016/j.imlet.2006.04.010; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Standage SW, 2011, EXPERT REV ANTI-INFE, V9, P71, DOI [10.1586/eri.10.154, 10.1586/ERI.10.154]; Tang BM, 2010, CRIT CARE, V14, DOI 10.1186/cc9392; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Torgersen C, 2009, ANESTH ANALG, V108, P1841, DOI 10.1213/ane.0b013e318195e11d; Valdes-Ferrer SI, 2013, J INTERN MED, V274, P381, DOI 10.1111/joim.12104; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC	40	234	245	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					484	498		10.1016/j.immuni.2015.02.001	http://dx.doi.org/10.1016/j.immuni.2015.02.001			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25746953	Bronze			2022-12-18	WOS:000351301900013
J	Ponpuak, M; Davis, AS; Roberts, EA; Delgado, MA; Dinkins, C; Zhao, ZJ; Virgin, HW; Kyei, GB; Johansen, T; Vergne, I; Deretic, V				Ponpuak, Marisa; Davis, Alexander S.; Roberts, Esteban A.; Delgado, Monica A.; Dinkins, Christina; Zhao, Zijiang; Virgin, Herbert W.; Kyei, George B.; Johansen, Terje; Vergne, Isabelle; Deretic, Vojo			Delivery of Cytosolic Components by Autophagic Adaptor Protein p62 Endows Autophagosomes with Unique Antimicrobial Properties	IMMUNITY			English	Article							UBIQUITIN-LIKE PROTEIN; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR MYCOBACTERIA; SELECTIVE AUTOPHAGY; STRUCTURAL BASIS; INNATE IMMUNITY; IN-VITRO; DEGRADATION; PEPTIDES; MACROPHAGES	Autophagy allows cells to self-digest portions of their own cytoplasm for a multitude of physiological purposes, including innate and adaptive immunity functions. In one of its innate immunity manifestations, autophagy, is known to contribute to the killing of intracellular microbes, including Mycobacterium tuberculosis, although the molecular mechanisms have been unclear. Here, we delineated sequential steps of the autophagic pathway necessary to control intracellular M. tuberculosis and found that in addition to autophagy initiation and maturation, an accessory autophagy-targeting molecule p62 (A170 or SQSTM1) was required for mycobactericidal activity. The p62 adaptor protein delivered specific ribosomal and bulk ubiquitinated cytosolic proteins to autolysosomes where they were proteolytically converted into products capable of killing M. tuberculosis. Thus, p62 brings cytosolic proteins to autolysosomes where they are processed from innocuous precursors into neo-antimicrobial peptides, explaining in part the unique bactericidal properties of autophagic organelles.	[Ponpuak, Marisa; Davis, Alexander S.; Roberts, Esteban A.; Delgado, Monica A.; Dinkins, Christina; Kyei, George B.; Vergne, Isabelle; Deretic, Vojo] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Ponpuak, Marisa] Mahidol Univ, Dept Microbiol, Fac Sci, Bangkok 10400, Thailand; [Zhao, Zijiang; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Johansen, Terje] Univ Tromso, Inst Med Biol, Dept Biochem, N-9037 Tromso, Norway	University of New Mexico; Mahidol University; Washington University (WUSTL); UiT The Arctic University of Tromso	Deretic, V (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	vderetic@salud.unm.edu	Johansen, Terje/AAY-1753-2021; Kyei, George/AAH-1059-2020; Johansen, Terje/N-2971-2015; Dinkins, Christina/AAD-7473-2019	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Ponpuak, Marisa/0000-0002-2889-1314; Vergne, Isabelle/0000-0003-1924-9474; Latagan, Christina/0000-0003-2535-625X; Virgin, Herbert/0000-0001-8580-7628; Deretic, Vojo/0000-0002-3624-5208; Kyei, George/0000-0002-8678-4656	NIH [AI069345, AI045148, AI042999, AI057160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045148, U54AI057160, T32AI007538, R01AI042999, R01AI069345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Komatsu, Fukushima Medical University School of Medicine, Japan, for p62-deficient and -sufficient mice and Z. Elazar, The Weizmann Institute of Science, Israel, and Takashi Ueno, Juntendo University School of Medicine, Japan, for LC3 antibodies. This work was supported by NIH grants A1069345, A1045148, and A1042999 to V.D. and A1057160 Project 5 to H.V.	Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; APLIN A, 1992, J CELL PHYSIOL, V152, P458, DOI 10.1002/jcp.1041520304; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Baker RT, 1996, J BIOL CHEM, V271, P13549, DOI 10.1074/jbc.271.23.13549; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Hiemstra PS, 1999, J LEUKOCYTE BIOL, V66, P423, DOI 10.1002/jlb.66.3.423; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Howell SJ, 2003, PEPTIDES, V24, P1763, DOI 10.1016/j.peptides.2003.07.028; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kieffer AE, 2003, FASEB J, V17, P776, DOI 10.1096/fj.02-0699fje; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kraft M, 2008, EUR RESPIR J, V31, P43, DOI 10.1183/09031936.00103307; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Miyakawa Y, 1996, INFECT IMMUN, V64, P926, DOI 10.1128/IAI.64.3.926-932.1996; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; OLVERA J, 1993, J BIOL CHEM, V268, P17967; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Ponpuak M, 2009, METHOD ENZYMOL, V452, P345, DOI 10.1016/S0076-6879(08)03621-5; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Sharma S, 2000, EUR RESPIR J, V16, P112, DOI 10.1034/j.1399-3003.2000.16a20.x; Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Tollin M, 2003, PEPTIDES, V24, P523, DOI 10.1016/S0196-9781(03)00114-1; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Wang YQ, 2002, EUR J BIOCHEM, V269, P512, DOI 10.1046/j.0014-2956.2001.02675.x; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	58	234	242	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 26	2010	32	3					329	341		10.1016/j.immuni.2010.02.009	http://dx.doi.org/10.1016/j.immuni.2010.02.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20206555	Green Accepted, Bronze			2022-12-18	WOS:000276125400007
J	Hauser, AE; Junt, T; Mempel, TR; Sneddon, MW; Kleinstein, SH; Henrickson, SE; von Andrian, UH; Shlomchik, MJ; Haberman, AM				Hauser, Anja E.; Junt, Tobias; Mempel, Thorsten R.; Sneddon, Michael W.; Kleinstein, Steven H.; Henrickson, Sarah E.; von Andrian, Ulrich H.; Shlomchik, Mark J.; Haberman, Ann M.			Definition of germinal-center B cell migration in vivo reveals predominant intrazonal circulation patterns	IMMUNITY			English	Article							FOLLICULAR DENDRITIC CELLS; GREEN FLUORESCENT PROTEIN; ANTIGEN-DRIVEN SELECTION; SOMATIC MUTATION; IMMUNE-RESPONSE; T-CELLS; AFFINITY MATURATION; LYMPH-NODES; MICE; IMMUNOGLOBULIN	Proliferation, mutation, and selection in the germinal center (GC) are thought to occur in distinct microanatomical compartments-the dark zone (DZ) and the light zone (LZ). Thus, affinity maturation has been posited to require frequent trafficking between zones. Here we report the use of multiphoton in vivo microscopy to determine migration patterns of GC B cells. Analysis of time-resolved images revealed unexpected patterns of movement as well as GC B cell morphology. Though frequent movement between the DZ and LZ was anticipated, few cells were observed to cross the interface between the two compartments. Moreover, cell-track trajectories indicated that cell movement in this region is predominantly parallel to the interface, suggesting that B cells circulate within individual LZ and DZ compartments. The results suggest a revision to our views of B cell circulation within GCs and the functional relationship of its two major compartments.	Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06511 USA; Yale Univ, Sch Med, Interdepartmental Program Computat Biol & Bioinfo, New Haven, CT 06511 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06511 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Yale University; Yale University; Yale University; Harvard University; Harvard Medical School	Haberman, AM (corresponding author), Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06511 USA.	ann.haberman@yale.edu	von Andrian, Ulrich H/A-5775-2008; Junt, Tobias/AAE-4389-2021; Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Hauser, Anja Erika/0000-0002-7725-9526; Henrickson, Sarah/0000-0001-5569-4132	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI43603] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Andersson G, 2003, MOL THER, V8, P385, DOI 10.1016/S1525-0016(03)00210-7; Arce S, 2004, J LEUKOCYTE BIOL, V75, P1022, DOI 10.1189/jlb.0603279; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Cattoretti G, 2005, J PATHOL, V206, P76, DOI 10.1002/path.1752; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Dubois B, 1999, J IMMUNOL, V162, P3428; Fischer MB, 1998, SCIENCE, V280, P582, DOI 10.1126/science.280.5363.582; Grouard G, 1996, NATURE, V384, P364, DOI 10.1038/384364a0; GulbransonJudge A, 1996, EUR J IMMUNOL, V26, P1830, DOI 10.1002/eji.1830260825; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; HARDIE DL, 1993, EUR J IMMUNOL, V23, P997, DOI 10.1002/eji.1830230502; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; Kim MY, 2003, IMMUNITY, V18, P643, DOI 10.1016/S1074-7613(03)00110-9; Kleinstein SH, 2001, J THEOR BIOL, V211, P253, DOI 10.1006/jtbi.2001.2344; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LINDHOUT E, 1993, CLIN EXP IMMUNOL, V91, P330; Liu YJ, 1997, CURR OPIN IMMUNOL, V9, P256, DOI 10.1016/S0952-7915(97)80145-8; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LIU YJ, 1992, IMMUNOL TODAY, V13, P17, DOI 10.1016/0167-5699(92)90199-H; Liu YJ, 1997, J EXP MED, V185, P165, DOI 10.1084/jem.185.1.165; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Oprea M, 1997, J IMMUNOL, V158, P5155; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Qin DH, 2000, J IMMUNOL, V164, P6268, DOI 10.4049/jimmunol.164.12.6268; RETH M, 1978, EUR J IMMUNOL, V8, P393, DOI 10.1002/eji.1830080605; ROGERSON B, 1991, EMBO J, V10, P4331, DOI 10.1002/j.1460-2075.1991.tb05011.x; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shlomchik MJ, 1998, CURR TOP MICROBIOL, V229, P173; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Ursini-Siegel J, 2002, J IMMUNOL, V169, P5505, DOI 10.4049/jimmunol.169.10.5505; Wang TJ, 2005, ENERG FUEL, V19, P22, DOI 10.1021/ef030116r; Wykes M, 1998, J IMMUNOL, V161, P1313; ZHANG J, 1988, IMMUNOL LETT, V18, P297, DOI 10.1016/0165-2478(88)90178-2	53	234	236	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2007	26	5					655	667		10.1016/j.immuni.2007.04.008	http://dx.doi.org/10.1016/j.immuni.2007.04.008			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17509908	Bronze			2022-12-18	WOS:000246895900017
J	Zhu, JF; Cote-Sierra, J; Guo, LY; Paul, WE				Zhu, JF; Cote-Sierra, J; Guo, LY; Paul, WE			Stat5 activation plays a critical role in Th2 differentiation	IMMUNITY			English	Article							CYTOKINE GENE-EXPRESSION; PERIPHERAL T-CELLS; IN-VIVO; TRANSCRIPTION FACTOR; IL-4 PRODUCTION; COORDINATE REGULATOR; LINEAGE COMMITMENT; MAST-CELLS; GATA-3; RECEPTOR	Upon TCR engagement, naive CD4 T cells differentiate toward the Th1 or Th2 phenotype. IL-4, acting through Stat6, plays a major role in Th2 differentiation; IL-2 has also been reported to be essential. Here, we report that retroviral (RV)-mediated expression of a constitutively active Stat5A mutant (STAT5A1*6) can fully restore IL-4 production when naive CD4 T cells are primed in the absence of IL-2. Furthermore, STAT5A1*6 expression causes Th2 differentiation in the absence of IL-4 or in Stat6- or IL-4Ralpha-deficient cells. Infection with STAT5A1*6-NGFR-RV does not enhance GATA-3 expression. STAT5A1*6-NGFR-RV and GATA-3-GFP-RV each render the II4 gene accessible, but the sites of restriction enzyme accessibility are different. Stat5A binds to HSII and HSIII sites of the II4 gene. Coinfection with STAT5A1*6-NGFR-RV and GATA-3-GFP-RV results in optimal Th2 priming.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhu, JF (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.		Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493, Z01AI000493] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ariyoshi K, 2000, J BIOL CHEM, V275, P24407, DOI 10.1074/jbc.M909771199; AUEMHAMMER CJ, 1999, P NATL ACAD SCI USA, V96, P6964; BENSASSON SZ, 1990, J IMMUNOL, V145, P1127; Boer AK, 2002, BLOOD, V100, P467, DOI 10.1182/blood.V100.2.467; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Hural JA, 2000, J IMMUNOL, V165, P3239, DOI 10.4049/jimmunol.165.6.3239; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Kagami S, 2000, BLOOD, V95, P1370, DOI 10.1182/blood.V95.4.1370.004k29_1370_1377; Kagami S, 2001, BLOOD, V97, P2358, DOI 10.1182/blood.V97.8.2358; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mora AL, 2001, J IMMUNOL, V166, P2218, DOI 10.4049/jimmunol.166.4.2218; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakajima H, 2001, EMBO J, V20, P6836, DOI 10.1093/emboj/20.23.6836; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamashita M, 2000, J EXP MED, V191, P1869, DOI 10.1084/jem.191.11.1869; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	42	234	239	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2003	19	5					739	748		10.1016/S1074-7613(03)00292-9	http://dx.doi.org/10.1016/S1074-7613(03)00292-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614860	Bronze			2022-12-18	WOS:000186672200013
J	Selin, LK; Lin, MY; Kraemer, KA; Pardoll, DM; Schneck, JP; Varga, SM; Santolucito, PA; Pinto, AK; Welsh, RM				Selin, LK; Lin, MY; Kraemer, KA; Pardoll, DM; Schneck, JP; Varga, SM; Santolucito, PA; Pinto, AK; Welsh, RM			Attrition of T cell memory: Selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; VIRAL-INFECTION; BYSTANDER ACTIVATION; DIRECT VISUALIZATION; ANCHOR RESIDUES; ANTIGEN; CD4(+); RECEPTOR; REPERTOIRE; STABILITY	Using a variety of techniques, including limiting dilution assays (LDA), intracellular IFN gamma assays, and D-b-IgG1 MHC dimer staining to measure viral peptide-specific T cell number and function, we show here that heterologous virus infections quantitatively delete and qualitatively alter the memory pool of T cells specific to a previously encountered virus. We also show that a prior history of a virus infection can alter the hierarchy of the immunodominant peptide response to a second virus and that virus infections selectively reactivate memory T cells with distinct specificities to earlier viruses. These results are consistent with a model for the immune system that accommodates memory T cell populations for multiple pathogens over the course of a lifetime.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	University of Massachusetts System; University of Massachusetts Worcester; Johns Hopkins University; Johns Hopkins University	Welsh, RM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.		Pinto, Amelia/AAD-7059-2020; Pinto, Amelia K/O-6658-2018; Varga, Steven/C-2009-2009	Pinto, Amelia/0000-0002-7147-3978; Pinto, Amelia K/0000-0002-7147-3978; Varga, Steven/0000-0001-7332-4290; Selin, Liisa/0000-0002-6993-4333	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017672, R37AI017672, K08AI001362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035506] Funding Source: NIH RePORTER; NIAID NIH HHS [AI01362, AI-17672] Funding Source: Medline; NIAMS NIH HHS [AR-35506] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; DALPORTO J, 1993, P NATL ACAD SCI USA, V90, P6671, DOI 10.1073/pnas.90.14.6671; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Hudrisier D, 1996, J BIOL CHEM, V271, P17829, DOI 10.1074/jbc.271.30.17829; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lin MY, 1998, J EXP MED, V188, P1993, DOI 10.1084/jem.188.11.1993; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; OEHEN S, 1992, J EXP MED, V176, P1273, DOI 10.1084/jem.176.5.1273; OLDSTONE MBA, 1995, J VIROL, V69, P7423, DOI 10.1128/JVI.69.12.7423-7429.1995; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; PROSS HF, 1981, J CLIN IMMUNOL, V1, P51, DOI 10.1007/BF00915477; SELIN LK, 1994, CURR OPIN IMMUNOL, V6, P553, DOI 10.1016/0952-7915(94)90140-6; Selin LK, 1997, J IMMUNOL, V158, P5366; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705; SELIN LK, 1994, J EXP MED, V179, P1933, DOI 10.1084/jem.179.6.1933; TANAKA Y, 1988, J IMMUNOL, V140, P4348; Varga SM, 1998, J IMMUNOL, V161, P3215; Varga SM, 1998, J IMMUNOL, V161, P367; Welsh RM, 1999, CURR OPIN MICROBIOL, V2, P382; WELSH RM, 1976, VIROLOGY, V73, P59, DOI 10.1016/0042-6822(76)90060-X; Welsh RM, 1997, IMMUNOL REV, V159, P79, DOI 10.1111/j.1600-065X.1997.tb01008.x; YANG HY, 1989, J IMMUNOL, V142, P1710; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zarozinski CC, 1997, J EXP MED, V185, P1629, DOI 10.1084/jem.185.9.1629	35	234	237	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1999	11	6					733	742		10.1016/S1074-7613(00)80147-8	http://dx.doi.org/10.1016/S1074-7613(00)80147-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626895	Bronze			2022-12-18	WOS:000084612900009
J	Koppelman, B; Neefjes, JJ; de Vries, JE; Malefyt, RD				Koppelman, B; Neefjes, JJ; de Vries, JE; Malefyt, RD			Interleukin-10 down-regulates MHC class II alpha beta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling	IMMUNITY			English	Article							HUMAN T-CELLS; INVARIANT-CHAIN; HLA-DR; MONOCLONAL-ANTIBODIES; ANTIGEN PRESENTATION; SURFACE EXPRESSION; CYTOKINE PRODUCTION; B-CELLS; IL-10; MOLECULES	Interleukin-10 (IL-10) inhibits antigen-specific T cell responses when human monocytes are used as antigen-presenting cells. This is correlated with a downregulation of MHC class II molecules on the surface of the monocyte. Here we show that IL-10 does not affect MHC class II transcription, polypeptide synthesis, subunit assembly, or antigenic peptide loading. Instead, newly synthesized mature MHC class II molecules are localized to the MHC class II loading compartment but are prevented from reaching the plasma membrane. In addition, treatment of monocytes with IL-10 leads to an accumulation of internalized MHC class II complexes in intracellular vesicles. These results indicate that IL-10 affects antigen presentation by regulating MHC exocytosis and recycling.	DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA 94304 USA; Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Netherlands Cancer Institute	Malefyt, RD (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, 901 Calif Ave, Palo Alto, CA 94304 USA.	rene@dnax.org	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; de Waal Malefyt, Rene/0000-0002-2663-383X				ABRAMS JS, 1992, IMMUNOL REV, V127, P5, DOI 10.1111/j.1600-065X.1992.tb01406.x; BARCY S, 1995, INT IMMUNOL, V7, P179, DOI 10.1093/intimm/7.2.179; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BASHAM TY, 1983, J IMMUNOL, V130, P1492; BENAROCH P, 1995, EMBO J, V14, P37, DOI 10.1002/j.1460-2075.1995.tb06973.x; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; CHIN J, 1993, J IMMUNOL, V151, P5574; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; FREI K, 1994, J IMMUNOL, V152, P2720; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; GRUBER MF, 1994, J IMMUNOL, V152, P1354; GUY K, 1982, EUR J IMMUNOL, V12, P942, DOI 10.1002/eji.1830121109; KOPPELMAN B, 1990, J IMMUNOL, V145, P2730; KRANGEL MS, 1979, CELL, V18, P979, DOI 10.1016/0092-8674(79)90210-1; KUBIN M, 1994, J EXP MED, V180, P211, DOI 10.1084/jem.180.1.211; LAMPSON LA, 1980, J IMMUNOL, V125, P293; LIU Y, 1994, J IMMUNOL, V152, P1821; MACHAMER CE, 1984, P NATL ACAD SCI-BIOL, V81, P1287, DOI 10.1073/pnas.81.5.1287; MACNEIL IA, 1990, J IMMUNOL, V145, P4167; MALEFYT RD, 1991, J EXP MED, V174, P1209; MALEFYT RD, 1991, J EXP MED, V174, P915; MALEFYT RD, 1989, J IMMUNOL, V142, P3634; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; MATTHES T, 1993, J EXP MED, V178, P521, DOI 10.1084/jem.178.2.521; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NOWELL J, 1985, J EXP MED, V162, P1371, DOI 10.1084/jem.162.4.1371; PEGUETNAVARRO J, 1994, EUR J IMMUNOL, V24, P884, DOI 10.1002/eji.1830240416; PHILLIPS JH, 1992, J EXP MED, V175, P1055, DOI 10.1084/jem.175.4.1055; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; QUARANTA V, 1981, IMMUNOGENETICS, V12, P175, DOI 10.1007/BF01561660; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; SalazarOnfray F, 1997, J IMMUNOL, V159, P3195; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; SHAW S, 1985, HUM IMMUNOL, V12, P191, DOI 10.1016/0198-8859(85)90336-2; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SMITH BR, 1981, J IMMUNOL, V127, P2020; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; VELDE AAT, 1992, J IMMUNOL, V149, P4048; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; Warmerdam PAM, 1996, J CELL BIOL, V133, P281, DOI 10.1083/jcb.133.2.281; WILLEMS F, 1994, EUR J IMMUNOL, V24, P1007, DOI 10.1002/eji.1830240435; YSSEL H, 1992, J IMMUNOL, V149, P2378; Zeidler R, 1997, BLOOD, V90, P2390; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429	54	234	239	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1997	7	6					861	871		10.1016/S1074-7613(00)80404-5	http://dx.doi.org/10.1016/S1074-7613(00)80404-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430231	Bronze			2022-12-18	WOS:000071351300013
J	Jondal, M; Schirmbeck, R; Reimann, J				Jondal, M; Schirmbeck, R; Reimann, J			MHC class I-restricted CTL responses to exogenous antigens	IMMUNITY			English	Review							CYTOTOXIC-T-LYMPHOCYTES; HISTOCOMPATIBILITY COMPLEX-MOLECULES; HEAT-SHOCK PROTEINS; SYNTHETIC LIPOPEPTIDE VACCINE; B SURFACE-ANTIGEN; MINOR H-ANTIGENS; DENDRITIC CELLS; SOLUBLE-PROTEIN; PEPTIDE LIGAND; IMMUNE-RESPONSES		UNIV ULM,INST MED MICROBIOL,D-89069 ULM,GERMANY	Ulm University	Jondal, M (corresponding author), KAROLINSKA INST,CTR MICROBIOL & TUMOR BIOL,S-17177 STOCKHOLM,SWEDEN.							AGGARWAL A, 1990, J EXP MED, V172, P1083, DOI 10.1084/jem.172.4.1083; ALCHELE P, 1990, J EXP MED, V171, P1815; ALDOVINI A, 1991, NATURE, V351, P479, DOI 10.1038/351479a0; ALLEN H, 1986, P NATL ACAD SCI USA, V83, P7447, DOI 10.1073/pnas.83.19.7447; Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; ANDREWS NW, 1994, BRAZ J MED BIOL RES, V27, P471; AUTHIER F, 1994, CELLULAR PROTEOLYTIC, P89; BACHMANN MF, 1995, EUR J IMMUNOL, V25, P1739, DOI 10.1002/eji.1830250637; BACHMANN MF, 1994, EUR J IMMUNOL, V24, P2128; BERNABEU C, 1984, NATURE, V308, P642, DOI 10.1038/308642a0; BEVAN MJ, 1976, J IMMUNOL, V117, P2233; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; BOHM W, 1995, J IMMUNOL, V155, P3313; BONIFACINO JS, 1994, CELLULAR PROTEOLYTIC, P137; BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707; CARRENO BM, 1994, EUR J IMMUNOL, V24, P1285, DOI 10.1002/eji.1830240607; CasciolaRosen L, 1996, P NATL ACAD SCI USA, V93, P1624, DOI 10.1073/pnas.93.4.1624; CHEN WS, 1993, J IMMUNOL METHODS, V160, P49, DOI 10.1016/0022-1759(93)90007-T; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; CIECHANOVER AJ, 1994, CELLULAR PROTEOLYTIC, P3; COLLINS DS, 1992, J IMMUNOL, V148, P3336; DACONCEICAOSILVA F, 1994, EUR J IMMUNOL, V24, P2813, DOI 10.1002/eji.1830241135; DASGUPTA JD, 1988, J IMMUNOL, V141, P2577; DEBRICK JE, 1991, J IMMUNOL, V147, P2846; DEBRUIJN MLH, 1995, EUR J IMMUNOL, V25, P1274, DOI 10.1002/eji.1830250522; DENKERS EY, 1993, J IMMUNOL, V150, P517; DERES K, 1989, NATURE, V342, P561, DOI 10.1038/342561a0; DICE JF, 1992, ANN NY ACAD SCI, V674, P58, DOI 10.1111/j.1749-6632.1992.tb27477.x; Dice JF, 1994, CELLULAR PROTEOLYTIC, P55; DOE B, 1994, EUR J IMMUNOL, V24, P2369, DOI 10.1002/eji.1830241017; ELBE A, 1994, J IMMUNOL, V153, P2878; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Fayolle C, 1996, IMMUNOLOGY, V89, P41, DOI 10.1046/j.1365-2567.1996.d01-704.x; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GONG JL, 1994, IMMUNOLOGY, V81, P343; GRIFFITHS JC, 1993, J VIROL, V67, P3191, DOI 10.1128/JVI.67.6.3191-3198.1993; HARDING CV, 1994, J IMMUNOL, V153, P4925; HARRIS SJ, 1992, IMMUNOLOGY, V77, P315; HAYWOOD AM, 1994, J VIROL, V68, P1; HEEG K, 1991, EUR J IMMUNOL, V21, P1523, DOI 10.1002/eji.1830210628; Huang AYC, 1996, J EXP MED, V183, P769, DOI 10.1084/jem.183.3.769; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; HUANG L, 1992, RES IMMUNOL, V143, P192, DOI 10.1016/S0923-2494(92)80164-G; ISENMAN LD, 1989, J BIOL CHEM, V264, P21591; JACKSON MR, 1993, ANNU REV CELL BIOL, V9, P207, DOI 10.1146/annurev.cb.09.110193.001231; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; KALEAB B, 1990, EUR J IMMUNOL, V20, P2651, DOI 10.1002/eji.1830201219; KNOWLES BB, 1979, J IMMUNOL, V122, P1798; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; KOZLOWSKI S, 1991, NATURE, V349, P74, DOI 10.1038/349074a0; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; LAYTON GT, 1993, J IMMUNOL, V151, P1097; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; LIE WR, 1990, NATURE, V344, P439, DOI 10.1038/344439a0; LIE WR, 1991, J EXP MED, V173, P449, DOI 10.1084/jem.173.2.449; LIPFORD GB, 1994, VACCINE, V12, P73, DOI 10.1016/0264-410X(94)90013-2; LIU TM, 1995, J IMMUNOL, V154, P3147; LJUNGGREN HG, 1995, INT IMMUNOL, V7, P975, DOI 10.1093/intimm/7.6.975; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LJUNGGREN HG, 1995, EUR J IMMUNOL, V25, P174, DOI 10.1002/eji.1830250129; LOPES LM, 1992, EUR J IMMUNOL, V22, P287, DOI 10.1002/eji.1830220143; MACHOLD RP, 1995, J EXP MED, V181, P1111, DOI 10.1084/jem.181.3.1111; MANCA F, 1991, J EXP MED, V173, P37, DOI 10.1084/jem.173.1.37; MARTINON F, 1992, J IMMUNOL, V149, P3416; MATKO J, 1994, J IMMUNOL, V152, P3353; MILLER MD, 1992, J EXP MED, V176, P1739, DOI 10.1084/jem.176.6.1739; MOREIN B, 1994, AIDS RES HUM RETROV, V10, P109; Mortimore G. E., 1994, CELLULAR PROTEOLYTIC, P65; MOTAL UMA, 1993, EUR J IMMUNOL, V23, P3224, DOI 10.1002/eji.1830231227; MOTAL UMA, 1995, EUR J IMMUNOL, V25, P1121, DOI 10.1002/eji.1830250441; MOTAL UMA, 1996, EUR J IMMUNOL, V26, P544; MOTAL UMA, 1995, J IMMUNOL METHODS, V188, P21; NAIR S, 1992, J EXP MED, V175, P609, DOI 10.1084/jem.175.2.609; NAIR S, 1992, J IMMUNOL METHODS, V152, P237, DOI 10.1016/0022-1759(92)90145-J; NAIR S, 1995, INT IMMUNOL, V4, P679; NARDELLI B, 1993, IMMUNOLOGY, V79, P355; NEWMAN MJ, 1992, J IMMUNOL, V148, P2357; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; NORKIN LC, 1995, CLIN MICROBIOL REV, V8, P293, DOI 10.1128/CMR.8.2.293; Pearson AM, 1996, CURR OPIN IMMUNOL, V8, P20, DOI 10.1016/S0952-7915(96)80100-2; PFEIFER JD, 1993, INFECT AGENT DIS, V2, P249; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; RAPOSO G, 1996, J EXP MED, V183, P1131; RAYCHAUDHURI S, 1992, P NATL ACAD SCI USA, V89, P8308, DOI 10.1073/pnas.89.17.8308; REDDEHASE MJ, 1984, EUR J IMMUNOL, V14, P56, DOI 10.1002/eji.1830140111; REDDY R, 1992, J IMMUNOL, V148, P1585; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; ROCK KL, 1993, J IMMUNOL, V150, P438; ROCK KL, 1990, P NATL ACAD SCI USA, V87, P7517, DOI 10.1073/pnas.87.19.7517; ROCK KL, 1991, CELL, V65, P611, DOI 10.1016/0092-8674(91)90093-E; Rock KL, 1996, IMMUNOL TODAY, V17, P131, DOI 10.1016/0167-5699(96)80605-0; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sandberg JK, 1996, EUR J IMMUNOL, V26, P288, DOI 10.1002/eji.1830260203; SCHAFER R, 1992, J IMMUNOL, V149, P53; SCHILD H, 1991, EUR J IMMUNOL, V21, P2649, DOI 10.1002/eji.1830211102; SCHILD H, 1991, J EXP MED, V174, P1665, DOI 10.1084/jem.174.6.1665; SCHIRMBECK R, 1993, EUR J IMMUNOL, V23, P1528, DOI 10.1002/eji.1830230720; SCHIRMBECK R, 1995, J IMMUNOL, V155, P4676; SCHIRMBECK R, 1992, EUR J IMMUNOL, V22, P759, DOI 10.1002/eji.1830220320; SCHIRMBECK R, 1994, EUR J IMMUNOL, V24, P2068, DOI 10.1002/eji.1830240920; SCHIRMBECK R, 1994, EUR J IMMUNOL, V24, P1478, DOI 10.1002/eji.1830240704; SCHIRMBECK R, 1994, EUR J IMMUNOL, V24, P1088, DOI 10.1002/eji.1830240512; SCHIRMBECK R, 1995, VACCINE, V13, P857, DOI 10.1016/0264-410X(94)00038-O; SCHIRMBECK R, 1994, J IMMUNOL, V152, P1110; SCHIRMBECK R, 1994, J VIROL, V68, P1418, DOI 10.1128/JVI.68.3.1418-1425.1994; SCHIRMBECK R, 1995, EUR J IMMUNOL, V25, P1063, DOI 10.1002/eji.1830250431; SCHIRMBECK R, 1996, IN PRESS EUR J IMMUN; SCHIRMBECK R, 1996, IN PRESS INTERVIROLO; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SHIRAI M, 1994, J IMMUNOL, V152, P549; SMITH JD, 1993, J EXP MED, V178, P2035, DOI 10.1084/jem.178.6.2035; SMITH JD, 1992, P NATL ACAD SCI USA, V89, P7767, DOI 10.1073/pnas.89.16.7767; SMITH JD, 1992, J EXP MED, V175, P191, DOI 10.1084/jem.175.1.191; SOUSA CRE, 1993, J EXP MED, V178, P509, DOI 10.1084/jem.178.2.509; SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841; SRIVASTAVA PK, 1993, ADV CANCER RES, V62, P153, DOI 10.1016/S0065-230X(08)60318-8; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; STAERZ UD, 1987, NATURE, V329, P449, DOI 10.1038/329449a0; STAHL PD, 1992, CURR OPIN IMMUNOL, V4, P49, DOI 10.1016/0952-7915(92)90123-V; STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; STOVER CK, 1993, J EXP MED, V178, P197, DOI 10.1084/jem.178.1.197; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Stryhn A, 1996, J IMMUNOL, V156, P4191; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; SUSS G, 1992, J IMMUNOL, V149, P1334; SZALAY G, 1994, EUR J IMMUNOL, V24, P1471, DOI 10.1002/eji.1830240703; TAKAHASHI H, 1990, NATURE, V344, P873, DOI 10.1038/344873a0; TEVETHIA SS, 1980, VIROLOGY, V107, P13, DOI 10.1016/0042-6822(80)90268-8; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; UDONO H, 1994, P NATL ACAD SCI USA, V91, P3077, DOI 10.1073/pnas.91.8.3077; UDONO H, 1994, J IMMUNOL, V152, P5398; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; ULMER JB, 1994, EUR J IMMUNOL, V24, P1590, DOI 10.1002/eji.1830240721; VANBINNENDIJK RS, 1992, J EXP MED, V176, P119, DOI 10.1084/jem.176.1.119; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; VITIELLO A, 1995, J CLIN INVEST, V95, P341, DOI 10.1172/JCI117662; VITIELLO A, 1990, SCIENCE, V250, P1423, DOI 10.1126/science.2124002; WELDT G, 1994, J IMMUNOL, V153, P2554; WOLF PR, 1995, J EXP MED, V181, P657, DOI 10.1084/jem.181.2.657; WRAITH DC, 1987, J GEN VIROL, V68, P433, DOI 10.1099/0022-1317-68-2-433; WRAITH DC, 1986, IMMUNOLOGY, V59, P173; WU JY, 1994, CELL IMMUNOL, V154, P393, DOI 10.1006/cimm.1994.1086; XU XX, 1995, J IMMUNOL, V155, P1652; YAMADA A, 1985, J EXP MED, V162, P663, DOI 10.1084/jem.162.2.663; YASUTOMI Y, 1993, J IMMUNOL, V150, P3101; YASUTOMI Y, 1993, J IMMUNOL, V151, P5096; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5; YOUNG JW, 1990, J EXP MED, V171, P1315, DOI 10.1084/jem.171.4.1315; ZHOU F, 1992, CANCER RES, V52, P6287; ZHOU F, 1992, J IMMUNOL, V149, P1599; ZHOU X, 1995, SCAND J IMMUNOL, V42, P66, DOI 10.1111/j.1365-3083.1995.tb03627.x; ZHOU XZ, 1992, J IMMUNOL METHODS, V153, P193, DOI 10.1016/0022-1759(92)90322-K	160	234	247	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1996	5	4					295	302		10.1016/S1074-7613(00)80255-1	http://dx.doi.org/10.1016/S1074-7613(00)80255-1			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VP444	8885862	Bronze			2022-12-18	WOS:A1996VP44400001
J	Chow, MT; Ozga, AJ; Servis, RL; Frederick, DT; Lo, JA; Fisher, DE; Freeman, GJ; Boland, GM; Luster, AD				Chow, Melvyn T.; Ozga, Aleksandra J.; Servis, Rachel L.; Frederick, Dennie T.; Lo, Jennifer A.; Fisher, David E.; Freeman, Gordon J.; Boland, Genevieve M.; Luster, Andrew D.			Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy	IMMUNITY			English	Article							T-CELL TRAFFICKING; CANCER-IMMUNOTHERAPY; PD-1 BLOCKADE; RESPONSES; RECEPTOR; IP-10; LYMPHOCYTES; EXPRESSION; CD4(+); MIGRATION	Despite compelling rates of durable clinical responses to programmed cell death-1 (PD-1) blockade, advances are needed to extend these benefits to resistant tumors. We found that tumor-bearing mice deficient in the chemokine receptor CXCR3 responded poorly to anti-PD-1 treatment. CXCR3 and its ligand CXCL9 were critical for a productive CD8(+) T cell response in tumor-bearing mice treated with anti-PD-1 but were not required for the infiltration of CD8(+) T cells into tumors. The anti-PD-1-induced anti-tumor response was facilitated by CXCL9 production from intratumoral CD103(+) dendritic cells, suggesting that CXCR3 facilitates dendritic cell-T cell interactions within the tumor micro-environment. CXCR3 ligands in murine tumors and in plasma of melanoma patients were an indicator of clinical response to anti-PD-1, and their induction in non-responsive murine tumors promoted responsiveness to anti-PD-1. Our data suggest that the CXCR3 chemokine system is a biomarker for sensitivity to PD-1 blockade and that augmenting the intratumoral function of this chemokine system could improve clinical outcomes.	[Chow, Melvyn T.; Ozga, Aleksandra J.; Servis, Rachel L.; Luster, Andrew D.] Harvard Med Sch, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Frederick, Dennie T.; Boland, Genevieve M.] Harvard Med Sch, Dept Surg, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Lo, Jennifer A.; Fisher, David E.] Harvard Med Sch, Cutaneous Biol Res Ctr, Dept Dermatol, Boston, MA 02114 USA; [Lo, Jennifer A.; Fisher, David E.] Harvard Med Sch, MGH Canc Ctr, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Freeman, Gordon J.] Harvard Med Sch, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Luster, AD (corresponding author), Harvard Med Sch, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Massachusetts Gen Hosp, Boston, MA 02114 USA.	aluster@mgh.harvard.edu	Fisher, David/AAH-2878-2019; Luster, Andrew/ABE-6504-2020; Boland, Genevieve/AAP-2767-2021; Freeman, Gordon/AAC-5380-2019	Luster, Andrew/0000-0001-9679-7912; Freeman, Gordon/0000-0002-7210-5616; /0000-0002-9520-6874	National Institutes of Health [AI112521, CA204028, AR043369, CA222871, CA163222]; Cancer Research Institute; American Association Cancer Research Genentech Immuno-oncology Research Fellowship [17-40-18-CHOW]; MGH Tosteson and Fund for Medical Discovery Postdoctoral Fellowship Awards; American Association Cancer Research Basic Science Fellowships Program [18-40-01-OZGA]; Swiss National Science Foundation Early Postdoctoral Mobility Award; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE [R01CA222871, P01CA163222, R01CA204028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI112521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; American Association Cancer Research Genentech Immuno-oncology Research Fellowship; MGH Tosteson and Fund for Medical Discovery Postdoctoral Fellowship Awards; American Association Cancer Research Basic Science Fellowships Program; Swiss National Science Foundation Early Postdoctoral Mobility Award; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (CA204028) and the Cancer Research Institute to A.D.L.; the American Association Cancer Research Genentech Immuno-oncology Research Fellowship (17-40-18-CHOW) and the MGH Tosteson and Fund for Medical Discovery Postdoctoral Fellowship Awards to M.T.C.; the American Association Cancer Research Basic Science Fellowships Program (18-40-01-OZGA) and the Swiss National Science Foundation Early Postdoctoral Mobility Award to A.J.O.; National Institutes of Health grants AR043369, CA222871, and CA163222, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, and the Melanoma Research Alliance to D.E.F.; and the National Institutes of Health grant AI112521 to G.J.F.	Ahrends T, 2017, IMMUNITY, V47, P848, DOI 10.1016/j.immuni.2017.10.009; Berghuis D, 2011, J PATHOL, V223, P347, DOI 10.1002/path.2819; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; Christen U, 2003, J IMMUNOL, V171, P6838, DOI 10.4049/jimmunol.171.12.6838; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Garris CS, 2018, IMMUNITY, V49, P1148, DOI 10.1016/j.immuni.2018.09.024; Gonzalez-Martin A, 2011, CANCER RES, V71, P5455, DOI 10.1158/0008-5472.CAN-11-1687; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Juneja VR, 2017, J EXP MED, V214, P895, DOI 10.1084/jem.20160801; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9; Liu JY, 2015, ONCOTARGET, V6, P24978, DOI 10.18632/oncotarget.4617; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; Martinez-Lostao L, 2015, CLIN CANCER RES, V21, P5047, DOI 10.1158/1078-0432.CCR-15-0685; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Messina JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00765; Mikucki ME, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8458; Mlecnik B, 2010, GASTROENTEROLOGY, V138, P1429, DOI 10.1053/j.gastro.2009.10.057; Park MK, 2002, J IMMUNOL, V169, P1433, DOI 10.4049/jimmunol.169.3.1433; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Pulido AD, 2018, CANCER CELL, V33, P60, DOI 10.1016/j.ccell.2017.11.019; Rashighi M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007811; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sanchez-Paulete AR, 2016, CANCER DISCOV, V6, P71, DOI 10.1158/2159-8290.CD-15-0510; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Speiser DE, 2016, NAT REV IMMUNOL, V16, P500, DOI 10.1038/nri.2016.80; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0089-6; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wang S, 2016, P NATL ACAD SCI USA, V113, pE7240, DOI 10.1073/pnas.1608555113; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001	56	233	243	6	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1498	+		10.1016/j.immuni.2019.04.010	http://dx.doi.org/10.1016/j.immuni.2019.04.010			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31097342	Bronze, Green Accepted			2022-12-18	WOS:000471876100019
J	Gross, CJ; Mishra, R; Schneider, KS; Medard, G; Wettmarshausen, J; Dittlein, DC; Shi, HX; Gorka, O; Koenig, PA; Fromm, S; Magnani, G; Cikovic, T; Hartjes, L; Smollich, J; Robertson, AAB; Cooper, MA; Schmidt-Supprian, M; Schuster, M; Schroder, K; Broz, P; Traidl-Hoffmann, C; Beutler, B; Kuster, B; Ruland, J; Schneider, S; Perocchi, F; Gross, O				Gross, Christina J.; Mishra, Ritu; Schneider, Katharina S.; Medard, Guillaume; Wettmarshausen, Jennifer; Dittlein, Daniela C.; Shi, Hexin; Gorka, Oliver; Koenig, Paul-Albert; Fromm, Stephan; Magnani, Giovanni; Cikovic, Tamara; Hartjes, Lara; Smollich, Joachim; Robertson, Avril A. B.; Cooper, Matthew A.; Schmidt-Supprian, Marc; Schuster, Michael; Schroder, Kate; Broz, Petr; Traidl-Hoffmann, Claudia; Beutler, Bruce; Kuster, Bernhard; Ruland, Juergen; Schneider, Sabine; Perocchi, Fabiana; Gross, Olaf			K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria	IMMUNITY			English	Article							IMMUNE CELLS; INHIBITOR; APOPTOSIS; OXYGEN; METABOLISM; CRYSTALS	Imiquimod is a small-molecule ligand of Toll-like receptor-7 (TLR7) that is licensed for the treatment of viral infections and cancers of the skin. Imiquimod has TLR7-independent activities that are mechanistically unexplained, including NLRP3 inflammasome activation in myeloid cells and apoptosis induction in cancer cells. We investigated the mechanism of inflammasome activation by imiquimod and the related molecule CL097 and determined that K+ efflux was dispensable for NLRP3 activation by these compounds. Imiquimod and CL097 inhibited the quinone oxidoreductases NQO2 and mitochondrial Complex I. This induced a burst of reactive oxygen species (ROS) and thiol oxidation, and led to NLRP3 activation via NEK7, a recently identified component of this inflammasome. Metabolic consequences of Complex I inhibition and endolysosomal effects of imiquimodmight also contribute to NLRP3 activation. Our results reveal a K+ efflux-independent mechanism for NLRP3 activation and identify targets of imiquimod that might be clinically relevant.	[Gross, Christina J.; Mishra, Ritu; Schneider, Katharina S.; Gorka, Oliver; Koenig, Paul-Albert; Magnani, Giovanni; Cikovic, Tamara; Hartjes, Lara; Smollich, Joachim; Ruland, Juergen; Gross, Olaf] TUM, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany; [Medard, Guillaume; Kuster, Bernhard] TUM, Chair Prote & Bioanalyt, D-85354 Freising Weihenstephan, Germany; [Fromm, Stephan; Schuster, Michael] TUM, Dept Chem, Fachgrp Analyt Chem, D-85748 Garching, Germany; [Schmidt-Supprian, Marc] TUM, Klinikum Rechts Isar, Dept Hematol & Oncol, D-81675 Munich, Germany; [Schmidt-Supprian, Marc; Ruland, Juergen; Gross, Olaf] TUM, TranslaTUM Zent Inst Translat Krebsforsch, D-81675 Munich, Germany; [Schneider, Sabine] TUM, Dept Chem, D-85748 Garching, Germany; [Dittlein, Daniela C.; Traidl-Hoffmann, Claudia] TUM, UNIKA T, Chair & Inst Environm Med, D-86156 Augsburg, Germany; [Wettmarshausen, Jennifer; Dittlein, Daniela C.; Traidl-Hoffmann, Claudia; Perocchi, Fabiana] Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Wettmarshausen, Jennifer; Perocchi, Fabiana] Ludwig Maximilians Univ Munchen, Dept Biochem, Genzentrum, D-81377 Munich, Germany; [Kuster, Bernhard; Schneider, Sabine] CIPSM, D-81377 Munich, Germany; [Shi, Hexin; Beutler, Bruce] Univ Texas Southwestern Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA; [Robertson, Avril A. B.; Cooper, Matthew A.; Schroder, Kate] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4067, Australia; [Broz, Petr] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4003 Basel, Switzerland	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Queensland; University of Basel	Gross, O (corresponding author), TUM, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany.; Gross, O (corresponding author), TUM, TranslaTUM Zent Inst Translat Krebsforsch, D-81675 Munich, Germany.	olaf.gross@tum.de	Gross, Olaf/E-4570-2010; Robertson, Avril/A-4043-2012; Cooper, Matthew A./C-7988-2009; Schmidt-Supprian, Marc/F-5893-2011; Schneider, Sabine/G-2908-2013; Schroder, Kate/C-6132-2008; Médard, Guillaume/HGC-8366-2022; Gorka, Oliver/AAF-1633-2020; Ruland, Jürgen/Q-6680-2018; Koenig, Paul-Albert/AAH-1595-2021; Broz, Petr/AAC-7940-2019; Kuster, Bernhard/Q-6031-2016	Gross, Olaf/0000-0001-8660-3619; Robertson, Avril/0000-0002-9652-8357; Cooper, Matthew A./0000-0003-3147-3460; Schmidt-Supprian, Marc/0000-0002-8543-6166; Schneider, Sabine/0000-0003-1054-8689; Schroder, Kate/0000-0001-9261-3805; Médard, Guillaume/0000-0002-4782-4029; Ruland, Jürgen/0000-0002-8381-3597; Koenig, Paul-Albert/0000-0001-5995-2557; Broz, Petr/0000-0002-2334-7790; perocchi, fabiana/0000-0002-1102-6500; Traidl-Hoffmann, Claudia/0000-0001-5085-5179; Kuster, Bernhard/0000-0002-9094-1677; Gross, Christina/0000-0002-5982-6881; Mishra, Ritu/0000-0002-3581-5918; Magnani, Giovanni/0000-0002-6805-9194; Gorka, Oliver/0000-0002-8245-3008	Natural Sciences and Engineering Research Council of Canada; TUM Graduate School stipend; post-doctoral fellowship of the TUM University Foundation; international doctoral program ''i-Target: Immunotargeting in Cancer,'' - Elite Network of Bavaria; National Health and Medical Research Council (NHMRC) [1086786]; NHMRC Fellowship [1059354]; Australian Research Council Future Fellowship [FT130100361]; Queensland Smart Futures Fund; Christine Kuhne Center for Allergy Research and Education; Helmholtz Alliance Preclinical Comprehensive Cancer Center; Deutsche Forschungsgemeinschaft (DFG) [SFB 1054, RU 695/6-1]; German Cancer Consortium (DKTK); German Center for Infection Research (DZIF); DFG; excellence cluster CIPSM; Fonds der chemischen Industrie; DFG under the Emmy Noether Programme [PE 2053/1-1]; European Research Council (ERC) under the European Union's Seventh Framework Programme by an ERC Advanced Grant [322865]; ERC Starting Grant [337689]; Bavarian Ministry of Sciences, Research and the Arts	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); TUM Graduate School stipend; post-doctoral fellowship of the TUM University Foundation; international doctoral program ''i-Target: Immunotargeting in Cancer,'' - Elite Network of Bavaria; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); Queensland Smart Futures Fund; Christine Kuhne Center for Allergy Research and Education; Helmholtz Alliance Preclinical Comprehensive Cancer Center; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Cancer Consortium (DKTK); German Center for Infection Research (DZIF); DFG(German Research Foundation (DFG)); excellence cluster CIPSM; Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); DFG under the Emmy Noether Programme(German Research Foundation (DFG)); European Research Council (ERC) under the European Union's Seventh Framework Programme by an ERC Advanced Grant(European Research Council (ERC)); ERC Starting Grant(European Research Council (ERC)); Bavarian Ministry of Sciences, Research and the Arts	The authors thank Susanne Weiss, Valentin Hofl, Tanja Ruff, Markus Utzt, Michaela Glos, Sandra Reuwand, and Beatrix Lunk for technical assistance, and Stefan Bauer, Hubertus Hochrein, Thomas Korn, Anne Krug, Fiona Mullner, Peter Luppa, Klaus Heger, Tobias Madl, Jean Boutin, and Holger Prokisch for helpful discussions. Thorsten Buch and Philipp Yu provided bone marrow from TLR7<SUP>-/-</SUP> and Unc93b1 3d/3d mice, respectively. Paul Schumacker provided adenovirus encoding organelle-targeted roGFP2, Laura Trovo and Thomas Misgeld helped setting up the ratiometric ROS measurement, and Deepak Ramanujam and Stefan Engelhardt assisted with adenovirus amplification. The SLS and ESRF provided access and assistance with X-ray crystallography. This work was supported by a postgraduate scholarship from the Natural Sciences and Engineering Research Council of Canada (to C.J.G.), a TUM Graduate School stipend (to K.S.S.), a post-doctoral fellowship of the TUM University Foundation (to P.A.K.), the international doctoral program ''i-Target: Immunotargeting in Cancer,''funded by the Elite Network of Bavaria (to L.H.), a National Health and Medical Research Council (NHMRC) Project Grant (1086786, to M.A.C. and K.S.), an NHMRC Fellowship (1059354, to AABR), an Australian Research Council Future Fellowship (FT130100361, to K.S.), the Queensland Smart Futures Fund (to K.S.), the Christine Kuhne Center for Allergy Research and Education (to C.T.-H.), the Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC, to J.R.), the Deutsche Forschungsgemeinschaft (DFG, grants SFB 1054 and RU 695/6-1, to J.R.), the German Cancer Consortium (DKTK, to J.R.), the German Center for Infection Research (DZIF, to J.R.), the DFG and the excellence cluster CIPSM and Fonds der chemischen Industrie (to S.S.), the DFG under the Emmy Noether Programme (PE 2053/1-1, to F.P.), the European Research Council (ERC) under the European Union's Seventh Framework Programme by an ERC Advanced Grant (grant agreement No. 322865, to J.R.) and an ERC Starting Grant (grant agreement No. 337689, to O. Gross), and the Bavarian Ministry of Sciences, Research and the Arts, in the Framework of the Bavarian Molecular Biosystems Research Network (BioSysNet, to O. Gross).	Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Baldwin AG, 2016, J MED CHEM, V59, P1691, DOI 10.1021/acs.jmedchem.5b01091; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; Erb M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036153; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Heger K, 2015, EUR J IMMUNOL, V45, P1614, DOI 10.1002/eji.201545457; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Medard G, 2015, J PROTEOME RES, V14, P1574, DOI 10.1021/pr5012608; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Miettinen TP, 2014, MOL PHARMACEUT, V11, P4395, DOI 10.1021/mp5004866; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Schneider Katharina S, 2013, Methods Mol Biol, V1040, P117, DOI 10.1007/978-1-62703-523-1_10; Schon M, 2003, J NATL CANCER I, V95, P1138, DOI 10.1093/jnci/djg016; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vella F, 2005, BIOCHEM PHARMACOL, V71, P1, DOI 10.1016/j.bcp.2005.09.019; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334; Wei PC, 2016, NATURE, V539, pE1, DOI 10.1038/nature19832; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Won JH, 2015, J BIOL CHEM, V290, P27425, DOI 10.1074/jbc.M115.667063; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	45	233	238	8	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					761	773		10.1016/j.immuni.2016.08.010	http://dx.doi.org/10.1016/j.immuni.2016.08.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27692612	Bronze, Green Submitted			2022-12-18	WOS:000389473200010
J	Zarbock, A; Lowell, CA; Ley, K				Zarbock, Alexander; Lowell, Clifford A.; Ley, Klaus			Spleen tyrosine kinase syk is necessary for E-Selectin-induced alpha(L)beta 2 integrin-mediated rolling on intercellular adhesion molecule-1	IMMUNITY			English	Article							I-LIKE DOMAIN; P-SELECTIN; CELL-ADHESION; GLYCOPROTEIN LIGAND-1; HUMAN-NEUTROPHILS; FLOW; MICE; INFLAMMATION; RECRUITMENT; CHEMOKINES	Engagement of neutrophils by E-selectin results in integrin activation. Here, we investigated primary mouse neutrophils in whole blood by using intravital microscopy and autoperfused flow chambers. Slow rolling on E-selectin coimmobilized with intercellular adhesion molecule-1 (ICAM-1) required P-selectin glycoprotein ligand (PSGL)-1, was dependent on alpha(L)beta(2) integrin (LFA-1), and required continuous E-selectin engagement. Slow rolling was abolished by pharmacological blockade of spleen tyrosine kinase (Syk) and was absent in Syk(-/-) bone-marrow chimeric mice. Treatment with tumor necrosis factor-alpha lowered rolling velocity further and induced CXC chemokine ligand-1 (CXCL1) and CXC chemokine receptor-2 (CXCR2)-dependent leukocyte arrest on E-selectin and ICAM-1. Arrest but not rolling was blocked by an allosteric inhibitor of LFA-1 activation. Neutrophil recruitment in a thioglycollate-induced peritonitis model was almost completely inhibited in Selplg(-/-) mice or Syk(-/-) bone-marrow chimeras treated with pertussis; toxin. This identifies a second neutrophil-activation pathway that is as important as activation through G protein-coupled receptors (GPCRs).	Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; Univ Virginia, Dept Physiol & Biol Phys, Charlottesville, VA 22908 USA; Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA; Univ Munster, Dept Anesthesiol & Intens Care Med, D-48155 Munster, Germany; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of Virginia; University of Virginia; University of Virginia; University of Munster; University of California System; University of California San Francisco	Ley, K (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	klausley@virginia.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073361, R01HL054136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002185] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL073361, HL 73361, R01 HL054136-08] Funding Source: Medline; NIBIB NIH HHS [R01 EB002185, R01 EB002185-06A2] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Abbal C, 2006, BLOOD, V108, P3352, DOI 10.1182/blood-2006-04-013912; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chesnutt BC, 2006, MICROCIRCULATION, V13, P99, DOI 10.1080/10739680500466376; Crutchfield KL, 2000, J LEUKOCYTE BIOL, V67, P196, DOI 10.1002/jlb.67.2.196; Dunne JL, 2003, J IMMUNOL, V171, P6105, DOI 10.4049/jimmunol.171.11.6105; Dunne JL, 2002, BLOOD, V99, P336, DOI 10.1182/blood.V99.1.336; FORSYTH KD, 1990, J IMMUNOL METHODS, V128, P159, DOI 10.1016/0022-1759(90)90206-B; Galt SW, 2001, CIRC RES, V89, P509, DOI 10.1161/hh1801.096339; GLASSER L, 1990, AM J CLIN PATHOL, V93, P662, DOI 10.1093/ajcp/93.5.662; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Green CE, 2004, J IMMUNOL, V172, P7780, DOI 10.4049/jimmunol.172.12.7780; HACHICHA M, 1995, J EXP MED, V182, P2019, DOI 10.1084/jem.182.6.2019; Hidari KIPJ, 1997, J BIOL CHEM, V272, P28750, DOI 10.1074/jbc.272.45.28750; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; KUIJPERS TW, 1991, BLOOD, V78, P1105; Kunkel EJ, 2000, J IMMUNOL, V164, P3301, DOI 10.4049/jimmunol.164.6.3301; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; Laudanna C, 2005, NAT IMMUNOL, V6, P429, DOI 10.1038/ni0505-429; Ley K, 1998, CIRC RES, V83, P287, DOI 10.1161/01.RES.83.3.287; LEY K, 1991, CIRC RES, V69, P1034, DOI 10.1161/01.RES.69.4.1034; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Lindemann SW, 2005, TRENDS CARDIOVAS MED, V15, P9, DOI 10.1016/j.tcm.2004.10.004; LIPOWSKY HH, 1978, MICROVASC RES, V15, P93, DOI 10.1016/0026-2862(78)90009-2; LO SK, 1991, J EXP MED, V173, P1493, DOI 10.1084/jem.173.6.1493; Mattila PE, 2005, AM J PHYSIOL-CELL PH, V289, pC323, DOI 10.1152/ajpcell.00603.2004; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; McEver RP, 1997, J CLIN INVEST, V100, pS97; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; Norman KE, 2000, BLOOD, V96, P3585; Parkos CA, 1997, AM J PHYSIOL-GASTR L, V273, pG763, DOI 10.1152/ajpgi.1997.273.4.G763; Rainger GE, 1997, AM J PHYSIOL-HEART C, V272, pH114, DOI 10.1152/ajpheart.1997.272.1.H114; RICHTER J, 1995, J IMMUNOL, V154, P4142; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Schymeinsky J, 2006, BLOOD, V108, P3919, DOI 10.1182/blood-2005-12-030387; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Simon SI, 2000, J IMMUNOL, V164, P4348, DOI 10.4049/jimmunol.164.8.4348; Smith DF, 2006, J LEUKOCYTE BIOL, V80, P1491, DOI 10.1189/jlb.0306227; Smith DF, 2005, AM J PHYSIOL-HEART C, V289, pH1976, DOI 10.1152/ajpheart.00153.2005; Smith K, 2004, ORG BIOMOL CHEM, V2, P935, DOI 10.1039/b400179f; Smith ML, 2004, J LEUKOCYTE BIOL, V76, P985, DOI 10.1189/jlb.1003483; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Thompson RD, 2001, BLOOD, V97, P1854, DOI 10.1182/blood.V97.6.1854; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Weyrich AS, 1996, J CLIN INVEST, V97, P1525, DOI 10.1172/JCI118575; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921; Xia LJ, 2002, J CLIN INVEST, V109, P939; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769; Zimmerman GA, 1996, J CLIN INVEST, V98, P1699, DOI 10.1172/JCI118967	55	233	241	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2007	26	6					773	783		10.1016/j.immuni.2007.04.011	http://dx.doi.org/10.1016/j.immuni.2007.04.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17543554	Green Accepted, Bronze			2022-12-18	WOS:000247646900013
J	Kumamoto, Y; Linehan, M; Weinstein, JS; Laidlaw, BJ; Craft, JE; Iwasaki, A				Kumamoto, Yosuke; Linehan, Melissa; Weinstein, Jason S.; Laidlaw, Brian J.; Craft, Joseph E.; Iwasaki, Akiko			CD301b(+) Dermal Dendritic Cells Drive T Helper 2 Cell-Mediated Immunity	IMMUNITY			English	Article							CD4(+) T-CELLS; TRANSCRIPTION FACTOR GATA-3; LANGERHANS CELLS; IN-VIVO; HELMINTH INFECTION; HELPER-CELLS; TH2 CELLS; INDUCTION; DISTINCT; SKIN	Unlike other types of T helper (Th) responses, whether the development of Th2 cells requires instruction from particular subset of dendritic cells (DCs) remains unclear. By using an in vivo depletion approach, we have shown that DCs expressing CD301b were required for the generation of Th2 cells after subcutaneous immunization with ovalbumin (OVA) along with papain or alum. CD301b(+) DCs are distinct from epidermal or CD207(+) dermal DCs (DDCs) and were responsible for transporting antigen injected subcutaneously with Th2-type adjuvants. Transient depletion of CD301b(+) DCs resulted in less effective accumulation and decreased expression of CD69 by polyclonal CD4(+) T cells in the lymph node. Moreover, despite intact cell division and interferon-gamma production, CD301b(+) DC depletion led to blunted interleukin-4 production by OVA-specific OT-II transgenic CD4(+) T cells and significantly impaired Th2 cell development upon infection with Nippostrongylus brasiliensis. These results reveal CD301b(+) DDCs as the key mediators of Th2 immunity.	[Kumamoto, Yosuke; Linehan, Melissa; Weinstein, Jason S.; Laidlaw, Brian J.; Craft, Joseph E.; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Craft, Joseph E.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University; Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856; Kumamoto, Yosuke/0000-0001-9369-4934	National Institutes of Health (NIH) [AI054359, AI062428, AR40072, AR44076]; Yale Rheumatic Diseases Research Core Center, NIH (NIAMS) [P30 AR053495]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359, R56AI062428, R01AI062428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044076, T32AR007107, R01AR040072, R37AR040072, P30AR053495] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Rheumatic Diseases Research Core Center, NIH (NIAMS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Kaplan and R. Medzhitov for critical reading of the manuscript and H. Dong for technical support. This work is supported by National Institutes of Health (NIH) grants to A. I. (AI054359 and AI062428) and J.E.C. (AR40072 and AR44076). The study was partly funded by a pilot grant from the Yale Rheumatic Diseases Research Core Center, NIH (NIAMS) P30 AR053495. Y.K. was an Astellas Foundation for Research on Metabolic Disorders fellow.	Baaten BJG, 2010, IMMUNITY, V32, P104, DOI 10.1016/j.immuni.2009.10.011; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; Brewig N, 2009, J IMMUNOL, V182, P774, DOI 10.4049/jimmunol.182.2.774; Camberis Mali, 2003, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1912s55; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Fahlen-Yrlid L, 2009, J IMMUNOL, V183, P5032, DOI 10.4049/jimmunol.0803992; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Guan HB, 2009, J IMMUNOL, V183, P172, DOI 10.4049/jimmunol.0802325; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hervouet C, 2010, J IMMUNOL, V184, P4842, DOI 10.4049/jimmunol.0901695; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Ishiwata K, 2010, J IMMUNOL, V184, P2086, DOI 10.4049/jimmunol.0804051; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kim TS, 2010, J EXP MED, V207, P1161, DOI 10.1084/jem.20092017; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kool Mirjam, 2012, F1000 Biol Rep, V4, P6, DOI 10.3410/B4-6; Kumamoto Y, 2004, J BIOL CHEM, V279, P49274, DOI 10.1074/jbc.M409300200; Kumamoto Y, 2011, P NATL ACAD SCI USA, V108, P8749, DOI 10.1073/pnas.1100567108; Kumamoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005619; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; MacDonald AS, 2002, J IMMUNOL, V168, P537, DOI 10.4049/jimmunol.168.2.537; Magalhaes JG, 2011, P NATL ACAD SCI USA, V108, P14896, DOI 10.1073/pnas.1015063108; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Matsumoto K, 2008, BIOCHEM BIOPH RES CO, V365, P170, DOI 10.1016/j.bbrc.2007.10.156; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Oflazoglu E, 2004, EUR J IMMUNOL, V34, P3326, DOI 10.1002/eji.200425197; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Otsuka A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2740; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Smith KA, 2012, INFECT IMMUN, V80, P3481, DOI 10.1128/IAI.00436-12; Smith KA, 2011, J IMMUNOL, V186, P7098, DOI 10.4049/jimmunol.1003636; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Yoo JK, 2010, J EXP MED, V207, P1435, DOI 10.1084/jem.20091373; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	61	232	235	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					733	743		10.1016/j.immuni.2013.08.029	http://dx.doi.org/10.1016/j.immuni.2013.08.029			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24076051	Green Accepted, Bronze			2022-12-18	WOS:000330950000014
J	Versteeg, GA; Rajsbaum, R; Sanchez-Aparicio, MT; Maestre, AM; Valdiviezo, J; Shi, M; Inn, KS; Fernandez-Sesma, A; Jung, J; Garcia-Sastre, A				Versteeg, Gijs A.; Rajsbaum, Ricardo; Sanchez-Aparicio, Maria Teresa; Maestre, Ana M.; Valdiviezo, Julio; Shi, Mude; Inn, Kyung-Soo; Fernandez-Sesma, Ana; Jung, Jae; Garcia-Sastre, Adolfo			The E3-Ligase TRIM Family of Proteins Regulates Signaling Pathways Triggered by Innate Immune Pattern-Recognition Receptors	IMMUNITY			English	Article							E3 UBIQUITIN LIGASE; RIG-I; SPLICE VARIANT; MOTIF; ACTIVATION; EXPRESSION; RESPONSES; REVEALS; ROLES; CELLS	Innate immunity conferred by the type I interferon is critical for antiviral defense. To date only a limited number of tripartite motif (TRIM) proteins have been implicated in modulation of innate immunity and anti-microbial activity. Here we report the complementary DNA cloning and systematic analysis of all known 75 human TRIMs. We demonstrate that roughly half of the 75 TRIM-family members enhanced the innate immune response and that they do this at multiple levels in signaling pathways. Moreover, messenger RNA levels and localization of most of these TRIMs were found to be altered during viral infection, suggesting that their regulatory activities are highly controlled at both pre- and post-transcriptional levels. Taken together, our data demonstrate a very considerable dedication of this large protein family to the positive regulation of the antiviral response, which supports the notion that this family of proteins evolved as a component of innate immunity.	[Versteeg, Gijs A.; Rajsbaum, Ricardo; Sanchez-Aparicio, Maria Teresa; Maestre, Ana M.; Valdiviezo, Julio; Fernandez-Sesma, Ana; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Shi, Mude; Inn, Kyung-Soo; Jung, Jae] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Inn, Kyung-Soo] Kyung Hee Univ, Coll Pharm, Dept Pharmaceut Sci, Seoul 130701, South Korea	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Southern California; Kyung Hee University	Garcia-Sastre, A (corresponding author), Mt Sinai Sch Med, Dept Microbiol, One Gustave L Levy Pl, New York, NY 10029 USA.	adolfo.garcia-sastre@mssm.edu	Inn, Kyung-Soo/AAJ-4118-2020; Merens, Ana Maestre/I-2445-2019; Rajsbaum, Ricardo/F-2046-2014; Rajsbaum, Ricardo/AAD-4775-2020; Sanchez-Aparicio, Maria T/K-7568-2017	Merens, Ana Maestre/0000-0002-2494-0879; Sanchez-Aparicio, Maria T/0000-0001-6556-5924; Versteeg, Gijs/0000-0002-6150-2165; Fernandez-Sesma, Ana/0000-0002-3405-6702; Garcia-Sastre, Adolfo/0000-0002-6551-1827	NIAID [U54 AI57158, R01DA033733, U19AI83025, P01AI090935]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, P01AI090935, U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033773, R01DA033733] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research is partially supported by NIAID grants U54 AI57158 (North East Biodefense Center) (to A.G.-S.), R01DA033733 (to A.G.-S.), U19AI83025, (to A.G.-S. and J.J.), and P01AI090935 (to A.G.-S. and A.F.-S.). We thank J. Ayllon for kindly providing the ISG54 ISRE-luciferase reporter plasmid and D. Littman for providing plasmid pSIV3+. We thank A. Ballabio, P. Bieniasz, and F. Naya for kindly providing the TRIM expression plasmids specified in the supplemental information. We are grateful to M. Ooms for technical assistance related to lentivirus production and to R. Cadagan and O. Lizardo for technical support.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Cuchet D, 2011, J CELL SCI, V124, P280, DOI 10.1242/jcs.075390; Fang S, 2003, SEMIN CANCER BIOL, V13, P5, DOI 10.1016/S1044-579X(02)00095-0; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Haye K, 2009, J VIROL, V83, P6849, DOI 10.1128/JVI.02323-08; Kahn AB, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-75; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Toniato E, 2002, J BIOL CHEM, V277, P37315, DOI 10.1074/jbc.M205900200; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Uchil PD, 2013, J VIROL, V87, P257, DOI 10.1128/JVI.01804-12; Xue QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046825; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Zhao W, 2012, J IMMUNOL, V188, P5311, DOI 10.4049/jimmunol.1103506; Zhao W, 2012, J IMMUNOL, V188, P2567, DOI 10.4049/jimmunol.1103255	28	232	245	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					384	398		10.1016/j.immuni.2012.11.013	http://dx.doi.org/10.1016/j.immuni.2012.11.013			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23438823	Green Accepted, Bronze			2022-12-18	WOS:000330940800019
J	Haas, JD; Ravens, S; Duber, S; Sandrock, I; Oberdorfer, L; Kashani, E; Chennupati, V; Fohse, L; Naumann, R; Weiss, S; Krueger, A; Forster, R; Prinz, I				Haas, Jan D.; Ravens, Sarina; Dueber, Sandra; Sandrock, Inga; Oberdoerfer, Linda; Kashani, Elham; Chennupati, Vijaykumar; Foehse, Lisa; Naumann, Ronald; Weiss, Siegfried; Krueger, Andreas; Foerster, Reinhold; Prinz, Immo			Development of Interleukin-17-Producing gamma delta T Cells Is Restricted to a Functional Embryonic Wave	IMMUNITY			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; INTERFERON-GAMMA; INTRAEPITHELIAL LYMPHOCYTES; IL-17 PRODUCTION; IMMUNE-SYSTEM; THYMUS; RECEPTORS; INFLAMMATION; PRECURSORS; INFECTION	gamma delta T cells are an important innate source of interleukin-17 (IL-17). In contrast to T helper 17 (Th17) cell differentiation, which occurs in the periphery, IL-17-producing gamma delta T cells (gamma delta T17 cells) are probably committed during thymic development. To study when gamma delta T17 cells arise during ontogeny, we used TcrdH2BeGFP reporter mice to monitor T cell receptor (TCR) rearrangement and IL-17 production in the embryonic thymus. We observed that several populations such as innate lymphoid cells and early T cell precursors were able to produce IL-17 prior to (and thus independent of) TCR recombination. gamma delta T17 cells were absent after transplantation of IL-17-sufficient bone marrow into mice lacking both Il17a and Il17f. Also, gamma delta T17 cells were not generated after genetic restoration of defective Rag1 function in adult mice. Together, these data suggested that these cells developed exclusively before birth and subsequently persisted in adult mice as self-renewing, long-lived cells.	[Haas, Jan D.; Ravens, Sarina; Sandrock, Inga; Oberdoerfer, Linda; Kashani, Elham; Chennupati, Vijaykumar; Foehse, Lisa; Krueger, Andreas; Foerster, Reinhold; Prinz, Immo] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Dueber, Sandra; Weiss, Siegfried] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Naumann, Ronald] MPI Mol Cell Biol & Genet, D-01307 Dresden, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research	Prinz, I (corresponding author), Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany.	prinz.immo@mh-hannover.de	Krueger, Andreas/B-9427-2009; Prinz, Immo/A-3026-2010; Krueger, Andreas/M-9769-2019; Förster, Reinhold/D-6770-2011	Krueger, Andreas/0000-0001-7873-7334; Prinz, Immo/0000-0002-8789-9578; Krueger, Andreas/0000-0001-7873-7334; Forster, Reinhold/0000-0001-6190-7923; Ravens, Sarina/0000-0002-3265-6341	Deutsche Forschungsgemeinschaft [DFG-PR727-2.1, SFB621-A14]; Hannover Biomedical Research School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hannover Biomedical Research School	This work was supported by the Deutsche Forschungsgemeinschaft, grants DFG-PR727-2.1 and SFB621-A14 (I.P.). J.D.H., V.C., L.F., E.K., and I.S. were supported by Hannover Biomedical Research School. We thank B. Malissen, F. Weih, T. Kamradt, E. Tolosa, O. Pabst, G. Bernhardt, L. Moschovakis, and C. Konecke for advice, P. Pereira and R. Tigelaar for mAb, A. Berns for providing Rosa26creERT2 mice, and M. Herberg for help with animal caretaking. We would like to acknowledge the assistance of the Cell Sorting Core Facility of the Hannover Medical School.	ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Caccamo N, 2011, BLOOD, V118, P129, DOI 10.1182/blood-2011-01-331298; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chennupati V, 2010, J IMMUNOL, V185, P5160, DOI 10.4049/jimmunol.1001652; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cui Y, 2009, J IMMUNOL, V183, P560, DOI 10.4049/jimmunol.0900241; deBarros A, 2011, EUR J IMMUNOL, V41, P195, DOI 10.1002/eji.201040905; Deknuydt F, 2009, IMMUNOL LETT, V127, P8, DOI 10.1016/j.imlet.2009.08.003; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Duber S, 2009, BLOOD, V114, P4960, DOI 10.1182/blood-2009-04-218156; Dunon D, 1997, J EXP MED, V186, P977, DOI 10.1084/jem.186.7.977; Gerber DJ, 1999, J IMMUNOL, V163, P3076; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Grigoriadou K, 2003, J IMMUNOL, V171, P2413, DOI 10.4049/jimmunol.171.5.2413; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jensen KDC, 2009, J IMMUNOL, V182, P7348, DOI 10.4049/jimmunol.0900465; Jensen KDC, 2009, CURR OPIN IMMUNOL, V21, P140, DOI 10.1016/j.coi.2009.02.008; Kisielow J, 2008, J IMMUNOL, V181, P1710, DOI 10.4049/jimmunol.181.3.1710; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Malinarich FH, 2010, EUR J IMMUNOL, V40, P3378, DOI 10.1002/eji.201040727; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Moens E, 2011, J LEUKOCYTE BIOL, V89, P743, DOI 10.1189/jlb.0910501; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Ness-Schwickerath KJ, 2010, J IMMUNOL, V184, P7268, DOI 10.4049/jimmunol.1000600; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Peng MY, 2008, CELL MOL IMMUNOL, V5, P203, DOI 10.1038/cmi.2008.25; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Powolny-Budnicka I, 2011, IMMUNITY, V34, P364, DOI 10.1016/j.immuni.2011.02.019; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Simonian PL, 2009, J IMMUNOL, V182, P6540, DOI 10.4049/jimmunol.0900013; Smith E, 2008, J IMMUNOL, V181, P1357, DOI 10.4049/jimmunol.181.2.1357; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; TAKAGAKI Y, 1989, NATURE, V339, P712, DOI 10.1038/339712a0; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008	68	232	233	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 27	2012	37	1					48	59		10.1016/j.immuni.2012.06.003	http://dx.doi.org/10.1016/j.immuni.2012.06.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22770884	Bronze			2022-12-18	WOS:000307133200009
J	Vladimer, GI; Weng, D; Paquette, SWM; Vanaja, SK; Rathinam, VAK; Aune, MH; Conlon, JE; Burbage, JJ; Proulx, MK; Liu, Q; Reed, G; Mecsas, JC; Iwakura, Y; Bertin, J; Goguen, JD; Fitzgerald, KA; Lien, E				Vladimer, Gregory I.; Weng, Dan; Paquette, Sara W. Montminy; Vanaja, Sivapriya Kailasan; Rathinam, Vijay A. K.; Aune, Marie Hjelmseth; Conlon, Joseph E.; Burbage, Joseph J.; Proulx, Megan K.; Liu, Qin; Reed, George; Mecsas, Joan C.; Iwakura, Yoichiro; Bertin, John; Goguen, Jon D.; Fitzgerald, Katherine A.; Lien, Egil			The NLRP12 Inflammasome Recognizes Yersinia pestis	IMMUNITY			English	Article							NF-KAPPA-B; CONTAINING APAF1-LIKE PROTEIN; III SECRETION SYSTEM; HOST-DEFENSE; REGULATES ACTIVATION; NALP3 INFLAMMASOME; COLON INFLAMMATION; CUTTING EDGE; LIPID-A; LIPOPOLYSACCHARIDE	Yersinia pestis, the causative agent of plague, is able to suppress production of inflammatory cytokines IL-18 and IL-1 beta, which are generated through caspase-1 -activating nucleotide-binding domain and leucine-rich repeat (NLR)-containing inflammasomes. Here, we sought to elucidate the role of NLRs and IL-18 during plague. Lack of IL-18 signaling led to increased susceptibility to Y. pestis, producing tetra-acylated lipid A, and an attenuated strain producing a Y. pseudotuberculosis-like hexa-acylated lipid A. We found that the NLRP12 inflammasome was an important regulator controlling IL-18 and IL-1 beta production after Y. pestis infection, and NLRP12-deficient mice were more susceptible to bacterial challenge. NLRP12 also directed interferon-gamma production via induction of IL-18, but had minimal effect on signaling to the transcription factor NF-kappa B. These studies reveal a role for NLRP12 in host resistance against pathogens. Minimizing NLRP12 inflammasome activation may have been a central factor in evolution of the high virulence of Y. pestis.	[Vladimer, Gregory I.; Weng, Dan; Paquette, Sara W. Montminy; Vanaja, Sivapriya Kailasan; Rathinam, Vijay A. K.; Conlon, Joseph E.; Burbage, Joseph J.; Fitzgerald, Katherine A.; Lien, Egil] UMass Med Sch, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Aune, Marie Hjelmseth; Lien, Egil] NTNU, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway; [Proulx, Megan K.; Goguen, Jon D.] UMass Med Sch, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; [Liu, Qin; Reed, George] UMass Med Sch, Div Prevent & Behav Med, Worcester, MA 01655 USA; [Mecsas, Joan C.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; [Bertin, John] GlaxoSmithKline, Pattern Recognit Receptor DPU, Collegeville, PA 19426 USA	University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Tufts University; University of Tokyo; GlaxoSmithKline	Lien, E (corresponding author), UMass Med Sch, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	egil.lien@umassmed.edu	Iwakura, Yoichiro/E-5457-2011; Rathinam, Vijay/ABE-7544-2020; Fitzgerald, Katherine/ABE-6317-2020; Vladimer, Gregory/X-4547-2018	Iwakura, Yoichiro/0000-0002-9934-5775; Rathinam, Vijay/0000-0002-8009-3977; Proulx, Megan/0000-0002-9524-8302; Vladimer, Gregory/0000-0003-4205-7585; Fitzgerald, Kate/0000-0003-3175-609X	NIH [AI057588, AI075318, AI64349, AI083713, AI095213]; NIH (NERCE fellowships) [AI057159]; Research Council of Norway; Norwegian Cancer Society; DERC grant NIH [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI075318, R01AI064349, R01AI075318, R01AI083713, R01AI057588, T32AI095213, U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (NERCE fellowships); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); DERC grant NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Cerny, H. Ducharme, M. Whalen, A. Zacharia, and C. Raskett for animal husbandry and X. He and members of the Lien, Fitzgerald, and Goguen labs for help and discussions. Work was supported by the NIH (grants AI057588-American Recovery and Reinvestment Act and AI075318 to E.L., AI64349 and AI083713 to K.F., AI095213 to G.I.V., and NERCE fellowships AI057159 to S.K.V. and V.A.K.R.), the Research Council of Norway, and the Norwegian Cancer Society. The study also utilized core services supported by DERC grant NIH DK32520. We thank those who provided reagents, B. Monks for help with cloning, and R. Ingalls for critical reading of the manuscript. J.B. is an employee and shareholder of GSK. J.C. is an employee of Milennium.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Averette KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007913; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; BRUBAKER R R, 1970, Infection and Immunity, V1, P446; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Cornelis GR, 2000, P NATL ACAD SCI USA, V97, P8778, DOI 10.1073/pnas.97.16.8778; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jeru I, 2011, ARTHRITIS RHEUM-US, V63, P2142, DOI 10.1002/art.30378; Jeru I, 2011, ARTHRITIS RHEUM-US, V63, P1459, DOI 10.1002/art.30241; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Knirel YA, 2005, BIOCHEMISTRY-US, V44, P1731, DOI 10.1021/bi048430f; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lich JD, 2007, MICROBES INFECT, V9, P672, DOI 10.1016/j.micinf.2007.01.018; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lilo S, 2008, INFECT IMMUN, V76, P3911, DOI 10.1128/IAI.01695-07; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Monack DM, 1998, J EXP MED, V188, P2127, DOI 10.1084/jem.188.11.2127; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Nilsen N, 2004, J BIOL CHEM, V279, P39727, DOI 10.1074/jbc.M405027200; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rebeil R, 2006, J BACTERIOL, V188, P1381, DOI 10.1128/JB.188.4.1381-1388.2006; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Therisod H, 2002, INT J MASS SPECTROM, V219, P549, DOI 10.1016/S1387-3806(02)00706-6; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zheng Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002026; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	62	232	241	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 27	2012	37	1					96	107		10.1016/j.immuni.2012.07.006	http://dx.doi.org/10.1016/j.immuni.2012.07.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22840842	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000307133200013
J	Haas, T; Metzger, J; Schmitz, F; Heit, A; Muller, T; Latz, E; Wagner, H				Haas, Tobias; Metzger, Jochen; Schmitz, Frank; Heit, Antje; Mueller, Thomas; Latz, Eicke; Wagner, Hermann			The DNA sugar backbone 2 ' deoxyribose determines toll-like receptor 9 activation	IMMUNITY			English	Article							TOLL-LIKE RECEPTOR-9; PLASMACYTOID DENDRITIC CELLS; BACTERIAL-DNA; CPG-DNA; ENDOSOMAL TRANSLOCATION; MACROPHAGE ACTIVATION; NUCLEIC-ACIDS; SELF-DNA; IN-VITRO; RECOGNITION	CpG motifs within phosphorothioate (PS)-modified DNA drive Toll-like receptor 9 (TLR9) activation, but the rules governing recognition of natural phosphodiester (PD) DNA are less understood. Here, we showed that the sugar backbone determined DNA recognition by TLR9. Homopolymeric, base-free PD 2' deoxyribose acted as a basal TLR9 agonist as it bound to and activated TLR9. This effect was enhanced by DNA bases, even short of CpG motifs. In contrast, PS-modified 2' deoxyribose homopolymers acted as TLR9 and TLR7 antagonists. They displayed high affinity to both TLRs and did not activate on their own, but they competitively inhibited ligand-TLR interaction and activation. Although addition of random DNA bases to the PS 2' deoxyribose backbone did not alter these effects, CpG motifs transformed TLR9-inhibitory to robust TLR9-stimulatory activity. Our results identified the PD 2' deoxyribose backbone as an important determinant of TLR9 activation by natural DNA, restrict CpG-motif dependency of TLR9 activation to synthetic PS-modified ligands, and define PS-modified 2' deoxyribose as a prime effector of TLR9 and TLR7 inhibition.	[Haas, Tobias; Schmitz, Frank; Heit, Antje; Mueller, Thomas; Wagner, Hermann] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hygiene, D-81675 Munich, Germany; [Metzger, Jochen] Tech Univ Munich, Inst Klin Chem & Pathobiochem, Klinikum Rechts Isar, D-81675 Munich, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	Technical University of Munich; Technical University of Munich; University of Massachusetts System; University of Massachusetts Worcester	Wagner, H (corresponding author), Tech Univ Munich, Inst Med Mikrobiol Immunol & Hygiene, Trogerstr 30, D-81675 Munich, Germany.	h.wagner@lrz.tum.de	Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666; Metzger, Jochen/0000-0003-4475-4499				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bishop JS, 1996, J BIOL CHEM, V271, P5698, DOI 10.1074/jbc.271.10.5698; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Dalpke AH, 2002, IMMUNOLOGY, V106, P102, DOI 10.1046/j.1365-2567.2002.01410.x; Diebold SS, 2006, EUR J IMMUNOL, V36, P3256, DOI 10.1002/eji.200636617; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Duramad O, 2005, J IMMUNOL, V174, P5193, DOI 10.4049/jimmunol.174.9.5193; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kerkmann M, 2005, J BIOL CHEM, V280, P8086, DOI 10.1074/jbc.M410868200; Kindrachuk J, 2007, J BIOL CHEM, V282, P13944, DOI 10.1074/jbc.M608089200; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Roberts TL, 2005, J IMMUNOL, V175, P3569, DOI 10.4049/jimmunol.175.6.3569; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Sester DP, 2000, J IMMUNOL, V165, P4165, DOI 10.4049/jimmunol.165.8.4165; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Yasuda K, 2006, EUR J IMMUNOL, V36, P431, DOI 10.1002/eji.200535210; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129	39	232	243	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR	2008	28	3					315	323		10.1016/j.immuni.2008.01.013	http://dx.doi.org/10.1016/j.immuni.2008.01.013			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18342006	Bronze			2022-12-18	WOS:000254142500009
J	Schulze-Luehrmann, J; Ghosh, S				Schulze-Luehrmann, Jan; Ghosh, Sankar			Antigen-receptor signaling to nuclear factor kappa B	IMMUNITY			English	Review							T-CELL-RECEPTOR; KINASE-C-THETA; ADAPTIVE IMMUNE-RESPONSES; DOMAIN-CONTAINING PROTEIN; LIPID RAFT RECRUITMENT; VAV-FAMILY PROTEINS; PKC-THETA; IMMUNOLOGICAL SYNAPSE; LYMPHOCYTE DEVELOPMENT; IKK ACTIVATION	Signal transduction events leading to the survival, differentiation, or apoptosis of cells of the innate or adaptive immune system must be properly coordinated to ensure the normal mounting and termination of immune responses. One of the key transcription factors in immune responses is nuclear factor kappa B (NF-kappa B), which has been the focus of intense investigation over the past two decades. With the identification of the CARMA1-BCL10-MALT1 complex and ongoing progress in understanding the molecular mechanisms connecting T cell and B cell receptor proximal signals to the I kappa B kinase (IKK) complex, a cohesive model of antigen receptor (AgR)-dependent signaling to NF-kappa B activation is beginning to emerge. In this review, we provide an overview of the current state of research into the mechanisms that regulate AgR-mediated NF-kappa B transcriptional activity, with particular focus on the events leading to activation of the IKK complex.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University	Ghosh, S (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.	sankar.ghosh@yale.edu		Ghosh, Sankar/0000-0002-3227-0588	NIAID NIH HHS [R01-AI68977, R37-AI33443, R37 AI033443] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068977, R37AI033443] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman A, 2004, EUR J IMMUNOL, V34, P2001, DOI 10.1002/eji.200324625; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brenner D, 2005, EMBO J, V24, P4279, DOI 10.1038/sj.emboj.7600894; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Dienz O, 2003, J IMMUNOL, V170, P365, DOI 10.4049/jimmunol.170.1.365; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Farinha P, 2005, J CLIN ONCOL, V23, P6370, DOI 10.1200/JCO.2005.05.011; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guiet C, 2000, J CELL BIOL, V148, P1131, DOI 10.1083/jcb.148.6.1131; Hans CP, 2005, MODERN PATHOL, V18, P1377, DOI 10.1038/modpathol.3800434; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Healy AM, 2006, J IMMUNOL, V177, P1886, DOI 10.4049/jimmunol.177.3.1886; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Herndon TM, 2001, J IMMUNOL, V166, P5654, DOI 10.4049/jimmunol.166.9.5654; Hikida M, 2003, J EXP MED, V198, P581, DOI 10.1084/jem.20030280; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Isaacson PG, 2005, BEST PRACT RES CL HA, V18, P57, DOI 10.1016/j.beha.2004.08.003; Ishizawa YH, 2006, BIOL CELL, V98, P465, DOI 10.1042/BC20050091; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Lemmon MA, 2005, CELL, V120, P574, DOI 10.1016/j.cell.2005.02.023; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li YQ, 2005, J BIOL CHEM, V280, P1217, DOI 10.1074/jbc.M409492200; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Manicassamy S, 2006, J MOL BIOL, V355, P347, DOI 10.1016/j.jmb.2005.10.043; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Medoff BD, 2006, J IMMUNOL, V176, P7272, DOI 10.4049/jimmunol.176.12.7272; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nakamura S, 2005, CANCER-AM CANCER SOC, V104, P1885, DOI 10.1002/cncr.21421; Narayan P, 2006, MOL CELL BIOL, V26, P2327, DOI 10.1128/MCB.26.6.2327-2336.2006; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nirula A, 2006, J EXP MED, V203, P1733, DOI 10.1084/jem.20051715; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Piccolella E, 2003, J IMMUNOL, V170, P2895, DOI 10.4049/jimmunol.170.6.2895; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rossman JS, 2006, MOL BIOL CELL, V17, P2166, DOI 10.1091/mbc.E05-10-0985; Ruefli-Brasse AA, 2004, J BIOL CHEM, V279, P1570, DOI 10.1074/jbc.C300460200; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Sanchez-Valdepenas C, 2006, J IMMUNOL, V176, P4666, DOI 10.4049/jimmunol.176.8.4666; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Schaefer BC, 2004, P NATL ACAD SCI USA, V101, P1004, DOI 10.1073/pnas.0307858100; Scharschmidt E, 2004, MOL CELL BIOL, V24, P3860, DOI 10.1128/MCB.24.9.3860-3873.2004; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Schmitz ML, 2006, CELL DEATH DIFFER, V13, P834, DOI 10.1038/sj.cdd.4401845; Schulze-Luehrmann J, 2002, BLOOD, V100, P954, DOI 10.1182/blood-2002-01-0089; Sedwick CE, 2004, MOL IMMUNOL, V41, P675, DOI 10.1016/j.molimm.2004.01.007; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Srinivasula SM, 1999, J BIOL CHEM, V274, P17946, DOI 10.1074/jbc.274.25.17946; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Suzuki N, 2006, SCIENCE, V311, P1927, DOI 10.1126/science.1124256; Tan JEL, 2001, J BIOL CHEM, V276, P20055, DOI 10.1074/jbc.M010800200; Tao L, 2002, BIOCHEM J, V363, P175, DOI 10.1042/0264-6021:3630175; Thebault S, 2004, MOL IMMUNOL, V40, P931, DOI 10.1016/j.molimm.2003.10.014; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Thome M, 2003, DEV CELL, V4, P3, DOI 10.1016/S1534-5807(02)00407-0; Thuille N, 2005, EMBO J, V24, P3869, DOI 10.1038/sj.emboj.7600856; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(00)00094-0; VERWEIJ CL, 1991, J BIOL CHEM, V266, P14179; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Villalba M, 2002, J CELL BIOL, V157, P253, DOI 10.1083/jcb.200201097; von Essen M, 2006, J IMMUNOL, V176, P7502, DOI 10.4049/jimmunol.176.12.7502; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Weil R, 2004, CURR OPIN IMMUNOL, V16, P374, DOI 10.1016/j.coi.2004.03.003; Weil R, 2003, IMMUNITY, V18, P13, DOI 10.1016/S1074-7613(02)00506-X; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yokozeki T, 2003, J IMMUNOL, V171, P1328, DOI 10.4049/jimmunol.171.3.1328; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	136	232	245	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2006	25	5					701	715		10.1016/j.immuni.2006.10.010	http://dx.doi.org/10.1016/j.immuni.2006.10.010			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17098202	Bronze			2022-12-18	WOS:000242063100005
J	Leibson, PJ				Leibson, PJ			Signal transduction during natural killer cell activation: Inside the mind of a killer	IMMUNITY			English	Review							PROTEIN-TYROSINE PHOSPHORYLATION; IGG FC-RECEPTOR; COMPLEX CLASS-I; NK CELLS; TRIGGERING MOLECULE; GAMMA-CHAIN; T-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; CYTOLYTIC LYMPHOCYTES; LIGAND-BINDING				Leibson, PJ (corresponding author), MAYO CLIN & MAYO FDN, DEPT IMMUNOL, ROCHESTER, MN 55905 USA.							ABRAMS SI, 1986, CELL IMMUNOL, V101, P558, DOI 10.1016/0008-8749(86)90166-8; ANDERSON P, 1989, NATURE, V341, P159, DOI 10.1038/341159a0; ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; AZZONI L, 1992, J EXP MED, V176, P1745, DOI 10.1084/jem.176.6.1745; AZZONI L, 1995, J IMMUNOL, V154, P491; BAJPAI A, 1994, J BIOL CHEM, V269, P18864; Biassoni R, 1996, J EXP MED, V183, P645, DOI 10.1084/jem.183.2.645; Binstadt BA, 1997, IMMUNOL REV, V155, P197, DOI 10.1111/j.1600-065X.1997.tb00952.x; Binstadt BA, 1996, IMMUNITY, V5, P629, DOI 10.1016/S1074-7613(00)80276-9; BONNEMA JD, 1994, J EXP MED, V180, P1427, DOI 10.1084/jem.180.4.1427; Bottino C, 1996, EUR J IMMUNOL, V26, P1816, DOI 10.1002/eji.1830260823; Brown MG, 1997, IMMUNOL REV, V155, P53, DOI 10.1111/j.1600-065X.1997.tb00939.x; Brumbaugh KM, 1996, J IMMUNOL, V157, P2804; BRUMBAUGH KM, 1997, IN PRESS CURR TOPICS; Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; CAMBIER JC, 1995, IMMUNOL LETT, V44, P77, DOI 10.1016/0165-2478(94)00196-X; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Campbell KS, 1996, J EXP MED, V184, P93, DOI 10.1084/jem.184.1.93; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; Chacko GW, 1996, J IMMUNOL, V157, P2234; CHAMBERS WH, 1989, J EXP MED, V169, P1373, DOI 10.1084/jem.169.4.1373; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; Colonna M, 1997, IMMUNOL REV, V155, P127, DOI 10.1111/j.1600-065X.1997.tb00945.x; CONE JC, 1993, EUR J IMMUNOL, V23, P2488; EINSPAHR KJ, 1991, P NATL ACAD SCI USA, V88, P6279, DOI 10.1073/pnas.88.14.6279; Eischen CM, 1996, J IMMUNOL, V156, P2693; EXLEY M, 1994, J BIOL CHEM, V269, P15140; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; FREY JL, 1991, J EXP MED, V174, P1527, DOI 10.1084/jem.174.6.1527; Fry AM, 1996, J EXP MED, V184, P295, DOI 10.1084/jem.184.1.295; GALANDRINI R, 1994, J IMMUNOL, V153, P4399; Galandrini R, 1996, J EXP MED, V183, P179, DOI 10.1084/jem.183.1.179; GIBBONEY JJ, 1992, NAT IMMUN, V11, P57; GISMONDI A, 1995, J IMMUNOL, V154, P3128; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Houchins JP, 1997, J IMMUNOL, V158, P3603; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Jewett A, 1996, J IMMUNOL, V156, P907; KANAKARAJ P, 1994, J EXP MED, V179, P551, DOI 10.1084/jem.179.2.551; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KAUFMAN DS, 1995, P NATL ACAD SCI USA, V92, P6484, DOI 10.1073/pnas.92.14.6484; KAUFMAN DS, 1992, P NATL ACAD SCI USA, V89, P8337, DOI 10.1073/pnas.89.17.8337; KUROSAKI T, 1991, P NATL ACAD SCI USA, V88, P3837, DOI 10.1073/pnas.88.9.3837; KUROSAKI T, 1989, NATURE, V342, P805, DOI 10.1038/342805a0; Lanier LL, 1997, IMMUNOL REV, V155, P145, DOI 10.1111/j.1600-065X.1997.tb00947.x; Lanier LL, 1996, IMMUNOL TODAY, V17, P86, DOI 10.1016/0167-5699(96)80585-8; Lanier LL, 1997, IMMUNITY, V6, P371, DOI 10.1016/S1074-7613(00)80280-0; LANIER LL, 1989, NATURE, V342, P803, DOI 10.1038/342803a0; Lazetic S, 1996, J IMMUNOL, V157, P4741; LEIBSON PJ, 1995, IMMUNITY, V3, P5, DOI 10.1016/1074-7613(95)90153-1; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1997, IMMUNOL REV, V155, P135, DOI 10.1111/j.1600-065X.1997.tb00946.x; LONG EO, 1997, IN PRESS CURR OPIN I; MAndelboim O, 1996, SCIENCE, V274, P2097, DOI 10.1126/science.274.5295.2097; MASON LH, 1994, J LEUKOCYTE BIOL, V55, P362, DOI 10.1002/jlb.55.3.362; Mason LH, 1996, J EXP MED, V184, P2119, DOI 10.1084/jem.184.6.2119; Milella M, 1997, J IMMUNOL, V158, P3148; Miyazaki T, 1996, SCIENCE, V272, P405, DOI 10.1126/science.272.5260.405; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MORETTA A, 1991, J EXP MED, V174, P1393, DOI 10.1084/jem.174.6.1393; MORETTA A, 1995, J EXP MED, V182, P875, DOI 10.1084/jem.182.3.875; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Nakamura MC, 1997, J EXP MED, V185, P673, DOI 10.1084/jem.185.4.673; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Olcese L, 1996, J IMMUNOL, V156, P4531; Olcese L, 1997, J IMMUNOL, V158, P5083; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; ORLOFF DG, 1990, NATURE, V347, P189, DOI 10.1038/347189a0; ORTALDO JR, 1995, J EXP MED, V181, P339, DOI 10.1084/jem.181.1.339; OSHEA JJ, 1992, J IMMUNOL, V148, P2497; OSHEA JJ, 1991, P NATL ACAD SCI USA, V88, P350, DOI 10.1073/pnas.88.2.350; Osman N, 1996, EUR J IMMUNOL, V26, P1063, DOI 10.1002/eji.1830260516; Pao LI, 1997, J IMMUNOL, V158, P2663; PAOLINI R, 1995, J EXP MED, V181, P247, DOI 10.1084/jem.181.1.247; PAYA CV, 1990, J IMMUNOL, V144, P4370; PEREZVILLAR JJ, 1995, J IMMUNOL, V154, P5779; PERUSSIA B, 1981, J IMMUNOL, V126, P754; PIGNATA C, 1993, J IMMUNOL, V151, P6794; RABINOWICH H, 1995, BLOOD, V85, P1858, DOI 10.1182/blood.V85.7.1858.bloodjournal8571858; Rabinowich H, 1996, J IMMUNOL, V157, P3860; RABINOWICH H, 1995, J IMMUNOL, V154, P1124; Raulet DH, 1997, IMMUNOL REV, V155, P41, DOI 10.1111/j.1600-065X.1997.tb00938.x; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Renard V, 1997, IMMUNOL REV, V155, P205, DOI 10.1111/j.1600-065X.1997.tb00953.x; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Reyburn HT, 1997, NATURE, V386, P514, DOI 10.1038/386514a0; RYAN JC, 1995, J EXP MED, V181, P1911, DOI 10.1084/jem.181.5.1911; SALCEDO TW, 1993, J EXP MED, V177, P1475, DOI 10.1084/jem.177.5.1475; Scharenberg AM, 1996, CELL, V87, P961, DOI 10.1016/S0092-8674(00)81790-0; SCONOCCHIA G, 1994, J IMMUNOL, V153, P5473; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; SILICIANO RF, 1985, NATURE, V317, P428, DOI 10.1038/317428a0; SPITS H, 1995, BLOOD, V85, P2654, DOI 10.1182/blood.V85.10.2654.bloodjournal85102654; STAHLS A, 1994, EUR J IMMUNOL, V24, P2491, DOI 10.1002/eji.1830241035; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; TING AT, 1992, J EXP MED, V176, P1751, DOI 10.1084/jem.176.6.1751; TING AT, 1995, J BIOL CHEM, V270, P16415, DOI 10.1074/jbc.270.27.16415; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Trinchieri G, 1995, Semin Immunol, V7, P83, DOI 10.1006/smim.1995.0012; Valiante NM, 1996, J EXP MED, V184, P2243, DOI 10.1084/jem.184.6.2243; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; VELY F, 1997, IN PRESS EUR J IMMUN; VIVIER E, 1991, J IMMUNOL, V146, P206; VIVIER E, 1993, EUR J IMMUNOL, V23, P1872, DOI 10.1002/eji.1830230821; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEN T, 1995, EUR J IMMUNOL, V25, P3155, DOI 10.1002/eji.1830251125; Xu XL, 1996, BIOCHEM PHARMACOL, V52, P527, DOI 10.1016/0006-2952(96)00303-6; Yamada H, 1996, J IMMUNOL, V157, P1523; ZANOVELLO P, 1989, J EXP MED, V170, P665, DOI 10.1084/jem.170.3.665; Zoller KE, 1997, J IMMUNOL, V158, P1650	115	232	238	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1997	6	6					655	661		10.1016/S1074-7613(00)80441-0	http://dx.doi.org/10.1016/S1074-7613(00)80441-0			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XG579	9208838	Bronze			2022-12-18	WOS:A1997XG57900001
J	Bodmer, JL; Burns, K; Schneider, P; Hofmann, K; Steiner, V; Thome, M; Bornand, T; Hahne, M; Schroter, M; Becker, K; Wilson, A; French, LE; Browning, JL; MacDonald, HR; Tschopp, J				Bodmer, JL; Burns, K; Schneider, P; Hofmann, K; Steiner, V; Thome, M; Bornand, T; Hahne, M; Schroter, M; Becker, K; Wilson, A; French, LE; Browning, JL; MacDonald, HR; Tschopp, J			TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)	IMMUNITY			English	Article							TNF RECEPTOR; DEATH DOMAIN; CELL-DEATH; LYMPHOTOXIN-BETA; FAS ANTIGEN; PROTEIN; VIRUS; ACTIVATION; EXPRESSION; INTERACTS	A novel member of the tumor necrosis factor (TNF) receptor family, designated TRAMP, has been identified. The structural organization of the 393 amino acid long human TRAMP is most homologous to TNF receptor 1. TRAMP is abundantly expressed on thymocytes and lymphocytes. Its extracellular domain is composed of four cysteine-rich domains, and the cytoplasmic region contains a death domain known to signal apoptosis. Overexpression of TRAMP leads to two major responses, NF-kappa B activation and apoptosis. TRAMP-induced cell death is inhibited by an inhibitor of ICE-like proteases, but not by Bcl-2. In addition, TRAMP does not appear to interact with any of the known apoptosis-inducing ligands of the TNF family.	UNIV LAUSANNE,LUDWIG INST CANC RES,LAUSANNE BRANCH,LAUSANNE,SWITZERLAND; SWISS INST EXPT CANC RES,BIL RES CTR,CH-1066 EPALINGES,SWITZERLAND; UNIV GENEVA,SCH MED,DEPT DERMATOL,CH-1211 GENEVA 4,SWITZERLAND; BIOGEN INC,DEPT IMMUNOL & INFLAMMAT,CAMBRIDGE,MA 02142	Ludwig Institute for Cancer Research; University of Lausanne; Swiss Institute Experimental Cancer Research; University of Geneva; Biogen	Bodmer, JL (corresponding author), UNIV LAUSANNE,INST BIOCHEM,LAUSANNE,SWITZERLAND.		Hofmann, Kay/D-6714-2011; French, Lars/AAL-5977-2020; Wilson, Anne/A-7131-2011; Thome, Margot/F-8167-2011	Hofmann, Kay/0000-0002-2289-9083; French, Lars/0000-0002-4629-1486; Thome, Margot/0000-0002-5656-2139; Browning, Jeffrey/0000-0001-9168-5233; Schneider, Pascal/0000-0003-0677-9409				BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BORNER C, 1994, J CELL BIOL, V126, P1059, DOI 10.1083/jcb.126.4.1059; Browning JL, 1996, J BIOL CHEM, V271, P8618, DOI 10.1074/jbc.271.15.8618; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; BYRN RA, 1990, NATURE, V344, P667, DOI 10.1038/344667a0; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; DIXIT VM, 1996, CURR BIOL, V6, P555; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; FRANCIS MJ, 1991, IMMUNOLOGY, V73, P249; FUCHS P, 1992, GENOMICS, V13, P219, DOI 10.1016/0888-7543(92)90226-I; FUCHS P, 1992, GENOMICS, V13, P1384; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; HAWKINS CJ, 1994, IMMUNOL REV, V142, P127, DOI 10.1111/j.1600-065X.1994.tb00886.x; HENG HHQ, 1993, CHROMOSOMA, V102, P325, DOI 10.1007/BF00661275; Henkart PA, 1996, IMMUNITY, V4, P195, DOI 10.1016/S1074-7613(00)80428-8; HOFMANN K, 1995, FEBS LETT, V371, P321, DOI 10.1016/0014-5793(95)00931-X; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; ITOH N, 1993, J BIOL CHEM, V268, P10932; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1; KRAMMER PH, 1994, IMMUNOL REV, V142, P175, DOI 10.1111/j.1600-065X.1994.tb00889.x; KUMAR S, 1995, TRENDS BIOCHEM SCI, V20, P198, DOI 10.1016/S0968-0004(00)89007-6; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagata S, 1994, Semin Immunol, V6, P3, DOI 10.1006/smim.1994.1002; PEITSCH MC, 1993, EMBO J, V12, P371, DOI 10.1002/j.1460-2075.1993.tb05666.x; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; RUSSELL JH, 1983, IMMUNOL REV, V72, P97, DOI 10.1111/j.1600-065X.1983.tb01074.x; Sambrook J, 1989, MOL CLONING LAB MANU; Schroter M, 1995, EUR J IMMUNOL, V25, P3509, DOI 10.1002/eji.1830251245; SMITH CA, 1991, BIOCHEM BIOPH RES CO, V176, P335, DOI 10.1016/0006-291X(91)90929-2; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; TARTAGLIA LA, 1993, CELL, V73, P213, DOI 10.1016/0092-8674(93)90222-C; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; UPTON C, 1991, VIROLOGY, V184, P370, DOI 10.1016/0042-6822(91)90853-4; Ware CF, 1996, J CELL BIOCHEM, V60, P47, DOI 10.1002/(SICI)1097-4644(19960101)60:1<47::AID-JCB8>3.3.CO;2-H; WATANABE FR, 1992, NATURE, V356, P314; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wilson A, 1996, IMMUNITY, V4, P37, DOI 10.1016/S1074-7613(00)80296-4	51	232	270	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1997	6	1					79	88		10.1016/S1074-7613(00)80244-7	http://dx.doi.org/10.1016/S1074-7613(00)80244-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB161	9052839	Bronze			2022-12-18	WOS:A1997XB16100008
J	Horai, R; Zarate-Blades, CR; Dillenburg-Pilla, P; Chen, J; Kielczewski, JL; Silver, PB; Jittayasothorn, Y; Chan, CC; Yamane, H; Honda, K; Caspi, RR				Horai, Reiko; Zarate-Blades, Carlos R.; Dillenburg-Pilla, Patricia; Chen, Jun; Kielczewski, Jennifer L.; Silver, Phyllis B.; Jittayasothorn, Yingyos; Chan, Chi-Chao; Yamane, Hidehiro; Honda, Kenya; Caspi, Rachel R.			Microbiota-Dependent Activation of an Autoreactive T Cell Receptor Provokes Autoimmunity in an Immunologically Privileged Site	IMMUNITY			English	Article							RETINOID-BINDING PROTEIN; GUT MICROBIOTA; TH17; INFLAMMATION; EXPRESSION; INDUCTION; RESPONSES; UVEITIS	Activated retina-specific T cells that have acquired the ability to break through the blood-retinal barrier are thought to be causally involved in autoimmune uveitis, a major cause of human blindness. It is unclear where these autoreactive T cells first become activated, given that their cognate antigens are sequestered within the immune-privileged eye. We demonstrate in a novel mouse model of spontaneous uveitis that activation of retina-specific T cells is dependent on gut commensal microbiota. Retina-specific T cell activation involved signaling through the autoreactive T cell receptor (TCR) in response to non-cognate antigen in the intestine and was independent of the endogenous retinal autoantigen. Our findings not only have implications for the etiology of human uveitis, but also raise the possibility that activation of autoreactive TCRs by commensal microbes might be a more common trigger of autoimmune diseases than is currently appreciated.	[Horai, Reiko; Zarate-Blades, Carlos R.; Chen, Jun; Kielczewski, Jennifer L.; Silver, Phyllis B.; Jittayasothorn, Yingyos; Chan, Chi-Chao; Caspi, Rachel R.] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Dillenburg-Pilla, Patricia] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Chen, Jun] Sun Yat Sen Univ, State Key Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Yamane, Hidehiro] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Honda, Kenya] Keio Univ, Sch Med, Tokyo 1608582, Japan; [Honda, Kenya] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Keio University; RIKEN	Caspi, RR (corresponding author), NEI, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	caspir@mail.nih.gov	Zárate-Bladés, Carlos R/C-9663-2015; Honda, Kenya/N-5297-2015	Zárate-Bladés, Carlos R/0000-0002-7728-7869; Caspi, Rachel/0000-0002-7140-7671; Chen, Jun/0000-0002-4059-3512	NEI intramural funding [EY000184]; CREST, Japan Science and Technology Agency (Tokyo, Japan); NATIONAL EYE INSTITUTE [ZIAEY000222, ZIAEY000184] Funding Source: NIH RePORTER	NEI intramural funding; CREST, Japan Science and Technology Agency (Tokyo, Japan); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Drs. Koji Atarashi (RIKEN) and Ivan Fuss (NIAID, NIH) for sharing protocols, Dr. Kristin Hogquist (University of Minnesota) for Nr4a1<SUP>GFP</SUP> reporter mice, Dr. Gregory Liou (Medical College of Georgia) for Rbp3<SUP>-/-</SUP> mice, all members of the R.R.C. lab for help and advice, NEI Flow Cytometry Core for assistance in cell sorting and analysis, NEI Genetic Engineering Core for the assistance in antibiotics treatment and mouse colony maintenance, NEI Histology Core for processing of histology specimens, and NIH-DVR Pathology and Bacteriology labs for bacteriological analysis. We thank Drs. Silvio Gutkind (NIDCR), William E. Paul (NIAID), Katsuko Sudo (Tokyo Medical University), and Kikuji Itoh (Japan SLC) for support and useful discussions. R.R.C. is supported by NEI intramural funding (project # EY000184) and K.H. is supported by CREST, Japan Science and Technology Agency (Tokyo, Japan).	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Durrani OM, 2004, OPHTHALMOLOGICA, V218, P223, DOI 10.1159/000078612; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gery I., 1996, PROG RETIN RES, V5, P75; GONZALEZFERNANDEZ F, 1993, EXP EYE RES, V56, P411, DOI 10.1006/exer.1993.1055; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Horai R, 2013, J AUTOIMMUN, V44, P21, DOI 10.1016/j.jaut.2013.06.003; Horai R, 2010, NEUROMETHODS, V46, P207, DOI 10.1007/978-1-60761-541-5_11; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Karabekian Z, 2005, INVEST OPHTH VIS SCI, V46, P3769, DOI 10.1167/iovs.05-0187; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Liou GI, 1998, J NEUROSCI, V18, P4511; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morton AM, 2014, P NATL ACAD SCI USA, V111, P6696, DOI 10.1073/pnas.1405634111; Proal AD, 2009, AUTOIMMUN REV, V8, P677, DOI 10.1016/j.autrev.2009.02.016; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramanan D, 2014, IMMUNITY, V41, P311, DOI 10.1016/j.immuni.2014.06.015; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Wang CK, 2012, INVEST OPHTH VIS SCI, V53, P4668, DOI 10.1167/iovs.12-9863; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Zhou R, 2012, J IMMUNOL, V188, P1742, DOI 10.4049/jimmunol.1102415	33	231	242	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					343	353		10.1016/j.immuni.2015.07.014	http://dx.doi.org/10.1016/j.immuni.2015.07.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26287682	Green Accepted, Bronze			2022-12-18	WOS:000360101200016
J	Schumann, K; Lammermann, T; Bruckner, M; Legler, DF; Polleux, J; Spatz, JP; Schuler, G; Forster, R; Lutz, MB; Sorokin, L; Sixt, M				Schumann, Kathrin; Laemmermann, Tim; Bruckner, Markus; Legler, Daniel F.; Polleux, Julien; Spatz, Joachim P.; Schuler, Gerold; Foerster, Reinhold; Lutz, Manfred B.; Sorokin, Lydia; Sixt, Michael			Immobilized Chemokine Fields and Soluble Chemokine Gradients Cooperatively Shape Migration Patterns of Dendritic Cells	IMMUNITY			English	Article							LYMPH-NODE; T-LYMPHOCYTES; CCR7; MOTILITY; MOUSE; ZONES; GENE; POLARIZATION; TRAFFICKING; RECRUITMENT	Chemokines orchestrate immune cell trafficking by eliciting either directed or random migration and by activating integrins in order to induce cell adhesion. Analyzing dendritic cell (DC) migration, we showed that these distinct cellular responses depended on the mode of chemokine presentation within tissues. The surface-immobilized form of the chemokine CCL21, the heparan sulfate-anchoring ligand of the CC-chemokine receptor 7 (CCR7), caused random movement of DCs that was confined to the chemokine-presenting surface because it triggered integrin-mediated adhesion. Upon direct contact with CCL21, DCs truncated the anchoring residues of CCL21, thereby releasing it from the solid phase. Soluble CCL21 functionally resembles the second CCR7 ligand, CCL19, which lacks anchoring residues and forms soluble gradients. Both soluble CCR7 ligands triggered chemotactic movement, but not surface adhesion. Adhesive random migration and directional steering cooperate to produce dynamic but spatially restricted locomotion patterns closely resembling the cellular dynamics observed in secondary lymphoid organs.	[Schumann, Kathrin; Laemmermann, Tim; Sixt, Michael] Max Planck Inst Biochem, Hofschneider Grp Leukocyte Migrat, D-82152 Martinsried, Germany; [Bruckner, Markus; Legler, Daniel F.] Univ Konstanz, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland; [Polleux, Julien; Spatz, Joachim P.] Max Planck Inst Met Res, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany; [Schuler, Gerold] Univ Hosp Erlangen, Dept Dermatol, D-91052 Erlangen, Germany; [Foerster, Reinhold] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Lutz, Manfred B.] Univ Wurzburg, Inst Virol & Immunbiol, D-97078 Wurzburg, Germany; [Sorokin, Lydia] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany	Max Planck Society; Max Planck Society; University of Erlangen Nuremberg; Hannover Medical School; University of Wurzburg; University of Munster	Sixt, M (corresponding author), Max Planck Inst Biochem, Hofschneider Grp Leukocyte Migrat, D-82152 Martinsried, Germany.	sixt@biochem.mpg.de	Sixt, Michael/F-3925-2010; Spatz, Joachim P/A-1107-2017; Förster, Reinhold/D-6770-2011; Lämmermann, Tim/AAD-7453-2022	Spatz, Joachim P/0000-0003-3419-9807; Forster, Reinhold/0000-0001-6190-7923; Schumann, Kathrin/0000-0002-0993-3910; Legler, Daniel F./0000-0001-8610-4764; Sixt, Michael/0000-0002-6620-9179; Sorokin, Lydia/0000-0001-7704-7921; Lutz, Manfred B./0000-0001-9193-1772	Peter Hans Hofschneider Foundation; German Research Foundation; Max Planck Society; Swiss National Science Foundation; Max Cloetta Foundation; University of Erlangen; European Union	Peter Hans Hofschneider Foundation; German Research Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max Cloetta Foundation; University of Erlangen; European Union(European Commission)	This work was funded by the Peter Hans Hofschneider Foundation for Experimental Biomedicine, the German Research Foundation, the Max Planck Society, the Swiss National Science Foundation, the Max Cloetta Foundation, the ELAN Fond of the University of Erlangen, and European Union Marie Curie Fellowships to M.S. and J.P. We thank the members of the Sixt laboratory for discussions and critical reading of the manuscript, N. Catone for technical assistance, and R. Fassler for continuous support.	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; de Paz LL, 2007, ACS CHEM BIOL, V2, P735, DOI 10.1021/cb700159m; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; HEIT B, 2003, SCI STKE, pPL5; Hirose J, 2002, BBA-GEN SUBJECTS, V1571, P219, DOI 10.1016/S0304-4165(02)00232-5; Junt T, 2004, J IMMUNOL, V173, P6684, DOI 10.4049/jimmunol.173.11.6684; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mempel TR, 2006, IMMUNITY, V25, P867, DOI 10.1016/j.immuni.2006.11.002; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Nakano H, 1998, BLOOD, V91, P2886, DOI 10.1182/blood.V91.8.2886.2886_2886_2895; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Patel DD, 2001, CLIN IMMUNOL, V99, P43, DOI 10.1006/clim.2000.4997; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Saeki H, 2000, EUR J IMMUNOL, V30, P2808, DOI 10.1002/1521-4141(200010)30:10<2808::AID-IMMU2808>3.0.CO;2-K; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Wedlich-Soldner R, 2003, NAT CELL BIOL, V5, P267, DOI 10.1038/ncb0403-267; WILSON RW, 1993, J IMMUNOL, V151, P1571; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Wu MT, 2002, J IMMUNOL, V168, P5096, DOI 10.4049/jimmunol.168.10.5096	49	231	235	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 28	2010	32	5					703	713		10.1016/j.immuni.2010.04.017	http://dx.doi.org/10.1016/j.immuni.2010.04.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20471289	Green Submitted, Bronze			2022-12-18	WOS:000278280500015
J	Matsumoto, R; Wang, DH; Blonska, M; Li, HX; Kobayashi, M; Pappu, B; Chen, YH; Wang, DM; Lin, X				Matsumoto, R; Wang, DH; Blonska, M; Li, HX; Kobayashi, M; Pappu, B; Chen, YH; Wang, DM; Lin, X			Phosphorylation of CARMA1 plays a critical role in T cell receptor-mediated NF-kappa B activation	IMMUNITY			English	Article							KINASE-C-THETA; IMMUNOLOGICAL SYNAPSE; LYMPHOCYTE-ACTIVATION; IMMUNE-RESPONSES; FAMILY MEMBER; PKC-THETA; BCL10; ANTIGEN; COSTIMULATION; RECRUITMENT	CARMA1 mediates T cell receptor (TCR)-induced NF-,KB activation. However, how TCR links to CARMA1 in the signaling pathway is not clear. Here, we show that CARMA1 is inducibly phosphorylated after TCR-CD28 costimulation. This phosphorylation is likely induced by PKC theta, since PKC theta induces phosphorylation of CARMA1 in vitro and in vivo. Our results indicate that the PKC theta-induced phosphorylation of CARMA1 likely occurs on Ser552 on the Linker region of CARMA1. Importantly, expression of CARMA1 mutant, in which Ser552 is mutated, fails to mediate TCR-induced NF-KB activation in CARMA1 -deficient T cells. The functional defect of this CARMA1 mutant is likely due to the fact that this mutant cannot be phosphorylated at the critical residue, thereby failing to recruit the downstream signaling components into the immunological synapse. Together, our studies provide the first genetic evidence that the phosphorylation of CARMA1 plays a critical role in the TCR signaling pathway.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; SUNY Buffalo, Grad Program Biochem, Buffalo, NY 14214 USA; Roswell Pk Canc Inst, Grad Program Immunol, Buffalo, NY 14263 USA; Ctr Blood Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	University of Texas System; UTMD Anderson Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Lin, X (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	xllin@mdanderson.org	Wang, Demin/AAX-4449-2020; Blonska, Marzenna/U-7751-2019	Wang, Demin/0000-0001-5549-3795; Blonska, Marzenna/0000-0001-5237-8732	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050848, R56AI050848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065899, R56GM065899] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL073284] Funding Source: Medline; NIAID NIH HHS [AI050848] Funding Source: Medline; NIGMS NIH HHS [GM065899] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Xavier R, 1999, CURR OPIN IMMUNOL, V11, P265, DOI 10.1016/S0952-7915(99)80043-0; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	34	231	242	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2005	23	6					575	585		10.1016/j.immuni.2005.10.007	http://dx.doi.org/10.1016/j.immuni.2005.10.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998KH	16356856	Bronze			2022-12-18	WOS:000234316900005
J	Shoda, LKM; Young, DL; Ramanujan, S; Whiting, CC; Atkinson, MA; Bluestone, JA; Eisenbarth, GS; Mathis, D; Rossini, AA; Campbell, SE; Kahn, R; Kreuwel, HT				Shoda, LKM; Young, DL; Ramanujan, S; Whiting, CC; Atkinson, MA; Bluestone, JA; Eisenbarth, GS; Mathis, D; Rossini, AA; Campbell, SE; Kahn, R; Kreuwel, HT			A comprehensive review of interventions in the NOD mouse and implications for translation	IMMUNITY			English	Review							NONOBESE DIABETIC MICE; ANTI-CD3 MONOCLONAL-ANTIBODY; REGULATORY T-CELLS; NECROSIS-FACTOR-ALPHA; ORAL INSULIN; GENE-TRANSFER; IN-VIVO; ENDOGENOUS INTERLEUKIN-12; NEONATAL INJECTION; SELF-TOLERANCE	Type 1 diabetes (T1D) animal models such as the non-obese diabetic (NOD) mouse have improved our understanding of disease pathophysiology, but many candidate therapeutics identified therein have failed to prevent/cure human disease. We have performed a comprehensive evaluation of disease-modifying agents tested in the NOD mouse based on treatment timing, duration, study length, and efficacy. Interestingly, some popular tenets regarding NOD interventions were not confirmed: all treatments do not prevent disease, treatment dose and timing strongly influence efficacy, and several therapies have successfully treated overtly diabetic mice. The analysis provides a unique perspective on NOD interventions and suggests that the response of this model to therapeutic interventions can be a useful predictor of the human response as long as careful consideration is given to treatment dose, timing, and protocols; more thorough investigation of these parameters should improve clinical translation.	Entelos Inc, Foster City, CA 94404 USA; Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp,Dept Med, Joslin Diabet Ctr,Sect Immunol & Immunogenet, Boston, MA 02215 USA; Univ Massachusetts, Sch Med, Diabet Div, Worcester, MA 01605 USA; Amer Diabet Assoc, Alexandria, VA 22311 USA	Entelos Inc.; State University System of Florida; University of Florida; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Massachusetts System; University of Massachusetts Worcester; American Diabetes Association	Shoda, LKM (corresponding author), Entelos Inc, 110 Marsh Dr, Foster City, CA 94404 USA.	shoda@entelos.com						AKHTAR I, 1995, J EXP MED, V182, P87, DOI 10.1084/jem.182.1.87; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; ATKINSON MA, 1990, DIABETES, V39, P933, DOI 10.2337/diabetes.39.8.933; Bachmair L., 2001, HDB AUTOMATED REASON, P19, DOI DOI 10.1016/B978-044450813-3/50004-7; BAEDER WL, 1992, CLIN EXP IMMUNOL, V89, P174; Balasa B, 1997, J IMMUNOL, V159, P4620; Beales PE, 1996, AUTOIMMUNITY, V24, P127, DOI 10.3109/08916939609001954; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; Bergerot I, 1996, ANN NY ACAD SCI, V778, P362, DOI 10.1111/j.1749-6632.1996.tb21144.x; Bergerot I, 1997, P NATL ACAD SCI USA, V94, P4610, DOI 10.1073/pnas.94.9.4610; Bour-Jordan H, 2004, J CLIN INVEST, V114, P979, DOI 10.1172/JCI200420483; Cameron MJ, 2000, GENE THER, V7, P1840, DOI 10.1038/sj.gt.3301309; *CDCP, 2004, NAT DIAB FACT SHEET; CetkovicCvrlje M, 1997, DIABETES, V46, P1975, DOI 10.2337/diabetes.46.12.1975; Chaillous L, 2000, LANCET, V356, P545, DOI 10.1016/S0140-6736(00)02579-4; Chang YG, 1999, J GENE MED, V1, P415, DOI 10.1002/(SICI)1521-2254(199911/12)1:6<415::AID-JGM66>3.0.CO;2-B; Chatenoud L, 1997, J IMMUNOL, V158, P2947; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; CHATENOUD L, 1992, CR ACAD SCI III-VIE, V315, P225; Classen JB, 1996, AUTOIMMUNITY, V24, P137, DOI 10.3109/08916939608995359; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Feili-Hariri M, 2003, HUM GENE THER, V14, P13, DOI 10.1089/10430340360464679; Fujihira K, 2000, DIABETES, V49, P1998, DOI 10.2337/diabetes.49.12.1998; Funda DP, 1998, APMIS, V106, P1009, DOI 10.1111/j.1699-0463.1998.tb00253.x; Goudy K, 2001, P NATL ACAD SCI USA, V98, P13913, DOI 10.1073/pnas.251532298; Goudy KS, 2003, J IMMUNOL, V171, P2270, DOI 10.4049/jimmunol.171.5.2270; Han HS, 1996, J AUTOIMMUN, V9, P331, DOI 10.1006/jaut.1996.0045; Harrison LC, 2004, DIABETES CARE, V27, P2348, DOI 10.2337/diacare.27.10.2348; Harrison LC, 1996, J EXP MED, V184, P2167, DOI 10.1084/jem.184.6.2167; Hartmann B, 1997, DIABETOLOGIA, V40, P902, DOI 10.1007/s001250050766; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; HAYWARD AR, 1992, J AUTOIMMUN, V5, P59, DOI 10.1016/S0896-8411(05)80051-4; HAYWARD AR, 1989, J IMMUNOL, V143, P1555; HEALEY D, 1995, J CLIN INVEST, V95, P2979, DOI 10.1172/JCI118006; HERMITTE L, 1989, AUTOIMMUNITY, V5, P79, DOI 10.3109/08916938909029145; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Homann D, 1999, J IMMUNOL, V163, P1833; IGUCHI M, 1992, CHEM PHARM BULL, V40, P1004, DOI 10.1248/cpb.40.1004; Ito A, 1997, J AUTOIMMUN, V10, P331, DOI 10.1006/jaut.1997.0142; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; Karounos D, 2003, DIABETES, V52, pA276; Karounos DG, 1997, J CLIN INVEST, V100, P1344, DOI 10.1172/JCI119654; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kim Jong-Yeon, 1997, Journal of Korean Medical Science, V12, P293; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; Mahmood I, 1999, J PHARM SCI-US, V88, P1101, DOI 10.1021/js9902163; Makhlouf L, 2004, TRANSPLANTATION, V77, P990, DOI 10.1097/01.TP.0000118410.61419.59; MAKI T, 1992, P NATL ACAD SCI USA, V89, P3434, DOI 10.1073/pnas.89.8.3434; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; Melo MEF, 2002, J IMMUNOL, V168, P4788, DOI 10.4049/jimmunol.168.9.4788; Menard V, 1999, PHARMACEUT RES, V16, P1059, DOI 10.1023/A:1018939900961; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Monetini L, 2004, DIABETOLOGIA, V47, P1795, DOI 10.1007/s00125-004-1521-5; Mordes JP, 1996, ANN NY ACAD SCI, V778, P418, DOI 10.1111/j.1749-6632.1996.tb21161.x; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; MORI Y, 1986, DIABETOLOGIA, V29, P244, DOI 10.1007/BF00454884; Mottram PL, 2002, TRANSPL IMMUNOL, V10, P63, DOI 10.1016/S0966-3274(02)00050-3; MUIR A, 1995, J CLIN INVEST, V95, P628, DOI 10.1172/JCI117707; Nicoletti F, 1999, IMMUNOLOGY, V97, P367; Nicoletti F, 1999, DIABETES, V48, P2333, DOI 10.2337/diabetes.48.12.2333; Nitta Y, 1998, HUM GENE THER, V9, P1701, DOI 10.1089/hum.1998.9.12-1701; O'Hara RM, 1996, ANN NY ACAD SCI, V795, P241, DOI 10.1111/j.1749-6632.1996.tb52673.x; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Pakala SV, 1997, J EXP MED, V186, P299, DOI 10.1084/jem.186.2.299; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; PENNLINE KJ, 1994, CLIN IMMUNOL IMMUNOP, V71, P169, DOI 10.1006/clin.1994.1068; Peterson JD, 1996, DIABETES, V45, P328, DOI 10.2337/diabetes.45.3.328; Peterson KP, 1997, P SOC EXP BIOL MED, V215, P264; Poulin M, 2000, J IMMUNOL, V164, P3072, DOI 10.4049/jimmunol.164.6.3072; Pozzilli P, 2000, DIABETOLOGIA, V43, P1000, DOI 10.1007/s001250051482; Ramiya VK, 1997, AUTOIMMUNITY, V26, P139, DOI 10.3109/08916939708994736; Reddy S, 1990, Diabetes Res, V15, P95; Roep BO, 2004, NAT REV IMMUNOL, V4, P989, DOI 10.1038/nri1502; Rosenbloom AL, 2000, J CLIN ENDOCR METAB, V85, P494; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SATOH J, 1989, J CLIN INVEST, V84, P1345, DOI 10.1172/JCI114304; SEINO H, 1991, CLIN EXP IMMUNOL, V86, P413; Shinomiya M, 1999, CLIN EXP IMMUNOL, V117, P38; SHIZURU JA, 1988, SCIENCE, V240, P659, DOI 10.1126/science.2966437; Skyler JS, 2005, DIABETES CARE, V28, P1630, DOI 10.2337/diacare.28.7.1630; Skyler JS, 2001, LANCET, V357, P331, DOI 10.1016/S0140-6736(00)03638-2; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Slavin AJ, 2001, INT IMMUNOL, V13, P825, DOI 10.1093/intimm/13.6.825; Song S, 2004, GENE THER, V11, P181, DOI 10.1038/sj.gt.3302156; Takahashi M, 2000, RADIAT RES, V154, P680, DOI 10.1667/0033-7587(2000)154[0680:POTIDB]2.0.CO;2; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; THIVOLET C, 1991, J IMMUNOL, V146, P85; Tominaga Y, 1998, CLIN IMMUNOL IMMUNOP, V86, P209, DOI 10.1006/clin.1997.4471; Trembleau S, 1997, EUR J IMMUNOL, V27, P2330, DOI 10.1002/eji.1830270930; Trembleau S, 2000, J IMMUNOL, V165, P6748, DOI 10.4049/jimmunol.165.12.6748; Tremeau A., 1995, Traitement du Signal, V12, P1; TSUKAMOTO K, 1995, CELL IMMUNOL, V165, P193, DOI 10.1006/cimm.1995.1205; WILLIAMS AJK, 1993, DIABETOLOGIA, V36, P487, DOI 10.1007/BF02743262; Wilson SS, 2001, J IMMUNOL, V167, P569, DOI 10.4049/jimmunol.167.1.569; Wu AJ, 2002, P NATL ACAD SCI USA, V99, P12287, DOI 10.1073/pnas.172382999; YAGI H, 1991, CELL IMMUNOL, V138, P142, DOI 10.1016/0008-8749(91)90139-3; YAMADA K, 1982, DIABETES, V31, P749, DOI 10.2337/diabetes.31.9.749; Yang W, 2004, J IMMUNOL, V173, P4407, DOI 10.4049/jimmunol.173.7.4407; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995; Yang ZD, 2002, DIABETOLOGIA, V45, P1307, DOI 10.1007/s00125-002-0901-y; Yang ZD, 2002, J IMMUNOL, V168, P6479, DOI 10.4049/jimmunol.168.12.6479; Zaccone P, 2003, EUR J IMMUNOL, V33, P1439, DOI 10.1002/eji.200323910; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252; Zheng XX, 1997, J IMMUNOL, V158, P4507	112	231	242	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2005	23	2					115	126		10.1016/j.immuni.2005.08.002	http://dx.doi.org/10.1016/j.immuni.2005.08.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	962HM	16111631	Bronze			2022-12-18	WOS:000231721700003
J	DeKoter, RP; Lee, HJ; Singh, H				DeKoter, RP; Lee, HJ; Singh, H			PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors	IMMUNITY			English	Article							B-CELL-DEVELOPMENT; SEVERE COMBINED IMMUNODEFICIENCY; THYMIC STROMAL LYMPHOPOIETIN; RESCUES T-LYMPHOPOIESIS; COMMON GAMMA-CHAIN; DEFICIENT MICE; SPI-B; TRANSCRIPTION FACTORS; DNA-BINDING; BONE-MARROW	Development of the lymphoid system is dependent on the Ets family transcription factor PU.1. We demonstrate that PU.1(-/-) hematopoietic progenitors fail to express IL-7Ralpha transcripts. Promoter and chromatin crosslinking analyses suggest that PU.1 directly regulates transcription of the IL-7Ralpha gene. Retroviral transduction of IL-7Ralpha into PU.1(-/-) progenitors restores IL-7-dependent proliferation and induces, at low frequency, the generation of pro-B cells undergoing an apparently normal program of differentiation. Although the related factor Spi-B can substitute for PU.1 in early B cell development, it is not required. These results demonstrate that PUA functions to regulate early B cell development in part by controlling the expression of the IL-7Ralpha gene.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, 5841 S Maryland Ave, Chicago, IL 60637 USA.		DeKoter, Rodney/A-9415-2009	DeKoter, Rodney/0000-0002-9201-1983				ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Anderson MK, 1999, DEVELOPMENT, V126, P3131; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Baird AM, 1999, CURR OPIN IMMUNOL, V11, P157, DOI 10.1016/S0952-7915(99)80027-2; Bemark M, 1999, J BIOL CHEM, V274, P10259, DOI 10.1074/jbc.274.15.10259; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; CONFREEDENJEFFR.U, 1995, J EXP MED, V181, P1519; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Di Santo JP, 1998, CURR OPIN IMMUNOL, V10, P196, DOI 10.1016/S0952-7915(98)80249-5; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Fisher RC, 1999, BLOOD, V94, P1283, DOI 10.1182/blood.V94.4.1283.416k16_1283_1290; Garrett-Sinha LA, 1999, IMMUNITY, V10, P399, DOI 10.1016/S1074-7613(00)80040-0; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Hashimoto S, 1999, INT IMMUNOL, V11, P1423, DOI 10.1093/intimm/11.9.1423; HAWLEY RG, 1994, GENE THER, V1, P136; HE YW, 1995, J IMMUNOL, V154, P1596; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; KONDO M, 1994, EUR J IMMUNOL, V24, P2026, DOI 10.1002/eji.1830240914; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lo M, 1999, BLOOD, V94, P3027, DOI 10.1182/blood.V94.9.3027.421k11_3027_3036; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; Nikolajczyk BS, 1999, IMMUNITY, V11, P11, DOI 10.1016/S1074-7613(00)80077-1; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 2000, IMMUNOL REV, V175, P94, DOI 10.1034/j.1600-065X.2000.017503.x; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PLEIMAN CM, 1991, MOL CELL BIOL, V11, P3052, DOI 10.1128/MCB.11.6.3052; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Rao S, 1999, J BIOL CHEM, V274, P11115, DOI 10.1074/jbc.274.16.11115; RAY D, 1992, MOL CELL BIOL, V12, P4297, DOI 10.1128/MCB.12.10.4297; RAYGALLET D, 1995, ONCOGENE, V11, P303; ROLINK A, 1993, BLOOD, V81, P2290; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Singh RS, 1999, J NONPARAMETR STAT, V11, P13, DOI 10.1080/10485259908832773; Spain LM, 1999, J IMMUNOL, V163, P2681; Su GH, 1996, J EXP MED, V184, P203, DOI 10.1084/jem.184.1.203; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; SUGAMURA K, 1995, ADV IMMUNOL, V59, P225, DOI 10.1016/S0065-2776(08)60632-X; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Tsai FY, 1998, DEV BIOL, V196, P218, DOI 10.1006/dbio.1997.8842; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; WINKLER TH, 1995, BLOOD, V85, P2045, DOI 10.1182/blood.V85.8.2045.bloodjournal8582045; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	78	231	235	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2002	16	2					297	309		10.1016/S1074-7613(02)00269-8	http://dx.doi.org/10.1016/S1074-7613(02)00269-8			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869689	Bronze			2022-12-18	WOS:000174039600012
J	Cumano, A; Ferraz, JC; Klaine, M; Di Santo, JP; Godin, I				Cumano, A; Ferraz, JC; Klaine, M; Di Santo, JP; Godin, I			Intraembryonic, but not yolk sac hematopoietic precursors, isolated before circulation, provide long-term multilineage reconstitution	IMMUNITY			English	Article							EARLY MOUSE EMBRYO; FETAL LIVER; STEM-CELLS; B-CELLS; CLASS-I; DIFFERENTIATION; EMERGENCE; EXPRESSION; SPLANCHNOPLEURA; GESTATION	The relative contribution of yolk sac and intraembryonic precursors to hematopoiesis has been a matter of long-standing controversy. As reconstitution activity has so far only been found in embryonic tissues after the onset of circulation, the origin of reconstituting cells could not be formally established. Here, we separated yolk sac and intraembryonic splanchnopleura prior to circulation and maintained the explants in organ culture before transfer. Precursors derived from the intraembryonic site generated multilineage hematopoietic progeny in adult mice for more than 6 months. Yolk sac cells only provided myeloid short-term reconstitution. The results reveal a differential hematopoietic capacity of precirculation embryonic tissues in vivo, and indicate that the only cells capable of adult long-term hematopoiesis are of intraembryonic origin.	CNRS, Inst Embryol Cellulaire & Mol, FRE 2160, F-94736 Nogent Sur Marne, France; Coll France, F-94736 Nogent Sur Marne, France; Inst Pasteur, Unite Dev Lymphocytes, URA 1961, CNRS, F-75724 Paris, France; Inst Pasteur, Unite Cytokines & Dev Lymphoide, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Godin, I (corresponding author), CNRS, Inst Embryol Cellulaire & Mol, FRE 2160, F-94736 Nogent Sur Marne, France.		Di Santo, James P/M-4298-2014; GODIN, Isabelle/K-5769-2013	Di Santo, James P/0000-0002-7146-1862; GODIN, Isabelle/0000-0001-8577-8388; Cumano, Ana/0000-0002-4578-959X				BECHTOLD TE, 1992, J IMMUNOL, V148, P2975; Ciau-Uitz A, 2000, CELL, V102, P787, DOI 10.1016/S0092-8674(00)00067-2; Colucci F, 1999, J IMMUNOL, V162, P2761; CUMANO A, 1992, EMBO J, V11, P593, DOI 10.1002/j.1460-2075.1992.tb05091.x; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; Douagi I, 2000, EUR J IMMUNOL, V30, P2201, DOI 10.1002/1521-4141(2000)30:8<2201::AID-IMMU2201>3.0.CO;2-2; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Dzierzak E, 1998, IMMUNOL TODAY, V19, P228, DOI 10.1016/S0167-5699(98)01258-4; Godin I, 1999, J EXP MED, V190, P43, DOI 10.1084/jem.190.1.43; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; HOUSSAINT E, 1981, CELL DIFFER DEV, V10, P243, DOI 10.1016/0045-6039(81)90007-5; HUANG H, 1994, EXP HEMATOL, V22, P19; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; JAFFE L, 1991, J IMMUNOL, V147, P2740; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Metcalf D., 1971, HAEMOPOIETIC CELLS, P173; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; Ohmura K, 1999, J IMMUNOL, V163, P4788; OZATO K, 1985, P NATL ACAD SCI USA, V82, P2427, DOI 10.1073/pnas.82.8.2427; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Tavian M, 1999, DEVELOPMENT, V126, P793; TURPEN JB, 1981, DEV BIOL, V85, P99, DOI 10.1016/0012-1606(81)90239-6; WEISSMANN I, 1978, COLD SPRING HARB SYM, V5, P33; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6	28	231	240	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2001	15	3			SI		477	485		10.1016/S1074-7613(01)00190-X	http://dx.doi.org/10.1016/S1074-7613(01)00190-X			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567637	Bronze			2022-12-18	WOS:000171211800014
J	Wardenburg, JB; Pappu, R; Bu, JY; Mayer, B; Chernoff, J; Straus, D; Chan, AC				Wardenburg, JB; Pappu, R; Bu, JY; Mayer, B; Chernoff, J; Straus, D; Chan, AC			Regulation of PAK activation and the T cell cytoskeleton by the linker protein SLP-76	IMMUNITY			English	Article							WISKOTT-ALDRICH SYNDROME; RECEPTOR SIGNAL-TRANSDUCTION; GUANINE-NUCLEOTIDE EXCHANGE; P21-ACTIVATED KINASE PAK1; DBL ONCOGENE PRODUCT; TYROSINE KINASES; ADAPTER PROTEIN; ACTIN POLYMERIZATION; GENE-EXPRESSION; MAMMALIAN-CELLS	Tyrosine phosphorylation of linker proteins enables the T cell antigen receptor (TCR)-associated protein tyrosine kinases to phosphorylate and regulate effector molecules that generate second messengers. We demonstrate here that the SLP-76 linker protein interacts with both nck, an adaptor protein, and Vav, a guanine nucleotide exchange factor for Rho-family GTPases. The assembly of this tri-molecular complex permits the activated Rho-family GTPases to regulate target effecters that interact through nck. In turn, assembly of this complex mediates the enzymatic activation of the p21-activated protein kinase 1 and facilitates actin polymerization. Hence, phosphorylation of linker proteins not only bridges the TCR-associated PTK, ZAP-70, with downstream effector proteins, but also provides a scaffold to integrate distinct signaling complexes to regulate T cell function.	Washington Univ, Sch Med, Ctr Immunol, Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Univ Chicago, Dept Internal Med, Div Gastroenterol, Chicago, IL 60637 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Fox Chase Cancer Center; University of Chicago	Chan, AC (corresponding author), Washington Univ, Sch Med, Ctr Immunol, Div Rheumatol, St Louis, MO 63110 USA.	achan@im.wustl.edu	Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836	NCI NIH HHS [R01CA71516] Funding Source: Medline; NIAID NIH HHS [T32AI01763] Funding Source: Medline; NIAMS NIH HHS [T32AR07279] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; CHENG AM, 1997, CURR OPIN IMMUNOL, V8, P394; CHOU MM, 1992, MOL CELL BIOL, V12, P5834, DOI 10.1128/MCB.12.12.5834; CHOU MM, 1995, J BIOL CHEM, V270, P7359, DOI 10.1074/jbc.270.13.7359; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; DIEKMANN D, 1995, EMBO J, V14, P5297, DOI 10.1002/j.1460-2075.1995.tb00214.x; Fang N, 1996, J IMMUNOL, V157, P3769; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Harden N, 1996, MOL CELL BIOL, V16, P1896; HART MJ, 1994, J BIOL CHEM, V269, P62; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; HU QJ, 1995, MOL CELL BIOL, V15, P1169; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; Kong GH, 1996, MOL CELL BIOL, V16, P5026; LEE AG, 1993, LIPOSOME TECHNOLOGY, V2, P1; LEHMANN JM, 1990, NUCLEIC ACIDS RES, V18, P1048, DOI 10.1093/nar/18.4.1048; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MEISENHELDER J, 1992, MOL CELL BIOL, V12, P5843, DOI 10.1128/MCB.12.12.5843; Motto DG, 1996, J EXP MED, V183, P1937, DOI 10.1084/jem.183.4.1937; Onodera H, 1996, J BIOL CHEM, V271, P22225, DOI 10.1074/jbc.271.36.22225; PARK D, 1992, MOL CELL BIOL, V12, P5816, DOI 10.1128/MCB.12.12.5816; PARSEY MV, 1993, J IMMUNOL, V151, P1881; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Quilliam LA, 1996, J BIOL CHEM, V271, P28772, DOI 10.1074/jbc.271.46.28772; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; RIVEROLEZCANO OM, 1994, J BIOL CHEM, V269, P17363; RON D, 1991, NEW BIOL, V3, P372; SCHLESSINGER J, 1994, COLD SPRING HARB SYM, V59, P173, DOI 10.1101/SQB.1994.059.01.021; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tuosto L, 1996, J EXP MED, V184, P1161, DOI 10.1084/jem.184.3.1161; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Wong J, 1998, MOL CELL BIOL, V18, P2855, DOI 10.1128/MCB.18.5.2855; WU J, 1995, MOL CELL BIOL, V15, P4337; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	64	231	234	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1998	9	5					607	616		10.1016/S1074-7613(00)80658-5	http://dx.doi.org/10.1016/S1074-7613(00)80658-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846482	Bronze			2022-12-18	WOS:000077298300003
J	Khare, S; Dorfleutner, A; Bryan, NB; Yun, C; Radian, AD; de Almeida, L; Rojanasakul, Y; Stehlik, C				Khare, Sonal; Dorfleutner, Andrea; Bryan, Nicole B.; Yun, Chawon; Radian, Alexander D.; de Almeida, Lucia; Rojanasakul, Yon; Stehlik, Christian			An NLRP7-Containing Inflammasome Mediates Recognition of Microbial Lipopeptides in Human Macrophages	IMMUNITY			English	Article							CASPASE RECRUITMENT DOMAIN; TOLL-LIKE RECEPTOR-2; SPECK-LIKE PROTEIN; NF-KAPPA-B; NALP3 INFLAMMASOME; INTERLEUKIN-1-BETA SECRETION; LISTERIA-MONOCYTOGENES; BACTERIAL LIPOPROTEINS; REPRODUCTIVE WASTAGE; CYTOKINE SECRETION	Cytosolic pathogen- and damage-associated molecular patterns are sensed by pattern recognition receptors, including members of the nucleotide-binding domain and leucine-rich repeat-containing gene family (NLR), which cause inflammasome assembly and caspase-1 activation to promote maturation and release of the inflammatory cytokines interleukin-1 beta (IL-1 beta) and IL-18 and induction of pyroptosis. However, the contribution of most of the NLRs to innate immunity, host defense, and inflammasome activation and their specific agonists are still unknown. Here we describe identification and characterization of an NLRP7 inflammasome in human macrophages, which is induced in response to microbial acylated lipopeptides. Activation of NLRP7 promoted ASC-dependent caspase-1 activation, IL-1 beta and IL-18 maturation, and restriction of intracellular bacterial replication, but not caspase-1-independent secretion of the proinflammatory cytokines IL-6 and tumor necrosis factor-alpha. Our study therefore increases our currently limited understanding of NLR activation, inflammasome assembly, and maturation of IL-1 beta and IL-18 in human macrophages.	[Khare, Sonal; Dorfleutner, Andrea; Bryan, Nicole B.; Yun, Chawon; Radian, Alexander D.; de Almeida, Lucia; Stehlik, Christian] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Rheumatol, Chicago, IL 60611 USA; [Stehlik, Christian] Northwestern Univ, Feinberg Sch Med, Interdept Immunobiol Ctr, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Stehlik, Christian] Northwestern Univ, Feinberg Sch Med, Skin Dis Res Ctr, Chicago, IL 60611 USA; [Radian, Alexander D.] Northwestern Univ, Feinberg Sch Med, Driskill Grad Program, Chicago, IL 60611 USA; [Bryan, Nicole B.] W Virginia Univ, Hlth Sci Ctr, Program Canc Cell Biol, Morgantown, WV 26506 USA; [Rojanasakul, Yon] W Virginia Univ, Sch Pharm, Dept Pharmaceut Sci, Morgantown, WV 26506 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; West Virginia University; West Virginia University	Stehlik, C (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Rheumatol, Chicago, IL 60611 USA.	c-stehlik@northwestern.edu	Dorfleutner, Andrea/AAG-5504-2021; Stehlik, Christian/AAG-2132-2021	Dorfleutner, Andrea/0000-0003-4406-2986; Stehlik, Christian/0000-0002-3782-2484; Yun, Chawon/0000-0002-0046-4732; Khare, Sonal/0000-0002-4044-3581; Rojanasakul, Yon/0000-0002-8839-6462	National Institutes of Health [GM071723, GM071723-S1, AI082406, AI082406-S1/S2, AR057216]; American Heart Association [11POST585000]; Northwestern University [CA060553]; Skin Disease Research Center [P30AR057216]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Northwestern University; Skin Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM071723, GM071723-S1, AI082406, AI082406-S1/S2, and AR057216 to C.S.). S.K. is an Arthritis Foundation fellow (AF161715) and L.deA. is supported by the American Heart Association (11POST585000). This work was supported by the Northwestern University Monoclonal Antibody Facility, Flow Cytometry Facility, a Cancer Center Support Grant (CA060553), and the Skin Disease Research Center (P30AR057216). We thank S. Kramer for isolation of PBMCs and C. Cuda and H. Perlman for help with flow cytometry.	Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Bernthal NM, 2011, J ORTHOP RES, V29, P1621, DOI 10.1002/jor.21414; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Garcia J, 1998, J BIOL CHEM, V273, P34391, DOI 10.1074/jbc.273.51.34391; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hoffman HM, 2010, ARTHRITIS RHEUM-US, V62, P2170, DOI 10.1002/art.27456; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Khare S, 2010, CRIT REV IMMUNOL, V30, P463, DOI 10.1615/CritRevImmunol.v30.i5.50; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Kung VL, 2012, P NATL ACAD SCI USA, V109, P1275, DOI 10.1073/pnas.1109285109; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McCoy AJ, 2010, J IMMUNOL, V185, P7077, DOI 10.4049/jimmunol.1002165; Messaed C, 2011, J BIOL CHEM, V286, P43313, DOI 10.1074/jbc.M111.306191; Messaed C, 2011, J MED GENET, V48, P540, DOI 10.1136/jmg.2011.089144; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Sacht G, 1998, EUR J IMMUNOL, V28, P4207, DOI 10.1002/(SICI)1521-4141(199812)28:12<4207::AID-IMMU4207>3.0.CO;2-R; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shen YN, 2010, INFECT IMMUN, V78, P2857, DOI 10.1128/IAI.01138-09; Slim R, 2007, CLIN GENET, V71, P25, DOI 10.1111/j.1399-0004.2006.00697.x; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Thacker JD, 2009, J NAT PROD, V72, P1993, DOI 10.1021/np900360m; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Vinzing M, 2008, J IMMUNOL, V180, P6808, DOI 10.4049/jimmunol.180.10.6808; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Yoo NJ, 2002, BIOCHEM BIOPH RES CO, V299, P652, DOI 10.1016/S0006-291X(02)02714-6; Zhang HW, 1997, J IMMUNOL, V159, P4868	52	230	240	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 23	2012	36	3					464	476		10.1016/j.immuni.2012.02.001	http://dx.doi.org/10.1016/j.immuni.2012.02.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22361007	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000302048400017
J	Bomsel, M; Tudor, D; Drillet, AS; Alfsen, A; Ganor, Y; Roger, MG; Mouz, N; Amacker, M; Chalifour, A; Diomede, L; Devillier, G; Cong, Z; Wei, QA; Gao, H; Qin, CA; Yang, GB; Zurbriggen, R; Lopalco, L; Fleury, S				Bomsel, Morgane; Tudor, Daniela; Drillet, Anne-Sophie; Alfsen, Annette; Ganor, Yonatan; Roger, Marie-Gaelle; Mouz, Nicolas; Amacker, Mario; Chalifour, Anick; Diomede, Lorenzo; Devillier, Gilles; Cong, Zhe; Wei, Qiang; Gao, Hong; Qin, Chuan; Yang, Gui-Bo; Zurbriggen, Rinaldo; Lopalco, Lucia; Fleury, Sylvain			Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EXPOSED SERONEGATIVE INDIVIDUALS; PROXIMAL EXTERNAL REGION; HUMAN EPITHELIAL-CELLS; GALACTOSYL CERAMIDE; IMMUNE-RESPONSES; MONOCLONAL-ANTIBODIES; INFLUENZA VIROSOMES; MEDIATED-IMMUNITY; RHESUS MACAQUES	Human immunodeficiency virus (HIV)-1 is mainly transmitted mucosally during sexual intercourse. We therefore evaluated the protective efficacy of a vaccine active at mucosal sites. Macaca mulatta monkeys were immunized via both the intramuscular and intranasal routes with an HIV-1 vaccine made of gp41-subunit antigens grafted on virosomes, a safe delivery carrier approved in humans with self-adjuvant properties. Six months after 13 vaginal challenges with simian-HIV (SHIV)-SF162P3, four out of five vaccinated animals remained virus-negative, and the fifth was only transiently infected. None of the five animals seroconverted to p27gag-SIV. In contrast, all 6 placebo-vaccinated animals became infected and seroconverted. All protected animals showed gp41-specific vaginal IgAs with HIV-1 transcytosis-blocking properties and vaginal IgGs with neutralizing and/or antibody-dependent cellular-cytotoxicity activities. In contrast, plasma IgGs totally lacked virus-neutralizing activity. The protection observed challenges the paradigm whereby circulating antiviral antibodies are required for protection against HIV-1 infection and may serve in designing a human vaccine against HIV-1-AIDS.	[Bomsel, Morgane; Tudor, Daniela; Drillet, Anne-Sophie; Alfsen, Annette; Ganor, Yonatan] CNRS, Cochin Inst, UMR 8104, Cell Biol & Host Pathogen Interact Dept, F-75014 Paris, France; [Bomsel, Morgane; Tudor, Daniela; Drillet, Anne-Sophie; Alfsen, Annette; Ganor, Yonatan] INSERM, U1016, F-75014 Paris, France; [Bomsel, Morgane; Tudor, Daniela; Drillet, Anne-Sophie; Alfsen, Annette; Ganor, Yonatan] Paris Descartes Univ, F-75006 Paris, France; [Roger, Marie-Gaelle; Mouz, Nicolas] PXTherapeutics, F-38040 Grenoble 9, France; [Amacker, Mario; Zurbriggen, Rinaldo] Pev Biotech Ldt, CH-3063 Ittigen Bern, Switzerland; [Chalifour, Anick; Fleury, Sylvain] Mymet Corp, CH-1066 Epalinges, Switzerland; [Diomede, Lorenzo; Lopalco, Lucia] San Rafaele Inst, I-20127 Milan, Italy; [Devillier, Gilles] BD Med Pharmaceut Syst, F-38801 Le Pont De Claix, France; [Cong, Zhe; Wei, Qiang; Gao, Hong; Qin, Chuan] Inst Lab Anim Sci, Beijing 100021, Peoples R China; [Yang, Gui-Bo] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Bomsel, M (corresponding author), CNRS, Cochin Inst, UMR 8104, Cell Biol & Host Pathogen Interact Dept, 22 Rue Mechain, F-75014 Paris, France.	morgane.bomsel@inserm.fr	Bomsel, Morgane/GSN-1948-2022; Tudor, Daniela/GSN-1837-2022; , Lopalco/AAN-2429-2020	Ganor, Yonatan/0000-0003-4430-7744; Lopalco, Lucia/0000-0003-3812-1759; Dangeard, Anne-Sophie/0000-0002-8974-9012; Tudor, Daniela/0000-0002-8281-4600; Bomsel, Morgane/0000-0002-9577-7474	European Commission [201433]; NIH [1 U19 AI062150]; Bill and Melinda Gates Foundation [53030, PP1008144]; Agence Nationale de Recherche sur le SIDA et les Hepatites (ANRS); SIDACTION-Ensemble contre le SIDA; La Fondation pour la Recherche Medica le (FRM); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062150] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Agence Nationale de Recherche sur le SIDA et les Hepatites (ANRS)(ANRSFrench National Research Agency (ANR)); SIDACTION-Ensemble contre le SIDA; La Fondation pour la Recherche Medica le (FRM)(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to C. Pastori (San Raffaele Scientific Institute, Milano, Italy) for technical help, to B. Weksler (Cornell University, New York, USA) for English editing, to Pr M. Girard for fruitful discussions and review of the manuscript, and to C. Rochet (Mymetics, Switzerland) for constant encouragement and support during our collaboration. L.L. and M.B. were supported by grant no. 201433 from European Commission/Seventh Framework Programme (www.ngin.eu) and L.L. by a grant (no. 1 U19 AI062150) from NIH and grants GCE no. 53030 and no. PP1008144 from Bill and Melinda Gates Foundation. M.B. was supported by grants from Agence Nationale de Recherche sur le SIDA et les Hepatites (ANRS), SIDACTION-Ensemble contre le SIDA, and La Fondation pour la Recherche Medica le (FRM). Y.G. was supported by SIDACTION and ANRS. R.Z. was Chief Scientific Officer and R.Z. and M.A. are shareholders of Pevion Biotech Ltd., which provided the vaccine. S.F. is Chief Scientific Officer and a member of the Executive Board of Mymetics Corp., A.C. is Scientific Officer of Mymetics Corp. G.D. is employee of BD Medical-Pharmaceutical, and M.G.R. and N.M. are employees of PX' Therapeutics	Alfsen A, 2002, J BIOL CHEM, V277, P25649, DOI 10.1074/jbc.M200554200; Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Amacker M, 2005, INT IMMUNOL, V17, P695, DOI 10.1093/intimm/dxh249; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Bomsel M, 2007, AIDS, V21, P13, DOI 10.1097/QAD.0b013e328011049b; Bouvet JP, 1999, INFECT IMMUN, V67, P2687, DOI 10.1128/IAI.67.6.2687-2691.1999; Bouvet JP, 2002, TRENDS IMMUNOL, V23, P209, DOI 10.1016/S1471-4906(02)02186-5; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Broliden K, 2001, IMMUNOL LETT, V79, P29, DOI 10.1016/S0165-2478(01)00263-2; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Corthesy B, 2007, J IMMUNOL, V178, P27, DOI 10.4049/jimmunol.178.1.27; Coutant J, 2008, FASEB J, V22, P4338, DOI 10.1096/fj.08-113142; Currier JR, 2002, J VIROL, V76, P4971, DOI 10.1128/JVI.76.10.4971-4986.2002; Delcroix-Genete D, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-16; Demberg T, 2009, INT REV IMMUNOL, V28, P20, DOI 10.1080/08830180802684331; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Devito C, 2000, AIDS, V14, P1917, DOI 10.1097/00002030-200009080-00006; Donadoni C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009920; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Herzog C, 2009, VACCINE, V27, P4381, DOI 10.1016/j.vaccine.2009.05.029; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hovanessian AG, 2004, IMMUNITY, V21, P617, DOI 10.1016/j.immuni.2004.08.015; Kammer AR, 2007, VACCINE, V25, P7065, DOI 10.1016/j.vaccine.2007.07.052; Li Y, 2009, CHINESE MED J-PEKING, V122, P2874, DOI 10.3760/cma.j.issn.0366-6999-2009.23.014; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Magerus-Chatinet A, 2007, VIROLOGY, V362, P67, DOI 10.1016/j.virol.2006.11.035; Miyazawa M, 2009, AIDS, V23, P161, DOI 10.1097/QAD.0b013e3283196a80; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Moser C, 2007, EXPERT REV VACCINES, V6, P711, DOI 10.1586/14760584.6.5.711; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nag P, 2004, J INFECT DIS, V190, P1970, DOI 10.1086/425582; Novitsky V, 2002, J VIROL, V76, P10155, DOI 10.1128/JVI.76.20.10155-10168.2002; OGRA PL, 1973, J IMMUNOL, V110, P1307; Pastori C, 2008, J VIROL, V82, P4125, DOI 10.1128/JVI.02232-07; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Serres PF, 2001, J AUTOIMMUN, V16, P287, DOI 10.1006/jaut.2000.0500; Shen RZ, 2010, J IMMUNOL, V184, P3648, DOI 10.4049/jimmunol.0903346; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tatsis N, 2009, J IMMUNOL, V182, P6587, DOI 10.4049/jimmunol.0900317; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Vajdy M, 2004, AIDS RES HUM RETROV, V20, P1269, DOI 10.1089/aid.2004.20.1269; Vajdy Michael, 2006, Drugs R D, V7, P267, DOI 10.2165/00126839-200607050-00001; Wilschut J, 2009, IMMUNOL LETT, V122, P118, DOI 10.1016/j.imlet.2008.11.006; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10; Yu HF, 2008, CELL CALCIUM, V43, P73, DOI 10.1016/j.ceca.2007.04.011; Zhou FM, 2009, CLIN VACCINE IMMUNOL, V16, P471, DOI 10.1128/CVI.00311-08	55	230	243	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 25	2011	34	2					269	280		10.1016/j.immuni.2011.01.015	http://dx.doi.org/10.1016/j.immuni.2011.01.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21315623	Bronze			2022-12-18	WOS:000287989500016
J	Snyder, CM; Cho, KS; Bonnett, EL; van Dommelen, S; Shellam, GR; Hill, AB				Snyder, Christopher M.; Cho, Kathy S.; Bonnett, Elizabeth L.; van Dommelen, Serani; Shellam, Geoffrey R.; Hill, Ann B.			Memory Inflation during Chronic Viral Infection Is Maintained by Continuous Production of Short-Lived, Functional T Cells	IMMUNITY			English	Article							MURINE CYTOMEGALOVIRUS-INFECTION; NECROSIS-FACTOR-ALPHA; RAT CYTOMEGALOVIRUS; HUMAN VIRUS; ENHANCER PROMOTER; PHENOTYPE; LYMPHOCYTES; EXPRESSION; DISEASE; ANTIGEN	During persistent murine cytomegalovirus (MCMV) infection, the T cell response is maintained at extremely high intensity for the life of the host. These cells closely resemble human CMV-specific cells, which compose a major component of the peripheral T cell compartment in most people. Despite a phenotype that suggests extensive antigen-driven differentiation, MCMV-specific T cells remain functional and respond vigorously to viral challenge. We hypothesized that a low rate of antigen-driven proliferation would account for the maintenance of this population. Instead, we found that most of these cells divided only sporadically in chronically infected hosts and had a short half-life in circulation. The overall population was supported, at least in part, by memory T cells primed early in infection, as well as by recruitment of naive T cells at late times. Thus, these data show that memory inflation is maintained by a continuous replacement of short-lived, functional cells during chronic MCMV infection.	[Snyder, Christopher M.; Cho, Kathy S.; Bonnett, Elizabeth L.; Hill, Ann B.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [van Dommelen, Serani; Shellam, Geoffrey R.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA 6009, Australia	Oregon Health & Science University; University of Western Australia	Snyder, CM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 1381 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	snydechr@ohsu.edu		Snyder, Christopher/0000-0003-1370-7198	National Institutes of Health [RO1 A 147206]; American Foundation; American Heart Association [0725786Z]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM072236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, grant RO1 A 147206, and the American Foundation for Aging Research (A.B.H.), as well as by a postdoctoral training grant from the American Heart Association (no. 0725786Z) awarded to C.M.S. The authors declare that they have no competing financial interests.	Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Avetisyan G, 2006, BONE MARROW TRANSPL, V38, P687, DOI 10.1038/sj.bmt.1705507; Boeckh M, 2003, BLOOD, V101, P407, DOI 10.1182/blood-2002-03-0993; Cobbold M, 2005, J EXP MED, V202, P379, DOI 10.1084/jem.20040613; Cook CH, 2006, J VIROL, V80, P9151, DOI 10.1128/JVI.00216-06; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Day EK, 2007, J IMMUNOL, V179, P3203, DOI 10.4049/jimmunol.179.5.3203; Gamadia LE, 2004, J IMMUNOL, V172, P6107, DOI 10.4049/jimmunol.172.10.6107; Gamadia LE, 2001, BLOOD, V98, P754, DOI 10.1182/blood.V98.3.754; Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000; HAAGMANS BL, 1994, J VIROL, V68, P2297, DOI 10.1128/JVI.68.4.2297-2304.1994; HAAGMANS BL, 1994, J VIROL, V68, P2305, DOI 10.1128/JVI.68.4.2305-2312.1994; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Holtappels R, 2002, J VIROL, V76, P151, DOI 10.1128/JVI.76.1.151-164.2002; Holtappels R, 2000, J VIROL, V74, P11495, DOI 10.1128/JVI.74.24.11495-11503.2000; Holtappels R, 2001, J VIROL, V75, P6584, DOI 10.1128/JVI.75.14.6584-6600.2001; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Karrer U, 2004, J VIROL, V78, P2255, DOI 10.1128/JVI.78.5.2255-2264.2004; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Kemball CC, 2005, J IMMUNOL, V174, P7950, DOI 10.4049/jimmunol.174.12.7950; Khan N, 2002, J INFECT DIS, V185, P1025, DOI 10.1086/339963; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Kuijpers TW, 2003, J IMMUNOL, V170, P4342, DOI 10.4049/jimmunol.170.8.4342; Lang KS, 2002, CELL MOL LIFE SCI, V59, P1076, DOI 10.1007/s00018-002-8488-5; Lloyd ML, 2003, BIOL REPROD, V68, P2024, DOI 10.1095/biolreprod.102.012880; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Munks MW, 2007, J IMMUNOL, V178, P7235, DOI 10.4049/jimmunol.178.11.7235; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Ouyang Qin, 2003, Experimental Gerontology, V38, P911, DOI 10.1016/S0531-5565(03)00134-7; Pahl-Seibert MF, 2005, J VIROL, V79, P5400, DOI 10.1128/JVI.79.9.5400-5413.2005; PROSCH S, 1995, VIROLOGY, V208, P197, DOI 10.1006/viro.1995.1143; REDDEHASE MJ, 1988, J VIROL, V62, P1061, DOI 10.1128/JVI.62.3.1061-1065.1988; REUSSER P, 1991, BLOOD, V78, P1373; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Sierro S, 2005, EUR J IMMUNOL, V35, P1113, DOI 10.1002/eji.200425534; Simon CO, 2005, J VIROL, V79, P326, DOI 10.1128/JVI.79.1.326-340.2005; SIMON CO, 2006, J VIROL, DOI DOI 10.1128/JVI.01248-01206; Steffens HP, 1998, J VIROL, V72, P1797, DOI 10.1128/JVI.72.3.1797-1804.1998; STEIN J, 1993, J GEN VIROL, V74, P2333, DOI 10.1099/0022-1317-74-11-2333; Streblow DN, 2007, J VIROL, V81, P3816, DOI 10.1128/JVI.02425-06; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Thimme R, 2005, J VIROL, V79, P12112, DOI 10.1128/JVI.79.18.12112-12116.2005; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; van Leeuwen EM, 2002, J IMMUNOL, V169, P5838, DOI 10.4049/jimmunol.169.10.5838; van Leeuwen EMM, 2005, BLOOD, V106, P2091, DOI 10.1182/blood-2005-02-0449; van Leeuwen EMM, 2004, J IMMUNOL, V173, P1834, DOI 10.4049/jimmunol.173.3.1834; van Leeuwen EMM, 2007, ADV EXP MED BIOL, V590, P121; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Waller ECP, 2007, BLOOD, V110, P4360, DOI 10.1182/blood-2007-07-104604; Weekes MP, 1999, IMMUNOLOGY, V98, P443, DOI 10.1046/j.1365-2567.1999.00901.x; Weekes MP, 1999, J IMMUNOL, V162, P7569; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	57	230	234	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					650	659		10.1016/j.immuni.2008.07.017	http://dx.doi.org/10.1016/j.immuni.2008.07.017			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18957267	Bronze, Green Accepted			2022-12-18	WOS:000260316700017
J	Ackerman, AL; Giodini, A; Cresswell, P				Ackerman, Anne L.; Giodini, Alessandra; Cresswell, Peter			A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells	IMMUNITY			English	Article							MHC CLASS-I; CROSS-PRESENTATION; EXOGENOUS ANTIGENS; RETRO-TRANSLOCATION; MEMBRANE-PROTEIN; T-CELLS; MEDIATED PHAGOCYTOSIS; MOLECULAR CHAPERONES; MISFOLDED PROTEINS; DEGRADATION ERAD	Crosspresentation of exogenous antigens (Ags) to CD8(+) T cells by dendritic cells generally requires their entry into the cytosol. Here we show that both soluble and phagocytosed extracellular Ags accessed the cytosol via molecular components required for endoplasmic reticulum (ER)-associated degradation (ERAD). Exogenous Pseudomonas aeruginosa Exotoxin A, which inhibits protein translocation from the ER to the cytosol, abrogated crosspresentation. Exotoxin A also prevented the transporter associated with antigen processing (TAP) inhibitor, ICP47, from entering the cytosol and blocking TAP-mediated peptide transport. In an in vitro model of retrotranslocation, the AAA ATPase p97, an enzyme critical for ERAD, was the only cytosolic cofactor required for protein export from isolated phagosomes. Functional p97 was also required for crosspresentation but not conventional presentation. Thus, crosspresentation appears to result from an adaptation of the retrotranslocation mechanisms involved in the degradation of misfolded ER proteins.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	peter.cresswell@yale.edu	Ackerman, A. Lenore/AAP-9844-2021; Ackerman, Anne/ABG-8182-2020					AbuJarour RJ, 2005, J BIOL CHEM, V280, P15865, DOI 10.1074/jbc.M406316200; Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Ackerman AL, 2003, J IMMUNOL, V170, P4178, DOI 10.4049/jimmunol.170.8.4178; ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; DACONCEICAOSILVA F, 1994, EUR J IMMUNOL, V24, P2813, DOI 10.1002/eji.1830241135; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; DESJARDINS M, 1994, J BIOL CHEM, V269, P32194; Eichler J, 2004, TRENDS BIOCHEM SCI, V29, P221, DOI 10.1016/j.tibs.2004.03.001; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Galocha B, 1997, J EXP MED, V185, P1565, DOI 10.1084/jem.185.9.1565; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hatsuzawa K, 2006, MOL BIOL CELL, V17, P3964, DOI 10.1091/mbc.E05-12-1174; Hitt R, 2004, FEMS YEAST RES, V4, P721, DOI 10.1016/j.femsyr.2004.02.003; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Imai J, 2005, INT IMMUNOL, V17, P45, DOI 10.1093/intimm/dxh184; KALEAB B, 1990, EUR J IMMUNOL, V20, P2651, DOI 10.1002/eji.1830201219; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Kirst ME, 2005, PLANT PHYSIOL, V138, P218, DOI 10.1104/pp.105.060087; Kiser GL, 2001, ARCH BIOCHEM BIOPHYS, V390, P195, DOI 10.1006/abbi.2001.2385; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; OGATA M, 1990, J BIOL CHEM, V265, P20678; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SZALAY G, 1994, EUR J IMMUNOL, V24, P1471, DOI 10.1002/eji.1830240703; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	57	230	236	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2006	25	4					607	617		10.1016/j.immuni.2006.08.017	http://dx.doi.org/10.1016/j.immuni.2006.08.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17027300	Bronze			2022-12-18	WOS:000241481500012
J	Taghon, T; Yui, MA; Pant, R; Diamond, RA; Rothenberg, EV				Taghon, T; Yui, MA; Pant, R; Diamond, RA; Rothenberg, EV			Developmental and molecular characterization of emerging beta- and gamma delta-selected pre-T cells in the adult mouse thymus	IMMUNITY			English	Article							ALPHA-BETA/GAMMA-DELTA; LINEAGE COMMITMENT; GENE REARRANGEMENT; IN-VIVO; THYMOCYTE DIFFERENTIATION; LYMPHOCYTE DEVELOPMENT; PROGENITOR CELLS; RUNX PROTEINS; TCR; RECEPTOR	The first checkpoint in T cell development, beta selection, has remained incompletely characterized for lack of specific surface markers. We show that CD27 is upregulated in DN3 thymocytes initiating beta selection, concomitant with intracellular TCR-beta expression. Clonal analysis determined that CD27 high DN3 cells generate CD4(+)CD8(+) progeny with more than 90% efficiency, faster and more efficiently than the CD27(low) majority. CD27 upregulation also occurs in gamma delta-selected DN3 thymocytes in TCR-beta(-/-) mice and in IL2-GFP transgenic reporter mice where GFP marks the earliest emerging TCR-gamma delta cells from DN3 thymocytes. With CD27 to distinguish pre- and postselection DN3 cells, a detailed gene expression analysis defined regulatory changes associated with checkpoint arrest, with beta selection, and with gamma delta selection. gamma delta selection induces higher CD5, Egr, and Runx3 expression as compared to beta selection, but it triggers less proliferation. Our results also reveal differences in Notch/Delta dependence at the earliest stages of divergence between developing alpha beta and gamma delta T-lineage cells.	CALTECH, Dept Biol, Pasadena, CA 91125 USA	California Institute of Technology	Rothenberg, EV (corresponding author), Univ Hosp Ghent, Pintelaan 185,4 Blok A, B-9000 Ghent, Belgium.	evroth@its.caltech.edu	Taghon, Tom/M-9111-2018	Rothenberg, Ellen/0000-0002-3901-347X; Yui, Mary/0000-0002-3136-2181; Taghon, Tom/0000-0002-5781-0288	NCI NIH HHS [R01 CA90233, R01 CA98925] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098925, R01CA090233] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Blom B, 1999, EMBO J, V18, P2793, DOI 10.1093/emboj/18.10.2793; Borowski C, 2002, CURR OPIN IMMUNOL, V14, P200, DOI 10.1016/S0952-7915(02)00322-9; Burtrum DB, 1996, J IMMUNOL, V157, P4293; Catchpole S, 2002, J BIOL CHEM, V277, P39015, DOI 10.1074/jbc.M202960200; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; De Smedt M, 2002, J IMMUNOL, V169, P3021, DOI 10.4049/jimmunol.169.6.3021; Diamond RA, 1997, J IMMUNOL, V158, P4052; Dionne CJ, 2005, DEV BIOL, V280, P448, DOI 10.1016/j.ydbio.2005.01.027; GRATIOTDEANS J, 1994, P NATL ACAD SCI USA, V91, P10685, DOI 10.1073/pnas.91.22.10685; Gravestein LA, 1996, J EXP MED, V184, P675, DOI 10.1084/jem.184.2.675; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Huang EY, 2003, J IMMUNOL, V171, P2296, DOI 10.4049/jimmunol.171.5.2296; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Kohu K, 2005, J IMMUNOL, V174, P2627, DOI 10.4049/jimmunol.174.5.2627; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; LECLERCQ G, 1993, J EXP MED, V178, P309, DOI 10.1084/jem.178.1.309; Lefebvre JM, 2005, J IMMUNOL, V174, P6184, DOI 10.4049/jimmunol.174.10.6184; Lehar SM, 2005, BLOOD, V105, P1440, DOI 10.1182/blood-2004-08-3257; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Livak F, 1999, J IMMUNOL, V162, P2575; Mertsching E, 1997, EUR J IMMUNOL, V27, P389, DOI 10.1002/eji.1830270208; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; PLUM J, 1993, J IMMUNOL, V150, P2706; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Rothenberg EV, 2000, CURR OPIN GENET DEV, V10, P370, DOI 10.1016/S0959-437X(00)00098-8; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shen HQ, 2003, J IMMUNOL, V171, P3401, DOI 10.4049/jimmunol.171.7.3401; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Wang H, 1998, INT IMMUNOL, V10, P1623, DOI 10.1093/intimm/10.11.1623; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wilson D. B., 1999, CORRECTIONS MANAGEME, V3, P8; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolff U, 2001, IEEE SENS J, V1, P4, DOI 10.1109/JSEN.2001.923583; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Yui MA, 2004, J IMMUNOL, V173, P5381, DOI 10.4049/jimmunol.173.9.5381; Yui MA, 2001, J IMMUNOL, V166, P1730, DOI 10.4049/jimmunol.166.3.1730; Yui MA, 2004, J IMMUNOL, V172, P4691, DOI 10.4049/jimmunol.172.8.4691; Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834	58	230	232	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2006	24	1					53	64		10.1016/j.immuni.2005.11.012	http://dx.doi.org/10.1016/j.immuni.2005.11.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413923	Bronze			2022-12-18	WOS:000234850200010
J	Serra, P; Amrani, A; Yamanouchi, J; Han, BY; Thiessen, S; Utsugi, T; Verdaguer, J; Santamaria, P				Serra, P; Amrani, A; Yamanouchi, J; Han, BY; Thiessen, S; Utsugi, T; Verdaguer, J; Santamaria, P			CD40 ligation releases immature dendritic cells from the control of regulatory CD4(+)CD25(+) T cells	IMMUNITY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; ANTIGEN-PRESENTING CELLS; GROWTH-FACTOR-BETA; INTESTINAL INFLAMMATION; ACTIVATION; CD154; AUTOIMMUNITY; SUPPRESSION; POPULATION; ALLOGRAFTS	We report that disruption of CD154 in nonobese diabetic (NOD) mice abrogates the helper function of CD4(+)CD25(-) T cells without impairing the regulatory activity of CD4(+)CD25(+) T cells. Whereas CD4(+) T cells from NOD mice enhanced a diabetogenic CD8(+) T cell response in monoclonal TCR-transgenic NOD mice, CD4(+) T cells from NOD.CD154(-/-) mice actively suppressed it. Suppression was mediated by regulatory CD4(+)CD25(+) T cells capable of inhibiting CD8(+) T cell responses induced by peptide-pulsed dendritic cells (DCs), but not peptide/MHC monomers. It involved inhibition of DC maturation, did not occur in the presence of CD154(+) T-helper cells, and could be inhibited by activation of DCs with LPS, CpG DNA, or an agonistic anti-CD40 mAb. Thus, in at least some genetic backgrounds, CD154-CD40 interactions and innate stimuli release immature DCs from suppression by CD4(+)CD25(+) T cells.	Univ Calgary, Julia McFarlane Diabet Res Ctr, Fac Med, Calgary, AB T2N 4N1, Canada; Gunma Univ, Sch Med, Dept Internal Med 2, Gunma 371, Japan	University of Calgary; Gunma University	Santamaria, P (corresponding author), Univ Calgary, Julia McFarlane Diabet Res Ctr, Fac Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	psantama@ucalgary.ca	Santamaria, Pere/ABF-6823-2021; Autonell, Joan Verdaguer/A-2059-2010	Autonell, Joan Verdaguer/0000-0003-1768-9310				Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Amrani A, 2002, IMMUNITY, V16, P719, DOI 10.1016/S1074-7613(02)00315-1; Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Annunziato F, 2002, J EXP MED, V196, P379, DOI 10.1084/jem.20020110; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Eshima K, 2003, INT IMMUNOL, V15, P351, DOI 10.1093/intimm/dxg035; Green EA, 2002, IMMUNITY, V16, P183, DOI 10.1016/S1074-7613(02)00279-0; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kenyon NS, 1999, P NATL ACAD SCI USA, V96, P8132, DOI 10.1073/pnas.96.14.8132; Kirk AD, 1999, NAT MED, V5, P686, DOI 10.1038/9536; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Liblau RS, 2002, IMMUNITY, V17, P1, DOI 10.1016/S1074-7613(02)00338-2; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Werkele T, 2000, NAT MED, V6, P464, DOI 10.1038/74731	38	230	245	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2003	19	6					877	889		10.1016/S1074-7613(03)00327-3	http://dx.doi.org/10.1016/S1074-7613(03)00327-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670304	Bronze			2022-12-18	WOS:000187230700012
J	Ogasawara, K; Hamerman, JA; Hsin, H; Chikuma, S; Bour-Jordan, H; Chen, T; Pertel, T; Carnaud, C; Bluestone, JA; Lanier, LL				Ogasawara, K; Hamerman, JA; Hsin, H; Chikuma, S; Bour-Jordan, H; Chen, T; Pertel, T; Carnaud, C; Bluestone, JA; Lanier, LL			Impairment of NK cell function by NKG2D modulation in NOD mice	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; DEPENDENT DIABETES-MELLITUS; TRIPLET REPEAT POLYMORPHISM; AUTOIMMUNE-DISEASE; COMPLEX; RECEPTOR; MOUSE; GENE; SUSCEPTIBILITY; INACTIVATION	Nonobese diabetic (NOD) mice, a model of insulin-dependent diabetes mellitus, have a defect in natural killer (NK) cell-mediated functions. Here we show impairment in an activating receptor, NKG2D, in NOD NK cells. While resting NK cells from C57BL/6 and NOD mice expressed equivalent levels of NKG2D, upon activation NOD NK cells but not C57BL/6 NK cells expressed NKG2D ligands, which resulted in downmodulation of the receptor. NKG2D-dependent cytotoxicity and cytokine production were decreased because of receptor modulation, accounting for the dysfunction. Modulation of NKG2D was mostly dependent on the YxxM motif of DAP10, the NKG2B-associated adaptor that activates phosphoinositide 3 kinase. These results suggest that NK cells may be desensitized by exposure to NKG2D ligands.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Hop Necker Enfants Malad, INSERM U25, F-75743 Paris 15, France	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, 513 Parnassus Ave HSW 1114, San Francisco, CA 94143 USA.	lanier@itsa.ucsf.edu	Lanier, Lewis L/E-2139-2014; Ogasawara, Kouetsu/G-9892-2011; Chikuma, Shunsuke/Y-1016-2019	Lanier, Lewis L/0000-0003-1308-3952; Pertel, Thomas/0000-0002-2286-6011; Hsin, Honor/0000-0002-0510-7494	NCI NIH HHS [CA 89189] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089189] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAMS SI, 1988, J IMMUNOL, V140, P2090; ATTALLAH AM, 1987, INT ARCH ALLER A IMM, V83, P278, DOI 10.1159/000234308; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Cameron MJ, 1998, DIABETES METAB REV, V14, P177, DOI 10.1002/(SICI)1099-0895(199806)14:2<177::AID-DMR209>3.0.CO;2-T; Carnaud C, 2001, J IMMUNOL, V166, P2404, DOI 10.4049/jimmunol.166.4.2404; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Cefai D, 1998, J IMMUNOL, V160, P2223; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chang CW, 1999, J IMMUNOL, V163, P4651; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; JEWETT A, 1995, CELL IMMUNOL, V160, P91, DOI 10.1016/0008-8749(95)80013-9; KATAOKA S, 1983, DIABETES, V32, P247, DOI 10.2337/diabetes.32.3.247; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Mizuki N, 1997, P NATL ACAD SCI USA, V94, P1298, DOI 10.1073/pnas.94.4.1298; NAIR MPN, 1986, J CLIN IMMUNOL, V6, P363, DOI 10.1007/BF00915375; NEGISHI K, 1986, DIABETOLOGIA, V29, P352, DOI 10.1007/BF00903343; Norris S, 2001, GASTROENTEROLOGY, V120, P1475, DOI 10.1053/gast.2001.24041; Ogasawara K, 2002, J IMMUNOL, V169, P3676, DOI 10.4049/jimmunol.169.7.3676; Onishi M, 1996, EXP HEMATOL, V24, P324; PERUSSIA B, 1981, J IMMUNOL, V126, P754; Poulton LD, 2001, INT IMMUNOL, V13, P887, DOI 10.1093/intimm/13.7.887; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Rogner UC, 2001, GENOMICS, V74, P163, DOI 10.1006/geno.2001.6508; Schneider H, 1999, J IMMUNOL, V163, P1868; SHULTZ LD, 1995, J IMMUNOL, V154, P180; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; Sugimura K, 2001, TISSUE ANTIGENS, V57, P9, DOI 10.1034/j.1399-0039.2001.057001009.x; TIMONEN T, 1979, CELL IMMUNOL, V48, P133, DOI 10.1016/0008-8749(79)90106-0; Touitou I, 2001, ARTHRITIS RHEUM, V44, P163, DOI 10.1002/1529-0131(200101)44:1<163::AID-ANR20>3.0.CO;2-Z; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Wallace GR, 1999, IMMUNOGENETICS, V49, P613, DOI 10.1007/s002510050656; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145	43	230	240	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2003	18	1					41	51		10.1016/S1074-7613(02)00505-8	http://dx.doi.org/10.1016/S1074-7613(02)00505-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530974	Green Submitted, Bronze			2022-12-18	WOS:000180860600005
J	Nakajima, H; Liu, XW; WynshawBoris, A; Rosenthal, LA; Imada, K; Finbloom, DS; Hennighausen, L; Leonard, WJ				Nakajima, H; Liu, XW; WynshawBoris, A; Rosenthal, LA; Imada, K; Finbloom, DS; Hennighausen, L; Leonard, WJ			An indirect effect of Stat5a in IL-2-induced proliferation: A critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction	IMMUNITY			English	Article							DEFECTIVE LYMPHOID DEVELOPMENT; DNA-BINDING ACTIVITY; MAMMARY-GLAND FACTOR; MICE LACKING JAK3; GAMMA-CHAIN; BETA-CHAIN; GENE-EXPRESSION; T-CELLS; INTERLEUKIN-2-DEFICIENT MICE; TARGETED DISRUPTION	Stat5a was identified as a prolactin-induced transcription factor but also is activated by other cytokines, including interleukin-2 (IL-2) and IL-7. We have now analyzed the immune system of Stat5a-deficient mice. Stat5a(-/-) splenocytes exhibited defective IL-2-induced expression of the IL-2 receptor alpha chain (IL-2R alpha), a protein that together with IL-2R beta and the common cytokine receptor gamma chain (gamma(c)) mediates high-affinity IL-2 binding. Correspondingly, Stat5a(-/-) splenocytes exhibited markedly decreased proliferation to IL-2, although maximal proliferation was still achieved at IL-2 concentrations high enough to titrate intermediate-affinity IL-2R beta/gamma(c) receptors. Thus, defective Stat5a expression results in diminished proliferation by an indirect mechanism, resulting from defective receptor expression. Correspondingly, we show that Stat5a is essential for maximal responsiveness to antigenic stimuli in vivo, underscoring the physiological importance of IL-2-induced IL-2R alpha expression.	NHLBI,LAB MOL IMMUNOL,NIHON UNIV,BETHESDA,MD 20892; NIDDKD,BIOCHEM & METAB LAB,NIH,BETHESDA,MD 20892; NATL HUMAN GENOME RES INST,LAB GENET DIS RES,NIH,BETHESDA,MD 20892; US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); US Food & Drug Administration (FDA)			Nakajima, Hiroshi/AFU-9313-2022; Rosenthal, Louis/A-8868-2008; Leonard, Warren/AAA-1397-2022	Nakajima, Hiroshi/0000-0001-8595-9381; Hennighausen, Lothar/0000-0001-8319-9841; Imada, Kazunori/0000-0002-0945-0513				Ascherman DP, 1997, J BIOL CHEM, V272, P8704, DOI 10.1074/jbc.272.13.8704; AZAM M, 1995, EMBO J, V14, P1402, DOI 10.1002/j.1460-2075.1995.tb07126.x; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; BEADLING C, 1994, EMBO J, V13, P5605, DOI 10.1002/j.1460-2075.1994.tb06898.x; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; FUJII H, 1995, P NATL ACAD SCI USA, V92, P5482, DOI 10.1073/pnas.92.12.5482; GAFFEN SL, 1995, P NATL ACAD SCI USA, V92, P7192, DOI 10.1073/pnas.92.16.7192; GILMOUR KC, 1995, P NATL ACAD SCI USA, V92, P10772, DOI 10.1073/pnas.92.23.10772; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GOLDSMITH MA, 1995, J BIOL CHEM, V270, P21729, DOI 10.1074/jbc.270.37.21729; Horvath CM, 1997, CURR OPIN CELL BIOL, V9, P233, DOI 10.1016/S0955-0674(97)80067-1; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; JOHN S, 1995, MOL CELL BIOL, V15, P1786; John S, 1996, EMBO J, V15, P5627, DOI 10.1002/j.1460-2075.1996.tb00947.x; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KNEITZ B, 1995, EUR J IMMUNOL, V25, P2572, DOI 10.1002/eji.1830250925; Lecine P, 1996, MOL CELL BIOL, V16, P6829; LEONARD WJ, 1994, IMMUNOL REV, V138, P61, DOI 10.1111/j.1600-065X.1994.tb00847.x; Leonard WJ, 1996, NAT MED, V2, P968, DOI 10.1038/nm0996-968; LEONARD WJ, 1984, NATURE, V311, P625; LEONARD WJ, 1998, IN PRESS ANN REV IMM; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MIGLIORATI G, 1993, BLOOD, V81, P1352; MILLER J, 1985, J IMMUNOL, V134, P4212; MUI A, 1995, EMBO J, V15, P2425; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; NELSON BH, 1994, NATURE, V369, P338; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; SPERISEN P, 1995, J BIOL CHEM, V270, P10743, DOI 10.1074/jbc.270.18.10743; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WAKAO H, 1995, EMBO J, V14, P2527, DOI 10.1002/j.1460-2075.1995.tb07250.x; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	64	230	232	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1997	7	5					691	701		10.1016/S1074-7613(00)80389-1	http://dx.doi.org/10.1016/S1074-7613(00)80389-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390692	Bronze			2022-12-18	WOS:A1997YH55400011
J	Jameson, SC; Masopust, D				Jameson, Stephen C.; Masopust, David			Understanding Subset Diversity in T Cell Memory	IMMUNITY			English	Review							TUMOR-INFILTRATING LYMPHOCYTES; RESIDENT MEMORY; TISSUE-RESIDENT; TRANSCRIPTION FACTORS; LEISHMANIA-MAJOR; IL-15-INDEPENDENT MAINTENANCE; RECALL RESPONSES; IMMUNE-RESPONSE; TGF-BETA; CD8(+)	Considerable advances have been made in recent years in understanding the generation and function of memory T cells. Memory T cells are typically parsed into discreet subsets based on phenotypic definitions that connote distinct roles in immunity. Here we consider new developments in the field and focus on how emerging differences between memory cells with respect to their trafficking, metabolism, epigenetic regulation, and longevity may fail to fit into small groups of "memory subsets.'' Rather, the properties of individual memory T cells fall on a continuum within each of these and other parameters. We discuss how this continuum influences the way that the efficacy of vaccination is assessed, as well as the suitability of a memory population for protective immunity.	[Jameson, Stephen C.] Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55414 USA; [Masopust, David] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN 55414 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jameson, SC (corresponding author), Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55414 USA.; Masopust, D (corresponding author), Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN 55414 USA.	james024@umn.edu; masopust@umn.edu	Jameson, Stephen C/D-9892-2013; masopust, david/B-5027-2008	Jameson, Stephen C/0000-0001-9137-1146; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084913, R01AI111671, R01AI038903] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI038903, R01 AI084913, R01 AI111671] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Beura LK, 2018, NAT IMMUNOL, V19, P173, DOI 10.1038/s41590-017-0029-3; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Boddupalli CS, 2016, J CLIN INVEST, V126, P3905, DOI 10.1172/JCI85329; Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Brewitz A, 2017, IMMUNITY, V46, P205, DOI 10.1016/j.immuni.2017.01.003; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Cheuk S, 2017, IMMUNITY, V46, P287, DOI 10.1016/j.immuni.2017.01.009; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; Djenidi F, 2015, J IMMUNOL, V194, P3475, DOI 10.4049/jimmunol.1402711; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Fraser KA, 2013, IMMUNITY, V39, P171, DOI 10.1016/j.immuni.2013.07.003; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Glennie ND, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006349; Glennie ND, 2015, J EXP MED, V212, P1405, DOI 10.1084/jem.20142101; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Hamilton SE, 2015, J EXP MED, V212, P1990, DOI 10.1084/jem.21212insight3; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Henrickson SE, 2013, IMMUNITY, V39, P496, DOI 10.1016/j.immuni.2013.08.034; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Iijima N, 2015, TRENDS IMMUNOL, V36, P556, DOI 10.1016/j.it.2015.07.002; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jameson SC, 2015, ADV IMMUNOL, V126, P173, DOI 10.1016/bs.ai.2014.12.001; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kakaradov B, 2017, NAT IMMUNOL, V18, P422, DOI 10.1038/ni.3688; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2015, J IMMUNOL, V194, P2059, DOI 10.4049/jimmunol.1402256; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Maekawa Y, 2015, NAT MED, V21, P55, DOI 10.1038/nm.3758; Malik BT, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6346; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Metz PJ, 2015, J IMMUNOL, V194, P2249, DOI 10.4049/jimmunol.1401652; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Nanan R, 2000, J GEN VIROL, V81, P1313, DOI 10.1099/0022-1317-81-5-1313; Nelson RW, 2013, J IMMUNOL, V190, P2828, DOI 10.4049/jimmunol.1202183; Newell EW, 2016, NAT IMMUNOL, V17, P890, DOI 10.1038/ni.3485; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Phan AT, 2016, IMMUNITY, V45, P1024, DOI 10.1016/j.immuni.2016.10.017; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Preza GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122723; Pulko V, 2016, NAT IMMUNOL, V17, P966, DOI 10.1038/ni.3483; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Ruiz AL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6150; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2016, J IMMUNOL, V196, P3920, DOI 10.4049/jimmunol.1502337; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Slutter B, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2031; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takamura S, 2016, J EXP MED, V213, P3057, DOI 10.1084/jem.20160938; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Tubo NJ, 2014, CLIN MICROBIOL REV, V27, P200, DOI 10.1128/CMR.00097-13; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; Ugur M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5821; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Verbist KC, 2011, J IMMUNOL, V186, P6667, DOI 10.4049/jimmunol.1004022; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang B, 2015, J UROLOGY, V194, P556, DOI 10.1016/j.juro.2015.02.2941; Wang ZQ, 2016, CLIN CANCER RES, V22, P6290, DOI 10.1158/1078-0432.CCR-16-0732; Webb JR, 2014, CLIN CANCER RES, V20, P434, DOI 10.1158/1078-0432.CCR-13-1877; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; White JT, 2017, NAT REV IMMUNOL, V17, P391, DOI 10.1038/nri.2017.34; Youngblood B., 2017, NATURE; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326	145	229	233	7	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					214	226		10.1016/j.immuni.2018.02.010	http://dx.doi.org/10.1016/j.immuni.2018.02.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466754	Green Accepted, Bronze			2022-12-18	WOS:000425507800009
J	Ouyang, SY; Song, XQ; Wang, YY; Ru, H; Shaw, N; Jiang, Y; Niu, FF; Zhu, YP; Qiu, WC; Parvatiyar, K; Li, Y; Zhang, RG; Cheng, GH; Liu, ZJ				Ouyang, Songying; Song, Xianqiang; Wang, Yaya; Ru, Heng; Shaw, Neil; Jiang, Yan; Niu, Fengfeng; Zhu, Yanping; Qiu, Weicheng; Parvatiyar, Kislay; Li, Yang; Zhang, Rongguang; Cheng, Genhong; Liu, Zhi-Jie			Structural Analysis of the STING Adaptor Protein Reveals a Hydrophobic Dimer Interface and Mode of Cyclic di-GMP Binding	IMMUNITY			English	Article							ALLOSTERIC CONTROL; MACROMOLECULAR STRUCTURES; SEQUENCE; SERVER; MPYS; IDENTIFICATION; CONSERVATION; DIFFRACTION; REFINEMENT; ACTIVATION	STING is an essential signaling molecule for DNA and cyclic di-GMP (c-di-GMP)-mediated type I interferon (IFN) production via TANK-binding kinase 1 (TBK1) and interferon regulatory factor 3 (IRF3) pathway. It contains an N-terminal transmembrane region and a cytosolic C-terminal domain (CTD). Here, we describe crystal structures of STING CTD alone and complexed with c-di-GMP in a unique binding mode. The strictly conserved aa 153-173 region was shown to be cytosolic and participated in dimerization via hydrophobic interactions. The STING CTD functions as a dimer and the dimerization was independent of posttranslational modifications. Binding of c-di-GMP enhanced interaction of a shorter construct of STING CTD (residues 139-344) with TBK1. This suggests an extra TBK1 binding site, other than serine 358. This study provides a glimpse into the unique architecture of STING and sheds light on the mechanism of c-di-GMP-mediated TBK1 signaling.	[Wang, Yaya; Parvatiyar, Kislay; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Ouyang, Songying; Song, Xianqiang; Ru, Heng; Shaw, Neil; Jiang, Yan; Niu, Fengfeng; Zhu, Yanping; Qiu, Weicheng; Li, Yang; Zhang, Rongguang; Liu, Zhi-Jie] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	University of California System; University of California Los Angeles; Chinese Academy of Sciences; Institute of Biophysics, CAS	Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	gcheng@mednet.ucla.edu; zjliu@ibp.ac.cn	Wang, Yaya/G-7587-2012; Liu, Zhi-Jie/A-3946-2012; Li, Yang/M-1246-2013; Song, Xianqiang/B-9768-2017	Liu, Zhi-Jie/0000-0001-7279-2893; Song, Xianqiang/0000-0002-5637-3119; Shaw, Neil/0000-0003-2722-9967	Ministry of Science and Technology of China [2009DFB30310, 2009CB918803, 2011CB911103]; National Natural Science Foundation of China [31070660, 30870483, 31021062]; Chinese Academy of Sciences [KSCX2-EW-J-3, 2010Y1SA1]; NIH [AI069120, AI056154, AI047868]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078389, R37AI047868, R01AI047868, R01AI056154, R01AI069120] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to G.N. Barber (University of Miami, USA) for providing the Tmem173<SUP>-/-</SUP> MEF cells, L.-W. Hung (Los Alamos National Laboratory) for the help on data collection; the staff at beamline 5.0.1 (ALS, Lawrence Berkeley National Laboratory, USA) and beamline BL17U1 (Shanghai Synchrotron Radiation Facility [SSRF], China) for help in the X-ray data collection; and Y.Y. Chen at the Protein Science Core Facility of IBP for technical help with ITC experiments. This work was supported by the Ministry of Science and Technology of China (grants 2009DFB30310, 2009CB918803, 2011CB911103), the National Natural Science Foundation of China (grants 31070660, 30870483, 31021062), the Chinese Academy of Sciences (grants KSCX2-EW-J-3, 2010Y1SA1), and NIH grants (AI069120, AI056154, and AI047868).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Bowzard JB, 2009, CYTOKINE GROWTH F R, V20, P1, DOI 10.1016/j.cytogfr.2009.01.001; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Habazettl J, 2011, J BIOL CHEM, V286, P14304, DOI 10.1074/jbc.M110.209007; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2011, CELL MOL LIFE SCI, V68, P1157, DOI 10.1007/s00018-010-0605-2; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2011, GENES IMMUN, V12, P263, DOI 10.1038/gene.2010.75; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015142; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Liang WG, 2011, FASEB J, V25, P497, DOI 10.1096/fj.10-171207; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200; Monie TP, 2009, IMMUNOL REV, V227, P161, DOI 10.1111/j.1600-065X.2008.00735.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakhaei P, 2010, J MOL CELL BIOL, V2, P110, DOI 10.1093/jmcb/mjp048; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Saitoh T, 2010, AUTOPHAGY, V6, P430, DOI 10.4161/auto.6.3.11611; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Su J, 2010, PROTEIN CELL, V1, P453, DOI 10.1007/s13238-010-0045-7; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	53	229	260	4	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 29	2012	36	6					1073	1086		10.1016/j.immuni.2012.03.019	http://dx.doi.org/10.1016/j.immuni.2012.03.019			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22579474	Bronze, Green Accepted			2022-12-18	WOS:000306097100022
J	Wei, G; Abraham, BJ; Yagi, R; Jothi, R; Cui, KR; Sharma, S; Narlikar, L; Northrup, DL; Tang, QS; Paul, WE; Zhu, JF; Zhao, KJ				Wei, Gang; Abraham, Brian J.; Yagi, Ryoji; Jothi, Raja; Cui, Kairong; Sharma, Suveena; Narlikar, Leelavati; Northrup, Daniel L.; Tang, Qingsong; Paul, William E.; Zhu, Jinfang; Zhao, Keji			Genome-wide Analyses of Transcription Factor GATA3-Mediated Gene Regulation in Distinct T Cell Types	IMMUNITY			English	Article							FACTOR GATA-3; CHROMATIN OCCUPANCY; LINEAGE COMMITMENT; DNA-BINDING; EXPRESSION; DIFFERENTIATION; CD4; FINGER; TH1; IDENTIFICATION	The transcription factor GATA3 plays an essential role during T cell development and T helper 2 (Th2) cell differentiation. To understand GATA3-mediated gene regulation, we identified genome-wide GATA3 binding sites in ten well-defined developmental and effector T lymphocyte lineages. In the thymus, GATA3 directly regulated many critical factors, including Th-POK, Notch1, and T cell receptor subunits. In the periphery, GATA3 induced a large number of Th2 cell-specific as well as Th2 cell-nonspecific genes, including several transcription factors. Our data also indicate that GATA3 regulates both active and repressive histone modifications of many target genes at their regulatory elements near GATA3 binding sites. Overall, although GATA3 binding exhibited both shared and cell-specific patterns among various T cell lineages, many genes were either positively or negatively regulated by GATA3 in a cell type-specific manner, suggesting that GATA3-mediated gene regulation depends strongly on cofactors existing in different T cells.	[Yagi, Ryoji; Sharma, Suveena; Paul, William E.; Zhu, Jinfang] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Wei, Gang; Abraham, Brian J.; Cui, Kairong; Northrup, Daniel L.; Tang, Qingsong; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Jothi, Raja; Narlikar, Leelavati] Natl Inst Environm Hlth Sci, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zhu, JF (corresponding author), NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA.	jfzhu@niaid.nih.gov; zhaok@nhlbi.nih.gov	cheng, yong/I-4270-2012; Jothi, Raja/G-3780-2015; Abraham, Brian/C-2230-2019; Zhu, Jinfang/B-7574-2012	Abraham, Brian/0000-0001-8085-3027; Zhu, Jinfang/0000-0002-0117-4745; Northrup, Daniel/0000-0002-2665-2686; Jothi, Raja/0000-0002-4833-1090	Division of Intramural Research, National Institute of Environmental Health Sciences [Z01ES102625]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102625] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank W. Leonard for critical reading of the manuscript. We thank I. Chepelev, G. Hu, and D. Schones for helpful discussions on data analysis. This work was supported by the Division of Intramural Research, National Institute of Environmental Health Sciences (R.J.; Project Number Z01ES102625), Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, USA.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Eisbacher M, 2003, MOL CELL BIOL, V23, P3427, DOI 10.1128/MCB.23.10.3427-3441.2003; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Laky K, 2008, CURR OPIN IMMUNOL, V20, P197, DOI 10.1016/j.coi.2008.03.004; Lavenu-Bombled C, 2002, J BIOL CHEM, V277, P18313, DOI 10.1074/jbc.M110013200; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Tao X, 1997, J IMMUNOL, V159, P5956; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zhu JF, 2009, J EXP MED, V206, P329, DOI 10.1084/jem.20081666	43	229	237	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 26	2011	35	2					299	311		10.1016/j.immuni.2011.08.007	http://dx.doi.org/10.1016/j.immuni.2011.08.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21867929	Green Accepted, Bronze			2022-12-18	WOS:000294387900018
J	Medzhitov, R				Medzhitov, Ruslan			Approaching the Asymptote: 20 Years Later	IMMUNITY			English	Article							PATTERN-RECOGNITION RECEPTORS; PERIPHERAL LYMPHOID ORGANS; NF-KAPPA-B; RIG-I; INNATE IMMUNITY; CELL-TYPE; LIPOPOLYSACCHARIDE LPS; BACTERIAL-INFECTIONS; HOST RECOGNITION; CUTTING EDGE	The pattern recognition theory proposed by the late Charles Janeway, Jr. 20 years ago provided a conceptual framework for our current understanding of the innate immune recognition and its role in the activation of adaptive immunity. Discovery of several families of pattern recognition receptors and their roles in mammalian immunity provided experimental support for the Janeway's theory. In addition to pattern recognition, there are other forms of innate immune sensing, which presumably work in specific combinations depending on the pathogen class and the type of the immune response they elicit. Here, the development of the Janeway's theory is discussed in the context of the advances made in field of innate immune recognition over the past two decades.	[Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Bottazzi B, 2006, CURR OPIN IMMUNOL, V18, P10, DOI 10.1016/j.coi.2005.11.009; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chaudhary PM, 1998, BLOOD, V91, P4020, DOI 10.1182/blood.V91.11.4020.411a44_4020_4027; CONDIE RM, 1955, P SOC EXP BIOL MED, V90, P355, DOI 10.3181/00379727-90-22032; COUTINHO A, 1977, EUR J IMMUNOL, V7, P325, DOI 10.1002/eji.1830070517; COUTINHO A, 1974, B I SIEROTER MILAN, V53, P131; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Gerard C, 1998, NATURE, V395, P217, DOI 10.1038/26104; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; GOTZE O, 1971, J EXP MED, V134, pS90; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; HEPPNER G, 1965, J BACTERIOL, V90, P696, DOI 10.1128/JB.90.3.696-703.1965; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kemper C, 2008, MOL IMMUNOL, V45, P4048, DOI 10.1016/j.molimm.2008.06.034; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; KOPP EB, 1995, ADV IMMUNOL, V58, P1, DOI 10.1016/S0065-2776(08)60618-5; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Landsteiner K., 1945, SPECIFICITY SEROLOGI; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mitcham JL, 1996, J BIOL CHEM, V271, P5777, DOI 10.1074/jbc.271.10.5777; NAGANO Y, 1958, CR SOC BIOL, V152, P1627; NAGATA S, 1980, NATURE, V284, P316, DOI 10.1038/284316a0; Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Palm NW, 2009, P NATL ACAD SCI USA, V106, P4782, DOI 10.1073/pnas.0809403105; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; PILLEMER L, 1954, SCIENCE, V120, P279, DOI 10.1126/science.120.3112.279; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rivera A, 2006, IMMUNITY, V25, P665, DOI 10.1016/j.immuni.2006.08.016; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; SKIDMORE BJ, 1976, J EXP MED, V143, P143, DOI 10.1084/jem.143.1.143; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1994, J EXP MED, V179, P1, DOI 10.1084/jem.179.1.1; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TANIGUCHI T, 1980, GENE, V10, P11, DOI 10.1016/0378-1119(80)90138-9; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Way SS, 2003, J IMMUNOL, V171, P533, DOI 10.4049/jimmunol.171.2.533; WEAVER CT, 1988, P NATL ACAD SCI USA, V85, P8181, DOI 10.1073/pnas.85.21.8181; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	126	229	243	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2009	30	6					766	775		10.1016/j.immuni.2009.06.004	http://dx.doi.org/10.1016/j.immuni.2009.06.004			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19538928	Bronze			2022-12-18	WOS:000267270700006
J	Shlomchik, MJ				Shlomchik, Mark J.			Sites and stages of autoreactive B cell activation and regulation	IMMUNITY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SHORT-LIVED PLASMABLASTS; ANTI-DNA AUTOANTIBODIES; DEVELOPMENTAL ARREST; TRANSGENIC MICE; MARGINAL-ZONE; SOMATIC HYPERMUTATION; FOLLICULAR EXCLUSION; LYMPHOCYTE DEPLETION; AUTOIMMUNE-DISEASE	B cells are essential for the development and pathogenesis of both systemic and organ-specific autoimmune diseases. Autoreactive B cells are typically thought of as sources of autoantibody, but their most important pathogenetic roles may be to present autoantigens to T cells and to secrete proinflammatory cytokines. A rate-limiting step in the genesis of autoimmunity then is the activation of autoreactive B cells. Here, mechanisms are discussed that normally prevent such activation and how they break down during disease. Integrating classic work with recent insights, emphasis is placed on efforts to pinpoint the precursor cells for autoantibody-secreting cells and the unique stimuli and pathways by which they are activated.	[Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Yale University; Yale University	Shlomchik, MJ (corresponding author), Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06510 USA.	mark.shlomchik@yale.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI036529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR050256] Funding Source: NIH RePORTER; NIAID NIH HHS [P01-AI36529] Funding Source: Medline; NIAMS NIH HHS [P01-AR50256] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahuja A, 2007, J IMMUNOL, V179, P3351, DOI 10.4049/jimmunol.179.5.3351; Antel J, 2006, J NEUROIMMUNOL, V180, P3, DOI 10.1016/j.jneuroim.2006.06.032; Aplin BD, 2003, J IMMUNOL, V171, P5890, DOI 10.4049/jimmunol.171.11.5890; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Cambridge G, 2003, ARTHRITIS RHEUM-US, V48, P2146, DOI 10.1002/art.11181; Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P3612, DOI 10.1002/art.22211; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chan O, 1998, J IMMUNOL, V160, P51; Chan OTM, 1999, IMMUNOL REV, V169, P107, DOI 10.1111/j.1600-065X.1999.tb01310.x; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Chen C, 2006, J IMMUNOL, V176, P5183, DOI 10.4049/jimmunol.176.9.5183; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Cook MC, 1998, EUR J IMMUNOL, V28, P2549, DOI 10.1002/(SICI)1521-4141(199808)28:08<2549::AID-IMMU2549>3.0.CO;2-O; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; Hande S, 1998, IMMUNITY, V8, P189, DOI 10.1016/S1074-7613(00)80471-9; Hannum LG, 1996, J EXP MED, V184, P1269, DOI 10.1084/jem.184.4.1269; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Herlands RA, 2007, EUR J IMMUNOL, V37, P3339, DOI 10.1002/eji.200737752; Hippen KL, 2005, J IMMUNOL, V175, P909, DOI 10.4049/jimmunol.175.2.909; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; JACOBSON BA, 1995, IMMUNITY, V3, P509, DOI 10.1016/1074-7613(95)90179-5; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; KLINMAN DM, 1987, J EXP MED, V165, P1755, DOI 10.1084/jem.165.6.1755; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leandro MJ, 2002, ARTHRITIS RHEUM-US, V46, P2673, DOI 10.1002/art.10541; Li H, 2001, IMMUNITY, V15, P947, DOI 10.1016/S1074-7613(01)00251-5; Li YJ, 2002, J EXP MED, V195, P181, DOI 10.1084/jem.20011453; Liu S, 2005, J IMMUNOL, V175, P5067, DOI 10.4049/jimmunol.175.8.5067; Liu XH, 2007, J IMMUNOL, V178, P5035, DOI 10.4049/jimmunol.178.8.5035; Liu Y, 2007, J IMMUNOL, V179, P1340, DOI 10.4049/jimmunol.179.2.1340; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Mandik-Nayak L, 2000, J IMMUNOL, V164, P1161, DOI 10.4049/jimmunol.164.3.1161; Mandik-Nayak L, 1999, J EXP MED, V189, P1799, DOI 10.1084/jem.189.11.1799; Manz RA, 2006, CURR TOP MICROBIOL, V305, P241, DOI 10.1007/3-540-29714-6_12; MARION TN, 1989, J IMMUNOL, V142, P4269; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Masuda A, 1999, LAB INVEST, V79, P849; MCHEYZERWILLIAMS MG, 1988, J IMMUNOL, V141, P4118; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Nemazee D, 1995, ANN NY ACAD SCI, V764, P397; NEMAZEE D, 1991, IMMUNOL REV, V122, P117, DOI 10.1111/j.1600-065X.1991.tb00600.x; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Noorchashm H, 1999, INT IMMUNOL, V11, P765, DOI 10.1093/intimm/11.5.765; NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602; NOSSAL GJV, 1978, J EXP MED, V148, P1161, DOI 10.1084/jem.148.5.1161; Novobrantseva T, 2005, INT IMMUNOL, V17, P343, DOI 10.1093/intimm/dxh214; Pewzner-Jung Y, 1998, J IMMUNOL, V161, P4634; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Qian Y, 2001, J IMMUNOL, V166, P2412, DOI 10.4049/jimmunol.166.4.2412; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; RANDEN I, 1993, SCAND J IMMUNOL, V37, P668, DOI 10.1111/j.1365-3083.1993.tb01681.x; RATHMELL JC, 1994, J IMMUNOL, V153, P2831; Rifkin IR, 2000, J IMMUNOL, V165, P1626, DOI 10.4049/jimmunol.165.3.1626; Roark JH, 1997, INT IMMUNOL, V9, P1615, DOI 10.1093/intimm/9.11.1615; ROARK JH, 1995, J IMMUNOL, V154, P4444; Rubio CF, 1996, J IMMUNOL, V157, P65; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; Sadanaga A, 2007, ARTHRITIS RHEUM-US, V56, P1618, DOI 10.1002/art.22571; Samuels J, 2005, J EXP MED, V201, P1659, DOI 10.1084/jem.20042321; Santulli-Marotto S, 1998, IMMUNITY, V8, P209, DOI 10.1016/S1074-7613(00)80473-2; Santulli-Marotto S, 2001, J IMMUNOL, V166, P5292, DOI 10.4049/jimmunol.166.8.5292; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Sekiguchi DR, 2006, J IMMUNOL, V176, P6879, DOI 10.4049/jimmunol.176.11.6879; Sekiguchi DR, 2002, J IMMUNOL, V168, P4142, DOI 10.4049/jimmunol.168.8.4142; Seo SJ, 2002, IMMUNITY, V16, P535, DOI 10.1016/S1074-7613(02)00298-4; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Sfikakis PP, 2005, CURR OPIN RHEUMATOL, V17, P550, DOI 10.1097/01.bor.0000172798.26249.fc; SHAN H, 1994, J IMMUNOL, V153, P5104; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SHLOMCHIK MJ, 1993, INT IMMUNOL, V5, P1329, DOI 10.1093/intimm/5.10.1329; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150; SOUROUJON M, 1988, J IMMUNOL, V140, P4173; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Wang HW, 1999, J EXP MED, V190, P639, DOI 10.1084/jem.190.5.639; Wang HW, 1998, J IMMUNOL, V160, P2263; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weisel F, 2007, EUR J IMMUNOL, V37, P3330, DOI 10.1002/eji.200737971; William J, 2005, J IMMUNOL, V174, P6879, DOI 10.4049/jimmunol.174.11.6879; William J, 2005, J IMMUNOL, V174, P6872, DOI 10.4049/jimmunol.174.11.6872; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; WINKLER TH, 1992, EUR J IMMUNOL, V22, P1719, DOI 10.1002/eji.1830220709; Witte T, 2000, RHEUMATOL INT, V19, P107, DOI 10.1007/s002960050112; Wong FS, 2004, DIABETES, V53, P2581, DOI 10.2337/diabetes.53.10.2581; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251	122	229	236	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2008	28	1					18	28		10.1016/j.immuni.2007.12.004	http://dx.doi.org/10.1016/j.immuni.2007.12.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18199415	Bronze			2022-12-18	WOS:000252627300007
J	Zhou, DL; Li, P; Lin, YL; Lott, JM; Hislop, AD; Canaday, DH; Brutkiewicz, RR; Blum, JS				Zhou, DL; Li, P; Lin, YL; Lott, JM; Hislop, AD; Canaday, DH; Brutkiewicz, RR; Blum, JS			Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens	IMMUNITY			English	Article							LYSOSOMAL PROTEIN-DEGRADATION; T-CELL RECOGNITION; RESTRICTED PRESENTATION; PEPTIDE TRANSLOCATION; MOLECULAR CHAPERONE; CYTOSOLIC ANTIGEN; IN-VIVO; TRANSPORTER; AUTOPHAGY; PATHWAY	Extracellular antigens are internalized and processed before binding MHC class II molecules within endosomal and lysosomal compartments of professional antigen presenting cells (APC) for subsequent presentation to T cells. Yet select cytoplasmic peptides derived from autoantigens also intersect and bind class II molecules via an unknown mechanism. In human B lymphoblasts, inhibition of the peptide transporter associated with antigen processing (TAP) failed to alter class II-restricted cytoplasmic epitope presentation. By contrast, decreased display of cytoplasmic epitopes via class II molecules was observed in cells with diminished expression of the lysosome-associated membrane protein-2 (Lamp-2). Overexpression of Lamp-2 isoform A (Lamp-2a), an established component of chaperone-mediated autophagy, enhanced cytoplasmic autoantigen presentation. Manipulating APC expression of heat shock cognate protein 70 (hsc70), a cofactor for Lamp-2a, also altered cytoplasmic class II peptide presentation. These results demonstrate a novel role for the lysosomal Lamp-2ahsc70 complex in promoting immunological recognition and antigen presentation.	Indiana Univ, Sch Med, Dept Microbiol & Immunol, Ctr Immunobiol, Indianapolis, IN 46202 USA; Walther Oncol Ctr, Walther Oncol Inst, Indianapolis, IN 46202 USA; Jackson State Univ, Dept Biol, Jackson, MS 39217 USA; Canc Res UK Inst Canc Studies, Birmingham B15 2TD, W Midlands, England; Univ Birmingham, Ctr Immune Regulat, MRC, Birmingham B15 2TD, W Midlands, England; Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Jackson State University; Cancer Research UK; University of Birmingham; University of Birmingham; Case Western Reserve University	Blum, JS (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Ctr Immunobiol, Indianapolis, IN 46202 USA.	jblum@iupui.edu		Brutkiewicz, Randy/0000-0002-7396-480X				Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; Armstrong TD, 1998, J IMMUNOL, V160, P661; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Canaday DH, 2003, J IMMUNOL METHODS, V281, P129, DOI 10.1016/j.jim.2003.07.004; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dissanayake SK, 2005, J IMMUNOL, V174, P1811, DOI 10.4049/jimmunol.174.4.1811; Dul JL, 2001, J CELL BIOL, V152, P705, DOI 10.1083/jcb.152.4.705; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Gough NR, 1997, J CELL BIOL, V137, P1161, DOI 10.1083/jcb.137.5.1161; Haque MA, 2002, J EXP MED, V195, P1267, DOI 10.1084/jem.20011853; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; JACOBSON S, 1989, J VIROL, V63, P1756, DOI 10.1128/JVI.63.4.1756-1762.1989; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; KONECKI DS, 1995, BIOCHEM BIOPH RES CO, V215, P757, DOI 10.1006/bbrc.1995.2528; Lautscham G, 2001, J EXP MED, V194, P1053, DOI 10.1084/jem.194.8.1053; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; MAINATI MS, 1992, NATURE, V357, P702; MALNATI MS, 1993, J IMMUNOL, V151, P6751; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; Munafo DB, 2001, J CELL SCI, V114, P3619; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; OHANNESIAN DW, 1994, CANCER RES, V54, P5992; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Panjwani N, 1999, J IMMUNOL, V163, P1936; Pathak SS, 2001, J IMMUNOL, V167, P632, DOI 10.4049/jimmunol.167.2.632; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SAITOH O, 1992, J BIOL CHEM, V267, P5700; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; TERADA K, 1995, MOL CELL BIOL, V15, P3708; Tewari MK, 2005, NAT IMMUNOL, V6, P287, DOI 10.1038/ni1171; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Wang J, 1999, ELECTROANAL, V11, P284	43	229	242	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2005	22	5					571	581		10.1016/j.immuni.2005.03.009	http://dx.doi.org/10.1016/j.immuni.2005.03.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894275	Bronze			2022-12-18	WOS:000229447200007
J	Croker, BA; Metcalf, D; Robb, L; Wei, W; Mifsud, S; DiRago, L; Cluse, LA; Sutherland, KD; Hartley, L; Williams, E; Zhang, JG; Hilton, DJ; Nicola, NA; Alexander, WS; Roberts, AW				Croker, BA; Metcalf, D; Robb, L; Wei, W; Mifsud, S; DiRago, L; Cluse, LA; Sutherland, KD; Hartley, L; Williams, E; Zhang, JG; Hilton, DJ; Nicola, NA; Alexander, WS; Roberts, AW			SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; BLOOD PROGENITOR CELLS; CYTOKINE SIGNALING-3; PERIPHERAL-BLOOD; FACTOR-RECEPTOR; HUMAN-NEUTROPHILS; TRANSGENIC MICE; BONE-MARROW; BOX MOTIF; IN-VITRO	To determine the importance of suppressor of cytokine signaling-3 (SOCS3) in the regulation of hematopoietic growth factor signaling generally, and of G-CSFinduced cellular responses specifically, we created mice in which the Socs3 gene was deleted in all hematopoietic cells. Although normal until young adulthood, these mice then developed neutrophilia and a spectrum of inflammatory pathologies. When stimulated with G-CSF in vitro, SOCS3-deficient cells of the neutrophilic granulocyte lineage exhibited prolonged STAT3 activation and enhanced cellular responses to G-CSF, including an increase in cloning frequency, survival, and proliferative capacity. Consistent with the in vitro findings, mutant mice injected with G-CSF displayed enhanced neutrophilia, progenitor cell mobilization, and splenomegaly, but unexpectedly also developed inflammatory neutrophil infiltration into multiple tissues and consequent hind-leg paresis. We conclude that SOCS3 is a key negative regulator of G-CSF signaling in myeloid cells and that this is of particular significance during G-CSF-driven emergency granulopoiesis.	Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Cooperat Res Ctr Cellular Growth Factors, Parkville, Vic 3050, Australia; Walter & Eliza Hall Inst Med Res, Victorian Breast Canc Res Consortium Lab, Cooperat Res Ctr Cell Growth Factors, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute	Roberts, AW (corresponding author), Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Cooperat Res Ctr Cellular Growth Factors, 1G Royal Parade, Parkville, Vic 3050, Australia.	roberts@wehi.edu.au	Nicola, Nicos/D-2989-2011; Mifsud, Sandra/AAM-6041-2021; Hilton, Douglas J/C-7250-2013; Roberts, Andrew W./C-6736-2012	Nicola, Nicos/0000-0003-1054-7889; Hilton, Douglas J/0000-0002-7698-2392; Roberts, Andrew W./0000-0002-7341-5720; Mifsud, Sandra/0000-0002-1010-292X; Sutherland, Kate/0000-0002-7453-3366; Croker, Ben/0000-0002-0885-3599	NATIONAL CANCER INSTITUTE [R01CA022556, R37CA022556] Funding Source: NIH RePORTER; NCI NIH HHS [CA22556] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akbarzadeh S, 2002, BLOOD, V99, P879, DOI 10.1182/blood.V99.3.879; Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; BEGLEY CG, 1986, BLOOD, V68, P162; Bode JG, 2003, J IMMUNOL, V171, P257, DOI 10.4049/jimmunol.171.1.257; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; DUHRSEN U, 1988, BLOOD, V72, P2074; Elefanty AG, 1999, BLOOD, V94, P3754, DOI 10.1182/blood.V94.11.3754.423k05_3754_3763; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; GRIGG AP, 1995, BLOOD, V86, P4437, DOI 10.1182/blood.V86.12.4437.bloodjournal86124437; Hermans MHA, 2003, BLOOD, V101, P2584, DOI 10.1182/blood-2002-07-2062; Hortner M, 2002, J IMMUNOL, V169, P1219, DOI 10.4049/jimmunol.169.3.1219; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Marine JC, 1999, CELL, V98, P617, DOI 10.1016/S0092-8674(00)80049-5; McLemore ML, 2001, IMMUNITY, V14, P193, DOI 10.1016/S1074-7613(01)00101-7; Metcalf D, 1996, BLOOD, V88, P3755, DOI 10.1182/blood.V88.10.3755.bloodjournal88103755; Metcalf D, 1984, CLONAL CULTURE HEMOP; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Ogilvy S, 1999, BLOOD, V94, P1855; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; ROBERTS AW, 1994, EXP HEMATOL, V22, P1156; Roberts AW, 1997, BLOOD, V89, P2736, DOI 10.1182/blood.V89.8.2736; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; SHERIDAN WP, 1992, LANCET, V339, P640, DOI 10.1016/0140-6736(92)90795-5; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI13568; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stoiber D, 1999, J IMMUNOL, V163, P2640; Suzuki K, 1999, BLOOD, V93, P341, DOI 10.1182/blood.V93.1.341.401k09_341_349; Takahashi Y, 2003, EMBO J, V22, P372, DOI 10.1093/emboj/cdg057; TIAN SS, 1994, BLOOD, V84, P1760; Woldman I, 2001, J BIOL CHEM, V276, P45722, DOI 10.1074/jbc.M105320200; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	47	229	235	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2004	20	2					153	165		10.1016/S1074-7613(04)00022-6	http://dx.doi.org/10.1016/S1074-7613(04)00022-6			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EI	14975238	Bronze			2022-12-18	WOS:000221442400005
J	Ramsdell, F				Ramsdell, F			Foxp3 and natural regulatory T cells: Key to a cell lineage?	IMMUNITY			English	Review							IN-VIVO; SCURFIN; PROTEIN; ANTIGEN; MOUSE; TRANSCRIPTION; ENTEROPATHY; TOLERANCE; INDUCTION; IL-10	The recent characterization of a mutant strain of mice generated five decades ago in a program to study ionizing radiation in mammals (and, ironically, derived from a nonmutagenized control animal) is helping to dissect a now resurgent area of immunology. Despite a vast literature during the 1970s, the study of suppressor T cells had been largely abandoned until the publication of several seminal papers rekindled interest in what are today generally referred to as regulatory T (T-R) cells. The identification of the transcription factor Foxp3 as the gene responsible for the defect in scurfy mice, and subsequently, the demonstration of its critical involvement in the generation of T-R cells, provides an important molecular insight into this essential cell lineage.	Cell Tech R&D Inc, Bothell, WA 98021 USA		Ramsdell, F (corresponding author), Cell Tech R&D Inc, 1631 220th St SE, Bothell, WA 98021 USA.							Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BLAIR PJ, 1994, J IMMUNOL, V153, P3764; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hoyne GF, 2000, INT IMMUNOL, V12, P177, DOI 10.1093/intimm/12.2.177; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Sundstedt A, 2003, J IMMUNOL, V170, P1240, DOI 10.4049/jimmunol.170.3.1240; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	22	229	266	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2003	19	2					165	168		10.1016/S1074-7613(03)00207-3	http://dx.doi.org/10.1016/S1074-7613(03)00207-3			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932350	Bronze			2022-12-18	WOS:000184929000004
J	Delon, J; Kaibuchi, K; Germain, RN				Delon, J; Kaibuchi, K; Germain, RN			Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin	IMMUNITY			English	Article							T-CELL ACTIVATION; EZRIN/RADIXIN/MOESIN ERM PROTEINS; RHO-ASSOCIATED KINASE; F-ACTIN BINDING; ANTIGEN RECOGNITION; FAMILY MEMBERS; B-CELLS; C-THETA; LYMPHOCYTES; RECEPTOR	Formation of the immunological synapse requires TOR signal-dependent protein redistribution. However, the specific molecular mechanisms controlling protein relocation are not well defined. Moesin is a widely expressed phospho-protein that links many transmembrane molecules to the cortical actin cytoskeleton. Here, we demonstrate that TCR-induced exclusion of the large sialoprotein CD43 from the synapse is an active event mediated by its reversible binding to moesin. Our results also reveal that relocalization of moesin is associated with changes in the phosphorylation status of this cytoskeletal adaptor protein. Finally, these findings raise the possibility that the change in moesin localization resulting from TCR engagement modifies the overall topology of the lymphocyte membrane and facilitates molecular interactions at the site of presenting cell contact.	NIAID, Immunol Lab, Lymphocyte Biol Sect, NIH, Bethesda, MD 20892 USA; Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Aichi 4668550, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Nagoya University	Germain, RN (corresponding author), NIAID, Immunol Lab, Lymphocyte Biol Sect, NIH, Bldg 10, Bethesda, MD 20892 USA.		Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019	Delon, Jerome/0000-0003-0222-1192				Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Carlow DA, 2001, J IMMUNOL, V166, P256, DOI 10.4049/jimmunol.166.1.256; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Huang LQ, 1999, J BIOL CHEM, V274, P12803, DOI 10.1074/jbc.274.18.12803; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; KUPFER A, 1987, J EXP MED, V165, P1565, DOI 10.1084/jem.165.6.1565; Lanzavecchia A, 2000, CURR OPIN IMMUNOL, V12, P92, DOI 10.1016/S0952-7915(99)00056-4; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; PARK JK, 1991, NATURE, V350, P706, DOI 10.1038/350706a0; Parlato S, 2000, EMBO J, V19, P5123, DOI 10.1093/emboj/19.19.5123; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Shcherbina A, 1999, FEBS LETT, V443, P31, DOI 10.1016/S0014-5793(98)01674-3; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Sperling AI, 1998, J IMMUNOL, V161, P6459; SPERLING AI, 1995, J EXP MED, V182, P139, DOI 10.1084/jem.182.1.139; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497	52	229	233	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2001	15	5					691	701		10.1016/S1074-7613(01)00231-X	http://dx.doi.org/10.1016/S1074-7613(01)00231-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728332	Bronze			2022-12-18	WOS:000172528200003
J	Arsura, M; Wu, M; Sonenshein, GE				Arsura, M; Wu, M; Sonenshein, GE			TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: Transcriptional activation of I kappa B alpha	IMMUNITY			English	Article							TRANSFORMING GROWTH FACTOR-BETA-1; C-MYC GENE; DNA-BINDING SUBUNIT; CYCLE ARREST; REL FAMILY; IMMUNOGLOBULIN-D; FACTOR-BETA; MURINE; LYMPHOMA; INDUCTION	TGF beta 1 treatment of B cell lymphomas decreases c-myc gene expression and induces apoptosis. Since we have demonstrated NF-kappa B/Rel factors play a key role in transcriptional control of c-myc, we explored the effects of TGF beta 1 on WEHI 231 immature B cells. A reduction in NF-kappa B/Rel activity followed TGF beta 1 treatment. In WEHI 231 and CH33 cells, we observed an increase in I kappa B alpha, a specific NF-kappa B/Rel inhibitor, due to transcriptional induction. Engagement of surface CD40 or ectopic c-Rel led to maintenance of NF-kappa B/ Rel and c-Myc expression and protection of WEHI 231 cells from TGF beta 1-mediated apoptosis. Ectopic c-Myc expression overrode apoptosis induced by TGF beta 1. Thus, downmodulation of NF-kappa B/Rel reduces c-Myc expression, which leads to apoptosis in these immature B cell models of clonal deletion. The inhibition of NF-kappa B/Rel activity represents a novel TGF beta signaling mechanism.			Arsura, M (corresponding author), BOSTON UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02118, USA.				NCI NIH HHS [CA36355] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA036355] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALESMARTINEZ JE, 1988, P NATL ACAD SCI USA, V85, P6919, DOI 10.1073/pnas.85.18.6919; ASKEW DS, 1991, ONCOGENE, V6, P1915; ASURA M, 1995, MOL CELL BIOL, V15, P6702; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630; BOND JF, 1983, MOL CELL BIOL, V3, P1333, DOI 10.1128/MCB.3.8.1333; BOURS V, 1992, MOL CELL BIOL, V12, P685, DOI 10.1128/MCB.12.2.685; BOYD AW, 1981, J IMMUNOL, V126, P2466; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; CHAOUCHI N, 1995, ONCOGENE, V11, P1615; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; COFFEY RJ, 1988, MOL CELL BIOL, V8, P3088, DOI 10.1128/MCB.8.8.3088; DAVIS N, 1991, SCIENCE, V253, P1268, DOI 10.1126/science.1891714; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; DUYAO MP, 1990, P NATL ACAD SCI USA, V87, P4727, DOI 10.1073/pnas.87.12.4727; DUYAO MP, 1992, J BIOL CHEM, V267, P16288; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; EWEN ME, 1993, CELL, V74, P1009, DOI 10.1016/0092-8674(93)90723-4; FISCHER G, 1994, J EXP MED, V179, P221, DOI 10.1084/jem.179.1.221; FRANCIS DA, 1995, INT IMMUNOL, V7, P151, DOI 10.1093/intimm/7.2.151; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILMORE TD, 1991, TRENDS GENET, V7, P318, DOI 10.1016/0168-9525(91)90200-A; GOTTSCHALK AR, 1994, P NATL ACAD SCI USA, V91, P7350, DOI 10.1073/pnas.91.15.7350; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GRILLI M, 1993, INT REV CYTOL, V143, P1; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HASBOLD J, 1990, EUR J IMMUNOL, V20, P1685, DOI 10.1002/eji.1830200810; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HIBNER U, 1994, EUR J IMMUNOL, V24, P1993; HOWE PH, 1991, MOL CELL BIOL, V11, P1185, DOI 10.1128/MCB.11.3.1185; KENTER AL, 1993, J IMMUNOL, V151, P4718; KESSLER DJ, 1992, ONCOGENE, V7, P2447; KESSLER DJ, 1992, J EXP MED, V176, P787, DOI 10.1084/jem.176.3.787; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KIM KJ, 1979, J IMMUNOL, V122, P549; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; LAROSA FA, 1994, MOL CELL BIOL, V14, P1039, DOI 10.1128/MCB.14.2.1039; LEE HY, 1995, J EXP MED, V181, P1169, DOI 10.1084/jem.181.3.1169; LEVINE RA, 1986, MOL CELL BIOL, V6, P4112, DOI 10.1128/MCB.6.11.4112; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; LOMO J, 1995, J IMMUNOL, V154, P1634; MAHESWARAN S, 1991, ONCOGENE, V6, P1965; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MCCORMACK JE, 1984, P NATL ACAD SCI-BIOL, V81, P5546, DOI 10.1073/pnas.81.17.5546; MIYAMOTO S, 1994, MOL CELL BIOL, V14, P3276, DOI 10.1128/MCB.14.5.3276; MONROE JG, 1988, IMMUNOL RES, V7, P136, DOI 10.1007/BF02918097; NEIMAN PE, 1991, P NATL ACAD SCI USA, V88, P5857, DOI 10.1073/pnas.88.13.5857; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; RALPH P, 1979, IMMUNOL REV, V48, P107, DOI 10.1111/j.1600-065X.1979.tb00300.x; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; ROBERTS AB, 1980, PEPTIDE GROWTH FACTO, P419; ROTELLO RJ, 1991, P NATL ACAD SCI USA, V88, P3412, DOI 10.1073/pnas.88.8.3412; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; SANTOSARGUMEDO L, 1994, CELL IMMUNOL, V156, P272, DOI 10.1006/cimm.1994.1174; SCHAUER SL, 1996, IN PRESS J IMMUNOL; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SHI YF, 1992, SCIENCE, V257, P212, DOI 10.1126/science.1378649; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; STANTON LW, 1983, NATURE, V303, P1697; STAVNEZER J, 1996, CYTOKINE REGULATION, P286; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; TISCH R, 1988, P NATL ACAD SCI USA, V85, P6914, DOI 10.1073/pnas.85.18.6914; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; WARNER GL, 1992, CELL GROWTH DIFFER, V3, P175; WHITE DW, 1995, ONCOGENE, V10, P857; WU M, 1996, IN PRESS EMBO J	86	229	233	2	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1996	5	1					31	40		10.1016/S1074-7613(00)80307-6	http://dx.doi.org/10.1016/S1074-7613(00)80307-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ454	8758892	hybrid			2022-12-18	WOS:A1996UZ45400004
J	VANOERS, NSC; KILLEEN, N; WEISS, A				VANOERS, NSC; KILLEEN, N; WEISS, A			ZAP-70 IS CONSTITUTIVELY ASSOCIATED WITH TYROSINE-PHOSPHORYLATED TCR-ZETA IN MURINE THYMOCYTES AND LYMPH-NODE T-CELLS	IMMUNITY			English	Article							IMMATURE CD4+CD8+ THYMOCYTES; ANTIGEN RECEPTOR-ZETA; SIGNAL TRANSDUCTION; DEFICIENT MICE; KINASE; CHAIN; ACTIVATION; EXPRESSION; CD4; P56(LCK)	Studies with T cell lines and clones have shown that engagement of the TCR results in the tyrosine phosphorylation of the TCR subunits. This leads to the recruitment of the ZAP-70 protein tyrosine kinase, an interaction involving the two SH2-domains of ZAP-70 with tyrosine-phosphorylated zeta and CD3. However, as previously described, murine thymocytes and lymph node T cells express a constitutively tyrosine-phosphorylated zeta subunit in the basal state. Here, we show that a fraction of ZAP-70 molecules are constitutively associated with tyrosine-phosphorylated zeta. TCR ligation promotes a large increase in the tyrosine phosphorylation of ZAP-70 as well as other TCR subunits. Genetic studies reveal that the constitutive ZAP-70 association with tyrosine-phosphorylated zeta does not absolutely require either TCR or coreceptor interactions with MHC molecules.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	VANOERS, NSC (corresponding author), UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT MED, SAN FRANCISCO, CA 94143 USA.		Van+Oers, Nicolai/ABA-2437-2021	van Oers, Nicolai/0000-0002-6545-8405	NIGMS NIH HHS [GM39553] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039553] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAN AC, 1994, J IMMUNOL, V152, P4758; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; FINKEL TH, 1987, NATURE, V330, P179, DOI 10.1038/330179a0; FINKEL TH, 1989, CELL, V58, P1047, DOI 10.1016/0092-8674(89)90503-5; FINKEL TH, 1989, J IMMUNOL, V142, P3006; FRANK SJ, 1992, J BIOL CHEM, V267, P13656; GILLILAND LK, 1991, J IMMUNOL, V146, P1759; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HUTCHCROFT JE, 1991, J BIOL CHEM, V266, P14846; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KEARSE KP, 1993, P NATL ACAD SCI USA, V90, P2438, DOI 10.1073/pnas.90.6.2438; KILLEEN N, 1993, EMBO J, V12, P1547, DOI 10.1002/j.1460-2075.1993.tb05798.x; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; NAKAYAMA T, 1993, P NATL ACAD SCI USA, V90, P10534, DOI 10.1073/pnas.90.22.10534; NAKAYAMA T, 1991, P NATL ACAD SCI USA, V88, P9949, DOI 10.1073/pnas.88.22.9949; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; PERLMUTTER RM, 1988, J CELL BIOCHEM, V38, P117, DOI 10.1002/jcb.240380206; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; QIAN DP, 1993, J BIOL CHEM, V268, P4488; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; STRAUS DB, 1993, J EXP MED, V178, P1523, DOI 10.1084/jem.178.5.1523; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; VANOERS NSC, 1994, J IMMUNOL METHODS, V170, P261, DOI 10.1016/0022-1759(94)90401-4; Veillette A, 1991, Semin Immunol, V3, P143; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WANGE RL, 1992, J BIOL CHEM, V267, P11685; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WATTS JD, 1992, J BIOL CHEM, V267, P901; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	49	229	230	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1994	1	8					675	685		10.1016/1074-7613(94)90038-8	http://dx.doi.org/10.1016/1074-7613(94)90038-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PT930	7600293				2022-12-18	WOS:A1994PT93000005
J	Hale, JS; Youngblood, B; Latner, DR; Mohammed, AUR; Ye, LL; Akondy, RS; Wu, TQ; Iyer, SS; Ahmed, R				Hale, J. Scott; Youngblood, Ben; Latner, Donald R.; Mohammed, Ata Ur Rasheed; Ye, Lilin; Akondy, Rama S.; Wu, Tuoqi; Iyer, Smita S.; Ahmed, Rafi			Distinct Memory CD4(+) T Cells with Commitment to T Follicular Helper- and T Helper 1-Cell Lineages Are Generated after Acute Viral Infection	IMMUNITY			English	Article							CXC CHEMOKINE RECEPTOR-5; EXPRESSION; BCL6; VACCINES; VACCINOLOGY; ACTIVATION; MECHANISMS; EFFECTOR; BLIMP-1; IL-21	CD4(+) T follicular helper (Tfh) cells provide the required signals to B cells for germinal center reactions that are necessary for long-lived antibody responses. However, it remains unclear whether there are CD4(+) memory T cells committed to the Tfh cell lineage after antigen clearance. By using adoptive transfer of antigen-specific memory CD4(+) T cell sub-populations in the lymphocytic choriomeningitis virus infection model, we found that there are distinct memory CD4(+) T cell populations with commitment to either Tfh- or Th1-cell lineages. Our conclusions are based on gene expression profiles, epigenetic studies, and phenotypic and functional analyses. Our findings indicate that CD4(+) memory T cells "remember" their previous effector lineage after antigen clearance, being poised to reacquire their lineage-specific effector functions upon antigen reencounter. These findings have important implications for rational vaccine design, where improving the generation and engagement of memory Tfh cells could be used to enhance vaccine-induced protective immunity.	[Hale, J. Scott; Youngblood, Ben; Latner, Donald R.; Mohammed, Ata Ur Rasheed; Ye, Lilin; Akondy, Rama S.; Wu, Tuoqi; Iyer, Smita S.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Hale, J. Scott; Youngblood, Ben; Latner, Donald R.; Mohammed, Ata Ur Rasheed; Ye, Lilin; Akondy, Rama S.; Wu, Tuoqi; Iyer, Smita S.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Hale, J. Scott; Youngblood, Ben; Ahmed, Rafi] Emory Univ, Sch Med, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	rahmed@emory.edu	Iyer, Smita/S-5398-2017; Iyer, Swaminathan/GRS-9668-2022; Youngblood, Benjamin/N-2508-2018; Rasheed, Mohammed/N-2749-2013; Akondy, Rama/AAC-4656-2020	Youngblood, Benjamin/0000-0002-1261-9957; Akondy, Rama/0000-0003-4737-5240; Ye, Lilin/0000-0003-0778-3311	NIH [P01 A1080192, RO1 AI030048]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [UM1AI100663]; American Cancer Society (ACS) postdoctoral fellowship [PF-09-134-01-MPC]; National Institute of Allergy and Infectious Diseases Training Grant [T32AI074492, F32 A1096709-01A1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; American Cancer Society (ACS) postdoctoral fellowship; National Institute of Allergy and Infectious Diseases Training Grant	We thank M. Pepper (University of Washington), M. Jenkins (University of Minnesota), and the NIH Tetramer Core Facility (Emory University) for providing I:Ab Gp<INF>66</INF> <INF>77</INF> tetramer. We thank R. Karaffa and S. Durham for FACS sorting at the Emory University School of Medicine Flow Cytometry Core Facility. This work was supported by the NIH grant P01 A1080192 (to R. A.), grant RO1 AI030048 (to R. A.), Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery UM1AI100663 (to R. A), the American Cancer Society (ACS) postdoctoral fellowship PF-09-134-01-MPC (to B. Y.), and the National Institute of Allergy and Infectious Diseases Training Grant T32AI074492 and F32 A1096709-01A1 (to J.S.H.).	Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; [Anonymous], 2013, VACCINES; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; D'Argenio DA, 2010, IMMUNITY, V33, P437, DOI 10.1016/j.immuni.2010.10.011; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; MacLeod MKL, 2011, J IMMUNOL, V186, P2889, DOI 10.4049/jimmunol.1002955; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Weber JP, 2012, EUR J IMMUNOL, V42, P1981, DOI 10.1002/eji.201242540; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Youngblood B, 2010, INT IMMUNOL, V22, P797, DOI 10.1093/intimm/dxq437; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505	40	228	233	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					805	817		10.1016/j.immuni.2013.02.020	http://dx.doi.org/10.1016/j.immuni.2013.02.020			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23583644	Green Accepted, Bronze			2022-12-18	WOS:000330942100021
J	DENZIN, LK; ROBBINS, NF; CARBOYNEWCOMB, C; CRESSWELL, P				DENZIN, LK; ROBBINS, NF; CARBOYNEWCOMB, C; CRESSWELL, P			ASSEMBLY AND INTRACELLULAR-TRANSPORT OF HLA-DM AND CORRECTION OF THE CLASS-II ANTIGEN-PROCESSING DEFECT IN T2 CELLS	IMMUNITY			English	Article							INVARIANT CHAIN PEPTIDES; LONG TERMINAL REPEAT; MONOCLONAL-ANTIBODY; DR MOLECULES; MHC; MUTANT; EXPRESSION; VIRUS; GENES; COMPARTMENTS	MHC class II molecules expressed in T2 cells fail to acquire a normal complement of endocytically generated peptides. The defect is repaired by introducing HLA DMA and HLA DMB cDNA expression vectors, determined by the restoration of SDS stability of class II alpha beta dimers, restoration of a normal conformation for HLA-DR3 as detected by a monoclonal antibody, and by a reduction in class II-associated invariant chain peptides. The intracellular distribution of class II and invariant chain molecules is also restored to that of wild-type cells. The HLA DMA and HLA-DMB products appear to form a heterodimer that, although transported at least to the medial Golgi, is not expressed at the cell surface. These findings are consistent with HLA-DM functioning intracellularly to facilitate class II-restricted antigen processing.			DENZIN, LK (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,333 CEDAR ST,NEW HAVEN,CT 06520, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023081, R01AI023081] Funding Source: NIH RePORTER; NIAID NIH HHS [AI23081] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BERGER AE, 1982, HYBRIDOMA, V1, P87, DOI 10.1089/hyb.1.1982.1.87; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; CAMPBELL RD, 1993, IMMUNOL TODAY, V14, P349, DOI 10.1016/0167-5699(93)90234-C; CEMAN S, 1992, J IMMUNOL, V149, P754; CHAMBERS SP, 1988, GENE, V68, P139, DOI 10.1016/0378-1119(88)90606-3; CHERVONSKY AV, 1994, INT IMMUNOL, V6, P973, DOI 10.1093/intimm/6.7.973; CRESSWELL P, 1994, CURR BIOL, V4, P541, DOI 10.1016/S0960-9822(00)00119-6; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; ERLICH H, 1986, HUM IMMUNOL, V16, P205, DOI 10.1016/0198-8859(86)90049-2; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GUY K, 1982, EUR J IMMUNOL, V12, P942, DOI 10.1002/eji.1830121109; JOHNSON JP, 1982, J EXP MED, V156, P104, DOI 10.1084/jem.156.1.104; JONES PP, 1979, MOL IMMUNOL, V16, P51, DOI 10.1016/0161-5890(79)90027-0; KELLY AP, 1991, NATURE, V353, P571, DOI 10.1038/353571a0; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LAMPSON LA, 1980, J IMMUNOL, V125, P293; MACHAMER CE, 1982, J IMMUNOL, V129, P2564; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; MELLINS E, 1994, J EXP MED, V179, P541, DOI 10.1084/jem.179.2.541; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; NEWCOMB JR, 1993, J IMMUNOL, V151, P4153; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PORATH J, 1973, J CHROMATOGR, V86, P53, DOI 10.1016/S0021-9673(01)81233-4; QUI Y, 1994, J CELL BIOL, V125, P595, DOI DOI 10.1083/JCB.125.3.595; RIBERDY JM, 1992, J IMMUNOL, V148, P2586; RIBERDY JM, 1994, J CELL BIOL, V125, P1225, DOI 10.1083/jcb.125.6.1225; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; RIBERDY JM, 1992, THESIS DUKE U DURHAM; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; SETTE A, 1992, SCIENCE, V258, P1801, DOI 10.1126/science.1465617; SHACKELFORD DA, 1983, J IMMUNOL, V130, P274; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; YOSHIMURA FK, 1985, MOL CELL BIOL, V5, P2832, DOI 10.1128/MCB.5.10.2832	44	228	229	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1994	1	7					595	606		10.1016/1074-7613(94)90049-3	http://dx.doi.org/10.1016/1074-7613(94)90049-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PN127	7600288				2022-12-18	WOS:A1994PN12700008
J	Nicolas-Avila, JA; Adrover, JM; Hidalgo, A				Angel Nicolas-Avila, Jose; Adrover, Jose M.; Hidalgo, Andres			Neutrophils in Homeostasis, Immunity, and Cancer	IMMUNITY			English	Review							TUMOR-ASSOCIATED NEUTROPHILS; LOW-DENSITY GRANULOCYTES; T-CELL RESPONSES; EXTRACELLULAR TRAP FORMATION; MARGINAL ZONE; CORPUS-LUTEUM; HUMAN-ENDOMETRIUM; SUPPRESSOR-CELLS; SEX-HORMONES; BONE-MARROW	Neutrophils were among the first leukocytes described and visualized by early immunologists. Prominent effector functions during infection and sterile inflammation classically placed them low in the immune tree as rapid, mindless aggressors with poor regulatory functions. This view is currently under reassessment as we uncover new aspects of their life cycle and identify transcriptional and phenotypic diversity that endows them with regulatory properties that extend beyond their lifetime in the circulation. These properties are revealing unanticipated roles for neutrophils in supporting homeostasis, as well as complex disease states such as cancer. We focus this review on these emerging functions in order to define the true roles of neutrophils in homeostasis, immunity, and disease.	[Angel Nicolas-Avila, Jose; Adrover, Jose M.; Hidalgo, Andres] Ctr Nacl Invest Cardiovasc Carlos III, Area Cell & Dev Biol, Madrid 20829, Spain; [Hidalgo, Andres] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, D-80539 Munich, Germany	Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Munich	Hidalgo, A (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III, Area Cell & Dev Biol, Madrid 20829, Spain.; Hidalgo, A (corresponding author), Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, D-80539 Munich, Germany.	ahidalgo@cnic.es	Nicolás-Ávila, José Ángel/G-9098-2017; Hidalgo, Andrés/L-5643-2014; Nicolás-Ávila, José Ángel/AAD-6550-2020; Grieshaber-Bouyer, Ricardo/R-7512-2016; Adrover, Jose M/G-9741-2017	Nicolás-Ávila, José Ángel/0000-0002-8301-7216; Hidalgo, Andrés/0000-0001-5513-555X; Nicolás-Ávila, José Ángel/0000-0002-8301-7216; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Adrover, Jose M/0000-0002-1395-5477	MINECO [SAF2015-65607-R, SAF2013-49662-EXP, PCIN-2014-103, SVP-2014-068595, BES-2013-065550]; Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO) [SEV-2015-0505]	MINECO(Spanish Government); Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO)(Spanish Government)	We are grateful to the members of the Hidalgo laboratory for discussion and to L. Weiss, S. Wculek, and E. Gomez-Perdiguero for insightful comments and corrections. We acknowledge funding from MINECO (SAF2015-65607-R, SAF2013-49662-EXP and PCIN-2014-103 to A.H; SVP-2014-068595 to J.A.N.-A.; and BES-2013-065550 to J.M.A). The CNIC is supported by the MINECO and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505).	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Adrover JM, 2016, TRENDS IMMUNOL, V37, P334, DOI 10.1016/j.it.2016.03.005; Amsalem H, 2014, J IMMUNOL, V193, P3070, DOI 10.4049/jimmunol.1303117; Andzinski L, 2016, INT J CANCER, V138, P1982, DOI 10.1002/ijc.29945; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Baik SH, 2014, NEUROBIOL AGING, V35, P1286, DOI 10.1016/j.neurobiolaging.2014.01.003; Bank U, 2001, J LEUKOCYTE BIOL, V69, P197; Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; BRANNSTROM M, 1994, BIOL REPROD, V50, P1161, DOI 10.1095/biolreprod50.5.1161; BRANNSTROM M, 1994, FERTIL STERIL, V61, P488; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Buckley CD, 2006, J LEUKOCYTE BIOL, V79, P303, DOI 10.1189/jlb.0905496; Bugl S, 2013, BLOOD, V121, P723, DOI 10.1182/blood-2012-05-429589; Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876; Carmona-Rivera C, 2013, SEMIN IMMUNOPATHOL, V35, P455, DOI 10.1007/s00281-013-0375-7; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Chevre R, 2014, CIRC RES, V114, P770, DOI 10.1161/CIRCRESAHA.114.302590; Chorny A, 2016, J EXP MED, V213, P2167, DOI 10.1084/jem.20150282; Christoffersson G, 2012, BLOOD, V120, P4653, DOI 10.1182/blood-2012-04-421040; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cloke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048939; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Coller BS, 2005, ARTERIOSCL THROM VAS, V25, P658, DOI 10.1161/01.ATV.0000156877.94472.a5; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656; Deng YT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153567; Denny MF, 2007, BLOOD, V110, P2907, DOI 10.1182/blood-2007-05-089086; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Deryugina EI, 2014, NEOPLASIA, V16, P771, DOI 10.1016/j.neo.2014.08.013; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Ermert D, 2009, J INNATE IMMUN, V1, P181, DOI 10.1159/000205281; Eruslanov EB, 2014, J CLIN INVEST, V124, P5466, DOI 10.1172/JCI77053; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Finisguerra V, 2015, NATURE, V522, P349, DOI 10.1038/nature14407; Fletcher M, 2015, CANCER RES, V75, P275, DOI 10.1158/0008-5472.CAN-14-1491; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Fu J, 2014, ANN ALLERG ASTHMA IM, V113, P635, DOI 10.1016/j.anai.2014.08.024; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gargett CE, 2001, HUM REPROD, V16, P1065, DOI 10.1093/humrep/16.6.1065; GERRARD TL, 1981, J NATL CANCER I, V66, P483; Gonzalez-Teran B, 2016, EMBO J, V35, P536, DOI 10.15252/embj.201591857; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Grayson PC, 2015, ARTHRITIS RHEUMATOL, V67, P1922, DOI 10.1002/art.39153; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; HACBARTH E, 1986, ARTHRITIS RHEUM-US, V29, P1334, DOI 10.1002/art.1780291105; Hagglof T, 2016, NAT IMMUNOL, V17, P1407, DOI 10.1038/ni.3583; Hergott CB, 2016, BLOOD, V127, P2460, DOI 10.1182/blood-2015-10-675173; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Jablonska E, 2005, CYTOKINE, V30, P93, DOI 10.1016/j.cyto.2004.12.004; Jablonska J, 2014, INT J CANCER, V134, P1346, DOI 10.1002/ijc.28551; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Jaeger BN, 2012, J EXP MED, V209, P565, DOI 10.1084/jem.20111908; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Jiemtaweeboon S, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-79; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Kawano Y., 2016, BLOOD; Kay AB, 2016, MICROBIOL SPECTR, V4, DOI [DOI 10.1128/MICR0BI0LSPEC.MCHD-0032-2016, 10.1128/microbiolspec.MCHD-0032-2016]; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kidoya H, 2015, DEV CELL, V33, P247, DOI 10.1016/j.devcel.2015.02.024; KING A, 1989, HUM IMMUNOL, V24, P195, DOI 10.1016/0198-8859(89)90060-8; Klemke M, 2008, IMMUNITY, V29, P404, DOI 10.1016/j.immuni.2008.06.016; Knaapen AM, 2006, MUTAGENESIS, V21, P225, DOI 10.1093/mutage/gel032; Knight JS, 2014, CIRC RES, V114, P947, DOI 10.1161/CIRCRESAHA.114.303312; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Kropf P, 2007, EUR J IMMUNOL, V37, P935, DOI 10.1002/eji.200636542; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lasarte S, 2016, J INFECT DIS, V213, P476, DOI 10.1093/infdis/jiv402; Leliefeld PHC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00471; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Maletto BA, 2006, BLOOD, V108, P3094, DOI 10.1182/blood-2006-04-016659; Manfredi AA, 2015, CLIN EXP IMMUNOL, V179, P24, DOI 10.1111/cei.12320; Mangerich A, 2012, P NATL ACAD SCI USA, V109, pE1820, DOI 10.1073/pnas.1207829109; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; Massena S, 2015, BLOOD, V126, P2016, DOI 10.1182/blood-2015-03-631572; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Mishalian I, 2013, CANCER IMMUNOL IMMUN, V62, P1745, DOI 10.1007/s00262-013-1476-9; MORISAKI T, 1992, SURG TODAY, V22, P322, DOI 10.1007/BF00308740; Mougiakakos D, 2009, BLOOD, V113, P3542, DOI 10.1182/blood-2008-09-181040; Munder M, 2006, BLOOD, V108, P1627, DOI 10.1182/blood-2006-11-010389; Nagelkerke SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088377; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Nourshargh S, 2016, TRENDS IMMUNOL, V37, P273, DOI 10.1016/j.it.2016.03.006; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Parsa R, 2016, J EXP MED, V213, P1537, DOI 10.1084/jem.20150577; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; POROPATICH C, 1987, INT J GYNECOL PATHOL, V6, P230, DOI 10.1097/00004347-198709000-00004; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Rocha BC, 2015, CELL REP, V13, P2829, DOI 10.1016/j.celrep.2015.11.055; Rossi B, 2011, J LEUKOCYTE BIOL, V89, P539, DOI 10.1189/jlb.0710432; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Scapini P, 1999, J IMMUNOL METHODS, V232, P121, DOI 10.1016/S0022-1759(99)00170-2; Shen MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098259; Shirasuna K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029054; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Silvestre-Roig C, 2016, BLOOD, V127, P2173, DOI 10.1182/blood-2016-01-688887; Singhal S, 2016, CANCER CELL, V30, P120, DOI 10.1016/j.ccell.2016.06.001; Spicer JD, 2012, CANCER RES, V72, P3919, DOI 10.1158/0008-5472.CAN-11-2393; Spiegel A, 2016, CANCER DISCOV, V6, P630, DOI 10.1158/2159-8290.CD-15-1157; Ssemaganda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085696; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stephenson HN, 2016, CURR OPIN IMMUNOL, V38, P59, DOI 10.1016/j.coi.2015.11.004; Suttmann H, 2006, CANCER RES, V66, P8250, DOI 10.1158/0008-5472.CAN-06-1416; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Tessier DR, 2015, J REPROD IMMUNOL, V110, P89, DOI 10.1016/j.jri.2015.01.006; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Uhl B., 2016, BLOOD; Underhill DM, 2016, NAT REV IMMUNOL, V16, P651, DOI 10.1038/nri.2016.89; Valayer A., 2016, J LEUKOC BIOL; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Wantha S, 2013, CIRC RES, V112, P792, DOI 10.1161/CIRCRESAHA.112.300666; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Wu CF, 2015, INT J CANCER, V137, P837, DOI 10.1002/ijc.29444; Yan B, 2013, J IMMUNOL, V190, P5882, DOI 10.4049/jimmunol.1201881; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yoo SK, 2011, J LEUKOCYTE BIOL, V89, P661, DOI 10.1189/jlb.1010567; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Yu P. F., 2016, ONCOGENE; Zenaro E, 2015, NAT MED, V21, P880, DOI 10.1038/nm.3913; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367	150	227	236	7	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					15	28		10.1016/j.immuni.2016.12.012	http://dx.doi.org/10.1016/j.immuni.2016.12.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28099862	Green Accepted, Bronze			2022-12-18	WOS:000392918300007
J	Sade-Feldman, M; Kanterman, J; Ish-Shalom, E; Elnekave, M; Horwitz, E; Baniyash, M				Sade-Feldman, Moshe; Kanterman, Julia; Ish-Shalom, Eliran; Elnekave, Mazal; Horwitz, Elad; Baniyash, Michal			Tumor Necrosis Factor-alpha Blocks Differentiation and Enhances Suppressive Activity of Immature Myeloid Cells during Chronic Inflammation	IMMUNITY			English	Article							TNF-ALPHA; T-CELLS; DOWN-REGULATION; IMMUNE SUPPRESSION; KILLER-CELL; CANCER; PROGRESSION; IMMUNOSUPPRESSION; ACCUMULATION; RECRUITMENT	Elevated concentrations of tumor necrosis factor-a (TNF-alpha) are detected in pathologies characterized by chronic inflammation. Whether TNF-alpha plays a role in manipulating the host's immune system toward generating an immunosuppressive milieu, typical of ongoing chronic inflammation, is unclear. Here we showed that TNF-alpha exhibited a dual function during chronic inflammation: arresting differentiation of immature myeloid-derived suppressor cells (MDSCs) primarily via the S100A8 and S100A9 inflammatory proteins and their corresponding receptor (RAGE) and augmenting MDSC suppressive activity. These functions led to in vivo T and NK cell dysfunction accompanied by T cell antigen receptor zeta chain downregulation. Furthermore, administration of etanercept (TNF-alpha antagonist) during early chronic inflammatory stages reduced MDSCs' suppressive activity and enhanced their maturation into dendritic cells and macrophages, resulting in the restoration of in vivo immune functions and recovery of zeta chain expression. Thus, TNF has a fundamental role in promoting an immunosuppressive environment generated during chronic inflammation.	[Sade-Feldman, Moshe; Kanterman, Julia; Ish-Shalom, Eliran; Horwitz, Elad; Baniyash, Michal] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel; [Elnekave, Mazal] Hebrew Univ Jerusalem, Hadassah Med Sch, Sch Dent Med, Inst Dent Sci, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Baniyash, M (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel.	baniyash@cc.huji.ac.il		Baniyash, Michal/0000-0002-1579-3192	Society of Research Associates of the Lautenberg Center; Concern Foundation of Los Angeles; Harold B. Abramson Chair in Immunology; Israel Science Foundation (ISF); Israeli Ministry of Health; Joint German-Israeli Research Program (DKFZ-MOST); Israel Cancer Research Fund (ICRF); United States-Israel Binational Science Foundation (BSF); Joseph and Matilda Melnick Funds	Society of Research Associates of the Lautenberg Center; Concern Foundation of Los Angeles; Harold B. Abramson Chair in Immunology; Israel Science Foundation (ISF)(Israel Science Foundation); Israeli Ministry of Health; Joint German-Israeli Research Program (DKFZ-MOST); Israel Cancer Research Fund (ICRF); United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Joseph and Matilda Melnick Funds	We gratefully acknowledge the support of the Society of Research Associates of the Lautenberg Center, the Concern Foundation of Los Angeles, and the Harold B. Abramson Chair in Immunology. We thank I. Vaknin for his help and advice. This study was supported by the Israel Science Foundation (ISF), the Israeli Ministry of Health, the Joint German-Israeli Research Program (DKFZ-MOST), the Israel Cancer Research Fund (ICRF), the United States-Israel Binational Science Foundation (BSF), and the Joseph and Matilda Melnick Funds.	Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Baniyash M, 2006, SEMIN CANCER BIOL, V16, P80, DOI 10.1016/j.semcancer.2005.12.002; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Binder C, 1999, LAB INVEST, V79, P1703; Bronstein-Sitton N, 2003, NAT IMMUNOL, V4, P957, DOI 10.1038/ni975; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Dietlin TA, 2007, J LEUKOCYTE BIOL, V81, P1205, DOI 10.1189/jlb.1006640; Elnekave M, 2010, J IMMUNOL, V185, P3463, DOI 10.4049/jimmunol.1001825; Ezernitchi AV, 2006, J IMMUNOL, V177, P4763, DOI 10.4049/jimmunol.177.7.4763; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Friedberg J, 2008, LEUKEMIA LYMPHOMA, V49, P902, DOI 10.1080/10428190801950033; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gao X, 2007, ARTERIOSCL THROM VAS, V27, P1269, DOI 10.1161/ATVBAHA.107.142521; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Goffe B, 2003, J AM ACAD DERMATOL, V49, pS105, DOI 10.1016/mjd.2003.554; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huye LE, 2010, DISCOV MED, V9, P297; Kanterman J, 2012, SEMIN CANCER BIOL, V22, P307, DOI 10.1016/j.semcancer.2012.02.008; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; Kusmartsev S, 2008, J IMMUNOL, V181, P346, DOI 10.4049/jimmunol.181.1.346; Mao HW, 2010, J VIROL, V84, P4148, DOI 10.1128/JVI.02340-09; Nagar M, 2010, J IMMUNOL, V184, P3570, DOI 10.4049/jimmunol.0902070; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Oberg L, 2004, EUR J IMMUNOL, V34, P1646, DOI 10.1002/eji.200424913; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pfeffer K, 2003, CYTOKINE GROWTH F R, V14, P185, DOI 10.1016/S1359-6101(03)00022-4; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Scott DL, 2005, INT J CLIN PRACT, V59, P114, DOI 10.1111/j.1742-1241.2005.00380.x; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Sutlu T, 2009, J INTERN MED, V266, P154, DOI 10.1111/j.1365-2796.2009.02121.x; Vaknin I, 2008, BLOOD, V111, P1437, DOI 10.1182/blood-2007-07-100404; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wilson JAP, 2008, NEW ENGL J MED, V358, P2733, DOI 10.1056/NEJMcibr0803116; Xu K, 2000, J IMMUNOL, V164, P4916, DOI 10.4049/jimmunol.164.9.4916; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yen T, 1997, BLOOD, V90, P4812, DOI 10.1182/blood.V90.12.4812.4812_4812_4821; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	48	227	239	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					541	554		10.1016/j.immuni.2013.02.007	http://dx.doi.org/10.1016/j.immuni.2013.02.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23477736	Bronze			2022-12-18	WOS:000330941500018
J	Siffrin, V; Radbruch, H; Glumm, R; Niesner, R; Paterka, M; Herz, J; Leuenberger, T; Lehmann, SM; Luenstedt, S; Rinnenthal, JL; Laube, G; Luche, H; Lehnardt, S; Fehling, HJ; Griesbeck, O; Zipp, F				Siffrin, Volker; Radbruch, Helena; Glumm, Robert; Niesner, Raluca; Paterka, Magdalena; Herz, Josephine; Leuenberger, Tina; Lehmann, Sabrina M.; Luenstedt, Sarah; Rinnenthal, Jan Leo; Laube, Gregor; Luche, Herve; Lehnardt, Seija; Fehling, Hans-Joerg; Griesbeck, Oliver; Zipp, Frauke			In Vivo Imaging of Partially Reversible Th17 Cell-Induced Neuronal Dysfunction in the Course of Encephalomyelitis	IMMUNITY			English	Article							MULTIPLE-SCLEROSIS LESIONS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SPINAL-CORD AXONS; T-CELLS; RECEPTOR EXPRESSION; TRANSGENIC MICE; DAMAGE; MODEL; BRAIN; DISEASE	Neuronal damage in autoimmune neuroinflammation is the correlate for long-term disability in multiple sclerosis (MS) patients. Here, we investigated the role of immune cells in neuronal damage processes in animal models of MS by monitoring experimental autoimmune encephalomyelitis (EAE) by using two-photon microscopy of living anaesthetized mice. In the brainstem, we detected sustained interaction between immune and neuronal cells, particularly during disease peak. Direct interaction of myelin oligodendrocyte glycoprotein (MOG)-specific Th17 and neuronal cells in demyelinating lesions was associated with extensive axonal damage. By combining confocal, electron, and intravital microscopy, we showed that these contacts remarkably resembled immune synapses or kinapses, albeit with the absence of potential T cell receptor engagement. Th17 cells induced severe, localized, and partially reversible fluctuation in neuronal intracellular Ca2+ concentration as an early sign of neuronal damage. These results highlight the central role of the Th17 cell effector phenotype for neuronal dysfunction in chronic neuroinflammation.	[Siffrin, Volker; Zipp, Frauke] Johannes Gutenberg Univ Mainz, Univ Med Ctr Mainz, Dept Neurol, D-55131 Mainz, Germany; [Siffrin, Volker; Radbruch, Helena; Glumm, Robert; Niesner, Raluca; Paterka, Magdalena; Herz, Josephine; Leuenberger, Tina; Luenstedt, Sarah; Rinnenthal, Jan Leo; Zipp, Frauke] Max Delbruck Ctr Mol Med Berlin Buch, D-13125 Berlin, Germany; [Radbruch, Helena; Glumm, Robert; Niesner, Raluca; Herz, Josephine; Luenstedt, Sarah] Charite Univ Med Ctr Berlin, D-10117 Berlin, Germany; [Lehmann, Sabrina M.; Laube, Gregor; Lehnardt, Seija] Charite, Inst Cell Biol & Neurobiol, D-10117 Berlin, Germany; [Luche, Herve; Fehling, Hans-Joerg] Univ Clin Ulm, Inst Immunol, D-89081 Ulm, Germany; [Griesbeck, Oliver] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Johannes Gutenberg University of Mainz; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ulm University; Max Planck Society	Zipp, F (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr Mainz, Dept Neurol, D-55131 Mainz, Germany.	siffrinv@gmx.de; frauke.zipp@unimedizin-mainz.de	Zipp, Frauke/C-9968-2015; Lehnardt, Seija/AAA-4113-2022; Siffrin, Volker/AAR-3632-2021; LUCHE, Herve/GLT-1401-2022	Zipp, Frauke/0000-0002-1231-1928; Radbruch, Helena/0000-0001-6941-3397; Siffrin, Volker/0000-0002-1532-2868; LUCHE, Herve/0000-0003-4309-8338; Griesbeck, Oliver/0000-0001-5883-5594	German Research Foundation (DFG) [GRK1258, SFB-TRR43, NI 1167/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	We thank N. Asselborn, T. Hohnstein, and R. Gunther for expert technical support. Furthermore, we thank S. Krakau for developing the contact evaluation software. Finally, we thank L. Mann and S. Duke for reading the manuscript as native speakers. This work was supported by the German Research Foundation (DFG) as follows: GRK1258 to J.H., T.L.; SFB-TRR43 to F.Z.; and NI 1167/2-1 to R.N.	Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Bannerman PG, 2005, BRAIN, V128, P1877, DOI 10.1093/brain/awh550; Basso AS, 2008, J CLIN INVEST, V118, P1532, DOI 10.1172/JCI33464; BERKE G, 1995, CELL, V81, P9, DOI 10.1016/0092-8674(95)90365-8; Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO;2-2; Bolton C, 1997, J PHARMACOL EXP THER, V282, P397; Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; LAMPSON LA, 1986, J IMMUNOL, V136, P4054; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lo AC, 2003, J NEUROPHYSIOL, V90, P3566, DOI 10.1152/jn.00434.2003; McKinney RA, 1999, P NATL ACAD SCI USA, V96, P11631, DOI 10.1073/pnas.96.20.11631; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Newcombe J, 2008, BRAIN PATHOL, V18, P52, DOI 10.1111/j.1750-3639.2007.00101.x; Nitsch R, 2004, J NEUROSCI, V24, P2458, DOI 10.1523/JNEUROSCI.4703-03.2004; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P18625, DOI 10.1073/pnas.0705033104; Ouardouz M, 2009, ANN NEUROL, V65, P151, DOI 10.1002/ana.21533; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Reynolds AD, 2010, J IMMUNOL, V184, P2261, DOI 10.4049/jimmunol.0901852; SCHLAEPFER WW, 1985, ANN NY ACAD SCI, V455, P552, DOI 10.1111/j.1749-6632.1985.tb50435.x; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Siffrin V, 2010, TRENDS NEUROSCI, V33, P202, DOI 10.1016/j.tins.2010.01.002; Siffrin V, 2009, BRAIN, V132, P1247, DOI 10.1093/brain/awn354; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; Wang DD, 2009, J NEUROIMMUNOL, V212, P17, DOI 10.1016/j.jneuroim.2009.04.007; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	43	227	235	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 24	2010	33	3					424	436		10.1016/j.immuni.2010.08.018	http://dx.doi.org/10.1016/j.immuni.2010.08.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20870176	Bronze			2022-12-18	WOS:000282798500016
J	Wei, L; Vahedi, G; Sun, HW; Watford, WT; Takatori, H; Ramos, HL; Takahashi, H; Liang, J; Gutierrez-Cruz, G; Zang, CZ; Peng, WQ; O'Shea, JJ; Kanno, Y				Wei, Lai; Vahedi, Golnaz; Sun, Hong-Wei; Watford, Wendy T.; Takatori, Hiroaki; Ramos, Haydee L.; Takahashi, Hayato; Liang, Jonathan; Gutierrez-Cruz, Gustavo; Zang, Chongzhi; Peng, Weiqun; O'Shea, John J.; Kanno, Yuka			Discrete Roles of STAT4 and STAT6 Transcription Factors in Tuning Epigenetic Modifications and Transcription during T Helper Cell Differentiation	IMMUNITY			English	Article							CHIP-SEQ DATA; GENOME-WIDE IDENTIFICATION; TARGET GENES; HISTONE MODIFICATIONS; FATE DETERMINATION; INTERFERON-GAMMA; BINDING-SITES; FACTOR GATA-3; DNA-BINDING; EXPRESSION	Signal transducer and activator of transcription 4 (STAT4) and STAT6 are key factors in the specification of helper T cells; however, their direct roles in driving differentiation are not well understood. Using chromatin immunoprecipitation and massive parallel sequencing, we quantitated the full complement of STAT-bound genes, concurrently assessing global STAT-dependent epigenetic modifications and gene transcription by using cells from cognate STAT-deficient mice. STAT4 and STAT6 each bound over 4000 genes with distinct binding motifs. Both played critical roles in maintaining chromatin configuration and transcription of a core subset of genes through the combination of different epigenetic patterns. Globally, STAT4 had a more dominant role in promoting active epigenetic marks, whereas STAT6 had a more prominent role in antagonizing repressive marks. Clusters of genes negatively regulated by STATs were also identified, highlighting previously unappreciated repressive roles of STATs. Therefore, STAT4 and STAT6 play wide regulatory roles in T helper cell specification.	[Wei, Lai; Vahedi, Golnaz; Watford, Wendy T.; Takatori, Hiroaki; Ramos, Haydee L.; Takahashi, Hayato; Liang, Jonathan; O'Shea, John J.; Kanno, Yuka] NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMS, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Gutierrez-Cruz, Gustavo] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Zang, Chongzhi; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); George Washington University	Kanno, Y (corresponding author), NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	kannoy@mail.nih.gov	Zang, Chongzhi/D-1445-2011; /AAI-2516-2019; Wei, Lai/D-1088-2014; Kanno, Yuka/B-5802-2013; cheng, yong/I-4270-2012	Zang, Chongzhi/0000-0003-4812-3627; Kanno, Yuka/0000-0001-5668-9319; Peng, Weiqun/0000-0001-5521-9091; Takatori, Hiroaki/0000-0003-0539-5040; Watford, Wendy/0000-0003-4261-5399	NIAMS; Grants-in-Aid for Scientific Research [22790925] Funding Source: KAKEN; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZICAR041181] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank K. Zhao, J. Bream, and V. Sartorelli for critical reading of the manuscript, W. Resch for help in data analysis, and J. Simone for technical help with cell sorting. This research was supported by the Intramural Research Programs of NIAMS.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Chen Z, 2003, J IMMUNOL, V171, P3627, DOI 10.4049/jimmunol.171.7.3627; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Gonzalo JA, 2007, J IMMUNOL, V179, P1740, DOI 10.4049/jimmunol.179.3.1740; Good SR, 2009, J IMMUNOL, V183, P3839, DOI 10.4049/jimmunol.0901411; Hirahara K, 2008, J ALLERGY CLIN IMMUN, V122, P512, DOI 10.1016/j.jaci.2008.06.004; Hoey T, 2003, EMBO J, V22, P4237, DOI 10.1093/emboj/cdg393; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; Kusunoki T, 2003, J ALLERGY CLIN IMMUN, V111, P136, DOI 10.1067/mai.2003.29; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Letimier FA, 2007, EMBO J, V26, P1292, DOI 10.1038/sj.emboj.7601586; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lund RJ, 2007, J IMMUNOL, V178, P3648, DOI 10.4049/jimmunol.178.6.3648; Lund RJ, 2004, J IMMUNOL, V172, P6775, DOI 10.4049/jimmunol.172.11.6775; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; O'Sullivan A, 2004, J BIOL CHEM, V279, P7339, DOI 10.1074/jbc.M309979200; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Pesu M, 2006, BLOOD, V108, P983, DOI 10.1182/blood-2005-09-3824; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Schaefer G, 2001, J IMMUNOL, V166, P5859, DOI 10.4049/jimmunol.166.10.5859; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wang M, 2005, IMMUNOLOGY, V114, P166, DOI 10.1111/j.1365-2567.2005.02094.x; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wirnsberger G, 2006, EUR J IMMUNOL, V36, P1882, DOI 10.1002/eji.200635972; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang Y, 2007, BLOOD, V110, P2494, DOI 10.1182/blood-2006-11-058271; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Yu Q, 2007, EMBO J, V26, P2052, DOI 10.1038/sj.emboj.7601653; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang FP, 2006, J EXP MED, V203, P1493, DOI 10.1084/jem.20060066; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	61	227	234	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 25	2010	32	6					840	851		10.1016/j.immuni.2010.06.003	http://dx.doi.org/10.1016/j.immuni.2010.06.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20620946	Green Accepted, Bronze			2022-12-18	WOS:000279365800014
J	Treanor, B; Depoil, D; Gonzalez-Granja, A; Barral, P; Weber, M; Dushek, O; Bruckbauer, A; Batista, FD				Treanor, Bebhinn; Depoil, David; Gonzalez-Granja, Aitor; Barral, Patricia; Weber, Michele; Dushek, Omer; Bruckbauer, Andreas; Batista, Facundo D.			The Membrane Skeleton Controls Diffusion Dynamics and Signaling through the B Cell Receptor	IMMUNITY			English	Article							SINGLE-PARTICLE TRACKING; UNDERGO HOP DIFFUSION; ANTIGEN RECEPTOR; PLASMA-MEMBRANE; LATERAL DIFFUSION; SYNAPSE FORMATION; CLASS-II; TRANSLATIONAL DIFFUSION; PHOSPHOLIPASE C-GAMMA-2; SURFACE-IMMUNOGLOBULIN	Early events of B cell activation after B cell receptor (BCR) triggering have been well characterized. However, little is known about the steady state of the BCR on the cell surface. Here, we simultaneously visualize single BCR particles and components of the membrane skeleton. We show that an ezrin- and actin-defined network influenced steady-state BCR diffusion by creating boundaries that restrict BCR diffusion. We identified the intracellular domain of Ig beta as important in mediating this restriction in diffusion. Importantly, alteration of this network was sufficient to induce robust intracellular signaling and concomitant increase in BCR mobility. Moreover, by using B cells deficient in key signaling molecules, we show that this signaling was most probably initiated by the BCR. Thus, our results suggest the membrane skeleton plays a crucial function in controlling BCR dynamics and thereby signaling, in a way that could be important for understanding tonic signaling necessary for B cell development and survival.	[Treanor, Bebhinn; Depoil, David; Gonzalez-Granja, Aitor; Barral, Patricia; Weber, Michele; Bruckbauer, Andreas; Batista, Facundo D.] Canc Res UK, London Res Inst, Lymphocyte Interact Lab, London WC2A 3PX, England; [Dushek, Omer] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Dushek, Omer] Univ Oxford, Ctr Math Biol, Oxford OX1 3RE, England	Cancer Research UK; University of Oxford; University of Oxford	Batista, FD (corresponding author), Canc Res UK, London Res Inst, Lymphocyte Interact Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	facundo.batista@cancer.org.uk	Granja, Aitor/K-8102-2014; Bruckbauer, Andreas/A-9598-2008	Bruckbauer, Andreas/0000-0003-1419-9674; Barral, Patricia/0000-0003-4324-8973; Weber, Michele/0000-0003-2056-3751	Cancer Research UK; Royal Society Wolfson Research Merit Award; National Science and Engineering Research Council of Canada; Mathematics in Technology and Complex Systems National Centre of Excellence, Canada	Cancer Research UK(Cancer Research UK); Royal Society Wolfson Research Merit Award(Royal Society of London); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mathematics in Technology and Complex Systems National Centre of Excellence, Canada	We thank T. Kurosaki for PLC gamma 2-deficient mice and M. Turner for Vav1 and 2 double-deficient mice. The authors would like to thank D. Coombs and R. Das for helpful discussions on single-particle analysis. We would also like to thank P. Mattila, N.E. Harwood, and E. Sahai for critically reading the manuscript and for helpful comments. This work was supported by Cancer Research UK and the Royal Society Wolfson Research Merit Award (F.D.B.). O.D. was supported by funding from National Science and Engineering Research Council of Canada and the Mathematics in Technology and Complex Systems National Centre of Excellence, Canada.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Aluvihare VR, 1997, EMBO J, V16, P3553, DOI 10.1093/emboj/16.12.3553; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; BAEKER TR, 1987, J IMMUNOL, V138, P2691; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; BOBROFF N, 1986, REV SCI INSTRUM, V57, P1152, DOI 10.1063/1.1138619; BRAUN J, 1982, J IMMUNOL, V128, P1198; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Carter RH, 1997, J IMMUNOL, V158, P3062; Charrier C, 2006, J NEUROSCI, V26, P8502, DOI 10.1523/JNEUROSCI.1758-06.2006; Chaturvedi A, 2002, NAT IMMUNOL, V3, P951, DOI 10.1038/ni839; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; EDIDIN M, 1994, P NATL ACAD SCI USA, V91, P3378, DOI 10.1073/pnas.91.8.3378; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Hao SL, 2005, MOL BIOL CELL, V16, P2275, DOI 10.1091/mbc.e04-10-0881; HARTWIG JH, 1995, J IMMUNOL, V155, P3769; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Okkenhaug K, 2002, SCIENCE, V297, P1031; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Reth M, 2000, IMMUNOL REV, V176, P10; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; SAXTON MJ, 1995, BIOPHYS J, V69, P389, DOI 10.1016/S0006-3495(95)79911-8; SAXTON MJ, 1993, BIOPHYS J, V64, P1766, DOI 10.1016/S0006-3495(93)81548-0; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; SHEETZ MP, 1983, SEMIN HEMATOL, V20, P175; SHEETZ MP, 1980, NATURE, V285, P510, DOI 10.1038/285510a0; Shinohara Hisaaki, 2006, Subcell Biochem, V40, P145; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Tang Q, 2003, BIOPHYS J, V84, P400, DOI 10.1016/S0006-3495(03)74860-7; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; TSUJI A, 1986, BIOCHEMISTRY-US, V25, P6133, DOI 10.1021/bi00368a045; Umemura YM, 2008, BIOPHYS J, V95, P435, DOI 10.1529/biophysj.107.123018; VRIJIC M, 2005, BIOPHYS J, V88, P334; Vrljic M, 2002, BIOPHYS J, V83, P2681, DOI 10.1016/S0006-3495(02)75277-6; WADE WF, 1989, J CELL BIOL, V109, P3325, DOI 10.1083/jcb.109.6.3325; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; WIENANDS J, 1992, NATURE, V356, P246, DOI 10.1038/356246a0; WILLIAMS GT, 1994, P NATL ACAD SCI USA, V91, P474, DOI 10.1073/pnas.91.2.474; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Zhou HX, 2009, J PHYS CHEM B, V113, P7995, DOI 10.1021/jp8107446	68	227	233	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					187	199		10.1016/j.immuni.2009.12.005	http://dx.doi.org/10.1016/j.immuni.2009.12.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20171124	Green Published, hybrid			2022-12-18	WOS:000275346000009
J	Sun, ZYJ; Oh, KJ; Kim, MY; Yu, J; Brusic, V; Song, LK; Qiao, ZS; Wang, JH; Wagner, G; Reinherz, EL				Sun, Zhen-Yu J.; Oh, Kyoung Joon; Kim, Milkyung; Yu, Jessica; Brusic, Vladimir; Song, Likai; Qiao, Zhisong; Wang, Jia-Huai; Wagner, Gerhard; Reinherz, Ellis L.			HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane	IMMUNITY			English	Article							PROXIMAL EXTERNAL REGION; VIRUS; GLYCOPROTEIN; 4E10; NMR; 2F5; TRYPTOPHAN; FUSION; IMMUNOGENICITY; CONFORMATION	Although rarely elicited during natural human infection, the most broadly neutralizing antibodies (BNAbs) against diverse human immunodeficiency virus (HIV)-1 strains target the membrane-proximal ectodomain region (MPER) of viral gp41. To gain insight into MPER antigenicity, immunogenicity, and viral function, we studied its structure in the lipid environment by a combination of nuclear magnetic resonance (NMR), electron paramagnetic resonance (EPR), and surface plasmon resonance (SPR) techniques. The analyses revealed a tilted N-terminal alpha helix (aa 664-672) connected via a short hinge to a flat C-terminal helical segment (675-683). This metastable L-shaped structure is immersed in viral membrane and, therefore, less accessible to immune attack. Nonetheless, the 4E10 BNAb extracts buried W672 and F673 after initial encounter with the surface-embedded MPER. The data suggest how BNAbs may perturb tryptophan residue-associated viral fusion involving the mobile N-terminal MPER segment and, given conservation of MPER sequences in HIV-1, HIV-2, and SIV, have important implications for structure-guided vaccine design.	[Oh, Kyoung Joon; Kim, Milkyung; Brusic, Vladimir; Song, Likai; Qiao, Zhisong; Reinherz, Ellis L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Sun, Zhen-Yu J.; Wang, Jia-Huai; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wang, Jia-Huai] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Oh, Kyoung Joon; Brusic, Vladimir; Song, Likai; Reinherz, Ellis L.] Harvard Univ, Sch Med, Canc Vaccine Ctr, Boston, MA 02115 USA; [Kim, Milkyung; Yu, Jessica; Qiao, Zhisong; Wang, Jia-Huai; Reinherz, Ellis L.] Harvard Univ, Sch Med, Immunol Lab, Boston, MA 02115 USA; [Kim, Milkyung; Yu, Jessica; Qiao, Zhisong; Wang, Jia-Huai; Reinherz, Ellis L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Reinherz, EL (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu	Brusic, Vladimir/B-1478-2008	Brusic, Vladimir/0000-0003-0523-5266; OH, KYOUNG JOON/0000-0002-4729-9674	NIAID NIH HHS [P30 AI060354, AI43649] Funding Source: Medline; NIGMS NIH HHS [GM47467] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, P01AI043649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P841; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chou JJ, 2002, J AM CHEM SOC, V124, P2450, DOI 10.1021/ja017875d; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dimitrov AS, 2007, BIOCHEMISTRY-US, V46, P1398, DOI 10.1021/bi062245f; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; FARAHBAKHSH ZT, 1992, PHOTOCHEM PHOTOBIOL, V56, P1019, DOI 10.1111/j.1751-1097.1992.tb09725.x; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hollis T, 2000, EMBO J, V19, P758, DOI 10.1093/emboj/19.4.758; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Ihaka Ross., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.1080/10618600.1996.10474713, 10.2307/1390807]; KELLER RLJ, 2004, COMPUTER RESONANCE A; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Law M, 2007, J VIROL, V81, P4272, DOI 10.1128/JVI.02536-06; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lorizate M, 2006, J BIOL CHEM, V281, P39598, DOI 10.1074/jbc.M605998200; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Oh KJ, 2000, METH MOL B, V145, P147; Pervushin K, 2000, Q REV BIOPHYS, V33, P161, DOI 10.1017/S0033583500003619; Popova AV, 2002, BBA-BIOMEMBRANES, V1561, P109, DOI 10.1016/S0005-2736(01)00462-X; Qiao ZS, 2005, J BIOL CHEM, V280, P23138, DOI 10.1074/jbc.M414515200; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; SHIN YK, 1992, BIOPHYS J, V61, P1443, DOI 10.1016/S0006-3495(92)81950-1; Suarez T, 2000, FEBS LETT, V477, P145, DOI 10.1016/S0014-5793(00)01785-3; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005	51	227	241	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2008	28	1					52	63		10.1016/j.immuni.2007.11.018	http://dx.doi.org/10.1016/j.immuni.2007.11.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18191596	Bronze			2022-12-18	WOS:000252627300010
J	Sale, JE; Neuberger, MS				Sale, JE; Neuberger, MS			TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line	IMMUNITY			English	Article							SHOWS SOMATIC HYPERMUTATION; CHAIN VARIABLE REGION; FOLLICULAR LYMPHOMA; ANTIGEN SELECTION; BURKITTS-LYMPHOMA; INTRACLONAL HETEROGENEITY; GENE HYPERMUTATION; ANTIBODY DIVERSITY; CLONAL EVOLUTION; STRAND BREAKS	Searching for an in vitro model for somatic hypermutation, we have identified an IgM-expressing Burkitt lymphoma line that constitutively diversifies its immunoglobulin V domain at high rate during culture. As in in vivo, the mutations are largely nucleotide substitutions with the pattern of substitutions revealing a component of the human hypermutation program that is preferentially targeted to G/C residues. The substitutions frequently create stop codons with IgM-loss variants also being generated by V domain-specific deletions and duplications. However, in transfectants expressing terminal deoxynucleotidyl transferase, many IgM-loss variants additionally arise through short nontemplated nucleotide insertions into the V (but not C) domain. Thus, antibody hypermutation is likely accompanied by DNA strand breaks scattered within the mutation domain.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Neuberger, MS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	msn@mrc-lmb.cam.ac.uk		Sale, Julian/0000-0002-5031-3780				ADETUGBO K, 1977, NATURE, V265, P299, DOI 10.1038/265299a0; ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; Bachl J, 1996, P NATL ACAD SCI USA, V93, P851, DOI 10.1073/pnas.93.2.851; BAHLER DW, 1992, P NATL ACAD SCI USA, V89, P6770, DOI 10.1073/pnas.89.15.6770; BEREK C, 1988, IMMUNOL REV, V105, P5, DOI 10.1111/j.1600-065X.1988.tb00763.x; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Braeuninger A, 1997, P NATL ACAD SCI USA, V94, P9337, DOI 10.1073/pnas.94.17.9337; BRUGGEMANN M, 1982, EMBO J, V1, P629, DOI 10.1002/j.1460-2075.1982.tb01219.x; CAPIZZI RL, 1973, MUTAT RES, V17, P147, DOI 10.1016/0027-5107(73)90265-0; CHAPMAN CJ, 1995, BLOOD, V85, P2176, DOI 10.1182/blood.V85.8.2176.bloodjournal8582176; Chapman CJ, 1996, BLOOD, V88, P3562, DOI 10.1182/blood.V88.9.3562.bloodjournal8893562; CHUI YL, 1995, J MOL BIOL, V249, P555, DOI 10.1006/jmbi.1995.0318; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9667; COFFINO P, 1971, P NATL ACAD SCI USA, V68, P219, DOI 10.1073/pnas.68.1.219; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; Diaz M, 1998, IMMUNOL REV, V162, P13, DOI 10.1111/j.1600-065X.1998.tb01425.x; Frey S, 1998, IMMUNITY, V9, P127, DOI 10.1016/S1074-7613(00)80594-4; GIUSTI AM, 1992, P NATL ACAD SCI USA, V89, P10321, DOI 10.1073/pnas.89.21.10321; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Green NS, 1998, IMMUNOL REV, V162, P77, DOI 10.1111/j.1600-065X.1998.tb01431.x; Hsu E, 1998, IMMUNOL REV, V162, P25, DOI 10.1111/j.1600-065X.1998.tb01426.x; Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735; JAIN R, 1994, J IMMUNOL, V153, P45; Jolly C J, 1996, Semin Immunol, V8, P159, DOI 10.1006/smim.1996.0020; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; KIM S, 1981, CELL, V27, P573, DOI 10.1016/0092-8674(81)90399-8; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Kong QZ, 1998, IMMUNOL REV, V162, P67, DOI 10.1111/j.1600-065X.1998.tb01430.x; Kosmas C, 1996, BRIT J HAEMATOL, V94, P306, DOI 10.1046/j.1365-2141.1996.d01-1815.x; Lo AKF, 1997, ANN NY ACAD SCI, V815, P432, DOI 10.1111/j.1749-6632.1997.tb52095.x; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; Parham P., 1998, IMMUNOL REV, V162; PHILLIPS JW, 1994, MOL CELL BIOL, V14, P5794, DOI 10.1128/MCB.14.9.5794; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; RATECH H, 1992, BIOCHEM BIOPH RES CO, V182, P1260, DOI 10.1016/0006-291X(92)91867-P; Reynaud C A, 1996, Semin Immunol, V8, P125, DOI 10.1006/smim.1996.0016; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; TOMLINSON IM, 1997, V BASE DATABASE HUMA; WABL M, 1985, P NATL ACAD SCI USA, V82, P479, DOI 10.1073/pnas.82.2.479; Wagner SD, 1996, INT IMMUNOL, V8, P701, DOI 10.1093/intimm/8.5.701; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Weill JC, 1996, IMMUNOL TODAY, V17, P92, DOI 10.1016/0167-5699(96)80586-X; WILSON M, 1992, EMBO J, V11, P4337, DOI 10.1002/j.1460-2075.1992.tb05533.x; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Winter DB, 1998, IMMUNOL REV, V162, P89, DOI 10.1111/j.1600-065X.1998.tb01432.x; Wu HY, 1995, EUR J IMMUNOL, V25, P3263, DOI 10.1002/eji.1830251210; WU HY, 1995, SCAND J IMMUNOL, V42, P52, DOI 10.1111/j.1365-3083.1995.tb03625.x; Zheng B, 1998, IMMUNOL REV, V162, P133, DOI 10.1111/j.1600-065X.1998.tb01436.x; ZHU MH, 1995, P NATL ACAD SCI USA, V92, P2810, DOI 10.1073/pnas.92.7.2810	54	227	237	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1998	9	6					859	869		10.1016/S1074-7613(00)80651-2	http://dx.doi.org/10.1016/S1074-7613(00)80651-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881976	Bronze			2022-12-18	WOS:000077836600011
J	SCHINDLER, U; WU, PG; ROTHE, M; BRASSEUR, M; MCKNIGHT, SL				SCHINDLER, U; WU, PG; ROTHE, M; BRASSEUR, M; MCKNIGHT, SL			COMPONENTS OF A STAT RECOGNITION CODE - EVIDENCE FOR 2 LAYERS OF MOLECULAR SELECTIVITY	IMMUNITY			English	Article							SIGNAL-TRANSDUCTION; FUNCTIONAL-ANALYSIS; RESPONSE ELEMENTS; BINDING; PROTEIN; ACTIVATION; INTERLEUKIN-4; PREFERENCES; EXPRESSION; PROMOTER	Latent and activated forms of Stat1 and Stat6 have been expressed and purified, enabling biochemical experiments relating to their functional activities. Stat1 bound to a phosphotyrosine peptide derived from the IFN gamma receptor with a K-D of 50 nM, whereas State bound to an IL-4 receptor peptide with a K-D Of 300 nM. Stat-receptor peptide interactions were specific and dependent upon tyrosine phosphorylation. Activated forms of Stat1 and Stat6 were used to select their optimal DNA binding sites. Stat1 selected a recognition site having dyad half-sites separated by 3 bp. Stat6 selected a recognition site composed of the same dyad half-sites, yet separated by 4 bp. Chimeric Stat1-Stat6 recombinants were expressed, purified, and assayed for receptor coupling and DNA binding specificity. Such studies led to the identification of polypeptide domains that specify these activities. These observations provide a framework for understanding how different cytokines elicit distinctive patterns of gene expression.			SCHINDLER, U (corresponding author), TULARIK INC,270 E GRAND AVE,S SAN FRANCISCO,CA 94080, USA.							BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BRISCOE J, 1994, CURR BIOL, V4, P1033, DOI 10.1016/S0960-9822(00)00236-0; Dandliker W B, 1981, Methods Enzymol, V74 Pt C, P3; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DELPHIN S, 1995, J EXP MED, V181, P181, DOI 10.1084/jem.181.1.181; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; GREENLUND AC, 1995, IMMUNITY, V2; HARPUR AG, 1992, ONCOGENE, V7, P1347; HEIDIN CH, 1995, CELL, V80, P213; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; ROTHMAN P, 1990, MOL CELL BIOL, V10, P1672, DOI 10.1128/MCB.10.4.1672; SAD S, 1994, J IMMUNOL, V153, P3514; Sambrook J., 1989, MOL CLONING LAB MANU; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SCHINDLER U, 1992, EMBO J, V11, P1275, DOI 10.1002/j.1460-2075.1992.tb05171.x; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; SIMS SH, 1993, MOL CELL BIOL, V13, P690, DOI 10.1128/MCB.13.1.690; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; SUTER U, 1989, J IMMUNOL, V143, P3087; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276	31	227	229	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1995	2	6					689	697		10.1016/1074-7613(95)90013-6	http://dx.doi.org/10.1016/1074-7613(95)90013-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7796300	Bronze			2022-12-18	WOS:A1995RE53800014
J	Ouyang, WM; Beckett, O; Flavell, RA; Li, MO				Ouyang, Weiming; Beckett, Omar; Flavell, Richard A.; Li, Ming O.			An Essential Role of the Forkhead-Box Transcription Factor Foxo1 in Control of T Cell Homeostasis and Tolerance	IMMUNITY			English	Article							RECEPTOR-DEFICIENT MICE; INTERLEUKIN-7 RECEPTOR; MEMORY CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; SELECTIVE EXPRESSION; IL-7 PROMOTES; SURVIVAL; NAIVE; ACTIVATION; GENERATION	Members of the Forkhead box O (Foxo) family of transcription factors are key regulators of cellular responses, but their function in the immune system remains incompletely understood. Here we showed that T cell-specific deletion of Foxo1 gene in mice led to spontaneous T cell activation, effector T cell differentiation, autoantibody production, and the induction of inflammatory bowel disease in a transfer model. In addition, Foxo1 was critical for the maintenance of naive T cells in the peripheral lymphoid organs. Transcriptome analyses of T cells identified Foxo1-regulated genes encoding, among others, cell-surface molecules, signaling proteins, and nuclear factors that control gene expression. Functional studies validated interleukin-7 receptor-alpha as a Foxo1 target gene essential for Foxo1 maintenance of naive T cells. These findings reveal crucial functions of Foxo1-dependent transcription in control of T cell homeostasis and tolerance.	[Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Ouyang, Weiming; Beckett, Omar; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	Yale University; Howard Hughes Medical Institute; Yale University; Memorial Sloan Kettering Cancer Center	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu; lim@mskcc.org		li, ming/0000-0002-1383-0535	NIAMS-NIH; Arthritis Foundation Investigator Award; American Diabetes Association [NIH DK51665]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051665] Funding Source: NIH RePORTER	NIAMS-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation Investigator Award; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to A. Singer (National Cancer Institute) for providing IL-713 transgenic mice. We thank L. Evangelisti, C. Hughes, and J. Stein for their help in creating the Foxol mutant mice; X. Zhang for analysis of gene expression data; and X. Wang for critical commentary on the manuscript. M.O.L. is a Rita Allen Foundation Scholar. R.A.F. is an investigator of the Howard Hughes Medical Institute. This work is supported by a NIAMS-NIH K01 grant (M.O.L.), an Arthritis Foundation Investigator Award (M.O.L.), the American Diabetes Association (R.A.F.), and NIH DK51665 (R.A.F.). The authors declare that they have no competing financial interests.	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Bayer AL, 2008, J IMMUNOL, V181, P225, DOI 10.4049/jimmunol.181.1.225; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Calzascia T, 2008, P NATL ACAD SCI USA, V105, P2999, DOI 10.1073/pnas.0712135105; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chandele A, 2008, J IMMUNOL, V180, P5309, DOI 10.4049/jimmunol.180.8.5309; Fabre S, 2005, J IMMUNOL, V174, P4161, DOI 10.4049/jimmunol.174.7.4161; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li WQ, 2006, J EXP MED, V203, P573, DOI 10.1084/jem.20051520; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Marleau AM, 2005, J LEUKOCYTE BIOL, V78, P575, DOI 10.1189/jlb.0105050; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Mazzucchelli R, 2008, BLOOD, V112, P3283, DOI 10.1182/blood-2008-02-137414; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Peng SL, 2008, ONCOGENE, V27, P2337, DOI 10.1038/onc.2008.26; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8	54	226	232	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					358	371		10.1016/j.immuni.2009.02.003	http://dx.doi.org/10.1016/j.immuni.2009.02.003			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19285438	Green Accepted, Bronze			2022-12-18	WOS:000264405500009
J	Ray, SJ; Franki, SN; Pierce, RH; Dimitrova, S; Koteliansky, V; Sprague, AG; Doherty, PC; de Fougerolles, AR; Topham, DJ				Ray, SJ; Franki, SN; Pierce, RH; Dimitrova, S; Koteliansky, V; Sprague, AG; Doherty, PC; de Fougerolles, AR; Topham, DJ			The collagen binding alpha 1 beta 1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection	IMMUNITY			English	Article							TISSUE-SPECIFIC MIGRATION; A VIRUS; LYMPH-NODE; LYMPHOCYTES-T; EXTRACELLULAR-MATRIX; VIRAL-INFECTION; SYNOVIAL-FLUID; MEMORY CELLS; ANTIGEN; EXPRESSION	A common feature of many infections is that many pathogen-specific memory T cells become established in diverse nonlymphoid tissues. A mechanism that promotes the retention and survival of the memory T cells in diverse tissues has not been described. Our studies show that the collagen binding alpha1beta1 integrin, VLA-1, is expressed by the majority of influenza-specific CD8 T cells recovered from nonlymphoid tissues during both the acute and memory phases of the response. Antibody treatment or genetic deficiency of VLA-1 decreased virus-specific CTL in the lung and other nonlymphoid tissues, and increased them in the spleen. In spite of the increase in the spleen, secondary heterosubtypic immunity against flu was compromised. This suggests that VLA-1 is responsible for retaining protective memory CD8 T cells in the lung and other tissues via attachment to the extracellular matrix.	Univ Rochester, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Arab Inst Biomed Sci, Rochester, NY 14642 USA; Univ Rochester, Dept Pathol & Lab Med, Rochester, NY 14642 USA; Biogen Idec Inc, Cambridge Ctr 14, Cambridge, MA 02142 USA; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	University of Rochester; University of Rochester; Biogen; St Jude Children's Research Hospital	Topham, DJ (corresponding author), Univ Rochester, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Arab Inst Biomed Sci, Rochester, NY 14642 USA.	david_topham@urmc.rochester.edu	; Doherty, Peter Charles/C-4185-2013	Pierce, MD, Robert Hamilton/0000-0002-2677-144X; Doherty, Peter Charles/0000-0002-5028-3489	NHLBI NIH HHS [1T32HL66988-02] Funding Source: Medline; NIA NIH HHS [P30 AG18254, R01 AG021970-01] Funding Source: Medline; NIEHS NIH HHS [ESO 1247] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021970, P30AG018254] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLAN W, 1990, J IMMUNOL, V144, P3980; Andreasen SO, 2003, J IMMUNOL, V171, P2804, DOI 10.4049/jimmunol.171.6.2804; Aoudjit F, 2000, BLOOD, V95, P2044, DOI 10.1182/blood.V95.6.2044; Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Bachmann MF, 1997, P NATL ACAD SCI USA, V94, P640, DOI 10.1073/pnas.94.2.640; BANK I, 1991, J CLIN IMMUNOL, V11, P29, DOI 10.1007/BF00918792; BELKIN VM, 1990, J CELL BIOL, V111, P2159, DOI 10.1083/jcb.111.5.2159; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Belz GT, 1998, P NATL ACAD SCI USA, V95, P13812, DOI 10.1073/pnas.95.23.13812; BENNINK J, 1978, IMMUNOLOGY, V35, P503; BLANKENSHIP JW, 1993, CONNECT TISSUE RES, V29, P311, DOI 10.3109/03008209309016836; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; Doherty P C, 1997, Semin Immunol, V9, P365, DOI 10.1006/smim.1997.0094; Doherty PC, 1996, IMMUNOL REV, V150, P23, DOI 10.1111/j.1600-065X.1996.tb00694.x; Doherty PC, 2000, PHILOS T R SOC B, V355, P1093, DOI 10.1098/rstb.2000.0647; Dustin ML, 2001, CURR OPIN IMMUNOL, V13, P286, DOI 10.1016/S0952-7915(00)00217-X; EFFROS RB, 1977, J EXP MED, V145, P557, DOI 10.1084/jem.145.3.557; EFFROS RB, 1978, CELL IMMUNOL, V36, P345, DOI 10.1016/0008-8749(78)90278-2; Ennis F A, 1976, Dev Biol Stand, V33, P220; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; GOLDMAN R, 1992, EUR J IMMUNOL, V22, P1109, DOI 10.1002/eji.1830220502; GOMORI G, 1950, AM J CLIN PATHOL, V20, P661, DOI 10.1093/ajcp/20.7_ts.661; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gretz JE, 1996, J IMMUNOL, V157, P495; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HEMLER ME, 1987, J IMMUNOL, V138, P2941; HEMLER ME, 1986, J CLIN INVEST, V78, P696, DOI 10.1172/JCI112629; HEMLER ME, 1985, EUR J IMMUNOL, V15, P502, DOI 10.1002/eji.1830150515; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HERNANDEZPANDO R, 1994, IMMUNOLOGY, V82, P591; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Ianaro A, 2000, LAB INVEST, V80, P73, DOI 10.1038/labinvest.3780010; Kambayashi T, 2001, EUR J IMMUNOL, V31, P1523, DOI 10.1002/1521-4141(200105)31:5<1523::AID-IMMU1523>3.0.CO;2-S; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Laver WG, 2000, PERSPECT BIOL MED, V43, P173; LIANG SH, 1994, J IMMUNOL, V152, P1653; Lohman BL, 1996, J VIROL, V70, P8199, DOI 10.1128/JVI.70.11.8199-8203.1996; MACKAY CR, 1992, EUR J IMMUNOL, V22, P887, DOI 10.1002/eji.1830220402; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; MENDRICK DL, 1995, LAB INVEST, V72, P367; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Munoz FM, 2000, ANTIVIR RES, V46, P91, DOI 10.1016/S0166-3542(00)00092-9; RAZVI ES, 1995, AM J PATHOL, V147, P79; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sado Y, 1998, J BIOCHEM-TOKYO, V123, P767; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SALTINI C, 1988, CLIN IMMUNOL IMMUNOP, V46, P221, DOI 10.1016/0090-1229(88)90185-7; SEKI N, 1989, Regional Immunology, V2, P203; SHIELDS JM, 1984, IMMUNOLOGY, V51, P259; STEMME S, 1992, ARTERIOSCLER THROMB, V12, P206, DOI 10.1161/01.ATV.12.2.206; TAKAHASHI H, 1992, EUR J IMMUNOL, V22, P2879, DOI 10.1002/eji.1830221119; TITE JP, 1990, IMMUNOLOGY, V71, P202; Topham DJ, 1998, J VIROL, V72, P882, DOI 10.1128/JVI.72.1.882-885.1998; Topham DJ, 2001, J IMMUNOL, V167, P6983, DOI 10.4049/jimmunol.167.12.6983; TRIPP RA, 1995, J IMMUNOL, V154, P6013; TRIPP RA, 1995, J IMMUNOL, V155, P2955; Van Parijs L, 1998, SCIENCE, V280, P243; VANKUPPEVELT TH, 1995, INT J BIOCHEM CELL B, V27, P775, DOI 10.1016/1357-2725(95)00047-S; Wang XTZ, 2003, IMMUNITY, V18, P631, DOI 10.1016/S1074-7613(03)00116-X; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Webster RG, 1998, EMERG INFECT DIS, V4, P436, DOI 10.3201/eid0403.980325; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wiley JA, 2001, J IMMUNOL, V167, P3293, DOI 10.4049/jimmunol.167.6.3293; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Young AJ, 1999, SEMIN IMMUNOL, V11, P73, DOI 10.1006/smim.1999.0163	71	226	236	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2004	20	2					167	179		10.1016/S1074-7613(04)00021-4	http://dx.doi.org/10.1016/S1074-7613(04)00021-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EI	14975239	Bronze			2022-12-18	WOS:000221442400006
J	Hamano, S; Himeno, K; Miyazaki, Y; Ishii, K; Yamanaka, A; Takeda, A; Zhang, M; Hisaeda, H; Mak, TW; Yoshimura, A; Yoshida, H				Hamano, S; Himeno, K; Miyazaki, Y; Ishii, K; Yamanaka, A; Takeda, A; Zhang, M; Hisaeda, H; Mak, TW; Yoshimura, A; Yoshida, H			WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production	IMMUNITY			English	Article							CD4(+) T-CELLS; IFN-GAMMA; INTERFERON-GAMMA; EXPERIMENTAL HEPATITIS; TOXOPLASMA-GONDII; IMMUNE-RESPONSE; NATURAL-KILLER; TH1 RESPONSES; LIVER-INJURY; MICE	WSX-1 is a class I cytokine receptor with homology to the IL-12 receptors and is essential for resistance to Leishmania major infection. In the present study, we demonstrated that WSX-1 was also required for resistance to Trypanosoma cruzi. WSX-1(-/-) mice exhibited prolonged parasitemia, severe liver injury, and increased mortality over wild-type mice. WSX-1(-/-) splenocytes produced enhanced levels of Th2 cytokines, which were responsible for the prolonged parasitemia. Massive necroinflammatory lesions were observed in the liver of infected WSX-1(-/-) mice, and IFN-gamma that was overproduced in WSX-1(-/-) mice compared with wild-type mice was responsible for the lesions. In addition, vast amounts of various proinflammatory cytokines, including IL-6 and TNF-alpha, were produced by liver mononuclear cells in WSX-1(-/-) mice. Thus, during T. cruzi infection, WSX-1 suppresses liver injury by regulating production of proinflammatory cytokines, while controlling parasitemia by suppression of Th2 responses, demonstrating its novel role as an inhibitory regulator of cytokine production.	Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3330012, Japan; Kyushu Univ, Fac Med Sci, Dept Parasitol, Fukuoka 8128582, Japan	Kyushu University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Japan Science & Technology Agency (JST); Kyushu University	Yoshida, H (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan.		Yoshimura, Akihiko/K-5515-2013	Hamano, Shinjiro/0000-0003-3881-8337; Yamanaka, Atsushi/0000-0002-4025-8650				Abrahamsohn IA, 1996, EXP PARASITOL, V84, P231, DOI 10.1006/expr.1996.0109; Abrahamsohn IA, 2000, INFECT IMMUN, V68, P1975, DOI 10.1128/IAI.68.4.1975-1979.2000; Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; BOGDAN C, 1993, ANN NY ACAD SCI, V685, P713, DOI 10.1111/j.1749-6632.1993.tb35934.x; Brombacher F, 2003, TRENDS IMMUNOL, V24, P207, DOI 10.1016/S1471-4906(03)00067-X; Camargo MM, 1997, J IMMUNOL, V158, P5890; Cao Q, 1998, IMMUNOL CELL BIOL, V76, P542, DOI 10.1046/j.1440-1711.1998.00779.x; Cardillo F, 1996, INFECT IMMUN, V64, P128, DOI 10.1128/IAI.64.1.128-134.1996; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Ely KH, 1999, J IMMUNOL, V162, P5449; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; HE XD, 1995, VIRUS RES, V36, P233, DOI 10.1016/0168-1702(95)00010-N; Hiyama K, 2001, PARASITOL RES, V87, P269, DOI 10.1007/PL00008577; Holscher C, 2000, INFECT IMMUN, V68, P4075, DOI 10.1128/IAI.68.7.4075-4083.2000; Hunter CA, 1997, J IMMUNOL, V158, P3311; KRETTLI AU, 1982, J IMMUNOL, V128, P2009; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; PAUL WE, 1989, CELL, V57, P521, DOI 10.1016/0092-8674(89)90121-9; PETRAY PB, 1993, IMMUNOL LETT, V35, P77, DOI 10.1016/0165-2478(93)90151-Q; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; REED SG, 1988, J IMMUNOL, V140, P4342; ROTTENBERG M, 1988, SCAND J IMMUNOL, V28, P573, DOI 10.1111/j.1365-3083.1988.tb01489.x; Sass G, 2002, CYTOKINE, V19, P115, DOI 10.1006/cyto.2002.1948; Schumann J, 2000, AM J PATHOL, V157, P1671, DOI 10.1016/S0002-9440(10)64804-3; SILVA JS, 1992, J EXP MED, V175, P169, DOI 10.1084/jem.175.1.169; Soares MBP, 2001, AM J PATHOL, V159, P703, DOI 10.1016/S0002-9440(10)61741-5; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; TAGA T, 1995, CURR OPIN IMMUNOL, V7, P17, DOI 10.1016/0952-7915(95)80024-7; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; TARLETON RL, 1990, J IMMUNOL, V144, P717; Tiegs G, 1997, ACTA GASTRO-ENT BELG, V60, P176; Trinchieri G, 2003, NAT IMMUNOL, V4, P509, DOI 10.1038/ni0603-509; Trinchieri G, 2001, J EXP MED, V194, pF53, DOI 10.1084/jem.194.10.f53; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Wakil AE, 1998, J EXP MED, V188, P1651, DOI 10.1084/jem.188.9.1651; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0	40	226	239	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2003	19	5					657	667		10.1016/S1074-7613(03)00298-X	http://dx.doi.org/10.1016/S1074-7613(03)00298-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614853	Bronze			2022-12-18	WOS:000186672200006
J	Hotamisligil, GS				Hotamisligil, Gokhan S.			Foundations of Immunometabolism and Implications for Metabolic Health and Disease	IMMUNITY			English	Review							TUMOR-NECROSIS-FACTOR; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RECEPTOR SUBSTRATE-1; ADIPOSE-TISSUE INFLAMMATION; DIET-INDUCED OBESITY; ALTERNATIVELY ACTIVATED MACROPHAGES; INNATE LYMPHOID-CELLS; AMINO-ACID-UPTAKE; FACTOR-ALPHA GENE; NF-KAPPA-B	Highly ordered interactions between immune and metabolic responses are evolutionarily conserved and paramount for tissue and organismal health. Disruption of these interactions underlies the emergence of many pathologies, particularly chronic non-communicable diseases such as obesity and diabetes. Here, we examine decades of research identifying the complex immunometabolic signaling networks and the cellular and molecular events that occur in the setting of altered nutrient and energy exposures and offer a historical perspective. Furthermore, we describe recent advances such as the discovery that a broad complement of immune cells play a role in immunometabolism and the emerging evidence that nutrients and metabolites modulate inflammatory pathways. Lastly, we discuss how this work may eventually lead to tangible therapeutic advancements to promote health.	[Hotamisligil, Gokhan S.] Harvard TH Chan Sch Publ Hlth, Broad Inst Harvard & MIT, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Hotamisligil, Gokhan S.] Harvard TH Chan Sch Publ Hlth, Broad Inst Harvard & MIT, Sabri Ulker Ctr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Broad Institute	Hotamisligil, GS (corresponding author), Harvard TH Chan Sch Publ Hlth, Broad Inst Harvard & MIT, Dept Genet & Complex Dis, Boston, MA 02115 USA.; Hotamisligil, GS (corresponding author), Harvard TH Chan Sch Publ Hlth, Broad Inst Harvard & MIT, Sabri Ulker Ctr, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu			National Institutes of Health [DK052539, HL125753, AI116901]; JDRF [2SRA-2016-147-Q-R]; UCB [A14189]; Servier [121720BR-VO]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); UCB(UCB Pharma SA); Servier(Servier); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	I am grateful to Dr. Kathryn Claiborn for editorial assistance and thank all members of the Hotamisligil Lab and Sabri Ulker Center for helpful discussions. Special thanks to Dr. Kacey Prentice for designing and drawing figures. Work in the Hotamisligil lab is supported by the National Institutes of Health (grants DK052539, HL125753, and AI116901), the JDRF (grant 2SRA-2016-147-Q-R), and sponsored research agreements from UCB (A14189) and Servier (121720BR-VO). We apologize to our colleagues for omitting many valuable references due to space constraints.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Ballak DB, 2013, CYTOKINE, V62, P96, DOI 10.1016/j.cyto.2013.02.009; BERSON SA, 1958, AM J MED, V25, P155, DOI 10.1016/0002-9343(58)90022-6; BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0; Bhargava P, 2012, NAT MED, V18, P1665, DOI 10.1038/nm.2962; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Boriushkin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep25013; Borst SE, 2002, METABOLISM, V51, P1061, DOI 10.1053/meta.2002.34043; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Burak MF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6336; Burrill JS, 2015, MOL ENDOCRINOL, V29, P411, DOI 10.1210/me.2014-1275; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Campbell JS, 2001, J CLIN INVEST, V107, P1285, DOI 10.1172/JCI11867; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Cao SS, 2016, J CELL PHYSIOL, V231, P288, DOI 10.1002/jcp.25098; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Cerami A, 2012, ANN RHEUM DIS, V71, P55, DOI 10.1136/annrheumdis-2011-200800; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang HR, 2016, OBESITY, V24, P172, DOI 10.1002/oby.21354; Chang YH, 2012, INT J OBESITY, V36, P993, DOI 10.1038/ijo.2011.168; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Cho KW, 2016, J IMMUNOL, V197, P3650, DOI 10.4049/jimmunol.1600820; Chung KJ, 2017, NAT IMMUNOL, V18, P654, DOI 10.1038/ni.3728; Cimen I, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9087; Cintra DE, 2008, J HEPATOL, V48, P628, DOI 10.1016/j.jhep.2007.12.017; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; da Costa RM, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0443-0; Darkhal P, 2015, INT J OBESITY, V39, P1292, DOI 10.1038/ijo.2015.52; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; DROBNY EC, 1984, J CLIN ENDOCR METAB, V58, P710, DOI 10.1210/jcem-58-4-710; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Ebstein W.M.J., 1876, BERL KLIN WOCHENSCHR, V13, P53; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eisenbarth SC, 2016, NATURE, V530, P504, DOI 10.1038/nature16074; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Faggioni R, 1999, AM J PHYSIOL-REG I, V276, pR136, DOI 10.1152/ajpregu.1999.276.1.R136; Fan RR, 2016, NAT MED, V22, P780, DOI 10.1038/nm.4114; FEINGOLD KR, 1989, J CLIN INVEST, V83, P1116, DOI 10.1172/JCI113991; FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055; Feve B, 2009, NAT REV ENDOCRINOL, V5, P305, DOI 10.1038/nrendo.2009.62; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; FOX MJ, 1947, ARCH INTERN MED, V79, P614, DOI 10.1001/archinte.1947.00220120044003; Fullerton MD, 2013, MOL CELL ENDOCRINOL, V366, P224, DOI 10.1016/j.mce.2012.02.004; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Fuster JJ, 2015, DIABETES, V64, P1235, DOI 10.2337/db14-1164; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Ghazarian M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai7616; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Gonzalez-Teran B, 2016, EMBO J, V35, P536, DOI 10.15252/embj.201591857; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Green EA, 1999, IMMUNOL REV, V169, P11, DOI 10.1111/j.1600-065X.1999.tb01302.x; HAUSBERGER FX, 1966, ANAT RECORD, V154, P651, DOI 10.1002/ar.1091540311; HELLMAN B, 1965, ANN NY ACAD SCI, V131, P541, DOI 10.1111/j.1749-6632.1965.tb34819.x; HELSON L, 1975, NATURE, V258, P731, DOI 10.1038/258731a0; Henao-Mejia J, 2014, ANNU REV PHYSIOL, V76, P57, DOI 10.1146/annurev-physiol-021113-170324; Hett EC, 2013, NAT CHEM BIOL, V9, P398, DOI [10.1038/nchembio.1236, 10.1038/NCHEMBIO.1236]; Hill AA, 2014, IMMUNOL REV, V262, P134, DOI 10.1111/imr.12216; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huang J, 2012, GENET TEST MOL BIOMA, V16, P246, DOI 10.1089/gtmb.2011.0170; Huang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038626; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; JENKINS AB, 1988, J CLIN INVEST, V82, P293, DOI 10.1172/JCI113586; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; JOHNSON AB, 1992, CLIN SCI, V82, P219, DOI 10.1042/cs0820219; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; JULLIEN D, 1993, J BIOL CHEM, V268, P15246; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kothari V, 2016, J INFLAMM RES, V9, P27, DOI 10.2147/JIR.S86917; Koulmanda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033254; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Kwon H, 2014, CELL REP, V9, P1574, DOI 10.1016/j.celrep.2014.10.068; Lancaster GI, 2014, TRENDS IMMUNOL, V35, P262, DOI 10.1016/j.it.2014.02.008; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Li PP, 2016, CELL, V167, P973, DOI 10.1016/j.cell.2016.10.025; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Liang HF, 2008, ENDOCRINOLOGY, V149, P2943, DOI 10.1210/en.2007-0978; LING PR, 1994, METABOLISM, V43, P279, DOI 10.1016/0026-0495(94)90093-0; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; LOWENTHAL JW, 1989, P NATL ACAD SCI USA, V86, P2331, DOI 10.1073/pnas.86.7.2331; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Lynch L, 2014, IMMUNOLOGY, V142, P337, DOI 10.1111/imm.12269; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; MAHONEY JR, 1985, J IMMUNOL, V134, P1673; Miles PDG, 1997, DIABETES, V46, P1678, DOI 10.2337/diabetes.46.11.1678; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Morris DL, 2013, DIABETES, V62, P2762, DOI 10.2337/db12-1404; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nishimura S, 2013, CELL METAB, V18, P759, DOI 10.1016/j.cmet.2013.09.017; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; OLIFF A, 1987, CELL, V50, P555, DOI 10.1016/0092-8674(87)90028-6; Oral EA, 2017, CELL METAB, V26, P157, DOI 10.1016/j.cmet.2017.06.006; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PALMBLAD J, 1980, BRIT J HAEMATOL, V44, P101, DOI 10.1111/j.1365-2141.1980.tb01188.x; Pamir N, 2015, J BIOL CHEM, V290, P14656, DOI 10.1074/jbc.M115.645820; Park SH, 2016, DIABETES, V65, P1616, DOI 10.2337/db15-1156; PEKALA P, 1983, J EXP MED, V157, P1360, DOI 10.1084/jem.157.4.1360; Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Plomgaard P, 2008, J CLIN ENDOCR METAB, V93, P543, DOI 10.1210/jc.2007-1761; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; RABINOWITZ D, 1962, J CLIN INVEST, V41, P2173, DOI 10.1172/JCI104676; RANDLE PJ, 1963, LANCET, V1, P785; RANDLE PJ, 1964, BIOCHEM J, V93, P652, DOI 10.1042/bj0930652; RAYMOND RM, 1981, CIRC SHOCK, V8, P425; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Scheen AJ, 2015, DIABETES METAB, V41, P183, DOI 10.1016/j.diabet.2015.02.003; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serra C, 2003, J CELL PHYSIOL, V196, P89, DOI 10.1002/jcp.10278; Shan B, 2017, NAT IMMUNOL, V18, P519, DOI 10.1038/ni.3709; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Snodgrass RG, 2013, J IMMUNOL, V191, P4337, DOI 10.4049/jimmunol.1300298; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sookoian SC, 2005, OBES RES, V13, P2122, DOI 10.1038/oby.2005.263; Spadaro O, 2017, CELL REP, V19, P225, DOI 10.1016/j.celrep.2017.03.046; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Spitzer J J, 1989, Prog Clin Biol Res, V286, P145; Stanya KJ, 2013, J CLIN INVEST, V123, P261, DOI 10.1172/JCI64941; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; Tack CJ, 2012, IMMUNOL REV, V249, P239, DOI 10.1111/j.1600-065X.2012.01145.x; Talbot NA, 2014, MOL CELL ENDOCRINOL, V393, P129, DOI 10.1016/j.mce.2014.06.010; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Thurmond DC, 2015, CELL METAB, V22, P346, DOI 10.1016/j.cmet.2015.07.024; Tsaousidou E, 2014, CELL REP, V9, P1495, DOI 10.1016/j.celrep.2014.10.045; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; VANDERPOLL T, 1991, AM J PHYSIOL, V261, pE457, DOI 10.1152/ajpendo.1991.261.4.E457; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Waeber G, 2000, NAT GENET, V24, P291, DOI 10.1038/73523; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Woods SC, 2015, CELL METAB, V22, P348, DOI 10.1016/j.cmet.2015.08.017; Xie M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13280; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yan H, 2017, MOL MED REP, V15, P180, DOI 10.3892/mmr.2016.5966; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yang L, 2015, SCIENCE, V349, P500, DOI 10.1126/science.aaa0079; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhao T, 2005, CELL IMMUNOL, V238, P19, DOI 10.1016/j.cellimm.2005.12.002; Zhao Y, 2017, STEM CELL TRANSL MED, V6, DOI 10.1002/sctm.17-0078; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	210	225	229	7	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					406	420		10.1016/j.immuni.2017.08.009	http://dx.doi.org/10.1016/j.immuni.2017.08.009			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930657	Green Accepted, Bronze			2022-12-18	WOS:000411128200008
J	Ward-Kavanagh, LK; Lin, WW; Sedy, JR; Ware, CF				Ward-Kavanagh, Lindsay K.; Lin, Wai Wai; Sedy, John R.; Ware, Carl F.			The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses	IMMUNITY			English	Review							HERPESVIRUS ENTRY MEDIATOR; T-LYMPHOCYTE ATTENUATOR; TUMOR-NECROSIS-FACTOR; GENOME-WIDE ASSOCIATION; KAPPA-B ACTIVATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GLUCOCORTICOID-INDUCED TNFR; I INTERFERON RESPONSE; VERSUS-HOST-DISEASE	Cytokines related to tumor necrosis factor (TNF) provide a communication network essential for coordinating multiple cell types into an effective host defense system against pathogens and malignant cells. The pathways controlled by the TNF superfamily differentiate both innate and adaptive immune cells and modulate stromal cells into microenvironments conducive to host defenses. Members of the TNF receptor superfamily activate diverse cellular functions from the production of type 1 interferons to the modulation of survival of antigen-activated T cells. Here, we focus attention on the subset of TNF superfamily receptors encoded in the immune response locus in chromosomal region 1p36. Recent studies have revealed that these receptors use diverse mechanisms to either co-stimulate or restrict immune responses. Translation of the fundamental mechanisms of TNF superfamily is leading to the design of therapeutics that can alter pathogenic processes in several autoimmune diseases or promote immunity to tumors.	[Ward-Kavanagh, Lindsay K.; Lin, Wai Wai; Sedy, John R.; Ware, Carl F.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Ware, CF (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	cware@sbpdiscovery.org		Sedy, John/0000-0002-6428-1054	NIH [R37AI33068, AI48073, AI067890, CA164679]; National Psoriasis Foundation [NPF-2015]; American Heart Association [14BGIA20380277]; E. Lilly and Co.; NATIONAL CANCER INSTITUTE [R01CA164679, P01CA177322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067890, R01AI048073, R37AI033068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Psoriasis Foundation; American Heart Association(American Heart Association); E. Lilly and Co.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH grants R37AI33068, AI48073, AI067890, and CA164679 and a gift from the Jean Perkins Foundation to C.F.W. and National Psoriasis Foundation (NPF-2015) and American Heart Association grants (14BGIA20380277) to J.R.S. Support for C.F.W. and J.R.S. is also provided by E. Lilly and Co.	Afaneh C, 2010, TRANSPLANTATION, V90, P1381, DOI 10.1097/TP.0b013e3181ffbadd; Albring JC, 2010, J EXP MED, V207, P2551, DOI 10.1084/jem.20102017; Allen SJ, 2014, J VIROL, V88, P1961, DOI 10.1128/JVI.02467-13; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Ascierto PA, 2010, SEMIN ONCOL, V37, P508, DOI 10.1053/j.seminoncol.2010.09.008; Baltz KM, 2007, FASEB J, V21, P2442, DOI 10.1096/fj.06-7724com; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2008, CLIN IMMUNOL, V129, P249, DOI 10.1016/j.clim.2008.07.014; Barrett DM, 2014, ANNU REV MED, V65, P333, DOI 10.1146/annurev-med-060512-150254; BEISKE K, 1988, INT J CANCER, V42, P521, DOI 10.1002/ijc.2910420409; Bekiaris V, 2013, IMMUNITY, V39, P1082, DOI 10.1016/j.immuni.2013.10.017; Bertrand F, 2015, CANCER RES, V75, P2619, DOI 10.1158/0008-5472.CAN-14-2524; Bienkowska J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112545; Biharat A, 2007, TRANSPLANTATION, V84, P1704, DOI 10.1097/01.tp.0000295973.31877.7b; Biswas P, 2006, J MED VIROL, V78, P1513, DOI 10.1002/jmv.20733; Bjordahl RL, 2013, CURR OPIN IMMUNOL, V25, P222, DOI 10.1016/j.coi.2013.01.001; Boddicker RL, 2015, BLOOD, V125, P3118, DOI 10.1182/blood-2014-05-578575; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Boettler T, 2013, J IMMUNOL, V191, P5026, DOI 10.4049/jimmunol.1300013; Boettler T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002913; Breloer M, 2015, J IMMUNOL, V194, P1413, DOI 10.4049/jimmunol.1402510; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Buchan SL, 2015, J IMMUNOL, V194, P125, DOI 10.4049/jimmunol.1401644; Buchan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045244; Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378; Byun M, 2013, J EXP MED, V210, P1743, DOI 10.1084/jem.20130592; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Cardinale CJ, 2013, WORLD J GASTROENTERO, V19, P6721, DOI 10.3748/wjg.v19.i40.6721; Cavallini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060136; Chen X, 2013, J IMMUNOL, V190, P1076, DOI 10.4049/jimmunol.1202659; Cheung KJJ, 2010, CANCER RES, V70, P9166, DOI 10.1158/0008-5472.CAN-10-2460; Cheung TC, 2010, J IMMUNOL, V185, P1949, DOI 10.4049/jimmunol.1001159; Cheung TC, 2009, J IMMUNOL, V183, P7286, DOI 10.4049/jimmunol.0902490; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Choi BK, 2015, J IMMUNOL, V194, P1580, DOI 10.4049/jimmunol.1303439; Clancy RM, 2010, ARTHRITIS RHEUM-US, V62, P3415, DOI 10.1002/art.27658; Clouthier DL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004517; Clouthier DL, 2014, J IMMUNOL, V193, P5033, DOI 10.4049/jimmunol.1401002; Clouthier DL, 2014, CYTOKINE GROWTH F R, V25, P91, DOI 10.1016/j.cytogfr.2013.12.003; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Croft M, 2014, SEMIN IMMUNOL, V26, P183, DOI 10.1016/j.smim.2014.02.005; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Croft M, 2009, IMMUNOL REV, V229, P173, DOI 10.1111/j.1600-065X.2009.00766.x; Curti BD, 2013, CANCER RES, V73, P7189, DOI 10.1158/0008-5472.CAN-12-4174; Dai HL, 2015, TRANSPL IMMUNOL, V32, P84, DOI 10.1016/j.trim.2015.01.001; Dai ZH, 2004, J CLIN INVEST, V113, P310, DOI 10.1172/JCI200419727; De Trez C, 2008, J IMMUNOL, V180, P238, DOI 10.4049/jimmunol.180.1.238; DeBerge MP, 2015, J LEUKOCYTE BIOL, V98, P423, DOI 10.1189/jlb.3A0914-432RR; del Rio ML, 2014, TRANSPLANTATION, V98, P1165, DOI 10.1097/TP.0000000000000417; Deppong C, 2008, J IMMUNOL, V181, P2973, DOI 10.4049/jimmunol.181.5.2973; Deppong C, 2006, J IMMUNOL, V176, P3909, DOI 10.4049/jimmunol.176.7.3909; Derre L, 2010, J CLIN INVEST, V120, P157, DOI 10.1172/JCI40070; Di CX, 2015, J BIOL CHEM, V290, P12523, DOI 10.1074/jbc.M115.642637; Doherty TA, 2011, NAT MED, V17, P596, DOI 10.1038/nm.2356; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; El-Far M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0217-y; Esparza EM, 2006, J BIOL CHEM, V281, P8559, DOI 10.1074/jbc.M512915200; Esparza EM, 2005, J IMMUNOL, V174, P7869, DOI 10.4049/jimmunol.174.12.7869; Esparza EM, 2004, CELL MOL LIFE SCI, V61, P3087, DOI 10.1007/s00018-004-4417-0; Etemadi N, 2013, FEBS J, V280, P5283, DOI 10.1111/febs.12419; Facco M, 2015, Clin Mol Allergy, V13, P16, DOI 10.1186/s12948-015-0022-z; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Faustman DL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00478; Findlay EG, 2014, P NATL ACAD SCI USA, V111, P2289, DOI 10.1073/pnas.1321071111; Florido M, 2009, IMMUNOBIOLOGY, V214, P643, DOI 10.1016/j.imbio.2008.12.002; Flynn R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077991; Foell J, 2003, J CLIN INVEST, V111, P1505, DOI 10.1172/JCI200317662; Folseraas T, 2012, J HEPATOL, V57, P366, DOI 10.1016/j.jhep.2012.03.031; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Garner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101428; Gauvreau GM, 2014, CLIN EXP ALLERGY, V44, P29, DOI 10.1111/cea.12235; Gertner-Dardenne J, 2013, BLOOD, V122, P922, DOI 10.1182/blood-2012-11-464685; Gill S, 2015, IMMUNOL REV, V263, P68, DOI 10.1111/imr.12243; Gomez JMM, 2012, J NEUROSCI, V32, P18246, DOI 10.1523/JNEUROSCI.2473-12.2012; Gommerman JL, 2014, CYTOKINE GROWTH F R, V25, P139, DOI 10.1016/j.cytogfr.2014.02.002; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Green MR, 2013, BLOOD, V121, P1604, DOI 10.1182/blood-2012-09-457283; Grenzi PC, 2015, TRANSPL IMMUNOL, V32, P61, DOI 10.1016/j.trim.2015.02.004; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Guo F, 2009, MOL IMMUNOL, V46, P2441, DOI 10.1016/j.molimm.2009.05.178; Guo Y, 2013, INFECT IMMUN, V81, P3923, DOI 10.1128/IAI.00887-13; Guo ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087029; Haga T, 2009, J MOL CELL CARDIOL, V46, P719, DOI 10.1016/j.yjmcc.2009.02.003; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Heikal NM, 2013, TRANSPL P, V45, P376, DOI 10.1016/j.transproceed.2012.04.034; Hong GU, 2015, EUR J PHARMACOL, V754, P111, DOI 10.1016/j.ejphar.2015.02.023; Horwitz DA, 2013, CLIN IMMUNOL, V149, P450, DOI 10.1016/j.clim.2013.08.007; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Humphreys IR, 2010, EUR J IMMUNOL, V40, P2762, DOI 10.1002/eji.200940256; Hurchla MA, 2007, J IMMUNOL, V178, P6073, DOI 10.4049/jimmunol.178.10.6073; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Kanodia S, 2010, CANCER RES, V70, P3955, DOI 10.1158/0008-5472.CAN-09-3773; Karaba AH, 2012, P NATL ACAD SCI USA, V109, P20649, DOI 10.1073/pnas.1216967109; Kaur D, 2012, CHEST, V141, P494, DOI 10.1378/chest.11-1730; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Khan SQ, 2013, J IMMUNOL, V190, P1540, DOI 10.4049/jimmunol.1201908; Kim EY, 2009, J IMMUNOL, V183, P6051, DOI 10.4049/jimmunol.0803482; Kim IK, 2015, NAT MED, V21, P1010, DOI 10.1038/nm.3922; Kim J, 2005, BLOOD, V105, P2206, DOI 10.1182/blood-2004-06-2080; Kim J, 2012, BIOL BLOOD MARROW TR, V18, P44, DOI 10.1016/j.bbmt.2011.09.004; Kim YH, 2011, J IMMUNOL, V187, P1120, DOI 10.4049/jimmunol.1002681; Kinkade A, 2006, TRENDS IMMUNOL, V27, P362, DOI 10.1016/j.it.2006.06.004; Kobayashi T, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.990793; Konsta M, 2013, RHEUMATOLOGY, V52, P448, DOI 10.1093/rheumatology/kes316; Krause P, 2014, GASTROENTEROLOGY, V146, P1752, DOI 10.1053/j.gastro.2014.02.010; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Kurreeman FAS, 2012, AM J HUM GENET, V90, P524, DOI 10.1016/j.ajhg.2012.01.010; Launay E, 2012, LEUKEMIA, V26, P559, DOI 10.1038/leu.2011.266; Le Bouteiller P, 2011, IMMUNOL LETT, V138, P93, DOI 10.1016/j.imlet.2011.02.003; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Lepenies B, 2007, J IMMUNOL, V179, P4093, DOI 10.4049/jimmunol.179.6.4093; Li JX, 2013, ADV IMMUNOL, V119, P135, DOI 10.1016/B978-0-12-407707-2.00005-9; Linch SN, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00034; Liu WF, 2014, STRUCTURE, V22, P1252, DOI 10.1016/j.str.2014.06.013; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Madireddi S, 2014, J EXP MED, V211, P1425, DOI 10.1084/jem.20132687; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Marriott CL, 2014, EUR J IMMUNOL, V44, P2437, DOI 10.1002/eji.201344211; Mbanwi AN, 2014, SEMIN IMMUNOL, V26, P210, DOI 10.1016/j.smim.2014.05.001; Meylan F, 2014, MUCOSAL IMMUNOL, V7, P958, DOI 10.1038/mi.2013.114; Meylan F, 2011, MUCOSAL IMMUNOL, V4, P172, DOI 10.1038/mi.2010.67; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Monaco C, 2015, INT IMMUNOL, V27, P55, DOI 10.1093/intimm/dxu102; Motta AC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-93; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; Nikaein A, 2007, CLIN TRANSPLANT, V21, P744, DOI 10.1111/j.1399-0012.2007.00732.x; Nishimura H, 2005, J IMMUNOL, V175, P4627, DOI 10.4049/jimmunol.175.7.4627; Oh HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126765; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Orozco G, 2014, ARTHRITIS RHEUMATOL, V66, P24, DOI 10.1002/art.38196; Palmer ND, 2015, DIABETES, V64, P1853, DOI 10.2337/db14-0732; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Pascutti MF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004675; Patel JR, 2012, ACTA NEUROPATHOL, V124, P847, DOI 10.1007/s00401-012-1034-0; Peretz Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002840; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Pobezinskaya YL, 2011, J IMMUNOL, V186, P5212, DOI 10.4049/jimmunol.1002374; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; Redmond WL, 2014, CANCER IMMUNOL RES, V2, P142, DOI 10.1158/2326-6066.CIR-13-0031-T; Redmond WL, 2009, EUR J IMMUNOL, V39, P2184, DOI 10.1002/eji.200939348; Richard AC, 2015, J IMMUNOL, V194, P3567, DOI 10.4049/jimmunol.1401220; Sakoda Y, 2011, BLOOD, V117, P2506, DOI 10.1182/blood-2010-08-301325; Salek-Ardakani S, 2011, J VIROL, V85, P9051, DOI 10.1128/JVI.00619-11; Salek-Ardakani S, 2008, J IMMUNOL, V181, P7969, DOI 10.4049/jimmunol.181.11.7969; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008; Schreiber TH, 2010, J CLIN INVEST, V120, P3629, DOI 10.1172/JCI42933; Sedy JR, 2008, NAT REV IMMUNOL, V8, P861, DOI 10.1038/nri2434; Sedy JR, 2013, J IMMUNOL, V191, P828, DOI 10.4049/jimmunol.1300894; Sedy J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016279; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shaikh RB, 2001, J IMMUNOL, V167, P6330, DOI 10.4049/jimmunol.167.11.6330; Shih DQ, 2009, EUR J IMMUNOL, V39, P3239, DOI 10.1002/eji.200839087; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Shui JW, 2012, NATURE, V488, P222, DOI 10.1038/nature11242; Siddiqui S, 2010, CHEST, V137, P797, DOI 10.1378/chest.09-1839; Sloan DD, 2006, J IMMUNOL, V176, P1825, DOI 10.4049/jimmunol.176.3.1825; Snell LM, 2011, IMMUNOL REV, V244, P197, DOI 10.1111/j.1600-065X.2011.01063.x; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; So T, 2011, J IMMUNOL, V186, P3547, DOI 10.4049/jimmunol.1003156; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Soroosh P, 2011, J EXP MED, V208, P797, DOI 10.1084/jem.20101562; Spear PG, 2006, VIROLOGY, V344, P17, DOI 10.1016/j.virol.2005.09.016; Spiridon C, 2006, TRANSPLANT P, V38, P3689, DOI 10.1016/j.transproceed.2006.10.088; Spiridon C, 2008, CLIN TRANSPLANT, V22, P765, DOI 10.1111/j.1399-0012.2008.00876.x; Steinberg MW, 2008, J EXP MED, V205, P1463, DOI 10.1084/jem.20071160; Steinberg MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077992; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Stohl W, 2014, EXPERT OPIN THER TAR, V18, P473, DOI 10.1517/14728222.2014.888415; Sun YL, 2009, J IMMUNOL, V183, P1946, DOI 10.4049/jimmunol.0801866; Tang C, 2008, J IMMUNOL, V181, P6316, DOI 10.4049/jimmunol.181.9.6316; Tang HM, 2013, P NATL ACAD SCI USA, V110, P9096, DOI 10.1073/pnas.1305187110; Tao R, 2008, J IMMUNOL, V180, P6649, DOI 10.4049/jimmunol.180.10.6649; Taraban VY, 2011, MUCOSAL IMMUNOL, V4, P186, DOI 10.1038/mi.2010.70; Taylor JM, 2007, CELL HOST MICROBE, V2, P19, DOI 10.1016/j.chom.2007.06.005; Thakar NY, 2015, MOL BIOL CELL, V26, P993, DOI 10.1091/mbc.E14-08-1290; Triplett TA, 2015, CANCER IMMUNOL RES, V3, P526, DOI 10.1158/2326-6066.CIR-14-0187; Tu TC, 2015, J EXP MED, V212, P415, DOI 10.1084/jem.20131601; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Twohig JP, 2012, FASEB J, V26, P3575, DOI 10.1096/fj.11-200618; Umeda K, 2011, MICROBIOL IMMUNOL, V55, P645, DOI 10.1111/j.1348-0421.2011.00362.x; Ungewickell A, 2015, NAT GENET, V47, P1056, DOI 10.1038/ng.3370; van der Stegen SJC, 2015, NAT REV DRUG DISCOV, V14, P499, DOI 10.1038/nrd4597; van der Werf N, 2011, J IMMUNOL, V187, P1411, DOI 10.4049/jimmunol.1100834; Vezys V, 2011, J IMMUNOL, V187, P1634, DOI 10.4049/jimmunol.1100077; Vigano S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004380; Vincent FB, 2014, NAT REV RHEUMATOL, V10, P365, DOI 10.1038/nrrheum.2014.33; Wang D, 2012, TRANSPL IMMUNOL, V27, P146, DOI 10.1016/j.trim.2012.10.002; Wang J, 2005, J IMMUNOL, V174, P8173, DOI 10.4049/jimmunol.174.12.8173; Wang J, 2001, J IMMUNOL, V167, P5099, DOI 10.4049/jimmunol.167.9.5099; Wang XH, 2013, J IMMUNOL, V191, P5420, DOI 10.4049/jimmunol.1301475; Ware CF, 2011, CURR OPIN IMMUNOL, V23, P627, DOI 10.1016/j.coi.2011.08.008; Weigelin B, 2015, P NATL ACAD SCI USA, V112, P7551, DOI 10.1073/pnas.1506357112; Willoughby JE, 2014, J IMMUNOL, V193, P244, DOI 10.4049/jimmunol.1301217; Withers DR, 2011, IMMUNOL REV, V244, P134, DOI 10.1111/j.1600-065X.2011.01057.x; Wortzman ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068911; Wortzman ME, 2013, IMMUNOL REV, V255, P125, DOI 10.1111/imr.12086; Wright CW, 2007, J BIOL CHEM, V282, P10252, DOI 10.1074/jbc.M608817200; Xu WD, 2015, RHEUMATOL INT, V35, P1435, DOI 10.1007/s00296-015-3277-2; Xu YH, 2007, BLOOD, V109, P4097, DOI 10.1182/blood-2006-09-047332; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; Yang SS, 2006, J GASTROEN HEPATOL, V21, P1789, DOI 10.1111/j.1440-1746.2006.04677.x; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Yu P, 2008, CYTOKINE GROWTH F R, V19, P285, DOI 10.1016/j.cytogfr.2008.04.004; Yu X, 2014, MUCOSAL IMMUNOL, V7, P730, DOI 10.1038/mi.2013.92; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	214	225	245	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1005	1019		10.1016/j.immuni.2016.04.019	http://dx.doi.org/10.1016/j.immuni.2016.04.019			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192566	Green Accepted, Bronze			2022-12-18	WOS:000376478500004
J	Sepulveda, FE; Maschalidi, S; Colisson, R; Heslop, L; Ghirelli, C; Sakka, E; Lennon-Dumenil, AM; Amigorena, S; Cabanie, L; Manoury, B				Sepulveda, Fernando E.; Maschalidi, Sophia; Colisson, Renaud; Heslop, Lea; Ghirelli, Cristina; Sakka, Emna; Lennon-Dumenil, Ana-Maria; Amigorena, Sebastian; Cabanie, Lucien; Manoury, Benedicte			Critical Role for Asparagine Endopeptidase in Endocytic Toll-like Receptor Signaling in Dendritic Cells	IMMUNITY			English	Article							INVARIANT CHAIN; CPG-DNA; ANTIGEN; PH; ACTIVATION; EXPRESSION; CATHEPSINS; INHIBITORS; CLEAVAGE; LEGUMAIN	Intracellular Toll-like receptor 3 (TLR3), TLR7, and TLR9 localize in endosomes and recognize single-stranded RNA and nucleotides from viruses and bacteria. This interaction induces their conformational changes resulting in the production of proinflammatory cytokines and upregulation of cell surface molecules. TLR9 requires a proteolytic cleavage for its signaling. Here, we report that myeloid and plasmacytoid dendritic cells (DCs) deficient for the asparagine endopeptidase (AEP), a cysteine lysosomal protease, showed a decrease in the secretion of proinflammatory cytokines in response to TLR9 stimulation in vitro and in vivo. Upon stimulation, full-length TLR9 was cleaved into a 72 kDa fragment and this processing was strongly reduced in DCs lacking AEP. Processed TLR9 coeluted with the adaptor molecule MyD88 and AEP after size exclusion chromatography. When expressed in AEP-deficient DCs, the 72 kDa proteolytic fragment restored TLR9 signaling. Thus, our results identify an endocytic protease playing a critical role in TLR processing and signaling in DCs.	[Sepulveda, Fernando E.; Maschalidi, Sophia; Colisson, Renaud; Heslop, Lea; Ghirelli, Cristina; Sakka, Emna; Lennon-Dumenil, Ana-Maria; Amigorena, Sebastian; Manoury, Benedicte] Inst Curie, U932, F-75005 Paris, France; [Cabanie, Lucien] Unite Prot Recombinantes, UMR144, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Manoury, B (corresponding author), Inst Curie, U932, 26 Rue Ulm, F-75005 Paris, France.	benedicte.manoury@curie.fr	Sepulveda, Fernando/O-7803-2016; Lennon-Dumenil, Ana-Maria/I-6716-2016	Sepulveda, Fernando/0000-0001-5865-4929; Amigorena, Sebastian/0000-0001-8583-8416; Manoury, Benedicte/0000-0001-7784-3389	l'Institut National de Sante et Recherche Medicale (AVENIR fellowship); La Mairie de Paris; Marie Curie Training network [MRTN-CT-2004-512585]; Region d' Ile de France	l'Institut National de Sante et Recherche Medicale (AVENIR fellowship); La Mairie de Paris; Marie Curie Training network(European Commission); Region d' Ile de France	We are grateful to S. Akira (Osaka, Japan) for providing Tlr9<SUP>-/-</SUP> and Myd88<SUP>-/-</SUP> mice (MTA) and H. Ploegh and B. Park (MIT, USA) for providing the cDNA encoding for the C-terminal Tlr9 fragment. We are especially grateful to C. Peters (Freiburg, Germany) and I. Werber for providing AEP-deficient mice. This study was funded by grants from l'Institut National de Sante et Recherche Medicale (AVENIR fellowship) and La Mairie de Paris to B.M. and fellowships to F.E.S. (Marie Curie Training network MRTN-CT-2004-512585 and RC), to S.M. (ANR), and to R.C. (Region d' Ile de France).	Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Chen JM, 1998, BIOCHEM J, V335, P111, DOI 10.1042/bj3350111; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Duramad O, 2005, J IMMUNOL, V174, P5193, DOI 10.4049/jimmunol.174.9.5193; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fiebiger E, 2002, J EXP MED, V196, P1263, DOI 10.1084/jem.20020762; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Hemmi Hiroaki, 2005, V86, P120, DOI 10.1159/000086657; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Lennon-Dumenil AM, 2001, EMBO J, V20, P4055, DOI 10.1093/emboj/20.15.4055; Loak K, 2003, BIOL CHEM, V384, P1239, DOI 10.1515/BC.2003.136; Maehr R, 2005, J IMMUNOL, V174, P7066, DOI 10.4049/jimmunol.174.11.7066; Manoury B, 2003, IMMUNITY, V18, P489, DOI 10.1016/S1074-7613(03)00085-2; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Yi AK, 1998, J IMMUNOL, V160, P4755	34	225	230	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2009	31	5					737	748		10.1016/j.immuni.2009.09.013	http://dx.doi.org/10.1016/j.immuni.2009.09.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19879164	Bronze			2022-12-18	WOS:000272097900009
J	Matsuzaki, Y; Kinjo, K; Mulligan, RC; Okano, H				Matsuzaki, Y; Kinjo, K; Mulligan, RC; Okano, H			Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells	IMMUNITY			English	Article							IN-VIVO; LONG-TERM; IRRADIATED MICE; MARROW; SPLEEN	Single-cell transplantation analysis revealed that the cells that had the strongest dye efflux activity ("Tip"-SP cells)and had the phenotype CD34- c-Kit+ Sca-1+ Lin- (CD34- KSL cells) exhibited very strong proliferation and multilineage differentiation capacity. Ninety-six percent of the lethally irradiated mice that received a single "Tip"-SP CD34- KSL cell showed significant donor cell engraftment for long term. These findings support the hypothesis that "Tip"-SP CD34- KSL cells represent the most primitive hematopoietic stem cells that are capable of migrating into the primary site and surviving and/or proliferating with nearly absolute efficiency. This led us to propose high marrow-seeding efficiency as a specific characteristic of primitive HSCs, in addition to their self-renewal and multipotent capacity.	Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; Harvard Univ, Sch Med, Childrens Hosp, Dept Mol Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; JST, CREST, Kawaguchi, Saitama 3320012, Japan; Keio Univ, Sch Med, Dept Internal Med, Div Hematol,Shinjuku Ku, Tokyo 1608582, Japan	Keio University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Japan Science & Technology Agency (JST); Keio University	Matsuzaki, Y (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	penguin@sc.itc.keio.ac.jp; hidokano@sc.itc.keio.ac.jp	Matsuzaki, Yumi/H-2476-2013; Okano, Hideyuki/I-7584-2019	Matsuzaki, Yumi/0000-0002-3729-2997				Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Cashman JD, 2000, BLOOD, V96, P3979, DOI 10.1182/blood.V96.12.3979.h8003979_3979_3981; Collaco Anne M, 2003, BMC Physiol, V3, P8, DOI 10.1186/1472-6793-3-8; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hendrikx PJ, 1996, EXP HEMATOL, V24, P129; JONES RJ, 1990, NATURE, V347, P188, DOI 10.1038/347188a0; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Lanzkron SM, 1999, ANN NY ACAD SCI, V872, P48, DOI 10.1111/j.1749-6632.1999.tb08452.x; Metcalf D, 1999, ANN NY ACAD SCI, V872, P289, DOI 10.1111/j.1749-6632.1999.tb08473.x; METCALF D, 1971, HAEMATOPOIETIC CELLS; Oostendorp RAJ, 2000, BONE MARROW TRANSPL, V26, P559, DOI 10.1038/sj.bmt.1702536; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Osawa M, 1996, J IMMUNOL, V156, P3207; Parmar K, 2003, EXP HEMATOL, V31, P244, DOI 10.1016/S0301-472X(02)01074-3; Schaaff TG, 2002, NANO LETT, V2, P507, DOI 10.1021/nl010088u; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; TILL J, 1961, RADIAT RES, V14, P1419; Uchida N, 1996, EXP HEMATOL, V24, P649; VANDERLOO JCM, 1995, BLOOD, V85, P2598, DOI 10.1182/blood.V85.9.2598.bloodjournal8592598; VONMELCHNER H, 1980, LEUKEMIA RES, V4, P393, DOI 10.1016/0145-2126(80)90021-1; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	24	225	238	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2004	20	1					87	93		10.1016/S1074-7613(03)00354-6	http://dx.doi.org/10.1016/S1074-7613(03)00354-6			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EG	14738767	Bronze			2022-12-18	WOS:000221442200009
J	Scott, EW; Fisher, RC; Olson, MC; Kehrli, EW; Simon, MC; Singh, H				Scott, EW; Fisher, RC; Olson, MC; Kehrli, EW; Simon, MC; Singh, H			PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; MICE LACKING; FETAL LIVER; YOLK-SAC; B-CELLS; EXPRESSION; GENE; PRECURSORS; LINEAGES; ABSENCE	Transcription factor PU.1 is required for the development of lymphoid and myeloid progenitors during fetal hematopoiesis. By generating chimeric animals using PU.1(-/-) ES cells or PU.1(-/-) hematopoietic progenitors, we demonstrate that PU.1 functions in an exclusively cell-autonomous manner to regulate the development of the lymphoid-myeloid system. Multipotential lymphoid-myeloid progenitors (AA4.1+, Lin(-)) are significantly reduced in PU.1(-/-) embryos and fail to differentiate into B lymphoid or myeloid cells in vitro. These results suggest that the lymphoid and myeloid lineages develop in the fetal liver from a common hematopoietic progenitor not shared with erythrocytes and megakaryocytes. Finally, the lkaros gene is expressed in PU.1 mutant embryos, suggesting that PU.1 and lkaros are independently required for specification of embryonic lymphoid cell fates.	UNIV CHICAGO, HOWARD HUGHES MED INST, CHICAGO, IL 60637 USA; UNIV CHICAGO, DEPT MOL GENET & CELL BIOL, CHICAGO, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago			Simon, Celeste/AAG-3941-2021		NIAID NIH HHS [F32 AI08933] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI008933] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; CHEN HM, 1995, ONCOGENE, V11, P1549; CUMANO A, 1992, EMBO J, V11, P593, DOI 10.1002/j.1460-2075.1992.tb05091.x; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; GALSON DL, 1993, MOL CELL BIOL, V13, P2929, DOI 10.1128/MCB.13.5.2929; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; HROMAS R, 1993, BLOOD, V82, P2998; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; MCKEARN JP, 1984, J IMMUNOL, V132, P332; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; MOREAUGACHELIN F, 1994, BBA-REV CANCER, V1198, P149, DOI 10.1016/0304-419X(94)90011-6; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; OGAWA M, 1993, BLOOD, V81, P2844; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Olson MC, 1995, IMMUNITY, V3, P703, DOI 10.1016/1074-7613(95)90060-8; Papaioannou V., 1993, Gene targeting: a practical approach., P107; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; SPANGRUDE GJ, 1994, ANNU REV MED, V45, P93; TAVASSOLI M, 1991, BLOOD CELLS, V17, P269; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; UCHIDA N, 1993, CURR OPIN IMMUNOL, V5, P177, DOI 10.1016/0952-7915(93)90002-A; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; WHITNEY J, 1978, BIOCH GENET, V16, P1184	33	225	226	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1997	6	4					437	447		10.1016/S1074-7613(00)80287-3	http://dx.doi.org/10.1016/S1074-7613(00)80287-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133423	hybrid			2022-12-18	WOS:A1997XC61900009
J	Kashem, SW; Riedl, MS; Yao, C; Honda, CN; Vulchanova, L; Kaplan, DH				Kashem, Sakeen W.; Riedl, Maureen S.; Yao, Chen; Honda, Christopher N.; Vulchanova, Lucy; Kaplan, Daniel H.			Nociceptive Sensory Fibers Drive Interleukin-23 Production from CD301b(+) Dermal Dendritic Cells and Drive Protective Cutaneous Immunity	IMMUNITY			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; DELTA T-CELLS; HOST-DEFENSE; INDEPENDENT GENERATION; LANGERHANS CELLS; TH17 CELLS; SKIN; IL-23; NEURONS; MICE	Innate resistance to Candida albicans in mucosal tissues requires the production of interleukin-17A (IL-17A) by tissue-resident cells early during infection, but the mechanism of cytokine production has not been precisely defined. In the skin, we found that dermal gamma delta T cells were the dominant source of IL-17A during C. albicans infection and were required for pathogen resistance. Induction of IL-17A from dermal gamma delta T cells and resistance to C. albicans required IL-23 production from CD301b(+) dermal dendritic cells (dDCs). In addition, we found that sensory neurons were directly activated by C. albicans. Ablation of sensory neurons increased susceptibility to C. albicans infection, which could be rescued by exogenous addition of the neuropeptide CGRP. These data define a model in which nociceptive pathways in the skin drive production of IL-23 by CD301b(+) dDCs resulting in IL-17A production from gamma delta T cells and resistance to cutaneous candidiasis.	[Kashem, Sakeen W.; Yao, Chen; Kaplan, Daniel H.] Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA; [Riedl, Maureen S.; Honda, Christopher N.; Vulchanova, Lucy] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kaplan, DH (corresponding author), Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA.	dankaplan@pitt.edu		Kashem, Sakeen/0000-0002-2594-2884; Vulchanova, Lucy/0000-0002-6577-4467; Yao, Chen/0000-0001-6852-5661	NIH [AR067187, AR060744]; Al Zelickson Family endowed professorship; University of Minnesota NIH [T32 GM008244, T32 AI007313]; University of Minnesota CTSI Translational Research Development Program Grant [UL1TR000114]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060744, R01AR067187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Al Zelickson Family endowed professorship; University of Minnesota NIH(University of Minnesota SystemUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota CTSI Translational Research Development Program Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the laboratories of Marc Jenkins and Daniel Mueller (University of Minnesota) for Tcra<SUP>-/-</SUP> mice, Nico Ghilardi (Genentech) for Il23a<SUP>-/-</SUP> mice, Lloyd Miller (Johns Hopkins) for Tcrd<SUP>-/-</SUP> mice, Akiko Iwasaki and Yosuke Kumamoto (Yale University) for Mgl2-DTR mice, and Immo Prinz (Hannover Medical School) and Bryce Binstadt (University of Minnesota) for Il17af<SUP>-/-</SUP> mice. B. Chicoine provided technical assistance. We also thank the University of Minnesota Research Animal Resources staff for expert animal care and P. Champoux and T. Martin of the Flow Cytometry Core Facility at the Center for Immunology for assistance flow cytometry experiments. This work was supported by grants from the NIH (AR067187 and AR060744) to D.H.K., who is also supported by the Al Zelickson Family endowed professorship. S.W.K. was supported by the University of Minnesota NIH MSTP grant T32 GM008244, Immunology Training Grant T32 AI007313, and University of Minnesota CTSI Translational Research Development Program Grant UL1TR000114.	Assas BM, 2014, MUCOSAL IMMUNOL, V7, P1283, DOI 10.1038/mi.2014.80; Augustyniak D, 2012, CURR PROTEIN PEPT SC, V13, P723, DOI 10.2174/138920312804871139; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bar E, 2014, IMMUNITY, V40, P117, DOI 10.1016/j.immuni.2013.12.002; Bannon Anthony W, 2007, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0809s41; Bertin S, 2014, NAT IMMUNOL, V15, P1055, DOI 10.1038/ni.3009; Cai Y., 2014, NAT COMMUN; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Conti HR, 2011, MUCOSAL IMMUNOL, V4, P448, DOI 10.1038/mi.2011.5; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Conti HR, 2010, MICROBES INFECT, V12, P518, DOI 10.1016/j.micinf.2010.03.013; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; El Karim IA, 2008, J NEUROIMMUNOL, V200, P11, DOI 10.1016/j.jneuroim.2008.05.014; Engel MA, 2011, NEUROPEPTIDES, V45, P229, DOI 10.1016/j.npep.2011.03.005; Farmer MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002613; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Gladiator A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003763; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Graham DM, 2013, J CELL SCI, V126, P4602, DOI 10.1242/jcs.122192; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Haley K, 2012, J IMMUNOL, V188, P4334, DOI 10.4049/jimmunol.1102759; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hernandez-Santos N, 2013, MUCOSAL IMMUNOL, V6, P900, DOI 10.1038/mi.2012.128; HONJO M, 1990, J INVEST DERMATOL, V95, P562, DOI 10.1111/1523-1747.ep12505543; Hsieh YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050805; Huppler AR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3893; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Jones TB, 2014, FASEB J, V28; Joseph T, 2005, BRIT J DERMATOL, V152, P185, DOI 10.1111/j.1365-2133.2005.06330.x; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153; Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kashem SW, 2015, IMMUNITY, V42, P356, DOI 10.1016/j.immuni.2015.01.008; Khasabova IA, 2002, NEUROSCIENCE, V115, P613, DOI 10.1016/S0306-4522(02)00449-9; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Li MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088738; MacLeod AS, 2013, J CLIN INVEST, V123, P4364, DOI 10.1172/JCI70064; McDonald DR, 2012, J ALLERGY CLIN IMMUN, V129, P1429, DOI 10.1016/j.jaci.2012.03.034; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Meng JH, 2009, J NEUROSCI, V29, P4981, DOI 10.1523/JNEUROSCI.5490-08.2009; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nash M S, 2000, J Spinal Cord Med, V23, P111; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Ren Ke, 1999, ILAR J, V40, P111; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Roggenkamp D, 2013, J INVEST DERMATOL, V133, P1620, DOI 10.1038/jid.2012.464; Rubin-Asher D, 2005, SPINAL CORD, V43, P175, DOI 10.1038/sj.sc.3101697; Saraceno R, 2006, BRIT J DERMATOL, V155, P876, DOI 10.1111/j.1365-2133.2006.07518.x; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Siebenhaar F, 2008, J ALLERGY CLIN IMMUN, V121, P955, DOI 10.1016/j.jaci.2007.11.013; Smeekens SP, 2013, EMBO MOL MED, V5, P805, DOI 10.1002/emmm.201201678; Smeekens SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029248; Stangenberg L, 2014, P NATL ACAD SCI USA, V111, P11419, DOI 10.1073/pnas.1410854111; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; THOMPSON M, 1962, ANN RHEUM DIS, V21, P370, DOI 10.1136/ard.21.4.370; Trautwein-Weidner K, 2015, MUCOSAL IMMUNOL, V8, P221, DOI 10.1038/mi.2014.57; Welty NE, 2013, J EXP MED, V210, P2011, DOI 10.1084/jem.20130728; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98	79	224	229	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					515	526		10.1016/j.immuni.2015.08.016	http://dx.doi.org/10.1016/j.immuni.2015.08.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE9NY	26377898	Green Accepted, Bronze			2022-12-18	WOS:000370965900004
J	Nava, P; Koch, S; Laukoetter, MG; Lee, WY; Kolegraff, K; Capaldo, CT; Beeman, N; Addis, C; Gerner-Smidt, K; Neumaier, I; Skerra, A; Li, LH; Parkos, CA; Nusrat, A				Nava, Porfirio; Koch, Stefan; Laukoetter, Mike G.; Lee, Winston Y.; Kolegraff, Keli; Capaldo, Christopher T.; Beeman, Neal; Addis, Caroline; Gerner-Smidt, Kirsten; Neumaier, Irmgard; Skerra, Arne; Li, Linheng; Parkos, Charles A.; Nusrat, Asma			Interferon-gamma Regulates Intestinal Epithelial Homeostasis through Converging beta-Catenin Signaling Pathways	IMMUNITY			English	Article							NECROSIS-FACTOR-ALPHA; INFLAMMATORY-BOWEL-DISEASE; STEM-CELLS; IFN-GAMMA; GENE-EXPRESSION; EXPERIMENTAL COLITIS; TNF-ALPHA; PHOSPHATIDYLINOSITOL 3-KINASE; COLORECTAL-CANCER; LEADING-EDGE	Inflammatory cytokines have been proposed to regulate epithelial homeostasis during intestinal inflammation. We report here that interferon-gamma (IFN-gamma) regulates the crucial homeostatic functions of cell proliferation and apoptosis through serine-threonine protein kinase AKT-beta-catenin and Wing-less-Int (Wnt)-beta-catenin signaling pathways. Shortterm exposure of intestinal epithelial cells to IFN-gamma resulted in activation of beta-catenin through AKT, followed by induction of the secreted Wnt inhibitor Dkk1. Consequently, we observed an increase in Dkk1-mediated apoptosis upon extended IFN-gamma treatment and reduced proliferation through depletion of the Wnt coreceptor LRP6. These effects were enhanced by tumor necrosis factor-alpha (INF-alpha), suggesting synergism between the two cytokines. Consistent with these results, colitis in vivo was associated with decreased beta-catenin-T cell factor (TCF) signaling, loss of plasma membrane-associated LRP6, and reduced epithelial cell proliferation. Proliferation was partially restored in IFN-gamma-deficient mice. Thus, we propose that IFN-gamma regulates intestinal epithelial homeostasis by sequential regulation of converging beta-catenin signaling pathways.	[Nava, Porfirio; Koch, Stefan; Laukoetter, Mike G.; Lee, Winston Y.; Kolegraff, Keli; Capaldo, Christopher T.; Beeman, Neal; Addis, Caroline; Gerner-Smidt, Kirsten; Parkos, Charles A.; Nusrat, Asma] Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol Unit, Atlanta, GA 30322 USA; [Laukoetter, Mike G.] Univ Munster, Dept Gen Surg, D-48149 Munster, Germany; [Neumaier, Irmgard; Skerra, Arne] Tech Univ Munich, D-85350 Freising Weihenstephan, Germany; [Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA	Emory University; University of Munster; Technical University of Munich; Stowers Institute for Medical Research	Nusrat, A (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol Unit, Atlanta, GA 30322 USA.	anusrat@emory.edu	Nava, Porfirio/D-8306-2012; Skerra, Arne/A-2269-2013; Capaldo, Chris/B-4143-2010	Nava, Porfirio/0000-0002-0506-1510; Skerra, Arne/0000-0002-5717-498X; Koch, Stefan/0000-0003-3579-4229; Li, Linheng/0000-0001-9963-430X	National Institutes of Health [DK72564, DK61379, DK79392, DK53202, DK55679, DK59888, DK64399]; Crohn's and Colitis Foundation of America; German Research Foundation (Deutsche Forschungsgemeinschaft, Bonn, Germany) [La 2359/1-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059888, R01DK055679, R24DK064399, R01DK072564, R01DK079392, R01DK061379, R29DK055679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; German Research Foundation (Deutsche Forschungsgemeinschaft, Bonn, Germany)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank K. den Beste and A. Akyildiz for expert technical assistance and J. Brazil for support with cell isolation. A.S. wishes to thank C. Niehrs (DKFZ, Heidelberg, Germany) for kindly providing the mouse Dkkl cDNA. Supported by grants from the National Institutes of Health (DK72564, DK61379, and DK79392 to CAP.; DK53202, DK55679, and DK59888 to A.N.; and DK64399 [NIH DDRC tissue culture and morphology grant]), the Crohn's and Colitis Foundation of America (fellowship award to P.N., S.K., and C.T.C.), and the German Research Foundation (Deutsche Forschungsgemeinschaft, Bonn, Germany - La 2359/1-1 to M.G.L.).	Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; COOPER HS, 1993, LAB INVEST, V69, P238; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Feagins LA, 2009, NAT REV GASTRO HEPAT, V6, P297, DOI 10.1038/nrgastro.2009.44; Fish SM, 1999, GUT, V45, P191, DOI 10.1136/gut.45.2.191; Ganster RW, 2005, J INTERF CYTOK RES, V25, P707, DOI 10.1089/jir.2005.25.707; Gollob JA, 2005, CANCER RES, V65, P8869, DOI 10.1158/0008-5472.CAN-05-1387; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gunzel D, 2006, AM J PHYSIOL-REG I, V290, pR1496, DOI 10.1152/ajpregu.00470.2005; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Kaiser GC, 1999, EXP CELL RES, V249, P349, DOI 10.1006/excr.1999.4488; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Koch S, 2009, MOL BIOL CELL, V20, P4816, DOI 10.1091/mbc.E09-05-0415; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mi KH, 2007, J NEUROCHEM, V101, P517, DOI 10.1111/j.1471-4159.2007.04447.x; NAKAMURA M, 1992, GUT, V33, P933, DOI 10.1136/gut.33.7.933; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Pimentel-Muinos FX, 1999, IMMUNITY, V11, P783, DOI 10.1016/S1074-7613(00)80152-1; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Renes IB, 2002, INT J COLORECTAL DIS, V17, P317, DOI 10.1007/s00384-002-0409-4; Robinson CM, 2003, J INTERF CYTOK RES, V23, P413, DOI 10.1089/107999003322277829; Ruemmele FM, 1998, J CELL PHYSIOL, V176, P120, DOI 10.1002/(SICI)1097-4652(199807)176:1<120::AID-JCP14>3.3.CO;2-O; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schmitz H, 1999, J CELL SCI, V112, P137; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Seidelin JB, 2004, CYTOKINE, V27, P113, DOI 10.1016/j.cyto.2004.04.001; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; SERAFINI EP, 1981, GUT, V22, P648, DOI 10.1136/gut.22.8.648; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Voorzanger-Rousselot N, 2009, BRIT J HAEMATOL, V145, P264, DOI 10.1111/j.1365-2141.2009.07587.x; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Yin JY, 2009, J IMMUNOL, V182, P7069, DOI 10.4049/jimmunol.0802410; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001	56	224	229	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 26	2010	32	3					392	402		10.1016/j.immuni.2010.03.001	http://dx.doi.org/10.1016/j.immuni.2010.03.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20303298	Green Accepted, Bronze			2022-12-18	WOS:000276125400012
J	Chaturvedi, A; Dorward, D; Pierce, SK				Chaturvedi, Akanksha; Dorward, David; Pierce, Susan K.			The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-Containing antigens	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; ISOLATED RAT HEPATOCYTES; PHOSPHOLIPASE-D; CPG-DNA; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; ACQUIRED-IMMUNITY; CROSS-LINKING; BACTERIAL-DNA; KAPPA-B	Synergistic engagement of the B cell receptor (BCR) and Toll-like receptor 9 (TLR9) in response to DNA-containing antigens underlies the production of many autoantibodies in systemic autoimmune diseases. However, the molecular basis of this synergistic engagement is not known. Given that these receptors are spatially segregated, with the BCR on the cell surface and TLR9 in endocytic vesicles, achieving synergy must involve unique mechanisms. We show that upon antigen binding, the BCR initiates signaling at the plasma membrane and continues to signal to activate MAP kinases as it traffics to autophagosome-like compartments. The internalized BCR signals through a phospholipase-D-dependent pathway to recruit TLR9-containing endosomes to the autophagosome via the microtubular network. The recruitment of TLR9 to the autophagosomes was necessary for hyperactivation of MAP kinases. This unique mechanism for BCR-induced TLR9 recruitment resulting in B cells hyperresponses may provide new targets for therapeutics for autoimmune diseases.	[Chaturvedi, Akanksha; Pierce, Susan K.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Dorward, David] NIAID, Microscopy Unit, Rocky Mt Labs, Res Technol Sec,NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pierce, SK (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	spierce@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000899] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000899-07] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; Chaturvedi A, 2002, NAT IMMUNOL, V3, P951, DOI 10.1038/ni839; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Clark MR, 2003, ANN NY ACAD SCI, V987, P26, DOI 10.1111/j.1749-6632.2003.tb06030.x; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Goeckeritz BE, 1999, INT IMMUNOL, V11, P1693, DOI 10.1093/intimm/11.10.1693; Grimes ML, 1996, J NEUROSCI, V16, P7950; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lankar D, 2002, J EXP MED, V195, P461, DOI 10.1084/jem.20011543; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Lenert PS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1888; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Melendez AJ, 2002, SEMIN IMMUNOL, V14, P49, DOI 10.1006/smim.2001.0341; Peters JD, 1996, J BIOL CHEM, V271, P4755; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Siemasko K, 2001, CURR OPIN IMMUNOL, V13, P32, DOI 10.1016/S0952-7915(00)00178-3; Snyder MD, 2006, TRAFFIC, V7, P993, DOI 10.1111/j.1600-0854.2006.00450.x; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Yi AK, 2003, INT IMMUNOL, V15, P577, DOI 10.1093/intimm/dxg058	49	224	230	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2008	28	6					799	809		10.1016/j.immuni.2008.03.019	http://dx.doi.org/10.1016/j.immuni.2008.03.019			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18513998	Green Accepted, Bronze			2022-12-18	WOS:000256760200011
J	Agarwal, S; Avni, O; Rao, A				Agarwal, S; Avni, O; Rao, A			Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo	IMMUNITY			English	Article							INTERFERON-GAMMA PROMOTER; CYTOKINE GENE-EXPRESSION; ACTIVATED T-CELLS; FACTOR GATA-3; NUCLEAR FACTOR; TH2 CELLS; C-MAF; TH2-SPECIFIC EXPRESSION; HYPERSENSITIVE SITE; REGULATORY ELEMENTS	By DNase I hypersensitivity analysis, we have identified an inducible, cyclosporin A-sensitive enhancer located 3' of the interleukin-4 (IL-4) gene. The enhancer binds the Th2-specific transcription factor GATA3 in vivo but is not perceptibly influenced by the absence of a second Th2-specific factor, cMaf. The antigen-inducible transcription factor NFAT1 binds the IL-4 enhancer and the IL-4 promoter only in stimulated Th2 cells; conversely, NFAT1 binds to the interferon (IFN)-gamma promoter only in stimulated Th1 cells. Our results support a model whereby transcription factors such as NFAT1, which are nonselectively induced in antigen-stimulated T cells, gain access to cytokine regulatory regions only in the appropriate subset of differentiated T cells in vivo. This restricted access enables antigen-dependent and subset-specific transcription of cytokine genes.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Rao, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [R01CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297, R01AI044432] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA42471] Funding Source: Medline; NIAID NIH HHS [R01 AI44432, P01 AI35297] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 1999, J ALLERGY CLIN IMMUN, V103, P990, DOI 10.1016/S0091-6749(99)70168-5; Aune TM, 1997, MOL CELL BIOL, V17, P199, DOI 10.1128/MCB.17.1.199; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Boyes J, 1996, EMBO J, V15, P2496, DOI 10.1002/j.1460-2075.1996.tb00607.x; Brown MA, 1997, CRIT REV IMMUNOL, V17, P1; Campbell PM, 1996, TRANSPLANTATION, V61, P933, DOI 10.1097/00007890-199603270-00016; Cockerill P N, 2000, Methods Mol Biol, V130, P29; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Cron RQ, 1999, J IMMUNOL, V162, P860; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; HENKEL G, 1992, J IMMUNOL, V149, P3239; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hodge MR, 1996, SCIENCE, V274, P1903, DOI 10.1126/science.274.5294.1903; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Huang H, 1997, J IMMUNOL, V159, P3731; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Lederer JA, 1996, J EXP MED, V184, P397, DOI 10.1084/jem.184.2.397; Lee HJ, 1998, J IMMUNOL, V160, P2343; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; LiWeber M, 1997, J IMMUNOL, V158, P1194; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Murphy KM, 1998, CURR OPIN IMMUNOL, V10, P226, DOI 10.1016/S0952-7915(98)80253-7; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; ORKIN SH, 1995, J BIOL CHEM, V270, P4955, DOI 10.1074/jbc.270.10.4955; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; PENIX L, 1993, J EXP MED, V178, P1483, DOI 10.1084/jem.178.5.1483; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; Range LM, 1998, J PERS INTERPERS LOS, V3, P161, DOI 10.1080/10811449808414438; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; RAO A, 1984, J EXP MED, V159, P479, DOI 10.1084/jem.159.2.479; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rincon M, 1997, CURR BIOL, V7, pR729, DOI 10.1016/S0960-9822(06)00368-X; Rincon M, 1997, MOL CELL BIOL, V17, P1522, DOI 10.1128/MCB.17.3.1522; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; SCHINDLER U, 1995, IMMUNITY, V2, P689, DOI 10.1016/1074-7613(95)90013-6; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 1997, CURR OPIN IMMUNOL, V9, P776, DOI 10.1016/S0952-7915(97)80177-X; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Timmerman LA, 1997, J IMMUNOL, V159, P2735; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Wang DZ, 1995, ANN NY ACAD SCI, V766, P182, DOI 10.1111/j.1749-6632.1995.tb26661.x; Wenner CA, 1997, J IMMUNOL, V158, P765; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Young HA, 1996, J INTERF CYTOK RES, V16, P563, DOI 10.1089/jir.1996.16.563; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	69	224	227	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2000	12	6					643	652		10.1016/S1074-7613(00)80215-0	http://dx.doi.org/10.1016/S1074-7613(00)80215-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894164	Bronze			2022-12-18	WOS:000087937300006
J	Oukka, M; Ho, IC; de la Brousse, FC; Hoey, T; Grusby, MJ; Glimcher, LH				Oukka, M; Ho, IC; de la Brousse, FC; Hoey, T; Grusby, MJ; Glimcher, LH			The transcription factor NFAT4 is involved in the generation and survival of T cells	IMMUNITY			English	Article							RECEPTOR-DEFICIENT MICE; NEGATIVE SELECTION; THYMIC SELECTION; CYCLOSPORINE-A; NF-AT; NUCLEAR FACTOR; THYMOCYTE DIFFERENTIATION; CD4(+)CD8(+) THYMOCYTES; POSITIVE SELECTION; DNA FRAGMENTATION	Nuclear factor of activated T cells (NFAT) is a family of four related transcription factors implicated in cytokine and early response gene expression in activated lymphocytes. Here we report that NFAT4, in contrast to NFATp and NFATc, is preferentially expressed in DP thymocytes. Mice lacking NFAT4 have impaired development of CD4 and CD8 SP thymocytes and peripheral T cells as well as hyperactivation of peripheral T cells. The thymic defect is characterized by increased apoptosis of DP thymocytes. The increased apoptosis and hyperactivation may reflect heightened sensitivity to TcR-mediated signaling. Further, mice lacking NFAT4 have impaired production of Bcl-2 mRNA and protein. NFAT4 thus plays an important role in the successful generation and survival of T cells.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Tularik Inc, San Francisco, CA 94080 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI037833] Funding Source: NIH RePORTER; NIAID NIH HHS [AI/AG 37833] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Amasaki Y, 1998, J IMMUNOL, V160, P2324; ANDERSON G, 1995, J IMMUNOL, V154, P3636; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Bevan MJ, 1997, IMMUNITY, V7, P175, DOI 10.1016/S1074-7613(00)80520-8; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; Brady HJM, 1996, EMBO J, V15, P6991, DOI 10.1002/j.1460-2075.1996.tb01091.x; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; CORY S, 1995, ANNU REV IMMUNOL, V13, P513, DOI 10.1146/annurev.iy.13.040195.002501; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GORCZYCA W, 1992, INT J ONCOL, V1, P639; GRATIOTDEANS J, 1994, P NATL ACAD SCI USA, V91, P10685, DOI 10.1073/pnas.91.22.10685; GULBINS E, 1993, SCIENCE, V260, P822, DOI 10.1126/science.8484124; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hodge MR, 1996, SCIENCE, V274, P1903, DOI 10.1126/science.274.5294.1903; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Jacobson MD, 1997, CURR BIOL, V7, pR277, DOI 10.1016/S0960-9822(06)00136-9; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JENKINS MK, 1988, NATURE, V336, P1655; KIZAKI H, 1989, J IMMUNOL, V143, P1790; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; Leonard WJ, 1996, ANNU REV MED, V47, P229; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; NEGRINI M, 1987, CELL, V49, P455, DOI 10.1016/0092-8674(87)90448-X; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Penninger JM, 1997, IMMUNITY, V7, P243, DOI 10.1016/S1074-7613(00)80527-0; Poetschke HL, 1996, DEV IMMUNOL, V5, P1, DOI 10.1155/1996/57362; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Rincon M, 1996, MOL CELL BIOL, V16, P1074; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1994, NATURE, V368, P457, DOI 10.1038/368457a0; STRASSER A, 1994, P NATL ACAD SCI USA, V91, P1376, DOI 10.1073/pnas.91.4.1376; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Thomis DC, 1997, J EXP MED, V185, P197, DOI 10.1084/jem.185.2.197; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Timmerman LA, 1997, J IMMUNOL, V159, P2735; Turner H, 1997, J EXP MED, V185, P43, DOI 10.1084/jem.185.1.43; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VEIS DJ, 1993, J IMMUNOL, V151, P2546; vonBoehmer H, 1997, CURR BIOL, V7, pR308, DOI 10.1016/S0960-9822(06)00145-X; WANG CR, 1995, J EXP MED, V181, P927, DOI 10.1084/jem.181.3.927; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; WU J, 1995, MOL CELL BIOL, V15, P4337; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892	75	224	226	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1998	9	3					295	304		10.1016/S1074-7613(00)80612-3	http://dx.doi.org/10.1016/S1074-7613(00)80612-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768749	Bronze			2022-12-18	WOS:000076202300002
J	Gonzalo, JA; Jia, GQ; Aguirre, V; Friend, D; Coyle, AJ; Jenkins, NA; Lin, GS; Katz, H; Lichtman, A; Copeland, N; Kopf, M; GutierrezRamos, JC				Gonzalo, JA; Jia, GQ; Aguirre, V; Friend, D; Coyle, AJ; Jenkins, NA; Lin, GS; Katz, H; Lichtman, A; Copeland, N; Kopf, M; GutierrezRamos, JC			Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; CELL-ADHESION MOLECULE-1; TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR; DIFFERENTIATION FACTOR; GENE JE; CYTOKINE; IL-4; CLONING; INTERLEUKIN-5	A model of lung eosinophilia based on the repeated exposure of mice to aerosolized OVA has been used to identify C-C chemokine genes expressed at stages of massive eosinophil infiltration. We describe the identification and cloning of a cDNA that encodes a mouse C-C chemokine with 68% amino acid identity to guinea pig Eotaxin. The recombinant protein encoded by this gene displays potent and specific chemotactic activity for eosinophils, both in vivo and in vitro. Its mRNA levels parallel the kinetics of eosinophil accumulation in the lung during the experimentally induced eosinophilia and it is mainly produced by type I alveolar epithelial cells. The mRNA expression of mouse Eotaxin is not restricted to Th2 T cells in vitro and is independent of the development of a Th2-type response during N. brasiliensis infection, in vivo.	HARVARD UNIV,SCH MED,DEPT GENET,CAMBRIDGE,MA 02138; BRIGHAM & WOMENS HOSP,DIV RHEUMATOL,BOSTON,MA 02115; NCI,FREDERICK CANC RES & DEV CTR,MAMMALIAN GENET LAB,FREDERICK,MD 21702; BASEL INST IMMUNOL,BASEL,SWITZERLAND	Harvard University; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Gonzalo, JA (corresponding author), HARVARD UNIV,SCH MED,CTR BLOOD RES INC,CAMBRIDGE,MA 02138, USA.		Kopf, Manfred/B-6907-2009	Kopf, Manfred/0000-0002-0628-7140	NHLBI NIH HHS [HL 148675-02] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BRADLEY BL, 1991, J ALLERGY CLIN IMMUN, V88, P661, DOI 10.1016/0091-6749(91)90160-P; BRISCOE DM, 1992, J IMMUNOL, V149, P2954; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLOTTA F, 1992, J IMMUNOL, V148, P760; CONLON RA, 1992, DEVELOPMENT, V116, P357; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; COTRAN R, 1994, LUNG PATHOLOGIC BASI; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; DELPRETE G, 1988, J IMMUNOL, V140, P4193; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; DURHAM SR, 1992, J IMMUNOL, V148, P2390; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FRUMAN DA, 1995, J IMMUNOL, V154, P1846; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; GRIFFITHSJOHNSON DA, 1993, BIOCHEM BIOPH RES CO, V197, P1167, DOI 10.1006/bbrc.1993.2599; HOGAN B, 1985, MANIPULATING MOUSE E; JENNINGS F, 1963, EXP PARASITOL, V13, P363; JIA GQ, 1995, EUR J IMMUNOL, V25, P2096, DOI 10.1002/eji.1830250744; JOSE PJ, 1994, BIOCHEM BIOPH RES CO, V205, P788, DOI 10.1006/bbrc.1994.2734; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KAWAHARA RS, 1989, J BIOL CHEM, V264, P679; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; LARRICK JW, 1992, TRENDS BIOTECHNOL, V10, P146, DOI 10.1016/0167-7799(92)90202-7; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; LEDERER JA, 1994, J IMMUNOL, V152, P77; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; LI YS, 1993, MOL CELL BIOCHEM, V126, P61, DOI 10.1007/BF01772208; LOPEZ AF, 1986, J EXP MED, V163, P1085, DOI 10.1084/jem.163.5.1085; LUO Y, 1994, J IMMUNOL, V153, P4616; Maniatis T., 1982, MOL CLONING; MINTY A, 1993, EUR CYTOKINE NETW, V4, P99; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MOSSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145; Mossmann TR, 1986, J IMMUNOL, V136, P2348; NAKAJIMA H, 1994, J EXP MED, V179, P1145, DOI 10.1084/jem.179.4.1145; NEILSON EG, 1992, KIDNEY INT, V41, P220; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; PEREZ VL, 1995, INT IMMUNOL, V7, P869, DOI 10.1093/intimm/7.5.869; PONATH PD, 1996, IN PRESS J EXP MED; RAZIN E, 1984, J IMMUNOL, V132, P1479; RESNICK MB, 1993, AM J RESP CELL MOL, V8, P349, DOI 10.1165/ajrcmb/8.4.349; ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738; ROT A, 1992, J EXP MED, V176, P1489, DOI 10.1084/jem.176.6.1489; ROTHENBERG ME, 1995, J EXP MED, V181, P1211, DOI 10.1084/jem.181.3.1211; ROTHENBERG ME, 1995, P NATL ACAD SCI USA, V92, P8960, DOI 10.1073/pnas.92.19.8960; Sambrook J., 1989, MOL CLONING LAB MANU; SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STREET NE, 1990, J IMMUNOL, V144, P1629; SVETIC A, 1993, J IMMUNOL, V150, P3434; TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851; WELLER PF, 1991, P NATL ACAD SCI USA, V88, P7430, DOI 10.1073/pnas.88.16.7430; WIERENGA EA, 1990, J IMMUNOL, V144, P4651; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3; YOUN BS, 1996, IN PRESS J IMMUNOL	62	224	236	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1996	4	1					1	14		10.1016/S1074-7613(00)80293-9	http://dx.doi.org/10.1016/S1074-7613(00)80293-9			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TT319	8574847	Bronze			2022-12-18	WOS:A1996TT31900001
J	MURRAY, AG; KHODADOUST, MM; POBER, JS; BOTHWELL, ALM				MURRAY, AG; KHODADOUST, MM; POBER, JS; BOTHWELL, ALM			PORCINE AORTIC ENDOTHELIAL-CELLS ACTIVATE HUMAN T-CELLS - DIRECT PRESENTATION OF MHC ANTIGENS AND COSTIMULATION BY LIGANDS FOR HUMAN CD2 AND CD28	IMMUNITY			English	Article							VASCULAR ENDOTHELIUM; XENOGRAFT REJECTION; PRESENTING CELLS; LYMPHOCYTES; EXPRESSION; RESPONSES; INVITRO; HLA-A2; MOUSE; GAMMA	We examined the human xenoresponse to cultured porcine aortic endothelial cells (PAECs). Human CD8(+) T cells proliferate to resting MHC class I-positive PAECs. CD4(+) T cells proliferate after MHC class II molecules are induced with swine interferon-gamma. These responses are greater than corresponding allogeneic responses to human umbilical vein endothelial cells (HUVECs). Limiting dilution analysis shows a 10-fold higher frequency of xenoreactive than alloreactive anti-endothelial lymphocytes. Species-specific monoclonal antibodies suggest that PAECs directly present swine MHC antigens to human T cells and that human CD4 and CD8 molecules participate in this interaction. Furthermore, PAECs bind CTLA-4-lg and costimulate human T cells by both the CD2 and CD28 pathways. In contrast, HUVECs do not bind CTLA-4-lg and only use the CD2 pathway.	YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06520; YALE UNIV,SCH MED,DEPT BIOL,NEW HAVEN,CT 06520	Yale University; Yale University	MURRAY, AG (corresponding author), YALE UNIV,SCH MED,BOYER CTR MOLEC MED,MOLEC CARDIOBIOL PROGRAM,333 CEDAR ST,NEW HAVEN,CT 06510, USA.		Murray, Allan/F-3204-2011		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040924] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-43364] Funding Source: Medline; NIGMS NIH HHS [GM-40924] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS PW, 1992, J IMMUNOL, V148, P3753; ALTER BJ, 1990, J EXP MED, V171, P333, DOI 10.1084/jem.171.1.333; AUCHINCLOSS H, 1990, TRANSPLANT P, V22, P2335; BOUSSIOTIS VA, 1993, P NATL ACAD SCI USA, V90, P11059, DOI 10.1073/pnas.90.23.11059; DOUKAS J, 1990, J IMMUNOL, V145, P1088; Gimbrone M A Jr, 1976, Prog Hemost Thromb, V3, P1; HEISER A, 1992, TRANSPLANT P, V24, P2881; HUGHES CCW, 1990, J EXP MED, V171, P1453, DOI 10.1084/jem.171.5.1453; KIRK AD, 1993, TRANSPLANTATION, V55, P924, DOI 10.1097/00007890-199304000-00043; KOLLER TD, 1987, J IMMUNOL, V138, P2044; LAROSA FG, 1983, J EXP MED, V157, P898, DOI 10.1084/jem.157.3.898; LUCAS PJ, 1990, J IMMUNOL, V144, P4548; MENTZER SJ, 1986, J IMMUNOL, V137, P408; MEUER SC, 1982, P NATL ACAD SCI-BIOL, V79, P4395, DOI 10.1073/pnas.79.14.4395; MOSES RD, 1992, TRANSPLANTATION, V53, P203, DOI 10.1097/00007890-199201000-00039; MOSES RD, 1990, J EXP MED, V172, P567, DOI 10.1084/jem.172.2.567; Mossmann T., 1983, J IMMUNOL METHODS, V65, P55; PARDI R, 1987, J IMMUNOL, V139, P2585; PAWELEC G, 1979, TISSUE ANTIGENS, V14, P367; PESCOVITZ MD, 1984, TRANSPLANTATION, V37, P627; PIERSON RN, 1989, J EXP MED, V170, P991, DOI 10.1084/jem.170.3.991; POBER JS, 1983, J EXP MED, V157, P1339, DOI 10.1084/jem.157.4.1339; SACHS DH, 1990, HUM IMMUNOL, V28, P245, DOI 10.1016/0198-8859(90)90025-K; SAVAGE COS, 1991, CELL IMMUNOL, V137, P150, DOI 10.1016/0008-8749(91)90065-J; STGROTH SF, 1982, J IMMUNOL METHODS, V49, pR11; SWAIN SL, 1981, P NATL ACAD SCI-BIOL, V78, P7101, DOI 10.1073/pnas.78.11.7101; TASWELL C, 1981, J IMMUNOL, V126, P1614; WOOLNOUGH JA, 1979, AUST J EXP BIOL MED, V57, P467, DOI 10.1038/icb.1979.48	28	224	236	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1994	1	1					57	63		10.1016/1074-7613(94)90009-4	http://dx.doi.org/10.1016/1074-7613(94)90009-4			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK154	7889399				2022-12-18	WOS:A1994PK15400007
J	Neves, P; Lampropoulou, V; Calderon-Gomez, E; Roch, T; Stervbo, U; Shen, P; Kuhl, AA; Loddenkemper, C; Haury, M; Nedospasov, SA; Kaufmann, SHE; Steinhoff, U; Calado, DP; Fillatreau, S				Neves, Patricia; Lampropoulou, Vicky; Calderon-Gomez, Elisabeth; Roch, Toralf; Stervbo, Ulrik; Shen, Ping; Kuehl, Anja A.; Loddenkemper, Christoph; Haury, Matthias; Nedospasov, Sergei A.; Kaufmann, Stefan H. E.; Steinhoff, Ulrich; Calado, Dinis P.; Fillatreau, Simon			Signaling via the MyD88 Adaptor Protein in B Cells Suppresses Protective Immunity during Salmonella typhimurium Infection	IMMUNITY			English	Article							GAMMA-INTERFERON PRODUCTION; DEFICIENT MICE; DENDRITIC CELLS; IFN-GAMMA; T-CELLS; LISTERIA-MONOCYTOGENES; TOLERANCE INDUCTION; TRANSGENIC MOUSE; HOST-RESISTANCE; CUTTING EDGE	The myeloid differentiation primary response gene 88 (Myd88) is critical for protection against pathogens. However, we demonstrate here that MyD88 expression in B cells inhibits resistance of mice to Salmonella typhimurium infection. Selective deficiency of Myd88 in B cells improved control of bacterial replication and prolonged survival of the infected mice. The B cell-mediated suppressive pathway was even more striking after secondary challenge. Upon vaccination, mice lacking Myd88 in B cells became completely resistant against this otherwise lethal infection, whereas control mice were only partially protected. Analysis of immune defenses revealed that MyD88 signaling in B cells suppressed three crucial arms of protective immunity: neutrophils, natural killer cells, and inflammatory T cells. We further show that interleukin-10 is an essential mediator of these inhibitory functions of B cells. Collectively, our data identify a role for MyD88 and B cells in regulation of cellular mechanisms of protective immunity during infection.	[Neves, Patricia; Lampropoulou, Vicky; Calderon-Gomez, Elisabeth; Roch, Toralf; Stervbo, Ulrik; Shen, Ping; Nedospasov, Sergei A.; Fillatreau, Simon] Leibniz Inst, Deutsch Rheuma Forshungszentrum, D-10117 Berlin, Germany; [Kuehl, Anja A.; Loddenkemper, Christoph] Charite, Inst Pathol, RCIS, D-12200 Berlin, Germany; [Haury, Matthias; Calado, Dinis P.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Nedospasov, Sergei A.] VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; [Kaufmann, Stefan H. E.; Steinhoff, Ulrich] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Calado, Dinis P.] Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Calado, Dinis P.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Instituto Gulbenkian de Ciencia; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Max Planck Society; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Fillatreau, S (corresponding author), Leibniz Inst, Deutsch Rheuma Forshungszentrum, Charitepl 1, D-10117 Berlin, Germany.	fillatreau@drfz.de	Roch, Toralf/AAQ-7480-2021; Nedospasov, Sergei/J-5936-2013; Calado, Dinis/U-8379-2019; Nedospasov, Sergei/C-3043-2018; Nedospasov, Sergei/L-1990-2015; Nedospasov, Sergei/Q-7319-2016; Roch, Toralf/K-9531-2013; Stervbo, Ulrik/AAV-1561-2020; Kaufmann, Stefan HE/I-5454-2014	Calado, Dinis/0000-0001-8239-7184; Stervbo, Ulrik/0000-0002-2831-8868; Kuhl, Anja/0000-0003-2293-5387; Shen, Ping/0000-0003-3046-3818; Calderon-Gomez, Elisabeth/0000-0002-0675-0959; Kaufmann, Stefan HE/0000-0001-9866-8268; Steinhoff, Ulrich/0000-0003-2141-7756; Roch, Toralf/0000-0003-2948-8700; Haury, Matthias/0000-0002-1796-1479; Fillatreau, Simon/0000-0002-7730-9917	Deutsche Forschungsgemeinschaft [SFB-650, SFB633, DFG FI1238/1-1]; Hertie Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hertie Stiftung(Austrian Science Fund (FWF))	We thank C. Romagnani, P. Boudinot, and O. Neyrolles for critical reading of the manuscript. We thank O. Neyrolles for help with infection experiments and S. Spieckermann, K. Grollich, and I. Eickmeier for excellent help and technical assistance. We thank A. Radbruch, F. Melchers, I. MacLenann, C. Berek, A. Hamann, U. Hoffmann, T. Barr, and D. Gray for helpful discussions and advices. We thank E. Schott for allowing us to perform the ALT and AST measurements in his laboratory, and S. Akira for providing the Myd88<SUP>-/-</SUP>, TIr2<SUP>-/-</SUP>, and Tlr4<SUP>-/-</SUP> mice. Further enquiries for the IL-10.eGFP reporter mice should be addressed to D. Calado (calado@idi.harvard.edu). This work was supported by the Deutsche Forschungsgemeinschaft (SFB-650, SFB633, and DFG FI1238/1-1) and the Hertie Stiftung.	Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; Brundler MA, 1996, EUR J IMMUNOL, V26, P2257, DOI 10.1002/eji.1830260943; Buendia AJ, 2002, INFECT IMMUN, V70, P6911, DOI 10.1128/IAI.70.12.6911-6918.2002; Buendia AJ, 2009, INFECT IMMUN, V77, P4868, DOI 10.1128/IAI.00503-09; Conlan JW, 1996, INFECT IMMUN, V64, P1043, DOI 10.1128/IAI.64.3.1043-1047.1996; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; Dai WJ, 1997, J IMMUNOL, V158, P2259; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; El-Amine M, 2000, J IMMUNOL, V165, P5631, DOI 10.4049/jimmunol.165.10.5631; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Fillatreau S, 2003, J EXP MED, V197, P195, DOI 10.1084/jem.20021750; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Gargano LM, 2008, J VIROL, V82, P3853, DOI 10.1128/JVI.02577-07; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Goetz M, 2007, INFLAMM BOWEL DIS, V13, P1365, DOI 10.1002/ibd.20215; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Guay HM, 2007, J IMMUNOL, V178, P5124, DOI 10.4049/jimmunol.178.8.5124; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Hamel K, 2008, J IMMUNOL, V180, P4994, DOI 10.4049/jimmunol.180.7.4994; Hess J, 1996, J IMMUNOL, V156, P3321; Hochweller K, 2008, EUR J IMMUNOL, V38, P2776, DOI 10.1002/eji.200838659; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2007, NAT BIOTECHNOL, V25, P303, DOI 10.1038/nbt0307-303; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Lampropoulou V, 2010, IMMUNOL REV, V233, P146, DOI 10.1111/j.0105-2896.2009.00855.x; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Litzinger MT, 2005, J IMMUNOL, V175, P780, DOI 10.4049/jimmunol.175.2.780; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Mastroeni P, 1996, INFECT IMMUN, V64, P189, DOI 10.1128/IAI.64.1.189-196.1996; MASTROENI P, 1993, INFECT IMMUN, V61, P3981, DOI 10.1128/IAI.61.9.3981-3984.1993; Mastroeni P, 1999, INFECT IMMUN, V67, P478, DOI 10.1128/IAI.67.2.478-483.1999; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Moulin V, 2000, J EXP MED, V192, P475, DOI 10.1084/jem.192.4.475; Pang T, 1998, TRENDS MICROBIOL, V6, P131, DOI 10.1016/S0966-842X(98)01236-0; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Skupsky J, 2007, CURR GENE THER, V7, P369, DOI 10.2174/156652307782151443; Smelt SC, 2000, J IMMUNOL, V164, P3681, DOI 10.4049/jimmunol.164.7.3681; Sporri R, 2006, J IMMUNOL, V176, P6162, DOI 10.4049/jimmunol.176.10.6162; Stephens LA, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; Tam MA, 2008, IMMUNOL REV, V225, P140, DOI 10.1111/j.1600-065X.2008.00679.x; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Zambidis ET, 1997, J IMMUNOL, V158, P2174; Zhou SH, 2007, J IMMUNOL, V178, P5173, DOI 10.4049/jimmunol.178.8.5173	59	223	233	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 24	2010	33	5					777	790		10.1016/j.immuni.2010.10.016	http://dx.doi.org/10.1016/j.immuni.2010.10.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21093317	Bronze			2022-12-18	WOS:000286082600015
J	Min, BK; McHugh, R; Sempowski, GD; Mackall, C; Foucras, G; Paul, WE				Min, BK; McHugh, R; Sempowski, GD; Mackall, C; Foucras, G; Paul, WE			Neonates support lymphopenia-induced proliferation	IMMUNITY			English	Article							NAIVE T-CELLS; HOMEOSTATIC PROLIFERATION; LYMPHOCYTES-T; MEMORY CELLS; IN-VIVO; SURVIVAL; EXPANSION; INTERLEUKIN-7; IMMUNITY; LIGANDS	T cells expand without intentional antigen stimulation when transferred into adult lymphopenic environments. In this study, we show that the physiologic lymphopenic environment existing in neonatal mice also supports CD4 T cell proliferation. Strikingly, naive CD4 T cells that proliferate within neonates acquire the phenotypic and functional characteristics of memory cells. Such proliferation is inhibited by the presence of both memory and naive CD4 T cells, is enhanced by 3-day thymectomy, is independent of IL-7, and requires a class If MHC-TCR interaction and a CD28mediated signal. CD44(bright) CD4 T cells in neonates have a wide repertoire as judged by the distribution of VP expression. Thus, lymphopenia-induced T cell proliferation is a physiologic process that occurs during the early postnatal period.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Med, Human Vaccine Inst, Durham, NC 27710 USA; NCI, Pediat Oncol Branch, NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Paul, WE (corresponding author), NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA.		Li, Dapeng/HGE-1586-2022; FOUCRAS, Gilles/A-3061-2014	Li, Dapeng/0000-0003-0571-5876; FOUCRAS, Gilles/0000-0002-0363-0337; Sempowski, Gregory/0000-0003-0391-6594	NATIONAL CANCER INSTITUTE [Z01SC010281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000926, Z01AI000926] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adkins B, 2002, J IMMUNOL, V169, P4998, DOI 10.4049/jimmunol.169.9.4998; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; ALDERUCCIO F, 1993, J EXP MED, V178, P419, DOI 10.1084/jem.178.2.419; BELL EB, 1987, J IMMUNOL, V139, P1379; Bender J, 1999, J EXP MED, V190, P367, DOI 10.1084/jem.190.3.367; BONOMO A, 1995, IMMUNOL TODAY, V16, P61, DOI 10.1016/0167-5699(95)80089-1; Boursalian TE, 1999, J IMMUNOL, V162, P3795; Chang CM, 1997, J INTERF CYTOK RES, V17, P567, DOI 10.1089/jir.1997.17.567; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Clarke SRM, 2000, J IMMUNOL, V165, P2458, DOI 10.4049/jimmunol.165.5.2458; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dummer W, 2001, J IMMUNOL, V166, P2460, DOI 10.4049/jimmunol.166.4.2460; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fadel S, 2000, Int Rev Immunol, V19, P173, DOI 10.3109/08830180009088504; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Fry TJ, 2001, BLOOD, V97, P1525, DOI 10.1182/blood.V97.6.1525; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; Garcia AM, 2000, IMMUNOL RES, V22, P177, DOI 10.1385/IR:22:2-3:177; Ge Q, 2001, P NATL ACAD SCI USA, V98, P1728, DOI 10.1073/pnas.98.4.1728; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Grossman Z, 2001, CURR OPIN IMMUNOL, V13, P687, DOI 10.1016/S0952-7915(01)00280-1; Gudmundsdottir H, 2001, J IMMUNOL, V167, P3699, DOI 10.4049/jimmunol.167.7.3699; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Le Campion A, 2002, P NATL ACAD SCI USA, V99, P4538, DOI 10.1073/pnas.062621699; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; MODIGLIANI Y, 1994, EUR J IMMUNOL, V24, P1223, DOI 10.1002/eji.1830240533; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; Oehen S, 1999, EUR J IMMUNOL, V29, P608, DOI 10.1002/(SICI)1521-4141(199902)29:02<608::AID-IMMU608>3.0.CO;2-A; PIGUET PF, 1981, J EXP MED, V154, P581, DOI 10.1084/jem.154.3.581; Porter BO, 2001, J IMMUNOL, V166, P262, DOI 10.4049/jimmunol.166.1.262; Press W., 1992, NUMERICAL RECIPES C, VSecond edition.; Prlic M, 2001, J IMMUNOL, V167, P5664, DOI 10.4049/jimmunol.167.10.5664; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tanchot C, 2002, J IMMUNOL, V168, P5042, DOI 10.4049/jimmunol.168.10.5042; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Wang Q, 2001, J EXP MED, V194, P1721, DOI 10.1084/jem.194.12.1721	50	223	226	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2003	18	1					131	140		10.1016/S1074-7613(02)00508-3	http://dx.doi.org/10.1016/S1074-7613(02)00508-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530982	Bronze			2022-12-18	WOS:000180860600013
J	Fremont, DH; Monnaie, D; Nelson, CA; Hendrickson, WA; Unanue, ER				Fremont, DH; Monnaie, D; Nelson, CA; Hendrickson, WA; Unanue, ER			Crystal structure of I-A(k) in complex with a dominant epitope of lysozyme	IMMUNITY			English	Article							CLASS-II MOLECULE; BOUND SINGLE PEPTIDES; T-CELL RECEPTOR; MHC CLASS-I; IMMUNOGENIC PEPTIDES; BINDING; EXPRESSION; HLA-DR1; PH; IDENTIFICATION	We have determined the structure of murine MHC class II I-A(k) in complex with a naturally processed peptide from hen egg lysozyme (HEL residues 50-62) at 1.9 Angstrom resolution. These results provide a structural basis for the I-A(k) peptide-binding motif. Binding is established by the deep burial of five anchor side chains into specific pockets of the I-A(k) binding groove, with a ten-like fit of an aspartic acid in the P1 pocket. We also show that in the I-A(k) alpha chain, a bulge occurs in the first strand of the peptide-binding platform, an insertion probably common to all I-A and HLA-DQ alleles. The I-A(k) beta chain has a deletion in the helical region adjacent to the P7 pocket and an insertion in the helical region neighboring the P1 pocket. As a result of these structural features, the extended HEL peptide dips low into the center of the I-A(k) groove and reaches toward solvent at its C-terminal end.	Washington Univ, Sch Med, Ctr Immunol, Dept Pathol, St Louis, MO 63110 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Washington University (WUSTL); Columbia University; Howard Hughes Medical Institute	Fremont, DH (corresponding author), Washington Univ, Sch Med, Ctr Immunol, Dept Pathol, St Louis, MO 63110 USA.	fremont@immunology.wustl.edu		Fremont, Daved/0000-0002-8544-2689				ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; ADORINI L, 1988, J EXP MED, V168, P2091, DOI 10.1084/jem.168.6.2091; ALLEN PM, 1984, J IMMUNOL, V132, P1077; ALLEN PM, 1987, NATURE, V327, P713, DOI 10.1038/327713a0; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Carson RT, 1997, IMMUNITY, V7, P387, DOI 10.1016/S1074-7613(00)80360-X; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; COSGROVE D, 1992, J EXP MED, V176, P629, DOI 10.1084/jem.176.2.629; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; FIGUEROA F, 1989, IMMUNOGENETICS, V30, P222, DOI 10.1007/BF02421211; FIGUEROA F, 1990, IMMUNOL REV, V113, P27, DOI 10.1111/j.1600-065X.1990.tb00035.x; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; HARDING CV, 1991, P NATL ACAD SCI USA, V88, P2740, DOI 10.1073/pnas.88.7.2740; HEINZ DW, 1993, NATURE, V361, P561, DOI 10.1038/361561a0; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABAT EA, 1991, NIH PUBLICATION, P2597; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Low M.G., 1992, LIPID MODIFICATION P, P117; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; Nelson CA, 1996, J IMMUNOL, V157, P755; Nelson CA, 1996, J IMMUNOL, V156, P176; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; Nelson CA, 1996, IMMUNOL REV, V151, P81, DOI 10.1111/j.1600-065X.1996.tb00704.x; NIZETIC D, 1987, P NATL ACAD SCI USA, V84, P5828, DOI 10.1073/pnas.84.16.5828; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; REAY PA, 1994, J IMMUNOL, V152, P3946; REAY PA, 1992, EMBO J, V11, P2829, DOI 10.1002/j.1460-2075.1992.tb05350.x; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SANT AJ, 1987, P NATL ACAD SCI USA, V84, P8065, DOI 10.1073/pnas.84.22.8065; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; SPENCER JS, 1993, J IMMUNOL, V151, P6822; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Viner NJ, 1996, J IMMUNOL, V156, P2365; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219	50	223	230	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1998	8	3					305	317		10.1016/S1074-7613(00)80536-1	http://dx.doi.org/10.1016/S1074-7613(00)80536-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZD622	9529148	hybrid			2022-12-18	WOS:000072705300004
J	Sigvardsson, M; ORiordan, M; Grosschedl, R				Sigvardsson, M; ORiordan, M; Grosschedl, R			EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes	IMMUNITY			English	Article							B-CELL DEVELOPMENT; LOOP-HELIX PROTEINS; ANTIGEN RECEPTOR COMPLEX; DNA-BINDING PROTEINS; LYMPHOCYTES-PRE-B; TRANSCRIPTION FACTOR; LAMBDA-5 GENE; HEAVY-CHAIN; IG-BETA; MOUSE	Early B cell factor (EBF) and E47 participate in the transcriptional control of early B lymphocyte differentiation. With the aim of identifying genetic targets for these transcription factors, we stably transfected cDNAs encoding EBF or a covalent homodimer of E47, individually or together, into immature hematopoietic Ba/F3 cells, which lack both factors. In combination, EBF and E47 induce efficient expression of the endogenous immunoglobulin surrogate light chain genes, lambda 5 and VpreB, whereas other pre-B cell-specific genes remain silent. Multiple functionally important EBF and E47 binding sites were identified in the lambda 5 promoter/enhancer region, indicating that lambda 5 is a direct genetic target for these transcription factors. Taken these data suggest that EBF and E47 synergize to activate expression of a subset of genes that define an early stage of the B cell lineage.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT MICROBIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco			O'Riordan, Mary/D-8227-2011	O'Riordan, Mary/0000-0001-6014-4637; Sigvardsson, Mikael/0000-0001-8527-7276				ALT F, 1987, SCIENCE, V236, P1079; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; Borst J, 1996, CURR OPIN IMMUNOL, V8, P181, DOI 10.1016/S0952-7915(96)80056-2; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; BROUNS GS, 1993, EUR J IMMUNOL, V23, P1088, DOI 10.1002/eji.1830230517; Choi JK, 1996, EMBO J, V15, P5014, DOI 10.1002/j.1460-2075.1996.tb00881.x; CORCORAN LM, 1993, GENE DEV, V7, P570, DOI 10.1101/gad.7.4.570; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; EMERSON CP, 1993, CURR OPIN GENET DEV, V3, P265, DOI 10.1016/0959-437X(93)90033-L; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; HAGMAN J, 1991, EMBO J, V10, P3409, DOI 10.1002/j.1460-2075.1991.tb04905.x; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; HOMBACH J, 1990, EUR J IMMUNOL, V20, P2795, DOI 10.1002/eji.1830201239; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; JACOBS Y, 1994, MOL CELL BIOL, V14, P4087, DOI 10.1128/MCB.14.6.4087; KADESCH T, 1992, IMMUNOL TODAY, V13, P31, DOI 10.1016/0167-5699(92)90201-H; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; KUDO A, 1987, EMBO J, V6, P103, DOI 10.1002/j.1460-2075.1987.tb04725.x; KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; MARTENSSON IL, 1994, INT IMMUNOL, V6, P863, DOI 10.1093/intimm/6.6.863; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MURRE C, 1991, MOL CELL BIOL, V11, P1156, DOI 10.1128/MCB.11.2.1156; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAKAMURA T, 1992, P NATL ACAD SCI USA, V89, P8522, DOI 10.1073/pnas.89.18.8522; NEUHOLD LA, 1993, CELL, V74, P1033, DOI 10.1016/0092-8674(93)90725-6; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; OKABE T, 1992, EUR J IMMUNOL, V22, P31, DOI 10.1002/eji.1830220106; OKABE T, 1992, EUR J IMMUNOL, V22, P37, DOI 10.1002/eji.1830220107; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; PEVERALI FA, 1994, EMBO J, V13, P4291, DOI 10.1002/j.1460-2075.1994.tb06749.x; QUONG MW, 1993, MOL CELL BIOL, V13, P792, DOI 10.1128/MCB.13.2.792; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sigvardsson M, 1996, J IMMUNOL, V156, P3788; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TRAVIS A, 1993, MOL CELL BIOL, V13, P3392, DOI 10.1128/MCB.13.6.3392; TRAVIS A, 1991, MOL CELL BIOL, V11, P5756, DOI 10.1128/MCB.11.11.5756; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; YANG J, 1995, J IMMUNOL, V155, P2498; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	71	223	225	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1997	7	1					25	36		10.1016/S1074-7613(00)80507-5	http://dx.doi.org/10.1016/S1074-7613(00)80507-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252117	Bronze			2022-12-18	WOS:A1997XN69300003
J	Bonnet, MC; Preukschat, D; Welz, PS; van Loo, G; Ermolaeva, MA; Bloch, W; Haase, I; Pasparakis, M				Bonnet, Marion C.; Preukschat, Daniela; Welz, Patrick-Simon; van Loo, Geert; Ermolaeva, Maria A.; Bloch, Wilhelm; Haase, Ingo; Pasparakis, Manolis			The Adaptor Protein FADD Protects Epidermal Keratinocytes from Necroptosis In Vivo and Prevents Skin Inflammation	IMMUNITY			English	Article							RECEPTOR-INTERACTING PROTEIN; CELL-DEATH; TARGETED DISRUPTION; PROGRAMMED NECROSIS; B-CELL; MICE; IMMUNE; INHIBITION; IDENTIFICATION; REQUIREMENT	Epidermal keratinocytes provide an essential structural and immunological barrier forming the first line of defense against potentially pathogenic microorganisms. Mechanisms regulating barrier integrity and innate immune responses in the epidermis are important for the maintenance of skin immune homeostasis and the pathogenesis of inflammatory skin diseases. Here, we show that epidermal keratinocyte-restricted deficiency of the adaptor protein FADD (FADD(E-KO)) induced severe inflammatory skin lesions in mice. The development of skin inflammation in FADD(E-KO) mice was triggered by RIP kinase 3 (RIP3)-mediated programmed necrosis (termed necroptosis) of FADD-deficient keratinocytes, which was partly dependent on the deubiquitinating enzyme CYLD and tumor necrosis factor (TNF)-TNF receptor 1 signaling. Collectively, our findings provide an in vivo experimental paradigm that regulation of necroptosis in keratinocytes is important for the maintenance of immune homeostasis and the prevention of chronic inflammation in the skin.	[Bonnet, Marion C.; Preukschat, Daniela; Welz, Patrick-Simon; Ermolaeva, Maria A.; Pasparakis, Manolis] Univ Cologne, Inst Genet, Ctr Mol Med CMMC, D-50674 Cologne, Germany; [van Loo, Geert] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [van Loo, Geert] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Bloch, Wilhelm] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, D-50933 Cologne, Germany; [Haase, Ingo] Univ Cologne, Dept Dermatol, D-50924 Cologne, Germany	University of Cologne; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; German Sport University Cologne; University of Cologne	Pasparakis, M (corresponding author), Univ Cologne, Inst Genet, Ctr Mol Med CMMC, Zulpicher Str 47A, D-50674 Cologne, Germany.	pasparakis@uni-koeln.de	Bonnet, Marion C/C-5612-2014; Welz, Patrick-Simon/F-3856-2016; , van Loo Geert/AAD-1220-2019; Pasparakis, Manolis/H-9292-2017; Pasparakis, Manolis/N-4350-2019; van Loo, Geert/C-1505-2009	Bonnet, Marion C/0000-0002-7559-2413; Welz, Patrick-Simon/0000-0001-8370-625X; , van Loo Geert/0000-0002-8427-4775; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; 	Deutsche Forschungsgemeinschaft [SFB829, SFB670]; European Commission (EC) [223151, 223404]; "Group-ID MRP" of the Ghent University; International Graduate School in Genetics and Functional Genomics at the University of Cologne	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); "Group-ID MRP" of the Ghent University; International Graduate School in Genetics and Functional Genomics at the University of Cologne	We thank C. Uthoff-Hachenberg, J. Pfeiffer, E. Mahlberg, D. Beier, J. Buchholz, B. Hulser, B. Wolff, and M. Ghilav for excellent technical support. We also thank V. Dixit and K. Newton (Genentech Inc.) for providing Ripk3<SUP>-/-</SUP> mice. This work was funded by grants from the Deutsche Forschungsgemeinschaft (SFB829, SFB670) and European Commission FP7 program grants "INFLA-CARE" (EC contract number 223151) and "Masterswitch" (EC contract number 223404) to M.P. G.v.L. was supported by the "Group-ID MRP" of the Ghent University. P.-S.W. was supported by a fellowship from the International Graduate School in Genetics and Functional Genomics at the University of Cologne.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Challa S, 2010, CELL MOL LIFE SCI, V67, P3241, DOI 10.1007/s00018-010-0413-8; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Elias PM, 2007, SEMIN IMMUNOPATHOL, V29, P3, DOI 10.1007/s00281-007-0060-9; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; Luschen S, 2000, J BIOL CHEM, V275, P24670, DOI 10.1074/jbc.M003280200; Mc Guire C, 2010, J IMMUNOL, V185, P7646, DOI 10.4049/jimmunol.1000930; Mossner R, 2008, CLIN DERMATOL, V26, P486, DOI 10.1016/j.clindermatol.2007.10.030; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nenci A, 2006, HUM MOL GENET, V15, P531, DOI 10.1093/hmg/ddi470; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Torres MJ, 2009, J INVEST ALLERG CLIN, V19, P80; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	45	222	232	3	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 28	2011	35	4					572	582		10.1016/j.immuni.2011.08.014	http://dx.doi.org/10.1016/j.immuni.2011.08.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22000287	Bronze, Green Accepted			2022-12-18	WOS:000296657700016
J	Lin, YY; Ritchea, S; Logar, A; Slight, S; Messmer, M; Rangel-Moreno, J; Guglani, L; Alcorn, JF; Strawbridge, H; Park, SM; Onishi, R; Nyugen, N; Walter, MJ; Pociask, D; Randall, TD; Gaffen, SL; Iwakura, Y; Kolls, JK; Khader, SA				Lin, Yinyao; Ritchea, Shane; Logar, Alison; Slight, Samantha; Messmer, Michelle; Rangel-Moreno, Javier; Guglani, Lokesh; Alcorn, John F.; Strawbridge, Heather; Park, Sang Mi; Onishi, Reiko; Nyugen, Nikki; Walter, Michael J.; Pociask, Derek; Randall, Troy D.; Gaffen, Sarah L.; Iwakura, Yoichiro; Kolls, Jay K.; Khader, Shabaana A.			Interleukin-17 Is Required for T Helper 1 Cell Immunity and Host Resistance to the Intracellular Pathogen Francisella tularensis	IMMUNITY			English	Article							IN-VIVO; DENDRITIC CELLS; GAMMA-INTERFERON; IL-17 RECEPTOR; T-CELLS; INFECTION; DEFENSE; IL-23; RESPONSES; MICE	The importance of T helper type 1 (Th1) cell immunity in host resistance to the intracellular bacterium Francisella tularensis is well established. However, the relative roles of interleukin (IL)-12-Th1 and IL-23-Th17 cell responses in immunity to F. tularensis have not been studied. The IL-23-Th17 cell pathway is critical for protective immunity against extracellular bacterial infections. In contrast, the IL-23-Th17 cell pathway is dispensable for protection against intracellular pathogens such as Mycobacteria. Here we show that the IL-23-Th17 pathway regulates the IL-12-Th1 cell pathway and was required for protective immunity against F.tularensis live vaccine strain. We show that IL-17A, but not IL-17F or IL-22, induced IL-12 production in dendritic cells and mediated Th1 responses. Furthermore, we show that IL-17A also induced IL-12 and interferon-gamma production in macrophages and mediated bacterial killing. Together, these findings illustrate a biological function for IL-17A in regulating IL-12-Th1 cell immunity and host responses to an intracellular pathogen.	[Lin, Yinyao; Ritchea, Shane; Logar, Alison; Slight, Samantha; Messmer, Michelle; Guglani, Lokesh; Alcorn, John F.; Strawbridge, Heather; Nyugen, Nikki; Pociask, Derek; Kolls, Jay K.; Khader, Shabaana A.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Rangel-Moreno, Javier; Randall, Troy D.] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Dept Med, Rochester, NY 12642 USA; [Park, Sang Mi; Onishi, Reiko; Gaffen, Sarah L.] Univ Pittsburgh, Sch Med, Dept Med, Div Clin Immunol & Rheumatol, Pittsburgh, PA 15213 USA; [Walter, Michael J.] Washington Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Tokyo 1088639, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); University of Tokyo	Khader, SA (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA.	shabaana.khader@chp.edu	Guglani, Lokesh/A-3159-2011; Kolls, Jay/AAH-1829-2019; Iwakura, Yoichiro/E-5457-2011; Messmer, Michelle N/J-8416-2013; Guglani, Lokesh/N-6530-2019	Guglani, Lokesh/0000-0001-8145-0430; Kolls, Jay/0000-0001-5151-6304; Iwakura, Yoichiro/0000-0002-9934-5775; Messmer, Michelle N/0000-0002-7597-8615; Guglani, Lokesh/0000-0001-8145-0430; Webb, Samantha/0000-0003-2653-1005; A Khader, Shabaana/0000-0002-9545-4982; Rangel-Moreno, Javier/0000-0002-9738-1182	Children's Hospital Of Pittsburgh [A1075106, HL69409, AR054389]; Amgen Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409, R37HL079142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI075106, K99AI075106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054389] Funding Source: NIH RePORTER	Children's Hospital Of Pittsburgh; Amgen Inc(Amgen); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Children's Hospital Of Pittsburgh and A1075106 to S.A.K., HL69409 to T.D.R., and AR054389 to S.L.G. The authors thank L. Bauer and A. Magill for technical help and G. Kirimanjeswara and D. Metzger, Albany Medical College, for F. tularensis LVS infection protocols. They also thank N. Ghilardi and O. Wenjun, Genentech Inc., for providing II23a<SUP>-/-</SUP> and II22<SUP>-/-</SUP> mice, respectively. II17ra<SUP>-/-</SUP> mice were a kind gift from Amgen Inc. The authors thank J. Piganelli for critical reading of the manuscript. S.L.G. has received travel reimbursement, honoraria, and a research grant from Amgen Inc.	Allen LAH, 2007, IMMUNOL REV, V219, P103, DOI 10.1111/j.1600-065X.2007.00544.x; ANTHONY LSD, 1989, MICROB PATHOGENESIS, V7, P421, DOI 10.1016/0882-4010(89)90022-3; Ashtekar AR, 2008, J LEUKOCYTE BIOL, V84, P1434, DOI 10.1189/jlb.0308215; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; Butchar JP, 2007, J IMMUNOL, V178, P4445, DOI 10.4049/jimmunol.178.7.4445; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Duckett NS, 2005, INFECT IMMUN, V73, P2306, DOI 10.1128/IAI.73.4.2306-2311.2005; FLESCH IEA, 1995, J EXP MED, V181, P1615, DOI 10.1084/jem.181.5.1615; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hong KJ, 2007, INFECT IMMUN, V75, P5338, DOI 10.1128/IAI.00561-07; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Jang S, 2004, J IMMUNOL, V173, P3392, DOI 10.4049/jimmunol.173.5.3392; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee KA, 2008, CELL IMMUNOL, V251, P50, DOI 10.1016/j.cellimm.2008.03.004; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Piccotti JR, 1999, TRANSPLANTATION, V67, P1453, DOI 10.1097/00007890-199906150-00011; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Shen F, 2008, CYTOKINE, V41, P92, DOI 10.1016/j.cyto.2007.11.013; SJOSTEDT A, 1994, INFECT IMMUN, V62, P2779; Skeen MJ, 1996, J IMMUNOL, V156, P1196; Smith E, 2008, J IMMUNOL, V181, P1357, DOI 10.4049/jimmunol.181.2.1357; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	47	222	227	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2009	31	5					799	810		10.1016/j.immuni.2009.08.025	http://dx.doi.org/10.1016/j.immuni.2009.08.025			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19853481	Bronze, Green Accepted			2022-12-18	WOS:000272097900014
J	Lechler, R; Ng, WF; Steinman, RM				Lechler, R; Ng, WF; Steinman, RM			Dendritic cells in transplantation - Friend or foe?	IMMUNITY			English	Review							ANTIGEN-PRESENTING CELLS; COMPLEX CLASS-I; MHC CLASS-II; DONOR-SPECIFIC HYPORESPONSIVENESS; CARDIAC ALLOGRAFT-REJECTION; CD8(+) T-CELLS; EPITHELIAL-CELLS; APOPTOTIC CELLS; SELF-ANTIGENS; EFFICIENT PRESENTATION		Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Dept Immunol,Div Med, London W12 0NN, England; Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA	Imperial College London; Rockefeller University	Lechler, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Dept Immunol,Div Med, Du Cane Rd, London W12 0NN, England.		Steinman, Ralph/F-7729-2012; Ng, Wan-Fai/R-8083-2016	Ng, Wan-Fai/0000-0002-5539-388X				Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Ali A, 2000, TRANSPLANTATION, V69, P221, DOI 10.1097/00007890-200001270-00005; Auchincloss H, 1996, CURR OPIN IMMUNOL, V8, P681, DOI 10.1016/S0952-7915(96)80086-0; BAKER RJ, 2001, IN PRESS TRANSPLANTA; BARKER CF, 1968, J EXP MED, V128, P197, DOI 10.1084/jem.128.1.197; Bingaman AW, 2000, J IMMUNOL, V164, P3065, DOI 10.4049/jimmunol.164.6.3065; BOWEN K M, 1980, Diabetes, V29, P98; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Chowdhury NC, 1996, TRANSPLANTATION, V62, P1878, DOI 10.1097/00007890-199612270-00034; Coulombe M, 1999, J IMMUNOL, V162, P2503; CYSTER JG, 1999, IMMUNITY, V8, P543; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Forster I, 1996, EUR J IMMUNOL, V26, P3194, DOI 10.1002/eji.1830261253; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; Frasca L, 1998, KIDNEY INT, V53, P679, DOI 10.1046/j.1523-1755.1998.00800.x; FREY JR, 1957, INT ARCH ALLER A IMM, V11, P81, DOI 10.1159/000228405; Fu FM, 1996, TRANSPLANTATION, V62, P659, DOI 10.1097/00007890-199609150-00021; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; HOLT PG, 1994, J IMMUNOL, V153, P256; Hornick PI, 1998, CIRCULATION, V97, P1257, DOI 10.1161/01.CIR.97.13.1257; Hornick PI, 2000, CIRCULATION, V101, P2405, DOI 10.1161/01.CIR.101.20.2405; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Josien R, 1998, BLOOD, V92, P4539, DOI 10.1182/blood.V92.12.4539.424k40_4539_4544; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; King WJ, 2000, TRANSPLANTATION, V70, P1225, DOI 10.1097/00007890-200010270-00017; Krasinskas AM, 2000, TRANSPLANTATION, V70, P514, DOI 10.1097/00007890-200008150-00020; Kronin V, 1996, J IMMUNOL, V157, P3819; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; LECHLER RI, 1990, IMMUNOL TODAY, V11, P83, DOI 10.1016/0167-5699(90)90033-6; LECHLER RI, 1982, J EXP MED, V155, P31, DOI 10.1084/jem.155.1.31; LECHLER RI, 1982, J EXP MED, V156, P1835, DOI 10.1084/jem.156.6.1835; Lee WC, 1998, TRANSPLANTATION, V66, P1810, DOI 10.1097/00007890-199812270-00040; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Liu ZR, 1996, J CLIN INVEST, V98, P1150, DOI 10.1172/JCI118898; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Marelli-Berg FM, 1997, J IMMUNOL, V159, P5853; Mason PD, 1996, KIDNEY INT, V50, P1019, DOI 10.1038/ki.1996.404; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Min WP, 2000, J IMMUNOL, V164, P161, DOI 10.4049/jimmunol.164.1.161; Morgan DJ, 1999, J IMMUNOL, V163, P723; Munz C, 2000, J EXP MED, V191, P1649, DOI 10.1084/jem.191.10.1649; Niederkorn J Y, 1999, Chem Immunol, V73, P59; O'Rourke RW, 2000, TRANSPLANTATION, V69, P1440, DOI 10.1097/00007890-200004150-00039; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Pietra BA, 2000, J CLIN INVEST, V106, P1003, DOI 10.1172/JCI10467; Rea D, 2000, BLOOD, V95, P3162, DOI 10.1182/blood.V95.10.3162.010k18_3162_3167; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; SAKAGUCHI S, 1990, J EXP MED, V172, P537, DOI 10.1084/jem.172.2.537; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Schuurhuis DH, 2000, J EXP MED, V192, P145, DOI 10.1084/jem.192.1.145; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; SivaSai KSR, 1999, TRANSPLANTATION, V67, P1094, DOI 10.1097/00007890-199904270-00002; Starzl TE, 1996, IMMUNOL TODAY, V17, P577, DOI 10.1016/S0167-5699(96)10070-0; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; SUN JH, 1995, TRANSPLANTATION, V60, P233, DOI 10.1097/00007890-199508000-00004; Takayama T, 1998, TRANSPLANTATION, V66, P1567, DOI 10.1097/00007890-199812270-00001; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Vella JP, 1997, TRANSPLANTATION, V64, P795, DOI 10.1097/00007890-199709270-00001; Zavazava N, 2000, J LEUKOCYTE BIOL, V67, P793, DOI 10.1002/jlb.67.6.793	78	222	242	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2001	14	4					357	368		10.1016/S1074-7613(01)00116-9	http://dx.doi.org/10.1016/S1074-7613(01)00116-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336681	Green Published, Bronze			2022-12-18	WOS:000168246700003
J	Mattila, PK; Feest, C; Depoil, D; Treanor, B; Montaner, B; Otipoby, KL; Carter, R; Justement, LB; Bruckbauer, A; Batista, FD				Mattila, Pieta K.; Feest, Christoph; Depoil, David; Treanor, Bebhinn; Montaner, Beatriz; Otipoby, Kevin L.; Carter, Robert; Justement, Louis B.; Bruckbauer, Andreas; Batista, Facundo D.			The Actin and Tetraspanin Networks Organize Receptor Nanoclusters to Regulate B Cell Receptor-Mediated Signaling	IMMUNITY			English	Article							IMMUNE-SYNAPSE FORMATION; ANTIGEN RECEPTOR; MICROCLUSTER FORMATION; LYMPHOCYTE DEVELOPMENT; MEMBRANE; MICE; ACTIVATION; RESPONSES; TRANSDUCTION; EXPRESSION	A key role is emerging for the cytoskeleton in coordinating receptor signaling, although the underlying molecular requirements remain unclear. Here we show that cytoskeleton disruption triggered signaling requiring not only the B cell receptor (BCR), but also the coreceptor CD19 and tetraspanin CD81, thus providing a mechanism for signal amplification upon surface-bound antigen stimulation. By using superresolution microscopy, we demonstrated that endogenous IgM, IgD, and CD19 exhibited distinct nanoscale organization within the plasma membrane of primary B cells. Upon stimulation, we detect a local convergence of receptors, although their global organization was not dramatically altered. Thus, we postulate that cytoskeleton reorganization releases BCR nanoclusters, which can interact with CD19 held in place by the tetraspanin network. These results not only suggest that receptor compartmentalization regulates antigen-induced activation but also imply a potential role for CD19 in mediating ligand-independent "tonic'' BCR signaling necessary for B cell survival.	[Mattila, Pieta K.; Feest, Christoph; Depoil, David; Treanor, Bebhinn; Montaner, Beatriz; Bruckbauer, Andreas; Batista, Facundo D.] Canc Res UK, London Res Inst, Lymphocyte Interact Lab, London WC2A 3LY, England; [Otipoby, Kevin L.] Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; [Otipoby, Kevin L.] Immune Dis Inst, Boston, MA 02115 USA; [Carter, Robert] NIAMSD, NIH, Bethesda, MD 20892 USA; [Justement, Louis B.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Cancer Research UK; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Alabama System; University of Alabama Birmingham	Batista, FD (corresponding author), Canc Res UK, London Res Inst, Lymphocyte Interact Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	facundo.batista@cancer.org.uk	Mattila, Pieta K/G-6815-2013; Feest, Christoph/C-7874-2013	Mattila, Pieta K/0000-0003-2805-0686; Feest, Christoph/0000-0002-0772-7267; Justement, Louis/0000-0001-7058-867X; Montaner, Beatriz/0000-0001-9877-7317	Cancer Research UK; Royal Society Wolfson Research Merit Award; Human Frontier Science Program; Cancer Research UK [15691] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Royal Society Wolfson Research Merit Award(Royal Society of London); Human Frontier Science Program(Human Frontier Science Program); Cancer Research UK(Cancer Research UK)	We are extremely thankful to K. Rajewsky, K. Okkenhaug, and S. Levy for providing B1-8f Igh, Cd21-cre, E mu-Bcl2 transgenic, PI3K delta-mutant, and CD81-deficient mice, respectively. We would also like to thank D. Bray and members of the Lymphocyte Interaction Laboratory for critically reading the manuscript and for helpful discussions and comments. This work was supported by Cancer Research UK, Royal Society Wolfson Research Merit Award (F. D. B.), and Human Frontier Science Program (P.K.M.).	BAEKER TR, 1987, J IMMUNOL, V138, P2691; Cherukuri A, 2004, J BIOL CHEM, V279, P31973, DOI 10.1074/jbc.M404410200; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Freeman SN, 2011, J IMMUNOL, V187, P5887, DOI 10.4049/jimmunol.1102233; Fujimoto M, 1999, IMMUNITY, V11, P191, DOI 10.1016/S1074-7613(00)80094-1; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Maecker HT, 1997, J EXP MED, V185, P1505, DOI 10.1084/jem.185.8.1505; Meyer-Bahlburg A, 2008, BLOOD, V112, P4158, DOI 10.1182/blood-2008-02-140814; Miyazaki T, 1997, EMBO J, V16, P4217, DOI 10.1093/emboj/16.14.4217; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sato S, 1997, J IMMUNOL, V159, P3278; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Sohn HW, 2008, J IMMUNOL, V180, P793, DOI 10.4049/jimmunol.180.2.793; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Treanor B, 2011, J EXP MED, V208, P1055, DOI 10.1084/jem.20101125; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; Tsitsikov EN, 1997, P NATL ACAD SCI USA, V94, P10844, DOI 10.1073/pnas.94.20.10844; UNANUE ER, 1972, J EXP MED, V136, P885, DOI 10.1084/jem.136.4.885; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yang JY, 2010, FEBS LETT, V584, P4872, DOI 10.1016/j.febslet.2010.09.045; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; Zhang J, 2006, MICRON, V37, P14, DOI 10.1016/j.micron.2005.03.014	43	221	224	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					461	474		10.1016/j.immuni.2012.11.019	http://dx.doi.org/10.1016/j.immuni.2012.11.019			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23499492	Bronze			2022-12-18	WOS:000330941500012
J	Sherman, E; Barr, V; Manley, S; Patterson, G; Balagopalan, L; Akpan, I; Regan, CK; Merrill, RK; Sommers, CL; Lippincott-Schwartz, J; Samelson, LE				Sherman, Eilon; Barr, Valerie; Manley, Suliana; Patterson, George; Balagopalan, Lakshmi; Akpan, Itoro; Regan, Carole K.; Merrill, Robert K.; Sommers, Connie L.; Lippincott-Schwartz, Jennifer; Samelson, Lawrence E.			Functional Nanoscale Organization of Signaling Molecules Downstream of the T Cell Antigen Receptor	IMMUNITY			English	Article							PROTEIN NETWORKS; ACTIN; LAT; COMPLEX; MICROCLUSTERS; ACTIVATION; CLUSTERS; DOMAINS; PALMITOYLATION; RECRUITMENT	Receptor-regulated cellular signaling often is mediated by formation of transient, heterogeneous protein complexes of undefined structure. We used single and two-color photoactivated localization microscopy to study complexes downstream of the T cell antigen receptor (TCR) in single-molecule detail at the plasma membrane of intact T cells. The kinase ZAP-70 distributed completely with the TCR zeta chain and both partially mixed with the adaptor LAT in activated cells, thus showing localized activation of LAT by TCR-coupled ZAP-70. In resting and activated cells, LAT primarily resided in nanoscale clusters as small as dimers whose formation depended on protein-protein and protein-lipid interactions. Surprisingly, the adaptor SLP-76 localized to the periphery of LAT clusters. This nanoscale structure depended on polymerized actin and its disruption affected TCR-dependent cell function. These results extend our understanding of the mechanism of T cell activation and the formation and organization of TCR-mediated signaling complexes, findings also relevant to other receptor systems.	[Sherman, Eilon; Barr, Valerie; Balagopalan, Lakshmi; Akpan, Itoro; Regan, Carole K.; Merrill, Robert K.; Sommers, Connie L.; Samelson, Lawrence E.] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA; [Manley, Suliana; Patterson, George; Lippincott-Schwartz, Jennifer] NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Samelson, LE (corresponding author), NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA.	samelson@helix.nih.gov	Manley, Suliana/D-3818-2012; Patterson, George/ABI-4751-2020; Sherman, Eilon/B-3688-2014	Manley, Suliana/0000-0002-4755-4778; Sherman, Eilon/0000-0002-7403-6036	National Cancer Institute (The Center for Cancer Research); Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008850] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZICBC010978, Z01BC010304, ZIABC010304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000071] Funding Source: NIH RePORTER	National Cancer Institute (The Center for Cancer Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors would like to thank B.J. Taylor at the NCI Flow Cytometry Core Facility, Zeiss, H. Hess (HHMI, Janelia Farm) for providing the PALM software, W. Lased (University of Maryland) for multiple discussions on data analyses, and T. Wiegand (Helmholtz Centre for Environmental Research - UFZ) for providing us his point-pattern analyses software. We thank P. Sengupta, M. Renz, and T. Jovanovic-Talisman (NIH/NICHD) for reading the manuscript. This research was supported by the Intramural Research Programs of the National Cancer Institute (The Center for Cancer Research) and of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Barr VA, 2006, TRAFFIC, V7, P1143, DOI 10.1111/j.1600-0854.2006.00464.x; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Braiman A, 2006, EMBO J, V25, P774, DOI 10.1038/sj.emboj.7600978; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Bunnell Stephen C, 2003, Sci STKE, V2003, pPL8, DOI 10.1126/stke.2003.177.pl8; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cebecauer M, 2010, J CELL SCI, V123, P309, DOI 10.1242/jcs.061739; D'Amico F, 2008, J MICROSC-OXFORD, V230, P9, DOI 10.1111/j.1365-2818.2008.01949.x; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; Harding A, 2008, CELL CYCLE, V7, P127, DOI 10.4161/cc.7.2.5237; Harwood NE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002360; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Hundt M, 2009, J IMMUNOL, V183, P1685, DOI 10.4049/jimmunol.0803921; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; ONO S, 1995, IMMUNITY, V2, P639, DOI 10.1016/1074-7613(95)90008-X; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sloan-Lancaster J, 1998, J CELL BIOL, V143, P613, DOI 10.1083/jcb.143.3.613; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	39	221	225	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 23	2011	35	5					705	720		10.1016/j.immuni.2011.10.004	http://dx.doi.org/10.1016/j.immuni.2011.10.004			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22055681	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000297390800011
J	Alon, R; Dustin, ML				Alon, Ronen; Dustin, Michael L.			Force as a facilitator of integrin conformational changes during leukocyte arrest on blood vessels and antigen-presenting cells	IMMUNITY			English	Review							INTERCELLULAR-ADHESION MOLECULE-1; HIGH ENDOTHELIAL VENULES; I-LIKE DOMAIN; L-SELECTIN; P-SELECTIN; CYTOPLASMIC DOMAIN; FIRM ADHESION; IMMUNOLOGICAL SYNAPSE; EXTRACELLULAR SEGMENT; CRYSTAL-STRUCTURE	Integrins comprise a large family of cell-cell and cell-matrix adhesion receptors that rapidly modulate their adhesiveness. The arrest of leukocyte integrins on target vascular beds involves instantaneous conformational switches generating shear-resistant adhesions. Structural data suggest that these integrins are maintained in low-affinity conformations and must rapidly undergo conformational switches transduced via cytoplasmic changes ("inside-out" signaling) and simultaneous ligand-induced rearrangements ("outside-in"). This bidirectional activation is accelerated by signals from endothelial chemoattractants (chemokines). Recent studies predict that shear forces in the piconewton (pN) range per integrin can facilitate these biochemical switches. After extravasation, antigen recognition involves smaller internal forces from cytoskeletal motors and actin polymers forming the immune synapse. In this review, we address how forces facilitate allosteric integrin activation by biochemical signals. Evidence suggests that preformed cytoskeletal anchorage rather than free integrin mobility is key for force-enhanced integrin activation by chemokines and TCR signals.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; NYU, Sch Med, Skirball Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	Weizmann Institute of Science; New York University; New York University	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il	ALON, RONEN/GRX-6987-2022; Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; Alon, Ronen/0000-0001-9161-6369	NEI NIH HHS [EY016586] Funding Source: Medline; NIAID NIH HHS [AI044931] Funding Source: Medline; NATIONAL EYE INSTITUTE [PN1EY016586, PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044931, R56AI044931] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Alon R, 2005, J CELL BIOL, V171, P1073, DOI 10.1083/jcb.200503155; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; Alon R, 2003, MICROCIRCULATION, V10, P297, DOI 10.1038/sj.mn.7800195; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Bednar B, 1997, CYTOMETRY, V28, P58, DOI 10.1002/(SICI)1097-0320(19970501)28:1<58::AID-CYTO7>3.0.CO;2-D; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; de Chateau M, 2001, BIOCHEMISTRY-US, V40, P13972, DOI 10.1021/bi011582f; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Dobereiner HG, 2005, J APPL PHYSIOL, V98, P1542, DOI 10.1152/japplphysiol.01181.2004; Dunne JL, 2003, J IMMUNOL, V171, P6105, DOI 10.4049/jimmunol.171.11.6105; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Dwir O, 2003, J CELL BIOL, V163, P649, DOI 10.1083/jcb.200303134; Dwir O, 2001, J CELL BIOL, V155, P145, DOI 10.1083/jcb.200103042; Feigelson SW, 2003, J BIOL CHEM, V278, P51203, DOI 10.1074/jbc.M303601200; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Fritz J, 1998, P NATL ACAD SCI USA, V95, P12283, DOI 10.1073/pnas.95.21.12283; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Heinrich V, 2005, BIOPHYS J, V88, P2299, DOI 10.1529/biophysj.104.051706; Henderson RB, 2001, J EXP MED, V194, P219, DOI 10.1084/jem.194.2.219; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; KANSAS GS, 1993, J EXP MED, V177, P833, DOI 10.1084/jem.177.3.833; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kinashi T, 2004, BLOOD, V103, P1033, DOI 10.1182/blood-2003-07-2499; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Setiadi H, 1998, J CELL BIOL, V142, P859, DOI 10.1083/jcb.142.3.859; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shao JY, 1998, P NATL ACAD SCI USA, V95, P6797, DOI 10.1073/pnas.95.12.6797; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Snapp KR, 2002, BLOOD, V99, P4494, DOI 10.1182/blood.V99.12.4494; SRIRAMARAO P, 1994, J IMMUNOL, V153, P4238; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Xie C, 2004, P NATL ACAD SCI USA, V101, P15422, DOI 10.1073/pnas.0406680101; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8; Zhu C, 2005, BIORHEOLOGY, V42, P443; Zwartz GJ, 2004, J BIOL CHEM, V279, P38277, DOI 10.1074/jbc.M402944200	97	221	228	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2007	26	1					17	27		10.1016/j.immuni.2007.01.002	http://dx.doi.org/10.1016/j.immuni.2007.01.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17241958	Bronze			2022-12-18	WOS:000243959000006
J	Das, V; Nal, B; Dujeancourt, A; Thoulouze, MI; Galli, T; Roux, P; Dautry-Varsat, A; Alcover, A				Das, V; Nal, B; Dujeancourt, A; Thoulouze, MI; Galli, T; Roux, P; Dautry-Varsat, A; Alcover, A			Activation-induced polarized recycling targets T cell antigen receptors to the immunological synapse: Involvement of SNARE complexes	IMMUNITY			English	Article							CLASS-II TRANSPORT; PLASMA-MEMBRANE; TRANSFERRIN RECEPTOR; CONTAINING VESICLES; TCR-CD3 COMPLEX; LYTIC GRANULES; DYNAMICS; CELLUBREVIN; EXPRESSION; PROTEIN	The mechanism by which T cell antigen receptors (TCR) accumulate at the immunological synapse has not been fully elucidated. Since TCRs are continuously internalized and recycled back to the cell surface, we investigated the role of polarized recycling in TCR targeting to the immunological synapse. We show here that the recycling endosomal compartment of T cells encountering activatory antigen-presenting cells (APCs) polarizes towards the T cell-APC contact site. Moreover, TCRs in transit through recycling endosomes are targeted to the immunological synapse. Inhibition of T cell polarity, constitutive TCR endocytosis, or recycling reduces TCR accumulation at the immunological synapse. Conversely, increasing the amount of TCRs in recycling endosomes before synapse formation enhanced their accumulation. Finally, we show that exocytic t-SNAREs from T cells cluster at the APC contact site and that tetanus toxin inhibits TCR accumulation at the immunological synapse, indicating that vesicle fusion mediated by SNARE complexes is involved in TCR targeting to the immunological synapse.	CNRS, URA 2582, Unite Biol Interact Cellulaires, F-75724 Paris 15, France; Inst Fer A Moulin, INSERM U536, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Alcover, A (corresponding author), CNRS, URA 2582, Unite Biol Interact Cellulaires, F-75724 Paris 15, France.	aalcover@pasteur.fr	Thoulouze, Maria-Isabel/AAK-6761-2021; Galli, Thierry/Q-2249-2019; NAL, Beatrice/GYU-8888-2022; Galli, Thierry/G-8842-2011	Thoulouze, Maria-Isabel/0000-0002-1780-0421; Galli, Thierry/0000-0001-8514-7455; Galli, Thierry/0000-0001-8514-7455; Alcover, Andres/0000-0002-9507-3450; Nal, Beatrice/0000-0003-3452-7524				Alcover A, 2000, CRIT REV IMMUNOL, V20, P325; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Booth JW, 2001, SEMIN IMMUNOL, V13, P357, DOI 10.1006/smim.2001.0332; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Clark R, 2003, CURR OPIN IMMUNOL, V15, P516, DOI 10.1016/S0952-7915(03)00113-4; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Dietrich J, 2002, J IMMUNOL, V168, P5434, DOI 10.4049/jimmunol.168.11.5434; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Favier B, 2001, INT IMMUNOL, V13, P1525, DOI 10.1093/intimm/13.12.1525; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GULDENFINGER ED, 2003, NAT REV MOL CELL BIO, V4, P127; Hay JC, 2001, EXP CELL RES, V271, P10, DOI 10.1006/excr.2001.5368; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Martinez-Arca S, 2003, J CELL SCI, V116, P2805, DOI 10.1242/jcs.00467; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montoya MC, 2002, NAT IMMUNOL, V3, P159, DOI 10.1038/ni753; Niedergang F, 1998, J IMMUNOL, V161, P6054; NIEDERGANG F, 1997, RES IMMUNOL, V148, P225; ONO S, 1995, IMMUNITY, V2, P639, DOI 10.1016/1074-7613(95)90008-X; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHONHORN JE, 1994, MOL CELL BIOCHEM, V135, P159, DOI 10.1007/BF00926519; Spiliotis ET, 2003, CURR OPIN CELL BIOL, V15, P430, DOI 10.1016/S0955-0674(03)00074-7; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yang CM, 2001, MOL CELL BIOL, V21, P1573, DOI 10.1128/MCB.21.5.1573-1580.2001	43	221	227	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					577	588		10.1016/S1074-7613(04)00106-2	http://dx.doi.org/10.1016/S1074-7613(04)00106-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142526	Bronze			2022-12-18	WOS:000221631900008
J	Cyster, JG; Goodnow, CC				Cyster, JG; Goodnow, CC			Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate	IMMUNITY			English	Article							REACTIVE LYMPHOCYTES-B; PRIMARY IMMUNE-RESPONSE; DEPENDENT ANTIBODY-RESPONSES; TRANSGENIC MOUSE MODEL; SELF-TOLERANCE; LYMPHOID FOLLICLES; BONE-MARROW; MICE; SPLEEN; LOCALIZATION	Anergic self-reactive B cells competing within a polyclonal B cell repertoire fail to migrate into primary follicles and die after 1-3 days residence in T cell zones. Transfer of anergic HEL-specific B cells to recipients lacking HEL autoantigen and continuous bromodeoxyuridine labeling in mixed bone marrow chimeras confirms that follicular exclusion and cell death in 1-3 days is not an intrinsic characteristic of anergic cells but results from competition with B cells bearing other specificities together with continued binding of autoantigen. When naive (nontolerant) HEL-specific B cells were transferred into mice expressing HEL autoantigen, they were also excluded from follicles and their lifespan was dramatically shortened, although they became activated to express CD86 (B7-2/B70). In the presence of helper T cells, activated B cells but not anergic B cells were rescued from death and formed large extrafollicular foci of autoantibody-secreting cells. Antigen-induced exclusion from follicles is therefore an independent process from anergy that prevents self-reactive B cells from recirculating in the long-lived repertoire and may foster interactions with T cells during immune responses. By contrast, anergy prevents self-reactive B cells from collaborating with helper T cells and secreting autoantibody while trapped in the T zone.	STANFORD UNIV, SCH MED, BECKMAN CTR, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Cyster, JG (corresponding author), STANFORD UNIV, SCH MED, BECKMAN CTR, DEPT MICROBIOL & IMMUNOL, STANFORD, CA 94305 USA.		Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155				ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; ALLISON JP, 1994, CURR OPIN IMMUNOL, V6, P414, DOI 10.1016/0952-7915(94)90120-1; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; ASPINALL R, 1983, IMMUNOLOGY, V48, P309; BASTEN A, 1991, IMMUNOL REV, V122, P5, DOI 10.1111/j.1600-065X.1991.tb00593.x; BELL SE, 1994, EMBO J, V13, P816, DOI 10.1002/j.1460-2075.1994.tb06324.x; CHAN EYT, 1993, EUR J IMMUNOL, V23, P357, DOI 10.1002/eji.1830230209; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; CLAASSEN E, 1986, EUR J IMMUNOL, V16, P271, DOI 10.1002/eji.1830160311; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; FINKELMAN FD, 1995, J EXP MED, V181, P515, DOI 10.1084/jem.181.2.515; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; FULCHER DA, 1994, AUTOIMMUNITY, V19, P135, DOI 10.3109/08916939409009541; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; GOODNOW CC, 1989, COLD SPRING HARB SYM, V54, P907, DOI 10.1101/SQB.1989.054.01.106; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRAY D, 1988, J EXP MED, V167, P805, DOI 10.1084/jem.167.3.805; GRAY D, 1990, CURR TOP MICROBIOL, V159, P1; GRAY D, 1988, IMMUNOLOGY, V65, P73; GUTMAN GA, 1973, TRANSPLANTATION, V16, P621, DOI 10.1097/00007890-197312000-00014; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HAY JB, 1974, CELL IMMUNOL, V10, P145, DOI 10.1016/0008-8749(74)90158-0; ILLERA VA, 1993, J IMMUNOL, V151, P2965; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; LEDERMAN S, 1992, J IMMUNOL, V149, P3817; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LORTAN JE, 1987, EUR J IMMUNOL, V17, P1311, DOI 10.1002/eji.1830170914; MACLENNAN ICM, 1992, IMMUNOL REV, V126, P143, DOI 10.1111/j.1600-065X.1992.tb00635.x; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NIEUWENHUIS P, 1976, CELL IMMUNOL, V23, P254, DOI 10.1016/0008-8749(76)90191-X; NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; PELLAS TC, 1990, AM J ANAT, V187, P355, DOI 10.1002/aja.1001870405; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; ROWLEY DA, 1972, J EXP MED, V136, P499, DOI 10.1084/jem.136.3.499; SHLOMCHIK MJ, 1993, INT IMMUNOL, V5, P1329, DOI 10.1093/intimm/5.10.1329; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; SPRENT J, 1973, CELL IMMUNOL, V7, P40, DOI 10.1016/0008-8749(73)90181-0; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; SPRENT J, 1972, EUR J IMMUNOL, V2, P384, DOI 10.1002/eji.1830020420; TIGHE H, 1995, J EXP MED, V181, P599, DOI 10.1084/jem.181.2.599; VANDENEERTWEGH AJM, 1993, J EXP MED, V178, P1555, DOI 10.1084/jem.178.5.1555; VANEWIJK W, 1977, CELL TISSUE RES, V183, P471, DOI 10.1007/BF00225661; VANROOIJEN N, 1983, ANAT REC, V206, P189, DOI 10.1002/ar.1092060207	56	221	223	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1995	3	6					691	701		10.1016/1074-7613(95)90059-4	http://dx.doi.org/10.1016/1074-7613(95)90059-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777715	Bronze			2022-12-18	WOS:A1995TM02300004
J	VELLA, AT; MCCORMACK, JE; LINSLEY, PS; KAPPLER, JW; MARRACK, P				VELLA, AT; MCCORMACK, JE; LINSLEY, PS; KAPPLER, JW; MARRACK, P			LIPOPOLYSACCHARIDE INTERFERES WITH THE INDUCTION OF PERIPHERAL T-CELL DEATH	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; STAPHYLOCOCCAL ENTEROTOXIN-B; NONOBESE DIABETIC MICE; FACTOR-ALPHA; MONOCLONAL-ANTIBODIES; ANTIGEN RECEPTOR; INVIVO; TOLERANCE; CTLA-4; ACTIVATION	In mice injected with superantigens, T cells specific for that antigen proliferate and then die. It has been suggested that the target cells die because they encounter superantigen on the surfaces of nonprofessional presenting cells, such as B cells, which cannot deliver costimulatory signals to T cells. A number of reagents that induce costimulatory molecules on B cells were tested. Lipopolysaccharide very effectively prevented T cell death driven by superantigen. Perhaps surprisingly, the action of lipopolysaccharide was not mediated through the expected costimulatory molecule, B7. Rather, the effects of lipopolysaccharide involved the production of inflammatory cytokines, in particular TNF alpha. The rescued cells survived in vitro culture and were resistant to Pas-induced killing. These data demonstrate that LPS can block antigen-induced T cell death perhaps by interfering with Fas signaling.	UNIV COLORADO,HLTH SCI CTR,DEPT IMMUNOL,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80206; BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Bristol-Myers Squibb	VELLA, AT (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED,HOWARD HUGHES MED INST,DEPT MED,DIV BASIC IMMUNOL,DENVER,CO 80206, USA.		Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	NIAID NIH HHS [AI-17134, AI-18785, AI-22295] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R01AI017134, R01AI018785, R37AI017134, R56AI018785, R56AI017134, R37AI018785] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAMS JS, 1992, IMMUNOL REV, V127, P5, DOI 10.1111/j.1600-065X.1992.tb01406.x; ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BEUTLER B, 1994, SCIENCE, V264, P667, DOI 10.1126/science.8171316; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; BURNS J, 1983, CELL IMMUNOL, V81, P435, DOI 10.1016/0008-8749(83)90250-2; CALLAHAN JE, 1990, J IMMUNOL, V144, P2473; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; CHILLER JM, 1973, J EXP MED, V137, P710; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; DRAKE CG, 1994, P NATL ACAD SCI USA, V91, P4062, DOI 10.1073/pnas.91.9.4062; ENYON EE, 1992, J EXP MED, V175, P131; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; FLEISCHER B, 1988, J EXP MED, V167, P1697, DOI 10.1084/jem.167.5.1697; FONG YM, 1989, J EXP MED, V170, P1627, DOI 10.1084/jem.170.5.1627; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; FREEMAN GJ, 1993, SCIENCE, V262, P8909; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; GONZALO JA, 1994, J IMMUNOL, V152, P4291; GONZALO JA, 1993, J EXP MED, V177, P1239, DOI 10.1084/jem.177.5.1239; GUERDER S, 1994, IMMUNITY, V1, P155; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; HIGUCHI Y, 1992, J EXP MED, V176, P1719, DOI 10.1084/jem.176.6.1719; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; JACOB CO, 1988, NATURE, V331, P356, DOI 10.1038/331356a0; JENKINS MK, 1987, IMMUNOL REV, V95, P113, DOI 10.1111/j.1600-065X.1987.tb00502.x; JENKINS MK, 1991, J IMMUNOL, V147, P2461; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LIAO NS, 1989, J EXP MED, V170, P135, DOI 10.1084/jem.170.1.135; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; LO D, 1986, IMMUNOL RES, V5, P221, DOI 10.1007/BF02919203; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MCCORMACK JE, 1994, P NATL ACAD SCI USA, V91, P2086, DOI 10.1073/pnas.91.6.2086; MCCORMACK JE, 1993, J IMMUNOL, V150, P3785; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; MORRIS SC, 1994, J IMMUNOL, V152, P3777; PARKS DE, 1981, J IMMUNOL, V126, P938; PATTERSON PY, 1960, J EXP MED, V111, P119; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; RAZIWOLF Z, 1992, P NATL ACAD SCI USA, V89, P4210, DOI 10.1073/pnas.89.9.4210; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; ROCKEN M, 1992, NATURE, V359, P79, DOI 10.1038/359079a0; ROCKEN M, 1994, J EXP MED, V179, P1885, DOI 10.1084/jem.179.6.1885; SATOH J, 1989, J CLIN INVEST, V84, P1345, DOI 10.1172/JCI114304; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SORGER SB, 1987, J EXP MED, V165, P279, DOI 10.1084/jem.165.2.279; STAERZ UD, 1985, J IMMUNOL, V134, P3994; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEBB S, 1990, CELL, V83, P1249; WOLLENBERG GK, 1993, AM J PATHOL, V143, P1121; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995	64	221	225	1	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1995	2	3					261	270		10.1016/1074-7613(95)90050-0	http://dx.doi.org/10.1016/1074-7613(95)90050-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QP276	7535182	Bronze			2022-12-18	WOS:A1995QP27600005
J	Chuang, E; Fisher, TS; Morgan, RW; Robbins, MD; Duerr, JM; Vander Heiden, MG; Gardner, JP; Hambor, JE; Neveu, MJ; Thompson, CB				Chuang, E; Fisher, TS; Morgan, RW; Robbins, MD; Duerr, JM; Vander Heiden, MG; Gardner, JP; Hambor, JE; Neveu, MJ; Thompson, CB			The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A	IMMUNITY			English	Article							CLATHRIN-ASSOCIATED PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; CELL-PROLIFERATION; SIGNALING PATHWAY; ANTIGEN-4 CTLA-4; RESPONSE ELEMENT; IL-2 PRODUCTION; 2A PP2A; T-CELLS	CD28 and CTLA-4 are related members of a family of T lymphocyte cell surface receptors that function to regulate T cell activation. We have found that the cytoplasmic domains of both CTLA-4 and CD28 can associate with members of the PP2A family of serine/threonine phosphatases. The association of PP2A with CD28 was negatively regulated by tyrosine phosphorylation of the CD28 cytoplasmic domain. Inhibition of PP2A activity in Jurkat leukemia T cells by treatment with okadaic acid or by expression of a dominant-negative mutant enhanced T cell activation induced by CD28 engagement. Interactions between cell surface receptors such as CTLA-4 and CD28 and serine/threonine phosphatases may represent a novel mechanism for modulating the intracellular signal transduction pathways associated with cell activation.	Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; Cornell Univ, Weill Med Coll, Dept Med, Div Hematol Oncol, New York, NY 10021 USA; Pfizer Inc, Global Res & Dev, Groton, CT 06340 USA; Univ Penn, Ctr Canc, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Chicago; Cornell University; Pfizer; University of Pennsylvania; Pennsylvania Medicine	Thompson, CB (corresponding author), Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA.				NATIONAL CANCER INSTITUTE [K08CA078591] Funding Source: NIH RePORTER; NCI NIH HHS [K08 CA78591] Funding Source: Medline; NIAID NIH HHS [P01 AI352942] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Barz C, 1998, J IMMUNOL, V161, P5366; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Bradshaw JD, 1997, BIOCHEMISTRY-US, V36, P15975, DOI 10.1021/bi971762i; Calvo CR, 1997, J EXP MED, V186, P1645, DOI 10.1084/jem.186.10.1645; Cefai D, 1998, J IMMUNOL, V160, P2223; Chuang E, 1999, J IMMUNOL, V162, P1270; Chuang E, 1997, J IMMUNOL, V159, P144; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gedrich RW, 1996, J BIOL CHEM, V271, P12852, DOI 10.1074/jbc.271.22.12852; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Hutchcroft JE, 1996, J BIOL CHEM, V271, P13362, DOI 10.1074/jbc.271.23.13362; Kaga S, 1998, J IMMUNOL, V160, P4182; Kempiak SJ, 1999, J IMMUNOL, V162, P3176; LAI JH, 1995, MOL CELL BIOL, V15, P4260; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Li-Weber M, 1998, J BIOL CHEM, V273, P32460, DOI 10.1074/jbc.273.49.32460; Lisbona C, 1997, J CLIN IMMUNOL, V17, P494, DOI 10.1023/A:1027375828134; MAKNI H, 1991, J IMMUNOL, V146, P2522; Mandelbrot DA, 1999, J EXP MED, V189, P435, DOI 10.1084/jem.189.2.435; Marengere LEM, 1997, J IMMUNOL, V159, P3220; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Miyatake S, 1998, BIOCHEM BIOPH RES CO, V249, P444, DOI 10.1006/bbrc.1998.9191; Nebl G, 1998, J IMMUNOL, V161, P1803; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; Reif K, 1998, IMMUNITY, V8, P395, DOI 10.1016/S1074-7613(00)80545-2; RICHARDS FM, 1992, IMMUNOLOGY, V76, P642; Rudd CE, 1996, IMMUNITY, V4, P527, DOI 10.1016/S1074-7613(00)80479-3; Salojin KV, 1999, J IMMUNOL, V163, P844; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Siefken R, 1998, J IMMUNOL, V161, P1645; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; THEVENIN C, 1991, J BIOL CHEM, V266, P9363; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Woerly G, 1999, J EXP MED, V190, P487, DOI 10.1084/jem.190.4.487; Yang WC, 1999, J BIOL CHEM, V274, P607, DOI 10.1074/jbc.274.2.607	48	220	232	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2000	13	3					313	322		10.1016/S1074-7613(00)00031-5	http://dx.doi.org/10.1016/S1074-7613(00)00031-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021529	Bronze			2022-12-18	WOS:000089616400004
J	Huang, JH; Kang, BH; Ishida, E; Zhou, TQ; Griesman, T; Sheng, ZZ; Wu, F; Doria-Rose, NA; Zhang, BS; McKee, K; O'Dell, S; Chuang, GY; Druz, A; Georgiev, IS; Schramm, CA; Zheng, AQ; Joyce, MG; Asokan, M; Ransier, A; Darko, S; Migueles, SA; Bailer, RT; Louder, MK; Alam, SM; Parks, R; Kelsoe, G; Von Holle, T; Haynes, BF; Douek, DC; Hirsch, V; Seaman, MS; Shapiro, L; Mascola, JR; Kwong, PD; Connors, M				Huang, Jinghe; Kang, Byong H.; Ishida, Elise; Zhou, Tongqing; Griesman, Trevor; Sheng, Zizhang; Wu, Fan; Doria-Rose, Nicole A.; Zhang, Baoshan; McKee, Krisha; O'Dell, Sijy; Chuang, Gwo-Yu; Druz, Aliaksandr; Georgiev, Ivelin S.; Schramm, Chaim A.; Zheng, Anqi; Joyce, M. Gordon; Asokan, Mangaiarkarasi; Ransier, Amy; Darko, Sam; Migueles, Stephen A.; Bailer, Robert T.; Louder, Mark K.; Alam, S. Munir; Parks, Robert; Kelsoe, Garnett; Von Holle, Tarra; Haynes, Barton F.; Douek, Daniel C.; Hirsch, Vanessa; Seaman, Michael S.; Shapiro, Lawrence; Mascola, John R.; Kwong, Peter D.; Connors, Mark			Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth	IMMUNITY			English	Article							TYPE-1 INFECTION; ESCAPE; MATURATION; ENVELOPE; EVOLUTION; GLYCOPROTEIN; PATTERNS; POTENCY; GLYCANS; LINEAGE	Detailed studies of the broadly neutralizing antibodies (bNAbs) that underlie the best available examples of the humoral immune response to HIV are providing important information for the development of therapies and prophylaxis for HIV-1 infection. Here, we report a CD4-binding site (CD4bs) antibody, named N6, that potently neutralized 98% of HIV-1 isolates, including 16 of 20 that were resistant to other members of its class. N6 evolved a mode of recognition such that its binding was not impacted by the loss of individual contacts across the immunoglobulin heavy chain. In addition, structural analysis revealed that the orientation of N6 permitted it to avoid steric clashes with glycans, which is a common mechanism of resistance. Thus, an HIV-1-specific bNAb can achieve potent, near-pan neutralization of HIV-1, making it an attractive candidate for use in therapy and prophylaxis.	[Huang, Jinghe; Kang, Byong H.; Ishida, Elise; Griesman, Trevor; Migueles, Stephen A.; Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Zhou, Tongqing; Doria-Rose, Nicole A.; Zhang, Baoshan; McKee, Krisha; O'Dell, Sijy; Chuang, Gwo-Yu; Druz, Aliaksandr; Zheng, Anqi; Joyce, M. Gordon; Asokan, Mangaiarkarasi; Ransier, Amy; Darko, Sam; Bailer, Robert T.; Louder, Mark K.; Douek, Daniel C.; Shapiro, Lawrence; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Wu, Fan; Hirsch, Vanessa] NIAID, Mol Microbiol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Sheng, Zizhang; Schramm, Chaim A.; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Alam, S. Munir; Parks, Robert; Kelsoe, Garnett; Von Holle, Tarra; Haynes, Barton F.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Seaman, Michael S.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; Vanderbilt University; Duke University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Connors, M (corresponding author), NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mconnors@nih.gov	Alam, S. Munir/AAC-6711-2019; Zhou, Tongqing/A-6880-2010; Huang, Jinghe/P-8068-2019; Shapiro, Lawrence/AAE-7172-2019; Mascola, John/AAI-7193-2021; Sheng, Zizhang/AFR-8049-2022	Zhou, Tongqing/0000-0002-3935-4637; Sheng, Zizhang/0000-0002-3253-3309; Wu, Fan/0000-0003-4741-3948; Asokan, Mangaiarkarasi/0000-0001-9294-1833; Huang, Jinghe/0000-0002-1968-871X; Griesman, Trevor/0000-0001-5333-0837; Kelsoe, Garnett/0000-0002-8770-040X; Ishida, Elise/0000-0003-0569-5094	Intramural Research Program and the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), NIH; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090, ZICAI005112, ZIAAI005095, ZIAAI005022, ZIAAI000686, ZICAI005111] Funding Source: NIH RePORTER	Intramural Research Program and the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), NIH; US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of the Vaccine Research Center for discussions of the manuscript. We thank Lynn Morris for arranging the testing of N6 against an extended clade C pseudovirus panel. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, L. Morris, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing the HIV-1 envelope plasmids used in our neutralization panel. Support for this work was provided by the Intramural Research Program and the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), NIH. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science under contract number W-31-109-Eng-38.	Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Crooks ET, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004932; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Haynes BF, 2015, CURR OPIN IMMUNOL, V35, P39, DOI 10.1016/j.coi.2015.05.007; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Liu MF, 2015, J VIROL, V89, P784, DOI 10.1128/JVI.02378-14; Lynch RM, 2015, J VIROL, V89, P4201, DOI 10.1128/JVI.03608-14; MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Rusert P, 2016, NAT MED; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Sommerstein R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005276; Stephenson KE, 2016, CURR HIV-AIDS REP, V13, P31, DOI 10.1007/s11904-016-0299-7; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Szakonyi G, 2006, NAT STRUCT MOL BIOL, V13, P996, DOI 10.1038/nsmb1161; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004	37	219	228	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					1108	1121		10.1016/j.immuni.2016.10.027	http://dx.doi.org/10.1016/j.immuni.2016.10.027			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851912	Green Accepted, Bronze			2022-12-18	WOS:000389473500020
J	Wang, Q; Liu, X; Cui, Y; Tang, YJ; Chen, W; Li, SL; Yu, HS; Pan, YD; Wang, C				Wang, Qiang; Liu, Xing; Cui, Ye; Tang, Yijun; Chen, Wei; Li, Senlin; Yu, Huansha; Pan, Youdong; Wang, Chen			The E3 Ubiquitin Ligase AMFR and INSIG1 Bridge the Activation of TBK1 Kinase by Modifying the Adaptor STING	IMMUNITY			English	Article							CELLULAR ANTIVIRAL RESPONSE; I INTERFERON INDUCTION; DNA-SENSING PATHWAYS; INTRACELLULAR DNA; INNATE IMMUNITY; RIG-I; ENDOPLASMIC-RETICULUM; NUCLEIC-ACIDS; PROTEIN; RECOGNITION	Stimulator of interferon genes (STING, also known as MITA, ERIS, or MPYS) is essential for host immune responses triggered by microbial DNAs. However, the regulatory mechanisms underlying STING-mediated signaling are not fully understood. We report here that, upon cytoplasmic DNA stimulation, the endoplasmic reticulum (ER) protein AMFR was recruited to and interacted with STING in an insulin- induced gene 1 (INSIG1)-dependent manner. AMFR and INSIG1, an E3 ubiquitin ligase complex, then catalyzed the K27-linked polyubiquitination of STING. This modification served as an anchoring platform for recruiting TANK-binding kinase 1 (TBK1) and facilitating its translocation to the perinuclear microsomes. Depletion of AMFR or INSIG1 impaired STING-mediated antiviral gene induction. Consistently, myeloid-cell-specific Insig1(-/-) mice were more susceptible to herpes simplex virus 1 (HSV-1) infection than wild-type mice. This study uncovers an essential role of the ER proteins AMFR and INSIG1 in innate immunity, revealing an important missing link in the STING signaling pathway.	[Wang, Qiang; Liu, Xing; Cui, Ye; Tang, Yijun; Chen, Wei; Li, Senlin; Yu, Huansha; Pan, Youdong; Wang, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Liu, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.	liuxing@sibcb.ac.cn; cwang01@sibcb.ac.cn	wang, chen/GWM-9481-2022		National Science Foundation of China [31030021, 31300735, 81161120542]; Ministry of Science and Technology of China [2012CB910200, 2011CB910904]; China Postdoctoral Research Program [2012M520953, 2013KIP301]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Postdoctoral Research Program	We thank B. Song (Wuhan University), Q. Leng (Shanghai Pasteur Institute), W. Qiao (Nankai University), C. Zheng (Suzhou University), and Y. Qian (SIBS) for virus and mice strains and reagents. This work was supported by grants from National Science Foundation of China (31030021, 31300735, 81161120542) and Ministry of Science and Technology of China (2012CB910200, 2011CB910904). X. L. is sponsored by China Postdoctoral Research Program (2012M520953, 2013KIP301).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Barber GN, 2011, NAT IMMUNOL, V12, P929, DOI 10.1038/ni.2118; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009; Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Liu X, 2013, CYTOKINE GROWTH F R, V24, P559, DOI 10.1016/j.cytogfr.2013.07.002; Liu X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003480; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Maelfait J, 2012, MICROBIOL MOL BIOL R, V76, P33, DOI 10.1128/MMBR.05012-11; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nakhaei P, 2010, J MOL CELL BIOL, V2, P110, DOI 10.1093/jmcb/mjp048; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Ran Y., 2014, CYTOKINE GROWTH FACT; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shi HX, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002057; Shu C., 2014, CYTOKINE GROWTH FACT; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van Montfoort N., 2014, CYTOKINE GROWTH FACT; Weber M., 2014, CYTOKINE GROWTH FACT; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	60	219	236	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					919	933		10.1016/j.immuni.2014.11.011	http://dx.doi.org/10.1016/j.immuni.2014.11.011			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526307	Bronze			2022-12-18	WOS:000346654100011
J	Keefe, D; Shi, LF; Feske, S; Massol, R; Navarro, F; Kirchhausen, T; Lieberman, J				Keefe, D; Shi, LF; Feske, S; Massol, R; Navarro, F; Kirchhausen, T; Lieberman, J			Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis	IMMUNITY			English	Article							GRANULE-MEDIATED CYTOTOXICITY; T-CELL GRANULES; GRANZYME-B; TARGET-CELLS; CYTOSOLIC DELIVERY; CHANNEL FORMATION; PORE FORMATION; EXOCYTOSIS; DEATH; PURIFICATION	Perforin delivers granzymes to induce target-cell apoptosis. At high concentrations, perforin multimerizes in the plasma membrane to form pores. However, whether granzymes enter target cells via membrane pores is uncertain. Here we find that perforin at physiologically relevant concentrations and during cell-mediated lysis creates pores in the target-cell membrane, transiently allowing Ca2+ and small dyes into the cell. The Ca2+ flux triggers a wounded membrane-repair response in which internal vesicles, including lysosomes and endosomes, donate their membranes to reseal the damaged membrane. Perforin also triggers the rapid endocytosis of granzymes into large EEA-1-staining vesicles. The restoration of target-cell membrane integrity by triggering the repair response is necessary for target cells subjected to cytotoxic T lymphocyte attack to avoid necrosis and undergo the slower process of programmed cell death. Thus, the target cell actively participates in determining its own fate during cell-mediated death.	CBR Inst Biomed Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), CBR Inst Biomed Res, Boston, MA 02215 USA.	lieberman@cbr.med.harvard.edu	Lieberman, Judy/A-2717-2015; Feske, stefan/ABB-3554-2021	Feske, stefan/0000-0001-5431-8178	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987, P01HL059561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R01AI045587, R56AI045587, R21AI054933] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL 66987, P01 HL 59561] Funding Source: Medline; NIAID NIH HHS [AI 45587, R21 AI 54933, U54 AI 57159] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Binah O, 1997, BIOCHEM BIOPH RES CO, V240, P647, DOI 10.1006/bbrc.1997.7695; Browne KA, 1999, MOL CELL BIOL, V19, P8604; Catalfamo M, 2003, CURR OPIN IMMUNOL, V15, P522, DOI 10.1016/S0952-7915(03)00114-6; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kawasaki Y, 2000, J IMMUNOL, V164, P4641, DOI 10.4049/jimmunol.164.9.4641; Kurschus FC, 2004, FEBS LETT, V562, P87, DOI 10.1016/S0014-5793(04)00187-5; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; MASSON D, 1985, J BIOL CHEM, V260, P9069; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; MILLARD PJ, 1984, J IMMUNOL, V132, P3197; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Pinkoski MJ, 1998, BLOOD, V92, P1044; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; POENIE M, 1987, EMBO J, V6, P2223, DOI 10.1002/j.1460-2075.1987.tb02494.x; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; RUSSELL JH, 1980, J IMMUNOL, V124, P1100; SAUER H, 1991, BIOCHIM BIOPHYS ACTA, V1063, P137, DOI 10.1016/0005-2736(91)90363-D; Shi L, 2005, J IMMUNOL, V174, P5456, DOI 10.4049/jimmunol.174.9.5456; Shi LF, 2000, METHOD ENZYMOL, V322, P125; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Shi LF, 1997, J EXP MED, V185, P855, DOI 10.1084/jem.185.5.855; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Trapani JA, 2003, J CELL BIOL, V160, P223, DOI 10.1083/jcb.200210150; TSCHOPP J, 1986, NATURE, V322, P831, DOI 10.1038/322831a0; Veugelers K, 2004, BLOOD, V103, P3845, DOI 10.1182/blood-2003-06-2156; Xia ZN, 1998, BIOCHEM BIOPH RES CO, V243, P384, DOI 10.1006/bbrc.1998.8102; YOUNG JDE, 1986, P NATL ACAD SCI USA, V83, P150, DOI 10.1073/pnas.83.1.150	38	219	229	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2005	23	3					249	262		10.1016/j.immuni.2005.08.001	http://dx.doi.org/10.1016/j.immuni.2005.08.001			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	971KJ	16169498	Bronze			2022-12-18	WOS:000232382500004
J	Wandstrat, AE; Nguyen, C; Limaye, N; Chan, AY; Subramanian, S; Tian, XH; Yim, YS; Pertsemlidis, A; Garner, HR; Morel, L; Wakeland, EK				Wandstrat, AE; Nguyen, C; Limaye, N; Chan, AY; Subramanian, S; Tian, XH; Yim, YS; Pertsemlidis, A; Garner, HR; Morel, L; Wakeland, EK			Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus	IMMUNITY			English	Article							ERYTHEMATOSUS SUSCEPTIBILITY LOCUS; CELL-SURFACE MOLECULES; CYTOPLASMIC DOMAINS; AUTOIMMUNE-DISEASE; SLE PATHOGENESIS; RECEPTOR 2B4; CD2 FAMILY; T-CELL; CD150; DISSECTION	Susceptibility to autoimmunity in B6.Sie1b mice is associated with extensive polymorphisms between two divergent haplotypes of the SLAM/CD2 family of genes. The B6.Sie1b-derived SLAM/CD2 family haplotype is found in many other laboratory mouse strains but only causes autoimmunity in the context of the C57BI/6 (136) genome. Phenotypic analyses have revealed variations in the structure and expression of several members of the SLAM/CD2 family in T and B lymphocytes from B6.Sie1b mice. T lymphocytes from B6.Sielb mice have modified signaling responses to stimulation at 4-6 weeks of age. While autoimmunity may be mediated by a combination of genes in the SLAM/CD2 family cluster, the strongest candidate is Ly1OB, a specific isoform of which is constitutively upregulated in B6.Sie1b lymphocytes.	Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75235 USA; Univ Florida, Sch Med, Dept Pathol & Lab Med, Gainesville, FL 32611 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; State University System of Florida; University of Florida	Wandstrat, AE (corresponding author), Univ Texas, SW Med Ctr, Ctr Immunol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	edward.wakeland@utsouthwestern.edu	Pertsemlidis, Alexander/Q-7899-2017	Pertsemlidis, Alexander/0000-0003-1624-9372	NIAID NIH HHS [T32AI005287] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blomhoff A, 2004, J CLIN ENDOCR METAB, V89, P3474, DOI 10.1210/jc.2003-031854; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Croker BP, 2003, GENES IMMUN, V4, P575, DOI 10.1038/sj.gene.6364028; de la Fuente MA, 1999, IMMUNOGENETICS, V49, P249, DOI 10.1007/s002510050490; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Howie D, 2002, BLOOD, V99, P957, DOI 10.1182/blood.V99.3.957; Hron JD, 2004, J EXP MED, V200, P261, DOI 10.1084/jem.20040526; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; Kang I, 2004, J IMMUNOL, V172, P1287, DOI 10.4049/jimmunol.172.2.1287; Kimberly WT, 2003, J NEUROSCI RES, V74, P353, DOI 10.1002/jnr.10736; Krogh A, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P179; Liu JN, 2004, EUR J BIOCHEM, V271, P2873, DOI 10.1111/j.1432-1033.2004.04198.x; Mohan C, 1998, J CLIN INVEST, V101, P1362; Moon UY, 2004, ARTHRITIS RES THER, V6, pR295, DOI 10.1186/ar1181; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Morel L, 1999, IMMUNITY, V11, P131, DOI 10.1016/S1074-7613(00)80088-6; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Muschen M, 1999, AM J PATHOL, V155, P915, DOI 10.1016/S0002-9440(10)65191-7; Osoegawa K, 2000, GENOME RES, V10, P116; Palou E, 2000, TISSUE ANTIGENS, V55, P118, DOI 10.1034/j.1399-0039.2000.550203.x; Peck SR, 2000, IMMUNOGENETICS, V52, P63, DOI 10.1007/s002510000252; Pekarsky Y, 1998, P NATL ACAD SCI USA, V95, P8744, DOI 10.1073/pnas.95.15.8744; Pertsemlidis A, 2000, GENOMICS, V70, P300, DOI 10.1006/geno.2000.6359; Quek HH, 1997, DNA CELL BIOL, V16, P275, DOI 10.1089/dna.1997.16.275; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; ROMERO X, 2004, 12 INT C IMM; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Schatzle JD, 1999, P NATL ACAD SCI USA, V96, P3870, DOI 10.1073/pnas.96.7.3870; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; Slev PR, 2002, CURR OPIN IMMUNOL, V14, P609, DOI 10.1016/S0952-7915(02)00381-3; Smith TS, 2000, BBA-GENE STRUCT EXPR, V1490, P184, DOI 10.1016/S0167-4781(99)00233-X; Sobel ES, 1999, J IMMUNOL, V162, P2415; Sobel ES, 2002, J IMMUNOL, V169, P2694, DOI 10.4049/jimmunol.169.5.2694; SOMOZA C, 1993, J EXP MED, V178, P549, DOI 10.1084/jem.178.2.549; Stepp SE, 1999, EUR J IMMUNOL, V29, P2392, DOI 10.1002/(SICI)1521-4141(199908)29:08<2392::AID-IMMU2392>3.3.CO;2-I; Tangye SG, 2000, SEMIN IMMUNOL, V12, P149, DOI 10.1006/smim.2000.0217; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; VANDENBERGHE PA, 1990, J IMMUNOL METHODS, V127, P197, DOI 10.1016/0022-1759(90)90069-8; Veillette A, 2004, J EXP MED, V199, P1175, DOI 10.1084/jem.20040588; Veillette A, 2003, CURR OPIN IMMUNOL, V15, P277, DOI 10.1016/S0952-7915(03)00041-4; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Wang N, 2001, IMMUNOGENETICS, V53, P382, DOI 10.1007/s002510100337; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	54	219	220	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2004	21	6					769	780		10.1016/j.immuni.2004.10.009	http://dx.doi.org/10.1016/j.immuni.2004.10.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589166	Bronze			2022-12-18	WOS:000225901600005
J	Lu, XB; Yu, HF; Liu, SH; Brodsky, FM; Peterlin, BM				Lu, XB; Yu, HF; Liu, SH; Brodsky, FM; Peterlin, BM			Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-SURFACE CD4; CLATHRIN-COATED VESICLES; DOWN-REGULATION; CYTOPLASMIC DOMAIN; PROTEIN; INFECTION; EXPRESSION; BINDING; SUBUNIT	CD4 is the primary receptor for the human immunodeficiency virus (HIV). Nef is an accessory protein of HIV that decreases the expression of CD4 on the surface of infected cells. In this study, we identified the Nef binding protein 1 (NBP1), which interacts specifically with Nef in vitro and in vivo. Since it shares sequence similarity with the catalytic subunit of the vacuolar ATPase (V-ATPase) and complements the loss of this VMA13 gene in yeast, NBP1 is the human homolog of Vma13p. Direct interactions between Nef and NBP1 were correlated with the ability of Nef to internalize CD4. The expression of the antisense NBP1 abrogated these effects. We conclude that NBP1 helps to connect Nef with the endocytic pathway.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, GW Hooper Fdn, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, GW Hooper Fdn, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, GW Hooper Fdn, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, GW Hooper Fdn, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Peterlin, BM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.	matija@itsa.ucsf.edu		Brodsky, Frances/0000-0002-1334-9258	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057657] Funding Source: NIH RePORTER; NIAID NIH HHS [AI38532] Funding Source: Medline; NIGMS NIH HHS [GM57657] Funding Source: Medline; FDA HHS [BM38093] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FDA HHS		AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Aiken C, 1996, VIROLOGY, V217, P293, DOI 10.1006/viro.1996.0116; Alexander L, 1997, J VIROL, V71, P6094, DOI 10.1128/JVI.71.8.6094-6099.1997; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; CHANG MP, 1993, EMBO J, V12, P2169, DOI 10.1002/j.1460-2075.1993.tb05865.x; Collette Y, 1996, J BIOL CHEM, V271, P6333, DOI 10.1074/jbc.271.11.6333; CULLEN BR, 1994, VIROLOGY, V205, P1, DOI 10.1006/viro.1994.1613; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DU ZJ, 1995, CELL, V82, P665, DOI 10.1016/0092-8674(95)90038-1; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Egan MA, 1996, J VIROL, V70, P6547, DOI 10.1128/JVI.70.10.6547-6556.1996; Foti M, 1997, J CELL BIOL, V139, P37, DOI 10.1083/jcb.139.1.37; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GARCIA JV, 1993, J VIROL, V67, P1511, DOI 10.1128/JVI.67.3.1511-1516.1993; GILBOA L, 1995, J BIOL CHEM, V270, P7061, DOI 10.1074/jbc.270.13.7061; GOLDSMITH MA, 1995, J VIROL, V69, P4112, DOI 10.1128/JVI.69.7.4112-4121.1995; GOLDSTEIN DJ, 1990, EMBO J, V9, P137, DOI 10.1002/j.1460-2075.1990.tb08089.x; GOLDSTEIN DJ, 1991, NATURE, V352, P347, DOI 10.1038/352347a0; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; GUATELLI JC, 1990, J VIROL, V64, P4093, DOI 10.1128/JVI.64.9.4093-4098.1990; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; HARRIS MPG, 1994, J MOL BIOL, V241, P136; HO MN, 1993, J BIOL CHEM, V268, P18286; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; Iafrate AJ, 1997, EMBO J, V16, P673, DOI 10.1093/emboj/16.4.673; JAMIESON BD, 1994, J VIROL, V68, P3478, DOI 10.1128/JVI.68.6.3478-3485.1994; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KESTLER HW, 1989, J MED PRIMATOL, V18, P305; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; LITTLE SJ, 1994, VIROLOGY, V205, P578, DOI 10.1006/viro.1994.1683; LIU Q, 1994, J BIOL CHEM, V269, P31592; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Lu XB, 1996, CURR BIOL, V6, P1677, DOI 10.1016/S0960-9822(02)70792-6; Luo W, 1997, J VIROL, V71, P9531, DOI 10.1128/JVI.71.12.9531-9537.1997; MCDOUGAL JS, 1986, J IMMUNOL, V137, P2937; MORIKAWA Y, 1993, J VIROL, V67, P3601, DOI 10.1128/JVI.67.6.3601-3604.1993; Myers G., 1993, HUMAN RETROVIRUSES A; MYERS M, 1993, J BIOL CHEM, V268, P9184; Nunn MF, 1996, J VIROL, V70, P6157, DOI 10.1128/JVI.70.9.6157-6161.1996; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P9848, DOI 10.1073/pnas.94.18.9848; Pantaleo G, 1996, ANNU REV MICROBIOL, V50, P825, DOI 10.1146/annurev.micro.50.1.825; PARNES JR, 1989, ADV IMMUNOL, V44, P265; PAULOIN A, 1993, BIOCHEM J, V296, P409, DOI 10.1042/bj2960409; Peterlin B. Matija, 1995, P185; RATNER L, 1995, CURR TOP MICROBIOL, V193, P169; RHEE SS, 1994, J VIROL, V68, P5156, DOI 10.1128/JVI.68.8.5156-5163.1994; ROBERTGUROFF M, 1990, J VIROL, V64, P3391, DOI 10.1128/JVI.64.7.3391-3398.1990; ROBEY E, 1990, CELL, V60, P697, DOI 10.1016/0092-8674(90)90082-P; ROILIDES E, 1994, ZBL BAKT-INT J MED M, V280, P433; Rossi F, 1996, VIROLOGY, V217, P397, DOI 10.1006/viro.1996.0130; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Sanfridson A, 1997, P NATL ACAD SCI USA, V94, P873, DOI 10.1073/pnas.94.3.873; Sawai ET, 1996, CURR BIOL, V6, P1519, DOI 10.1016/S0960-9822(96)00757-9; SCHWARTZ O, 1993, J VIROL, V67, P3274, DOI 10.1128/JVI.67.6.3274-3280.1993; Smith BL, 1996, J BIOL CHEM, V271, P16753, DOI 10.1074/jbc.271.28.16753; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; TRONO D, 1995, CELL, V82, P189, DOI 10.1016/0092-8674(95)90306-2; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	65	219	221	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1998	8	5					647	656		10.1016/S1074-7613(00)80569-5	http://dx.doi.org/10.1016/S1074-7613(00)80569-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ611	9620685	Bronze			2022-12-18	WOS:000073885400012
J	Li, LH; Milner, LA; Deng, Y; Iwata, M; Banta, A; Graf, L; Marcovina, S; Friedman, C; Trask, BJ; Hood, L; Torok-Storb, B				Li, LH; Milner, LA; Deng, Y; Iwata, M; Banta, A; Graf, L; Marcovina, S; Friedman, C; Trask, BJ; Hood, L; Torok-Storb, B			The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1	IMMUNITY			English	Article							DEVELOPING DROSOPHILA EYE; C-ELEGANS; GRANULOCYTIC DIFFERENTIATION; MOUSE NOTCH; DELTA; GENE; FATE; SERRATE; RECEPTOR; NEUROGENESIS	A cDNA clone encoding the human homolog of rat Jagged1 was isolated from normal human marrow. Analyses of human stromal cell lines indicate that this gene, designated hJagged1, is expressed by marrow stromal cells typified by the cell line HS-27a, which supports the long-term maintenance of hematopoietic progenitor cells. G-CSF-induced differentiation of 32D cells expressing Notch1 was inhibited by coculturing with HS-27a. A peptide corresponding to the Delta/Serrate/LAG-2 domain of hJagged1 and supernatants from COS cells expressing a soluble form of the extracellular portion of hJagged1 were able to mimic this effect. These observations suggest that hJagged1 may function as a ligand for Notch1 and play a role in mediating cell fate decisions during hematopoiesis.	Univ Washington, Stower Inst Med Res, Seattle, WA 98195 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Washington, NW Lipid Res Lab, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; Fudan Univ, Inst Genet, Shanghai 200433, Peoples R China	Stowers Institute for Medical Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fudan University	Hood, L (corresponding author), Univ Washington, Stower Inst Med Res, Seattle, WA 98195 USA.	molbiotik@u.washington.edu		Banta, Amy/0000-0002-1843-5059; Li, Linheng/0000-0001-9963-430X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028834] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034431] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50HL54881] Funding Source: Medline; NICHD NIH HHS [P30HD28834] Funding Source: Medline; NIDDK NIH HHS [DK34431] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; CHURCH GM, 1988, SCIENCE, V240, P185, DOI 10.1126/science.3353714; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; CUOSO JP, 1994, CELL, V67, P311; CWIRLA SE, 1997, SCIENCE, V276, P696; DELAMO FF, 1992, DEVELOPMENT, V115, P737; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; Fitzgerald K, 1995, DEVELOPMENT, V121, P4275; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; GINIGER E, 1993, DEVELOPMENT, V117, P431; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Henderson ST, 1997, MOL BIOL CELL, V8, P1751, DOI 10.1091/mbc.8.9.1751; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; KOOH PJ, 1993, DEVELOPMENT, V117, P493; KOPAN R, 1993, J CELL BIOL, V121, P631, DOI 10.1083/jcb.121.3.631; KOPAN R, 1994, DEVELOPMENT, V120, P2385; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; LIEBER T, 1992, NEURON, V9, P847, DOI 10.1016/0896-6273(92)90238-9; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; MARCOVINA S, 1990, J LIPID RES, V31, P375; MELLO CC, 1994, CELL, V77, P95, DOI 10.1016/0092-8674(94)90238-0; Milner LA, 1996, P NATL ACAD SCI USA, V93, P13014, DOI 10.1073/pnas.93.23.13014; Mitsiadis TA, 1997, DEVELOPMENT, V124, P1473; MITSIADIS TA, 1995, J CELL BIOL, V130, P407, DOI 10.1083/jcb.130.2.407; MLLNER LA, 1994, BLOOD, V83, P2057; Moore KA, 1997, P NATL ACAD SCI USA, V94, P4011, DOI 10.1073/pnas.94.8.4011; Muskavitch M.A.T., 1990, Current Topics in Developmental Biology, V24, P289, DOI 10.1016/S0070-2153(08)60091-5; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; NYE JS, 1995, CURR BIOL, V5, P966, DOI 10.1016/S0960-9822(95)00189-8; NYE JS, 1994, DEVELOPMENT, V120, P2421; PALKA J, 1990, DEVELOPMENT, V109, P167; REAUME AG, 1992, DEV BIOL, V154, P377, DOI 10.1016/0012-1606(92)90076-S; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; ROWEN L, 1994, AUTOMATED DNA SEQUEN, P167; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; SIMPSON P, 1995, NATURE, V375, P736, DOI 10.1038/375736a0; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; Sun X, 1996, DEVELOPMENT, V122, P2465; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; TAX FE, 1994, NATURE, V368, P150, DOI 10.1038/368150a0; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; VALTIERI M, 1987, J IMMUNOL, V138, P3829; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; XU T, 1992, DEVELOPMENT, V115, P913; Zimrin AB, 1996, J BIOL CHEM, V271, P32499, DOI 10.1074/jbc.271.51.32499	62	219	259	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1998	8	1					43	55		10.1016/S1074-7613(00)80457-4	http://dx.doi.org/10.1016/S1074-7613(00)80457-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462510	Bronze			2022-12-18	WOS:000071765700005
J	Sawai, CM; Babovic, S; Upadhaya, S; Knapp, DJHF; Lavin, Y; Lau, CM; Goloborodko, A; Feng, J; Fujisaki, J; Ding, L; Mirny, LA; Merad, M; Eaves, CJ; Reizis, B				Sawai, Catherine M.; Babovic, Sonja; Upadhaya, Samik; Knapp, David J. H. F.; Lavin, Yonit; Lau, Colleen M.; Goloborodko, Anton; Feng, Jue; Fujisaki, Joji; Ding, Lei; Mirny, Leonid A.; Merad, Miriam; Eaves, Connie J.; Reizis, Boris			Hematopoietic Stem Cells Are the Major Source of Multilineage Hematopoiesis in Adult Animals	IMMUNITY			English	Article							MURINE BONE-MARROW; SELF-RENEWAL; IN-VIVO; GENE-EXPRESSION; PROGENITOR CELLS; CLONAL DYNAMICS; PROGRAMS; REVEALS; NICHES; HETEROGENEITY	Hematopoietic stem cells (HSCs) sustain long-term reconstitution of hematopoiesis in transplantation recipients, yet their role in the endogenous steady-state hematopoiesis remains unclear. In particular, recent studies suggested that HSCs provide a relatively minor contribution to immune cell development in adults. We directed transgene expression in a fraction of HSCs that maintained reconstituting activity during serial transplantations. Inducible genetic labeling showed that transgene-expressing HSCs gave rise to other phenotypic HSCs, confirming their top position in the differentiation hierarchy. The labeled HSCs rapidly contributed to committed progenitors of all lineages and to mature myeloid cells and lymphocytes, but not to B-1a cells or tissue macrophages. Importantly, labeled HSCs gave rise to more than two-thirds of all myeloid cells and platelets in adult mice, and this contribution could be accelerated by an induced interferon response. Thus, classically defined HSCs maintain immune cell development in the steady state and during systemic cytokine responses.	[Sawai, Catherine M.; Upadhaya, Samik; Lau, Colleen M.; Feng, Jue; Reizis, Boris] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Babovic, Sonja; Knapp, David J. H. F.; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 4E6, Canada; [Babovic, Sonja; Knapp, David J. H. F.; Eaves, Connie J.] Univ British Columbia, Vancouver, BC V5Z 4E6, Canada; [Upadhaya, Samik] Columbia Univ, Med Ctr, Grad Program Pathobiol & Mol Med, New York, NY 10032 USA; [Lavin, Yonit; Merad, Miriam] Mt Sinai Sch Med, Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA; [Lavin, Yonit; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Goloborodko, Anton; Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Fujisaki, Joji] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Fujisaki, Joji] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA; [Ding, Lei] Columbia Univ, Med Ctr, Dept Regenerat Med, New York, NY 10032 USA; [Ding, Lei] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Mirny, Leonid A.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Reizis, Boris] NYU, Langone Med Ctr, Dept Med, New York, NY 10016 USA; [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA	New York University; NYU Langone Medical Center; British Columbia Cancer Agency; University of British Columbia; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT); Columbia University; Columbia University; Columbia University; Columbia University; Massachusetts Institute of Technology (MIT); New York University; NYU Langone Medical Center; Columbia University	Sawai, CM; Reizis, B (corresponding author), NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA.; Reizis, B (corresponding author), NYU, Langone Med Ctr, Dept Med, New York, NY 10016 USA.; Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	catherine.sawai@nyumc.org; boris.reizis@nyumc.org	Mirny, Leonid/ABE-8083-2020; Sawai, Catherine M/E-5023-2018	Mirny, Leonid/0000-0002-0785-5410; Sawai, Catherine M/0000-0002-2509-474X; Goloborodko, Anton/0000-0002-2210-8616; Lavin, Yonit/0000-0003-0593-3910; Reizis, Boris/0000-0003-1140-7853; Eaves, Connie/0000-0002-3452-1926; Knapp, David JHF/0000-0002-2161-9959	NIH [AG049074, AI115382, AI072571, HL113678, HD055165, AI100853]; Leona M. and Harry B. Helmsley Charitable Trust; Terry Fox Program Project grant; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA173861, R01CA190400, P30CA016087, R01CA154947] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132074, R21HL113678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI115382, R01AI072571, T32AI100853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG049074] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Terry Fox Program Project grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Drs. C. Park, W. Hu, and C. Borsotti for instruction on obtaining BM biopsies. This work was supported by the NIH grants AG049074, AI115382, AI072571, and HL113678 (B.R.), Leona M. and Harry B. Helmsley Charitable Trust (B.R.), NIH training grant HD055165 (C.M.S.) and AI100853 (C.M.L.), and a Terry Fox Program Project grant (C.J.E.). S.B. and D.J.H.F.K. were recipients of Vanier Scholarships from the Canadian Institutes of Health Research.	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Adams PD, 2015, CELL STEM CELL, V16, P601, DOI 10.1016/j.stem.2015.05.002; Bagger FO, 2016, NUCLEIC ACIDS RES, V44, pD917, DOI 10.1093/nar/gkv1101; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Boulais PE, 2015, BLOOD, V125, P2621, DOI 10.1182/blood-2014-09-570192; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; Elias HK, 2014, ONCOGENE, V33, P5139, DOI 10.1038/onc.2013.520; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gazit R, 2014, J EXP MED, V211, P1314, DOI 10.1084/jem.20130428; Geering B, 2013, TRENDS IMMUNOL, V34, P398, DOI 10.1016/j.it.2013.04.002; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pietras EM, 2014, J EXP MED, V211, P245, DOI 10.1084/jem.20131043; Sanchez-Aguilera A, 2014, CELL STEM CELL, V15, P791, DOI 10.1016/j.stem.2014.11.002; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Verlinden SFF, 1998, EXP HEMATOL, V26, P627; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wilson NK, 2015, CELL STEM CELL, V16, P712, DOI 10.1016/j.stem.2015.04.004; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007	47	218	225	3	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					597	609		10.1016/j.immuni.2016.08.007	http://dx.doi.org/10.1016/j.immuni.2016.08.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27590115	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000388454300016
J	Staron, MM; Gray, SM; Marshall, HD; Parish, IA; Chen, JH; Perry, CJ; Cui, GL; Li, MO; Kaech, SM				Staron, Matthew M.; Gray, Simon M.; Marshall, Heather D.; Parish, Ian A.; Chen, Jonathan H.; Perry, Curtis J.; Cui, Guoliang; Li, Ming O.; Kaech, Susan M.			The Transcription Factor FoxO1 Sustains Expression of the Inhibitory Receptor PD-1 and Survival of Antiviral CD8(+) T Cells during Chronic Infection	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; EFFECTOR FUNCTIONS; MEMORY; DIFFERENTIATION; METABOLISM; ACTIVATION; EXHAUSTION; RESPONSES; TOLERANCE; PATHWAYS	Protein kinase B (also known as AKT) and the mechanistic target of rapamycin (mTOR) are central regulators of T cell differentiation, proliferation, metabolism, and survival. Here, we show that during chronic murine lymphocytic choriomeningitis virus infection, activation of AKT and mTOR are impaired in antiviral cytotoxic T lymphocytes (CTLs), resulting in enhanced activity of the transcription factor FoxO1. Blockade of inhibitory receptor programmed cell death protein 1 (PD-1) in vivo increased mTOR activity in virus-specific CTLs, and its therapeutic effects were abrogated by the mTOR inhibitor rapamycin. FoxO1 functioned as a transcriptional activator of PD-1 that promoted the differentiation of terminally exhausted CTLs. Importantly, FoxO1-null CTLs failed to persist and control chronic viral infection. Collectively, this study shows that CTLs adapt to persistent infection through a positive feedback pathway (PD-1-->FoxO1-->PD-1) that functions to both desensitize virus-specific CTLs to antigen and support their survival during chronic viral infection.	[Staron, Matthew M.; Gray, Simon M.; Marshall, Heather D.; Parish, Ian A.; Chen, Jonathan H.; Perry, Curtis J.; Cui, Guoliang; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Li, Ming O.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Kaech, SM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	susan.kaech@yale.edu		Cui, Guoliang/0000-0001-5559-7957; Parish, Ian/0000-0003-3528-478X; li, ming/0000-0002-1383-0535	NIH [R37AI066232, R01AI074699, R01AI102888, F32AI096718, T325T32AI007019, F32AI094791, 1-S10-RR-026526-01]; Howard Hughes Medical Institute; Australian NHMRC Overseas Biomedical Postdoctoral Fellowship; Yale Trudeau Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074699, T32AI007019, R01AI066232, R01AI102888, R37AI066232, F32AI094791, F32AI096718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR040072, P30AR053495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Australian NHMRC Overseas Biomedical Postdoctoral Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Yale Trudeau Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the S.M.K. lab and members of the Craft lab for their discussions and critical review of the manuscript, M. Suresh for his thoughtful discussions and suggestions, J. Boss for the PD-1 promoter luciferase plasmids, T. Unterman for the FoxO1-AAA plasmid, and W.K. Ip for firefly luciferase plasmid and help with luciferase reporter assays. This work was supported by the NIH (R37AI066232 and R01AI074699 to S.M.K.; R01AI102888 to M.O.L.; F32AI096718 and T325T32AI007019 to M.M.S.; F32AI094791 to H.D.M.; and the Shared Instrument Grant, 1-S10-RR-026526-01) and Howard Hughes Medical Institute. I.A.P. was supported by the Australian NHMRC Overseas Biomedical Postdoctoral Fellowship. G.C. was supported by the Yale Trudeau Fellowship.	Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brooks DG, 2006, J CLIN INVEST, V116, P1675, DOI 10.1172/JCI26856; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Finlay DK, 2009, J EXP MED, V206, P2441, DOI 10.1084/jem.20090219; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Grayson JM, 2006, J VIROL, V80, P8627, DOI 10.1128/JVI.00855-06; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim EH, 2012, J IMMUNOL, V188, P4305, DOI 10.4049/jimmunol.1103568; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Lu P., 2014, J EXP MED, V211, P515; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Michalek RD, 2010, IMMUNOL REV, V236, P190, DOI 10.1111/j.1600-065X.2010.00911.x; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Patsoukis N, 2013, MOL CELL BIOL, V33, P3091, DOI 10.1128/MCB.00319-13; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Puglielli MT, 2001, J VIROL, V75, P5099, DOI 10.1128/JVI.75.11.5099-5107.2001; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Sullivan JA, 2012, J VIROL, V86, P9025, DOI 10.1128/JVI.00942-12; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Tomasoni R, 2011, EUR J IMMUNOL, V41, P2086, DOI 10.1002/eji.201041130; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	68	218	228	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					802	814		10.1016/j.immuni.2014.10.013	http://dx.doi.org/10.1016/j.immuni.2014.10.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25464856	Green Accepted, Bronze			2022-12-18	WOS:000345504900016
J	Yokosuka, T; Kobayashi, W; Sakata-Sogawa, K; Takamatsu, M; Hashimoto-Tane, A; Dustin, ML; Tokunaga, M; Saito, T				Yokosuka, Tadashi; Kobayashi, Wakana; Sakata-Sogawa, Kumiko; Takamatsu, Masako; Hashimoto-Tane, Akiko; Dustin, Michael L.; Tokunaga, Makio; Saito, Takashi			Spatiotemporal Regulation of T Cell Costimulation by TCR-CD28 Microclusters and Protein Kinase C theta Translocation	IMMUNITY			English	Article							KAPPA-B ACTIVATION; IMMUNOLOGICAL SYNAPSE; PKC-THETA; CYTOPLASMIC DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; RECEPTOR MICROCLUSTERS; FILAMIN-A; CD28; CTLA-4; TCR	T cell activation is mediated by microclusters; (MCs) containing T cell receptors (TCRs), kinases, and adaptors. Although TCR MCs translocate to form a central supramolecular activation cluster (cSMAC) of the immunological synapse at the interface of a T cell and an antigen- presenting cell, the role of MC translocation in T cell signaling remains unclear. Here, we found that the accumulation of MCs at cSMAC was important for T cell costimulation. Costimulatory receptor CD28 was initially recruited coordinately with TCR to MCs, and its signals were mediated through the assembly with the kinase PKC theta. The accumulation of MCs at the cSMAC was accompanied by the segregation of CD28 from the TCR, which resulted in the translocation of both CD28 and PKC theta to a spatially unique subregion of cSMAC. Thus, costimulation is mediated by the generation of a unique costimulatory compartment in the cSMAC via the dynamic regulation of MC translocation.	[Dustin, Michael L.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Dustin, Michael L.] NYU, Sch Med, Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA; [Tokunaga, Makio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Saito, Takashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka 5650871, Japan; [Yokosuka, Tadashi; Kobayashi, Wakana; Takamatsu, Masako; Hashimoto-Tane, Akiko; Saito, Takashi] RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	New York University; New York University; Tokyo Institute of Technology; Osaka University; RIKEN	Saito, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	saito@rcai.riken.jp	Dustin, Michael/AAM-4611-2020; Saito, Takashi/C-9684-2009	Saito, Takashi/0000-0001-9495-3547; Hashimoto-Tane, Akiko/0000-0001-8519-266X; Dustin, Michael/0000-0003-4983-6389	Ministry of Education, Culture, Sports, Science, and Technology of Japan; New Energy Development Organization; NIH [AI043542, AI044931]; Grants-in-Aid for Scientific Research [20114004] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043542, R01AI043542, R56AI044931, R01AI044931] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy Development Organization; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank R. Verma for discussion, J.P. Allison and R. Abe for reagents, R.N. Germain and K. Yasutomo for mice, and H. Yamaguchi and S. Kato for secretarial assistance. We especially thank the late T. Starr for instructions pertaining to planar bilayer preparation. This work was supported by a Grant-in-Aid for Priority Area Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (T.Y., A.H.T., M.T., and T.S.), the New Energy Development Organization (M.T.), and the NIH (AI043542 and AI044931 to M.L.D.).	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Andres PG, 2004, J IMMUNOL, V172, P5880, DOI 10.4049/jimmunol.172.10.5880; Andres PG, 2004, NAT IMMUNOL, V5, P435, DOI 10.1038/ni1044; Berg-Brown NN, 2004, J EXP MED, V199, P743, DOI 10.1084/jem.20031022; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Harada Y, 2003, J EXP MED, V197, P257, DOI 10.1084/jem.20021305; Hayashi K, 2006, J IMMUNOL, V177, P1721, DOI 10.4049/jimmunol.177.3.1721; Herndon TM, 2001, J IMMUNOL, V166, P5654, DOI 10.4049/jimmunol.166.9.5654; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Kaga S, 1998, J IMMUNOL, V160, P24; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; KRUISBEEK AM, 1997, CURRENT PROTOCALS IM; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Liu YH, 2000, J BIOL CHEM, V275, P3603, DOI 10.1074/jbc.275.5.3603; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; Riley JL, 2005, BLOOD, V105, P13, DOI 10.1182/blood-2004-04-1596; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; Tseng SY, 2005, J IMMUNOL, V175, P7829, DOI 10.4049/jimmunol.175.12.7829; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Villalba M, 2002, J CELL BIOL, V157, P253, DOI 10.1083/jcb.200201097; Watanabe R, 2006, J IMMUNOL, V177, P1085, DOI 10.4049/jimmunol.177.2.1085; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	49	218	221	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					589	601		10.1016/j.immuni.2008.08.011	http://dx.doi.org/10.1016/j.immuni.2008.08.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18848472	Green Accepted, Bronze			2022-12-18	WOS:000260316700012
J	Kim, YG; Park, JH; Shaw, MH; Franchi, L; Inohara, N; Nunez, G				Kim, Yun-Gi; Park, Jong-Hwan; Shaw, Michael H.; Franchi, Luigi; Inohara, Naohiro; Nunez, Gabriel			The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to toll-like receptor ligands	IMMUNITY			English	Article							INTESTINAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSES; NF-KAPPA-B; MYD88-INDEPENDENT PATHWAYS; MICROBIAL INTERACTIONS; NEGATIVE REGULATOR; LIPOTEICHOIC ACID; SEPTIC SHOCK; PEPTIDOGLYCAN; TOLERANCE	The cytosolic sensors Nod1 and Nod2 and Toll-like receptors (TLRs) activate defense signaling pathways in response to microbial stimuli. However, the role of Nod1 and Nod2 and their interplay with TLRs during systemic bacterial infection remains poorly understood. Here, we report that macrophages or mice made insensitive to TLRs by previous exposure to microbial ligands remained responsive to Nod1 and Nod2 stimulation. Furthermore, Nod1 - and Nod2-mediated signaling and gene expression are enhanced in TLR-tolerant macrophages. Further analyses revealed that innate immune responses induced by bacterial infection relied on Nod1 and Nod2 and their adaptor RICK in macrophages pretreated with TLR ligands but not in naive macrophages. In addition, bacterial clearance upon systemic infection with L. monocytogenes was critically dependent on Nod1 and Nod2 when mice were previously stimulated with lipopolysaccharide or E coli. Thus, Nod1 and Nod2 are important for microbial recognition and host defense after TLR stimulation.	[Kim, Yun-Gi; Park, Jong-Hwan; Shaw, Michael H.; Franchi, Luigi; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Ctr Comprehens Canc, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Ctr Comprehens Canc, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014		NHLBI NIH HHS [2T32 HL 007517] Funding Source: Medline; NIDCR NIH HHS [R01 DE018503] Funding Source: Medline; NIDDK NIH HHS [R01 DK 61707] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061707] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu MT, 2003, J ENDOTOXIN RES, V9, P322, DOI 10.1179/096805103225002593; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Crabtree TD, 2001, INFECT IMMUN, V69, P2123, DOI 10.1128/IAI.69.4.2123-2129.2001; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Foster SL, 2008, NATURE, V451, P102, DOI 10.1038/nature06541; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Hellman J, 2000, INFECT IMMUN, V68, P2566, DOI 10.1128/IAI.68.5.2566-2572.2000; Higgins DE, 1999, MOL MICROBIOL, V31, P1631, DOI 10.1046/j.1365-2958.1999.01272.x; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lehner MD, 2001, J IMMUNOL, V166, P5161, DOI 10.4049/jimmunol.166.8.5161; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Opitz B, 2006, J IMMUNOL, V176, P484, DOI 10.4049/jimmunol.176.1.484; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang JH, 2003, J IMMUNOL, V170, P14, DOI 10.4049/jimmunol.170.1.14; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Yang SH, 2001, INFECT IMMUN, V69, P2045, DOI 10.1128/IAI.69.4.2045-2053.2001; Zilbauer M, 2007, CELL MICROBIOL, V9, P2541, DOI 10.1111/j.1462-5822.2007.01008.x	48	218	229	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2008	28	2					246	257		10.1016/j.immuni.2007.12.012	http://dx.doi.org/10.1016/j.immuni.2007.12.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18261938	Bronze			2022-12-18	WOS:000253275000014
J	Yang, K; Puel, A; Zhang, SY; Eidenschenk, C; Ku, CL; Casrouge, A; Picard, C; von Bernuth, H; Senechal, B; Plancoulaine, S; Al-Hajjar, S; Al-Ghonaium, A; Marodi, L; Davidson, D; Speert, D; Roifman, C; Garty, BZ; Ozinsky, A; Barrat, FJ; Coffman, RL; Miller, RL; Li, XX; Lebon, P; Rodriguez-Gallego, C; Chapel, H; Geissmann, F; Jouanguy, E; Casanova, JL				Yang, K; Puel, A; Zhang, SY; Eidenschenk, C; Ku, CL; Casrouge, A; Picard, C; von Bernuth, H; Senechal, B; Plancoulaine, S; Al-Hajjar, S; Al-Ghonaium, A; Marodi, L; Davidson, D; Speert, D; Roifman, C; Garty, BZ; Ozinsky, A; Barrat, FJ; Coffman, RL; Miller, RL; Li, XX; Lebon, P; Rodriguez-Gallego, C; Chapel, H; Geissmann, F; Jouanguy, E; Casanova, JL			Human TLR-7-,-8-, and -9-mediated induction of IFN-alpha/beta and -lambda is IRAK-4 dependent and redundant for protective immunity to viruses	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; DOUBLE-STRANDED-RNA; NF-KAPPA-B; PLASMACYTOID DENDRITIC CELLS; SIGNALING PATHWAY; BACTERIAL-INFECTIONS; ANTIVIRAL RESPONSE; INTERFERON-ALPHA/BETA; ESSENTIAL COMPONENTS; REGULATORY FACTOR-3	Five TLRs are thought to play an important role in antiviral immunity, sensing viral products and inducing IFN-alpha/beta and -lambda. Surprisingly, patients with a defect of IRAK-4, a critical kinase downstream from TLRs, are resistant to common viruses. We show here that alpha/beta and -lambda induction via TLR-7, TLR-8, and TLR-9 was abolished in IRAK-4-deficient blood cells. In contrast, IFN-alpha/beta and -lambda were induced normally by TLR-3 and TLR-4 agonists. Moreover, IFN-beta and -lambda were normally induced by TLR-3 agonists and viruses in IRAK-4-deficient fibroblasts. We further show that IFN-alpha/beta and -lambda production in response to 9 of 11 viruses tested was normal or weakly affected in IRAK-4-deficient blood cells. Thus, IRAK-4-deficient patients may control viral infections by TLR-3- and TLR-4-dependent and/or TLR-independent production of IFNs. The TLR-7-, TLR-8-, and TLR-9-dependent induction of IFN-alpha/beta and -lambda is strictly IRAK-4 dependent and paradoxically redundant for protective immunity to most viruses in humans.	Univ Paris, INSERM, U550, Lab Human Genet Infect Dis,Necker Med Sch, F-75015 Paris, France; Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, French Chinese Lab Genet Life Sci, Shanghai 200025, Peoples R China; Necker Enfants Malades Hosp, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM Avenir, Lab Mononuclear Cell Biol, F-75015 Paris, France; King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; Res Ctr, Riyadh 11211, Saudi Arabia; Univ Debrecen, Dept Infect & Pediat Immunol, H-4012 Debrecen, Hungary; Univ Debrecen, Hlth Sci Ctr, H-4012 Debrecen, Hungary; British Columbia Res Inst Child & Family, Div Infect & Immunol Dis, Vancouver, BC V5Z 4H4, Canada; Hosp Sick Children, Dept Paediat, Div Immunol Allergy, Toronto, ON M5G 1X8, Canada; Schneider Childrens Med Ctr Israel, Dept Pediat, IL-49202 Petah Tiqwa, Israel; Inst Syst Biol, Seattle, WA 98103 USA; Dynavax Technol, Berkeley, CA 94710 USA; 3M Co, St Paul, MN 55144 USA; Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; Univ Paris, St Vincent Paul Hosp, Dept Virol, F-75015 Paris, France; Gran Canaria Dr Negrin Hosp, Dept Immunol, Las Palmas Gran Canaria 35020, Spain; John Radcliffe Hosp, Dept Immunol, Oxford OX3 9DU, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; King Faisal Specialist Hospital & Research Center; University of Debrecen; University of Debrecen; Child & Family Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Institute for Systems Biology (ISB); 3M; Cleveland Clinic Foundation; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Oxford	Casanova, JL (corresponding author), Univ Paris, INSERM, U550, Lab Human Genet Infect Dis,Necker Med Sch, F-75015 Paris, France.	casanova@necker.fr	Puel, Anne/H-7305-2017; Picard, Capucine/H-3914-2017; von Bernuth, Horst/AAQ-9797-2021; PLANCOULAINE, Sabine/E-2824-2017; Casanova, Jean-Laurent/I-3418-2017; Marodi, Laszlo/AAU-9915-2020; Jouanguy, Emmanuelle/H-7901-2017; RODRIGUEZ-GALLEGO, CARLOS/AAB-7516-2022; KU, Cheng-Lung/L-6073-2015; KU, Cheng-Lung/AAT-1033-2020	Puel, Anne/0000-0003-2603-0323; Picard, Capucine/0000-0001-8788-5056; von Bernuth, Horst/0000-0002-5812-7675; PLANCOULAINE, Sabine/0000-0003-0725-8306; Jouanguy, Emmanuelle/0000-0002-7358-9157; KU, Cheng-Lung/0000-0002-0643-2256; KU, Cheng-Lung/0000-0002-0643-2256; Casanova, Jean-Laurent/0000-0002-7782-4169; geissmann, frederic/0000-0001-5029-2468; Rodriguez-Gallego, Carlos/0000-0002-4344-8644				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Avota E, 2001, NAT MED, V7, P725, DOI 10.1038/89106; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Boehme KW, 2004, J VIROL, V78, P7867, DOI 10.1128/JVI.78.15.7867-7873.2004; Bourke E, 2003, BLOOD, V102, P956, DOI 10.1182/blood-2002-11-3355; CARDENES M, 2005, IN PRESS J PEDIAT; Casanova JL, 2005, J EXP MED, V202, P197, DOI 10.1084/jem.20050854; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Chapel H, 2005, CLIN INFECT DIS, V40, P1227, DOI 10.1086/428733; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Currie AJ, 2004, J PEDIATR-US, V144, P512, DOI 10.1016/j.jpeds.2003.10.034; Day N, 2004, J PEDIATR-US, V144, P524, DOI 10.1016/j.jpeds.2003.11.025; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Ehl S, 2004, EUR J IMMUNOL, V34, P1146, DOI 10.1002/eji.200324449; Enders A, 2004, J PEDIATR-US, V145, P698, DOI 10.1016/j.jpeds.2004.06.065; Fairweather D, 2003, J IMMUNOL, V170, P4731, DOI 10.4049/jimmunol.170.9.4731; Finberg RW, 2004, MICROBES INFECT, V6, P1356, DOI 10.1016/j.micinf.2004.08.013; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kato A, 2004, J IMMUNOL, V172, P6185, DOI 10.4049/jimmunol.172.10.6185; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Ku CL, 2005, IMMUNOL REV, V203, P10, DOI 10.1111/j.0105-2896.2005.00235.x; Kulka M, 2004, J ALLERGY CLIN IMMUN, V114, P174, DOI 10.1016/j.jaci.2004.03.049; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Servant MJ, 2002, BIOCHEM PHARMACOL, V64, P985, DOI 10.1016/S0006-2952(02)01165-6; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Siren J, 2005, J IMMUNOL, V174, P1932, DOI 10.4049/jimmunol.174.4.1932; Sivori S, 2004, P NATL ACAD SCI USA, V101, P10116, DOI 10.1073/pnas.0403744101; Suzuki N, 2003, J IMMUNOL, V171, P6065, DOI 10.4049/jimmunol.171.11.6065; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; van der Sluijs KF, 2003, IMMUNOL LETT, V89, P201, DOI 10.1016/S0165-2478(03)00138-X; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	66	218	235	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2005	23	5					465	478		10.1016/j.immuni.2005.09.016	http://dx.doi.org/10.1016/j.immuni.2005.09.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	989GK	16286015	Green Published, Bronze			2022-12-18	WOS:000233660700004
J	Weninger, W; Ulfman, LH; Cheng, G; Souchkova, N; Quackenbush, EJ; Lowe, JB; von Andrian, UH				Weninger, W; Ulfman, LH; Cheng, G; Souchkova, N; Quackenbush, EJ; Lowe, JB; von Andrian, UH			Specialized contributions by alpha(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels	IMMUNITY			English	Article							SELECTIN-DEFICIENT MICE; ADHESION IN-VIVO; P-SELECTIN; CONTACT HYPERSENSITIVITY; RABBIT MESENTERY; T-CELLS; VENULES; SKIN; RECRUITMENT; CYTOKINE	Noninflamed skin venules support constitutive leukocyte rolling. P-selectin controls the rolling frequency, whereas E-selectin dictates rolling velocity (V-roll). Fucosylated selectin ligands are essential for all interactions, as rolling was absent in mice doubly deficient in alpha 1,3-fucosyltransferase (FucT)-IV and FucT-VII. The rolling fraction was reduced in FucT-VII-/- animals but normal in FucT-IV-/- mice. However, V-roll was markedly increased in both strains. P-selectin ligands generated by FucT-VII are crucial for initial leukocyte tethering, whereas E-selectin ligands that permit maximum slowing of V-roll require simultaneous expression of FucT-IV and FucT-VII. These results demonstrate a role for FucT-IV in selectin-dependent adhesion and suggest that the endothelial selectins and FucTs have distinct but overlapping functions in the immunosurveillance of the skin.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Pathol,Div Clin Genet, Boston, MA 02115 USA; Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48105 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.	uva@cbr.med.harvard.edu	von Andrian, Ulrich H/A-5775-2008	Weninger, Wolfgang/0000-0003-3133-8699	NHLBI NIH HHS [HL48675, HL56949, HL54936] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054936, P01HL056949] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alaibac M, 1997, INT J CLIN LAB RES, V27, P158, DOI 10.1007/BF02912452; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CARLOS TM, 1994, BLOOD, V84, P2068; Diacovo TG, 1996, J EXP MED, V183, P1193, DOI 10.1084/jem.183.3.1193; FIEBIG E, 1991, INT J MICROCIRC, V10, P127; Frenette PS, 1998, BLOOD, V91, P1318, DOI 10.1182/blood.V91.4.1318; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Hickey MJ, 1999, J IMMUNOL, V162, P1137; JANSSEN GHGW, 1994, AM J PHYSIOL, V267, pH1199, DOI 10.1152/ajpheart.1994.267.3.H1199; Jung U, 1997, MICROCIRCULATION-LON, V4, P311, DOI 10.3109/10739689709146794; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; Ley K, 1998, CIRC RES, V83, P287, DOI 10.1161/01.RES.83.3.287; Lowe JB, 1997, KIDNEY INT, V51, P1418, DOI 10.1038/ki.1997.194; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MAYROVITZ HN, 1992, AM J PHYSIOL, V262, pH157, DOI 10.1152/ajpheart.1992.262.1.H157; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; MENGER MD, 1993, IMMUNOL TODAY, V14, P519, DOI 10.1016/0167-5699(93)90179-O; Milstone DS, 1998, MICROCIRCULATION-LON, V5, P153, DOI 10.1080/713773857; Niemela R, 1998, J BIOL CHEM, V273, P4021, DOI 10.1074/jbc.273.7.4021; NOLTE D, 1994, AM J PHYSIOL-HEART C, V267, pH1637, DOI 10.1152/ajpheart.1994.267.4.H1637; OLOFSSON AM, 1994, BLOOD, V84, P2749, DOI 10.1182/blood.V84.8.2749.bloodjournal8482749; Puri KD, 1998, NATURE, V392, P930, DOI 10.1038/31954; Ramos CL, 1997, BLOOD, V89, P3009, DOI 10.1182/blood.V89.8.3009; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Robert C, 1999, J EXP MED, V189, P627, DOI 10.1084/jem.189.4.627; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sriramarao P, 1996, J IMMUNOL, V157, P4672; Sriramarao P, 1996, LAB INVEST, V74, P634; Staite ND, 1996, BLOOD, V88, P2973, DOI 10.1182/blood.V88.8.2973.bloodjournal8882973; Stein JV, 1999, J EXP MED, V189, P37, DOI 10.1084/jem.189.1.37; STEINMAN R, 1995, J INVEST DERMATOL, V105, pS2, DOI 10.1111/1523-1747.ep12315162; SUBRAMANIAM M, 1995, J EXP MED, V181, P2277, DOI 10.1084/jem.181.6.2277; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; von Andrian UH, 1998, CELL ADHES COMMUN, V6, P85; Wagner R., 1839, ERLAUTERUNGSTAFELN P; Walter UM, 1997, IMMUNOLOGY, V92, P290, DOI 10.1046/j.1365-2567.1997.d01-2314.x; YAMADA S, 1995, BLOOD, V86, P3487, DOI 10.1182/blood.V86.9.3487.bloodjournal8693487	41	218	223	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2000	12	6					665	676		10.1016/S1074-7613(00)80217-4	http://dx.doi.org/10.1016/S1074-7613(00)80217-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894166	Bronze			2022-12-18	WOS:000087937300008
J	Peh, CA; Burrows, SR; Barnden, M; Khanna, R; Cresswell, P; Moss, DJ; McCluskey, J				Peh, CA; Burrows, SR; Barnden, M; Khanna, R; Cresswell, P; Moss, DJ; McCluskey, J			HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading	IMMUNITY			English	Article							MHC CLASS-I; CELL-LINE; ANKYLOSING-SPONDYLITIS; MONOCLONAL-ANTIBODY; T-CELLS; INFLAMMATORY DISEASE; HLA-B27 MOLECULES; TRANSGENIC RATS; POINT MUTATION; TAP	Tapasin is a resident ER protein believed to be critical for antigen presentation by HLA class I molecules. We demonstrate that allelic variation in MHC class I molecules influences their dependence on tapasin for peptide loading and antigen presentation. HLA-B*2705 molecules achieve high levels of surface expression and present specific viral peptides in the absence of tapasin. In contrast, HLA-B*4402 molecules are highly dependent upon human tapasin for these functions, while HLA-B8 molecules are intermediate in this regard. Significantly, HLA-B*2705 like HLA-B*4402, requires tapasin to associate efficiently with TAP (transporters associated with antigen processing). The unusual ability of HLA-B*2705 to form peptide complexes without associating with TAP or tapasin confers flexibility in the repertoire of peptides presented by this molecule. We speculate that these properties might contribute to the role of HLA-B27 in conferring susceptibility to inflammatory spondyloarthropathies.	Flinders Univ S Australia, Flinders Med Ctr, Dept Immunol Allergy & Arthrit, Bedford Pk, SA 5042, Australia; Queensland Inst Med Res, EBV Unit, Herston, Qld 4006, Australia; Australian Red Cross, Blood Serv, So Reg, S Melbourne, Vic 3333, Australia; Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Flinders Medical Centre; Flinders University South Australia; QIMR Berghofer Medical Research Institute; Australian Red Cross Blood Service; Howard Hughes Medical Institute; Yale University; University of Melbourne	Peh, CA (corresponding author), Flinders Univ S Australia, Flinders Med Ctr, Dept Immunol Allergy & Arthrit, Bedford Pk, SA 5042, Australia.		Khanna, Rajiv/A-7691-2008; McCluskey, James/A-1291-2007; Burrows, Scott/G-2050-2011	Khanna, Rajiv/0000-0003-2241-0353; McCluskey, James/0000-0002-8597-815X; Burrows, Scott/0000-0002-1430-0472; Peh, Chen Au/0000-0002-9712-0396				Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; BENJAMIN RJ, 1991, NATURE, V351, P74, DOI 10.1038/351074a0; Breban M, 1996, J IMMUNOL, V156, P794; BROOKS AG, 1994, J IMMUNOL, V153, P5382; BURROWS SR, 1994, J GEN VIROL, V75, P2489, DOI 10.1099/0022-1317-75-9-2489; BURROWS SR, 1992, EUR J IMMUNOL, V22, P191, DOI 10.1002/eji.1830220128; CARRENO BM, 1995, J IMMUNOL, V155, P4726; CERUNDOLO V, 1995, EUR J IMMUNOL, V25, P554, DOI 10.1002/eji.1830250238; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; DIBRINO M, 1995, BIOCHEMISTRY-US, V34, P10130, DOI 10.1021/bi00032a005; Elliott T, 1997, IMMUNOL TODAY, V18, P375, DOI 10.1016/S0167-5699(97)01097-9; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; GRUMET FC, 1981, LANCET, V2, P174; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; HENDERSON RA, 1992, SCIENCE, V255, P1263; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; HERMANN E, 1993, LANCET, V342, P646, DOI 10.1016/0140-6736(93)91760-J; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; HOWARD JC, 1995, CURR OPIN IMMUNOL, V7, P69, DOI 10.1016/0952-7915(95)80031-X; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; KAPASI K, 1992, J IMMUNOL, V148, P3554; KAVATHAS P, 1983, P NATL ACAD SCI-BIOL, V80, P524, DOI 10.1073/pnas.80.2.524; Khan Muhammad Asim, 1995, Current Opinion in Rheumatology, V7, P263, DOI 10.1097/00002281-199507000-00001; KHANNA R, 1991, IMMUNOLOGY, V74, P504; KHARE SD, 1995, J EXP MED, V182, P1153, DOI 10.1084/jem.182.4.1153; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; MURRAY RJ, 1992, J EXP MED, V176, P157, DOI 10.1084/jem.176.1.157; Neisig A, 1996, J IMMUNOL, V156, P3196; NOSSNER E, 1995, J EXP MED, V181, P327, DOI 10.1084/jem.181.1.327; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Parham P, 1996, IMMUNOL REV, V154, P137, DOI 10.1111/j.1600-065X.1996.tb00932.x; PARHAM P, 1979, J IMMUNOL, V123, P342; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Sadasivan BK, 1995, COLD SPRING HARB SYM, V60, P267, DOI 10.1101/SQB.1995.060.01.031; SALTER RD, 1989, NATURE, V338, P345, DOI 10.1038/338345a0; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Sambrook J, 1989, MOL CLONING LAB MANU; SCOTT JE, 1995, J IMMUNOL, V155, P143; Solheim JC, 1997, J IMMUNOL, V158, P2236; STAM NJ, 1986, J IMMUNOL, V137, P2299; SUGITA M, 1994, J EXP MED, V180, P2163, DOI 10.1084/jem.180.6.2163; Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; THOMSEN DR, 1984, P NATL ACAD SCI-BIOL, V81, P659, DOI 10.1073/pnas.81.3.659; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TRAPANI JA, 1983, HUM IMMUNOL, V7, P205, DOI 10.1016/0198-8859(83)90058-7; TUSSEY LG, 1995, IMMUNITY, V3, P65, DOI 10.1016/1074-7613(95)90159-0; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; VALERIO RM, 1991, ANAL BIOCHEM, V197, P168, DOI 10.1016/0003-2697(91)90374-3; Vigna JL, 1996, J IMMUNOL, V157, P4503; WANG J, 1994, J IMMUNOL, V152, P1197; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; WEISS EH, 1985, IMMUNOBIOLOGY, V170, P367, DOI 10.1016/S0171-2985(85)80061-9; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	73	218	220	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1998	8	5					531	542		10.1016/S1074-7613(00)80558-0	http://dx.doi.org/10.1016/S1074-7613(00)80558-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ611	9620674	hybrid			2022-12-18	WOS:000073885400001
J	Ziegler, H; Thale, R; Lucin, P; Muranyi, W; Flohr, T; Hengel, H; Farrell, H; Rawlinson, W; Koszinowski, UH				Ziegler, H; Thale, R; Lucin, P; Muranyi, W; Flohr, T; Hengel, H; Farrell, H; Rawlinson, W; Koszinowski, UH			A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments	IMMUNITY			English	Article							CYTOLYTIC LYMPHOCYTE-T; IMMEDIATE-EARLY PROTEIN-PP89; ANTIGEN PRESENTATION; ENDOPLASMIC-RETICULUM; INFECTED-CELLS; SURFACE EXPRESSION; SECRETORY PATHWAY; DOWN-REGULATION; HEAVY-CHAINS; VIRUS	The principle by which mouse cytomegalovirus blocks antigen presentation in the MHC class I pathway was investigated. The responsible gene m152, encoding a type I transmembrane glycoprotein of 40 kDa, is a member of a gene family located in the right-hand terminal region of the 230 kb virus genome. Expression of m152 in murine and human cells arrested the export of mouse class I complexes from the ER-Golgi intermediate compartment/cis-Golgi compartment and inhibited lysis by cytotoxic T cells. The plasma membrane transport of human MHC class I molecules was not affected. The deletion of the cytoplasmic tail of gp40 did not lift its effect on class I molecule export, indicating that this protein differs in its functions from known immunosubversive viral gene products and represents a novel principle by which a herpesvirus shuts off MHC class I function.	UNIV RIJEKA, DEPT PHYSIOL & IMMUNOL, RIJEKA 51000, CROATIA; UNIV WESTERN AUSTRALIA, DEPT MICROBIOL, NEDLANDS, WA 6907, AUSTRALIA; ICPMR, DEPT VIROL, WESTMEAD, NSW 2145, AUSTRALIA	University of Rijeka; University of Western Australia	Ziegler, H (corresponding author), UNIV MUNICH, MAX VON PETTENKOFER INST, D-80336 MUNICH, GERMANY.		Lučin, Pero/R-8341-2018; Farrell, Helen/F-8583-2011	Lučin, Pero/0000-0001-8776-8634; Farrell, Helen/0000-0002-7214-2767; Rawlinson, William/0000-0003-0988-7827; Ziegler, Heike/0000-0003-2207-197X				Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; ANDERSSON M, 1985, CELL, V43, P215, DOI 10.1016/0092-8674(85)90026-1; ARNOLD B, 1984, CELL, V38, P79, DOI 10.1016/0092-8674(84)90528-2; BEERSMA MFC, 1993, J IMMUNOL, V151, P4455; BURGERT HG, 1985, CELL, V41, P987, DOI 10.1016/S0092-8674(85)80079-9; CAMPBELL AE, 1994, J VIROL, V68, P1805, DOI 10.1128/JVI.68.3.1805-1811.1994; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; DELVAL M, 1988, J VIROL, V62, P3965, DOI 10.1128/JVI.62.11.3965-3972.1988; DELVAL M, 1989, CELL, V58, P305, DOI 10.1016/0092-8674(89)90845-3; DELVAL M, 1992, J EXP MED, V176, P729, DOI 10.1084/jem.176.3.729; DELVAL M, 1991, CELL, V66, P1145, DOI 10.1016/0092-8674(91)90037-Y; EBELING A, 1983, J VIROL, V47, P421, DOI 10.1128/JVI.47.3.421-433.1983; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; GUAMLER FG, 1993, J BIOL CHEM, V268, P1941; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hendriks R J, 1994, Subcell Biochem, V22, P101; HENGEL H, 1994, J VIROL, V68, P289, DOI 10.1128/JVI.68.1.289-297.1994; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JONES TR, 1995, J VIROL, V69, P4830, DOI 10.1128/JVI.69.8.4830-4841.1995; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; KLEIJNEN MF, 1996, IN PRESS EMBO J; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; MADER S, 1993, P NATL ACAD SCI USA, V90, P5603, DOI 10.1073/pnas.90.12.5603; MELLERT W, 1990, AIDS, V4, P527, DOI 10.1097/00002030-199006000-00006; MOREMEN KW, 1991, J BIOL CHEM, V266, P16876; REDDEHASE MJ, 1986, J VIROL, V60, P1125, DOI 10.1128/JVI.60.3.1125-1129.1986; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; SARASTE J, 1991, J CELL SCI, V100, P415; SCHRIER PI, 1983, NATURE, V305, P771, DOI 10.1038/305771a0; SIGNAS C, 1982, NATURE, V299, P175, DOI 10.1038/299175a0; Smith Geoffrey L., 1994, Trends in Microbiology, V2, P81, DOI 10.1016/0966-842X(94)90539-8; THALE R, 1995, J VIROL, V69, P6098; THALE R, 1994, J VIROL, V68, P7757; TOOZE J, 1989, J CELL BIOL, V109, P35, DOI 10.1083/jcb.109.1.35; VOLKMER H, 1987, J EXP MED, V166, P668, DOI 10.1084/jem.166.3.668; WARREN AP, 1994, J VIROL, V68, P2822, DOI 10.1128/JVI.68.5.2822-2829.1994; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; WILLIAMS DB, 1995, CURR OPIN IMMUNOL, V7, P77, DOI 10.1016/0952-7915(95)80032-8; YAMASHITA Y, 1993, VIROLOGY, V193, P727, DOI 10.1006/viro.1993.1181; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5; YORK IA, 1994, CELL, V77, P525, DOI 10.1016/0092-8674(94)90215-1	44	218	221	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1997	6	1					57	66		10.1016/S1074-7613(00)80242-3	http://dx.doi.org/10.1016/S1074-7613(00)80242-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB161	9052837	Bronze			2022-12-18	WOS:A1997XB16100006
J	Beltra, JC; Manne, S; Abdel-Hakeem, MS; Kurachi, M; Giles, JR; Chen, Z; Casella, V; Ngiow, SF; Khan, O; Huang, YHJ; Yan, P; Nzingha, K; Xu, W; Amaravadi, RK; Xu, X; Karakousis, GC; Mitchell, TC; Schuchter, LM; Huang, AC; Wherry, EJ				Beltra, Jean-Christophe; Manne, Sasikanth; Abdel-Hakeem, Mohamed S.; Kurachi, Makoto; Giles, Josephine R.; Chen, Zeyu; Casella, Valentina; Ngiow, Shin Foong; Khan, Omar; Huang, Yinghui Jane; Yan, Patrick; Nzingha, Kito; Xu, Wei; Amaravadi, Ravi K.; Xu, Xiaowei; Karakousis, Giorgos C.; Mitchell, Tara C.; Schuchter, Lynn M.; Huang, Alexander C.; Wherry, E. John			Developmental Relationships of Four Exhausted CD8(+) T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms	IMMUNITY			English	Article							CHECKPOINT BLOCKADE; READ ALIGNMENT; EFFECTOR; BET; PD-1; CHROMATIN; PERSISTENCE; EXPRESSION; INFECTION; EOMES	CD8(+) T cell exhaustion is a major barrier to current anti-cancer immunotherapies. Despite this, the developmental biology of exhausted CD8(+) T cells (Tex) remains poorly defined, restraining improvement of strategies aimed at "re-invigorating'' Tex cells. Here, we defined a four-cell-stage developmental framework for Tex cells. Two TCF1(+) progenitor subsets were identified, one tissue restricted and quiescent and one more blood accessible, that gradually lost TCF1 as it divided and converted to a third intermediate Tex subset. This intermediate subset re-engaged some effector biology and increased upon PD-L1 blockade but ultimately converted into a fourth, terminally exhausted subset. By using transcriptional and epigenetic analyses, we identified the control mechanisms underlying subset transitions and defined a key interplay between TCF1, T-bet, and Tox in the process. These data reveal a four-stage developmental hierarchy for Tex cells and define the molecular, transcriptional, and epigenetic mechanisms that could provide opportunities to improve cancer immunotherapy.	[Beltra, Jean-Christophe; Manne, Sasikanth; Abdel-Hakeem, Mohamed S.; Giles, Josephine R.; Chen, Zeyu; Ngiow, Shin Foong; Khan, Omar; Huang, Yinghui Jane; Yan, Patrick; Nzingha, Kito; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Beltra, Jean-Christophe; Manne, Sasikanth; Abdel-Hakeem, Mohamed S.; Giles, Josephine R.; Chen, Zeyu; Ngiow, Shin Foong; Khan, Omar; Huang, Yinghui Jane; Yan, Patrick; Nzingha, Kito; Huang, Alexander C.; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Beltra, Jean-Christophe; Abdel-Hakeem, Mohamed S.; Giles, Josephine R.; Ngiow, Shin Foong; Huang, Alexander C.; Wherry, E. John] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Abdel-Hakeem, Mohamed S.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Kurachi, Makoto] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Genet, Kanazawa, Ishikawa, Japan; [Casella, Valentina] Univ Pompeu Fabra, Dept Expt & Hlth Sci DCEXS, Infect Biol Lab, Barcelona, Spain; [Khan, Omar; Yan, Patrick] Arsenal Biosci, San Francisco, CA USA; [Xu, Wei; Amaravadi, Ravi K.; Mitchell, Tara C.; Schuchter, Lynn M.; Huang, Alexander C.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xu, Wei; Amaravadi, Ravi K.; Xu, Xiaowei; Karakousis, Giorgos C.; Mitchell, Tara C.; Schuchter, Lynn M.; Huang, Alexander C.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xu, Xiaowei] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Karakousis, Giorgos C.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Egyptian Knowledge Bank (EKB); Cairo University; Kanazawa University; Pompeu Fabra University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.	wherry@pennmedicine.upenn.edu	Wherry, John/ABI-1280-2020; Chen, Zeyu/HGF-2358-2022; Chen, Zeyu/HGE-0239-2022	Khan, Omar/0000-0002-7641-6163; Beltra, Jean-Christophe/0000-0002-6363-3572; Abdel Hakeem, Mohamed/0000-0003-0226-3464	NIH [N2T32CA009615, CA230157, CA234842, AI105343, AI108545, AI117950, AI082630, CA210944]; Tara Miller Foundation; Melanoma Research Alliance; David and Hallee Adelman Immunotherapy Research Fund; Parker Institute for Cancer Immunotherapy Bridge Scholar Award; NHMRC CJ Martin Fellowship [GNT1111469]; Mark Foundation for Cancer Research Momentum Fellowship; Parker Institute for Cancer Immunotherapy;  [T32CA009140];  [P30-CA016520];  [P50-CA174523]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tara Miller Foundation; Melanoma Research Alliance; David and Hallee Adelman Immunotherapy Research Fund; Parker Institute for Cancer Immunotherapy Bridge Scholar Award; NHMRC CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Mark Foundation for Cancer Research Momentum Fellowship; Parker Institute for Cancer Immunotherapy; ; ; 	We thank the Wherry lab for input. This work was funded by NIH grants N2T32CA009615; CA230157 (A.C.H.); CA234842 (Z.C.); and AI105343, AI108545, AI117950, AI082630, and CA210944 (E.J.W.). This work was also supported by the Tara Miller Foundation (A.C.H.), the Melanoma Research Alliance (E.J.W.), the David and Hallee Adelman Immunotherapy Research Fund (E.J.W.), and the Parker Institute for Cancer Immunotherapy Bridge Scholar Award (A.C.H.). S.F.N. is supported by the NHMRC CJ Martin Fellowship GNT1111469 and the Mark Foundation for Cancer Research Momentum Fellowship. M.S.A.H. is a Cancer Research Institute (CRI) Irvington Postdoctoral fellows. J.R.G. is a Cancer Research Institute-Mark Foundation Fellow and was previously supported by T32CA009140. We thank the Human Immunology Core and the Tumor Tissue and Biospecimen Bank of the University of Pennsylvania (supported by P30-CA016520 and P50-CA174523). Work in the Wherry lab is supported by the Parker Institute for Cancer Immunotherapy.	Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Beltra JC, 2016, P NATL ACAD SCI USA, V113, pE5444, DOI 10.1073/pnas.1604256113; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Berrien-Elliott MM, 2015, CANCER IMMUNOL RES, V3, P116, DOI 10.1158/2326-6066.CIR-14-0159; Beura LK, 2015, J LEUKOCYTE BIOL, V97, P217, DOI 10.1189/jlb.1HI0314-154R; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Daud AI, 2016, J CLIN INVEST, V126, P3447, DOI 10.1172/JCI87324; Gehart H, 2019, NAT REV GASTRO HEPAT, V16, P19, DOI 10.1038/s41575-018-0081-y; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Grompe M, 2012, CELL STEM CELL, V10, P685, DOI 10.1016/j.stem.2012.04.006; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kurachi M, 2017, NAT PROTOC, V12, P1980, DOI 10.1038/nprot.2017.083; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Leek JT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku864; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; McCracken MN, 2016, COLD SH Q B, V81, P1, DOI 10.1101/sqb.2016.81.030965; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Muroyama Y, 2017, CANCER IMMUNOL RES, V5, P992, DOI 10.1158/2326-6066.CIR-17-0040; Ngiow SF, 2016, CANCER RES, V76, P6266, DOI 10.1158/0008-5472.CAN-16-2141; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Taqueti VR, 2006, J IMMUNOL, V177, P5890, DOI 10.4049/jimmunol.177.9.5890; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wu TD, 2020, NATURE, V579, P274, DOI 10.1038/s41586-020-2056-8; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Wykes MN, 2018, NAT REV IMMUNOL, V18, P91, DOI 10.1038/nri.2017.112; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x	67	217	223	26	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					825	+		10.1016/j.immuni.2020.04.014	http://dx.doi.org/10.1016/j.immuni.2020.04.014			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32396847	Bronze, Green Accepted			2022-12-18	WOS:000535371100015
J	Galon, J; Bruni, D				Galon, Jerome; Bruni, Daniela			Tumor Immunology and Tumor Evolution: Intertwined Histories	IMMUNITY			English	Review							REGULATORY T-CELLS; NATURAL-KILLER-CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; ATOMIC-BOMB SURVIVORS; COLORECTAL-CANCER; MAST-CELLS; NK CELLS; INFILTRATING LYMPHOCYTES; BREAST-CANCER; IMMUNE CONTEXTURE	Cancer is a complex disease whose outcome depends largely on the cross-talk between the tumor and its microenvironment. Here, we review the evolution of the field of tumor immunology and the advances, in lockstep, of our understanding of cancer as a disease. We discuss the involvement of different immune cells at distinct stages of tumor progression and how immune contexture determinants shaping tumor development are being exploited therapeutically. Current clinical stratification schemes focus on the tumor histopathology and the molecular characteristics of the tumor cell. We argue for the importance of revising these stratification systems to include immune parameters so as to address the immediate need for improved prognostic and/or predictive information to guide clinical decisions.	[Galon, Jerome; Bruni, Daniela] Univ Paris, Univ Paris Diderot, Univ Paris Descartes,Sorbonne Univ,Sorbonne Paris, INSERM,Lab Integrat Canc Immunol,Equipe Labellise, F-75006 Paris, France; [Galon, Jerome; Bruni, Daniela] Ctr Rech Cordeliers, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Galon, J (corresponding author), Univ Paris, Univ Paris Diderot, Univ Paris Descartes,Sorbonne Univ,Sorbonne Paris, INSERM,Lab Integrat Canc Immunol,Equipe Labellise, F-75006 Paris, France.; Galon, J (corresponding author), Ctr Rech Cordeliers, F-75006 Paris, France.	jerome.galon@crc.jussieu.fr		Bruni, Daniela/0000-0003-2015-3891	INSERM; National Cancer Institute of France (INCa); Canceropole Ile de France; La Ligue Contre le Cancer; La Fondation ARC; Cancer Research for Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); LabEx Immuno-oncology	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); National Cancer Institute of France (INCa); Canceropole Ile de France(Region Ile-de-France); La Ligue Contre le Cancer(Ligue nationale contre le cancer); La Fondation ARC; Cancer Research for Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); LabEx Immuno-oncology	For their support, we thank INSERM, the National Cancer Institute of France (INCa), Canceropole Ile de France, La Ligue Contre le Cancer, La Fondation ARC, Cancer Research for Personalized Medicine (CARPEM), Paris Alliance of Cancer Research Institutes (PACRI), and LabEx Immuno-oncology.	Ahmadzadeh M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aao4310; Aiello NM, 2018, DEV CELL, V45, P681, DOI 10.1016/j.devcel.2018.05.027; Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Allavena P, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/547179; Androulla MN, 2018, CURR PHARM BIOTECHNO, V19, P5, DOI 10.2174/1389201019666180418095526; Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012; Angelova M, 2018, CELL, V175, P751, DOI 10.1016/j.cell.2018.09.018; [Anonymous], 2018, JAMA J AM MED ASSOC, DOI [DOI 10.1001/JAMA.2018.17585, DOI 10.1001/jama.2018.17585]; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Aponte-Lopez A, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2584243; Aras S, 2017, BRIT J CANCER, V117, P1583, DOI 10.1038/bjc.2017.356; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Augestad KM, 2017, CLIN MED INSIGHTS-ON, V11, DOI 10.1177/1179554917690766; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BARND DL, 1989, P NATL ACAD SCI USA, V86, P7159, DOI 10.1073/pnas.86.18.7159; Beatson George T, 1896, Trans Med Chir Soc Edinb, V15, P153; Benson DM, 2015, CLIN CANCER RES, V21, P4055, DOI 10.1158/1078-0432.CCR-15-0304; Berghoff AS, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1057388; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Bindea G, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27456; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Blank CU, 2016, SCIENCE, V352, P658, DOI 10.1126/science.aaf2834; Boda D, 2018, INT J ONCOL, V52, P637, DOI 10.3892/ijo.2018.4256; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; BOTTAZZI B, 1983, SCIENCE, V220, P210, DOI 10.1126/science.6828888; Brieu N., 2018, ANN ONCOL, V29, P14, DOI DOI 10.1093/ANN0NC/MDY1269; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Buchbinder EI, 2016, AM J CLIN ONCOL-CANC, V39, P98, DOI 10.1097/COC.0000000000000239; BURNET M, 1957, BRIT MED J, V1, P779, DOI 10.1136/bmj.1.5022.779; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calmette A, 1927, BRIT MED J, V1927, P987; Canli O, 2017, CANCER CELL, V32, P869, DOI 10.1016/j.ccell.2017.11.004; Cantoni C, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4684268; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Cheever MA, 2011, CLIN CANCER RES, V17, P3520, DOI 10.1158/1078-0432.CCR-10-3126; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Cheng M, 2011, CELL TRANSPLANT, V20, P1731, DOI 10.3727/096368911X580536; Cheon H, 2014, SEMIN ONCOL, V41, P156, DOI 10.1053/j.seminoncol.2014.02.002; Chew V, 2012, J ONCOL, V2012, DOI 10.1155/2012/608406; Chiossone L, 2018, NAT REV IMMUNOL, V18, P671, DOI 10.1038/s41577-018-0061-z; Cho H, 2016, J PATHOL TRANSL MED, V50, P45, DOI 10.4132/jptm.2015.10.16; Chockley PJ, 2018, J CLIN INVEST, V128, P1384, DOI 10.1172/JCI97611; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5; Clever D, 2016, CELL, V166, P1117, DOI 10.1016/j.cell.2016.07.032; Coley WB, 1893, AM J MED SCI, V105, P487, DOI [DOI 10.1097/00000441-189305000-00001, 10.1097/00000441-189305000-00001]; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Cooper ML, 2018, LEUKEMIA, V32, P1970, DOI 10.1038/s41375-018-0065-5; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Coyle C, 2016, CURR COLORECT CANC R, V12, P27, DOI 10.1007/s11888-016-0306-9; Cramer W, 1944, CANCER RES, V4, P601; Cremonesi E, 2018, GUT, V67, P1984, DOI 10.1136/gutjnl-2016-313498; Cui GL, 2012, SCAND J GASTROENTERO, V47, P367, DOI 10.3109/00365521.2011.648950; Dangaj D, 2019, CANCER CELL, V35, P885, DOI 10.1016/j.ccell.2019.05.004; DARIAVACH P, 1988, EUR J IMMUNOL, V18, P1901, DOI 10.1002/eji.1830181206; Das A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14340-w; Delahaye NF, 2011, NAT MED, V17, P700, DOI 10.1038/nm.2366; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; DeRenzo C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00218; Dickinson AM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00496; Dietz WH, 2016, JAMA-J AM MED ASSOC, V316, P1645, DOI 10.1001/jama.2016.14370; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dong HP, 2006, AM J CLIN PATHOL, V125, P451, DOI 10.1309/15B66DQMFYYM78CJ; Dreno B, 2018, LANCET ONCOL, V19, P916, DOI 10.1016/S1470-2045(18)30254-7; Dukes CE, 1932, J PATHOL BACTERIOL, V35, P323, DOI 10.1002/path.1700350303; Dundar E, 2008, J INT MED RES, V36, P88, DOI 10.1177/147323000803600112; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dwyer AR, 2017, CANCERS, V9, DOI 10.3390/cancers9060068; Dyduch G, 2012, POL J PATHOL, V63, P1; Ehrlich P., 1879, ARCH ANAT PHYSL, V3, P166; Ehrlich P, 1879, ARCH ANAT PHYSL, V571; Ehrrlich P., 1909, NED TIJDSCHR GENEES, V5, P273; Enamorado M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16073; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Erfani N, 2012, LUNG CANCER, V77, P306, DOI 10.1016/j.lungcan.2012.04.011; ESCUDIER B, 1994, EUR J CANCER, V30A, P1078, DOI 10.1016/0959-8049(94)90460-X; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Faustino-Rocha AI, 2017, ANTICANCER RES, V37, P1013, DOI 10.21873/anticanres.11411; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fenn JE, 2011, J AM COLL SURGEONS, V212, P413, DOI 10.1016/j.jamcollsurg.2010.10.018; Fessenden TB, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0380-4; FOLEY EJ, 1953, CANCER RES, V13, P835; Formenti SC, 2013, JNCI-J NATL CANCER I, V105, P256, DOI 10.1093/jnci/djs629; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fuge O, 2015, RES REP UROL, V7, P65, DOI 10.2147/RRU.S63447; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2007, CANCER RES, V67, P1883, DOI 10.1158/0008-5472.CAN-06-4806; Galon J, 2019, NAT REV DRUG DISCOV, V18, P197, DOI 10.1038/s41573-018-0007-y; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gao D, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3817-0; Garcia-Albeniz X, 2011, BEST PRACT RES CL GA, V25, P461, DOI 10.1016/j.bpg.2011.10.015; Gardner A, 2016, TRENDS IMMUNOL, V37, P855, DOI 10.1016/j.it.2016.09.006; Gargett T, 2016, MOL THER, V24, P1135, DOI 10.1038/mt.2016.63; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; GERA JF, 1991, CELL IMMUNOL, V138, P108, DOI 10.1016/0008-8749(91)90136-Y; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gharwan H, 2015, ENDOCR-RELAT CANCER, V22, pR339, DOI 10.1530/ERC-14-0550; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Golstein P, 2018, NAT REV IMMUNOL, V18, P526, DOI 10.1038/s41577-018-0009-3; Gonzalez H, 2018, FEBS J, V285, P654, DOI 10.1111/febs.14325; Gopalakrishnan V, 2018, CANCER CELL, V33, P570, DOI 10.1016/j.ccell.2018.03.015; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; GRAHAM JB, 1959, SURG GYNECOL OBSTET, V109, P131; Griesmann H, 2017, GUT, V66, P1278, DOI 10.1136/gutjnl-2015-310049; GROSS G, 1989, P NATL ACAD SCI USA, V86, P10024, DOI 10.1073/pnas.86.24.10024; Gross L, 1943, CANCER RES, V3, P326; Gu-Trantien C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91487; Gyori D, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120631; Halama N, 2011, CANCER RES, V71, P5670, DOI 10.1158/0008-5472.CAN-11-0268; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hayakawa Y, 2002, J IMMUNOL, V169, P5377, DOI 10.4049/jimmunol.169.10.5377; Headley MB, 2016, NATURE, V531, P513, DOI 10.1038/nature16985; HERBERMAN RB, 1975, INT J CANCER, V16, P216, DOI 10.1002/ijc.2910160204; Heslin MJ, 2001, ANN SURG, V233, P786, DOI 10.1097/00000658-200106000-00008; Hilf N, 2019, NATURE, V565, P240, DOI 10.1038/s41586-018-0810-y; Hofman P, 2019, CANCERS, V11, DOI 10.3390/cancers11030283; Holsti LR, 1995, ACTA ONCOL, V34, P995, DOI 10.3109/02841869509127225; Hosoya T, 2018, P NATL ACAD SCI USA, V115, pE6836, DOI 10.1073/pnas.1803281115; Huang YJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0421-3; Huo XJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36605-8; Introna M, 2007, HAEMATOLOGICA, V92, P952, DOI 10.3324/haematol.11132; Introna M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020358; Introna M, 2017, BIOL BLOOD MARROW TR, V23, P2070, DOI 10.1016/j.bbmt.2017.07.005; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Jadus MR, 1996, BLOOD, V87, P5232, DOI 10.1182/blood.V87.12.5232.bloodjournal87125232; Jiang D, 2016, CANCER MICROENVIRON, V9, P45, DOI 10.1007/s12307-016-0181-6; Johnson SD, 2014, CANCERS, V6, P756, DOI 10.3390/cancers6020756; Jones PA, 2019, NAT REV CANCER, V19, P151, DOI 10.1038/s41568-019-0109-9; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kanda Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040867; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Karre K, 1985, MECHANISMS CYTOTOXIC, P81; Karre K, 1981, IMMUNOBIOLOGY NATURA; KAVOUSSI LR, 1990, J CLIN INVEST, V85, P62, DOI 10.1172/JCI114434; Kersey JH, 2007, IMMUNOL RES, V38, P149, DOI 10.1007/s12026-007-0037-8; Keskin DB, 2019, NATURE, V565, P234, DOI 10.1038/s41586-018-0792-9; Key TJA, 1995, MUTAT RES-FUND MOL M, V333, P59, DOI 10.1016/0027-5107(95)00132-8; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Kilvaer TK, 2016, BRIT J CANCER, V114, P1145, DOI 10.1038/bjc.2016.92; Kim H.N, 2017, BLOOD, V130; Kim TM, 2015, CLIN CANCER RES, V21, P4461, DOI 10.1158/1078-0432.CCR-14-2413; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kitamura J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117986; Kiziltas S, 2008, TURK J GASTROENTEROL, V19, P239; KLEIN G, 1960, CANCER RES, V20, P1561; Kodelja V, 1998, J IMMUNOL, V160, P1411; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Koeppel M, 2015, CELL REP, V11, P1703, DOI 10.1016/j.celrep.2015.05.030; Kottschade LA, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0671-4; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Kwak Y, 2016, ONCOTARGET, V7, P81778, DOI 10.18632/oncotarget.13207; Lakritz JR, 2015, ONCOTARGET, V6, P9387, DOI 10.18632/oncotarget.3328; Larsen Stine K., 2014, Critical Reviews in Oncogenesis, V19, P91; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lee C, 2018, CLIN EXP VACCINE RES, V7, P16, DOI 10.7774/cevr.2018.7.1.16; Lee W, 2019, J EXP MED, V216, P176, DOI 10.1084/jem.20181170; Leek RD, 1998, BRIT J CANCER, V77, P2246, DOI 10.1038/bjc.1998.373; Lengagne R, 2008, J IMMUNOL, V180, P130, DOI 10.4049/jimmunol.180.1.130; Lewis CE, 2016, CANCER CELL, V30, P18, DOI 10.1016/j.ccell.2016.05.017; Lim YW, 2018, P NATL ACAD SCI USA, V115, pE11701, DOI 10.1073/pnas.1804506115; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin RH, 2016, ONCOTARGET, V7, P24564, DOI 10.18632/oncotarget.8356; Lindau D, 2013, IMMUNOLOGY, V138, P105, DOI 10.1111/imm.12036; Linde N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02481-5; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Liu CY, 1998, BRIT J CANCER, V78, P534, DOI 10.1038/bjc.1998.528; Liu SY, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-111856; LOTZE MT, 1985, J IMMUNOL, V134, P157; LU PH, 1994, J IMMUNOL, V153, P1687; Luca Simona, 2013, Maedica (Bucur), V8, P53; LUTZ, 2014, CANC IMMUNOLOGY RES, V2, P616; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; MacCarty WC, 1921, J LAB CLIN MED, V6, P473; MALONEY DG, 1994, BLOOD, V84, P2457; Mansfield AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20622-8; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Mascaux C, 2019, NATURE, V571, P570, DOI 10.1038/s41586-019-1330-0; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; MATSUZAWA A, 1991, INT J CANCER, V49, P303, DOI 10.1002/ijc.2910490227; McBride AA, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0273; McNally A, 2011, P NATL ACAD SCI USA, V108, P7529, DOI 10.1073/pnas.1103782108; Mego M, 2016, J CANCER, V7, P1095, DOI 10.7150/jca.13098; Metchnikoff E., 1883, BIOL ZBL, V3, P560; Metelli A, 2016, CANCER RES, V76, P7106, DOI 10.1158/0008-5472.CAN-16-1456; MILLER JFA, 1967, NATURE, V214, P992, DOI 10.1038/214992a0; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Mlecnik B, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx123; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Mlecnik B, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6352; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Mlecnik B, 2010, GASTROENTEROLOGY, V138, P1429, DOI 10.1053/j.gastro.2009.10.057; Modi BG, 2012, SCIENCE, V335, P104, DOI 10.1126/science.1211600; Moezzi J, 2000, AM J GASTROENTEROL, V95, P520; Molgora M, 2017, NATURE, V551, P110, DOI 10.1038/nature24293; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Morales C, 2014, CANCER RES, V74, P446, DOI 10.1158/0008-5472.CAN-13-1677; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Murphy N, 2019, CLIN GASTROENTEROL H, V17, P1323, DOI 10.1016/j.cgh.2018.07.030; Mussai F, 2012, J IMMUNOTHER, V35, P449, DOI 10.1097/CJI.0b013e31825be926; Nagakawa Y, 2002, PANCREAS, V24, P169, DOI 10.1097/00006676-200203000-00008; Naito Y, 1998, CANCER RES, V58, P3491; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Nielsen SR, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9624760; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; NORTH RJ, 1978, J IMMUNOL, V121, P806; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Nussinov R, 2016, SEMIN CELL DEV BIOL, V58, P79, DOI 10.1016/j.semcdb.2016.04.001; Okada F, 2014, YONAGO ACTA MED, V57, P65; Okayama H, 2013, INT J CANCER, V132, P9, DOI 10.1002/ijc.27644; Oliver AJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00070; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Ozdemir BC, 2019, CLIN CANCER RES, V25, P4603, DOI 10.1158/1078-0432.CCR-19-0137; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2018, LANCET, V391, P2128, DOI 10.1016/S0140-6736(18)30789-X; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Parfenov M, 2014, P NATL ACAD SCI USA, V111, P15544, DOI 10.1073/pnas.1416074111; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pasero C, 2015, ONCOTARGET, V6, P14360, DOI 10.18632/oncotarget.3965; Pearl R, 1929, AM J HYG, V9, P97, DOI 10.1093/oxfordjournals.aje.a121646; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Powell DR, 2016, TRENDS IMMUNOL, V37, P41, DOI 10.1016/j.it.2015.11.008; PREHN RT, 1957, J NATL CANCER I, V18, P769; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rajput AB, 2008, BREAST CANCER RES TR, V107, P249, DOI 10.1007/s10549-007-9546-3; RATLIFF TL, 1988, J UROLOGY, V139, P410, DOI 10.1016/S0022-5347(17)42445-1; Remark R, 2015, AM J RESP CRIT CARE, V191, P377, DOI 10.1164/rccm.201409-1671PP; Riabov V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00075; Romero I, 2014, CANCER RES, V74, P1958, DOI 10.1158/0008-5472.CAN-13-2084; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; ROSENBERG SA, 1990, NEW ENGL J MED, V323, P570, DOI 10.1056/NEJM199008303230904; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Rouette A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34019; Ruella M, 2018, NAT MED, V24, P1499, DOI 10.1038/s41591-018-0201-9; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Saito H, 2014, ANTICANCER RES, V34, P3365; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Saltz J, 2018, CELL REP, V23, P181, DOI 10.1016/j.celrep.2018.03.086; Sanchez-Paulete AR, 2017, ANN ONCOL, V28, P74, DOI 10.1093/annonc/mdx727; Santegoets SJ, 2019, CLIN CANCER RES, V25, P240, DOI 10.1158/1078-0432.CCR-18-1749; Sautes-Fridman C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00407; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; Seymour L, 2017, LANCET ONCOL, V18, pE143, DOI 10.1016/S1470-2045(17)30074-8; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shevach J, 2019, CLIN ADV HEMATOL ONC, V17, P45; Shi HF, 2017, INT J CANCER, V140, P1370, DOI 10.1002/ijc.30538; Shi WW, 2018, EXP CELL RES, V372, P35, DOI 10.1016/j.yexcr.2018.09.006; Siegel RL, 2015, JAMA INTERN MED, V175, P1574, DOI 10.1001/jamainternmed.2015.2398; Sierra JR, 2008, J EXP MED, V205, P1673, DOI 10.1084/jem.20072602; Sigal LJ, 1998, J IMMUNOL, V161, P2740; Singel KL, 2016, IMMUNOL REV, V273, P329, DOI 10.1111/imr.12459; Singhal S, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat1500; Sinnamon MJ, 2008, CARCINOGENESIS, V29, P880, DOI 10.1093/carcin/bgn040; Sivori S, 2019, CELL MOL IMMUNOL, V16, P430, DOI 10.1038/s41423-019-0206-4; Slebos RJC, 2013, INT J CANCER, V132, P568, DOI 10.1002/ijc.27699; Smyrk TC, 2001, CANCER, V91, P2417, DOI 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Sommer C, 2019, MOL THER, V27, P1126, DOI 10.1016/j.ymthe.2019.04.001; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Souza-Fonseca-Guimaraes F, 2019, TRENDS IMMUNOL, V40, P142, DOI 10.1016/j.it.2018.12.003; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Stenholm S, 2016, INT J EPIDEMIOL, V45, P1260, DOI 10.1093/ije/dyw126; Strachan DC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26968; Sun HY, 2019, HEPATOLOGY, V70, P168, DOI 10.1002/hep.30347; Sun WW, 2017, ONCOTARGETS THER, V10, P2413, DOI 10.2147/OTT.S130087; Szczerba BM, 2019, NATURE, V566, P553, DOI 10.1038/s41586-019-0915-y; Takeuchi Y, 2016, INT IMMUNOL, V28, P401, DOI 10.1093/intimm/dxw025; TALPAZ M, 1983, BLOOD, V62, P689; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Tao LY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004932; Tazawa H, 2003, AM J PATHOL, V163, P2221, DOI 10.1016/S0002-9440(10)63580-8; Tazzari M, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5804230; Terry S, 2017, MOL ONCOL, V11, P824, DOI 10.1002/1878-0261.12093; Thirlwell C, 2010, GASTROENTEROLOGY, V138, P1441, DOI 10.1053/j.gastro.2010.01.033; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Thomas L, 1959, CELLULAR HUMORAL ASP, P529; Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TOPALIAN SL, 1987, J IMMUNOL METHODS, V102, P127, DOI 10.1016/S0022-1759(87)80018-2; Truxova I, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0446-3; Tuting T, 2016, SCIENCE, V352, P145, DOI 10.1126/science.aaf7300; Uno S, 2007, ONCOL REP, V17, P1189; Van Berckelaer C, 2018, P 2018 SAN ANT BREAS, DOI [10.1158/1538-7445.SABCS18-P4-06-08, DOI 10.1158/1538-7445.SABCS18-P4-06-08]; Van den Eynde M, 2018, CANCER CELL, V34, P1012, DOI 10.1016/j.ccell.2018.11.003; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vansteenkiste JF, 2016, LANCET ONCOL, V17, P822, DOI 10.1016/S1470-2045(16)00099-1; VANWAUWE JP, 1980, J IMMUNOL, V124, P2708; Varricchi G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00424; Vasaikar S, 2019, CELL, V177, P1035, DOI 10.1016/j.cell.2019.03.030; Vely F, 1996, IMMUNOL LETT, V54, P145, DOI 10.1016/S0165-2478(96)02664-8; Vey Norbert, 2018, Oncotarget, V9, P17675, DOI 10.18632/oncotarget.24832; Vicent S, 2012, CANCER RES, V72, P5744, DOI 10.1158/0008-5472.CAN-12-1097; Viitala M, 2019, CLIN CANCER RES, V25, P3289, DOI 10.1158/1078-0432.CCR-18-3016; Vitre B, 2015, P NATL ACAD SCI USA, V112, pE6321, DOI 10.1073/pnas.1519388112; Wade KH, 2019, OBESITY, V27, P349, DOI 10.1002/oby.22397; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang E, 2002, CANCER RES, V62, P3581; Wang QRZ, 2014, CELL IMMUNOL, V287, P100, DOI 10.1016/j.cellimm.2014.01.002; Wang W, 2015, MOL MED REP, V11, P2397, DOI 10.3892/mmr.2014.3018; Wang XJ, 2012, CELL RES, V22, P1696, DOI 10.1038/cr.2012.128; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; WEINHOLD KJ, 1979, J EXP MED, V149, P745, DOI 10.1084/jem.149.3.745; Wellenstein MD, 2018, IMMUNITY, V48, P399, DOI 10.1016/j.immuni.2018.03.004; Williams ED, 2004, BRIT J CANCER, V90, P2219, DOI 10.1038/sj.bjc.6601860; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Wouters MCA, 2018, CLIN CANCER RES, V24, P6125, DOI 10.1158/1078-0432.CCR-18-1481; Wrobel P, 2007, SCAND J IMMUNOL, V66, P320, DOI 10.1111/j.1365-3083.2007.01963.x; Wu D, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.992749; Xia J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/516395; Xiang R, 1999, J IMMUNOL, V163, P3676; Xu B, 2016, ONCOTARGET, V7, P74904, DOI 10.18632/oncotarget.12484; Yang L, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0430-2; Yano Hiroshi, 1999, Gastric Cancer, V2, P26, DOI 10.1007/s101200050017; Yao M, 2016, ADV CANCER RES, V132, P265, DOI 10.1016/bs.acr.2016.05.005; Ye LY, 2016, CANCER RES, V76, P818, DOI 10.1158/0008-5472.CAN-15-0977; Yeshurun M, 2019, BLOOD ADV, V3, P670, DOI 10.1182/bloodadvances.2018027003; Yi BQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13367; Zaalberg A, 2019, J INVEST DERMATOL, V139, P62, DOI 10.1016/j.jid.2018.06.185; Zang YQ, 2019, CANCER MED-US, V8, P1339, DOI 10.1002/cam4.2044; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang LH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01578; Zhao JJ, 2018, CANCER MANAG RES, V10, P6457, DOI 10.2147/CMAR.S181949; Zhao XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0066-8; Zhou H, 2012, ANGIOGENESIS, V15, P391, DOI 10.1007/s10456-012-9268-y; Zhou X, 2013, LEUKEMIA LYMPHOMA, V54, P209, DOI 10.3109/10428194.2012.701741; Zhu W, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1051922; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	371	217	225	36	144	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					55	81		10.1016/j.immuni.2019.12.018	http://dx.doi.org/10.1016/j.immuni.2019.12.018			27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31940273	Green Published, Bronze			2022-12-18	WOS:000507384600009
J	Chen, ZY; Ji, ZC; Ngiow, SF; Manne, S; Cai, ZY; Huang, AC; Johnson, J; Staupe, RP; Bengsch, B; Xu, CY; Yu, SX; Kurachi, M; Herati, RS; Vella, LA; Baxter, AE; Wu, JE; Khan, O; Beltra, JC; Giles, JR; Stelekati, E; McLane, LM; Lau, CW; Yang, XL; Berger, SL; Vahedi, G; Ji, HK; Wherry, EJ				Chen, Zeyu; Ji, Zhicheng; Ngiow, Shin Foong; Manne, Sasikanth; Cai, Zhangying; Huang, Alexander C.; Johnson, John; Staupe, Ryan P.; Bengsch, Bertram; Xu, Caiyue; Yu, Sixiang; Kurachi, Makoto; Herati, Ramin S.; Vella, Laura A.; Baxter, Amy E.; Wu, Jennifer E.; Khan, Omar; Beltra, Jean-Christophe; Giles, Josephine R.; Stelekati, Erietta; McLane, Laura M.; Lau, Chi Wai; Yang, Xiaolu; Berger, Shelley L.; Vahedi, Golnaz; Ji, Hongkai; Wherry, E. John			TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision	IMMUNITY			English	Article							TERMINAL DIFFERENTIATION; PD-1; BET; DYSFUNCTION; EXPRESSION; PERSISTENCE; CHECKPOINT; LANDSCAPE; INFECTION; COOPERATE	TCF-1 is a key transcription factor in progenitor exhausted CD8 T cells (Tex). Moreover, this Tex cell subset mediates responses to PD-1 checkpoint pathway blockade. However, the role of the transcription factor TCF-1 in early fate decisions and initial generation of Tex cells is unclear. Single-cell RNA sequencing (scRNA-seq) and lineage tracing identified a TCF-1(+)Ly108(+)PD-1(+) CD8 T cell population that seeds development of mature Tex cells early during chronic infection. TCF-1 mediated the bifurcation between divergent fates, repressing development of terminal KLRG1(Hi) effectors while fostering KLRG1(Lo) Tex precursor cells, and PD-1 stabilized this TCF-1(+) Tex precursor cell pool. TCF-1 mediated a T-bet-to-Eomes transcription factor transition in Tex precursors by promoting Eomes expression and drove c-Myb expression that controlled Bcl-2 and survival. These data define a role for TCF-1 in early-fate-bifurcation-driving Tex precursor cells and also identify PD-1 as a protector of this early TCF-1 subset.	[Chen, Zeyu; Ngiow, Shin Foong; Manne, Sasikanth; Cai, Zhangying; Huang, Alexander C.; Staupe, Ryan P.; Bengsch, Bertram; Kurachi, Makoto; Herati, Ramin S.; Vella, Laura A.; Wu, Jennifer E.; Khan, Omar; Beltra, Jean-Christophe; Giles, Josephine R.; Stelekati, Erietta; McLane, Laura M.; Lau, Chi Wai; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Chen, Zeyu; Ngiow, Shin Foong; Manne, Sasikanth; Cai, Zhangying; Huang, Alexander C.; Johnson, John; Staupe, Ryan P.; Bengsch, Bertram; Kurachi, Makoto; Herati, Ramin S.; Vella, Laura A.; Baxter, Amy E.; Wu, Jennifer E.; Khan, Omar; Beltra, Jean-Christophe; Giles, Josephine R.; Stelekati, Erietta; McLane, Laura M.; Lau, Chi Wai; Vahedi, Golnaz; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Ji, Zhicheng; Ji, Hongkai] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Huang, Alexander C.; Herati, Ramin S.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Xu, Caiyue; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Xu, Caiyue; Berger, Shelley L.; Vahedi, Golnaz] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA; [Yu, Sixiang; Yang, Xiaolu] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Vella, Laura A.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Vahedi, Golnaz] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Wherry, E. John] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Bengsch, Bertram] Univ Med Ctr Freiburg, Fac Med, Dept Med Gastroenterol Hepatol Endocrinol & Infec, D-79106 Freiburg, Germany; [Kurachi, Makoto] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem 1, Kanazawa, Ishikawa 9201192, Japan	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Freiburg; Kanazawa University	Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.	wherry@pennmedicine.upenn.edu	Bengsch, Bertram/ABF-2142-2020; Xu, Caiyue/GQZ-4365-2022; Chen, Zeyu/HGE-0239-2022; Wu, Jennifer/GRX-1831-2022; Yu, Sixiang/AFM-0114-2022; Ji, Zhicheng/I-5650-2019; Wherry, John/ABI-1280-2020	Bengsch, Bertram/0000-0003-2552-740X; Ji, Zhicheng/0000-0002-9457-4704; Khan, Omar/0000-0002-7641-6163; Beltra, Jean-Christophe/0000-0002-6363-3572; Herati, Ramin/0000-0003-2613-4050	NIH [AI105343, AI117950, AI082630, AI112521, AI115712, AI108545, HG009518, CA234842, AI114852, CA009140, CA210944]; Stand Up 2 Cancer; Parker Institute for Cancer Immunotherapy - cancer immunology program at UPenn; Australia NHAMP;MRC C.J. Martin Fellowship [1111469]; Mark Foundation Momentum Fellowship; Cancer Research Institute-Mark Foundation Fellowship; NATIONAL CANCER INSTITUTE [P01CA210944, T32CA009140, F99CA234842, R01CA078831] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL145754] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI108545, K08AI114852, P01AI112521, U19AI117950, R01AI115712, U19AI082630, R01AI105343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up 2 Cancer; Parker Institute for Cancer Immunotherapy - cancer immunology program at UPenn; Australia NHAMP;MRC C.J. Martin Fellowship; Mark Foundation Momentum Fellowship; Cancer Research Institute-Mark Foundation Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Wherry lab for helpful discussions. This work was supported by NIH grants (AI105343, AI117950, AI082630, AI112521, AI115712, AI108545, and CA210944) and Stand Up 2 Cancer funding to E.J.W.; NIH grant HG009518 to H.J.; NIH grant CA234842 to Z. Chen; NIH grant AI114852 to R.S.H.; and NIH grant CA009140 to J.R.G. E.J.W. is supported by the Parker Institute for Cancer Immunotherapy, which supports the cancer immunology program at UPenn; S.F.N. is supported by an Australia NH&MRC C.J. Martin Fellowship (1111469) and the Mark Foundation Momentum Fellowship; and J.R.G. is supported by Cancer Research Institute-Mark Foundation Fellowship.	Adams WC, 2016, CELL REP, V17, P3142, DOI 10.1016/j.celrep.2016.11.065; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Chen ZY, 2017, CELL REP, V20, P2584, DOI 10.1016/j.celrep.2017.08.060; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Guan TX, 2018, J EXP MED, V215, P1153, DOI 10.1084/jem.20171352; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Gupta S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004828; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Herndler-Brandstetter D, 2018, IMMUNITY, V48, P716, DOI 10.1016/j.immuni.2018.03.015; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; JI ZC, 2016, NUCLEIC ACIDS RES, V44, DOI DOI 10.1093/NAR/GKW430; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Knight DA, 2016, J CLIN INVEST, V126, P402, DOI 10.1172/JCI84828; Kurachi M, 2017, NAT PROTOC, V12, P1980, DOI 10.1038/nprot.2017.083; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Lin WHW, 2016, CELL REP, V17, P1773, DOI 10.1016/j.celrep.2016.10.032; Lin WHW, 2015, CELL REP, V13, P2203, DOI 10.1016/j.celrep.2015.10.072; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mognol GP, 2017, P NATL ACAD SCI USA, V114, pE2776, DOI 10.1073/pnas.1620498114; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Omilusik KD, 2018, J EXP MED, V215, P773, DOI 10.1084/jem.20171584; Paley MA, 2013, J LEUKOCYTE BIOL, V93, P307, DOI 10.1189/jlb.0812400; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Stelekati E, 2018, CELL REP, V23, P2142, DOI 10.1016/j.celrep.2018.04.038; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yee TW., 2015, VECTOR GEN LINEAR AD; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	71	217	220	14	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					840	+		10.1016/j.immuni.2019.09.013	http://dx.doi.org/10.1016/j.immuni.2019.09.013			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31606264	Green Accepted, Bronze			2022-12-18	WOS:000497811300009
J	Fielding, CA; Jones, GW; McLoughlin, RM; McLeod, L; Hammond, VJ; Uceda, J; Williams, AS; Lambie, M; Foster, TL; Liao, CT; Rice, CM; Greenhill, CJ; Colmont, CS; Hams, E; Coles, B; Kift-Morgan, A; Newton, Z; Craig, KJ; Williams, JD; Williams, GT; Davies, SJ; Humphreys, IR; O'Donnell, VB; Taylor, PR; Jenkins, BJ; Topley, N; Jones, SA				Fielding, Ceri A.; Jones, Gareth W.; McLoughlin, Rachel M.; McLeod, Louise; Hammond, Victoria J.; Uceda, Javier; Williams, Anwen S.; Lambie, Mark; Foster, Thomas L.; Liao, Chia-Te; Rice, Christopher M.; Greenhill, Claire J.; Colmont, Chantal S.; Hams, Emily; Coles, Barbara; Kift-Morgan, Ann; Newton, Zarabeth; Craig, Katherine J.; Williams, John D.; Williams, Geraint T.; Davies, Simon J.; Humphreys, Ian R.; O'Donnell, Valerie B.; Taylor, Philip R.; Jenkins, Brendan J.; Topley, Nicholas; Jones, Simon A.			Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation	IMMUNITY			English	Article							REGULATORY T-CELLS; HYPER-IGE SYNDROME; IFN-GAMMA; NEUTROPHIL TRAFFICKING; RESPIRATORY-INFECTION; MOLECULAR-MECHANISMS; PERITONEAL-DIALYSIS; STAT3 ACTIVATION; INTERFERON-GAMMA; DENDRITIC CELLS	Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, we have examined how repeated inflammatory activation promotes fibrotic tissue injury. In this context, fibrosis was strictly dependent on interleukin-6 (IL-6). Repeat inflammation induced IL-6-mediated T helper 1 (Th1) cell effector commitment and the emergence of STAT1 (signal transducer and activator of transcription-1) activity within the peritoneal membrane. Fibrosis was not observed in mice lacking interferon-gamma (IFN-gamma), STAT1, or RAG-1. Here, IFN-gamma and STAT1 signaling disrupted the turnover of extracellular matrix by metalloproteases. Whereas IL-6-deficient mice resisted fibrosis, transfer of polarized Th1 cells or inhibition of MMP activity reversed this outcome. Thus, IL-6 causes compromised tissue repair by shifting acute inflammation into a more chronic pro-fibrotic state through induction of Th1 cell responses as a consequence of recurrent inflammation.	[Fielding, Ceri A.; Jones, Gareth W.; McLoughlin, Rachel M.; Hammond, Victoria J.; Uceda, Javier; Williams, Anwen S.; Foster, Thomas L.; Liao, Chia-Te; Rice, Christopher M.; Greenhill, Claire J.; Colmont, Chantal S.; Hams, Emily; Coles, Barbara; Kift-Morgan, Ann; Newton, Zarabeth; Humphreys, Ian R.; O'Donnell, Valerie B.; Taylor, Philip R.; Topley, Nicholas; Jones, Simon A.] Cardiff Univ, Sch Med, Cardiff Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [McLeod, Louise; Jenkins, Brendan J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Lambie, Mark; Davies, Simon J.] Keele Univ, Univ Hosp North Staffordshire, Dept Nephrol, Stoke On Trent ST4 7QB, Staffs, England; [Lambie, Mark; Davies, Simon J.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England; [Craig, Katherine J.; Williams, John D.] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales; [Williams, Geraint T.] Cardiff Univ, Sch Med, Inst Canc & Genet, Sect Pathol, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Monash University; Keele University; Keele University; Cardiff University; Cardiff University	Topley, N (corresponding author), Cardiff Univ, Sch Med, Cardiff Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	topley@cf.ac.uk; jonessa@cf.ac.uk	Lambie, Mark/AAA-9104-2020; Fielding, Ceri A/F-5638-2014; Jones, Simon Arnett/Q-7017-2018	Lambie, Mark/0000-0002-6285-5368; Fielding, Ceri A/0000-0002-5817-3153; /0000-0003-4089-8460; Jones, Gareth/0000-0002-0125-4841; McLeod, Louise/0000-0002-7595-6432; Davies, Simon/0000-0001-5127-4755; Taylor, Philip/0000-0003-0163-1421; Humphreys, Ian/0000-0002-9512-5337; Rice, Christopher/0000-0002-8158-4022; Jenkins, Brendan/0000-0002-7552-4656; Hams, Emily/0000-0002-9745-3246; McLoughlin, Rachel/0000-0003-4553-018X; Jones, Simon Arnett/0000-0001-7297-9711	Wellcome Trust [065961, 069630, 079044]; Arthritis Research UK [20305, 19796, 19381, 18286]; Kidney Research UK [CDF2/2006]; Kenyon Gilson EPS Research Fund; MRC capacity-building PhD Studentship; Sylvia and Charles Viertel Charitable Foundation; Victorian Government of Australia; National Health and Medical Research Council of Australia; CITER Summer Student Stipend; Medical Research Council [MR/J002151/1, G0601617, MR/K02003X/1] Funding Source: researchfish; Versus Arthritis [20305, 19796, 19381] Funding Source: researchfish; MRC [MR/K02003X/1, MR/J002151/1, G0601617] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research UK(Versus Arthritis); Kidney Research UK(Kidney Research UK (KRUK)); Kenyon Gilson EPS Research Fund; MRC capacity-building PhD Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sylvia and Charles Viertel Charitable Foundation; Victorian Government of Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); CITER Summer Student Stipend; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research was supported by The Wellcome Trust (to S.A.J. and N.T., Ref. 065961, 069630, 079044), Arthritis Research UK (to S.A.J. and G.W.J.; Ref. 20305, 19796, 19381, 18286), Kidney Research UK (to C. A. F.; Ref. CDF2/2006), the Kenyon Gilson EPS Research Fund (to C. A. F., S.A.J., and N.T.), and an MRC capacity-building PhD Studentship (to S.A.J. and V. B.O'D.). B.J.J. is supported by Senior Fellowship Awards from the Sylvia and Charles Viertel Charitable Foundation, an Operational Infrastructure Support Program from the Victorian Government of Australia, and a National Health and Medical Research Council of Australia Project Grant. J.U. is recipient of a CITER Summer Student Stipend. The authors appreciate the support of I. Campbell, G. Wilkinson, and A. Gallimore and are also indebted to G. Stockinger for her support and encouragement. Finally, we thank the Peritoneal Biopsy Registry and Bro Taf NHS Trust surgical teams for clinical samples.	Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Barr TA, 2010, J IMMUNOL, V185, P2783, DOI 10.4049/jimmunol.1001431; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Chinen T, 2006, GASTROENTEROLOGY, V130, P373, DOI 10.1053/j.gastro.2005.10.051; Colmont CS, 2011, NEPHROL DIAL TRANSPL, V26, P4079, DOI 10.1093/ndt/gfr217; Davies SJ, 1996, NEPHROL DIAL TRANSPL, V11, P498; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; Detournay O, 2005, HUM IMMUNOL, V66, P460, DOI 10.1016/j.humimm.2005.01.012; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Dominitzki S, 2007, J IMMUNOL, V179, P2041, DOI 10.4049/jimmunol.179.4.2041; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Finotto S, 2007, INT IMMUNOL, V19, P685, DOI 10.1093/intimm/dxm037; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; GURUJEYALAKSHMI G, 1995, EXP LUNG RES, V21, P791, DOI 10.3109/01902149509050842; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Hu XY, 2005, J IMMUNOL, V175, P131, DOI 10.4049/jimmunol.175.1.131; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Jenkins BJ, 2007, BLOOD, V109, P2380, DOI 10.1182/blood-2006-08-040352; Jones GW, 2010, J IMMUNOL, V184, P2130, DOI 10.4049/jimmunol.0901528; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Judd LM, 2006, GASTROENTEROLOGY, V131, P1073, DOI 10.1053/j.gastro.2006.07.018; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lee SW, 1999, VACCINE, V17, P490, DOI 10.1016/S0264-410X(98)00223-0; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; Matsukawa A, 2003, J IMMUNOL, V171, P6198, DOI 10.4049/jimmunol.171.11.6198; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; McLoughlin RM, 2005, P NATL ACAD SCI USA, V102, P9589, DOI 10.1073/pnas.0501794102; MILLS KHG, 1993, INFECT IMMUN, V61, P399, DOI 10.1128/IAI.61.2.399-410.1993; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; Murphy EA, 2008, J INTERF CYTOK RES, V28, P589, DOI 10.1089/jir.2007.0103; Nishimoto N, 2004, CURR OPIN PHARMACOL, V4, P386, DOI 10.1016/j.coph.2004.03.005; Nowell MA, 2009, J IMMUNOL, V182, P613, DOI 10.4049/jimmunol.182.1.613; Ogata H, 2006, GASTROENTEROLOGY, V131, P179, DOI 10.1053/j.gastro.2006.04.025; Oldroyd SD, 1999, KIDNEY INT, V56, P2116, DOI 10.1046/j.1523-1755.1999.00775.x; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Puel A, 2008, J IMMUNOL, V180, P647, DOI 10.4049/jimmunol.180.1.647; Quinton LJ, 2008, AM J RESP CELL MOL, V38, P699, DOI 10.1165/rcmb.2007-0365OC; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; SEMPOWSKI GD, 1994, J IMMUNOL, V152, P3606; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; WYNN TA, 1995, NATURE, V376, P594, DOI 10.1038/376594a0; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	59	217	229	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					40	50		10.1016/j.immuni.2013.10.022	http://dx.doi.org/10.1016/j.immuni.2013.10.022			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24412616	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000331476900008
J	Ziegler, AG; Nepom, GT				Ziegler, Anette-G.; Nepom, Gerald T.			Prediction and Pathogenesis in Type 1 Diabetes	IMMUNITY			English	Review							REGULATORY T-CELLS; LYMPHOID TYROSINE PHOSPHATASE; ANTIBODY STANDARDIZATION PROGRAM; SINGLE-NUCLEOTIDE POLYMORPHISM; SYSTEMIC-LUPUS-ERYTHEMATOSUS; INSULIN AUTOANTIBODIES; ISLET AUTOANTIBODIES; 1ST-DEGREE RELATIVES; EPITOPE SPECIFICITY; HEALTHY-SUBJECTS	A combination of genetic and immunological features is useful for prediction of autoimmune diabetes. Patterns of immune response correspond to the progression from a preclinical phase of disease to end-stage islet damage, with biomarkers indicating transition from susceptibility to active autoimmunity, and to a final loss of immune regulation. Here, we review the markers that provide evidence for immunological checkpoint failure and that also provide tools for assessment of individualized disease risk. When viewed in the context of genetic variation that influences immune response thresholds, progression from susceptibility to overt disease displays predictable modalities of clinical presentation resulting from a sequential series of failed homeostatic checkpoints for selection and activation of immunity.	[Ziegler, Anette-G.] Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, D-80804 Munich, Germany; [Nepom, Gerald T.] Virginia Mason, Benaroya Res Inst, Seattle, WA 98101 USA	Technical University of Munich; Benaroya Research Institute; Virginia Mason Medical Center	Ziegler, AG (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, Kolner Pl 1, D-80804 Munich, Germany.		Ziegler, Anette-Gabriele/M-4614-2014	Ziegler, Anette-Gabriele/0000-0002-6290-5548; Nepom, Gerald/0000-0002-8063-1464	Juvenile Diabetes Research Foundation; National Institutes of Health; German Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the Juvenile Diabetes Research Foundation, the National Institutes of Health, the German Federal Ministry of Education and Research, and the Deutsche Forschungsgemeinschaft for their support of the authors' work cited in this article Studies in the authors' laboratories cited in this article were conducted with institutional review board approval at their respective Institutions	Achenbach P, 2004, J CLIN INVEST, V114, P589, DOI 10.1172/JCI200421307; Achenbach P, 2004, DIABETES, V53, P384, DOI 10.2337/diabetes.53.2.384; Achenbach P, 2009, DIABETOLOGIA, V52, P1881, DOI 10.1007/s00125-009-1438-0; Achenbach P, 2007, CLIN IMMUNOL, V122, P85, DOI 10.1016/j.clim.2006.09.004; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Aly TA, 2006, P NATL ACAD SCI USA, V103, P14074, DOI 10.1073/pnas.0606349103; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BAISCH JM, 1990, NEW ENGL J MED, V322, P1836, DOI 10.1056/NEJM199006283222602; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bergholdt R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006250; Bielekova B, 2004, J IMMUNOL, V172, P3893, DOI 10.4049/jimmunol.172.6.3893; Bingley PJ, 1996, DIABETES, V45, P1720, DOI 10.2337/diabetes.45.12.1720; Bingley PJ, 2003, DIABETES, V52, P1128, DOI 10.2337/diabetes.52.5.1128; BINGLEY PJ, 1994, DIABETES, V43, P1304, DOI 10.2337/diabetes.43.11.1304; Bingley PJ, 2001, DIABETES CARE, V24, P398, DOI 10.2337/diacare.24.2.398; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Bonifacio E, 2008, DIABETOLOGIA, V51, P1245, DOI 10.1007/s00125-008-1022-z; Bonifacio E, 2004, DIABETES CARE, V27, P2695, DOI 10.2337/diacare.27.11.2695; Bonifacio E, 1999, J IMMUNOL, V163, P525; Bottazzo GF, 2005, DIABETOLOGIA, V48, P703, DOI 10.1007/s00125-005-1691-9; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; CASTANO L, 1993, DIABETES, V42, P1202, DOI 10.2337/diabetes.42.8.1202; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Danke NA, 2005, J AUTOIMMUN, V25, P303, DOI 10.1016/j.jaut.2005.08.007; Durinovic-Bello I, 2002, J AUTOIMMUN, V18, P55, DOI 10.1006/jaut.2001.0566; Durinovic-Bello I, 2010, GENES IMMUN, V11, P188, DOI 10.1038/gene.2009.108; Emery LM, 2005, PEDIATR DIABETES, V6, P136, DOI 10.1111/j.1399-543X.2005.00117.x; Graham J, 2002, DIABETES, V51, P1346, DOI 10.2337/diabetes.51.5.1346; Grant J, 2009, CYTOM PART B-CLIN CY, V76B, P69, DOI 10.1002/cyto.b.20446; Hagopian WA, 2006, ANN NY ACAD SCI, V1079, P320, DOI 10.1196/annals.1375.049; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hemminki K, 2009, DIABETOLOGIA, V52, P1820, DOI 10.1007/s00125-009-1427-3; Hummel M, 2004, ANN INTERN MED, V140, P882, DOI 10.7326/0003-4819-140-11-200406010-00009; Jackson A, 2008, TRANSPL P, V40, P430, DOI 10.1016/j.transproceed.2008.01.021; Kulmala P, 1998, J CLIN INVEST, V101, P327, DOI 10.1172/JCI119879; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Ladner MB, 2005, HUM IMMUNOL, V66, P60, DOI 10.1016/j.humimm.2004.09.016; LaGasse JM, 2002, DIABETES CARE, V25, P505, DOI 10.2337/diacare.25.3.505; Lambert AP, 2004, J CLIN ENDOCR METAB, V89, P4037, DOI 10.1210/jc.2003-032084; Lampasona V, 2010, DIABETES CARE, V33, P104, DOI 10.2337/dc08-2305; Lawson JM, 2008, CLIN EXP IMMUNOL, V154, P353, DOI 10.1111/j.1365-2249.2008.03810.x; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Link M, 2008, APMIS, V116, P896, DOI 10.1111/j.1600-0463.2008.00889.x; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Long SA, 2009, EUR J IMMUNOL, V39, P612, DOI 10.1002/eji.200838819; Lu J, 1996, P NATL ACAD SCI USA, V93, P2307, DOI 10.1073/pnas.93.6.2307; LUCZYNSKI W, 2009, PEDIAT ENDOCRINOL DI, V56, P1527; Mayr A, 2007, DIABETES, V56, P1527, DOI 10.2337/db06-1715; Monti P, 2008, DIABETES, V57, P2341, DOI 10.2337/db08-0138; Monti P, 2007, J IMMUNOL, V179, P5785, DOI 10.4049/jimmunol.179.9.5785; Muraro PA, 2000, J IMMUNOL, V164, P5474, DOI 10.4049/jimmunol.164.10.5474; Naserke HE, 1999, J CLIN ENDOCR METAB, V84, P1239, DOI 10.1210/jc.84.4.1239; Naserke HE, 2001, J CLIN ENDOCR METAB, V86, P4826; Oling V, 2007, ANN NY ACAD SCI, V1107, P363, DOI 10.1196/annals.1381.038; Onengut-Gumuscu S, 2004, GENES IMMUN, V5, P678, DOI 10.1038/sj.gene.6364138; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; Pascual V, 2008, IMMUNOL REV, V223, P39, DOI 10.1111/j.1600-065X.2008.00643.x; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; PUGLIESE A, 1995, DIABETES, V44, P608, DOI 10.2337/diabetes.44.6.608; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; RABIN DU, 1994, J IMMUNOL, V152, P3183; Redondo MJ, 2008, NEW ENGL J MED, V359, P2849, DOI 10.1056/NEJMc0805398; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Rubio-Cabezas O, 2009, DIABETES CARE, V32, P111, DOI 10.2337/dc08-1188; Ryden A, 2009, DIABETES-METAB RES, V25, P335, DOI 10.1002/dmrr.958; SANJEEVI CB, 1995, TISSUE ANTIGENS, V45, P148, DOI 10.1111/j.1399-0039.1995.tb02434.x; Schenker M, 1999, DIABETOLOGIA, V42, P671, DOI 10.1007/s001250051214; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; SRIKANTA S, 1985, NEW ENGL J MED, V313, P461, DOI 10.1056/NEJM198508223130801; Standifer NE, 2009, CLIN IMMUNOL, V132, P312, DOI 10.1016/j.clim.2009.04.013; Tree TIM, 2006, ANN NY ACAD SCI, V1079, P9, DOI 10.1196/annals.1375.002; Turunen JA, 2006, IMMUNOGENETICS, V58, P331, DOI 10.1007/s00251-006-0088-3; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; Vrabelova Z, 2008, SCAND J IMMUNOL, V67, P404, DOI 10.1111/j.1365-3083.2008.02074.x; Wang XJ, 2008, J IMMUNOL, V180, P1929, DOI 10.4049/jimmunol.180.3.1929; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yang JB, 2008, J AUTOIMMUN, V31, P30, DOI 10.1016/j.jaut.2008.02.001; Yang ZF, 2007, DIABETES RES CLIN PR, V76, P126, DOI 10.1016/j.diabres.2006.08.013; Yu J, 2000, J CLIN ENDOCR METAB, V85, P2421, DOI 10.1210/jc.85.7.2421; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460; ZIEGLER AG, 1991, DIABETES, V40, P1146, DOI 10.2337/diabetes.40.9.1146; 2009, CLIN IMMUNOL, V130, P272	96	217	220	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					468	478		10.1016/j.immuni.2010.03.018	http://dx.doi.org/10.1016/j.immuni.2010.03.018			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20412757	Bronze, Green Accepted			2022-12-18	WOS:000277171900004
J	Paget, C; Mallevaey, T; Speak, AO; Torres, D; Fontaine, J; Sheehan, KCF; Capron, M; Ryffel, B; Faveeuw, C; de Moraes, ML; Platt, F; Trottein, F				Paget, Christophe; Mallevaey, Thierry; Speak, Anneliese O.; Torres, David; Fontaine, Josette; Sheehan, Kathleen C. F.; Capron, Monique; Ryffel, Bernhard; Faveeuw, Christelle; de Moraes, Maria Leite; Platt, Frances; Trottein, Francois			Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged Glycosphingolipids	IMMUNITY			English	Article							KILLER T-CELLS; GLYCOLIPID ANTIGENS; INNATE; RECOGNITION; IMMUNITY; MICE; ISOGLOBOTRIHEXOSYLCERAMIDE; GALACTOSYLCERAMIDE; BIOSYNTHESIS; RESPONSES	Invariant natural killer T (iNKT) cells area subset of innate lymphocytes that recognize lipid antigens in the context of CD1 d and mediate potent immune regulatory functions via the rapid production of interferon-gamma (IFN-y) and interleukin-4 (IL-4). We investigated whether diverse Toll-like receptor (TLR) signals in myeloid dendritic cells (DCs) could differentially stimulate iNKT cells. Together with the lipopolysaccharide-detecting receptor TLR4, activation of the nucleic acid sensors TLR7 and TLF19 in DCs were particularly potent in stimulating iNKT cells to produce IFN-y, but not IL-4. iNKT cell activation in response to TLR9 stimulation required combined synthesis of type I interferon and de novo production of charged beta-linked glycosphingolipid(s) by DCs. In addition, DCs stimulated via TLR9 activated both iNKT cells and NK cells in vivo and protected mice against 131 6F10-induced melanoma metastases. These data underline the role of TLR9 in iNKT cell activation and might have relevance to infectious diseases and cancer.	Inst Natl Rech Med, U547, F-59019 Lille, France; Inst Pasteur, F-59019 Lille, France; Univ Lille 2, F-59019 Lille, France; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Washington Univ, Sch Med, St Louis, MO 63119 USA; Univ Orleans, CNRS, UMR 6218, F-45071 Orleans, France; Hop Necker Enfants Malad, Fac Med Rene Descartes Paris 5, CNRS, UMR 8147, F-75743 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; University of Oxford; Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Trottein, F (corresponding author), Inst Natl Rech Med, U547, F-59019 Lille, France.	francois.trottein@pasteur-lille.fr	Mallevaey, Thierry/AAH-4499-2020; Capron, monique/Z-2207-2019; TROTTEIN, Francois/C-2405-2018; Paget, Christophe/P-5165-2014; Dombrowicz, David/F-7044-2013; de Moraes, Maria Leite/AAV-9159-2020; Platt, Frances/G-1004-2010; Faveeuw, Christelle/N-6303-2017	Capron, monique/0000-0001-5625-5158; TROTTEIN, Francois/0000-0003-3373-1814; Paget, Christophe/0000-0002-5374-5407; Dombrowicz, David/0000-0002-0485-8923; de Moraes, Maria Leite/0000-0002-2891-2269; Faveeuw, Christelle/0000-0002-8373-3992; Platt, Frances/0000-0001-7614-0403; Speak, Anneliese/0000-0003-4890-4685				Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; BUTTERS TD, 1981, BIOCHIM BIOPHYS ACTA, V640, P672, DOI 10.1016/0005-2736(81)90097-3; De Libero G, 2005, IMMUNITY, V22, P763, DOI 10.1016/j.immuni.2005.04.013; Deane JA, 2006, J IMMUNOL, V177, P6573, DOI 10.4049/jimmunol.177.10.6573; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Fujii SI, 2006, P NATL ACAD SCI USA, V103, P11252, DOI 10.1073/pnas.0604812103; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Hafner M, 2001, CANCER RES, V61, P5523; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Mallevaey T, 2006, J IMMUNOL, V176, P2476, DOI 10.4049/jimmunol.176.4.2476; Marschner A, 2005, EUR J IMMUNOL, V35, P2347, DOI 10.1002/eji.200425721; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Montoya CJ, 2006, J IMMUNOL, V177, P1028, DOI 10.4049/jimmunol.177.2.1028; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; PLATT FM, 1994, J BIOL CHEM, V269, P27108; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Raghuraman G, 2006, J IMMUNOL, V177, P7841, DOI 10.4049/jimmunol.177.11.7841; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Smyth MJ, 2005, J EXP MED, V201, P1973, DOI 10.1084/jem.20042280; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; Stanic AK, 2003, P NATL ACAD SCI USA, V100, P1849, DOI 10.1073/pnas.0430327100; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Suzuki Y, 2004, CANCER RES, V64, P8754, DOI 10.1158/0008-5472.CAN-04-1691; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeda K, 1996, J IMMUNOL, V156, P3366; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Trobonjaca Z, 2002, J IMMUNOL, V168, P3763, DOI 10.4049/jimmunol.168.8.3763; Van Kaer L, 2005, CURR BIOL, V15, pR429, DOI 10.1016/j.cub.2005.05.032; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Zanoni I, 2005, J IMMUNOL, V175, P286, DOI 10.4049/jimmunol.175.1.286; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	48	217	225	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2007	27	4					597	609		10.1016/j.immuni.2007.08.017	http://dx.doi.org/10.1016/j.immuni.2007.08.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17950005	Bronze			2022-12-18	WOS:000250490700011
J	Hidalgo, A; Peired, AJ; Wild, MK; Vestweber, D; Frenette, PS				Hidalgo, Andres; Peired, Anna J.; Wild, Martin K.; Vestweber, Dietmar; Frenette, Paul S.			Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44	IMMUNITY			English	Article							GROWTH-FACTOR RECEPTOR; P-SELECTIN; GLYCOPROTEIN LIGAND-1; LEUKOCYTE ADHESION; DEFICIENT MICE; BINDING; LYMPHOCYTES; GOLGI; SIALOGLYCOPROTEIN; SUSCEPTIBILITY	The selectins and their ligands are required for leukocyte extravasation during inflammation. Several glycoproteins have been suggested to bind to E-selectin in vitro, but the complete identification of its physiological ligands has remained elusive. Here, we showed that E-selectin ligand-1 (ESIL-1), P-selectin glycoprotein ligand-1 (PSGL-1), and CD44 encompassed all endothelial-selectin ligand activity on neutrophils by using gene- and RNA-targeted loss of function. PSGL-1 played a major role in the initial leukocyte capture, whereas ESL-1 was critical for converting initial tethers into steady slow rolling. CD44 controlled rolling velocity and mediated E-selectin-dependent redistribution of PSGL-1 and L-selectin to a major pole on slowly rolling leukocytes through p38 signaling These results suggest distinct and dynamic contributions of these three glycoproteins in selectin-mediated neutrophil adhesion and signaling.	CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Black Family Stern Cell Inst, New York, NY 10029 USA; Max Planck Inst Mol Biomed, Dept Cell Biol, D-48149 Munster, Germany	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Max Planck Society	Hidalgo, A (corresponding author), CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	andres.hidalgo@mssm.edu; paul.frenette@mssm.edu	Peired, Anna Julie/J-9952-2019; Frenette, Paul S/J-8272-2012; Hidalgo, Andrés/L-5643-2014	Peired, Anna Julie/0000-0001-9732-1369; Frenette, Paul S/0000-0003-0862-9922; Hidalgo, Andrés/0000-0001-5513-555X; Vestweber, Dietmar/0000-0002-3517-732X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL69438, R01 HL069438] Funding Source: Medline; NIDDK NIH HHS [R01 DK056638, R01 DK56638] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alon R, 1996, J CELL BIOL, V135, P849, DOI 10.1083/jcb.135.3.849; ALON R, 1995, J IMMUNOL, V154, P5356; BARGATZE RF, 1994, J EXP MED, V180, P1785, DOI 10.1084/jem.180.5.1785; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; BURRUS LW, 1992, MOL CELL BIOL, V12, P5600, DOI 10.1128/MCB.12.12.5600; Chesnutt BC, 2006, MICROCIRCULATION, V13, P99, DOI 10.1080/10739680500466376; Chiang EY, 2007, NAT METHODS, V4, P219, DOI 10.1038/nmeth1018; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Evangelista V, 1999, BLOOD, V93, P876, DOI 10.1182/blood.V93.3.876.403k25_876_885; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Fuhlbrigge RC, 2006, BLOOD, V107, P1421, DOI 10.1182/blood-2005-05-2112; Gonatas JO, 1998, J CELL SCI, V111, P249; GONATAS JO, 1989, J BIOL CHEM, V264, P646; Green CE, 2004, J IMMUNOL, V172, P7780, DOI 10.4049/jimmunol.172.12.7780; Hirata T, 2000, J EXP MED, V192, P1669, DOI 10.1084/jem.192.11.1669; Huang MC, 2000, J BIOL CHEM, V275, P31353, DOI 10.1074/jbc.M005449200; Jones WM, 1997, J IMMUNOL, V159, P3574; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kohl R, 2000, J BIOL CHEM, V275, P15741, DOI 10.1074/jbc.M903271199; KOTOVUORI P, 1993, GLYCOBIOLOGY, V3, P131, DOI 10.1093/glycob/3.2.131; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; Ley K, 1998, CIRC RES, V83, P287, DOI 10.1161/01.RES.83.3.287; LO SK, 1991, J EXP MED, V173, P1493, DOI 10.1084/jem.173.6.1493; Matsumoto M, 2005, J IMMUNOL, V175, P8042, DOI 10.4049/jimmunol.175.12.8042; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Montoya MC, 1999, J CLIN INVEST, V103, P1317, DOI 10.1172/JCI4705; MOORE KL, 1994, J BIOL CHEM, V269, P23318; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Olofsson A, 1997, BIOCHEM J, V324, P427, DOI 10.1042/bj3240427; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; PICKER LJ, 1991, CELL, V66, P921, DOI 10.1016/0092-8674(91)90438-5; Protin U, 1999, J IMMUNOL, V163, P4917; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Ruchaud-Sparagano MH, 1998, EUR J IMMUNOL, V28, P80, DOI 10.1002/(SICI)1521-4141(199801)28:01<80::AID-IMMU80>3.0.CO;2-7; Simon SI, 2000, J IMMUNOL, V164, P4348, DOI 10.4049/jimmunol.164.8.4348; Smith K, 2004, ORG BIOMOL CHEM, V2, P935, DOI 10.1039/b400179f; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Steegmaier M, 1997, J CELL SCI, V110, P687; STEEGMAIER M, 1995, NATURE, V373, P615, DOI 10.1038/373615a0; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Wild MK, 2001, J BIOL CHEM, V276, P31602, DOI 10.1074/jbc.M104844200; Xia LJ, 2002, J CLIN INVEST, V109, P939; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769; Zollner O, 1997, J CELL BIOL, V136, P707, DOI 10.1083/jcb.136.3.707	51	217	226	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2007	26	4					477	489		10.1016/j.immuni.2007.03.011	http://dx.doi.org/10.1016/j.immuni.2007.03.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17442598	Green Accepted, Bronze			2022-12-18	WOS:000246126400012
J	Kobayashi, T; Walsh, PT; Walsh, MC; Speirs, KM; Chiffoleau, E; King, CG; Hancock, WW; Caamano, JH; Hunter, CA; Scott, P; Turka, LA; Choi, YW				Kobayashi, T; Walsh, PT; Walsh, MC; Speirs, KM; Chiffoleau, E; King, CG; Hancock, WW; Caamano, JH; Hunter, CA; Scott, P; Turka, LA; Choi, YW			TRAF6 is a critical factor for dendritic cell maturation and development	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; TOLL SIGNALING PATHWAY; KAPPA-B; DEFECTIVE INTERLEUKIN-1; FAMILY-MEMBER; T-CELLS; RECEPTOR; ACTIVATION; EXPRESSION; MICE	IL-1 receptor (IL-1R)/Toll-like receptor (TLR) family and TNF receptor (TNFR) superfamily members are critical for regulating multiple aspects of dendritic cell (DC) biology. Several signaling pathways associated with each family utilize the adapter molecule, TRAF6, but its role in DCs is unclear. By examining TRAF6-deficient mice and bone marrow (BM) chimeras reconstituted with TRAF6-deficient fetal liver cells, we show that proper DC maturation requires TRAF6. In response to either microbial components or CD40L, TRAF6-deficient DCs fail to upregulate surface expression of MHCII and B7.2, or produce inflammatory cytokines. Moreover, LPS-treated TRAF6-deficient DCs do not exhibit an enhanced capacity to stimulate naive T cells. Interestingly, a major population of splenic DCs, the CD4(+)CD8alpha(-) subset, is nearly absent in both TRAF6-deficient mice and BM chimeras. Together these results indicate that TRAF6 regulates the critical processes required for maturation, activation, and development of DCs, the primary cellular bridge between innate and adaptive immunity.	Univ Penn, Sch Vet Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Birmingham	Choi, YW (corresponding author), Univ Penn, Sch Vet Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Walsh, Patrick/I-7909-2014; Caamano, Jorge/I-6778-2012; Caamano, Jorge/O-7530-2019; Chiffoleau, Elise/N-2982-2018; Hunter, Christopher/H-1970-2011	Walsh, Patrick/0000-0002-0130-8766; Caamano, Jorge/0000-0003-3530-7056; Caamano, Jorge/0000-0003-3530-7056; Chiffoleau, Elise/0000-0001-6167-682X; Viner, Kendra/0000-0002-3567-9784; King, Carolyn G./0000-0001-6059-323X	NIAID NIH HHS [AI46288, AI54720-01, AI35914, AI37691, AI44264] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035914, R21AI035914, R01AI046288, R01AI044264, R01AI054720, R01AI037691] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chung JY, 2002, J CELL SCI, V115, P679; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Legge KL, 2002, J EXP MED, V196, P217, DOI 10.1084/jem.20011061; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miga AJ, 2001, EUR J IMMUNOL, V31, P959, DOI 10.1002/1521-4141(200103)31:3<959::AID-IMMU959>3.0.CO;2-A; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Speirs K, 2002, J IMMUNOL, V168, P4406, DOI 10.4049/jimmunol.168.9.4406; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949	40	217	232	2	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2003	19	3					353	363		10.1016/S1074-7613(03)00230-9	http://dx.doi.org/10.1016/S1074-7613(03)00230-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499111	Bronze			2022-12-18	WOS:000185499800007
J	Tsutsui, H; Kayagaki, N; Kuida, K; Nakano, H; Hayashi, N; Takeda, K; Matsui, K; Kashiwamura, S; Hada, T; Akira, S; Yagita, H; Okamura, H; Nakanishi, K				Tsutsui, H; Kayagaki, N; Kuida, K; Nakano, H; Hayashi, N; Takeda, K; Matsui, K; Kashiwamura, S; Hada, T; Akira, S; Yagita, H; Okamura, H; Nakanishi, K			Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice	IMMUNITY			English	Article							GAMMA-INDUCING FACTOR; INTERLEUKIN-1-BETA CONVERTING-ENZYME; A-INDUCED HEPATITIS; FAS LIGAND; IFN-GAMMA; T-CELLS; CRYPTOCOCCUS-NEOFORMANS; DOWN-REGULATION; DEFICIENT MICE; TNF-ALPHA	IL-18, produced as a biologically inactive precursor, is processed by caspase-1 in LPS-activated macrophages. Here, we investigated caspase-1-independent processing of IL-18 in Fas ligand (FasL)-stimulated macrophages and its involvement in liver injury. Administration of Propionibacterium acnes (P. acnes) upregulated functional Fas expression on macrophages in an IFN gamma-dependent manner, and these macrophages became competent to secrete mature IL-18 upon stimulation with Fast. This was also the case for caspase-1-deficient mice. Administration of recombinant soluble Fast (rFasL) after P. acnes priming induced comparable elevation of serum IL-18 in parallel with elevated serum liver enzyme levels. However, liver injury was not induced in IL-18-deficient mice after rFasL administration. These results indicate a caspase-1-independent pathway of IL-18 secretion from Fast-stimulated macrophages and its critical involvement in Fast-induced liver injury.	Hyogo Coll Med, Dept Immunol & Med Zool, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Dept Internal Med 3, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Host Def Lab, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan; Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; Vertex Pharmaceut, Cambridge, MA 02139 USA; Japan Sci & Technol Corp, Tokyo 1010062, Japan	Hyogo College of Medicine; Hyogo College of Medicine; Hyogo College of Medicine; Osaka University; Juntendo University; Vertex Pharmaceuticals; Japan Science & Technology Agency (JST)	Nakanishi, K (corresponding author), Hyogo Coll Med, Dept Immunol & Med Zool, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan.	nakaken@hyo-med.ac.jp	Akira, Shizuo/C-3134-2009; Takeda, Kiyoshi/C-9331-2009	Tsutsui, Hiroko/0000-0001-7928-4875				Akita K, 1997, J BIOL CHEM, V272, P26595, DOI 10.1074/jbc.272.42.26595; Bazan JF, 1996, NATURE, V379, P591, DOI 10.1038/379591a0; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Conceicao-Silva F, 1998, EUR J IMMUNOL, V28, P237, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;237::AID-IMMU237&gt;3.0.CO;2-O; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Dai WJ, 1997, J IMMUNOL, V158, P5297; Dao T, 1996, CELL IMMUNOL, V173, P230, DOI 10.1006/cimm.1996.0272; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Fantuzzi G, 1997, J IMMUNOL, V158, P1818; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hayashi N, 1997, J GASTROEN HEPATOL, V12, pS223, DOI 10.1111/j.1440-1746.1997.tb00504.x; Hyodo Y, 1999, J IMMUNOL, V162, P1662; Kawakami K, 1997, J IMMUNOL, V159, P5528; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Kayagaki N, 1997, P NATL ACAD SCI USA, V94, P3914, DOI 10.1073/pnas.94.8.3914; Kondo T, 1997, NAT MED, V3, P409, DOI 10.1038/nm0497-409; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Mastroeni P, 1999, INFECT IMMUN, V67, P478, DOI 10.1128/IAI.67.2.478-483.1999; Matsui K, 1997, J IMMUNOL, V159, P97; Miwa K, 1998, NAT MED, V4, P1287, DOI 10.1038/3276; Nakanishi K, 1996, INT IMMUNOL, V8, P791, DOI 10.1093/intimm/8.5.791; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Okamura H, 1998, ADV IMMUNOL, V70, P281, DOI 10.1016/S0065-2776(08)60389-2; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Oyaizu N, 1997, BIOCHEM BIOPH RES CO, V238, P670, DOI 10.1006/bbrc.1997.7357; Sakao Y, 1999, INT IMMUNOL, V11, P471, DOI 10.1093/intimm/11.3.471; Seino KI, 1997, GASTROENTEROLOGY, V113, P1315, DOI 10.1053/gast.1997.v113.pm9322527; Spanaus KS, 1998, EUR J IMMUNOL, V28, P4398, DOI 10.1002/(SICI)1521-4141(199812)28:12<4398::AID-IMMU4398>3.0.CO;2-Y; Strand S, 1998, NAT MED, V4, P588, DOI 10.1038/nm0598-588; Tagawa Y, 1998, EUR J IMMUNOL, V28, P4105, DOI 10.1002/(SICI)1521-4141(199812)28:12<4105::AID-IMMU4105>3.3.CO;2-#; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Taieb J, 1998, LANCET, V351, P1930, DOI 10.1016/S0140-6736(05)78614-1; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Tsutsui H, 1997, J IMMUNOL, V159, P3961; Tsutsui H, 1996, J IMMUNOL, V157, P3967; TSUTSUI H, 1992, HEPATO-GASTROENTEROL, V39, P553; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zhang TT, 1997, INFECT IMMUN, V65, P3594, DOI 10.1128/IAI.65.9.3594-3599.1997; Zheng TS, 1998, P NATL ACAD SCI USA, V95, P13618, DOI 10.1073/pnas.95.23.13618	45	217	231	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1999	11	3					359	367		10.1016/S1074-7613(00)80111-9	http://dx.doi.org/10.1016/S1074-7613(00)80111-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514014	Bronze			2022-12-18	WOS:000082918500011
J	Walsh, CM; Wen, BG; Chinnaiyan, AM; O'Rourke, K; Dixit, VM; Hedrick, SM				Walsh, CM; Wen, BG; Chinnaiyan, AM; O'Rourke, K; Dixit, VM; Hedrick, SM			A role for FADD in T cell activation and development	IMMUNITY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; RECEPTOR TRANSGENIC MICE; NECROSIS-FACTOR RECEPTOR; INDUCED APOPTOSIS; NEGATIVE SELECTION; TNF RECEPTOR; DEATH-DOMAIN; FAS-LIGAND; LPR MICE; IN-VIVO	FADD is a cytoplasmic adapter molecule that links the family of death receptors to the activation of caspases during apoptosis. We have produced transgenic mice expressing a dominantly interfering mutant of FADD, lacking the caspase-dimerizing death effector domain, as well as mice overexpressing the poxvirus serpin, CrmA, an inhibitor of caspases downstream of FADD. While thymocytes from either line of mice were completely protected from CD95-dependent cytotoxicity, neither transgene afforded protection from apoptosis induced during thymocyte selection and neither led to the lymphoproliferative disorders associated with deficiencies in CD95. However, in FADD dominant negative (FADDdd) mice, early thymocyte development was retarded and peripheral lymphocyte pools were devoid of normal populations of T cells. We show that thymocytes and peripheral T cells from FADDdd display signaling anomalies, implying that FADD plays a previously uncharacterized role in T cell development and activation.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Michigan System; University of Michigan	Hedrick, SM (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.		Hedrick, Stephen M/E-9171-2010; dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Walsh, Craig/0000-0001-7808-2817; Hedrick, Stephen/0000-0002-6345-8751	NIAID NIH HHS [2RO1AI37988] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037988] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi M, 1996, P NATL ACAD SCI USA, V93, P2131, DOI 10.1073/pnas.93.5.2131; ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; ALLEN RD, 1990, J EXP MED, V172, P1367, DOI 10.1084/jem.172.5.1367; AMAKAWA R, 1996, CELL, V84, P561; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Baker SJ, 1996, ONCOGENE, V12, P1; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Castedo M, 1995, EUR J IMMUNOL, V25, P3277, DOI 10.1002/eji.1830251212; Castro JE, 1996, IMMUNITY, V5, P617, DOI 10.1016/S1074-7613(00)80275-7; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Darnay BG, 1997, J LEUKOCYTE BIOL, V61, P559, DOI 10.1002/jlb.61.5.559; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737; FOY TM, 1995, J EXP MED, V182, P1377, DOI 10.1084/jem.182.5.1377; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Griffith TS, 1996, IMMUNITY, V5, P7, DOI 10.1016/S1074-7613(00)80305-2; GROETTRUP M, 1993, IMMUNOL TODAY, V14, P610, DOI 10.1016/0167-5699(93)90201-U; GROSS JA, 1992, J IMMUNOL, V149, P380; HERRON LR, 1993, J IMMUNOL, V151, P3450; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; KOJIMA H, 1994, IMMUNITY, V1, P357, DOI 10.1016/1074-7613(94)90066-3; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; KOTZIN BL, 1988, J EXP MED, V168, P2221, DOI 10.1084/jem.168.6.2221; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; LYNCH DH, 1994, IMMUNITY, V1, P131, DOI 10.1016/1074-7613(94)90106-6; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Martins LM, 1997, J BIOL CHEM, V272, P7421, DOI 10.1074/jbc.272.11.7421; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; MATSUZAWA A, 1990, J EXP MED, V171, P519, DOI 10.1084/jem.171.2.519; MATSUZAWA A, 1991, EUR J IMMUNOL, V21, P1535, DOI 10.1002/eji.1830210630; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Page DM, 1998, J IMMUNOL, V160, P120; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; PENIT C, 1995, J IMMUNOL, V154, P5103; PENNINGTON MW, 1994, PEPTIDE RES, V7, P72; PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SHI YF, 1991, J IMMUNOL, V146, P3340; SHIRAI T, 1990, J IMMUNOL, V144, P3756; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; Tewari M, 1996, CURR OPIN GENET DEV, V6, P39, DOI 10.1016/S0959-437X(96)90008-8; Varfolomeev EE, 1996, J EXP MED, V183, P1271, DOI 10.1084/jem.183.3.1271; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; WADSWORTH S, 1990, EUR J IMMUNOL, V20, P723, DOI 10.1002/eji.1830200403; WALSH CM, 1994, J IMMUNOL, V153, P2506; WALSH CM, 1994, P NATL ACAD SCI USA, V91, P10854, DOI 10.1073/pnas.91.23.10854; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Yuan JY, 1997, CURR OPIN CELL BIOL, V9, P247, DOI 10.1016/S0955-0674(97)80069-5; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhang J, 1996, MOL CELL BIOL, V16, P2756; ZHOU T, 1991, J IMMUNOL, V147, P466	80	217	221	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1998	8	4					439	449		10.1016/S1074-7613(00)80549-X	http://dx.doi.org/10.1016/S1074-7613(00)80549-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586634	Bronze			2022-12-18	WOS:000073348000006
J	VanderVieren, M; LeTrong, H; Wood, CL; Moore, PF; StJohn, T; Staunton, DE; Gallatin, WM				VanderVieren, M; LeTrong, H; Wood, CL; Moore, PF; StJohn, T; Staunton, DE; Gallatin, WM			A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3	IMMUNITY			English	Article							LEUKOCYTE ADHESION GLYCOPROTEIN; ALPHA-SUBUNIT; CELL-ADHESION; I-DOMAIN; INTEGRINS; FAMILY; MAC-1; LFA-1; P150,95; CLONING	The leukocyte-restricted beta 2 (CD18) integrins mediate cell adhesion in a variety of events essential for normal immune function. Despite extensive research in this field, only three members of this integrin subfamily have been described: CD11a/CD18 (LFA-1), CD11b/ CD18 (Mac-1), and CD11c/CD18 (p150,95). We have identified a cDNA encoding a fourth alpha chain, ad, that associates with CD18. The alpha d subunit is more closely related to CD11b and CD11c than to CD11a. This integrin is expressed at moderate levels on myelomonocytic cell lines and subsets of peripheral blood leukocytes, and more strongly on tissue-compartmentalized cells such as foam cells, specialized macrophages found in aortic fatty streaks that may develop into atherosclerotic lesions. The alpha d/CD18 molecule exhibits preferential recognition of ICAM-3 over ICAM-1.	UNIV CALIF DAVIS, SCH VET MED, DEPT PATHOL MICROBIOL & IMMUNOL, DAVIS, CA 95616 USA	University of California System; University of California Davis	VanderVieren, M (corresponding author), ICOS CORP, 22021 20TH AVE SE, BOTHELL, WA 98021 USA.							ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; COLE SR, 1987, MOL IMMUNOL, V24, P699, DOI 10.1016/0161-5890(87)90051-4; COLLINS SJ, 1987, BLOOD, V70, P1233; CORBI AL, 1987, EMBO J, V6, P4023, DOI 10.1002/j.1460-2075.1987.tb02746.x; CORBI AL, 1988, J BIOL CHEM, V263, P12403; DANILENKO DM, 1995, J IMMUNOL, V155, P35; DANILENKO DM, 1992, TISSUE ANTIGENS, V40, P13, DOI 10.1111/j.1399-0039.1992.tb01952.x; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; EDWARDS CP, 1995, J BIOL CHEM, V270, P12635, DOI 10.1074/jbc.270.21.12635; FERRANTE A, 1982, J IMMUNOL METHODS, V48, P81, DOI 10.1016/0022-1759(82)90212-5; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LANDIS RC, 1993, J CELL BIOL, V120, P1519, DOI 10.1083/jcb.120.6.1519; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; MARTIN S, 1995, J IMMUNOL, V154, P1951; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MOORE PF, 1992, TISSUE ANTIGENS, V40, P75, DOI 10.1111/j.1399-0039.1992.tb01963.x; RANDI AM, 1994, J BIOL CHEM, V269, P12395; ROJIANI MV, 1991, BIOCHEMISTRY-US, V30, P9859, DOI 10.1021/bi00105a008; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SADHU C, 1994, CELL ADHES COMMUN, V2, P429, DOI 10.3109/15419069409004453; SPRINGER TA, 1984, J EXP MED, V160, P1901, DOI 10.1084/jem.160.6.1901; Stone K.L., 1992, TECHNIQUES PROTEIN C, P23; UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; VIVES J, 1994, IMMUNOLOGIST, V2, P93; ZHOU LB, 1994, J BIOL CHEM, V269, P17075	34	217	233	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1995	3	6					683	690		10.1016/1074-7613(95)90058-6	http://dx.doi.org/10.1016/1074-7613(95)90058-6			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777714	Bronze			2022-12-18	WOS:A1995TM02300003
J	Ma, EH; Verway, MJ; Johnson, RM; Roy, DG; Steadman, M; Hayes, S; Williams, KS; Sheldon, RD; Samborska, B; Kosinski, PA; Kim, H; Griss, T; Faubert, B; Condotta, SA; Krawczyk, CM; DeBerardinis, RJ; Stewart, KM; Richer, MJ; Chubukov, V; Roddy, TP; Jones, RG				Ma, Eric H.; Verway, Mark J.; Johnson, Radia M.; Roy, Dominic G.; Steadman, Mya; Hayes, Sebastian; Williams, Kelsey S.; Sheldon, Ryan D.; Samborska, Bozena; Kosinski, Penelope A.; Kim, Hyeryun; Griss, Takla; Faubert, Brandon; Condotta, Stephanie A.; Krawczyk, Connie M.; DeBerardinis, Ralph J.; Stewart, Kelly M.; Richer, Martin J.; Chubukov, Victor; Roddy, Thomas P.; Jones, Russell G.			Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8(+) T Cells	IMMUNITY			English	Article							ONE-CARBON METABOLISM; EFFECTOR FUNCTION; MITOCHONDRIAL DYNAMICS; MEMORY; ACETATE; SERINE; PHOSPHOENOLPYRUVATE; PROLIFERATION; ADAPTATION; SURVIVAL	Naive CD8(+) T cells differentiating into effector T cells increase glucose uptake and shift from quiescent to anabolic metabolism. Although much is known about the metabolism of cultured T cells, how T cells use nutrients during immune responses in vivo is less well defined. Here, we combined bioenergetic profiling and C-13-glucose infusion techniques to investigate the metabolism of CD8(+) T cells responding to Listeria infection. In contrast to in vitro-activated T cells, which display hallmarks of Warburg metabolism, physiologically activated CD8(+) T cells displayed greater rates of oxidative metabolism, higher bioenergetic capacity, differential use of pyruvate, and prominent flow of C-13-glucose carbon to anabolic pathways, including nucleotide and serine biosynthesis. Glucose-dependent serine biosynthesis mediated by the enzyme Phgdh was essential for CD8(+) T cell expansion in vivo. Our data highlight fundamental differences in glucose use by pathogen-specific T cells in vivo, illustrating the impact of environment on T cell metabolic phenotypes.	[Ma, Eric H.; Williams, Kelsey S.; Sheldon, Ryan D.; Krawczyk, Connie M.; Jones, Russell G.] Van Andel Inst, Ctr Canc & Cell Biol, Metab & Nutr Programming, Grand Rapids, MI 49503 USA; [Ma, Eric H.; Verway, Mark J.; Johnson, Radia M.; Roy, Dominic G.; Samborska, Bozena; Griss, Takla; Condotta, Stephanie A.; Krawczyk, Connie M.; Richer, Martin J.; Jones, Russell G.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Ma, Eric H.; Verway, Mark J.; Roy, Dominic G.; Samborska, Bozena; Griss, Takla; Jones, Russell G.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Steadman, Mya; Hayes, Sebastian; Kosinski, Penelope A.; Kim, Hyeryun; Stewart, Kelly M.; Chubukov, Victor; Roddy, Thomas P.] Agios Pharmaceut, Cambridge, MA 02139 USA; [Faubert, Brandon; DeBerardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Condotta, Stephanie A.; Krawczyk, Connie M.; Richer, Martin J.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3G 1Y6, Canada; [Condotta, Stephanie A.; Richer, Martin J.] McGill Univ, Microbiome & Dis Tolerance Ctr, Montreal, PQ H3G 1Y6, Canada; [DeBerardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Van Andel Institute; McGill University; McGill University; Agios Pharmaceuticals; University of Texas System; University of Texas Southwestern Medical Center Dallas; McGill University; McGill University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jones, RG (corresponding author), Van Andel Inst, Ctr Canc & Cell Biol, Metab & Nutr Programming, Grand Rapids, MI 49503 USA.; Jones, RG (corresponding author), McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.; Jones, RG (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada.	russell.jones@vai.org	Jones, Russell/AAC-2861-2022; Johnson, Radia/GYV-4663-2022; Jones, Russell Graham/ABD-5261-2021	Johnson, Radia/0000-0002-9755-9307; Jones, Russell Graham/0000-0003-2250-4675; Sheldon, Ryan/0000-0002-1573-9719; Williams, Kelsey/0000-0002-4163-5075; Roy, Dominic/0000-0002-6044-0118; HAYES, SEBASTIAN/0000-0002-2383-9461; Faubert, Brandon/0000-0002-2886-886X	Canadian Foundation for Innovation (CFI); Canadian Institutes of Health Research (CIHR); Terry Fox Research Institute (TFRI); CIHR [MOP-142259]; Agios Pharmaceuticals	Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Terry Fox Research Institute (TFRI); CIHR(Canadian Institutes of Health Research (CIHR)); Agios Pharmaceuticals	We thank Shona Mookerjee; members of the Jones, Krawczyk, and Richer laboratories; and colleagues at Agios Pharmaceuticals for advice regarding the manuscript. We acknowledge technical assistance from Jeanie Wedberg, Michelle Minard, VAI Operations, and the Metabolomics and Flow Cytometry Core facilities at the VAI and McGill/GCRC. The GCRC Metabolomics Core Facility is supported by grants from the Canadian Foundation for Innovation (CFI), Canadian Institutes of Health Research (CIHR), and Terry Fox Research Institute (TFRI). We acknowledge salary support from the McGill Integrated Cancer Research Training Program (to E.H.M.), Fonds de la Recherche du Quebec Sante (FRQS; to E.H.M., D.G.R., and M.J.R.), and the CIHR (to D.G.R. and R.G.J.). This research was supported by grants from the CIHR (including MOP-142259 to R.G.J.) and funding from Agios Pharmaceuticals.	Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Binek A, 2019, J PROTEOME RES, V18, P169, DOI 10.1021/acs.jproteome.8b00472; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Cantor JR, 2017, CELL, V169, P258, DOI 10.1016/j.cell.2017.03.023; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; Faubert B, 2014, P NATL ACAD SCI USA, V111, P2554, DOI 10.1073/pnas.1312570111; Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Griss T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002309; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; Jones RG, 2007, IMMUNITY, V27, P268, DOI 10.1016/j.immuni.2007.05.023; Kishton RJ, 2016, CELL METAB, V23, P649, DOI 10.1016/j.cmet.2016.03.008; Klarquist J, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aas9822; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Krawczyk CM, 2007, INFECT IMMUN, V75, P3556, DOI 10.1128/IAI.00086-07; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Lee CF, 2015, CELL REP, V13, P760, DOI 10.1016/j.celrep.2015.09.036; Liu Feng-Lin, 2012, Acta Anaesthesiol Taiwan, V50, P172, DOI 10.1016/j.aat.2012.12.001; Llufrio EM, 2018, REDOX BIOL, V16, P381, DOI 10.1016/j.redox.2018.03.004; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; McGuirk S, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-22; Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Qiu J, 2019, CELL REP, V27, P2063, DOI 10.1016/j.celrep.2019.04.022; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sun RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01518-z; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021	57	216	231	7	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					856	+		10.1016/j.immuni.2019.09.003	http://dx.doi.org/10.1016/j.immuni.2019.09.003			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31747582	Bronze			2022-12-18	WOS:000497811300010
J	Nadjsombati, MS; McGinty, JW; Lyons-Cohen, MR; Jaffe, JB; DiPeso, L; Schneider, C; Miller, CN; Pollack, JL; Gowda, GAN; Fontana, MF; Erle, DJ; Anderson, MS; Locksley, RM; Raftery, D; von Moltke, J				Nadjsombati, Marija S.; McGinty, John W.; Lyons-Cohen, Miranda R.; Jaffe, James B.; DiPeso, Lucian; Schneider, Christoph; Miller, Corey N.; Pollack, Joshua L.; Gowda, G. A. Nagana; Fontana, Mary F.; Erle, David J.; Anderson, Mark S.; Locksley, Richard M.; Raftery, Daniel; von Moltke, Jakob			Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit	IMMUNITY			English	Article							CHEMOSENSORY CELLS; GPR91; HOMEOSTASIS; METABOLISM; ACTIVATION; EVOLUTION; DISEASE; IL-13; MICE	In the small intestine, type 2 responses are regulated by a signaling circuit that involves tuft cells and group 2 innate lymphoid cells (ILC2s). Here, we identified the microbial metabolite succinate as an activating ligand for small intestinal (SI) tuft cells. Sequencing analyses of tuft cells isolated from the small intestine, gall bladder, colon, thymus, and trachea revealed that expression of tuft cell chemosensory receptors is tissue specific. SI tuft cells expressed the succinate receptor (SUCNR1), and providing succinate in drinking water was sufficient to induce a multifaceted type 2 immune response via the tuft-ILC2 circuit. The helminth Nippostrongylus brasiliensis and a tritricho-monad protist both secreted succinate as a metabolite. In vivo sensing of the tritrichomonad required SUCNR1, whereas N. brasiliensis was SUCNR1 independent. These findings define a paradigm wherein tuft cells monitor microbial metabolites to initiate type 2 immunity and suggest the existence of other sensing pathways triggering the response to helminths.	[Nadjsombati, Marija S.; McGinty, John W.; Lyons-Cohen, Miranda R.; Jaffe, James B.; DiPeso, Lucian; Fontana, Mary F.; von Moltke, Jakob] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA; [Gowda, G. A. Nagana; Raftery, Daniel] Univ Washington, Dept Anesthesiol & Pain Med, Northwest Metabol Res Ctr, Seattle, WA 98109 USA; [Schneider, Christoph; Miller, Corey N.; Pollack, Joshua L.; Erle, David J.; Anderson, Mark S.; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Schneider, Christoph; Anderson, Mark S.; Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Schneider, Christoph; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Miller, Corey N.; Anderson, Mark S.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Pollack, Joshua L.] Pionyr Immunotherapeut, San Francisco, CA 94107 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Moltke, J (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA.	jmoltke@uw.edu		Nadjsombati, Marija/0000-0001-6632-8381; Lyons-Cohen, Miranda R./0000-0002-6537-8827; Schneider, Christoph/0000-0002-0452-2960	University of Washington Immunology Training Grant [T32 AI106677]; NIH [1DP2 OD024087, R01 AI26918]; SABRE enter at the University of California, San Francisco University of Washington; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, DP2AI136596, T32AI106677, T32AI007334] Funding Source: NIH RePORTER	University of Washington Immunology Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SABRE enter at the University of California, San Francisco University of Washington; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank staff at the University of Washington Gnotobiotic Core for assistance with germ-free mouse experiments, H.E. Liang for assistance with Gnat3 CRISPR targeting and validation, Z. Wang for experimental assistance, N. Arpaia for guidance on NMR analysis of intestinal samples, D. Hailey and the Garvey Cell Imaging Lab in the Institute for Stem & Cell Regenerative Medicine for microscopy support, and K. Smith for mice, reagents, and advice. J.W.M. is supported by the University of Washington Immunology Training Grant (T32 AI106677). J.V.M. is a Damon Runyon - Dale Frey Breakthrough Scientist and a Searle Scholar. This work was supported by NIH 1DP2 OD024087 (J.V.M.) and the University of Washington. mRNA sequencing was supported by NIH R01 AI26918 (R.M.L.) and the SABRE enter at the University of California, San Francisco.	Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Bezencon C, 2008, J COMP NEUROL, V509, P514, DOI 10.1002/cne.21768; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chudnovskiy A, 2016, CELL, V167, P444, DOI 10.1016/j.cell.2016.08.076; De Vadder F, 2016, CELL METAB, V24, P151, DOI 10.1016/j.cmet.2016.06.013; Deckmann K, 2014, P NATL ACAD SCI USA, V111, P8287, DOI 10.1073/pnas.1402436111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Escalante NK, 2016, J EXP MED, V213, P2841, DOI 10.1084/jem.20161776; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Ferreyra JA, 2014, CELL HOST MICROBE, V16, P770, DOI 10.1016/j.chom.2014.11.003; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gray EE, 2016, IMMUNITY, V45, P255, DOI 10.1016/j.immuni.2016.06.015; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Helmby H, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0074-3; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Krasteva G, 2011, P NATL ACAD SCI USA, V108, P9478, DOI 10.1073/pnas.1019418108; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Littlewood-Evans A, 2016, J EXP MED, V213, P1655, DOI 10.1084/jem.20160061; Mohrs M, 1999, J IMMUNOL, V162, P7302; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Odegaard JI, 2015, CURR OPIN IMMUNOL, V36, P67, DOI 10.1016/j.coi.2015.07.003; Paik J, 2015, GUT MICROBES, V6, P255, DOI 10.1080/19490976.2015.1064576; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Rubic-Schneider T, 2017, ALLERGY, V72, P444, DOI 10.1111/all.13005; SAEKI H, 1983, JPN J VET SCI, V45, P151; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; SAZ DK, 1971, J PARASITOL, V57, P1159, DOI 10.2307/3277956; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; TIELENS AGM, 1994, PARASITOL TODAY, V10, P346, DOI 10.1016/0169-4758(94)90245-3; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; WOLFFRAM S, 1994, EXP PHYSIOL, V79, P215, DOI 10.1113/expphysiol.1994.sp003754	41	216	219	7	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					33	+		10.1016/j.immuni.2018.06.016	http://dx.doi.org/10.1016/j.immuni.2018.06.016			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	30021144	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000438949100009
J	Speer, T; Rohrer, L; Blyszczuk, P; Shroff, R; Kuschnerus, K; Krankel, N; Kania, G; Zewinger, S; Akhmedov, A; Shi, Y; Martin, T; Perisa, D; Winnik, S; Muller, MF; Sester, U; Wernicke, G; Jung, A; Gutteck, U; Eriksson, U; Geisel, J; Deanfield, J; von Eckardstein, A; Luscher, TF; Fliser, D; Bahlmann, FH; Landmesser, U				Speer, Thimoteus; Rohrer, Lucia; Blyszczuk, Przemyslaw; Shroff, Rukshana; Kuschnerus, Kira; Kraenkel, Nicolle; Kania, Gabriela; Zewinger, Stephen; Akhmedov, Alexander; Shi, Yi; Martin, Tina; Perisa, Damir; Winnik, Stephan; Mueller, Maja F.; Sester, Urban; Wernicke, Gabriel; Jung, Andreas; Gutteck, Ursula; Eriksson, Urs; Geisel, Juergen; Deanfield, John; von Eckardstein, Arnold; Luescher, Thomas F.; Fliser, Danilo; Bahlmann, Ferdinand H.; Landmesser, Ulf			Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2	IMMUNITY			English	Article							CHRONIC KIDNEY-DISEASE; NITRIC-OXIDE SYNTHASE; STAGE RENAL-DISEASE; ASYMMETRIC DIMETHYLARGININE; SCAVENGER RECEPTOR; OXIDATIVE STRESS; PROGENITOR CELLS; BLOOD-PRESSURE; HEART-DISEASE; ATHEROSCLEROSIS	Endothelial injury and dysfunction (ED) represent a link between cardiovascular risk factors promoting hypertension and atherosclerosis, the leading cause of death in Western populations. High-density lipoprotein (HDL) is considered antiatherogenic and known to prevent ED. Using HDL from children and adults with chronic kidney dysfunction (HDLCKD), a population with high cardiovascular risk, we have demonstrated that HDLCKD incontrast toHDL(Healthy) promoted endothelial superoxide production, substantially reduced nitric oxide (NO) bioavailability, and subsequently increased arterial blood pressure (ABP). We have identified symmetric dimethylarginine (SDMA) in HDLCKD that causes transformation from physiological HDL into an abnormal lipoprotein inducing ED. Furthermore, we report that HDLCKD reduced endothelial NO availability via toll-like receptor-2 (TLR-2), leading to impaired endothelial repair, increased proinflammatory activation, and ABP. These data demonstrate how SDMA can modify the HDL particle to mimic a damage-associated molecular pattern that activates TLR-2 via a TLR-1- or TLR-6-coreceptor-independent pathway, linking abnormal HDL to innate immunity, ED, and hypertension.	[Speer, Thimoteus; Blyszczuk, Przemyslaw; Kuschnerus, Kira; Kraenkel, Nicolle; Kania, Gabriela; Akhmedov, Alexander; Shi, Yi; Winnik, Stephan; Mueller, Maja F.; Eriksson, Urs; Luescher, Thomas F.; Landmesser, Ulf] Univ Zurich, Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Speer, Thimoteus; Blyszczuk, Przemyslaw; Kuschnerus, Kira; Kraenkel, Nicolle; Kania, Gabriela; Akhmedov, Alexander; Shi, Yi; Winnik, Stephan; Mueller, Maja F.; Luescher, Thomas F.; Landmesser, Ulf] Univ Zurich, Inst Physiol, CH-8091 Zurich, Switzerland; [Speer, Thimoteus; Zewinger, Stephen; Martin, Tina; Sester, Urban; Wernicke, Gabriel; Jung, Andreas; Fliser, Danilo; Bahlmann, Ferdinand H.] Saarland Univ Hosp, Dept Internal Med Nephrol & Hypertens, D-66421 Homburg, Germany; [Geisel, Juergen] Saarland Univ Hosp, Inst Clin Chem, D-66421 Homburg, Germany; [Rohrer, Lucia; von Eckardstein, Arnold; Luescher, Thomas F.] Univ Zurich, Ctr Integrat Human Physiol, CH-8091 Zurich, Switzerland; [Rohrer, Lucia; Perisa, Damir; Gutteck, Ursula; von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8001 Zurich, Switzerland; [Shroff, Rukshana] UCL, Inst Child Hlth, Vasc Physiol Unit, London WC1N 3JE, England; [Shroff, Rukshana] Great Ormond St Hosp Sick Children, Renal Unit, London WC1N 3JH, England; [Eriksson, Urs] GZO Spital Wetzikon, Dept Internal Med, CH-8620 Wetzikon, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Speer, T (corresponding author), Univ Zurich, Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland.	timo.speer@uks.eu	Shroff, Rukshana/AAG-5383-2019; Kania, Gabriela/E-8715-2017; Shroff, Rukshana C/C-7347-2008; Blyszczuk, Przemyslaw/J-2153-2019	Shroff, Rukshana/0000-0001-8501-1072; Kania, Gabriela/0000-0003-3788-4594; Shroff, Rukshana C/0000-0001-8501-1072; Blyszczuk, Przemyslaw/0000-0003-2521-3232; Deanfield, John/0000-0001-8806-6052; Shi, Yi/0000-0003-3005-9655; Eriksson, Urs/0000-0003-1217-9696; Speer, Thimoteus/0000-0002-2491-6393; Kraenkel, Nicolle/0000-0002-9363-1770; Sester, Urban/0000-0003-4007-5595; Winnik, Stephan/0000-0002-1277-5132	Deutsche Forschungsgemeinschaft [SP 1293/1-1]; Deutsche Hochdruckliga; Swiss National Science Foundation [31003A-130836]; Fondation Leducq; Zurich Center of Integrative Physiology; Seventh Framework Programme for research and technological development [SysKID-Health-F2-2009-241544]; SNF "ambizione" fellowship [PZ00P3_126621/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Hochdruckliga; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Leducq(Leducq Foundation); Zurich Center of Integrative Physiology; Seventh Framework Programme for research and technological development; SNF "ambizione" fellowship	We thank Stephan Keller, Silvija Radosavljevic, Sarah Triem, and Claudia Noll for their excellent technical support. This project has been supported by the Deutsche Forschungsgemeinschaft (SP 1293/1-1), Deutsche Hochdruckliga, and by grants from the Swiss National Science Foundation (31003A-130836), the Fondation Leducq, the Zurich Center of Integrative Physiology, and the Seventh Framework Programme for research and technological development (SysKID-Health-F2-2009-241544). N. K. is supported by an SNF "ambizione" fellowship (PZ00P3_126621/1). A. v. E. and U. L. are affiliated with the COST action BM903 "HDLnet."	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI200523858; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Beaulieu LM, 2011, BLOOD, V117, P5963, DOI 10.1182/blood-2010-09-304949; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bisoendial RJ, 2003, CIRCULATION, V107, P2944, DOI 10.1161/01.CIR.0000070934.69310.1A; Bode-Boger SM, 2006, J AM SOC NEPHROL, V17, P1128, DOI 10.1681/ASN.2005101119; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cabanski M, 2008, AM J RESP CELL MOL, V38, P26, DOI 10.1165/rcmb.2007-0010OC; Charakida M, 2009, JAMA-J AM MED ASSOC, V302, P1210, DOI 10.1001/jama.2009.1346; Di Gangi IM, 2010, ANAL CHIM ACTA, V677, P140, DOI 10.1016/j.aca.2010.08.011; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Favre J, 2007, ARTERIOSCL THROM VAS, V27, P1064, DOI 10.1161/ATVBAHA.107.140723; Fliser D, 2005, J AM SOC NEPHROL, V16, P2456, DOI 10.1681/ASN.2005020179; Fujita M, 2003, J IMMUNOL, V171, P3675, DOI 10.4049/jimmunol.171.7.3675; Grote K, 2010, BLOOD, V115, P2543, DOI 10.1182/blood-2009-05-224402; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kania G, 2009, CIRC RES, V105, P462, DOI 10.1161/CIRCRESAHA.109.196287; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Kleschyov AL, 2000, BIOCHEM BIOPH RES CO, V275, P672, DOI 10.1006/bbrc.2000.3361; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Meinitzer A, 2011, CLIN CHEM, V57, P112, DOI 10.1373/clinchem.2010.150854; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Osto E, 2008, CIRCULATION, V118, P2073, DOI 10.1161/CIRCULATIONAHA.108.765032; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Pullamsetti S, 2005, FASEB J, V19, P1175, DOI 10.1096/fj.04-3223fje; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Roux AL, 2011, CELL MICROBIOL, V13, P692, DOI 10.1111/j.1462-5822.2010.01565.x; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Schepers E, 2011, CLIN J AM SOC NEPHRO, V6, P2374, DOI 10.2215/CJN.01720211; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Shi Y, 2011, ARTERIOSCL THROM VAS, V31, P2090, DOI 10.1161/ATVBAHA.111.229260; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Sorrentino SA, 2010, CIRCULATION, V121, P110, DOI 10.1161/CIRCULATIONAHA.108.836346; Spieker LE, 2002, CIRCULATION, V105, P1399, DOI 10.1161/01.CIR.0000013424.28206.8F; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	60	216	231	2	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					754	768		10.1016/j.immuni.2013.02.009	http://dx.doi.org/10.1016/j.immuni.2013.02.009			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23477738	Bronze			2022-12-18	WOS:000330942100017
J	Metkar, SS; Menaa, C; Pardo, J; Wang, BK; Wallich, R; Freudenberg, M; Kim, S; Raja, SM; Shi, LF; Simon, MM; Froelich, CJ				Metkar, Sunil S.; Menaa, Cheikh; Pardo, Julian; Wang, Baikun; Wallich, Reinhard; Freudenberg, Marina; Kim, Stephen; Raja, Srikumar M.; Shi, Lianfa; Simon, Markus M.; Froelich, Christopher J.			Human and Mouse Granzyme A Induce a Proinflammatory Cytokine Response	IMMUNITY			English	Article							CELL-MEDIATED CYTOTOXICITY; CYTOLYTIC LYMPHOCYTES-T; ASSEMBLY PROTEIN SET; TARGET-CELLS; EXTRACELLULAR ACTIVITIES; DNA FRAGMENTATION; APOPTOSIS; CTL; PERFORIN; DEATH	Granzyme A (GzmA) is considered a major proapoptotic protease. We have discovered that GzmA-induced cell death involves rapid membrane damage that depends on the synergy between micromolar concentrations of GzmA and sublytic perforin (PFN). Ironically, GzmA and GzmB, independent of their catalytic activity, both mediated this swift necrosis. Even without PFN, lower concentrations of human GzmA stimulated monocytic cells to secrete proinflammatory cytokines (interfeukin-1 beta [IL-1 beta], TNF alpha, and IL-6) that were blocked by a caspase-1 inhibitor. Moreover, murine GzmA and GzmA(+) cytotoxic T lymphocytes (CTLs) induce IL-1 beta from primary mouse macrophages, and GzmA(-/-) mice resist lipopolysaccharide-induced toxicity. Thus, the granule secretory pathway plays an unexpected role in inflammation, with GzmA acting as an endogenous modulator.	[Metkar, Sunil S.; Menaa, Cheikh; Wang, Baikun; Kim, Stephen; Raja, Srikumar M.; Shi, Lianfa; Froelich, Christopher J.] NorthShore Univ, HealthSyst Res Inst, Dept Med, Evanston, IL 60201 USA; [Pardo, Julian] Univ Zaragoza, Fac Sci, Dept Biochem & Mol & Cellular Biol, E-50009 Zaragoza, Spain; [Pardo, Julian; Freudenberg, Marina; Simon, Markus M.] Max Planck Inst Immunobiol, Metschnikoff Lab, D-79108 Freiburg, Germany; [Wallich, Reinhard] Univ Heidelberg, Inst Immunol, D-69120 Heidelberg, Germany	NorthShore University Health System; University of Zaragoza; Max Planck Society; Ruprecht Karls University Heidelberg	Froelich, CJ (corresponding author), NorthShore Univ, HealthSyst Res Inst, Dept Med, Evanston, IL 60201 USA.	c-froelich@northwestern.edu	Pardo, Julián/K-6764-2014	Pardo, Julián/0000-0003-0154-0730; Freudenberg, Marina Alexandra/0000-0001-5894-1805	Alexander von Humboldt Foundation; Fundacion Agencia Aragonesa para Investigacion y Desarrollo;  [5ROlAI04494-03];  [KO1 CA100095]; NATIONAL CANCER INSTITUTE [K01CA100095] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Fundacion Agencia Aragonesa para Investigacion y Desarrollo; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Gary Klimpel and Laurie Sower, who helped to start it all; Aynur Ekiciler, Anton Grubisic, and Thomas Stehle for expert technical assistance; and Lars Joeckel, Adrian Koch, and Praxedis Martin for providing mouse CTL lines. This work was supported in part by the grants 5ROlAI04494-03 to C.J.F and KO1 CA100095 to C.M. J.P. was supported by the Alexander von Humboldt Foundation and the Fundacion Agencia Aragonesa para Investigacion y Desarrollo.	Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Beresford PJ, 1997, P NATL ACAD SCI USA, V94, P9285, DOI 10.1073/pnas.94.17.9285; Dhote R, 2003, ARTHRIT RHEUM-ARTHR, V49, P633, DOI 10.1002/art.11368; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Franchi L, 2006, J IMMUNOL, V177, P3507, DOI 10.4049/jimmunol.177.6.3507; Froelich CJ, 1996, BIOCHEM BIOPH RES CO, V229, P44, DOI 10.1006/bbrc.1996.1755; Froelich CJ, 2004, CELL DEATH DIFFER, V11, P369, DOI 10.1038/sj.cdd.4401381; FRUTH U, 1987, EUR J IMMUNOL, V17, P1625, DOI 10.1002/eji.1830171116; Goldberg JE, 1999, J IMMUNOL METHODS, V224, P1, DOI 10.1016/S0022-1759(98)00038-6; HANNA WL, 1993, PROTEIN EXPRES PURIF, V4, P398, DOI 10.1006/prep.1993.1052; HAYES MP, 1989, J EXP MED, V170, P933, DOI 10.1084/jem.170.3.933; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Hu D, 1999, CELL IMMUNOL, V195, P43, DOI 10.1006/cimm.1999.1513; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; KRAMER MD, 1987, IMMUNOL TODAY, V8, P140, DOI 10.1016/0167-5699(87)90141-1; Maki G, 2001, J HEMATOTH STEM CELL, V10, P369, DOI 10.1089/152581601750288975; Martinon F, 2007, EUR J IMMUNOL, V37, P3003, DOI 10.1002/eji.200737871; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; MASSON D, 1987, CELL, V49, P679, DOI 10.1016/0092-8674(87)90544-7; Menasche G, 2005, IMMUNOL REV, V203, P165, DOI 10.1111/j.0105-2896.2005.00224.x; Metkar SS, 2003, J CELL BIOL, V160, P875, DOI 10.1083/jcb.200210158; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Mullbacher A, 1996, P NATL ACAD SCI USA, V93, P5783, DOI 10.1073/pnas.93.12.5783; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; Pardo J, 2002, EUR J IMMUNOL, V32, P1980, DOI 10.1002/1521-4141(200207)32:7<1980::AID-IMMU1980>3.0.CO;2-Z; Raja SM, 2005, J BIOL CHEM, V280, P20752, DOI 10.1074/jbc.M501181200; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; SHIVER JW, 1992, CELL, V71, P315, DOI 10.1016/0092-8674(92)90359-K; SIMON MM, 1986, EMBO J, V5, P3267, DOI 10.1002/j.1460-2075.1986.tb04638.x; SIMON MM, 1993, CYTOTOXIC CELLS RECO, P278; Sower LE, 1996, CELL IMMUNOL, V171, P159, DOI 10.1006/cimm.1996.0187; Sower LE, 1996, J IMMUNOL, V156, P2585; van Dommelen SLH, 2006, IMMUNITY, V25, P835, DOI 10.1016/j.immuni.2006.09.010; Zhang D, 2003, BLOOD, V101, P226, DOI 10.1182/blood-2002-03-0791; Zhang D, 2001, J BIOL CHEM, V276, P3683, DOI 10.1074/jbc.M005390200	42	216	218	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					720	733		10.1016/j.immuni.2008.08.014	http://dx.doi.org/10.1016/j.immuni.2008.08.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	18951048	Bronze			2022-12-18	WOS:000261036000010
J	Steinman, RM				Steinman, Ralph M.			Dendritic cells in vivo: A key target for a new vaccine science	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; COMPLEX CLASS-I; CROSS-PRESENTATION; INNATE IMMUNITY; GASTROINTESTINAL-TRACT; ANTIGEN PRESENTATION; DEC-205 RECEPTOR; EPITHELIAL-CELLS; DENTRITIC CELLS; RETINOIC-ACID	Dendritic cells (DCs) are the antigen presenting cells that initiate and regulate immunity. By studying these cells in vivo, we will be able to move beyond standard approaches and design vaccines that directly harness the elaborate properties of DCs to control immunity.	[Steinman, Ralph M.] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10065 USA; [Steinman, Ralph M.] Chris Browne Ctr Immunol & Immune Dis, New York, NY 10065 USA	Rockefeller University	Steinman, RM (corresponding author), Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10065 USA.	steinma@mail.rockefeller.edu	Steinman, Ralph/F-7729-2012					Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dhodapkar KM, 2002, J EXP MED, V195, P125, DOI 10.1084/jem.20011097; Dhodapkar MV, 2002, P NATL ACAD SCI USA, V99, P13009, DOI 10.1073/pnas.202491499; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; DUBOS R, 1988, PASTEUR MODERN SCI; Dubsky P, 2007, EUR J IMMUNOL, V37, P1678, DOI 10.1002/eji.200636329; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kasturi SP, 2008, NAT IMMUNOL, V9, P461, DOI 10.1038/ni0508-461; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Liang S, 2008, P NATL ACAD SCI USA, V105, P8357, DOI 10.1073/pnas.0803341105; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; MacDonald KPA, 2005, J IMMUNOL, V174, P1841, DOI 10.4049/jimmunol.174.4.1841; Manavalan JS, 2003, TRANSPL IMMUNOL, V11, P245, DOI 10.1016/S0966-3274(03)00058-3; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shah JA, 2003, J EXP MED, V198, P281, DOI 10.1084/jem.20030645; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Sporri R, 2003, J IMMUNOL, V171, P6406, DOI 10.4049/jimmunol.171.12.6406; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Yang L, 2008, NAT BIOTECHNOL, V26, P326, DOI 10.1038/nbt1390	67	216	230	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 19	2008	29	3					319	324		10.1016/j.immuni.2008.08.001	http://dx.doi.org/10.1016/j.immuni.2008.08.001			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18799140	Bronze, Green Submitted			2022-12-18	WOS:000259708900001
J	Kanazawa, S; Okamoto, T; Peterlin, BM				Kanazawa, S; Okamoto, T; Peterlin, BM			Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BARE LYMPHOCYTE SYNDROME; ACCESSORY CELL-FUNCTION; TRANSACTIVATOR CIITA; MONOCYTIC CELLS; CYCLIN T1; IN-VITRO; COMPLEX; PROTEIN; TRANSCRIPTION	AIDS and the bare lymphocyte syndrome (BLS) are severe combined immunodeficiencies. BLS results from mutations in genes that regulate the expression of class II major histocompatibility (MHC II) determinants. One of these is the class II transactivator (CIITA). HIV and its transcriptional transactivator (Tat) also block the expression of MHC II genes. By binding to the same surface in the cyclin T1, which together with CDK9 forms the positive transcription elongation factor b (P-TEFb) complex, Tat inhibits CIITA. CIITA can also activate transcription when tethered artificially to RNA. Moreover, a dominant-negative CDK9 protein inhibits the activity of MHC II promoters. Thus, CIITA is a novel cellular coactivator that binds to P-TEFb for the expression of its target genes.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Nagoya City Univ, Sch Med, Dept Mol Genet, Nagoya, Aichi 467, Japan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Nagoya City University	Peterlin, BM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.	matija@itsa.ucsf.edu						AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BIENIASZ PD, 1999, P NATL ACAD SCI USA, V17, P7056; Brown JA, 1998, J ACQ IMMUN DEF SYND, V17, P9, DOI 10.1097/00042560-199801010-00002; CALMAN AF, 1988, P NATL ACAD SCI USA, V85, P8830, DOI 10.1073/pnas.85.23.8830; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; Douhan J, 1996, J EXP MED, V183, P1063, DOI 10.1084/jem.183.3.1063; ENNEN J, 1990, EUR J IMMUNOL, V20, P2451, DOI 10.1002/eji.1830201114; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Fontes JD, 1996, J EXP MED, V183, P2517, DOI 10.1084/jem.183.6.2517; Fontes JD, 1999, MOL CELL BIOL, V19, P941; Fujinaga K, 1999, P NATL ACAD SCI USA, V96, P1285, DOI 10.1073/pnas.96.4.1285; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; GELDERBLOM H, 1987, Z NATURFORSCH C, V42, P1328; Gold MO, 1998, NUCLEIC ACIDS RES, V26, P3784, DOI 10.1093/nar/26.16.3784; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; Hockett RD, 1999, J EXP MED, V189, P1545, DOI 10.1084/jem.189.10.1545; HOWCROFT TK, 1993, SCIENCE, V260, P1320, DOI 10.1126/science.8493575; Ivanov D, 1999, J MOL BIOL, V288, P41, DOI 10.1006/jmbi.1999.2663; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.biochem.63.1.717; KNIGHT S C, 1990, International Reviews of Immunology, V6, P163, DOI 10.3109/08830189009056627; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Kwak YT, 1999, J MOL BIOL, V288, P57, DOI 10.1006/jmbi.1999.2664; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; MACATONIA SE, 1992, IMMUNOLOGY, V75, P576; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; McMichael A, 1998, CELL, V93, P673, DOI 10.1016/S0092-8674(00)81428-2; Meltzer M S, 1992, Curr Top Microbiol Immunol, V181, P239; Miedema F, 1992, Immunodefic Rev, V3, P173; Miller DM, 1998, J EXP MED, V187, P675, DOI 10.1084/jem.187.5.675; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nagarajan UM, 1999, IMMUNITY, V10, P153, DOI 10.1016/S1074-7613(00)80016-3; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; PETIT AJC, 1988, J IMMUNOL, V140, P1485; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Polyak S, 1997, J IMMUNOL, V159, P2177; ROILIDES E, 1990, J PEDIATR-US, V117, P531, DOI 10.1016/S0022-3476(05)80684-5; Rosenberg ES, 1999, IMMUNOL LETT, V66, P89, DOI 10.1016/S0165-2478(98)00165-5; Rowland-Jones SL, 1999, IMMUNOL LETT, V66, P9, DOI 10.1016/S0165-2478(98)00179-5; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; SEDMAK DD, 1994, AM J PATHOL, V144, P683; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Shilatifard A, 1998, BIOL CHEM, V379, P27; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; GENES DEV, V6, P2077	61	216	224	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2000	12	1					61	70		10.1016/S1074-7613(00)80159-4	http://dx.doi.org/10.1016/S1074-7613(00)80159-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	278WL	10661406	Bronze			2022-12-18	WOS:000085011900007
J	Rast, JP; Anderson, MK; Strong, SJ; Luer, C; Litman, RT; Litman, GW				Rast, JP; Anderson, MK; Strong, SJ; Luer, C; Litman, RT; Litman, GW			alpha, beta, gamma and delta T cell antigen receptor genes arose early in vertebrate phylogeny	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CARTILAGINOUS FISH; CHAIN GENES; PRIMITIVE VERTEBRATE; IMMUNE-SYSTEM; RAJA-ERINACEA; SEQUENCE; ORGANIZATION; DIVERSIFICATION; IDENTIFICATION	A series of products were amplified using a PCR strategy based on short minimally degenerate primers and R. eglanteria (clearnose skate) spleen cDNA as template. These products were used as probes to select corresponding cDNAs from a spleen cDNA library. The cDNA sequences exhibit significant identity with prototypic alpha, beta, gamma, and delta T cell antigen receptor (TCR) genes. Characterization of cDNAs reveals extensive variable region diversity, putative diversity segments, and varying degrees of junctional diversification. This demonstrates expression of both alpha/beta and gamma/delta TCR genes at an early level of vertebrate phylogeny and indicates that the three major known classes of rearranging antigen receptors were present in the common ancestor of the present-day jawed vertebrates.	UNIV S FLORIDA,ALL CHILDRENS HOSP,DEPT PEDIAT,ST PETERSBURG,FL 33701; MOTE MARINE LAB,SARASOTA,FL 34236	State University System of Florida; University of South Florida; Mote Marine Laboratory & Aquarium				Anderson, Michele/0000-0002-8820-5910	NIAID NIH HHS [R37 AI23338] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023338] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMEMIYA CT, 1996, ANAL NONMAMMALIAN GE, P223; ANDERSON M, 1994, INT IMMUNOL, V6, P1661, DOI 10.1093/intimm/6.11.1661; ANDERSON MK, 1995, J EXP MED, V181, P109; Arden Bernhard, 1995, Immunogenetics, V42, P455; Arden Bernhard, 1995, Immunogenetics, V42, P501; BARTL S, 1994, P NATL ACAD SCI USA, V91, P10769, DOI 10.1073/pnas.91.23.10769; BARTL S, 1994, P NATL ACAD SCI USA, V91, P262, DOI 10.1073/pnas.91.1.262; BRUTLAG DL, 1990, COMPUT APPL BIOSCI, V6, P237; Carroll R. L., 1988, VERTEBRATE PALEONTOL; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; Clark Stephen P., 1995, Immunogenetics, V42, P531; DAVODEAU F, 1994, J EXP MED, V180, P1685, DOI 10.1084/jem.180.5.1685; Du Pasquier Louis, 1993, P199; FELLAH JS, 1993, P NATL ACAD SCI USA, V90, P6811, DOI 10.1073/pnas.90.14.6811; GOBEL TWF, 1994, P NATL ACAD SCI USA, V91, P1094, DOI 10.1073/pnas.91.3.1094; Greenberg AS, 1996, EUR J IMMUNOL, V26, P1123, DOI 10.1002/eji.1830260525; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Haire RN, 1996, J IMMUNOL, V157, P1544; HAIRE RN, 1994, HUM MOL GENET, V3, P897, DOI 10.1093/hmg/3.6.897; HAIRE RN, 1993, J EXP MED, V178, P825, DOI 10.1084/jem.178.3.825; HAIRE RN, 1990, J EXP MED, V171, P1721, DOI 10.1084/jem.171.5.1721; HARDING FA, 1990, NUCLEIC ACIDS RES, V18, P1015, DOI 10.1093/nar/18.4.1015; HARDING FA, 1990, NUCLEIC ACIDS RES, V18, P6369, DOI 10.1093/nar/18.21.6369; HASHIMOTO K, 1992, P NATL ACAD SCI USA, V89, P2209, DOI 10.1073/pnas.89.6.2209; Hawke NA, 1996, J IMMUNOL, V156, P2458; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Kandil E, 1996, J IMMUNOL, V156, P4245; KASAHARA M, 1993, EUR J IMMUNOL, V23, P2160, DOI 10.1002/eji.1830230917; KASAHARA M, 1992, P NATL ACAD SCI USA, V89, P6688, DOI 10.1073/pnas.89.15.6688; KOKUBU F, 1988, EMBO J, V7, P3413, DOI 10.1002/j.1460-2075.1988.tb03215.x; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; LITMAN GW, 1993, MOL BIOL EVOL, V10, P60; Luer C.A., 1989, P121; LUER CA, 1995, J EXP ZOOL, V273, P342, DOI 10.1002/jez.1402730408; MAKELA O, 1980, NATURE, V287, P639, DOI 10.1038/287639a0; PARTULA S, 1995, J IMMUNOL, V155, P699; RAST JP, 1994, IMMUNOGENETICS, V40, P83; RAST JP, 1995, IMMUNOGENETICS, V42, P204, DOI 10.1007/BF00191226; RAST JP, 1994, P NATL ACAD SCI USA, V91, P9248, DOI 10.1073/pnas.91.20.9248; RAYNAUD CA, 1989, CELL, V59, P171; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Schwartz F.J., 1986, P148; SHAMBLOTT MJ, 1989, EMBO J, V8, P3733, DOI 10.1002/j.1460-2075.1989.tb08549.x; SMITH LC, 1992, IMMUNOL TODAY, V13, P356, DOI 10.1016/0167-5699(92)90172-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TJOELKER LW, 1990, P NATL ACAD SCI USA, V87, P7856, DOI 10.1073/pnas.87.20.7856; ZAPATA AG, 1990, IMMUNE SYSTEM COMP H, P1	48	216	221	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1997	6	1					1	11		10.1016/S1074-7613(00)80237-X	http://dx.doi.org/10.1016/S1074-7613(00)80237-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB161	9052832	Bronze			2022-12-18	WOS:A1997XB16100001
J	Shi, JW; Hou, SY; Fang, Q; Liu, X; Liu, XL; Qi, H				Shi, Jingwen; Hou, Shiyue; Fang, Qian; Liu, Xin; Liu, Xiaolong; Qi, Hai			PD-1 Controls Follicular T Helper Cell Positioning and Function	IMMUNITY			English	Article							B-CELLS; ACTIVATION; GENERATION; EXPRESSION; INDUCTION; MOLECULE; T-HELPER-1; RESPONSES; DRIVEN; CTLA-4	Follicular T helper (Tfh) cells highly express the programmed cell death-1 (PD-1) molecule. Whereas inhibition of T cell receptor (TCR) signaling and CD28 co-stimulation is thought to be the primary mode of PD-1 functions, whether and how PD-1 regulates Tfh cell development and function is unclear. Here we showed that, when engaged by the ensemble of bystander B cells constitutively expressing PD-1 ligand 1 (PD-L1), PD-1 inhibited T cell recruitment into the follicle. This inhibition involved suppression of PI3K activities downstream of the follicle-guidance receptor CXCR5, was independent of co-signaling with the TCR, and necessitated ICOS signaling to overcome. PD-1 further restricted CXCR3 upregulation on Tfh cells, serving to concentrate these cells toward the germinal center territory, where PD-L1-PD-1 interactions between individual Tfh and B cells optimized B cell competition and affinity maturation. Therefore, operating in both costimulation- independent and -dependent manners, PD-1 controls tissue positioning and function of Tfh cells.	[Shi, Jingwen; Hou, Shiyue; Fang, Qian; Liu, Xin; Qi, Hai] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Shi, Jingwen; Hou, Shiyue; Fang, Qian; Liu, Xin; Qi, Hai] Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing 100084, Peoples R China; [Shi, Jingwen; Hou, Shiyue; Fang, Qian; Liu, Xin; Qi, Hai] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Shi, Jingwen; Fang, Qian; Qi, Hai] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Shi, Jingwen; Hou, Shiyue; Fang, Qian; Liu, Xin; Qi, Hai] Tsinghua Univ, Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China; [Liu, Xiaolong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol,Ctr Excellence Mol Cell S, Shanghai 200031, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Qi, H (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing 100084, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China.	qihai@tsinghua.edu.cn	Liu, Xin/R-1101-2019	Liu, Xin/0000-0002-6634-4012; Qi, Hai/0000-0001-5475-3989; Shi, Jingwen/0000-0002-4802-0727	Ministry of Science and Technology "973'' program [2014CB542501]; National Natural Science Foundation of China [81330070, 81425011, 81621002]; Tsinghua-Peking Center for Life Sciences; Bill AMP; Melinda Gates Foundation; Howard Hughes Medical Institute	Ministry of Science and Technology "973'' program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences; Bill AMP; Melinda Gates Foundation(CGIAR); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The authors thank Dr. P. Schwartzberg for providing the Sap<SUP>-/-</SUP> mice and Dr. Y.-C. Liu for the MSCV-LMP vector. This work was funded in part by the Ministry of Science and Technology "973'' program (grant no. 2014CB542501), National Natural Science Foundation of China (grant no. 81330070, 81425011, 81621002), and the Tsinghua-Peking Center for Life Sciences. This work was also funded in part by the Bill & Melinda Gates Foundation and the Howard Hughes Medical Institute. The findings and conclusions within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation or the Howard Hughes Medical Institute.	Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen X, 2015, PROTEIN CELL, V6, P825, DOI 10.1007/s13238-015-0210-0; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Hams E, 2011, J IMMUNOL, V186, P5648, DOI 10.4049/jimmunol.1003161; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Johnson RMG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00961; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kythreotou A, 2018, J CLIN PATHOL, V71, P189, DOI 10.1136/jclinpath-2017-204853; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu PW, 2017, SCIENCE, V356, DOI 10.1126/science.aai9264; McDonald PW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10285; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakajima C, 2002, EUR J IMMUNOL, V32, P1792, DOI 10.1002/1521-4141(200206)32:6<1792::AID-IMMU1792>3.0.CO;2-0; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Schneider H, 2005, P NATL ACAD SCI USA, V102, P12861, DOI 10.1073/pnas.0505802102; Schreiner B, 2004, J NEUROIMMUNOL, V155, P172, DOI 10.1016/j.jneuroim.2004.06.013; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Suan D, 2015, IMMUNITY, V42, P704, DOI 10.1016/j.immuni.2015.03.002; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Wang P, 2016, J IMMUNOL, V197, P1169, DOI 10.4049/jimmunol.1600411; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Xiao G, 2012, P NATL ACAD SCI USA, V109, P15419, DOI 10.1073/pnas.1206370109; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	56	215	227	9	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					264	+		10.1016/j.immuni.2018.06.012	http://dx.doi.org/10.1016/j.immuni.2018.06.012			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30076099	Green Published, hybrid			2022-12-18	WOS:000442354500012
J	Steichen, JM; Kulp, DW; Tokatlian, T; Escolano, A; Dosenovic, P; Stanfield, RL; McCoy, LE; Ozorowski, G; Hu, XZ; Kalyuzhniy, O; Briney, B; Schiffner, T; Garces, F; Freund, NT; Gitlin, AD; Menis, S; Georgeson, E; Kubitz, M; Adachi, Y; Jones, M; Mutafyan, AA; Yun, DS; Mayer, CT; Ward, AB; Burton, DR; Wilson, IA; Irvine, DJ; Nussenzweig, MC; Schief, WR				Steichen, Jon M.; Kulp, Daniel W.; Tokatlian, Talar; Escolano, Amelia; Dosenovic, Pia; Stanfield, Robyn L.; McCoy, Laura E.; Ozorowski, Gabriel; Hu, Xiaozhen; Kalyuzhniy, Oleksandr; Briney, Bryan; Schiffner, Torben; Garces, Fernando; Freund, Natalia T.; Gitlin, Alexander D.; Menis, Sergey; Georgeson, Erik; Kubitz, Michael; Adachi, Yumiko; Jones, Meaghan; Mutafyan, Andrew A.; Yun, Dong Soo; Mayer, Christian T.; Ward, Andrew B.; Burton, Dennis R.; Wilson, Ian A.; Irvine, Darrell J.; Nussenzweig, Michel C.; Schief, William R.			HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies	IMMUNITY			English	Article							MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; IMMUNOGEN DESIGN; B-CELLS; POTENT; RECOGNITION; EVOLUTION; IMMUNIZATION; FRAMEWORK; AFFINITY	Broadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) trimer are the most common bnAbs induced during infection, making them promising leads for vaccine design. Wild-type Env glycoproteins lack detectable affinity for supersite-bnAb germline precursors and are therefore unsuitable immunogens to prime supersite-bnAb responses. We employed mammalian cell surface display to design stabilized Env trimers with affinity for germline-reverted precursors of PGT121-class supersite bnAbs. The trimers maintained native-like antigenicity and structure, activated PGT121 inferred-germline B cells ex vivo when multimerized on liposomes, and primed PGT121-like responses in PGT121 inferred-germline knockin mice. Design intermediates have levels of epitope modification between wild-type and germline-targeting trimers; their mutation gradient suggests sequential immunization to induce bnAbs, in which the germline- targeting prime is followed by progressively less-mutated design intermediates and, lastly, with native trimers. The vaccine design strategies described could be utilized to target other epitopes on HIV or other pathogens.	[Steichen, Jon M.; Kulp, Daniel W.; McCoy, Laura E.; Hu, Xiaozhen; Kalyuzhniy, Oleksandr; Briney, Bryan; Schiffner, Torben; Menis, Sergey; Georgeson, Erik; Kubitz, Michael; Adachi, Yumiko; Jones, Meaghan; Burton, Dennis R.; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Steichen, Jon M.; Kulp, Daniel W.; Stanfield, Robyn L.; McCoy, Laura E.; Ozorowski, Gabriel; Hu, Xiaozhen; Kalyuzhniy, Oleksandr; Briney, Bryan; Schiffner, Torben; Garces, Fernando; Menis, Sergey; Georgeson, Erik; Kubitz, Michael; Adachi, Yumiko; Jones, Meaghan; Ward, Andrew B.; Burton, Dennis R.; Wilson, Ian A.; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Steichen, Jon M.; Kulp, Daniel W.; Stanfield, Robyn L.; McCoy, Laura E.; Ozorowski, Gabriel; Hu, Xiaozhen; Kalyuzhniy, Oleksandr; Briney, Bryan; Schiffner, Torben; Garces, Fernando; Menis, Sergey; Georgeson, Erik; Kubitz, Michael; Adachi, Yumiko; Jones, Meaghan; Ward, Andrew B.; Burton, Dennis R.; Wilson, Ian A.; Schief, William R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Tokatlian, Talar; Mutafyan, Andrew A.; Yun, Dong Soo; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Escolano, Amelia; Dosenovic, Pia; Freund, Natalia T.; Gitlin, Alexander D.; Mayer, Christian T.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Stanfield, Robyn L.; Ozorowski, Gabriel; Garces, Fernando; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Burton, Dennis R.; Irvine, Darrell J.; Schief, William R.] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Irvine, Darrell J.; Nussenzweig, Michel C.; Schief, William R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Massachusetts Institute of Technology (MIT); Rockefeller University; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Scripps Research Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Schief, WR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Schief, WR (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.; Schief, WR (corresponding author), Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; Schief, WR (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA.; Nussenzweig, MC (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	nussen@mail.rockefeller.edu; schief@scripps.edu	Schief, William/ABF-3645-2020; Ward, Andrew/ABD-7728-2021; Ozorowski, Gabriel/HCH-0634-2022; Stanfield, Robyn/AAH-3190-2019; Ward, Andrew B/F-9203-2014; Nussenzweig, Michel/AAE-7292-2019; Dosenovic, Pia/S-6894-2018	Schief, William/0000-0002-1120-0150; Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Dosenovic, Pia/0000-0002-0426-4586; Kalyuzhniy, Oleksandr/0000-0002-5273-1951; Gitlin, Alexander/0000-0002-9229-0919; McCoy, Laura/0000-0001-9503-7946	National Institute of Allergy and Infectious Diseases [CHAVI-ID 1UM1AI100663, P01 AI110657, R01 AI084817]; Ragon Institute of MGH; Harvard; Internation AIDS Vaccine Initiative (IAVI); United States Agency for International Development; Ministry of Foreign Affairs of the Netherlands; Bill AMP; Melinda Gates Foundation; DOE Office of Biological and Environmental Research; NIH; National Institute of General Medical Sciences [P41GM103393]; MIT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113867, T32AI007244, UM1AI100663, P01AI100148, P01AI110657, R01AI084817, R56AI084817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, T32GM007739] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ragon Institute of MGH; Harvard; Internation AIDS Vaccine Initiative (IAVI); United States Agency for International Development(United States Agency for International Development (USAID)); Ministry of Foreign Affairs of the Netherlands; Bill AMP; Melinda Gates Foundation; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MIT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Takayuki Ota and David Nemazee for providing lentivirus protocols and reagents and Leo Stamatatos and Jean-Philippe Julien for comments on the manuscript. This work was supported by National Institute of Allergy and Infectious Diseases grants CHAVI-ID 1UM1AI100663 (to W.R.S., D.J.I., M.C.N., I.A.W., D.R.B., and A.B.W.), P01 AI110657 (to I.A.W.), and R01 AI084817 (to I.A.W.) and by the Ragon Institute of MGH, MIT, and Harvard (to D.R.B., D.J.I., and W.R.S.). This work was also partially funded by the Internation AIDS Vaccine Initiative (IAVI) with the generous support of the United States Agency for International Development, the Ministry of Foreign Affairs of the Netherlands, and the Bill & Melinda Gates Foundation; a full list of IAVI donors is available at www.iavi.org (W.R.S., D.R.B, A.B.W., and I.A.W.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a directorate of the SLAC National Accelerator Laboratory, and an Office of Science user facility operated for the U.S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, the NIH, and the National Institute of General Medical Sciences (including P41GM103393). The Scripps Research Institute and IAVI have filed for a patent related to immunogens in this manuscript, with inventors J.M.S., D.W.K., X.H., S.M., and W.R.S. Materials and information will be provided under a material transfer agreement. W.R.S. is a co-founder and stockholder in Compuvax, which has programs in non-HIV vaccine design that might benefit indirectly from this research.	Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Chen KC, 2008, CHEM BIOL, V15, P1277, DOI 10.1016/j.chembiol.2008.10.008; de Taeye SW, 2016, TRENDS IMMUNOL, V37, P221, DOI 10.1016/j.it.2016.01.007; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Georgiev IS, 2014, J IMMUNOL, V192, P1100, DOI 10.4049/jimmunol.1302515; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Gorny MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027780; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Hu JK, 2015, J VIROL, V89, P10383, DOI 10.1128/JVI.01653-15; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005815; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Ota T, 2012, J IMMUNOL, V189, P4816, DOI 10.4049/jimmunol.1202165; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Quan JY, 2014, METHODS MOL BIOL, V1116, P103, DOI 10.1007/978-1-62703-764-8_8; Salmon P, 2007, CURRENT PROTOCOLS HU; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scharf L, 2015, CELL, V162, P1379, DOI 10.1016/j.cell.2015.08.035; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	59	215	224	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					483	496		10.1016/j.immuni.2016.08.016	http://dx.doi.org/10.1016/j.immuni.2016.08.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27617678	Green Published, hybrid			2022-12-18	WOS:000388454300008
J	Huttenhower, C; Kostic, AD; Xavier, RJ				Huttenhower, Curtis; Kostic, Aleksandar D.; Xavier, Ramnik J.			Inflammatory Bowel Disease as a Model for Translating the Microbiome	IMMUNITY			English	Review							CROHNS-DISEASE; GUT MICROBIOTA; ULCERATIVE-COLITIS; FECAL MICROBIOTA; INTESTINAL INFLAMMATION; HOST GENETICS; MOUSE MODEL; COMMENSAL; PATHOGENESIS; BACTERIA	The inflammatory bowel diseases (IBDs) are among the most closely studied chronic inflammatory disorders that involve environmental, host genetic, and commensal microbial factors. This combination of features has made IBD both an appropriate and a high-priority platform for translatable research in host-microbiome interactions. Decades of epidemiology have identified environmental risk factors, although most mechanisms of action remain unexplained. The genetic architecture of IBD has been carefully dissected in multiple large populations, identifying several responsible host epithelial and immune pathways but without yet a complete systems-level explanation. Most recently, the commensal gut microbiota have been found to be both ecologically and functionally perturbed during the disease, but with as-yet-unexplained heterogeneity among IBD subtypes and individual patients. IBD thus represents perhaps the most comprehensive current model for understanding the human microbiome's role in complex inflammatory disease. Here, we review the influences of the microbiota on IBD and its potential for translational medicine.	[Huttenhower, Curtis; Kostic, Aleksandar D.; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Huttenhower, Curtis; Kostic, Aleksandar D.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Huttenhower, Curtis; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Huttenhower, Curtis; Kostic, Aleksandar D.; Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Kostic, Aleksandar D.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Huttenhower, C (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	chuttenh@hsph.harvard.edu; xavier@molbio.mgh.harvard.edu		Kostic, Aleksandar/0000-0002-0837-4360	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U54DE023798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, R01DK092405, U54DK102557] Funding Source: NIH RePORTER; NIDCR NIH HHS [U54 DE023798] Funding Source: Medline; NIDDK NIH HHS [U54 DK102557, R01 DK092405, P30 DK043351] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Ananthakrishnan AN, 2014, INFLAMM BOWEL DIS, V20, P783, DOI 10.1097/MIB.0000000000000014; Andoh A, 2007, INFLAMM BOWEL DIS, V13, P955, DOI 10.1002/ibd.20151; Aroniadis OC, 2013, CURR OPIN GASTROEN, V29, P79, DOI 10.1097/MOG.0b013e32835a4b3e; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; BERNSTEIN LH, 1980, GASTROENTEROLOGY, V79, P357; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; COOKE EM, 1969, GUT, V10, P565, DOI 10.1136/gut.10.7.565; COOKE EM, 1967, J PATHOL BACTERIOL, V94, P439, DOI 10.1002/path.1700940225; Dasgupta S, 2013, INFLAMM BOWEL DIS, V19, P2478, DOI 10.1097/MIB.0b013e318297d884; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; DuPont AW, 2011, NAT REV GASTRO HEPAT, V8, P523, DOI 10.1038/nrgastro.2011.133; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gajer P., 2012, SCI TRANSL MED, V4; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; GORBACH SL, 1968, GASTROENTEROLOGY, V54, P575; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Iacucci M, 2010, CAN J GASTROENTEROL, V24, P127, DOI 10.1155/2010/586092; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kamm MA, 2004, ALIMENT PHARM THERAP, V20, P102, DOI 10.1111/j.1365-2036.2004.02052.x; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim SC, 2007, INFLAMM BOWEL DIS, V13, P1457, DOI 10.1002/ibd.20246; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Leone V, 2013, J GASTROENTEROL, V48, P315, DOI 10.1007/s00535-013-0777-2; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026542; Lichtman JS, 2013, MOL CELL PROTEOMICS, V12, P3310, DOI 10.1074/mcp.M113.029967; Lu K, 2012, J PROTEOME RES, V11, P4916, DOI 10.1021/pr300429x; MALLORY A, 1973, GASTROENTEROLOGY, V64, P34; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McHardy IH, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-17; McNulty NP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001637; Michail S, 2012, INFLAMM BOWEL DIS, V18, P1799, DOI 10.1002/ibd.22860; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Narushima S., 2014, GUT MICROBES; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ooi M, 2011, INFLAMM RES, V60, P831, DOI 10.1007/s00011-011-0340-7; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; PEPPERCORN MA, 1972, J PHARMACOL EXP THER, V181, P555; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Peyrin-Biroulet L, 2013, NAT REV GASTRO HEPAT, V10, P345, DOI 10.1038/nrgastro.2013.31; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Presley LL, 2012, INFLAMM BOWEL DIS, V18, P409, DOI 10.1002/ibd.21793; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rath HC, 2001, INFECT IMMUN, V69, P2277, DOI 10.1128/IAI.69.4.2277-2285.2001; Rivera-Nieves J, 2003, GASTROENTEROLOGY, V124, P972, DOI 10.1053/gast.2003.50148; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; RUTGEERTS P, 1995, GASTROENTEROLOGY, V108, P1617, DOI 10.1016/0016-5085(95)90121-3; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; SARTOR RB, 1990, CAN J GASTROENTEROL, V4, P271; Sasai M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003380; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; SENECA H, 1950, GASTROENTEROLOGY, V15, P34, DOI 10.1016/S0016-5085(50)80058-6; Sha S, 2014, ALIMENT PHARM THER, V39, P1003, DOI 10.1111/apt.12699; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smits LP, 2013, GASTROENTEROLOGY, V145, P946, DOI 10.1053/j.gastro.2013.08.058; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Tickle TL, 2013, ISME J, V7, P2330, DOI 10.1038/ismej.2013.139; Tyler AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066934; VINCE A, 1972, J MED MICROBIOL, V5, P219, DOI 10.1099/00222615-5-2-219; WEINSTEIN L, 1961, GASTROENTEROLOGY, V40, P323; WENSINCK F, 1981, J HYG-CAMBRIDGE, V87, P1, DOI 10.1017/S0022172400069187; WEST B, 1974, GUT, V15, P960, DOI 10.1136/gut.15.12.960; Whelan K, 2013, CURR OPIN GASTROEN, V29, P184, DOI 10.1097/MOG.0b013e32835d7bba; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	116	215	224	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					843	854		10.1016/j.immuni.2014.05.013	http://dx.doi.org/10.1016/j.immuni.2014.05.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24950204	Green Accepted, Bronze			2022-12-18	WOS:000341440200004
J	Dudda, JC; Salaun, B; Ji, Y; Palmer, DC; Monnot, GC; Merck, E; Boudousquie, C; Utzschneider, DT; Escobar, TM; Perret, R; Muljo, SA; Hebeisen, M; Rufer, N; Zehn, D; Donda, A; Restifo, NP; Held, W; Gattinoni, L; Romero, P				Dudda, Jan C.; Salaun, Bruno; Ji, Yun; Palmer, Douglas C.; Monnot, Gwennaelle C.; Merck, Estelle; Boudousquie, Caroline; Utzschneider, Daniel T.; Escobar, Thelma M.; Perret, Rachel; Muljo, Stefan A.; Hebeisen, Michael; Rufer, Nathalie; Zehn, Dietmar; Donda, Alena; Restifo, Nicholas P.; Held, Werner; Gattinoni, Luca; Romero, Pedro			MicroRNA-155 Is Required for Effector CD8(+) T Cell Responses to Virus Infection and Cancer	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; IMMUNE-SYSTEM; CYTOKINE SIGNALING-1; B-CELL; DIFFERENTIATION; EXPRESSION; ANTIGEN; MEMORY; PERSISTENCE; ACTIVATION	MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8(+) T cell immunity remains unknown. Here we report that miRNA-155 is required for CD8(+) T cell responses to both virus and cancer. In the absence of miRNA-155, accumulation of effector CD8(+) T cells was severely reduced during acute and chronic viral infections and control of virus replication was impaired. Similarly, Mir155(-/-) CD8(+) T cells were ineffective at controlling tumor growth, whereas miRNA-155 overexpression enhanced the antitumor response. miRNA-155 deficiency resulted in accumulation of suppressor of cytokine signaling-1 (SOCS-1) causing defective cytokine signaling through STAT5. Consistently, enforced expression of SOCS-1 in CD8(+) T cells phenocopied the miRNA-155 deficiency, whereas SOCS-1 silencing augmented tumor destruction. These findings identify miRNA-155 and its target SOCS-1 as key regulators of effector CD8(+) T cells that can be modulated to potentiate immunotherapies for infectious diseases and cancer.	[Dudda, Jan C.; Salaun, Bruno; Monnot, Gwennaelle C.; Merck, Estelle; Boudousquie, Caroline; Perret, Rachel; Hebeisen, Michael; Rufer, Nathalie; Donda, Alena; Held, Werner; Romero, Pedro] Univ Lausanne, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland; [Ji, Yun; Palmer, Douglas C.; Restifo, Nicholas P.; Gattinoni, Luca] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Escobar, Thelma M.; Muljo, Stefan A.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Utzschneider, Daniel T.; Zehn, Dietmar] Univ Lausanne Hosp, Swiss Vaccine Res Inst, CH-1011 Lausanne, Switzerland; [Hebeisen, Michael; Rufer, Nathalie] Univ Lausanne Hosp, Dept Res, CH-1011 Lausanne, Switzerland	University of Lausanne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Romero, P (corresponding author), Univ Lausanne, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland.	pedro.romero@unil.ch	Romero, Pedro/S-6015-2017; Utzschneider, Daniel/D-5855-2016; Gattinoni, Luca/A-2281-2008; Ji, Yun/B-7245-2009; Utzschneider, Daniel/E-2563-2013; Restifo, Nicholas Phillip/M-6549-2019; Waldmann, Thomas/AAT-5972-2021; Perret, Rachel/AAI-8391-2020; Monnot, Gwennaelle C/AAN-6166-2020; Muljo, Stefan A/F-5671-2015; Palmer, Douglas/B-9454-2008; Restifo, Nicholas Phillip/Z-1614-2019	Romero, Pedro/0000-0002-9688-2882; Utzschneider, Daniel/0000-0003-2205-9057; Gattinoni, Luca/0000-0003-2239-3282; Ji, Yun/0000-0001-6340-7009; Waldmann, Thomas/0000-0003-4500-6660; Monnot, Gwennaelle C/0000-0003-1084-3450; Muljo, Stefan A/0000-0003-1013-446X; Palmer, Douglas/0000-0001-5018-5734; Perret, Rachel/0000-0003-1225-5097; Escobar, Thelma/0000-0001-5352-3903; Restifo, Nicholas P./0000-0003-4229-4580	MEDIC Foundation; New Zealand Foundation for Research, Science and Technology; Swiss National Science Foundation (SNSF); US NIH National Cancer Institute, Center for Cancer Research; NIH National Institute of Allergy and Infectious Diseases; NATIONAL CANCER INSTITUTE [ZIABC011480, ZIABC010763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001131] Funding Source: NIH RePORTER	MEDIC Foundation; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); US NIH National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Labes for technical assistance and I. Luescher for providing tetramers. We also thank P. Martiat and B. Badran for critical input. J. C. D. and B. S. were supported in part by a grant from the MEDIC Foundation, R. P. by New Zealand Foundation for Research, Science and Technology, W. H. and C. B. by the Swiss National Science Foundation (SNSF). G. C. M., D. Z., and P. R. were supported in part by a Prodoc and a Sinergia grants from the SNSF. Y. J., D. C. P., N. P. R. and L. G. were supported by the Intramural Research Programs of the US NIH National Cancer Institute, Center for Cancer Research. T. M. E. and S. A. M. were supported by the Intramural Research Program of the NIH National Institute of Allergy and Infectious Diseases.	Almanza G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011243; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Cornish AL, 2003, J BIOL CHEM, V278, P22755, DOI 10.1074/jbc.M303021200; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Davey GM, 2005, J EXP MED, V202, P1099, DOI 10.1084/jem.20050003; Decaluwe H, 2010, P NATL ACAD SCI USA, V107, P9311, DOI 10.1073/pnas.0913729107; Derre L, 2008, P NATL ACAD SCI USA, V105, P15010, DOI 10.1073/pnas.0807954105; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Salaun B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-44; SALVATO M, 1991, J VIROL, V65, P1863, DOI 10.1128/JVI.65.4.1863-1869.1991; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Schmid DA, 2010, J IMMUNOL, V184, P4936, DOI 10.4049/jimmunol.1000173; Seki Y, 2007, J IMMUNOL, V178, P262, DOI 10.4049/jimmunol.178.1.262; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Turner M, 2008, BIOCHEM SOC T, V36, P531, DOI 10.1042/BST0360531; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zhang N, 2010, P NATL ACAD SCI USA, V107, P21629, DOI 10.1073/pnas.1016299107	57	215	238	3	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					742	753		10.1016/j.immuni.2012.12.006	http://dx.doi.org/10.1016/j.immuni.2012.12.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23601686	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000330942100016
J	Yamamoto, M; Okuyama, M; Ma, JS; Kimura, T; Kamiyama, N; Saiga, H; Ohshima, J; Sasai, M; Kayama, H; Okamoto, T; Huang, DCS; Soldati-Favre, D; Horie, K; Takeda, J; Takeda, K				Yamamoto, Masahiro; Okuyama, Megumi; Ma, Ji Su; Kimura, Taishi; Kamiyama, Naganori; Saiga, Hiroyuki; Ohshima, Jun; Sasai, Miwa; Kayama, Hisako; Okamoto, Toru; Huang, David C. S.; Soldati-Favre, Dominique; Horie, Kyoji; Takeda, Junji; Takeda, Kiyoshi			A Cluster of Interferon-gamma-Inducible p65 GTPases Plays a Critical Role in Host Defense against Toxoplasma gondii	IMMUNITY			English	Article							IMMUNITY-RELATED GTPASES; NECROSIS-FACTOR-ALPHA; INTRACELLULAR PATHOGENS; INNATE RESISTANCE; NITRIC-OXIDE; P47 GTPASES; L-ARGININE; TNF-ALPHA; VIRULENCE; MACROPHAGES	Interferon-gamma (IFN-gamma) is essential for host defense against intracellular pathogens. Stimulation of innate immune cells by IFN-gamma upregulates similar to 2,000 effector genes such as immunity-related GTPases including p65 guanylate-binding protein (Gbp) family genes. We show that a cluster of Gbp genes was required for host cellular immunity against the intracellular parasite Toxoplasma gondii. We generated mice deficient for all six Gbp genes located on chromosome 3 (Gbp(chr3)) by targeted chromosome engineering. Mice lacking Gbp(chr3) were highly susceptible to T. gondii infection, resulting in increased parasite burden in immune organs. Furthermore, Gbp(chr3)-deleted macrophages were defective in IFN-gamma-mediated suppression of T. gondii intracellular growth and recruitment of IFN-gamma-inducible p47 GTPase Irgb6 to the parasitophorous vacuole. In addition, some members of Gbp(chr3) restored the protective response against T. gondii in Gbp(chr3)-deleted cells. Our results suggest that Gbp(chr3) play a pivotal role in anti-T. gondii host defense by controlling IFN-gamma-mediated Irgb6-dependent cellular innate immunity.	[Yamamoto, Masahiro; Okuyama, Megumi; Ma, Ji Su; Kimura, Taishi; Kamiyama, Naganori; Saiga, Hiroyuki; Ohshima, Jun; Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Suita, Osaka 5650871, Japan; [Yamamoto, Masahiro; Ma, Ji Su; Kimura, Taishi; Kamiyama, Naganori; Ohshima, Jun; Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, Lab Mucosal Immunol, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Yamamoto, Masahiro; Ma, Ji Su; Kamiyama, Naganori; Ohshima, Jun] Osaka Univ, Lab Immunoparasitol, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Yamamoto, Masahiro; Ma, Ji Su; Kamiyama, Naganori; Ohshima, Jun; Sasai, Miwa] Osaka Univ, Dept Immunoparasitol, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Okamoto, Toru] Osaka Univ, Dept Mol Virol, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Horie, Kyoji; Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; [Yamamoto, Masahiro; Kayama, Hisako; Takeda, Kiyoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Okamoto, Toru; Huang, David C. S.] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Soldati-Favre, Dominique] Univ Geneva, CMU, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland; [Okamoto, Toru] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST); University of Melbourne; Walter & Eliza Hall Institute; University of Geneva; University of Melbourne	Yamamoto, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Suita, Osaka 5650871, Japan.	myamamoto@biken.osaka-u.ac.jp; ktakeda@ongene.med.osaka-u.ac.jp	Huang, David C. S./C-7586-2013; Takeda, Kiyoshi/C-9331-2009	Huang, David C. S./0000-0002-3101-4873; Sasai, Miwa/0000-0001-6440-3958; Horie, Kyoji/0000-0001-9036-8180; Takeda, Kiyoshi/0000-0002-1778-6332; Soldati-Favre, Dominique/0000-0003-4156-2109	Ministry of Education, Culture, Sports, Science and Technology; Kanae Foundation for the Promotion of Medical Science; Cell Science Research Foundation; Kato Memorial Bioscience Foundation; Uehara Memorial Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Waksman Foundation of Japan Inc.; Senri Life Science Foundation; Tokyo Biochemical Research Foundation; Research Foundation for Microbial Diseases of Osaka University; Nakajima Foundation; Asahi Glass Foundation; Osaka Foundation for Promotion of Clinical Immunology; Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kanae Foundation for the Promotion of Medical Science; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Kato Memorial Bioscience Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Waksman Foundation of Japan Inc.(Waksman Foundation of Japan Inc.); Senri Life Science Foundation; Tokyo Biochemical Research Foundation; Research Foundation for Microbial Diseases of Osaka University; Nakajima Foundation; Asahi Glass Foundation; Osaka Foundation for Promotion of Clinical Immunology; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	We thank C. Hidaka for excellent secretarial assistance, Y. Magota and M. Enomoto for technical assistance, and members of K.T.'s lab for discussions. Rabbit anti-Irgb6 and Irgb10 and mouse anti-Irgm3 were kindly provided by J.C. Howard. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology; Kanae Foundation for the Promotion of Medical Science; The Cell Science Research Foundation; Kato Memorial Bioscience Foundation; The Uehara Memorial Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; The Waksman Foundation of Japan Inc.; Senri Life Science Foundation; The Tokyo Biochemical Research Foundation; The Research Foundation for Microbial Diseases of Osaka University; The Nakajima Foundation; The Asahi Glass Foundation; and The Osaka Foundation for Promotion of Clinical Immunology. M.Y. and D.S.-F. are supported by the Japanese-Swiss bilateral program of The Strategic International Cooperative Program (Research Exchange Type), the Japan Science and Technology Agency (JST).	ADAMS LB, 1990, J IMMUNOL, V144, P2725; Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Boothroyd JC, 2009, INT J PARASITOL, V39, P935, DOI 10.1016/j.ijpara.2009.02.003; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Deretic V, 2006, CURR OPIN IMMUNOL, V18, P375, DOI 10.1016/j.coi.2006.05.019; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gorbacheva VY, 2002, J BIOL CHEM, V277, P6080, DOI 10.1074/jbc.M110542200; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; HUNTER CA, 1995, IMMUNOLOGY, V84, P16; Hunter CA, 1995, RES IMMUNOL, V146, P546, DOI 10.1016/0923-2494(96)83030-6; ISRAELSKI DM, 1993, CLIN INFECT DIS, V17, pS423, DOI 10.1093/clinids/17.Supplement_2.S423; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Keller CW, 2011, J BIOL CHEM, V286, P3970, DOI 10.1074/jbc.M110.159392; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kresse A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-158; LANGERMANS JAM, 1992, J IMMUNOL, V148, P568; LEENEN PJM, 1994, J IMMUNOL, V153, P5141; Li M, 2011, J EXP MED, V208, P2657, DOI 10.1084/jem.20111102; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Montoya JG, 2008, CLIN INFECT DIS, V47, P554, DOI 10.1086/590149; Nguyen TD, 2003, J MED MICROBIOL, V52, P869, DOI 10.1099/jmm.0.04860-0; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; SIBLEY LD, 1991, J IMMUNOL, V147, P2340; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Taylor GA, 2007, MICROBES INFECT, V9, P1644, DOI 10.1016/j.micinf.2007.09.004; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Traver MK, 2011, J BIOL CHEM, V286, P30471, DOI 10.1074/jbc.M111.251967; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Virreira Winter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024434; Whitmarsh RJ, 2011, CELL HOST MICROBE, V10, P224, DOI 10.1016/j.chom.2011.07.009; Yamamoto M, 2011, J EXP MED, V208, P1533, DOI 10.1084/jem.20101660; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yarovinsky F, 2006, INT J PARASITOL, V36, P255, DOI 10.1016/j.ijpara.2005.12.003; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	50	215	221	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 24	2012	37	2					302	313		10.1016/j.immuni.2012.06.009	http://dx.doi.org/10.1016/j.immuni.2012.06.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22795875	Bronze, Green Accepted			2022-12-18	WOS:000308261800014
J	Zhang, ZK; Ohto, U; Shibata, T; Krayukhina, E; Taoka, M; Yamauchi, Y; Tanji, H; Isobe, T; Uchiyama, S; Miyake, K; Shimizu, T				Zhang, Zhikuan; Ohto, Umeharu; Shibata, Takuma; Krayukhina, Elena; Taoka, Masato; Yamauchi, Yoshio; Tanji, Hiromi; Isobe, Toshiaki; Uchiyama, Susumu; Miyake, Kensuke; Shimizu, Toshiyuki			Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; LEUCINE-RICH REPEATS; PROTEOLYTIC CLEAVAGE; RECOGNITION; ACTIVATION; TLR4; TOLL-LIKE-RECEPTOR-7; LIPOPOLYSACCHARIDE; RESPONSIVENESS; INTERFERON	Toll-like receptor 7 (TLR7) is a single-stranded RNA (ssRNA) sensor in innate immunity and also responds to guanosine and chemical ligands, such as imidazoquinoline compounds. However, TLR7 activation mechanism by these ligands remain largely unknown. Here, we generated crystal structures of three TLR7 complexes, and found that all formed an activated m-shaped dimer with two ligand-binding sites. The first site conserved in TLR7 and TLR8 was used for small ligand-binding essential for its activation. The second site spatially distinct from that of TLR8 was used for a ssRNA-binding that enhanced the affinity of the first-site ligands. The first site preferentially recognized guanosine and the second site specifically bound to uridine moieties in ssRNA. Our structural, biochemical, and mutagenesis studies indicated that TLR7 is a dual receptor for guanosine and uridine-containing ssRNA. Our findings have important implications for understanding of TLR7 function, as well as for therapeutic manipulation of TLR7 activation.	[Zhang, Zhikuan; Ohto, Umeharu; Tanji, Hiromi; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Shibata, Takuma; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Div Innate Immun, Dept Microbiol & Immunol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Krayukhina, Elena; Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Taoka, Masato; Yamauchi, Yoshio; Isobe, Toshiaki] Tokyo Metropolitan Univ, Grad Sch Sci & Technol, Dept Chem, Minami Osawa 1-1, Hachioji, Tokyo 1920397, Japan; [Uchiyama, Susumu] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan	University of Tokyo; University of Tokyo; Osaka University; Tokyo Metropolitan University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Shimizu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp	UCHIYAMA, Susumu/F-9590-2017; Isobe, Toshiaki/Q-9279-2017; Shibata, Takuma/M-8196-2019	UCHIYAMA, Susumu/0000-0002-5181-179X; 	Japanese Ministry of Education, Culture, Sports, Science, and Technology; CREST, JST; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiichi Sankyo Foundation of Life Science	We thank the beamline staff members at Photon Factory and SPring- 8 for their assistance with data collection. This work was supported by a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (U.O., T. Shibata, S.U., K.M., and T. Shimizu.); CREST, JST, (T. Shibata, T. Shimizu, T. I.); the Takeda Science Foundation (U.O. and T. Shimizu.); the Mochida Memorial Foundation for Medical and Pharmaceutical Research (U.O.); and the Daiichi Sankyo Foundation of Life Science (U.O.). The data presented in this manuscript are tabulated in and the Supplemental Information. The coordinates and structure-factor data have been deposited in the Protein Data Bank.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Diebold SS, 2006, EUR J IMMUNOL, V36, P3256, DOI 10.1002/eji.200636617; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hipp MM, 2013, IMMUNITY, V39, P711, DOI 10.1016/j.immuni.2013.09.004; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ishii N, 2014, J IMMUNOL, V193, P5118, DOI 10.4049/jimmunol.1401375; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanno A, 2013, INT IMMUNOL, V25, P413, DOI 10.1093/intimm/dxt007; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Otwinowski Z, 1997, METHODS ENZYMOL, V276, P307; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Santiago-Raber ML, 2009, J AUTOIMMUN, V33, P231, DOI 10.1016/j.jaut.2009.10.001; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Shibata T., 2015, INT IMMUNOL; Song DH, 2012, IMMUNOL REV, V250, P216, DOI 10.1111/j.1600-065X.2012.01167.x; Song W, 2015, NAT STRUCT MOL BIOL, V22, P782, DOI 10.1038/nsmb.3080; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanji H, 2016, P NATL ACAD SCI USA, V113, P3012, DOI 10.1073/pnas.1516000113; Tanji H, 2015, NAT STRUCT MOL BIOL, V22, P109, DOI 10.1038/nsmb.2943; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Taoka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp732; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860	44	214	244	9	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					737	748		10.1016/j.immuni.2016.09.011	http://dx.doi.org/10.1016/j.immuni.2016.09.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27742543	Bronze			2022-12-18	WOS:000389473200008
J	Montecino-Rodriguez, E; Dorshkind, K				Montecino-Rodriguez, Encarnacion; Dorshkind, Kenneth			B-1 B Cell Development in the Fetus and Adult	IMMUNITY			English	Review							HEMATOPOIETIC STEM-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; COMMON LYMPHOID PROGENITORS; MOUSE BONE-MARROW; YOLK-SAC; DEVELOPMENT PATHWAYS; BLOOD PROGENITORS; HUMAN EQUIVALENT; PRO-B; FETAL	Models of hematopoiesis often depict lymphocyte production as a uniform process in which a homogenous population of hematopoietic stem cells (HSCs) generates progenitors from which all types of lymphocytes are derived. However, it is increasingly evident that these schemes are too simplistic and that the lymphoid potential of HSCs and precursors arising in the embryo, fetus, neonate, and adult is remarkably distinct. We review recent findings regarding the development of B lymphocytes, and the B-1 B cell lineage in particular, as a case in point. These studies show that B-1 and B-2 B cells involved in innate and adaptive immune responses, respectively, arise in staggered waves of development from distinct progenitors. We discuss the implications of this layered model of B cell development for understanding normal and dysregulated B lymphopoiesis.	[Montecino-Rodriguez, Encarnacion; Dorshkind, Kenneth] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dorshkind, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	kdorshki@mednet.ucla.edu		Montecino Rodriguez, Encarnacion/0000-0002-2826-7503	NIH [AI021256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021256, R01AI021256] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI021256.	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Alugupalli KR, 2005, IMMUNITY, V23, P1, DOI 10.1016/j.immuni.2005.07.001; Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; ANTIN JH, 1986, J IMMUNOL, V136, P505; Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; Barber CL, 2011, P NATL ACAD SCI USA, V108, P13700, DOI 10.1073/pnas.1107172108; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BHAT NM, 1992, INT IMMUNOL, V4, P243, DOI 10.1093/intimm/4.2.243; BOFILL M, 1985, J IMMUNOL, V134, P1531; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bueno C, 2011, LEUKEMIA, V25, P400, DOI 10.1038/leu.2010.284; CARMACK CE, 1990, J EXP MED, V172, P371, DOI 10.1084/jem.172.1.371; Carpenter L, 2011, BLOOD, V117, P4008, DOI 10.1182/blood-2010-08-299941; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Casola S, 2007, CURR OPIN IMMUNOL, V19, P143, DOI 10.1016/j.coi.2007.02.010; CHEN CS, 1993, BLOOD, V81, P2386; Chhabra A, 2011, GENE DEV, V25, P1557, DOI 10.1101/gad.17328611; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; CUMANO A, 1993, P NATL ACAD SCI USA, V90, P6429, DOI 10.1073/pnas.90.14.6429; DAUPHINEE M, 1988, ARTHRITIS RHEUM, V31, P642, DOI 10.1002/art.1780310509; de Andres B, 2002, BLOOD, V100, P4074, DOI 10.1182/blood-2002-03-0809; Descatoire M, 2011, J EXP MED, V208, P2563, DOI 10.1084/jem.20112232; Donze HH, 1997, CLIN EXP IMMUNOL, V109, P356, DOI 10.1046/j.1365-2249.1997.4541352.x; Dorshkind K, 2007, NAT REV IMMUNOL, V7, P213, DOI 10.1038/nri2019; Duber S, 2009, BLOOD, V114, P4960, DOI 10.1182/blood-2009-04-218156; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Esplin BL, 2009, P NATL ACAD SCI USA, V106, P5773, DOI 10.1073/pnas.0811632106; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Ghosn EEB, 2011, P NATL ACAD SCI USA, V108, P2879, DOI 10.1073/pnas.1019764108; Godin I, 1995, Semin Immunol, V7, P131, DOI 10.1016/1044-5323(95)90041-1; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Griffin DO, 2011, J EXP MED, V208, P2566, DOI 10.1084/jem.20111761; Griffin DO, 2011, J EXP MED, V208, P2591, DOI 10.1084/jem.20110978; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hardy R.R, 2003, FUNDAMENTAL IMMUNOLO, P159; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; HARDY RR, 1984, J EXP MED, V159, P1169, DOI 10.1084/jem.159.4.1169; Hardy RR, 2005, SPRINGER SEMIN IMMUN, V26, P363, DOI 10.1007/s00281-004-0183-1; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hastings WD, 2006, EUR J IMMUNOL, V36, P1114, DOI 10.1002/eji.200535142; HAUGHTON G, 1993, IMMUNOL TODAY, V14, P84, DOI 10.1016/0167-5699(93)90064-R; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; He SH, 2011, GENE DEV, V25, P1613, DOI 10.1101/gad.2052911; Herzenberg LA, 2006, NAT IMMUNOL, V7, P225, DOI 10.1038/ni0306-225; HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4; IKUTA K, 1992, ANNU REV IMMUNOL, V10, P759; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Irion S, 2010, DEVELOPMENT, V137, P2829, DOI 10.1242/dev.042119; Jensen CT, 2007, NAT IMMUNOL, V8, P897, DOI 10.1038/ni0907-897; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LANIER LL, 1981, J EXP MED, V153, P998, DOI 10.1084/jem.153.4.998; Mackay F, 2010, IMMUNOL REV, V237, P205, DOI 10.1111/j.1600-065X.2010.00944.x; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Merbl Y, 2007, J CLIN INVEST, V117, P712, DOI 10.1172/JCI29943; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Monroe JG, 2007, ADV IMMUNOL, V95, P1, DOI 10.1016/S0065-2776(07)95001-4; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Montecino-Rodriguez E, 2006, NAT PROTOC, V1, P1140, DOI 10.1038/nprot.2006.163; Montecino-Rodriguez E, 2011, J IMMUNOL, V187, P5712, DOI 10.4049/jimmunol.1102416; OWEN JJT, 1974, NATURE, V249, P361, DOI 10.1038/249361a0; OWEN JJT, 1975, EUR J IMMUNOL, V5, P468, DOI 10.1002/eji.1830050708; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Pelayo R, 2006, SEMIN IMMUNOL, V18, P2, DOI 10.1016/j.smim.2005.10.005; Perez-Andres M, 2011, J EXP MED, V208, P2565, DOI 10.1084/jem.20112203; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rolink A, 1996, IMMUNOL LETT, V54, P157, DOI 10.1016/S0165-2478(96)02666-1; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Sanz E, 2010, P NATL ACAD SCI USA, V107, P5925, DOI 10.1073/pnas.0907942107; SOLVASON N, 1992, J EXP MED, V175, P397, DOI 10.1084/jem.175.2.397; SOLVASON N, 1991, INT IMMUNOL, V3, P543, DOI 10.1093/intimm/3.6.543; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Tung JW, 2006, P NATL ACAD SCI USA, V103, P6293, DOI 10.1073/pnas.0511305103; Vale AM, 2010, J IMMUNOL, V185, P6085, DOI 10.4049/jimmunol.1001423; Vosshenrich CAJ, 2004, P NATL ACAD SCI USA, V101, P11070, DOI 10.1073/pnas.0402919101; Ye M, 2005, J EXP MED, V202, P1411, DOI 10.1084/jem.20051089; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522	93	214	219	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 27	2012	36	1					13	21		10.1016/j.immuni.2011.11.017	http://dx.doi.org/10.1016/j.immuni.2011.11.017			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22284417	Bronze, Green Accepted			2022-12-18	WOS:000299766000006
J	Schlenner, SM; Madan, V; Busch, K; Tietz, A; Laufle, C; Costa, C; Blum, C; Fehling, HJ; Rodewald, HR				Schlenner, Susan M.; Madan, Vikas; Busch, Katrin; Tietz, Annette; Laeufle, Carolin; Costa, Celine; Blum, Carmen; Fehling, Hans Joerg; Rodewald, Hans-Reimer			Fate Mapping Reveals Separate Origins of T Cells and Myeloid Lineages in the Thymus	IMMUNITY			English	Article							COMMON LYMPHOID PROGENITORS; DENDRITIC CELLS; BONE-MARROW; STEM-CELLS; INTERLEUKIN-7 RECEPTOR; REPORTER MICE; STEADY-STATE; IN-VITRO; PRO-T; MOUSE	The cellular differentiation pathway originating from the bone marrow leading to early T lymphocytes remains poorly understood. The view that T cells branch off from a lymphoid-restricted pathway has recently been challenged by a model proposing a common progenitor for T cell and myeloid lineages. We generated interleukin-7 receptor alpha (II7r) Cre recombinase knockin mice and traced lymphocyte development by visualizing the history of II7r expression. II7r fate mapping labeled all T cells but few myeloid cells. More than 85% of T cell progenitors were II7r reporter + and, hence, had arisen from an II7r-expressing pathway. In contrast, the overwhelming majority of myeloid cells in the thymus were derived from II7r reporter(-) cells. Thus, lymphoid-restricted progenitors are the major route to T cells, and distinct origins of lymphoid and myeloid lineages represent a fundamental hallmark of hematopoiesis.	[Schlenner, Susan M.; Madan, Vikas; Busch, Katrin; Tietz, Annette; Laeufle, Carolin; Costa, Celine; Blum, Carmen; Fehling, Hans Joerg; Rodewald, Hans-Reimer] Univ Ulm, Inst Immunol, D-89081 Ulm, Germany	Ulm University	Rodewald, HR (corresponding author), German Canc Res Ctr, Dept Cellular Immunol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	hans-reimer.rodewald@uni-ulm.de	Schlenner, Susan/P-7905-2017	Schlenner, Susan/0000-0002-8553-3388	Deutsche Forschungsgemeinschaft [SFB-497-B5, KFO 142-P8]; Excellence Initiative; European Community [FP7/2007-2013]; ERC [233074]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative; European Community(European Commission); ERC(European Research Council (ERC)European Commission)	We thank A. Cumano for OP9 and OP9-DII4 cells; J. C. ainiga-Pfklicker for OP9-DII1 cells; U. Koch and F. Radtke for the anti-DII4; M. Reth for the pANMerCreMer plasmid; T. Feyerabend and G. Terszowski for help with flow cytometry; T. Boehm, T. Feyerabend, and A. Singer for critical reading of the manuscript; and members of the animal facility in Ulm for mouse husbandry. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB-497-B5; KFO 142-P8) to H.R.R. and by the International Graduate School in Molecular Medicine Ulm, funded by the Excellence Initiative, to K.B. H.R.R. receives funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 233074.	Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Bhattacharya D, 2008, EUR J IMMUNOL, V38, P2060, DOI 10.1002/eji.200838383; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; Chi AW, 2009, CURR OPIN IMMUNOL, V21, P121, DOI 10.1016/j.coi.2009.01.012; Di Santo JP, 1998, CURR OPIN IMMUNOL, V10, P196, DOI 10.1016/S0952-7915(98)80249-5; Di Santo JP, 2000, CURR OPIN IMMUNOL, V12, P159, DOI 10.1016/S0952-7915(99)00066-7; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Graf T, 2008, NATURE, V452, P702, DOI 10.1038/452702a; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Iyoda T, 2005, J IMMUNOL, V175, P3475, DOI 10.4049/jimmunol.175.6.3475; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; Krueger A, 2007, IMMUNITY, V26, P105, DOI 10.1016/j.immuni.2006.12.004; Krueger A, 2006, J EXP MED, V203, P1977, DOI 10.1084/jem.20060731; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; MCGARRY MP, 1991, J LEUKOCYTE BIOL, V50, P471, DOI 10.1002/jlb.50.5.471; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Petrie HT, 2005, J EXP MED, V202, P11, DOI 10.1084/jem.20050990; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Puel A, 2000, CURR OPIN IMMUNOL, V12, P468, DOI 10.1016/S0952-7915(00)00122-9; Puellmann K, 2006, P NATL ACAD SCI USA, V103, P14441, DOI 10.1073/pnas.0603406103; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; RODEWALD HR, 1995, CURR OPIN IMMUNOL, V7, P176, DOI 10.1016/0952-7915(95)80002-6; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wu L, 2006, CURR OPIN IMMUNOL, V18, P121, DOI 10.1016/j.coi.2006.01.006; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	54	214	215	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 26	2010	32	3					426	436		10.1016/j.immuni.2010.03.005	http://dx.doi.org/10.1016/j.immuni.2010.03.005			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20303297	Green Accepted, Bronze			2022-12-18	WOS:000276125400015
J	de Gorter, DJJ; Beuling, EA; Kersseboom, R; Middendorp, S; van Gils, JM; Hendriks, RW; Pals, ST; Spaargaren, M				de Gorter, David J. J.; Beuling, Esther A.; Kersseboom, Rogier; Middendorp, Sabine; van Gils, Janine M.; Hendriks, Rudolf W.; Pals, Steven T.; Spaargaren, Marcel			Bruton's tyrosine kinase and phospholipase C gamma 2 mediate chemokine-controlled B cell migration and homing	IMMUNITY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; FOCAL ADHESION PROTEINS; TEC FAMILY KINASES; BONE-MARROW; PHOSPHOINOSITIDE 3-KINASES; INTEGRIN ACTIVATION; ANTIGEN RECEPTOR; LYMPHOCYTE CHEMOTAXIS; SIGNAL-TRANSDUCTION; ALPHA-4 INTEGRINS	Control of integrin-mediated adhesion and migration by chemokines plays a critical role in B cell development, differentiation, and function; however, the underlying signaling mechanisms are poorly defined. Here we show that the chemokine SDF-1 induced activation of Bruton's tyrosine kinase (Btk) and that integrin-mediated adhesion and migration in response to SDF-1 or CXCL13, as well as in vivo homing to lymphoid organs, was impaired in Btk-deficient (pre-)B cells. Furthermore, SDF-1 induced tyrosine phosphorylation of Phospholipase C gamma 2 (PLC gamma 2), which, unlike activation of the migration regulatory GTPases Rac or Rap1, was mediated by Btk. PLC gamma 2-deficient B cells also exhibited impaired SDF-1-controlled migration. These results reveal that Btk and PLC gamma 2 mediate chemokine-controlled migration, thereby providing insights into the control of B cell homeostasis, trafficking, and function, as well as into the pathogenesis of the immunodeficiency disease X-linked agammaglobulinemia (XLA).	Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Immunol, NL-3000 DR Rotterdam, Netherlands; Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Mol Cell Biol, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam	Spaargaren, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	marcel.spaargaren@amc.uva.nl	Spaargaren, Marcel/AAU-1298-2021; Middendorp, Sabine/B-8357-2013; Middendorp, Sabine/J-8205-2012	Spaargaren, Marcel/0000-0002-3135-5109; Middendorp, Sabine/0000-0002-0925-0095; Middendorp, Sabine/0000-0002-0925-0095; van Gils, Janine/0000-0003-2429-7462; Pals, Steven/0000-0002-1419-0939				Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bowman EP, 2000, J EXP MED, V191, P1303, DOI 10.1084/jem.191.8.1303; Brakebusch C, 2002, IMMUNITY, V16, P465, DOI 10.1016/S1074-7613(02)00281-9; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Cariappa A, 1999, J IMMUNOL, V162, P4417; Chau CH, 2005, AM J PHYSIOL-CELL PH, V289, pC444, DOI 10.1152/ajpcell.00410.2004; Conley ME, 2005, IMMUNOL REV, V203, P216, DOI 10.1111/j.0105-2896.2005.00233.x; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; Ellmeier W, 2000, J EXP MED, V192, P1611, DOI 10.1084/jem.192.11.1611; Fernandes MJG, 2005, J LEUKOCYTE BIOL, V78, P524, DOI 10.1189/jlb.0804479; Fischer AM, 2004, J BIOL CHEM, V279, P29816, DOI 10.1074/jbc.M312848200; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; GILERT C, 2003, J IMMUNOL, V170, P5235; Hendriks RW, 1996, EMBO J, V15, P4862, DOI 10.1002/j.1460-2075.1996.tb00867.x; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Katagiri K, 2004, J BIOL CHEM, V279, P11875, DOI 10.1074/jbc.M310717200; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; KOOPMAN G, 1991, J EXP MED, V173, P1297, DOI 10.1084/jem.173.6.1297; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Lachance G, 2002, J BIOL CHEM, V277, P21537, DOI 10.1074/jbc.M201903200; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Leuker CE, 2001, J EXP MED, V193, P755, DOI 10.1084/jem.193.6.755; Lowry WE, 2002, J BIOL CHEM, V277, P1488, DOI 10.1074/jbc.M110390200; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Martins PAD, 2006, J LEUKOCYTE BIOL, V79, P499, DOI 10.1189/jlb.0605318; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; Middendorp S, 2002, J IMMUNOL, V168, P2695, DOI 10.4049/jimmunol.168.6.2695; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Nomura K, 2000, BLOOD, V96, P610; Nore BF, 2000, EUR J IMMUNOL, V30, P145, DOI 10.1002/1521-4141(200001)30:1<145::AID-IMMU145>3.0.CO;2-0; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Ortolano S, 2006, EUR J IMMUNOL, V36, P1285, DOI 10.1002/eji.200535799; Reif K, 2004, J IMMUNOL, V173, P2236, DOI 10.4049/jimmunol.173.4.2236; Ridderstad A, 1996, J IMMUNOL, V157, P3357; Rose DM, 2002, IMMUNOL REV, V186, P118, DOI 10.1034/j.1600-065X.2002.18611.x; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Smit MJ, 2003, BLOOD, V102, P1959, DOI 10.1182/blood-2002-12-3945; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; Takesono A, 2004, CURR BIOL, V14, P917, DOI 10.1016/j.cub.2004.04.011; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; van den Akker E, 2004, BIOL CHEM, V385, P409; Vinuesa CG, 2001, EUR J IMMUNOL, V31, P1340, DOI 10.1002/1521-4141(200105)31:5<1340::AID-IMMU1340>3.0.CO;2-H; Wang JF, 2000, BLOOD, V95, P2505, DOI 10.1182/blood.V95.8.2505.008k24_2505_2513; Ward SG, 2004, TRENDS IMMUNOL, V25, P67, DOI 10.1016/j.it.2003.12.003; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	59	214	218	1	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2007	26	1					93	104		10.1016/j.immuni.2006.11.012	http://dx.doi.org/10.1016/j.immuni.2006.11.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17239630	Bronze			2022-12-18	WOS:000243959000012
J	Bluestone, JA; St Clair, EW; Turka, LA				Bluestone, JA; St Clair, EW; Turka, LA			CTLA41g: Bridging the basic immunology with clinical application	IMMUNITY			English	Editorial Material							RENAL-ALLOGRAFT REJECTION; T-CELL COSTIMULATION; LONG-TERM ACCEPTANCE; TRYPTOPHAN CATABOLISM; MONOCLONAL-ANTIBODY; CARDIAC ALLOGRAFTS; DENDRITIC CELLS; CTLA-4; TRANSPLANTATION; BLOCKADE	After a very long and windy road, in December of 2005 the FDA approved CTLA4lg for the treatment of rheumatoid arthritis. Orencia is the first-in-class antagonist of CD28 costimulation. In this perspective, we discuss the science that led to CTLA4lg development and the clinical challenges in bringing the drug from the bench to the bedside.	Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Immune Tolerance Network, San Francisco, CA 94143 USA; Duke Univ, Med Ctr, Div Rheumatol & Immunol, Durham, NC 27708 USA; Univ Penn, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; Immune Tolerance Network; University of California System; University of California San Francisco; Duke University; University of Pennsylvania	Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	jbluest@immunetolerance.org						Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Adams AB, 2005, J IMMUNOL, V174, P542, DOI 10.4049/jimmunol.174.1.542; Boden Elisa, 2003, Novartis Found Symp, V252, P55; Bour-Jordan W, 2005, J IMMUNOL, V175, P5649, DOI 10.4049/jimmunol.175.9.5649; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Haanstra KG, 2003, TRANSPLANTATION, V75, P637, DOI 10.1097/01.TP.0000054835.58014.C2; Jansson A, 2005, J IMMUNOL, V175, P1575, DOI 10.4049/jimmunol.175.3.1575; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; Kemball CC, 2006, J IMMUNOL, V176, P1814, DOI 10.4049/jimmunol.176.3.1814; Kirk AD, 1997, P NATL ACAD SCI USA, V94, P8789, DOI 10.1073/pnas.94.16.8789; Kirk AD, 2001, TRANSPLANTATION, V72, P377, DOI 10.1097/00007890-200108150-00005; Kirk AD, 1999, NAT MED, V5, P686, DOI 10.1038/9536; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; LAFFERTY KJ, 1977, IMMUNOL REV, V35, P231, DOI 10.1111/j.1600-065X.1977.tb00241.x; LAFFERTY KJ, 1983, ANNU REV IMMUNOL, V1, P143, DOI 10.1146/annurev.iy.01.040183.001043; Lakkis FG, 1997, J IMMUNOL, V158, P2443; Larsen CP, 2005, AM J TRANSPLANT, V5, P443, DOI 10.1111/j.1600-6143.2005.00749.x; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; Levisetti MG, 1997, J IMMUNOL, V159, P5187; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Moreland LW, 2002, ARTHRITIS RHEUM, V46, P1470, DOI 10.1002/art.10294; PEACH RJ, 1994, J EXP MED, V180, P2049, DOI 10.1084/jem.180.6.2049; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sidiropoulos PI, 2004, LUPUS, V13, P391, DOI 10.1191/0961203304lu1032oa; Szot GL, 2000, TRANSPLANTATION, V69, P904; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260	46	214	235	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2006	24	3					233	238		10.1016/j.immuni.2006.03.001	http://dx.doi.org/10.1016/j.immuni.2006.03.001			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546089	Bronze			2022-12-18	WOS:000236504500001
J	Rauh, MJ; Ho, V; Pereira, C; Sham, A; Sly, LM; Lam, V; Huxham, L; Minchinton, AI; Mui, A; Krystal, G				Rauh, MJ; Ho, V; Pereira, C; Sham, A; Sly, LM; Lam, V; Huxham, L; Minchinton, AI; Mui, A; Krystal, G			SHIP represses the generation of alternatively activated macrophages	IMMUNITY			English	Article							NITRIC-OXIDE SYNTHASE; INFLAMMATORY RESPONSE SYNDROME; MOTH-EATEN; TRANSLATIONAL CONTROL; ARGININE METABOLISM; MYELOID CELLS; EXPRESSION; PHOSPHATASE; ARGINASE; YM1	We recently reported that SHIP restrains LPS-induced classical (M1) activation of in vitro differentiated, bone marrow-derived macrophages (BMM Phi s) and that SHIP upregulation is essential for endotoxin tolerance. Herein, we show that in vivo differentiated SHIP-/- peritoneal (PM Phi s) and alveolar (AM Phi s) macrophages, unlike their wild-type counterparts, are profoundly M2 skewed (alternatively activated), possessing constitutively high arginase I (Argl) and Ym1 levels and impaired LPS-induced NO production. Consistent with this, SHIP-/- mice display M2-mediated lung pathology and enhanced tumor implant growth. Interestingly, BMM Phi s from SHIP-/- mice do not display this M2 phenotype unless exposed to TGF beta within normal mouse plasma (MP) during in vitro differentiation. Our results suggest that SHIP functions in vivo to repress M2 skewing and that macrophage polarization can occur during differentiation in response to TGF beta if progenitors have elevated PIP3.	British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; British Columbia Canc Agcy, Dept Med Biophys, Vancouver, BC V5Z 1L3, Canada; Jack Bell Res Ctr, Vancouver, BC V6H 3Z6, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia	Krystal, G (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.	gkrystal@bccrc.ca	Hughes, Michael/N-6039-2015	Hughes, Michael/0000-0002-7925-6070; Krystal, Gerald/0000-0002-1961-6281; Sly, Laura/0000-0002-1673-467X; Rauh, Michael/0000-0002-8346-5537				Adib-Conquy M, 2003, AM J RESP CRIT CARE, V168, P158, DOI 10.1164/rccm.200209-1077OC; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Bussiere FI, 2005, J BIOL CHEM, V280, P2409, DOI 10.1074/jbc.C400498200; Cook AD, 2003, J IMMUNOL, V171, P4816, DOI 10.4049/jimmunol.171.9.4816; Dal-Pizzol F, 2004, CRIT CARE MED, V32, P1971, DOI 10.1097/01.CCM.0000139620.32448.12; Damen JE, 1998, BLOOD, V92, P1199, DOI 10.1182/blood.V92.4.1199.416k16_1199_1205; El-Gayar S, 2003, J IMMUNOL, V171, P4561, DOI 10.4049/jimmunol.171.9.4561; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guo L, 2000, J BIOL CHEM, V275, P8032, DOI 10.1074/jbc.275.11.8032; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hung SL, 2002, J LEUKOCYTE BIOL, V72, P72; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Jost MM, 2003, FASEB J, V17, P2281, DOI 10.1096/fj.03-0071fje; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737, DOI 10.4049/jimmunol.168.9.4737; Keller Y, 2003, IEEE T CIRC SYST VID, V13, P300, DOI 10.1109/TCSVT.2003.811360; Kim WK, 2004, J IMMUNOL, V172, P7015, DOI 10.4049/jimmunol.172.11.7015; Learn CA, 2001, J BIOL CHEM, V276, P20234, DOI 10.1074/jbc.M100316200; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mills CD, 2001, CRIT REV IMMUNOL, V21, P399, DOI 10.1615/critrevimmunol.v21.i5.10; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Montaner LJ, 1999, J IMMUNOL, V162, P4606; Morrison AC, 2002, J IMMUNOL, V168, P853, DOI 10.4049/jimmunol.168.2.853; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Munder M, 1999, J IMMUNOL, V163, P3771; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Nakamura K, 2004, J EXP MED, V199, P243, DOI 10.1084/jem.20031193; Nio J, 2004, HISTOCHEM CELL BIOL, V121, P473, DOI 10.1007/s00418-004-0654-4; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Ravasi T, 2002, J IMMUNOL, V168, P44, DOI 10.4049/jimmunol.168.1.44; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Rhee SH, 2003, J BIOL CHEM, V278, P22506, DOI 10.1074/jbc.M208633200; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Ruetten H, 1997, SHOCK, V8, P409, DOI 10.1097/00024382-199712000-00003; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; STOUT RD, 2004, J LEUKOCYTE BIOL, V76, P1; Takahashi H, 2004, CRIT CARE MED, V32, P1879, DOI 10.1097/01.CCM.0000139606.34631.61; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Valderrama-Carvajal H, 2002, NAT CELL BIOL, V4, P963, DOI 10.1038/ncb885; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438; WARD JM, 1978, VET PATHOL, V15, P170, DOI 10.1177/030098587801500203; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; Weinstein SL, 2000, J LEUKOCYTE BIOL, V67, P405, DOI 10.1002/jlb.67.3.405; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Williams DL, 2004, J IMMUNOL, V172, P449, DOI 10.4049/jimmunol.172.1.449; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	56	214	238	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2005	23	4					361	374		10.1016/j.immuni.2005.09.003	http://dx.doi.org/10.1016/j.immuni.2005.09.003			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	980EC	16226502	Bronze			2022-12-18	WOS:000232995800005
J	Hawlisch, H; Belkaid, Y; Baelder, R; Hildeman, D; Gerard, C; Kohl, J				Hawlisch, H; Belkaid, Y; Baelder, R; Hildeman, D; Gerard, C; Kohl, J			C5a negatively regulates Toll-like receptor 4-induced immune responses	IMMUNITY			English	Article							ACTIVATED PROTEIN-KINASES; IL-12 PRODUCTION; T-CELLS; LEISHMANIA-MAJOR; DIFFERENTIAL REGULATION; BIOACTIVE IL-12; HUMAN MONOCYTES; INTERLEUKIN-12; RESISTANCE; P40	The complement system and the Toll-like receptors (TLRs) are two central arms of innate immunity that are critical to host defense as well as the development of adaptive immunity. Most pathogens activate both complement and TLRs, suggesting the potential for crosstalk between the two systems. We show here that the complement-derived C5a anaphylatoxin negatively regulates TLR4- and CD40-induced synthesis of IL-12 family cytokines (IL-12, IL-23, and IL-27) from inflammatory macrophages (M phi s) by extracellular signal-regulated kinase- and phosphoinositide 3 kinase-dependent pathways. This decreased cytokine response translates into a decreased T helper type 1 (Th1) response in vitro and in vivo. Accordingly, we found enhanced Th1 immunity in C5a receptor-deficient mice, something that conferred protection from Leishmania major infection. Our findings identify the negative impact of C5a on IL-12 family cytokines as an important mechanism for regulating Th1 polarization in response to innate and adaptive immune network activation.	Univ Cincinnati, Coll Med, Div Mol Immunol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Div Immunobiol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; Harvard Univ, Sch Med, Childrens Hosp, Ina Sue Perlmutter Lab, Boston, MA 02115 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Harvard University; Boston Children's Hospital; Harvard Medical School	Kohl, J (corresponding author), Univ Cincinnati, Coll Med, Div Mol Immunol, Cincinnati, OH 45229 USA.	joerg.koehl@chmcc.org	Hildeman, David/AAA-1757-2020; Koehl, Joerg/C-8531-2011; Hildeman, David/I-4884-2015	Hildeman, David/0000-0002-0421-8483; Koehl, Joerg/0000-0003-1121-3178; Hildeman, David/0000-0002-0421-8483; Belkaid, Yasmine/0000-0001-9962-3571				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; BARBER SA, 1995, INFECT IMMUN, V63, P601, DOI 10.1128/IAI.63.2.601-608.1995; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; BUHL AM, 1995, J BIOL CHEM, V270, P19828, DOI 10.1074/jbc.270.34.19828; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dominguez M, 2002, J EXP MED, V195, P451, DOI 10.1084/jem.20011319; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; GERVAIS F, 1989, J IMMUNOL, V142, P2057; Goodridge HS, 2003, IMMUNOLOGY, V109, P415, DOI 10.1046/j.1365-2567.2003.01689.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hacker H, 1999, EMBO J, V18, P6973, DOI 10.1093/emboj/18.24.6973; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Marth T, 1997, J EXP MED, V185, P1987, DOI 10.1084/jem.185.11.1987; Maruyama S, 2003, J IMMUNOL, V170, P997, DOI 10.4049/jimmunol.170.2.997; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Mendez S, 2004, J EXP MED, V200, P201, DOI 10.1084/jem.20040298; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Perianayagam MC, 2002, KIDNEY INT, V61, P456, DOI 10.1046/j.1523-1755.2002.00139.x; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Sam H, 1999, CLIN EXP IMMUNOL, V117, P343; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Snijders A, 1996, J IMMUNOL, V156, P1207; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tsuji RF, 2000, J IMMUNOL, V165, P1588, DOI 10.4049/jimmunol.165.3.1588; Villarino AV, 2004, J IMMUNOL, V173, P715, DOI 10.4049/jimmunol.173.2.715; Wang XB, 2000, INT J MACH TOOL MANU, V40, P165, DOI 10.1016/S0890-6955(99)00064-4; Wang Y, 1996, P NATL ACAD SCI USA, V93, P8563, DOI 10.1073/pnas.93.16.8563; Wittmann M, 1999, J IMMUNOL, V162, P6763; Yadav D, 2003, CURR OPIN IMMUNOL, V15, P697, DOI 10.1016/j.coi.2003.09.006; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0	46	214	232	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2005	22	4					415	426		10.1016/j.immuni.2005.02.006	http://dx.doi.org/10.1016/j.immuni.2005.02.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	923KU	15845447	Bronze			2022-12-18	WOS:000228909600004
J	Ruuls, SR; Hoek, RM; Ngo, VN; McNeil, T; Lucian, LA; Janatpour, MJ; Korner, H; Scheerens, H; Hessel, EM; Cyster, JG; McEvoy, LM; Sedgwick, JD				Ruuls, SR; Hoek, RM; Ngo, VN; McNeil, T; Lucian, LA; Janatpour, MJ; Korner, H; Scheerens, H; Hessel, EM; Cyster, JG; McEvoy, LM; Sedgwick, JD			Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; FACTOR-ALPHA; B-CELL; GERMINAL-CENTERS; FACTOR RECEPTOR; DEFICIENT MICE; IN-VITRO; FOLLICLES; METALLOPROTEINASE	Mice without secreted TNF but with functional, normally regulated and expressed membrane-bound TNF (memTNF(Delta/Delta) mice) were created by knocking-in the uncleavable Delta1-9,K11E TNF allele. In contrast to TNF-deficient mice (TNF-/-), memTNF supported many features of lymphoid organ structure, except generation of primary B cell follicles. Splenic chemokine expression was near normal. MemTNF-induced apoptosis was mediated through both TNF-R1 and TNF-R2. That memTNF is suboptimal for development of inflammation was revealed in experimental autoimmune encephalomyelitis. Disease severity was reduced in memTNF(Delta/Delta) mice relative to wild-type mice, and the nature of spinal cord infiltrates resembled that in TNF-/- mice. We conclude that memTNF supports many processes underlying lymphoid tissue structure, but secreted TNF is needed for optimal inflammatory lesion development.	DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Erlangen Nurnberg, Interdisziplinares Zentrum Klin Forsch, Erlangen, Germany	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; University of California System; University of California San Francisco; University of Erlangen Nuremberg	Sedgwick, JD (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, 901 Calif Ave, Palo Alto, CA 94304 USA.	jon.sedgwick@dnax.org	Korner, Heinrich/D-9970-2014; Hessel, Edith M/AAB-6002-2021	Korner, Heinrich/0000-0003-4610-2814; Hessel, Edith M/0000-0002-2339-4482; Ngo, Vu/0000-0002-9501-6990				Akassoglou K, 1997, J IMMUNOL, V158, P438; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BAKER D, 1994, EUR J IMMUNOL, V24, P2040, DOI 10.1002/eji.1830240916; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Cook MC, 1998, J EXP MED, V188, P1503, DOI 10.1084/jem.188.8.1503; Cope AP, 1998, CURR OPIN IMMUNOL, V10, P669, DOI 10.1016/S0952-7915(98)80087-3; Cyster JG, 2000, IMMUNOL REV, V176, P181; DECKER T, 1987, J IMMUNOL, V138, P957; DECOSTER E, 1995, J BIOL CHEM, V270, P18473, DOI 10.1074/jbc.270.31.18473; Feldmann M, 1998, SPRINGER SEMIN IMMUN, V20, P211, DOI 10.1007/BF00832008; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; GORDON HM, 1992, J IMMUNOL, V148, P4021; Green EA, 1999, IMMUNOL REV, V169, P11, DOI 10.1111/j.1600-065X.1999.tb01302.x; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Kassiotis G, 1999, EUR J IMMUNOL, V29, P774, DOI 10.1002/(SICI)1521-4141(199903)29:03<774::AID-IMMU774>3.0.CO;2-T; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Korner H, 1997, J EXP MED, V186, P1585, DOI 10.1084/jem.186.9.1585; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Lemckert FA, 1997, NUCLEIC ACIDS RES, V25, P917, DOI 10.1093/nar/25.4.917; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Matthys P, 2000, J LEUKOCYTE BIOL, V68, P447; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mueller C, 1999, J BIOL CHEM, V274, P38112, DOI 10.1074/jbc.274.53.38112; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Pasparakis M, 2000, CELL IMMUNOL, V201, P33, DOI 10.1006/cimm.2000.1636; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; RIMINTON DS, 2000, BIOL GENE THERAPY AU, P50; Ruuls SR, 1999, AM J HUM GENET, V65, P294, DOI 10.1086/302517; Scheerens H, 2001, EUR J IMMUNOL, V31, P1465, DOI 10.1002/1521-4141(200105)31:5<1465::AID-IMMU1465>3.0.CO;2-E; Sedgwick JD, 2000, IMMUNOL TODAY, V21, P110, DOI 10.1016/S0167-5699(99)01573-X; Sedgwick JD, 1998, J IMMUNOL, V160, P5320; Solomon KA, 1997, J IMMUNOL, V159, P4524; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Voigt I, 2000, EUR J IMMUNOL, V30, P560, DOI 10.1002/1521-4141(200002)30:2<560::AID-IMMU560>3.0.CO;2-T; Weiss T, 1997, J IMMUNOL, V158, P2398; Yeh WC, 1999, IMMUNOL REV, V169, P283, DOI 10.1111/j.1600-065X.1999.tb01323.x	48	214	222	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2001	15	4					533	543		10.1016/S1074-7613(01)00215-1	http://dx.doi.org/10.1016/S1074-7613(01)00215-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672536	Bronze			2022-12-18	WOS:000171757800005
J	Shires, J; Theodoridis, E; Hayday, AC				Shires, J; Theodoridis, E; Hayday, AC			Biological insights into TCR gamma delta(+) and TCR alpha beta(+) intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE)	IMMUNITY			English	Article							DELTA T-LYMPHOCYTES; TRANSCRIPTION FACTOR; INTESTINAL EPITHELIUM; THYMOCYTE DEVELOPMENT; ANTIGEN RECEPTORS; DEFICIENT MICE; CUTTING EDGE; IN-VIVO; CELLS; GAMMA	Intraepithelial lymphocytes (IELs) are abundant, evolutionarily conserved T cells, commonly enriched in T cell receptor (TCR) gamma delta expression. However, their primary functional potential and constitutive activation state are incompletely understood. To address this, serial analysis of gene expression (SAGE) was applied to murine TCR gamma delta (+) and TCR alpha beta (+) intestinal IELs directly ex vivo, identifying 15,574 unique transcripts that collectively portray an "activated yet resting," Th1-skewed, cytolytic, and immunoregulatory phenotype applicable to multiple subsets of gut IELs. Expression of granzymes, Fas ligand, RANTES, prothymosin beta4 junB, RGS1, Btg1, and related molecules is high: whereas expression of conventional cytokines and high-affinity cytokine receptors is low. Differentially expressed genes readily identify heterogeneity among TCR alpha beta (+) IELs, whereas differences between resident TCR gamma delta (+) IELs and TCR alpha beta (+) IELs are less obvious.	Kings Coll London, Guys Kings & St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	University of London; King's College London; Yale University	Hayday, AC (corresponding author), Kings Coll London, Guys Kings & St Thomas Med Sch, Peter Gorer Dept Immunobiol, London Bridge, London SE1 9RT, England.	adrian.hayday@kcl.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793				Agrawal S, 1999, J IMMUNOL, V162, P1223; ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; Anumanthan A, 1998, J IMMUNOL, V161, P2780; Avice MN, 1999, J IMMUNOL, V162, P2748; Beadling C, 1999, J IMMUNOL, V162, P2677; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Boismenu R, 1996, J IMMUNOL, V157, P985; Carlsen KH, 1994, EUR RESPIR REV, V4, P5; Das G, 2000, J EXP MED, V192, P1521, DOI 10.1084/jem.192.10.1521; DeBenedette MA, 1997, J IMMUNOL, V158, P551; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; DSouza CD, 1997, J IMMUNOL, V158, P1217; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; FINDLY RC, 1993, EUR J IMMUNOL, V23, P2557, DOI 10.1002/eji.1830231027; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; FU YX, 1994, J IMMUNOL, V153, P3101; Fujihashi K, 1996, J EXP MED, V183, P1929, DOI 10.1084/jem.183.4.1929; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Halary F, 1997, EUR J IMMUNOL, V27, P2812, DOI 10.1002/eji.1830271111; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday A, 2000, SCIENCE, V290, P97, DOI 10.1126/science.290.5489.97; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; Ke Y, 1997, J IMMUNOL, V158, P3610; KILSHAW PJ, 1991, EUR J IMMUNOL, V21, P2591, DOI 10.1002/eji.1830211041; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; King DP, 1999, J IMMUNOL, V162, P5033; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Lanier LL, 2001, NAT IMMUNOL, V2, P23, DOI 10.1038/83130; Lepage AC, 1998, J IMMUNOL, V161, P4902; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Lin TS, 1999, J CLIN INVEST, V104, P1297, DOI 10.1172/JCI7437; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Margulies EH, 2000, BIOINFORMATICS, V16, P650, DOI 10.1093/bioinformatics/16.7.650; Mazzucchelli L, 1996, J PATHOL, V178, P201, DOI 10.1002/(SICI)1096-9896(199602)178:2<201::AID-PATH440>3.0.CO;2-4; McVay LD, 1998, J IMMUNOL, V160, P5851; Muller S, 2000, J IMMUNOL, V164, P1986, DOI 10.4049/jimmunol.164.4.1986; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAKAMURA M, 1995, P NATL ACAD SCI USA, V92, P3463, DOI 10.1073/pnas.92.8.3463; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Reif K, 2000, J IMMUNOL, V164, P4720, DOI 10.4049/jimmunol.164.9.4720; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; ROCHA B, 1994, J EXP MED, V180, P681, DOI 10.1084/jem.180.2.681; RUDIN CM, 1990, J IMMUNOL, V144, P4857; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Shi YG, 2000, J BIOL CHEM, V275, P19167, DOI 10.1074/jbc.M910228199; Shiohara T, 1996, J EXP MED, V183, P1483, DOI 10.1084/jem.183.4.1483; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; SUEMORI S, 1991, J CLIN INVEST, V87, P2216, DOI 10.1172/JCI115256; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; TAGUCHI T, 1991, J IMMUNOL, V147, P3736; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; VINEY JL, 1990, EUR J IMMUNOL, V20, P1623, DOI 10.1002/eji.1830200734; Young JD, 1999, NAT MED, V5, P1424	63	214	221	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2001	15	3			SI		419	434		10.1016/S1074-7613(01)00192-3	http://dx.doi.org/10.1016/S1074-7613(01)00192-3			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567632	Bronze			2022-12-18	WOS:000171211800009
J	Fukita, Y; Jacobs, H; Rajewsky, K				Fukita, Y; Jacobs, H; Rajewsky, K			Somatic hypermutation in the heavy chain locus correlates with transcription	IMMUNITY			English	Article							RNA POLYMERASE-I; COMPLEMENTARITY-DETERMINING REGIONS; CYTOPLASMIC MESSENGER-RNA; CELL-FREE SYSTEM; IMMUNOGLOBULIN-KAPPA; GERMINAL-CENTERS; MONOCLONAL-ANTIBODIES; TRANSGENIC MICE; NONSENSE CODONS; DEFICIENT MICE	Three mutant immunoglobulin heavy chain (IgH) insertion mice were generated in which a targeted nonfunctional IgH passenger transgene was either devoid of promoter (p Delta) or was placed under the transcriptional control of either its own RNA polymerase II-dependent IgH promoter (pII) or a RNA polymerase I-dependent promoter (pI). While the transgene mutation-frequency (0.85%) in memory B cells of pI mice was reduced compared to that in pII mice (1.4%), the distribution and the base exchange pattern of point mutations were comparable. In p Delta mice, the mutation frequency was drastically reduced (0.09%). The mutation frequencies correlated with the levels of transgene-specific pre-mRNA expressed in germinal center B cells isolated from the mutant mice.	Univ Cologne, Genet Inst, D-50931 Cologne, Germany	University of Cologne	Jacobs, H (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.			Jacobs, Heinz/0000-0001-6227-9850; Rajewsky, Klaus/0000-0002-6633-6370				ALESSANDRINI A, 1991, MOL CELL BIOL, V11, P2096, DOI 10.1128/MCB.11.4.2096; Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Coffman R L, 1982, Immunol Rev, V69, P5; FORD JE, 1994, EUR J IMMUNOL, V24, P1816, DOI 10.1002/eji.1830240814; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; GEARHART PJ, 1983, P NATL ACAD SCI-BIOL, V80, P3439, DOI 10.1073/pnas.80.11.3439; GONZALEZFERNANDEZ A, 1994, P NATL ACAD SCI USA, V91, P12614, DOI 10.1073/pnas.91.26.12614; Goyenechea B, 1997, EMBO J, V16, P3987, DOI 10.1093/emboj/16.13.3987; GRUMMT I, 1985, P NATL ACAD SCI USA, V82, P722, DOI 10.1073/pnas.82.3.722; GUNTER KC, 1984, J EXP MED, V159, P716, DOI 10.1084/jem.159.3.716; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735; KABAT EA, 1991, J IMMUNOL, V147, P1709; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; KIM S, 1981, CELL, V27, P573, DOI 10.1016/0092-8674(81)90399-8; Klein U, 1997, BLOOD, V89, P1288, DOI 10.1182/blood.V89.4.1288; KOTTMANN AH, 1994, EUR J IMMUNOL, V24, P817, DOI 10.1002/eji.1830240407; KOTTMANN AH, 1992, EUR J IMMUNOL, V22, P2113, DOI 10.1002/eji.1830220823; KUHN A, 1990, P NATL ACAD SCI USA, V87, P7527, DOI 10.1073/pnas.87.19.7527; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LACY E, 1983, CELL, V34, P343, DOI 10.1016/0092-8674(83)90369-0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; MAQUAT LE, 1995, RNA, V1, P453; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; OBRIEN RL, 1987, NATURE, V326, P405, DOI 10.1038/326405a0; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PELTZ SW, 1994, PROG NUCLEIC ACID RE, V47, P271, DOI 10.1016/S0079-6603(08)60254-8; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Rada C, 1997, EUR J IMMUNOL, V27, P3115, DOI 10.1002/eji.1830271206; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; REEDER RH, 1990, TRENDS GENET, V6, P390, DOI 10.1016/0168-9525(90)90298-K; RETH M, 1979, EUR J IMMUNOL, V9, P1004, DOI 10.1002/eji.1830091216; ROES J, 1995, J IMMUNOL METHODS, V183, P231, DOI 10.1016/0022-1759(95)00059-J; ROES J, 1989, J IMMUNOL, V142, P1022; ROGERSON BJ, 1994, MOL IMMUNOL, V31, P83, DOI 10.1016/0161-5890(94)90081-7; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; ROTHENFLUH HS, 1993, EUR J IMMUNOL, V23, P2152, DOI 10.1002/eji.1830230916; Sambrook J, 1989, MOL CLONING LAB MANU; SCHRECK R, 1989, EMBO J, V8, P3011, DOI 10.1002/j.1460-2075.1989.tb08451.x; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SHARPE MJ, 1991, EMBO J, V10, P2139, DOI 10.1002/j.1460-2075.1991.tb07748.x; SMALE ST, 1985, MOL CELL BIOL, V5, P352, DOI 10.1128/MCB.5.2.352; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; TAKI S, 1993, SCIENCE, V262, P1268, DOI 10.1126/science.8235657; THOMPSON A, 1995, EUR J IMMUNOL, V25, P257, DOI 10.1002/eji.1830250142; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239; WEBER JS, 1991, J IMMUNOL, V146, P3652; WOOD C, 1983, P NATL ACAD SCI-BIOL, V80, P3030, DOI 10.1073/pnas.80.10.3030; YELAMOS J, 1995, NATURE, V376, P225; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; ZAWEL L, 1992, Current Opinion in Cell Biology, V4, P488, DOI 10.1016/0955-0674(92)90016-6; ZHANG GH, 1994, NATURE, V372, P809	63	214	229	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	1998	9	1					105	114		10.1016/S1074-7613(00)80592-0	http://dx.doi.org/10.1016/S1074-7613(00)80592-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697840	Bronze			2022-12-18	WOS:000075066600010
J	Yu, YYL; George, T; Dorfman, JR; Roland, J; Kumar, V; Bennett, M				Yu, YYL; George, T; Dorfman, JR; Roland, J; Kumar, V; Bennett, M			The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; BONE-MARROW ALLOGRAFTS; CLASS-I MHC; GRAFT-REJECTION; TARGET-CELLS; EXPRESSION; RECOGNITION; SPECIFICITY; GENE; MICE	We address the mechanism of hybrid resistance (HR) in vitro using NK effector cells and target lymphoblasts from H-2(b), H-2(d), and H-2(b/d) mice. The 5E6 (Ly49C)(+) subset of F1 NK cells lyse BALB/c (H-2(d)) but not B6 (H-2(b)) targets unless either anti-5E6 or anti-H-2K(b) MAbs are present. H-2D(d) transgenic B6 (D8) targets are not susceptible to F1 Ly49A(+) effecters. Furthermore, 5E6(+) Ly49A(+) F1 effecters lyse B6 and BALB/c targets only in the presence of anti-5E6 and anti-Ly49A MAbs, respectively. Thus, recognition of H-2K(b) by 5E6 and H-2D(d) by Ly49A transduce independent inhibitory signals. Moreover, anti-5E6 MAbs enable 5E6(+) BALB/c NK cells to lyse (BALB/c x B6)F1 targets. These data support the ''missing self'' and not the ''hemopoietic histocompatibility antigen'' hypothesis for HR. In addition, 5E6(+) NK cells from BALB/c and BALB.B, but not B6 or (BALB/c x B6)F1, mice receive negative signals from both H-2(d) and K-b class I antigens. Thus, allelic differences in 5E6 (C57BL versus BALB) may regulate recognition events by NK cells.	UNIV TEXAS,SW MED CTR,DEPT PATHOL,DALLAS,TX 75235; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720; UNIV PARIS 06,UNITE IMMUNOCHIM ANALYT,DEPT IMMUNOL,INST PASTEUR,CNRS 359,F-75724 PARIS 15,FRANCE	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite			Dorfman, Jeffrey R/M-4218-2017; Dorfman, Jeffrey R/B-4854-2011	Dorfman, Jeffrey R/0000-0001-9938-8911	NCI NIH HHS [CA36921, CA36922] Funding Source: Medline; NIAID NIH HHS [AI20451] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA036922, R01CA036921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020451] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGUILA HL, 1995, INT C IMMUNOL, V9, P477; BAKER M, 1995, IN PRESS BIOL BLOOD; BELLONE G, 1993, J EXP MED, V177, P1117, DOI 10.1084/jem.177.4.1117; BENNETT M, 1987, TRANSPLANT P, V19, P5; BIEBERICH C, 1987, MOL CELL BIOL, V7, P4003, DOI 10.1128/MCB.7.11.4003; BRENNAN J, 1994, J EXP MED, V180, P2287, DOI 10.1084/jem.180.6.2287; CHADWICK BS, 1992, J IMMUNOL, V148, P2307; CHADWICK BS, 1992, J IMMUNOL, V149, P3150; CICCONE E, 1992, J EXP MED, V175, P709, DOI 10.1084/jem.175.3.709; CICCONE E, 1992, J EXP MED, V176, P963, DOI 10.1084/jem.176.4.963; CICCONE E, 1990, P NATL ACAD SCI USA, V87, P9794, DOI 10.1073/pnas.87.24.9794; CICCONE E, 1990, J EXP MED, V172, P47, DOI 10.1084/jem.172.1.47; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; CORREA I, 1995, IMMUNITY, V2, P61, DOI 10.1016/1074-7613(95)90079-9; CUDKOWICZ G, 1971, J EXP MED, V134, P1513, DOI 10.1084/jem.134.6.1513; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; DANIELS BF, 1994, J EXP MED, V180, P687, DOI 10.1084/jem.180.2.687; DAVENPORT C, 1995, J IMMUNOL, V154, P2568; HELD W, 1995, NATURE, V376, P35; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; LAFUSE WP, 1992, IMMUNOGENETICS, V36, P110, DOI 10.1007/BF00215287; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MALNATI MS, 1995, SCIENCE, V267, P1016, DOI 10.1126/science.7863326; MORETTA A, 1995, J EXP MED, V182, P875, DOI 10.1084/jem.182.3.875; MURPHY WJ, 1990, J IMMUNOL, V144, P3305; MURPHY WJ, 1987, J EXP MED, V165, P1212, DOI 10.1084/jem.165.4.1212; NAGASAWA R, 1987, J IMMUNOL, V138, P815; REMBECKI RM, 1988, J IMMUNOL, V141, P2253; REMBECKI RM, 1987, J IMMUNOL, V138, P2734; REMBECKI RM, 1987, H2 ANTIGENS GENES MO, P103; ROLAND J, 1992, INT IMMUNOL, V4, P699, DOI 10.1093/intimm/4.6.699; SENTMAN CL, 1989, J IMMUNOL, V142, P1847; SENTMAN CL, 1989, J EXP MED, V170, P191, DOI 10.1084/jem.170.1.191; STONEMAN ER, 1995, J EXP MED, V182, P305, DOI 10.1084/jem.182.2.305; STORKUS WJ, 1991, CRIT REV IMMUNOL, V10, P393; STORKUS WJ, 1989, P NATL ACAD SCI USA, V86, P2361, DOI 10.1073/pnas.86.7.2361; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VAAGE JT, 1994, J EXP MED, V180, P641, DOI 10.1084/jem.180.2.641; YU YYL, 1994, INT IMMUNOL, V6, P1297, DOI 10.1093/intimm/6.9.1297; YU YYL, 1992, ANNU REV IMMUNOL, V10, P189, DOI 10.1146/annurev.iy.10.040192.001201	43	214	219	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1996	4	1					67	76		10.1016/S1074-7613(00)80299-X	http://dx.doi.org/10.1016/S1074-7613(00)80299-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TT319	8574853	Bronze			2022-12-18	WOS:A1996TT31900007
J	Marcus, A; Mao, AJ; Lensink-Vasan, M; Wang, L; Vance, RE; Raulet, DH				Marcus, Assaf; Mao, Amy J.; Lensink-Vasan, Monisha; Wang, LeeAnn; Vance, Russell E.; Raulet, David H.			Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response	IMMUNITY			English	Article							CYCLIC GMP-AMP; NATURAL-KILLER-CELLS; DNA-DAMAGE RESPONSE; CYTOSOLIC DNA; INNATE IMMUNITY; NKG2D RECEPTOR; LYMPHOID-CELLS; CUTTING EDGE; IN-VIVO; RECOGNITION	Detection of cytosolic DNA by the enzyme cGAS triggers the production of cGAMP, a second messenger that binds and activates the adaptor protein STING, which leads to interferon (IFN) production. Here, we found that in vivo natural killer (NK) cell killing of tumor cells, but not of normal cells, depends on STING expression in non-tumor cells. Experiments using transplantable tumor models in STING-and cGAS-deficient mice revealed that cGAS expression by tumor cells was critical for tumor rejection by NK cells. In contrast, cGAS expression by host cells was dispensable, suggesting that tumor-derived cGAMP is transferred to non-tumor cells, where it activates STING. cGAMP administration triggered STING activation and IFN-beta production in myeloid cells and B cells but not NK cells. Our results reveal that the anti-tumor response of NK cells critically depends on the cytosolic DNA sensing pathway, similar to its role in defense against pathogens, and identify tumor-derived cGAMP as a major determinant of tumor immunogenicity with implications for cancer immunotherapy.	[Marcus, Assaf; Mao, Amy J.; Lensink-Vasan, Monisha; Wang, LeeAnn; Vance, Russell E.; Raulet, David H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA; [Vance, Russell E.; Raulet, David H.] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Vance, Russell E.; Raulet, David H.] Univ Calif Berkeley, Immunotherapeut & Vaccine Res Initiat, Berkeley, CA 94720 USA; [Vance, Russell E.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Vance, RE; Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.; Vance, RE; Raulet, DH (corresponding author), Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA.; Vance, RE; Raulet, DH (corresponding author), Univ Calif Berkeley, Immunotherapeut & Vaccine Res Initiat, Berkeley, CA 94720 USA.; Vance, RE (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	rvance@berkeley.edu; raulet@berkeley.edu			NIH [R01-AI0113041, AI075039, AI063302]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, R01AI113041] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Zhang and T. Trevino for their assistance in the lab and members of the Raulet and Vance labs for discussions. Hector Nolla and Alma Valeros provided assistance with cell sorting. We acknowledge the technical support of Chulho Kang and the Cancer Research Laboratory Gene Targeting Facility with the generation of Cgas-deficient mice. This research was supported by NIH grant R01-AI0113041 to D.H.R. R.E.V. is supported by an investigator award from the Howard Hughes Medical Institute and by NIH grants AI075039 and AI063302.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Brzostek-Racine S, 2011, J IMMUNOL, V187, P5336, DOI 10.4049/jimmunol.1100040; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gasser S, 2006, CANCER RES, V66, P3959, DOI 10.1158/0008-5472.CAN-05-4603; Gasser S, 2006, SEMIN CANCER BIOL, V16, P344, DOI 10.1016/j.semcancer.2006.07.004; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Guia S, 2008, BLOOD, V111, P5008, DOI 10.1182/blood-2007-11-122259; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; HERBERMAN RB, 1975, INT J CANCER, V16, P216, DOI 10.1002/ijc.2910160204; Ho SSW, 2016, IMMUNITY, V44, P1177, DOI 10.1016/j.immuni.2016.04.010; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Karre K, 2008, NAT IMMUNOL, V9, P477, DOI 10.1038/ni0508-477; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Klarquist J, 2014, J IMMUNOL, V193, P6124, DOI 10.4049/jimmunol.1401869; Lam AR, 2014, CANCER RES, V74, P2193, DOI 10.1158/0008-5472.CAN-13-1703; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Marcus A, 2014, ADV IMMUNOL, V122, P91, DOI 10.1016/B978-0-12-800267-4.00003-1; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Ohkuri T, 2014, CANCER IMMUNOL RES, V2, P1199, DOI 10.1158/2326-6066.CIR-14-0099; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Shen YJ, 2015, CELL REP, V11, P460, DOI 10.1016/j.celrep.2015.03.041; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia TL, 2016, CANCER RES, V76, P6747, DOI 10.1158/0008-5472.CAN-16-1404; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Xu ST, 2016, CELL HOST MICROBE, V20, P443, DOI 10.1016/j.chom.2016.09.003; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051	46	213	222	15	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					754	+		10.1016/j.immuni.2018.09.016	http://dx.doi.org/10.1016/j.immuni.2018.09.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30332631	Bronze, Green Accepted			2022-12-18	WOS:000447386700019
J	Zeng, H; Cohen, S; Guy, C; Shrestha, S; Neale, G; Brown, SA; Cloer, C; Kishton, RJ; Gao, X; Youngblood, B; Do, M; Li, MO; Locasale, JW; Rathmell, JC; Chi, HB				Zeng, Hu; Cohen, Sivan; Guy, Cliff; Shrestha, Sharad; Neale, Geoffrey; Brown, Scott A.; Cloer, Caryn; Kishton, Rigel J.; Gao, Xia; Youngblood, Ben; Do, Mytrang; Li, Ming O.; Locasale, Jason W.; Rathmell, Jeffrey C.; Chi, Hongbo			mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation	IMMUNITY			English	Article							FOXO TRANSCRIPTION FACTORS; PHOSPHOINOSITIDE 3-KINASE; FH DIFFERENTIATION; NUCLEAR PTEN; REG CELLS; ACTIVATION; EXPRESSION; MIGRATION; RESPONSES; RECEPTOR	Follicular helper T (Tfh) cells are crucial for germinal center (GC) formation and humoral adaptive immunity. Mechanisms underlying Tfh cell differentiation in peripheral and mucosal lymphoid organs are incompletely understood. We report here that mTOR kinase complexes 1 and 2 (mTORC1 and mTORC2) are essential for Tfh cell differentiation and GC reaction under steady state and after antigen immunization and viral infection. Loss of mTORC1 and mTORC2 in T cells exerted distinct effects on Tfh cell signature gene expression, whereas increased mTOR activity promoted Tfh responses. Deficiency of mTORC2 impaired CD4(+) T cell accumulation and immunoglobulin A production and aberrantly induced the transcription factor Foxo1. Mechanistically, the costimulatory molecule ICOS activated mTORC1 and mTORC2 to drive glycolysis and lipogenesis, and glucose transporter 1-mediated glucose metabolism promoted Tfh cell responses. Altogether, mTOR acts as a central node in Tfh cells by linking immune signals to anabolic metabolism and transcriptional activity.	[Zeng, Hu; Guy, Cliff; Shrestha, Sharad; Brown, Scott A.; Cloer, Caryn; Youngblood, Ben; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Cohen, Sivan; Kishton, Rigel J.; Gao, Xia; Locasale, Jason W.; Rathmell, Jeffrey C.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Do, Mytrang; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Rathmell, Jeffrey C.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Rathmell, Jeffrey C.] Vanderbilt Univ, Med Ctr, Ctr Immunobiol, Nashville, TN 37232 USA	St Jude Children's Research Hospital; Duke University; St Jude Children's Research Hospital; Memorial Sloan Kettering Cancer Center; Vanderbilt University; Vanderbilt University	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Rathmell, JC (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.; Rathmell, JC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Rathmell, JC (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Immunobiol, Nashville, TN 37232 USA.	jeff.rathmell@vanderbilt.edu; hongbo.chi@stjude.org	Gao, Xia/CAF-4717-2022; Chi, Hongbo/M-9397-2018; Zeng, Hu/AAA-2706-2020; Youngblood, Benjamin/N-2508-2018; Locasale, Jason W/ABE-6505-2020	Gao, Xia/0000-0003-0979-9990; Chi, Hongbo/0000-0002-9997-2496; Zeng, Hu/0000-0002-9909-7732; Youngblood, Benjamin/0000-0002-1261-9957; Locasale, Jason W/0000-0002-7766-3502; li, ming/0000-0002-1383-0535	NIH [AI105887, AI101407, CA176624, NS064599, DK105550, R01 CA193256]; American Asthma Foundation; Crohn's & Colitis Foundation of America; Alliance for Lupus Research; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA176624, R01CA193256, F31CA183529, R00CA168997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105887, R01AI101407, R37AI105887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Crohn's & Colitis Foundation of America; Alliance for Lupus Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge N. Chapman and H. Shi for help with immunological assays, Y. Wang for editing the manuscript, and St. Jude Immunology FACS core facility for cell sorting. This work was supported by NIH AI105887, AI101407, CA176624, and NS064599, American Asthma Foundation, and Crohn's & Colitis Foundation of America (to H.C.), Alliance for Lupus Research and NIH DK105550 (to J.C.R.), and R01 CA193256 (to J.W.L).	Awe O, 2015, J IMMUNOL, V195, P3705, DOI 10.4049/jimmunol.1500780; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Deane JA, 2007, BLOOD, V109, P2894, DOI 10.1182/blood-2006-07-038620; Donahue AC, 2007, EUR J IMMUNOL, V37, P2923, DOI 10.1002/eji.200737281; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Iiyama R, 2003, IMMUNOL LETT, V88, P63, DOI 10.1016/S0165-2478(03)00054-3; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	44	213	221	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					540	554		10.1016/j.immuni.2016.08.017	http://dx.doi.org/10.1016/j.immuni.2016.08.017			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27637146	Green Accepted, Bronze			2022-12-18	WOS:000388454300012
J	Graef, P; Buchholz, VR; Stemberger, C; Flossdorf, M; Henkel, L; Schiemann, M; Drexler, I; Hofer, T; Riddell, SR; Busch, DH				Graef, Patricia; Buchholz, Veit R.; Stemberger, Christian; Flossdorf, Michael; Henkel, Lynette; Schiemann, Matthias; Drexler, Ingo; Hoefer, Thomas; Riddell, Stanley R.; Busch, Dirk H.			Serial Transfer of Single-Cell-Derived Immunocompetence Reveals Stemness of CD8(+) Central Memory T Cells	IMMUNITY			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; COLONY-FORMING CELLS; ADOPTIVE TRANSFER; LISTERIA-MONOCYTOGENES; SELF-RENEWAL; EFFECTOR; DIFFERENTIATION; NAIVE; CYTOMEGALOVIRUS; RECONSTITUTION	Maintenance of immunological memory has been proposed to rely on stem-cell-like lymphocytes. However, data supporting this hypothesis are focused on the developmental potential of lymphocyte populations and are thus insufficient to establish the functional hallmarks of stemness. Here, we investigated self-renewal capacity and multipotency of individual memory lymphocytes by in vivo fate mapping of CD8(+) T cells and their descendants across three generations of serial single-cell adoptive transfer and infection-driven re-expansion. We found that immune responses derived from single naive T (Tn) cells, single primary, and single secondary central memory T (Tcm) cells reached similar size and phenotypic diversity, were subjected to comparable stochastic variation, and could ultimately reconstitute immunocompetence against an otherwise lethal infection with the bacterial pathogen Listeria monocytogenes. These observations establish that adult tissue stem cells reside within the CD62L(+) Tcm cell compartment and highlight the promising therapeutic potential of this immune cell subset.	[Graef, Patricia; Buchholz, Veit R.; Stemberger, Christian; Henkel, Lynette; Schiemann, Matthias; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Stemberger, Christian; Riddell, Stanley R.; Busch, Dirk H.] TUM, Inst Adv Study, Focus Grp Clin Cell Proc & Purificat, D-81675 Munich, Germany; [Flossdorf, Michael; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany; [Flossdorf, Michael; Hoefer, Thomas] Heidelberg Univ, BioQuant Ctr, D-69120 Heidelberg, Germany; [Schiemann, Matthias; Busch, Dirk H.] TUM, Helmholtz Ctr Munich Neuherberg, Clin Cooperat Grp Antigen Specif Immunotherapy &, D-81675 Munich, Germany; [Drexler, Ingo] Univ Dusseldorf, Univ Klinikum Dusseldorf, Inst Virol, D-40225 Dusseldorf, Germany; [Riddell, Stanley R.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Immunol, Seattle, WA 98109 USA; [Riddell, Stanley R.] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Busch, Dirk H.] German Ctr Infect Res DZIF, D-81675 Munich, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; German Center for Infection Research	Busch, DH (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany.	dirk.busch@tum.de	Höfer, Thomas/G-5665-2013; Buchholz, Veit R./AAF-6966-2021	Höfer, Thomas/0000-0003-3560-8780; Buchholz, Veit R./0000-0003-0441-3913	Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer; BMBF e:Bio program (T-Sys); National Science Foundation [NSF PHY11-25915];  [SFB TR36 (TP-B10/13)];  [SFB 1054 (TP-B09)]	Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer; BMBF e:Bio program (T-Sys)(Federal Ministry of Education & Research (BMBF)); National Science Foundation(National Science Foundation (NSF)); ; 	D.H.B. holds shares in STAGE Cell Therapeutics and S.R.R. holds shares in Juno Therapeutics. This work was supported by the SFB TR36 (TP-B10/13), the SFB 1054 (TP-B09), the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer, the BMBF e:Bio program (T-Sys), and the National Science Foundation under Grant No. NSF PHY11-25915.	BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Buchholz VR, 2011, CURR OPIN IMMUNOL, V23, P549, DOI 10.1016/j.coi.2011.05.002; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Ciocca ML, 2012, J IMMUNOL, V188, P4145, DOI 10.4049/jimmunol.1200176; Cobbold M, 2005, J EXP MED, V202, P379, DOI 10.1084/jem.20040613; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Holmes S, 2005, P NATL ACAD SCI USA, V102, P5519, DOI 10.1073/pnas.0501437102; Jensen MC, 2014, IMMUNOL REV, V257, P127, DOI 10.1111/imr.12139; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Lugli E, 2013, J CLIN INVEST, V123, P594, DOI 10.1172/JCI66327; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Maus MV, 2014, ANNU REV IMMUNOL, V32, P189, DOI 10.1146/annurev-immunol-032713-120136; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Neuenhahn M, 2009, IMMUNITY, V31, P702, DOI 10.1016/j.immuni.2009.10.002; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Plumlee CR, 2013, IMMUNITY, V39, P347, DOI 10.1016/j.immuni.2013.07.014; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schiemann M, 2003, EUR J IMMUNOL, V33, P2875, DOI 10.1002/eji.200324224; Schmitt A, 2011, TRANSFUSION, V51, P591, DOI 10.1111/j.1537-2995.2010.02940.x; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Schumacher TNM, 2010, NAT REV IMMUNOL, V10, P621, DOI 10.1038/nri2822; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Staib Caroline, 2004, Methods Mol Biol, V269, P77; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Stemberger C, 2009, SEMIN IMMUNOL, V21, P62, DOI 10.1016/j.smim.2009.02.004; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; Wakim LM, 2010, CURR OPIN IMMUNOL, V22, P274, DOI 10.1016/j.coi.2010.03.003; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; WU AM, 1968, J EXP MED, V127, P455, DOI 10.1084/jem.127.3.455; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326	65	213	217	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					116	126		10.1016/j.immuni.2014.05.018	http://dx.doi.org/10.1016/j.immuni.2014.05.018			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035956	Bronze			2022-12-18	WOS:000341444200015
J	Wies, E; Wang, MK; Maharaj, NP; Chen, K; Zhou, S; Finberg, RW; Gack, MU				Wies, Effi; Wang, May K.; Maharaj, Natalya P.; Chen, Kan; Zhou, Shenghua; Finberg, Robert W.; Gack, Michaela U.			Dephosphorylation of the RNA Sensors RIG-I and MDA5 by the Phosphatase PP1 Is Essential for Innate Immune Signaling	IMMUNITY			English	Article							PATTERN-RECOGNITION RECEPTORS; UBIQUITIN LIGASE; PROTEIN PHOSPHATASE-1; NEGATIVE REGULATION; ANTIVIRAL ACTIVITY; STRUCTURAL BASIS; ADAPTER PROTEIN; VIRAL-RNA; PHOSPHORYLATION; ACTIVATION	RIG-I and MDA5 have emerged as key cytosolic sensors for the detection of RNA viruses and lead to antiviral interferon (IFN) production. Recent studies have highlighted the importance of posttranslational modifications for controlling RIG-I antiviral activity. However, the regulation of MDA5 signal-transducing ability remains unclear. Here, we show that MDA5 signaling activity is regulated by a dynamic balance between phosphorylation and dephosphorylation of its caspase recruitment domains (CARDs). Employing a phosphatome RNAi screen, we identified PP1 alpha and PP1 gamma as the primary phosphatases that are responsible for MDA5 and RIG-I dephosphorylation and that lead to their activation. Silencing of PP1 alpha and PP1 gamma enhanced RIG-I and MDA5 CARD phosphorylation and reduced antiviral IFN-beta production. PP1 alpha- and PP1 gamma-depleted cells were impaired in their ability to induce IFN-stimulated gene expression, which resulted in enhanced RNA virus replication. This work identifies PP1 alpha and PP1 gamma as regulators of antiviral innate immune responses to various RNA viruses, including influenza virus, paramyxovirus, dengue virus, and picornavirus.	[Wies, Effi; Wang, May K.; Maharaj, Natalya P.; Chen, Kan; Gack, Michaela U.] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Microbiol, Southborough, MA 01772 USA; [Wang, May K.; Gack, Michaela U.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Zhou, Shenghua; Finberg, Robert W.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA	Harvard University; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	Gack, MU (corresponding author), Harvard Univ, Sch Med, New England Primate Res Ctr, Div Microbiol, 1 Pine Hill Dr, Southborough, MA 01772 USA.	michaela_gack@hms.harvard.edu		Chen, Kan/0000-0002-5007-0205	United States Public Health Service [R01 AI087846, R21 AI097699, RR00168]; German Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097699, R01AI087846] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); German Research Foundation(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Public Health Service grants R01 AI087846, R21 AI097699, and RR00168 (M. U. G.) and by the German Research Foundation (E. W.). We greatly thank J. Jung, L. Gehrke, S. Whelan, M. Colonna, and A. Garcia-Sastre for providing reagents and R. Tomaino for mass spectrometry. E. Wies and M. Wang performed the majority of the experiments. M. Gack performed experiments and analyzed data. N. Maharaj and K. Chen performed experiments and assisted in data collection. S. Zhou and R. Finberg provided Mda5-deficient MEFs. M. Gack organized this study and wrote the paper.	Aebersold R, 2001, CHEM REV, V101, P269, DOI 10.1021/cr990076h; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Cohen PTW, 2002, J CELL SCI, V115, P241; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garcia A, 2004, CR BIOL, V327, P93, DOI 10.1016/j.crvi.2004.01.001; Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Maharaj NP, 2012, J VIROL, V86, P1358, DOI 10.1128/JVI.06543-11; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun ZG, 2011, J VIROL, V85, P1036, DOI 10.1128/JVI.01734-10; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	34	213	219	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					437	449		10.1016/j.immuni.2012.11.018	http://dx.doi.org/10.1016/j.immuni.2012.11.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23499489	Green Accepted, Bronze			2022-12-18	WOS:000330941500010
J	Mukasa, R; Balasubramani, A; Lee, YK; Whitley, SK; Weaver, BT; Shibata, Y; Crawford, GE; Hatton, RD; Weaver, CT				Mukasa, Ryuta; Balasubramani, Arland; Lee, Yun Kyung; Whitley, Sarah K.; Weaver, Benjamin T.; Shibata, Yoichiro; Crawford, Gregory E.; Hatton, Robin D.; Weaver, Casey T.			Epigenetic Instability of Cytokine and Transcription Factor Gene Loci Underlies Plasticity of the T Helper 17 Cell Lineage	IMMUNITY			English	Article							ROR-GAMMA-T; TH17 CELLS; DIFFERENTIATION; EXPRESSION; INFLAMMATION; ELEMENTS; DEVELOP; CHIP	Phenotypic plasticity of T helper 17 (Th17) cells suggests instability of chromatin structure of key genes of this lineage. We identified epigenetic modifications across the clustered II17a and II17f and the Ifng loci before and after differential IL-12 or TGF-beta cytokine signaling, which induce divergent fates of Th17 cell precursors. We found that Th17 cell precursors had substantial remodeling of the Ifng locus, but underwent critical additional modifications to enable high expression when stimulated by IL-12. Permissive modifications across the II17a-II17f locus were amplified by TGF-beta signaling in Th17 cells, but were rapidly reversed downstream of IL-12-induced silencing of the Rorc gene by the transcription factors STAT4 and T-bet. These findings reveal substantial chromatin instability of key transcription factor and cytokine genes of Th17 cells and support a model of Th17 cell lineage plasticity in which cell-extrinsic factors modulate Th17 cell fates through differential effects on the epigenetic status of Th17 cell lineage factors.	[Mukasa, Ryuta; Balasubramani, Arland; Lee, Yun Kyung; Weaver, Benjamin T.; Hatton, Robin D.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Balasubramani, Arland; Lee, Yun Kyung; Whitley, Sarah K.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Mukasa, Ryuta] Daiichi Sankyo Co Ltd, Biol Res Labs 3, Tokyo 1348630, Japan; [Shibata, Yoichiro; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Daiichi Sankyo Company Limited; Duke University	Hatton, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	rdzialo@uab.edu; cweaver@uab.edu		Hatton, Robin/0000-0002-4797-9899; Weaver, Casey/0000-0002-2180-1793	National Institutes of Health; Daichi-Sankyo Co. Ltd.; UAB Medical Scientist Training Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035783, R01AI077574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daichi-Sankyo Co. Ltd.(Daiichi Sankyo Company Limited); UAB Medical Scientist Training Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are thankful to members of the Weaver laboratory for helpful comments and suggestions. We gratefully acknowledge M.H. Kaplan (University of Indiana) for provision of spleens from B6.Stat4<SUP>-/-</SUP> mice and C.A. Klug (UAB) for provision of the IRES-GFP retroviral vector. We also thank J. Oliver, C. Song, M. Blake, B.J. Parsons, and S. Sinclair for expert technical assistance and G. Gaskins for editorial assistance and acknowledge X. He and the UAB Epitope Recognition and Immunoreagent Core Facility for antibody preparations and the UAB Digestive Diseases Research Developmental Center (DDRDC) for generation and phenotyping of gene-targeted mice. This work was supported by grants from the National Institutes of Health (C.T.W., R.D.H., and G.E.C.), Daichi-Sankyo Co. Ltd. (C.T.W. and R.M.), and the UAB Medical Scientist Training Program (S.K.W.).	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; GOTTA CV, 2003, BLOOD, V101, P4342; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mukasa R, 2005, J IMMUNOL METHODS, V303, P105, DOI 10.1016/j.jim.2005.06.006; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Shibata Y, 2009, METHODS MOL BIOL, V556, P177, DOI 10.1007/978-1-60327-192-9_13; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Thal MA, 2009, P NATL ACAD SCI USA, V106, P552, DOI 10.1073/pnas.0802550106; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	36	213	219	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 28	2010	32	5					616	627		10.1016/j.immuni.2010.04.016	http://dx.doi.org/10.1016/j.immuni.2010.04.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20471290	Green Accepted, Bronze			2022-12-18	WOS:000278280500008
J	Tsai, SE; Shameli, A; Yamanouchi, J; Clemente-Casares, X; Wang, JG; Serra, P; Yang, Y; Medarova, Z; Moore, A; Santamaria, P				Tsai, Sue; Shameli, Afshin; Yamanouchi, Jun; Clemente-Casares, Xavier; Wang, Jinguo; Serra, Pau; Yang, Yang; Medarova, Zdravka; Moore, Anna; Santamaria, Pere			Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells	IMMUNITY			English	Article							NONOBESE DIABETIC MICE; AVIDITY MATURATION; NOD MICE; EFFECTOR; POPULATION; TOLERANCE; RESPONSES; ANTIGENS	Blunting autoreactivity without compromising immunity remains an elusive goal in the treatment of autoimmunity. We show that progression to autoimmune diabetes results in the conversion of naive low-avidity autoreactive CD8(+) T cells into memory-like autoregulatory cells that can be expanded in vivo with nanoparticles coated with disease-relevant peptide-major histocompatibility complexes (pMHC-NP). Treatment of NOD mice with monospecific pMHC-NPs expanded cognate autoregulatory T cells, suppressed the recruitment of noncognate specificities, prevented disease in prediabetic mice, and restored normoglycemia in diabetic animals. pMHC-NP therapy was inconsequential in mice engineered to bear an immune system unresponsive to the corresponding epitope, owing to absence of epitope-experienced autoregulatory T cells. pMHC-NP-expanded autoregulatory T cells suppressed local presentation of autoantigens in an interferon-gamma-, indoleamine 2,3-dioxygenase-, and perforin-dependent manner. Nanoparticles coated with human diabetes-relevant pHLA complexes restored normoglycemia in a humanized model of diabetes. These observations expose a paradigm in the pathogenesis of autoimmunity amenable for therapeutic intervention.	[Tsai, Sue; Shameli, Afshin; Yamanouchi, Jun; Clemente-Casares, Xavier; Wang, Jinguo; Serra, Pau; Yang, Yang; Santamaria, Pere] Univ Calgary, Dept Microbiol & Infect Dis, Julia McFarlane Diabet Res Ctr, Calgary, AB T2N 4N1, Canada; [Tsai, Sue; Shameli, Afshin; Yamanouchi, Jun; Clemente-Casares, Xavier; Wang, Jinguo; Serra, Pau; Yang, Yang; Santamaria, Pere] Univ Calgary, Inst Inflammat Infect & Immun, Calgary, AB T2N 4N1, Canada; [Yang, Yang] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Medarova, Zdravka; Moore, Anna] Massachusetts Gen Hosp, Dept Radiol, MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Mol Imaging Lab, Charlestown, MA 02129 USA	University of Calgary; University of Calgary; University of Calgary; Harvard University; Massachusetts General Hospital	Santamaria, P (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Julia McFarlane Diabet Res Ctr, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	psantama@ucalgary.ca	Santamaria, Pere/ABF-6823-2021	Tsai, Sue/0000-0002-6261-5233; Wang, Jinguo/0000-0002-5213-8314; Clemente-Casares, Xavier/0000-0002-8627-4971	Canadian Institutes of Health Research; Juvenile Diabetes Research Foundation (JDRF); Natural Sciences and Engineering Research Council of Canada; Canadian Diabetes Association (CDA); Alberta Innovates-Health Solutions; Diabetes Association (Foothills)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Diabetes Association (CDA); Alberta Innovates-Health Solutions; Diabetes Association (Foothills)	We thank N Ghyselinck for the pFIEx vector, V Cerundolo for the A2-Kb construct, D Serreze for NOD Ifng<SUP>-/-</SUP> and NOD HHD mice. S Bou, M DeCrom, M Foote. C Gwozd, B Han, T Irvine, J Mauricio, H Metselaar and S Thiessen for technical assistance. L Kennedy and L Robertson for FACS, C Huang for help with IPGTTs, and L Edelstein-Keshet, J Elliott, A Khadra, Y Shi, T Stratmann, and J Verdaguer for reading the manuscript This work was supported by the Canadian Institutes of Health Research, the Juvenile Diabetes Research Foundation (JDRF), the Natural Sciences and Engineering Research Council of Canada, and the Canadian Diabetes Association (CDA) S T,A S, and P Serra were supported by Alberta Innovates-Health Solutions, and J W is supported by the CDA P Santamaria is a Scientist of Alberta Innovates and a JDRF Scholar The JMDRC is supported by the Diabetes Association (Foothills)	AICHELE P, 1994, P NATL ACAD SCI USA, V91, P444, DOI 10.1073/pnas.91.2.444; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Amrani A, 2001, J IMMUNOL, V167, P655, DOI 10.4049/jimmunol.167.2.655; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Cernea S, 2010, CLIN IMMUNOL, V134, P121, DOI 10.1016/j.clim.2009.09.005; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; Han BY, 2005, NAT MED, V11, P645, DOI 10.1038/nm1250; Jiang H, 2009, ADV IMMUNOL, V102, P95, DOI 10.1016/S0065-2776(09)01202-4; Jurgens B, 2009, BLOOD, V114, P3235, DOI 10.1182/blood-2008-12-195073; Kaufman A, 2009, DIABETES-METAB RES, V25, P302, DOI 10.1002/dmrr.933; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lieberman SM, 2004, J IMMUNOL, V173, P6727, DOI 10.4049/jimmunol.173.11.6727; Lieberman SM, 2003, TISSUE ANTIGENS, V62, P359, DOI 10.1034/j.1399-0039.2003.00152.x; MILLER SD, 1979, J EXP MED, V149, P758, DOI 10.1084/jem.149.3.758; Moore A, 2004, DIABETES, V53, P1459, DOI 10.2337/diabetes.53.6.1459; Oh S, 2004, P NATL ACAD SCI USA, V101, P15154, DOI 10.1073/pnas.0406649101; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Serreze DV, 2001, DIABETES, V50, P1992, DOI 10.2337/diabetes.50.9.1992; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; Trudeau JD, 2003, J CLIN INVEST, V111, P217, DOI 10.1172/JCI200316409; Tsai S, 2008, ADV IMMUNOL, V100, P79, DOI 10.1016/S0065-2776(08)00804-3; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Walter U, 2005, CURR OPIN IMMUNOL, V17, P624, DOI 10.1016/j.coi.2005.09.014; Williams MA, 2006, IMMUNOL REV, V211, P146, DOI 10.1111/j.0105-2896.2006.00389.x; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	33	213	231	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					568	580		10.1016/j.immuni.2010.03.015	http://dx.doi.org/10.1016/j.immuni.2010.03.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20381385	Bronze			2022-12-18	WOS:000277171900015
J	Merrell, KT; Benschop, RJ; Gauld, SB; Aviszus, K; Decote-Ricardo, D; Wysocki, LJ; Cambier, JC				Merrell, Kevin T.; Benschop, Robert J.; Gauld, Stephen B.; Aviszus, Katja; Decote-Ricardo, Debora; Wysocki, Lawrence J.; Cambier, John C.			Identification of anergic B cells within a wild-type repertoire	IMMUNITY			English	Article							TRANSGENIC MICE; SELF-TOLERANCE; LYMPHOCYTES-B; CLONAL ANERGY; MARGINAL ZONE; DEVELOPMENTAL ARREST; IN-VIVO; RECEPTOR; ANTIGEN; ANTIBODY	The contribution of anergy to silencing of autoreactive B cells in physiologic settings is unknown. By comparing anergic and nonanergic immunoglobulin-transgenic mouse strains, we defined a set of surface markers that were used for presumptive identification of an anergic B cell cohort within a normal repertoire. Like anergic transgenic B cells, these physiologic anergic cells exhibited high basal intracellular free calcium and did not mobilize calcium, initiate tyrosine phosphorylation, proliferate, upregulate activation markers, or mount an immune response upon antigen-receptor stimulation. Autoreactive B cells were overrepresented in this cohort. On the basis of the frequency and lifespan of these cells, it appears that as many as 50% of newly produced B cells are destined to become anergic. In conclusion, our findings indicate that anergy is probably the primary mechanism by which autoreactive B cells are silenced. Thus maintenance of the unresponsiveness of anergic cells is critical for prevention of autoimmunity.	Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Denver, CO 80206 USA; Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; Eli Lilly	Cambier, JC (corresponding author), Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, Denver, CO 80206 USA.	CambierJ@njc.org	Decote-Ricardo, Debora/O-6480-2019	Cambier, John/0000-0002-7803-242X				Acevedo-Suarez CA, 2005, J IMMUNOL, V174, P827, DOI 10.4049/jimmunol.174.2.827; ADAMS E, 1990, P NATL ACAD SCI USA, V87, P5687, DOI 10.1073/pnas.87.15.5687; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Bell SE, 2004, EUR J IMMUNOL, V34, P2237, DOI 10.1002/eji.200425054; Benschop RJ, 1999, J EXP MED, V190, P749, DOI 10.1084/jem.190.6.749; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Borrero M, 2002, J IMMUNOL, V168, P13, DOI 10.4049/jimmunol.168.1.13; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chu YP, 2002, INT IMMUNOL, V14, P45, DOI 10.1093/intimm/14.1.45; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3; Devireddy LR, 2003, MOL CELL BIOL, V23, P4532, DOI 10.1128/MCB.23.13.4532-4541.2003; ERIS JM, 1994, P NATL ACAD SCI USA, V91, P4392, DOI 10.1073/pnas.91.10.4392; Fields ML, 2005, IMMUNOL REV, V204, P165, DOI 10.1111/j.0105-2896.2005.00238.x; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Glynne R, 2000, IMMUNOL REV, V176, P216; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hippen KL, 2005, J IMMUNOL, V175, P909, DOI 10.4049/jimmunol.175.2.909; Huang KP, 2004, J NEUROSCI, V24, P10660, DOI 10.1523/JNEUROSCI.2213-04.2004; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; MCKEARN JP, 1984, J IMMUNOL, V132, P332; Mechta-Grigoriou F, 2000, DEVELOPMENT, V127, P119; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Nemazee D, 1996, IMMUNOL TODAY, V17, P25, DOI 10.1016/0167-5699(96)80565-2; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Noorchashm H, 1999, INT IMMUNOL, V11, P765, DOI 10.1093/intimm/11.5.765; Norsworthy PJ, 2004, J IMMUNOL, V172, P3406, DOI 10.4049/jimmunol.172.6.3406; NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; PIKE BL, 1983, EUR J IMMUNOL, V13, P214, DOI 10.1002/eji.1830130307; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Srivastava B, 2005, J EXP MED, V202, P1225, DOI 10.1084/jem.20051038; Svaren J, 1996, MOL CELL BIOL, V16, P3545; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; TSAO BP, 1993, EUR J IMMUNOL, V23, P2332, DOI 10.1002/eji.1830230942; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907	48	213	216	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2006	25	6					953	962		10.1016/j.immuni.2006.10.017	http://dx.doi.org/10.1016/j.immuni.2006.10.017			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17174121	Bronze			2022-12-18	WOS:000243087500014
J	Simmons, A; Aluvihare, V; McMichael, A				Simmons, A; Aluvihare, V; McMichael, A			Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators	IMMUNITY			English	Article							LONG TERMINAL REPEAT; SIMIAN IMMUNODEFICIENCY VIRUS; PERIPHERAL-BLOOD LYMPHOCYTES; TAT-ASSOCIATED KINASE; GROWTH-FACTOR-BETA; MYB PROTEIN BINDS; RNA-POLYMERASE-II; NF-KAPPA-B; P-TEFB; EXPRESSION	Gene expression profiling was used to explore the role of Nef in HIV. Nef induces a transcriptional program in T cells that is 97% identical to that of anti-CD3 T cell activation. This program is inhibited in the presence of cyclosporin. A requirement for TCR zeta and ZAP-70 is demonstrated for formation of the complete profile. Among eight factors particular to the anti-CDS activation profile are IL16 and YY1, negative regulators of HIV transcription. In contrast, Nef exclusively upregulates factors positively regulating HIV, including Tat-SF1, U1 SNRNP, and IRF-2. New genes associated with Nef include CDK9, the induction of which enhances Tat function. Thus, Nef acts as a master switch early in the viral life cycle, forcing an environment conducive to dynamic viral production.	John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England; Wellcome Trust Immunol Unit, Cambridge CB2 2QH, England	University of Oxford; University of Cambridge	McMichael, A (corresponding author), John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England.	andrew.mcmichael@ndm.ox.ac.uk		Simmons, Alison/0000-0003-3454-0710				Aiken C, 1998, VIROLOGY, V248, P139, DOI 10.1006/viro.1998.9254; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Ashe MP, 1997, EMBO J, V16, P5752, DOI 10.1093/emboj/16.18.5752; BANDRES JC, 1994, J VIROL, V68, P3243, DOI 10.1128/JVI.68.5.3243-3249.1994; Baskaran R, 1999, CELL GROWTH DIFFER, V10, P387; Bassuk AG, 1997, J VIROL, V71, P3563, DOI 10.1128/JVI.71.5.3563-3573.1997; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; BOSSELUT R, 1992, VIROLOGY, V186, P764, DOI 10.1016/0042-6822(92)90044-P; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Center DM, 2000, IMMUNOL TODAY, V21, P273, DOI 10.1016/S0167-5699(00)01629-7; Charreau B, 2000, TRANSPLANTATION, V70, P354, DOI 10.1097/00007890-200007270-00021; Chepenik LG, 1998, GENE, V210, P37, DOI 10.1016/S0378-1119(98)00033-X; CHOWERS MY, 1995, VIROLOGY, V212, P451, DOI 10.1006/viro.1995.1502; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Collette Y, 1996, J BIOL CHEM, V271, P6333, DOI 10.1074/jbc.271.11.6333; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; DASGUPTA P, 1990, P NATL ACAD SCI USA, V87, P8090, DOI 10.1073/pnas.87.20.8090; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fackler OT, 2000, MOL CELL BIOL, V20, P2619, DOI 10.1128/MCB.20.7.2619-2627.2000; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Flory E, 1996, J VIROL, V70, P2260, DOI 10.1128/JVI.70.4.2260-2268.1996; Gatignol A, 1996, GENE EXPRESSION, V5, P217; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Greenway A, 1996, J VIROL, V70, P6701, DOI 10.1128/JVI.70.10.6701-6708.1996; Gulizia RJ, 1997, J VIROL, V71, P4161, DOI 10.1128/JVI.71.5.4161-4164.1997; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Herrmann CH, 1998, J VIROL, V72, P9881, DOI 10.1128/JVI.72.12.9881-9888.1998; Hodge DR, 1998, J BIOL CHEM, V273, P15727, DOI 10.1074/jbc.273.25.15727; Howe AYM, 1998, J VIROL, V72, P9827, DOI 10.1128/JVI.72.12.9827-9834.1998; Iafrate AJ, 1997, EMBO J, V16, P673, DOI 10.1093/emboj/16.4.673; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; KEKOW J, 1990, P NATL ACAD SCI USA, V87, P8321, DOI 10.1073/pnas.87.21.8321; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim JB, 1999, MOL CELL BIOL, V19, P5960; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Li JM, 1998, MOL CELL BIOL, V18, P110, DOI 10.1128/MCB.18.1.110; Luo W, 1997, J VIROL, V71, P9531, DOI 10.1128/JVI.71.12.9531-9537.1997; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; MERCIER G, 1994, RES VIROLOGY, V145, P361, DOI 10.1016/S0923-2516(07)80041-0; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; MODIANO JF, 1994, J BIOL CHEM, V269, P32972; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Rabbi MF, 1997, VIROLOGY, V233, P235, DOI 10.1006/viro.1997.8602; Renkema GH, 1999, CURR BIOL, V9, P1407, DOI 10.1016/S0960-9822(00)80086-X; ROSEN CA, 1986, J VIROL, V57, P379, DOI 10.1128/JVI.57.1.379-384.1986; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; Saifuddin M, 2000, J IMMUNOL, V164, P3941, DOI 10.4049/jimmunol.164.8.3941; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; SANCHEZPESCADOR R, 1985, SCIENCE, V227, P484, DOI 10.1126/science.2578227; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Sieweke MH, 1998, EMBO J, V17, P1728, DOI 10.1093/emboj/17.6.1728; Smith BL, 1996, J BIOL CHEM, V271, P16753, DOI 10.1074/jbc.271.28.16753; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Valentine PV, 1998, CRISIS INTERV TIME-L, V4, P1; VanLint C, 1997, J VIROL, V71, P6113, DOI 10.1128/JVI.71.8.6113-6127.1997; Wainberg Z, 1997, VIROLOGY, V233, P364, DOI 10.1006/viro.1997.8618; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	75	213	222	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2001	14	6					763	777		10.1016/S1074-7613(01)00158-3	http://dx.doi.org/10.1016/S1074-7613(01)00158-3			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420046	Bronze			2022-12-18	WOS:000169495100012
J	Okada, T; Maeda, A; Iwamatsu, A; Gotoh, K; Kurosaki, T				Okada, T; Maeda, A; Iwamatsu, A; Gotoh, K; Kurosaki, T			BCAP: The tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation	IMMUNITY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; GUANOSINE TRIPHOSPHATASES; PHOSPHOLIPASE C-GAMMA-2; SIGNAL-TRANSDUCTION; MEDIATED ACTIVATION; LIPID RAFTS; PI 3-KINASE; C-JUN; CD19; SYK	Tyrosine phosphorylation of adaptor proteins permits the B cell antigen receptor (BCR)-associated protein tyrosine kinases to regulate downstream effector molecules. Here, we report the identification of a novel B cell adaptor for phosphoinositide 3-kinase (PI3K), termed BCAP. Tyrosine phosphorylation of BCAP is mediated by Syk and Btk, thereby providing binding site(s) for the p85 subunit of PI3K. Disruption of the BCAP gene in the DT40 B cell line inhibits BCR-mediated phosphatidylinositol 3,4,5-trisphosphate generation, leading to impaired Akt response. Moreover, recruitment of PI3K to glycolipid-enriched microdomains (GEMs) is significantly attenuated in the absence of BCAP. Hence, these data suggest that BCAP bridges BCR-associated kinases to the PI3K pathway by regulating PI3K localization.	Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan; Kirin Brewery Co Ltd, Ctr Labs Key Technol, Yokohama, Kanagawa 2360004, Japan; Natl Inst Physiol Sci, Labs Humoral Informat, Okazaki, Aichi 4448585, Japan	Kansai Medical University; Kirin Brewery Company Limited; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Kurosaki, T (corresponding author), Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan.	kurosaki@mxr.mesh.ne.jp	Kurosaki, Tomohiro/D-1306-2009; Okada, Takaharu/N-7931-2015; Maeda, Akito/AAX-6252-2020	Kurosaki, Tomohiro/0000-0002-6352-304X; Maeda, Akito/0000-0001-8776-9135				Aman MJ, 2000, CURR BIOL, V10, P393, DOI 10.1016/S0960-9822(00)00415-2; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; Buhl AM, 1999, J IMMUNOL, V162, P4438; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Gillham H, 1999, J CELL BIOL, V146, P869, DOI 10.1083/jcb.146.4.869; Gold MR, 2000, CURR TOP MICROBIOL, V245, P77; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Ishiai M, 2000, J EXP MED, V192, P847, DOI 10.1084/jem.192.6.847; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kurosaki T, 1997, J BIOL CHEM, V272, P15595, DOI 10.1074/jbc.272.25.15595; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Langlet C, 2000, CURR OPIN IMMUNOL, V12, P250, DOI 10.1016/S0952-7915(00)00084-4; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Nishizumi H, 1998, J EXP MED, V187, P1343, DOI 10.1084/jem.187.8.1343; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; SHOELSON SE, 1993, EMBO J, V12, P795, DOI 10.1002/j.1460-2075.1993.tb05714.x; Smith BP, 1998, EXP APPL ACAROL, V22, P187, DOI 10.1023/A:1006010230247; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Tamir I, 2000, CURR OPIN IMMUNOL, V12, P307, DOI 10.1016/S0952-7915(00)00092-3; Tamir I, 1998, ONCOGENE, V17, P1353, DOI 10.1038/sj.onc.1202187; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yasuda T, 2000, J EXP MED, V191, P641, DOI 10.1084/jem.191.4.641; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	50	213	218	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2000	13	6					817	827		10.1016/S1074-7613(00)00079-0	http://dx.doi.org/10.1016/S1074-7613(00)00079-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	387VJ	11163197	Bronze			2022-12-18	WOS:000166142300007
J	Ishido, S; Choi, JK; Lee, BS; Wang, CY; DeMaria, M; Johnson, RP; Cohen, GB; Jung, JU				Ishido, S; Choi, JK; Lee, BS; Wang, CY; DeMaria, M; Johnson, RP; Cohen, GB; Jung, JU			Inhibition of natural killer cell-mediated cytotoxicity by kaposi's sarcoma-associated herpesvirus K5 protein	IMMUNITY			English	Article							MHC CLASS-I; ACTIN-BINDING PROTEIN-280; HEAVY-CHAINS FREE; NK CELLS; CYTOPLASMIC DOMAIN; DNA-SEQUENCES; FILAMIN; LINE; IDENTIFICATION; RECEPTORS	Kaposi's sarcoma-associated herpesvirus (KSHV) K3 and K5 proteins dramatically downregulate MHC class I molecules. However, although MHC class I downregulation may protect KSHV-infected cells from cytotoxic T lymphocyte recognition, these cells become potential targets for natural killer (NK) cell-mediated lysis. We now show that K5 also downregulates ICAM-1 and B7-2, which are ligands for NK cell-mediated cytotoxicity receptors. As a consequence, K5 expression drastically inhibits NK cell-mediated cytotoxicity. Conversely, de novo expression of B7-2 and ICAM-1 resensitizes the W-expressing cells to NK cell-mediated cytotoxicity. This is a novel viral immune evasion strategy where KSHV K5 achieves immune avoidance by downregulation of cellular ligands for NK cell-mediated cytotoxicity receptors.	Harvard Univ, Sch Med, New England Reg Primate Res Ctr, Div Tumor Virol, Southborough, MA 01772 USA; Harvard Univ, Sch Med, New England Reg Primate Res Ctr, Div Immunol, Southborough, MA 01772 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, AIDS Res Ctr, Charlestown, MA 02129 USA	Harvard University; Harvard University; Harvard University; Massachusetts General Hospital	Jung, JU (corresponding author), Harvard Univ, Sch Med, New England Reg Primate Res Ctr, Div Tumor Virol, Southborough, MA 01772 USA.				NATIONAL CANCER INSTITUTE [R01CA082057, R01CA031363, R01CA086841] Funding Source: NIH RePORTER; NCI NIH HHS [CA86841, CA31363, CA82057] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AZUMA M, 1992, J IMMUNOL, V149, P1115; Bakker ABH, 2000, HUM IMMUNOL, V61, P18, DOI 10.1016/S0198-8859(99)00160-3; BECK S, 1988, NATURE, V331, P269, DOI 10.1038/331269a0; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Blery M, 2000, HUM IMMUNOL, V61, P51, DOI 10.1016/S0198-8859(99)00157-3; Bottino C, 2000, HUM IMMUNOL, V61, P1, DOI 10.1016/S0198-8859(99)00162-7; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Cunningham JG, 1996, J BIOL CHEM, V271, P11581, DOI 10.1074/jbc.271.19.11581; DANG LH, 1990, J IMMUNOL, V144, P4082; Desrosiers RC, 1997, J VIROL, V71, P9764, DOI 10.1128/JVI.71.12.9764-9769.1997; DU ZJ, 1995, BIOTECHNIQUES, V18, P376; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; Galea-Lauri J, 1999, J IMMUNOL, V163, P62; Ganem D, 1997, CELL, V91, P157, DOI 10.1016/S0092-8674(00)80398-0; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; Geginat J, 2000, EUR J IMMUNOL, V30, P1136, DOI 10.1002/(SICI)1521-4141(200004)30:4<1136::AID-IMMU1136>3.0.CO;2-3; Giacomini P, 1997, TISSUE ANTIGENS, V50, P555, DOI 10.1111/j.1399-0039.1997.tb02913.x; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Haque M, 2000, J VIROL, V74, P2867, DOI 10.1128/JVI.74.6.2867-2875.2000; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Karre K, 1997, NATURE, V386, P446, DOI 10.1038/386446a0; Lanier LL, 2000, J EXP MED, V191, P1259, DOI 10.1084/jem.191.8.1259; Lanier LL, 1998, CELL, V92, P705, DOI 10.1016/S0092-8674(00)81398-7; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Leibson PJ, 1998, IMMUNITY, V9, P289, DOI 10.1016/S1074-7613(00)80611-1; Liu AG, 1999, J VAC SCI TECHNOL B, V17, P875, DOI 10.1116/1.590667; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Martin-Fontecha A, 1999, J IMMUNOL, V162, P5910; Mesri EA, 1996, J EXP MED, V183, P2385, DOI 10.1084/jem.183.5.2385; Miller DM, 1999, CURR OPIN IMMUNOL, V11, P94, DOI 10.1016/S0952-7915(99)80017-X; Neipel F, 1997, J VIROL, V71, P4187, DOI 10.1128/JVI.71.6.4187-4192.1997; Nichols RW, 1997, TECHNOL SOC, V19, P71, DOI 10.1016/S0160-791X(96)00047-4; OHTA Y, 1991, CELL, V67, P275, DOI 10.1016/0092-8674(91)90179-3; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; PATARROYO M, 1990, IMMUNOL REV, V114, P67, DOI 10.1111/j.1600-065X.1990.tb00562.x; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Reyburn HT, 1997, NATURE, V386, P514, DOI 10.1038/386514a0; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Rose TM, 1997, J VIROL, V71, P4138, DOI 10.1128/JVI.71.5.4138-4144.1997; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; SCHULZ TF, 1998, HUMAN TUMOR VIRUSES, P87; Searles RP, 1999, J VIROL, V73, P3040, DOI 10.1128/JVI.73.4.3040-3053.1999; Setini A, 1996, HUM IMMUNOL, V46, P69, DOI 10.1016/0198-8859(96)00011-0; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Sprent J, 1999, J IMMUNOL, V163, P4629; SPRING B, 1985, IMMUNOGENETICS, V21, P277, DOI 10.1007/BF00375380; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Takafuta T, 1998, J BIOL CHEM, V273, P17531, DOI 10.1074/jbc.273.28.17531; Thompson TG, 2000, J CELL BIOL, V148, P115, DOI 10.1083/jcb.148.1.115; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Wilson JL, 1999, J IMMUNOL, V163, P4207; YODOI J, 1985, J IMMUNOL, V134, P1623; Yokoyama WM, 1998, CURR OPIN IMMUNOL, V10, P298, DOI 10.1016/S0952-7915(98)80168-4	61	213	219	1	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2000	13	3					365	374		10.1016/S1074-7613(00)00036-4	http://dx.doi.org/10.1016/S1074-7613(00)00036-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021534	Bronze			2022-12-18	WOS:000089616400009
J	Chambers, BJ; Salcedo, M; Ljunggren, HG				Chambers, BJ; Salcedo, M; Ljunggren, HG			Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)	IMMUNITY			English	Article							H-2-DEFICIENT LYMPHOMA VARIANTS; COLONY-STIMULATING FACTOR; NK CELLS; T-CELLS; MEDIATED CYTOTOXICITY; DENDRITIC CELLS; MICE DEFICIENT; MHC MOLECULES; EXPRESSION; REJECTION	NK cell-mediated cytotoxicity is influenced by triggering as well as inhibitory signals. The identification of inhibitory signals provided by MHC class I molecules has recently attracted significant attention. Much less is known about putative triggering signals. Using purified populations of mouse NK cells, we demonstrate that the CD80 (B7-1) gene product functions as a triggering signal for NK cell-mediated cytotoxicity. The strength of this response is such that it overrides the protection mediated by MHC class I molecules. Triggering of mouse NK cells by B7-1 occurred even in the absence of CD28 and could not be blocked by either anti-CD28 or anti-CTLA-4 antibodies. NK cells may thus, at least in part, use receptors other than CD28 and CTLA-4 in their interaction with B7-1. Furthermore, we demonstrate that bone marrow-derived macrophages and dendritic cells are highly susceptible to lysis by autologous NK cells.			Chambers, BJ (corresponding author), KAROLINSKA INST,CTR MICROBIOL & TUMOR BIOL,S-17177 STOCKHOLM,SWEDEN.							ALLISON JP, 1994, CURR OPIN IMMUNOL, V6, P414, DOI 10.1016/0952-7915(94)90120-1; AZUMA M, 1992, J IMMUNOL, V149, P1115; CAVALLO F, 1995, EUR J IMMUNOL, V25, P1154, DOI 10.1002/eji.1830250504; CHEN LP, 1994, J EXP MED, V179, P523, DOI 10.1084/jem.179.2.523; CORREA I, 1994, EUR J IMMUNOL, V24, P1323, DOI 10.1002/eji.1830240613; GELDHOF AB, 1995, CANCER RES, V55, P2730; GILBERTSON SM, 1986, J IMMUNOL, V136, P3567; GLAS R, 1992, J EXP MED, V175, P843, DOI 10.1084/jem.175.3.843; GUMPERZ JE, 1995, NATURE, V378, P245, DOI 10.1038/378245a0; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1995, SCIENCE, V267, P978, DOI 10.1126/science.7863341; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Lanier LL, 1996, IMMUNOL TODAY, V17, P86, DOI 10.1016/0167-5699(96)80585-8; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MONTEL AH, 1995, CELL IMMUNOL, V160, P104, DOI 10.1016/0008-8749(95)80015-B; MONTEL AH, 1995, CELL IMMUNOL, V166, P236, DOI 10.1006/cimm.1995.9974; NANDI D, 1994, J IMMUNOL, V152, P3361; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Raulet DH, 1996, CURR OPIN IMMUNOL, V8, P372, DOI 10.1016/S0952-7915(96)80127-0; Roger R, 1996, CELL IMMUNOL, V168, P24, DOI 10.1006/cimm.1996.0045; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SHARPE AH, 1995, CURR OPIN IMMUNOL, V7, P389, DOI 10.1016/0952-7915(95)80115-4; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WU TC, 1995, J EXP MED, V182, P1415, DOI 10.1084/jem.182.5.1415; YEH KY, 1995, CELL IMMUNOL, V165, P217, DOI 10.1006/cimm.1995.1208; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; Yu YYL, 1996, IMMUNITY, V4, P67, DOI 10.1016/S1074-7613(00)80299-X	33	213	222	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1996	5	4					311	317		10.1016/S1074-7613(00)80257-5	http://dx.doi.org/10.1016/S1074-7613(00)80257-5			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VP444	8885864	Bronze			2022-12-18	WOS:A1996VP44400003
J	Yang, RL; Qu, CY; Zhou, Y; Konkel, JE; Shi, SH; Liu, Y; Chen, CD; Liu, SY; Liu, DW; Chen, YB; Zandi, E; Chen, WJ; Zhou, YH; Shi, ST				Yang, Ruili; Qu, Cunye; Zhou, Yu; Konkel, Joanne E.; Shi, Shihong; Liu, Yi; Chen, Chider; Liu, Shiyu; Liu, Dawei; Chen, Yibu; Zandi, Ebrahim; Chen, Wanjun; Zhou, Yanheng; Shi, Songtao			Hydrogen Sulfide Promotes Tet1-and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis	IMMUNITY			English	Article							CYSTATHIONINE-BETA-SYNTHASE; GENE-EXPRESSION; TARGET GENES; CIS-ELEMENT; MOUSE MODEL; TRANSCRIPTION; TET2; 5-HYDROXYMETHYLCYTOSINE; PROLIFERATION; GENERATION	Regulatory T (Treg) cells are essential for maintenance of immune homeostasis. Here we found that hydrogen sulfide (H2S) was required for Foxp3(+) Treg cell differentiation and function and that H2S deficiency led to systemic autoimmune disease. H2S maintained expression of methylcytosine dioxygenases Tet1 and Tet2 by sulfhydrating nuclear transcription factor Y subunit beta (NFYB) to facilitate its binding to Tet1 and Tet2 promoters. Transforming growth factor-beta (TGF-beta)-activated Smad3 and interleukin-2 (IL-2)-activated Stat5 facilitated Tet1 and Tet2 binding to Foxp3. Tet1 and Tet2 catalyzed conversion of 5-methylcytosine (5mC) to 5-hydroxy-methylcytosine (5hmC) in Foxp3 to establish a Treg-cell-specific hypomethylation pattern and stable Foxp3 expression. Consequently, Tet1 and Tet2 deletion led to Foxp3 hypermethylation, impaired Treg cell differentiation and function, and autoimmune disease. Thus, H2S promotes Tet1 and Tet2 expression, which are recruited to Foxp3 by TGF-beta and IL-2 signaling to maintain Foxp3 demethylation and Treg-cell-associated immune homeostasis.	[Yang, Ruili; Liu, Dawei; Zhou, Yanheng] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing 100081, Peoples R China; [Yang, Ruili; Chen, Chider; Shi, Songtao] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Yang, Ruili; Qu, Cunye; Shi, Shihong; Chen, Chider; Liu, Shiyu; Shi, Songtao] Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Zhou, Yu; Zandi, Ebrahim] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Konkel, Joanne E.; Chen, Wanjun] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; [Liu, Yi] Capital Med Univ, Sch Stomatol, Lab Tissue Regenerat & Immunol, Beijing 100050, Peoples R China; [Liu, Yi] Capital Med Univ, Sch Stomatol, Dept Periodont, Beijing 100050, Peoples R China; [Chen, Yibu] Univ So Calif, Keck Sch Med, Norris Med Lib, Los Angeles, CA 90033 USA	Peking University; University of Pennsylvania; University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Capital Medical University; Capital Medical University; University of Southern California	Zhou, YH (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China.	yanhengzhou@gmail.com; songtaos@dental.upenn.edu	, 许开源 18362929861 赛德阳光口腔/AFX-1820-2022; Chen, Chider/L-9880-2016; Zhou, Yanheng/ABG-5432-2021; Zhou, Yu/M-7975-2014	Chen, Chider/0000-0003-2899-1208; Zhou, Yanheng/0000-0002-5610-9967; 	National Institute of Dental and Craniofacial Research, NIH, Department of Health and Human Services [R01DE017449, R01DE019932]; Ministry of Science and Technology, China [2010DFB32980]; Intramural Research Program of NIDCR, NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101, R01DE017449, R01DE019932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, NIH, Department of Health and Human Services; Ministry of Science and Technology, China(Ministry of Science and Technology, China); Intramural Research Program of NIDCR, NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Dental and Craniofacial Research, NIH, Department of Health and Human Services (R01DE017449 and R01DE019932 to Songao Shi), the Ministry of Science and Technology, China (2010DFB32980 to Yanheng Zhou), and the Intramural Research Program of NIDCR, NIH (for W.C.).	Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Han YF, 2013, CELL PHYSIOL BIOCHEM, V31, P795, DOI 10.1159/000350097; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kallin EM, 2012, MOL CELL, V48, P266, DOI 10.1016/j.molcel.2012.08.007; Kelly PJ, 2003, NEUROLOGY, V60, P275, DOI 10.1212/01.WNL.0000042479.55406.B3; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Konkel JE, 2014, P NATL ACAD SCI USA, V111, pE465, DOI 10.1073/pnas.1320319111; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nair VS, 2014, BIOCHEM BIOPH RES CO, V450, P918, DOI 10.1016/j.bbrc.2014.06.110; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Peng YJ, 2014, P NATL ACAD SCI USA, V111, P1174, DOI 10.1073/pnas.1322172111; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Toker A, 2013, J IMMUNOL, V190, P3180, DOI 10.4049/jimmunol.1203473; Tsagaratou A, 2014, P NATL ACAD SCI USA, V111, pE3306, DOI 10.1073/pnas.1412327111; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang LQ, 2013, MOL CELL BIOL, V33, P4106, DOI 10.1128/MCB.00144-13; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamanaka T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4354; Zhang GS, 2013, AM J PATHOL, V182, P1188, DOI 10.1016/j.ajpath.2012.12.008; Zhang L, 2010, MOL MED, V16, P417, DOI 10.2119/molmed.2010.00027; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	42	212	225	3	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					251	263		10.1016/j.immuni.2015.07.017	http://dx.doi.org/10.1016/j.immuni.2015.07.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26275994	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000360101200009
J	Huang, J; Brameshuber, M; Zeng, X; Xie, JM; Li, QJ; Chien, YH; Valitutti, S; Davis, MM				Huang, Jun; Brameshuber, Mario; Zeng, Xun; Xie, Jianming; Li, Qi-jing; Chien, Yueh-hsiu; Valitutti, Salvatore; Davis, Mark M.			A Single Peptide-Major Histocompatibility Complex Ligand Triggers Digital Cytokine Secretion in CD4(+) T Cells	IMMUNITY			English	Article							IMMUNOLOGICAL SYNAPSE; RECEPTOR MICROCLUSTERS; MINIMAL NUMBER; QUANTUM-DOT; LIVE CELLS; ACTIVATION; TCR; ANTIGEN; RECOGNITION; SEGREGATION	We have developed a single-molecule imaging technique that uses quantum-dot-labeled peptide-major histocompatibility complex (pMHC) ligands to study CD4(+) T cell functional sensitivity. We found that naive T cells, T cell blasts, and memory T cells could all be triggered by a single pMHC to secrete tumor necrosis factor-alpha (TNF-alpha) and interleukin-2 (IL-2) cytokines with a rate of similar to 1,000, similar to 10,000, and similar to 10,000 molecules/min, respectively, and that additional pMHCs did not augment secretion, indicating a digital response pattern. We also found that a single pMHC localized to the immunological synapse induced the slow formation of a long-lasting T cell receptor (TCR) cluster, consistent with a serial engagement mechanism. These data show that scaling up CD4(+) T cell cytokine responses involves increasingly efficient T cell recruitment rather than greater cytokine production per cell.	[Huang, Jun; Brameshuber, Mario; Zeng, Xun; Xie, Jianming; Li, Qi-jing; Chien, Yueh-hsiu; Valitutti, Salvatore; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Zeng, Xun; Chien, Yueh-hsiu] Stanford Univ, Program Immunol, Stanford, CA 94305 USA; [Li, Qi-jing] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Valitutti, Salvatore] CNRS, U5282, INSERM U1043, Ctr Physiopathol Toulouse Purpan, F-31300 Toulouse, France; [Valitutti, Salvatore] Univ Toulouse 3, F-31300 Toulouse, France; [Davis, Mark M.] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Duke University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Zeng, Xun/HHM-7791-2022; Valitutti, Salvatore/M-2999-2014; Xie, Jianming/AAC-6359-2019	Valitutti, Salvatore/0000-0002-6432-4421; Xie, Jianming/0000-0003-4112-650X; Brameshuber, Mario/0000-0001-8672-2255; Davis, Mark/0000-0001-6868-657X	Howard Hughes Medical Institute; US National Institutes of Health [R01 AI022511]; Association pour la Recherche sur le Cancer [SL220100601347]; Institut National du Cancer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022511] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Lund, C. Meyer, H. McGuire, and M. Mamedov for reading the manuscript; Y. Xia for help on data analysis; L. Klein, A. Girvin, and J. Huppa for training and advice on microscopy; E. Newell and F. Tynan for help on protein purification; F. Wang for sharing reagents; N. Prado for technical support; Y.-l. Wei for helping ELISA experiment; M. Huse for showing the utility of the cytokine capture method; and members of the M. M. D. and Y.-h.C. laboratories for helpful discussions. This work has been supported by funding from the Howard Hughes Medical Institute (M. M. D.), the US National Institutes of Health (R01 AI022511 to M. M. D.), the Association pour la Recherche sur le Cancer (Grant SL220100601347 to S. V.), and Institut National du Cancer (S.V.).	Alakoskela JM, 2011, BIOPHYS J, V100, P2865, DOI 10.1016/j.bpj.2011.05.013; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chang YP, 2008, J BIOPHOTONICS, V1, P287, DOI 10.1002/jbio.200810029; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; CROFT M, 1994, J IMMUNOL, V152, P2675; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Ebert PJR, 2008, IMMUNITY, V29, P734, DOI 10.1016/j.immuni.2008.09.014; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Fomenko V, 2008, NANO LETT, V8, P287, DOI 10.1021/nl0726609; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kimachi K, 1997, EUR J IMMUNOL, V27, P3310, DOI 10.1002/eji.1830271230; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lopez Jose M, 2010, Commun Integr Biol, V3, P146; MANZ R, 1995, P NATL ACAD SCI USA, V92, P1921, DOI 10.1073/pnas.92.6.1921; MILLER SM, 1995, DRUG DEVELOP RES, V35, P20, DOI 10.1002/ddr.430350105; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moqbel Redwan, 2006, Sci STKE, V2006, ppe26, DOI 10.1126/stke.3382006pe26; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; Pinaud F, 2010, NAT METHODS, V7, P275, DOI [10.1038/NMETH.1444, 10.1038/nmeth.1444]; Priyadharshini B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015038; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; RUSCETTI FW, 1977, J IMMUNOL, V119, P131; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Ueda H, 2011, P NATL ACAD SCI USA, V108, P17099, DOI 10.1073/pnas.1113703108; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Xie JM, 2012, NAT IMMUNOL, V13, P674, DOI 10.1038/ni.2344; Xie XS, 2008, ANNU REV BIOPHYS, V37, P417, DOI 10.1146/annurev.biophys.37.092607.174640; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	55	212	217	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					846	857		10.1016/j.immuni.2013.08.036	http://dx.doi.org/10.1016/j.immuni.2013.08.036			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24120362	Green Accepted, Bronze			2022-12-18	WOS:000330950600008
J	Koblansky, AA; Jankovic, D; Oh, H; Hieny, S; Sungnak, W; Mathur, R; Hayden, MS; Akira, S; Sher, A; Ghosh, S				Koblansky, A. Alicia; Jankovic, Dragana; Oh, Hyunju; Hieny, Sara; Sungnak, Waradon; Mathur, Ramkumar; Hayden, Matthew S.; Akira, Shizuo; Sher, Alan; Ghosh, Sankar			Recognition of Profilin by Toll-like Receptor 12 Is Critical for Host Resistance to Toxoplasma gondii	IMMUNITY			English	Article							DENDRITIC CELLS; CUTTING EDGE; INTERFERON-GAMMA; IFN-GAMMA; IL-12 PRODUCTION; ACUTE INFECTION; STRANDED-RNA; PARASITE; INTERLEUKIN-12; ACTIVATION	Toll-like receptor 11 (TLR11) recognizes T. gondii profilin (TgPRF) and is required for interleukin-12 production and induction of immune responses that limit cyst burden in Toxoplasma gondii-infected mice. However, TLR11 only modestly affects survival of T. gondii-challenged mice. We report that TLR12, a previously uncharacterized TLR, also recognized TgPRF. TLR12 was sufficient for recognition of TgPRF by plasmacytoid dendritic cells (pDCs), whereas TLR11 and TLR12 were both required in macrophages and conventional DCs. In contrast to TLR11, TLR12-deficient mice succumb rapidly to T. gondii infection. TLR12-dependent induction of IL-12 and IFN-alpha in pDCs led to production of IFN-gamma by NK cells. Consistent with this observation, the partial resistance of Tlr11(-/-) mice is lost upon pDC or NK cell depletion. Thus, TLR12 is critical for the innate immune response to T. gondii, and this TLR may promote host resistance by triggering pDC and NK cell function.	[Koblansky, A. Alicia; Oh, Hyunju; Sungnak, Waradon; Mathur, Ramkumar; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Hayden, Matthew S.] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; [Jankovic, Dragana; Hieny, Sara; Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Suita, Osaka 5650871, Japan	Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Osaka University	Ghosh, S (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA.	sg2715@columbia.edu	Akira, Shizuo/C-3134-2009; Mathur, Ramkumar/AAZ-4314-2020	mathur, Ramkumar/0000-0002-9317-2631; Hayden, Matthew/0000-0003-1670-6430	NIH [RO1-59440, R37-33443]; Columbia University; ARRA [P30 AR058886-01]; NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000579, R01AI033443, R01AI059440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR044535, P30AR058886] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University; ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank B. Beulter (Scripps Research Institue) for the Unc93b-GFP plasmid, R. Medzhitov (Yale University) for MyD88-deficient mice, Y. Modis (Yale University) for PfPRF, and G. Trinchieri for kindly providing CD317 mAb and control ascites. The studies in this manuscript were supported by grants from NIH (RO1-59440 and R37-33443) and institutional support from Columbia University. M.S.H. is supported by ARRA P30 AR058886-01. This work was supported in part by the intramural research program of NIAID, NIH.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Combe CL, 2005, INFECT IMMUN, V73, P4913, DOI 10.1128/IAI.73.8.4913-4921.2005; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hunter CA, 1997, IMMUNOL LETT, V59, P1, DOI 10.1016/S0165-2478(97)00091-6; Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405; Kucera K, 2010, J MOL BIOL, V403, P616, DOI 10.1016/j.jmb.2010.09.022; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Melo MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001071; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Pifer R, 2011, TRENDS PARASITOL, V27, P388, DOI 10.1016/j.pt.2011.03.009; Pifer R, 2011, J BIOL CHEM, V286, P3307, DOI 10.1074/jbc.M110.171025; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628; Yarovinsky F, 2008, J IMMUNOL, V181, P8478, DOI 10.4049/jimmunol.181.12.8478; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	33	212	227	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					119	130		10.1016/j.immuni.2012.09.016	http://dx.doi.org/10.1016/j.immuni.2012.09.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23246311	Green Accepted, Bronze			2022-12-18	WOS:000314195500014
J	Dong, G; Wearsch, PA; Peaper, DR; Cresswell, P; Reinisch, KM				Dong, Gang; Wearsch, Pamela A.; Peaper, David R.; Cresswell, Peter; Reinisch, Karin M.			Insights into MHC Class I Peptide Loading from the Structure of the Tapasin-ERp57 Thiol Oxidoreductase Heterodimer	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; N-LINKED GLYCANS; CRYSTAL-STRUCTURE; QUALITY-CONTROL; HLA-DM; PROTEIN; MOLECULES; BINDING; ERP57; ANTIGEN	Tapasin is a glycoprotein critical for loading major histocompatibility complex (MHC) class I molecules with high-affinity peptides. It functions within the multimeric peptide-loading complex (PLC) as a disulfide-linked, stable heterodimer with the thiol oxidoreductase ERp57, and this covalent interaction is required to support optimal PLC activity. Here, we present the 2.6 angstrom resolution structure of the tapasin-ERp57 core of the PLC. The structure revealed that tapasin interacts with both ERp57 catalytic domains, accounting for the stability of the heterodimer, and provided an example of a protein disulfide isomerase family member interacting with substrate. Mutational analysis identified a conserved surface on tapasin that interacted with MHC class I molecules and was critical for peptide loading and editing functions of the tapasin-ERp57 heterodimer. By combining the tapasin-ERp57 structure with those of other defined PLC components, we present a molecular model that illuminates the processes involved in MHC class I peptide loading.	[Dong, Gang; Cresswell, Peter; Reinisch, Karin M.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Wearsch, Pamela A.; Peaper, David R.; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	peter.cresswell@yale.edu; karin.reinisch@yale.edu	; Wearsch, Pamela/K-8505-2014	Dong, Gang/0000-0001-9745-8103; Wearsch, Pamela/0000-0002-9569-3852	National Institutes of Health [GM070521]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank H. Zhou for sharing her expertise regarding the production of selenomethionine-substituted proteins in insect cells and H. Zheng and S. Mitchell for their technical help. We thank the staff of ID24 at the Advanced Photon Source for help with data collection, and K.M.R. thanks D.W. Rodgers for discussions. This work was supported by National Institutes of Health grant GM070521 to K.M.R.; P.C. is an investigator of the Howard Hughes Medical Institute.	Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; CARRENO BM, 1995, J IMMUNOL, V155, P4726; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W. L, 2002, PYMOL MOL GENETICS G; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellgaard L, 2002, J MOL BIOL, V322, P773, DOI 10.1016/S0022-2836(02)00812-4; Elliott T, 1997, IMMUNOL TODAY, V18, P375, DOI 10.1016/S0167-5699(97)01097-9; Elliott T, 2005, IMMUNOL REV, V207, P89, DOI 10.1111/j.0105-2896.2005.00311.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fremont DH, 1998, IMMUNITY, V9, P385, DOI 10.1016/S1074-7613(00)80621-4; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2003, EUR J IMMUNOL, V33, P264, DOI 10.1002/immu.200390029; Hansen TH, 2005, IMMUNOL REV, V207, P100, DOI 10.1111/j.0105-2896.2005.00315.x; Harris MR, 1998, J IMMUNOL, V160, P5404; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Lindquist JA, 2001, FASEB J, V15, P1448, DOI 10.1096/fj.00-0720fje; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Olson R, 2005, PLOS BIOL, V3, P1436, DOI 10.1371/journal.pbio.0030257; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peaper DR, 2008, P NATL ACAD SCI USA, V105, P10477, DOI 10.1073/pnas.0805044105; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Russell SJ, 2004, J BIOL CHEM, V279, P18861, DOI 10.1074/jbc.M400575200; Sadegh-Nasseri S, 2008, TRENDS IMMUNOL, V29, P141, DOI 10.1016/j.it.2008.01.001; Santos SG, 2007, J BIOL CHEM, V282, P17587, DOI 10.1074/jbc.M702212200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Sharff AJ, 2000, ACTA CRYSTALLOGR D, V56, P785, DOI 10.1107/S090744490000370X; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Turnquist HR, 2004, J IMMUNOL, V172, P2976, DOI 10.4049/jimmunol.172.5.2976; Walker KW, 1997, J BIOL CHEM, V272, P8845; Wearsch PA, 2004, J BIOL CHEM, V279, P25112, DOI 10.1074/jbc.M401721200; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Wright CA, 2004, BIOL CHEM, V385, P763, DOI 10.1515/BC.2004.100; Yu YYL, 1999, J IMMUNOL, V163, P4427; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200	55	212	217	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					21	32		10.1016/j.immuni.2008.10.018	http://dx.doi.org/10.1016/j.immuni.2008.10.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19119025	Green Accepted, Bronze			2022-12-18	WOS:000262769900007
J	Izon, DJ; Aster, JC; He, YP; Weng, A; Karnell, FG; Patriub, V; Xu, LW; Bakkour, S; Rodriguez, C; Allman, D; Pear, WS				Izon, DJ; Aster, JC; He, YP; Weng, A; Karnell, FG; Patriub, V; Xu, LW; Bakkour, S; Rodriguez, C; Allman, D; Pear, WS			Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1	IMMUNITY			English	Article							MOUSE BONE-MARROW; ANKYRIN REPEATS; DROSOPHILA-MELANOGASTER; SIGNALING PATHWAY; HUMAN HOMOLOG; DIFFERENTIATION; GENE; EXPRESSION; REGULATOR; PROTEINS	Notch1 signaling drives T cell development at the expense of B cell development from a common precursor, an effect that is dependent on a C-terminal Notch1 transcriptional activation domain. The function of Deltex1, initially identified as a positive modulator of Notch function in a genetic screen in Drosophila, is poorly understood. We now demonstrate that, in contrast to Notch1, enforced expression of Deltex1 in hematopoietic progenitors results in B cell development at the expense of T cell development in fetal thymic organ culture and in vivo. Consistent with these effects, Deltex1 antagonizes Notch1 signaling in transcriptional reporter assays by inhibiting coactivator recruitment. These data suggest that a balance of inductive Notch1 signals and inhibitory signals mediated through Deltex1 and other modulators regulate T-B lineage commitment.	Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Inst Med & Engn, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Pear, WS (corresponding author), Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	wpear@mail.med.upenn.edu	Aster, Jon C/B-6857-2009; Weng, Andrew P/I-5015-2014	Weng, Andrew/0000-0001-7394-5425				Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Aster JC, 2001, CURR OPIN HEMATOL, V8, P237, DOI 10.1097/00062752-200107000-00010; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; BUSSEAU I, 1994, GENETICS, V136, P585; Carter RS, 1997, MOL CELL BIOL, V17, P18, DOI 10.1128/MCB.17.1.18; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GORMAN MJ, 1992, GENETICS, V131, P99; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Hsieh JJD, 1997, J VIROL, V71, P1938, DOI 10.1128/JVI.71.3.1938-1945.1997; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; IZON DJ, 2002, IN PRESS CURR OPIN I; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kishi N, 2001, INT J DEV NEUROSCI, V19, P21, DOI 10.1016/S0736-5748(00)00071-X; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Levelt CN, 1995, IMMUNITY, V3, P667, DOI 10.1016/1074-7613(95)90056-X; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Luo B, 1997, MOL CELL BIOL, V17, P6057, DOI 10.1128/MCB.17.10.6057; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Matsuno K, 1998, NAT GENET, V19, P74, DOI 10.1038/ng0598-74; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085; Royet J, 1998, EMBO J, V17, P7351, DOI 10.1093/emboj/17.24.7351; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shawber C, 1996, DEVELOPMENT, V122, P3765; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; XU T, 1990, GENETICS, V126, P665; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000	57	212	220	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2002	16	2					231	243		10.1016/S1074-7613(02)00271-6	http://dx.doi.org/10.1016/S1074-7613(02)00271-6			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869684	Bronze			2022-12-18	WOS:000174039600007
J	Schamel, WWA; Reth, M				Schamel, WWA; Reth, M			Monomeric and oligomeric complexes of the B cell antigen receptor	IMMUNITY			English	Article							BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; IG-BETA; SIGNAL-TRANSDUCTION; J-CHAIN; TYROSINE PHOSPHORYLATION; ERYTHROPOIETIN RECEPTOR; ACCESSORY PROTEINS; ASPARTATE RECEPTOR; IMMUNOGLOBULIN-D	The current structural model of the B cell antigen receptor (BCR) describes it as a symmetric protein complex in which one membrane-bound immunoglobulin molecule (mlg) is noncovalently bound on each side by an Ig-alpha/Ig-beta heterodimer. Using peptide-tagged Ig-alpha proteins, blue native polyacrylamide gel electrophoresis (BN-PAGE), and biosynthetical labeling of B cells, we find that the mIg:Ig-alpha/Ig-beta complex has a stoichiometry of 1:1 and not 1:2. An anti-flag stimulation of B cells coexpressing Flag-tagged and wild-type Ig-alpha proteins results in the phosphorylation of both Ig-alpha proteins, suggesting that on the surface of living B cells, several BCR monomers are in contact with each other. A BN-PAGE analysis after limited detergent lysis provides further evidence for an oligomeric BCR structure.	Univ Freiburg, Dept Mol Immunol Biol 3, D-79108 Freiburg, Germany; Max Planck Inst Immunobiol, D-79108 Freiburg, Germany	University of Freiburg; Max Planck Society	Reth, M (corresponding author), Univ Freiburg, Dept Mol Immunol Biol 3, Stubeweg 51, D-79108 Freiburg, Germany.	reth@immunbio.mpg.de						Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x; ALESMARTINEZ JE, 1988, P NATL ACAD SCI USA, V85, P6919, DOI 10.1073/pnas.85.18.6919; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Benlagha K, 1999, J BIOL CHEM, V274, P19389, DOI 10.1074/jbc.274.27.19389; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Burke CL, 1998, MOL CELL BIOL, V18, P5371, DOI 10.1128/MCB.18.9.5371; Campbell K S, 1994, Semin Immunol, V6, P393, DOI 10.1006/smim.1994.1049; CAMPBELL KS, 1991, J IMMUNOL, V147, P1575; Carsetti R, 2000, J EXP MED, V191, P5, DOI 10.1084/jem.191.1.5; CATTANEO A, 1987, EMBO J, V6, P2753, DOI 10.1002/j.1460-2075.1987.tb02569.x; CHEN JZ, 1990, EMBO J, V9, P2117, DOI 10.1002/j.1460-2075.1990.tb07380.x; Chi YI, 1997, FEBS LETT, V414, P327, DOI 10.1016/S0014-5793(97)01027-2; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; DELAHERA A, 1991, J EXP MED, V173, P7, DOI 10.1084/jem.173.1.7; DINTZIS RZ, 1982, P NATL ACAD SCI-BIOL, V79, P884, DOI 10.1073/pnas.79.3.884; DINTZIS RZ, 1989, J IMMUNOL, V143, P1239; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; GOLD MR, 1991, P NATL ACAD SCI USA, V88, P3436, DOI 10.1073/pnas.88.8.3436; GRUPP SA, 1993, J BIOL CHEM, V268, P25776; HOMBACH J, 1988, EMBO J, V7, P3451, DOI 10.1002/j.1460-2075.1988.tb03219.x; HOMBACH J, 1990, EUR J IMMUNOL, V20, P2795, DOI 10.1002/eji.1830201239; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; KIM KM, 1995, J EXP MED, V181, P1005, DOI 10.1084/jem.181.3.1005; KIM KM, 1994, EMBO J, V13, P3793, DOI 10.1002/j.1460-2075.1994.tb06690.x; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Liu Y, 1997, EMBO J, V16, P7231, DOI 10.1093/emboj/16.24.7231; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; MATSUUCHI L, 1992, P NATL ACAD SCI USA, V89, P3404, DOI 10.1073/pnas.89.8.3404; Moro F, 1999, EMBO J, V18, P3667, DOI 10.1093/emboj/18.13.3667; Neuberger MS, 1997, CELL, V90, P971, DOI 10.1016/S0092-8674(00)80362-1; NILES MJ, 1995, P NATL ACAD SCI USA, V92, P2884, DOI 10.1073/pnas.92.7.2884; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Pillai S, 1999, IMMUNITY, V10, P493, DOI 10.1016/S1074-7613(00)80049-7; POGUE SL, 1994, J IMMUNOL, V152, P3925; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RETH M, 1991, ADV EXP MED BIOL, V292, P207; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rolink AG, 1999, CURR TOP MICROBIOL, V246, P39; SANCHEZ M, 1993, J EXP MED, V178, P1049, DOI 10.1084/jem.178.3.1049; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schamel WWA, 2000, MOL IMMUNOL, V37, P253, DOI 10.1016/S0161-5890(00)00025-0; Schamel WWA, 1999, ANAL BIOCHEM, V274, P144, DOI 10.1006/abio.1999.4238; SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A; STEVENS TL, 1994, J IMMUNOL, V152, P4397; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; WIENANDS J, 1991, EUR J IMMUNOL, V21, P2373, DOI 10.1002/eji.1830211012; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; WIENANDS J, 1999, B CELL ANTIGEN RECEP; Wiersma EJ, 1998, J IMMUNOL, V160, P5979; WILLIAMS GT, 1993, MOL IMMUNOL, V30, P1427, DOI 10.1016/0161-5890(93)90104-J; Wiseman PW, 1997, FEBS LETT, V401, P43, DOI 10.1016/S0014-5793(96)01429-9	60	212	215	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2000	13	1					5	14		10.1016/S1074-7613(00)00003-0	http://dx.doi.org/10.1016/S1074-7613(00)00003-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933390	hybrid			2022-12-18	WOS:000088463600002
J	Murakami, M; Kamimura, D; Hirano, T				Murakami, Masaaki; Kamimura, Daisuke; Hirano, Toshio			Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines	IMMUNITY			English	Review							LEUKEMIA INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; HEPATOCYTE-STIMULATING FACTOR; INDUCED SWEATING SYNDROME; IL-6 SIGNAL TRANSDUCER; ONCOSTATIN-M RECEPTOR; RECOMBINANT HUMAN INTERLEUKIN-11; CARDIOTROPHIN-LIKE CYTOKINE; MESSENGER-RNA STABILITY; GENOME-WIDE ASSOCIATION	since the molecular dolling of interleukin-6 (IL-6) in 1986, many other cytokines have been found to share the same signal transducer, gp130, in their receptor complexes. Thus, the IL-6 family of cytokines now consists of ten members. Although some of the family members' functions are redundant as a result of the expression of gp130, there are also functional distinctions between members. The mechanisms that determine functional redundancies and distinctions are not completely understood. Yet, research has clarified the role of IL-6 family cytokines in autoimmune diseases and has led to effective therapies that target them. Here, we review the IL-6 family of cytokines in autoimmune diseases, with a particular focus on the prototypical member IL-6, from the viewpoints of their structure, signaling, and biological features and discuss possible mechanisms of their functional pleiotropy.	[Murakami, Masaaki; Kamimura, Daisuke; Hirano, Toshio] Hokkaido Univ, Inst Genet Med, Div Mol Psychoimmunol, Sapporo, Hokkaido 0600815, Japan; [Murakami, Masaaki; Kamimura, Daisuke; Hirano, Toshio] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0600815, Japan; [Hirano, Toshio] Natl Inst Quantum & Radiol Sci & Technol, Chiba 2638555, Japan	Hokkaido University; Hokkaido University; National Institutes for Quantum Science & Technology	Hirano, T (corresponding author), Hokkaido Univ, Inst Genet Med, Div Mol Psychoimmunol, Sapporo, Hokkaido 0600815, Japan.; Hirano, T (corresponding author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0600815, Japan.; Hirano, T (corresponding author), Natl Inst Quantum & Radiol Sci & Technol, Chiba 2638555, Japan.	hirano.toshio@qst.go.jp		, Masaaki/0000-0001-7159-7279	JSPS-KAKENHI; Grant for Joint Research Program of the Institute for Genetic Medicine, Hokkaido University	JSPS-KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant for Joint Research Program of the Institute for Genetic Medicine, Hokkaido University	We appreciate Dr. P. Karagiannis (CiRA, Kyoto University, Kyoto, Japan) for carefully reading the manuscript and thank Dr. Y. Tanaka (IGM, Hokkaido University, Japan) for the figures. This work was supported by JSPS-KAKENHI and the Grant for Joint Research Program of the Institute for Genetic Medicine, Hokkaido University.	Alexander WS, 1999, CURR BIOL, V9, P605, DOI 10.1016/S0960-9822(99)80266-8; ANDUS T, 1987, FEBS LETT, V221, P18, DOI 10.1016/0014-5793(87)80344-7; [Anonymous], 1989, Ann N Y Acad Sci, V557, P1; [Anonymous], 2017, NAT REV RHEUMATOL; Arima Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25517; Arima Y, 2015, ELIFE, V4, DOI 10.7554/eLife.08733; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Arita K, 2008, AM J HUM GENET, V82, P73, DOI 10.1016/j.ajhg.2007.09.002; Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Baier PC, 2009, BEHAV BRAIN RES, V200, P192, DOI 10.1016/j.bbr.2009.01.013; Ball P, 2011, NATURE, V474, P272, DOI 10.1038/474272a; Bamberger AM, 2004, NEUROIMMUNOMODULAT, V11, P10, DOI 10.1159/000072964; Bartoe JL, 2000, J NEUROCHEM, V74, P2021, DOI 10.1046/j.1471-4159.2000.0742021.x; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; BAUMANN H, 1991, J BIOL CHEM, V266, P20424; Bender H, 2009, HEPATOLOGY, V50, P585, DOI 10.1002/hep.22988; BERNAD A, 1994, IMMUNITY, V1, P725, DOI 10.1016/S1074-7613(94)80014-6; Bernard C, 1999, CIRC RES, V85, P1124; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Bialuk I, 2018, NEUROBIOL LEARN MEM, V155, P21, DOI 10.1016/j.nlm.2018.06.006; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Boyce EG, 2018, ANN PHARMACOTHER, V52, P780, DOI 10.1177/1060028018761599; BRANDT SJ, 1990, J CLIN INVEST, V86, P592, DOI 10.1172/JCI114749; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Cao W, 2011, IMMUNITY, V35, P273, DOI 10.1016/j.immuni.2011.06.011; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Chen CY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105414, 10.1371/journal.pone.0089305, 10.1371/journal.pone.0104899]; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; CHEREL M, 1995, BLOOD, V86, P2534; Chevalier S, 1996, J BIOL CHEM, V271, P14764, DOI 10.1074/jbc.271.25.14764; Chew EY, 2019, OPHTHALMOLOGY, V126, P540, DOI 10.1016/j.ophtha.2018.09.041; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Dagoneau N, 2004, AM J HUM GENET, V74, P298, DOI 10.1086/381715; Dalrymple SA, 1996, INFECT IMMUN, V64, P3231, DOI 10.1128/IAI.64.8.3231-3235.1996; Dar SA, 2017, AUTOIMMUNITY, V50, P158, DOI 10.1080/08916934.2016.1261833; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; DITTRICH F, 1994, ANN NEUROL, V35, P151, DOI 10.1002/ana.410350206; Diveu C, 2006, J BIOL CHEM, V281, P36673, DOI 10.1074/jbc.M607005200; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Do JS, 2017, P NATL ACAD SCI USA, V114, P10190, DOI 10.1073/pnas.1703100114; Dong SS, 2013, AM J RESP CELL MOL, V48, P518, DOI 10.1165/rcmb.2012-0340OC; Drutskaya M S, 2018, Mol Biol (Mosk), V52, P963, DOI 10.1134/S0026898418060058; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Elks CM, 2016, J BIOL CHEM, V291, P17066, DOI 10.1074/jbc.M116.739110; Erdmann J, 1998, BIOCHEM BIOPH RES CO, V244, P494, DOI 10.1006/bbrc.1998.8311; Esashi E, 2009, EUR J IMMUNOL, V39, P1664, DOI 10.1002/eji.200839149; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; Esparza-Gordillo J, 2013, J ALLERGY CLIN IMMUN, V132, P371, DOI 10.1016/j.jaci.2013.01.057; Fajgenbaum DC, 2018, BLOOD, V132, P2323, DOI 10.1182/blood-2018-05-848671; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Fragoulis GE, 2019, RHEUMATOLOGY, V58, P43, DOI 10.1093/rheumatology/key276; Fujita M, 2019, J INVEST DERMATOL, V139, P333, DOI 10.1016/j.jid.2018.07.044; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; FULLER GM, 1987, BIOCHEM BIOPH RES CO, V144, P1003, DOI 10.1016/S0006-291X(87)80063-3; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; GEARING DP, 1991, CELL, V66, P9, DOI 10.1016/0092-8674(91)90131-H; GEARING DP, 1987, EMBO J, V6, P3995, DOI 10.1002/j.1460-2075.1987.tb02742.x; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; GEIGER T, 1988, EUR J IMMUNOL, V18, P717, DOI 10.1002/eji.1830180510; Giess R, 2002, ARCH NEUROL-CHICAGO, V59, P407, DOI 10.1001/archneur.59.3.407; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Gu ZJ, 1996, J IMMUNOL METHODS, V190, P21, DOI 10.1016/0022-1759(95)00232-4; Gubernatorova EO, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02718; Guillet C, 1995, ANN NY ACAD SCI, V762, P407; Gurfein BT, 2009, J IMMUNOL, V183, P4229, DOI 10.4049/jimmunol.0900622; HAEGEMAN G, 1986, EUR J BIOCHEM, V159, P625, DOI 10.1111/j.1432-1033.1986.tb09931.x; Hahn AF, 2006, J NEUROL SCI, V250, P62, DOI 10.1016/j.jns.2006.07.001; Hamet P, 2017, METABOLISM, V69, pS36, DOI 10.1016/j.metabol.2017.01.011; Haroon F, 2011, J IMMUNOL, V186, P6521, DOI 10.4049/jimmunol.1001135; Hasegawa H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00479; Heaney ML, 1996, BLOOD, V87, P847, DOI 10.1182/blood.V87.3.847.bloodjournal873847; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hermanns HM, 2015, CYTOKINE GROWTH F R, V26, P545, DOI 10.1016/j.cytogfr.2015.07.006; Hermanns HM, 2000, J BIOL CHEM, V275, P40742, DOI 10.1074/jbc.M005408200; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hirano T, 1998, Int Rev Immunol, V16, P249; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; HIRANO T, 1988, IMMUNOL LETT, V17, P41, DOI 10.1016/0165-2478(88)90099-5; HIRANO T, 1987, P NATL ACAD SCI USA, V84, P228, DOI 10.1073/pnas.84.1.228; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; HIRATA Y, 1989, J IMMUNOL, V143, P2900; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hobbs BD, 2016, AM J RESP CRIT CARE, V194, P48, DOI 10.1164/rccm.201510-2053OC; Holz K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00836; Hou HF, 2015, INFLAMM RES, V64, P707, DOI 10.1007/s00011-015-0850-9; Hu LL, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00696; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Janssens K, 2015, GLIA, V63, P1729, DOI 10.1002/glia.22840; Jenkins BJ, 2004, MOL CELL BIOL, V24, P1453, DOI 10.1128/MCB.24.4.1453-1463.2004; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Jones BE, 2018, CURR OPIN IMMUNOL, V55, P9, DOI 10.1016/j.coi.2018.09.002; Jones GW, 2010, J IMMUNOL, V184, P2130, DOI 10.4049/jimmunol.0901528; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kamimura D, 2018, INT IMMUNOL, V30, P281, DOI 10.1093/intimm/dxy034; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Keasey MP, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-35; Kida H, 2008, AM J PATHOL, V172, P1542, DOI 10.2353/ajpath.2008.071052; Knappskog PM, 2003, AM J HUM GENET, V72, P375, DOI 10.1086/346120; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kosfeld A, 2017, HUM MOL GENET, V26, P1716, DOI 10.1093/hmg/ddx086; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Kuhn C, 2017, J IMMUNOL, V198, P1202, DOI 10.4049/jimmunol.1600921; Lamertz L, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar7388; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Le Goff B, 2014, CYTOKINE, V68, P101, DOI 10.1016/j.cyto.2014.04.001; Lee J, 2012, J IMMUNOL, V189, P1928, DOI 10.4049/jimmunol.1103613; Lee N, 2008, EUR J NEUROSCI, V27, P2830, DOI 10.1111/j.1460-9568.2008.06298.x; Lewis VO, 2017, P NATL ACAD SCI USA, V114, P8065, DOI 10.1073/pnas.1704173114; Li F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05714; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Lin WW, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5157; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Linossi EM, 2018, GROWTH FACTORS, V36, P104, DOI 10.1080/08977194.2018.1518324; Liu JG, 2007, J EXP MED, V204, P141, DOI 10.1084/jem.20061440; Lokau J, 2017, BBA-MOL CELL RES, V1864, P2105, DOI 10.1016/j.bbamcr.2017.06.008; Luchtefeld M, 2007, J EXP MED, V204, P1935, DOI 10.1084/jem.20070120; Ma J, 2018, NEUROCHEM RES, V43, P1624, DOI 10.1007/s11064-018-2577-9; Ma YS, 1999, NUCLEIC ACIDS RES, V27, P4649, DOI 10.1093/nar/27.23.4649; Maeda K, 2017, INT IMMUNOL, V29, P149, DOI 10.1093/intimm/dxx015; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; Marais A, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0640; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; MAY LT, 1986, P NATL ACAD SCI USA, V83, P8957, DOI 10.1073/pnas.83.23.8957; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; Mease PJ, 2016, ARTHRITIS RHEUMATOL, V68, P2163, DOI 10.1002/art.39700; Mendoza JL, 2019, NATURE, V567, P56, DOI 10.1038/s41586-019-0988-7; METCALF D, 1990, BLOOD, V76, P50; Minehata K, 2006, INT J HEMATOL, V84, P319, DOI 10.1532/IJH97.06090; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Murakami M, 2013, CELL REP, V3, P946, DOI 10.1016/j.celrep.2013.01.028; Murakami M, 2011, J EXP MED, V208, P103, DOI 10.1084/jem.20100900; Nagashima H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01986; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Narazaki M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113528; Neipel F, 1997, J VIROL, V71, P839, DOI 10.1128/JVI.71.1.839-842.1997; Nguyen HN, 2017, IMMUNITY, V46, P220, DOI 10.1016/j.immuni.2017.01.004; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nicola NA, 2015, CYTOKINE GROWTH F R, V26, P533, DOI 10.1016/j.cytogfr.2015.07.001; Nieminen P, 2011, AM J HUM GENET, V89, P67, DOI 10.1016/j.ajhg.2011.05.024; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; Nowell MA, 2009, J IMMUNOL, V182, P613, DOI 10.4049/jimmunol.182.1.613; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Pasqualini R, 2015, CANCER-AM CANCER SOC, V121, P2411, DOI 10.1002/cncr.29344; PAUL SR, 1990, P NATL ACAD SCI USA, V87, P7512, DOI 10.1073/pnas.87.19.7512; Pavlov VA, 2018, ANNU REV IMMUNOL, V36, P783, DOI 10.1146/annurev-immunol-042617-053158; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; PETERS M, 1995, FEBS LETT, V372, P177, DOI 10.1016/0014-5793(95)00972-C; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Plun-Favreau H, 2001, EMBO J, V20, P1692, DOI 10.1093/emboj/20.7.1692; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Poltorak A, 2001, J IMMUNOL, V167, P2106, DOI 10.4049/jimmunol.167.4.2106; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Pulido EJ, 1999, J SURG RES, V84, P240, DOI 10.1006/jsre.1999.5655; Putoczki TL, 2014, ACTA CRYSTALLOGR D, V70, P2277, DOI 10.1107/S1399004714012267; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Quintana A, 2013, BRAIN BEHAV IMMUN, V27, P162, DOI 10.1016/j.bbi.2012.10.011; Quinton LJ, 2008, AM J RESP CELL MOL, V38, P699, DOI 10.1165/rcmb.2007-0365OC; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Reid J, 2018, BRIT J CLIN PHARMACO, V84, P2280, DOI 10.1111/bcp.13669; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; Rose-John S, 2017, CLIN PHARMACOL THER, V102, P591, DOI 10.1002/cpt.782; Rousseau F, 2006, P NATL ACAD SCI USA, V103, P10068, DOI 10.1073/pnas.0509598103; Rousseau F, 2010, P NATL ACAD SCI USA, V107, P19420, DOI 10.1073/pnas.1005793107; Sackett SD, 2019, FASEB J, V33, P6035, DOI 10.1096/fj.201802118R; Sander LE, 2008, J IMMUNOL, V181, P3586, DOI 10.4049/jimmunol.181.5.3586; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Sawa S, 2006, J EXP MED, V203, P1459, DOI 10.1084/jem.20052187; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Schaper F, 2015, CYTOKINE GROWTH F R, V26, P475, DOI 10.1016/j.cytogfr.2015.07.004; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; SCHOOLTINK H, 1992, FEBS LETT, V314, P280, DOI 10.1016/0014-5793(92)81489-9; Schwerd T, 2017, J EXP MED, V214, P2547, DOI 10.1084/jem.20161810; Sehgal PB, 2003, ACTA BIOCHIM POL, V50, P583; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Shahin T, 2019, HAEMATOLOGICA, V104, P609, DOI 10.3324/haematol.2018.194233; Shaw S, 2014, MABS-AUSTIN, V6, P773, DOI 10.4161/mabs.28612; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; SIDELL N, 1991, J IMMUNOL, V146, P3809; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Sitaraman S V, 2001, Curr Opin Investig Drugs, V2, P1395; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Sommer J, 2012, J BIOL CHEM, V287, P13743, DOI 10.1074/jbc.M111.349167; Son HJ, 2017, J IMMUNOL, V198, P1484, DOI 10.4049/jimmunol.1502314; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stankoff B, 2002, J NEUROSCI, V22, P9221; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Stofkova A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38895-y; Streetz KL, 2003, GASTROENTEROLOGY, V125, P532, DOI 10.1016/S0016-5085(03)00901-6; SUEMATSU S, 1992, P NATL ACAD SCI USA, V89, P232, DOI 10.1073/pnas.89.1.232; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Suthaus J, 2012, BLOOD, V119, P5173, DOI 10.1182/blood-2011-09-377705; Suthaus J, 2011, EUR J CELL BIOL, V90, P495, DOI 10.1016/j.ejcb.2010.10.016; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TAKAHASHI R, 1994, NAT GENET, V7, P79, DOI 10.1038/ng0594-79; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Takeuchi T, 2016, MOD RHEUMATOL, V26, P15, DOI 10.3109/14397595.2015.1074648; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7; Upadhyay A, 2012, CLIN EXP IMMUNOL, V169, P71, DOI 10.1111/j.1365-2249.2012.04601.x; van Rhee F, 2014, LANCET ONCOL, V15, P966, DOI 10.1016/S1470-2045(14)70319-5; VANDAMME J, 1987, J EXP MED, V165, P914, DOI 10.1084/jem.165.3.914; VANSNICK J, 1988, EUR J IMMUNOL, V18, P193; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Voiriot G, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0553-6; Wallace PM, 1995, ANN NY ACAD SCI, V762, P42; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wan B, 2015, CYTOKINE, V76, P138, DOI 10.1016/j.cyto.2015.08.001; Wang JM, 2000, J IMMUNOL, V165, P4051, DOI 10.4049/jimmunol.165.7.4051; Wang QR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03050-0; Wang XY, 2016, IEEE INT SYMP NANO, P23, DOI 10.1145/2950067.2950082; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; WARD LD, 1994, J BIOL CHEM, V269, P23286; WARE CB, 1995, DEVELOPMENT, V121, P1283; Watowich SS, 1996, ANNU REV CELL DEV BI, V12, P91, DOI 10.1146/annurev.cellbio.12.1.91; Weber MA, 2005, LAB INVEST, V85, P276, DOI 10.1038/labinvest.3700216; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Xu E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14803; Yamanaka Y, 1996, EMBO J, V15, P1557, DOI 10.1002/j.1460-2075.1996.tb00500.x; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; YONEMURA Y, 1993, BRIT J HAEMATOL, V84, P16, DOI 10.1111/j.1365-2141.1993.tb03020.x; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; Zhang XH, 2015, J CELL BIOCHEM, V116, P2098, DOI 10.1002/jcb.25167; Zhang YT, 2006, J NEUROSCI, V26, P12174, DOI 10.1523/JNEUROSCI.2289-06.2006; ZILBERSTEIN A, 1986, EMBO J, V5, P2529, DOI 10.1002/j.1460-2075.1986.tb04531.x; Zimmermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7061; Zou X, 2009, VET PATHOL, V46, P514, DOI 10.1354/vp.08-VP-0239-B-BC	279	211	222	8	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					812	831		10.1016/j.immuni.2019.03.027	http://dx.doi.org/10.1016/j.immuni.2019.03.027			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995501	Bronze			2022-12-18	WOS:000464660800005
J	Menon, M; Blair, PA; Isenberg, DA; Mauri, C				Menon, Madhvi; Blair, Paul A.; Isenberg, David A.; Mauri, Claudia			A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus	IMMUNITY			English	Article							I INTERFERON; IFN-ALPHA; T-CELLS; AUTOIMMUNE-DISEASES; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; GENE-EXPRESSION; DIFFERENTIATION; SIGNATURE; DEPLETION	Signals controlling the generation of regulatory B (Breg) cells remain ill-defined. Here we report an "auto"-regulatory feedback mechanism between plasmacytoid dendritic cells (pDCs) and Breg cells. In healthy individuals, pDCs drive the differentiation of CD19(+)CD24(hi)CD38(hi) (immature) B cells into IL-10-producing CD24(+)CD38(hi) Breg cells and plasmablasts, via the release of IFN-alpha and CD40 engagement. CD24(+)CD38(hi) Breg cells conversely restrained IFN-alpha production by pDCs via IL-10 release. In systemic lupus erythematosus (SLE), this cross-talk was compromised; pDCs promoted plasmablast differentiation but failed to induce Breg cells. This defect was recapitulated in healthy B cells upon exposure to a high concentration of IFN-alpha. Defective pDC-mediated expansion of CD24(+)CD38(hi) Breg cell numbers in SLE was associated with altered STAT1 and STAT3 activation. Both altered pDC-CD24(+)CD38(hi) Breg cell interactions and STAT1-STAT3 activation were normalized in SLE patients responding to rituximab. We propose that alteration in pDC-CD24(+)CD38(hi) Breg cell interaction contributes to the pathogenesis of SLE.	[Menon, Madhvi; Blair, Paul A.; Isenberg, David A.; Mauri, Claudia] UCL, Ctr Rheumatol, Div Med, 5 Univ St, London WC1E 6JF, England	University of London; University College London	Mauri, C (corresponding author), UCL, Ctr Rheumatol, Div Med, 5 Univ St, London WC1E 6JF, England.	c.mauri@ucl.ac.uk	Mauri, Chiara/GXN-0766-2022	Mauri, Claudia/0000-0001-9761-2625; Menon, Madhvi/0000-0003-2516-9438	Wellcome Trust [090406/Z/09/Z]; Versus Arthritis [17707] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Versus Arthritis(Versus Arthritis)	This work is funded by a Wellcome Trust grant (090406/Z/09/Z) awarded to C.M. We would like to thank Biolegend for anti-human CD19-PECy7 (302216), J. Evans for cell sorting, and E.C. Rosser and K. Oleinika for critically reviewing the manuscript.	Anolik JH, 2007, ARTHRITIS RHEUM, V56, P3044, DOI 10.1002/art.22810; Baccala R, 2013, P NATL ACAD SCI USA, V110, P2940, DOI 10.1073/pnas.1222798110; Baccala R, 2012, J IMMUNOL, V189, P5976, DOI 10.4049/jimmunol.1201477; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bosma A, 2012, IMMUNITY, V36, P477, DOI 10.1016/j.immuni.2012.02.008; Cederblad B, 1998, J AUTOIMMUN, V11, P465, DOI 10.1006/jaut.1998.0215; Duramad O, 2003, BLOOD, V102, P4487, DOI 10.1182/blood-2003-07-2465; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Frisullo G, 2014, MULT SCLER J, V20, P1265, DOI 10.1177/1352458514521311; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Georg P, 2012, AUTOIMMUNITY, V45, P579, DOI 10.3109/08916934.2012.719955; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hartmann G, 2003, EUR J IMMUNOL, V33, P1633, DOI 10.1002/eji.200323813; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Leandro MJ, 2006, ARTHRITIS RHEUM-US, V54, P613, DOI 10.1002/art.21617; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Li H, 2015, J CLIN INVEST, V125, P2877, DOI 10.1172/JCI81059; Luu K, 2014, IMMUNOL CELL BIOL, V92, P761, DOI 10.1038/icb.2014.51; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; Mauri C, 2014, NAT MED, V20, P580, DOI 10.1038/nm.3594; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; RIVERO SJ, 1978, ARTHRITIS RHEUM, V21, P295, DOI 10.1002/art.1780210302; Ronnblom L, 2013, CURR OPIN RHEUMATOL, V25, P248, DOI 10.1097/BOR.0b013e32835c7e32; Rosser EC, 2014, MOL IMMUNOL, V62, P296, DOI 10.1016/j.molimm.2014.01.014; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Schubert RD, 2015, J IMMUNOL, V194, P2110, DOI 10.4049/jimmunol.1402029; Shibuya H, 2005, J ALLERGY CLIN IMMUN, V116, P205, DOI 10.1016/j.jaci.2005.03.016; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Siewe B, 2013, J LEUKOCYTE BIOL, V93, P811, DOI 10.1189/jlb.0912436; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Thibault DL, 2008, J CLIN INVEST, V118, P1417, DOI 10.1172/JCI30065; Tothova E, 2002, Vnitr Lek, V48, P230; Verweij CL, 2013, DISCOV MED, V15, P51; Wilson LE, 2002, SEMIN ARTHRITIS RHEU, V32, P163, DOI 10.1053/sarh.2002.37277; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Zhang XM, 2007, J EXP MED, V204, P1107, DOI 10.1084/jem.20062013	55	211	227	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					683	697		10.1016/j.immuni.2016.02.012	http://dx.doi.org/10.1016/j.immuni.2016.02.012			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26968426	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000372784200024
J	Motomura, Y; Morita, H; Moro, K; Nakae, S; Artis, D; Endo, TA; Kuroki, Y; Ohara, O; Koyasu, S; Kubo, M				Motomura, Yasutaka; Morita, Hideaki; Moro, Kazuyo; Nakae, Susumu; Artis, David; Endo, Takaho A.; Kuroki, Yoko; Ohara, Osamu; Koyasu, Shigeo; Kubo, Masato			Basophil-Derived Interleukin-4 Controls the Function of Natural Helper Cells, a Member of ILC2s, in Lung Inflammation	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; AIRWAY INFLAMMATION; IN-VIVO; PROTEASE ALLERGEN; TYPE-2 IMMUNITY; MAST-CELLS; T-CELLS; CYTOKINE RESPONSES; ADAPTIVE IMMUNITY; EPITHELIAL-CELLS	Allergic asthma is an inflammatory disease characterized by lung eosinophilia controlled by type 2 cytokines. Cysteine proteases are potent triggers of allergic inflammation by causing barrier disruption in lung epithelial cells inducing the elevation of interleukin-5 (IL-5) and IL-13 from natural helper (NH) cells, a member of ILC2s, which leads to lung eosinophilia. In this study, we found that basophils play a crucial role in NH cell-mediated eosinophilic inflammation induced by protease allergens. Conditional deletion of basophils caused a resolution of the papain-induced eosinophilia and mucus production. Resolution of eosinophilia was also observed in mice lacking IL-4 specifically in basophils, indicating that basophil-derived IL-4 enhanced expression of the chemokine CCL11, as well as IL-5, IL-9, and IL-13 in NH cells, thus attracting eosinophils. These results demonstrate that IL-4 from basophils has an important role in the NH-derived cytokine and chemokine expression, subsequently leading to protease allergen-induced airway inflammation.	[Motomura, Yasutaka; Kubo, Masato] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Noda, Chiba 2780022, Japan; [Motomura, Yasutaka; Kubo, Masato] RIKEN Ctr Integrat Med Sci IMS, Lab Cytokine Regulat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Moro, Kazuyo; Koyasu, Shigeo] RIKEN Ctr Integrat Med Sci IMS, Lab Immune Cell Syst, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Endo, Takaho A.; Kuroki, Yoko; Ohara, Osamu] RIKEN Ctr Integrat Med Sci IMS, Lab Integrat Genom, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Moro, Kazuyo] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Div Immunobiol, Yokohama, Kanagawa 2300045, Japan; [Morita, Hideaki] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo 1578535, Japan; [Moro, Kazuyo] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Chiyoda Ku, Tokyo 1020076, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol,Minato Ku, Tokyo 1088639, Japan; [Artis, David] Univ Penn, Perelman Sch Med, Inst Immunol, Dept Microbiol, Philadelphia, PA 19104 USA	Tokyo University of Science; RIKEN; RIKEN; RIKEN; Yokohama City University; National Center for Child Health & Development - Japan; Japan Science & Technology Agency (JST); University of Tokyo; University of Pennsylvania; Pennsylvania Medicine	Kubo, M (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, 2669 Yamazaki, Noda, Chiba 2780022, Japan.	raysolfc@rcai.riken.jp	Ohara, Osamu/G-5448-2015; Morita, Hideaki/S-2214-2016; Morita, Hideaki/ADL-2008-2022; Endo, Takaho/B-5763-2017; Koyasu, Shigeo/J-5583-2015; Kubo, Masato/A-5918-2016	Ohara, Osamu/0000-0002-3328-9571; Morita, Hideaki/0000-0003-0928-8322; Endo, Takaho/0000-0002-2801-2463; Koyasu, Shigeo/0000-0001-9585-3038; Artis, David/0000-0002-1753-4100; Moro, Kazuyo/0000-0002-7377-1303	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23118526]; Japan Society for the Promotion of Science (JSPS) [24249058, 22689013, 22229004]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Japan Science and Technology Agency (JST); Takeda Foundation; Grants-in-Aid for Scientific Research [22229004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Takeda Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Fujimoto, Y. Hachiman, Y. Suzuki, S. Law, C. Ohashi, N. Takeno, and M. Mochizuki for technical support and animal maintenance. We thank P. Burrows for helpful comments on the manuscript. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (23118526) to K.M. from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, a Grant-in-Aid for Scientific Research (A) (24249058) to M.K., a Grant-in Aid for Young Scientist (A) (22689013) to K.M., a Grant-in-Aid for Scientific Research (S) (22229004) to S.K. from the Japan Society for the Promotion of Science (JSPS), the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) to K.M., Precursory Research for Embryonic Science and Technology (PRESTO) to K.M. from the Japan Science and Technology Agency (JST), and a grant from the Takeda Foundation to M.K.	Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hamelmann E, 2001, IMMUNOL REV, V179, P182, DOI 10.1034/j.1600-065X.2001.790118.x; Harada Y, 2012, IMMUNITY, V36, P188, DOI 10.1016/j.immuni.2012.02.002; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Ishikawa Y, 2006, INT IMMUNOL, V18, P847, DOI 10.1093/intimm/dxl021; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kaiko GE, 2011, CURR OPIN ALLERGY CL, V11, P39, DOI 10.1097/ACI.0b013e328342322f; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Mach N, 1998, BLOOD, V91, P778; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schneider E, 2009, J IMMUNOL, V183, P3591, DOI 10.4049/jimmunol.0900328; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Shen T, 2008, INT IMMUNOL, V20, P1201, DOI 10.1093/intimm/dxn077; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Strickland DH, 2010, CURR OPIN IMMUNOL, V22, P789, DOI 10.1016/j.coi.2010.10.019; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Yagi R, 2007, MOL CELL BIOL, V27, P8087, DOI 10.1128/MCB.00631-07	50	211	219	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					758	771		10.1016/j.immuni.2014.04.013	http://dx.doi.org/10.1016/j.immuni.2014.04.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24837103	Bronze			2022-12-18	WOS:000336026100014
J	Goulder, PJR; Walker, BD				Goulder, Philip J. R.; Walker, Bruce D.			HIV and HLA Class I: An Evolving Relationship	IMMUNITY			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTES; LONG-TERM CONTROL; CELL RESPONSES; DISEASE PROGRESSION; VIRAL LOAD; ESCAPE MUTATIONS; INFECTED-CELLS; IMMUNE CONTROL; P24 GAG	Successful vaccine development for infectious diseases has largely been achieved in settings where natural immunity to the pathogen results in clearance in at least some individuals. HIV presents an additional challenge in that natural clearance of infection does not occur, and the correlates of immune protection are still uncertain. However, partial control of viremia and markedly different outcomes of disease are observed in HIV-infected persons. Here, we examine the antiviral mechanisms implicated by one variable that has been consistently associated with extremes of outcome, namely HLA class I alleles, and in particular HLA-B, and examine the mechanisms by which this modulation is likely to occur and the impact of these interactions on evolution of the virus and the host. Studies to date provide evidence for both H LA-dependent and epitope-dependent influences on viral control and viral evolution and have important implications for the continued quest for an effective HIV vaccine.	[Goulder, Philip J. R.; Walker, Bruce D.] MIT & Harvard, Ragon Inst MGH, Boston, MA 02114 USA; [Goulder, Philip J. R.] Univ Oxford, Dept Paediat, Oxford OX3 9DU, England; [Goulder, Philip J. R.; Walker, Bruce D.] Univ KwaZulu Natal, HIV Pathogenesis Programme, ZA-4013 Congella, South Africa; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Oxford; University of Kwazulu Natal; Howard Hughes Medical Institute	Goulder, PJR (corresponding author), MIT & Harvard, Ragon Inst MGH, Boston, MA 02114 USA.	philip.goulder@paediatrics.ox.ac.uk; bwalker@partners.org			NIH; Wellcome Trust; Collaboration for Vaccine Discovery of the Bill and Melinda Gates Foundation [P30 AI 060354]; Harvard University Center for AIDS Research; Mark and Lisa Schwartz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI030914, R01AI046995] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Collaboration for Vaccine Discovery of the Bill and Melinda Gates Foundation; Harvard University Center for AIDS Research; Mark and Lisa Schwartz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work came from the NIH (B.D.W. and P.J.R.G.), the Wellcome Trust (P.J.R.G.), the Collaboration for Vaccine Discovery of the Bill and Melinda Gates Foundation (P30 AI 060354, B.D.W.), the Harvard University Center for AIDS Research (B.D.W.), and the Mark and Lisa Schwartz Foundation (B.D.W.).	Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Altfeld M, 2007, NAT GENET, V39, P708, DOI 10.1038/ng0607-708; Ammaranond P, 2011, J IMMUNOL, V186, P479, DOI 10.4049/jimmunol.0903227; Bailey JR, 2009, J VIROL, V83, P88, DOI 10.1128/JVI.01958-08; Bennett MS, 2008, J INFECT DIS, V197, P390, DOI 10.1086/525281; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Blanco-Gelaz MA, 2006, INT IMMUNOL, V18, P211, DOI 10.1093/intimm/dxh364; Brander C, 1999, J VIROL, V73, P10191, DOI 10.1128/JVI.73.12.10191-10198.1999; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Carrington M, 2012, ANNU REV MED, V63, P131, DOI 10.1146/annurev-med-062909-130018; Carrington M, 2008, TRENDS MICROBIOL, V16, P620, DOI 10.1016/j.tim.2008.09.002; Chen DY, 2012, BLOOD, V120, P100, DOI 10.1182/blood-2012-02-409870; Chen DY, 2011, J VIROL, V85, P2474, DOI 10.1128/JVI.01726-10; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Chen H, 2009, J VIROL, V83, P3138, DOI 10.1128/JVI.02073-08; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Costello C, 1999, AIDS, V13, P1990, DOI 10.1097/00002030-199910010-00031; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dinges WL, 2010, J VIROL, V84, P4461, DOI 10.1128/JVI.02438-09; DOHERTY PC, 1975, LANCET, V1, P1406, DOI 10.1016/S0140-6736(75)92610-0; Dorak MT, 2003, J INFECT DIS, V188, P856, DOI 10.1086/378071; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Fagerberg T, 2006, J MOL BIOL, V356, P521, DOI 10.1016/j.jmb.2005.11.059; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Goulder PJR, 2000, J VIROL, V74, P5679, DOI 10.1128/JVI.74.12.5679-5690.2000; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Harrer T, 1996, J IMMUNOL, V156, P2616; Hendel H, 1999, J IMMUNOL, V162, P6942; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hindorff L, 2012, CATALOG PUBLISHED GE; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Huang JH, 2010, J VIROL, V84, P9463, DOI 10.1128/JVI.01009-10; Huang JH, 2009, J EXP MED, V206, P2959, DOI 10.1084/jem.20091386; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Iglesias MC, 2011, BLOOD, V118, P2138, DOI 10.1182/blood-2011-01-328781; Ishii H, 2012, J VIROL, V86, P738, DOI 10.1128/JVI.06226-11; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; Kawada M, 2007, J VIROL, V81, P5202, DOI 10.1128/JVI.02881-06; Kawashima Y, 2010, J VIROL, V84, P7151, DOI 10.1128/JVI.00171-10; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; Klenerman P, 1996, AIDS, V10, P348, DOI 10.1097/00002030-199603000-00023; Kloverpris H.N., 2012, J VIROL IN PRESS; Koehler RN, 2010, J INFECT DIS, V202, P1562, DOI 10.1086/656913; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Lazaryan A, 2006, J VIROL, V80, P6056, DOI 10.1128/JVI.02119-05; Lazaryan A, 2011, HUM IMMUNOL, V72, P312, DOI 10.1016/j.humimm.2011.01.003; Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JCI32047; Leslie A, 2006, J IMMUNOL, V177, P4699, DOI 10.4049/jimmunol.177.7.4699; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Lichterfeld M, 2012, J LEUKOCYTE BIOL, V91, P27, DOI 10.1189/jlb.0811442; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Maness NJ, 2008, J VIROL, V82, P5245, DOI 10.1128/JVI.00292-08; Marsh S. G. E., 2000, HLA FACTSBOOK; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; McLaren P.J., 2012, HUM MOL GEN IN PRESS; Mendoza D, 2012, BLOOD, V119, P4645, DOI 10.1182/blood-2011-10-381996; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Miura T, 2009, J VIROL, V83, P3407, DOI 10.1128/JVI.02459-08; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Mudd PA, 2012, NATURE; Mudd PA, 2011, J VIROL, V85, P12804, DOI 10.1128/JVI.05841-11; Ngumbela KC, 2008, AIDS RES HUM RETROV, V24, P72, DOI 10.1089/aid.2007.0124; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; Nomura T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00234; Norstrom MM, 2012, J VIROL, V86, P9802, DOI 10.1128/JVI.01165-12; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Parsons MS, 2012, J VIROL, V86, P4488, DOI 10.1128/JVI.06112-11; Payne RP, 2010, J VIROL, V84, P10543, DOI 10.1128/JVI.00793-10; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; RIVIERE Y, 1995, AIDS RES HUM RETROV, V11, P903, DOI 10.1089/aid.1995.11.903; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Sacha JB, 2007, J VIROL, V81, P11703, DOI 10.1128/JVI.00926-07; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Shrestha S, 2009, AIDS, V23, P673, DOI 10.1097/QAD.0b013e328325d414; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Smith MZ, 2005, J VIROL, V79, P684, DOI 10.1128/JVI.79.2.684-695.2005; Steers NJ, 2011, J VIROL, V85, P1541, DOI 10.1128/JVI.01790-10; Stewart-Jones GBE, 2005, J IMMUNOL, V175, P2459, DOI 10.4049/jimmunol.175.4.2459; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Tang JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009629; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; Tsukamoto T, 2009, J VIROL, V83, P9339, DOI 10.1128/JVI.01120-09; Valentine LE, 2009, J VIROL, V83, P11514, DOI 10.1128/JVI.01298-09; Valentine LE, 2008, TRENDS MICROBIOL, V16, P605, DOI 10.1016/j.tim.2008.08.010; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Yang OO, 2003, J EXP MED, V197, P1365, DOI 10.1084/jem.20022138; Yang OO, 2002, J VIROL, V76, P1626, DOI 10.1128/JVI.76.4.1626-1631.2002; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	130	211	216	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 21	2012	37	3					426	440		10.1016/j.immuni.2012.09.005	http://dx.doi.org/10.1016/j.immuni.2012.09.005			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22999948	Green Accepted, Bronze			2022-12-18	WOS:000309199000005
J	Kang, ZZ; Altuntas, CZ; Gulen, MF; Liu, CN; Giltiay, N; Qin, HW; Liu, LP; Qian, W; Ransohoff, RM; Bergmann, C; Stohlman, S; Tuohy, VK; Li, XX				Kang, Zizhen; Altuntas, Cengiz Zubeyir; Gulen, Muhammet Fatih; Liu, Caini; Giltiay, Natalia; Qin, Hongwei; Liu, Liping; Qian, Wen; Ransohoff, Richard M.; Bergmann, Cornelia; Stohlman, Stephen; Tuohy, Vincent K.; Li, Xiaoxia			Astrocyte-Restricted Ablation of Interleukin-17-Induced Act1-Mediated Signaling Ameliorates Autoimmune Encephalomyelitis	IMMUNITY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NERVOUS-SYSTEM AUTOIMMUNITY; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; T-CELLS; IFN-GAMMA; EPITHELIAL-CELLS; TNF-ALPHA; IMMUNE FUNCTION; TH17 CELLS	Interleukin-17 (IL-17) secreted by T helper 17 (Th17) cells is essential in the development of experimental autoimmune encephalomyelitis (EAE). However, it remains unclear how IL-17-mediated signaling in different cellular compartments participates in the central nervous system (CNS) inflammatory process. We examined CNS inflammation in mice with specific deletion of Act1, a critical component required for IL-17 signaling, in endothelial cells, macrophages and microglia, and neuroectoderm (neurons, astrocytes, and oligodendrocytes). In Act1-deficient mice, Th17 cells showed normal infiltration into the CNS but failed to recruit lymphocytes, neutrophils, and macrophages. Act1 deficiency in endothelial cells or in macrophages and microglia did not substantially impact the development of EAE. However, targeted Act1 deficiency in neuroectoderm-derived CNS-resident cells resulted in markedly reduced severity in EAE. Specifically, Act1-deficient astrocytes showed impaired IL-17-mediated inflammatory gene induction. Thus, astroctyes are critical in IL-17-Act1-mediated leukocyte recruitment during autoimmune-induced inflammation of the CNS.	[Kang, Zizhen; Altuntas, Cengiz Zubeyir; Gulen, Muhammet Fatih; Liu, Caini; Giltiay, Natalia; Qian, Wen; Tuohy, Vincent K.; Li, Xiaoxia] Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA; [Liu, Liping; Ransohoff, Richard M.; Bergmann, Cornelia; Stohlman, Stephen] Cleveland Clin, Dept Neurosci, Neuroinflammat Res Ctr, Cleveland, OH 44195 USA; [Qin, Hongwei] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Alabama System; University of Alabama Birmingham	Tuohy, VK (corresponding author), Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA.	tuohyv@ccf.org; lix@ccf.org	liu, li/HGC-0900-2022; Giltiay, Natalia V./H-8655-2019; Giltiay, Natalia/AAH-2130-2019	Giltiay, Natalia/0000-0001-7284-514X; , Zizhen/0000-0001-5621-8912; Bergmann, Cornelia/0000-0003-1319-402X; Gulen, Muhammet/0000-0002-7139-6781	National Multiple Sclerosis Society [RG 4056-A-1]; National Institutes of Health [R01 A1065470]; NATIONAL CANCER INSTITUTE [R01CA140350] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453, R01HL098935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065470] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge G. Kollias for provision of CD11bCre transgenic mice. This investigation was supported by a grant from the National Multiple Sclerosis Society (RG 4056-A-1) and National Institutes of Health (R01 A1065470).	Agrawal A, 2006, J IMMUNOL, V176, P5788, DOI 10.4049/jimmunol.176.10.5788; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Awane M, 1999, J IMMUNOL, V162, P5337; Bauer M, 2009, P NATL ACAD SCI USA, V106, P1920, DOI 10.1073/pnas.0808909106; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Butti E, 2008, GENE THER, V15, P504, DOI 10.1038/gt.2008.10; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Das MP, 1997, J EXP MED, V186, P867, DOI 10.1084/jem.186.6.867; Das Sarma Jayasri, 2009, J Neuroinflammation, V6, P14, DOI 10.1186/1742-2094-6-14; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Ferber IA, 1996, J IMMUNOL, V156, P5; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gonzalez-Garcia I, 2009, J IMMUNOL, V182, P2665, DOI 10.4049/jimmunol.0802221; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Halonen SK, 2006, J NEUROIMMUNOL, V175, P19, DOI 10.1016/j.jneuroim.2006.02.015; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Inoue D, 2006, BIOCHEM BIOPH RES CO, V347, P852, DOI 10.1016/j.bbrc.2006.06.137; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2002, P NATL ACAD SCI USA, V99, P9386, DOI 10.1073/pnas.142294499; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Ramirez F, 2000, EUR J IMMUNOL, V30, P747; Ransohoff RM, 2009, NATURE, V462, P41, DOI 10.1038/462041a; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinhaus M, 2008, OSTEOLOGIE, V17, P205; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Trajkovic V, 2001, J NEUROIMMUNOL, V119, P183, DOI 10.1016/S0165-5728(01)00391-5; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Wohler JE, 2009, EUR J IMMUNOL, V39, P1516, DOI 10.1002/eji.200839176; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584	59	211	226	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 26	2010	32	3					414	425		10.1016/j.immuni.2010.03.004	http://dx.doi.org/10.1016/j.immuni.2010.03.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20303295	Green Accepted, Bronze			2022-12-18	WOS:000276125400014
J	Ramet, M; Pearson, A; Manfruelli, P; Li, XH; Koziel, H; Gobel, V; Chung, E; Krieger, M; Ezekowitz, RAB				Ramet, M; Pearson, A; Manfruelli, P; Li, XH; Koziel, H; Gobel, V; Chung, E; Krieger, M; Ezekowitz, RAB			Drosophila scavenger receptor Cl is a pattern recognition receptor for bacteria	IMMUNITY			English	Article							HOST-DEFENSE; BINDING PROTEIN; BOMBYX-MORI; APOPTOTIC CELLS; INNATE IMMUNITY; LIGAND-BINDING; CLONING; GENE; PHAGOCYTOSIS; MELANOGASTER	One hallmark of innate immunity apparently conserved from primitive life forms through to humans is the ability of the host to recognize pathogen-associated molecular patterns (PAMPs). Since macrophage pattern recognition receptors are not well defined in Drosophila, we set out to identify such receptors. Our findings reveal that Drosophila macrophages express multiple pattern recognition receptors and that the Drosophila scavenger receptor, dSR-CI, is one such receptor capable of recognizing both gram-negative and gram-positive bacteria, but not yeast. Our data indicate that scavenger receptor bacteria[ recognition is conserved from insects to humans and may represent one of the most primitive forms of microbial recognition.	Harvard Univ, Sch Med, Dept Pediat, MassGen Hosp Children,Lab Dev Immunol, Boston, MA 02114 USA; MIT, Dept Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Pulm & Crit Care Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Ramet, M (corresponding author), Harvard Univ, Sch Med, Dept Pediat, MassGen Hosp Children,Lab Dev Immunol, Boston, MA 02114 USA.		Krieger, Marco/AAE-8611-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052212, P01HL041484] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL41484, HL52212] Funding Source: Medline; PHS HHS [P01 A144220-03] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABRAMS JM, 1992, P NATL ACAD SCI USA, V89, P10375, DOI 10.1073/pnas.89.21.10375; ACTON S, 1993, J BIOL CHEM, V268, P3530; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; ASHKENAS J, 1993, J LIPID RES, V34, P983; Beschin A, 1998, J BIOL CHEM, V273, P24948, DOI 10.1074/jbc.273.38.24948; Daugherty A, 2000, J LIPID RES, V41, P1568; Dimarcq JL, 1997, INSECT BIOCHEM MOLEC, V27, P877, DOI 10.1016/S0965-1748(97)00072-6; DOI T, 1993, J BIOL CHEM, V268, P2126; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Ezekowitz RAB, 2001, CURR OPIN IMMUNOL, V13, P53, DOI 10.1016/S0952-7915(00)00181-3; Fortin A, 2000, MAMM GENOME, V11, P779, DOI 10.1007/s003350010131; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; FRASER I, 1993, NATURE, V364, P343, DOI 10.1038/364343a0; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Hannuksela ML, 1996, ARTERIOSCL THROM VAS, V16, P213, DOI 10.1161/01.ATV.16.2.213; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Kobayashi Y, 2000, J PATHOL, V192, P263; KODOMA T, 1990, NATURE, V343, P531; KOZARSKY KF, 1986, J CELL BIOL, V102, P1567, DOI 10.1083/jcb.102.5.1567; Krieger M, 1997, CURR OPIN LIPIDOL, V8, P275, DOI 10.1097/00041433-199710000-00006; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; MEDZHITOV R, 1997, NATURE, V388, P323; Ochiai M, 1999, J BIOL CHEM, V274, P11854, DOI 10.1074/jbc.274.17.11854; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000; Ramet M, 2001, J PEDIATR-US, V138, P266, DOI 10.1067/mpd.2001.110133; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; RIZKI TM, 1980, EXPERIENTIA, V36, P1223, DOI 10.1007/BF01976142; ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Shimaoka T, 2001, J IMMUNOL, V166, P5108, DOI 10.4049/jimmunol.166.8.5108; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; Turner M W, 2000, Rev Immunogenet, V2, P305; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772	57	211	225	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2001	15	6					1027	1038		10.1016/S1074-7613(01)00249-7	http://dx.doi.org/10.1016/S1074-7613(01)00249-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754822	Bronze			2022-12-18	WOS:000172961400015
J	Eberl, G; MacDonald, HR				Eberl, G; MacDonald, HR			Rapid death and regeneration of NKT cells in anti-CD3 epsilon- or IL-12-treated mice: A major role for bone marrow in NKT cell homeostasis	IMMUNITY			English	Article							BETA T-CELLS; IMMUNOGLOBULIN-E PRODUCTION; RECEPTOR-ALPHA/BETA(+) CELLS; SELECTIVE REDUCTION; INTERFERON-GAMMA; ANTIGEN RECEPTOR; GRAFT-REJECTION; CD8 THYMOCYTES; IN-VIVO; LIVER	Natural killer T (NKT) cells express a T cell receptor (TCR) and markers common to NK cells, including NK1.1. In vivo, NKT cells are triggered by anti-CD3 epsilon MAb to rapidly produce large amounts of IL-4 and by IL-12 to reject tumors. We show here that anti-CD3 epsilon MAb treatment rapidly depletes the liver (and partially the spleen) of NKT cells and that homeostasis is achieved 1 to 2 days later via NKT cell proliferation that occurs mainly in bone marrow. Similar results were obtained in mice treated with IL-12. Collectively, our data demonstrate that peripheral NKT cells are highly sensitive to activation-induced cell death and that bone marrow plays a major role in restoring NKT cell homeostasis.	Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne	MacDonald, HR (corresponding author), Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland.		Eberl, Gerard/A-1160-2013	Eberl, Gerard/0000-0002-1119-5638				ARASE H, 1992, P NATL ACAD SCI USA, V89, P6506, DOI 10.1073/pnas.89.14.6506; ARASE H, 1993, EUR J IMMUNOL, V23, P307, DOI 10.1002/eji.1830230151; Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391; BALLAS ZK, 1990, J IMMUNOL, V145, P1039; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; BOEHME SA, 1993, EUR J IMMUNOL, V23, P1552, DOI 10.1002/eji.1830230724; Chen HJ, 1997, J IMMUNOL, V159, P2240; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Emoto M, 1997, EUR J IMMUNOL, V27, P183, DOI 10.1002/eji.1830270127; Emoto M, 1997, INT IMMUNOL, V9, P563, DOI 10.1093/intimm/9.4.563; HAMMOND K, 1998, IN PRESS INT IMMUNOL; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; HASHIMOTO W, 1995, J IMMUNOL, V154, P4333; HIRSCH R, 1988, J IMMUNOL, V140, P3766; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kawamura T, 1998, J IMMUNOL, V160, P16; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KIKLY K, 1992, J IMMUNOL, V149, P403; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Launois P, 1995, EUR J IMMUNOL, V25, P3298, DOI 10.1002/eji.1830251215; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LEVITSKY HI, 1991, J IMMUNOL, V146, P1113; MACDONALD HR, 1995, J EXP MED, V182, P633, DOI 10.1084/jem.182.3.633; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Mieza MA, 1996, J IMMUNOL, V156, P4035; MUNN DH, 1995, J EXP MED, V181, P127, DOI 10.1084/jem.181.1.127; Ohteki T, 1996, J EXP MED, V183, P1277, DOI 10.1084/jem.183.3.1277; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; OPSTELTEN D, 1983, J IMMUNOL, V131, P2635; RAVIOLA E, 1972, J EXP MED, V136, P466, DOI 10.1084/jem.136.3.466; RENNO T, 1995, J EXP MED, V181, P2283, DOI 10.1084/jem.181.6.2283; RUSSELL JH, 1995, CURR OPIN IMMUNOL, V7, P382, DOI 10.1016/0952-7915(95)80114-6; SATO K, 1995, J EXP MED, V182, P759, DOI 10.1084/jem.182.3.759; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; SUMIDA T, 1995, J EXP MED, V182, P1163, DOI 10.1084/jem.182.4.1163; SYKES M, 1990, J IMMUNOL, V145, P3209; Takahashi M, 1996, J IMMUNOL, V156, P2436; Takeda K, 1996, J IMMUNOL, V156, P3366; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; WHYTE MKB, 1993, J IMMUNOL, V150, P5124; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; YANKELEVICH B, 1989, J IMMUNOL, V142, P3423; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	50	211	215	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1998	9	3					345	353		10.1016/S1074-7613(00)80617-2	http://dx.doi.org/10.1016/S1074-7613(00)80617-2			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768754	Bronze			2022-12-18	WOS:000076202300007
J	tenBoekel, E; Melchers, F; Rolink, AG				tenBoekel, E; Melchers, F; Rolink, AG			Changes in the V-H gene repertoire of developing precursor B lymphocytes in mouse bone marrow mediated by the pre-B cell receptor	IMMUNITY			English	Article							SURROGATE LIGHT-CHAIN; TEMPERATURE-SENSITIVE MUTANT; MURINE LEUKEMIA-VIRUS; ADULT MICE; EXPRESSION; REGION; FAMILIES; DIVERSITY; SELECTION; SEGMENTS	The V-H repertoire on both H chain alleles of normal and lambda 5-deficient B lineage cells were analyzed by single-cell PCR. The mu H chains were tested for their capacity to form a pre-B cell receptor. In bone marrow, D-proximal V-H genes were found preferentially expressed in lambda 5-deficient pre-B cells and in a newly identified early c-kit(+) cytoplasmic mu H chain(+) pre-B cell population of normal mice. Only half of the mu H chains expressed in these cells have the capacity to form a pre-B cell receptor. Representation of the D-proximal V-H genes was found suppressed on the productive but not on the nonproductive V(H)DJ(H) rearranged alleles of c-kit(-) preB-II cells and splenic lambda 5-deficient B cells. More than 95% of the mu H chains expressed in preB-II cells can form a pre-B cell receptor. These results demonstrate that the pre-B cell receptor in normal mice and the B cell receptor in lambda 5-deficient mice mediate a shift in the V-H repertoire.			tenBoekel, E (corresponding author), BASEL INST IMMUNOL,GRENZACHERSTR 487,CH-4005 BASEL,SWITZERLAND.							ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; Backstrom BT, 1996, IMMUNITY, V5, P437, DOI 10.1016/S1074-7613(00)80500-2; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; CARLSSON L, 1992, EUR J IMMUNOL, V22, P71, DOI 10.1002/eji.1830220112; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; CHANG Y, 1992, EMBO J, V11, P1891, DOI 10.1002/j.1460-2075.1992.tb05241.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; CONNOR AM, 1995, J IMMUNOL, V155, P5268; COVEY LR, 1990, INT IMMUNOL, V2, P579, DOI 10.1093/intimm/2.6.579; DECKER DJ, 1995, J IMMUNOL, V154, P4924; DECKER DJ, 1991, J IMMUNOL, V147, P1406; DILDROP R, 1985, EUR J IMMUNOL, V15, P1154, DOI 10.1002/eji.1830151117; FEENEY AJ, 1993, IMMUNOGENETICS, V37, P217; FREITAS AA, 1990, INT IMMUNOL, V2, P15, DOI 10.1093/intimm/2.1.15; GERSTEIN RM, 1993, NATURE, V363, P625, DOI 10.1038/363625a0; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HUETZ F, 1993, EMBO J, V12, P1819, DOI 10.1002/j.1460-2075.1993.tb05830.x; ICHIHARA Y, 1989, EUR J IMMUNOL, V19, P1849, DOI 10.1002/eji.1830191014; IGLESIAS A, 1993, EUR J IMMUNOL, V23, P2622, DOI 10.1002/eji.1830231036; JEONG HD, 1989, J IMMUNOL, V143, P2752; JEONG HD, 1988, J EXP MED, V168, P589, DOI 10.1084/jem.168.2.589; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KEYNA U, 1995, J IMMUNOL, V155, P5536; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; KOFLER R, 1992, IMMUNOL REV, V128, P5, DOI 10.1111/j.1600-065X.1992.tb00830.x; LAWLER AM, 1987, P NATL ACAD SCI USA, V84, P2454, DOI 10.1073/pnas.84.8.2454; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; Marshall AJ, 1996, J IMMUNOL, V156, P2077; Marshall AJ, 1997, J IMMUNOL, V158, P4282; MARTIN F, 1997, INT IMMUNOL, V9, P492; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; MICELI RM, 1991, FASEB J, V5, pA1381; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PERLMUTTER RM, 1985, SCIENCE, V227, P1597, DOI 10.1126/science.3975629; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; RETH MG, 1986, EMBO J, V5, P2131, DOI 10.1002/j.1460-2075.1986.tb04476.x; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; ROLINK A, 1991, CELL, V66, P1081, DOI 10.1016/0092-8674(91)90032-T; ROLINK A, 1993, EUR J IMMUNOL, V23, P1284, DOI 10.1002/eji.1830230614; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; SCHULZE DH, 1987, J EXP MED, V166, P163, DOI 10.1084/jem.166.1.163; SHEEHAN KM, 1989, EMBO J, V8, P2313, DOI 10.1002/j.1460-2075.1989.tb08358.x; SHIRASAWA T, 1992, J EXP MED, V176, P1209, DOI 10.1084/jem.176.4.1209; TAKEMORI T, 1987, EMBO J, V6, P951, DOI 10.1002/j.1460-2075.1987.tb04844.x; TAKI S, 1995, EUR J IMMUNOL, V25, P1888, DOI 10.1002/eji.1830250715; Teale J M, 1992, Int Rev Immunol, V8, P95, DOI 10.3109/08830189209055566; TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; WALDSCHMIDT TJ, 1991, INT IMMUNOL, V3, P305, DOI 10.1093/intimm/3.4.305; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221; WINTER E, 1985, EMBO J, V4, P2861, DOI 10.1002/j.1460-2075.1985.tb04015.x; WU GE, 1986, EMBO J, V5, P3475, DOI 10.1002/j.1460-2075.1986.tb04672.x; YANCOPOULOS GD, 1988, J EXP MED, V168, P417, DOI 10.1084/jem.168.1.417; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0	60	211	213	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1997	7	3					357	368						12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830	9324356				2022-12-18	WOS:A1997XY83000005
J	Reizis, B				Reizis, Boris			Plasmacytoid Dendritic Cells: Development, Regulation, and Function	IMMUNITY			English	Review							IFN-ALPHA PRODUCTION; INTERFERON-PRODUCING CELLS; VIRUS-INFECTED CELLS; DEPENDENT VIRAL RECOGNITION; TRANSCRIPTION FACTOR E2-2; IIFN-PRODUCING CELLS; I INTERFERON; ANTIGEN-PRESENTATION; PREDENDRITIC CELLS; EXOSOMAL TRANSFER	Plasmacytoid dendritic cells (pDCs) are a unique sentinel cell type that can detect pathogen-derived nucleic acids and respond with rapid and massive production of type I interferon. This review summarizes our current understanding of pDC biology, including transcriptional regulation, heterogeneity, role in antiviral immune responses, and involvement in immune pathology, particularly in autoimmune diseases, immunodeficiency, and cancer. We also highlight the remaining gaps in our knowledge and important questions for the field, such as the molecular basis of unique interferon-producing capacity of pDCs. A better understanding of cell type-specific positive and negative control of pDC function should pave the way for translational applications focused on this immune cell type.	[Reizis, Boris] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Reizis, Boris] NYU, Sch Med, Dept Med, New York, NY 10016 USA	New York University; New York University	Reizis, B (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.; Reizis, B (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	boris.reizis@nyumc.org		Reizis, Boris/0000-0003-1140-7853	NIH [AI072571, AI128949]; Lupus Research Alliance; Colton Center for Autoimmunity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI128949, R37AI072571, R01AI072571] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Alliance; Colton Center for Autoimmunity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the NIH grants AI072571 and AI128949, the Lupus Research Alliance, and the Colton Center for Autoimmunity.	Aiello A, 2018, CYTOKINE GROWTH F R, V40, P77, DOI 10.1016/j.cytogfr.2018.03.009; Alcantara-Hernandez M., 2017, IMMUNITY, V47; Alculumbre SG, 2018, NAT IMMUNOL, V19, P63, DOI 10.1038/s41590-017-0012-z; Allen JS, 2009, DIABETES, V58, P138, DOI 10.2337/db08-0964; Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Aouar B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156063; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Assil S, 2018, ANTIVIRAL RESPONSE P, DOI [10.1101/374496, DOI 10.1101/374496]; Baglio SR, 2016, P NATL ACAD SCI USA, V113, pE587, DOI 10.1073/pnas.1518130113; Bao MS, 2016, J EXP MED, V213, P2383, DOI 10.1084/jem.20160438; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Bauer J, 2016, J IMMUNOL, V196, P4447, DOI 10.4049/jimmunol.1500383; Blasius A, 2004, BLOOD, V103, P4201, DOI 10.1182/blood-2003-09-3108; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Bruni D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1552; Bunin A, 2015, IMMUNITY, V43, P277, DOI 10.1016/j.immuni.2015.07.009; Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Ceribelli M, 2016, CANCER CELL, V30, P764, DOI 10.1016/j.ccell.2016.10.002; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Cervantes-Barragan L, 2009, J IMMUNOL, V182, P1099, DOI 10.4049/jimmunol.182.2.1099; Chopin M, 2016, CELL REP, V15, P866, DOI 10.1016/j.celrep.2016.03.066; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Conrad C, 2012, CANCER RES, V72, P5240, DOI 10.1158/0008-5472.CAN-12-2271; Cormier SA, 2014, J VIROL, V88, P9350, DOI 10.1128/JVI.00818-14; Crother TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048655; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; Dai PH, 2011, J VIROL, V85, P10814, DOI 10.1128/JVI.00104-11; Dallari S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14830; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Dasgupta S, 2014, CELL HOST MICROBE, V15, P413, DOI 10.1016/j.chom.2014.03.006; Davidson S, 2011, J IMMUNOL, V186, P5938, DOI 10.4049/jimmunol.1002635; Davison LM, 2015, ARTHRITIS RHEUMATOL, V67, P1012, DOI 10.1002/art.38989; Deal EM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000931; Decembre E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004434; Dekker JD, 2018, LYMPHOID ORIGIN LINE, V2018, DOI [DOI 10.1101/310680, 10.1101/310680]; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Doring M, 2014, J VIROL, V88, P13638, DOI 10.1128/JVI.00216-14; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Dursun E, 2016, SCI REP-UK, V6, DOI 10.1038/srep37462; Eloranta ML, 2010, ANN RHEUM DIS, V69, P1396, DOI 10.1136/ard.2009.121400; Esashi E, 2012, EUR J IMMUNOL, V42, P573, DOI 10.1002/eji.201142045; Feng ZD, 2015, J CLIN INVEST, V125, P169, DOI 10.1172/JCI77527; Frenz T, 2014, J IMMUNOL, V193, P2496, DOI 10.4049/jimmunol.1400215; Garcia-Nicolas O, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00771; Ghosh HS, 2014, J EXP MED, V211, P1623, DOI 10.1084/jem.20132121; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Glitzner E, 2014, EMBO MOL MED, V6, P1312, DOI 10.15252/emmm.201404114; Grajkowska LT, 2017, IMMUNITY, V46, P65, DOI 10.1016/j.immuni.2016.11.006; Griesbeck M, 2015, J IMMUNOL, V195, P5327, DOI 10.4049/jimmunol.1501684; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Hansen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144090; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Ippolito GC, 2014, P NATL ACAD SCI USA, V111, pE998, DOI 10.1073/pnas.1319228111; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jing Y, 2009, HUM IMMUNOL, V70, P777, DOI 10.1016/j.humimm.2009.07.005; Kaitani A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25646-8; Kaminsky LW, 2015, J VIROL, V89, P9974, DOI 10.1128/JVI.01024-15; Kim D, 2008, ARTHRITIS RHEUM-US, V58, P2163, DOI 10.1002/art.23486; Kim JW, 2018, GLYCOBIOLOGY, V28, P592, DOI 10.1093/glycob/cwy050; Kim S, 2014, EUR J IMMUNOL, V44, P807, DOI 10.1002/eji.201343806; Kim TW, 2016, J IMMUNOL, V197, P3348, DOI 10.4049/jimmunol.1502385; Kioon MDA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam8458; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Kumagai Y, 2009, J IMMUNOL, V182, P3960, DOI 10.4049/jimmunol.0804315; Labidi-Galy SI, 2011, CANCER RES, V71, P5423, DOI 10.1158/0008-5472.CAN-11-0367; Laffont S, 2014, J IMMUNOL, V193, P5444, DOI 10.4049/jimmunol.1303400; Lau CM, 2018, J EXP MED, V215, P2265, DOI 10.1084/jem.20172323; Lau CM, 2016, J EXP MED, V213, P415, DOI 10.1084/jem.20150642; Laustsen A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05816-y; Le Mercier I, 2013, CANCER RES, V73, P4629, DOI 10.1158/0008-5472.CAN-12-3058; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee LN, 2009, J IMMUNOL, V182, P7178, DOI 10.4049/jimmunol.0802526; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Lin DS, 2018, CELL REP, V22, P2557, DOI 10.1016/j.celrep.2018.02.046; Liu CW, 2008, J CLIN INVEST, V118, P1165, DOI 10.1172/JCI33583; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lynch JP, 2018, J EXP MED, V215, P537, DOI 10.1084/jem.20170298; Ma SX, 2017, J EXP MED, V214, P1471, DOI 10.1084/jem.20161149; Macal M, 2018, IMMUNITY, V48, P730, DOI 10.1016/j.immuni.2018.03.020; Macal M, 2016, J IMMUNOL, V196, P1900, DOI 10.4049/jimmunol.1501658; Macal M, 2012, CELL HOST MICROBE, V11, P617, DOI 10.1016/j.chom.2012.04.017; Manuse MJ, 2010, VIROLOGY, V405, P383, DOI 10.1016/j.virol.2010.06.023; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; Megjugorac Nicholas J, 2007, Immunol Invest, V36, P739, DOI 10.1080/08820130701715845; Menon M, 2016, IMMUNITY, V44, P683, DOI 10.1016/j.immuni.2016.02.012; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nehmar R, 2017, ARTHRITIS RHEUMATOL, V69, P2124, DOI 10.1002/art.40225; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Oon S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86131; Panda SK, 2018, J CLIN INVEST, V128, P1873, DOI 10.1172/JCI97333; Panda SK, 2017, CURR OPIN IMMUNOL, V44, P20, DOI 10.1016/j.coi.2016.10.006; Pellerin A, 2015, EMBO MOL MED, V7, P464, DOI 10.15252/emmm.201404719; Puttur F, 2016, CELL REP, V17, P1113, DOI 10.1016/j.celrep.2016.09.055; Puttur F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003648; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Rogers GL, 2017, BLOOD, V129, P3184, DOI 10.1182/blood-2016-11-751040; Ronnblom L, 2001, J EXP MED, V194, pF59, DOI 10.1084/jem.194.12.f59; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Rua R, 2012, J VIROL, V86, P909, DOI 10.1128/JVI.06235-11; Sage AP, 2014, CIRCULATION, V130, P1363, DOI 10.1161/CIRCULATIONAHA.114.011090; Saitoh SI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01687-x; Salvi V, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98204; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Sasaki I, 2012, BLOOD, V120, P4733, DOI 10.1182/blood-2012-06-436527; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Sawai CM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02475; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Sawai CM, 2013, J EXP MED, V210, P2151, DOI 10.1084/jem.20130443; Schlitzer A, 2011, BLOOD, V117, P6562, DOI 10.1182/blood-2010-12-326678; Schmitt H, 2016, J EXP MED, V213, P1627, DOI 10.1084/jem.20160189; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Sisirak V, 2013, INT J CANCER, V133, P771, DOI 10.1002/ijc.28072; Sisirak V, 2012, CANCER RES, V72, P5188, DOI 10.1158/0008-5472.CAN-11-3468; Smith N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14253; Spaulding E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005975; Stout-Delgado HW, 2008, J IMMUNOL, V181, P6747, DOI 10.4049/jimmunol.181.10.6747; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Swiecki M, 2014, J IMMUNOL, V192, P4409, DOI 10.4049/jimmunol.1303135; Swiecki M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003728; Swiecki M, 2012, J IMMUNOL, V188, P2488, DOI 10.4049/jimmunol.1103145; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Tel J, 2013, CANCER RES, V73, P1063, DOI 10.1158/0008-5472.CAN-12-2583; Terra M, 2018, CANCER RES, V78, P3014, DOI 10.1158/0008-5472.CAN-17-2719; Tomasello E, 2018, EMBO J, V37, DOI 10.15252/embj.201798836; Upadhaya S, 2018, J EXP MED, V215, P2815, DOI 10.1084/jem.20180136; van Bon L, 2014, NEW ENGL J MED, V370, P433, DOI 10.1056/NEJMoa1114576; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Webster B, 2018, ELIFE, V7, DOI 10.7554/eLife.34273; Wieland SF, 2014, J VIROL, V88, P752, DOI 10.1128/JVI.01714-13; Wimmers F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05784-3; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185; Wu XD, 2016, P NATL ACAD SCI USA, V113, P14775, DOI 10.1073/pnas.1611408114; Wu XD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064800, 10.1371/journal.pone.0071258]; Yu X, 2016, IMMUNITY, V45, P1093, DOI 10.1016/j.immuni.2016.10.001; Yun TJ, 2016, CELL METAB, V23, P852, DOI 10.1016/j.cmet.2016.04.010; Zhan YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep25060; Zhang H, 2017, P NATL ACAD SCI USA, V114, P1988, DOI 10.1073/pnas.1610630114; Zhang XM, 2014, J INFECT DIS, V210, P424, DOI 10.1093/infdis/jiu103; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	175	210	215	12	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					37	50		10.1016/j.immuni.2018.12.027	http://dx.doi.org/10.1016/j.immuni.2018.12.027			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650380	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000455661600009
J	Rodda, LB; Lu, E; Bennett, ML; Sokol, CL; Wang, XM; Luther, SA; Barres, BA; Luster, AD; Ye, CJ; Cyster, JG				Rodda, Lauren B.; Lu, Erick; Bennett, Mariko L.; Sokol, Caroline L.; Wang, Xiaoming; Luther, Sanjiv A.; Barres, Ben A.; Luster, Andrew D.; Ye, Chun Jimmie; Cyster, Jason G.			Single-Cell RNA Sequencing of Lymph Node Stromal Cells Reveals Niche-Associated Heterogeneity	IMMUNITY			English	Article							FOLLICULAR DENDRITIC CELLS; FIBROBLASTIC RETICULAR CELLS; DARK ZONE; CHEMOKINE; RECEPTOR; PROMOTES; LIGAND; MOUSE; MACROPHAGES; RESPONSES	Stromal cells (SCs) establish the compartmentalization of lymphoid tissues critical to the immune response. However, the full diversity of lymph node (LN) SCs remains undefined. Using droplet-based single-cell RNA sequencing, we identified nine peripheral LN non-endothelial SC clusters. Included are the established subsets, Ccl19(hi) T-zone reticular cells (TRCs), marginal reticular cells, follicular dendritic cells (FDCs), and perivascular cells. We also identified Ccl19(lo) TRCs, likely including cholesterol-25-hydroxylase(+) cells located at the T-zone perimeter, Cxcl9(+) TRCs in the T-zone and interfollicular region, CD34(+) SCs in the capsule and medullary vessel adventitia, indolethylamine N-methyltransferase(+) SCs in the medullary cords, and Nr4a1(+) SCs in several niches. These data help define how transcriptionally distinct LN SCs support niche-restricted immune functions and provide evidence that many SCs are in an activated state.	[Rodda, Lauren B.; Lu, Erick; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Rodda, Lauren B.; Lu, Erick; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Bennett, Mariko L.; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Sokol, Caroline L.; Luster, Andrew D.] Harvard Med Sch, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Wang, Xiaoming] Nanjing Med Univ, Dept Immunol, Nanjing, Jiangsu, Peoples R China; [Luther, Sanjiv A.] Univ Lausanne, Ctr Immun & Infect, Dept Biochem, CH-1066 Epalinges, Switzerland; [Ye, Chun Jimmie] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Dept Epidemiol & Biostat, Inst Human Genet, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Nanjing Medical University; University of Lausanne; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.; Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	Luther, Sanjiv/AAP-6525-2020; Luster, Andrew/ABE-6504-2020; Luther, Sanjiv A/B-4380-2016; Ye, Chun/AAK-4868-2021	Luther, Sanjiv/0000-0002-8758-957X; Luster, Andrew/0000-0001-9679-7912; Luther, Sanjiv A/0000-0002-8758-957X; Ye, Chun/0000-0001-6560-3783; Lu, Erick/0000-0001-8175-5146; Bennett, Mariko/0000-0002-1642-2887	National Institutes of Health [AI040098, AI45073]; NSF [1144247]; NIH [K08AI121421, R01CA204028]; Swiss National Science Foundation [31003-146944/1]; NATIONAL CANCER INSTITUTE [R01CA204028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI121421, R01AI045073, T32AI007334, R01AI040098, R37AI040098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Xu and J. An for technical assistance, H.-Y. Huang for the SC isolation protocol, E. Wan, S. Wong, and the Genomics Core Facility for mRNA library processing, sequencing, and alignment, R. Camire for preparation of REX3 LNs, M. Spitzer and M. Subramaniam for coding advice, T. Nagasawa for the Cxcl12-GFP mice, K. Rajewsky for the Cr2-Cre mice, D. Myers and J. Roose for the Nr4a1-GFP mice, and J. Browning for LT beta R-Fc and TNFR1-Fc. This work and L.B.R. were supported by National Institutes of Health grants AI040098 and AI45073, E.L. was supported by NSF grant 1144247, C.L.S. was supported by NIH grant K08AI121421, A.D.L. was supported by NIH grant R01CA204028, and S.A.L. was supported by Swiss National Science Foundation grant 31003-146944/1. J.G.C. is an investigator of the Howard Hughes Medical Institute.	Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Baratin M, 2017, IMMUNITY, V47, P349, DOI 10.1016/j.immuni.2017.07.019; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Brown FD, 2015, J IMMUNOL, V194, P1389, DOI 10.4049/jimmunol.1402520; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chang JE, 2015, TRENDS IMMUNOL, V36, P30, DOI 10.1016/j.it.2014.11.003; Chappaz S, 2010, J IMMUNOL, V185, P3514, DOI 10.4049/jimmunol.1000665; Clingan JM, 2013, J IMMUNOL, V191, P810, DOI 10.4049/jimmunol.1300244; Cordeiro OG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151848; Corselli M, 2012, STEM CELLS DEV, V21, P1299, DOI 10.1089/scd.2011.0200; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Cyster JG, 2000, IMMUNOL REV, V176, P181; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Diaz-Flores L, 2014, HISTOL HISTOPATHOL, V29, P831, DOI 10.14670/HH-29.831; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Goldstein BJ, 2015, J COMP NEUROL, V523, P15, DOI 10.1002/cne.23653; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; He C, 2013, P NATL ACAD SCI USA, V110, pE1879, DOI 10.1073/pnas.1212155110; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Huang YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10398; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Jarjour M, 2014, J EXP MED, V211, P1109, DOI 10.1084/jem.20132409; Kanamoto T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-70; Kanazawa N, 1999, EUR J IMMUNOL, V29, P1925, DOI 10.1002/(SICI)1521-4141(199906)29:06<1925::AID-IMMU1925>3.0.CO;2-U; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Katakai T, 2014, J IMMUNOL, V193, P617, DOI 10.4049/jimmunol.1400565; Khan KA, 2017, ONCOGENE, V36, P6097, DOI 10.1038/onc.2017.214; Kitazawa T, 2011, GENE EXPR PATTERNS, V11, P371, DOI 10.1016/j.gep.2011.04.001; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lain E, 2009, J BIOL CHEM, V284, P8921, DOI 10.1074/jbc.M809491200; Lasoudris F, 2011, EUR J IMMUNOL, V41, P1629, DOI 10.1002/eji.201041119; Lax S, 2010, EUR J IMMUNOL, V40, P1884, DOI 10.1002/eji.200939877; Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu E., 2017, SCI IMMUNOL, V2, P2; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Mavlyutov TA, 2012, NEUROSCIENCE, V206, P60, DOI 10.1016/j.neuroscience.2011.12.040; McCauley LK, 2012, J BONE MINER RES, V27, P1231, DOI 10.1002/jbmr.1617; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mionnet C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001672; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; O'Sullivan ML, 2012, NEURON, V73, P903, DOI 10.1016/j.neuron.2012.01.018; Onder L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00050; Py BF, 2013, IMMUNITY, V38, P1063, DOI 10.1016/j.immuni.2013.01.015; Rodda LB, 2015, J IMMUNOL, V195, P4781, DOI 10.4049/jimmunol.1501191; Sainte-Marie G, 2010, ANAT REC, V293, P320, DOI 10.1002/ar.21051; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schulz O, 2016, ANNU REV IMMUNOL, V34, P203, DOI 10.1146/annurev-immunol-041015-055649; Sitnik KM, 2016, CELL REP, V14, P2375, DOI 10.1016/j.celrep.2016.02.033; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tokuda N, 2010, HISTOCHEM CELL BIOL, V134, P445, DOI 10.1007/s00418-010-0754-2; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wilke G, 2010, EUR J IMMUNOL, V40, P2165, DOI 10.1002/eji.200940202; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	79	210	210	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					1014	+		10.1016/j.immuni.2018.04.006	http://dx.doi.org/10.1016/j.immuni.2018.04.006			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29752062	Green Accepted, Bronze			2022-12-18	WOS:000432488600020
J	Kollmann, TR; Kampmann, B; Mazmanian, SK; Marchant, A; Levy, O				Kollmann, Tobias R.; Kampmann, Beate; Mazmanian, Sarkis K.; Marchant, Arnaud; Levy, Ofer			Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny	IMMUNITY			English	Review							BACILLUS-CALMETTE-GUERIN; BOVINE LACTOFERRIN SUPPLEMENTATION; BIRTH-WEIGHT INFANTS; REGULATORY T-CELLS; IFN-GAMMA PROMOTER; LATE-ONSET SEPSIS; EARLY-LIFE; INNATE IMMUNITY; NECROTIZING ENTEROCOLITIS; COLONIZATION RESISTANCE	Infections in the first year of life are common and often severe. The newborn host demonstrates both quantitative and qualitative differences to the adult in nearly all aspects of immunity, which at least partially explain the increased susceptibility to infection. Here we discuss how differences in susceptibility to infection result not out of a state of immaturity, but rather reflect adaptation to the particular demands placed on the immune system in early life. We review the mechanisms underlying host defense in the very young, and discuss how specific developmentaldemands increase the risk of particular infectious diseases. In this context, wediscuss how this plasticity, i. e. the capacity to adapt to demands encountered in early life, also provides the potential to leverage protection of the young against infection and disease through a number of interventions.	[Kollmann, Tobias R.] Univ British Columbia, Dept Paediat, Div Infect Dis, Vancouver, BC, Canada; [Kollmann, Tobias R.] BC Childrens Hosp, 938 28th Ave,A5-175, Vancouver, BC V5Z 4H4, Canada; [Kampmann, Beate] Imperial Coll London, Dept Paediat, Ctr Int Child Hlth, London, England; [Kampmann, Beate] MRC Unit Gambia, Serrekunda, Gambia; [Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, 1200 Calif Bl,Mailcode 156-29, Pasadena, CA 91125 USA; [Levy, Ofer] Boston Childrens Hosp, Dept Med, Div Infect Dis, Precis Vaccines Program, Boston, MA USA; [Levy, Ofer] Harvard Med Sch, Boston, MA 02115 USA; [Marchant, Arnaud] Univ Libre Bruxelles, Inst Med Immunol, B-6041 Gosselies, Belgium	University of British Columbia; BC Childrens Hospital; University of British Columbia; Imperial College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; California Institute of Technology; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Universite Libre de Bruxelles	Kollmann, TR (corresponding author), Univ British Columbia, Dept Paediat, Div Infect Dis, Vancouver, BC, Canada.; Kollmann, TR (corresponding author), BC Childrens Hosp, 938 28th Ave,A5-175, Vancouver, BC V5Z 4H4, Canada.; Levy, O (corresponding author), Boston Childrens Hosp, Dept Med, Div Infect Dis, Precis Vaccines Program, Boston, MA USA.; Levy, O (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	tkollm@mac.com; ofer.levy@childrens.harvard.edu		Kollmann, Tobias/0000-0003-2403-9762; Levy, Ofer/0000-0002-5859-1945	Medical Research Council [MC_UP_A900_1122, MR/R005990/1] Funding Source: Medline; MRC [MC_UP_A900_1122, MR/R005990/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aaby P, 2014, NAT IMMUNOL, V15, P895, DOI 10.1038/ni.2961; Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Abel L, 2010, J PEDIATR-US, V157, P623, DOI 10.1016/j.jpeds.2010.04.020; AlFaleh K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005496.pub4; Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Barnighausen T, 2014, P NATL ACAD SCI USA, V111, P12313, DOI 10.1073/pnas.1400475111; Battersby AJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00309; Beigi RH, 2014, CLIN INFECT DIS, V59, pS408, DOI 10.1093/cid/ciu708; BEISEL WR, 1992, J NUTR, V122, P591, DOI 10.1093/jn/122.suppl_3.591; Bertoletti A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00441; Bhutta ZA, 2013, NEW ENGL J MED, V369, P2226, DOI 10.1056/NEJMra1111853; Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203; Boer MC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00217; Buchmann K, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00459; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Buffen K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004485; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Bullen J, 2000, MICROBES INFECT, V2, P409, DOI 10.1016/S1286-4579(00)00326-9; Carr R, 2000, BRIT J HAEMATOL, V110, P18, DOI 10.1046/j.1365-2141.2000.01992.x; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Chan AC, 2013, CLIN EXP IMMUNOL, V172, P129, DOI 10.1111/cei.12045; Chan M, 2012, LANCET, V379, P2119, DOI 10.1016/S0140-6736(12)60908-8; Chaurasia S, 2016, LANCET GLOB HEALTH, V4, pE752, DOI 10.1016/S2214-109X(16)30148-6; Cheng SC, 2014, CYTOKINE GROWTH F R, V25, P707, DOI 10.1016/j.cytogfr.2014.06.008; CHIRICO G, 1985, BIOL NEONATE, V47, P125; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Cuervo AM, 2012, MOL ASPECTS MED, V33, P2, DOI 10.1016/j.mam.2011.09.001; Curtis N, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6091; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X; Dauby N, 2012, LANCET INFECT DIS, V12, P330, DOI 10.1016/S1473-3099(11)70341-3; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; De Kleer I, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00423; Debock I, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00393; Denkel LA, 2015, ANTIMICROB RESIST S1, V4, pO39, DOI DOI 10.1186/2047-2994-4-S1-039; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Di Bartolomeo S, 2010, TRAFFIC, V11, P1280, DOI 10.1111/j.1600-0854.2010.01103.x; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Dimova T, 2015, P NATL ACAD SCI USA, V112, pE556, DOI 10.1073/pnas.1412058112; Dominguez-Bello MG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad2741; Dorrestein PC, 2014, IMMUNITY, V40, P824, DOI 10.1016/j.immuni.2014.05.015; Dorschner RA, 2003, PEDIATR RES, V53, P566, DOI 10.1203/01.PDR.0000057205.64451.B7; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Driessche KV, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/781320; Elahi S, 2006, INFECT IMMUN, V74, P2338, DOI 10.1128/IAI.74.4.2338-2352.2006; Elahi S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00376; Fink PJ, 2013, ANNU REV IMMUNOL, V31, P31, DOI 10.1146/annurev-immunol-032712-100010; Gantt S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00387; Gantt S, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/369172; Garcia-Vidal C, 2013, CURR OPIN INFECT DIS, V26, P270, DOI 10.1097/QCO.0b013e32835fb920; Gervassi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107816; Ghazal P, 2013, CURR OPIN INFECT DIS, V26, P213, DOI 10.1097/QCO.0b013e32835fb8bf; Gomez-Lopez N, 2014, CELL MOL IMMUNOL, V11, P571, DOI 10.1038/cmi.2014.46; Goodridge HS, 2016, NAT REV IMMUNOL, V16, P392, DOI 10.1038/nri.2016.43; Hackam DJ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/475415; Haines CJ, 2009, J EXP MED, V206, P275, DOI 10.1084/jem.20080996; HALSEY N, 1985, B WORLD HEALTH ORGAN, V63, P1151; Hanson Lars A, 2002, Semin Neonatol, V7, P275, DOI 10.1016/S1084-2756(02)90124-7; Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085; Hay G, 2007, AM J CLIN NUTR, V86, P64, DOI 10.1093/ajcn/86.1.64; Hermann E, 2002, BLOOD, V100, P2153, DOI 10.1182/blood.V100.6.2153.h81802002153_2153_2158; Hong D. K., 2015, INFECT DIS FETUS NEW, P81; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hornef MW, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00474; Hostetter MK, 2012, NEW ENGL J MED, V366, P1328, DOI 10.1056/NEJMra1111421; Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937; Huygens A, 2015, J INFECT DIS, V212, P484, DOI 10.1093/infdis/jiv071; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; de Castro MJ, 2015, CLIN INFECT DIS, V60, P1611, DOI 10.1093/cid/civ144; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kinder JM, 2015, CELL, V162, P505, DOI 10.1016/j.cell.2015.07.006; King AE, 2007, PLACENTA, V28, P1099, DOI 10.1016/j.placenta.2007.06.002; Kleinnijenhuis J, 2015, T ROY SOC TROP MED H, V109, P29, DOI 10.1093/trstmh/tru168; Kleinnijenhuis J, 2014, J INNATE IMMUN, V6, P152, DOI 10.1159/000355628; KOCHAN I, 1969, J BACTERIOL, V100, P64, DOI 10.1128/JB.100.1.64-70.1969; Koff WC, 2016, EXPERT REV VACCINES, V15, P1235, DOI 10.1586/14760584.2016.1170600; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Krow-Lucal ER, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00314; Landwehr-Kenzel S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00519; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Legrand D, 2016, J PEDIATR-US, V173, pS10, DOI 10.1016/j.jpeds.2016.02.071; Lemoine S, 2015, J ALLERGY CLIN IMMUN, V136, P1355, DOI 10.1016/j.jaci.2015.02.030; Levine MM, 2011, VACCINE, V29, pD116, DOI 10.1016/j.vaccine.2011.11.090; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Levy O, 2014, PEDIATR RES, V75, P184, DOI 10.1038/pr.2013.214; Li Q, 2009, ACTA PHARMACOL SIN, V30, P125, DOI 10.1038/aps.2008.3; Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019; Libraty Daniel H, 2014, Trials Vaccinol, V3, P1, DOI 10.1016/j.trivac.2013.11.004; Lindsey B, 2012, PATHOG GLOB HEALTH, V106, P137, DOI 10.1179/204777312X13462106637684; Lindsey B, 2013, CURR OPIN INFECT DIS, V26, P248, DOI 10.1097/QCO.0b013e3283607a58; Lissner MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132061; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lund N, 2015, CLIN INFECT DIS, V61, P1504, DOI 10.1093/cid/civ617; MacGillivray DM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00434; Mansbach JM, 2012, J ALLERGY CLIN IMMUN, V130, P1007, DOI 10.1016/j.jaci.2012.07.044; Manzoni P, 2014, EARLY HUM DEV, V90, pS60, DOI 10.1016/S0378-3782(14)70020-9; Manzoni P, 2012, PEDIATRICS, V129, P116, DOI 10.1542/peds.2011-0279; Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403; Marchant A, 1999, J IMMUNOL, V163, P2249; Marchant EA, 2015, PEDIATR RES, V78, P492, DOI 10.1038/pr.2015.132; Marchant EA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/586076; Marchini G, 2002, BRIT J DERMATOL, V147, P1127, DOI 10.1046/j.1365-2133.2002.05014.x; Mascart F, 2003, J IMMUNOL, V170, P1504, DOI 10.4049/jimmunol.170.3.1504; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Muenchhoff M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1048; Muenchhoff M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00391; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152; Nakazawa T, 1997, IMMUNOLOGY, V92, P180, DOI 10.1046/j.1365-2567.1997.00343.x; Netea MG, 2015, NAT IMMUNOL, V16, P675, DOI 10.1038/ni.3178; Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Oh DY, 2016, MOL CELL PROTEOMICS, V15, P1877, DOI 10.1074/mcp.M115.055541; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Oh JE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00300; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Oncel MY, 2014, ARCH DIS CHILD-FETAL, V99, pF110, DOI 10.1136/archdischild-2013-304745; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Oppenheimer S, 2012, PAEDIATR INT CHILD H, V32, DOI 10.1179/2046904712Z.00000000075; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Pammi M, 2015, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD007137.pub4, DOI 10.1002/14651858.CD007137.PUB4]; Pandiyan P, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00060; Panigrahi P., 2013, PAS ANN M; Pettengill M, 2013, J BIOL CHEM, V288, P27315, DOI 10.1074/jbc.M113.484212; Pettengill MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00457; Power Coombs M. R., 2013, CLIN DEV IMMUNOL, V2013; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; Rao S, 2005, J Postgrad Med, V51 Suppl 1, pS27; Recalcati S, 2012, SEMIN IMMUNOL, V24, P393, DOI 10.1016/j.smim.2013.01.001; Rechavi E., 2015, SCI TRANSL MED, V7; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Richetta C, 2013, CELL MICROBIOL, V15, P368, DOI 10.1111/cmi.12043; Rochette L, 2015, PHARMACOL THERAPEUT, V146, P35, DOI 10.1016/j.pharmthera.2014.09.004; Rousseau MC, 2008, PEDIAT ALLERG IMM-UK, V19, P438, DOI 10.1111/j.1399-3038.2007.00669.x; Roy A, 2014, N AM J MED SCI, V6, P50, DOI 10.4103/1947-2714.125870; Ruchala P, 2014, TRENDS PHARMACOL SCI, V35, P155, DOI 10.1016/j.tips.2014.01.004; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Samanta M, 2009, J TROP PEDIATRICS, V55, P128, DOI 10.1093/tropej/fmn091; Saso A, 2016, LANCET INFECT DIS, V16, pE153, DOI 10.1016/S1473-3099(16)00119-5; Sassone-Corsi M, 2015, J IMMUNOL, V194, P4081, DOI 10.4049/jimmunol.1403169; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Sepulveda J, 2014, SCIENCE, V345, P1275, DOI 10.1126/science.1257099; Sharma AA, 2012, CLIN IMMUNOL, V145, P61, DOI 10.1016/j.clim.2012.08.006; Sherrid AM, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/917198; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Singh VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062845; Sorup S, 2014, JAMA-J AM MED ASSOC, V311, P826, DOI 10.1001/jama.2014.470; SPEER CP, 1988, PEDIATR RES, V24, P213, DOI 10.1203/00006450-198808000-00015; Starner TD, 2005, J IMMUNOL, V174, P1608, DOI 10.4049/jimmunol.174.3.1608; Strunk T, 2009, ARCH DIS CHILD-FETAL, V94, pF230, DOI 10.1136/adc.2008.143438; Strunk T, 2015, LANCET INFECT DIS, V15, P378, DOI 10.1016/S1473-3099(15)70088-5; STURGEON P, 1954, PEDIATRICS, V13, P107; Szabo M, 2001, ACTA PAEDIATR, V90, P1167, DOI 10.1080/080352501317061585; The United Nations Children's Fund World Health Orginization, 2014, IMM SUMM STAT REF CO; Thome JJC, 2016, NAT MED, V22, P72, DOI 10.1038/nm.4008; Tian YJ, 2016, IMMUNITY, V44, P1204, DOI 10.1016/j.immuni.2016.04.008; Tollin M, 2005, CELL MOL LIFE SCI, V62, P2390, DOI 10.1007/s00018-005-5260-7; Tourneur E, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/270301; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; Turvey SE, 2010, J ALLERGY CLIN IMMUN, V125, pS24, DOI 10.1016/j.jaci.2009.07.016; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; van Haren SD, 2016, J IMMUNOL, V197, P4413, DOI 10.4049/jimmunol.1600282; van Haren SD, 2016, CYTOKINE, V83, P99, DOI 10.1016/j.cyto.2016.04.001; Vergnano S., 2005, J EXP MED, V90, pF220; Vermijlen D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00486; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Visscher M, 2014, ADV WOUND CARE, V3, P291, DOI 10.1089/wound.2013.0467; Wander K, 2009, AM J HUM BIOL, V21, P172, DOI 10.1002/ajhb.20839; Weiner J, 2014, J INTERN MED, V275, P467, DOI 10.1111/joim.12212; White GP, 2002, J IMMUNOL, V168, P2820, DOI 10.4049/jimmunol.168.6.2820; White GP, 2006, PEDIAT ALLERG IMM-UK, V17, P557, DOI 10.1111/j.1399-3038.2006.00465.x; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wilcox DR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004580; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wynn JL, 2015, J IMMUNOL, V195, P1064, DOI 10.4049/jimmunol.1500771; Yoshio H, 2003, PEDIATR RES, V53, P211, DOI 10.1203/01.PDR.0000047471.47777.B0; Zhang X, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008748	189	210	221	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					350	363		10.1016/j.immuni.2017.03.009	http://dx.doi.org/10.1016/j.immuni.2017.03.009			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329702	Green Submitted, Bronze			2022-12-18	WOS:000396818100009
J	Casanova, JL; Holland, SM; Notarangelo, LD				Casanova, Jean-Laurent; Holland, Steven M.; Notarangelo, Luigi D.			Inborn Errors of Human JAKs and STATs	IMMUNITY			English	Review							INTERLEUKIN-2-RECEPTOR GAMMA-CHAIN; SEVERE COMBINED IMMUNODEFICIENCY; COMBINED IMMUNE-DEFICIENCY; HYPER-IGE SYNDROME; DEFECTIVE LYMPHOID DEVELOPMENT; T-CELL HOMEOSTASIS; IL-2 RECEPTOR; CUTTING EDGE; ANTIBODY-RESPONSES; JOBS-SYNDROME	Inborn errors of the genes encoding two of the four human JAKs (JAK3 and TYK2) and three of the six human STATs (STAT1, STA T3, and STAT5B) have been described. We review the disorders arising from mutations in these five genes, highlighting the way in which the molecular and cellular pathogenesis of these conditions has been clarified by the discovery of inborn errors of cytokines, hormones, and their receptors, including those interacting with JAKs and STATs. The phenotypic similarities between mice and humans lacking individual JAK-STAT components suggest that the functions of JAKs and STATs are largely conserved in mammals. However, a wide array of phenotypic differences has emerged between mice and humans carrying biallelic null alleles of JAK3, TYK2, STAT1, or STAT5B. Moreover, the high degree of allelic heterogeneity at the human JAK3, TYK2, STAT1, and STAT3 loci has revealed highly diverse immunological and clinical phenotypes, which had not been anticipated.	[Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Univ Hosp, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10065 USA; [Casanova, Jean-Laurent] Univ Paris 05, Necker Branch, Lab Human Genet Infect Dis, Paris 75005, France; [Casanova, Jean-Laurent] Inserm, Necker Med Sch, Paris 75005, France; [Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Div Immunol, Childrens Hosp Boston, Boston, MA 02115 USA	Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Casanova, JL (corresponding author), Rockefeller Univ, Rockefeller Univ Hosp, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10065 USA.	jean-laurent.casanova@rockefeller.edu	Casanova, Jean-Laurent/I-3418-2017; Notarangelo, Luigi D/F-9718-2016	Notarangelo, Luigi D/0000-0002-8335-0262; Casanova, Jean-Laurent/0000-0002-7782-4169	Rockefeller University; Institut National de la Sante et de la Recherche Medicale; University Paris Descartes; St. Giles Foundation; Rockefeller University Center for Clinical and Translational Science [UL1RR024143]; National Institute of Allergy and Infectious Diseases [1R37AI095983-01, 5R01AI089970-02]; Manton Foundation; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089970, R37AI095983, ZIAAI000646, ZIAAI000647] Funding Source: NIH RePORTER	Rockefeller University; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Paris Descartes; St. Giles Foundation; Rockefeller University Center for Clinical and Translational Science; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Manton Foundation; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	J.L.C. received support from the Rockefeller University, the Institut National de la Sante et de la Recherche Medicale, the University Paris Descartes, the St. Giles Foundation, the Rockefeller University Center for Clinical and Translational Science grant number UL1RR024143, and the National Institute of Allergy and Infectious Diseases grant numbers 1R37AI095983-01 and 5R01AI089970-02. L.D.N. was supported in part by the Manton Foundation. S.M.H. was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH.	Al-Herz W., 2011, FRONT IMMUNOL, V10, P9; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Aoki CA, 2006, J AUTOIMMUN, V27, P50, DOI 10.1016/j.jaut.2006.04.005; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Averbuch D, 2011, PEDIATR INFECT DIS J, V30, P352, DOI 10.1097/INF.0b013e3181fdff4a; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Ayling RM, 1997, NAT GENET, V16, P13, DOI 10.1038/ng0597-13; Behbod F, 2003, J IMMUNOL, V171, P3919, DOI 10.4049/jimmunol.171.8.3919; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bernasconi A, 2006, PEDIATRICS, V118, pE1584, DOI 10.1542/peds.2005-2882; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brugnoni D, 1998, BLOOD, V91, P949, DOI 10.1182/blood.V91.3.949.949_949_955; Buckley RH, 2010, J ALLERGY CLIN IMMUN, V125, P790, DOI 10.1016/j.jaci.2010.02.012; BUCKLEY RH, 1972, PEDIATRICS, V49, P59; BUCKLEY RH, 1978, IMMUNOL REV, V41, P288, DOI 10.1111/j.1600-065X.1978.tb01469.x; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Bustamante J, 2011, ANN NY ACAD SCI, V1246, P92, DOI 10.1111/j.1749-6632.2011.06273.x; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Candotti F, 1997, BLOOD, V90, P3996, DOI 10.1182/blood.V90.10.3996; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Chandesris MO, 2012, CIRC-CARDIOVASC GENE, V5, P25, DOI 10.1161/CIRCGENETICS.111.961235; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Chen M, 2000, MOL CELL BIOL, V20, P947, DOI 10.1128/MCB.20.3.947-956.2000; Chen MY, 2009, EUR J IMMUNOL, V39, P2525, DOI 10.1002/eji.200838879; Cohen AC, 2006, J IMMUNOL, V177, P2770, DOI 10.4049/jimmunol.177.5.2770; Cohen P, 2008, CARDIOL REV, V16, P301, DOI 10.1097/CRD.0b013e3181852659; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; DAVIS SD, 1966, LANCET, V1, P1013; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; DONABEDIAN H, 1983, MEDICINE, V62, P195, DOI 10.1097/00005792-198307000-00001; Donnelly RP, 2010, CYTOKINE GROWTH F R, V21, P393, DOI 10.1016/j.cytogfr.2010.09.001; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; DUQUESNOY P, 1994, EMBO J, V13, P1386, DOI 10.1002/j.1460-2075.1994.tb06392.x; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Freeman AF, 2011, J ALLERGY CLIN IMMUN, V128, P1124, DOI 10.1016/j.jaci.2011.07.046; Freeman AF, 2011, J CLIN IMMUNOL, V31, P338, DOI 10.1007/s10875-011-9515-9; Freeman AF, 2010, DIS MARKERS, V29, P123, DOI [10.1155/2010/580197, 10.3233/DMA-2010-0734]; Frucht DM, 2001, GENES IMMUN, V2, P422, DOI 10.1038/sj.gene.6363802; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GITLIN D, 1963, PEDIATRICS, V32, P517; GLANZMANN E, 1950, Ann Paediatr, V175, P1; Glocker EO, 2010, LANCET, V376, P1272, DOI 10.1016/S0140-6736(10)61008-2; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hwa V, 2011, BEST PRACT RES CL EN, V25, P61, DOI 10.1016/j.beem.2010.09.003; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kida H, 2008, AM J PATHOL, V172, P1542, DOI 10.2353/ajpath.2008.071052; Kilic SS, 2012, J PEDIATR-US, V160, P1055, DOI 10.1016/j.jpeds.2012.01.056; KIMURA Y, 1995, INT IMMUNOL, V7, P115, DOI 10.1093/intimm/7.1.115; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Kong XF, 2010, BLOOD, V116, P5895, DOI 10.1182/blood-2010-04-280586; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Kristensen IA, 2011, J CLIN IMMUNOL, V31, P265, DOI 10.1007/s10875-010-9480-8; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Leonard GD, 2004, LEUKEMIA LYMPHOMA, V45, P2521, DOI 10.1080/10428190400004463; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Mella P, 2000, CLIN IMMUNOL, V95, P39, DOI 10.1006/clim.2000.4842; Meyer-Bahlburg A, 2012, J ALLERGY CLIN IMMUN, V129, P559, DOI 10.1016/j.jaci.2011.09.017; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Minegishi Y, 2011, ANN NY ACAD SCI, V1246, P34, DOI 10.1111/j.1749-6632.2011.06280.x; Minegishi Y, 2009, CURR OPIN IMMUNOL, V21, P487, DOI 10.1016/j.coi.2009.07.013; Minegishi Y, 2009, J EXP MED, V206, P1291, DOI 10.1084/jem.20082767; Murawski MR, 2006, ANN NY ACAD SCI, V1079, P198, DOI 10.1196/annals.1375.031; Nadeau K, 2011, J PEDIATR-US, V158, P701, DOI 10.1016/j.jpeds.2010.12.042; Nieminen P, 2011, AM J HUM GENET, V89, P67, DOI 10.1016/j.ajhg.2011.05.024; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Notarangelo LD, 2000, IMMUNOL REV, V178, P39, DOI 10.1034/j.1600-065X.2000.17812.x; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; O'Shea JJ, 2011, J IMMUNOL, V187, P5475, DOI 10.4049/jimmunol.1102913; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Pene J, 2004, J IMMUNOL, V172, P5154, DOI 10.4049/jimmunol.172.9.5154; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Puck JM, 1997, BLOOD, V89, P1968; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Pugliese-Pires PN, 2010, EUR J ENDOCRINOL, V163, P349, DOI 10.1530/EJE-10-0272; Recher M, 2011, BLOOD, V118, P6824, DOI 10.1182/blood-2011-06-362533; Renner ED, 2004, J PEDIATR-US, V144, P93, DOI 10.1016/S0022-3476(03)00449-9; Roesler J, 2004, J PEDIATR-US, V145, P806, DOI 10.1016/j.jpeds.2004.08.021; ROSEN FS, 1966, NEW ENGL J MED, V274, P18, DOI 10.1056/NEJM196601062740104; Rottman M, 2008, PLOS MED, V5, P152, DOI 10.1371/journal.pmed.0050026; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; Saito M, 2011, J EXP MED, V208, P235, DOI 10.1084/jem.20100799; Sampaio E.P., 2012, J CLIN IMMU IN PRESS; Sancho-Shimizu V, 2011, CURR OPIN VIROL, V1, P487, DOI 10.1016/j.coviro.2011.10.016; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; Schmalstieg FC, 2002, MOL GENET METAB, V76, P163, DOI 10.1016/S1096-7192(02)00042-2; Sharfe N, 1997, J CLIN INVEST, V100, P3036, DOI 10.1172/JCI119858; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; SHEERIN KA, 1991, J ALLERGY CLIN IMMUN, V87, P803, DOI 10.1016/0091-6749(91)90126-9; Shimoda K, 2000, IMMUNITY, V13, P561, DOI 10.1016/S1074-7613(00)00055-8; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Snow JW, 2003, J IMMUNOL, V171, P5042, DOI 10.4049/jimmunol.171.10.5042; Speckmann C, 2008, CLIN IMMUNOL, V129, P448, DOI 10.1016/j.clim.2008.08.002; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Strobl B., 2012, FRONT BIOSCI, V17, P3214; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Tangye SG, 2009, J IMMUNOL, V182, P21, DOI 10.4049/jimmunol.182.1.21; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Vairo D, 2011, BLOOD, V118, P1806, DOI 10.1182/blood-2011-01-330571; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; Vinh DC, 2009, CLIN INFECT DIS, V49, pE62, DOI 10.1086/605532; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Vogt G, 2008, J EXP MED, V205, P1729, DOI 10.1084/jem.20071987; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wesemann DR, 2011, J EXP MED, V208, P2733, DOI 10.1084/jem.20111155; White H, 2000, EUR J IMMUNOL, V30, P732; White UA, 2011, CURR PHARM DESIGN, V17, P340; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	150	210	218	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 20	2012	36	4					515	528		10.1016/j.immuni.2012.03.016	http://dx.doi.org/10.1016/j.immuni.2012.03.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22520845	Green Accepted, Bronze			2022-12-18	WOS:000303223900002
J	Jeannin, P; Bottazzi, B; Sironi, M; Doni, A; Rusnatl, M; Presta, M; Maina, V; Magistrelli, G; Haeuw, JF; Hoeffel, G; Thieblemont, N; Corvaia, N; Garlanda, C; Delneste, Y; Mantovani, A				Jeannin, P; Bottazzi, B; Sironi, M; Doni, A; Rusnatl, M; Presta, M; Maina, V; Magistrelli, G; Haeuw, JF; Hoeffel, G; Thieblemont, N; Corvaia, N; Garlanda, C; Delneste, Y; Mantovani, A			Complexity and complementarity of outer membrane protein a recognition by cellular and humoral innate immunity receptors	IMMUNITY			English	Article							C-REACTIVE PROTEIN; ACUTE PHASE PROTEINS; LONG PENTRAXIN PTX3; AMYLOID-P COMPONENT; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; SCAVENGER RECEPTORS; MACROPHAGES; DIFFERENTIATION; INFLAMMATION	Outer membrane protein A (OmpA) is a conserved major component of the outer membrane of Enterobacteriaceae. Here, we report that OmpA from Klebsiella pneumoniae (KpOmpA) activates macrophages and dendritic cells (DCs) in a TLR2-dependent way. However, TLR2 does not account for binding of KpOmPA to innate immune cells. KpOmPA binds the scavenger receptors (SRs) LOX-1 and SREC-I, but not other members of the same family. LOX-1 colocalizes and cooperates with TLR2 in triggering cellular responses. The TLR2-activated functional program includes production of the long pentraxin PTX3, a soluble pattern recognition receptor involved in resistance against diverse pathogens. PTX3, in turn, binds KpOmpA but does not affect recognition of this microbial moiety by cellular receptors. KpOmpA-elicited in vivo inflammation is abrogated in TLR2(-/-) mice and significantly reduced in PTX3(-/-) mice. Thus, SR-mediated KpOmpA recognition and TLR2-dependent cellular activation set in motion a nonredundant PTX3-mediated humoral amplification loop of innate immunity.	Mario Negri Inst Pharmacol Res, Dept Immunol & Cell Biol, I-20157 Milan, Italy; Ctr Immunol Pierre Fabre, F-74164 St Julien En Genevois, France; Univ Brescia, Dept Biomed Sci & Biotechnol, Unity Gen Pathol & Immunol, I-25123 Brescia, Italy; Univ Paris 05, CNRS, Hop Necker, F-75015 Paris, France; Univ Milan, Inst Gen Pathol, I-20133 Milan, Italy; Univ Hosp Angers, Immunol & Allergol Lab, F-49933 Angers, France; Univ Hosp Angers, INSERM, U564, F-49933 Angers, France	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Centre d'Immunologie Pierre Fabre; University of Brescia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Milan; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Mantovani, A (corresponding author), Mario Negri Inst Pharmacol Res, Dept Immunol & Cell Biol, Via Eritrea 62, I-20157 Milan, Italy.	mantovani@marionegri.it	Garlanda, Cecilia/K-4601-2016; Mantovani, Alberto/HCI-7449-2022; JEANNIN, Pascale/K-8656-2015; sironi, marina/AAB-5757-2020; DELNESTE, Yves/K-7367-2015; Rusnati, Marco/F-1168-2010; Hoeffel, Guillaume/ABG-4881-2021; Delneste, Yves/O-3956-2016; Presta, Marco/B-4345-2010; Thieblemont, Nathalie/P-1329-2017; bottazzi, barbara/ABH-9274-2020	Garlanda, Cecilia/0000-0002-1510-7703; Mantovani, Alberto/0000-0001-5578-236X; sironi, marina/0000-0002-3342-1149; DELNESTE, Yves/0000-0002-2142-596X; Rusnati, Marco/0000-0001-9968-5908; Hoeffel, Guillaume/0000-0002-2534-4972; Thieblemont, Nathalie/0000-0002-8898-9217; bottazzi, barbara/0000-0002-1930-9257; JEANNIN, Pascale/0000-0002-3666-3856; PRESTA, Marco/0000-0002-4398-8376; Doni, Andrea/0000-0001-9203-5814				ABRAHAM R, 1995, J IMMUNOL, V154, P1; ALLES VV, 1994, BLOOD, V84, P3483; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; D'Amico G, 1998, BLOOD, V92, P207, DOI 10.1182/blood.V92.1.207.413a02_207_214; DAVIES RL, 1990, J IMMUNOL METHODS, V134, P215, DOI 10.1016/0022-1759(90)90383-7; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Dhaliwal BS, 1999, CLIN CHIM ACTA, V286, P191, DOI 10.1016/S0009-8981(99)00101-1; Diniz SN, 2004, J LEUKOCYTE BIOL, V75, P649, DOI 10.1189/jlb.0803371; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Haeuw JF, 2004, PROTEOMICS: BIOMEDICAL AND PHARMACEUTICAL APPLICATIONS, P243, DOI 10.1007/1-4020-2323-5_11; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jeannin P, 2003, EUR J IMMUNOL, V33, P326, DOI 10.1002/immu.200310006; Jeannin P, 2000, NAT IMMUNOL, V1, P502, DOI 10.1038/82751; LEE GW, 1993, J IMMUNOL, V150, P1804; Maisnier-Patin K, 2003, VACCINE, V21, P3765, DOI 10.1016/S0264-410X(03)00316-5; Mantovani A, 2003, VACCINE, V21, pS43, DOI 10.1016/S0264-410X(03)00199-3; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; Peiser L, 2001, MICROBES INFECT, V3, P149, DOI 10.1016/S1286-4579(00)01362-9; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; PERI G, 1994, J IMMUNOL METHODS, V174, P249, DOI 10.1016/0022-1759(94)90029-9; Piemonti L, 1995, EUR CYTOKINE NETW, V6, P245; Poolman J T, 1996, Adv Exp Med Biol, V397, P73; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Shimaoka T, 2001, J IMMUNOL, V166, P5108, DOI 10.4049/jimmunol.166.8.5108; Szalai AJ, 1999, CLIN CHEM LAB MED, V37, P265, DOI 10.1515/CCLM.1999.046; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; van den Berg BM, 1999, INFECT IMMUN, V67, P1056, DOI 10.1128/IAI.67.3.1056-1062.1999; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154	40	210	223	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2005	22	5					551	560		10.1016/j.immuni.2005.03.008	http://dx.doi.org/10.1016/j.immuni.2005.03.008			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894273	Bronze			2022-12-18	WOS:000229447200005
J	Kim, SJ; Elkon, KB; Ma, XJ				Kim, SJ; Elkon, KB; Ma, XJ			Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROINFLAMMATORY CYTOKINE; NOD MICE; MACROPHAGES; IL-12; CLEARANCE; BINDING; AUTOIMMUNITY; PREVENTION; PROTEINS	Phagocytosis of apoptotic cells usually results in an anti-inflammatory state with inhibition of proinflammatory cytokines such as IL-12. How apoptotic cell-derived signals regulate IL-12 gene expression is not understood. We demonstrate that cell-cell contact with apoptotic cells is sufficient to induce profound inhibition of IL-12 production by activated macrophages. Phosphatidylserine could mimic the inhibitory effect. The inhibition does not involve autocrine or paracrine actions of IL-10 and TGF-beta. We report the identification, purification, and cloning of a novel zinc finger nuclear factor, named GC binding protein (GC-BP), that is induced following phagocytosis of apoptotic cells by macrophages or by treatment with phosphatidylserine. GC-BP selectively inhibits IL-12 p35 gene transcription by binding to its promoter in vitro and in vivo, thus decreasing IL-12 production. Blocking GC-BP by RNA interference restores IL-12 p35 transcription and IL-12 p70 synthesis. Finally, GC-BP itself undergoes functionally significant tyrosine dephosphorylation in response to apoptotic cells.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Univ Washington, Div Rheumatol, Seattle, WA 98195 USA	Cornell University; University of Washington; University of Washington Seattle	Ma, XJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10021 USA.	xim2002@med.cornell.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045899] Funding Source: NIH RePORTER; NIAID NIH HHS [AI45899] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Cappiello MG, 2001, J IMMUNOL, V166, P4498, DOI 10.4049/jimmunol.166.7.4498; DUCLOS TW, 1994, CLIN IMMUNOL IMMUNOP, V70, P22, DOI 10.1006/clin.1994.1005; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; HASLETT C, 1994, PHILOS T ROY SOC B, V345, P327, DOI 10.1098/rstb.1994.0113; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; Klenova EM, 1998, J BIOL CHEM, V273, P26571, DOI 10.1074/jbc.273.41.26571; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonard JP, 1997, CRIT REV IMMUNOL, V17, P545; LEONARD JP, 1995, J EXP MED, V181, P381, DOI 10.1084/jem.181.1.381; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Liu JJ, 2002, J IMMUNOL, V169, P581, DOI 10.4049/jimmunol.169.1.581; McIntyre KW, 1996, EUR J IMMUNOL, V26, P2933, DOI 10.1002/eji.1830261219; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; MILLER FR, 1983, INVAS METAST, V3, P22; Mitchell DA, 2002, J IMMUNOL, V168, P2538, DOI 10.4049/jimmunol.168.5.2538; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Park M, 1998, DEV GENET, V22, P201, DOI 10.1002/(SICI)1520-6408(1998)22:3<201::AID-DVG3>3.0.CO;2-A; Rajeevan MS, 2001, METHODS, V25, P443, DOI 10.1006/meth.2001.1266; Rothe H, 1997, DIABETOLOGIA, V40, P641, DOI 10.1007/s001250050728; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Simpson PB, 2003, J IMMUNOL, V171, P3333, DOI 10.4049/jimmunol.171.7.3333; Spadaro A, 2002, Reumatismo, V54, P113; TREMBLEAU S, 1995, IMMUNOL TODAY, V16, P383, DOI 10.1016/0167-5699(95)80006-9; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Voll RE, 1997, ARTHRITIS RHEUM-US, V40, P2162, DOI 10.1002/art.1780401210; VOLLMAR AM, 1994, J CLIN INVEST, V94, P539, DOI 10.1172/JCI117367; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Yokoi H, 1997, EUR J IMMUNOL, V27, P641, DOI 10.1002/eji.1830270310	34	210	239	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2004	21	5					643	653		10.1016/j.immuni.2004.09.009	http://dx.doi.org/10.1016/j.immuni.2004.09.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539151	Bronze			2022-12-18	WOS:000225365000006
J	Martin, E; O'Sullivan, B; Low, P; Thomas, R				Martin, E; O'Sullivan, B; Low, P; Thomas, R			Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10	IMMUNITY			English	Article							KAPPA-B; IN-VIVO; COSTIMULATORY MOLECULES; NUCLEAR TRANSLOCATION; CD40-DEFICIENT MICE; TARGETED DISRUPTION; MULTIFOCAL DEFECTS; TOXOPLASMA-GONDII; RELB; EXPRESSION	Antigen-specific suppression of a previously primed immune response is a major challenge for immunotherapy of autoimmune disease. ReIB activation is required for myeloid DC differentiation. Here, we show that antigen-exposed DCs in which ReIB function is inhibited lack cell surface CD40, prevent priming of immunity, and suppress previously primed immune responses. DCs generated from CD40-deficient mice similarly confer suppression. Regulatory CD4(+) T cells induced by the DCs transfer antigen-specific "Infectious" tolerance to primed recipients in an interleukin10-dependent fashion. Thus CD40, regulated by ReIB activity, determines the consequences of antigen presentation by myeloid DCs. These observations have significance for autoimmune immunotherapy and suggest a mechanism by which peripheral tolerance might be constitutively maintained by RelB(-) CD40(-) DCs.	Univ Queensland, Princess Alexandra Hosp, Ctr Immunol & Canc Res, Brisbane, Qld 4102, Australia	University of Queensland	Thomas, R (corresponding author), Univ Queensland, Princess Alexandra Hosp, Ctr Immunol & Canc Res, Brisbane, Qld 4102, Australia.		Thomas, Ranjeny/B-4504-2013; O'Sullivan, Brendan/G-5108-2014	Thomas, Ranjeny/0000-0002-0518-8386; O'Sullivan, Brendan/0000-0001-9773-2571				Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; BUHLMANN JE, 1995, IMMUNITY, V2, P645; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Caamano J, 1999, J IMMUNOL, V163, P4453; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Cobbold S, 1998, CURR OPIN IMMUNOL, V10, P518, DOI 10.1016/S0952-7915(98)80217-3; de Jong EC, 1999, J LEUKOCYTE BIOL, V66, P201, DOI 10.1002/jlb.66.2.201; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Diehl L, 2000, J MOL MED, V78, P363, DOI 10.1007/s001090000126; Feldmann M, 2001, NAT IMMUNOL, V2, P771, DOI 10.1038/ni0901-771; Gao JX, 1999, IMMUNOLOGY, V98, P159; Giannoukakis N, 2000, MOL THER, V1, P430, DOI 10.1006/mthe.2000.0060; Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Hackstein H, 2001, J IMMUNOL, V166, P7053, DOI 10.4049/jimmunol.166.12.7053; Hanninen A, 2002, J CLIN INVEST, V109, P261; Hofer S, 2001, MICROBES INFECT, V3, P259, DOI 10.1016/S1286-4579(01)01378-8; Hollander GA, 1996, P NATL ACAD SCI USA, V93, P4994, DOI 10.1073/pnas.93.10.4994; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Lawlor KE, 2001, ARTHRITIS RHEUM, V44, P442, DOI 10.1002/1529-0131(200102)44:2<442::AID-ANR63>3.0.CO;2-M; Lee JI, 1999, TRANSPLANTATION, V68, P1255, DOI 10.1097/00007890-199911150-00007; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; MacDonald AS, 2002, J IMMUNOL, V168, P4643, DOI 10.4049/jimmunol.168.9.4643; MacDonald AS, 2002, J IMMUNOL, V168, P537, DOI 10.4049/jimmunol.168.2.537; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Mehling A, 2000, J IMMUNOL, V165, P2374, DOI 10.4049/jimmunol.165.5.2374; Neumann M, 2000, BLOOD, V95, P277; O'Sullivan BJ, 2000, P NATL ACAD SCI USA, V97, P11421, DOI 10.1073/pnas.97.21.11421; O'Sullivan BJ, 2002, J IMMUNOL, V168, P5491, DOI 10.4049/jimmunol.168.11.5491; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Ozaki ME, 1999, J IMMUNOL, V163, P5250; Pai S, 2002, J VIROL, V76, P1914, DOI 10.1128/JVI.76.4.1914-1921.2002; Pettit AR, 2000, ARTHRITIS RHEUM, V43, P791, DOI 10.1002/1529-0131(200004)43:4<791::AID-ANR9>3.0.CO;2-E; Pettit AR, 1997, J IMMUNOL, V159, P3681; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; SANDER B, 1991, IMMUNOL REV, V119, P65, DOI 10.1111/j.1600-065X.1991.tb00578.x; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Subauste CS, 1999, J IMMUNOL, V162, P6690; Thompson AG, 2002, IMMUNOL CELL BIOL, V80, P164, DOI 10.1046/j.1440-1711.2002.01070.x; Weih F, 1997, J IMMUNOL, V158, P5211; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Yoshimura S, 2001, INT IMMUNOL, V13, P675, DOI 10.1093/intimm/13.5.675; Zhou P, 1998, J EXP MED, V187, P1315, DOI 10.1084/jem.187.8.1315	54	210	233	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2003	18	1					155	167		10.1016/S1074-7613(02)00503-4	http://dx.doi.org/10.1016/S1074-7613(02)00503-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530984	Bronze			2022-12-18	WOS:000180860600015
J	Metkar, SS; Wang, BK; Aguilar-Santelises, M; Raja, SM; Uhlin-Hansen, L; Podack, E; Trapani, JA; Froelich, CJ				Metkar, SS; Wang, BK; Aguilar-Santelises, M; Raja, SM; Uhlin-Hansen, L; Podack, E; Trapani, JA; Froelich, CJ			Cytotoxic cell granule-mediated apoptosis: Perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; CYTOSOLIC DELIVERY; PROTEOGLYCANS; CTL; PURIFICATION; COMPONENTS; PROTEASES; CLEAVAGE; IDENTIFICATION; LYMPHOCYTES	The mechanism underlying perforin (PFN)-dependent delivery of apoptotic granzymes during cytotoxic cell granule-mediated death remains speculative. Granzyme B. (GrB) and perforin were found to coexist as multimeric complexes with the proteoglycan serglycin (SG) in cytotoxic granules, and cytotoxic cells were observed to secrete exclusively macromolecular GrB-SG. Contrary to the view that PFN acts as a gateway for granzymes through the plasma membrane, monomeric PFN and, strikingly, PFN-SG complexes were shown to mediate cytosolic delivery of macromolecular GrB-SG without producing detectable plasma membrane pores. These results indicate that granule-mediated apoptosis represents a phenomenon whereby the target cell perceives granule contents as a multimeric complex consisting of SG, PFN, and granzymes, which are, respectively, the scaffold, translocator, and targeting/informational components of this modular delivery system.	Evanston NW Healthcare Res Inst, Evanston, IL 60201 USA; Univ Tromso, Inst Med Biol, Tromso, Norway; Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA; Peter McCallum Canc Inst, Melbourne, Vic 3002, Australia	UiT The Arctic University of Tromso; University of Miami; Peter Maccallum Cancer Center	Froelich, CJ (corresponding author), Evanston NW Healthcare Res Inst, Evanston, IL 60201 USA.	c-froelich@northwestern.edu		Trapani, Joseph/0000-0003-0983-1532	NATIONAL CANCER INSTITUTE [R01CA039201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044941] Funding Source: NIH RePORTER; NCI NIH HHS [CA 7904, CA 39201] Funding Source: Medline; NIAID NIH HHS [AI/GM 44941, AI 80228] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrade F, 1998, IMMUNITY, V8, P451, DOI 10.1016/S1074-7613(00)80550-6; Browne KA, 1999, MOL CELL BIOL, V19, P8604; Browne KA, 2000, J BIOL CHEM, V275, P39262, DOI 10.1074/jbc.C000622200; Froelich CJ, 1996, BIOCHEM BIOPH RES CO, V229, P44, DOI 10.1006/bbrc.1996.1755; Froelich CJ, 1996, BIOCHEM BIOPH RES CO, V227, P658, DOI 10.1006/bbrc.1996.1565; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Froelich CJ, 1998, IMMUNOL TODAY, V19, P30, DOI 10.1016/S0167-5699(97)01184-5; Galvin JP, 1999, J IMMUNOL, V162, P5345; GEISBERG M, 1990, TISSUE ANTIGENS, V35, P229, DOI 10.1111/j.1399-0039.1990.tb01788.x; Goldberg JE, 1999, J IMMUNOL METHODS, V224, P1, DOI 10.1016/S0022-1759(98)00038-6; HAMEED A, 1992, AM J PATHOL, V140, P1025; HANNA WL, 1993, PROTEIN EXPRES PURIF, V4, P398, DOI 10.1006/prep.1993.1052; Hu D, 1999, CELL IMMUNOL, V195, P43, DOI 10.1006/cimm.1999.1513; Kawasaki Y, 2000, J IMMUNOL, V164, P4641, DOI 10.4049/jimmunol.164.9.4641; MACDERMOTT RP, 1985, J EXP MED, V162, P1771, DOI 10.1084/jem.162.6.1771; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Oshimi S, 1996, J PHYSIOL-LONDON, V495, P319, DOI 10.1113/jphysiol.1996.sp021596; Oynebraten I, 2000, J LEUKOCYTE BIOL, V67, P183, DOI 10.1002/jlb.67.2.183; PETERS R, 1990, EMBO J, V9, P2447, DOI 10.1002/j.1460-2075.1990.tb07421.x; Pinkoski MJ, 1998, BLOOD, V92, P1044; PODACK ER, 1988, ANN NY ACAD SCI, V532, P292, DOI 10.1111/j.1749-6632.1988.tb36347.x; Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610; STEVENS RL, 1989, CURR TOP MICROBIOL, V140, P93; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; TOYAMASORIMACHI N, 1995, J BIOL CHEM, V270, P7437, DOI 10.1074/jbc.270.13.7437; TSCHOPP J, 1987, MOL IMMUNOL, V24, P907, DOI 10.1016/0161-5890(87)90002-2; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; UGOZZOLI M, 1992, BIOTECHNIQUES, V12, P187; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; Yang XH, 1998, J BIOL CHEM, V273, P34278, DOI 10.1074/jbc.273.51.34278; YOUNG JDE, 1986, CELL, V44, P849, DOI 10.1016/0092-8674(86)90007-3	32	210	224	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2002	16	3					417	428		10.1016/S1074-7613(02)00286-8	http://dx.doi.org/10.1016/S1074-7613(02)00286-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911826	Bronze			2022-12-18	WOS:000174572800010
J	Shi, W; Kumanogoh, A; Watanabe, C; Uchida, J; Wang, XS; Yasui, T; Yukawa, K; Ikawa, M; Okabe, M; Parnes, JR; Yoshida, K; Kikutani, H				Shi, W; Kumanogoh, A; Watanabe, C; Uchida, J; Wang, XS; Yasui, T; Yukawa, K; Ikawa, M; Okabe, M; Parnes, JR; Yoshida, K; Kikutani, H			The class IV semaphorin CD100 plays nonredundant roles in the immune system: Defective B and T cell activation in CD100-deficient mice	IMMUNITY			English	Article							TYROSINE-PHOSPHATASE SHP-1; SURFACE PROTEIN CD72; GROWTH CONE GUIDANCE; LEUKOCYTE SEMAPHORIN; DIFFERENTIATION ANTIGEN; CD22-DEFICIENT MICE; AXON GUIDANCE; LUNG-CANCER; STEM-CELLS; RECEPTOR	The class IV semaphorin CD100/Sema4D differentially utilizes two distinct receptors: plexin-B1 in nonlymphoid tissues, such as brain and kidney, and CD72 in lymphoid tissues. We have generated CD100-deficient mice and demonstrated that they have functional defects in their immune system, without apparent abnormalities in other tissues. The number of CD5(+) B-1 cells was considerably decreased in the mutant mice, whereas conventional B cells and T cells appeared to develop normally. In vitro proliferative responses and immunoglobulin production were reduced in CD100-deficient B cells. The humoral immune response against a T cell-dependent antigen and in vivo priming of T cells were also defective in the mutant mice. These results demonstrate nonredundant and essential roles of CD100-CD72 interactions in the immune system.	Osaka Univ, Res Inst Microbial Dis, Dept Mol Immunol, Suita, Osaka 5650871, Japan; Wakayama Med Coll, Dept Physiol 2, Wakayama 6410012, Japan; Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA	Osaka University; Wakayama Medical University; Osaka University; Stanford University	Kikutani, H (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Mol Immunol, 3-1 Yamada-oka, Suita, Osaka 5650871, Japan.		ikawa, masahito/A-5315-2009; Kikutani, Hitoshi/C-9525-2009; Kumanogoh, Atsushi/C-7354-2009; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Okabe, Masaru/0000-0002-0803-9044	NCI NIH HHS [CA68675] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068675] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adachi T, 1998, J IMMUNOL, V160, P4662; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Billard C, 2000, BLOOD, V95, P965, DOI 10.1182/blood.V95.3.965.003k39_965_972; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Delaire S, 1998, CELL MOL LIFE SCI, V54, P1265, DOI 10.1007/s000180050252; DODD J, 1995, CELL, V81, P471, DOI 10.1016/0092-8674(95)90066-7; Dorfman DM, 1998, AM J PATHOL, V153, P255, DOI 10.1016/S0002-9440(10)65566-6; Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; GORDON J, 1994, IMMUNOL TODAY, V15, P411, DOI 10.1016/0167-5699(94)90270-4; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HEROLD C, 1995, INT IMMUNOL, V7, P1, DOI 10.1093/intimm/7.1.1; KANTOR AB, 1991, IMMUNOL TODAY, V12, P389, DOI 10.1016/0167-5699(91)90136-H; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; LANDOLFI MT, 1997, LEUKOCYTE TYPING, V6, P162; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCHEYZERWILLIAMS MG, 1991, NATURE, V350, P502, DOI 10.1038/350502a0; NAKAYAMA E, 1989, P NATL ACAD SCI USA, V86, P1352, DOI 10.1073/pnas.86.4.1352; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; Robinson WH, 1997, IMMUNOGENETICS, V45, P195, DOI 10.1007/s002510050189; Roche J, 1996, ONCOGENE, V12, P1289; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; VONHOEGEN I, 1990, J IMMUNOL, V144, P4870; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wu YJ, 1998, CURR BIOL, V8, P1009, DOI 10.1016/S0960-9822(07)00421-6; Yu HH, 1999, NEURON, V22, P11, DOI 10.1016/S0896-6273(00)80672-8	44	210	247	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2000	13	5					633	642		10.1016/S1074-7613(00)00063-7	http://dx.doi.org/10.1016/S1074-7613(00)00063-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114376	Bronze			2022-12-18	WOS:000165598500006
J	Scott, CA; Peterson, PA; Teyton, L; Wilson, IA				Scott, CA; Peterson, PA; Teyton, L; Wilson, IA			Crystal structures of two I-A(d)-peptide complexes reveal that high affinity can be achieved without large anchor residues	IMMUNITY			English	Article							CLASS-II MOLECULES; BOUND SINGLE PEPTIDES; T-CELLS; HISTOCOMPATIBILITY ANTIGEN; POLYMORPHIC RESIDUES; SURFACE EXPRESSION; BINDING PEPTIDES; PROTEIN ANTIGENS; RECOGNITION; HLA-DR1	We have determined the structures of I-A(d) covalently linked to an ovalbumin peptide (OVA(323-339)) and to an influenza virus hemagglutinin peptide (HA(126-138)). The floor of the peptide-binding groove contains an unusual beta bulge, not seen in I-E and DR structures, that affects numerous interactions between the alpha and beta chains and bound peptide. Unlike other MHC-peptide complexes, the peptides do not insert any large anchor residues into the binding pockets of the shallow I-A(d) binding groove. The previously identified six-residue "core" binding motif of I-A(d) occupies only the P4 to P9 pockets, implying that specificity of T cell receptor recognition of I-A(d)-peptide complexes can be accomplished by peptides that only partially fill the MHC groove.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; RW Johnson Pharmaceut Res Inst, San Diego, CA 92121 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Johnson & Johnson; Johnson & Johnson USA	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu			NCI NIH HHS [CA-58896] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BROWN JH, 1988, NATURE, V332, P845, DOI 10.1038/332845a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; BUERSTEDDE JM, 1989, J EXP MED, V169, P1645, DOI 10.1084/jem.169.5.1645; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; CAMPBELL RD, 1993, CURR OPIN IMMUNOL, V5, P887, DOI 10.1016/0952-7915(93)90101-W; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P859; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; ENGLAND RD, 1995, J IMMUNOL, V155, P4295; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; GAUTAM AM, 1995, P NATL ACAD SCI USA, V92, P335, DOI 10.1073/pnas.92.1.335; GERHARD W, 1991, J VIROL, V65, P364, DOI 10.1128/JVI.65.1.364-372.1991; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; HILL CM, 1994, J IMMUNOL, V152, P2890; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Klein J., 1986, NATURAL HIST MAJOR H; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LECHLER RI, 1990, J IMMUNOL, V144, P329; LEE JM, 1991, J IMMUNOL, V146, P2952; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; NALEFSKI EA, 1995, J BIOL CHEM, V270, P22351, DOI 10.1074/jbc.270.38.22351; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nelson CA, 1996, J IMMUNOL, V156, P176; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OTWINOWSKI Z, 1993, P CCP4 STUD WEEK DAT, P80; Paliakasis K, 1996, J STRUCT BIOL, V117, P145, DOI 10.1006/jsbi.1996.0079; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; ROSSMANN MG, 1975, J BIOL CHEM, V250, P7525; Runnels HA, 1996, J EXP MED, V183, P127, DOI 10.1084/jem.183.1.127; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SANT AJ, 1991, J EXP MED, V174, P799, DOI 10.1084/jem.174.4.799; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; Scott CA, 1998, PROTEIN SCI, V7, P413; SETTE A, 1989, J IMMUNOL, V143, P1268; SETTE A, 1989, P NATL ACAD SCI USA, V86, P3296, DOI 10.1073/pnas.86.9.3296; SETTE A, 1988, J IMMUNOL, V141, P45; SETTE A, 1989, J IMMUNOL, V142, P35; SETTE A, 1987, NATURE, V328, P395, DOI 10.1038/328395a0; SETTE A, 1990, J IMMUNOL, V145, P1809; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STURA EA, 1992, CRYSTALLIZATION NUCL, P99; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; WILSON IA, 1994, STRUCTURE, V2, P561, DOI 10.1016/S0969-2126(00)00056-3; Wilson IA, 1996, SCIENCE, V272, P973, DOI 10.1126/science.272.5264.973; WITT SN, 1994, BIOCHEMISTRY-US, V33, P1861, DOI 10.1021/bi00173a032; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	62	210	213	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1998	8	3					319	329		10.1016/S1074-7613(00)80537-3	http://dx.doi.org/10.1016/S1074-7613(00)80537-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZD622	9529149	Bronze			2022-12-18	WOS:000072705300005
J	Noelle, RJ				Noelle, RJ			CD40 and its ligand in host defense	IMMUNITY			English	Article							VIVO CD40-GP39 INTERACTIONS; DEPENDENT HUMORAL IMMUNITY; ANTIBODY; GP39	At the onset, it appeared that immunology had finally identified a molecule with a singular function in the regulation of humoral immunity. Early studies in mice and mutations in humans (hyper immunoglobulin M syndrome; HIM) all pointed an accusatory finger at the ligand for CD40 (gp39; CD40L) as the cardinal element in the initiation of humoral immune responses to thymus-dependent (TD) antigens (reviewed by Durie et al., 1994b). However, just as interleukin-2 (IL-2) and IL-4 have lost their identity as unique T cell and B cell growth factors, respectively, so CD40L is losing its identity as an effector molecule that is exclusively involved in the regulation of humoral immunity. A recent flurry of manuscripts underscore the importance of this ligand-receptor pair in host defense outside of its central function in the regulation of humoral immunity.			Noelle, RJ (corresponding author), DARTMOUTH COLL SCH MED, DEPT MICROBIOL, LEBANON, NH 03756 USA.							ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BUHLMANN JE, 1995, IMMUNITY, V2, P645; CAMPBELL KA, 1996, IMMUNITY, V4, P263; CASAMAYOR PM, 1995, J EXP MED, V181, P1293; CAYABYAB M, 1994, J IMMUNOL, V152, P1523; DECKER DJ, 1995, IMMUNITY, V2, P195, DOI 10.1016/S1074-7613(95)80092-1; DURIE FH, 1994, J CLIN INVEST, V94, P1333, DOI 10.1172/JCI117453; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; DURIE FH, 1994, IMMUNOL TODAY, V15, P406, DOI 10.1016/0167-5699(94)90269-0; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; GALIBERT L, 1995, EUR J IMMUNOL, V25, P733, DOI 10.1002/eji.1830250316; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; Griggs ND, 1996, J EXP MED, V183, P801, DOI 10.1084/jem.183.3.801; HAN SH, 1995, J IMMUNOL, V155, P556; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; HOLLENBAUGH D, 1995, J EXP MED, V182, P33, DOI 10.1084/jem.182.1.33; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; Kallberg E, 1996, SCIENCE, V271, P1285, DOI 10.1126/science.271.5253.1285; Kamanaka M, 1996, IMMUNITY, V4, P275, DOI 10.1016/S1074-7613(00)80435-5; KARMANN K, 1995, P NATL ACAD SCI USA, V92, P4342, DOI 10.1073/pnas.92.10.4342; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KIENER PA, 1995, J IMMUNOL, V155, P4917; Larsen CP, 1996, TRANSPLANTATION, V61, P4, DOI 10.1097/00007890-199601150-00002; LARSEN CP, 1994, J IMMUNOL, V152, P5208; LEDERMAN S, 1992, J IMMUNOL, V149, P3817; LIU YJ, 1992, IMMUNOL TODAY, V13, P17, DOI 10.1016/0167-5699(92)90199-H; NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101; PARKER DC, 1995, P NATL ACAD SCI USA, V92, P9560, DOI 10.1073/pnas.92.21.9560; PEGUET NJ, 1995, J IMMUNOL, V155, P4241; RANHEIM EA, 1995, CELL IMMUNOL, V161, P226, DOI 10.1006/cimm.1995.1031; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; ROY M, 1995, EUR J IMMUNOL, V25, P596, DOI 10.1002/eji.1830250243; SHU U, 1995, EUR J IMMUNOL, V25, P1125, DOI 10.1002/eji.1830250442; Soong L, 1996, IMMUNITY, V4, P263, DOI 10.1016/S1074-7613(00)80434-3; Stout RD, 1996, J IMMUNOL, V156, P8; Stuber E, 1996, J EXP MED, V183, P693, DOI 10.1084/jem.183.2.693; TIAN LC, 1995, EUR J IMMUNOL, V25, P306, DOI 10.1002/eji.1830250152; VANDENEERTWEGH AJM, 1993, J EXP MED, V178, P1555, DOI 10.1084/jem.178.5.1555; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; WILEY JA, 1995, J IMMUNOL, V155, P3525; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; YELLIN MJ, 1995, J EXP MED, V182, P1857, DOI 10.1084/jem.182.6.1857	44	210	220	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1996	4	5					415	419		10.1016/S1074-7613(00)80408-2	http://dx.doi.org/10.1016/S1074-7613(00)80408-2			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UM678	8630727	Bronze			2022-12-18	WOS:A1996UM67800001
J	NIEDERMANN, G; BUTZ, S; IHLENFELDT, HG; GRIMM, R; LUCCHIARI, M; HOSCHUTZKY, H; JUNG, G; MAIER, B; EICHMANN, K				NIEDERMANN, G; BUTZ, S; IHLENFELDT, HG; GRIMM, R; LUCCHIARI, M; HOSCHUTZKY, H; JUNG, G; MAIER, B; EICHMANN, K			CONTRIBUTION OF PROTEASOME-MEDIATED PROTEOLYSIS TO THE HIERARCHY OF EPITOPES PRESENTED BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-1 MOLECULES	IMMUNITY			English	Article							RESTRICTED ANTIGEN PRESENTATION; PH-SENSITIVE LIPOSOMES; MULTICATALYTIC PROTEINASE COMPLEX; H-2-DEFICIENT LYMPHOMA VARIANTS; CYTOTOXIC LYMPHOCYTES-T; CLASS-I PRESENTATION; LINKED LMP GENE; PEPTIDE TRANSLOCATION; SOLUBLE-PROTEIN; HUMAN MHC	Major histocompatibility complex (MHC) class 1-restricted cytotoxic T lymphocytes (CTL) recognize peptide epitopes of protein antigens in a hierarchical fashion, We investigated whether proteolytic cleavage, in particular by proteasomes, is important in determining epitope hierarchy. Using highly purified 20S proteasomes, we find preferred cleavage sites directly adjacent to the N- and C-terminal ends of the immunodominant epitope of chicken ovalbumin, Ova257-264, while most of the subdominant epitope, Ova55-62, is destroyed by a major cleavage site located within this epitope. Moreover, we shaw that variations in amino acid sequences flanking these epitopes influence proteasomal cleavage patterns in parallel with the efficacy of their presentation, The results suggest that proteasomal cleavage within and adjacent to class 1-restricted epitopes contributes to their level of presentation.	UNIV TUBINGEN,INST ORGAN CHEM,D-72076 TUBINGEN,GERMANY; HEWLETT PACKARD CORP,D-76337 WALDBRONN,GERMANY	Eberhard Karls University of Tubingen; Hewlett-Packard	NIEDERMANN, G (corresponding author), MAX PLANCK INST IMMUNBIOL,STUBEWEG 51,D-79108 FREIBURG,GERMANY.							ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; BARBER LD, 1994, J EXP MED, V180, P1191, DOI 10.1084/jem.180.4.1191; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; CARDOZO C, 1992, BIOCHEMISTRY-US, V31, P7373, DOI 10.1021/bi00147a023; CHEN WS, 1994, J EXP MED, V180, P1471, DOI 10.1084/jem.180.4.1471; CHIMINI G, 1989, J EXP MED, V169, P297, DOI 10.1084/jem.169.1.297; DELVAL M, 1991, CELL, V66, P1145, DOI 10.1016/0092-8674(91)90037-Y; DEMUTH HU, 1993, FEBS LETT, V320, P23, DOI 10.1016/0014-5793(93)81649-K; DICK LR, 1994, J IMMUNOL, V152, P3884; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; EISENLOHR LC, 1992, J EXP MED, V175, P481, DOI 10.1084/jem.175.2.481; EISENLOHR LC, 1992, CELL, V71, P963, DOI 10.1016/0092-8674(92)90392-P; ELLIOTT T, 1993, CURR BIOL, V3, P854, DOI 10.1016/0960-9822(93)90219-E; ENGELHARD VH, 1994, CURR OPIN IMMUNOL, V6, P13, DOI 10.1016/0952-7915(94)90028-0; Falk K, 1993, Semin Immunol, V5, P81, DOI 10.1006/smim.1993.1012; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FEHLING HJ, 1994, SCIENCE, V256, P1234; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; HAHN YS, 1991, J EXP MED, V174, P733, DOI 10.1084/jem.174.3.733; HAHN YS, 1992, J EXP MED, V176, P1335, DOI 10.1084/jem.176.5.1335; HARDING CV, 1991, J IMMUNOL, V147, P2860; HEEMELS MT, 1994, IMMUNITY, V1, P775, DOI 10.1016/S1074-7613(94)80019-7; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HOUBIERS JGA, 1993, EUR J IMMUNOL, V23, P2072, DOI 10.1002/eji.1830230905; HOWARD JC, 1993, NATURE, V365, P211, DOI 10.1038/365211a0; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KELLY A, 1991, NATURE, V353, P667, DOI 10.1038/353667a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPFORD GB, 1993, J IMMUNOL, V150, P1212; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; MARTIN S, 1993, IMMUNOL LETT, V37, P97, DOI 10.1016/0165-2478(93)90017-V; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; MCGUIRE MJ, 1986, BIOCHIM BIOPHYS ACTA, V873, P279, DOI 10.1016/0167-4838(86)90055-5; MICHALEK MT, 1993, NATURE, V363, P552, DOI 10.1038/363552a0; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; MOMBURG F, 1992, NATURE, V360, P174, DOI 10.1038/360174a0; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; NIEDERMANN G, 1991, BIOCHIM BIOPHYS ACTA, V1070, P401, DOI 10.1016/0005-2736(91)90080-R; NONACS R, 1992, J EXP MED, V176, P519, DOI 10.1084/jem.176.2.519; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; ORTIZNAVARRETE V, 1991, NATURE, V353, P662, DOI 10.1038/353662a0; OUKKA M, 1994, J IMMUNOL, V152, P4843; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; REDDY R, 1991, J IMMUNOL METHODS, V141, P157, DOI 10.1016/0022-1759(91)90142-3; ROCK LK, 1994, CELL, V78, P761; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; SADOVNIKOVA E, 1994, INT IMMUNOL, V6, P289, DOI 10.1093/intimm/6.2.289; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; SHEIL JM, 1992, J EXP MED, V175, P545, DOI 10.1084/jem.175.2.545; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SIJTS AJAM, 1994, J IMMUNOL, V152, P106; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; WALDEN PR, 1990, P NATL ACAD SCI USA, V87, P9015, DOI 10.1073/pnas.87.22.9015; WIPKE BT, 1993, EUR J IMMUNOL, V23, P2005, DOI 10.1002/eji.1830230842; YEWDELL J, 1994, J IMMUNOL, V152, P1163; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; ZHOU F, 1991, J IMMUNOL METHODS, V145, P143, DOI 10.1016/0022-1759(91)90320-F; ZHOU XZ, 1994, EUR J IMMUNOL, V24, P1863, DOI 10.1002/eji.1830240822	71	210	216	0	5	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1995	2	3					289	299		10.1016/1074-7613(95)90053-5	http://dx.doi.org/10.1016/1074-7613(95)90053-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QP276	7535183	Bronze			2022-12-18	WOS:A1995QP27600008
J	Galluzzi, L; Lopez-Soto, A; Kumar, S; Kroemer, G				Galluzzi, Lorenzo; Lopez-Soto, Alejandro; Kumar, Sharad; Kroemer, Guido			Caspases Connect Cell-Death Signaling to Organismal Homeostasis	IMMUNITY			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; NF-KAPPA-B; ORGANELLE-SPECIFIC INITIATION; GAMMA-INDUCING FACTOR; I INTERFERONS; CUTTING EDGE; MAMMALIAN CASPASES; IMMUNE-RESPONSES; CYTOCHROME-C; APOPTOSIS	Some forms of regulated cell death, such as apoptosis, are precipitated by the activation of cysteine proteases of the caspase family, including caspase 8, 9, and 3. Other caspases, such as caspase 1 and 4, are well known for their pro-inflammatory functions but regulate cell death in a limited number of pathophysiological settings. Accumulating evidence suggests that the most conserved function of mammalian caspases is not to control cell death sensu stricto, but to regulate inflammatory and immune reactions to dying cells and infectious challenges. Here, we review the molecular and cellular mechanisms though which mammalian caspases connect cell-death signaling to the maintenance of organismal homeostasis.	[Galluzzi, Lorenzo; Lopez-Soto, Alejandro; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, F-75006 Paris, France; [Galluzzi, Lorenzo; Lopez-Soto, Alejandro; Kroemer, Guido] INSERM, U1138, F-75006 Paris, France; [Galluzzi, Lorenzo; Lopez-Soto, Alejandro; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Galluzzi, Lorenzo; Lopez-Soto, Alejandro; Kroemer, Guido] Univ Paris 06, F-75006 Paris, France; [Galluzzi, Lorenzo; Lopez-Soto, Alejandro] Gustave Roussy Comprehens Canc Inst, F-94805 Villejuif, France; [Lopez-Soto, Alejandro] Univ Oviedo, IUOPA, Area Inmunol, Hosp Univ Cent Asturia, E-33006 Oviedo, Spain; [Kumar, Sharad] Univ S Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Kroemer, Guido] Gustave Roussy Comprehens Canc Inst, Metabol & Cell Biol Platforms, F-94805 Villejuif, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France; [Kroemer, Guido] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Central University Hospital Asturias; University of Oviedo; Centre for Cancer Biology; University of South Australia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital	Galluzzi, L; Kroemer, G (corresponding author), Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, F-75006 Paris, France.; Galluzzi, L; Kroemer, G (corresponding author), INSERM, U1138, F-75006 Paris, France.; Galluzzi, L; Kroemer, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France.; Galluzzi, L; Kroemer, G (corresponding author), Univ Paris 06, F-75006 Paris, France.; Galluzzi, L (corresponding author), Gustave Roussy Comprehens Canc Inst, F-94805 Villejuif, France.; Kroemer, G (corresponding author), Gustave Roussy Comprehens Canc Inst, Metabol & Cell Biol Platforms, F-94805 Villejuif, France.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France.; Kroemer, G (corresponding author), Karolinska Univ Hosp, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden.	deadoc@vodafone.it; kroemer@orange.fr	KROEMER, Guido/B-4263-2013; Kumar, Sharad/AAX-7787-2020; Galluzzi, Lorenzo/AAG-6294-2019; Galluzzi, Lorenzo/AAH-3286-2021; López-Soto, Alejandro/A-9779-2018; Kroemer, Guido/AAY-9859-2020; Galluzzi, Lorenzo/AAG-6432-2019	KROEMER, Guido/0000-0002-9334-4405; Kumar, Sharad/0000-0001-7126-9814; López-Soto, Alejandro/0000-0002-6360-5205; 	Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR) - Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la Recherche sur le Cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Fondation Bettencourt-Schueller; Fondation de France; Fondation pour la Recherche Medicale (FRM); European Commission (ArtForce); European Research Council (ERC); LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); National Health and Medical Research Council (NHMRC) of Australia	Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR) - Projets blancs(French National Research Agency (ANR)); ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation Bettencourt-Schueller; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)European Commission); LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	F We are indebted to Dr. Jose-Manuel Bravo San-Pedro (Centre de Recherche de Cordeliers, Paris, France) for help with figure preparation. The authors are supported by the Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR) - Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la Recherche sur le Cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Fondation Bettencourt-Schueller; Fondation de France; Fondation pour la Recherche Medicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); the LabEx Immuno-Oncology; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); the Paris Alliance of Cancer Research Institutes (PACRI); and the National Health and Medical Research Council (NHMRC) of Australia.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; Ballaun C, 2008, BIOCHEM BIOPH RES CO, V371, P261, DOI 10.1016/j.bbrc.2008.04.050; Bayo P, 2008, ENDOCRINOLOGY, V149, P1377, DOI 10.1210/en.2007-0814; Berta T, 2014, J CLIN INVEST, V124, P1173, DOI 10.1172/JCI72230; Bondanza A, 2004, J EXP MED, V200, P1157, DOI 10.1084/jem.20040327; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Bronner DN, 2015, IMMUNITY, V43, P451, DOI 10.1016/j.immuni.2015.08.008; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Casson CN, 2015, P NATL ACAD SCI USA, V112, P6688, DOI 10.1073/pnas.1421699112; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Daish TJ, 2004, DEV CELL, V7, P909, DOI 10.1016/j.devcel.2004.09.018; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Eckhart L, 2008, MOL BIOL EVOL, V25, P831, DOI 10.1093/molbev/msn012; Evans ACO, 2004, BIOL REPROD, V70, P1475, DOI 10.1095/biolreprod.103.025114; Fernandes-Alnemri T, 2013, J IMMUNOL, V191, P3995, DOI 10.4049/jimmunol.1301681; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Galluzzi L, 2014, SEMIN CELL DEV BIOL, V35, P24, DOI 10.1016/j.semcdb.2014.02.006; Galluzzi L, 2014, NAT CELL BIOL, V16, P728, DOI 10.1038/ncb3005; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Hoffmann PR, 2005, J IMMUNOL, V174, P1393, DOI 10.4049/jimmunol.174.3.1393; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8515; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kenneth NS, 2012, BIOCHEM J, V443, P355, DOI 10.1042/BJ20120249; Kepp O, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.955691; Khalil H, 2014, TRENDS CELL BIOL, V24, P83, DOI 10.1016/j.tcb.2013.08.002; Kobayashi H, 2011, J IMMUNOL, V186, P403, DOI 10.4049/jimmunol.1001906; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Kroemer G, 1997, CELL DEATH DIFFER, V4, P443, DOI 10.1038/sj.cdd.4400266; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Kubica M, 2014, EXP DERMATOL, V23, P561, DOI 10.1111/exd.12458; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Labbe K, 2010, J IMMUNOL, V185, P5495, DOI 10.4049/jimmunol.1002517; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043512; Lippens S, 2000, CELL DEATH DIFFER, V7, P1218, DOI 10.1038/sj.cdd.4400785; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Maltez VI, 2015, IMMUNITY, V43, P987, DOI 10.1016/j.immuni.2015.10.010; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; O'Brien AJ, 2014, NAT MED, V20, P522, DOI 10.1038/nm.3516; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Puccini J, 2013, P NATL ACAD SCI USA, V110, P19920, DOI 10.1073/pnas.1311947110; Py BF, 2014, CELL REP, V6, P1122, DOI 10.1016/j.celrep.2014.02.015; Quinn LM, 2000, J BIOL CHEM, V275, P40416, DOI 10.1074/jbc.M002935200; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Roy S, 2008, P NATL ACAD SCI USA, V105, P4133, DOI 10.1073/pnas.0706658105; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Sica V, 2015, MOL CELL, V59, P522, DOI 10.1016/j.molcel.2015.07.021; Skeldon AM, 2016, J IMMUNOL, V196, P437, DOI 10.4049/jimmunol.1501529; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vanden Berghe T, 2013, AM J RESP CRIT CARE, V188, P120, DOI 10.1164/rccm.201210-1775LE; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Walsh DS, 2005, J DERMATOL SCI, V37, P61, DOI 10.1016/j.jdermsci.2004.10.003; Wang PH, 2010, NAT IMMUNOL, V11, P912, DOI 10.1038/ni.1933; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Yang DH, 2015, IMMUNITY, V43, P923, DOI 10.1016/j.immuni.2015.10.009; Yeretssian G, 2009, P NATL ACAD SCI USA, V106, P9016, DOI 10.1073/pnas.0813362106; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	111	209	223	2	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					221	231		10.1016/j.immuni.2016.01.020	http://dx.doi.org/10.1016/j.immuni.2016.01.020			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885855	Bronze			2022-12-18	WOS:000370294000007
J	Ichiyama, K; Chen, TT; Wang, XH; Yan, XW; Kim, BS; Tanaka, S; Ndiaye-Lobry, D; Deng, YH; Zou, YL; Zheng, P; Tian, Q; Aifantis, I; Wei, L; Dong, C				Ichiyama, Kenji; Chen, Tingting; Wang, Xiaohu; Yan, Xiaowei; Kim, Byung-Seok; Tanaka, Shinya; Ndiaye-Lobry, Delphine; Deng, Yuhua; Zou, Yanli; Zheng, Pan; Tian, Qiang; Aifantis, Iannis; Wei, Lai; Dong, Chen			The Methylcytosine Dioxygenase Tet2 Promotes DNA Demethylation and Activation of Cytokine Gene Expression in T Cells	IMMUNITY			English	Article							METHYLATION; DIFFERENTIATION; INTERLEUKIN-27; SPECIFICATION; TRANSCRIPTION; POPULATIONS; GENERATION; PLASTICITY; PATTERNS; DISEASE	Epigenetic regulation of lineage-specific genes is important for the differentiation and function of T cells. Ten-eleven translocation (Tet) proteins catalyze 5-methylcytosine (5mC) conversion to 5-hydroxymethylcytosine (5hmC) to mediate DNA demethylation. However, the roles of Tet proteins in the immune response are unknown. Here, we characterized the genome-wide distribution of 5hmC in CD4(+) T cells and found that 5hmC marks putative regulatory elements in signature genes associated with effector cell differentiation. Moreover, Tet2 protein was recruited to 5hmC-containing regions, dependent on lineage-specific transcription factors. Deletion of Tet2 in T cells decreased their cytokine expression, associated with reduced p300 recruitment. In vivo, Tet2 plays a critical role in the control of cytokine gene expression in autoimmune disease. Collectively, our findings suggest that Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells.	[Ichiyama, Kenji; Zheng, Pan] Childrens Natl Med Ctr, Ctr Canc & Immunol Res, Washington, DC 20010 USA; [Chen, Tingting; Deng, Yuhua; Zou, Yanli; Wei, Lai] Sun Yat Sen Univ, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Xiaohu; Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Yan, Xiaowei; Tian, Qiang] Inst Syst Biol, Seattle, WA 98109 USA; [Kim, Byung-Seok] MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Tanaka, Shinya] Osaka Univ, Immunol Frontier Res Ctr, Osaka 5650871, Japan; [Ndiaye-Lobry, Delphine; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Ndiaye-Lobry, Delphine; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	Children's National Health System; Sun Yat Sen University; Tsinghua University; Institute for Systems Biology (ISB); University of Texas System; UTMD Anderson Cancer Center; Osaka University; Howard Hughes Medical Institute; New York University; New York University	Wei, L (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	weil9@mail.sysu.edu.cn; chendong@tsinghua.edu.cn	Tanaka, Shinya/D-3586-2011; Zheng, Pan/E-8691-2011; Tanaka, Shinya/AAO-8771-2021; dong, chen/B-3181-2009	Zheng, Pan/0000-0003-2598-3544; Tanaka, Shinya/0000-0001-6470-3301; dong, chen/0000-0002-0084-9130; Ichiyama, Kenji/0000-0002-3340-9799	NIH [AR050772]; National Basic Research Program of China [2013CB967001, 2015CB964601]; JSPS postdoctoral fellowships; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China(National Basic Research Program of China); JSPS postdoctoral fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank our colleagues for their help and suggestions. The work was supported in part by grants from NIH to C.D. (AR050772) and grants from National Basic Research Program of China (2013CB967001 and 2015CB964601) to L.W. K.I. receives JSPS postdoctoral fellowships for research abroad. C.D. is a Bayer Chair Professor at Tsinghua University.	Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Ku CS, 2011, J MED GENET, V48, P721, DOI 10.1136/jmedgenet-2011-100242; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Shen L, 2013, CURR OPIN CELL BIOL, V25, P289, DOI 10.1016/j.ceb.2013.02.017; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	30	209	217	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					613	626		10.1016/j.immuni.2015.03.005	http://dx.doi.org/10.1016/j.immuni.2015.03.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25862091	Bronze, Green Accepted			2022-12-18	WOS:000353347500009
J	Rivas, MN; Burton, OT; Wise, P; Charbonnier, LM; Georgiev, P; Oettgen, HC; Rachid, R; Chatila, TA				Rivas, Magali Noval; Burton, Oliver T.; Wise, Petra; Charbonnier, Louis-Marie; Georgiev, Peter; Oettgen, Hans C.; Rachid, Rima; Chatila, Talal A.			Regulatory T Cell Reprogramming toward a Th2-Cell-like Lineage Impairs Oral Tolerance and Promotes Food Allergy	IMMUNITY			English	Article							EGG ALLERGY; IL-4; ANAPHYLAXIS; PROTEIN; DIFFERENTIATION; IMMUNOTHERAPY; DISRUPTION; INDUCTION; DELETION; FOXP3	Oral immunotherapy has had limited success in establishing tolerance in food allergy, reflecting failure to elicit an effective regulatory T (Treg) cell response. We show that disease-susceptible (Il4ra(F709)) mice with enhanced interleukin-4 receptor (IL-4R) signaling exhibited STAT6-dependent impaired generation and function of mucosal allergen-specific Treg cells. This failure was associated with the acquisition by Treg cells of a T helper 2 (Th2)-cell-like phenotype, also found in peripheral-blood allergen-specific Treg cells of food-allergic children. Selective augmentation of IL-4R signaling in Treg cells induced their reprogramming into Th2-like cells and disease susceptibility, whereas Treg-cell-lineage-specific deletion of Il4 and Il13 was protective. IL-4R signaling impaired the capacity of Treg cells to suppress mast cell activation and expansion, which in turn drove Th2 cell reprogramming of Treg cells. Interruption of Th2 cell reprogramming of Treg cells might thus provide candidate therapeutic strategies in food allergy.	[Rivas, Magali Noval; Burton, Oliver T.; Charbonnier, Louis-Marie; Georgiev, Peter; Oettgen, Hans C.; Rachid, Rima; Chatila, Talal A.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Rivas, Magali Noval; Burton, Oliver T.; Charbonnier, Louis-Marie; Oettgen, Hans C.; Chatila, Talal A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Wise, Petra] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Children's Hospital Los Angeles	Chatila, TA (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	talal.chatila@childrens.harvard.edu	Noval Rivas, Magali/R-4987-2016	Noval Rivas, Magali/0000-0001-5570-8928; Georgiev, Peter/0000-0002-4613-1255; Burton, Oliver/0000-0003-3884-7373; Chatila, Talal/0000-0001-7439-2762; Oettgen, Hans/0000-0003-1199-1391; Charbonnier, Louis-Marie/0000-0002-4594-7893	NIH NIAID [R01 AI085090, R56 AI100889, T32 AI007512]; Boston Children's Hospital Translational Research Program; Rao Chakravorti Family Fund; Bunning Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085090, R01AI065617, R56AI100889, T32AI007512] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Boston Children's Hospital Translational Research Program; Rao Chakravorti Family Fund; Bunning Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Calvin B. Williams and Dipica Haribhai for discussions. This work was supported by NIH NIAID grants R01 AI085090 (T.A.C.), R56 AI100889 (H.C.O.), and T32 AI007512 (O.T.B.), by the Boston Children's Hospital Translational Research Program (T.A.C., R.R., and H.C.O.), by the Rao Chakravorti Family Fund (H.C.O.), and by the Bunning Foundation (H.C.O. and T.A.C.).	Amoli MM, 2002, GENES IMMUN, V3, P220, DOI 10.1038/sj.gene.6363872; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Berin MC, 2013, J ALLERGY CLIN IMMUN, V131, P14, DOI 10.1016/j.jaci.2012.10.058; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Brown P, 2012, EUR FOOD RES TECHNOL, V235, P971, DOI 10.1007/s00217-012-1827-3; Burton OT, 2013, MUCOSAL IMMUNOL, V6, P740, DOI 10.1038/mi.2012.112; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Fiocchi A, 2010, PEDIAT ALLERG IMM-UK, V21, P1, DOI [10.1111/j.1399-3038.2010.01068.x, 10.1097/WOX.0b013e3181defeb9]; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Ganeshan K, 2009, J ALLERGY CLIN IMMUN, V123, P231, DOI 10.1016/j.jaci.2008.10.011; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Johnson DJ, 2013, J EXP MED, V210, P1419, DOI 10.1084/jem.20122239; Jones SM, 2014, J ALLERGY CLIN IMMUN, V133, P318, DOI 10.1016/j.jaci.2013.12.1040; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Karlsson MR, 2004, J EXP MED, V199, P1679, DOI 10.1084/jem.20032121; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; Mathias CB, 2011, J ALLERGY CLIN IMMUN, V127, P795, DOI 10.1016/j.jaci.2010.11.009; Moran TP, 2013, CURR OPIN IMMUNOL, V25, P781, DOI 10.1016/j.coi.2013.07.011; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Rivas MN, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P492, DOI 10.1016/j.jaci.2013.12.1041; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1077, DOI 10.1016/j.jaci.2010.02.038; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tachdjian R, 2010, J ALLERGY CLIN IMMUN, V125, P1128, DOI 10.1016/j.jaci.2010.01.054; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Torgerson TR, 2007, GASTROENTEROLOGY, V132, P1705, DOI 10.1053/j.gastro.2007.02.044; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Voehringer D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-69; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	47	209	217	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					512	523		10.1016/j.immuni.2015.02.004	http://dx.doi.org/10.1016/j.immuni.2015.02.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25769611	Green Accepted, Bronze			2022-12-18	WOS:000351301900015
J	Lecuyer, E; Rakotobe, S; Lengline-Garnier, H; Lebreton, C; Picard, M; Juste, C; Fritzen, R; Eberl, G; McCoy, KD; Macpherson, AJ; Reynaud, CA; Cerf-Bensussan, N; Gaboriau-Routhiau, V				Lecuyer, Emelyne; Rakotobe, Sabine; Lengline-Garnier, Helene; Lebreton, Corinne; Picard, Marion; Juste, Catherine; Fritzen, Remi; Eberl, Gerard; McCoy, Kathy D.; Macpherson, Andrew J.; Reynaud, Claude-Agnes; Cerf-Bensussan, Nadine; Gaboriau-Routhiau, Valerie			Segmented Filamentous Bacterium Uses Secondary and Tertiary Lymphoid Tissues to Induce Gut IgA and Specific T Helper 17 Cell Responses	IMMUNITY			English	Article							MUCOSAL IMMUNE-SYSTEM; COMMENSAL BACTERIA; PEYERS-PATCHES; MICROBIOTA; MATURATION; COMPLEX	Segmented filamentous bacterium (SFB) is a symbiont that drives postnatal maturation of gut adaptive immune responses. In contrast to nonpathogenic E. coli, SFB stimulated vigorous development of Peyer's patches germinal centers but paradoxically induced only a low frequency of specific immunoglobulin A (IgA)-secreting cells with delayed accumulation of somatic mutations. Moreover, blocking Peyer's patch development abolished IgA responses to E. coli, but not to SFB. Indeed, SFB stimulated the postnatal development of isolated lymphoid follicles and tertiary lymphoid tissue, which substituted for Peyer's patches as inductive sites for intestinal IgA and SFB-specific T helper 17 (Th17) cell responses. Strikingly, in mice depleted of gut organized lymphoid tissue, SFB still induced a substantial but nonspecific intestinal Th17 cell response. These results demonstrate that SFB has the remarkable capacity to induce and stimulate multiple types of intestinal lymphoid tissues that cooperate to generate potent IgA and Th17 cell responses displaying only limited target specificity.	[Lecuyer, Emelyne; Rakotobe, Sabine; Lengline-Garnier, Helene; Lebreton, Corinne; Picard, Marion; Cerf-Bensussan, Nadine; Gaboriau-Routhiau, Valerie] INSERM UMR1163, Lab Intestinal Immun, F-75015 Paris, France; [Lecuyer, Emelyne; Rakotobe, Sabine; Lengline-Garnier, Helene; Lebreton, Corinne; Picard, Marion; Fritzen, Remi; Reynaud, Claude-Agnes; Cerf-Bensussan, Nadine; Gaboriau-Routhiau, Valerie] Univ Paris 05, Sorbonne Paris Cite & Inst Imagine, F-75015 Paris, France; [Rakotobe, Sabine; Juste, Catherine; Gaboriau-Routhiau, Valerie] INRA Micalis UMR1319, F-78350 Jouy En Josas, France; [Lengline-Garnier, Helene] Hop Necker Enfants Malad, AP HP, Dept Pediat Gastroenterol, F-75015 Paris, France; [Fritzen, Remi; Reynaud, Claude-Agnes] Univ Paris 05, Sorbonne Paris Cite, Inst Necker Enfants Malades, INSERM UMR 1151, F-75014 Paris, France; [Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, F-75015 Paris, France; [McCoy, Kathy D.; Macpherson, Andrew J.] Univ Bern, UVCM, Maurice Muller Labs, CH-3008 Bern, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; INRAE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Bern	Cerf-Bensussan, N (corresponding author), INSERM UMR1163, Lab Intestinal Immun, F-75015 Paris, France.	nadine.cerf-bensussan@inserm.fr; valerie.gaboriau-routhiau@inserm.fr	Eberl, Gerard/A-1160-2013; Picard, Marion/H-9468-2017; Cerf-Bensussan, nadine/H-9505-2017; RAKOTOBE, Sabine/H-9535-2017; LECUYER, Emelyne/ABG-2277-2020; GABORIAU-ROUTHIAU, Valérie/H-9493-2017; McCoy, Kathy/ABD-5814-2021	Picard, Marion/0000-0003-2994-0218; Cerf-Bensussan, nadine/0000-0003-0665-1245; RAKOTOBE, Sabine/0000-0001-7622-755X; LECUYER, Emelyne/0000-0002-4396-9511; GABORIAU-ROUTHIAU, Valérie/0000-0002-7662-4034; LEBRETON, Corinne/0000-0003-1011-8224; Eberl, Gerard/0000-0002-1119-5638; Fritzen, Remi/0000-0003-3457-8364	INSERM, Universite Paris Descartes; INRA; Agence Nationale pour la Recherche (ANR) [BLAN1317]; Tornado FP7 EU [222720]; Fondation Princesse Grace; programme "Investissement d'Avenir'' [ANR-10-IAHU-01, ANR-10-LABX-62-01]; Marie Curie network Cross-Talk [PITN-GA-2008-215553]; Fondation pour la Recherche Medicale;  [ERC-2013-AdG 339407-IMMUNOBIOTA]	INSERM, Universite Paris Descartes; INRA; Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Tornado FP7 EU; Fondation Princesse Grace; programme "Investissement d'Avenir''; Marie Curie network Cross-Talk; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); 	The authors are supported by INSERM, Universite Paris Descartes, INRA, and by grants from Agence Nationale pour la Recherche (ANR 2010 BLAN1317), Tornado FP7 EU grant 222720, and Fondation Princesse Grace. N.C.-B. is recipient of ERC-2013-AdG 339407-IMMUNOBIOTA. The laboratory and Institut Imagine are supported respectively by the programmes "Investissement d'Avenir'' ANR-10-IAHU-01 and ANR-10-LABX-62-01. E. L. has been supported by the Marie Curie network Cross-Talk (PITN-GA-2008-215553) and by Fondation pour la Recherche Medicale. Authors thank J. Browning for providing LTbR-Ig reagent; O. Pelle, J. Megret, and N. Montcuquet for cell-sorting experiments; M. Duriez, I. Quetier, and F. Pages from the Immunomonitoring Plateform (Hopital Europeen Georges Pompidou) for scanning experiments and the Structure Federative de Recherche-Necker for providing access to the Imaging Plateform.	Barone F, 2011, GASTROENTEROLOGY, V140, P947, DOI 10.1053/j.gastro.2010.12.005; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Bergqvist P, 2010, J IMMUNOL, V184, P3545, DOI 10.4049/jimmunol.0901895; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; CHASE DG, 1976, J BACTERIOL, V127, P572, DOI 10.1128/JB.127.1.572-583.1976; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Knoop KA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00084; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Lochner M, 2011, J IMMUNOL, V186, P1531, DOI 10.4049/jimmunol.1001723; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Slack E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00100; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Talham GL, 1999, INFECT IMMUN, V67, P1992; TANNOCK GW, 1984, APPL ENVIRON MICROB, V47, P441, DOI 10.1128/AEM.47.2.441-442.1984; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Yamamoto M, 2000, J IMMUNOL, V164, P5184, DOI 10.4049/jimmunol.164.10.5184	34	209	217	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					608	620		10.1016/j.immuni.2014.03.009	http://dx.doi.org/10.1016/j.immuni.2014.03.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24745335	Bronze			2022-12-18	WOS:000334849400017
J	Yang, K; Shrestha, S; Zeng, H; Karmaus, PWF; Neale, G; Vogel, P; Guertin, DA; Lamb, RF; Chi, HB				Yang, Kai; Shrestha, Sharad; Zeng, Hu; Karmaus, Peer W. F.; Neale, Geoffrey; Vogel, Peter; Guertin, David A.; Lamb, Richard F.; Chi, Hongbo			T Cell Exit from Quiescence and Differentiation into Th2 Cells Depend on Raptor-mTORC1-Mediated Metabolic Reprogramming	IMMUNITY			English	Article							FATE DECISIONS; REG CELLS; MTOR; ACTIVATION; EFFECTOR; AXIS; COMMITMENT; CHECKPOINT; EXPRESSION; SURVIVAL	Naive T cells respond to antigen stimulation by exiting from quiescence and initiating clonal expansion and functional differentiation, but the control mechanism is elusive. Here we describe that Raptor-mTORC1-dependent metabolic reprogramming is a central determinant of this transitional process. Loss of Raptor abrogated T cell priming and T helper 2 (Th2) cell differentiation, although Raptor function is less important for continuous proliferation of actively cycling cells. mTORC1 coordinated multiple metabolic programs in T cells including glycolysis, lipid synthesis, and oxidative phosphorylation to mediate antigen-triggered exit from quiescence. mTORC1 further linked glucose metabolism to the initiation of Th2 cell differentiation by orchestrating cytokine receptor expression and cytokine responsiveness. Activation of Raptor-mTORC1 integrated T cell receptor and CD28 costimulatory signals in antigen-stimulated T cells. Our studies identify a Raptor-mTORC1-dependent pathway linking signal-dependent metabolic reprogramming to quiescence exit, and this in turn coordinates lymphocyte activation and fate decisions in adaptive immunity.	[Yang, Kai; Shrestha, Sharad; Zeng, Hu; Karmaus, Peer W. F.; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Guertin, David A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Lamb, Richard F.] Univ Liverpool, Canc Res UK Ctr, Liverpool L3 9TA, Merseyside, England	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Massachusetts System; University of Massachusetts Worcester; Cancer Research UK; University of Liverpool	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Chi, Hongbo/M-9397-2018; Zeng, Hu/AAA-2706-2020; Vogel, Peter/N-2490-2018	Chi, Hongbo/0000-0002-9997-2496; Zeng, Hu/0000-0002-9909-7732; Vogel, Peter/0000-0002-7535-0545	US National Institutes of Health [R01 AI101407, R01 NS064599, R21 AI094089]; American Cancer Society [RSG-13-248-01-LIB]; Arthritis Foundation; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094089, R01AI101407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Arthritis Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge the D. Green laboratory for help with the Seahorse analyzer; R. Cross, G. Lennon, and P. Ingle for cell sorting; and Y. Wang for editing. This work was supported by US National Institutes of Health (R01 AI101407, R01 NS064599, and R21 AI094089) and American Cancer Society (RSG-13-248-01-LIB) (H. C.) and by a postdoctoral fellowship from the Arthritis Foundation (K.Y.).	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013; CORRY DB, 1994, J IMMUNOL, V153, P4142; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Goorden SMI, 2011, MOL CELL BIOL, V31, P1672, DOI 10.1128/MCB.00985-10; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hamilton SE, 2012, TRENDS IMMUNOL, V33, P224, DOI 10.1016/j.it.2012.01.007; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Lea NC, 2003, MOL CELL BIOL, V23, P2351, DOI 10.1128/MCB.23.7.2351-2361.2003; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Neuman NA, 2011, EMBO MOL MED, V3, P189, DOI 10.1002/emmm.201100131; Rowell EA, 2006, CRIT REV IMMUNOL, V26, P189, DOI 10.1615/CritRevImmunol.v26.i3.10; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zeng H, 2013, CURR OPIN IMMUNOL, V25, P347, DOI 10.1016/j.coi.2013.05.002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	209	211	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1043	1056		10.1016/j.immuni.2013.09.015	http://dx.doi.org/10.1016/j.immuni.2013.09.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24315998	Green Accepted, Bronze			2022-12-18	WOS:000330951000011
J	Xia, XJ; Cui, J; Wang, HLY; Zhu, L; Matsueda, S; Wang, QF; Yang, XA; Hong, J; Songyang, Z; Chen, ZJJ; Wang, RF				Xia, Xiaojun; Cui, Jun; Wang, Helen Y.; Zhu, Liang; Matsueda, Satoko; Wang, Qinfu; Yang, Xiaoang; Hong, Jun; Songyang, Zhou; Chen, Zhijian J.; Wang, Rong-Fu			NLRX1 Negatively Regulates TLR-Induced NF-kappa B Signaling by Targeting TRAF6 and IKK	IMMUNITY			English	Article							PATTERN-RECOGNITION RECEPTORS; ADAPTER PROTEIN; INNATE; IMMUNITY; ACTIVATION; UBIQUITIN; PATHWAY; VIRUS; CYLD	Tight regulation of NF-kappa B signaling is essential for innate and adaptive immune responses, yet the molecular mechanisms responsible for its negative regulation are not completely understood. Here, we report that NLRX1, a NOD-like receptor family member, negatively regulates Toll-like receptor-mediated NE-kappa B activation. NLRX1 interacts with TRAF6 or I kappa B kinase (IKK) in an activation signal-dependent fashion. Upon LPS stimulation, NLRX1 is rapidly ubiquitinated, disassociates from TRAF6, and then binds to the IKK complex, resulting in inhibition of IKK alpha and IKK(3 phosphorylation and NF-kappa B activation. Knockdown of NLRX1 in various cell types markedly enhances IKK phosphorylation and the production of NF-kappa B-responsive cytokines after LPS stimulation. We further provide in vivo evidence that NLRX1 knockdown in mice markedly enhances susceptibility to LPS-induced septic shock and plasma IL-6 level. Our study identifies a previously unrecognized role for NLRX1 in the negative regulation of TLR-induced NF-kappa B activation by dynamically interacting with TRAF6 and the IKK complex.	[Xia, Xiaojun; Cui, Jun; Wang, Helen Y.; Zhu, Liang; Matsueda, Satoko; Wang, Qinfu; Yang, Xiaoang; Hong, Jun; Wang, Rong-Fu] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Wang, Rong-Fu] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Wang, Rong-Fu] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; [Songyang, Zhou] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Songyang, Zhou] Baylor Coll Med, Dept Mol Biol, Houston, TX 77030 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Howard Hughes Med Inst, Dallas, TX 75390 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, RF (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	rongfuw@bcm.tmc.edu	Wang, Qinfu/H-3517-2011; Chen, Zhijian/C-6039-2012	Wang, Qinfu/0000-0001-8155-8345; Chen, Zhijian/0000-0002-8475-8251	National Cancer Institute; National Institutes of Health; Cancer Research Institute; NATIONAL CANCER INSTITUTE [P01CA094237, R01CA090327, R01CA116408, P50CA126752, R01CA121191, R01CA101795] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Ting for Nlrx1<SUP>-/-</SUP> MEF cells, M. Karin, B. Su, S.-C. Sun, and M. Kunihiro for IKK alpha., IKK beta, NEMO, p38, p100, and TAB1 constructs, and H. Shu for TRAF constructs. We would also like to thank A. Aboseda Alagbala for generating bone marrow-derived macrophages and critical reading of the manuscript. This work was supported in part by grants from National Cancer Institute, National Institutes of Health and Cancer Research Institute.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014	30	209	218	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 24	2011	34	6					843	853		10.1016/j.immuni.2011.02.022	http://dx.doi.org/10.1016/j.immuni.2011.02.022			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21703539	Green Accepted, Bronze			2022-12-18	WOS:000292349700006
J	Araki, Y; Wang, ZB; Zang, CZ; Wood, WH; Schones, D; Cui, KR; Roh, TY; Lhotsky, B; Wersto, RP; Peng, WQ; Becker, KG; Zhao, K; Weng, NP				Araki, Yasuto; Wang, Zhibin; Zang, Chongzhi; Wood, William H., III; Schones, Dustin; Cui, Kairong; Roh, Tae-Young; Lhotsky, Brad; Wersto, Robert P.; Peng, Weiqun; Becker, Kevin G.; Zhao, Keji; Weng, Nan-ping			Genome-wide Analysis of Histone Methylation Reveals Chromatin State-Based Regulation of Gene Transcription and Function of Memory CD8(+) T Cells	IMMUNITY			English	Article							IFN-GAMMA LOCI; CUTTING EDGE; EXPRESSION; EFFECTOR; ACETYLATION; PROTEIN; DIFFERENTIATION; EOMESODERMIN; RECRUITMENT; HOMEOSTASIS	Memory lymphocytes are characterized by their ability to exhibit a rapid response to the recall antigen, in which differential transcription is important, yet the underlying mechanism is not understood. We report here a genome-wide analysis of histone methylation on two histone H3 lysine residues (H3K4me3 and H3K27me3) and gene expression profiles in naive and memory CD8(+) T cells. We found that specific correlation exists between gene expression and the amounts of H3K4me3 (positive correlation) and H3K27me3 (negative correlation) across the gene body. These correlations displayed four distinct modes (repressive, active, poised, and bivalent), reflecting different functions of these genes in CD8(+) T cells. Furthermore, a permissive chromatin state of each gene was established by a combination of different histone modifications. Our findings reveal a complex regulation by histone methylation in differential gene expression and suggest that histone methylation may be responsible for memory CD8(+) T cell function.	[Wang, Zhibin; Schones, Dustin; Cui, Kairong; Roh, Tae-Young; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Araki, Yasuto; Weng, Nan-ping] NIA, Immunol Lab, NIH, Baltimore, MD 21224 USA; [Wood, William H., III; Becker, Kevin G.] NIA, DNA Array Unit, NIH, Baltimore, MD 21224 USA; [Lhotsky, Brad] NIA, IT Sect, NIH, Baltimore, MD 21224 USA; [Wersto, Robert P.] NIA, Flow Cytometry Unit, NIH, Baltimore, MD 21224 USA; [Zang, Chongzhi; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); George Washington University	Zhao, K (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10,9000 Rockville Pike, Bethesda, MD 20892 USA.	zhaok@mail.nih.gov; wengn@mail.nih.gov	/AAI-2516-2019; Weng, Nan-ping/AAC-5037-2020; Zang, Chongzhi/D-1445-2011	Zang, Chongzhi/0000-0003-4812-3627; Roh, Tae-Young/0000-0001-5833-0844; Peng, Weiqun/0000-0001-5521-9091; Becker, Kevin/0000-0002-6794-6656	National Institute on Aging and National Heart, Lung, and Blood Institute; National Institutes of Health (NIH); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZICHL006018, ZIAHL006030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000616, ZICAG000912, ZIAAG000757, ZICAG000618] Funding Source: NIH RePORTER	National Institute on Aging and National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)NIH National Institute on Aging (NIA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Hodes and M. Pazin for critical reading the manuscript. We thank C. Nguyen of the Flow Cytometry Unit for cell sort, A. Sharov of Laboratory of Genetics for helping the microarray analysis, and the NIA Apheresis Unit for collecting blood samples. This research was supported by the Intramural Research Programs of the National Institute on Aging and National Heart, Lung, and Blood Institute, National Institutes of Health (NIH).	Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Araki Y, 2008, J IMMUNOL, V180, P8102, DOI 10.4049/jimmunol.180.12.8102; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Beyersdorf NB, 2001, EUR J IMMUNOL, V31, P3443, DOI 10.1002/1521-4141(200112)31:12<3443::AID-IMMU3443>3.0.CO;2-J; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chandele A, 2008, J IMMUNOL, V180, P5309, DOI 10.4049/jimmunol.180.8.5309; Chtanova T, 2001, J IMMUNOL, V167, P3057, DOI 10.4049/jimmunol.167.6.3057; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Fann M, 2005, IMMUNOL REV, V205, P190, DOI 10.1111/j.0105-2896.2005.00262.x; Fann M, 2006, BLOOD, V108, P3363, DOI 10.1182/blood-2006-02-005520; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Masztalerz A, 2007, J CELL SCI, V120, P219, DOI 10.1242/jcs.03328; Mazzocco M, 2002, GENE, V291, P233, DOI 10.1016/S0378-1119(02)00602-9; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Nishimura Y, 2001, J BIOL CHEM, V276, P19921, DOI 10.1074/jbc.M010332200; Northrop JK, 2008, J IMMUNOL, V181, P865, DOI 10.4049/jimmunol.181.2.865; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Varrault A, 1998, P NATL ACAD SCI USA, V95, P8835, DOI 10.1073/pnas.95.15.8835; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Yamashita M, 2004, J BIOL CHEM, V279, P39454, DOI 10.1074/jbc.M405989200	49	209	210	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 19	2009	30	6					912	925		10.1016/j.immuni.2009.05.006	http://dx.doi.org/10.1016/j.immuni.2009.05.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19523850	Green Accepted, Bronze			2022-12-18	WOS:000267270700017
J	Kurobe, H; Liu, C; Ueno, T; Saito, F; Ohigashi, L; Seach, N; Arakaki, R; Hayashi, Y; Kitagawa, T; Lipp, M; Boyd, RL; Takahama, Y				Kurobe, H; Liu, C; Ueno, T; Saito, F; Ohigashi, L; Seach, N; Arakaki, R; Hayashi, Y; Kitagawa, T; Lipp, M; Boyd, RL; Takahama, Y			CCR7-Dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance	IMMUNITY			English	Article							PERIPHERAL LYMPHOID ORGANS; NEGATIVE SELECTION; CELL DEVELOPMENT; SELF-TOLERANCE; PROGENITOR LOCALIZATION; THYMUS; AIRE; EXPRESSION; RECEPTOR; MICROENVIRONMENTS	Immature CD4(+)CD8(+) thymocytes, which are generated in the thymic cortex, are induced upon positive selection to differentiate into mature T lymphocytes and relocate to the thymic medulla. It was recently shown that a chemokine signal via CCR7 is essential for the cortex-to-medulla migration of positively selected thymocytes in the thymus. However, the role of the cortex-to-medulla migration in T cell development and selection has remained unclear. The present study shows that the developmental kinetics and the thymic export of mature thymocytes were undisturbed in adult mice lacking CCR7 or its ligands (CCR7L). The inhibition of sphingosine-1-phosphate-mediated lymphocyte egress from the thymus led to the accumulation of mature thymocytes in the cortex of CCR7- or CCR7L-deficient mice, unlike the accumulation in the medulla of normal mice, thereby suggesting that mature thymocytes may be exported directly from the cortex in the absence of CCR7 signals. However, the thymocytes that were generated in the absence of CCR7 or CCR7L were potent in causing autoimmune dacryoadenitis and sialadenitis in mice and were thus incapable of establishing central tolerance to organ-specific antigens. These results indicate that CCR7-mediated cortex-to-medulla migration of thymocytes is essential for establishing central tolerance rather than for supporting the maturation or export of thymocytes.	Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan; Univ Tokushima, Inst Hlth Biosci, Dept Cardiovasc Surg, Tokushima 7708503, Japan; Univ Tokushima, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 7708503, Japan; Max Delbruck Ctr Mol Med, Dept Mol Tumorgenet & Immunogenet, D-13125 Berlin, Germany; Monash Univ, Monash Immunol Lab, Clayton, Vic 3800, Australia; Monash Univ, Monash Stem Cell Lab, Clayton, Vic 3800, Australia	Tokushima University; Tokushima University; Tokushima University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Monash University; Monash University	Kurobe, H (corresponding author), Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan.	takahama@genome.tokushima-u.ac.jp	KUROBE, Hirotsugu/ABC-8384-2021; KUROBE, Hirotsugu/E-6982-2011; Takahama, Yousuke/A-5863-2010; Lipp, Martin/G-2235-2010	KUROBE, Hirotsugu/0000-0002-5789-5402; KUROBE, Hirotsugu/0000-0002-5789-5402; Takahama, Yousuke/0000-0002-4992-9174; Lister, Natalie/0000-0001-9223-5875; Lipp, Martin/0000-0002-0087-2672				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Benz C, 2004, EUR J IMMUNOL, V34, P3652, DOI 10.1002/eji.200425248; Bjorses P, 1999, HUM MOL GENET, V8, P259, DOI 10.1093/hmg/8.2.259; Blackburn CC, 2002, TRENDS IMMUNOL, V23, P391, DOI 10.1016/S1471-4906(02)02265-2; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Campbell JJ, 1999, J IMMUNOL, V163, P2353; Chiba K, 1998, J IMMUNOL, V160, P5037; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; FAIRCHILD P J, 1990, International Reviews of Immunology, V6, P187, DOI 10.3109/08830189009056629; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; Ferrero I, 1997, BLOOD, V90, P1943, DOI 10.1182/blood.V90.5.1943; FINK PJ, 1985, NATURE, V313, P233, DOI 10.1038/313233a0; FLOTTE TJ, 1983, AM J PATHOL, V111, P112; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; GODFREY DI, 1990, IMMUNOLOGY, V70, P66; Gotter J, 2004, CURR OPIN IMMUNOL, V16, P741, DOI 10.1016/j.coi.2004.08.004; Gray DHD, 2005, CURR OPIN IMMUNOL, V17, P137, DOI 10.1016/j.coi.2005.02.001; Ishimaru N, 2000, AM J PATHOL, V156, P1557, DOI 10.1016/S0002-9440(10)65027-4; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kato S, 1997, MICROSC RES TECHNIQ, V38, P287, DOI 10.1002/(SICI)1097-0029(19970801)38:3<287::AID-JEMT9>3.0.CO;2-J; Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Liu CL, 2005, BLOOD, V105, P31, DOI 10.1182/blood-2004-04-1369; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MILLER JF, 1961, LANCET, V2, P748; Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383; MOORE NC, 1994, J IMMUNOL, V152, P4826; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nakano H, 1998, BLOOD, V91, P2886, DOI 10.1182/blood.V91.8.2886.2886_2886_2895; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; REICHERT RA, 1986, J IMMUNOL, V136, P3535; REICHERT RA, 1984, CELL, V38, P89, DOI 10.1016/0092-8674(84)90529-4; REICHERT RA, 1986, J IMMUNOL, V136, P3521; Rinderle C, 1999, HUM MOL GENET, V8, P277, DOI 10.1093/hmg/8.2.277; RITTER MA, 1993, IMMUNOL TODAY, V14, P462, DOI 10.1016/0167-5699(93)90250-O; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; Sheard MA, 2004, EUR J IMMUNOL, V34, P25, DOI 10.1002/eji.200324460; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; TAKAHAMA Y, 1994, J EXP MED, V179, P1495, DOI 10.1084/jem.179.5.1495; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4; USHIKI T, 1986, CELL TISSUE RES, V244, P285; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; VANVLIET E, 1984, CELL IMMUNOL, V87, P101, DOI 10.1016/0008-8749(84)90134-5; WHITE SC, 1974, J IMMUNOL, V112, P178; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976	66	209	215	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2006	24	2					165	177		10.1016/j.immuni.2005.12.011	http://dx.doi.org/10.1016/j.immuni.2005.12.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	014KN	16473829	Bronze			2022-12-18	WOS:000235479000008
J	Allenspach, EJ; Cullinan, P; Tong, JK; Tang, QZ; Tesciuba, AG; Cannon, JL; Takahashi, SM; Morgan, R; Burkhardt, JK; Sperling, AI				Allenspach, EJ; Cullinan, P; Tong, JK; Tang, QZ; Tesciuba, AG; Cannon, JL; Takahashi, SM; Morgan, R; Burkhardt, JK; Sperling, AI			ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse	IMMUNITY			English	Article							T-CELL ACTIVATION; KINASE C-THETA; PLASMA-MEMBRANE; FAMILY MEMBERS; ACTIN-BINDING; IN-VITRO; EZRIN; MOESIN; ADHESION; LYMPHOCYTE	The large mucin CD43 is actively excluded from T cell/APC interaction sites, concentrating in a membrane domain distal to the site of TCR engagement. The cytoplasmic region of CD43 was necessary and sufficient for this antipodal movement. ERM cytoskeletal adaptor proteins colocalized with CD43 in this domain. An ERM dominant-negative mutant blocked the distal accumulation of CD43 and another known ERM binding protein, Rho-GDI. Inhibition of ERM function decreased the production of IL-2 and IFN gamma, without affecting PKC theta focusing or CD69 upregulation. These results indicate that ERM proteins organize a complex distal to the T cell/APC interaction site and provide evidence that full T cell activation may involve removal of inhibitory proteins from the immunological synapse.	Univ Chicago, Pulm & Crit Care Med Sect, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Sperling, AI (corresponding author), Univ Chicago, Pulm & Crit Care Med Sect, Dept Med, Chicago, IL 60637 USA.		Sperling, Anne/ACZ-2351-2022	Sperling, Anne I./0000-0002-4265-9212; Allenspach, Eric/0000-0001-7346-5835; Tang, Qizhi/0000-0001-7313-3574; Cannon, Judy/0000-0003-0069-8106	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044835, R01AI044932] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI44835, R01 AI44932] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABE R, 1995, J IMMUNOL, V154, P985; Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; Amieva MR, 1999, J CELL SCI, V112, P111; ANDREOLI C, 1994, J CELL SCI, V107, P2509; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Bretscher A, 1997, J CELL SCI, V110, P3011; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; del Pozo MA, 1998, CELL ADHES COMMUN, V6, P125, DOI 10.3109/15419069809004468; delPozo MA, 1997, J CELL BIOL, V137, P493; DELPOZO MA, 1995, J CELL BIOL, V131, P495, DOI 10.1083/jcb.131.2.495; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hayashi K, 1999, J CELL SCI, V112, P1149; MANJUNATH N, 1995, NATURE, V377, P535, DOI 10.1038/377535a0; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; NONG YH, 1989, J EXP MED, V170, P259, DOI 10.1084/jem.170.1.259; PedrazaAlva G, 1996, J BIOL CHEM, V271, P27564, DOI 10.1074/jbc.271.44.27564; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Seveau S, 1997, J CELL SCI, V110, P1465; Shcherbina A, 1999, FEBS LETT, V443, P31, DOI 10.1016/S0014-5793(98)01674-3; Sperling AI, 1996, IMMUNOL REV, V153, P155, DOI 10.1111/j.1600-065X.1996.tb00924.x; Sperling AI, 1998, J IMMUNOL, V161, P6459; SPERLING AI, 1995, J EXP MED, V182, P139, DOI 10.1084/jem.182.1.139; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; THUILLIER L, 1994, CELL IMMUNOL, V156, P322, DOI 10.1006/cimm.1994.1178; Thurman EC, 1998, INT IMMUNOL, V10, P691, DOI 10.1093/intimm/10.5.691; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Turunen O, 1998, BBA-PROTEIN STRUCT M, V1387, P1, DOI 10.1016/S0167-4838(98)00103-4; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wang WM, 2000, CELL IMMUNOL, V205, P34, DOI 10.1006/cimm.2000.1716; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	40	209	213	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2001	15	5					739	750		10.1016/S1074-7613(01)00224-2	http://dx.doi.org/10.1016/S1074-7613(01)00224-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728336	Bronze			2022-12-18	WOS:000172528200007
J	Blake, N; Lee, S; Redchenko, I; Thomas, W; Steven, N; Leese, A; Steigerwald-Mullen, P; Kurilla, MG; Frappier, L; Rickinson, A				Blake, N; Lee, S; Redchenko, I; Thomas, W; Steven, N; Leese, A; Steigerwald-Mullen, P; Kurilla, MG; Frappier, L; Rickinson, A			Human CD8(+) T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing	IMMUNITY			English	Article							EPSTEIN-BARR-VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; HUMAN CYTOMEGALOVIRUS; NUCLEAR ANTIGEN-1; BURKITT-LYMPHOMA; MHC PRESENTATION; EXPRESSION; DNA; EPITOPE; IDENTIFICATION	Epstein-Barr virus (EBV)-induced cytotoxic T lymphocyte (CTL) responses have been detected against many EBV antigens but not the nuclear antigen EBNA1; this has been attributed to the presence of a glycine-alanine repeat (GAr) domain in the protein. Here we describe the isolation of human CD8(+) CTL clones recognizing EBNA1-specific peptides in the context of HLA-B35.01 and HLA-A2.03. Using these clones, we show that full-length EBNA1 is not presented when expressed endogenously in target cells, whereas the GAr-deleted form is presented efficiently. However, when supplied as an exogenous antigen, the full-length protein can be presented on HLA class I molecules by a TAP-independent pathway; this may explain how EBNA1-specific CTLs are primed in vivo.	Univ Birmingham, CRC, Inst Canc Studies, Birmingham B15 2TA, W Midlands, England; Univ Virginia, Dept Pathol & Microbiol, Charlottesville, VA 22901 USA; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Birmingham; University of Virginia; University of Toronto	Rickinson, A (corresponding author), Univ Birmingham, CRC, Inst Canc Studies, Birmingham B15 2TA, W Midlands, England.			Lee, Steven/0000-0001-7391-2404				Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; BALL LA, 1987, J VIROL, V61, P1788, DOI 10.1128/JVI.61.6.1788-1795.1987; BURROWS SR, 1992, EUR J IMMUNOL, V22, P191, DOI 10.1002/eji.1830220128; BURROWS SR, 1992, IMMUNOLOGY, V76, P174; CHEN F, 1995, J VIROL, V69, P3752, DOI 10.1128/JVI.69.6.3752-3758.1995; FALK K, 1995, J GEN VIROL, V76, P779, DOI 10.1099/0022-1317-76-4-779; Floettmann JE, 1996, VIROLOGY, V223, P29, DOI 10.1006/viro.1996.0452; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; GAVIOLI R, 1992, P NATL ACAD SCI USA, V89, P5862, DOI 10.1073/pnas.89.13.5862; GAVIOLI R, 1993, J VIROL, V67, P1572, DOI 10.1128/JVI.67.3.1572-1578.1993; Gilbert MJ, 1996, NATURE, V383, P720, DOI 10.1038/383720a0; GOLDSMITH K, 1993, J VIROL, V67, P3418, DOI 10.1128/JVI.67.6.3418-3426.1993; GRASSER FA, 1994, BLOOD, V84, P3792, DOI 10.1182/blood.V84.11.3792.bloodjournal84113792; GRUNHAUS A, 1992, SEMIN VIROL, V3, P237; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; HENLE W, 1987, P NATL ACAD SCI USA, V84, P570, DOI 10.1073/pnas.84.2.570; HENNESSY K, 1983, P NATL ACAD SCI-BIOL, V80, P5665, DOI 10.1073/pnas.80.18.5665; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; KAY R, 1987, NUCLEIC ACIDS RES, V15, P2778, DOI 10.1093/nar/15.6.2778; Khanna R, 1997, INT IMMUNOL, V9, P1537, DOI 10.1093/intimm/9.10.1537; Khanna R, 1995, VIROLOGY, V214, P633, DOI 10.1006/viro.1995.0076; KHANNA R, 1992, J EXP MED, V176, P169, DOI 10.1084/jem.176.1.169; KOVACSOVICSBANK.M, 1993, P NATL ACAD SCI USA, V90, P4924; Lee SP, 1997, J IMMUNOL, V158, P3325; LEE SP, 1995, EUR J IMMUNOL, V25, P102, DOI 10.1002/eji.1830250119; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; LIU TM, 1995, J IMMUNOL, V154, P3147; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; MURRAY RJ, 1992, J EXP MED, V176, P157, DOI 10.1084/jem.176.1.157; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; RIDDELL SR, 1991, J IMMUNOL, V146, P2795; Rock KL, 1996, IMMUNOL TODAY, V17, P131, DOI 10.1016/0167-5699(96)80605-0; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; SCHIRMBECK R, 1995, EUR J IMMUNOL, V25, P1063, DOI 10.1002/eji.1830250431; Steven NM, 1996, J EXP MED, V184, P1801, DOI 10.1084/jem.184.5.1801; Steven NM, 1997, J EXP MED, V185, P1605, DOI 10.1084/jem.185.9.1605; TAKIGUCHI M, 1994, INT IMMUNOL, V6, P1345, DOI 10.1093/intimm/6.9.1345; TAMAKI H, 1995, J INFECT DIS, V172, P739, DOI 10.1093/infdis/172.3.739; TIERNEY RJ, 1994, J VIROL, V68, P7374, DOI 10.1128/JVI.68.11.7374-7385.1994; TIGGES MA, 1992, J VIROL, V66, P1622, DOI 10.1128/JVI.66.3.1622-1634.1992; ULMER JB, 1994, EUR J IMMUNOL, V24, P1590, DOI 10.1002/eji.1830240721; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WILKINSON GWG, 1992, NUCLEIC ACIDS RES, V20, P2233, DOI 10.1093/nar/20.9.2233; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	53	209	214	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1997	7	6					791	802		10.1016/S1074-7613(00)80397-0	http://dx.doi.org/10.1016/S1074-7613(00)80397-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430224	Bronze			2022-12-18	WOS:000071351300006
J	Maxwell, JR; Zhang, Y; Brown, WA; Smith, CL; Byrne, FR; Fiorino, M; Stevens, E; Bigler, J; Davis, JA; Rottman, JB; Budelsky, AL; Symons, A; Towne, JE				Maxwell, Joseph R.; Zhang, Yu; Brown, William A.; Smith, Carole L.; Byrne, Fergus R.; Fiorino, Mike; Stevens, Erin; Bigler, Jeannette; Davis, John A.; Rottman, James B.; Budelsky, Alison L.; Symons, Antony; Towne, Jennifer E.			Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; LIPOPOLYSACCHARIDE-BINDING PROTEIN; CHRONIC PLAQUE PSORIASIS; CROHNS-DISEASE; TH17 CELLS; T-CELLS; RECEPTOR COMPLEX; EPITHELIAL-CELLS; DOUBLE-BLIND; COLITIS	Interleukin-23 (IL-23) and IL-17 are cytokines currently being targeted in clinical trials. Although inhibition of both of these cytokines is effective for treating psoriasis, IL-12 and IL-23 p40 inhibition attenuates Crohn's disease, whereas IL-17A or IL-17 receptor A (IL-17RA) inhibition exacerbates Crohn's disease. This dichotomy between IL-23 and IL-17 was effectively modeled in the multidrug resistance-1a-ablated (Abcb1a(-/-)) mouse model of colitis. IL-23 inhibition attenuated disease by decreasing colonic inflammation while enhancing regulatory T (Treg) cell accumulation. Exacerbation of colitis by IL-17A or IL-17RA inhibition was associated with severe weakening of the intestinal epithelial barrier, culminating in increased colonic inflammation and accelerated mortality. These data show that IL-17A acts on intestinal epithelium to promote barrier function and provide insight into mechanisms underlying exacerbation of Crohn's disease when IL-17A or IL-17RA is inhibited.	[Maxwell, Joseph R.; Zhang, Yu; Brown, William A.; Smith, Carole L.; Budelsky, Alison L.; Symons, Antony; Towne, Jennifer E.] Amgen Inc, Dept Inflammat, Seattle, WA 98117 USA; [Byrne, Fergus R.; Fiorino, Mike] Amgen Inc, Dept Inflammat, Thousand Oaks, CA 91320 USA; [Stevens, Erin] Amgen Inc, Dept Clin Immunol, Seattle, WA 98117 USA; [Bigler, Jeannette] Amgen Inc, Dept Mol Sci & Computat Biol, Seattle, WA 98117 USA; [Davis, John A.] Amgen Inc, Dept Pharmacokinet & Drug Metab, Seattle, WA 98117 USA; [Rottman, James B.] Amgen Inc, Dept Pathol, Cambridge, MA 02142 USA	Amgen; Amgen; Amgen; Amgen; Amgen; Amgen	Towne, JE (corresponding author), Janssen Res & Dev, San Diego, CA 92121 USA.	jtowne1@its.jnj.com						Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Cao AT, 2012, J IMMUNOL, V189, P4666, DOI 10.4049/jimmunol.1200955; Collett A, 2008, INFLAMM BOWEL DIS, V14, P620, DOI 10.1002/ibd.20375; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Globig AM, 2014, INFLAMM BOWEL DIS, V20, P2321, DOI 10.1097/MIB.0000000000000210; Gordon KB, 2014, J AM ACAD DERMATOL, V71, P1176, DOI 10.1016/j.jaad.2014.07.048; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Khanna P.V., 2014, SEMIN IMMUNOPATHOL, V36, P541; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Lakatos PL, 2011, INFLAMM BOWEL DIS, V17, P767, DOI 10.1002/ibd.21402; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Lee JW, 2008, J IMMUNOL, V181, P6536, DOI 10.4049/jimmunol.181.9.6536; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Maggio-Price L, 2002, AM J PATHOL, V160, P739, DOI 10.1016/S0002-9440(10)64894-8; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Noth R, 2012, J CROHNS COLITIS, V6, P464, DOI 10.1016/j.crohns.2011.10.004; Olson TS, 2006, J EXP MED, V203, P541, DOI 10.1084/jem.20050407; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Panwala CM, 1998, J IMMUNOL, V161, P5733; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Rojo OP, 2007, INFLAMM BOWEL DIS, V13, P269, DOI 10.1002/ibd.20019; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Resta-Lenert S, 2005, AM J PHYSIOL-GASTR L, V289, pG153, DOI 10.1152/ajpgi.00395.2004; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sands BE, 2015, J CROHNS COLITIS, V9, pS15; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Targan SR, 2012, GASTROENTEROLOGY, V143, pE26, DOI 10.1053/j.gastro.2012.07.084; Tausend W, 2014, J CUTAN MED SURG, V18, P156, DOI 10.2310/7750.2013.13125; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Wild GE, 2003, ALIMENT PHARM THER, V18, P309, DOI 10.1046/j.1365-2036.2003.01611.x; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799	40	208	217	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					739	750		10.1016/j.immuni.2015.08.019	http://dx.doi.org/10.1016/j.immuni.2015.08.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26431947	Bronze			2022-12-18	WOS:000363478700016
J	O'Sullivan, TE; Sun, JC; Lanier, LL				O'Sullivan, Timothy E.; Sun, Joseph C.; Lanier, Lewis L.			Natural Killer Cell Memory	IMMUNITY			English	Review							HUMAN CYTOMEGALOVIRUS-INFECTION; HUMAN NK CELLS; SIMIAN IMMUNODEFICIENCY VIRUS; ANTIGEN-SPECIFIC MEMORY; EPSTEIN-BARR-VIRUS; CUTTING EDGE; T-CELLS; INFLUENZA INFECTION; VIRAL-INFECTION; RHESUS MACAQUES	Natural killer (NK) cells have historically been considered short-lived cytolytic cells that can rapidly respond against pathogens and tumors in an antigen-independent manner and then undergo cell death. Recently, however, NK cells have been shown to possess traits of adaptive immunity and can acquire immunological memory in a manner similar to that of T and B cells. In this review, we discuss evidence of NK cell memory and the mechanisms involved in the generation and survival of these innate lymphocytes.	[O'Sullivan, Timothy E.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Sun, Joseph C.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA; [Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California San Francisco	Sun, JC (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.	sunj@mskcc.org; lewis.lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014; O'Sullivan, Timothy/D-3422-2018	Lanier, Lewis L/0000-0003-1308-3952; O'Sullivan, Timothy/0000-0003-1435-8188	American Cancer Society; Searle Scholars Program; Cancer Research Institute; NIH [AI085034, P30CA008748, AI100874, AI066897, AI068129]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066897, R00AI085034, R01AI068129, R01AI100874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Searle Scholars Program; Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Cancer Society, Searle Scholars Program, Cancer Research Institute, and grants from the NIH (AI085034, P30CA008748, and AI100874). L.L.L. is an American Cancer Society Professor and funded by NIH grants AI066897 and AI068129.	Abdul-Careem MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032821; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545; Beziat V, 2012, EUR J IMMUNOL, V42, P447, DOI 10.1002/eji.201141826; Biron CA, 2015, MED MICROBIOL IMMUN, V204, P345, DOI 10.1007/s00430-015-0412-3; Bjorkstrom NK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027664; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Bostik P, 2009, J IMMUNOL, V182, P3638, DOI 10.4049/jimmunol.0803580; Boyman O, 2012, CELL MOL LIFE SCI, V69, P1597, DOI 10.1007/s00018-012-0968-7; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Brunetta E, 2010, AIDS, V24, P27, DOI 10.1097/QAD.0b013e3283328d1f; Chen M, 2014, NAT MED, V20, P507, DOI 10.1038/nm.3521; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Della Chiesa M, 2012, BLOOD, V119, P399, DOI 10.1182/blood-2011-08-372003; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; Firth MA, 2013, J EXP MED, V210, P2981, DOI 10.1084/jem.20130417; Foley B, 2012, J IMMUNOL, V189, P5082, DOI 10.4049/jimmunol.1201964; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Giavedoni LD, 2000, J VIROL, V74, P1648, DOI 10.1128/JVI.74.4.1648-1657.2000; Gillard GO, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002141; Goodier MR, 2014, BLOOD, V124, P2213, DOI 10.1182/blood-2014-05-576124; Gorbachev AV, 2001, CRIT REV IMMUNOL, V21, P451; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hendricks DW, 2014, J IMMUNOL, V192, P4492, DOI 10.4049/jimmunol.1303211; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Hwang I, 2012, INT IMMUNOL, V24, P793, DOI 10.1093/intimm/dxs080; Jamieson AM, 2004, J IMMUNOL, V172, P864, DOI 10.4049/jimmunol.172.2.864; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kamimura Y, 2015, CELL REP, V10, P280, DOI 10.1016/j.celrep.2014.12.025; Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026; Keppel MP, 2013, J IMMUNOL, V190, P4754, DOI 10.4049/jimmunol.1201742; Kish DD, 2009, J IMMUNOL, V182, P5949, DOI 10.4049/jimmunol.0802830; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kuijpers TW, 2008, BLOOD, V112, P914, DOI 10.1182/blood-2008-05-157354; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LANIER LL, 1989, NATURE, V342, P803, DOI 10.1038/342803a0; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Luetke-Eversloh M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004441; Madera S, 2015, J IMMUNOL, V194, P1408, DOI 10.4049/jimmunol.1402001; Majewska-Szczepanik M, 2013, IMMUNOLOGY, V140, P98, DOI 10.1111/imm.12120; Levy EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/676198; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Matusali G, 2012, J VIROL, V86, P4496, DOI 10.1128/JVI.05788-11; Min-Oo G, 2014, J EXP MED, V211, P2669, DOI 10.1084/jem.20141172; Min-Oo G, 2014, J EXP MED, V211, P1289, DOI 10.1084/jem.20132459; Muntasell A, 2013, EUR J IMMUNOL, V43, P3268, DOI 10.1002/eji.201343773; Nabekura T, 2015, J IMMUNOL, V194, P5948, DOI 10.4049/jimmunol.1500424; Nabekura T, 2014, J EXP MED, V211, P2455, DOI 10.1084/jem.20140798; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Ni J, 2012, J EXP MED, V209, P2351, DOI 10.1084/jem.20120944; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; O'Sullivan TE, 2015, IMMUNITY, V43, P331, DOI 10.1016/j.immuni.2015.07.012; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Passweg JR, 2006, BEST PRACT RES CL HA, V19, P811, DOI 10.1016/j.beha.2006.06.004; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Prlic M, 2008, P NATL ACAD SCI USA, V105, P16689, DOI 10.1073/pnas.0808997105; Puleston DJ, 2014, ELIFE, V3, DOI 10.7554/eLife.03706; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rolle A, 2014, J CLIN INVEST, V124, P5305, DOI 10.1172/JCI77440; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Saghafian-Hedengren S, 2013, J VIROL, V87, P13446, DOI 10.1128/JVI.02382-13; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Strauss-Albee DM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5722; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2011, J IMMUNOL, V186, P1891, DOI 10.4049/jimmunol.1003035; Sun JC, 2011, J EXP MED, V208, P357, DOI 10.1084/jem.20100479; Sun JC, 2010, IMMUNOL REV, V236, P83, DOI 10.1111/j.1600-065X.2010.00900.x; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Takahashi Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003929; van Helden MJG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052027; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025; Yokoyama WM, 2013, COLD SH Q B, V78, P149, DOI 10.1101/sqb.2013.78.020354; Zawislak CL, 2013, P NATL ACAD SCI USA, V110, P6967, DOI 10.1073/pnas.1304410110; Zhang TX, 2013, J IMMUNOL, V190, P1402, DOI 10.4049/jimmunol.1203034	100	208	217	1	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					634	645		10.1016/j.immuni.2015.09.013	http://dx.doi.org/10.1016/j.immuni.2015.09.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26488815	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000363478700008
J	Zhu, JF; Jankovic, D; Oler, AJ; Wei, G; Sharma, S; Hu, GQ; Guo, LY; Yagi, R; Yamane, H; Punkosdy, G; Feigenbaum, L; Zhao, KJ; Paul, WE				Zhu, Jinfang; Jankovic, Dragana; Oler, Andrew J.; Wei, Gang; Sharma, Suveena; Hu, Gangqing; Guo, Liying; Yagi, Ryoji; Yamane, Hidehiro; Punkosdy, George; Feigenbaum, Lionel; Zhao, Keji; Paul, William E.			The Transcription Factor T-bet Is Induced by Multiple Pathways and Prevents an Endogenous Th2 Cell Program during Th1 Cell Responses	IMMUNITY			English	Article							IN-VIVO; GENE-EXPRESSION; FACTOR GATA-3; DIFFERENTIATION; IL-4; BASOPHILS; PLAYS; GAMMA; CD4; RECRUITMENT	T-bet is a critical transcription factor for T helper 1 (Th1) cell differentiation. To study the regulation and functions of T-bet, we developed a T-bet-ZsGreen reporter mouse strain. We determined that interleukin-12 (IL-12) and interferon-gamma (IFN-gamma) were redundant in inducing T-bet in mice infected with Toxoplasma gondii and that T-bet did not contribute to its own expression when induced by IL-12 and IFN-gamma. By contrast, T-bet and the transcription factor Stat4 were critical for IFN-gamma production whereas IFN-gamma signaling was dispensable for inducing IFN-gamma. Loss of T-bet resulted in activation of an endogenous program driving Th2 cell differentiation in cells expressing T-bet-ZsGreen. Genome-wide analyses indicated that T-bet directly induced many Th1 cell-related genes but indirectly suppressed Th2 cell-related genes. Our study revealed redundancy and synergy among several Th1 cell-inducing pathways in regulating the expression of T-bet and IFN-gamma, and a critical role of T-bet in suppressing an endogenous Th2 cell-associated program.	[Zhu, Jinfang; Sharma, Suveena; Guo, Liying; Yagi, Ryoji; Yamane, Hidehiro; Punkosdy, George; Paul, William E.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Jankovic, Dragana] NIAID, Lab Parasit Dis, NIH, Bethesda, MD 20892 USA; [Oler, Andrew J.] NIAID, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD 20892 USA; [Wei, Gang; Hu, Gangqing; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] NCI, Lab Anim Sci Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhu, JF (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	jfzhu@niaid.nih.gov	Oler, Andrew/B-5053-2013; HU, GANGQING/K-5849-2012; Zhu, Jinfang/B-7574-2012; Hu, Gangqing/ABA-3507-2020	Oler, Andrew/0000-0002-6310-0434; HU, GANGQING/0000-0001-5453-6888; Zhu, Jinfang/0000-0002-0117-4745; 	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZIAHL005801, ZIAHL006030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000579, ZIAAI001045, ZIAAI001169] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Sher, R. Germain, J. O'Shea, and P. Schwartzberg for their critical reading of our manuscript; J. Edwards for her excellent assistance in cell sorting; J. O'Shea, Y. Kanno and M. Kaplan for providing Stat4<SUP>-/-</SUP> mice on C57BL/6 background. The work is supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kim S, 2010, J IMMUNOL, V184, P1143, DOI 10.4049/jimmunol.0902447; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lieberman LA, 2004, J IMMUNOL, V172, P457, DOI 10.4049/jimmunol.172.1.457; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Oestreich KJ, 2012, CURR OPIN IMMUNOL, V24, P191, DOI 10.1016/j.coi.2011.12.004; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yang Y, 2007, BLOOD, V110, P2494, DOI 10.1182/blood-2006-11-058271; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	46	208	220	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 19	2012	37	4					660	673		10.1016/j.immuni.2012.09.007	http://dx.doi.org/10.1016/j.immuni.2012.09.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23041064	Bronze, Green Accepted			2022-12-18	WOS:000310185400011
J	Gurish, MF; Austen, KF				Gurish, Michael F.; Austen, K. Frank			Developmental Origin and Functional Specialization of Mast Cell Subsets	IMMUNITY			English	Review							MOUSE BONE-MARROW; RAT GASTROINTESTINAL MUCOSA; ANTIGEN-INDUCED RECRUITMENT; SPIRALIS-INFECTED MICE; TRICHINELLA-SPIRALIS; CONNECTIVE-TISSUE; HEMATOPOIETIC-CELLS; MOLECULAR-CLONING; SERINE-PROTEASE; SMALL-INTESTINE	Mast cells (MCs) are constitutively present in most tissues and a distinct subset of MCs can also be induced upon host responses to inflammation. The hematopoietic lineage development of tissue MCs is unique compared to other myeloid-derived cells because it is early lineage progenitors, undetectable by histochemistry, that leave the bone marrow to enter the circulation. These immature lineage MCs immediately undergo transendothelial recruitment into peripheral tissues wherein the appearance of secretory granules with a particular protease phenotype is regulated by the peripheral tissue. In this Perspective, we discuss our current understanding of how these unique immunocytes arise, traffic to various sites, and may or may not mature into tissue-directed granulated phenotypes and query whether a granulated end stage is their only intended role.	[Gurish, Michael F.; Austen, K. Frank] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Gurish, Michael F.; Austen, K. Frank] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Gurish, MF (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.	mgurish@partners.org; fausten@partners.org		Gurish, Michael/0000-0002-7893-3156	NIH [GM052585, AI083516]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM052585] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.F.G. is supported by NIH grants GM052585 and AI083516.	Abonia JP, 2006, BLOOD, V108, P1588, DOI 10.1182/blood-2005-12-012781; Abonia JP, 2005, BLOOD, V105, P4308, DOI 10.1182/blood-2004-09-3578; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2005, CELL, V121, P160, DOI 10.1016/j.cell.2005.04.005; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Artis D, 2000, EUR J IMMUNOL, V30, P1656, DOI 10.1002/1521-4141(200006)30:6&lt;1656::AID-IMMU1656&gt;3.0.CO;2-Z; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; CLARKLEWIS I, 1982, J IMMUNOL METHODS, V51, P311, DOI 10.1016/0022-1759(82)90398-2; CRAPPER RM, 1983, J IMMUNOL, V131, P923; CRAPPER RM, 1984, J IMMUNOL, V133, P2174; DAYTON ET, 1988, P NATL ACAD SCI USA, V85, P569, DOI 10.1073/pnas.85.2.569; DILLON SB, 1986, PARASITE IMMUNOL, V8, P503, DOI 10.1111/j.1365-3024.1986.tb00865.x; Du T, 1996, CLIN EXP IMMUNOL, V103, P316, DOI 10.1046/j.1365-2249.1996.d01-610.x; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; EKLUND KK, 1993, J IMMUNOL, V151, P4266; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P303, DOI 10.1111/apm.1966.66.3.303; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P289, DOI 10.1111/apm.1966.66.3.289; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Franco CB, 2010, CELL STEM CELL, V6, P361, DOI 10.1016/j.stem.2010.02.013; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Friend DS, 1998, J IMMUNOL, V160, P5537; FUKUZUMI T, 1990, EXP HEMATOL, V18, P843; GHILDYAL N, 1992, J IMMUNOL, V149, P2123; GHILDYAL N, 1992, J BIOL CHEM, V267, P8473; GINSBURG H, 1967, J CELL BIOL, V35, P685, DOI 10.1083/jcb.35.3.685; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; GURISH MF, 1992, J IMMUNOL, V149, P1964; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; GUYGRAND D, 1984, J EXP MED, V160, P12, DOI 10.1084/jem.160.1.12; Hallgren J, 2007, P NATL ACAD SCI USA, V104, P20478, DOI 10.1073/pnas.0709651104; HATANAKA K, 1979, BLOOD, V53, P142; HAYASHI C, 1985, DEV BIOL, V109, P234, DOI 10.1016/0012-1606(85)90363-X; HEAVEY DJ, 1988, J IMMUNOL, V140, P1953; Huang CF, 1998, J IMMUNOL, V160, P1910; IRANI AMA, 1987, J IMMUNOL, V138, P4381; Jamur MC, 2001, J HISTOCHEM CYTOCHEM, V49, P219, DOI 10.1177/002215540104900209; Jamur MC, 2005, BLOOD, V105, P4282, DOI 10.1182/blood-2004-02-0756; Jones TG, 2010, J IMMUNOL, V185, P1804, DOI 10.4049/jimmunol.1001146; Jones TG, 2009, J IMMUNOL, V183, P5251, DOI 10.4049/jimmunol.0901471; Kaieda S, 2010, J BIOL CHEM, V285, P21478, DOI 10.1074/jbc.M110.114991; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; KITAMURA Y, 1979, BLOOD, V53, P492; LANTZ CS, 1995, J IMMUNOL, V154, P355; LEVISCHAFFER F, 1987, J IMMUNOL, V139, P3431; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; Lilla JN, 2011, BLOOD, V118, P6930, DOI 10.1182/blood-2011-03-343962; Lin L, 2011, J BIOL CHEM, V286, P37358, DOI 10.1074/jbc.M111.272401; McDermott JR, 2003, P NATL ACAD SCI USA, V100, P7761, DOI 10.1073/pnas.1231488100; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; NABEL G, 1981, NATURE, V291, P332, DOI 10.1038/291332a0; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Pennock JL, 2004, BLOOD, V103, P2655, DOI 10.1182/blood-2003-09-3146; RAZIN E, 1981, P NATL ACAD SCI-BIOL, V78, P2559, DOI 10.1073/pnas.78.4.2559; RENNICK D, 1995, BLOOD, V85, P57, DOI 10.1182/blood.V85.1.57.bloodjournal85157; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; ROBINSON HC, 1978, J BIOL CHEM, V253, P6687; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; SCHRADER JW, 1981, J IMMUNOL, V126, P452; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; SERAFIN WE, 1987, J IMMUNOL, V139, P3771; SERAFIN WE, 1986, J BIOL CHEM, V261, P5017; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; SONODA T, 1983, DEV BIOL, V97, P89, DOI 10.1016/0012-1606(83)90066-0; STEVENS RL, 1986, J IMMUNOL, V137, P291; TRONG HL, 1987, BIOCHEMISTRY-US, V26, P6988; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; WOODBURY RG, 1978, BIOCHEMISTRY-US, V17, P811, DOI 10.1021/bi00598a010; Xia ZN, 1996, J BIOL CHEM, V271, P8747, DOI 10.1074/jbc.271.15.8747; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702; Yuan Q, 1998, J IMMUNOL, V161, P5143; YURT RW, 1977, J BIOL CHEM, V252, P518	76	208	214	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 27	2012	37	1					25	33		10.1016/j.immuni.2012.07.003	http://dx.doi.org/10.1016/j.immuni.2012.07.003			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22840841	Bronze			2022-12-18	WOS:000307133200007
J	Zhang, JG; Czabotar, PE; Policheni, AN; Caminschi, I; Wan, SS; Kitsoulis, S; Tullett, KM; Robin, AY; Brammananth, R; van Delft, MF; Lu, JH; O'Reilly, LA; Josefsson, EC; Kile, BT; Chin, WJ; Mintern, JD; Olshina, MA; Wong, W; Baum, J; Wright, MD; Huang, DCS; Mohandas, N; Coppel, RL; Colman, PM; Nicola, NA; Shortman, K; Lahoud, MH				Zhang, Jian-Guo; Czabotar, Peter E.; Policheni, Antonia N.; Caminschi, Irina; Wan, Soo San; Kitsoulis, Susie; Tullett, Kirsteen M.; Robin, Adeline Y.; Brammananth, Rajini; van Delft, Mark F.; Lu, Jinhua; O'Reilly, Lorraine A.; Josefsson, Emma C.; Kile, Benjamin T.; Chin, Wei Jin; Mintern, Justine D.; Olshina, Maya A.; Wong, Wilson; Baum, Jake; Wright, Mark D.; Huang, David C. S.; Mohandas, Narla; Coppel, Ross L.; Colman, Peter M.; Nicola, Nicos A.; Shortman, Ken; Lahoud, Mireille H.			The Dendritic Cell Receptor Clec9A Binds Damaged Cells via Exposed Actin Filaments	IMMUNITY			English	Article							LECTIN-LIKE; CRYSTAL-STRUCTURE; ANTIGEN; PROTEIN; TARGET; MOUSE; SPECTRIN; CLEC12A; LIGAND; DOMAIN	The immune system must distinguish viable cells from cells damaged by physical and infective processes. The damaged cell-recognition molecule Clec9A is expressed on the surface of the mouse and human dendritic cell subsets specialized for the uptake and processing of material from dead cells. Clec9A recognizes a conserved component within nucleated and nonnucleated cells, exposed when cell membranes are damaged. We have identified this Clec9A ligand as a filamentous form of actin in association with particular actin-binding domains of cytoskeletal proteins. We have determined the crystal structure of the human CLEC9A C-type lectin domain and propose a functional dimeric structure with conserved tryptophans in the ligand recognition site. Mutation of these residues ablated CLEC9A binding to damaged cells and to the isolated ligand complexes. We propose that Clec9A provides targeted recruitment of the adaptive immune system during infection and can also be utilized to enhance immune responses generated by vaccines.	[Zhang, Jian-Guo; Czabotar, Peter E.; Policheni, Antonia N.; Caminschi, Irina; Wan, Soo San; Kitsoulis, Susie; Tullett, Kirsteen M.; Robin, Adeline Y.; O'Reilly, Lorraine A.; Josefsson, Emma C.; Kile, Benjamin T.; Chin, Wei Jin; Mintern, Justine D.; Olshina, Maya A.; Wong, Wilson; Baum, Jake; Huang, David C. S.; Colman, Peter M.; Nicola, Nicos A.; Shortman, Ken; Lahoud, Mireille H.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Zhang, Jian-Guo; Czabotar, Peter E.; Policheni, Antonia N.; Caminschi, Irina; Robin, Adeline Y.; O'Reilly, Lorraine A.; Josefsson, Emma C.; Kile, Benjamin T.; Olshina, Maya A.; Baum, Jake; Huang, David C. S.; Colman, Peter M.; Nicola, Nicos A.; Shortman, Ken; Lahoud, Mireille H.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Chin, Wei Jin] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Mintern, Justine D.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Caminschi, Irina; Kitsoulis, Susie; Tullett, Kirsteen M.; Lahoud, Mireille H.] Burnet Inst, Ctr Immunol, Melbourne, Vic 3004, Australia; [Brammananth, Rajini; Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Coppel, Ross L.] Monash Univ, Fac Med, Clayton, Vic 3800, Australia; [van Delft, Mark F.] Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada; [van Delft, Mark F.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada; [Lu, Jinhua] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Wright, Mark D.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Mohandas, Narla] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10065 USA	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Melbourne; Burnet Institute; Monash University; Monash University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; National University of Singapore; Monash University; New York Blood Center	Shortman, K (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	shortman@wehi.edu.au; lahoud@burnet.edu.au	Josefsson, Emma/CAF-4970-2022; Coppel, Ross L/A-6626-2008; Kile, Benjamin/GNP-3246-2022; Nicola, Nicos/D-2989-2011; Lahoud, Mireille/F-1299-2013; Huang, David C. S./C-7586-2013; Kile, Benjamin T/F-6593-2011	Coppel, Ross L/0000-0002-4476-9124; Kile, Benjamin/0000-0002-8836-8947; Nicola, Nicos/0000-0003-1054-7889; Lahoud, Mireille/0000-0001-8472-6201; Huang, David C. S./0000-0002-3101-4873; Kile, Benjamin T/0000-0002-8836-8947; Lu, Jinhua/0000-0002-3699-9894; Baum, Jake/0000-0002-0275-352X; Josefsson, Emma/0000-0001-6478-5204; Robin, Adeline/0000-0002-1199-2135; Mintern, Justine/0000-0002-3797-8577; van Delft, Mark/0000-0002-3866-4318; Wong, Wilson/0000-0003-1335-8047; Wright, Mark/0000-0002-2177-5214; Caminschi, Irina/0000-0002-9027-2098; Shortman, Ken/0000-0002-9107-3007; Czabotar, Peter/0000-0002-2594-496X; Tullett, Kirsteen/0000-0002-2389-9819	National Health and Medical Research Council of Australia (NHMRC) [454465, 461219, 461221, 575546, 1009145]; Human Frontier Science Program; Australian Research Council; NHMRC; Australian Cancer Research Foundation; Leukemia & Lymphoma Society [SCOR 7413]; Melbourne University; Cancer Council	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program(Human Frontier Science Program); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Melbourne University(University of Melbourne); Cancer Council(Cancer Council Australia)	We thank A. Cowman and R. Simpson for critical discussions and L. Zhang for his assistance with CD measurements. We thank L. Connolly, H. Patsiouras, and T. Nebl for MS sequencing analysis. Crystallization trials were performed at the Bio21 Collaborative Crystallisation Centre, Australia. Diffraction data were collected at the Australian Synchrotron and we thank staff for their assistance. This work was supported by the National Health and Medical Research Council of Australia (NHMRC) program grants 454465 (KS.), 461219 (N.A.N., J.-G.Z.), and 461221 (D.C.S.H.), project grants 575546 (KS., M.H.L., IC.) and 1009145 (L.O.R.), Human Frontier Science Program (J.B.), Australian Research Council Future Fellowships (P.E.C., J.B.), NHMRC fellowships (KS., P.M.C., N.A.N., D.C.S.H.), NHMRC Career Development Fellowship (J.D.M.), Australian Cancer Research Foundation (P.M.C., D.C.S.H.), Leukemia & Lymphoma Society Grant SCOR 7413 (D.C.S.H., L.O.R.) and Fellowship (E.C.J.), Melbourne University International Research Scholarship (M.F.v.D.), and Cancer Council Victoria Postdoctoral Research Fellowship (M.F.v.D.). This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIIS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; An XL, 2011, BBA-PROTEINS PROTEOM, V1814, P420, DOI 10.1016/j.bbapap.2010.12.010; Baines AJ, 2010, PROTOPLASMA, V244, P99, DOI 10.1007/s00709-010-0181-1; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bergeron SE, 2010, J BIOL CHEM, V285, P16087, DOI 10.1074/jbc.M110.110130; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Caminschi I, 2001, MOL IMMUNOL, V38, P365, DOI 10.1016/S0161-5890(01)00067-0; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; GRATZER WB, 1982, METHOD ENZYMOL, V85, P475; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Korenbaum E, 2002, J CELL SCI, V115, P3543, DOI 10.1242/jcs.00003; Lahoud MH, 2011, J IMMUNOL, V187, P842, DOI 10.4049/jimmunol.1101176; Lahoud MH, 2009, J IMMUNOL, V182, P7587, DOI 10.4049/jimmunol.0900464; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Natarajan K, 2000, BIOCHEMISTRY-US, V39, P14779, DOI 10.1021/bi0018180; Ohki I, 2005, STRUCTURE, V13, P905, DOI 10.1016/j.str.2005.03.016; Park H, 2005, J BIOL CHEM, V280, P13593, DOI 10.1074/jbc.M500768200; Pei XH, 2005, J BIOL CHEM, V280, P31166, DOI 10.1074/jbc.M505298200; Pyz E, 2008, EUR J IMMUNOL, V38, P1157, DOI 10.1002/eji.200738057; Rotter B, 2004, BIOCHEM J, V378, P161, DOI 10.1042/BJ20030955; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; Uribe R, 2009, MOL BIOL REP, V36, P121, DOI 10.1007/s11033-007-9159-2; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; Wong W, 2011, P NATL ACAD SCI USA, V108, P9869, DOI 10.1073/pnas.1018927108; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	36	208	220	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 20	2012	36	4					646	657		10.1016/j.immuni.2012.03.009	http://dx.doi.org/10.1016/j.immuni.2012.03.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22483802	Bronze			2022-12-18	WOS:000303223900016
J	Savina, A; Peres, A; Cebrian, I; Carmo, N; Moita, C; Hacohen, N; Moita, LF; Amigorena, S				Savina, Ariel; Peres, Audrey; Cebrian, Ignacio; Carmo, Nuno; Moita, Catarina; Hacohen, Nir; Moita, Luis F.; Amigorena, Sebastian			The Small GTPase Rac2 Controls Phagosomal Alkalinization and Antigen Crosspresentation Selectively in CD8(+) Dendritic Cells	IMMUNITY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PHAGOCYTE NADPH OXIDASE; IN-VIVO; CROSS-PRESENTATION; PRESENTING CELLS; RHO-GTPASES; MURINE MACROPHAGES; CATHEPSIN-S; ACTIVATION; LOCALIZATION	A unique subpopulation of spleen dendritic cells (DCs) that express the CD8 surface marker efficiently present phagocytosed antigens to CD8(+) T lymphocytes in a process called "crosspresentation," which initiates cytotoxic immune responses. We now show that the small GTPase Rac2 plays a critical role in antigen crosspresentation selectively in this DC subpopulation. In CD8(+) DCs, Rac2 determines the subcellular assembly of the NADPH oxidase complex (NOX2) to phagosomes, whereas in CD8(-) DCs, Rac1 mediates the assembly of NOX2 at the plasma membrane. In the absence of Rac2, the production of reactive oxygen species (ROS) in DC-phagosomes was abolished, the phagosomal pH dropped, and the efficiency of antigen crosspresentation was reduced. We conclude that the activity of Racl and 2 control crosspresentation in DC subpopulations through the regulation of phagosomal oxidation and pH.	[Savina, Ariel; Peres, Audrey; Cebrian, Ignacio; Amigorena, Sebastian] Inst Curie, INSERM U653, F-75248 Paris 05, France; [Carmo, Nuno; Moita, Catarina; Moita, Luis F.] Univ Lisbon, Fac Med, Inst Mol Med, Cell Biol Immune Syst Unit, P-1649028 Lisbon, Portugal; [Hacohen, Nir] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Hacohen, Nir] Broad Inst Harvard, Cambridge, MA 02142 USA; [Hacohen, Nir] MIT, Cambridge, MA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universidade de Lisboa; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Savina, A (corresponding author), Inst Curie, INSERM U653, 26 Rue Ulm, F-75248 Paris 05, France.	ariel.savina@curie.fr; sebastian.amigorena@curie.fr	Carmo, Nuno/L-9869-2017; Moita, Luis F./L-1296-2013; Moita, Luis/HCI-2793-2022; Cebrian, Ignacio/L-2764-2016; Carmo, Nuno/AAP-7327-2021	Carmo, Nuno/0000-0001-6570-7400; Moita, Luis F./0000-0003-0707-315X; Moita, Luis/0000-0003-0707-315X; Cebrian, Ignacio/0000-0001-6505-0875; Ferreira Moita, Catarina/0000-0002-9910-2343; Amigorena, Sebastian/0000-0001-8583-8416	Institut National de la Sainte et de la Recherche Medicale (INSERM); Ligue National de Lutte contre le Cancer (LLNC); Institut Curie; Contrat CEE DC-Thera [LSBH-CT-2004-512074, LSHC-CT-2006-518234]; Fondation Bettencourt and Association de Recherche contre le Cancer; Fundacao, Luso-Americana para o Desenvolvimento and Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-MII/69280/2006, PTDC/SAU-MII/78333/2006]	Institut National de la Sainte et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue National de Lutte contre le Cancer (LLNC); Institut Curie; Contrat CEE DC-Thera; Fondation Bettencourt and Association de Recherche contre le Cancer; Fundacao, Luso-Americana para o Desenvolvimento and Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology)	We are grateful to J. Villadangos and P. Schnorrer (Melbourne University) for help with the DC sorting protocols. We also specially thank A. Boissonnas, C. Hivroz, S. Dogniaux, S. Krumeich, and K. Chemin for experimental help and reagents and A. Lennon for comments on the manuscript. This work was supported by Institut National de la Sainte et de la Recherche Medicale (INSERM), Ligue National de Lutte contre le Cancer (LLNC), the Institut Curie, Contrat CEE DC-Thera No LSBH-CT-2004-512074 "Dendritic Cells for novel immunotherapies" and Contrat CEE CancerImmunotherapy LSHC-CT-2006-518234 "Cancer Immunology and Immunotherapy," Fondation Bettencourt and Association de Recherche contre le Cancer (prix L. Griffuel), and Fundacao, Luso-Americana para o Desenvolvimento and Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-MII/69280/2006 and PTDC/SAU-MII/78333/2006). A.S. was supported by INSERM; A.P. by LLNC.	BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Forman HJ, 2001, IUBMB LIFE, V51, P365; Graham DB, 2007, J EXP MED, V204, P2889, DOI 10.1084/jem.20071283; Greenberg S, 1999, J LEUKOCYTE BIOL, V66, P712, DOI 10.1002/jlb.66.5.712; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Lutzner N, 2008, J BIOL CHEM, V283, P36185, DOI 10.1074/jbc.M806500200; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Maldonado-Lopez R, 2001, J IMMUNOL, V167, P4345, DOI 10.4049/jimmunol.167.8.4345; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Ming WY, 2007, MOL CELL BIOL, V27, P312, DOI 10.1128/MCB.00985-06; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Niedergang F, 2005, CURR TOP MICROBIOL, V291, P43; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Ritter U, 2004, EUR J IMMUNOL, V34, P1542, DOI 10.1002/eji.200324586; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Werner E, 2004, J CELL SCI, V117, P143, DOI 10.1242/jcs.00937; Williams DA, 2000, BLOOD, V96, P1646; Yamauchi A, 2004, J IMMUNOL, V173, P5971, DOI 10.4049/jimmunol.173.10.5971; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	44	208	213	4	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 17	2009	30	4					544	555		10.1016/j.immuni.2009.01.013	http://dx.doi.org/10.1016/j.immuni.2009.01.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19328020	Bronze			2022-12-18	WOS:000265319000011
J	Ng, G; Sharma, K; Ward, SM; Desrosiers, MD; Stephens, LA; Schoel, WM; Li, TL; Lowell, CA; Ling, CC; Amrein, MW; Shi, Y				Ng, Gilbert; Sharma, Karan; Ward, Sandra M.; Desrosiers, Melanie D.; Stephens, Leslie A.; Schoel, W. Michael; Li, Tonglei; Lowell, Clifford A.; Ling, Chang-Chun; Amrein, Matthias W.; Shi, Yan			Receptor-Independent, Direct Membrane Binding Leads to Cell-Surface Lipid Sorting and Syk Kinase Activation in Dendritic Cells	IMMUNITY			English	Article							MONOSODIUM URATE CRYSTALS; URIC-ACID; TYROSINE KINASES; INNATE IMMUNITY; DANGER SIGNAL; PHAGOCYTOSIS; RAFTS; MACROPHAGES; INFLAMMATION; SYSTEM	Binding of particulate antigens by antigen-presenting cells is a critical step in immune activation. Previously, we demonstrated that uric acid crystals are potent adjuvants, initiating a robust adaptive immune response. However, the mechanisms of activation are unknown. By using atomic force microscopy as a tool for real-time single-cell activation analysis, we report that uric acid crystals could directly engage cellular membranes, particularly the cholesterol components, with a force substantially stronger than protein-based cellular contacts. Binding of particulate substances activated Syk kinase-dependent signaling in dendritic cells. These observations suggest a mechanism whereby immune cell activation can be triggered by solid structures via membrane lipid alteration without the requirement for specific cell-surface receptors, and a testable hypothesis for crystal-associated arthropathies, inflammation, and adjuvanticity.	[Ng, Gilbert; Sharma, Karan; Desrosiers, Melanie D.; Stephens, Leslie A.; Shi, Yan] Univ Calgary, Dept Microbiol & Infect Dis, Immunol Res Grp, Calgary, AB T2N 4N1, Canada; [Ward, Sandra M.; Ling, Chang-Chun] Univ Calgary, Dept Chem, Immunol Res Grp, Calgary, AB T2N 4N1, Canada; [Schoel, W. Michael; Amrein, Matthias W.] Univ Calgary, Dept Biol & Anat, Immunol Res Grp, Calgary, AB T2N 4N1, Canada; [Li, Tonglei] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of Calgary; University of Calgary; University of Calgary; University of Kentucky; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shi, Y (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Immunol Res Grp, Calgary, AB T2N 4N1, Canada.	yshi@ucalgary.ca	Sharma, Kiran/C-5715-2014; Shi, Yan/Y-6642-2019; Sharma, Kiran/GZL-1834-2022	Sharma, Kiran/0000-0002-1200-8857; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064666] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI064666, R21 AI064666-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abram C.L., 2007, SCI STKE, V2007, pre2; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Behrens MD, 2008, BLOOD, V111, P1472, DOI 10.1182/blood-2007-10-117184; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Desrosiers MD, 2007, J IMMUNOL, V179, P1884, DOI 10.4049/jimmunol.179.3.1884; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; Gardiner EE, 2008, BLOOD, V111, P165, DOI 10.1182/blood-2007-04-086983; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Hu DE, 2004, CANCER RES, V64, P5059, DOI 10.1158/0008-5472.CAN-04-1586; Hughes AL, 1996, J MOL EVOL, V42, P247, DOI 10.1007/BF02198851; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Liu-Bryan R, 2005, J IMMUNOL, V174, P5016, DOI 10.4049/jimmunol.174.8.5016; Lohi O, 1998, APOPTOSIS, V3, P335, DOI 10.1023/A:1009672903627; MANDEL N, 1994, J AM SOC NEPHROL, V5, pS37; MANDEL NS, 1976, ARTHRITIS RHEUM, V19, P439, DOI 10.1002/1529-0131(197605/06)19:3+<439::AID-ART1780190719>3.0.CO;2-L; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Moriya K, 1997, P NATL ACAD SCI USA, V94, P12539, DOI 10.1073/pnas.94.23.12539; Panorchan P, 2006, J MOL BIOL, V358, P665, DOI 10.1016/j.jmb.2006.02.021; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Scott P, 2006, J IMMUNOL, V177, P6370, DOI 10.4049/jimmunol.177.9.6370; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2006, J IMMUNOL, V176, P3905, DOI 10.4049/jimmunol.176.7.3905; SMYTH CJ, 1998, GOUT HYPERURICEMIA O; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; van Meer G, 2005, EMBO REP, V6, P418, DOI 10.1038/sj.embor.7400410; WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	43	208	217	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					807	818		10.1016/j.immuni.2008.09.013	http://dx.doi.org/10.1016/j.immuni.2008.09.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	18993083	Green Accepted, Bronze			2022-12-18	WOS:000261036000017
J	Ludford-Menting, MJ; Oliaro, J; Sacirbegovic, F; Cheah, ETY; Pedersen, N; Thomas, SJ; Pasam, A; Iazzolino, R; Dow, LE; Waterhouse, NJ; Murphy, A; Ellis, S; Smyth, MJ; Kershaw, MH; Darcy, PK; Humbert, PO; Russell, SM				Ludford-Menting, MJ; Oliaro, J; Sacirbegovic, F; Cheah, ETY; Pedersen, N; Thomas, SJ; Pasam, A; Iazzolino, R; Dow, LE; Waterhouse, NJ; Murphy, A; Ellis, S; Smyth, MJ; Kershaw, MH; Darcy, PK; Humbert, PO; Russell, SM			A network of PDZ-containing proteins regulates T cell polarity and morphology during migration and immunological synapse formation	IMMUNITY			English	Article							LARGE TUMOR-SUPPRESSOR; DISCS-LARGE; COMPLEMENT REGULATOR; HUMAN HOMOLOG; GIANT-LARVAE; CD46; ACTIVATION; RECEPTOR; PROLIFERATION; COMPLEXES	T cell shape is dictated by the selective recruitment of molecules to different regions of the cell (polarity) and is integral to every aspect of T cell function, from migration to cytotoxicity. This study describes a mechanism for the regulation of T cell polarity. We show that T cells contain a network of asymmetrically distributed proteins with the capacity to dictate the subcellular localization of both cell surface receptors and morphological determinants in T cells. Proteins from the Scribble, Crumbs3, and Par3 complexes, previously shown to regulate epithelial polarity, were polarized in T cells containing either uropods or immunological synapses. Reduction in Scribble expression prevented the polarization of cell surface receptors and prevented morphological changes associated with uropod formation, migration, and antigen presentation. By dynamically coordinating molecular distribution throughout the T cell, this network provides a mechanism by which T cell function and polarity are linked.	Peter MacCallum Canc Ctr, Immune Signalling Lab, Melbourne, Vic 3002, Australia; Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet Lab, Melbourne, Vic 3002, Australia; Peter MacCallum Canc Ctr, Canc Cell Death Lab, Melbourne, Vic 3002, Australia; Peter MacCallum Canc Ctr, Cellular Immun Lab, Melbourne, Vic 3002, Australia; Peter MacCallum Canc Ctr, Microscopy Facil, Melbourne, Vic 3002, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center	Russell, SM (corresponding author), Peter MacCallum Canc Ctr, Immune Signalling Lab, Melbourne, Vic 3002, Australia.	sarah.russell@petermac.org	Smyth, Mark J/H-8709-2014; Waterhouse, Nigel/I-9813-2016; Humbert, Patrick O/L-4264-2016; Russell, Sarah M/B-9341-2009	Smyth, Mark J/0000-0001-7098-7240; Humbert, Patrick O/0000-0002-1366-6691; Russell, Sarah M/0000-0001-5826-9641; Darcy, Phillip/0000-0002-5303-9561; Kershaw, Michael/0000-0002-2697-487X; Dow, Lukas/0000-0001-7048-1418; Ellis, Sarah/0000-0002-5772-6051; Oliaro, Jane/0000-0002-2097-6428	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDREOLI C, 1994, J CELL SCI, V107, P2509; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Crimeen-Irwin B, 2003, J BIOL CHEM, V278, P46927, DOI 10.1074/jbc.M308261200; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; Das V, 2002, IMMUNOL REV, V189, P123, DOI 10.1034/j.1600-065X.2002.18911.x; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Dow LE, 2003, ONCOGENE, V22, P9225, DOI 10.1038/sj.onc.1207154; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Friedl P, 2004, TRENDS CELL BIOL, V14, P557, DOI 10.1016/j.tcb.2004.09.005; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Haynes NM, 1999, CANCER IMMUNOL IMMUN, V47, P278, DOI 10.1007/s002620050532; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lee OK, 2003, NAT CELL BIOL, V5, P987, DOI 10.1038/ncb1055; Ludford-Menting MJ, 2002, J BIOL CHEM, V277, P4477, DOI 10.1074/jbc.M108479200; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Montoya MC, 2002, IMMUNOL REV, V186, P68, DOI 10.1034/j.1600-065X.2002.18607.x; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Ralston KJ, 2004, J BIOL CHEM, V279, P33816, DOI 10.1074/jbc.M401040200; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Roh MH, 2003, AM J PHYSIOL-RENAL, V285, pF377, DOI 10.1152/ajprenal.00086.2003; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Russell S, 2004, TISSUE ANTIGENS, V64, P111, DOI 10.1111/j.1399-0039.2004.00277.x; RUSSELL SM, 1992, EUR J IMMUNOL, V22, P1513, DOI 10.1002/eji.1830220625; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; San-Antonio B, 2002, J BIOL CHEM, V277, P27073, DOI 10.1074/jbc.M106983200; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; SINCHCOMBE J, 2004, SCIENCE, V305, P55; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tibaldi EV, 2002, P NATL ACAD SCI USA, V99, P7582, DOI 10.1073/pnas.112212699; van der Merwe PA, 2002, CURR OPIN IMMUNOL, V14, P293, DOI 10.1016/S0952-7915(02)00350-3; Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233; WEI X, 1996, P NATL ACAD SCI USA, V96, P8471; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Zaffran Y, 2001, J IMMUNOL, V167, P6780, DOI 10.4049/jimmunol.167.12.6780; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158	66	208	210	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					737	748		10.1016/j.immuni.2005.04.009	http://dx.doi.org/10.1016/j.immuni.2005.04.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963788	Bronze			2022-12-18	WOS:000230180300011
J	Zheng, XX; Sanchez-Fueyo, A; Sho, M; Domenig, C; Sayegh, MH; Strom, TB				Zheng, XX; Sanchez-Fueyo, A; Sho, M; Domenig, C; Sayegh, MH; Strom, TB			Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance	IMMUNITY			English	Article							NONOBESE DIABETIC MICE; IN-VIVO; NOD MICE; ALLOGRAFT TOLERANCE; CLONAL EXPANSION; GENE TRANSCRIPTS; IL-2; LYMPHOCYTES; APOPTOSIS; INDUCTION	Therapeutic application of broadly reactive anti-T cell antibodies can lead not only to potent immunosuppression but also to profound and long-lived T cell depletion. We reasoned that a strategy that almost exclusively targets activated cytopathic donor reactive T cells and spares immunoregulatory networks might prove to be an exceptionally potent and highly selective means of producing long-term engraftment and tolerance. Herein we show that the combined administration of rapamycin and agonist IL-2- and antagonist IL-15-related cytolytic fusion proteins provides for long-term engraftment/tolerance in exceptionally stringent allotransplant models by (1) limiting the early expansion of activated T cells, (2) preserving and even exaggerating their subsequent apoptotic clearance, and (3) further amplifying the depletion of these activated T cells by antibody-dependent mechanisms, while (4) preserving CD4(+)CD25(+) T cell-dependent immunoregulatory networks.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Immunol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Lab Immunogenet & Transplantat, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zheng, XX (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Immunol, Boston, MA 02215 USA.			Domenig, Christoph/0000-0001-5240-5331				Adachi M, 1996, BLOOD, V88, P4118, DOI 10.1182/blood.V88.11.4118.bloodjournal88114118; Banz A, 2002, J IMMUNOL, V169, P750, DOI 10.4049/jimmunol.169.2.750; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Cobbold S, 1998, CURR OPIN IMMUNOL, V10, P518, DOI 10.1016/S0952-7915(98)80217-3; Dai ZH, 1999, J IMMUNOL, V163, P3131; Dai ZH, 1998, J IMMUNOL, V161, P1659; Faust A, 1996, TRANSPLANTATION, V62, P648, DOI 10.1097/00007890-199609150-00019; Ferrari-Lacraz S, 2001, J IMMUNOL, V167, P3478, DOI 10.4049/jimmunol.167.6.3478; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Graca L, 2002, J IMMUNOL, V168, P5558, DOI 10.4049/jimmunol.168.11.5558; HALL BM, 1990, J EXP MED, V171, P141, DOI 10.1084/jem.171.1.141; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kim YS, 1998, J IMMUNOL, V160, P5742; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Kishimoto K, 2000, J CLIN INVEST, V106, P63, DOI 10.1172/JCI9586; KNEITZ B, 1995, EUR J IMMUNOL, V25, P2572, DOI 10.1002/eji.1830250925; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Li XC, 2001, NAT MED, V7, P114, DOI 10.1038/83253; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; LINDAHL KF, 1977, J EXP MED, V145, P508, DOI 10.1084/jem.145.3.508; LINDAHL KF, 1977, J EXP MED, V145, P500, DOI 10.1084/jem.145.3.500; LIPMAN ML, 1992, TRANSPLANTATION, V53, P73, DOI 10.1097/00007890-199201000-00014; LIPMAN ML, 1994, J IMMUNOL, V152, P5120; MAKI T, 1992, P NATL ACAD SCI USA, V89, P3434, DOI 10.1073/pnas.89.8.3434; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Markees TG, 1999, DIABETES, V48, P967, DOI 10.2337/diabetes.48.5.967; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Noorchashm H, 2000, J IMMUNOL, V165, P4685, DOI 10.4049/jimmunol.165.8.4685; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Papiernik M, 1997, J IMMUNOL, V158, P4642; Rabinovitch A, 2002, DIABETES, V51, P638, DOI 10.2337/diabetes.51.3.638; Renno T, 1999, J IMMUNOL, V162, P6312; Sanchez-Fueyo A, 2002, J IMMUNOL, V168, P2274, DOI 10.4049/jimmunol.168.5.2274; STEIGER J, 1995, J IMMUNOL, V155, P489; STEURER W, 1995, J IMMUNOL, V155, P1165; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Taylor PA, 2001, J EXP MED, V193, P1311, DOI 10.1084/jem.193.11.1311; TEH HS, 1977, J IMMUNOL, V118, P1049; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(09)00091-0; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wells AD, 2001, J CLIN INVEST, V108, P895, DOI 10.1172/JCI200113220; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Zelenika D, 2002, J IMMUNOL, V168, P1069, DOI 10.4049/jimmunol.168.3.1069; Zheng XX, 1999, J IMMUNOL, V163, P4041	49	208	224	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2003	19	4					503	514		10.1016/S1074-7613(03)00259-0	http://dx.doi.org/10.1016/S1074-7613(03)00259-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563315	Bronze			2022-12-18	WOS:000186051900007
J	WINDHAGEN, A; SCHOLZ, C; HOLLSBERG, P; FUKAURA, H; SETTE, A; HAFLER, DA				WINDHAGEN, A; SCHOLZ, C; HOLLSBERG, P; FUKAURA, H; SETTE, A; HAFLER, DA			MODULATION OF CYTOKINE PATTERNS OF HUMAN AUTOREACTIVE T-CELL CLONES BY A SINGLE AMINO-ACID SUBSTITUTION OF THEIR PEPTIDE LIGAND	IMMUNITY			English	Article							MYELIN BASIC-PROTEIN; GROWTH-FACTOR-BETA; ANTIGEN-PRESENTING CELLS; HUMAN LYMPHOCYTES-T; RECEPTOR ANTAGONISM; ORAL TOLERIZATION; FACTOR-BETA-1; ENCEPHALOMYELITIS; PROLIFERATION; SEPARATION	We demonstrate that cognate peptide ligands altered at T cell receptor (TCR) contact residues and bound to class II major histocompatability complex can change the cytokine pattern of mature T cell clones. Myelin basic protein peptide 85-99-reactive ThO T cell clones were stimulated with altered peptide ligands, which acted both as TCR antagonist and induced new mRNA synthesis and protein secretion of TGF-beta 1, while no longer inducing mRNA synthesis or protein secretion of IL-2, IL-4, IL-10, and IFN gamma. The modified peptides failed to induce a detectable calcium flux, p56(lck) activation, or thymidine incorporation, yet triggered nearly equal amounts of IL-4 secretion in the presence of ionomycin. Antigen-induced modulation of T cell cytokine secretion may be important In regulating the immune response.	HARVARD UNIV,SCH MED,BOSTON,MA 02115; CYTEL CORP,SAN DIEGO,CA 92121	Harvard University; Harvard Medical School	WINDHAGEN, A (corresponding author), BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,MOLEC IMMUNOL LAB,BOSTON,MA 02115, USA.		Scholz, Christian W/Q-2778-2017; Sette, Alessandro/AFO-8916-2022	Scholz, Christian W/0000-0001-6260-4086; 				ALEXANDER J, 1993, J IMMUNOL, V150, P1; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOLLSBERG P, 1994, J IMMUNOL, V153, P566; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; KUCHROO VK, 1994, J IMMUNOL, V153, P3326; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; MILLER A, 1992, P NATL ACAD SCI USA, V89, P421, DOI 10.1073/pnas.89.1.421; MILLER A, 1993, J IMMUNOL, V151, P7307; Mossmann TR, 1986, J IMMUNOL, V136, P2348; OSTROV D, 1993, J IMMUNOL, V150, P4277; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; RACKE MK, 1991, J IMMUNOL, V146, P3012; ROJO JM, 1989, COLD SPRING HARB SYM, V2, P657; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; RUDD CE, 1994, IMMUNOL TODAY, V15, P225, DOI 10.1016/0167-5699(94)90248-8; RUPPERT J, 1993, P NATL ACAD SCI USA, V90, P2671, DOI 10.1073/pnas.90.7.2671; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SLOANLANCASTER J, 1994, J EXP MED, V180, P1195, DOI 10.1084/jem.180.4.1195; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; SMITH LS, 1976, BIOCHEM BIOPH RES CO, V71, P459, DOI 10.1016/0006-291X(76)90809-3; WAHL SM, 1991, IMMUNOL RES, V10, P249, DOI 10.1007/BF02919701; WOLD F, 1981, ANNU REV BIOCHEM, V50, P783, DOI 10.1146/annurev.bi.50.070181.004031; WUCHERPFENNIG KW, 1990, SCIENCE, V248, P1016, DOI 10.1126/science.1693015; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P1	38	208	218	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1995	2	4					373	380		10.1016/1074-7613(95)90145-0	http://dx.doi.org/10.1016/1074-7613(95)90145-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU616	7536622	Bronze			2022-12-18	WOS:A1995QU61600007
J	Bonnardel, J; T'Jonck, W; Gaublomme, D; Browaeys, R; Scott, CL; Martens, L; Vanneste, B; De Prijck, S; Nedospasov, SA; Kremer, A; Van Hamme, E; Borghgraef, P; Toussaint, W; De Bleser, P; Mannaerts, I; Beschin, A; van Grunsven, LA; Lambrecht, BN; Taghon, T; Lippens, S; Elewaut, D; Saeys, Y; Guilliams, M				Bonnardel, Johnny; T'Jonck, Wouter; Gaublomme, Djoere; Browaeys, Robin; Scott, Charlotte L.; Martens, Liesbet; Vanneste, Bavo; De Prijck, Sofie; Nedospasov, Sergei A.; Kremer, Anna; Van Hamme, Evelien; Borghgraef, Peter; Toussaint, Wendy; De Bleser, Pieter; Mannaerts, Inge; Beschin, Alain; van Grunsven, Leo A.; Lambrecht, Bart N.; Taghon, Tom; Lippens, Saskia; Elewaut, Dirk; Saeys, Yvan; Guilliams, Martin			Stellate Cells, Hepatocytes, and Endothelial Cells Imprint the Kupffer Cell Identity on Monocytes Colonizing the Liver Macrophage Niche	IMMUNITY			English	Article							GENE-EXPRESSION; TISSUE; SIGNALS; LIGHT	Macrophages are strongly adapted to their tissue of residence. Yet, little is known about the cell-cell interactions that imprint the tissue-specific identities of macrophages in their respective niches. Using conditional depletion of liver Kupffer cells, we traced the developmental stages of monocytes differentiating into Kupffer cells and mapped the cellular interactions imprinting the Kupffer cell identity. Kupffer cell loss induced tumor necrosis factor (TNF)- and interleukin-1 (IL-1) receptor-dependent activation of stellate cells and endothelial cells, resulting in the transient production of chemokines and adhesion molecules orchestrating monocyte engraftment. Engrafted circulating monocytes transmigrated into the perisinusoidal space and acquired the liver-associated transcription factors inhibitor of DNA 3 (ID3) and liver X receptor-alpha (LXR-alpha). Coordinated interactions with hepatocytes induced ID3 expression, whereas endothelial cells and stellate cells induced LXR-alpha via a synergistic NOTCH-BMP pathway. This study shows that the Kupffer cell niche is composed of stellate cells, hepatocytes, and endothelial cells that together imprint the liver-specific macrophage identity.	[Bonnardel, Johnny; T'Jonck, Wouter; Scott, Charlotte L.; Vanneste, Bavo; De Prijck, Sofie; Guilliams, Martin] VIB Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium; [Bonnardel, Johnny; T'Jonck, Wouter; Scott, Charlotte L.; Martens, Liesbet; Vanneste, Bavo; De Prijck, Sofie; Kremer, Anna; Van Hamme, Evelien; Borghgraef, Peter; De Bleser, Pieter; Lippens, Saskia; Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Gaublomme, Djoere; Elewaut, Dirk] VIB Ctr Inflammat Res, Unit Mol Immunol & Inflammat, Ghent, Belgium; [Gaublomme, Djoere; Toussaint, Wendy; Lambrecht, Bart N.; Elewaut, Dirk] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium; [Browaeys, Robin; Martens, Liesbet; De Bleser, Pieter; Saeys, Yvan] VIB Ctr Inflammat Res, Data Min & Modeling Biomed, Ghent, Belgium; [Browaeys, Robin; Saeys, Yvan] Univ Ghent, Dept Appl Math Comp Sci & Stat, Ghent, Belgium; [Scott, Charlotte L.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Nedospasov, Sergei A.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Nedospasov, Sergei A.] Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia; [Kremer, Anna; Van Hamme, Evelien; Borghgraef, Peter; Lippens, Saskia] VIB, VIB Bioimaging Core, Ghent, Belgium; [Toussaint, Wendy; Lambrecht, Bart N.] VIB Ctr Inflammat Res, Lab Mucosal Immunol & Immunoregulat, Ghent, Belgium; [Mannaerts, Inge; van Grunsven, Leo A.] Vrije Univ Brussel, Liver Cell Biol Res Grp, Brussels, Belgium; [Beschin, Alain] VIB Ctr Inflammat Res, Myeloid Cell Immunol Lab, Brussels, Belgium; [Beschin, Alain] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Taghon, Tom] Univ Ghent, Dept Diagnost Sci, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Glasgow; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Ghent University; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Ghent University	Guilliams, M (corresponding author), VIB Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium.; Guilliams, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	johnny.bonnardel@irc.vib-ugent.be; martin.guilliams@irc.vib-ugent.be	Browaeys, Robin/AAF-6627-2019; Saeys, Yvan/C-1311-2009; Guilliams, Martin/N-7803-2013; De Bleser, Pieter/AAB-2968-2021; T'Jonck, Wouter/AAY-1476-2021; Mannaerts, Inge/AAC-5487-2019; Lambrecht, Bart N/K-2484-2014; van Grunsven, Leo/E-5839-2010	Browaeys, Robin/0000-0003-2934-5195; Saeys, Yvan/0000-0002-0415-1506; Guilliams, Martin/0000-0003-3525-7570; T'Jonck, Wouter/0000-0002-9390-525X; Mannaerts, Inge/0000-0002-2235-2555; Lambrecht, Bart N/0000-0003-4376-6834; van Grunsven, Leo/0000-0002-0990-7034; Elewaut, Dirk/0000-0002-7468-974X; Martens, Liesbet/0000-0001-9180-7456; T'Jonck, Wouter/0000-0002-7494-1458; Vanneste, Bavo/0000-0002-4152-5634; Lippens, Saskia/0000-0002-8261-3462; Taghon, Tom/0000-0002-5781-0288; Bonnardel, Johnny/0000-0003-2359-3438	Fonds voor Wetenschappelijk Onderzoek (FWO) [12I0617N]; FWO [1181318N]; BOF Ghent University fellowship; FWO; ERC Consolidator Grant; GOA Ghent University	Fonds voor Wetenschappelijk Onderzoek (FWO)(FWO); FWO(FWO); BOF Ghent University fellowship; FWO(FWO); ERC Consolidator Grant(Estonian Research Council); GOA Ghent University	We thank the VIB-IRC Flow Cytometry and the VIB-IRC Microscopy Core Facilities for assistance. We thank Kiavash Movahedi for the PLX3397 protocol and Mohamed Lamkanfi for the Anakinra. This study benefitted from data assembled by the Immgen Consortium. J.B. is supported by an Fonds voor Wetenschappelijk Onderzoek (FWO) postdoctoral fellowship (12I0617N). R.B. is supported by an FWO PhD fellowship (1181318N). W.T. is supported by a BOF Ghent University fellowship. The Guilliams lab is supported by the FWO, a GOA Ghent University grant and an ERC Consolidator Grant (KupfferCellNiche).	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Begemann Isabell, 2016, Front Synaptic Neurosci, V8, P28, DOI 10.3389/fnsyn.2016.00028; Bishop D, 2011, NAT METHODS, V8, P568, DOI [10.1038/NMETH.1622, 10.1038/nmeth.1622]; Browaeys R.S, 2019, NICHENET MODELING IN; Cavalli G, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01157; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gerhardt T, 2015, CARDIOVASC RES, V107, P321, DOI 10.1093/cvr/cvv147; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Halpern KB, 2018, NAT BIOTECHNOL, V36, P962, DOI 10.1038/nbt.4231; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Metchnikoff E, 1892, LECONS PATHOLOGIE CO, VG; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Paul-Gilloteaux P, 2017, NAT METHODS, V14, P102, DOI 10.1038/nmeth.4170; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Steeland S, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708300; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Urwyler O, 2015, DEVELOPMENT, V142, P394, DOI 10.1242/dev.115071; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Van de Walle I, 2011, BLOOD, V117, P4449, DOI 10.1182/blood-2010-06-290049; von Kupffer K. W., 1876, ARCH MIKROSK ANAT, V12, P353, DOI DOI 10.1007/BF02933897; Wake Kenjiro, 2004, Comp Hepatol, V3 Suppl 1, pS2, DOI 10.1186/1476-5926-2-S1-S2; Wang YM, 2014, EUR J IMMUNOL, V44, P1575, DOI 10.1002/eji.201344365; Yan D, 2017, ONCOGENE, V36, P6049, DOI 10.1038/onc.2017.261; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015	42	207	209	5	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					638	654		10.1016/j.immuni.2019.08.017	http://dx.doi.org/10.1016/j.immuni.2019.08.017			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31561945	hybrid, Green Published			2022-12-18	WOS:000490141700011
J	Bachem, A; Makhlouf, C; Binger, KJ; de Souza, DP; Tull, D; Hochheiser, K; Whitney, PG; Fernandez-Ruiz, D; Dahling, S; Kastemuller, W; Jonsson, J; Gressier, E; Lew, AM; Perdomo, C; Kupz, A; Figgett, W; Mackay, F; Oleshansky, M; Russ, BE; Parish, IA; Kallies, A; McConville, MJ; Tumer, SJ; Gebhardt, T; Bedoui, S				Bachem, Annabel; Makhlouf, Christina; Binger, Katrina J.; de Souza, David P.; Tull, Deidra; Hochheiser, Katharina; Whitney, Paul G.; Fernandez-Ruiz, Daniel; Dahling, Sabrina; Kastemuller, Wolfgang; Jonsson, Johanna; Gressier, Elise; Lew, Andrew M.; Perdomo, Carolina; Kupz, Andreas; Figgett, William; Mackay, Fabienne; Oleshansky, Moshe; Russ, Brendan E.; Parish, Ian A.; Kallies, Axel; McConville, Malcolm J.; Tumer, Stephen J.; Gebhardt, Thomas; Bedoui, Sammy			Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8(+) T Cells	IMMUNITY			English	Article							COMMENSAL BACTERIA; GUT MICROBIOTA; TRANSCRIPTIONAL CONTROL; METABOLISM; EFFECTOR; VIRUS; IMMUNITY; SUBSETS; DISEASE; LIMIT	Interactions with the microbiota influence many aspects of immunity, including immune cell development, differentiation, and function. Here, we examined the impact of the microbiota on CD8(+) T cell memory. Antigen-activated CD8(+) T cells transferred into germ-free mice failed to transition into long-lived memory cells and had transcriptional impairments in core genes associated with oxidative metabolism. The microbiota-derived short-chain fatty acid (SCFA) butyrate promoted cellular metabolism, enhanced memory potential of activated CD8(+) T cells, and SCFAs were required for optimal recall responses upon antigen re-encounter. Mechanistic experiments revealed that butyrate uncoupled the tricarboxylic acid cycle from glycolytic input in CD8(+) T cells, which allowed preferential fueling of oxidative phosphorylation through sustained glutamine utilization and fatty acid catabolism. Our findings reveal a role for the microbiota in promoting CDS+ T cell long-term survival as memory cells and suggest that microbial metabolites guide the metabolic rewiring of activated CD8(+) T cells to enable this transition.	[Bachem, Annabel; Makhlouf, Christina; Hochheiser, Katharina; Whitney, Paul G.; Fernandez-Ruiz, Daniel; Dahling, Sabrina; Jonsson, Johanna; Gressier, Elise; Figgett, William; Mackay, Fabienne; Kallies, Axel; Gebhardt, Thomas; Bedoui, Sammy] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Binger, Katrina J.; de Souza, David P.; Tull, Deidra; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Kastemuller, Wolfgang] Univ Wurzburg, Inst Syst Immunol, D-97070 Wurzburg, Germany; [Lew, Andrew M.] Walter & Eliza Hall Inst Med Res, Immunol Div, Parkville, Vic 3010, Australia; [Perdomo, Carolina; Kupz, Andreas] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Kupz, Andreas] James Cook Univ, Ctr Biosecur & Trop Infect Dis, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia; [Oleshansky, Moshe; Russ, Brendan E.; Tumer, Stephen J.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Parish, Ian A.] Peter MacCallum Canc Ctr, Canc Immunol Program, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Wurzburg; Walter & Eliza Hall Institute; Max Planck Society; James Cook University; Monash University; Peter Maccallum Cancer Center	Bedoui, S (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	sbedoui@unimelb.edu.au	Mackay, Fabienne/B-7440-2008; De Souza, David P/O-9800-2016; Fernandez Ruiz, Daniel/N-2304-2014; Binger, Katrina/G-6640-2018	Mackay, Fabienne/0000-0002-6074-2693; De Souza, David P/0000-0002-7225-2632; Parish, Ian/0000-0003-3528-478X; Fernandez Ruiz, Daniel/0000-0002-4040-9121; Binger, Katrina/0000-0003-1139-3308; Bachem, Annabell/0000-0002-0047-2097; BEDOUI, SAMMY/0000-0002-7443-0543; Tull, Dedreia/0000-0003-2546-6707; Kupz, Andreas/0000-0002-9259-7873; Russ, Brendan/0000-0001-6862-5283; Figgett, William/0000-0003-2947-478X; Kallies, Axel/0000-0002-6312-6968	National Health and Medical Research Council of Australia [APP1124815, APP1071916, APP1103895, APP1154540]; Sylvia & Charles Viertel Charitable Foundation; 350 th Anniversary Research Grant from Merck KgGA (Darmstadt, Germany); German Research Council [BA 5108/1-1]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sylvia & Charles Viertel Charitable Foundation; 350 th Anniversary Research Grant from Merck KgGA (Darmstadt, Germany); German Research Council(German Research Foundation (DFG))	We would like to thank Dr. Francis Carbone, Dr. William R. Heath, and Ms. Maike Effern for critical reading of the manuscript; Drs. Ian Trounce and Jonathan Crowston for expert advice; and Dr. Stefan Offermanns for generously providing Ffar2<SUP>-/-</SUP>; Ffar3<SUP>-/-</SUP> mice. The excellent technical expertise in breeding, maintaining, and manipulating SPF mice by the Doherty Bio-resources facility and GF mice by Cameron Mackenzie at the Walter & Eliza Hall Institute for Medical Research is gratefully acknowledged. Our research is supported by the National Health and Medical Research Council of Australia (APP1124815, APP1071916, APP1103895, and APP1154540), the Sylvia & Charles Viertel Charitable Foundation, a 350 th Anniversary Research Grant from Merck KgGA (Darmstadt, Germany), and the German Research Council (BA 5108/1-1).	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Bedoui S, 2016, IMMUNOL REV, V272, P52, DOI 10.1111/imr.12426; Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008; Best SA, 2018, CELL METAB, V27, P935, DOI 10.1016/j.cmet.2018.02.006; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Busch DH, 2016, SEMIN IMMUNOL, V28, P28, DOI 10.1016/j.smim.2016.02.001; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kespohl M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01036; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kowalski GM, 2015, BIOCHEM BIOPH RES CO, V462, P27, DOI 10.1016/j.bbrc.2015.04.096; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Man K, 2015, NAT REV IMMUNOL, V15, P574, DOI 10.1038/nri3874; Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Mittrucker HW, 2014, EUR J IMMUNOL, V44, P1710, DOI 10.1002/eji.201343927; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Raud B, 2018, IMMUNOL REV, V283, P213, DOI 10.1111/imr.12655; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tanaka K, 2007, J IMMUNOL, V178, P5209, DOI 10.4049/jimmunol.178.8.5209; Tang C, 2015, NAT MED, V21, P173, DOI 10.1038/nm.3779; Tanoue T, 2019, NATURE, V565, P600, DOI 10.1038/s41586-019-0878-z; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319	53	207	212	10	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					285	+		10.1016/j.immuni.2019.06.002	http://dx.doi.org/10.1016/j.immuni.2019.06.002			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31272808	Bronze			2022-12-18	WOS:000482088500012
J	Britton, GJ; Contijoch, EJ; Mogno, I; Vennaro, OH; Llewellyn, SR; Ng, R; Li, ZH; Mortha, A; Merad, M; Das, A; Gevers, D; McGovern, DPB; Singh, N; Braun, J; Jacobs, JP; Clemente, JC; Grinspan, A; Sands, BE; Colombel, JF; Dubinsky, MC; Faith, JJ				Britton, Graham J.; Contijoch, Eduardo J.; Mogno, Ilaria; Vennaro, Olivia H.; Llewellyn, Sean R.; Ng, Ruby; Li, Zhihua; Mortha, Arthur; Merad, Miriam; Das, Anuk; Gevers, Dirk; McGovern, Dermot P. B.; Singh, Namita; Braun, Jonathan; Jacobs, Jonathan P.; Clemente, Jose C.; Grinspan, Ari; Sands, Bruce E.; Colombel, Jean-Frederic; Dubinsky, Marla C.; Faith, Jeremiah J.			Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and ROR gamma t(+) Regulatory T Cells and Exacerbate Colitis in Mice	IMMUNITY			English	Article							ACTIVE ULCERATIVE-COLITIS; INTESTINAL INFLAMMATION; BACTERIA; INDUCTION; COMMENSAL; MODEL; DIFFERENTIATION; TRANSPLANTATION; SUSCEPTIBILITY; IDENTIFICATION	Microbiota are thought to influence the development and progression of inflammatory bowel disease (IBD), but determining generalizable effects of microbiota on IBD etiology requires larger-scale functional analyses. We colonized germ-free mice with intestinal microbiotas from 30 healthy and IBD donors and determined the homeostatic intestinal T cell response to each microbiota. Compared to microbiotas from healthy donors, transfer of IBD microbiotas into germ-free mice increased numbers of intestinal Th17 cells and Th2 cells and decreased numbers of ROR gamma t(+) Treg cells. Colonization with IBD microbiotas exacerbated disease in a model where colitis is induced upon transfer of naive T cells into Rag1(-/-) mice. The proportions of Th17 and ROR gamma t(+) Treg cells induced by each microbiota were predictive of human disease status and accounted for disease severity in the Rag1(-/-) colitis model. Thus, an impact on intestinal Th17 and ROR gamma t(+) Treg cell compartments emerges as a unifying feature of IBD microbiotas, suggesting a general mechanism for microbial contribution to IBD pathogenesis.	[Britton, Graham J.; Contijoch, Eduardo J.; Mogno, Ilaria; Vennaro, Olivia H.; Llewellyn, Sean R.; Ng, Ruby; Li, Zhihua; Clemente, Jose C.; Faith, Jeremiah J.] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Britton, Graham J.; Contijoch, Eduardo J.; Mogno, Ilaria; Vennaro, Olivia H.; Llewellyn, Sean R.; Ng, Ruby; Li, Zhihua; Merad, Miriam; Clemente, Jose C.; Faith, Jeremiah J.] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Mortha, Arthur; Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Grinspan, Ari; Sands, Bruce E.; Colombel, Jean-Frederic; Dubinsky, Marla C.] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA; [Dubinsky, Marla C.] Icahn Sch Med Mt Sinai, Pediat Gastroenterol & Hepatol, New York, NY 10029 USA; [Mortha, Arthur] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Das, Anuk; Gevers, Dirk] Janssen Res & Dev LLC, Janssen Human Microbiome Inst, Spring House, PA USA; [McGovern, Dermot P. B.] Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Singh, Namita] Cedars Sinai Med Ctr, Pediat Gastroenterol & Inflammatory Bowel Dis, Los Angeles, CA 90048 USA; [Braun, Jonathan] UCLA, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Jacobs, Jonathan P.] Univ Calif Los Angeles, Dept Med, Div Digest Dis, Los Angeles, CA 90024 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Toronto; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Faith, JJ (corresponding author), Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA.; Faith, JJ (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.	jeremiah.faith@mssm.edu	Sands, Bruce/R-7887-2019; Britton, Graham/V-1370-2019; Britton, Graham/CAI-2177-2022; Gevers, Dirk/C-1451-2009; Mortha, Arthur/ABE-6250-2020	Sands, Bruce/0000-0001-5762-5042; Britton, Graham/0000-0003-4630-1223; Braun, Jonathan/0000-0003-1646-2974; Contijoch, Eduardo/0000-0002-2873-6808; Jacobs, Jonathan/0000-0003-4698-0254; Mortha, Arthur/0000-0003-2673-0485	NIH (NIGMS) [GM108505]; NIH (NCCIH) [AT008661]; Janssen Human Microbiome Institute; CCFA Microbiome Innovation Award [362048]; New York Crohn's Foundation; NIH [DK108487, DK112679, DK085691, CA016042, UL1TR000124]; Crohn's and Colitis Foundation of America; Cancer Center Support Grant [P30CA016087]; NATIONAL CANCER INSTITUTE [P30CA016042, P30CA016087] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P50AT008661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI118644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763, R01DK085691, F30DK108487, F31DK112679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108505] Funding Source: NIH RePORTER	NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH (NCCIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janssen Human Microbiome Institute; CCFA Microbiome Innovation Award; New York Crohn's Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Fermin, E. Vazquez, and G.N. Escano of the Mount Sinai Immunology Institute Gnotobiotic Facility for technical support. This work was supported by grants from the NIH (NIGMS GM108505 and NCCIH AT008661), Janssen Human Microbiome Institute, CCFA Microbiome Innovation Award (362048), and the New York Crohn's Foundation to J.J.F., NIH DK108487 to S.R.L., NIH DK112679 to E.J.C., and NIH DK085691, CA016042, and UL1TR000124 to J.B.G.J.B. is supported by a Research Fellowship Award from the Crohn's and Colitis Foundation of America. Next-generation sequencing was performed at NYU School of Medicine by the Genome Technology Center partially supported by the Cancer Center Support Grant, P30CA016087. This work was supported in part by the staff and resources of Scientific Computing and of the Flow Cytometry Core at the Icahn School of Medicine at Mount Sinai.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Allen JE, 2014, SEMIN IMMUNOL, V26, P329, DOI 10.1016/j.smim.2014.06.003; Atarashi K, 2017, SCIENCE, V358, P359, DOI 10.1126/science.aan4526; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cekanaviciute E, 2017, P NATL ACAD SCI USA, V114, P10713, DOI 10.1073/pnas.1711235114; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Chudnovskiy A, 2016, CELL, V167, P444, DOI 10.1016/j.cell.2016.08.076; Contijoch E, 2018, GUT MICROBIOTA DENSI, DOI [10.1101/277095, DOI 10.1101/277095]; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; De Palma G, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6397; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Du ZY, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0080-2; Eun CS, 2014, INFECT IMMUN, V82, P2239, DOI 10.1128/IAI.01513-13; Faith J. J, 2013, SCIENCE, V341; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Hansen J, 2010, CURR OPIN GASTROEN, V26, P564, DOI 10.1097/MOG.0b013e32833f1195; Hegazy AN, 2017, GASTROENTEROLOGY, V153, P1320, DOI 10.1053/j.gastro.2017.07.047; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Hovhannisyan Z, 2011, GASTROENTEROLOGY, V140, P957, DOI 10.1053/j.gastro.2010.12.002; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jacobs JP, 2016, CELL MOL GASTROENTER, V2, P750, DOI 10.1016/j.jcmgh.2016.06.004; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Llewellyn SR, 2018, GASTROENTEROLOGY, V154, P1037, DOI 10.1053/j.gastro.2017.11.030; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Moran JP, 2009, INFLAMM BOWEL DIS, V15, P1022, DOI 10.1002/ibd.20900; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Nagao-Kitamoto H, 2016, CELL MOL GASTROENTER, V2, P468, DOI 10.1016/j.jcmgh.2016.02.003; Natividad JM, 2015, INFLAMM BOWEL DIS, V21, P1883, DOI 10.1097/MIB.0000000000000422; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; Omenetti S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00639; Ostman S, 2006, EUR J IMMUNOL, V36, P2336, DOI 10.1002/eji.200535244; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Paramsothy S, 2017, LANCET, V389, P1218, DOI 10.1016/S0140-6736(17)30182-4; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Reyes A, 2013, P NATL ACAD SCI USA, V110, P20236, DOI 10.1073/pnas.1319470110; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Viladomiu M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9655; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	66	207	218	18	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					212	+		10.1016/j.immuni.2018.12.015	http://dx.doi.org/10.1016/j.immuni.2018.12.015			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650377	Green Accepted, Bronze			2022-12-18	WOS:000455661600021
J	Yoon, S; Kovalenko, A; Bogdanov, K; Wallach, D				Yoon, Seongmin; Kovalenko, Andrew; Bogdanov, Konstantin; Wallach, David			MLKL, the Protein that Mediates Necroptosis, Also Regulates Endosomal Trafficking and Extracellular Vesicle Generation	IMMUNITY			English	Article							MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; CELL-DEATH PATHWAY; PROGRAMMED NECROSIS; IN-VIVO; ACTIVATION; RECEPTORS; MECHANISM; RIP3; PHOSPHORYLATION	Activation of the pseudokinase mixed lineage kinase domain-like (MLKL) upon its phosphorylation by the protein kinase RIPK3 triggers necroptosis, a form of programmed cell death in which rupture of cellular membranes yields release of intracellular components. We report that MLKL also associated with endosomes and controlled the transport of endocytosed proteins, thereby enhancing degradation of receptors and ligands, modulating their induced signaling and facilitating the generation of extracellular vesicles. This role was exerted on two quantitative grades: a constitutive one independent of RIPK3, and an enhanced one, triggered by RIPK3, where the association of MLKL with the endosomes was enhanced, and it was found to bind endosomal sorting complexes required for transport (ESCRT) proteins and the flotillins and to be excluded, together with them, from cells within vesicles. We suggest that release of phosphorylated MLKL within extracellular vesicles serves as a mechanism for self-restricting the necroptotic activity of this protein.	[Yoon, Seongmin; Kovalenko, Andrew; Bogdanov, Konstantin; Wallach, David] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Wallach, D (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel.	d.wallach@weizmann.ac.il	Yoon, Seongmin/AAX-9394-2020					Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bissig C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016816; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Chiou N.-T., 2016, PROTOC EXCH; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Conos SA, 2017, P NATL ACAD SCI USA, V114, pE961, DOI 10.1073/pnas.1613305114; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gur G., 2006, ENDOCYTOSIS RECEPTOR; Han-Min S., 2014, NECROTIC CELL DEATH; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Krelin Y, 2008, CELL DEATH DIFFER, V15, P1350, DOI 10.1038/cdd.2008.88; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Maminska A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0848; Meister M, 2014, MEMBRANES-BASEL, V4, P356, DOI 10.3390/membranes4030356; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2016, CELL DEATH DIFFER, V23, P1565, DOI 10.1038/cdd.2016.46; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Quarato G, 2016, MOL CELL, V61, P589, DOI 10.1016/j.molcel.2016.01.011; Shalit T, 2015, J PROTEOME RES, V14, P1979, DOI 10.1021/pr501045t; Su LJ, 2014, STRUCTURE, V22, P1489, DOI 10.1016/j.str.2014.07.014; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Verweij FJ, 2011, EMBO J, V30, P2115, DOI 10.1038/emboj.2011.123; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wallach D, 2008, CELL DEATH DIFFER, V15, P1533, DOI 10.1038/cdd.2008.41; Wallach D, 2014, CYTOKINE GROWTH F R, V25, P157, DOI 10.1016/j.cytogfr.2013.12.001; Wallach D, 2011, TRENDS IMMUNOL, V32, P505, DOI 10.1016/j.it.2011.07.004; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Yoon S, 2016, CELL DEATH DIFFER, V23, P253, DOI 10.1038/cdd.2015.92; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.316; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	61	207	211	7	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					51	+		10.1016/j.immuni.2017.06.001	http://dx.doi.org/10.1016/j.immuni.2017.06.001			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28666573	Bronze			2022-12-18	WOS:000405712800009
J	Yoo, BB; Mazmanian, SK				Yoo, Bryan B.; Mazmanian, Sarkis K.			The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut	IMMUNITY			English	Review							VASOACTIVE-INTESTINAL-PEPTIDE; CHAIN FATTY-ACIDS; REGULATORY T-CELLS; INFLAMMATORY-BOWEL-DISEASE; GAMMA-AMINOBUTYRIC-ACID; MUSCARINIC RECEPTORS CONTRIBUTE; PROTEIN-COUPLED RECEPTORS; MESSENGER-RNA EXPRESSION; GLUCAGON-LIKE PEPTIDE-1; PIG SMALL-INTESTINE	Interactions between the nervous and immune systems enable the gut to respond to the variety of dietary products that it absorbs, the broad spectrum of pathogens that it encounters, and the diverse microbiome that it harbors. The enteric nervous system (ENS) senses and reacts to the dynamic ecosystem of the gastrointestinal (GI) tract by translating chemical cues from the environment into neuronal impulses that propagate throughout the gut and into other organs in the body, including the central nervous system (CNS). This review will describe the current understanding of the anatomy and physiology of the GI tract by focusing on the ENS and the mucosal immune system. We highlight emerging literature that the ENS is essential for important aspects of microbe-induced immune responses in the gut. Although most basic and applied research in neuroscience has focused on the brain, the proximity of the ENS to the immune system and its interface with the external environment suggest that novel paradigms for nervous system function await discovery.	[Yoo, Bryan B.; Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Yoo, BB; Mazmanian, SK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	byoo@caltech.edu; sarkis@caltech.edu		J, Garcia-Foncillas/0000-0002-7591-8006	NIH xTrain Predoctoral Training grant [5T32GM007616-38]; NIH [MH100556, DK078938, NS085910]; Defense Advanced Research Projects Agency; Heritage Medical Research Institute; Simons Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078938, R56DK078938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085910] Funding Source: NIH RePORTER	NIH xTrain Predoctoral Training grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Heritage Medical Research Institute; Simons Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Gregory Donaldson and Drs. Timothy Sampson and Hiutung Chu for critical reading of this manuscript. B.B.Y. is supported by an NIH xTrain Predoctoral Training grant (5T32GM007616-38). Related research in the Mazmanian laboratory is funded by grants from the NIH (MH100556, DK078938, and NS085910), the Defense Advanced Research Projects Agency, the Heritage Medical Research Institute, and the Simons Foundation.	Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; AHLMAN H, 1976, ACTA PHYSIOL SCAND, V98, P366, DOI 10.1111/j.1748-1716.1976.tb10321.x; AHMAD A, 1991, J IMMUNOL, V146, P3563; Amato A, 2010, NEUROGASTROENT MOTIL, V22, P664, DOI 10.1111/j.1365-2982.2010.01476.x; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Anini Y, 2003, ENDOCRINOLOGY, V144, P3244, DOI 10.1210/en.2003-0143; Anitha M, 2006, GASTROENTEROLOGY, V131, P1164, DOI 10.1053/j.gastro.2006.07.019; Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Asano Y, 2012, AM J PHYSIOL-GASTR L, V303, pG1288, DOI 10.1152/ajpgi.00341.2012; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Austin KM, 2012, SEMIN PEDIATR SURG, V21, P319, DOI 10.1053/j.sempedsurg.2012.07.006; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bar KJ, 1997, GASTROENTEROLOGY, V112, P1381, DOI 10.1016/S0016-5085(97)70154-9; Barajon I, 2009, J HISTOCHEM CYTOCHEM, V57, P1013, DOI 10.1369/jhc.2009.953539; Barrett E, 2012, J APPL MICROBIOL, V113, P411, DOI 10.1111/j.1365-2672.2012.05344.x; BERTHOUD HR, 1993, J AUTONOM NERV SYST, V42, P153, DOI 10.1016/0165-1838(93)90046-W; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Bohorquez DV, 2015, J CLIN INVEST, V125, P782, DOI 10.1172/JCI78361; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bradley JS, 1997, CELL TISSUE RES, V289, P455, DOI 10.1007/s004410050891; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Brooks AS, 2005, CLIN GENET, V67, P6, DOI 10.1111/j.1399-0004.2004.00319.x; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Brown DR, 2008, FEMS IMMUNOL MED MIC, V52, P29, DOI 10.1111/j.1574-695X.2007.00348.x; Brun P, 2015, MOL CELL NEUROSCI, V68, P24, DOI 10.1016/j.mcn.2015.03.018; Brun P, 2013, GASTROENTEROLOGY, V145, P1323, DOI 10.1053/j.gastro.2013.08.047; Buhner S, 2009, GASTROENTEROLOGY, V137, P1425, DOI 10.1053/j.gastro.2009.07.005; BULBRING E, 1958, J PHYSIOL-LONDON, V140, P381; Burgueno JF, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0653-0; Burton-Freeman B, 1999, AM J PHYSIOL-REG I, V276, pR429, DOI 10.1152/ajpregu.1999.276.2.R429; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Campbell JM, 1997, J NUTR, V127, P130, DOI 10.1093/jn/127.1.130; Carretta MD, 2013, J DAIRY SCI, V96, P2507, DOI 10.3168/jds.2012-6111; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Charney AN, 1998, AM J PHYSIOL-GASTR L, V274, pG518, DOI 10.1152/ajpgi.1998.274.3.G518; Cherbut C, 1998, AM J PHYSIOL-GASTR L, V275, pG1415, DOI 10.1152/ajpgi.1998.275.6.G1415; Chorny A, 2005, P NATL ACAD SCI USA, V102, P13562, DOI 10.1073/pnas.0504484102; Chu HT, 2016, SCIENCE, V352, P1116, DOI 10.1126/science.aad9948; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; Collins J, 2014, NEUROGASTROENT MOTIL, V26, P98, DOI 10.1111/nmo.12236; COLLINS SM, 1992, ANN NY ACAD SCI, V664, P415, DOI 10.1111/j.1749-6632.1992.tb39780.x; Conlin VS, 2009, AM J PHYSIOL-GASTR L, V297, pG735, DOI 10.1152/ajpgi.90551.2008; COSTA M, 1979, BRIT J PHARMACOL, V65, P237, DOI 10.1111/j.1476-5381.1979.tb07824.x; Covasa M, 2016, FASEB J, V30; CSABA G, 1975, ENDOKRINOLOGIE, V65, P219; de las Casas-Engel M, 2013, J IMMUNOL, V190, P2301, DOI 10.4049/jimmunol.1201133; DELAFUENTE M, 1993, IMMUNOLOGY, V80, P259; Delgado M, 2005, J IMMUNOL, V175, P7311, DOI 10.4049/jimmunol.175.11.7311; Delgado M, 2005, J LEUKOCYTE BIOL, V78, P1327, DOI 10.1189/jlb.0605299; Delgado M, 1999, J IMMUNOL, V162, P1707; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Dhawan S, 2016, AM J PHYSIOL-GASTR L, V311, pG920, DOI 10.1152/ajpgi.00114.2016; Diakos C, 2006, BIOCHEM BIOPH RES CO, V349, P863, DOI 10.1016/j.bbrc.2006.08.117; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; DUBOS RJ, 1960, J EXP MED, V111, P407, DOI 10.1084/jem.111.3.407; Duca FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039748; EFTIMIADI C, 1987, J INFECTION, V14, P43, DOI 10.1016/S0163-4453(87)90808-5; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; ERSPAMER V, 1952, NATURE, V169, P800, DOI 10.1038/169800b0; Espinosa-Medina I, 2016, SCIENCE, V354, P893, DOI 10.1126/science.aah5454; Fantaguzzi CM, 2009, CELL TISSUE RES, V336, P179, DOI 10.1007/s00441-009-0773-2; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Foster N, 2007, J LEUKOCYTE BIOL, V81, P893, DOI 10.1189/jlb.0206086; FRIELING T, 1994, GASTROENTEROLOGY, V107, P1602, DOI 10.1016/0016-5085(94)90798-6; FUJIMOTO T, 1988, PEDIATR RES, V24, P152, DOI 10.1203/00006450-198808000-00002; FURNESS JB, 1980, NEUROSCIENCE, V5, P1, DOI 10.1016/0306-4522(80)90067-6; Furness JB, 2014, ADV EXP MED BIOL, V817, P39, DOI 10.1007/978-1-4939-0897-4_3; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; GADELLE D, 1985, APPL ENVIRON MICROB, V49, P682, DOI 10.1128/AEM.49.3.682-685.1985; Ganea D, 2006, J NEUROIMMUNE PHARM, V1, P400, DOI 10.1007/s11481-006-9044-0; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gianino S, 2003, DEVELOPMENT, V130, P2187, DOI 10.1242/dev.00433; Gomariz RP, 2005, J LEUKOCYTE BIOL, V78, P491, DOI 10.1189/jlb.1004564; Grasa L, 2015, MICROB ECOL, V70, P835, DOI 10.1007/s00248-015-0613-8; Gribble FM, 2016, ANNU REV PHYSIOL, V78, P277, DOI 10.1146/annurev-physiol-021115-105439; Grubisic V, 2017, J PHYSL; Grundy D., 2011, C SERIES INTEGRATED; Gunawardene AR, 2011, INT J EXP PATHOL, V92, P219, DOI 10.1111/j.1365-2613.2011.00767.x; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011., 10.1152/ajpgi.00405.2011]; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Hadjifrangiskou M, 2011, MOL MICROBIOL, V80, P1516, DOI 10.1111/j.1365-2958.2011.07660.x; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Han TY, 2015, NEUROSCIENCE, V290, P357, DOI 10.1016/j.neuroscience.2015.01.056; Hansen GH, 1999, GASTROENTEROLOGY, V116, P610, DOI 10.1016/S0016-5085(99)70183-6; Hayes MR, 2006, AM J PHYSIOL-REG I, V291, pR115, DOI 10.1152/ajpregu.00002.2006; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Helander HF, 2014, SCAND J GASTROENTERO, V49, P681, DOI 10.3109/00365521.2014.898326; Herrera JL, 2009, J CELL MOL MED, V13, P3209, DOI 10.1111/j.1582-4934.2009.00662.x; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Hillsley K, 1998, J PHYSIOL-LONDON, V509, P717, DOI 10.1111/j.1469-7793.1998.717bm.x; Hira T, 2008, FEBS J, V275, P4620, DOI 10.1111/j.1742-4658.2008.06604.x; Hoban AE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.42; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; HURST SM, 1993, GASTROENTEROLOGY, V105, P1754, DOI 10.1016/0016-5085(93)91073-Q; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; IMAMURA A, 1992, GUT, V33, P801, DOI 10.1136/gut.33.6.801; ISHIZAKA T, 1980, P NATL ACAD SCI-BIOL, V77, P1903, DOI 10.1073/pnas.77.4.1903; Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88; Kabouridis PS, 2015, NEURON, V85, P289, DOI 10.1016/j.neuron.2014.12.037; Kagnoff M.F., 1987, PHYSL GASTROINTESTIN; Kalff JC, 1998, J LEUKOCYTE BIOL, V63, P683, DOI 10.1002/jlb.63.6.683; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; King CD, 2000, CURR DRUG METAB, V1, P143, DOI 10.2174/1389200003339171; Kunze WA, 2009, J CELL MOL MED, V13, P2261, DOI 10.1111/j.1582-4934.2009.00686.x; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lelievre V, 2007, PEPTIDES, V28, P1688, DOI 10.1016/j.peptides.2007.05.006; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; Levite M, 1998, P NATL ACAD SCI USA, V95, P12544, DOI 10.1073/pnas.95.21.12544; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li Y, 2010, J AFFECT DISORDERS, V124, P68, DOI 10.1016/j.jad.2009.10.018; Li ZS, 2004, J NEUROSCI, V24, P1330, DOI 10.1523/JNEUROSCI.3982-03.2004; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; LIGUMSKY M, 1990, GUT, V31, P686, DOI 10.1136/gut.31.6.686; Lin Q, 2013, BRAZ J MICROBIOL, V44, P183, DOI 10.1590/S1517-83822013000100028; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lv YL, 2010, PFLUG ARCH EUR J PHY, V460, P1063, DOI 10.1007/s00424-010-0880-7; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; MANTYH CR, 1988, P NATL ACAD SCI USA, V85, P3235, DOI 10.1073/pnas.85.9.3235; Mao YK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2478; Matsumura K, 2005, BIOCHEM BIOPH RES CO, V336, P1028, DOI 10.1016/j.bbrc.2005.08.259; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McDermott JR, 2006, GUT, V55, P492, DOI 10.1136/gut.2005.081752; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; McLean LP, 2016, AM J PHYSIOL-GASTR L, V311, pG130, DOI 10.1152/ajpgi.00461.2014; McLean LP, 2015, INFLAMM BOWEL DIS, V21, P1860, DOI 10.1097/MIB.0000000000000408; Merchant JL, 2007, J CLIN INVEST, V117, P6, DOI 10.1172/JCI30974; Meredith EJ, 2005, FASEB J, V19, P1187, DOI 10.1096/fj.04-3477fje; Moreira CG, 2016, MBIO, V7, DOI 10.1128/mBio.00826-16; Moreira CG, 2012, INFECT IMMUN, V80, P4344, DOI 10.1128/IAI.00803-12; Murphy F, 2005, PEDIATR SURG INT, V21, P773, DOI 10.1007/s00383-005-1551-1; Nassif A, 1995, MEDIAT INFLAMM, V4, P452, DOI 10.1155/S096293519500072X; Neufeld KAM, 2013, NEUROGASTROENT MOTIL, V25, P183, DOI 10.1111/nmo.12049; Neunlist M, 2003, AM J PHYSIOL-GASTR L, V285, pG1049, DOI 10.1152/ajpgi.00487.2002; Neunlist M, 1999, J PHYSIOL-LONDON, V517, P533, DOI 10.1111/j.1469-7793.1999.0533t.x; NGU MC, 1985, J PHYSIOL-LONDON, V364, P31, DOI 10.1113/jphysiol.1985.sp015727; Njoroge J, 2012, INFECT IMMUN, V80, P688, DOI 10.1128/IAI.05921-11; NOGUEIRA AMMF, 1994, EUR J HISTOCHEM, V38, P213; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; O'Connell PJ, 2006, BLOOD, V107, P1010, DOI 10.1182/blood-2005-07-2903; O'Hara JR, 2006, CELL MICROBIOL, V8, P646, DOI 10.1111/j.1462-5822.2005.00657.x; ORLAND FJ, 1954, J DENT RES, V33, P147, DOI 10.1177/00220345540330020201; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; Palazzo M, 2007, J IMMUNOL, V178, P4296, DOI 10.4049/jimmunol.178.7.4296; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Perez-Burgos A, 2013, AM J PHYSIOL-GASTR L, V304, pG211, DOI 10.1152/ajpgi.00128.2012; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Rakhilin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11800; RAPPORT MM, 1948, J BIOL CHEM, V176, P1243; Reigstad CS, 2015, FASEB J, V29, P1395, DOI 10.1096/fj.14-259598; Reimann F, 2012, CELL METAB, V15, P421, DOI 10.1016/j.cmet.2011.12.019; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Reyniers JA, 1932, P NATL ACAD SCI USA, V42, P35; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Rubin DC, 2000, MICROSC RES TECHNIQ, V51, P112, DOI 10.1002/1097-0029(20001015)51:2<112::AID-JEMT2>3.0.CO;2-D; Rudd ML, 2005, J NEUROIMMUNOL, V159, P113, DOI 10.1016/j.jneuroim.2004.10.013; Ruhl A, 2001, NEUROGASTROENT MOTIL, V13, P89, DOI 10.1046/j.1365-2982.2001.00245.x; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SATOH Y, 1992, CELL TISSUE RES, V269, P213, DOI 10.1007/BF00319611; SATOH Y, 1988, CELL TISSUE RES, V253, P397; SATOH Y, 1986, DIGESTION, V34, P115, DOI 10.1159/000199319; Schafer KH, 1999, J INTERF CYTOK RES, V19, P527, DOI 10.1089/107999099313974; Schele E, 2013, ENDOCRINOLOGY, V154, P3643, DOI 10.1210/en.2012-2151; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Shajib MS, 2015, ACTA PHYSIOL, V213, P561, DOI 10.1111/apha.12430; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Siragusa S, 2007, APPL ENVIRON MICROB, V73, P7283, DOI 10.1128/AEM.01064-07; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Song J, 2015, J NEUROGASTROENTEROL, V21, P236, DOI 10.5056/jnm14095; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Soret R, 2010, GASTROENTEROLOGY, V138, P1772, DOI 10.1053/j.gastro.2010.01.053; Stadnyk AW, 1996, INFECT IMMUN, V64, P5138, DOI 10.1128/IAI.64.12.5138-5143.1996; STANISZ AM, 1986, J IMMUNOL, V136, P152; Starke-Buzetti WA, 2008, INT J EXP PATHOL, V89, P458, DOI 10.1111/j.1365-2613.2008.00606.x; Starodub AM, 2000, J PHARMACOL EXP THER, V294, P555; Stefulj J, 2000, BRAIN BEHAV IMMUN, V14, P219, DOI 10.1006/brbi.1999.0579; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sun W, 2000, J NEUROIMMUNOL, V107, P88, DOI 10.1016/S0165-5728(00)00245-9; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; THEOHARIDES TC, 1982, NATURE, V297, P229, DOI 10.1038/297229a0; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; Vallance BA, 1997, AM J PHYSIOL-GASTR L, V272, pG321, DOI 10.1152/ajpgi.1997.272.2.G321; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; von Boyen GBT, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-3; Vulchanova L, 2007, J NEUROIMMUNOL, V185, P64, DOI 10.1016/j.jneuroim.2007.01.014; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Z, 2014, MUCOSAL IMMUNOL, V7, P1290, DOI 10.1038/mi.2014.17; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; WOLIN MJ, 1981, SCIENCE, V213, P1463, DOI 10.1126/science.7280665; WRIGHT KA, 1979, J PARASITOL, V65, P441, DOI 10.2307/3280292; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xia Y, 1999, J CLIN INVEST, V103, P1309, DOI 10.1172/JCI5823; YAMASAKI Y, 1983, AGENTS ACTIONS, V13, P310, DOI 10.1007/BF01971482; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yissachar N, 2017, CELL, V168, P1135, DOI 10.1016/j.cell.2017.02.009; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	226	207	213	8	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					910	926		10.1016/j.immuni.2017.05.011	http://dx.doi.org/10.1016/j.immuni.2017.05.011			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636959	Green Accepted, Bronze			2022-12-18	WOS:000403665900002
J	Vahl, JC; Drees, C; Heger, K; Heink, S; Fischer, JC; Nedjic, J; Ohkura, N; Morikawa, H; Poeck, H; Schallenberg, S; Riess, D; Hein, MY; Buch, T; Polic, B; Schonle, A; Zeiser, R; Schmitt-Graff, A; Kretschmer, K; Klein, L; Korn, T; Sakaguchi, S; Schmidt-Supprian, M				Vahl, J. Christoph; Drees, Christoph; Heger, Klaus; Heink, Sylvia; Fischer, Julius C.; Nedjic, Jelena; Ohkura, Naganari; Morikawa, Hiromasa; Poeck, Hendrik; Schallenberg, Sonja; Riess, David; Hein, Marco Y.; Buch, Thorsten; Polic, Bojan; Schoenle, Anne; Zeiser, Robert; Schmitt-Graeff, Annette; Kretschmer, Karsten; Klein, Ludger; Korn, Thomas; Sakaguchi, Shimon; Schmidt-Supprian, Marc			Continuous T Cell Receptor Signals Maintain a Functional Regulatory T Cell Pool	IMMUNITY			English	Article							EPIGENETIC CHANGES; FOXP3 EXPRESSION; DIFFERENTIATION; SPECIFICATION; STIMULATION; MECHANISMS; REG; TCR	Regulatory T (Treg) cells maintain immune homeostasis and prevent inflammatory and autoimmune responses. During development, thymocytes bearing a moderately self-reactive T cell receptor (TCR) can be selected to become Treg cells. Several observations suggest that also in the periphery mature Treg cells continuously receive self-reactive TCR signals. However, the importance of this inherent autoreactivity for Treg cell biology remains poorly defined. To address this open question, we genetically ablated the TCR of mature Treg cells in vivo. These experiments revealed that TCR-induced Treg lineage-defining Foxp3 expression and gene hypomethylation were uncoupled from TCR input in mature Treg cells. However, Treg cell homeostasis, cell-type-specific gene expression and suppressive function critically depend on continuous triggering of their TCR.	[Vahl, J. Christoph; Heger, Klaus; Riess, David; Hein, Marco Y.; Schmidt-Supprian, Marc] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Drees, Christoph; Heger, Klaus; Fischer, Julius C.; Poeck, Hendrik; Riess, David; Schmidt-Supprian, Marc] Tech Univ Munich, Klinikum Rechts Isar, Dept Hematol, D-81675 Munich, Germany; [Heink, Sylvia; Korn, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany; [Nedjic, Jelena; Klein, Ludger] Univ Munich, Inst Immunol, D-80336 Munich, Germany; [Ohkura, Naganari; Morikawa, Hiromasa; Sakaguchi, Shimon] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka 5650871, Japan; [Schallenberg, Sonja; Kretschmer, Karsten] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden CRTD, D-01307 Dresden, Germany; [Buch, Thorsten] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Buch, Thorsten] Univ Zurich, Inst Lab Anim Sci, CH-8057 Zurich, Switzerland; [Polic, Bojan] Univ Rijeka, Sch Med, HR-51000 Rijeka, Croatia; [Schoenle, Anne; Zeiser, Robert] Univ Freiburg, Dept Hematol Oncol & Stem Cell Transplantat, D-79106 Freiburg, Germany; [Schmitt-Graeff, Annette] Univ Hosp Freiburg, Dept Pathol, D-79106 Freiburg, Germany	Max Planck Society; Technical University of Munich; Technical University of Munich; University of Munich; Osaka University; Technische Universitat Dresden; Technical University of Munich; University of Zurich; University of Rijeka; University of Freiburg; University of Freiburg	Schmidt-Supprian, M (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	supprian@lrz.tum.de	Klein, Ludger/G-8785-2011; Morikawa, Hiromasa/AAU-9261-2020; Fischer, Julius/T-7511-2017; Buch, Thorsten/P-1659-2019; Hein, Marco/C-2994-2014; Korn, Thomas/AAE-6960-2019; Kretschmer, Karsten/E-8174-2010; Sakaguchi, Shimon/C-9535-2009; Morikawa, Hiromasa/H-5958-2013; Schmidt-Supprian, Marc/F-5893-2011; Polic, Bojan/B-8622-2014; Schallenberg, Sonja/F-6220-2012	Morikawa, Hiromasa/0000-0002-6793-5885; Fischer, Julius/0000-0002-6951-3416; Buch, Thorsten/0000-0002-2236-9074; Hein, Marco/0000-0002-9490-2261; Korn, Thomas/0000-0002-3633-0955; Kretschmer, Karsten/0000-0001-6770-4078; Morikawa, Hiromasa/0000-0002-6793-5885; Schmidt-Supprian, Marc/0000-0002-8543-6166; Polic, Bojan/0000-0003-3930-9630; Heink, Sylvia/0000-0002-3276-6313; Klein, Ludger/0000-0003-2054-071X; Zeiser, Robert/0000-0001-6565-3393; Vahl, Christoph/0000-0002-1683-8196	DFG [SFB 1054 TPA02]; Emmy Noether grant; Ernst Schering Foundation; Boehringer Ingelheim Fonds; DFG (Heisenberg) [SFB 1054 TPB06]; DFG (SyNergy)	DFG(German Research Foundation (DFG)); Emmy Noether grant(German Research Foundation (DFG)); Ernst Schering Foundation; Boehringer Ingelheim Fonds(Boehringer Ingelheim); DFG (Heisenberg)(German Research Foundation (DFG)); DFG (SyNergy)	This study was supported by the DFG through SFB 1054 TPA02 and an Emmy Noether grant to M.S.-S. J.C.V. and K.H. received PhD stipends from the Ernst Schering Foundation and the Boehringer Ingelheim Fonds, respectively. T.K. is supported by the DFG (Heisenberg, SFB 1054 TPB06, and SyNergy). We are grateful to R. Fassler for support. We thank J. Knogler, B. Habermehl, M. Schmickl, and A. Kawasaki for technical assistance.	Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; delPeso L, 1997, SCIENCE, V278, P687; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Jorgensen TN, 2007, J IMMUNOL, V179, P3417, DOI 10.4049/jimmunol.179.6.3417; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Peng S, 2007, EUR J IMMUNOL, V37, P2868, DOI 10.1002/eji.200636979; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Stephens GL, 2007, J IMMUNOL, V178, P6901, DOI 10.4049/jimmunol.178.11.6901; Szymczak-Workman AL, 2009, J IMMUNOL, V182, P5188, DOI 10.4049/jimmunol.0803123; Vahl JC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001589; Xing Y., 2012, COLD SPRING HARB PER, V4; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	34	207	210	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					722	736		10.1016/j.immuni.2014.10.012	http://dx.doi.org/10.1016/j.immuni.2014.10.012			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25464853	Bronze			2022-12-18	WOS:000345504900010
J	Tamir, I; Stolpa, JC; Helgason, CD; Nakamura, K; Bruhns, P; Daeron, M; Cambier, JC				Tamir, I; Stolpa, JC; Helgason, CD; Nakamura, K; Bruhns, P; Daeron, M; Cambier, JC			The RasGAP-binding protein p62(dok) is a mediator of inhibitory Fc gamma RIIB signals in B cells	IMMUNITY			English	Article							INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE; GAP-ASSOCIATED PROTEINS; AFFINITY IGE RECEPTOR; PHOSPHATASE SHIP; NEGATIVE REGULATION; TYROSINE PHOSPHORYLATION; CYTOPLASMIC DOMAIN; LYMPHOCYTES-B; SH2 DOMAIN; ACTIVATION	The low affinity receptor for IgG, Fc gamma RIIB, functions to dampen the antibody response and reduce the risk of autoimmunity. This function is reportedly mediated in part by inhibition of B cell antigen receptor (BCR)mediated p21(ras) activation, though the basis of this inhibition is unknown. We show here that Fc gamma RIIB-BCR coaggregation leads to increased tyrosine phosphorylation of the RasGAP-binding protein p62(dok), with a concomitant increase in its binding to RasGAP. These effects require the recruitment and tyrosine phosphorylation of the phosphatidylinositol 5-phosphatase SHIP, which further recruits p62(dok) via the latter's phosphotyrosine-binding domain. Using chimeric Fc gamma RIIB containing the RasGAP-binding domain of p62dok, we demonstrate that p62(dok) contains all structural information required to mediate the inhibitory effect of Fc gamma RIIB on Erk activation.	Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80206 USA; British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; INSERM, Lab Immunol Cellulaire & Clin, U255, Inst Curie, F-75005 Paris, France	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; British Columbia Cancer Agency; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Cambier, JC (corresponding author), Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA.		Bruhns, Pierre/F-5567-2013	Bruhns, Pierre/0000-0002-4709-8936; Cambier, John/0000-0002-7803-242X				AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; BIJSTERBOSCH MK, 1985, J EXP MED, V162, P1825, DOI 10.1084/jem.162.6.1825; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; CAMBIER J, 1988, P NATL ACAD SCI USA, V85, P6493, DOI 10.1073/pnas.85.17.6493; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chacko GW, 1996, J IMMUNOL, V157, P2234; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; DAmbrosio D, 1996, IMMUNOL LETT, V54, P77, DOI 10.1016/S0165-2478(96)02653-3; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Fong DC, 1996, IMMUNOL LETT, V54, P83, DOI 10.1016/S0165-2478(96)02654-5; GOLD MR, 1993, J IMMUNOL, V150, P377; Gupta N, 1997, J EXP MED, V186, P473, DOI 10.1084/jem.186.3.473; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Jones N, 1999, CURR BIOL, V9, P1057, DOI 10.1016/S0960-9822(99)80458-8; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; Kimura T, 1997, J BIOL CHEM, V272, P13991, DOI 10.1074/jbc.272.21.13991; Lamkin TD, 1997, J BIOL CHEM, V272, P10396; Latour S, 1996, J IMMUNOL, V157, P189; LAZARUS AH, 1993, J EXP MED, V178, P1765, DOI 10.1084/jem.178.5.1765; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Liu L, 1997, J BIOL CHEM, V272, P8983; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; MORGAN EL, 1978, J IMMUNOL, V120, P1669; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; Nakamura K, 1998, J IMMUNOL, V161, P684; Nelms K, 1998, IMMUNITY, V9, P13, DOI 10.1016/S1074-7613(00)80584-1; Noguchi T, 1999, EMBO J, V18, P1748, DOI 10.1093/emboj/18.7.1748; Nolan GP, 1998, CURR OPIN BIOTECH, V9, P447, DOI 10.1016/S0958-1669(98)80027-X; Onishi M, 1996, EXP HEMATOL, V24, P324; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Osborne MA, 1996, J BIOL CHEM, V271, P29271, DOI 10.1074/jbc.271.46.29271; PARIKH VS, 1991, J EXP MED, V174, P1103, DOI 10.1084/jem.174.5.1103; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pradhan M, 1997, J CELL BIOCHEM, V67, P32, DOI 10.1002/(SICI)1097-4644(19971001)67:1<32::AID-JCB4>3.0.CO;2-X; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Sarmay G, 1996, J BIOL CHEM, V271, P30499; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tridandapani S, 1997, IMMUNOL TODAY, V18, P424, DOI 10.1016/S0167-5699(97)01112-2; Tridandapani S, 1999, J IMMUNOL, V162, P1408; Tridandapani S, 1997, MOL CELL BIOL, V17, P4305, DOI 10.1128/MCB.17.8.4305; WILSON HA, 1987, J IMMUNOL, V138, P1712; Yamanashi Y, 2000, GENE DEV, V14, P11; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187	50	207	213	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2000	12	3					347	358		10.1016/S1074-7613(00)80187-9	http://dx.doi.org/10.1016/S1074-7613(00)80187-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	301DC	10755621	Bronze			2022-12-18	WOS:000086292100012
J	Wang, KP; Kim, MK; Di Caro, G; Wong, J; Shalapour, S; Wan, J; Zhang, W; Zhong, ZY; Sanchez-Lopez, E; Wu, LW; Taniguchi, K; Feng, Y; Fearon, E; Grivennikov, SI; Karin, M				Wang, Kepeng; Kim, Min Kyoung; Di Caro, Giuseppe; Wong, Jerry; Shalapour, Shabnam; Wan, Jun; Zhang, Wei; Zhong, Zhenyu; Sanchez-Lopez, Elsa; Wu, Li-Wha; Taniguchi, Koji; Feng, Ying; Fearon, Eric; Grivennikov, Sergei I.; Karin, Michael			Interleukin-17 Receptor A Signaling in Transformed Enterocytes Promotes Early Colorectal Tumorigenesis	IMMUNITY			English	Article							INTESTINAL EPITHELIAL-CELLS; T-CELLS; SUPPRESSOR-CELLS; MOUSE MODEL; IFN-GAMMA; INFLAMMATION; PROGRESSION; IL-6; SURVIVAL; IMMUNE	Interleukin-17A (IL-17A) is a pro-inflammatory cytokine linked to rapid malignant progression of colorectal cancer (CRC) and therapy resistance. IL-17A exerts its pro-tumorigenic activity through its type A receptor (IL-17RA). However, IL-17RA is expressed in many cell types, including hematopoietic, fibro-blastoid, and epithelial cells, in the tumor microenvironment, and how IL-17RA engagement promotes colonic tumorigenesis is unknown. Here we show that IL-17RA signals directly within transformed colonic epithelial cells (enterocytes) to promote early tumor development. IL-17RA engagement activates ERK, p38 MAPK, and NF-kappa B signaling and promotes the proliferation of tumorigenic enterocytes that just lost expression of the APC tumor suppressor. Although IL-17RA signaling also controls the production of IL-6, this mechanism makes only a partial contribution to colonic tumorigenesis. Combined treatment with chemotherapy, which induces IL-17A expression, and an IL-17A neutralizing antibody enhanced the therapeutic responsiveness of established colon tumors. These findings establish IL-17A and IL-17RA as therapeutic targets in colorectal cancer.	[Wang, Kepeng; Di Caro, Giuseppe; Wong, Jerry; Shalapour, Shabnam; Zhong, Zhenyu; Sanchez-Lopez, Elsa; Taniguchi, Koji; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Wang, Kepeng; Di Caro, Giuseppe; Wong, Jerry; Shalapour, Shabnam; Zhong, Zhenyu; Sanchez-Lopez, Elsa; Taniguchi, Koji; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Kim, Min Kyoung] Yeungnam Univ, Coll Med, Dept Med, Div Hematol Oncol, Taegu 705717, South Korea; [Wan, Jun] Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Biomed Res Inst, Shenzhen Key Lab Neuronal Struct Biol, Shenzhen 518036, Guangdong, Peoples R China; [Wan, Jun] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong 100044, Hong Kong, Peoples R China; [Zhang, Wei] Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Biomed Res Inst, Shenzhen Key Lab Translat Med Dermatol, Shenzhen 518036, Guangdong, Peoples R China; [Wu, Li-Wha] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [Taniguchi, Koji] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Feng, Ying; Fearon, Eric] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Feng, Ying; Fearon, Eric] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Feng, Ying; Fearon, Eric] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Grivennikov, Sergei I.] Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19111 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Yeungnam University; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; National Cheng Kung University; Keio University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fox Chase Cancer Center	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Wang, Kepeng/F-8363-2014; Zhong, Zhenyu/A-8339-2017; Grivennikov, Sergei/AAE-7365-2019; Sanchez-Lopez, Elsa/A-7131-2017; Wu, Li-Wha/AAH-7768-2021	Wang, Kepeng/0000-0001-6428-4709; Grivennikov, Sergei/0000-0003-2987-0555; Sanchez-Lopez, Elsa/0000-0002-4236-1985; Wu, Li-Wha/0000-0001-7010-6220; Wan, Jun/0000-0001-7308-0150; Zhong, Zhenyu/0000-0002-9441-7645	Croucher Foundation; China Postdoctoral Science Foundation [20110490919]; Italian Association for Cancer Research, AIRC Fellowship for Abroad; Canadian Institutes of Health Research Postdoctoral Fellowship; German Research Foundation; Shenzhen Science and Technology [GJHZ20120616153140827]; Cancer Research Institute Irvington Postdoctoral Fellowship; National Science Council in Taiwan [NSC-101-2918-I-006-005]; Japan Society for the Promotion of Science; Uehara Memorial Foundation; NIH/NIDDK [R00DK088589]; FCCC-Temple University Nodal grant; AACR-Landon Innovator Award; Pew Scholar in Biomedical Sciences Programto; NIH [AI043477, DK035108]; American Association for Cancer Research [07-60-21-KARI]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK088589, P01DK035108, P01DK098108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA022614] Funding Source: NIH RePORTER	Croucher Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Italian Association for Cancer Research, AIRC Fellowship for Abroad(Fondazione AIRC per la ricerca sul cancro); Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); German Research Foundation(German Research Foundation (DFG)); Shenzhen Science and Technology; Cancer Research Institute Irvington Postdoctoral Fellowship; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FCCC-Temple University Nodal grant; AACR-Landon Innovator Award; Pew Scholar in Biomedical Sciences Programto; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Dr. Shujuan Chen for scientific discussion; eBioscience, GeneTex, Santa Cruz, and Cell Signaling for antibodies; Amgen and Dr. Sylvie Robine for Il17ra<SUP>-/-</SUP> and Villin<SUP>Cre-ERT2</SUP> mice, respectively. This work was supported by the Croucher Foundation and China Postdoctoral Science Foundation (20110490919) to K.W.; Italian Association for Cancer Research, AIRC Fellowship for Abroad to G.D.C.; Canadian Institutes of Health Research Postdoctoral Fellowship to J. Wong; German Research Foundation Fellowship to S.S.; Shenzhen Science and Technology Project (GJHZ20120616153140827) to J.W.; Cancer Research Institute Irvington Postdoctoral Fellowship to Z.Z.; traveling grant NSC-101-2918-I-006-005 by the National Science Council in Taiwan to L.W.W.; Postdoctoral Fellowship for Research Abroad, the Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science, and the Uehara Memorial Foundation Fellowship to K.T.; NIH/NIDDK R00DK088589, FCCC-Temple University Nodal grant, AACR-Landon Innovator Award in Tumor Microenvironment, and the Pew Scholar in Biomedical Sciences Programto S.I.G.; and NIH (AI043477; DK035108) and American Association for Cancer Research (07-60-21-KARI) grants to M.K., who is an American Cancer Society Research Professor and the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Alshaker HA, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-33; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Chae WJ, 2011, BIOCHEM BIOPH RES CO, V414, P31, DOI 10.1016/j.bbrc.2011.09.016; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Chang SH, 2014, P NATL ACAD SCI USA, V111, P5664, DOI 10.1073/pnas.1319051111; Chen DY, 2012, CELL IMMUNOL, V272, P166, DOI 10.1016/j.cellimm.2011.10.015; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dungan LS, 2011, CYTOKINE, V56, P126, DOI 10.1016/j.cyto.2011.07.007; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Feng Y, 2013, AM J PATHOL, V183, P493, DOI 10.1016/j.ajpath.2013.04.013; Feng Y, 2011, GASTROENTEROLOGY, V141, P1003, DOI 10.1053/j.gastro.2011.05.007; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; He DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032126; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Hu JH, 2011, INT IMMUNOPHARMACOL, V11, P1173, DOI 10.1016/j.intimp.2011.03.015; Hyun YS, 2012, CARCINOGENESIS, V33, P931, DOI 10.1093/carcin/bgs106; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Martin-Orozco N, 2009, CURR OPIN INVEST DR, V10, P543; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Patel DD, 2013, ANN RHEUM DIS, V72, P116, DOI 10.1136/annrheumdis-2012-202371; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SHEN FW, 1985, P NATL ACAD SCI USA, V82, P7360, DOI 10.1073/pnas.82.21.7360; Song XY, 2014, IMMUNITY, V40, P140, DOI 10.1016/j.immuni.2013.11.018; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Tong Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034959; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vizio B, 2012, EXP THER MED, V4, P70, DOI 10.3892/etm.2012.553; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yamada Y, 2012, J SURG RES, V178, P685, DOI 10.1016/j.jss.2012.07.055; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhuang Y, 2012, GASTROENTEROLOGY, V143, P951, DOI 10.1053/j.gastro.2012.06.010; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	47	206	213	4	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					1052	1063		10.1016/j.immuni.2014.11.009	http://dx.doi.org/10.1016/j.immuni.2014.11.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526314	Green Accepted, Bronze			2022-12-18	WOS:000346654100021
J	Gomez, TS; Kumar, K; Mecleiros, RB; Shimizu, Y; Leibson, PJ; Billadeau, DD				Gomez, Timothy S.; Kumar, Karan; Mecleiros, Ricardo B.; Shimizu, Yoji; Leibson, Paul J.; Billadeau, Daniel D.			Formins regulate the actin-related protein 2/3 complex-independent polarization of the centrosome to the immunological synapse	IMMUNITY			English	Article							MICROTUBULE-ORGANIZING CENTER; T-CELL-ACTIVATION; TUBULIN CYTOSKELETON; SIGNAL-TRANSDUCTION; FILOPODIA FORMATION; IMMUNE SYNAPSE; B-CELLS; POLYMERIZATION; REORIENTATION; PATHWAY	T cell receptor (TCR)-mediated cytoskeletal reorganization is considered to be actin-related protein (Arp) 2/3 complex dependent. We therefore examined the requirement for Arp2/3- and formin-dependent F-actin nucleation during T cell activation. We demonstrated that without Arp2/3-mediated actin nucleation, stimulated T cells could not form an F-actin-rich lamellipod, but instead produced polarized filopodia-like structures. Moreover, the microtubule-organizing center (MTOC, or centrosome), which rapidly reorients to the immunological synapse through an unknown mechanism, polarized in the absence of Arp2/3. Conversely, the actin-nucleating formins, Diaphanous-1 (DIA1) and Formin-like-1 (FMNL1), did not affect TCR-stimulated F-actin-rich structures, but instead displayed unique patterns of centrosome colocalization and controlled TCR-mediated centrosome polarization. Depletion of FMNL1 or DIA1 in cytotoxic lymphocytes abrogated cell-mediated killing. Altogether, our results have identifed Arp2/3 complex-independent cytoskeletal reorganization events in T lymphocytes and indicate that formins are essential cytoskeletal regulators of centrosome polarity in T cells.	Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA; Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Immunol,Canc Ctr, Minneapolis, MN 55455 USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Billadeau, DD (corresponding author), Mayo Clin, Coll Med, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.	billadeau.daniel@mayo.edu		Kumar, Karan/0000-0001-9196-6350; Shimizu, Yoji/0000-0001-9760-0288	NATIONAL CANCER INSTITUTE [R01CA047752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031126, R01AI038474, R01AI065474, F31AI068624] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA047752, R01-CA47752] Funding Source: Medline; NIAID NIH HHS [R01-AI038474, R01 AI038474, R01 AI065474, F31 AI068624, R01 AI031126, F31-AI068624, R01 AI065474-03, R01-AI031126, R01-AI065474] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; Barr VA, 2006, TRAFFIC, V7, P1143, DOI 10.1111/j.1600-0854.2006.00464.x; Billadeau DD, 2000, J EXP MED, V192, P381, DOI 10.1084/jem.192.3.381; Biyasheva A, 2004, J CELL SCI, V117, P837, DOI 10.1242/jcs.00921; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Butler B, 2006, CURR BIOL, V16, P242, DOI 10.1016/j.cub.2005.12.033; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Favaro PMB, 2006, LEUKEMIA RES, V30, P735, DOI 10.1016/j.leukres.2005.10.003; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Hao SL, 2005, MOL BIOL CELL, V16, P2275, DOI 10.1091/mbc.e04-10-0881; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; KUPFER A, 1987, J EXP MED, V165, P1565, DOI 10.1084/jem.165.6.1565; KUPFER A, 1984, J IMMUNOL, V133, P2762; Martin-Cofreces NB, 2006, J IMMUNOL, V176, P4201, DOI 10.4049/jimmunol.176.7.4201; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Rivas FV, 2004, MOL CELL BIOL, V24, P1628, DOI 10.1128/MCB.24.4.1628-1639.2004; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; SMALL JV, 1981, J CELL BIOL, V91, P695, DOI 10.1083/jcb.91.3.695; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Tolliday N, 2002, CURR BIOL, V12, P1864, DOI 10.1016/S0960-9822(02)01238-1; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yayoshi-Yamamoto S, 2000, MOL CELL BIOL, V20, P6872, DOI 10.1128/MCB.20.18.6872-6881.2000; Zipfel PA, 2006, CURR BIOL, V16, P35, DOI 10.1016/j.cub.2005.12.024	44	206	210	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2007	26	2					177	190		10.1016/j.immuni.2007.01.008	http://dx.doi.org/10.1016/j.immuni.2007.01.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17306570	Green Accepted, Bronze			2022-12-18	WOS:000244628600009
J	Solana, R; Pawelec, G; Tarazona, R				Solana, Rafael; Pawelec, Graham; Tarazona, Raquel			Aging and innate immunity	IMMUNITY			English	Editorial Material							KILLER-CELL ACTIVITY; DENDRITIC CELLS; IMPACT; AGE; NK; RECOGNITION; NEUTROPHILS; IMPAIRMENT; RECEPTORS; MICE	Adaptive immunity undergoes severe deterioration with age and represents the main problem in the elderly. However, evidence accumulated over the last decade supports the hypothesis that aging also has a profound impact on innate immunity, which in turn markedly impacts the health and longevity of older people.	Univ Cordoba, Dept Cellular Biol Physiol & Immunol, E-14004 Cordoba, Spain; Univ Tubingen, Med Res Ctr, D-72076 Tubingen, Germany; Univ Extremadura, Dept Physiol, Immunol Unit, E-10071 Caceres, Spain	Universidad de Cordoba; Eberhard Karls University of Tubingen; Universidad de Extremadura	Solana, R (corresponding author), Univ Cordoba, Dept Cellular Biol Physiol & Immunol, E-14004 Cordoba, Spain.	rsolana@uco.es	Pawelec, Graham/H-2713-2019; Solana, Rafael/R-9978-2019	Pawelec, Graham/0000-0002-3600-0163; Solana, Rafael/0000-0001-8985-0295; Tarazona, Raquel/0000-0002-2926-6377				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Boehmer ED, 2005, MECH AGEING DEV, V126, P1305, DOI 10.1016/j.mad.2005.07.009; Bottino C, 2006, CURR TOP MICROBIOL, V298, P175; Bruunsgaard H, 2001, EXP GERONTOL, V37, P127, DOI 10.1016/S0531-5565(01)00162-0; Cumberbatch M, 2002, IMMUNOLOGY, V105, P466, DOI 10.1046/j.1365-2567.2002.01381.x; DEMARTINIS M, 2006, IN PRESS EXP MOL PAT; Fortin CF, 2006, J LEUKOCYTE BIOL, V79, P1061, DOI 10.1189/jlb.0805481; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Fulop T, 2004, AGING CELL, V3, P217, DOI 10.1111/j.1474-9728.2004.00110.x; Gomez CR, 2005, CURR OPIN IMMUNOL, V17, P457, DOI 10.1016/j.coi.2005.07.013; Herrero C, 2001, J CLIN INVEST, V107, P485, DOI 10.1172/JCI11696; Lung TL, 2000, VACCINE, V18, P1606, DOI 10.1016/S0264-410X(99)00494-6; Lutz CT, 2005, MECH AGEING DEV, V126, P722, DOI 10.1016/j.mad.2005.01.004; Mariani E, 2002, EUR J IMMUNOL, V32, P1524, DOI 10.1002/1521-4141(200206)32:6<1524::AID-IMMU1524>3.0.CO;2-E; Murasko DM, 2005, IMMUNOL REV, V205, P285, DOI 10.1111/j.0105-2896.2005.00273.x; Mysliwska J, 2004, EXP GERONTOL, V39, P1447, DOI 10.1016/j.exger.2004.08.005; Ogata K, 2001, CLIN EXP IMMUNOL, V124, P392, DOI 10.1046/j.1365-2249.2001.01571.x; Pawelec G, 1998, J LEUKOCYTE BIOL, V64, P703, DOI 10.1002/jlb.64.6.703; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Pawelec G, 2002, FRONT BIOSCI-LANDMRK, V7, pD1056; Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x; Solana R, 2000, VACCINE, V18, P1613, DOI 10.1016/S0264-410X(99)00495-8; Tarazona R, 2000, MECH AGEING DEV, V121, P77; Uyemura K, 2002, MECH AGEING DEV, V123, P955, DOI 10.1016/S0047-6374(02)00033-7; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556	25	206	211	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2006	24	5					491	494		10.1016/j.immuni.2006.05.003	http://dx.doi.org/10.1016/j.immuni.2006.05.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713963	Bronze			2022-12-18	WOS:000237970100002
J	Egawa, T; Eberl, G; Taniuchi, I; Benlagha, K; Geissmann, F; Hennighausen, L; Bendelac, A; Littman, DR				Egawa, T; Eberl, G; Taniuchi, I; Benlagha, K; Geissmann, F; Hennighausen, L; Bendelac, A; Littman, DR			Genetic evidence supporting selection of the V alpha 14i NKT cell lineage from double-positive thymocyte precursors	IMMUNITY			English	Article							NATURAL-KILLER; T-CELLS; CUTTING EDGE; ROR-GAMMA; MEMBRANE LYMPHOTOXIN; EXPRESSION; MICE; REQUIREMENT; HOMEOSTASIS; SURVIVAL	Invariant V alpha 14i NKT (iNKT) cells are a specialized subset of T lymphocytes with regulatory functions. They coexpress TCR alpha beta and natural killer cell markers. They differentiate through interaction of their V alpha 14-J alpha 18 invariant TCR alpha chains with CD1d expressed on double-positive (DP) thymocytes. Although their development has been shown to be thymus dependent, their developmental pathway has not been definitively established. By using genetic analyses, we show here that all iNKT cells are selected from a pool of DP thymocytes. Their development is absolutely dependent on Runx1 and ROR gamma t, transcription factors that influence, but are not required for, development of conventional T cells. Our results indicate that even though CD1d binding DP thymocytes have yet to be observed, V alpha 14-J alpha 18 rearrangement in these cells is required for development of iNKT cells.	NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, Howard Hughes Med Inst, New York, NY 10016 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; NIDDKD, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA	New York University; Howard Hughes Medical Institute; New York University; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, 540 1st Ave, New York, NY 10016 USA.	littman@saturn.med.nyu.edu	Benlagha, Kamel/GLQ-8342-2022; Taniuchi, Ichiro/N-6399-2015; Benlagha, Kamel/I-5035-2016; Eberl, Gerard/A-1160-2013	Taniuchi, Ichiro/0000-0002-9853-9068; Hennighausen, Lothar/0000-0001-8319-9841; benlagha, kamel/0000-0002-3251-9195; Eberl, Gerard/0000-0002-1119-5638; geissmann, frederic/0000-0001-5029-2468	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK061000, Z01DK061000] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ballas ZK, 1997, J IMMUNOL, V159, P1174; Bendelac A, 2004, NAT IMMUNOL, V5, P557, DOI 10.1038/ni0604-557; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bezbradica JS, 2005, P NATL ACAD SCI USA, V102, P5114, DOI 10.1073/pnas.0408449102; Burdin N, 1999, EUR J IMMUNOL, V29, P2014, DOI 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO;2-G; Cole DN, 2000, US FOR SERV RMRS-P, V1, P1; Dao T, 2004, EUR J IMMUNOL, V34, P3542, DOI 10.1002/eji.200425546; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 1999, J IMMUNOL, V163, P4091; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Elewaut D, 2000, J IMMUNOL, V165, P671, DOI 10.4049/jimmunol.165.2.671; Gangadharan D, 2004, CURR OPIN IMMUNOL, V16, P264, DOI 10.1016/j.coi.2004.03.015; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Guo JH, 2002, ASIAN J ANDROL, V4, P3; Guy-Grand D, 2001, EUR J IMMUNOL, V31, P2593, DOI 10.1002/1521-4141(200109)31:9<2593::AID-IMMU2593>3.0.CO;2-X; Iizuka K, 1999, P NATL ACAD SCI USA, V96, P6336, DOI 10.1073/pnas.96.11.6336; Iwabuchi K, 2001, BLOOD, V97, P1765, DOI 10.1182/blood.V97.6.1765; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Legendre V, 1999, EUR J IMMUNOL, V29, P2330, DOI 10.1002/(SICI)1521-4141(199907)29:07<2330::AID-IMMU2330>3.3.CO;2-7; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; MacDonald HR, 2002, CURR OPIN IMMUNOL, V14, P250, DOI 10.1016/S0952-7915(02)00329-1; MAKINO Y, 1993, J EXP MED, V177, P1399, DOI 10.1084/jem.177.5.1399; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Poulton LD, 2001, INT IMMUNOL, V13, P887, DOI 10.1093/intimm/13.7.887; Rucker EB, 2000, MOL ENDOCRINOL, V14, P1038, DOI 10.1210/me.14.7.1038; Sato H, 1999, P NATL ACAD SCI USA, V96, P7439, DOI 10.1073/pnas.96.13.7439; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Shimamura M, 1997, EUR J IMMUNOL, V27, P1576, DOI 10.1002/eji.1830270638; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tilloy F, 1999, EUR J IMMUNOL, V29, P3313, DOI 10.1002/(SICI)1521-4141(199910)29:10<3313::AID-IMMU3313>3.0.CO;2-8; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Walunas TL, 2000, J IMMUNOL, V164, P2857, DOI 10.4049/jimmunol.164.6.2857; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	52	206	212	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					705	716		10.1016/j.immuni.2005.03.011	http://dx.doi.org/10.1016/j.immuni.2005.03.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963785	Bronze			2022-12-18	WOS:000230180300008
J	Jankovic, D; Kullberg, MC; Hieny, S; Caspar, P; Collazo, CM; Sher, A				Jankovic, D; Kullberg, MC; Hieny, S; Caspar, P; Collazo, CM; Sher, A			In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting	IMMUNITY			English	Article							IFN-GAMMA PRODUCTION; LEISHMANIA-MAJOR; TOXOPLASMA-GONDII; INTERFERON-GAMMA; IN-VIVO; DENDRITIC CELLS; MICE LACKING; CUTANEOUS LEISHMANIASIS; IL-12-DEFICIENT MICE; INTERLEUKIN-18 IL-18	IL-12-deficient mice exposed to nonlethal infections with intracellular pathogens or repeatedly immunized with a pathogen extract developed lowered but nevertheless substantial numbers of IFN-gamma(+) CD4(+) T cells compared to those observed in wild-type animals. Moreover, the CD4(+) responses in these knockout animals failed to default to a Th2 pattern. The protective efficacy of the Th1 cells developing in an IL-12-deficient setting was found to be limited by IL-10 since mice doubly deficient in IL-10 and IL-12 survived, while animals deficient in IL-12 alone succumbed to pathogen challenge. In contrast to IL-12 knockout mice, MyD88-deficient animals exposed to a Th1 microbial stimulus developed a pure Th2 response, arguing that this signaling element plays a more critical function than IL-12 in determining pathogen-induced CD4 polarization.	NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jankovic, D (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	djankovic@niaid.nih.gov	Kullberg, Marika/AAO-8703-2020; Kullberg, Marika/AAG-3428-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000579, Z01AI000579] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAMS JS, 1992, IMMUNOL REV, V127, P5, DOI 10.1111/j.1600-065X.1992.tb01406.x; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; BOROS DL, 1970, J EXP MED, V132, P488, DOI 10.1084/jem.132.3.488; Brombacher F, 1999, INT IMMUNOL, V11, P325, DOI 10.1093/intimm/11.3.325; Cai GF, 2000, J IMMUNOL, V165, P2619, DOI 10.4049/jimmunol.165.5.2619; Cai GF, 2000, INFECT IMMUN, V68, P6932, DOI 10.1128/IAI.68.12.6932-6938.2000; CHATELAIN R, 1992, J IMMUNOL, V148, P1182; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; Doherty TM, 1997, J IMMUNOL, V158, P4822; Ely KH, 1999, J IMMUNOL, V162, P5449; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984; HEINZEL FP, 1995, J IMMUNOL, V155, P730; HEINZEL FP, 1991, P NATL ACAD SCI USA, V88, P7011, DOI 10.1073/pnas.88.16.7011; Hoffmann KF, 1999, J IMMUNOL, V163, P927; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Jankovic D, 1999, J IMMUNOL, V163, P337; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Kaplan MH, 1998, J EXP MED, V188, P1191, DOI 10.1084/jem.188.6.1191; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Launois P, 1995, EUR J IMMUNOL, V25, P3298, DOI 10.1002/eji.1830251215; Leitenberg D, 1999, SEMIN IMMUNOL, V11, P283, DOI 10.1006/smim.1999.0184; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Marovich MA, 2000, J IMMUNOL, V164, P5858, DOI 10.4049/jimmunol.164.11.5858; Mattner F, 1997, INFECT IMMUN, V65, P4378, DOI 10.1128/IAI.65.11.4378-4383.1997; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; MORRIS L, 1992, J IMMUNOL, V149, P2715; MOSMANN TR, 1990, J IMMUNOL, V145, P2938; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Noben-Trauth N, 2000, J IMMUNOL, V165, P3620, DOI 10.4049/jimmunol.165.7.3620; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Park AY, 2000, J IMMUNOL, V165, P896, DOI 10.4049/jimmunol.165.2.896; PFEFFERKORN ER, 1976, EXP PARASITOL, V36, P365, DOI 10.1016/0014-4894(76)90040-0; Pohl-Koppe A, 1998, J IMMUNOL, V160, P1804; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; ROMANI L, 1994, J IMMUNOL, V153, P5167; SARAWAR SR, 1994, J VIROL, V68, P3112, DOI 10.1128/JVI.68.5.3112-3119.1994; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; Scharton-Kersten T, 1998, J IMMUNOL, V160, P2565; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Schijns VECJ, 1998, J IMMUNOL, V160, P3958; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Sommer F, 1998, INT IMMUNOL, V10, P1853, DOI 10.1093/intimm/10.12.1853; Stamm LM, 1999, EUR J IMMUNOL, V29, P2524, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2524::AID-IMMU2524&gt;3.0.CO;2-H; Stamm LM, 1998, J IMMUNOL, V161, P6180; Stobie L, 2000, P NATL ACAD SCI USA, V97, P8427, DOI 10.1073/pnas.160197797; Sugawara I, 1999, INFECT IMMUN, V67, P2585, DOI 10.1128/IAI.67.5.2585-2589.1999; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; SVETIC A, 1993, INT IMMUNOL, V5, P877, DOI 10.1093/intimm/5.8.877; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tarleton RL, 2000, J IMMUNOL, V165, P1520, DOI 10.4049/jimmunol.165.3.1520; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Wakeham J, 1998, J IMMUNOL, V160, P6101; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307; Xu DM, 2000, EUR J IMMUNOL, V30, P3147, DOI 10.1002/1521-4141(200011)30:11<3147::AID-IMMU3147>3.0.CO;2-J; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628; Yap GS, 2001, J IMMUNOL, V166, P5720, DOI 10.4049/jimmunol.166.9.5720; Yap GS, 1999, IMMUNOBIOLOGY, V201, P240, DOI 10.1016/S0171-2985(99)80064-3; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811	79	206	234	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2002	16	3					429	439		10.1016/S1074-7613(02)00278-9	http://dx.doi.org/10.1016/S1074-7613(02)00278-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911827	Bronze			2022-12-18	WOS:000174572800011
J	Arens, R; Tesselaar, K; Baars, PA; van Schijndel, GMW; Hendriks, J; Pals, ST; Krimpenfort, P; Borst, J; van Oers, MHJ; van Lier, RAW				Arens, R; Tesselaar, K; Baars, PA; van Schijndel, GMW; Hendriks, J; Pals, ST; Krimpenfort, P; Borst, J; van Oers, MHJ; van Lier, RAW			Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFN gamma-mediated B cell depletion	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; NATURAL-KILLER-CELLS; FAMILY MEMBER CD27; N-TERMINAL KINASE; RECEPTOR FAMILY; COSTIMULATORY MOLECULES; ANTITUMOR IMMUNITY; TRANSGENIC MICE; CO-STIMULATION; DENDRITIC CELL	The interaction between the TNF receptor family member CD27 and its ligand CD70 provides a costimulatory signal for T cell expansion. Normally, tightly regulated expression of CD70 ensures the transient availability of this costimulatory signal. Mice expressing constitutive CD70 on B cells had higher peripheral T cell numbers that showed increased differentiation toward effector-type T cells. B cell numbers in CD70 transgenic (TG) mice progressively decreased in primary and secondary lymphoid organs. This B cell depletion was caused by CD27-induced production of IFN gamma in T cells. We conclude that apart from its role in controlling the size of the activated T cell pool, CD27 ligation contributes to immunity by facilitating effector T cell differentiation.	Univ Amsterdam, Acad Med Ctr, Dept Immunobiol, CLB,Sanquin Blood Supply Fdn, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Immunobiol, Expt & Clin Immunol Lab, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Expt Immunol Lab, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Netherlands Cancer Institute; Netherlands Cancer Institute	van Lier, RAW (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Immunobiol, CLB,Sanquin Blood Supply Fdn, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Arens, Ramon/V-4010-2018	Arens, Ramon/0000-0001-5058-4110; Borst, Jannie/0000-0002-8043-5009; Tesselaar, Kiki/0000-0002-9847-0814; Pals, Steven/0000-0002-1419-0939; van Lier, Rene/0000-0002-3201-7144				Akiba H, 2000, J EXP MED, V191, P375, DOI 10.1084/jem.191.2.375; Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Boonen GJJC, 1999, EUR J IMMUNOL, V29, P789; BOWMAN MR, 1994, J IMMUNOL, V152, P1756; BROWN GR, 1995, J IMMUNOL, V154, P3686; Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; Couderc B, 1998, CANCER GENE THER, V5, P163; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DeBenedette MA, 1999, J IMMUNOL, V163, P4833; DEJONG R, 1991, J IMMUNOL, V146, P2488; Fournier S, 1997, IMMUNITY, V6, P327, DOI 10.1016/S1074-7613(00)80335-0; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Gamadia LE, 2001, BLOOD, V98, P754, DOI 10.1182/blood.V98.3.754; GARVY BA, 1994, IMMUNOLOGY, V81, P381; GIMBLE JM, 1993, EXP HEMATOL, V21, P224; GOODWIN RG, 1993, CELL, V73, P447, DOI 10.1016/0092-8674(93)90133-B; Gravestein LA, 1998, EUR J IMMUNOL, V28, P2208, DOI 10.1002/(SICI)1521-4141(199807)28:07<2208::AID-IMMU2208>3.0.CO;2-L; GRAVESTEIN LA, 1995, INT IMMUNOL, V7, P551, DOI 10.1093/intimm/7.4.551; GRAWUNDER U, 1993, EUR J IMMUNOL, V23, P544, DOI 10.1002/eji.1830230237; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; HARDY RR, 1982, NATURE, V297, P589, DOI 10.1038/297589a0; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; HINTZEN RQ, 1995, J IMMUNOL, V154, P2612; HINTZEN RQ, 1994, J IMMUNOL, V152, P1762; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Lens SMA, 1996, EUR J IMMUNOL, V26, P2964, DOI 10.1002/eji.1830261223; Lens SMA, 1997, IMMUNOLOGY, V90, P38, DOI 10.1046/j.1365-2567.1997.00134.x; Lens SMA, 1999, BRIT J HAEMATOL, V106, P491, DOI 10.1046/j.1365-2141.1999.01573.x; Lorenz MGO, 1999, HUM GENE THER, V10, P1095, DOI 10.1089/10430349950018094; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Nieland JD, 1998, J IMMUNOTHER, V21, P225, DOI 10.1097/00002371-199805000-00009; Oshima H, 1998, INT IMMUNOL, V10, P517, DOI 10.1093/intimm/10.4.517; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; Screaton G, 2000, CURR OPIN IMMUNOL, V12, P316, DOI 10.1016/S0952-7915(00)00093-5; SETHNA MP, 1994, IMMUNITY, V1, P415, DOI 10.1016/1074-7613(94)90072-8; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; SUGITA K, 1992, J IMMUNOL, V149, P1199; Tan JT, 1999, J IMMUNOL, V163, P4859; Tesselaar K, 1997, J IMMUNOL, V159, P4959; Van Parijs L, 1997, J IMMUNOL, V159, P5336; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; VANLIER RAW, 1987, J IMMUNOL, V139, P1589; Watts TH, 1999, CURR OPIN IMMUNOL, V11, P286, DOI 10.1016/S0952-7915(99)80046-6; Wiesmann A, 2000, IMMUNITY, V12, P193, DOI 10.1016/S1074-7613(00)80172-7; Wiley SR, 1996, J IMMUNOL, V157, P3635; Wolthers KC, 1996, EUR J IMMUNOL, V26, P1700, DOI 10.1002/eji.1830260806; Young HA, 1997, BLOOD, V89, P583, DOI 10.1182/blood.V89.2.583	58	206	222	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2001	15	5					801	812		10.1016/S1074-7613(01)00236-9	http://dx.doi.org/10.1016/S1074-7613(01)00236-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728341	Bronze			2022-12-18	WOS:000172528200012
J	Hiraoka, N; Petryniak, B; Nakayama, J; Tsuboi, S; Suzuki, M; Yeh, JC; Izawa, D; Tanaka, T; Miyasaka, M; Lowe, JB; Fukuda, M				Hiraoka, N; Petryniak, B; Nakayama, J; Tsuboi, S; Suzuki, M; Yeh, JC; Izawa, D; Tanaka, T; Miyasaka, M; Lowe, JB; Fukuda, M			A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34	IMMUNITY			English	Article							ALPHA(1,3)FUCOSYLTRANSFERASE FUC-TVII; CELL-ADHESION MOLECULE; O-GLYCANS; CHONDROITIN 6-SULFOTRANSFERASE; VASCULAR ADDRESSIN; LYMPH-NODES; CLONING; OLIGOSACCHARIDES; IDENTIFICATION; BINDING	L-selectin mediates lymphocyte homing by facilitating lymphocyte adhesion to unique carbohydrate ligands, sulfated sialyl Lewis(x), which are expressed on high endothelial venules (HEV) in secondary lymphoid organs. The nature of the sulfotransferase(s) that contribute to sulfation of such L-selectin counterreceptors has been uncertain. We herein describe a novel L-selectin ligand sulfotransferase, termed LSST, that directs the synthesis of the 6-sulfo sialyl Lewis(x) on L-selectin counterreceptors CD34, GlyCAM-1, and MAdCAM-1. LSST is predominantly expressed in HEV and exhibits striking catalytic preference for core 2-branched mucin-type O-glycans as found in natural L-selectin counterreceptors. LSST enhances L-selectin-mediated adhesion under shear compared to nonsulfated controls. LSST therefore corresponds to an HEV-specific sulfotransferase that contributes to the biosynthesis of L-selectin ligands required for lymphocyte homing.	Burnham Inst, Glycobiol Program, Canc Res Ctr, La Jolla, CA 92037 USA; Univ Michigan, Sch Med, Dept Pathol, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; Osaka Univ, Sch Med, Biomed Res Ctr, Suita, Osaka 5650871, Japan	Sanford Burnham Prebys Medical Discovery Institute; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Shinshu University; Osaka University	Fukuda, M (corresponding author), Burnham Inst, Glycobiol Program, Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	johnlowe@umich.edu; minoru@burnham-inst.org	Tanaka, Toshiyuki/D-1193-2010	Tanaka, Toshiyuki/0000-0003-3659-9994	NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI033189] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA71932] Funding Source: Medline; NIAID NIH HHS [P01AI33189] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; BIERHUIZEN MFA, 1994, J BIOL CHEM, V269, P4473; Bowman KG, 1998, CHEM BIOL, V5, P447, DOI 10.1016/S1074-5521(98)90161-2; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CARLSSON SR, 1986, J BIOL CHEM, V261, P2787; Clark RA, 1998, J CELL BIOL, V140, P721, DOI 10.1083/jcb.140.3.721; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; FUKUDA M, 1986, J BIOL CHEM, V261, P2796; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; Galustian C, 1997, BIOCHEM BIOPH RES CO, V240, P748, DOI 10.1006/bbrc.1997.7737; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; Habuchi O, 1997, GLYCOBIOLOGY, V7, P405, DOI 10.1093/glycob/7.3.405; HANNINEN A, 1993, J CLIN INVEST, V92, P2509, DOI 10.1172/JCI116859; HEMMERICH S, 1994, J EXP MED, V180, P2219, DOI 10.1084/jem.180.6.2219; HEMMERICH S, 1994, BIOCHEMISTRY-US, V33, P4820, DOI 10.1021/bi00182a010; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; IMAI Y, 1993, NATURE, V361, P555; Kakuta Y, 1998, TRENDS BIOCHEM SCI, V23, P129, DOI 10.1016/S0968-0004(98)01182-7; Kimura N, 1999, P NATL ACAD SCI USA, V96, P4530, DOI 10.1073/pnas.96.8.4530; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; MAEMURA K, 1992, J BIOL CHEM, V267, P24379; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MICHIE SA, 1995, AM J PATHOL, V147, P412; MICHIE SA, 1993, AM J PATHOL, V143, P1688; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; NAGASAWA K, 1979, J BIOCHEM-TOKYO, V86, P1323, DOI 10.1093/oxfordjournals.jbchem.a132648; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; SALMI M, 1994, GASTROENTEROLOGY, V106, P596, DOI 10.1016/0016-5085(94)90691-2; Sanders WJ, 1996, BIOCHEMISTRY-US, V35, P14862, DOI 10.1021/bi9613640; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; SAWADA R, 1994, J BIOL CHEM, V269, P1425; SCHACHTER H, 1994, MOL GLYCOBIOLOGY, P88; Smith PL, 1996, J BIOL CHEM, V271, P8250, DOI 10.1074/jbc.271.14.8250; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STANLEY P, 1975, P NATL ACAD SCI USA, V72, P3323, DOI 10.1073/pnas.72.9.3323; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; SUDA J, 1992, BLOOD, V79, P2288; TORII T, 1998, SEIKAGAKU, V70, P963; Tsuboi S, 1997, EMBO J, V16, P6364, DOI 10.1093/emboj/16.21.6364; Tsuboi S, 1996, J BIOL CHEM, V271, P27213, DOI 10.1074/jbc.271.44.27213; TURUNEN JP, 1995, J EXP MED, V182, P1133, DOI 10.1084/jem.182.4.1133; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; Ujita M, 1998, J BIOL CHEM, V273, P34843, DOI 10.1074/jbc.273.52.34843; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215	55	206	208	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1999	11	1					79	89		10.1016/S1074-7613(00)80083-7	http://dx.doi.org/10.1016/S1074-7613(00)80083-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220ND	10435581	Bronze			2022-12-18	WOS:000081671300008
J	Huang, S; Jiang, Y; Li, ZJ; Nishida, E; Mathias, P; Lin, SC; Ulevitch, RJ; Nemerow, GR; Han, JH				Huang, S; Jiang, Y; Li, ZJ; Nishida, E; Mathias, P; Lin, SC; Ulevitch, RJ; Nemerow, GR; Han, JH			Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b	IMMUNITY			English	Article							POLY(ADP-RIBOSE) POLYMERASE; RECEPTOR SUPERFAMILY; ADENOVIRUS VECTORS; MOLECULAR-CLONING; SURFACE ANTIGEN; FAS LIGAND; DEATH; ACTIVATION; ENDOTOXIN; PHOSPHORYLATION	Fas/APO-1(CD95) ligation activates programmed cell death, a cellular process that plays an important role in the maturation of the host immune response. We show that activation of a specific MAP kinase kinase (MKK), MKK6b, is necessary and sufficient for Fas-induced apoptosis of Jurkat T cells. MKK6b activation occurs downstream of an interleukin-1 converting enzyme-like (ICE-like) protease(s), while execution of the apoptotic pathway by MKK6b requires both ICE- and CPP32-like proteases. Surprisingly, the p38 MAP kinase protein, a known substrate of MKK6b, does not participate in Fas/MKK6b-mediated apoptosis. These findings indicate a divergence of the MKK6b signaling pathways, one of which activates p38 and leads to regulation of gene expression, and one of which activates the ICE/Ced-3 family of proteases and leads to cell death. These studies represent a demonstration of an apoptotic pathway that is comprised of both the ICE/Ced-3 family of proteases and MAP kinase kinase 6.	KYOTO UNIV, INST VIRUS RES, SAKYO KU, KYOTO 60601, JAPAN; NATL UNIV SINGAPORE, INST MOL & CELL BIOL, SINGAPORE 119260, SINGAPORE	Kyoto University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Huang, S (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.		Lin, SC/G-4666-2010; Ulevitch, Richard J/Q-3393-2017; Han, J/G-4671-2010		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015136] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54352] Funding Source: Medline; NIAID NIH HHS [AI15136] Funding Source: Medline; NIGMS NIH HHS [GM51417] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbas AK, 1996, CELL, V84, P655, DOI 10.1016/S0092-8674(00)81042-9; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; CHANG MW, 1995, J CLIN INVEST, V96, P2260, DOI 10.1172/JCI118281; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; CHOW SC, 1995, FEBS LETT, V364, P134, DOI 10.1016/0014-5793(95)00370-O; CLEVELAND JL, 1995, CELL, V81, P479, DOI 10.1016/0092-8674(95)90068-3; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; FEARNHEAD HO, 1995, FEBS LETT, V375, P283, DOI 10.1016/0014-5793(95)01228-7; FRAZER A, 1996, CELL, V85, P781; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; GULBINS E, 1995, IMMUNITY, V2, P341, DOI 10.1016/1074-7613(95)90142-6; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Han JH, 1997, FEBS LETT, V403, P19, DOI 10.1016/S0014-5793(97)00021-5; HAN JH, 1993, J BIOL CHEM, V268, P25009; Hasegawa J, 1996, CANCER RES, V56, P1713; Henkart PA, 1996, IMMUNITY, V4, P195, DOI 10.1016/S1074-7613(00)80428-8; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229; JOMARY C, 1994, FEBS LETT, V347, P117, DOI 10.1016/0014-5793(94)00512-5; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lenczowski JM, 1997, MOL CELL BIOL, V17, P170, DOI 10.1128/MCB.17.1.170; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; Moriguchi T, 1996, J BIOL CHEM, V271, P26981, DOI 10.1074/jbc.271.43.26981; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAKAJIMA H, 1995, J EXP MED, V181, P1905, DOI 10.1084/jem.181.5.1905; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; NISHINA N, 1997, NATURE, V385, P350; OEHM A, 1992, J BIOL CHEM, V267, P10709; Pronk GJ, 1996, SCIENCE, V271, P808, DOI 10.1126/science.271.5250.808; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Schlegel J, 1996, J BIOL CHEM, V271, P1841, DOI 10.1074/jbc.271.4.1841; SCHULZEOSTHOFF K, 1994, J CELL BIOL, V127, P15, DOI 10.1083/jcb.127.1.15; Shi LF, 1996, P NATL ACAD SCI USA, V93, P11002, DOI 10.1073/pnas.93.20.11002; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099; Stein B, 1996, J BIOL CHEM, V271, P11427, DOI 10.1074/jbc.271.19.11427; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wilson DJ, 1996, EUR J IMMUNOL, V26, P989, DOI 10.1002/eji.1830260505; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	66	206	217	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1997	6	6					739	749		10.1016/S1074-7613(00)80449-5	http://dx.doi.org/10.1016/S1074-7613(00)80449-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XG579	9208846	Bronze			2022-12-18	WOS:A1997XG57900009
J	Xu, Y; Cheng, GH; Baltimore, D				Xu, Y; Cheng, GH; Baltimore, D			Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses	IMMUNITY			English	Article							NECROSIS-FACTOR RECEPTOR; NF-KAPPA-B; CD40 LIGAND; CYTOPLASMIC DOMAIN; MICE LACKING; FAMILY; ACTIVATION; SIGNAL; CELLS; PROTEINS	TRAF3 was found as a protein that binds to the cytoplasmic tail of CD40 but is part of a family of proteins with common structure and activity. To clarify the physiological roles of TRAF3, we introduced a TRAF3 null mutation in mice through homologous recombination. TRAF3-deficient mice appear normal at birth but become progressively runted, correlating with progressive hypoglycemia and depletion of peripheral white cells. The mutant mice die by 10 days of age. Fetal liver cells from TRAF3-deficient embryos can reconstitute all hematopoietic lineages in lethally irradiated mice. However, these reconstituted mice are impaired in their immune responses to T-dependent antigen, and their T cells are functionally defective. These findings indicate that TRAF3 is required for postnatal development and for a competent immune system.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)				Xu, Yang/0000-0001-5574-921X				ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; Baker SJ, 1996, ONCOGENE, V12, P1; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; ELLIS TM, 1993, J IMMUNOL, V151, P2380; Gedrich RW, 1996, J BIOL CHEM, V271, P12852, DOI 10.1074/jbc.271.22.12852; GORDON J, 1995, BLOOD REV, V9, P53, DOI 10.1016/0268-960X(95)90040-3; GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; HINTZEN RQ, 1995, J IMMUNOL, V154, P2612; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; HU HM, 1994, J BIOL CHEM, V269, P30069; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kehry M R, 1994, Semin Immunol, V6, P287, DOI 10.1006/smim.1994.1037; Lee SY, 1996, J EXP MED, V183, P669, DOI 10.1084/jem.183.2.669; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MCDONALD PP, 1995, EUR J IMMUNOL, V25, P2870, DOI 10.1002/eji.1830251024; MEYAARD L, 1995, EUR J IMMUNOL, V25, P232, DOI 10.1002/eji.1830250138; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Noelle RJ, 1996, IMMUNITY, V4, P415, DOI 10.1016/S1074-7613(00)80408-2; PROBERT L, 1993, J IMMUNOL, V151, P1894; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SATO T, 1995, FEBS LETT, V358, P113, DOI 10.1016/0014-5793(94)01406-Q; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4	33	206	220	2	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1996	5	5					407	415		10.1016/S1074-7613(00)80497-5	http://dx.doi.org/10.1016/S1074-7613(00)80497-5			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VV658	8934568	Bronze			2022-12-18	WOS:A1996VV65800002
J	Druzd, D; Matveeva, O; Ince, L; Harrison, U; He, WY; Schmal, C; Herzel, H; Tsang, AH; Kawakami, N; Leliavski, A; Uhl, O; Yao, L; Sander, LE; Chen, CS; Kraus, K; de Juan, A; Hergenhan, SM; Ehlers, M; Koletzko, B; Haas, R; Solbach, W; Oster, H; Scheiermann, C				Druzd, David; Matveeva, Olga; Ince, Louise; Harrison, Ute; He, Wenyan; Schmal, Christoph; Herzel, Hanspeter; Tsang, Anthony H.; Kawakami, Naoto; Leliavski, Alexei; Uhl, Olaf; Yao, Ling; Sander, Leif Erik; Chen, Chien-Sin; Kraus, Kerstin; de Juan, Alba; Hergenhan, Sophia Martina; Ehlers, Marc; Koletzko, Berthold; Haas, Rainer; Solbach, Werner; Oster, Henrik; Scheiermann, Christoph			Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune Responses	IMMUNITY			English	Article							MORNING VACCINATION; ANTIBODY-RESPONSE; NAIVE CD4(+); T-CELLS; SPHINGOSINE-1-PHOSPHATE; EGRESS; DIFFERENTIATION; RECIRCULATION; OSCILLATIONS; INFLAMMATION	Lymphocytes circulate through lymph nodes (LN) in search for antigen in what is believed to be a continuous process. Here, we show that lymphocyte migration through lymph nodes and lymph occurred in a non-continuous, circadianmanner. Lymphocytehoming to lymph nodes peaked at night onset, with cells leaving the tissue during the day. This resulted in strong oscillations in lymphocyte cellularity in lymph nodes and efferent lymphatic fluid. Using lineage-specific genetic ablation of circadian clock function, we demonstrated this to be dependent on rhythmic expression of promigratory factors on lymphocytes. Dendritic cell numbers peaked in phase with lymphocytes, with diurnal oscillations being present in disease severity after immunization to induce experimental autoimmune encephalomyelitis (EAE). These rhythms were abolished by genetic disruption of T cell clocks, demonstrating a circadian regulation of lymphocyte migration through lymph nodes with time-of-day ofimmunization being critical for adaptive immune responses weeks later.	[Druzd, David; Ince, Louise; He, Wenyan; Chen, Chien-Sin; Kraus, Kerstin; de Juan, Alba; Hergenhan, Sophia Martina; Scheiermann, Christoph] Ludwig Maximilians Univ Munchen, Walter Brendel Ctr Expt Med, BioMed Ctr, D-82152 Planegg Martinsried, Germany; [Matveeva, Olga; Tsang, Anthony H.; Oster, Henrik] Univ Lubeck, Dept Med 1, D-23562 Lubeck, Germany; [Harrison, Ute; Haas, Rainer] Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; [Schmal, Christoph] Charite, D-10117 Berlin, Germany; [Herzel, Hanspeter] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Kawakami, Naoto] Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, Biomed Ctr, D-82152 Planegg Martinsried, Germany; [Leliavski, Alexei; Ehlers, Marc] Univ Lubeck, Inst Nutr Med, Immunol Lab, D-23562 Lubeck, Germany; [Uhl, Olaf; Koletzko, Berthold] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Univ Munich Med Ctr, D-80337 Munich, Germany; [Yao, Ling; Sander, Leif Erik] Charite, Dept Infect Dis & Pulm Med, D-10117 Berlin, Germany; [Solbach, Werner] Univ Lubeck, Ctr Infect & Inflammat, Lubeck, Germany	University of Munich; University of Lubeck; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; University of Munich; University of Lubeck; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck	Scheiermann, C (corresponding author), Ludwig Maximilians Univ Munchen, Walter Brendel Ctr Expt Med, BioMed Ctr, D-82152 Planegg Martinsried, Germany.	christoph.scheiermann@med.uni-muenchen.de	Solbach, Werner/O-8582-2015; Ehlers, Marc/C-9441-2011; Chen, Chien-Sin/AAT-4242-2021; Ince, Louise/K-6149-2019; Schmal, Christoph/AAM-2311-2020; Oster, Henrik/O-4426-2019; Scheiermann, Christoph/B-8261-2014; Sander, Leif Erik/AAI-8619-2020; Leliavski, Alexei/N-9333-2017	Solbach, Werner/0000-0002-3608-8652; Ehlers, Marc/0000-0002-5383-8603; Chen, Chien-Sin/0000-0002-5847-1441; Ince, Louise/0000-0002-2093-0876; Oster, Henrik/0000-0002-1414-7068; Scheiermann, Christoph/0000-0002-9212-0995; Matveeva, Olga/0000-0001-8032-810X; Yao, Ling/0000-0002-0482-9604; Leliavski, Alexei/0000-0003-0279-9226; de Juan, Alba/0000-0003-0174-4389; Sander, Leif Erik/0000-0002-0476-9947; Uhl, Olaf/0000-0001-8064-7717; Tsang, Anthony/0000-0002-3673-6365; Kawakami, Naoto/0000-0001-7693-3489	German Research Foundation (DFG) [SCHE 1645/2-1, SFB914, SFB654, TR128, SFB-TR84, BO 3612/2-1]; European Research Council (ERC) [635872]; Else Kroner Fresenius Foundation (EKFS) [2012_A56]	German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)); Else Kroner Fresenius Foundation (EKFS)	We thank Reinhold Forster and Leandro Moschovakis for providing Ccr<SUP>7-/-</SUP> mice, Steffen Massberg, Markus Sperandio, and Martha Merrow for critical comments on the manuscript and Victor Lavilla for designing the video. This work was supported by the German Research Foundation (DFG) (Emmy-Noether grant (SCHE 1645/2-1) and SFB914 projects B09 and Z03 to C. Scheiermann, SFB914 project B05 to R.H., SFB654 project C08 to W.S. and H.O., TR128 project B10 and a Heisenberg fellowship to N.K., SFB-TR84 project C08 to L.E.S., C. Schmal and H.H. are supported by BO 3612/2-1. C. Scheiermann holds a European Research Council (ERC) starting grant (635872, CIRCODE). H.O. is a Lichtenberg fellow of the Volkswagen Foundation. L.E.S. and L.Y. are supported by the Else Kroner Fresenius Foundation (EKFS, 2012_A56 to L.E.S.).	Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618; Arjona A, 2012, TRENDS IMMUNOL, V33, P607, DOI 10.1016/j.it.2012.08.007; Bollinger T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029801; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Esquifino AI, 1996, BRAIN BEHAV IMMUN, V10, P92, DOI 10.1006/brbi.1996.0010; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fortier EE, 2011, J IMMUNOL, V187, P6291, DOI 10.4049/jimmunol.1004030; Gasteiger G, 2016, IMMUNOL REV, V271, P200, DOI 10.1111/imr.12399; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; Hemmers S, 2015, CELL REP, V11, P1339, DOI 10.1016/j.celrep.2015.04.058; Kawakami N, 2012, IMMUNOL REV, V248, P140, DOI 10.1111/j.1600-065X.2012.01133.x; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Labrecque N, 2015, J BIOL RHYTHM, V30, P277, DOI 10.1177/0748730415577723; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Long JE, 2016, VACCINE, V34, P2679, DOI 10.1016/j.vaccine.2016.04.032; Lucas D, 2008, CELL STEM CELL, V3, P364, DOI 10.1016/j.stem.2008.09.004; Mandl JN, 2012, P NATL ACAD SCI USA, V109, P18036, DOI 10.1073/pnas.1211717109; Massberg S, 2006, NEW ENGL J MED, V355, P1088, DOI 10.1056/NEJMp068159; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Phillips AC, 2008, PSYCHOPHYSIOLOGY, V45, P663, DOI 10.1111/j.1469-8986.2008.00662.x; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Silver AC, 2012, BRAIN BEHAV IMMUN, V26, P407, DOI 10.1016/j.bbi.2011.10.001; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sun YM, 2006, IMMUNOLOGY, V119, P451, DOI 10.1111/j.1365-2567.2006.02456.x; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884	45	205	210	3	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					120	132		10.1016/j.immuni.2016.12.011	http://dx.doi.org/10.1016/j.immuni.2016.12.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28087238	Green Published, hybrid			2022-12-18	WOS:000392918300015
J	Durai, V; Murphy, KM				Durai, Vivek; Murphy, Kenneth M.			Functions of Murine Dendritic Cells	IMMUNITY			English	Review							DIPHTHERIA-TOXIN RECEPTOR; INNATE LYMPHOID-CELLS; ANTIGEN-PRESENTING CELLS; NATURAL-KILLER-CELLS; IN-VIVO DEPLETION; REGULATORY T-CELLS; ADENOSINE-DIPHOSPHATE RIBOSYLATION; EFFACING BACTERIAL PATHOGENS; LEISHMANIA-MAJOR INFECTION; HELPER TYPE-2 RESPONSE		[Durai, Vivek; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Durai, V; Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.	duraiv@wustl.edu; kmurphy@wustl.edu			NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK108498] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCATS NIH HHS [UL1 TR000448] Funding Source: Medline; NCI NIH HHS [P30 CA091842] Funding Source: Medline; NIAID NIH HHS [R01 AI049653] Funding Source: Medline; NIDDK NIH HHS [F30 DK108498] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Alexandre YO, 2016, J EXP MED, V213, P75, DOI 10.1084/jem.20142350; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Arnold IC, 2016, MUCOSAL IMMUNOL, V9, P352, DOI 10.1038/mi.2015.65; Ashok D, 2014, EUR J IMMUNOL, V44, P1422, DOI 10.1002/eji.201344242; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Bajana S, 2016, J IMMUNOL, V196, P1666, DOI 10.4049/jimmunol.1501870; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; BREITMAN ML, 1990, MOL CELL BIOL, V10, P474, DOI 10.1128/MCB.10.2.474; Briseno CG, 2016, CELL REP, V15, P2462, DOI 10.1016/j.celrep.2016.05.025; Briseno CG, 2014, CURR OPIN IMMUNOL, V29, P69, DOI 10.1016/j.coi.2014.04.006; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Calabro S, 2016, J EXP MED, V213, P887, DOI 10.1084/jem.20151720; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chu DK, 2014, J EXP MED, V211, P1657, DOI 10.1084/jem.20131800; Ciavarra RP, 2006, J IMMUNOL, V177, P492, DOI 10.4049/jimmunol.177.1.492; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Cuda CM, 2014, J IMMUNOL, V192, P5548, DOI 10.4049/jimmunol.1400122; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; de Jong JMH, 2006, IMMUNOLOGY, V119, P499, DOI 10.1111/j.1365-2567.2006.02464.x; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Esterhazy D, 2016, NAT IMMUNOL, V17, P545, DOI 10.1038/ni.3408; Everts B, 2016, J EXP MED, V213, P35, DOI 10.1084/jem.20150235; Ferris ST, 2014, IMMUNITY, V41, P657, DOI 10.1016/j.immuni.2014.09.012; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Fukaya T, 2012, P NATL ACAD SCI USA, V109, P11288, DOI 10.1073/pnas.1202208109; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gainey MD, 2012, P NATL ACAD SCI USA, V109, pE3260, DOI 10.1073/pnas.1217111109; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Geem D, 2014, J IMMUNOL, V193, P431, DOI 10.4049/jimmunol.1303167; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guimond M, 2010, J IMMUNOL, V184, P2769, DOI 10.4049/jimmunol.0900685; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Han D, 2013, IMMUNITY, V38, P1211, DOI 10.1016/j.immuni.2013.05.012; Headley MB, 2016, NATURE, V531, P513, DOI 10.1038/nature16985; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hochweller K, 2008, EUR J IMMUNOL, V38, P2776, DOI 10.1002/eji.200838659; HONJO T, 1968, J BIOL CHEM, V243, P3553; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Hua ZL, 2014, J IMMUNOL, V192, P875, DOI 10.4049/jimmunol.1300683; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Kassim SH, 2006, J VIROL, V80, P3985, DOI 10.1128/JVI.80.8.3985-3993.2006; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim TS, 2010, J EXP MED, V207, P1161, DOI 10.1084/jem.20092017; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Lamagna C, 2013, P NATL ACAD SCI USA, V110, pE3311, DOI 10.1073/pnas.1300617110; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Lau LS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004135; Lauterbach H, 2006, J EXP MED, V203, P1963, DOI 10.1084/jem.20060039; Lauvau G, 2015, SEMIN IMMUNOL, V27, P397, DOI 10.1016/j.smim.2016.03.014; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Leventhal DS, 2016, IMMUNITY, V44, P847, DOI 10.1016/j.immuni.2016.01.025; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Linehan JL, 2015, P NATL ACAD SCI USA, V112, P12782, DOI 10.1073/pnas.1513532112; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Loschko J, 2016, J IMMUNOL METHODS, V434, P32, DOI 10.1016/j.jim.2016.04.004; Loschko J, 2016, J EXP MED, V213, P517, DOI 10.1084/jem.20160062; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Luda KM, 2016, IMMUNITY, V44, P860, DOI 10.1016/j.immuni.2016.02.008; Male V, 2014, J EXP MED, V211, P635, DOI 10.1084/jem.20132398; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Martinez-Lopez M, 2015, EUR J IMMUNOL, V45, P119, DOI 10.1002/eji.201444651; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; Milanovic M, 2008, J IMMUNOL, V181, P5045, DOI 10.4049/jimmunol.181.7.5045; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; MITAMURA T, 1995, J BIOL CHEM, V270, P1015, DOI 10.1074/jbc.270.3.1015; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Muzaki ARBM, 2016, MUCOSAL IMMUNOL, V9, P336, DOI 10.1038/mi.2015.64; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Nopora K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00348; NUSSENZWEIG MC, 1980, J EXP MED, V152, P1070, DOI 10.1084/jem.152.4.1070; NUSSENZWEIG MC, 1982, P NATL ACAD SCI-BIOL, V79, P161, DOI 10.1073/pnas.79.1.161; Ochiai S, 2014, J IMMUNOL, V193, P2504, DOI 10.4049/jimmunol.1400536; Ohta T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23505; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Orr SL, 2013, GLYCOBIOLOGY, V23, P363, DOI 10.1093/glycob/cws150; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Panea C, 2015, CELL REP, V12, P1314, DOI 10.1016/j.celrep.2015.07.040; PAPPENHEIMER AM, 1982, J INFECT DIS, V145, P94, DOI 10.1093/infdis/145.1.94; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; PERUSSIA B, 1985, Natural Immunity and Cell Growth Regulation, V4, P120; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Piva L, 2012, J IMMUNOL, V189, P1128, DOI 10.4049/jimmunol.1201171; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Probst HC, 2005, J IMMUNOL, V174, P3920, DOI 10.4049/jimmunol.174.7.3920; Puttur F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003648; Reboldi A, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4822; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; ROBINSON EA, 1974, J BIOL CHEM, V249, P5088; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Samstein M, 2013, ELIFE, V2, DOI 10.7554/eLife.01086; Sanchez-Paulete AR, 2016, CANCER DISCOV, V6, P71, DOI 10.1158/2159-8290.CD-15-0510; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Sasaki H, 2015, BLOOD, V125, P358, DOI 10.1182/blood-2014-02-557983; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Scarlett UK, 2012, J EXP MED, V209, P495, DOI 10.1084/jem.20111413; SchartonKersten T, 1997, J EXP MED, V186, P1523, DOI 10.1084/jem.186.9.1523; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schleicher U, 2007, J EXP MED, V204, P893, DOI 10.1084/jem.20061293; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Sharma Suveena, 2014, Curr Protoc Immunol, V105, DOI 10.1002/0471142735.im1034s105; Shimizu K, 2007, J EXP MED, V204, P2641, DOI 10.1084/jem.20070458; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Smith KA, 2012, INFECT IMMUN, V80, P3481, DOI 10.1128/IAI.00436-12; Smith KA, 2011, J IMMUNOL, V186, P7098, DOI 10.4049/jimmunol.1003636; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1979, J EXP MED, V149, P1, DOI 10.1084/jem.149.1.1; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Swiecki M, 2014, J IMMUNOL, V192, P4409, DOI 10.4049/jimmunol.1303135; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Teichmann LL, 2013, IMMUNITY, V38, P528, DOI 10.1016/j.immuni.2012.11.017; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; Torti N, 2011, EUR J IMMUNOL, V41, P2612, DOI 10.1002/eji.201041075; Trautwein-Weidner K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005164; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; van Blijswijk J, 2015, J IMMUNOL, V194, P307, DOI 10.4049/jimmunol.1401999; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; VANNESS BG, 1980, J BIOL CHEM, V255, P717; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Waithman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066136; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Welty NE, 2013, J EXP MED, V210, P2011, DOI 10.1084/jem.20130728; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zaft T, 2005, J IMMUNOL, V175, P6428, DOI 10.4049/jimmunol.175.10.6428; Zahner SP, 2011, J IMMUNOL, V187, P5069, DOI 10.4049/jimmunol.1101880; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	220	205	210	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					719	736		10.1016/j.immuni.2016.10.010	http://dx.doi.org/10.1016/j.immuni.2016.10.010			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760337	Bronze, Green Accepted			2022-12-18	WOS:000389473200007
J	Zeng, MY; Cisalpino, D; Varadarajan, S; Hellman, J; Warren, HS; Cascalho, M; Inohara, N; Nunez, G				Zeng, Melody Y.; Cisalpino, Daniel; Varadarajan, Saranyaraajan; Hellman, Judith; Warren, H. Shaw; Cascalho, Marilia; Inohara, Naohiro; Nunez, Gabriel			Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens	IMMUNITY			English	Article							PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN; TOLL-LIKE RECEPTORS; MEMBRANE PROTEIN-A; MUREIN-LIPOPROTEIN; ESCHERICHIA-COLI; COMMENSAL BACTERIA; NATURAL IGG; RESPONSES; CELLS; SEPSIS	The gut microbiota is compartmentalized in the intestinal lumen and induces local immune responses, but it remains unknown whether the gut microbiota can induce systemic response and contribute to systemic immunity. We report that selective gut symbiotic gram-negative bacteria were able to disseminate systemically to induce immunoglobulin G (IgG) response, which primarily targeted gram-negative bacterial antigens and conferred protection against systemic infections by E. coli and Salmonella by directly coating bacteria to promote killing by phagocytes. T cells and Toll-like receptor 4 on B cells were important in the generation of microbiota-specific IgG. We identified murein lipoprotein (MLP), a highly conserved gram-negative outer membrane protein, as a major antigen that induced systemic IgG homeostatically in both mice and humans. Administration of anti-MLP IgG conferred crucial protection against systemic Salmonella infection. Thus, our findings reveal an important function for the gut microbiota in combating systemic infection through the induction of protective IgG.	[Zeng, Melody Y.; Cisalpino, Daniel; Varadarajan, Saranyaraajan; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Zeng, Melody Y.; Cisalpino, Daniel; Varadarajan, Saranyaraajan; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Cisalpino, Daniel] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil; [Hellman, Judith] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Div Crit Care Med, San Francisco, CA 94110 USA; [Warren, H. Shaw] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA; [Cascalho, Marilia] Univ Michigan, Sch Med, Dept Surg, Transplantat Biol, Ann Arbor, MI 48109 USA; [Cascalho, Marilia] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universidade Federal de Minas Gerais; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.; Nunez, G (corresponding author), Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	gabriel.nunez@umich.edu	Nuñez, Gabriel/A-7160-2014	Cisalpino, Daniel/0000-0003-1611-0661; Varadarajan, Saranyaraajan/0000-0002-4473-9435	NIH [T32DK094775, T32HL007517, R01 GM59694, 5R21AI117561, DK091191, DK095782]; University of Michigan Center for Gastrointestinal Research [NIH 5P30DK034933]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095782, T32DK094775, R01DK091191, P30DK034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Center for Gastrointestinal Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Kamada for suggestions and critical reading of the manuscript, W.V. Giannobile (University of Michigan School of Dentistry) for providing human serum samples, and L. Burmeister for mouse care and husbandry. We appreciate assistance from Joel Whitfield from the University of Michigan ELISA Core, the Flow Cytometry Core, the Gnotobiotic Animal Facility, and the Host Microbiome Initiative at the University of Michigan Medical School. D.C. was an exchange student from the PDSE program of the CAPES agency from Brazil. M.Y.Z. was supported by NIH training grants T32DK094775 and T32HL007517 and received additional research support from the University of Michigan Center for Gastrointestinal Research (NIH 5P30DK034933). This work was supported by NIH grants R01 GM59694 (H.S.W.), 5R21AI117561 (M.C.), and DK091191 and DK095782 (G.N.).	Alejandria MM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001090.pub2; Almansa R, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0793-0; Alverdy JC, 2008, J LEUKOCYTE BIOL, V83, P461, DOI 10.1189/jlb.0607372; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Cascalho M, 1997, J IMMUNOL, V159, P5795; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; Geuking MB, 2012, SEMIN IMMUNOL, V24, P36, DOI 10.1016/j.smim.2011.11.005; Haas A, 2011, GUT, V60, P1506, DOI 10.1136/gut.2010.224774; Harmsen HJM, 2012, CLIN VACCINE IMMUNOL, V19, P515, DOI 10.1128/CVI.05517-11; Hasegawa M, 2014, IMMUNITY, V41, P620, DOI 10.1016/j.immuni.2014.09.010; Hellman J, 2001, J ENDOTOXIN RES, V7, P69, DOI 10.1177/09680519010070010101; Hellman J, 2000, INFECT IMMUN, V68, P2566, DOI 10.1128/IAI.68.5.2566-2572.2000; Hofer U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000867; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kang CI, 2004, ANTIMICROB AGENTS CH, V48, P4574, DOI 10.1128/AAC.48.12.4574-4581.2004; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Kubinak JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002785; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Liang MD, 2005, J INFECT DIS, V191, P939, DOI 10.1086/427815; MacFie J, 2004, BRIT MED BULL, V71, P1, DOI 10.1093/bmb/ldh029; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2013, SEMIN IMMUNOL, V25, P358, DOI 10.1016/j.smim.2013.09.004; Macpherson AJ, 2012, IMMUNOL REV, V245, P132, DOI 10.1111/j.1600-065X.2011.01072.x; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Rodriguez JM, 2015, MICROB ECOL HEALTH D, V26, DOI 10.3402/mehd.v26.26050; Panda S, 2013, EMBO J, V32, P2905, DOI 10.1038/emboj.2013.199; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Puga I, 2013, EMBO J, V32, P2897, DOI 10.1038/emboj.2013.235; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; SEDMAN PC, 1994, GASTROENTEROLOGY, V107, P643, DOI 10.1016/0016-5085(94)90110-4; Shankar-Hari M, 2012, CRIT CARE, V16, DOI 10.1186/cc10597; Shin HS, 2011, J IMMUNOL, V186, P1119, DOI 10.4049/jimmunol.1001647; SUZUKI H, 1978, MOL GEN GENET, V167, P1; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Thoene-Reineke C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113406; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991	45	205	215	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					647	658		10.1016/j.immuni.2016.02.006	http://dx.doi.org/10.1016/j.immuni.2016.02.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26944199	Green Accepted, Bronze			2022-12-18	WOS:000372784200021
J	Maazi, H; Patel, N; Sankaranarayanan, I; Suzuki, Y; Rigas, D; Soroosh, P; Freeman, GJ; Sharpe, AH; Akbari, O				Maazi, Hadi; Patel, Nisheel; Sankaranarayanan, Ishwarya; Suzuki, Yuzo; Rigas, Diamanda; Soroosh, Pejman; Freeman, Gordon J.; Sharpe, Arlene H.; Akbari, Omid			ICOS:ICOS-Ligand Interaction Is Required for Type 2 Innate Lymphoid Cell Function, Homeostasis, and Induction of Airway Hyperreactivity	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA3; HUMAN INTERLEUKIN-5; MOLECULE ICOS; DIFFERENTIATION; EXPRESSION; RECEPTOR; STAT5; IL-33; IL-13; IDENTIFICATION	Allergic asthma is caused by Th2-cell-type cytokines in response to allergen exposure. Type 2 innate lymphoid cells (ILC2s) are a newly identified subset of immune cells that, along with Th2 cells, contribute to the pathogenesis of asthma by producing copious amounts of IL-5 and IL-13, which cause eosinophilia and airway hyperreactivity (AHR), a cardinal feature of asthma. ILC2s express ICOS, a T cell costimulatory molecule with a currently unknown function. Here we showed that a lack of ICOS on murine ILC2s and blocking the ICOS: ICOS-ligand interaction in human ILC2s reduced AHR and lung inflammation. ILC2s expressed both ICOS and ICOS-ligand, and the ICOS: ICOS-ligand interaction promoted cytokine production and survival in ILC2s through STAT5 signaling. Thus, ICOS: ICOS-ligand signaling pathway is critically involved in ILC2 function and homeostasis.	[Maazi, Hadi; Patel, Nisheel; Sankaranarayanan, Ishwarya; Suzuki, Yuzo; Rigas, Diamanda; Akbari, Omid] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Soroosh, Pejman] Janssen Res & Dev, San Diego, CA 92121 USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med,Dept Med Oncol, Boston, MA 02115 USA; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	University of Southern California; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Akbari, O (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	akbari@usc.edu	Freeman, Gordon/AAC-5380-2019; Suzuki, Yuzo/AAE-6747-2020; Soroosh, Pejman/AAD-8386-2021	Freeman, Gordon/0000-0002-7210-5616; Suzuki, Yuzo/0000-0001-6154-9791; Maazi, Hadi/0000-0002-8979-3769	National Institutes of Health public health service [R01 AI 066020, R01 ES 021801, R21 ES 024707, P01 AI 056299]; American Association of Immunology (AAI) Careers in Immunology Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056299, R01AI066020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024707, P30ES007048, R01ES021801] Funding Source: NIH RePORTER	National Institutes of Health public health service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); American Association of Immunology (AAI) Careers in Immunology Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Studies described in this article were financially supported by National Institutes of Health public health service grants R01 AI 066020, R01 ES 021801, R21 ES 024707 (O.A.), and P01 AI 056299 (G.J.F. and A.H.S.). H.M. is supported by an American Association of Immunology (AAI) Careers in Immunology Fellowship.	Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Burmeister Y, 2008, J IMMUNOL, V180, P774, DOI 10.4049/jimmunol.180.2.774; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gonzalo JA, 2001, NAT IMMUNOL, V2, P597, DOI 10.1038/89739; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; Hoyler T, 2013, CURR OPIN IMMUNOL, V25, P139, DOI 10.1016/j.coi.2013.02.007; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; INGLEY E, 1991, EUR J BIOCHEM, V196, P623, DOI 10.1111/j.1432-1033.1991.tb15858.x; Junttila IS, 2013, J ALLERGY CLIN IMMUN, V132, P704, DOI 10.1016/j.jaci.2013.03.033; Kerzerho J, 2013, J ALLERGY CLIN IMMUN, V131, P1048, DOI 10.1016/j.jaci.2012.09.027; Kim HK, 2014, INT ARCH ALLERGY IMM, V163, P92, DOI 10.1159/000356341; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; Qian XS, 2006, EUR J IMMUNOL, V36, P906, DOI 10.1002/eji.200535253; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; TAVERNIER J, 1995, P NATL ACAD SCI USA, V92, P5194, DOI 10.1073/pnas.92.11.5194; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2351, DOI 10.1038/jid.2014.146; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Watanabe M, 2008, J IMMUNOL, V180, P5222, DOI 10.4049/jimmunol.180.8.5222; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	44	205	214	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					538	551		10.1016/j.immuni.2015.02.007	http://dx.doi.org/10.1016/j.immuni.2015.02.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25769613	Bronze, Green Accepted			2022-12-18	WOS:000351301900017
J	Behnsen, J; Jellbauer, S; Wong, CP; Edwards, RA; George, MD; Ouyang, WJ; Raffatellu, M				Behnsen, Judith; Jellbauer, Stefan; Wong, Christina P.; Edwards, Robert A.; George, Michael D.; Ouyang, Wenjun; Raffatellu, Manuela			The Cytokine IL-22 Promotes Pathogen Colonization by Suppressing Related Commensal Bacteria	IMMUNITY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INNATE IMMUNE-RESPONSE; MUCOSAL HOST-DEFENSE; SALMONELLA-ENTERICA; SEROTYPE TYPHIMURIUM; INTESTINAL MICROBIOTA; GENE-CLUSTER; INFLAMED GUT; INFLAMMATION; RECEPTOR	Interleukin-22 (IL-22) is highly induced in response to infections with a variety of pathogens, and its main functions are considered to be tissue repair and host defense at mucosal surfaces. Here we showed that IL-22 has a unique role during infection in that its expression suppressed the intestinal microbiota and enhanced the colonization of a pathogen. IL-22 induced the expression of antimicrobial proteins, including lipocalin-2 and calprotectin, which sequester essential metal ions from microbes. Because Salmonella enterica ser. Typhimurium can overcome metal ion starvation mediated by lipocalin-2 and calprotectin via alternative pathways, IL-22 boosted its colonization of the inflamed intestine by suppressing commensal Enterobacteriaceae, which are susceptible to the antimicrobial proteins. Thus, IL-22 tipped the balance between pathogenic and commensal bacteria in favor of a pathogen. Taken together, IL-22 induction can be exploited by pathogens to suppress the growth of their closest competitors, thereby enhancing pathogen colonization of mucosal surfaces.	[Behnsen, Judith; Jellbauer, Stefan; Wong, Christina P.; Raffatellu, Manuela] Univ Calif Irvine, Dept Microbiol, Irvine, CA 92697 USA; [Behnsen, Judith; Jellbauer, Stefan; Wong, Christina P.; Edwards, Robert A.; Raffatellu, Manuela] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA; [Edwards, Robert A.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [George, Michael D.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Davis; Roche Holding; Genentech	Raffatellu, M (corresponding author), Univ Calif Irvine, Dept Microbiol, Irvine, CA 92697 USA.	manuelar@uci.edu	Pacific-Southwest, RCE/B-6155-2009; Behnsen, Judith/O-2656-2015; Ouyang, Wenjun/ABA-8763-2020	Behnsen, Judith/0000-0003-0109-1090; Raffatellu, Manuela/0000-0001-6487-4215; Ouyang, Wenjun/0000-0002-1811-5864	Public Health Service Grant [AI083663]; Pacific Southwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease [U54AI065359]; American Heart Postdoctoral Fellowship [11POST7090006]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083663, U54AI065359] Funding Source: NIH RePORTER	Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Pacific Southwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease; American Heart Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to acknowledge Sean-Paul Nuccio for help with editing the manuscript and Ellena Peterson for help with strain identification. Furthermore, we would like to thank Nita Salzman for providing the SFB plasmid, Matthew Rolston at the UC Davis School of Medicine Host-Microbe Systems Biology Core for processing samples for Illumina MiSeq analysis, and Janet Z. Liu for generating the artwork for our model. Work in the M. R. laboratory is supported by Public Health Service Grant AI083663 and by funds from the Pacific Southwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease (Award Number U54AI065359 from the National Institute of Allergy and Infectious Diseases). J.B. was supported by an American Heart Postdoctoral Fellowship (11POST7090006). W.O. is an employee of Genentech.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Awoniyi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037311; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Baumler AJ, 1998, J BACTERIOL, V180, P1446; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Blaschitz C, 2010, J CLIN IMMUNOL, V30, P196, DOI 10.1007/s10875-010-9368-7; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Crouch MLV, 2008, MOL MICROBIOL, V67, P971, DOI 10.1111/j.1365-2958.2007.06089.x; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Feinen B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00011; Ferreira RBR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020338; Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Graham AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017171; Hantke K, 2003, P NATL ACAD SCI USA, V100, P3677, DOI 10.1073/pnas.0737682100; Hayden JA, 2013, J AM CHEM SOC, V135, P775, DOI 10.1021/ja3096416; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Liu JZ, 2009, CYTOKINE, V48, P156, DOI 10.1016/j.cyto.2009.07.005; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Mastelic B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00085; Muhl H, 2011, CELL MICROBIOL, V13, P340, DOI 10.1111/j.1462-5822.2010.01559.x; Poulsen KP, 2013, MICROB PATHOGENESIS, V56, P47, DOI 10.1016/j.micpath.2012.11.003; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	54	205	206	3	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					262	273		10.1016/j.immuni.2014.01.003	http://dx.doi.org/10.1016/j.immuni.2014.01.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24508234	Bronze, Green Accepted			2022-12-18	WOS:000331637600013
J	Zhu, LL; Zhao, XQ; Jiang, CY; You, Y; Chen, XP; Jiang, YY; Jia, XM; Lin, X				Zhu, Le-Le; Zhao, Xue-Qiang; Jiang, Changying; You, Yun; Chen, Xiao-Ping; Jiang, Yuan-Ying; Jia, Xin-Ming; Lin, Xin			C-Type Lectin Receptors Dectin-3 and Dectin-2 Form a Heterodimeric Pattern-Recognition Receptor for Host Defense against Fungal Infection	IMMUNITY			English	Article							BETA-GLUCAN RECEPTOR; NF-KAPPA-B; CANDIDA-ALBICANS; INNATE IMMUNE; CELL-SURFACE; ACTIVATION; SUSCEPTIBILITY; ASSOCIATION; MACROPHAGES; NEUTROPHILS	C-type lectin receptors (CLRs) play critical roles as pattern-recognition receptors (PRRs) for sensing Candida albicans infection, which can be life-threatening for immunocompromised individuals. Here we have shown that Dectin-3 (also called CLECSF8, MCL, or Clec4d), a previously uncharacterized CLR, recognized alpha-mannans on the surfaces of C. albicans hyphae and induced NF-kappa B activation. Mice with either blockade or genetically deleted Dectin-3 were highly susceptible to C. albicans infection. Dectin-3 constantly formed heterodimers with Dectin-2, a well-characterized CLR, for recognizing C. albicans hyphae. Compared to their respective homodimers, Dectin-3 and Dectin-2 heterodimers bound alpha-mannans more effectively, leading to potent inflammatory responses against fungal infections. Together, our study demonstrates that Dectin-3 forms a heterodimeric PRR with Dectin-2 for sensing fungal infection and suggests that different CLRs may form different hetero- and homodimers, which provide different sensitivity and diversity for host cells to detect various microbial infections.	[Zhu, Le-Le; Chen, Xiao-Ping; Jia, Xin-Ming] Tongji Univ, Sch Med, Dept Immunol, Shanghai 200092, Peoples R China; [Zhao, Xue-Qiang; Jiang, Changying; You, Yun; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Jiang, Yuan-Ying] Second Mil Med Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Lin, Xin] Univ Texas Houston, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA	Tongji University; University of Texas System; UTMD Anderson Cancer Center; Naval Medical University; University of Texas System; University of Texas Health Science Center Houston	Jia, XM (corresponding author), Tongji Univ, Sch Med, Dept Immunol, Shanghai 200092, Peoples R China.	jiaxm@tongji.edu.cn; xllin@mdanderson.org	Jiang, Changying/AAL-3711-2020; ZHU, LELE/AAP-9075-2020	ZHU, LELE/0000-0002-1732-8753; CHEN, XIAO-PING/0000-0002-5852-9965; Jiang, Changying/0000-0003-3778-4438	Shanghai Basic Research Program [12JC1408401]; National Basic Research Program of China (Program 973) [2013CB531602]; NIH [AI050848, GM065899]; Tongji University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050848, R56AI050848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065899, R56GM065899] Funding Source: NIH RePORTER	Shanghai Basic Research Program; National Basic Research Program of China (Program 973)(National Basic Research Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tongji University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The Shanghai Basic Research Program (12JC1408401; X.-M.J), The National Basic Research Program of China (Program 973, 2013CB531602; Y.-Y.J.), NIH grants AI050848 and GM065899 (X.L.), and a Lecture Professorship Fund from Tongji University (X.L.).	Arce I, 2004, EUR J IMMUNOL, V34, P210, DOI 10.1002/eji.200324230; Balch SG, 1998, J BIOL CHEM, V273, P18656, DOI 10.1074/jbc.273.29.18656; Basu S, 2008, GROWTH FACTORS, V26, P23, DOI 10.1080/08977190801987513; Bi LK, 2010, J BIOL CHEM, V285, P25969, DOI 10.1074/jbc.M110.131300; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Bugarcic A, 2008, GLYCOBIOLOGY, V18, P679, DOI 10.1093/glycob/cwn046; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gorjestani S, 2011, J BIOL CHEM, V286, P43651, DOI 10.1074/jbc.M111.307389; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Graham LM, 2009, CYTOKINE, V48, P148, DOI 10.1016/j.cyto.2009.07.010; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jia X, 2009, CELL MOL LIFE SCI, V66, P122, DOI 10.1007/s00018-008-8409-3; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Kanazawa N, 2004, IMMUNOBIOLOGY, V209, P179, DOI 10.1016/j.imbio.2004.03.004; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kingeter LM, 2012, CELL MOL IMMUNOL, V9, P105, DOI 10.1038/cmi.2011.58; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lobato-Pascual A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057406; Marshall ASJ, 2004, EUR J IMMUNOL, V34, P18, DOI 10.1002/eji.200324641; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Netea MG, 1999, J IMMUNOL, V163, P1498; Netea MG, 2002, J INFECT DIS, V185, P1483, DOI 10.1086/340511; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Plantinga TS, 2012, MED MYCOL, V50, P785, DOI 10.3109/13693786.2012.690902; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Shahan TA, 1998, AM J RESP CELL MOL, V18, P435, DOI 10.1165/ajrcmb.18.3.2856; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Takahara K, 2011, EUR J IMMUNOL, V41, P1435, DOI 10.1002/eji.200940188; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Vautier S, 2010, CYTOKINE GROWTH F R, V21, P405, DOI 10.1016/j.cytogfr.2010.10.001; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	51	205	213	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					324	334		10.1016/j.immuni.2013.05.017	http://dx.doi.org/10.1016/j.immuni.2013.05.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23911656	Bronze			2022-12-18	WOS:000330948800014
J	Carotta, S; Dakic, A; D'Amico, A; Pang, SHM; Greig, KT; Nutt, SL; Wu, L				Carotta, Sebastian; Dakic, Aleksandar; D'Amico, Angela; Pang, Swee Heng Milon; Greig, Kylie T.; Nutt, Stephen L.; Wu, Li			The Transcription Factor PU.1 Controls Dendritic Cell Development and Flt3 Cytokine Receptor Expression in a Dose-Dependent Manner	IMMUNITY			English	Article							LINEAGE-COMMITMENT; TARGETED DISRUPTION; C/EBP-ALPHA; STEM-CELLS; LIGAND; PROGENITORS; MACROPHAGE; IDENTIFICATION; MAINTENANCE; GENERATION	The transcription factor PU.1 plays multiple context and concentration dependent roles in lymphoid and myeloid cell development. Here we showed that PU.1 (encoded by Sfpi1) was essential for dendritic cell (DC) development in vivo and that conditional ablation of PU.1 in defined precursors, including the common DC progenitor, blocked Flt3 ligand-induced DC generation in vitro. PU.1 was also required for the parallel granulocyte-macrophage colony stimulating factor-induced DC pathway from early hematopoietic progenitors. Molecular studies demonstrated that PU.1 directly regulated Flt3 in a concentration-dependent manner, as Sfpi1(+/-) cells displayed reduced expression of Flt3 and impaired DC formation. These studies identify PU.1 as a critical regulator of both conventional and plasmacytoid DC development and provide one mechanism how altered PU.1 concentration can have profound functional consequences for hematopoietic cell development.	[Carotta, Sebastian; Dakic, Aleksandar; D'Amico, Angela; Pang, Swee Heng Milon; Greig, Kylie T.; Nutt, Stephen L.; Wu, Li] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Pang, Swee Heng Milon; Greig, Kylie T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Nutt, SL (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.	nutt@wehi.edu.au; wu@wehi.edu.au	Nutt, Stephen L/C-9256-2013; Dakic, Aleksandar/B-8290-2013	Nutt, Stephen L/0000-0002-0020-6637; Pang, Milon/0000-0001-7958-0244	National Health and Medical Research Council (NHMRC) of Australia; Australian Research Council; Leukaemia Foundation; University of Melbourne; Pfizer	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Leukaemia Foundation; University of Melbourne(University of Melbourne); Pfizer(Pfizer)	We thank A. Kallies, K. Shortman, and G. Belz for comments on the manuscript; K. Elder and N. Bernard for technical assistance; and M. Busslinger (IMP, Vienna Austria) for providing the Flt3<SUP>+/-</SUP> mice and plasmid vectors. This work was supported by the National Health and Medical Research Council (NHMRC) of Australia. S.C. was supported by an Australian Research Council Discovery Fellowship, S.H.M.P. by the Leukaemia Foundation, K.T.G. by a Stella Mary Langford Scholarship from the University of Melbourne, S.L.N. by the Pfizer Australia Research Fellowship, and L.W. by an NHMRC Fellowship. S.C, A. Dakic, and A. D'Amico designed and performed most of the experiments and provided input in the manuscript. S.H.M.P and K.T.G performed analysis of the Flt3 promoter. S.L.N and L.W supervised the experimental design, analyzed experiments, and cowrote the manuscript.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Back J, 2005, EXP HEMATOL, V33, P395, DOI 10.1016/j.exphem.2004.12.010; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Carotta S, 2006, EUR J IMMUNOL, V36, P3294, DOI 10.1002/eji.200636325; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Dakic A, 2007, TRENDS IMMUNOL, V28, P108, DOI 10.1016/j.it.2007.01.006; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Houston IB, 2007, EXP HEMATOL, V35, P1056, DOI 10.1016/j.exphem.2007.04.005; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Polli M, 2005, BLOOD, V106, P2083, DOI 10.1182/blood-2005-01-0283; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Sitnicka E, 2007, BLOOD, V110, P2955, DOI 10.1182/blood-2006-10-054726; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wu L, 2001, BLOOD, V98, P3376, DOI 10.1182/blood.V98.12.3376; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Ye M, 2005, J EXP MED, V202, P1411, DOI 10.1084/jem.20051089; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	51	205	208	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 28	2010	32	5					628	641		10.1016/j.immuni.2010.05.005	http://dx.doi.org/10.1016/j.immuni.2010.05.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20510871	Bronze			2022-12-18	WOS:000278280500009
J	Zammit, DJ; Turner, DL; Klonowski, KD; Lefrancois, L; Cauley, LS				Zammit, DJ; Turner, DL; Klonowski, KD; Lefrancois, L; Cauley, LS			Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration	IMMUNITY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; A VIRUS; DENDRITIC CELLS; HETEROSUBTYPIC IMMUNITY; LUNG AIRWAYS; IN-VIVO; NONSPECIFIC RECRUITMENT; SELECTIVE EXPRESSION; IMMUNOLOGICAL MEMORY; A/WSN/33 VIRUS	Activated virus-specific CD8 T cells remain in the lung airways for several months after influenza virus infection. We show that maintenance of this cell population is dependent upon the route of infection and prolonged presentation of viral antigen in the draining lymph nodes (DLN) of the respiratory tract. The local effects on T cell migration have been examined. We show retention of virus-specific CD8 T cells in the mediastinal lymph node (MLN) and continuing recruitment of blood-borne migrants into the lung airways during antigen presentation. These data show that antigen that is retained after pulmonary influenza virus infection controls the migratory pattern and activation state of virus-specific CD8 T cells near the site of virus amplification.	Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06032 USA	University of Connecticut	Cauley, LS (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06032 USA.	lcauley@uchc.edu			NIAID NIH HHS [R01 AI041576, F32 AI053970, AI053970, R01 AI051583-04, R01 AI051583, R01 AI041576-06, AI41576, AI0515 83] Funding Source: Medline; NIDDK NIH HHS [R01 DK045260, R01 DK045260-10, DK45260] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000515, R01AI051583, F32AI053970, R01AI041576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045260] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aronsson F, 2002, J NEUROVIROL, V8, P353, DOI 10.1080/13550280290100480; Aronsson F, 2001, J NEUROVIROL, V7, P117; Chang J, 2002, NAT MED, V8, P54, DOI 10.1038/nm0102-54; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; DALY K, 1995, J VIROL, V69, P7416, DOI 10.1128/JVI.69.12.7416-7422.1995; Doherty PC, 1996, IMMUNOL REV, V150, P23, DOI 10.1111/j.1600-065X.1996.tb00694.x; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Ely KH, 2003, J IMMUNOL, V171, P3338, DOI 10.4049/jimmunol.171.7.3338; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Gray D, 2002, NAT REV IMMUNOL, V2, P60, DOI 10.1038/nri706; HAMILTONEASTON A, 1995, J VIROL, V69, P6359, DOI 10.1128/JVI.69.10.6359-6366.1995; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Kranzer K, 2000, IMMUNOLOGY, V99, P170, DOI 10.1046/j.1365-2567.2000.00964.x; Kundig TM, 1996, P NATL ACAD SCI USA, V93, P9716, DOI 10.1073/pnas.93.18.9716; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; LIANG SH, 1994, J IMMUNOL, V152, P1653; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Moskophidis D, 1998, J EXP MED, V188, P223, DOI 10.1084/jem.188.2.223; Nguyen HH, 1999, VIROLOGY, V254, P50, DOI 10.1006/viro.1998.9521; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; Ostler T, 2002, EUR J IMMUNOL, V32, P2562, DOI 10.1002/1521-4141(200209)32:9<2562::AID-IMMU2562>3.0.CO;2-4; Ostler T, 2001, EUR J IMMUNOL, V31, P2574, DOI 10.1002/1521-4141(200109)31:9<2574::AID-IMMU2574>3.0.CO;2-V; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schwartz DA, 1997, J CLIN INVEST, V100, P68, DOI 10.1172/JCI119523; Stephens R, 2002, J IMMUNOL, V169, P5458, DOI 10.4049/jimmunol.169.10.5458; Sun S, 2000, CURR TOP MICROBIOL, V247, P107; Topham DJ, 1997, J IMMUNOL, V159, P5197; Topham DJ, 2001, J IMMUNOL, V167, P6983, DOI 10.4049/jimmunol.167.12.6983; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Woodland DL, 2002, MICROBES INFECT, V4, P1091, DOI 10.1016/S1286-4579(02)01633-7; Yamamoto N, 2000, EUR J IMMUNOL, V30, P316, DOI 10.1002/1521-4141(200001)30:1<316::AID-IMMU316>3.0.CO;2-0; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zinkernagel RM, 2002, CURR OPIN IMMUNOL, V14, P523, DOI 10.1016/S0952-7915(02)00367-9	51	205	208	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2006	24	4					439	449		10.1016/j.immuni.2006.01.015	http://dx.doi.org/10.1016/j.immuni.2006.01.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618602	Bronze, Green Accepted			2022-12-18	WOS:000237153000013
J	Yu, YX; Wang, SZE; Hayward, GS				Yu, YX; Wang, SZE; Hayward, GS			The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation	IMMUNITY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; INTERFERON REGULATORY FACTOR-7; C-TERMINAL REGION; KAPOSIS-SARCOMA; LYTIC-CYCLE; SIGNALING PATHWAY; GENE-EXPRESSION; VIRUS-INFECTION; I INTERFERON; PROTEIN	Many viruses encode proteins that counteract the development of the interferon (IFN)-mediated antiviral state. Here, we report that interferon regulatory factor 7 (IRF7), a key mediator of type I IFN induction, is targeted for degradation by binding to the RTA immediate-early nuclear transcription factor encoded by Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8). Cotransfection with RTA blocked IRF7-mediated IFNalpha and IFNbeta mRNA production and promoted the ubiquitination and degradation of IRF7 protein in a proteasome-dependent fashion. Addition of RTA also promoted polyubiquitination of IRF7 in an in vitro cell free assay, demonstrating that RTA itself acts as a ubiquitin E3 ligase. RTA also autoregulated its own polyubiquitination and stability, and both activities were abolished by point mutations in a Cys plus His-rich N-terminal domain. Therefore, manipulation of the stability and function of IRF7 by the KSHV RTA transcription factor provides an unexpected regulatory strategy for circumventing the innate immune defence system.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Viral Oncol Program,Mol Virol Labs, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Hayward, GS (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Viral Oncol Program,Mol Virol Labs, 1650 Orleans St, Baltimore, MD 21231 USA.	ghayward@jhmi.edu		Wang, Shizhen Emily/0000-0002-5036-8175	NATIONAL CANCER INSTITUTE [R01CA073585, P01CA081400] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA73585, P01 CA81400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Gao SJ, 1997, ONCOGENE, V15, P1979, DOI 10.1038/sj.onc.1201571; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Hagglund R, 2002, P NATL ACAD SCI USA, V99, P631, DOI 10.1073/pnas.022531599; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li M, 2000, MOL CELL BIOL, V20, P8254, DOI 10.1128/MCB.20.21.8254-8263.2000; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Poole LJ, 2002, J VIROL, V76, P3395, DOI 10.1128/JVI.76.7.3395-3420.2002; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Wang SE, 2003, J VIROL, V77, P600, DOI 10.1128/JVI.77.1.600-623.2003; Wu FY, 2003, J VIROL, V77, P1481, DOI 10.1128/JVI.77.2.1481-1500.2003; Yokosawa N, 2002, J VIROL, V76, P12683, DOI 10.1128/JVI.76.24.12683-12690.2002; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599; Zhu H, 1997, P NATL ACAD SCI USA, V94, P13985, DOI 10.1073/pnas.94.25.13985; Zimring JC, 1998, J VIROL, V72, P701, DOI 10.1128/JVI.72.1.701-707.1998	33	205	215	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2005	22	1					59	70		10.1016/j.immuni.2004.11.011	http://dx.doi.org/10.1016/j.immuni.2004.11.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664159	Bronze			2022-12-18	WOS:000226682900007
J	Kuroda, K; Han, H; Tani, S; Tanigaki, K; Tun, T; Furukawa, T; Taniguchi, Y; Kurooka, H; Hamada, Y; Toyokuni, S; Honjo, T				Kuroda, K; Han, H; Tani, S; Tanigaki, K; Tun, T; Furukawa, T; Taniguchi, Y; Kurooka, H; Hamada, Y; Toyokuni, S; Honjo, T			Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway	IMMUNITY			English	Article							DNA-BINDING PROTEIN; RBP-J-KAPPA; MAMMALIAN NOTCH; MOUSE NOTCH; INTRACELLULAR DOMAIN; COREPRESSOR COMPLEX; DROSOPHILA HOMOLOG; ANKYRIN REPEATS; DENDRITIC CELLS; FAMILY MEMBERS	We found that Msx2-interacting nuclear target protein (MINT) competed with the intracellular region of Notch for binding to a DNA binding protein RBP-J and suppressed the transactivation activity of Notch signaling. Although MINT null mutant mice were embryonic lethal, MINT-deficient splenic B cells differentiated about three times more efficiently into marginal zone B cells with a concomitant reduction of follicular B cells. MINT is expressed in a cell-specific manner: high in follicular B cells and low in marginal zone B cells. Since Notch signaling directs differentiation of marginal zone B lymphocytes and suppresses that of follicular B lymphocytes in mouse spleen, the results indicate that high levels of MINT negatively regulate Notch signaling and block differentiation of precursor B cells into marginal zone B cells. MINT may serve as a functional homolog of Drosophila Hairless.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan; Natl Inst Basic Biol, Okazaki 4448585, Japan	Kyoto University; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016; Toyokuni, Shinya/C-1358-2010; Taniguchi, Yoshihito/L-5746-2013; Toyokuni, Shinya/ABE-7714-2021	Toyokuni, Shinya/0000-0002-5757-1109; Toyokuni, Shinya/0000-0002-5757-1109				Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033; BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752; Beatus P, 1998, J NEUROSCI RES, V54, P125, DOI 10.1002/(SICI)1097-4547(19981015)54:2<125::AID-JNR1>3.3.CO;2-C; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X; Hamada Y, 1999, DEVELOPMENT, V126, P3415; HAMAGUCHI Y, 1992, J BIOCHEM-TOKYO, V112, P314, DOI 10.1093/oxfordjournals.jbchem.a123898; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Izon DJ, 2002, CURR OPIN IMMUNOL, V14, P192, DOI 10.1016/S0952-7915(02)00321-7; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kamata T, 2000, J IMMUNOL, V165, P1387, DOI 10.4049/jimmunol.165.3.1387; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; Kato H, 1997, DEVELOPMENT, V124, P4133; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kuang B, 2000, DEVELOPMENT, V127, P1517; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; McCright B, 2001, DEVELOPMENT, V128, P491; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998; Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085; Rebay I, 2000, GENETICS, V154, P695; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; Yamaguchi E, 2002, IMMUNOL LETT, V81, P59, DOI 10.1016/S0165-2478(01)00326-1; Zhou SF, 2001, MOL CELL BIOL, V21, P6222, DOI 10.1128/MCB.21.18.6222-6232.2001	54	205	214	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2003	18	2					301	312		10.1016/S1074-7613(03)00029-3	http://dx.doi.org/10.1016/S1074-7613(03)00029-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594956	Bronze			2022-12-18	WOS:000181138100013
J	Cai, ZL; de Bruijn, M; Ma, XQ; Dortland, B; Luteijn, T; Downing, JR; Dzierzak, E				Cai, ZL; de Bruijn, M; Ma, XQ; Dortland, B; Luteijn, T; Downing, JR; Dzierzak, E			Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo	IMMUNITY			English	Article							MURINE LEUKEMIA-VIRUS; FETAL LIVER HEMATOPOIESIS; DEFINITIVE HEMATOPOIESIS; TRANSCRIPTION FACTOR; DISEASE SPECIFICITY; ENDOTHELIAL-CELLS; DNA-BINDING; RUNT; ENHANCER; IDENTIFICATION	The AML1:CBF beta transcription factor complex is essential for definitive hematopoiesis. Null mutations in mouse AML1 result in midgestational lethality with a complete lack of fetal liver hematopoiesis. While the cell autonomous nature and expression pattern of AML1 suggest an intrinsic role for this transcription factor in the developing hematopoietic system, no direct link to a functional cell type has been made. Here, we examine the consequences of AML1 loss in hematopoietic stem cells (HSC) of the mouse embryo. We demonstrate an absolute requirement for AML1 in functional HSCs. Moreover, haploinsufficiency results in a dramatic change in the temporal and spatial distribution of HSCs, leading to their early appearance in the normal position in the aorta-gonad-mesonephros region and also in the yolk sac.	Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Univ Tennessee, Coll Med, Dept Pathol, Memphis, TN 37232 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	Erasmus University Rotterdam; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Dzierzak, E (corresponding author), Erasmus Univ, Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	dzierzak@ch1.fgg.eur.nl	Downing, James R./N-8102-2018		NCI NIH HHS [CA-21765, P01 CA71907] Funding Source: Medline; NIDDK NIH HHS [R01 DK51077-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA071907] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Corsetti MT, 1997, BLOOD, V89, P2359, DOI 10.1182/blood.V89.7.2359; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 1998, J IMMUNOL METHODS, V217, P27, DOI 10.1016/S0022-1759(98)00080-5; DEBRUIJN M, 2000, IN PRESS BLOOD; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; Dormand EL, 1998, DEVELOPMENT, V125, P1659; Downing JR, 1999, BRIT J HAEMATOL, V106, P296, DOI 10.1046/j.1365-2141.1999.01377.x; DZIERZAK E, 2000, IN PRESS METHODS MOL; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; HALLBERG B, 1991, J VIROL, V65, P4177, DOI 10.1128/JVI.65.8.4177-4181.1991; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; KAMACHI Y, 1990, J VIROL, V64, P4808, DOI 10.1128/JVI.64.10.4808-4819.1990; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lewis AF, 1999, J VIROL, V73, P5535, DOI 10.1128/JVI.73.7.5535-5547.1999; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MEYERHOF GG, 1993, P INT S LIM STAT DES, V1, P1; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Mukouyama Y, 2000, DEV BIOL, V220, P27, DOI 10.1006/dbio.2000.9617; MULLER AM, 1993, DEVELOPMENT, V118, P1343; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; North T, 1999, DEVELOPMENT, V126, P2563; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; PROSSER HM, 1992, P NATL ACAD SCI USA, V89, P9934, DOI 10.1073/pnas.89.20.9934; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; SIMEONE A, 1995, DEV DYNAM, V203, P61, DOI 10.1002/aja.1002030107; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; Speck NA, 1999, CANCER RES, V59, p1789S; SPECK NA, 1990, GENE DEV, V4, P233, DOI 10.1101/gad.4.2.233; TAKAHASHI A, 1995, BLOOD, V86, P607, DOI 10.1182/blood.V86.2.607.bloodjournal862607; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Tracey WD, 1998, DEVELOPMENT, V125, P1371; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WANG SW, 1993, MOL CELL BIOL, V13, P3324, DOI 10.1128/MCB.13.6.3324; WEIHER H, 1983, SCIENCE, V219, P626, DOI 10.1126/science.6297005; ZHANG DE, 1994, MOL CELL BIOL, V14, P8085, DOI 10.1128/MCB.14.12.8085	44	205	209	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2000	13	4					423	431		10.1016/S1074-7613(00)00042-X	http://dx.doi.org/10.1016/S1074-7613(00)00042-X			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070161	Bronze			2022-12-18	WOS:000090079100002
J	Brugnera, E; Bhandoola, A; Cibotti, R; Yu, Q; Guinter, TI; Yamashita, Y; Sharrow, SO; Singer, A				Brugnera, E; Bhandoola, A; Cibotti, R; Yu, Q; Guinter, TI; Yamashita, Y; Sharrow, SO; Singer, A			Coreceptor reversal in the thymus: Signaled CD4(+)8(+) thymocytes initially terminate CD8 transcription even when differentiating into CD8(+) T cells	IMMUNITY			English	Article							CD4/CD8 LINEAGE COMMITMENT; INTERLEUKIN-7 RECEPTOR; POSITIVE SELECTION; GENE-EXPRESSION; NUCLEAR-RNA; LYMPHOCYTES; OVEREXPRESSION; SPECIFICITY; PRECURSORS; MATURATION	A central paradigm of T cell development is that CD4(+)8(+) (DP) thymocytes differentiate into CD4(+) or CD8(+) T cells in response to intrathymic signals that extinguish transcription of the inappropriate coreceptor molecule. Contrary to this prevailing paradigm, we now demonstrate that signaled DP thymocytes initially terminate CD8 transcription even when differentiating into CD8(+) T cells. Remarkably, thymocytes that have selectively terminated CD8 transcription can be signaled by IL-7 to differentiate into CD8(+) T cells by silencing CD4 transcription and reinitiating CD8 transcription, events we refer to as "coreceptor reversal." These observations significantly alter our understanding of CD8(+) T cell differentiation and lead to a new perspective ("kinetic signaling") on CD4/CD8 lineage determination in the thymus. These observations also suggest a novel mechanism by which bipotential cells throughout development can determine their appropriate cell fate.	NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; Oklahoma Med Res Fdn, Immunobiol Program, Oklahoma City, OK 73104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oklahoma Medical Research Foundation	Singer, A (corresponding author), NCI, Expt Immunol Branch, Bethesda, MD 20892 USA.	singera@nih.gov			NATIONAL CANCER INSTITUTE [ZIABC009273, Z01BC009273] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; Bommhardt U, 1998, IMMUNOL REV, V165, P181, DOI 10.1111/j.1600-065X.1998.tb01239.x; CEREDIG R, 1982, J EXP MED, V155, P617, DOI 10.1084/jem.155.2.617; Chang SY, 1998, MET MATER INT, V4, P165, DOI 10.1007/BF03026034; CHEN SS, 1983, P NATL ACAD SCI-BIOL, V80, P5980, DOI 10.1073/pnas.80.19.5980; CHENKIANG S, 1989, METHOD ENZYMOL, V180, P82; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; Hedrick SM, 1998, IMMUNOL REV, V165, P95, DOI 10.1111/j.1600-065X.1998.tb01233.x; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Iwata M, 1996, EUR J IMMUNOL, V26, P2081, DOI 10.1002/eji.1830260918; JANEWAY CA, 1988, NATURE, V335, P208, DOI 10.1038/335208a0; KOTEWICZ ML, 1985, GENE, V35, P249, DOI 10.1016/0378-1119(85)90003-4; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Moore TA, 1996, J IMMUNOL, V157, P2366; NEVINS JR, 1987, METHOD ENZYMOL, V152, P234; Noguchi M, 1997, P NATL ACAD SCI USA, V94, P11534, DOI 10.1073/pnas.94.21.11534; Ohoka Y, 1996, INT IMMUNOL, V8, P297, DOI 10.1093/intimm/8.3.297; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Singer A, 1999, SEMIN IMMUNOL, V11, P273, DOI 10.1006/smim.1999.0183; SINGER A, 1987, TRANSPLANT P, V19, P107; Singer A., 1986, PROG IMMUNOL, V6, P60; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TAKAHAMA Y, 1992, SCIENCE, V258, P1456, DOI 10.1126/science.1439838; TAO W, 1994, J EXP MED, V179, P145, DOI 10.1084/jem.179.1.145; vonBoehmer H, 1996, J EXP MED, V183, P713, DOI 10.1084/jem.183.3.713; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; Yamashita Y, 1999, J IMMUNOL, V162, P5940	36	205	208	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2000	13	1					59	71		10.1016/S1074-7613(00)00008-X	http://dx.doi.org/10.1016/S1074-7613(00)00008-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933395	Bronze			2022-12-18	WOS:000088463600007
J	Kearley, J; Silver, JS; Sanden, C; Liu, Z; Berlin, AA; White, N; Mori, M; Pham, TH; Ward, CK; Criner, GJ; Marchetti, N; Mustelin, T; Erjefalt, JS; Kolbeck, R; Humbles, AA				Kearley, Jennifer; Silver, Jonathan S.; Sanden, Caroline; Liu, Zheng; Berlin, Aaron A.; White, Natalie; Mori, Michiko; Pham, Tuyet-Hang; Ward, Christine K.; Criner, Gerard J.; Marchetti, Nathaniel; Mustelin, Tomas; Erjefalt, Jonas S.; Kolbeck, Roland; Humbles, Alison A.			Cigarette Smoke Silences Innate Lymphoid Cell Function and Facilitates an Exacerbated Type I Interleukin-33-Dependent Response to Infection	IMMUNITY			English	Article							AIRWAY INFLAMMATION; CYTOKINE IL-33; VIRUS; PATHOGENESIS; EXPRESSION; IMMUNE; T1/ST2; HYPERREACTIVITY; INTERLEUKIN-10; PROMOTE	Cigarette smoking is a major risk factor for chronic obstructive pulmonary disease and is presumed to be central to the altered responsiveness to recurrent infection in these patients. We examined the effects of smoke priming underlying the exacerbated response to viral infection in mice. Lack of interleukin-33 (IL-33) signaling conferred complete protection during exacerbation and prevented enhanced inflammation and exaggerated weight loss. Mechanistically, smoke was required to upregulate epithelial-derived IL-33 and simultaneously alter the distribution of the IL-33 receptor ST2. Specifically, smoke decreased ST2 expression on group 2 innate lymphoid cells (ILC2s) while elevating ST2 expression on macrophages and natural killer (NK) cells, thus altering IL-33 responsiveness within the lung. Consequently, upon infection and release, increased local IL-33 significantly amplified type I proinflammatory responses via synergistic modulation of macrophage and NK cell function. Therefore, in COPD, smoke alters the lung microenvironment to facilitate an alternative IL-33-dependent exaggerated proinflammatory response to infection, exacerbating disease.	[Kearley, Jennifer; Silver, Jonathan S.; Berlin, Aaron A.; White, Natalie; Mustelin, Tomas; Kolbeck, Roland; Humbles, Alison A.] MedImmune LLC, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD 20878 USA; [Sanden, Caroline; Mori, Michiko; Erjefalt, Jonas S.] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden; [Liu, Zheng; Pham, Tuyet-Hang; Ward, Christine K.] MedImmune LLC, Dept Translat Sci, Gaithersburg, MD 20878 USA; [Criner, Gerard J.; Marchetti, Nathaniel] Temple Univ Sch Med, Pulm & Crit Care Med, Dept Med, Philadelphia, PA 19140 USA	AstraZeneca; Medimmune; Lund University; AstraZeneca; Medimmune; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Humbles, AA (corresponding author), MedImmune LLC, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD 20878 USA.	humblesa@medimmune.com		Erjefalt, Jonas/0000-0002-6716-3010; Mustelin, Tomas/0000-0001-5912-8840	MedImmune LLC.	MedImmune LLC.(AstraZenecaMedimmune)	This work was funded by MedImmune LLC. J.K., J.S.S., Z.L., N.W., A.A.B., T.-H.P., C.K.W., T.M., R.K., and A.A.H. are all full-time employees and shareholders of MedImmune LLC. G.J.C. and J.S.E. have received research funding from MedImmune LLC.	Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Bauer CMT, 2013, CHEST, V143, P196, DOI 10.1378/chest.12-0930; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Botelho FM, 2011, AM J RESP CELL MOL, V45, P753, DOI 10.1165/rcmb.2010-0404OC; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Chakraborty K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037173; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cho KA, 2012, AM J PHYSIOL-LUNG C, V302, pL429, DOI 10.1152/ajplung.00252.2011; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; De Serres G, 2009, J CLIN VIROL, V46, P129, DOI 10.1016/j.jcv.2009.07.010; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hams E, 2012, CURR OPIN PHARMACOL, V12, P503, DOI 10.1016/j.coph.2012.06.001; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; MacDonald M, 2013, RESPIROLOGY, V18, P1280, DOI 10.1111/resp.12197; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mohan A, 2010, RESPIROLOGY, V15, P536, DOI 10.1111/j.1440-1843.2010.01722.x; Monteiro JM, 1998, J VIROL, V72, P4825, DOI 10.1128/JVI.72.6.4825-4831.1998; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ohno T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018404; Onda H, 1999, J CEREBR BLOOD F MET, V19, P1279, DOI 10.1097/00004647-199911000-00013; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qiu CA, 2013, IMMUNOLOGY, V138, P76, DOI 10.1111/imm.12020; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sethi Sanjay, 2008, N Engl J Med, V359, P2355, DOI 10.1056/NEJMra0800353; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Verri WA, 2008, P NATL ACAD SCI USA, V105, P2723, DOI 10.1073/pnas.0712116105; Villarreal DO, 2014, CANCER RES, V74, P1789, DOI 10.1158/0008-5472.CAN-13-2729; Wang SZ, 2004, J IMMUNOL, V173, P4040, DOI 10.4049/jimmunol.173.6.4040; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang QT, 2011, EUR J IMMUNOL, V41, P3351, DOI 10.1002/eji.201141629	55	204	209	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					566	579		10.1016/j.immuni.2015.02.011	http://dx.doi.org/10.1016/j.immuni.2015.02.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786179	Bronze			2022-12-18	WOS:000351301900019
J	Sheridan, BS; Pham, QM; Lee, YT; Cauley, LS; Puddington, L; Lefrancois, L				Sheridan, Brian S.; Pham, Quynh-Mai; Lee, Young-Tae; Cauley, Linda S.; Puddington, Lynn; Lefrancois, Leo			Oral Infection Drives a Distinct Population of Intestinal Resident Memory CD8(+) T Cells with Enhanced Protective Function	IMMUNITY			English	Article							E-CADHERIN; LISTERIA-MONOCYTOGENES; CUTTING EDGE; TGF-BETA; RM CELLS; TISSUE; MIGRATION; DIFFERENTIATION; ACTIVATION; EXPRESSION	The intestinal mucosa promotes T cell responses that might be beneficial for effective mucosal vaccines. However, intestinal resident memory T (Trm) cell formation and function are poorly understood. We found that oral infection with Listeria monocytogenes induced a robust intestinal CD8 T cell response and blocking effector T cell migration showed that intestinal Trm cells were critical for secondary protection. Intestinal effector CD8 T cells were predominately composed of memory precursor effector cells (MPECs) that rapidly upregulated CD103, which was needed for T cell accumulation in the intestinal epithelium. CD103 expression, rapid MPEC formation, and maintenance in intestinal tissues were dependent on T cell intrinsic transforming growth factor beta signals. Moreover, intestinal Trm cells generated after intranasal or intravenous infection were less robust and phenotypically distinct from Trm cells generated after oral infection, demonstrating the critical contribution of infection route for directing the generation of protective intestinal Trm cells.	[Sheridan, Brian S.; Pham, Quynh-Mai; Lee, Young-Tae; Cauley, Linda S.; Puddington, Lynn; Lefrancois, Leo] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA	University of Connecticut	Sheridan, BS (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA.	bsheridan@uchc.edu			National Institutes of Health [P01AI056172, R01AI076457]; Crohn's and Colitis Foundation of America [2813]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076457, P01AI056172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grants P01AI056172 to L.L. and L.S.C. and R01AI076457 to L.L., and by "Visualizing orally-induced T cell responses in the intestinal mucosa" reference number 2813 from the Crohn's and Colitis Foundation of America (B.S.S.). We gratefully acknowledge the NIAID Tetramer Core Facility for providing LLO<INF>91</INF> K<SUP>d</SUP> tetramers, Wolf-Dieter Schubert (University of Pretoria) and Nancy Freitag (University of Illinois at Chicago) for providing L. monocytogenes mutants, and Michael Bevan (University of Washington) for providing Tgfbr2<SUP>fl/fl</SUP> dLck-cre mice. B.S.S., Q.-M.P., and Y.-T.L. performed experiments. L.S.C. and L.P. contributed to the study design. B.S.S. and L.L. designed the experiments, analyzed and interpreted the data, and wrote the manuscript.	Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Bonazzi M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003087; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Ericsson A, 2004, ANN NY ACAD SCI, V1029, P334, DOI 10.1196/annals.1309.014; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Ghanem ENB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003015; Grundemann C, 2006, J IMMUNOL, V176, P1311, DOI 10.4049/jimmunol.176.3.1311; HAMANN A, 1994, J IMMUNOL, V152, P3282; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; Lefrancois L, 1999, J EXP MED, V189, P1631, DOI 10.1084/jem.189.10.1631; Lefrancois L, 2009, NAT IMMUNOL, V10, P369, DOI 10.1038/ni0409-369; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Sheridan B.S., 2012, CURR PROTOC IMMUNOL; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Zhang N., 2012, IMMUNITY, V13, P667	40	204	211	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					747	757		10.1016/j.immuni.2014.03.007	http://dx.doi.org/10.1016/j.immuni.2014.03.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24792910	Green Accepted, Bronze			2022-12-18	WOS:000336026100013
J	Chen, ZJ; Barbi, J; Bu, SR; Yang, HY; Li, ZY; Gao, YY; Jinasena, D; Fu, J; Lin, F; Chen, C; Zhang, J; Yu, N; Li, XP; Shan, Z; Nie, J; Gao, ZM; Tian, H; Li, YY; Yao, ZJ; Zheng, Y; Park, BV; Pan, ZY; Zhang, J; Dang, E; Li, ZG; Wang, HL; Luo, WB; Li, LW; Semenza, GL; Zheng, SG; Loser, K; Tsun, A; Greene, MI; Pardoll, DM; Pan, F; Li, B				Chen, Zuojia; Barbi, Joseph; Bu, Shurui; Yang, Huang-Yu; Li, Zhiyuan; Gao, Yayi; Jinasena, Dilini; Fu, Juan; Lin, Fang; Chen, Chen; Zhang, Jing; Yu, Ning; Li, Xiangpei; Shan, Zhao; Nie, Jia; Gao, Zhimei; Tian, Hong; Li, Yangyang; Yao, Zhengju; Zheng, Ying; Park, Benjamin V.; Pan, Ziyi; Zhang, Jing; Dang, Eric; Li, Zhiguang; Wang, Honglin; Luo, Weibo; Li, Liwu; Semenza, Gregg L.; Zheng, Song-Guo; Loser, Karin; Tsun, Andy; Greene, Mark I.; Pardoll, Drew M.; Pan, Fan; Li, Bin			The Ubiquitin Ligase Stub1 Negatively Modulates Regulatory T Cell Suppressive Activity by Promoting Degradation of the Transcription Factor Foxp3	IMMUNITY			English	Article							HEAT-SHOCK PROTEINS; INTESTINAL INFLAMMATION; TGF-BETA; CHIP; EXPRESSION; INDUCE; DIFFERENTIATION; ACTIVATION; PLASTICITY; STABILITY	Regulatory T (Treg) cells suppress inflammatory immune responses and autoimmunity caused by self-reactive T cells. The key Treg cell transcription factor Foxp3 is downregulated during inflammation to allow for the acquisition of effector T cell-like functions. Here, we demonstrate that stress signals elicited by proinflammatory cytokines and lipopolysaccharides lead to the degradation of Foxp3 through the action of the E3 ubiquitin ligase Stub1. Stub1 interacted with Foxp3 to promote its K48-linked polyubiquitination in an Hsp70-dependent manner. Knockdown of endogenous Stub1 or Hsp70 prevented Foxp3 degradation. Furthermore, the overexpression of Stub1 in Treg cells abrogated their ability to suppress inflammatory immune responses in vitro and in vivo and conferred a T-helper-1-cell-like phenotype. Our results demonstrate the critical role of the stress-activated Stub1-Hsp70 complex in promoting Treg cell inactivation, thus providing a potential therapeutic target for the intervention against autoimmune disease, infection, and cancer.	[Chen, Zuojia; Li, Zhiyuan; Gao, Yayi; Lin, Fang; Chen, Chen; Zhang, Jing; Shan, Zhao; Nie, Jia; Gao, Zhimei; Li, Yangyang; Yao, Zhengju; Tsun, Andy; Li, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Unit Mol Immunol,Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China; [Barbi, Joseph; Bu, Shurui; Yang, Huang-Yu; Jinasena, Dilini; Fu, Juan; Zheng, Ying; Park, Benjamin V.; Pan, Ziyi; Zhang, Jing; Dang, Eric; Li, Zhiguang; Pardoll, Drew M.; Pan, Fan] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol,Immunol & Hematopoiesis Div, Baltimore, MD 21287 USA; [Bu, Shurui] Fudan Univ, Affiliated Jinshan Hosp, Dept Gastroenterol, Shanghai 201508, Peoples R China; [Yang, Huang-Yu] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Nephrol, Tao Yuan 333, Taiwan; [Zheng, Song-Guo] Penn State Univ, Coll Med, Dept Med, Div Rheumatol, Hershey, PA 17033 USA; [Loser, Karin] Univ Munster, Dept Dermatol, D-48149 Munster, Germany; [Greene, Mark I.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Yu, Ning; Li, Xiangpei] Anhui Med Univ, Affiliated Anhui Prov Hosp, Dept Rheumatol & Immunol, Hefei 230001, Peoples R China; [Wang, Honglin] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200025, Peoples R China; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA; [Luo, Weibo; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Tian, Hong; Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Johns Hopkins University; Johns Hopkins Medicine; Fudan University; Chang Gung Memorial Hospital; Chang Gung University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Munster; University of Pennsylvania; Anhui Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Virginia Polytechnic Institute & State University	Pan, F (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol,Immunol & Hematopoiesis Div, Baltimore, MD 21287 USA.	fpan1@jhmi.edu; binli@sibs.ac.cn	li, zhiyuan/HGD-9581-2022; WANG, Honglin/AAJ-2708-2020; Chen, Zuojia/AAM-9465-2020; lI, Bin/AAR-4966-2021	WANG, Honglin/0000-0001-6302-6927; lI, Bin/0000-0002-7640-8884; Li, Liwu/0000-0001-8870-5299; Dang, Eric/0000-0002-2389-6167; Hong, Tian/0000-0002-8212-7050; YANG, HUANG-YU/0000-0001-6826-9717; Luo, Weibo/0000-0002-1992-0320; li, zhiguang/0000-0003-2474-3485	National Natural Science Foundation of China [30972702, 31170825, 31200647, 31200646, 81271835, 81270083, 31150110337, 81161120417]; National Science and Technology Major Project [2012ZX10002007-003, 2013ZX10003009-002]; NN-CAS Foundation; Shanghai Science and Technology "Rising Star" Program [10QA1407900]; CAS "100-talent" program; SA-SIBS scholarship program; Knowledge Innovation Program of the Shanghai Institute for Biological Sciences, Chinese Academy of Sciences [2012KIP204]; National Institutes of Health [RO1AI099300, RO1AI089830]; "Kelly's Dream" Foundation; Janey Fund; Seraph Foundation; Crohn's and Colitis Foundation of America Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099300, R01AI089830, T32AI007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059103] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; NN-CAS Foundation; Shanghai Science and Technology "Rising Star" Program; CAS "100-talent" program(Chinese Academy of Sciences); SA-SIBS scholarship program; Knowledge Innovation Program of the Shanghai Institute for Biological Sciences, Chinese Academy of Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Kelly's Dream" Foundation; Janey Fund; Seraph Foundation; Crohn's and Colitis Foundation of America Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Coffer and J. van Loosdregt for helpful discussions. Our research is supported by National Natural Science Foundation of China grants 30972702, 31170825, 31200647, 31200646, 81271835, 81270083, 31150110337, and 81161120417; National Science and Technology Major Project 2012ZX10002007-003, 2013ZX10003009-002; and the NN-CAS Foundation. B.L. is supported by the Shanghai Science and Technology "Rising Star" Program (10QA1407900) and CAS "100-talent" program. S.Z. is a Tina C. Foundation Lupus Research Award winner. We gratefully acknowledge the support of the SA-SIBS scholarship program and the Knowledge Innovation Program of the Shanghai Institute for Biological Sciences, Chinese Academy of Sciences (2012KIP204). We thank X. Cao and Y.-J. Liu for their critical reading for the manuscript. We thank the members of the Pan and Pardoll Labs for helpful discussions. F.P. is a Stewart Trust Scholar and Melanoma Research Alliance Young Investigator Award winner. F.P.'s laboratory is partially supported by grants from the National Institutes of Health (RO1AI099300 and RO1AI089830), "Kelly's Dream" Foundation, the Janey Fund, and the Seraph Foundation, and gifts from Bill and Betty Topecer and Dorothy Needle. J.B. is supported by a Crohn's and Colitis Foundation of America Research Fellowship.	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bryn T, 2008, INT IMMUNOL, V20, P235, DOI 10.1093/intimm/dxm134; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Milkova L, 2010, EXP DERMATOL, V19, P29, DOI 10.1111/j.1600-0625.2009.00953.x; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mougiakakos D, 2011, BLOOD, V117, P857, DOI 10.1182/blood-2010-09-307041; Nagar M, 2008, INT IMMUNOL, V20, P1041, DOI 10.1093/intimm/dxn062; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Tattevin P, 2010, J INFECT DIS, V201, P956, DOI 10.1086/650996; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zheng QH, 2009, J MOL MED, V87, P1191, DOI 10.1007/s00109-009-0530-8; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	37	204	229	6	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					272	285		10.1016/j.immuni.2013.08.006	http://dx.doi.org/10.1016/j.immuni.2013.08.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23973223	Green Accepted, Bronze			2022-12-18	WOS:000330948800010
J	Masters, SL; Gerlic, M; Metcalf, D; Preston, S; Pellegrini, M; O'Donnell, JA; McArthur, K; Baldwin, TM; Chevrier, S; Nowell, CJ; Cengia, LH; Henley, KJ; Collinge, JE; Kastner, DL; Feigenbaum, L; Hilton, DJ; Alexander, WS; Kile, BT; Croker, BA				Masters, Seth L.; Gerlic, Motti; Metcalf, Donald; Preston, Simon; Pellegrini, Marc; O'Donnell, Joanne A.; McArthur, Kate; Baldwin, Tracey M.; Chevrier, Stephane; Nowell, Cameron J.; Cengia, Louise H.; Henley, Katya J.; Collinge, Janelle E.; Kastner, Daniel L.; Feigenbaum, Lionel; Hilton, Douglas J.; Alexander, Warren S.; Kile, Benjamin T.; Croker, Ben A.			NLRP1 Inflammasome Activation Induces Pyroptosis of Hematopoietic Progenitor Cells	IMMUNITY			English	Article							BINDING-PROTEIN; LETHAL TOXIN; TIR DOMAIN; DISEASE; INFECTION; DEATH; IL-18; INTERLEUKIN-1-BETA; PREDISPOSITION; EXPRESSION	Cytopenias are key prognostic indicators of life-threatening infection, contributing to immunosuppression and mortality. Here we define a role for Caspase-1 -dependent death, known as pyroptosis, in infection-induced cytopenias by studying inflammasome activation in hematopoietic progenitor cells. The NLRP1a inflammasome is expressed in hematopoietic progenitor cells and its activation triggers their pyroptotic death. Active NLRP1a induced a lethal systemic inflammatory disease that was driven by Caspase-1 and IL-1 beta but was independent of apoptosis-associated speck-like protein containing a CARD (ASC) and ameliorated by IL-18. Surprisingly, in the absence of IL-1 beta-driven inflammation, active NLRP1a triggered pyroptosis of hematopoietic progenitor cells resulting in leukopenia at steady state. During periods of hematopoietic stress induced by chemotherapy or lymphocytic choriomeningitis virus (LCMV) infection, active NLRP1 a caused prolonged cytopenia, bone marrow hypoplasia, and immunosuppression. Conversely, NLRP1-deficient mice showed enhanced recovery from chemotherapy and LCMV infection, demonstrating that NLRP1 acts as a cellular sentinel to alert Caspase-1 to hematopoietic and infectious stress.	[Masters, Seth L.; Gerlic, Motti; Metcalf, Donald; Preston, Simon; Pellegrini, Marc; O'Donnell, Joanne A.; McArthur, Kate; Baldwin, Tracey M.; Chevrier, Stephane; Cengia, Louise H.; Henley, Katya J.; Collinge, Janelle E.; Hilton, Douglas J.; Alexander, Warren S.; Kile, Benjamin T.; Croker, Ben A.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Masters, Seth L.; Gerlic, Motti; Metcalf, Donald; Preston, Simon; Pellegrini, Marc; O'Donnell, Joanne A.; McArthur, Kate; Hilton, Douglas J.; Alexander, Warren S.; Kile, Benjamin T.; Croker, Ben A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Nowell, Cameron J.] Ludwig Inst Canc Res, Melbourne Parkville Branch, Parkville, Vic 3052, Australia; [Kastner, Daniel L.] NHGRI, Inflammatory Dis Sect, NIH, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] Sci Applicat Int Corp, NCI, Frederick, MD 21702 USA	Walter & Eliza Hall Institute; University of Melbourne; Ludwig Institute for Cancer Research; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Kile, BT (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	kile@wehi.edu.au; croker@wehi.edu.au	gerlic, Motti/I-5492-2019; Masters, Seth L/N-2886-2013; Hilton, Douglas J/C-7250-2013; Pellegrini, Marc/F-7670-2014; Kile, Benjamin/GNP-3246-2022; Gerlic, Motti/U-3484-2017; Chevrier, Stephane/I-4257-2012; Kile, Benjamin T/F-6593-2011	gerlic, Motti/0000-0001-9518-1833; Masters, Seth L/0000-0003-4763-576X; Hilton, Douglas J/0000-0002-7698-2392; Kile, Benjamin/0000-0002-8836-8947; Gerlic, Motti/0000-0001-9518-1833; Kile, Benjamin T/0000-0002-8836-8947; McArthur, Kate/0000-0002-8838-4146; Pellegrini, Marc/0000-0003-3627-3126; Preston, Simon/0000-0001-8969-8297; Nowell, Cameron/0000-0002-8662-9840; O'Donnell, Joanne/0000-0002-8434-1050; Chevrier, Stephane/0000-0002-9216-7910; Croker, Ben/0000-0002-0885-3599	Australian National Health and Medical Research Council (NHMRC) [361646]; Australian Research Council; Sylvia and Charles Viertel Foundation; Cancer Council of Victoria; Australian Cancer Research Fund; Australian Phenomics Network; Victorian State Government Operational Infrastructure Support Grant;  [637367];  [1002426];  [461219]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373, ZIAHG200372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041083] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Sylvia and Charles Viertel Foundation; Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Australian Cancer Research Fund; Australian Phenomics Network; Victorian State Government Operational Infrastructure Support Grant; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Mifsud, L. DiRago, and J. Corbin for excellent technical assistance and E. Lanera, S. Ross, S. Guzzardi, S. Brown, E. Salt, and M. Salzone for outstanding animal husbandry. We thank V. Dixit for Caspase-11-deficient mice. This work was supported by Project Grants (637367, 1002426), a Program Grant (461219), Fellowships (B.A.C., D.J.H., W.S.A., S.L.M., B.T.K.), and an Independent Research Institutes Infrastructure Support Scheme Grant (361646) from the Australian National Health and Medical Research Council (NHMRC); Fellowships from the Australian Research Council (B.A.C., B.T.K.), the Sylvia and Charles Viertel Foundation (B.T.K.), and the Cancer Council of Victoria (D.M.); the Australian Cancer Research Fund; the Australian Phenomics Network; and a Victorian State Government Operational Infrastructure Support Grant.	Arber C, 2003, BLOOD, V102, P421, DOI 10.1182/blood-2002-12-3834; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Binder D, 1997, J EXP MED, V185, P517, DOI 10.1084/jem.185.3.517; BitMansour A, 2002, BLOOD, V100, P4660, DOI 10.1182/blood-2002-05-1552; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Croker BA, 2011, P NATL ACAD SCI USA, V108, P13135, DOI 10.1073/pnas.1110358108; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85; Mallat Z, 2001, CIRC RES, V89, pE41, DOI 10.1161/hh1901.098735; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2010, EMBO REP, V11, P640, DOI 10.1038/embor.2010.93; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Plater-Zyberk C, 2001, J CLIN INVEST, V108, P1825, DOI 10.1172/JCI200112097; Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432; Pontillo A, 2012, AUTOIMMUNITY, V45, P271, DOI 10.3109/08916934.2011.637532; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Swiderski MR, 2009, MOL PLANT MICROBE IN, V22, P157, DOI 10.1094/MPMI-22-2-0157; Tak PP, 2006, EUR J DRUG METAB PH, V31, P109; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; Venet F, 2010, SHOCK, V34, P358, DOI 10.1097/SHK.0b013e3181dc0977; Wang BH, 2002, J IMMUNOL, V168, P3303, DOI 10.4049/jimmunol.168.7.3303; Yoshida A, 2002, LIFE SCI, V70, P1225, DOI 10.1016/S0024-3205(01)01509-0; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhang YL, 2003, PLANT CELL, V15, P2636, DOI 10.1105/tpc.015842	42	204	221	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					1009	1023		10.1016/j.immuni.2012.08.027	http://dx.doi.org/10.1016/j.immuni.2012.08.027			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23219391	Green Accepted, Bronze			2022-12-18	WOS:000312575000010
J	Belkaid, Y; Oldenhove, G				Belkaid, Yasmine; Oldenhove, Guillaume			Tuning microenvironments: Induction of regulatory T cells by dendritic cells	IMMUNITY			English	Review							TRANSCRIPTION FACTOR FOXP3; MESENTERIC LYMPH-NODES; TRANS-RETINOIC ACID; GROWTH-FACTOR-BETA; TGF-BETA; IMMUNE-RESPONSES; IFN-GAMMA; ORAL TOLERANCE; LAMINA-PROPRIA; IN-VITRO	The body requires the generation of regulatory T (Treg) cells to preserve its integrity. Each microenvironment is controlled by a specific set of regulatory elements that have to be finefrly and constantly tuned to maintain local homeostasis. These environments could be site specific, such as the gut environment, or induced by chronic exposure to microbes or tumors. Various populations of dendritic cells (DCs) are central to the orchestration of this control. In this review, we will discuss some new findings associating DCs from defined compartments with the induction of antigen-specific Treg cells.	[Belkaid, Yasmine; Oldenhove, Guillaume] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), NIAID, Mucosal Immunol Unit, Parasit Dis Lab, Bethesda, MD 20894 USA.	ybelkaid@niaid.nih.gov		Belkaid, Yasmine/0000-0001-9962-3571	Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000955, ZIAAI001115, Z01AI001061] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and National Institutes of Health. We apologize to those authors whose work we were unable to cite because of space limitations.	Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; BARNARD JA, 1993, GASTROENTEROLOGY, V105, P67, DOI 10.1016/0016-5085(93)90011-Z; BEIGHITH M, 2003, NAT MED, V9, P1202; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Braat H, 2007, GUT, V56, P351, DOI 10.1136/gut.2006.099861; Cantorna MT, 2005, J RHEUMATOL, V32, P11; Cantorna MT, 1996, J IMMUNOL, V156, P2674; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Degauque N, 2008, J CLIN INVEST, V118, P735, DOI 10.1172/JCI32562; DEL PG, 1993, J IMMUNOL, V150, P353; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Elliott DE, 2003, AM J PHYSIOL-GASTR L, V284, pG385, DOI 10.1152/ajpgi.00049.2002; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Geerts A, 2004, J HEPATOL, V40, P331, DOI 10.1016/j.jhep.2003.12.006; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; GomezEscobar N, 1997, GENE, V199, P101, DOI 10.1016/S0378-1119(97)00353-3; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Griffin MD, 2000, BIOCHEM BIOPH RES CO, V270, P701, DOI 10.1006/bbrc.2000.2490; Hoffmann KF, 2000, J IMMUNOL, V164, P6406, DOI 10.4049/jimmunol.164.12.6406; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; King CL, 1996, J IMMUNOL, V156, P4715; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Li C, 1999, INFECT IMMUN, V67, P4435, DOI 10.1128/IAI.67.9.4435-4442.1999; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340; Mahanty S, 1997, INFECT IMMUN, V65, P1742, DOI 10.1128/IAI.65.5.1742-1747.1997; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Meyaard L, 1996, J IMMUNOL, V156, P2776; Mills KHG, 2004, SEMIN IMMUNOL, V16, P107, DOI 10.1016/j.smim.2003.12.006; Montagnoli C, 2006, J IMMUNOL, V176, P1712, DOI 10.4049/jimmunol.176.3.1712; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Ocana-Morgner C, 2007, EUR J IMMUNOL, V37, P1562, DOI 10.1002/eji.200737068; Oderup C, 2006, TRANSPLANTATION, V82, P1493, DOI 10.1097/01.tp.0000244064.66136.04; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443; Plebanski M, 1999, IMMUNITY, V10, P651, DOI 10.1016/S1074-7613(00)80064-3; Pohl-Koppe A, 1998, J IMMUNOL, V160, P1804; Poncini CV, 2008, INFECT IMMUN, V76, P2633, DOI 10.1128/IAI.01298-07; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Saurer L, 2007, J IMMUNOL, V179, P3504, DOI 10.4049/jimmunol.179.6.3504; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Siewert C, 2007, EUR J IMMUNOL, V37, P978, DOI 10.1002/eji.200636575; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Spahn TW, 2002, EUR J IMMUNOL, V32, P1109, DOI 10.1002/1521-4141(200204)32:4<1109::AID-IMMU1109>3.3.CO;2-B; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tai P, 2008, J CELL PHYSIOL, V214, P456, DOI 10.1002/jcp.21221; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Trinchieri G, 2001, J EXP MED, V194, pF53, DOI 10.1084/jem.194.10.f53; Van der Kleij D, 2002, J INFECT DIS, V185, P531, DOI 10.1086/338574; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vignali DAAA, 2008, EUR J IMMUNOL, V38, P908, DOI 10.1002/eji.200738114; Vijay-Kumar M, 2008, INFECT IMMUN, V76, P1276, DOI 10.1128/IAI.01491-07; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Wong KA, 2008, J IMMUNOL, V180, P716, DOI 10.4049/jimmunol.180.2.716; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831; Zaccone P, 2003, EUR J IMMUNOL, V33, P1439, DOI 10.1002/eji.200323910; Zheng SG, 2006, J IMMUNOL, V176, P3321, DOI 10.4049/jimmunol.176.6.3321; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Ziegler TR, 2003, ANNU REV NUTR, V23, P229, DOI 10.1146/annurev.nutr.23.011702.073036	117	204	214	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2008	29	3					362	371		10.1016/j.immuni.2008.08.005	http://dx.doi.org/10.1016/j.immuni.2008.08.005			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18799144	Green Accepted, Bronze			2022-12-18	WOS:000259708900005
J	Hernandez-Hoyos, G; Anderson, MK; Wang, C; Rothenberg, EV; Alberola-Ila, J				Hernandez-Hoyos, G; Anderson, MK; Wang, C; Rothenberg, EV; Alberola-Ila, J			GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation	IMMUNITY			English	Article							T-CELL DEVELOPMENT; TRANSCRIPTION FACTOR GATA-3; DOMINANT-NEGATIVE MUTANT; LYMPHOCYTE DEVELOPMENT; ENFORCED EXPRESSION; LINEAGE DECISION; INTERFERING RNAS; MAMMALIAN-CELLS; RECEPTOR-ALPHA; GENE	GATA-3 is expressed at higher levels in CD4 than in CD8 SP thymocytes. Here we show that upregulation of GATA-3 expression in DP thymocytes is triggered by TCR stimulation, and the extent of upregulation correlates with the strength of the TCR signal. Overexpression of GATA-3 or a partial GATA-3 agonist during positive selection inhibits CD8 SP cell development but is not sufficient to divert class I-restricted T cell precursors to the CD4 lineage. Conversely, expression of the GATA-3 antagonist ROG or of a GATA-3 siRNA hairpin markedly enhances development of CD8 SP cells and reduces CD4 SP development. We propose that GATA-3 contributes to linking the TCR signal strength to the differentiation program of CD4 and CD8 thymocytes.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Rothenberg, EV (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	alberola@caltech.edu; evroth@its.caltech.edu		Anderson, Michele/0000-0002-8820-5910; alberola-ila, Jose/0000-0003-2439-553X; Rothenberg, Ellen/0000-0002-3901-347X	NATIONAL CANCER INSTITUTE [R01CA090233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045072] Funding Source: NIH RePORTER; NCI NIH HHS [CA90233] Funding Source: Medline; NIAID NIH HHS [R01 AI045072-05, R01 AI045072, AI45072] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 2002, CELL, V109, pS1, DOI 10.1016/S0092-8674(02)00689-X; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Anderson MK, 2002, DEV BIOL, V246, P103, DOI 10.1006/dbio.2002.0674; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Bommhardt U, 1998, IMMUNOL REV, V165, P181, DOI 10.1111/j.1600-065X.1998.tb01239.x; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; Hayashi K, 2001, J IMMUNOL, V167, P4957, DOI 10.4049/jimmunol.167.9.4957; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hernandez-Hoyos G, 2003, SEMIN CELL DEV BIOL, V14, P121, DOI 10.1016/S1084-9521(02)00180-5; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Iwata M, 1996, EUR J IMMUNOL, V26, P2081, DOI 10.1002/eji.1830260918; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Sebzda E, 1997, IMMUNITY, V6, P643, DOI 10.1016/S1074-7613(00)80352-0; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; SMITH VM, 1995, J BIOL CHEM, V270, P1515, DOI 10.1074/jbc.270.4.1515; Taghon T, 2001, J IMMUNOL, V167, P4468, DOI 10.4049/jimmunol.167.8.4468; Takemoto N, 2002, J IMMUNOL, V169, P4103, DOI 10.4049/jimmunol.169.8.4103; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Yamagata T, 2000, EMBO J, V19, P4676, DOI 10.1093/emboj/19.17.4676; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3	45	204	208	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2003	19	1					83	94		10.1016/S1074-7613(03)00176-6	http://dx.doi.org/10.1016/S1074-7613(03)00176-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871641	Bronze			2022-12-18	WOS:000184260400010
J	Bennett, AR; Farley, A; Blair, NF; Gordon, J; Sharp, L; Blackburn, CC				Bennett, AR; Farley, A; Blair, NF; Gordon, J; Sharp, L; Blackburn, CC			Identification and characterization of thymic epithelial progenitor cells	IMMUNITY			English	Article							STROMAL CELLS; DIFFERENTIATION; MOUSE; MICROENVIRONMENTS; PROLIFERATION; EXPRESSION; STEPS; THY-1; MICE	T cell differentiation and repertoire selection depend critically on several distinct thymic epithelial cell types, whose lineage relationships are unclear. We have investigated these relationships via functional analysis of the epithelial populations within the thymic primordium. Here, we show that mAbs MTS20 and MTS24 identify a population of cells that, when purified and grafted ectopically, can differentiate into all known thymic epithelial cell types, attract lymphoid progenitors, and support CD4(+) and CD8(+) T cell development in nude mice. In contrast, other epithelial populations in the thymic primordium can fulfill none of these functions. These data establish that the MTS20(+)24(+) population is sufficient to generate a functional thymus in vivo and thus argue strongly that all thymic epithelial cell types derive from a common progenitor cell.	Univ Edinburgh, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Edinburgh, Div Biomed & Clin Lab Sci, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Blackburn, CC (corresponding author), Univ Edinburgh, Ctr Genome Res, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.		Blackburn, Clare/AAM-7954-2020; Blackburn, Clare/B-2847-2009	Blackburn, Clare/0000-0002-6326-640X; Blackburn, Clare/0000-0002-6326-640X; FARLEY, ALISON/0000-0002-9609-8983				Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Anderson M, 2000, INT IMMUNOL, V12, P1105, DOI 10.1093/intimm/12.7.1105; AUERBACH R, 1960, DEV BIOL, V2, P271, DOI 10.1016/0012-1606(60)90009-9; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; CHOU MY, 1990, AM J PATHOL, V136, P729; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; CORDIER AC, 1975, SCAND J IMMUNOL, V4, P193, DOI 10.1111/j.1365-3083.1975.tb02616.x; DeKoning J, 1997, J IMMUNOL, V158, P2558; Fairchild PJ, 2000, EUR J IMMUNOL, V30, P1948, DOI 10.1002/1521-4141(200007)30:7<1948::AID-IMMU1948>3.0.CO;2-3; Ge Q, 2000, INT IMMUNOL, V12, P1127, DOI 10.1093/intimm/12.8.1127; GODFREY DI, 1990, IMMUNOLOGY, V70, P66; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; HAYNES BF, 1984, J EXP MED, V159, P1149, DOI 10.1084/jem.159.4.1149; HOFFMANN MW, 1992, P NATL ACAD SCI USA, V89, P2526, DOI 10.1073/pnas.89.7.2526; Imami N, 1992, Dev Immunol, V2, P161, DOI 10.1155/1992/18016; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; Janeway C., 1996, IMMUNOBIOLOGY; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; Kaestner KH, 2000, GENE DEV, V14, P142; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Lampert I. A., 1988, THYMUS UPDATE, P5; LEDOUARIN NM, 1975, J EXP MED, V142, P17, DOI 10.1084/jem.142.1.17; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Manley NR, 2000, SEMIN IMMUNOL, V12, P421, DOI 10.1006/smim.2000.0263; Markert ML, 1999, NEW ENGL J MED, V341, P1180, DOI 10.1056/NEJM199910143411603; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; MILLER JF, 1961, LANCET, V2, P748; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; OWEN JJT, 1969, J EXP MED, V129, P431, DOI 10.1084/jem.129.2.431; PARHAM P, 2000, IMMUNE SYSTEM; RITTER MA, 1993, IMMUNOL TODAY, V14, P462, DOI 10.1016/0167-5699(93)90250-O; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; ROPKE C, 1995, DEV IMMUNOL, V4, P149, DOI 10.1155/1995/23168; SCHLUEP M, 1988, J AUTOIMMUN, V1, P445, DOI 10.1016/0896-8411(88)90067-4; SMITH C, 1965, AM J ANAT, V116, P611, DOI 10.1002/aja.1001160307; TUCEK CL, 1990, INT IMMUNOL, V2, P593, DOI 10.1093/intimm/2.7.593; van Ewijk W, 1999, SEMIN IMMUNOL, V11, P57, DOI 10.1006/smim.1998.0158; VANEWIJK W, 1982, EUR J IMMUNOL, V12, P262, DOI 10.1002/eji.1830120403	42	204	208	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2002	16	6					803	814		10.1016/S1074-7613(02)00321-7	http://dx.doi.org/10.1016/S1074-7613(02)00321-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121662	Bronze			2022-12-18	WOS:000176534000006
J	Takahashi, Y; Ohta, H; Takemori, T				Takahashi, Y; Ohta, H; Takemori, T			Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire	IMMUNITY			English	Article							PRIMARY IMMUNE-RESPONSE; ANTIBODY-FORMING-CELLS; AFFINITY MATURATION; PLASMA-CELLS; MEDIATED APOPTOSIS; NEGATIVE SELECTION; TRANSGENIC MICE; BONE-MARROW; T-CELLS; ANTIGEN	In T cell-dependent immune responses, high-affinity B cells are selected and differentiate into memory cells; however, the mechanism behind this process remains largely unknown. Here, we report that the selection of high-affinity B cells within germinal centers (GCs) is impaired in Fas-deficient Ipr mice in the primary response, probably owing to inefficient negative selection. The memory compartment in control mice is mostly established by precursors generated from the early GCs, whereas the Ipr defect expands the memory compartment by the increased recruitment of newly generated precursors from the late GCs, resulting in the accumulation of heavily mutated memory B cells at high frequency. These results suggest that Fas is required for clonal selection within GCs and the establishment of the memory B cell repertoire.	Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID)	Takemori, T (corresponding author), Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.		Takemori, Toshitada/A-5909-2016	Takahashi, Yoshimasa/0000-0001-6342-4087				ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Arpin C, 1997, J EXP MED, V186, P931, DOI 10.1084/jem.186.6.931; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; BEREK C, 1987, EUR J IMMUNOL, V17, P1121, DOI 10.1002/eji.1830170808; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Bothwell AL, 1982, CELL, V24, P625, DOI 10.1016/0092-8674 (81)90089-1; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559; Foote LC, 1998, J EXP MED, V187, P847, DOI 10.1084/jem.187.6.847; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; GRAY D, 1994, J EXP MED, V180, P141, DOI 10.1084/jem.180.1.141; GULLEY ML, 1988, J IMMUNOL, V140, P3751; HAN SH, 1995, J IMMUNOL, V155, P556; Hande S, 1998, IMMUNITY, V8, P189, DOI 10.1016/S1074-7613(00)80471-9; IMANISHI T, 1973, EUR J IMMUNOL, V3, P323, DOI 10.1002/eji.1830030602; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOBSON BA, 1995, IMMUNITY, V3, P509, DOI 10.1016/1074-7613(95)90179-5; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; Kimoto H, 1997, EUR J IMMUNOL, V27, P268, DOI 10.1002/eji.1830270140; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LIU YJ, 1995, IMMUNITY, V2, P239, DOI 10.1016/1074-7613(95)90048-9; MAIZELS N, 1985, CELL, V43, P715, DOI 10.1016/0092-8674(85)90244-2; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Oliver AM, 1997, J IMMUNOL, V158, P1108; Pulendran B, 1997, IMMUNOL TODAY, V18, P27, DOI 10.1016/S0167-5699(97)80011-4; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Ridderstad A, 1998, J IMMUNOL, V160, P4688; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Schneider TJ, 1997, J IMMUNOL, V159, P4834; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; SMITH KGC, 1995, P NATL ACAD SCI USA, V92, P11628, DOI 10.1073/pnas.92.25.11628; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Takahashi Y, 1999, J EXP MED, V190, P399, DOI 10.1084/jem.190.3.399; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; VIEIRA P, 1990, INT IMMUNOL, V2, P487, DOI 10.1093/intimm/2.6.487; Wang HW, 1999, J EXP MED, V190, P639, DOI 10.1084/jem.190.5.639; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEISS U, 1992, EUR J IMMUNOL, V22, P511, DOI 10.1002/eji.1830220233	50	204	208	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2001	14	2					181	192		10.1016/S1074-7613(01)00100-5	http://dx.doi.org/10.1016/S1074-7613(01)00100-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404HZ	11239450	Bronze			2022-12-18	WOS:000167092500008
J	Zander, R; Schauder, D; Xin, G; Nguyen, C; Wu, XP; Zajac, A; Cui, WG				Zander, Ryan; Schauder, David; Xin, Gang; Nguyen, Christine; Wu, Xiaopeng; Zajac, Allan; Cui, Weiguo			CD4(+) T Cell Help Is Required for the Formation of a Cytolytic CD8(+) T Cell Subset that Protects against Chronic Infection and Cancer	IMMUNITY			English	Article							TERMINAL DIFFERENTIATION; ANTITUMOR IMMUNITY; TUMOR-IMMUNITY; EFFECTOR; IL-21; PD-1; INTERLEUKIN-21; PERSISTENCE; EXHAUSTION; EXPRESSION	Although CD4(+) T cell "help" is crucial to sustain antiviral immunity, the mechanisms by which CD4(+) T cells regulate CD8(+) T cell differentiation during chronic infection remain elusive. Here, using single-cell RNA sequencing, we show that CD8(+) T cells responding to chronic infection were more heterogeneous than previously appreciated. Importantly, our findings uncovered the formation of a CX(3)CR1-expressing CD8(+) T cell subset that exhibited potent cytolytic function and was required for viral control. Notably, our data further demonstrate that formation of this cytotoxic subset was critically dependent on CD4(+) T cell help via interleukin-21 (IL-21) and that exploitation of this developmental pathway could be used therapeutically to enhance the killer function of CD8(+) T cells infiltrated into the tumor. These findings uncover additional molecular mechanisms of how "CD4(+) T cell help" regulates CD8(+) T cell differentiation during persistent infection and have implications toward optimizing the generation of protective CD8(+) T cells in immunotherapy.	[Zander, Ryan; Xin, Gang; Wu, Xiaopeng; Cui, Weiguo] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53213 USA; [Schauder, David; Nguyen, Christine; Cui, Weiguo] Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA; [Zajac, Allan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35233 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham	Cui, WG (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53213 USA.; Cui, WG (corresponding author), Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA.	weiguo.cui@bcw.edu	Xin, Gang/AAX-7651-2020; Xin, Gang/N-5788-2018	Cui, Weiguo/0000-0003-1562-9218; Zander, Ryan/0000-0002-7431-8535	NIH [AI125741, DK108557]; American Cancer Society (ACS) Research Scholar Grant; A Healthier Wisconsin (AHW) Grant; Cancer Research Institute Irvington Fellowship; Elizabeth Elser Doolittle Postdoctoral Fellowship; NIGMS [T32-GM080202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049360, R01AI125741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK108557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS) Research Scholar Grant(American Cancer Society); A Healthier Wisconsin (AHW) Grant; Cancer Research Institute Irvington Fellowship; Elizabeth Elser Doolittle Postdoctoral Fellowship; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grants AI125741 (W.C.) and DK108557 (D.S.) and by American Cancer Society (ACS) Research Scholar Grant and A Healthier Wisconsin (AHW) Grant (W.C.). R.Z. is supported by the Cancer Research Institute Irvington Fellowship. G.X. is supported by The Elizabeth Elser Doolittle Postdoctoral Fellowship. D.S. is a member of the Medical Scientist Training Program at MCW, which is partially supported by a training grant from NIGMS T32-GM080202. This research was completed in part with computational resources and technical support provided by the Research Computing Center at MCW.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BATTEGAY M, 1994, J VIROL, V68, P4700, DOI 10.1128/JVI.68.7.4700-4704.1994; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Hanada KI, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124405; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kahan SM, 2015, VIROLOGY, V479, P180, DOI 10.1016/j.virol.2014.12.033; KLATZMANN D, 1984, SCIENCE, V225, P59, DOI 10.1126/science.6328660; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Liang XJ, 2014, J LEUKOCYTE BIOL, V95, P179, DOI 10.1189/jlb.0613330; Lu Y, 2014, P NATL ACAD SCI USA, V111, P2265, DOI 10.1073/pnas.1317431111; MASUR H, 1989, ANN INTERN MED, V111, P223, DOI 10.7326/0003-4819-111-3-223; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; Moroz A, 2004, J IMMUNOL, V173, P900, DOI 10.4049/jimmunol.173.2.900; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Overwijk W. W., 2001, CURR PROTOC IMMUNOL; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Sondergaard H, 2010, J IMMUNOTHER, V33, P236, DOI 10.1097/CJI.0b013e3181c0c1cb; Tian Y, 2016, J IMMUNOL, V196, P2153, DOI 10.4049/jimmunol.1401236; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Vegran F, 2014, NAT IMMUNOL, V15, P758, DOI 10.1038/ni.2925; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725	52	203	208	12	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					1028	+		10.1016/j.immuni.2019.10.009	http://dx.doi.org/10.1016/j.immuni.2019.10.009			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31810883	Bronze, Green Accepted			2022-12-18	WOS:000503162900010
J	Crotti, A; Ransohoff, RM				Crotti, Andrea; Ransohoff, Richard M.			Microglial Physiology and Pathophysiology: Insights from Genome-wide Transcriptional Profiling	IMMUNITY			English	Review							MONOCYTE-DERIVED MACROPHAGES; GENE-EXPRESSION SIGNATURE; CENTRAL-NERVOUS-SYSTEM; CELL-PROLIFERATION; ALZHEIMERS-DISEASE; PROGENITOR-CELL; ADULT MICROGLIA; MOUSE MODEL; REVEALS; MICE	Microglia originate from erythromyeloid progenitors (EMPs) in the yolk sac and develop in the forming CNS. Microglia are fundamental for the development and function of a healthy brain. By contrast, their role in immune host defense of the CNS remains speculative, given the immune privilege of this organ. Alterations inmicroglia functionality are involved in brain aging, as well as in neurodegenerative disease severity and progression. The combination of their ontogeny with the influence of the complex environment of the CNS makes microglia a unique cell population. Recent observations about microglia ontogeny combined with extensive gene expression profiling allow us to better capture the variety of nuances that microglia can manifest. Here, we provide a contemporary appraisal of microglial uniqueness based on their origin, functions, and expression profiles. Furthermore, we give an overview of the impact of aging and neurodegenerative diseases on microglia transcriptomes.	[Crotti, Andrea; Ransohoff, Richard M.] Biogen Inc, Neuroimmunol, 225 Binney St, Cambridge, MA 02142 USA	Biogen	Crotti, A; Ransohoff, RM (corresponding author), Biogen Inc, Neuroimmunol, 225 Binney St, Cambridge, MA 02142 USA.	andrea.crotti@biogen.com; richard.ransohoff@biogen.com						Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; ALLIOT F, 1991, P NATL ACAD SCI USA, V88, P1541, DOI 10.1073/pnas.88.4.1541; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Arnoux I, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/689404; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Beutner C, 2013, GLIA, V61, P1429, DOI 10.1002/glia.22524; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Castellano JM, 2012, P NATL ACAD SCI USA, V109, P15502, DOI 10.1073/pnas.1206446109; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Choi YS, 2008, GLIA, V56, P791, DOI 10.1002/glia.20653; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Elliott R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075346; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; FINCH CE, 1993, J CELL BIOCHEM, V53, P314, DOI 10.1002/jcb.240530408; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hoehn HJ, 2008, BRAIN RES, V1240, P1, DOI 10.1016/j.brainres.2008.08.076; Holtman IR, 2015, GLIA, V63, P1495, DOI 10.1002/glia.22810; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Hughes V, 2012, NATURE, V485, P570, DOI 10.1038/485570a; Kim CC, 2013, CURR OPIN IMMUNOL, V25, P593, DOI 10.1016/j.coi.2013.09.013; Lalancette-Hebert M, 2012, J NEUROSCI, V32, P10383, DOI 10.1523/JNEUROSCI.1498-12.2012; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lewis ND, 2014, J NEUROIMMUNOL, V277, P26, DOI 10.1016/j.jneuroim.2014.09.014; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; LLorens-Martin M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Morsch M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00321; Nazmi A, 2014, NEUROBIOL DIS, V69, P235, DOI 10.1016/j.nbd.2014.05.036; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Raj DDA, 2014, NEUROBIOL AGING, V35, P2147, DOI 10.1016/j.neurobiolaging.2014.03.025; Ransohoff RM, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.14; Ransohoff RM, 2014, SCIENCE, V346, P36, DOI 10.1126/science.1260705; Romanoski CE, 2015, TRENDS IMMUNOL, V36, P507, DOI 10.1016/j.it.2015.07.006; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Schafer DP, 2013, CURR OPIN NEUROBIOL, V23, P1034, DOI 10.1016/j.conb.2013.09.012; Schallner N, 2015, J CLIN INVEST, V125, P2609, DOI 10.1172/JCI78443; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shay T, 2013, TRENDS IMMUNOL, V34, P602, DOI 10.1016/j.it.2013.03.004; Solga AC, 2015, GLIA, V63, P531, DOI 10.1002/glia.22754; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319; Torkildsen O, 2008, ACTA NEUROL SCAND, V117, P72, DOI 10.1111/j.1600-0404.2008.01036.x; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Verheijden S, 2015, GLIA, V63, P1606, DOI 10.1002/glia.22831; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Waisman A, 2015, TRENDS IMMUNOL, V36, P625, DOI 10.1016/j.it.2015.08.005; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Xu J, 2015, DEV CELL, V34, P632, DOI 10.1016/j.devcel.2015.08.018; Yan YP, 2009, BRAIN RES, V1288, P116, DOI 10.1016/j.brainres.2009.06.073; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zusso M, 2012, J NEUROSCI, V32, P11285, DOI 10.1523/JNEUROSCI.6182-11.2012	82	203	207	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					505	515		10.1016/j.immuni.2016.02.013	http://dx.doi.org/10.1016/j.immuni.2016.02.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982357	Bronze			2022-12-18	WOS:000372784200006
J	Marshall, HD; Chandele, A; Jung, YW; Meng, HL; Poholek, AC; Parish, IA; Rutishauser, R; Cui, WG; Kleinstein, SH; Craft, J; Kaech, SM				Marshall, Heather D.; Chandele, Anmol; Jung, Yong Woo; Meng, Hailong; Poholek, Amanda C.; Parish, Ian A.; Rutishauser, Rachel; Cui, Weiguo; Kleinstein, Steven H.; Craft, Joe; Kaech, Susan M.			Differential Expression of Ly6C and T-bet Distinguish Effector and Memory Th1 CD4(+) Cell Properties during Viral Infection	IMMUNITY			English	Article							SURVIVAL; ANTIGEN; IL-7; TRANSITION; ALPHA; TRANSCRIPTION; REGULATORS; MIGRATION; RESPONSES; SUBSETS	CD4(+) T cells differentiate into multiple effector types, but it is unclear how they form memory T cells during infection in vivo. Profiling virus-specific CD4(+) T cells revealed that effector cells with T helper 1 (Th1) or T follicular helper (Tfh) cell characteristics differentiated into memory cells, although expression of Tfh cell markers declined over time. In contrast to virus-specific effector CD8(+) T cells, increased IL-7R expression was not a reliable marker of CD4(+) memory precursor cells. However, decreased Ly6C and T-bet (Tbx21) expression distinguished a subset of Th1 cells that displayed greater longevity and proliferative responses to secondary infection. Moreover, the gene expression profile of Ly6C(lo)T-bet(int) Th1 effector cells was virtually identical to mature memory CD4(+) T cells, indicating early maturation of memory CD4(+) T cell features in this subset during acute viral infection. This study provides a framework for memory CD4(+) T cell development after acute viral infection.	[Marshall, Heather D.; Chandele, Anmol; Jung, Yong Woo; Poholek, Amanda C.; Parish, Ian A.; Rutishauser, Rachel; Cui, Weiguo; Craft, Joe; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Meng, Hailong; Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Craft, Joe] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA; [Jung, Yong Woo] Korea Univ, Dept Pharm, Chungnam 339700, South Korea; [Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Yale University; Yale University; Yale University; Korea University; Howard Hughes Medical Institute	Kaech, SM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	susan.kaech@yale.edu	Bremner, James D/B-1632-2013	Rutishauser, Rachel/0000-0003-3596-059X; Parish, Ian/0000-0003-3528-478X	NIH [RO1 AI074699, AI07019]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066232, F32AI094791, T32AI007019, R01AI074699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040072, R37AR040072] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors would like to thank C. Dominguez, C. Perry, and other members of the S.M.K. and J.C. labs for helpful comments and technical expertise. We also thank M. Shlomchik for use of his fluorescent microscope and H. Hengartner for Stg transgenic mice supplied by R. Ahmed. This work was supported by NIH RO1 AI074699 (S.M.K.) and NIH AI07019 (H.D.M.).	Bamezai A, 2004, ARCH IMMUNOL THER EX, V52, P255; Blander JM, 2000, J EXP MED, V191, P2065, DOI 10.1084/jem.191.12.2065; Chandele A, 2008, J IMMUNOL, V180, P5309, DOI 10.4049/jimmunol.180.8.5309; De Riva A, 2007, J IMMUNOL, V178, P5488, DOI 10.4049/jimmunol.178.9.5488; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jung YW, 2010, J IMMUNOL, V185, P5315, DOI 10.4049/jimmunol.1001948; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KHAN KD, 1990, MOL CELL BIOL, V10, P5150, DOI 10.1128/MCB.10.10.5150; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Liu N, 2004, NAT IMMUNOL, V5, P919, DOI 10.1038/ni1107; MacLeod MKL, 2011, J IMMUNOL, V186, P2889, DOI 10.4049/jimmunol.1002955; MacLeod MKL, 2009, SEMIN IMMUNOL, V21, P53, DOI 10.1016/j.smim.2009.02.006; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; McKinstry KK, 2007, J EXP MED, V204, P2199, DOI 10.1084/jem.20070041; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; R Development CoreTeam, 2010, R LANG ENV STAT COMP; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Tripathi P, 2007, J IMMUNOL, V178, P4027, DOI 10.4049/jimmunol.178.7.4027; Tripathi P, 2010, J IMMUNOL, V185, P2116, DOI 10.4049/jimmunol.1000842; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014	37	203	204	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					633	646		10.1016/j.immuni.2011.08.016	http://dx.doi.org/10.1016/j.immuni.2011.08.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22018471	Green Accepted, Bronze			2022-12-18	WOS:000296657700021
J	Hayes, SM; Li, LQ; Love, PE				Hayes, SM; Li, LQ; Love, PE			TCR signal strength influences alpha beta/gamma delta lineage fate	IMMUNITY			English	Article							T-CELL-RECEPTOR; GAMMA-TRANSGENIC MICE; EPSILON-RI-GAMMA; THYMOCYTE SELECTION; ZETA-CHAIN; LYMPHOCYTE DEVELOPMENT; MURINE THYMOCYTES; BETA; PRE; GENE	Signals transduced by T cell antigen receptors (TCRs) have been shown to be critical for alpha beta and gamma delta T cell development, but their role in lineage determination remains poorly defined. Two models have been forwarded for alpha beta/gamma delta lineage choice: the instructive model and the stochastic model. Recent data, however, are inconsistent with either model. In this study, we devised an experimental system in which lineage fate was controlled exclusively by the gamma delta TCR. We then analyzed the impact of TCR signal strength on alpha beta/gamma delta lineage development by altering the surface expression or signaling potential of the gamma delta TCR complex. We found that increasing the gamma delta TCR signal strength favored gamma delta lineage development, whereas weakening the gamma delta TCR signal favored up lineage development. These results support a model in which the strength of the TCR signal is a critical determinant in the lineage fate decision.	NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Love, PE (corresponding author), NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA.	lovep@mail.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001803] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aifantis I, 2002, NAT IMMUNOL, V3, P483, DOI 10.1038/ni779; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Borowski C, 2004, J EXP MED, V199, P607, DOI 10.1084/jem.20031973; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; CROMPTON T, 1994, EUR J IMMUNOL, V24, P1903, DOI 10.1002/eji.1830240828; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; Fehling H J, 1999, Adv Immunol, V71, P1; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Flamand V, 1996, J EXP MED, V184, P1725, DOI 10.1084/jem.184.5.1725; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; GROETTRUP M, 1993, CELL, V75, P282; Haks MC, 2003, J IMMUNOL, V170, P2853, DOI 10.4049/jimmunol.170.6.2853; Hayday AC, 1999, SEMIN IMMUNOL, V11, P239, DOI 10.1006/smim.1999.0180; Hayes SM, 1996, J IMMUNOL, V156, P2723; Hayes SM, 2003, IMMUNOL REV, V191, P28, DOI 10.1034/j.1600-065X.2003.00011.x; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Hozumi K, 1998, EUR J IMMUNOL, V28, P1368, DOI 10.1002/(SICI)1521-4141(199804)28:04&lt;1368::AID-IMMU1368&gt;3.0.CO;2-B; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; Kang J, 1997, Semin Immunol, V9, P171, DOI 10.1006/smim.1997.0069; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; Kang JS, 1998, IMMUNITY, V8, P713, DOI 10.1016/S1074-7613(00)80576-2; Livak F, 1997, EUR J IMMUNOL, V27, P2948, DOI 10.1002/eji.1830271130; Love PE, 2000, IMMUNITY, V12, P591, DOI 10.1016/S1074-7613(00)80210-1; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; Love PE, 2000, J IMMUNOL, V165, P3080, DOI 10.4049/jimmunol.165.6.3080; MacDonald HR, 1998, IMMUNOL REV, V165, P87, DOI 10.1111/j.1600-065X.1998.tb01232.x; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Nakajima H, 1999, J IMMUNOL, V162, P782; Pena-Rossi C, 1999, J IMMUNOL, V163, P6494; PETRIE HT, 1990, J EXP MED, V172, P1583, DOI 10.1084/jem.172.6.1583; PUNT JA, 1994, J EXP MED, V180, P587, DOI 10.1084/jem.180.2.587; Robey E, 1998, CURR OPIN IMMUNOL, V10, P181, DOI 10.1016/S0952-7915(98)80247-1; Schweighoer E, 1996, J EXP MED, V183, P2033, DOI 10.1084/jem.183.5.2033; Shores EW, 1998, J EXP MED, V187, P1093, DOI 10.1084/jem.187.7.1093; Shores EW, 1997, J EXP MED, V185, P893, DOI 10.1084/jem.185.5.893; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; SHORTMAN K, 1988, CELL IMMUNOL, V113, P462, DOI 10.1016/0008-8749(88)90042-1; SIM GK, 1995, J IMMUNOL, V154, P5821; Sommers CL, 2001, J EXP MED, V194, P135, DOI 10.1084/jem.194.2.135; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; van Oers NSC, 1998, J IMMUNOL, V160, P163; Vasseur F, 2001, EUR J IMMUNOL, V31, P3038, DOI 10.1002/1521-4141(2001010)31:10<3038::AID-IMMU3038>3.0.CO;2-3	46	203	205	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2005	22	5					583	593		10.1016/j.immuni.2005.03.014	http://dx.doi.org/10.1016/j.immuni.2005.03.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894276	Bronze			2022-12-18	WOS:000229447200008
J	Angeli, V; Llodra, J; Rong, JX; Satoh, K; Ishii, S; Shimizu, T; Fisher, EA; Randolph, GJ				Angeli, V; Llodra, J; Rong, JX; Satoh, K; Ishii, S; Shimizu, T; Fisher, EA; Randolph, GJ			Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization	IMMUNITY			English	Article							PLATELET-ACTIVATING-FACTOR; LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; FACTOR-ACETYLHYDROLASE; IMMUNE-RESPONSES; LYMPH-NODES; STREPTOCOCCUS-PNEUMONIAE; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; IN-VIVO	High LDL and/or low HDL are risk factors for atherosclerosis and are also a common clinical feature in systemic lupus erythematosus, rheumatoid arthritis, and psoriasis. Here, we show that changes in lipid profiles that reflect atherosclerotic disease led to activation of skin murine dendritic cells (DCs) locally, promoted dermal inflammation, and induced lymph node hypertrophy. Paradoxically, DC migration to lymph nodes was impaired, suppressing immunologic priming. Impaired migration resulted from inhibitory signals generated by platelet-activating factor (PAF) or oxidized LDL that acts as a PAF mimetic. Normal DC migration and priming was restored by HDL or HDL associated PAF acetylhydrolase (PAFAH), which mediates inactivation of PAF and oxidized LDL. Thus, atherosclerotic changes can sequester activated DCs in the periphery where they may aggravate local inflammation even as they poorly carry out functions that require their migration to lymph nodes. In this context, HDL and PAFAH maintain a normally functional DC compartment.	CUNY Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; NYU, Marc & Ruti Bell Vasc Biol & Dis Program, New York, NY 10016 USA; NYU, New York Univ Lipid Treatment & Res Ctr, New York, NY 10016 USA; Hirosaki Univ, Sch Med, Dept Vasc Biol, Hirosaki, Aomori 0368562, Japan; Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 1130033, Japan	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; New York University; New York University; Hirosaki University; University of Tokyo	Randolph, GJ (corresponding author), CUNY Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA.	gwendalyn.randolph@mssm.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069446, R01HL061814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI049653, R01AI049653] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL61814, HL69446] Funding Source: Medline; NIAID NIH HHS [AI49653] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alderman CJJ, 2002, CARDIOVASC RES, V55, P806, DOI 10.1016/S0008-6363(02)00447-9; AMARA A, 1995, CLIN EXP IMMUNOL, V101, P233; Angeli V, 2001, J EXP MED, V193, P1135, DOI 10.1084/jem.193.10.1135; Aprahamian T, 2004, J EXP MED, V199, P1121, DOI 10.1084/jem.20031557; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Bobryshev YV, 2001, HISTOL HISTOPATHOL, V16, P801, DOI 10.14670/HH-16.801; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; BRILES DE, 1982, J EXP MED, V156, P1177, DOI 10.1084/jem.156.4.1177; BRUGER D, 2002, AUTOIMMUN REV, V1, P111; Cvetkovic JT, 2002, RHEUMATOLOGY, V41, P988, DOI 10.1093/rheumatology/41.9.988; Dansky HM, 1999, J CLIN INVEST, V104, P31, DOI 10.1172/JCI6577; de Bont N, 1999, J LIPID RES, V40, P680; Dentan C, 1996, BBA-LIPID LIPID MET, V1299, P353, DOI 10.1016/0005-2760(95)00226-X; Dichmann S, 2000, J CELL PHYSIOL, V185, P394, DOI 10.1002/1097-4652(200012)185:3<394::AID-JCP9>3.3.CO;2-Q; FEINGOLD KR, 1995, J INVEST DERMATOL, V104, P246, DOI 10.1111/1523-1747.ep12612790; Flores-Romo L, 2001, IMMUNOLOGY, V102, P255, DOI 10.1046/j.1365-2567.2001.01204.x; Forte TM, 2002, J LIPID RES, V43, P477; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hayem G, 2001, LUPUS, V10, P346, DOI 10.1191/096120301667475689; HEERY JM, 1995, J CLIN INVEST, V96, P2322, DOI 10.1172/JCI118288; IIOWITE NT, 1988, ARTHRITIS RHEUM, V31, P859; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Laskowitz DT, 2000, J LIPID RES, V41, P613; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Ludewig B, 2004, J LEUKOCYTE BIOL, V76, P300, DOI 10.1189/jlb.1203605; Ludewig B, 2001, J IMMUNOL, V166, P3369, DOI 10.4049/jimmunol.166.5.3369; Marathe GK, 2003, J BIOL CHEM, V278, P3937, DOI 10.1074/jbc.M211126200; Marathe GK, 1999, J BIOL CHEM, V274, P28395, DOI 10.1074/jbc.274.40.28395; McIntyre TM, 1999, J BIOL CHEM, V274, P25189, DOI 10.1074/jbc.274.36.25189; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Mehling A, 2001, J EXP MED, V194, P615, DOI 10.1084/jem.194.5.615; Moazed TC, 1997, J INFECT DIS, V175, P883, DOI 10.1086/513986; Montrucchio G, 2000, ARTERIOSCL THROM VAS, V20, P80, DOI 10.1161/01.ATV.20.1.80; Netea MG, 1997, INFECT IMMUN, V65, P2663, DOI 10.1128/IAI.65.7.2663-2667.1997; OFLAHERTY JT, 1987, BIOCHEM BIOPH RES CO, V147, P18, DOI 10.1016/S0006-291X(87)80081-5; OREKHOV AN, 1991, ARTERIOSCLER THROMB, V11, P316, DOI 10.1161/01.ATV.11.2.316; Orem A, 1999, CLIN CHIM ACTA, V284, P81, DOI 10.1016/S0009-8981(99)00062-5; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Palinski W, 2000, J INTERN MED, V247, P371, DOI 10.1046/j.1365-2796.2000.00656.x; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Quarck R, 2001, CIRCULATION, V103, P2495; Randolph GJ, 1998, P NATL ACAD SCI USA, V95, P6924, DOI 10.1073/pnas.95.12.6924; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Rong JX, 2000, ANN MED, V32, P642, DOI 10.3109/07853890009002035; Rong JX, 2001, CIRCULATION, V104, P2447, DOI 10.1161/hc4501.098952; Roselaar SE, 1998, J LIPID RES, V39, P1740; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; SCHULTZ JR, 1993, NATURE, V365, P762, DOI 10.1038/365762a0; Sekigawa I, 2002, CLIN EXP RHEUMATOL, V20, P559; Shimaoka T, 2004, J BIOL CHEM, V279, P26807, DOI 10.1074/jbc.C400163200; Sozzani S, 1997, FEBS LETT, V418, P98, DOI 10.1016/S0014-5793(97)01358-6; STAFFORINI DM, 1996, J CLIN INVEST, V97, P2689; Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1; Tselepis AD, 1999, ARTHRITIS RHEUM-US, V42, P373, DOI 10.1002/1529-0131(199902)42:2<373::AID-ANR21>3.0.CO;2-3; Van Lenten BJ, 2002, CIRCULATION, V106, P1127, DOI 10.1161/01.CIR.0000030182.35880.3E; VANREE JH, 1995, ATHEROSCLEROSIS, V112, P237, DOI 10.1016/0021-9150(94)05419-J; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; WU R, 1999, ANTIBODIES LYSOPHOSP, V8, P142; Yamada Y, 1998, METABOLISM, V47, P177, DOI 10.1016/S0026-0495(98)90216-5; Zebrack James S, 2003, Prog Cardiovasc Nurs, V18, P42, DOI 10.1111/j.0889-7204.2003.01421.x	69	203	213	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2004	21	4					561	574		10.1016/j.immuni.2004.09.003	http://dx.doi.org/10.1016/j.immuni.2004.09.003			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485633	Bronze			2022-12-18	WOS:000224744400012
J	Yoshida, H; Naito, A; Inoue, J; Satoh, M; Santee-Cooper, SM; Ware, CF; Togawa, A; Nishikawa, S; Nishikawa, S				Yoshida, H; Naito, A; Inoue, J; Satoh, M; Santee-Cooper, SM; Ware, CF; Togawa, A; Nishikawa, S; Nishikawa, S			Different cytokines induce surface lymphotoxin-alpha beta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches	IMMUNITY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; C-KIT ANTIBODY; DEFICIENT MICE; LT-ALPHA; MELANOCYTE DEVELOPMENT; ABNORMAL-DEVELOPMENT; ORGAN DEVELOPMENT; FAMILY MEMBER; B-CELL; EXPRESSION	The formation of lymph nodes (LN) and Peyer's patches (PP) can be distinguished by the requirement of RANK for LN but not IL-7Ralpha, which is essential for PP development. However, lymphotoxin-alphabeta (LTalphabeta) signaling is required for both organs. The cellular basis underlying this dichotomy was revealed by the finding that the fetal IL-7Ralpha(+) population responded equally well to IL-7 and RANKL to express LTalphabeta. IL-7Ralpha(+) cells harvested from TRAF6(-/-) embryos expressed I-Tap in response to IL-7 but not RANKL, demonstrating that the RANK-TRAF6 signaling pathway regulates LTalphabeta expression in LN but not in PP. Soluble IL-7 administered to TRAF6(-/-) embryos was sufficient to restore LN genesis indicating the functional similarities of the IL-7Ralpha(+) inducer cells for LN and PP genesis.	RIKEN, Yokohama Inst, Div Immunogenet, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; Kyoto Univ, Grad Sch Med, Dept Mol Genet, Sakyo Ku, Kyoto 6068507, Japan; Univ Tokyo, Inst Med Sci, Div Oncol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Cellular & Mol Biol,Minato Ku, Tokyo 1088639, Japan; La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA	RIKEN; Kyoto University; University of Tokyo; University of Tokyo; La Jolla Institute for Immunology	Yoshida, H (corresponding author), RIKEN, Yokohama Inst, Div Immunogenet, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan.				NCI NIH HHS [CA69381] Funding Source: Medline; NIAID NIH HHS [AI48073, AI03368] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI148073, R01AI048073] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Alcamo E, 2002, J EXP MED, V195, P233, DOI 10.1084/jem.20011885; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; BANKS TA, 1995, J IMMUNOL, V155, P1685; Browning JL, 2002, J IMMUNOL, V168, P5079, DOI 10.4049/jimmunol.168.10.5079; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; CROWE PD, 1994, J IMMUNOL METHODS, V168, P79, DOI 10.1016/0022-1759(94)90212-7; Cuff CA, 1999, J IMMUNOL, V162, P5965; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; FORCE WR, 1995, J IMMUNOL, V155, P5280; Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Isaksen DE, 2002, J IMMUNOL, V168, P3288, DOI 10.4049/jimmunol.168.7.3288; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Kong YY, 1999, IMMUNOL CELL BIOL, V77, P188, DOI 10.1046/j.1440-1711.1999.00815.x; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Naito A, 2002, P NATL ACAD SCI USA, V99, P8766, DOI 10.1073/pnas.132636999; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nishikawa S, 1998, CYTOKINE GROWTH F R, V9, P213, DOI 10.1016/S1359-6101(98)00014-8; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takakura N, 1996, J INVEST DERMATOL, V107, P770, DOI 10.1111/1523-1747.ep12371802; Wong BR, 1999, J LEUKOCYTE BIOL, V65, P715, DOI 10.1002/jlb.65.6.715; Wu Q, 2001, J EXP MED, V193, P1327, DOI 10.1084/jem.193.11.1327; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511; Yoshida H, 1996, DEVELOPMENT, V122, P1207; YOSHIDA H, 1993, DEV GROWTH DIFFER, V35, P209	47	203	206	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2002	17	6					823	833		10.1016/S1074-7613(02)00479-X	http://dx.doi.org/10.1016/S1074-7613(02)00479-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479827	Bronze			2022-12-18	WOS:000179985500013
J	Sitnicka, E; Bryder, D; Theilgaard-Monch, K; Buza-Vidas, N; Adolfsson, J; Jacobsen, SEW				Sitnicka, E; Bryder, D; Theilgaard-Monch, K; Buza-Vidas, N; Adolfsson, J; Jacobsen, SEW			Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool	IMMUNITY			English	Article							RECEPTOR TYROSINE KINASE; LONG-TERM HEMATOPOIESIS; C-KIT LIGAND; SELF-RENEWAL; FLT3/FLK-2 LIGAND; DEFICIENT MICE; T-LYMPHOCYTES; IN-VITRO; EXPRESSION; MOUSE	The first lineage commitment step of hematopoietic stem cells (HSC) results in separation into distinct lymphoid and myeloid differentiation pathways, reflected in the generation of common lymphoid and myeloid progenitors (CLIP and CMP, respectively). In this report we present the first evidence for a nonredundant regulator of this process, in that adult mice deficient in expression of the flt3 ligand (FL) have severely (10-fold) reduced levels of the CLIP, accompanied by reductions in the earliest identifiable B and T cell progenitors. In contrast, CMP and HSC are unaffected in FL-deficient mice. Noteworthy, CLIP express high levels of both the flt3 receptor and ligand, indicating a potential autocrine role of FL in regulation of the earliest lymphoid commitment step from HSC.	Univ Lund Hosp, BMC, Inst Lab Med, Dept Stem Cell Biol, S-22184 Lund, Sweden; Univ Copenhagen, Rigshosp, Dept Hematol 9322, Granulocyte Res Lab, DK-2100 Copenhagen, Denmark	Lund University; Skane University Hospital; Rigshospitalet; University of Copenhagen	Sitnicka, E (corresponding author), Univ Lund Hosp, BMC, Inst Lab Med, Dept Stem Cell Biol, B12,Klin Gatan 26, S-22184 Lund, Sweden.	ewa.sitnicka@stemcell.lu.se	Bryder, David/Q-6292-2019; Jacobsen, Sten Eirik W/D-3974-2018	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Bryder, David/0000-0002-8761-4237; Theilgaard-Monch, Kim/0000-0002-4239-4939				Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, CURR OPIN IMMUNOL, V12, P144, DOI 10.1016/S0952-7915(99)00064-3; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Borge OJ, 1996, BLOOD, V88, P2859, DOI 10.1182/blood.V88.8.2859.bloodjournal8882859; Bryder D, 2000, BLOOD, V96, P1748, DOI 10.1182/blood.V96.5.1748.h8001748_1748_1755; Chklovskaia E, 2001, BLOOD, V97, P1027, DOI 10.1182/blood.V97.4.1027; Chklovskaia E, 1999, BLOOD, V93, P2595, DOI 10.1182/blood.V93.8.2595.408k16_2595_2604; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Dao MA, 1997, BLOOD, V89, P446, DOI 10.1182/blood.V89.2.446; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Domen J, 1999, MOL MED TODAY, V5, P201, DOI 10.1016/S1357-4310(99)01464-1; Elwood NJ, 1996, BLOOD, V88, P4452, DOI 10.1182/blood.V88.12.4452.bloodjournal88124452; GEISSLER EN, 1983, EXP HEMATOL, V11, P452; GODFREY DI, 1993, J IMMUNOL, V150, P4244; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Ito T, 2000, EXP HEMATOL, V28, P1269, DOI 10.1016/S0301-472X(00)00535-X; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; KELLER JR, 1995, BLOOD, V86, P1757, DOI 10.1182/blood.V86.5.1757.bloodjournal8651757; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Lemieux ME, 1997, EXP HEMATOL, V25, P951; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; LI CL, 1994, BLOOD, V84, P408, DOI 10.1182/blood.V84.2.408.bloodjournal842408; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; LYMAN SD, 1995, BLOOD, V86, P4091, DOI 10.1182/blood.V86.11.4091.bloodjournal86114091; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Matsunaga T, 1998, BLOOD, V92, P452, DOI 10.1182/blood.V92.2.452.414k09_452_461; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; McKinstry WJ, 1997, BLOOD, V89, P65, DOI 10.1182/blood.V89.1.65.65_65_71; Miller CL, 1996, EXP HEMATOL, V24, P185; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Osawa M, 1996, J IMMUNOL, V156, P3207; Petzer AL, 1996, J EXP MED, V183, P2551, DOI 10.1084/jem.183.6.2551; Piacibello W, 1997, BLOOD, V89, P2644, DOI 10.1182/blood.V89.8.2644; Rasko JEJ, 1995, LEUKEMIA, V9, P2058; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Theilgaard-Monch K, 2001, J IMMUNOL METHODS, V252, P175, DOI 10.1016/S0022-1759(01)00340-4; Veiby OP, 1996, J IMMUNOL, V157, P2953; WodnarFilipowicz A, 1996, BLOOD, V88, P4493, DOI 10.1182/blood.V88.12.4493.bloodjournal88124493; Yonemura Y, 1997, BLOOD, V89, P1915, DOI 10.1182/blood.V89.6.1915; ZEIGLER FC, 1994, BLOOD, V84, P2422, DOI 10.1182/blood.V84.8.2422.bloodjournal8482422	51	203	211	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2002	17	4					463	472		10.1016/S1074-7613(02)00419-3	http://dx.doi.org/10.1016/S1074-7613(02)00419-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	605FQ	12387740	Bronze			2022-12-18	WOS:000178667100007
J	EVAVOLD, BD; SLOANLANCASTER, J; WILSON, KJ; ROTHBARD, JB; ALLEN, PM				EVAVOLD, BD; SLOANLANCASTER, J; WILSON, KJ; ROTHBARD, JB; ALLEN, PM			SPECIFIC T-CELL RECOGNITION OF MINIMALLY HOMOLOGOUS PEPTIDES - EVIDENCE FOR MULTIPLE ENDOGENOUS LIGANDS	IMMUNITY			English	Article							MYELIN BASIC-PROTEIN; ANTIGEN RECOGNITION; RECEPTOR LIGAND; MHC; AUTOIMMUNITY; DETERMINANT; MOLECULES; RESIDUES; CLONES; SELF	The T cell receptor (TCR) can interact with a spectrum of peptides as part of its ligand, including the immunogenic peptide, variants of this peptide, and apparently unrelated peptides. The basis of this broad specificity for ligand was investigated by substitution analysis of a peptide antigen and functional testing using a B cell apoptosis assay. A peptide containing as few as 1 aa in common with this peptide could stimulate a specific T cell response. Two endogenous ligands, an agonist and a partial agonist, were readily identified from a search of the SwissProt database, indicating that multiple endogenous ligands likely exist for a given T cell. These findings strongly support the concept that one TCR has the ability to interact productively with multiple different ligands, and provide evidence that such ligands exist in the endogenous peptide repertoire.	WASHINGTON UNIV,SCH MED,CTR IMMUNOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110; IMMULOG,PALO ALTO,CA 94304	Washington University (WUSTL); Washington University (WUSTL)				Evavold, Brian/0000-0002-3561-3494				ALLEN PM, 1987, NATURE, V327, P713, DOI 10.1038/327713a0; ANDERSON DC, 1988, SCIENCE, V242, P259, DOI 10.1126/science.2459778; ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; BEVERLEY PCL, 1990, IMMUNOL TODAY, V11, P203, DOI 10.1016/0167-5699(90)90083-L; BHARDWAJ V, 1993, J IMMUNOL, V151, P5000; CAO WX, 1994, J EXP MED, V179, P195, DOI 10.1084/jem.179.1.195; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CLAYBERGER C, 1983, J EXP MED, V157, P1906, DOI 10.1084/jem.157.6.1906; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; DUKE RC, 1994, CURRENT PROTOCOLS IM; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; EVAVOLD BD, 1993, P NATL ACAD SCI USA, V91, P2300; FOX BS, 1987, J IMMUNOL, V139, P1578; FUJINAMI RS, 1985, SCIENCE, V230, P1043, DOI 10.1126/science.2414848; GUILLET JG, 1987, SCIENCE, V235, P865, DOI 10.1126/science.2433769; GUIMEZANES A, 1992, EUR J IMMUNOL, V22, P1651, DOI 10.1002/eji.1830220647; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HSU BL, 1995, J EXP MED, V181, P805, DOI 10.1084/jem.181.2.805; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JANEWAY C, 1992, Current Biology, V2, P26, DOI 10.1016/0960-9822(92)90419-B; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; KAO I, 1977, SCIENCE, V195, P74, DOI 10.1126/science.831257; KNUDSEN KA, 1990, EXP CELL RES, V188, P175, DOI 10.1016/0014-4827(90)90157-6; LANDSTEINER K, 1917, 7 MITT ANT ZEIT IMM, V26, P122; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LEIGHTON J, 1991, J IMMUNOL, V147, P198; LORENZ RG, 1989, J EXP MED, V170, P203, DOI 10.1084/jem.170.1.203; LORENZ RG, 1989, NATURE, V337, P560, DOI 10.1038/337560a0; LUO AM, 1993, J CLIN INVEST, V92, P2117, DOI 10.1172/JCI116812; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MANNIE MD, 1991, J THEOR BIOL, V151, P169, DOI 10.1016/S0022-5193(05)80360-1; MARRACK P, 1988, IMMUNOL TODAY, V9, P308, DOI 10.1016/0167-5699(88)91324-2; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; MIYATANI S, 1994, SCIENCE, V245, P631; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NALEFSKI EA, 1993, J IMMUNOL, V150, P3806; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; REAY PA, 1994, J IMMUNOL, V152, P3946; Rothbard J B, 1989, Int Immunol, V1, P479, DOI 10.1093/intimm/1.5.479; ROTHBARD JB, 1988, CELL, V52, P515, DOI 10.1016/0092-8674(88)90464-3; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; SCHUMACHER TNM, 1994, IMMUNITY, V1, P721, DOI 10.1016/S1074-7613(94)80013-8; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SELIN LK, 1994, J EXP MED, V179, P1993; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; SILICIANO RF, 1986, CELL, V47, P161, DOI 10.1016/0092-8674(86)90439-3; SLOANLANCASTER J, 1994, J EXP MED, V180, P1195, DOI 10.1084/jem.180.4.1195; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; SORGER SB, 1990, J IMMUNOL, V144, P1127; SPAIN LM, 1994, J IMMUNOL, V152, P1709; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; VASQUEZ NJ, 1994, IMMUNITY, V1, P45, DOI 10.1016/1074-7613(94)90008-6; WRAITH DC, 1992, J IMMUNOL, V149, P3765	65	203	203	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1995	2	6					655	663		10.1016/1074-7613(95)90010-1	http://dx.doi.org/10.1016/1074-7613(95)90010-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7540944	Bronze			2022-12-18	WOS:A1995RE53800011
J	Xiao, S; Yosef, N; Yang, JF; Wang, YH; Zhou, L; Zhu, C; Wu, C; Baloglu, E; Schmidt, D; Ramesh, R; Lobera, M; Sundrud, MS; Tsai, PY; Xiang, ZJ; Wang, JS; Xu, Y; Lin, XC; Kretschmer, K; Rahl, PB; Young, RA; Zhong, Z; Hafler, DA; Regev, A; Ghosh, S; Marson, A; Kuchroo, VK				Xiao, Sheng; Yosef, Nir; Yang, Jianfei; Wang, Yonghui; Zhou, Ling; Zhu, Chen; Wu, Chuan; Baloglu, Erkan; Schmidt, Darby; Ramesh, Radha; Lobera, Mercedes; Sundrud, Mark S.; Tsai, Pei-Yun; Xiang, Zhijun; Wang, Jinsong; Xu, Yan; Lin, Xichen; Kretschmer, Karsten; Rahl, Peter B.; Young, Richard A.; Zhong, Zhong; Hafler, David A.; Regev, Aviv; Ghosh, Shomir; Marson, Alexander; Kuchroo, Vijay K.			Small-Molecule ROR gamma t Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms	IMMUNITY			English	Article							ANTI-INTERLEUKIN-17 MONOCLONAL-ANTIBODY; TARGET GENES; REGULATORY NETWORK; FOXP3 OCCUPANCY; TH17 CELLS; DIFFERENTIATION; T(H)17; PATHWAYS; PSORIASIS; RECEPTOR	We identified three retinoid-related orphan receptor gamma t (ROR gamma t)-specific inhibitors that suppress T helper 17 (Th17) cell responses, including Th17-cell-mediated autoimmune disease. We systemically characterized ROR gamma t binding in the presence and absence of drugs with corresponding whole-genome transcriptome sequencing. ROR gamma t acts as a direct activator of Th17 cell signature genes and a direct repressor of signature genes from other T cell lineages; its strongest transcriptional effects are on cis-regulatory sites containing the ROR alpha binding motif. ROR gamma t is central in a densely interconnected regulatory network that shapes the balance of T cell differentiation. Here, the three inhibitors modulated the ROR gamma t-dependent transcriptional network to varying extents and through distinct mechanisms. Whereas one inhibitor displaced ROR gamma t from its target loci, the other two inhibitors affected transcription predominantly without removing DNA binding. Our work illustrates the power of a system-scale analysis of transcriptional regulation to characterize potential therapeutic compounds that inhibit pathogenic Th17 cells and suppress autoimmunity.	[Xiao, Sheng; Yosef, Nir; Zhu, Chen; Wu, Chuan; Kuchroo, Vijay K.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Xiao, Sheng; Yosef, Nir; Zhu, Chen; Wu, Chuan; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Yosef, Nir; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Yang, Jianfei; Baloglu, Erkan; Schmidt, Darby; Ramesh, Radha; Lobera, Mercedes; Sundrud, Mark S.; Ghosh, Shomir] Tempero Pharmaceut, Cambridge, MA 02139 USA; [Wang, Yonghui; Zhou, Ling; Xiang, Zhijun; Wang, Jinsong; Xu, Yan; Lin, Xichen; Zhong, Zhong] GlaxoSmithKline Res & Dev Ctr, Shanghai 201203, Peoples R China; [Tsai, Pei-Yun; Kretschmer, Karsten] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Rahl, Peter B.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06511 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Marson, Alexander] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; GlaxoSmithKline; German Research Foundation (DFG); Technische Universitat Dresden; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Yale University; Yale University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marson, A (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	alexander.marson@ucsf.edu; vkuchroo@rics.bwh.harvard.edu	Kretschmer, Karsten/E-8174-2010; Young, Richard A/F-6495-2012; Wu, Chuan/H-6379-2013	Kretschmer, Karsten/0000-0001-6770-4078; Young, Richard A/0000-0001-8855-8647; Wu, Chuan/0000-0003-2288-353X	National Multiple Sclerosis Society [RG5030, PP1943]; NIH [R01NS030843, P01NS076410, P01AI039671, K01DK090105]; NIH Pioneer Award [DP1OD003958-01]; HHMI; Klarman Cell Observatory at the Broad Institute; Brigham and Women's Hospital Department of Medicine; Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society; FZT 111 (DFG-Center for Regenerative Therapies Dresden, Cluster of Excellence); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, U01AI102011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS076410, R01NS030843] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Klarman Cell Observatory at the Broad Institute; Brigham and Women's Hospital Department of Medicine; Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); FZT 111 (DFG-Center for Regenerative Therapies Dresden, Cluster of Excellence)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Kozoriz for cell sorting. This work was supported by research grants from the National Multiple Sclerosis Society (RG5030 to V. K. K. and PP1943 to S. X.) and the NIH (R01NS030843, P01NS076410, and P01AI039671 to V. K. K. and K01DK090105 to S. X.). Work was supported in part by an NIH Pioneer Award (DP1OD003958-01), the HHMI, and the Klarman Cell Observatory at the Broad Institute (A. R.). The work was supported in part by a grant from the Brigham and Women's Hospital Department of Medicine to A. M., a grant from The Guthy-Jackson Charitable Foundation to V. K. K., and a grant from the National Multiple Sclerosis Society to A. M., R.A.Y., V. K. K., and D. A. H. P.-Y.T. and K. K. were supported by the FZT 111 (DFG-Center for Regenerative Therapies Dresden, Cluster of Excellence). V. K. K. has a financial interest in Tempero Pharmaceuticals. His interests were reviewed and are managed by Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict-of-interest policies. J.Y., E. B., D. S., R. R., M. L., M. S. S., and S. G. are employees or former employees and shareholders of Tempero Pharmaceuticals, a GSK company. Y.W., L.Z., Z.X., J.W., Y.X., X. L., and Z.Z. are GSK employees.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Patel DD, 2013, ANN RHEUM DIS, V72, P116, DOI 10.1136/annrheumdis-2012-202371; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038510; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	29	202	233	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					477	489		10.1016/j.immuni.2014.04.004	http://dx.doi.org/10.1016/j.immuni.2014.04.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24745332	Green Accepted, Bronze			2022-12-18	WOS:000334849400007
J	Blanchet, FP; Moris, A; Nikolic, DS; Lehmann, M; Cardinaud, S; Stalder, R; Garcia, E; Dinkins, C; Leuba, F; Wu, L; Schwartz, O; Deretic, V; Piguet, V				Blanchet, Fabien P.; Moris, Arnaud; Nikolic, Damjan S.; Lehmann, Martin; Cardinaud, Sylvain; Stalder, Romaine; Garcia, Eduardo; Dinkins, Christina; Leuba, Florence; Wu, Li; Schwartz, Olivier; Deretic, Vojo; Piguet, Vincent			Human Immunodeficiency Virus-1 Inhibition of Immunoamphisomes in Dendritic Cells Impairs Early Innate and Adaptive Immune Responses	IMMUNITY			English	Article							CD8(+) T-CELLS; ANTIGEN PRESENTATION; INFECTIOUS SYNAPSE; AUTOPHAGY PROTEIN; HIV-1 REPLICATION; VIRAL EVASION; IN-VITRO; MACROPHAGES; IMMATURE; PATHWAY	Dendritic cells (DCs) in mucosal surfaces are early targets for human immunodeficiency virus-1 (HIV-1). DCs mount rapid and robust immune responses upon pathogen encounter. However, immune response in the early events of HIV-1 transmission appears limited, suggesting that HIV-1 evade early immune control by DCs. We report that HIV-1 induces a rapid shutdown of autophagy and immunoamphisomes in DCs. HIV-1 envelope activated the mammalian target of rapamycin pathway in DCs, leading to autophagy exhaustion. HIV-1-induced inhibition of autophagy in DC increased cell-associated HIV-1 and transfer of HIV-1 infection to CD4(+) T cells. HIV-1-mediated downregulation of autophagy in DCs impaired innate and adaptive immune responses. Immunoamphisomes in DCs engulf incoming pathogens and appear to amplify pathogen degradation as well as Toll-like receptor responses and antigen presentation. The findings that HIV-1 downregulates autophagy and impedes immune functions of DCs represent a pathogenesis mechanism that can be pharmacologically countered with therapeutic and prophylactic implications.	[Blanchet, Fabien P.; Nikolic, Damjan S.; Lehmann, Martin; Stalder, Romaine; Garcia, Eduardo; Leuba, Florence; Piguet, Vincent] Univ Hosp & Med Sch Geneva, Dept Dermatol & Venerol, CH-1211 Geneva, Switzerland; [Blanchet, Fabien P.; Nikolic, Damjan S.; Lehmann, Martin; Stalder, Romaine; Garcia, Eduardo; Leuba, Florence; Piguet, Vincent] Univ Hosp & Med Sch Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Moris, Arnaud; Schwartz, Olivier] Inst Pasteur, Virus & Immun Unit, F-75015 Paris, France; [Dinkins, Christina; Deretic, Vojo] Univ New Mexico, Albuquerque, NM 87131 USA; [Wu, Li] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Moris, Arnaud; Cardinaud, Sylvain] UPMC, INSERM, UMRS 945, F-75013 Paris, France	University of Geneva; University of Geneva; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of New Mexico; University System of Ohio; Ohio State University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Piguet, V (corresponding author), Univ Hosp & Med Sch Geneva, Dept Dermatol & Venerol, CH-1211 Geneva, Switzerland.	vincent.piguet@unige.ch	Wu, Li/ABB-2813-2020; Schwartz, Olivier/AAZ-3765-2021; Wu, Li/E-4330-2011; Dinkins, Christina/AAD-7473-2019; Blanchet, Fabien/AAL-1379-2021	Wu, Li/0000-0002-5468-2487; Schwartz, Olivier/0000-0002-0729-1475; Wu, Li/0000-0002-5468-2487; Latagan, Christina/0000-0003-2535-625X; CARDINAUD, Sylvain/0000-0002-2650-1108; Piguet, Vincent/0000-0001-6079-4517; Moris, Arnaud/0000-0002-5052-1678; BLANCHET, Fabien/0000-0003-3168-0697; Deretic, Vojo/0000-0002-3624-5208	amfAR [107160-44-RGRL]; Bill and Melinda Gates Grand Challenge Explorations; NIH [R01-AI068493]; Swiss National Science Foundation [PP00A3-114755]; E.M.B.O; Human Science Frontier Program; University of Geneva; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068493, R01AI042999, T32AI007538] Funding Source: NIH RePORTER	amfAR; Bill and Melinda Gates Grand Challenge Explorations; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); E.M.B.O(European Molecular Biology Organization (EMBO)); Human Science Frontier Program(Human Frontier Science Program); University of Geneva; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by amfAR grant 107160-44-RGRL and Bill and Melinda Gates Grand Challenge Explorations grant to V.D. and in part by grants from the NIH (R01-AI068493) to LW. This work was supported by Swiss National Science Foundation grants PP00A3-114755 to V.P. and E.M.B.O long-term fellowship to F.P.B. This work was also supported by The Human Science Frontier Program to V.P. We thank J. Villard and the HLA-genotyping plateform for HLA-DR screening of PBMCs. We also thank F. Guivel-Benhassine, P. Carraux, G. Kyei, and C. Dong for excellent technical help. We are grateful to J. Curran for the kind gift of rapamycin. We also thank B. Mangeat, S. Anghel, and R. Correa for discussions and critical review of the text and figures. Electron microscopy samples preparation was carried out with the help of the "Pole Facultaire de Microscopie Ultrastructurale (PFMU)" at the Faculty of Medicine of the University of Geneva. Flow cytometry analysis was performed with the support of the Flow Cytometry Core Facility of the Faculty of Medicine of the University of Geneva. Confocal immunofluorescence was done with the help of the Bioimaging core facility of the faculty of Medicine. F.P.B. and V.P. conceived the study. F.P.B., L.W., O.S., AM, V.D., and V.P. helped in experimental design; F.P.B., D.S.N., M.L., E.G., R.S, and F.L. carried out experiments; F.P.B., V.D., and V.P. wrote the manuscript.	Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; Amer AO, 2005, AUTOPHAGY, V1, P53, DOI 10.4161/auto.1.1.1589; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Buseyne F, 2001, NAT MED, V7, P344, DOI 10.1038/85493; Castedo M, 2001, J EXP MED, V194, P1097, DOI 10.1084/jem.194.8.1097; Castedo M, 2002, EMBO J, V21, P4070, DOI 10.1093/emboj/cdf391; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; Davenport MP, 2004, J VIROL, V78, P10096, DOI 10.1128/JVI.78.18.10096-10103.2004; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Garcia E, 2008, TRAFFIC, V9, P200, DOI 10.1111/j.1600-0854.2007.00678.x; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harman AN, 2006, J IMMUNOL, V177, P7103, DOI 10.4049/jimmunol.177.10.7103; Harman AN, 2009, BLOOD, V114, P85, DOI 10.1182/blood-2008-12-194845; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jones L, 2007, AIDS RES HUM RETROV, V23, P812, DOI 10.1089/aid.2006.0280; Kawamura T, 2003, J IMMUNOL, V170, P4260, DOI 10.4049/jimmunol.170.8.4260; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; MACATONIA SE, 1990, IMMUNOLOGY, V71, P38; Martinson JA, 2007, CELL IMMUNOL, V250, P75, DOI 10.1016/j.cellimm.2008.01.007; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moris A, 2004, BLOOD, V103, P2648, DOI 10.1182/blood-2003-07-2532; Moris A, 2006, BLOOD, V108, P1643, DOI 10.1182/blood-2006-02-006361; Munz C, 2007, CELL HOST MICROBE, V1, P9, DOI 10.1016/j.chom.2007.02.005; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; Munz C, 2006, CELL MICROBIOL, V8, P891, DOI 10.1111/j.1462-5822.2006.00714.x; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nicol MQ, 2008, J VIROL, V82, P7790, DOI 10.1128/JVI.00362-08; Orvedahl A, 2008, AUTOPHAGY, V4, P280, DOI 10.4161/auto.5289; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Patterson S, 2005, J IMMUNOL, V174, P8200, DOI 10.4049/jimmunol.174.12.8200; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sabado RL, 2007, EUR J IMMUNOL, V37, P1752, DOI 10.1002/eji.200636981; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836	82	202	208	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 28	2010	32	5					654	669		10.1016/j.immuni.2010.04.011	http://dx.doi.org/10.1016/j.immuni.2010.04.011			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20451412	Green Accepted, Bronze			2022-12-18	WOS:000278280500011
J	Bhandoola, A; von Boehmer, H; Petrie, HT; Zuniga-Pflucker, JC				Bhandoola, Avinash; von Boehmer, Harald; Petrie, Howard T.; Zuniga-Pfluecker, Juan Carlos			Commitment and developmental potential of extrathymic and intrathymic T cell precursors: Plenty to choose from	IMMUNITY			English	Review							MOUSE BONE-MARROW; MULTIPOTENT HEMATOPOIETIC PROGENITORS; COMMON LYMPHOID PROGENITORS; BETA-SELECTION CHECKPOINT; MURINE FETAL BLOOD; LINEAGE COMMITMENT; STEM-CELLS; ALPHA-BETA; C-KIT; THYMIC MICROENVIRONMENT	T cells developing in the thymus are derived from hematopoietic stem cells (HSCs) in the bone marrow (BM). Understanding the developmental steps linking multipotent HSCs to intrathymic T lineage-committed progenitors is important for understanding cancer in T lineage cells, improving T cell reconstitution after BM transplantation, and designing gene-therapy approaches to treat defective T cell development or function. Such an understanding may also help ameliorate immunological defects in aging. This review covers the differentiation steps between HSCs and committed T cell progenitors within the thymus.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Scripps Florida Res Inst, Jupiter, FL 33458 USA; Univ Toronto, Dept Immunol, Toronto, ON M4N 3M5, Canada; Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada	University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; State University System of Florida; University of Florida; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Bhandoola, A (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu; harald_von_boehmer@dfci.harvard.edu; hpetrie@scripps.edu; jczp@sri.utoronto.ca	Zuniga-Pflucker, Juan C/H-1295-2012	Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178				Adkins B, 2003, J IMMUNOL, V171, P5157, DOI 10.4049/jimmunol.171.10.5157; Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, J IMMUNOL, V164, P5221, DOI 10.4049/jimmunol.164.10.5221; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Boehm T, 2006, TRENDS IMMUNOL, V27, P477, DOI 10.1016/j.it.2006.08.004; Carlyle JR, 1998, IMMUNITY, V9, P187, DOI 10.1016/S1074-7613(00)80601-9; Ceredig R, 2007, EUR J IMMUNOL, V37, P830, DOI 10.1002/eji.200636728; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Dejbakhsh-Jones S, 2001, P NATL ACAD SCI USA, V98, P7455, DOI 10.1073/pnas.131559798; Dejbakhsh-Jones S, 1999, P NATL ACAD SCI USA, V96, P14493, DOI 10.1073/pnas.96.25.14493; DONSKOY E, 1992, J IMMUNOL, V148, P1604; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; Garcia-Ojeda ME, 2005, J IMMUNOL, V175, P4363, DOI 10.4049/jimmunol.175.7.4363; GODFREY DI, 1992, J IMMUNOL, V149, P2281; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Gounari F, 2002, NAT IMMUNOL, V3, P489, DOI 10.1038/ni778; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Harman BC, 2005, BLOOD, V106, P886, DOI 10.1182/blood-2004-12-4881; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Heinzel K, 2007, J IMMUNOL, V178, P858, DOI 10.4049/jimmunol.178.2.858; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Krueger A, 2007, IMMUNITY, V26, P105, DOI 10.1016/j.immuni.2006.12.004; Krueger A, 2006, J EXP MED, V203, P1977, DOI 10.1084/jem.20060731; KYEWSKI BA, 1987, J EXP MED, V166, P520, DOI 10.1084/jem.166.2.520; Lai AY, 2007, P NATL ACAD SCI USA, V104, P6311, DOI 10.1073/pnas.0609608104; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; Lancrin C, 2002, J EXP MED, V195, P919, DOI 10.1084/jem.20011475; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; LESLEY J, 1985, CELL IMMUNOL, V91, P397, DOI 10.1016/0008-8749(85)90237-0; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Liu CL, 2005, BLOOD, V105, P31, DOI 10.1182/blood-2004-04-1369; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Lu M, 2005, J IMMUNOL, V175, P5848, DOI 10.4049/jimmunol.175.9.5848; Lu M, 2002, J IMMUNOL, V169, P3519, DOI 10.4049/jimmunol.169.7.3519; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Michie AM, 1998, J IMMUNOL, V160, P1735; MILNER LA, 1994, BLOOD, V83, P2057; Min H, 2004, J IMMUNOL, V173, P245, DOI 10.4049/jimmunol.173.1.245; Mohtashami M, 2006, J IMMUNOL, V176, P730, DOI 10.4049/jimmunol.176.2.730; Mori S, 2001, BLOOD, V98, P696, DOI 10.1182/blood.V98.3.696; PENIT C, 1995, J IMMUNOL, V154, P5103; PENIT C, 1988, J HISTOCHEM CYTOCHEM, V36, P473, DOI 10.1177/36.5.2895787; Perry SS, 2006, J IMMUNOL, V177, P2880, DOI 10.4049/jimmunol.177.5.2880; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Petrie HT, 2007, IMMUNITY, V26, P7, DOI 10.1016/j.immuni.2007.01.003; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; RUIZ M, 1995, NEUROREPORT, V6, P2041, DOI 10.1097/00001756-199510010-00021; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Schwarz BA, 2007, J IMMUNOL, V178, P2008, DOI 10.4049/jimmunol.178.4.2008; Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103; SCOLLAY R, 1986, IMMUNOL REV, V91, P129, DOI 10.1111/j.1600-065X.1986.tb01487.x; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Shortman K, 1990, Semin Immunol, V2, P3; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Umland O, 2007, J IMMUNOL, V178, P4147, DOI 10.4049/jimmunol.178.7.4147; Warren LA, 2003, CURR OPIN IMMUNOL, V15, P166, DOI 10.1016/S0952-7915(03)00011-6; Weerkamp F, 2006, BLOOD, V107, P3131, DOI 10.1182/blood-2005-08-3412; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu L, 2006, CURR OPIN IMMUNOL, V18, P121, DOI 10.1016/j.coi.2006.01.006; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; Wurbel MA, 2006, EUR J IMMUNOL, V36, P73, DOI 10.1002/eji.200535203; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	104	202	205	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2007	26	6					678	689		10.1016/j.immuni.2007.05.009	http://dx.doi.org/10.1016/j.immuni.2007.05.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17582341	Bronze			2022-12-18	WOS:000247646900003
J	Zehn, D; Bevan, MJ				Zehn, Dietmar; Bevan, Michael J.			T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity	IMMUNITY			English	Article							DEPENDENT DIABETES-MELLITUS; NEGATIVE SELECTION; CROSS-PRESENTATION; DENDRITIC CELLS; SELF-ANTIGENS; CLONAL DELETION; VIRUS-INFECTION; CD8(+); AIRE; EXPRESSION	T cells causing autoimmunity must escape tolerance. We observed that CD8(+) T cells with high avidity for an antigen expressed in the pancreas, kidney, and thymic medulla were efficiently removed from a polyclonal repertoire by central and peripheral tolerance mechanisms. However, both mechanisms spared low-avidity T cells from elimination. Neither the introduction of activated, self-antigen-specific CD4 helper T cells nor a global inflammatory stimulus were sufficient to activate the low-avidity CD8(+) T cells and did not break tolerance. In contrast, challenge with a recombinant bacterium expressing the self antigen primed the low-avidity T cells, and the animals rapidly developed autoimmune diabetes. We suggest that whereas thymic and peripheral tolerance mechanisms remove cells that can be primed by endogenous amounts of self antigen, they do not guard against tissue destruction by low-avidity effector T cells, which have been primed by higher amounts of self antigen or by crossreactive antigens.	Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA.	mbevan@u.washington.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335, R37AI019335] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI019335, R01 AI019335-19, AI19335] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DILLON SR, 1994, J IMMUNOL, V152, P1790; Engelhorn ME, 2006, NAT MED, V12, P198, DOI 10.1038/nm1363; FINK PJ, 1992, J EXP MED, V176, P1733, DOI 10.1084/jem.176.6.1733; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gronski MA, 2004, NAT MED, V10, P1234, DOI 10.1038/nm1114; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Klein L, 2001, EUR J IMMUNOL, V31, P2476, DOI 10.1002/1521-4141(200108)31:8<2476::AID-IMMU2476>3.0.CO;2-T; KNOBLOCH M, 1992, INT IMMUNOL, V4, P1169, DOI 10.1093/intimm/4.10.1169; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Liston A, 2005, IMMUNOL REV, V204, P87, DOI 10.1111/j.0105-2896.2005.00253.x; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; Morgan DJ, 1999, P NATL ACAD SCI USA, V96, P3854, DOI 10.1073/pnas.96.7.3854; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Sant'Angelo DB, 2002, P NATL ACAD SCI USA, V99, P6931, DOI 10.1073/pnas.102182499; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Trembleau S, 1999, J IMMUNOL, V163, P2960; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954	38	202	206	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2006	25	2					261	270		10.1016/j.immuni.2006.06.009	http://dx.doi.org/10.1016/j.immuni.2006.06.009			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16879996	Green Accepted, Bronze			2022-12-18	WOS:000240047500012
J	Diehl, GE; Yue, HH; Hsieh, K; Kuang, AA; Ho, M; Morici, LA; Lenz, LL; Cado, D; Riley, LW; Winoto, A				Diehl, GE; Yue, HH; Hsieh, K; Kuang, AA; Ho, M; Morici, LA; Lenz, LL; Cado, D; Riley, LW; Winoto, A			TRAIL-R as a negative regulator of innate immune cell responses	IMMUNITY			English	Article							APOPTOSIS-INDUCING LIGAND; NF-KAPPA-B; MURINE CYTOMEGALOVIRUS-INFECTION; NATURAL-KILLER-CELLS; IFN-GAMMA PRODUCTION; DEATH DOMAIN KINASE; T-CELLS; TUMORICIDAL ACTIVITY; ANTIVIRAL DEFENSE; VIRAL-INFECTIONS	TRAIL receptor (TRAIL-R) signaling has been implicated in inducing apoptosis in tumor cells, but little is understood about its physiological function. Here, we report the generation and characterization of TRAILR(-1-) mice, which develop normal lymphocyte populations but possess enhanced innate immune responses. TRAIL-R-1- mice exhibited increased clearance of murine cytomegalovirus that correlated with increased levels of IL-12, IFN-alpha., and IFN-gamma. Stimulation of macrophages with Mycobacterium and Toll-like receptor (TLR)-2, -3, and -4, but not TLR9, ligands resulted in high levels of TRAIL upregulation and enhanced cytokine production in TRAIL-R-1- cells. The immediate early TLR signaling events in TRAIL-R-1- macrophages and dendritic cells are normal, but IkappaB-alpha homeostatic regulation and NF-kappaB activity at later time points is perturbed. These data suggest that TRAIL-R negatively regulates innate immune responses.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Winoto, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, 469 Life Sci Addit, Berkeley, CA 94720 USA.	winoto@berkeley.edu		Lenz, Laurel/0000-0002-4933-8913; Diehl, Gretchen/0000-0002-1841-2842	NATIONAL CANCER INSTITUTE [R01CA092000] Funding Source: NIH RePORTER; NCI NIH HHS [CA92000] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Barton GHM, 2003, NAT IMMUNOL, V4, P432, DOI 10.1038/ni0503-432; Barton GM, 2004, NAT IMMUNOL, V5, P472, DOI 10.1038/ni0504-472; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Biron CA, 1999, CURR OPIN MICROBIOL, V2, P374; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Chou AH, 2001, J IMMUNOL, V167, P1347, DOI 10.4049/jimmunol.167.3.1347; Clarke P, 2000, J VIROL, V74, P8135, DOI 10.1128/JVI.74.17.8135-8139.2000; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Cretney E, 2003, J EXP MED, V198, P491, DOI 10.1084/jem.20030634; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; EZEKOWITZ RAB, 1982, J EXP MED, V155, P1623; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Halaas O, 2000, SCAND J IMMUNOL, V51, P244; Heldwein KA, 2003, J LEUKOCYTE BIOL, V74, P277, DOI 10.1189/jlb.0103026; Hilliard B, 2001, J IMMUNOL, V166, P1314, DOI 10.4049/jimmunol.166.2.1314; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lum JJ, 2001, J VIROL, V75, P11128, DOI 10.1128/JVI.75.22.11128-11136.2001; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Muhlenbeck F, 1998, J BIOL CHEM, V273, P33091, DOI 10.1074/jbc.273.49.33091; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Orange JS, 1996, J IMMUNOL, V156, P1138; Orange JS, 1996, J IMMUNOL, V156, P4746; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Schneider P, 2003, J BIOL CHEM, V278, P5444, DOI 10.1074/jbc.M210783200; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; TOMONARI K, 1993, IMMUNOL REV, V131, P131, DOI 10.1111/j.1600-065X.1993.tb01534.x; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Warschkau H, 1999, J IMMUNOL, V163, P3409; Wendling U, 2000, CELL DEATH DIFFER, V7, P637, DOI 10.1038/sj.cdd.4400692; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; WOODLAND DL, 1991, NATURE, V349, P529, DOI 10.1038/349529a0; WOODLAND DL, 1991, J EXP MED, V174, P1255, DOI 10.1084/jem.174.5.1255; WU GS, 1989, CANCER RES, V59, P2770; Zheng SJ, 2004, J CLIN INVEST, V113, P58, DOI 10.1172/JCI200419255; Zhou T, 1996, J IMMUNOL, V156, P2661	58	202	210	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2004	21	6					877	889		10.1016/j.immuni.2004.11.008	http://dx.doi.org/10.1016/j.immuni.2004.11.008			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589175	Bronze			2022-12-18	WOS:000225901600014
J	Reits, E; Neijssen, J; Herberts, C; Benckhuijsen, W; Janssen, L; Drijfhout, JW; Neefjes, J				Reits, E; Neijssen, J; Herberts, C; Benckhuijsen, W; Janssen, L; Drijfhout, JW; Neefjes, J			A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation	IMMUNITY			English	Article							TRIPEPTIDYL PEPTIDASE-II; ENDOPLASMIC-RETICULUM; RAT-BRAIN; AMINOPEPTIDASE; GENERATION; PROTEIN; TRANSLOCATION; TRANSPORTERS; DESTRUCTION; EXPRESSION	Intracellular proteins are degraded by the proteasome, and resulting peptides surviving cytoplasmic peptidase activity can be presented by MHC class I molecules. Here, we show that intracellular aminopeptidases degrade peptides within seconds, almost irrespectively of amino acid sequence. N- but not C-terminal extension increases the half-life of peptides until they are 15 amino acids long. Beyond 15 amino acids, peptides are exclusively trimmed by the peptidase TPPII, which displays both exo- and endopeptidase activity. Surprisingly, most proteasomal degradation products are handled by TPPII before presentation by MHC class I molecules. We define three distinct proteolytic activities during antigen processing in vivo. Proteasome-generated peptides relevant for antigen presentation are mostly 15 amino acids or longer. These require TPPII activity for further trimming before becoming substrates for other peptidases and MHC class I. The heterogeneous pool of aminopeptidases will process TPPII products into MHC class I peptides and beyond.	Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Immunohematol & Blooc Transfus, NL-2300 RC Leiden, Netherlands	Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Neefjes, J (corresponding author), Netherlands Canc Inst, Div Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.neefjes@nki.nl	Drijfhout, Jan Wouter/ABA-6318-2021; Benckhuijsen, Willemina/Y-2490-2018; Neefjes, Jacques J.C./H-8780-2017	Drijfhout, Jan Wouter/0000-0003-4808-5296; Benckhuijsen, Willemina/0000-0002-8898-5195; Neefjes, Jacques J.C./0000-0001-6763-2211; Neijssen, Joost/0000-0001-6697-4324; Janssen, Lennert/0000-0001-9705-0204				Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Breslin HJ, 2002, J MED CHEM, V45, P5303, DOI 10.1021/jm0202831; Bromme D, 1996, BIOCHEMISTRY-US, V35, P6706, DOI 10.1021/bi960092y; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Fruci D, 2003, J IMMUNOL, V170, P2977, DOI 10.4049/jimmunol.170.6.2977; Ganellin CR, 2000, J MED CHEM, V43, P664, DOI 10.1021/jm990226g; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; JOHNSON GD, 1990, ARCH BIOCHEM BIOPHYS, V276, P305, DOI 10.1016/0003-9861(90)90724-D; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; Mo XY, 1999, J IMMUNOL, V163, P5851; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Princiotta MF, 2001, P NATL ACAD SCI USA, V98, P513, DOI 10.1073/pnas.021132398; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Renn SCP, 1998, J BIOL CHEM, V273, P19173, DOI 10.1074/jbc.273.30.19173; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Rose C, 1996, NATURE, V380, P403, DOI 10.1038/380403a0; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; SUGAWARA S, 1987, J IMMUNOL METHODS, V100, P83; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Tomkinson B, 1999, TRENDS BIOCHEM SCI, V24, P355, DOI 10.1016/S0968-0004(99)01435-8; TURZYNSKI A, 1990, EUR J BIOCHEM, V190, P509, DOI 10.1111/j.1432-1033.1990.tb15603.x; YellenShaw AJ, 1997, J IMMUNOL, V158, P3227; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	42	202	206	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2004	20	4					495	506		10.1016/S1074-7613(04)00074-3	http://dx.doi.org/10.1016/S1074-7613(04)00074-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084277	Bronze			2022-12-18	WOS:000221442800014
J	Cochran, JR; Cameron, TO; Stern, LJ				Cochran, JR; Cameron, TO; Stern, LJ			The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers	IMMUNITY			English	Article							RECEPTOR SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; PLANAR MEMBRANES; ZETA-CHAIN; COMPLEXES; INDUCTION; LIGANDS; CLONES; PROLIFERATION; DIMERIZATION	A series of novel chemically defined soluble oligomers of the human MHC class II protein HLA-DR1 was constructed to probe the molecular requirements for initiation of T cell activation. MHC dimers, trimers, and tetramers stimulated T cells, as measured by upregulation of the activation markers CD69 and CD25, and by internalization of activated T cell receptor subunits. Monomeric MHC-peptide complexes engaged T cell receptors but did not induce activation. For a given amount of receptor engagement, the extent of activation was equivalent for each of the oligomers and correlated with the number of T cell receptor cross-links induced. These results suggest that formation or rearrangement of a T cell receptor dimer is necessary and sufficient for initiation of T cell signaling.	MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Stern, LJ (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008334] Funding Source: NIH RePORTER; NIAID NIH HHS [N01AI95361] Funding Source: Medline; NIGMS NIH HHS [T32 GM08334] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABASTADO JP, 1995, J EXP MED, V182, P439, DOI 10.1084/jem.182.2.439; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BEKOFF M, 1986, J IMMUNOL, V137, P1411; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Casares S, 1999, J EXP MED, V190, P543, DOI 10.1084/jem.190.4.543; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; FOX BS, 1987, J IMMUNOL, V138, P3367; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GERMAIN RN, 1993, CURR BIOL, V3, P586, DOI 10.1016/0960-9822(93)90004-8; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hamad ARA, 1998, J EXP MED, V188, P1633, DOI 10.1084/jem.188.9.1633; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Itoh Y, 1999, J IMMUNOL, V162, P2073; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; LAMB JR, 1982, NATURE, V300, P66, DOI 10.1038/300066a0; LAUFFENBURGER DA, 1993, RECEPTORS MODELS BIN, P133; LETOURNEUR F, 1991, P NATL ACAD SCI USA, V88, P8905, DOI 10.1073/pnas.88.20.8905; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; PERELSON AS, 1980, MATH BIOSCI, V48, P71, DOI 10.1016/0025-5564(80)90017-6; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; QUILL H, 1987, J IMMUNOL, V138, P3704; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; SYMER DE, 1992, J EXP MED, V176, P1421, DOI 10.1084/jem.176.5.1421; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VANSCHOOTEN WCA, 1992, J IMMUNOL, V148, P1043; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WATTS TH, 1988, J IMMUNOL, V141, P3708; WATTS TH, 1984, P NATL ACAD SCI-BIOL, V81, P7564, DOI 10.1073/pnas.81.23.7564; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; ZANDERS ED, 1983, NATURE, V303, P625, DOI 10.1038/303625a0	62	202	213	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2000	12	3					241	250		10.1016/S1074-7613(00)80177-6	http://dx.doi.org/10.1016/S1074-7613(00)80177-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	301DC	10755611	Bronze			2022-12-18	WOS:000086292100002
J	Comeau, MR; Johnson, R; DuBose, RF; Petersen, M; Gearing, P; VandenBos, T; Park, L; Farrah, T; Buller, RM; Cohen, JI; Strockbine, LD; Rauch, C; Spriggs, MK				Comeau, MR; Johnson, R; DuBose, RF; Petersen, M; Gearing, P; VandenBos, T; Park, L; Farrah, T; Buller, RM; Cohen, JI; Strockbine, LD; Rauch, C; Spriggs, MK			A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR	IMMUNITY			English	Article							GROWTH CONE GUIDANCE; MONOCLONAL-ANTIBODIES; SURFACE MOLECULE; AXON GUIDANCE; B-CELLS; EXPRESSION; IDENTIFICATION; PLEXIN; SEQUENCE; PROTEINS	The vaccinia virus A39R protein is a member of the semaphorin family. A39R.Fc protein was used to affinity purify an A39R receptor from a human B cell line. Tandem mass spectrometry of receptor peptides yielded partial amino acid sequences that allowed the identification of corresponding cDNA clones. Sequence analysis of this receptor indicated that it is a novel member of the plexin family and identified a semaphorin-like domain within this family, thus suggesting an evolutionary relationship between receptor and ligand. A39R up-regulated ICAM-1 on, and induced cytokine production from, human monocytes. These data, then, describe a receptor for an immunologically active semaphorin and suggest that it may serve as a prototype for other plexin-semaphorin binding pairs.	Immunex Res & Dev Corp, Dept Mol Biol, Seattle, WA 98101 USA; Immunex Res & Dev Corp, Dept Prot Chem, Seattle, WA 98101 USA; Immunex Res & Dev Corp, Dept Bioinformat, Seattle, WA 98101 USA; Immunex Res & Dev Corp, Dept Biochem, Seattle, WA 98101 USA; St Louis Univ, Dept Mol Biol & Immunol, St Louis, MO 63104 USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	Saint Louis University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Spriggs, MK (corresponding author), Immunex Res & Dev Corp, Dept Mol Biol, 51 Univ St, Seattle, WA 98101 USA.	spriggs@immunex.com						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAUM PR, 1994, CIRC SHOCK, V44, P30; BECKMANN MP, 1990, J IMMUNOL, V144, P4212; BENJAMIN D, 1990, BLOOD, V75, P2017; BOUGERET C, 1992, J IMMUNOL, V148, P318; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; COSMAN D, 1986, MOL IMMUNOL, V23, P935, DOI 10.1016/0161-5890(86)90123-9; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; DOWER SK, 1984, J IMMUNOL, V132, P751; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ENSSER A, 1995, J GEN VIROL, V76, P1063, DOI 10.1099/0022-1317-76-4-1063; Fujisawa H, 1997, DEV NEUROSCI-BASEL, V19, P101, DOI 10.1159/000111192; Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; HAZIOT A, 1994, J IMMUNOL, V152, P5868; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Herold C, 1996, J IMMUNOL, V157, P5262; HEROLD C, 1994, INT IMMUNOL, V7, P1; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; HUNT DF, 1986, P NATL ACAD SCI USA, V83, P6233, DOI 10.1073/pnas.83.17.6233; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Kameyama T, 1996, BIOCHEM BIOPH RES CO, V226, P396, DOI 10.1006/bbrc.1996.1367; Kameyama T, 1996, BIOCHEM BIOPH RES CO, V226, P524, DOI 10.1006/bbrc.1996.1388; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; Muller BK, 1996, CURR OPIN GENET DEV, V6, P469, DOI 10.1016/S0959-437X(96)80069-4; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; PLOWRIGHT W, 1960, NATURE, V188, P1167, DOI 10.1038/1881167a0; Sambrook J, 1989, MOL CLONING LAB MANU; SATODA M, 1995, J NEUROSCI, V15, P942; SEGAL DM, 1977, J IMMUNOL, V118, P1338; Spriggs MK, 1996, ANNU REV IMMUNOL, V14, P101, DOI 10.1146/annurev.immunol.14.1.101; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Yao ZB, 1996, J IMMUNOL, V156, P3260; Zhou L, 1997, MOL CELL NEUROSCI, V9, P26, DOI 10.1006/mcne.1997.0607	47	202	215	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1998	8	4					473	482		10.1016/S1074-7613(00)80552-X	http://dx.doi.org/10.1016/S1074-7613(00)80552-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586637	Bronze			2022-12-18	WOS:000073348000009
J	Nepomuceno, RR; HenschenEdman, AH; Burgess, WH; Tenner, AJ				Nepomuceno, RR; HenschenEdman, AH; Burgess, WH; Tenner, AJ			cDNA cloning and primary structure analysis of C1qR(p), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro	IMMUNITY			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; MOUSE PERITONEAL-MACROPHAGES; HUMAN MONONUCLEAR PHAGOCYTES; AMINO-ACID-SEQUENCE; SURFACTANT APOPROTEIN; HUMAN-MONOCYTES; C1Q RECEPTOR; SP-A; CR1-MEDIATED PHAGOCYTOSIS; C1Q-MEDIATED ENHANCEMENT	The complement protein C1q, mannose-binding lectin (MEL), and pulmonary surfactant protein A (SPA) are structurally similar molecules that enhance phagocytic function in vitro. Monoclonal antibodies R3 and R139, which inhibit the enhancement triggered by these three ligands, were used to purify a 126,000 M-r cell surface protein designated C1qR(p). Amino acid sequence was obtained and the corresponding cDNA was cloned. C1qR(p) is a novel type I membrane protein with the following putative structural elements: a C-type carbohydrate recognition domain, five EGF-like domains, a transmembrane domain, and a short cytoplasmic tail. All peptides identified by amino acid sequencing are encoded by the cDNA. Additionally, an anti-peptide antiserum was generated, which is reactive with C1qR(p). The data indicate that the cloned cDNA encodes the receptor that plays a role in C1q/MBL/SPA-mediated removal or destruction of pathogens and immune complexes by phagocytosis.	AMER RED CROSS,JEROME H HOLLAND LAB,ROCKVILLE,MD 20855	American Red Cross	Nepomuceno, RR (corresponding author), UNIV CALIF IRVINE,DEPT MOL BIOL & BIOCHEM,IRVINE,CA 92697, USA.				NCI NIH HHS [5T32-CA09054] Funding Source: Medline; NIAID NIH HHS [AI 41090] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041090] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDREW SM, 1991, CURRENT PROTOCOLS IM; ARGRAVES WS, 1990, J CELL BIOL, V111, P3155, DOI 10.1083/jcb.111.6.3155; ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; BABINEAU TJ, 1994, ANN SURG, V220, P601, DOI 10.1097/00000658-199411000-00002; BOBAK DA, 1988, EUR J IMMUNOL, V18, P2001, DOI 10.1002/eji.1830181220; BOBAK DA, 1987, J IMMUNOL, V138, P1150; BOBAK DA, 1988, J IMMUNOL, V141, P592; BORDIN S, 1990, J IMMUNOL, V145, P2520; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; BROWN EJ, 1986, J LEUKOCYTE BIOL, V39, P579, DOI 10.1002/jlb.39.5.579; CRONEOS Z, 1995, AM J PHYSIOL-LUNG C, V269, pL721; DAHA MR, 1990, J IMMUNOL, V144, P1227; DEDHAR S, 1994, TRENDS BIOCHEM SCI, V19, P269, DOI 10.1016/0968-0004(94)90001-9; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; Epstein J, 1996, CURR OPIN IMMUNOL, V8, P29, DOI 10.1016/S0952-7915(96)80101-4; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; GEERTSMA MF, 1994, IMMUNOLOGY, V82, P450; GHEBREHIWET B, 1984, J EXP MED, V160, P1375, DOI 10.1084/jem.160.5.1375; GHEBREHIWET B, 1988, J IMMUNOL METHODS, V110, P251, DOI 10.1016/0022-1759(88)90111-1; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; GOODMAN EB, 1992, J IMMUNOL, V148, P3920; GRESHAM HD, 1988, J CLIN INVEST, V82, P1192, DOI 10.1172/JCI113716; GRESHAM HD, 1986, J IMMUNOL, V137, P868; GRESHAM HD, 1989, J CELL BIOL, V108, P1935, DOI 10.1083/jcb.108.5.1935; GUAN E, 1991, J BIOL CHEM, V266, P20345; GUAN E, 1994, J IMMUNOL, V152, P4005; GUEST JR, 1985, J MOL BIOL, V185, P743, DOI 10.1016/0022-2836(85)90059-2; HAMADA A, 1988, J CLIN INVEST, V82, P945, DOI 10.1172/JCI113702; HAMADA A, 1987, J IMMUNOL, V138, P1240; HOPPE HJ, 1994, PROTEIN SCI, V3, P1143, DOI 10.1002/pro.5560030801; HUNTER MJ, 1995, PROTEIN SCI, V4, P2129, DOI 10.1002/pro.5560041019; JENSENIUS JC, 1995, SCIENCE, V270, P1104; JIANG HX, 1992, J BIOL CHEM, V267, P25597; Knott V, 1996, J MOL BIOL, V255, P22, DOI 10.1006/jmbi.1996.0003; KOROTZER AR, 1995, EXP NEUROL, V134, P214, DOI 10.1006/exnr.1995.1051; KOVACSOVICS T, 1985, J IMMUNOL, V135, P2695; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEU RW, 1989, J IMMUNOL, V143, P3250; Lim BL, 1996, J BIOL CHEM, V271, P26739, DOI 10.1074/jbc.271.43.26739; LOZADA C, 1995, P NATL ACAD SCI USA, V92, P8378, DOI 10.1073/pnas.92.18.8378; MALHOTRA R, 1993, IMMUNOLOGY, V78, P341; MALHOTRA R, 1989, BIOCHEM J, V262, P625, DOI 10.1042/bj2620625; MALOY WL, 1991, CURRENT PROTOCOLS IM; MANZKEINKE H, 1992, EUR J CELL BIOL, V57, P95; McIntosh JC, 1996, AM J PHYSIOL-LUNG C, V271, pL310, DOI 10.1152/ajplung.1996.271.2.L310; OHKURO M, 1994, IMMUNOLOGY, V83, P507; OIKI S, 1988, J IMMUNOL, V141, P3177; PATSCHINSKY T, 1982, P NATL ACAD SCI-BIOL, V79, P973, DOI 10.1073/pnas.79.4.973; PEERSCHKE EIB, 1987, J IMMUNOL, V138, P1537; PEERSCHKE EIB, 1993, J EXP MED, V178, P579, DOI 10.1084/jem.178.2.579; PEERSCHKE EIB, 1990, J IMMUNOL, V145, P2984; PISON U, 1992, AM J PHYSIOL, V262, pL412, DOI 10.1152/ajplung.1992.262.4.L412; POMMIER CG, 1983, J EXP MED, V157, P1844, DOI 10.1084/jem.157.6.1844; POUTSLAKA D, 1993, BLOOD, V12, P3695; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; RIMOLDI MT, 1989, J CLIN INVEST, V84, P1982, DOI 10.1172/JCI114388; Ruiz S, 1995, J BIOL CHEM, V270, P30627, DOI 10.1074/jbc.270.51.30627; RYAN US, 1989, INFECT IMMUN, V57, P1356, DOI 10.1128/IAI.57.5.1356-1362.1989; Sambrook J, 1989, MOL CLONING LAB MANU; SAMPSON LL, 1991, J IMMUNOL, V146, P1005; SHINGU M, 1989, INFLAMMATION, V13, P561, DOI 10.1007/BF00916762; SOELL M, 1995, J IMMUNOL, V154, P851; SUMMERFIELD JA, 1995, LANCET, V345, P886, DOI 10.1016/S0140-6736(95)90009-8; SUPER M, 1989, LANCET, V2, P1236; TENNER AJ, 1980, J IMMUNOL, V125, P1658; TENNER AJ, 1989, J BIOL CHEM, V264, P13923; TENNER AJ, 1995, IMMUNITY, V3, P485, DOI 10.1016/1074-7613(95)90177-9; TESTERMAN TL, 1995, J LEUKOCYTE BIOL, V58, P365, DOI 10.1002/jlb.58.3.365; Tino MJ, 1996, AM J PHYSIOL-LUNG C, V270, pL677, DOI 10.1152/ajplung.1996.270.4.L677; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; vandenDobbelsteen MEA, 1996, J AM SOC NEPHROL, V7, P573; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; VEERHUIS R, 1985, IMMUNOLOGY, V54, P801; WADA I, 1995, J BIOL CHEM, V270, P20298, DOI 10.1074/jbc.270.35.20298; WARD LD, 1990, J CHROMATOGR, V519, P199, DOI 10.1016/0021-9673(90)85148-O; WRIGHT JR, 1987, J BIOL CHEM, V262, P2888; YOUNG KR, 1991, J IMMUNOL, V146, P3356	79	202	212	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1997	6	2					119	129		10.1016/S1074-7613(00)80419-7	http://dx.doi.org/10.1016/S1074-7613(00)80419-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC616	9047234	Bronze			2022-12-18	WOS:A1997XC61600002
J	HOU, JZ; SCHINDLER, U; HENZEL, WJ; WONG, SC; MCKNIGHT, SL				HOU, JZ; SCHINDLER, U; HENZEL, WJ; WONG, SC; MCKNIGHT, SL			IDENTIFICATION AND PURIFICATION OF HUMAN STAT PROTEINS ACTIVATED IN RESPONSE TO INTERLEUKIN-2	IMMUNITY			English	Article							RECEPTOR GAMMA-CHAIN; HUMAN IL-2 RECEPTOR; TYROSINE PHOSPHORYLATION; MOLECULAR-CLONING; CELL-LINE; SEQUENCE; ALPHA; EXPRESSION; SYSTEM; CDNAS	A key cytokine induced during the immune response is IL-2. Following T cell activation, the genes encoding IL-2 and the various chains of its receptor are transcriptionally induced. In turn, secreted IL-2 serves to stimulate the proliferation and differentiation of T lymphocytes. Several recent studies have implicated Jak kinases in the signaling pathway induced by IL-2. Following this lead, we set out to identify transcription factors induced in response to IL-2. Human peripheral blood lymphocytes were observed to contain several IL-2-inducible DNA binding activities. Similar activities were also observed in a transformed human lymphocyte line, termed YT. We have purified these activities and found that the principal IL-2-inducible component bears significant relatedness to a prolactin-induced transcription factor first identified in sheep mammary gland tissue. We hypothesize that activation of this protein, designated hStat5, helps govern the biological effects of IL-2 during the immune response.	GENENTECH INC,S SAN FRANCISCO,CA 94080	Roche Holding; Genentech	HOU, JZ (corresponding author), TULARIK INC,270 E GRAND AVE,S SAN FRANCISCO,CA 94080, USA.			Henzel, William/0000-0003-2940-3797				AEBERSOLD R, 1991, ANAL BIOCHEM, V199, P51, DOI 10.1016/0003-2697(91)90268-X; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; BEADLING C, 1994, EMBO J, V13, P5605, DOI 10.1002/j.1460-2075.1994.tb06898.x; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GILMOUR KC, 1994, P NATL ACAD SCI USA, V91, P6850, DOI 10.1073/pnas.91.15.6850; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; Henzel William J., 1994, Methods (Orlando), V6, P239, DOI 10.1006/meth.1994.1026; HENZEL WJ, 1987, J CHROMATOGR, V404, P41, DOI 10.1016/S0021-9673(01)86835-7; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KAWAHARA A, 1994, MOL CELL BIOL, V14, P5433, DOI 10.1128/MCB.14.8.5433; KELLY PA, 1991, ENDOCR REV, V12, P235, DOI 10.1210/edrv-12-3-235; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; KRUTSCH HC, 1983, ANAL BIOCHEM, V209, P109; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; MINAMOTO S, 1990, J IMMUNOL, V145, P2177; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; RUI H, 1994, J BIOL CHEM, V269, P5364; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; Sambrook J., 1989, MOL CLONING; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TAKESHITA T, 1990, INT IMMUNOL, V2, P477, DOI 10.1093/intimm/2.5.477; TANIGUCHI T, 1986, IMMUNOL REV, V92, P121, DOI 10.1111/j.1600-065X.1986.tb01497.x; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; VOSS SD, 1993, P NATL ACAD SCI USA, V90, P2428, DOI 10.1073/pnas.90.6.2428; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; WALDMANN TA, 1993, IMMUNOL TODAY, V15, P19; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; YIP TT, 1992, FEBS LETT, V308, P149, DOI 10.1016/0014-5793(92)81264-M; YODOI J, 1985, J IMMUNOL, V134, P1623	43	202	209	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1995	2	4					321	329		10.1016/1074-7613(95)90140-X	http://dx.doi.org/10.1016/1074-7613(95)90140-X			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU616	7719937	Bronze			2022-12-18	WOS:A1995QU61600002
J	van Loosdregt, J; Fleskens, V; Fu, J; Brenkman, AB; Bekker, CPJ; Pals, CEGM; Meerding, J; Berkers, CR; Barbi, J; Grone, A; Sijts, AJAM; Maurice, MM; Kalkhoven, E; Prakken, BJ; Ovaa, H; Pan, F; Zaiss, DMW; Coffer, PJ				van Loosdregt, Jorg; Fleskens, Veerle; Fu, Juan; Brenkman, Arjan B.; Bekker, Cornelis P. J.; Pals, Cornelieke E. G. M.; Meerding, Jenny; Berkers, Celia R.; Barbi, Joseph; Grone, Andrea; Sijts, Alice J. A. M.; Maurice, Madelon M.; Kalkhoven, Eric; Prakken, Berent J.; Ovaa, Huib; Pan, Fan; Zaiss, Dietmar M. W.; Coffer, Paul J.			Stabilization of the Transcription Factor Foxp3 by the Deubiquitinase USP7 Increases Treg-Cell-Suppressive Capacity	IMMUNITY			English	Article							REGULATORY T-CELLS; MEDIATED DEGRADATION; EXPRESSION; UBIQUITINATION; PLASTICITY; DISEASE; MONOUBIQUITINATION; DIFFERENTIATION; CONTRIBUTES; METHYLATION	Stable Foxp3 expression is required for the development of functional regulatory T (Treg) cells. Here, we demonstrate that the expression of the transcription factor Foxp3 can be regulated through the polyubiquitination of multiple lysine residues, resulting in proteasome-mediated degradation. Expression of the deubiquitinase (DUB) USP7 was found to be upregulated and active in Treg cells, being associated with Foxp3 in the nucleus. Ectopic expression of USP7 decreased Foxp3 polyubiquitination and increased Foxp3 expression. Conversely, either treatment with DUB inhibitor or USP7 knockdown decreased endogenous Foxp3 protein expression and decreased Treg-cell-mediated suppression in vitro. Furthermore, in a murine adoptive-transfer-induced colitis model, either inhibition of DUB activity or USP7 knockdown in Treg cells abrogated their ability to resolve inflammation in vivo. Our data reveal a molecular mechanism in which rapid temporal control of Foxp3 expression in Treg cells can be regulated by USP7, thereby modulating Treg cell numbers and function.	[van Loosdregt, Jorg; Fleskens, Veerle; Pals, Cornelieke E. G. M.; Coffer, Paul J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Immunol, NL-3584 EA Utrecht, Netherlands; [van Loosdregt, Jorg; Meerding, Jenny; Prakken, Berent J.; Coffer, Paul J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, NL-3584 EA Utrecht, Netherlands; [van Loosdregt, Jorg; Fleskens, Veerle; Bekker, Cornelis P. J.; Pals, Cornelieke E. G. M.; Maurice, Madelon M.; Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 EA Utrecht, Netherlands; [Brenkman, Arjan B.; Kalkhoven, Eric] Univ Med Ctr Utrecht, NL-3584 EA Utrecht, Netherlands; [Fu, Juan; Barbi, Joseph; Pan, Fan] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Immunol & Hematopoiesis Div, Baltimore, MD 21231 USA; [Bekker, Cornelis P. J.; Sijts, Alice J. A. M.; Zaiss, Dietmar M. W.] Fac Vet Med Utrecht, Dept Immunol & Infect Dis, NL-3584 CL Utrecht, Netherlands; [Grone, Andrea; Ovaa, Huib] Fac Vet Med Utrecht, Dept Pathobiol, NL-3584 CL Utrecht, Netherlands; [Berkers, Celia R.] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Utrecht University; Utrecht University; Netherlands Cancer Institute	Coffer, PJ (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Immunol, NL-3584 EA Utrecht, Netherlands.	p.j.coffer@umcutrecht.nl	Berkers, Celia/I-3848-2016; Coffer, Paul/AAF-7970-2020; ovaa, huib/M-2334-2016	Maurice, Madelon/0000-0001-6885-5361; Zaiss, Dietmar M.W./0000-0003-3596-7062; Berkers, Celia/0000-0003-0746-8565; ovaa, huib/0000-0002-0068-054X; Sijts, Alice/0000-0003-3815-4788; van Loosdregt, Jorg/0000-0003-1411-3754	Netherlands Foundation for Scientific Research; Dutch Cancer Society [2006-3508]; Utrecht University (High Potential Program); European Research Council [242958]; National Institutes of Health [R01AI099300]; Melanoma Research Alliance; Stewart Trust Award; Kelly's Dream Award; Dutch Rheumatism Foundation; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099300] Funding Source: NIH RePORTER	Netherlands Foundation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); Utrecht University (High Potential Program); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Stewart Trust Award; Kelly's Dream Award; Dutch Rheumatism Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors like to thank M. Klein, S. Vervoort, I. Kuper, and A. Veenstra for technical assistance and S. Sakaguchi (Institute for Physical and Chemical Research, Yokohama, Japan) and B.M.T. Burgering (University Medical Center Utrecht) for providing several constructs. H.O. was supported by a VIDI grant from the Netherlands Foundation for Scientific Research. M.M.M. is supported by the Dutch Cancer Society (2006-3508), Utrecht University (High Potential Program), and the European Research Council (starting grant 242958). F.P.'s research is partially supported by grants from the National Institutes of Health (R01AI099300), the Melanoma Research Alliance, a Stewart Trust Award, and a Kelly's Dream Award. J.v.L. and V.F. were supported by a grant from the Dutch Rheumatism Foundation. H.O. is a cofounder of UbiQ B. V. and a member of its scientific advisory board.	Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Ciechanover A, 2002, HEPATOLOGY, V35, P3, DOI 10.1053/jhep.2002.30316; Colombo M, 2010, CHEMMEDCHEM, V5, P552, DOI 10.1002/cmdc.200900409; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Eldridge AG, 2010, CELL DEATH DIFFER, V17, P4, DOI 10.1038/cdd.2009.82; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HOU D, 1994, J BIOL CHEM, V269, P14244; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hybrigenics SA, 2007, [No title captured], Patent No. [WO2007017758, 2007017758]; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kwon HS, 2012, J IMMUNOL, V188, P2712, DOI 10.4049/jimmunol.1100903; Lee JS, 2004, PROTEOMICS, V4, P3376, DOI 10.1002/pmic.200401000; Lu YZ, 2007, MOL ENDOCRINOL, V21, P651, DOI 10.1210/me.2006-0188; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Onizuka S, 1999, CANCER RES, V59, P3128; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Song XM, 2012, CELL REPORTS, V1, P665, DOI 10.1016/j.celrep.2012.04.012; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang Z, 2012, FEBS LETT, V586, P3013, DOI 10.1016/j.febslet.2012.06.025; Yang ZZ, 2006, CANCER RES, V66, P10145, DOI 10.1158/0008-5472.CAN-06-1822; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	48	201	215	7	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					259	271		10.1016/j.immuni.2013.05.018	http://dx.doi.org/10.1016/j.immuni.2013.05.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23973222	Bronze, Green Accepted			2022-12-18	WOS:000330948800009
J	Goldszmid, RS; Caspar, P; Rivollier, A; White, S; Dzutsev, A; Hieny, S; Kelsall, B; Trinchieri, G; Sher, A				Goldszmid, Romina S.; Caspar, Pat; Rivollier, Aymeric; White, Sandy; Dzutsev, Amiran; Hieny, Sara; Kelsall, Brian; Trinchieri, Giorgio; Sher, Alan			NK Cell-Derived Interferon-gamma Orchestrates Cellular Dynamics and the Differentiation of Monocytes into Dendritic Cells at the Site of Infection	IMMUNITY			English	Article							TOXOPLASMA-GONDII INFECTION; NECROSIS-FACTOR-ALPHA; NATURAL-KILLER-CELLS; INNATE IMMUNE DEFENSE; IFN-GAMMA; IN-VIVO; INFLAMMATORY MONOCYTES; IL-12 PRODUCTION; CUTTING EDGE; RESISTANCE	Dendritic cells (DCs), monocytes, and/or macrophages initiate host-protective immune responses to intracellular pathogens in part through interleukin-12 (IL-12) production, although the relative contribution of tissue resident versus recruited cells has been unclear. Here, we showed that after intra-peritoneal infection with Toxoplasma gondii cysts, resident mononuclear phagocytes are replaced by circulating monocytes that differentiate in situ into inflammatory DCs (moDCs) and F4/80(+) macrophages. Importantly, NK cell-derived interferon-gamma (IFN-gamma) was required for both the loss of resident mononuclear phagocytes and the local differentiation of monocytes into macrophages and moDCs. This newly generated moDC population and not the resident DCs (or macrophages) served as the major source of IL-12 at the site of infection. Thus, NK cell-derived IFN-gamma is important in both regulating inflammatory cell dynamics and in driving the local differentiation of monocytes into the cells required for initiating the immune response to an important intracellular pathogen.	[Goldszmid, Romina S.; Dzutsev, Amiran; Trinchieri, Giorgio] NCI, Expt Immunol Lab, Canc & Inflammat Program, Ctr Canc Res,Natl Inst Hlth, Frederick, MD 21702 USA; [Goldszmid, Romina S.; Caspar, Pat; White, Sandy; Hieny, Sara; Trinchieri, Giorgio; Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Rivollier, Aymeric; Kelsall, Brian] NIAID, Mucosal Immunobiol Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Dzutsev, Amiran] SAIC Frederick Inc, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Science Applications International Corporation (SAIC); SAIC-Frederick	Goldszmid, RS (corresponding author), NCI, Expt Immunol Lab, Canc & Inflammat Program, Ctr Canc Res,Natl Inst Hlth, Frederick, MD 21702 USA.	rgoldszmid@mail.nih.gov; trinchig@mail.nih.gov; asher@niaid.nih.gov	Trinchieri, Giorgio/F-9369-2015	Trinchieri, Giorgio/0000-0001-5892-7464; Rivollier, Aymeric Marie Christian/0000-0001-8734-2916	MAID; NCI; NIH; NATIONAL CANCER INSTITUTE [ZIABC011153, ZIABC010793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000579, ZIAAI000833] Funding Source: NIH RePORTER	MAID; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to the NIAID Flow Cytometry core facility and in particular T. Moyer for performing sorting. We are also indebted to R. Locksley for kindly providing the Yet40 mice and M. Grigg for the RFP expressing parasites. We also gratefully acknowledge D. McVicar, K. Mayer-Barber, and D. Barber for critical reading of the manuscript. This research was supported by the Intramural Research Program of the MAID and NCI, NIH. The authors have no conflicting financial interests.	Abdi K, 2006, SCAND J IMMUNOL, V64, P83, DOI 10.1111/j.1365-3083.2006.01767.x; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bedoui S, 2009, J IMMUNOL, V182, P4200, DOI 10.4049/jimmunol.0802286; Bliss SK, 1999, J IMMUNOL, V163, P2081; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; DENKERS EY, 1993, J EXP MED, V178, P1465, DOI 10.1084/jem.178.5.1465; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Goldszmid RS, 2007, J EXP MED, V204, P2591, DOI 10.1084/jem.20070634; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; Guan HB, 2007, J IMMUNOL, V179, P590, DOI 10.4049/jimmunol.179.1.590; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hou BD, 2011, P NATL ACAD SCI USA, V108, P278, DOI 10.1073/pnas.1011549108; HUNTER CA, 1994, INFECT IMMUN, V62, P2818, DOI 10.1128/IAI.62.7.2818-2824.1994; HUNTER CA, 1995, J IMMUNOL, V155, P4347; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; SHER A, 1993, J IMMUNOL, V150, P3982; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869	50	201	205	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 29	2012	36	6					1047	1059		10.1016/j.immuni.2012.03.026	http://dx.doi.org/10.1016/j.immuni.2012.03.026			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22749354	Green Accepted, Bronze			2022-12-18	WOS:000306097100020
J	McElrath, MJ; Haynes, BF				McElrath, M. Juliana; Haynes, Barton F.			Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination	IMMUNITY			English	Review							T-CELL RESPONSES; TEST-OF-CONCEPT; NEUTRALIZING ANTIBODY-RESPONSE; HIV-1 VACCINE; MONOCLONAL-ANTIBODIES; PROTECTIVE EFFICACY; BOOST VACCINE; DOUBLE-BLIND; ENVELOPE; INFECTION	Recent findings have brought optimism that development of a successful human immunodeficiency virus type-1 (HIV-1) vaccine lies within reach Studies of early events in HIV-1 infection have revealed when and where HIV-1 is potentially vulnerable to vaccine-targeted immune responses With technical advances in human antibody production, clues about how antibodies recognize HIV-1 envelope proteins have uncovered new targets for immunogen design A recent vaccine regimen has shown modest efficacy against HIV-1 acquisition However, inducing long-term T and B cell memory and coping with HIV-1 diversity remain high priorities Mediators of innate immunity may play pivotal roles in blocking infection and shaping immunity, vaccine strategies to capture these activities are under investigation Challenges remain in integrating basic, preclinical and clinical research to improve predictions of types of immunity associated with vaccine efficacy, to apply these insights to immunogen design, and to accelerate evaluation of vaccine efficacy in persons at-risk for infection	[McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Haynes, Barton F.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA	Fred Hutchinson Cancer Center; Duke University	McElrath, MJ (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1100 Fairview Ave N,D3-100, Seattle, WA 98109 USA.				HIV Vaccine Dials Network Laboratory; NIH NIAID Division of AIDS; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, U01AI068618] Funding Source: NIH RePORTER	HIV Vaccine Dials Network Laboratory; NIH NIAID Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the following colleagues for discussions preliminary data or review of the manuscript S Voght N Frahm L Corey S Self S De Rosa P Gilbert J Hural A McMichael M Cohen D Goldstein N Letvin J Sodroski G Shaw A Lanzavecchia D Corti G Alter G Tomaras G Kel soe D Dimitrov L Verkoczy A Moody H X Liao M Alam M Sekaran and J Arthos We thank W Schief for Figure 1 We apologize to colleagues whose publications we were unable to cite due to space limitations and are grateful for all of their exceptional work done in the effort to develop an HIV 1 vaccine This work was supported by the HIV Vaccine Dials Network Laboratory Program and the Center for HIV/AIDS Vaccine Immunology (CHAVI) funded by the NIH NIAID Division of AIDS and by Collaboration for AIDS Vaccine Discovery (CAVD) grants to B F H and M J M funded by the Bill and Melinda Gates Foundation	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2009, J VIROL, V83, P6798, DOI 10.1128/JVI.00256-09; Asmuth DM, 2010, J INFECT DIS, V201, P132, DOI 10.1086/648591; Astronomo RD, 2008, J VIROL, V82, P6359, DOI 10.1128/JVI.00293-08; Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cao JH, 2003, J IMMUNOL, V171, P3837, DOI 10.4049/jimmunol.171.7.3837; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Carter D, 2010, CURR OPIN HIV AIDS, V5, P409, DOI 10.1097/COH.0b013e32833d2cdb; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; COONEY EL, 1993, P NATL ACAD SCI USA, V90, P1882, DOI 10.1073/pnas.90.5.1882; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DeVico AL, 2004, NAT REV MICROBIOL, V2, P401, DOI 10.1038/nrmicro878; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Dinges WL, 2010, J VIROL, V84, P4461, DOI 10.1128/JVI.02438-09; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Evans TG, 2001, VACCINE, V19, P2080, DOI 10.1016/S0264-410X(00)00415-1; Fellay J, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S3-P398; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Forthal DN, 2005, J VIROL, V79, P2042, DOI 10.1128/JVI.79.4.2042-2049.2005; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gilbert P, 2010, J INFECT DIS, V202, P595, DOI 10.1086/654816; GNANN JW, 1987, J INFECT DIS, V156, P261, DOI 10.1093/infdis/156.2.261; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Graham BS, 2005, J INFECT DIS, V191, P647, DOI 10.1086/428406; Gray G, 2010, CURR OPIN HIV AIDS, V5, P357, DOI 10.1097/COH.0b013e32833d2d2b; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Horton RE, 2009, AIDS RES HUM RETROV, V25, P83, DOI 10.1089/aid.2008.0207; JEFFERIS R, 1995, IMMUNOL LETT, V44, P111, DOI 10.1016/0165-2478(94)00201-2; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Malhotra U, 2001, J CLIN INVEST, V107, P505, DOI 10.1172/JCI11275; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2002, VACCINE, V20, P1922, DOI 10.1016/S0264-410X(02)00068-3; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McElrath MJ, 2000, AIDS RES HUM RETROV, V16, P907, DOI 10.1089/08892220050042846; McElrath MJ, 1995, SEMIN CANCER BIOL, V6, P375, DOI 10.1016/1044-579X(95)90007-1; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Meffre E, 2001, J CLIN INVEST, V108, P879, DOI 10.1172/JCI13051; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Montefiori DC, 2009, CURR OPIN HIV AIDS, V4, P347, DOI 10.1097/COH.0b013e32832f4a4d; Moore JS, 2005, AIDS, V19, P381, DOI 10.1097/01.aids.0000161767.21405.68; Moore PL, 2009, CURR OPIN HIV AIDS, V4, P358, DOI 10.1097/COH.0b013e32832ea7e8; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; PALKER TJ, 1987, P NATL ACAD SCI USA, V84, P2479, DOI 10.1073/pnas.84.8.2479; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; RERKS NS, 2009, NEW ENGL J MED, V361, P2209; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rolland M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S3-O42; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Ross AL, 2010, LANCET INFECT DIS, V10, P305, DOI 10.1016/S1473-3099(10)70069-4; SAEZ CA, 2007, P NATL ACAD SCI USA, V104, P6776; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Shiokawa S, 1999, J IMMUNOL, V162, P6060; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Sun JC, 2010, IMMUNOL REV, V236, P83, DOI 10.1111/j.1600-065X.2010.00900.x; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Vasan S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S3-O31; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zheng NN, 2004, J VIROL, V78, P13934, DOI 10.1128/JVI.78.24.13934-13942.2004; ZOLLA PS, 2010, NAT REV IMMUNOL, V10, P527	115	201	228	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					542	554		10.1016/j.immuni.2010.09.011	http://dx.doi.org/10.1016/j.immuni.2010.09.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029964	Green Accepted, Bronze			2022-12-18	WOS:000284300200010
J	Schulz, EG; Mariani, L; Radbruch, A; Hofer, T				Schulz, Edda G.; Mariani, Luca; Radbruch, Andreas; Hoefer, Thomas			Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-gamma and Interleukin-12	IMMUNITY			English	Article							IFN-GAMMA; CELL-DIFFERENTIATION; TRANSCRIPTION FACTOR; LINEAGE COMMITMENT; T-HELPER-1 CELLS; T(H)1 CELLS; BET; EXPRESSION; GENE; TH1	Differentiation of naive T lymphocytes into type I T helper (Th1) cells requires interferon-gamma and interleukin-12. it is puzzling that interferon-gamma induces the Th1 transcription factor T-bet, whereas interleukin-12 mediates Th1 cell lineage differentiation. We use mathematical modeling to analyze the expression kinetics of T-bet, interferon-gamma, and the IL-12 receptor beta 2 chain (IL-12R beta 2) during Th1 cell differentiation, in the presence or absence of interleukin-12 or interferon-gamma signaling. We show that interferon-gamma induced initial T-bet expression, whereas IL-12R beta 2 was repressed by T cell receptor (TCR) signaling. The termination of TCR signaling permitted upregulation of IL-12R beta 2 by T-bet and interleukin-12 signaling that maintained T-bet expression. This late expression of T-bet, accompanied by the upregulation of the transcription factors Runx3 and Hlx, was required to imprint the Th cell for interferon-gamma re-expression. Thus initial polarization and subsequent imprinting of Th1 cells are mediated by interlinked, sequentially acting positive feedback loops of TCR-interferon-gamma-Stat1-T-bet and interleukin-12-Stat4-T-bet signaling.	[Schulz, Edda G.; Mariani, Luca; Hoefer, Thomas] Deutsch Krebsforschungszentrum, Modeling Biol Syst, D-69120 Heidelberg, Germany; [Schulz, Edda G.; Mariani, Luca] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Schulz, Edda G.; Radbruch, Andreas] Deutsch Rheuma Forschungszentrum, Cell Biol Grp, D-10117 Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Humboldt University of Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ)	Hofer, T (corresponding author), Deutsch Krebsforschungszentrum, Modeling Biol Syst, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	t.hoefer@dkfz-heidelberg.de	Höfer, Thomas/G-5665-2013	Höfer, Thomas/0000-0003-3560-8780; Radbruch, Andreas/0000-0001-5753-0000	Deutsche Forschungsgemeinschaft [IRTG1360, SFB 618, SFB TR52]; BMBF-ForSys program; European Commission	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF-ForSys program(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank all members of the Radbruch and Hofer laboratories for helpful discussions, K.M. Ansel, N. Bluthgen, H.-D. Chang, Z. Ignatova, M. Lohning, S. RuM and K. Tokoyoda for critical reading of the manuscript. In particular, we thank N. Blijthgen for valuable help with the statistical analysis. This work was supported by the Deutsche Forschungsgemeinschaft (IRTG1360, SFB 618, and SFB TR52), the BMBF-ForSys program, and by the European Commission through the SYBILLA and MUGEN consortia.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Assenmacher M, 1998, J IMMUNOL, V161, P2825; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Chang HD, 2007, EUR J IMMUNOL, V37, P807, DOI 10.1002/eji.200636385; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Efron B., 1994, MONOGR STAT APPL PRO, DOI DOI 10.1007/978-1-4899-4541-9; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HuLi J, 1997, P NATL ACAD SCI USA, V94, P3189, DOI 10.1073/pnas.94.7.3189; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Niesner U, 2008, J EXP MED, V205, P1889, DOI 10.1084/jem.20072468; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Rutz S, 2008, P NATL ACAD SCI USA, V105, P3497, DOI 10.1073/pnas.0712102105; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Sieber M, 2007, EUR J IMMUNOL, V37, P2617, DOI 10.1002/eji.200737087; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Timmer J, 2004, INT J BIFURCAT CHAOS, V14, P2069, DOI 10.1142/S0218127404010461; Tong YK, 2005, P NATL ACAD SCI USA, V102, P2034, DOI 10.1073/pnas.0409510102; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Wenner CA, 1996, J IMMUNOL, V156, P1442; Yang Y, 2007, BLOOD, V110, P2494, DOI 10.1182/blood-2006-11-058271; Zhang FP, 2006, J EXP MED, V203, P1493, DOI 10.1084/jem.20060066; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	39	201	207	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 22	2009	30	5					673	683		10.1016/j.immuni.2009.03.013	http://dx.doi.org/10.1016/j.immuni.2009.03.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19409816	Green Submitted, Bronze			2022-12-18	WOS:000266356900010
J	Hoeffel, G; Ripoche, AC; Matheoud, D; Nascimbeni, M; Escriou, N; Lebon, P; Heshmati, F; Guillet, JG; Gannage, M; Caillat-Zucman, S; Casartelli, N; Schwartz, O; De la Salle, H; Hanau, D; Hosmalin, A; Maranon, C				Hoeffel, Guillaume; Ripoche, Anne-Claire; Matheoud, Diana; Nascimbeni, Michelina; Escriou, Nicolas; Lebon, Pierre; Heshmati, Farhad; Guillet, Jean-Gerard; Gannage, Monique; Caillat-Zucman, Sophie; Casartelli, Nicoletta; Schwartz, Olivier; De la Salle, Henri; Hanau, Daniel; Hosmalin, Anne; Maranon, Concepcion			Antigen crosspresentation by human plasmacytoid dendritic cells	IMMUNITY			English	Article							REGULATORY T-CELLS; CROSS-PRESENTATION; IN-VIVO; INFLUENZA-VIRUS; SURFACE EXPRESSION; CD4(+); GENERATION; RESPONSES; ACTIVATION; MECHANISMS		Inst Cochin Genet Mol, Dept Immunol, F-75014 Paris, France; INSERM, U567, F-75014 Paris, France; CNRS, UMR 8104, F-75014 Paris, France; Univ Paris 05, F-75014 Paris, France; Inst Pasteur, CNRS, URA Unite Genet Mol Virus Resp 1966, F-75724 Paris 15, France; Hop Cochin, Unite Med Transfus, F-75014 Paris, France; Hop St Vincent de Paul, INSERM, U561, F-75014 Paris, France; Inst Pasteur, CNRS, URA Unite Virus & Immunite 3015, F-75724 Paris 15, France; INSERM, U725, F-67065 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hosmalin, A (corresponding author), Inst Cochin Genet Mol, Dept Immunol, F-75014 Paris, France.	hosmalin@cochin.inserm.fr	De La Salle, Henri/H-9353-2016; Schwartz, Olivier/AAZ-3765-2021; Casartelli, Nicoletta/AAD-5583-2021; Escriou, Nicolas/A-2392-2016; C, maranon/E-1484-2013; Hoeffel, Guillaume/ABG-4881-2021; Casartelli, Nicoletta/L-4798-2015; Hosmalin, Anne/AAF-8561-2019	De La Salle, Henri/0000-0001-5136-0776; Schwartz, Olivier/0000-0002-0729-1475; Escriou, Nicolas/0000-0002-1224-6839; C, maranon/0000-0002-7827-6301; Hoeffel, Guillaume/0000-0002-2534-4972; Hosmalin, Anne/0000-0001-9021-3488; Gannage, Monique/0000-0003-3533-1937; Caillat-Zucman, Sophie/0000-0002-4535-3550				Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Albert ML, 2001, NAT IMMUNOL, V2, P1010, DOI 10.1038/ni722; Andrieu M, 2003, J VIROL, V77, P1564, DOI 10.1128/JVI.77.2.1564-1570.2003; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Benitez-Ribas D, 2006, J EXP MED, V203, P1629, DOI 10.1084/jem.20052364; BEVAN MJ, 1976, J IMMUNOL, V117, P2233; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Blasius AL, 2006, TRENDS IMMUNOL, V27, P255, DOI 10.1016/j.it.2006.04.005; Boasso A, 2006, AIDS REV, V8, P141; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Chen WS, 2004, EUR J IMMUNOL, V34, P194, DOI 10.1002/eji.200324257; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Durier C, 2006, AIDS, V20, P1039, DOI 10.1097/01.aids.0000222077.68243.22; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Gahery H, 2005, THERAPIE, V60, P243, DOI 10.2515/therapie:2005031; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Lore K, 2003, J IMMUNOL, V171, P4320, DOI 10.4049/jimmunol.171.8.4320; Maranon C, 2004, P NATL ACAD SCI USA, V101, P6092, DOI 10.1073/pnas.0304860101; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Patterson S, 2001, J VIROL, V75, P6710, DOI 10.1128/JVI.75.14.6710-6713.2001; Pichlmair A, 2007, J VIROL, V81, P539, DOI 10.1128/JVI.01818-06; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Salio M, 2003, EUR J IMMUNOL, V33, P1052, DOI 10.1002/eji.200323676; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schlecht G, 2004, BLOOD, V104, P1808, DOI 10.1182/blood-2004-02-0426; Schnurr M, 2005, BLOOD, V105, P2465, DOI 10.1182/blood-2004-08-3105; SCHWARTZ O, 1993, J VIROL, V67, P3274, DOI 10.1128/JVI.67.6.3274-3280.1993; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Shortman K, 2001, NAT IMMUNOL, V2, P988, DOI 10.1038/ni1101-988; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sol-Foulon N, 2004, J BIOL CHEM, V279, P31398, DOI 10.1074/jbc.M401621200; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tang QZ, 2006, NAT IMMUNOL, V7, P551, DOI 10.1038/ni0606-551; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842	62	201	209	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2007	27	3					481	492		10.1016/j.immuni.2007.07.021	http://dx.doi.org/10.1016/j.immuni.2007.07.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17869134	Bronze			2022-12-18	WOS:000249843400014
J	Schebesta, A; McManus, S; Salvagiotto, G; Delogu, A; Busslinger, GA; Busslinger, M				Schebesta, Alexandra; McManus, Shane; Salvagiotto, Giorgia; Delogu, Alessio; Busslinger, Georg A.; Busslinger, Meinrad			Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function	IMMUNITY			English	Article							MICE LACKING; EXCHANGE FACTOR; MARGINAL ZONE; PLASMA-CELLS; T-CELLS; PRE-BCR; PROTEIN; EXPRESSION; BSAP; DIFFERENTIATION	The transcription factor Pax5 represses B lineage-inappropriate genes and activates B cell-specific genes in B lymphocytes. Here we have identified 170 Pax5-activated genes. Conditional mutagenesis demonstrated that the Pax5-regulated genes require continuous Pax5 activity for normal expression in pro-13 and mature B cells. Expression of half of the Pax5-activated genes is either absent or substantially reduced upon Pax5 loss in plasma cells. Direct Pax:5 target genes were identified based on their protein synthesis-independent activation by a Pax5-estrogen receptor fusion protein. Chromatin immunoprecipitation (ChIP) of Pax5 together with chromatin profiling by ChIP-on-chip analysis demonstrated that Pax5 directly activates the chromatin at promoters or putative enhancers of Pax5 target genes. The Pax5-activated genes code for key regulatory and structural proteins involved in B cell signaling, adhesion, migration, antigen presentation, and germinal-center B cell formation, thus revealing a complex regulatory network that is activated by Pax5 to control B cell development and function.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	busslinger@imp.ac.at	Delogu, Alessio/F-5033-2010; Busslinger, Meinrad J./J-1249-2016	Delogu, Alessio/0000-0002-4414-4714; Busslinger, Meinrad J./0000-0002-9111-9351; Busslinger, Georg/0000-0002-7851-9895	Medical Research Council [G9900989B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Allam A, 2005, IMMUNOL LETT, V97, P7, DOI 10.1016/j.imlet.2004.09.019; Barlev NA, 2003, MOL CELL BIOL, V23, P6944, DOI 10.1128/MCB.23.19.6944-6957.2003; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Cai DP, 2003, J IMMUNOL, V170, P969, DOI 10.4049/jimmunol.170.2.969; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Funaro A, 2004, BLOOD, V104, P4269, DOI 10.1182/blood-2004-06-2129; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Fuxa M, 2007, J IMMUNOL, V178, P3031, DOI 10.4049/jimmunol.178.5.3031; Gotoh T, 2000, J BIOL CHEM, V275, P30118, DOI 10.1074/jbc.M003074200; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Itoh M, 1998, J IMMUNOL, V161, P3974; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kanaya H, 2005, GENES CELLS, V10, P665, DOI 10.1111/j.1365-2443.2005.00867.x; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Longhi MP, 2006, TRENDS IMMUNOL, V27, P102, DOI 10.1016/j.it.2005.12.008; Mandemakers WJ, 2005, CURR BIOL, V15, pR302, DOI 10.1016/j.cub.2005.04.002; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Nagano K, 2006, EMBO J, V25, P1871, DOI 10.1038/sj.emboj.7601059; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Protin U, 1999, J IMMUNOL, V163, P4917; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Seo S, 2005, J IMMUNOL, V175, P3492, DOI 10.4049/jimmunol.175.6.3492; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Su YW, 2003, IMMUNITY, V19, P295, DOI 10.1016/S1074-7613(03)00202-4; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wei XC, 2005, EUR J IMMUNOL, V35, P612, DOI 10.1002/eji.200425185; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Yamashita Y, 1999, J IMMUNOL, V162, P5940	62	201	204	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2007	27	1					49	63		10.1016/j.immuni.2007.05.019	http://dx.doi.org/10.1016/j.immuni.2007.05.019			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17658281	Bronze			2022-12-18	WOS:000248398100008
J	Walsh, JC; DeKoter, RP; Lee, HJ; Smith, ED; Lancki, DW; Gurish, MF; Friend, DS; Stevens, RL; Anastasi, J; Singh, H				Walsh, JC; DeKoter, RP; Lee, HJ; Smith, ED; Lancki, DW; Gurish, MF; Friend, DS; Stevens, RL; Anastasi, J; Singh, H			Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA-2; MAST-CELLS; HEMATOPOIETIC-CELLS; CARBOXYPEPTIDASE-A; MOLECULAR-CLONING; DIFFERENTIATION; EXPRESSION; GENE; LYMPHOCYTE; PROTEASE-5	PU.1 and GATA transcription factors appear to antagonize each other's function in the development of distinct lineages of the hematopoietic system. In contrast, we demonstrate that PU.1, like GATA-2, is essential for the generation of mast cells. PU.1-/- hematopoietic progenitors can be propagated in IL-3 and differentiate into mast cells or macrophages upon restoration of PU.1 activity. Using these progenitors and a conditionally activatable PU.1 protein, we show that PU.1 can negatively regulate expression of the GATA-2 gene. In the absence of GATA-2, PU.1 promotes macrophage but not mast cell differentiation. Reexpression of GATA-2 in such progenitors enables the generation of mast cells. We propose a developmental model in which cooperative function or antagonistic crossregulation by PU.1 of GATA-2 promotes distinct myeloid cell fates.	Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Chicago; University of Chicago	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA.	hsingh@midway.uchicago.edu	DeKoter, Rodney/A-9415-2009	DeKoter, Rodney/0000-0002-9201-1983	NHLBI NIH HHS [HL-07237, HL-36110] Funding Source: Medline; NIAID NIH HHS [AI-23483, AI-31599] Funding Source: Medline; NIGMS NIH HHS [GM-07151] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031599, U19AI031599, R01AI023483] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; CHEN HM, 1993, J BIOL CHEM, V268, P8230; Cheng T, 1996, P NATL ACAD SCI USA, V93, P13158, DOI 10.1073/pnas.93.23.13158; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Fisher RC, 1998, MOL CELL BIOL, V18, P4347, DOI 10.1128/MCB.18.7.4347; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; GALLI SJ, 1982, J CELL BIOL, V95, P435, DOI 10.1083/jcb.95.2.435; GALSON DL, 1993, MOL CELL BIOL, V13, P2929, DOI 10.1128/MCB.13.5.2929; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; Harigae H, 1998, GENES CELLS, V3, P39, DOI 10.1046/j.1365-2443.1998.00166.x; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; Jippo T, 1996, BLOOD, V87, P993, DOI 10.1182/blood.V87.3.993.bloodjournal873993; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kitajima K, 2002, EMBO J, V21, P3060, DOI 10.1093/emboj/cdf301; KITAMURA Y, 1979, DEV BIOL, V70, P510, DOI 10.1016/0012-1606(79)90042-3; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; LANTZ CS, 1995, J IMMUNOL, V155, P4024; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; McNagny KM, 1998, EMBO J, V17, P3669, DOI 10.1093/emboj/17.13.3669; MCNEIL HP, 1992, J IMMUNOL, V149, P2466; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; PEVNY L, 1995, DEVELOPMENT, V121, P163; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; REYNOLDS DS, 1989, J BIOL CHEM, V264, P20094; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Singh H, 1999, COLD SPRING HARB SYM, V64, P13, DOI 10.1101/sqb.1999.64.13; Spain LM, 1999, J IMMUNOL, V163, P2681; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; ZON LI, 1991, J BIOL CHEM, V266, P22948	40	201	204	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2002	17	5					665	676		10.1016/S1074-7613(02)00452-1	http://dx.doi.org/10.1016/S1074-7613(02)00452-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433372	Bronze			2022-12-18	WOS:000179335100012
J	Anguita, J; Ramamoorthi, N; Hovius, JWR; Das, S; Thomas, V; Persinski, R; Conze, D; Askenase, PW; Rincon, M; Kantor, FS; Fikrig, E				Anguita, J; Ramamoorthi, N; Hovius, JWR; Das, S; Thomas, V; Persinski, R; Conze, D; Askenase, PW; Rincon, M; Kantor, FS; Fikrig, E			Salp15, an Ixodes scapularis salivary protein, inhibits CD4(+) T cell activation	IMMUNITY			English	Article							LYME-DISEASE VECTOR; GROWTH-FACTOR-BETA; INTERFERON-GAMMA; RICINUS TICKS; CYTOKINE PRODUCTION; BINDING-PROTEINS; GLAND EXTRACT; HOST IMMUNITY; IL-2 GENE; IN-VITRO	Tick saliva has pleiotropic properties that facilitate persistence of the arthropod upon the host. We now describe a feeding-inducible protein in Ixodes scapularis saliva, Salp15, that inhibits CD4(+) T cell activation. The mechanism involves the repression of calcium fluxes triggered by TCR ligation and results in lower production of interleukin-2. Salp15 also inhibits the development of CD4+ T cell-mediated immune responses in vivo, demonstrating the functional importance of this protein. Salp15 provides a molecular basis for understanding the immunosuppressive activity of L scapularis saliva and vector-host interactions.	Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, Allergy & Clin Immunol Sect, New Haven, CT 06520 USA; Univ Vermont, Dept Med, Burlington, VT 05405 USA; Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA	Yale University; Yale University; University of Vermont; University of North Carolina; University of North Carolina Charlotte	Fikrig, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, 333 Cedar St, New Haven, CT 06520 USA.		Anguita, Juan/D-5432-2011; Hovius, Joppe/GZL-6894-2022	Anguita, Juan/0000-0003-2061-7182; Hovius, Joppe/0000-0003-0066-2437				ALLEN JR, 1989, EXP APPL ACAROL, V7, P5, DOI 10.1007/BF01200448; Anguita J, 1996, J CLIN INVEST, V97, P1028, DOI 10.1172/JCI118494; Anguita J, 2001, J IMMUNOL, V167, P3383, DOI 10.4049/jimmunol.167.6.3383; ASKENASE PW, 1982, IMMUNOLOGY, V45, P501; Bajenoff M, 2002, J IMMUNOL, V168, P1723, DOI 10.4049/jimmunol.168.4.1723; BINNINGTON KC, 1980, ADV PARASIT, V18, P315; BROWN SJ, 1985, EXP PARASITOL, V59, P248, DOI 10.1016/0014-4894(85)90079-7; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; CHEN SM, 1994, J CLIN MICROBIOL, V32, P589, DOI 10.1128/JCM.32.3.589-595.1994; Christe M, 1998, PARASITOL RES, V84, P388, DOI 10.1007/s004360050415; Das S, 2000, AM J TROP MED HYG, V62, P99, DOI 10.4269/ajtmh.2000.62.99; Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; Ferreira BR, 1999, IMMUNOLOGY, V96, P434, DOI 10.1046/j.1365-2567.1999.00683.x; Ferreira BR, 1998, VET IMMUNOL IMMUNOP, V64, P279, DOI 10.1016/S0165-2427(98)00135-4; Ganapamo F, 1996, IMMUNOLOGY, V87, P259, DOI 10.1046/j.1365-2567.1996.450512.x; Gillespie RD, 2001, J IMMUNOL, V166, P4319, DOI 10.4049/jimmunol.166.7.4319; GIRARDIN P, 1989, PARASITOL RES, V75, P657, DOI 10.1007/BF00930966; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Kopecky J, 1999, PARASITE IMMUNOL, V21, P351, DOI 10.1046/j.1365-3024.1999.00233.x; Kopecky J, 1998, PARASITE IMMUNOL, V20, P169; Leboulle G, 2002, J BIOL CHEM, V277, P10083, DOI 10.1074/jbc.M111391200; Mannie MD, 1996, CELL IMMUNOL, V172, P108, DOI 10.1006/cimm.1996.0221; MASON AJ, 1985, NATURE, V318, P659, DOI 10.1038/318659a0; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; Millet I, 2000, J BIOL CHEM, V275, P15114, DOI 10.1074/jbc.275.20.15114; RAMACHANDRA RN, 1992, J MED ENTOMOL, V29, P818, DOI 10.1093/jmedent/29.5.818; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335; RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243; RIBEIRO JMC, 1985, J EXP MED, V161, P332, DOI 10.1084/jem.161.2.332; Rincon M, 1997, MOL CELL BIOL, V17, P1522, DOI 10.1128/MCB.17.3.1522; Schoeler GB, 1999, EXP PARASITOL, V92, P239, DOI 10.1006/expr.1999.4426; SCHORDERET S, 1994, VET PARASITOL, V54, P375, DOI 10.1016/0304-4017(94)90004-3; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Theze J, 1996, IMMUNOL TODAY, V17, P481, DOI 10.1016/0167-5699(96)10057-C; TRAGER WILLIAM, 1939, JOUR PARASITOL, V25, P57, DOI 10.2307/3272160; URIOSTE S, 1994, J EXP MED, V180, P1077, DOI 10.1084/jem.180.3.1077; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Wang H, 1999, CELL MOL LIFE SCI, V56, P286, DOI 10.1007/s000180050430; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Wikel SK, 1997, PARASITOL TODAY, V13, P383, DOI 10.1016/S0169-4758(97)01126-5; Wikel SK, 1996, ANNU REV ENTOMOL, V41, P1, DOI 10.1146/annurev.en.41.010196.000245; WORMS MJ, 1988, VET PARASITOL, V28, P153, DOI 10.1016/0304-4017(88)90027-1; Yasui DH, 1998, J IMMUNOL, V160, P4433; Zeidner N, 1996, J INFECT DIS, V173, P187, DOI 10.1093/infdis/173.1.187	46	201	214	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2002	16	6					849	859		10.1016/S1074-7613(02)00325-4	http://dx.doi.org/10.1016/S1074-7613(02)00325-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121666	Bronze			2022-12-18	WOS:000176534000010
J	Kuhn, JR; Poenie, M				Kuhn, JR; Poenie, M			Dynamic polarization of the microtubule cytoskeleton during CTL-Mediated killing	IMMUNITY			English	Article							T-CELL ACTIVATION; TOXIC LYMPHOCYTE-T; SURFACE MOLECULES; ORGANIZING CENTER; ANTIGEN RECEPTOR; GOLGI-APPARATUS; TARGET-CELLS; REORIENTATION; BINDING; RAFTS	Efficient unidirectional killing by cytotoxic T lymphocytes (CTL) requires translocation of the microtubule organizing center (MTOC) to the target cell contact site. Here we utilize modulated polarization microscopy and computerized 3D reconstruction of tubulin and LFA-1 immunofluoresence images to investigate how this is accomplished. The results show that the MTOC is drawn vectorially to the contact site by a microtubule sliding mechanism. Once the MTOC arrives at the contact site, it oscillates laterally. Microtubules loop through and anchor to a ring-shaped zone (pSMAC) defined by the dense clustering of LFA-1 at the target contact site. Microtubules that run straight between the MTOC and pSMAC and then turn sharply may indicate the action of a microtubule motor such as dynein.	Univ Texas, Div Mol Cell & Dev Biol, Patterson Labs 141, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Poenie, M (corresponding author), Univ Texas, Div Mol Cell & Dev Biol, Patterson Labs 141, Austin, TX 78712 USA.	poenie@mail.utexas.edu		Poenie, Martin/0000-0003-2524-4039	NIGMS NIH HHS [T32 GM 08368] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008368] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Conchello JA, 1996, P SOC PHOTO-OPT INS, V2655, P199, DOI 10.1117/12.237477; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; FARRAR JJ, 1980, J IMMUNOL, V125, P2555; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Griffiths G M, 1997, Semin Immunol, V9, P109, DOI 10.1006/smim.1997.0059; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jin TQ, 2001, J BIOL CHEM, V276, P12879, DOI 10.1074/jbc.M010513200; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Krauss K, 1999, J BIOL CHEM, V274, P36921, DOI 10.1074/jbc.274.52.36921; Kuhn JR, 2001, BIOPHYS J, V80, P972, DOI 10.1016/S0006-3495(01)76076-6; KUPFER A, 1984, J IMMUNOL, V133, P2762; KUPFER A, 1985, J MOL CELL IMMUNOL, V2, P37; Lowin B, 1995, Curr Top Microbiol Immunol, V198, P1; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Millan J, 2001, EUR J IMMUNOL, V31, P467, DOI 10.1002/1521-4141(200102)31:2<467::AID-IMMU467>3.0.CO;2-1; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mullbacher A, 1999, P NATL ACAD SCI USA, V96, P13950, DOI 10.1073/pnas.96.24.13950; PERELSON AS, 1982, J IMMUNOL, V129, P2796; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Rubbi CP, 1996, J IMMUNOL METHODS, V192, P157, DOI 10.1016/0022-1759(96)00046-4; Salojin KV, 2000, J BIOL CHEM, V275, P5966, DOI 10.1074/jbc.275.8.5966; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Sato Y, 2000, IEEE T VIS COMPUT GR, V6, P160, DOI 10.1109/2945.856997; Sedwick CE, 1999, J IMMUNOL, V162, P1367; SMITH R, 1985, J IMMUNOL, V134, P2191; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Woods A, 2000, J BIOL CHEM, V275, P24233, DOI 10.1074/jbc.R000001200; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yue LL, 1999, J CELL PHYSIOL, V181, P355, DOI 10.1002/(SICI)1097-4652(199911)181:2<355::AID-JCP17>3.0.CO;2-B	35	201	208	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2002	16	1					111	121		10.1016/S1074-7613(02)00262-5	http://dx.doi.org/10.1016/S1074-7613(02)00262-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825570	Bronze			2022-12-18	WOS:000173575700011
J	Sutkowski, N; Conrad, B; Thorley-Lawson, DA; Huber, BT				Sutkowski, N; Conrad, B; Thorley-Lawson, DA; Huber, BT			Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen	IMMUNITY			English	Article							MAMMARY-TUMOR VIRUS; RECEPTOR BETA-CHAIN; INJECTED SCID MICE; MEMORY B-CELLS; CD8(+) T-CELLS; PERIPHERAL-BLOOD; IN-VIVO; LYMPHOPROLIFERATIVE DISEASE; VIRAL SUPERANTIGEN; IMMUNE-RESPONSE	Superantigens (SAgs) are proteins produced by pathogenic microbes to elicit potent, antigen-independent T cell responses that are believed to enhance the microbes' pathogenicity. Here we show that the human lymphotropic herpesvirus Epstein-Barr virus (EBV) transcriptionally activates the env gene of an endogenous retrovirus, HERV-K18, that possesses SAg activity. SAg activity was demonstrated by MHC class II dependent preferential activation of TCRVB13 T cells in response to murine B cells transfected with the HERV-K18 env gene. This is a unique demonstration of a pathogen inducing a host-encoded Sag and accounts for the previously described EBV associated Sag activity. The T cell activation elicited by the Sag could play a central role in EBV infection and associated diseases.	Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Univ Geneva, Sch Med, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland	Tufts University; University of Geneva	Huber, BT (corresponding author), Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014910, R37AI014910] Funding Source: NIH RePORTER; NIAID NIH HHS [AI14910] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acha-Orbea H, 1999, IMMUNOL REV, V168, P287, DOI 10.1111/j.1600-065X.1999.tb01299.x; ALFIERI C, 1991, VIROLOGY, V181, P595, DOI 10.1016/0042-6822(91)90893-G; Anderson HA, 1999, J IMMUNOL, V163, P5435; Babcock GJ, 1999, J EXP MED, V190, P567, DOI 10.1084/jem.190.4.567; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; Barois N, 1997, J BIOL CHEM, V272, P3641, DOI 10.1074/jbc.272.6.3641; BEUTNER U, 1994, J EXP MED, V179, P1457, DOI 10.1084/jem.179.5.1457; Beutner U, 1992, Int Rev Immunol, V8, P279, DOI 10.3109/08830189209053513; BEUTNER U, 1992, P NATL ACAD SCI USA, V89, P5432, DOI 10.1073/pnas.89.12.5432; Blake N, 2000, J IMMUNOL, V165, P7078, DOI 10.4049/jimmunol.165.12.7078; BLANK U, 1993, EUR J IMMUNOL, V23, P3057, DOI 10.1002/eji.1830231203; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; CHOI YW, 1991, P NATL ACAD SCI USA, V88, P8357, DOI 10.1073/pnas.88.19.8357; CHOI YW, 1990, NATURE, V346, P471, DOI 10.1038/346471a0; Conrad B, 1997, CELL, V90, P303, DOI 10.1016/S0092-8674(00)80338-4; Coppola MA, 1999, J IMMUNOL, V163, P1481; Denis F, 2000, J VIROL, V74, P3067, DOI 10.1128/JVI.74.7.3067-3073.2000; DOBRESCU D, 1995, CELL, V82, P753, DOI 10.1016/0092-8674(95)90472-7; Duboise M, 1998, J VIROL, V72, P6770, DOI 10.1128/JVI.72.8.6770-6776.1998; FINN PW, 1991, J IMMUNOL, V146, P4011; Fleischer B, 1996, INFECT IMMUN, V64, P987, DOI 10.1128/IAI.64.3.987-994.1996; Gray D, 1997, Semin Immunol, V9, P249, DOI 10.1006/smim.1997.0077; Hasuike S, 1999, J HUM GENET, V44, P343, DOI 10.1007/s100380050173; HERMAN SA, 1986, J VIROL, V60, P497, DOI 10.1128/JVI.60.2.497-505.1986; Hsu PN, 2001, J IMMUNOL, V166, P3309, DOI 10.4049/jimmunol.166.5.3309; Huber BT, 1996, MICROBIOL REV, V60, P473, DOI 10.1128/MMBR.60.3.473-482.1996; KLAMAN LD, 1995, J VIROL, V69, P871, DOI 10.1128/JVI.69.2.871-881.1995; KYLE J, 1982, J MOL BIOL, V157, P105; Liu Y J, 1997, Semin Immunol, V9, P235, DOI 10.1006/smim.1997.0080; Liu YJ, 1997, IMMUNOL REV, V156, P111, DOI 10.1111/j.1600-065X.1997.tb00963.x; MARRACK P, 1990, SCIENCE, V248, P1066; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Mix D, 1996, J EXP MED, V184, P1549, DOI 10.1084/jem.184.4.1549; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; ONO M, 1986, J VIROL, V60, P589, DOI 10.1128/JVI.60.2.589-598.1986; PESANDO JM, 1986, J IMMUNOL, V137, P1932; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; ROEHM NW, 1984, J EXP MED, V160, P679, DOI 10.1084/jem.160.3.679; Stauffer Y, 2001, IMMUNITY, V15, P591, DOI 10.1016/S1074-7613(01)00212-6; Sutkowski N, 1996, J EXP MED, V184, P971, DOI 10.1084/jem.184.3.971; THORLEYLAWSON DA, 1982, CELL, V30, P415, DOI 10.1016/0092-8674(82)90239-2; Tonjes RR, 1999, J VIROL, V73, P9187; Tripp RA, 1997, J EXP MED, V185, P1641, DOI 10.1084/jem.185.9.1641; VERONESE ML, 1992, J EXP MED, V176, P1763, DOI 10.1084/jem.176.6.1763; VERONESI A, 1994, INT J CANCER, V59, P676, DOI 10.1002/ijc.2910590516; Yao ZB, 1996, J IMMUNOL, V156, P3260; YASUKAWA M, 1988, BLOOD, V72, P102	49	201	212	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2001	15	4					579	589		10.1016/S1074-7613(01)00210-2	http://dx.doi.org/10.1016/S1074-7613(01)00210-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672540	Bronze			2022-12-18	WOS:000171757800009
J	Hida, S; Ogasawara, K; Sato, K; Abe, M; Takayanagi, H; Yokochi, T; Sato, T; Hirose, S; Shirai, T; Taki, S; Taniguchi, T				Hida, S; Ogasawara, K; Sato, K; Abe, M; Takayanagi, H; Yokochi, T; Sato, T; Hirose, S; Shirai, T; Taki, S; Taniguchi, T			CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling	IMMUNITY			English	Article							TARGETED DISRUPTION; I INTERFERON; FAMILY; INDUCTION; PSORIASIS; VIRUS; GAMMA; IFN; ACTIVATION; CHEMOKINES	The balanced action of cytokines is known to be critical for the maintenance of homeostatic immune responses. Here, we report the development of an inflammatory skin disease involving CD8(+) T cells, in mice lacking the transcription factor, interferon regulatory factor-2 (IRF-2). CD8(+) T cells exhibit in vitro hyperresponsiveness to antigen stimulation, accompanied with a notable upregulation of the expression of genes induced by interferon-alpha/beta (IFN-alpha/beta). Furthermore, both disease development and CD8(+) T cell abnormality are suppressed by the introduction of nullizygosity to the genes that positively regulate the IFN-alpha/beta signaling pathway. IRF-2 may represent a unique negative regulator, attenuating IFN-alpha/beta -induced gene transcription, which is necessary for balancing the beneficial and harmful effects of IFN-alpha/beta signaling in the immune system.	Univ Tokyo, Fac Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Juntendo Univ, Sch Med, Dept Pathol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; Juntendo University	Taniguchi, T (corresponding author), Univ Tokyo, Fac Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp	Ogasawara, Kouetsu/G-9892-2011	Taki, Shinsuke/0000-0001-5143-3496				ASANO Y, 1990, INT IMMUNOL, V2, P1203, DOI 10.1093/intimm/2.12.1203; Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; BAKER BS, 1987, BRIT J DERMATOL, V116, P503, DOI 10.1111/j.1365-2133.1987.tb05869.x; Belardelli F, 1996, IMMUNOL TODAY, V17, P369, DOI 10.1016/0167-5699(96)10027-X; Binder D, 1997, J EXP MED, V185, P517, DOI 10.1084/jem.185.3.517; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bluyssen Hans A. R., 1996, Cytokine and Growth Factor Reviews, V7, P11, DOI 10.1016/1359-6101(96)00005-6; BOCCI V, 1985, IMMUNOL TODAY, V6, P7, DOI 10.1016/0167-5699(85)90159-8; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DEMAEYER E, 1988, INTERFERONS OTHER CY; Dusheiko G, 1997, HEPATOLOGY, V26, pS112, DOI 10.1002/hep.510260720; Ehl S, 1998, J EXP MED, V187, P763, DOI 10.1084/jem.187.5.763; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; FUNK J, 1991, BRIT J DERMATOL, V125, P463, DOI 10.1111/j.1365-2133.1991.tb14774.x; GOTTLIEB AB, 1990, J INVEST DERMATOL, V95, pS18, DOI 10.1111/1523-1747.ep12505675; GOTTLIEB SL, 1995, NAT MED, V1, P442, DOI 10.1038/nm0595-442; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; GRESSER I, 1990, J INVEST DERMATOL, V95, pS66, DOI 10.1111/1523-1747.ep12874776; GUILLE MJ, 1994, EUR J BIOCHEM, V219, P547, DOI 10.1111/j.1432-1033.1994.tb19970.x; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kovanen PE, 1999, CURR BIOL, V9, pR899, DOI 10.1016/S0960-9822(00)80079-2; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Leonard W.J., 1999, FUNDAMENTAL IMMUNOLO, Vfourth, P741; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Losman JA, 1999, J IMMUNOL, V162, P3770; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; MCKENZIE IFC, 1979, J EXP MED, V150, P1323, DOI 10.1084/jem.150.6.1323; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; Naka T, 1999, TRENDS BIOCHEM SCI, V24, P394, DOI 10.1016/S0968-0004(99)01454-1; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Nonkwelo C, 1997, J VIROL, V71, P6887, DOI 10.1128/JVI.71.9.6887-6897.1997; PAUKKONEN K, 1995, ARCH DERMATOL RES, V287, P165, DOI 10.1007/BF01262326; QUESADA JR, 1986, LANCET, V1, P1466; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; REIMANN J, 1985, J EXP MED, V162, P592, DOI 10.1084/jem.162.2.592; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; SCHLAAK JF, 1994, J INVEST DERMATOL, V102, P145, DOI 10.1111/1523-1747.ep12371752; Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SMOLLER BR, 1990, ARCH DERMATOL, V126, P1457, DOI 10.1001/archderm.126.11.1457; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stern RS, 1997, LANCET, V350, P349, DOI 10.1016/S0140-6736(97)05257-4; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Taniguchi T, 1999, COLD SPRING HARB SYM, V64, P465, DOI 10.1101/sqb.1999.64.465; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; VANGURI P, 1990, J BIOL CHEM, V265, P15049; VILCEK J, 1990, PEPTIDE GROWTH FACTO, V2, P3; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Yoshimura A, 1998, CYTOKINE GROWTH F R, V9, P197, DOI 10.1016/S1359-6101(98)00019-7; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	65	201	205	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2000	13	5					643	655		10.1016/S1074-7613(00)00064-9	http://dx.doi.org/10.1016/S1074-7613(00)00064-9			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114377	Bronze			2022-12-18	WOS:000165598500007
J	Al Nabhani, Z; Dulauroy, S; Marques, R; Cousu, C; Al Bounny, S; Dejardin, F; Sparwasser, T; Berard, M; Cerf-Bensussan, N; Eberl, G				Al Nabhani, Ziad; Dulauroy, Sophie; Marques, Rute; Cousu, Clara; Al Bounny, Shahed; Dejardin, Francois; Sparwasser, Tim; Berard, Marion; Cerf-Bensussan, Nadine; Eberl, Gerard			A Weaning Reaction to Microbiota Is Required for Resistance to Immunopathologies in the Adult	IMMUNITY			English	Article							REGULATORY T-CELLS; SEGMENTED FILAMENTOUS BACTERIA; EARLY-LIFE; GUT MICROBIOTA; INNATE; SHAPES; SUSCEPTIBILITY; MECHANISMS; IMMUNITY; EXPOSURE	Microbes colonize all body surfaces at birth and participate in the development of the immune system. In newborn mammals, the intestinal microbiota is first shaped by the dietary and immunological components of milk and then changes upon the introduction of solid food during weaning. Here, we explored the reactivity of the mouse intestinal immune system during the first weeks after birth and into adulthood. At weaning, the intestinal microbiota induced a vigorous immune response-a "weaning reaction"-that was programmed in time. Inhibition of the weaning reaction led to pathological imprinting and increased susceptibility to colitis, allergic inflammation, and cancer later in life. Prevention of this pathological imprinting was associated with the generation of ROR gamma t(+) regulatory T cells, which required bacterial and dietary metabolites-short-chain fatty acids and retinoic acid. Thus, the weaning reaction to microbiota is required for immune ontogeny, the perturbation of which leads to increased susceptibility to immunopathologies later in life.	[Al Nabhani, Ziad; Dulauroy, Sophie; Marques, Rute; Cousu, Clara; Al Bounny, Shahed; Dejardin, Francois; Eberl, Gerard] Inst Pasteur, Microenvironm & Immun Unit, F-75724 Paris, France; [Al Nabhani, Ziad; Dulauroy, Sophie; Marques, Rute; Cousu, Clara; Al Bounny, Shahed; Dejardin, Francois; Eberl, Gerard] INSERM, U1224, F-75724 Paris, France; [Sparwasser, Tim] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Microbiol & Hyg, D-55131 Mainz, Germany; [Berard, Marion] Inst Pasteur, Animalerie Cent, Ctr Gnotobiol, DTPS, F-75724 Paris, France; [Cerf-Bensussan, Nadine] INSERM, U1163, Inst Imagine, F-75015 Paris, France; [Cerf-Bensussan, Nadine] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Johannes Gutenberg University of Mainz; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Eberl, G (corresponding author), Inst Pasteur, Microenvironm & Immun Unit, F-75724 Paris, France.; Eberl, G (corresponding author), INSERM, U1224, F-75724 Paris, France.	gerard.eberl@pasteur.fr	Eberl, Gerard/A-1160-2013; Sparwasser, Tim/AAF-7085-2019; Sparwasser, Tim D/AAA-4306-2022; Nabhani, Ziad Al/X-8983-2019	Sparwasser, Tim/0000-0001-5645-902X; Dejardin, Francois/0000-0001-7523-8679; AL NABHANI, Ziad/0000-0002-4179-9555; Eberl, Gerard/0000-0002-1119-5638	Pasteur-Roux Postdoctoral Fellowships from the Institut Pasteur; Institut Pasteur; INSERM; Association Francois Aupetit; Crohn's and Colitis Foundation of America; European Crohn's and Colitis Organisation; Fondation pour la Recherche Medicale; Janssen; Innovator and Breakthrough awards from the Kenneth Rainin Foundation	Pasteur-Roux Postdoctoral Fellowships from the Institut Pasteur; Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francois Aupetit; Crohn's and Colitis Foundation of America; European Crohn's and Colitis Organisation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Innovator and Breakthrough awards from the Kenneth Rainin Foundation	We thank all the members of the Microenvironment & Immunity Unit, as well as those from the Stroma, Inflammation & Tissue Repair Unit, for support and discussion; the members of the Gnotobiology Platform of the Institut Pasteur for technical support with GF mice; the members of Biomics of the Institut Pasteur for microbial sequencing and analysis; and Ivo Gomperts Boneca (Institut Pasteur) for providing Myd88/Trif-double-deficient mice. Z.A.N. was supported by Pasteur-Roux Postdoctoral Fellowships from the Institut Pasteur. This work was supported by Institut Pasteur and INSERM, the Association Francois Aupetit, a Senior Research Award from the Crohn's and Colitis Foundation of America, the European Crohn's and Colitis Organisation, the Fondation pour la Recherche Medicale, Janssen, and Innovator and Breakthrough awards from the Kenneth Rainin Foundation.	Al Nabhani Z, 2016, J CROHNS COLITIS, V10, P1428, DOI 10.1093/ecco-jcc/jjw095; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Chatterton DEW, 2013, INT J BIOCHEM CELL B, V45, P1730, DOI 10.1016/j.biocel.2013.04.028; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gollwitzer ES, 2015, TRENDS IMMUNOL, V36, P684, DOI 10.1016/j.it.2015.09.009; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Hesselmar B, 2013, PEDIATRICS, V131, pE1829, DOI 10.1542/peds.2012-3345; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Knoop KA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aao1314; Kronman MP, 2012, PEDIATRICS, V130, pE794, DOI 10.1542/peds.2011-3886; Le Doare K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00361; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; MORAN JR, 1983, J PEDIATR-US, V103, P402, DOI 10.1016/S0022-3476(83)80412-0; Narushima S, 2014, GUT MICROBES, V5, P333, DOI 10.4161/gmic.28572; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Prioult G, 2005, IMMUNOL REV, V206, P204, DOI 10.1111/j.0105-2896.2005.00277.x; Rakoff-Nahoum S, 2015, P NATL ACAD SCI USA, V112, P1929, DOI 10.1073/pnas.1424886112; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Snel J, 1997, IMMUNOL LETT, V58, P25, DOI 10.1016/S0165-2478(97)02715-6; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; 2010, NAT METHODS, V7, P335, DOI DOI 10.1038/NMETH.F.303	48	200	202	8	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1276	+		10.1016/j.immuni.2019.02.014	http://dx.doi.org/10.1016/j.immuni.2019.02.014			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	30902637	Green Published, Bronze			2022-12-18	WOS:000468429500017
J	Wei, QZ; Frenette, PS				Wei, Qiaozhi; Frenette, Paul S.			Niches for Hematopoietic Stem Cells and Their Progeny	IMMUNITY			English	Review							COLONY-STIMULATING FACTOR; BONE-MARROW ADIPOCYTES; MESENCHYMAL STROMAL CELLS; CHEMOKINE RECEPTOR CXCR4; REGULATORY T-CELLS; NF-KAPPA-B; SELF-RENEWAL; ENDOTHELIAL-CELLS; EXTRAMEDULLARY HEMATOPOIESIS; LYMPHOID PROGENITORS	Steady-state hematopoietic stem cells' (HSCs) self-renewal and differentiation toward their mature progeny in the adult bone marrow is tightly regulated by cues from the microenvironment. Recent insights into the cellular and molecular constituents have uncovered a high level of complexity. Here, we review emerging evidence showing how HSCs and their progeny are regulated by an interdependent network of mesenchymal stromal cells, nerve fibers, the vasculature, and also other hematopoietic cells. Understanding the interaction mechanisms in these intricate niches will provide great opportunities for HSC-related therapies and immune modulation.	[Wei, Qiaozhi; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Wei, Qiaozhi; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.	paul.frenette@einstein.yu.edu	Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922; Wei, Qiaozhi/0000-0003-3062-5071	National Institutes of Health [DK056638, HL069438, DK116312, DK112976]; Leukemia and Lymphoma Society [LLS-TRP 6475-15]; New York State Department of Health [NYSTEM IIRP C029570, C029154]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112976, R01DK056638, U01DK116312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); New York State Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We give our appreciation to the published work that could not be cited in this review owing to the space limitation. We thank the National Institutes of Health (DK056638, HL069438, DK116312, DK112976), the Leukemia and Lymphoma Society (LLS-TRP 6475-15), and the New York State Department of Health (NYSTEM IIRP C029570 and C029154) for their support of our laboratory.	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Albiero M, 2015, DIABETES, V64, P2957, DOI 10.2337/db14-1473; Alp OS, 2015, EUR J IMMUNOL, V45, P975, DOI 10.1002/eji.201445295; Ambrosi TH, 2017, CELL STEM CELL, V20, P771, DOI 10.1016/j.stem.2017.02.009; Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012; Asada N, 2017, NAT CELL BIOL, V19, P214, DOI 10.1038/ncb3475; Asada N, 2013, CELL STEM CELL, V12, P737, DOI 10.1016/j.stem.2013.05.001; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Bajayo A, 2012, P NATL ACAD SCI USA, V109, P15455, DOI 10.1073/pnas.1206061109; Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Belnoue E, 2012, J IMMUNOL, V188, P1283, DOI 10.4049/jimmunol.1103169; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Bilwani FA, 2012, J IMMUNOL, V189, P4379, DOI 10.4049/jimmunol.1201176; Bonomo A, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00184; Boulais PE, 2015, BLOOD, V125, P2621, DOI 10.1182/blood-2014-09-570192; Bowers E, 2018, NAT MED, V24, P95, DOI 10.1038/nm.4448; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Broome CS, 2000, ANN NY ACAD SCI, V917, P424; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calderon L, 2012, CELL, V149, P159, DOI 10.1016/j.cell.2012.01.049; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cao JJ, 2015, EUR J IMMUNOL, V45, P2650, DOI 10.1002/eji.201445405; Caraux A, 2011, IMMUNOLOGY, V132, P266, DOI 10.1111/j.1365-2567.2010.03361.x; Carrelha J, 2018, NATURE, V554, P106, DOI 10.1038/nature25455; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chaix J, 2014, J IMMUNOL, V193, P1013, DOI 10.4049/jimmunol.1400488; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Charbord P, 1996, BLOOD, V87, P4109, DOI 10.1182/blood.V87.10.4109.bloodjournal87104109; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Chen X., 2017, CELL STEM CELL, V21, P747; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; Churchman SM, 2012, ARTHRITIS RHEUM-US, V64, P2632, DOI 10.1002/art.34434; Coutu DL, 2017, NAT BIOTECHNOL, V35, P1202, DOI 10.1038/nbt.4006; Crane GM, 2017, NAT REV IMMUNOL, V17, P573, DOI 10.1038/nri.2017.53; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Day RB, 2015, BLOOD, V125, P3114, DOI 10.1182/blood-2015-02-629444; Di Rosa F, 2002, EUR J IMMUNOL, V32, P1873; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Dudakov JA, 2009, J IMMUNOL, V182, P6247, DOI 10.4049/jimmunol.0802446; Dutta P, 2015, J EXP MED, V212, P497, DOI 10.1084/jem.20141642; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; FRASSONI F, 1982, CELL TISSUE KINET, V15, P447, DOI 10.1111/j.1365-2184.1982.tb01062.x; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Gandy KL, 1999, IMMUNITY, V11, P579, DOI 10.1016/S1074-7613(00)80133-8; Gomes AC, 2016, IMMUNITY, V45, P1219, DOI 10.1016/j.immuni.2016.11.004; GONG JK, 1978, SCIENCE, V199, P1443, DOI 10.1126/science.75570; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hanoun M, 2015, NEURON, V86, P360, DOI 10.1016/j.neuron.2015.01.026; Haylock DN, 2007, STEM CELLS, V25, P1062, DOI 10.1634/stemcells.2006-0528; Heazlewood SY, 2013, STEM CELL RES, V11, P782, DOI 10.1016/j.scr.2013.05.007; Herault A, 2017, NATURE, V544, P53, DOI 10.1038/nature21693; Hidalgo A, 2017, BLOOD, V129, P540, DOI 10.1182/blood-2016-11-751867; Hirata Y, 2018, CELL STEM CELL, V22, P445, DOI 10.1016/j.stem.2018.01.017; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hu XB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13095; Hu ZC, 2015, J EXP MED, V212, P1947, DOI 10.1084/jem.20150178; Hur J, 2016, CELL STEM CELL, V18, P508, DOI 10.1016/j.stem.2016.01.013; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Inra CN, 2015, NATURE, V527, P466, DOI 10.1038/nature15530; Isern J, 2013, CELL REP, V3, P1714, DOI 10.1016/j.celrep.2013.03.041; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Joseph C, 2013, CELL STEM CELL, V13, P520, DOI 10.1016/j.stem.2013.10.010; Jung WC, 2017, SEMIN CELL DEV BIOL, V61, P60, DOI 10.1016/j.semcdb.2016.08.010; Katayama Y, 2003, IMMUNITY, V18, P789, DOI 10.1016/S1074-7613(03)00150-X; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; KAUFMAN CL, 1994, BLOOD, V84, P2436; Kawano Y, 2017, BLOOD, V129, P587, DOI 10.1182/blood-2016-07-725754; Kfoury Y, 2015, CELL STEM CELL, V16, P239, DOI 10.1016/j.stem.2015.02.019; Khan JA, 2016, SCIENCE, V351, P176, DOI 10.1126/science.aad0084; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kim S, 2015, EUR J IMMUNOL, V45, P167, DOI 10.1002/eji.201444532; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Kuksin CA, 2015, BLOOD, V125, P2087, DOI 10.1182/blood-2014-08-594796; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; LAMBERTSEN RH, 1984, BLOOD, V63, P287; Lander AD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-19; Langen UH, 2017, NAT CELL BIOL, V19, P189, DOI 10.1038/ncb3476; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; Lo Celso C, 2011, NAT PROTOC, V6, P1, DOI 10.1038/nprot.2010.168; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; LORD BI, 1975, BLOOD, V46, P65; Lucas D, 2008, CELL STEM CELL, V3, P364, DOI 10.1016/j.stem.2008.09.004; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Ludin A, 2012, NAT IMMUNOL, V13, P1072, DOI 10.1038/ni.2408; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; MALONEY MA, 1978, BLOOD, V51, P521; Manabe N, 2001, J IMMUNOL, V167, P2625, DOI 10.4049/jimmunol.167.5.2625; Mattiucci D, 2018, J CELL PHYSIOL, V233, P1500, DOI 10.1002/jcp.26037; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Monteiro JP, 2005, BLOOD, V105, P1484, DOI 10.1182/blood-2004-07-2856; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morita Y, 2011, EXP HEMATOL, V39, P351, DOI 10.1016/j.exphem.2010.12.008; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakai A, 2014, J EXP MED, V211, P2583, DOI 10.1084/jem.20141132; Nakamura-Ishizu A, 2015, J EXP MED, V212, P2133, DOI 10.1084/jem.20150057; Nakamura-Ishizu A, 2014, BIOCHEM BIOPH RES CO, V454, P353, DOI 10.1016/j.bbrc.2014.10.095; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nemoto Y, 2007, GASTROENTEROLOGY, V132, P176, DOI 10.1053/j.gastro.2006.10.035; Nemoto Y, 2013, GUT, V62, P1142, DOI 10.1136/gutjnl-2012-302029; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Olson TS, 2013, BLOOD, V121, P5238, DOI 10.1182/blood-2012-10-463414; Omatsu Y, 2014, NATURE, V508, P536, DOI 10.1038/nature13071; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Ono N, 2014, DEV CELL, V29, P330, DOI 10.1016/j.devcel.2014.03.014; Pangrazzi L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00715; Park MH, 2015, EMBO J, V34, P1648, DOI 10.15252/embj.201490174; Parretta E, 2005, J IMMUNOL, V174, P7654, DOI 10.4049/jimmunol.174.12.7654; Pereira MR, 2016, J CELL PHYSIOL, V231, P1862, DOI 10.1002/jcp.25307; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Pierce H, 2017, CELL STEM CELL, V20, P648, DOI 10.1016/j.stem.2017.01.002; Pinho S, 2018, DEV CELL, V44, P634, DOI 10.1016/j.devcel.2018.01.016; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Poulos MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13829; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; Price PW, 1999, EUR J IMMUNOL, V29, P1051, DOI 10.1002/(SICI)1521-4141(199903)29:03<1051::AID-IMMU1051>3.0.CO;2-Y; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Ramasamy SK, 2016, ANNU REV CELL DEV BI, V32, P649, DOI 10.1146/annurev-cellbio-111315-124936; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; RAMESHWAR P, 1995, BLOOD, V86, P482, DOI 10.1182/blood.V86.2.482.bloodjournal862482; Repass JF, 2009, GENESIS, V47, P281, DOI 10.1002/dvg.20497; Rodriguez-Fraticelli AE, 2018, NATURE, V553, P212, DOI 10.1038/nature25168; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Sato M, 2013, CELL METAB, V18, P749, DOI 10.1016/j.cmet.2013.09.014; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schurch CM, 2014, CELL STEM CELL, V14, P460, DOI 10.1016/j.stem.2014.01.002; Sharara LI, 1997, EUR J IMMUNOL, V27, P990, DOI 10.1002/eji.1830270428; Shimoto M, 2017, BLOOD, V129, P2124, DOI 10.1182/blood-2016-09-740563; Silberstein L, 2016, CELL STEM CELL, V19, P530, DOI 10.1016/j.stem.2016.07.004; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Smith-Berdan S, 2011, CELL STEM CELL, V8, P72, DOI 10.1016/j.stem.2010.11.030; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723; Tak T, 2013, J LEUKOCYTE BIOL, V94, P595, DOI 10.1189/jlb.1112571; Takaku T, 2010, BLOOD, V116, pE41, DOI 10.1182/blood-2010-02-268466; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Tsunokuma N, 2017, J IMMUNOL, V198, P156, DOI 10.4049/jimmunol.1502592; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Urbieta M, 2010, BLOOD, V115, P4934, DOI 10.1182/blood-2009-04-218826; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Watchman CJ, 2007, J NUCL MED, V48, P645, DOI 10.2967/jnumed.106.035337; WILKINS BS, 1992, J CLIN PATHOL, V45, P645, DOI 10.1136/jcp.45.8.645; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Winkler IG, 2010, BLOOD, V116, P375, DOI 10.1182/blood-2009-07-233437; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yokoyama T, 2003, J VET MED SCI, V65, P449, DOI 10.1292/jvms.65.449; Yu VWC, 2016, STEM CELL REP, V7, P220, DOI 10.1016/j.stemcr.2016.06.009; Yu VWC, 2016, CURR OPIN HEMATOL, V23, P331, DOI 10.1097/MOH.0000000000000265; Yu VWC, 2015, J EXP MED, V212, P759, DOI 10.1084/jem.20141843; Yue R, 2016, CELL STEM CELL, V18, P782, DOI 10.1016/j.stem.2016.02.015; Zehentmeier S, 2014, EUR J IMMUNOL, V44, P2306, DOI 10.1002/eji.201344313; Zeng DF, 2002, BLOOD, V99, P1449, DOI 10.1182/blood.V99.4.1449; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367; Zhang JZ, 2016, J BONE MINER RES, V31, P2001, DOI 10.1002/jbmr.2877; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706; Zhou BO, 2017, NAT CELL BIOL, V19, P891, DOI 10.1038/ncb3570; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; Zhu RJ, 2013, INT J HEMATOL, V97, P58, DOI 10.1007/s12185-012-1233-4; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	216	200	211	12	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					632	648		10.1016/j.immuni.2018.03.024	http://dx.doi.org/10.1016/j.immuni.2018.03.024			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669248	Bronze, Green Accepted			2022-12-18	WOS:000430198900012
J	Li, CF; Deng, YQ; Wang, S; Ma, F; Aliyari, R; Huang, XY; Zhang, NN; Watanabe, M; Dong, HL; Liu, P; Li, XF; Ye, Q; Tian, M; Hong, S; Fan, JW; Zhao, H; Li, LL; Vishlaghi, N; Buth, JE; Au, C; Liu, Y; Lu, N; Du, PS; Qin, FXF; Zhang, B; Gong, DY; Dai, XH; Sun, R; Novitch, BG; Xu, ZH; Qin, CF; Cheng, GH				Li, Chunfeng; Deng, Yong-Qiang; Wang, Shuo; Ma, Feng; Aliyari, Roghiyh; Huang, Xing-Yao; Zhang, Na-Na; Watanabe, Momoko; Dong, Hao-Long; Liu, Ping; Li, Xiao-Feng; Ye, Qing; Tian, Min; Hong, Shuai; Fan, Junwan; Zhao, Hui; Li, Lili; Vishlaghi, Neda; Buth, Jessie E.; Au, Connie; Liu, Ying; Lu, Ning; Du, Peishuang; Qin, F. Xiao-Feng; Zhang, Bo; Gong, Danyang; Dai, Xinghong; Sun, Ren; Novitch, Bennett G.; Xu, Zhiheng; Qin, Cheng-Feng; Cheng, Genhong			25-Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model	IMMUNITY			English	Article							PLACENTAL TROPHOBLASTS; CHOLESTEROL; OXYSTEROLS; IDENTIFICATION; TRANSCRIPTION; REPLICATION; MACROPHAGES; ACTIVATION; INHIBITORS; RHESUS	Zika virus (ZIKV) has become a public health threat due to its global transmission and link to severe congenital disorders. The host immune responses to ZIKV infection have not been fully elucidated, and effective therapeutics are not currently available. Herein, we demonstrated that cholesterol-25-hydroxylase (CH25H) was induced in response to ZIKV infection and that its enzymatic product, 25-hydroxycholesterol (25HC), was a critical mediator of host protection against ZIKV. Synthetic 25HC addition inhibited ZIKV infection in vitro by blocking viral entry, and treatment with 25HC reduced viremia and conferred protection against ZIKV in mice and rhesus macaques. 25HC suppressed ZIKV infection and reduced tissue damage in human cortical organoids and the embryonic brain of the ZIKV-induced mouse microcephaly model. Our findings highlight the protective role of CH25H during ZIKV infection and the potential use of 25HC as a natural antiviral agent to combat ZIKV infection and prevent ZIKV-associated outcomes, such as microcephaly.	[Li, Chunfeng; Ma, Feng; Qin, F. Xiao-Feng; Cheng, Genhong] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China; [Li, Chunfeng; Ma, Feng; Qin, F. Xiao-Feng; Cheng, Genhong] Peking Union Med Coll, Beijing 100005, Peoples R China; [Li, Chunfeng; Ma, Feng; Qin, F. Xiao-Feng; Cheng, Genhong] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China; [Li, Chunfeng; Deng, Yong-Qiang; Huang, Xing-Yao; Zhang, Na-Na; Dong, Hao-Long; Li, Xiao-Feng; Ye, Qing; Tian, Min; Zhao, Hui; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China; [Wang, Shuo; Hong, Shuai; Fan, Junwan; Xu, Zhiheng] Chinese Acad Sci, State Key Lab Mol Dev Biol, Ctr Excellence Brain Sci & Intelligence Technol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Wang, Shuo; Hong, Shuai; Fan, Junwan; Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China; [Ma, Feng; Aliyari, Roghiyh; Au, Connie; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Zhang, Na-Na; Qin, Cheng-Feng] Guangxi Med Univ, Nanning 530021, Peoples R China; [Watanabe, Momoko; Vishlaghi, Neda; Buth, Jessie E.; Novitch, Bennett G.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Watanabe, Momoko; Vishlaghi, Neda; Buth, Jessie E.; Novitch, Bennett G.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Liu, Ping; Li, Lili; Liu, Ying; Lu, Ning; Du, Peishuang] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100101, Peoples R China; [Tian, Min] Capital Med Univ, Beijing Tradit Med Chinese Hosp, Beijing 100069, Peoples R China; [Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China; [Gong, Danyang; Dai, Xinghong; Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Gong, Danyang; Dai, Xinghong; Sun, Ren] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Institute of Microbiology & Epidemiology; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of California System; University of California Los Angeles; Guangxi Medical University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Institute of Biophysics, CAS; Capital Medical University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cheng, GH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.; Cheng, GH (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Cheng, GH (corresponding author), Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.; Xu, ZH (corresponding author), Chinese Acad Sci, State Key Lab Mol Dev Biol, Ctr Excellence Brain Sci & Intelligence Technol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.; Xu, ZH (corresponding author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.; Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Qin, CF (corresponding author), Guangxi Med Univ, Nanning 530021, Peoples R China.; Novitch, BG (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.; Novitch, BG (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.	bnovitch@ucla.edu; zhxu@genetics.ac.cn; qincf@bmi.ac.cn; gcheng@mednet.ucla.edu	Li, Chunfeng/S-3185-2019; Fan, Junwan/HDO-1627-2022; li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022; Qin, Cheng-Feng/I-6839-2019	Li, Chunfeng/0000-0001-8883-9078; Qin, Cheng-Feng/0000-0002-0632-2807; Dai, Xinghong/0000-0002-4102-3175; Xu, Zhiheng/0000-0002-4809-2851; Buth, Jessie/0000-0001-9709-4274; huang, xingyao/0000-0002-3917-8100; QIN, FRANK XIAOFENG/0000-0002-5395-0304; Wang, Shuo/0000-0001-7462-6178; Novitch, Bennett/0000-0002-2696-3708	CAMS Initiative for Innovative Medicine [2016-I2M-1-005]; National Science and Technology Major Project for "Significant New Drugs Innovation and Development" [2015ZX09102023]; NSFC (China) [91542201, 81590765]; NIH [R01AI069120, AI056154, AI078389, R01 NS089817]; PUMC Youth Fund [3332016125]; NSFC [31500145, 31670883, 31430037]; MOST (China) [2016YFD0500304]; State Key Laboratory of Pathogen and Biosecurity [SKLPBS1601]; NSFC Excellent Young Scientist [81522025]; Innovative Research Group [81621005]; Newton Advanced Fellowship from the UK Academy of Medical Sciences [NAF003/1003]; NSFC of China [81661130162]; Shanghai brain-intelligence project from STCSM [16JC1420500]; Beijing brain project [Z161100002616004]; MOST [2014CB942801, 2012YQ03026006]; CIRM [DISC1-08819]; UCLA Broad Stem Cell Research Center (BSCRC); UCLA BSCRC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056154, R01AI078389, R01AI069120, R56AI078389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089817] Funding Source: NIH RePORTER	CAMS Initiative for Innovative Medicine; National Science and Technology Major Project for "Significant New Drugs Innovation and Development"; NSFC (China)(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PUMC Youth Fund; NSFC(National Natural Science Foundation of China (NSFC)); MOST (China)(Ministry of Science and Technology, China); State Key Laboratory of Pathogen and Biosecurity; NSFC Excellent Young Scientist; Innovative Research Group; Newton Advanced Fellowship from the UK Academy of Medical Sciences; NSFC of China(National Natural Science Foundation of China (NSFC)); Shanghai brain-intelligence project from STCSM; Beijing brain project; MOST; CIRM(California Institute for Regenerative Medicine); UCLA Broad Stem Cell Research Center (BSCRC); UCLA BSCRC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the CAMS Initiative for Innovative Medicine (No. 2016-I2M-1-005), National Science and Technology Major Project for "Significant New Drugs Innovation and Development" (2015ZX09102023), NSFC (China, 91542201, 81590765), NIH R01AI069120, AI056154, and AI078389 grants to G.C., PUMC Youth Fund (3332016125) and NSFC (31500145) to C.L., NSFC (31670883) to F.M., MOST (China, 2016YFD0500304) and the State Key Laboratory of Pathogen and Biosecurity (SKLPBS1601), the NSFC Excellent Young Scientist (81522025), the Innovative Research Group (81621005), and the Newton Advanced Fellowship from the UK Academy of Medical Sciences (NAF003/1003) and the NSFC of China (81661130162) to C.-F.Q., NSFC (31430037), Shanghai brain-intelligence project from STCSM (16JC1420500), Beijing brain project (Z161100002616004) and MOST (2014CB942801 and 2012YQ03026006) to Z.X., NIH R01 NS089817, CIRM DISC1-08819, and a research award from the UCLA Broad Stem Cell Research Center (BSCRC) to B.G.N. M.W. was supported by a training fellowship from the UCLA BSCRC. We thank Natalie Quanquin (UCLA) and Lina Yuan (Suzhou Institute of Systems Medicine) for their help in editing the manuscript and RNA sequencing, respectively. We wish to thank Pei-Gang Wang (Capital Medical University, Beijing), Qi-Bin Leng (Institute Pasteur of Shanghai, CAS), Pei-Yong Shi (Novartis Institute for Infectious Diseases), and Guanghou Shui (Institute of Genetics and Developmental Biology, CAS), for providing us with critical reagents and helpful discussions.	Aye ILMH, 2012, MOL HUM REPROD, V18, P341, DOI 10.1093/molehr/gas001; Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Chen YZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07242; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Holmes RS, 2011, 3 BIOTECH, V1, P99, DOI 10.1007/s13205-011-0013-9; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Larkin JC, 2014, PLACENTA, V35, P919, DOI 10.1016/j.placenta.2014.09.002; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Moog C, 1998, ANTIVIR CHEM CHEMOTH, V9, P491, DOI 10.1177/095632029800900605; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074; Shibata N, 2013, J BIOL CHEM, V288, P35812, DOI 10.1074/jbc.M113.519637; Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Wang F, 2012, CARDIOVASC RES, V93, P190, DOI 10.1093/cvr/cvr260; Woollett LA, 2001, FRONT BIOSCI-LANDMRK, V6, pD536, DOI 10.2741/Woollett; Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184; Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zhang NN, 2016, HUM VACC IMMUNOTHER, V12, P3107, DOI 10.1080/21645515.2016.1219004; Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695	48	200	209	4	96	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					446	456		10.1016/j.immuni.2017.02.012	http://dx.doi.org/10.1016/j.immuni.2017.02.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28314593	Green Accepted, Bronze			2022-12-18	WOS:000396818100016
J	Mandl, JN; Monteiro, JP; Vrisekoop, N; Germain, RN				Mandl, Judith N.; Monteiro, Joao P.; Vrisekoop, Nienke; Germain, Ronald N.			T Cell-Positive Selection Uses Self-Ligand Binding Strength to Optimize Repertoire Recognition of Foreign Antigens	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SENSORY ADAPTATION; NAIVE CD4(+); PEPTIDE; MHC; RECEPTOR; AFFINITY; SPECIFICITY; ACTIVATION; EXPRESSION	Developing T cells express diverse antigen receptors whose specificities are not prematched to the foreign antigens they eventually encounter. Past experiments have revealed that thymocytes must productively signal in response to self antigens to mature and enter the peripheral T cell pool (positive selection), but how this process enhances effective mature T cell responses to foreign antigen is not fully understood. Here we have documented an unsuspected connection between thymic recognition events and foreign antigen-driven T cell responses. We find that the strength of self-reactivity is a clone-specific property unexpectedly directly related to the strength of T cell receptor (TCR) binding to presented foreign antigen. T cells with receptors showing stronger interaction with self dominate in responses to infections and accumulate in aging individuals, revealing that positive selection contributes to effective immunity by skewing the mature TCR repertoire toward highly effective recognition of pathogens that pose a danger to the host.	[Mandl, Judith N.; Monteiro, Joao P.; Vrisekoop, Nienke; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020		NIAID, NIH, DHHS; Netherlands Organization for Scientific Research; NIH Office of AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000403] Funding Source: NIH RePORTER	NIAID, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIH Office of AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank J. Edwards for performing the CD5 sorts; N. Subramanian for assistance with immunoblots; M. Levy and A. Yates for statistical advice; Y. Belkaid for providing germ-free mice; P. Love for providing AND Cd5<SUP>-/-</SUP> mice; M. K. Jenkins and M. Pepper for providing L. monocytogenes Delta ActA, tetramer reagents, and assistance with the tetramer bead enrichment methodology; the NIH Tetramer Facility for providing pMHC tetramer reagents; G. Punkosdy and R. Ahmed for providing LCMV-Armstrong; P. Thomas and P. Doherty for providing the initial stock of influenza A virus; D. van Baarle for providing human blood samples and reagents; and N. Nanlohy for providing assistance with human experiments. We are grateful to I. Stefanova and M. Jenkins for discussion and technical advice, J.D. Ashwell, G. I. Germain, M.J. Lenardo, A. Poholek, and C. Reis e Sousa for their critical review of the manuscript, and members of the Lymphocyte Biology Section for intellectual support and critical discussions. This work was supported by the Intramural Research Program of NIAID, NIH, DHHS, and also by the Netherlands Organization for Scientific Research (N. V.) and by the NIH Office of AIDS Research (J.N.M.). J.P.M. is a Pew Latin American Fellow in the Biomedical Sciences. J.P.M., J.N.M., N. V., and R. N. G. designed the study. J.N.M., J.P.M., and N. V. conducted all experiments. All authors contributed to interpreting the data and writing the paper.	Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Barton GM, 1999, SCIENCE, V283, P67, DOI 10.1126/science.283.5398.67; Berg RE, 1999, IMMUNITY, V11, P33, DOI 10.1016/S1074-7613(00)80079-5; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; Bhandoola A, 2002, EUR J IMMUNOL, V32, P1811, DOI 10.1002/1521-4141(200206)32:6<1811::AID-IMMU1811>3.0.CO;2-G; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; Ihaka Ross., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.1080/10618600.1996.10474713, 10.2307/1390807]; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kruisbeek A M, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0314s24; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Mandl JN, 2012, P NATL ACAD SCI USA, V109, P18036, DOI 10.1073/pnas.1211717109; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; OKADA CY, 1989, J EXP MED, V169, P1703, DOI 10.1084/jem.169.5.1703; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Ryan KR, 2005, J LEUKOCYTE BIOL, V78, P43, DOI 10.1189/jlb.0205059; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Sasada T, 2001, J EXP MED, V194, P883, DOI 10.1084/jem.194.7.883; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Scott-Browne JP, 2011, IMMUNITY, V35, P526, DOI 10.1016/j.immuni.2011.09.005; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Sporri R, 2002, EUR J IMMUNOL, V32, P3161, DOI 10.1002/1521-4141(200211)32:11<3161::AID-IMMU3161>3.0.CO;2-6; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Yee C, 1999, J IMMUNOL, V162, P2227; ZINKERNAGEL RM, 1978, NATURE, V271, P251, DOI 10.1038/271251a0	51	200	204	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					263	274		10.1016/j.immuni.2012.09.011	http://dx.doi.org/10.1016/j.immuni.2012.09.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23290521	Green Accepted, Bronze			2022-12-18	WOS:000330940800009
J	Gatto, D; Paus, D; Basten, A; Mackay, CR; Brink, R				Gatto, Dominique; Paus, Didrik; Basten, Antony; Mackay, Charles R.; Brink, Robert			Guidance of B Cells by the Orphan G Protein-Coupled Receptor EBI2 Shapes Humoral Immune Responses	IMMUNITY			English	Article							PLASMA-CELL; SOMATIC HYPERMUTATION; DENDRITIC CELLS; ACTIVATION; MIGRATION; GENES; MICROENVIRONMENTS; DIFFERENTIATION; RESPONSIVENESS; ORGANIZATION	Humoral immunity depends on both rapid and long-term antibody production against invading pathogens. This is achieved by the generation of spatially distinct extrafollicular plasmablast and follicular germinal center (GC) B cell populations, but the signals that guide responding B cells to these alternative compartments have not been fully elucidated. Here, we show that expression of the orphan G protein-coupled receptor Epstein-Barr virus-induced gene 2 (EBI2, also known as GPR183) by activated B cells was essential for their movement to extrafollicular sites and induction of early plasmablast responses. Conversely, downregulation of EBI2 enabled B cells to access the center of follicles and promoted efficient GC formation. EBI2 therefore provides a previously uncharacterized dimension to B cell migration that is crucial for coordinating rapid versus long-term antibody responses.	[Gatto, Dominique; Basten, Antony; Mackay, Charles R.; Brink, Robert] Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Paus, Didrik] Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia; [Basten, Antony; Mackay, Charles R.; Brink, Robert] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research; University of Sydney; Centenary Institute; University of New South Wales Sydney	Gatto, D (corresponding author), Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	d.gatto@garvan.org.au; r.brink@garvan.org.au	Brink, Robert/B-7910-2010; Mackay, Charles R/A-9673-2008	Brink, Robert/0000-0002-9586-3655; Mackay, Charles R/0000-0002-6338-7340	NHMRC [427620]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank S. Tangye and A. Swarbrick for helpful discussions and critical reading of the manuscript; K. Wood, T. Camidge, and V. Turner for technical assistance; C. Brownlee for cell sorting; the staff of the Garvan Institute Biological Testing Facility for animal husbandry, and Ozgene for generation of Gpr183<SUP>-/-</SUP> mice. This work was funded by NHMRC Australia Program Grant 427620 to R.B, A.B., and C.R.M; D.G. and R.B. are supported by fellowships from the NHMRC Australia.	Aalto Y, 2001, LEUKEMIA, V15, P1721, DOI 10.1038/sj.leu.2402282; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Benned-Jensen T, 2008, MOL PHARMACOL, V74, P1008, DOI 10.1124/mol.108.049676; Benson MJ, 2007, CURR OPIN IMMUNOL, V19, P275, DOI 10.1016/j.coi.2007.04.009; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Brink R, 2008, IMMUNOL CELL BIOL, V86, P31, DOI 10.1038/sj.icb.7100143; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; CHAN TD, 2009, J IMMUNOL IN PRESS; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Glynne R, 2000, IMMUNOL REV, V176, P216; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; KELSOE G, 1993, CURR OPIN IMMUNOL, V5, P418, DOI 10.1016/0952-7915(93)90062-W; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Levoye A, 2006, EMBO REP, V7, P1094, DOI 10.1038/sj.embor.7400838; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; NIEDOBITEK G, 1992, BLOOD, V79, P2520; O'Connor BP, 2003, IMMUNOL REV, V194, P61, DOI 10.1034/j.1600-065X.2003.00055.x; Okada T, 2006, CURR OPIN IMMUNOL, V18, P278, DOI 10.1016/j.coi.2006.02.005; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2005, J IMMUNOL, V174, P4567, DOI 10.4049/jimmunol.174.8.4567; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Seo SJ, 2002, IMMUNITY, V16, P535, DOI 10.1016/S1074-7613(02)00298-4; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; SWIFT S, CURR PROTOC IMMUNOL, pCH10; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Ye S, 2003, RHEUMATOLOGY, V42, P1155, DOI 10.1093/rheumatology/keg315	40	200	204	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					259	269		10.1016/j.immuni.2009.06.016	http://dx.doi.org/10.1016/j.immuni.2009.06.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19615922	Bronze			2022-12-18	WOS:000269338600012
J	Soares, MP; Hamza, I				Soares, Miguel P.; Hamza, Iqbal			Macrophages and Iron Metabolism	IMMUNITY			English	Review							NF-KAPPA-B; INNATE IMMUNE-RESPONSE; NITRIC-OXIDE SYNTHASE; HEME OXYGENASE-1 EXPRESSION; REV-ERB-ALPHA; CARBON-MONOXIDE; TRANSCRIPTION FACTOR; REACTIVE OXYGEN; GENE-EXPRESSION; INFLAMMASOME ACTIVATION	Iron is a transition metal that due to its inherent ability to exchange electrons with a variety of molecules is essential to support life. In mammals, iron exists mostly in the form of heme, enclosed within an organic protoporphyrin ring and functioning primarily as a prosthetic group in proteins. Paradoxically, free iron also has the potential to become cytotoxic when electron exchange with oxygen is unrestricted and catalyzes the production of reactive oxygen species. These biological properties demand that iron metabolism is tightly regulated such that iron is available for core biological functions while preventing its cytotoxic effects. Macrophages play a central role in establishing this delicate balance. Here, we review the impact of macrophages on heme-iron metabolism and, reciprocally, how heme-iron modulates macrophage function.	[Soares, Miguel P.] Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal; [Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Hamza, Iqbal] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	Instituto Gulbenkian de Ciencia; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Soares, MP (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	mpsoares@igc.gulbenkian.pt		Soares, Miguel/0000-0002-9314-4833; Hamza, Iqbal/0000-0003-0045-0610	Fundacao Calouste Gulbenkian; Fundacao para a Ciencia e Tecnologia [PTDC/SAU TOX/116627/2010, HMSP-ICT/0022/2010]; European Community [ERC-2011-AdG 294709-DAMAGECONTROL]; US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI113998, R01AI067979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085035, R01DK074797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES025661] Funding Source: NIH RePORTER	Fundacao Calouste Gulbenkian(European Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Jessica Thompson and Faouzi Brazza for insightful comments incorporated into the final version of the manuscript and Ana Rita Carlos and Susana Ramos for careful review and editing of the manuscript (Instituto Gulbenkian de Ciencia). M.P.S. is supported by Fundacao Calouste Gulbenkian, by Fundacao para a Ciencia e Tecnologia (PTDC/SAU TOX/116627/2010, HMSP-ICT/0022/2010), and by the European Community 7th Framework (ERC-2011-AdG 294709-DAMAGECONTROL). I.H. is supported by grants from the US National Institutes of Health. I.H. is the President and Founder of Rakta Therapeutics Inc., a company involved in the development of heme transporter-related diagnostics.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Ashino T, 2008, MOL IMMUNOL, V45, P2106, DOI 10.1016/j.molimm.2007.10.011; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bilban M, 2006, IMMUNITY, V24, P601, DOI 10.1016/j.immuni.2006.03.012; BRADY FO, 1975, BIOINORG CHEM, V5, P167, DOI 10.1016/S0006-3061(00)80058-7; Brock JH, 2002, BIOCHEM CELL BIOL, V80, P1, DOI 10.1139/o01-212; Cairo G, 2011, TRENDS IMMUNOL, V32, P241, DOI 10.1016/j.it.2011.03.007; Carter EL, 2016, J BIOL CHEM, V291, P2196, DOI 10.1074/jbc.M115.670281; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Du RJ, 2010, EMBO J, V29, P632, DOI 10.1038/emboj.2009.380; Dutra FF, 2014, P NATL ACAD SCI USA, V111, pE4110, DOI 10.1073/pnas.1405023111; Elton L, 2015, IMMUNOL REV, V266, P208, DOI 10.1111/imr.12307; Fernandez PL, 2010, J BIOL CHEM, V285, P32844, DOI 10.1074/jbc.M110.146076; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fritsche G, 2008, EUR J IMMUNOL, V38, P3060, DOI 10.1002/eji.200838449; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Garg S, 2006, J BIOL CHEM, V281, P38712, DOI 10.1074/jbc.M606235200; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gozzelino R, 2014, ANTIOXID REDOX SIGN, V20, P1754, DOI 10.1089/ars.2013.5666; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Haider A, 2002, J PHARMACOL EXP THER, V300, P188, DOI 10.1124/jpet.300.1.188; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Inoue H, 2000, J BIOL CHEM, V275, P28028; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; KACA W, 1994, J BIOL CHEM, V269, P25078; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; Kleingardner JG, 2015, ACCOUNTS CHEM RES, V48, P1845, DOI 10.1021/acs.accounts.5b00106; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; KOIZUMI T, 1995, J BIOL CHEM, V270, P21779, DOI 10.1074/jbc.270.37.21779; Korolnek T, 2015, BLOOD, V125, P2893, DOI 10.1182/blood-2014-12-567776; Kosman DJ, 2010, J BIOL CHEM, V285, P26729, DOI 10.1074/jbc.R110.113217; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; KWAK EL, 1995, J BIOL CHEM, V270, P15285, DOI 10.1074/jbc.270.25.15285; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Leimberg MJ, 2008, J CELL BIOCHEM, V103, P1211, DOI 10.1002/jcb.21499; Mancardi D, 2009, BBA-BIOENERGETICS, V1787, P864, DOI 10.1016/j.bbabio.2009.03.005; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Palacios-Callender M, 2004, P NATL ACAD SCI USA, V101, P7630, DOI 10.1073/pnas.0401723101; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Phelan D, 1998, ARCH BIOCHEM BIOPHYS, V357, P155, DOI 10.1006/abbi.1998.0814; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Regev D, 2012, LAB INVEST, V92, P1541, DOI 10.1038/labinvest.2012.125; Ricchetti GA, 2004, J LEUKOCYTE BIOL, V76, P719, DOI 10.1189/jlb.0104046; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Rushworth SA, 2005, J IMMUNOL, V175, P4408, DOI 10.4049/jimmunol.175.7.4408; Sakamoto K, 2009, MOL BIOL CELL, V20, P1606, DOI 10.1091/mbc.E08-07-0762; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Senge MO, 2015, CHEM COMMUN, V51, P17031, DOI 10.1039/c5cc06254c; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Siegert I, 2015, CELL REP, V13, P2048, DOI 10.1016/j.celrep.2015.11.005; Silva-Gomes S, 2013, INFECT IMMUN, V81, P2536, DOI 10.1128/IAI.00251-13; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Soares MP, 2016, CURR OPIN IMMUNOL, V38, P94, DOI 10.1016/j.coi.2015.11.006; Soares MP, 2015, EMBO REP, V16, P1482, DOI 10.15252/embr.201540558; Soares MP, 2014, TRENDS IMMUNOL, V35, P483, DOI 10.1016/j.it.2014.08.001; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Taille C, 2004, J BIOL CHEM, V279, P28681, DOI 10.1074/jbc.M310661200; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; VANDEROUDERAA FJ, 1979, BIOCHIM BIOPHYS ACTA, V572, P29, DOI 10.1016/0005-2760(79)90197-8; Vidal SM, 1996, J IMMUNOL, V157, P3559; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Wegiel B, 2014, J CLIN INVEST, V124, P4926, DOI 10.1172/JCI72853; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; WEISS G, 1992, EXP HEMATOL, V20, P605; Weiss G, 2013, NAT REV RHEUMATOL, V9, P205, DOI 10.1038/nrrheum.2012.183; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	146	199	209	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					492	504		10.1016/j.immuni.2016.02.016	http://dx.doi.org/10.1016/j.immuni.2016.02.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982356	Green Accepted, Bronze			2022-12-18	WOS:000372784200005
J	Gerner, MY; Torabi-Parizi, P; Germain, RN				Gerner, Michael Y.; Torabi-Parizi, Parizad; Germain, Ronald N.			Strategically Localized Dendritic Cells Promote Rapid T Cell Responses to Lymph-Borne Particulate Antigens	IMMUNITY			English	Article							SUBCAPSULAR SINUS MACROPHAGES; IN-VIVO; B-CELLS; IMMUNITY; NODES; CD4; DYNAMICS; DISTINCT; IMMUNIZATION; CHEMOKINES	Upon infection, adaptive immune responses play catch-up with rapidly replicating pathogens. While mechanisms for efficient humoral responses to lymph-borne antigens have been characterized, the current paradigm for T cell responses to infections and particulate vaccines involves delayed migration of peripheral antigen-bearing dendritic cells (DCs) to lymph nodes (LNs), where they elicit effector T cell responses. Utilizing whole LN 3D imaging, histo-cytometry, and intravital 2-photon microscopy, we have identified a specialized population of DCs, enriched in the LN-resident CD11b(+) subset, which resides within the lymphatic sinus endothelium and scans lymph with motile dendrites. These DCs capture draining particles and present associated antigens to T lymphocytes, inducing T cell responses much sooner than and independently of migratory DCs. Thus, strategic DC subset positioning in LNs limits a potentially costly delay in generation of T cell responses to lymph-borne antigens, contributing to effective host defense. These findings are also highly relevant to vaccine design.	[Gerner, Michael Y.; Torabi-Parizi, Parizad; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Torabi-Parizi, Parizad] NIH, Crit Care Med Dept, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Gerner, MY (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA.	gernermy@niaid.nih.gov; rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Gerner, Michael/0000-0001-5406-8308	NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Dr. Michel Nussenzweig for providing the Zbtb46-DTR mouse line. We would also like to thank Dr. Yasmine Belkaid, Dr. Timothy Hand, and Dr. Denise Morais Da Fonseca for experimental contributions. In addition, we thank members of the LBS, LSB, as well as Dr. Kerry Casey, for many helpful comments during the course of these studies and for critical input during preparation of this manuscript. This research was supported by the Intramural Research Program, NIAID, NIH.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Catron DM, 2010, J IMMUNOL, V184, P3609, DOI 10.4049/jimmunol.1000077; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Grigorova IL, 2010, P NATL ACAD SCI USA, V107, P20447, DOI 10.1073/pnas.1009968107; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Iezzi G, 2006, J IMMUNOL, V177, P1250, DOI 10.4049/jimmunol.177.2.1250; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller K, 2011, J CLIN INVEST, V121, P1782, DOI 10.1172/JCI45416; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kondratieva TK, 2000, CLIN EXP IMMUNOL, V121, P275, DOI 10.1046/j.1365-2249.2000.01222.x; Lee HK, 2007, SEMIN IMMUNOL, V19, P48, DOI 10.1016/j.smim.2006.12.001; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Misslitz AC, 2004, EUR J IMMUNOL, V34, P715, DOI 10.1002/eji.200324391; Ohtani O, 2003, ARCH HISTOL CYTOL, V66, P261, DOI 10.1679/aohc.66.261; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Woodruff MC, 2014, J EXP MED, V211, P1611, DOI 10.1084/jem.20132327	44	199	205	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					172	185		10.1016/j.immuni.2014.12.024	http://dx.doi.org/10.1016/j.immuni.2014.12.024			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25607462	Bronze			2022-12-18	WOS:000348197500020
J	Di Meglio, P; Perera, GK; Nestle, FO				Di Meglio, Paola; Perera, Gayathri K.; Nestle, Frank O.			The Multitasking Organ: Recent Insights into Skin Immune Function	IMMUNITY			English	Review							EPIDERMAL LANGERHANS CELLS; MEMORY T-CELLS; LANGERIN(+) DENDRITIC CELLS; CONTACT HYPERSENSITIVITY; ANTIMICROBIAL PEPTIDE; INNATE IMMUNITY; TNF INHIBITION; INTERLEUKIN 22; CUTTING EDGE; MOUSE MODEL	The skin provides the first line defense of the human body against injury and infection. By integrating recent findings in cutaneous immunology with fundamental concepts of skin biology, we portray the skin as a multitasking organ ensuring body homeostasis. Crosstalk between the skin and its microbial environment is also highlighted as influencing the response to injury, infection, and autoimmunity. The importance of the skin immune network is emphasized by the identification of several skin-resident cell subsets, each with its unique functions. Lessons learned from targeted therapy in inflammatory skin conditions, such as psoriasis, provide further insights into skin immune function. Finally, we look at the skin as an interacting network of immune signaling pathways exemplified by the development of a disease interactome for psoriasis.	[Di Meglio, Paola; Perera, Gayathri K.; Nestle, Frank O.] Kings Coll London, St Johns Inst Dermatol, London SE1 9RT, England; [Di Meglio, Paola; Perera, Gayathri K.; Nestle, Frank O.] Guys & St Thomas Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London SE1 9RT, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Nestle, FO (corresponding author), Kings Coll London, St Johns Inst Dermatol, London SE1 9RT, England.	frank.nestle@kcl.ac.uk		Di Meglio, Paola/0000-0002-2066-7780	Wellcome Trust [GR078173MA]; NIH [RO1AR040065]; NIHR Comprehensive Biomedical Research Centre Guy's; St. Thomas' Hospital and King's College London; Medical Research Council UK [G0601387]; Dunhill Medical Trust; Pfizer; Advances in Psoriasis Research Grant Programme Award; Medical Research Council; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040065] Funding Source: NIH RePORTER; MRC [G0601387] Funding Source: UKRI; Medical Research Council [G0601387] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR Comprehensive Biomedical Research Centre Guy's; St. Thomas' Hospital and King's College London; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dunhill Medical Trust(Dunhill Medical Trust); Pfizer(Pfizer); Advances in Psoriasis Research Grant Programme Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Ainali and L. Napolitano for their help with Figure 3. We thank F.O.N. laboratory members for their contribution over the years to the work cited in this review. We acknowledge support by the following grant funding bodies: Wellcome Trust Programme GR078173MA (F.O.N.), NIH RO1AR040065 (F.O.N.), NIHR Comprehensive Biomedical Research Centre Guy's and St. Thomas' Hospital and King's College London (F.O.N.), Medical Research Council UK Programme G0601387 (F.O.N.), Dunhill Medical Trust (F.O.N), Wyeth (now Pfizer) Advances in Psoriasis Research Grant Programme Award (F.O.N. and P.D.M.), and Medical Research Council Clinical Training Research Fellowship (G.K.P.). F.O.N. has provided consultant advice to Celgene, Abbott Laboratories, Eisai, Pfizer, and Janssen Cilag. F.O.N. and P.D.M. have received an unrestricted Advances in Psoriasis Research Grant Programme Award from Wyeth (now Pfizer).	Albanesi C, 2001, J LEUKOCYTE BIOL, V70, P617; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bennett CL, 2011, BLOOD, V117, P7063, DOI 10.1182/blood-2011-01-329185; Benoist C, 2006, IMMUNOL REV, V210, P229, DOI 10.1111/j.0105-2896.2006.00374.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; BOS JD, 1986, IMMUNOL TODAY, V7, P235, DOI 10.1016/0167-5699(86)90111-8; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Boyman O, 2007, TRENDS IMMUNOL, V28, P51, DOI 10.1016/j.it.2006.12.005; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cavani A, 2008, CURR OPIN ALLERGY CL, V8, P294, DOI 10.1097/ACI.0b013e3283079ea4; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Chu CC, 2011, SEMIN IMMUNOL, V23, P28, DOI 10.1016/j.smim.2011.01.006; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Conrad C, 2007, NAT MED, V13, P836, DOI 10.1038/nm1605; Conrad C, 2009, SEMIN IMMUNOL, V21, P101, DOI 10.1016/j.smim.2009.01.004; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Feldmeyer L, 2010, EUR J CELL BIOL, V89, P638, DOI 10.1016/j.ejcb.2010.04.008; Flacher V, 2010, J INVEST DERMATOL, V130, P755, DOI 10.1038/jid.2009.343; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; GRABBE S, 1995, J IMMUNOL, V155, P4207; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Gudjonsson JE, 2007, J INVEST DERMATOL, V127, P1292, DOI 10.1038/sj.jid.5700807; Guiducci C, 2010, J EXP MED, V207, P2931, DOI 10.1084/jem.20101048; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Honda T, 2010, J ALLERGY CLIN IMMUN, V125, P1154, DOI 10.1016/j.jaci.2009.12.005; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Igyarto BZ, 2009, J IMMUNOL, V183, P5085, DOI 10.4049/jimmunol.0901884; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Kadow S, 2011, J IMMUNOL, V187, P3104, DOI 10.4049/jimmunol.1100912; Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153; Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Lutz MB, 2009, EUR J IMMUNOL, V39, P2325, DOI 10.1002/eji.200939548; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; NICKOLOFF BJ, 1993, DERMAL IMMUNE SYSTEM; Noordegraaf M, 2010, J INVEST DERMATOL, V130, P2752, DOI 10.1038/jid.2010.223; Nosbaum A, 2009, EUR J DERMATOL, V19, P325, DOI 10.1684/ejd.2009.0686; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pennino D, 2010, J IMMUNOL, V184, P4880, DOI 10.4049/jimmunol.0901767; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Sarin R, 2011, P NATL ACAD SCI USA, V108, P9560, DOI 10.1073/pnas.1017854108; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; STREILEIN JW, 1983, J INVEST DERMATOL, V80, pS12, DOI 10.1111/1523-1747.ep12536743; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tonel G, 2010, J IMMUNOL, V185, P5688, DOI 10.4049/jimmunol.1001538; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Valeyev NV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001024; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolf R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001108; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046; Zaba LC, 2009, J INVEST DERMATOL, V129, P302, DOI 10.1038/jid.2008.225; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	118	199	201	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 23	2011	35	6					857	869		10.1016/j.immuni.2011.12.003	http://dx.doi.org/10.1016/j.immuni.2011.12.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22195743	Bronze			2022-12-18	WOS:000298777300006
J	SU, L; KANESHIMA, H; BONYHADI, M; SALIMI, S; KRAFT, D; RABIN, L; MCCUNE, JM				SU, L; KANESHIMA, H; BONYHADI, M; SALIMI, S; KRAFT, D; RABIN, L; MCCUNE, JM			HIV-1-INDUCED THYMOCYTE DEPLETION IS ASSOCIATED WITH INDIRECT CYTOPATHICITY AND INFECTION OF PROGENITOR CELLS IN-VIVO	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SCID-HU MOUSE; AIDS-RELATED LYMPHADENOPATHY; IMMUNE-DEFICIENCY SYNDROME; HTLV-III/LAV ENVELOPE; CD4+ T-CELLS; HIV-INFECTION; INSITU HYBRIDIZATION; THYMIC LYMPHOCYTES; PERIPHERAL-BLOOD	Direct and indirect cytopathic mechanisms have been proposed to account for the loss of CD4(+) T cells after infection with human immunodeficiency virus type 1 (HIV-1). We report here that HIV-1 infection of the human thymus in vivo results in thymocyte depletion by at least two different mechanisms. Thymocytes within multiple stages of differentiation are induced to die of apoptosis; most of these cells are uninfected. Additionally, thymopoiesis is interrupted by direct infection and destruction of intrathymic CD3(-)CD4(+)CD8(-) progenitor cells. These mechanisms are differentially induced by distinct isolates of HIV-1.			SU, L (corresponding author), SYSTEMIX INC, HIV GRP, 1501 CALIF AVE, PALO ALTO, CA 94304 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029323] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-05080, AI-29323] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ADLEMAN LM, 1993, J ACQ IMMUN DEF SYND, V6, P144; ALDROVANDI GM, 1993, NATURE, V363, P732, DOI 10.1038/363732a0; AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102; ARMSTRONG JA, 1984, LANCET, V2, P370; ASCHER MS, 1988, CLIN EXP IMMUNOL, V73, P165; ATKINSON K, 1982, BLOOD, V59, P1292; BANDA NK, 1992, J EXP MED, V176, P1099, DOI 10.1084/jem.176.4.1099; BASKIN GB, 1991, LAB INVEST, V65, P400; BEEBE AM, 1994, J VIROL, V68, P3080, DOI 10.1128/JVI.68.5.3080-3091.1994; BIBERFELD P, 1985, CANCER RES, V45, P4665; BONYHADI ML, 1993, NATURE, V363, P728, DOI 10.1038/363728a0; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; CALENDA V, 1992, EUR J HAEMATOL, V48, P181; CASTELLA A, 1985, American Journal of Clinical Pathology, V84, P425; CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945; CHERVENAK R, 1993, J IMMUNOL, V151, P4486; CLERICI M, 1993, SCIENCE, V262, P1721, DOI 10.1126/science.7903123; CULLEN BR, 1991, ANNU REV MICROBIOL, V45, P219; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DELWART EL, 1994, J VIROL, V68, P6672, DOI 10.1128/JVI.68.10.6672-6683.1994; DEROSSI A, 1990, AIDS RES HUM RETROV, V6, P287, DOI 10.1089/aid.1990.6.287; DUESBERG P, 1994, INT ARCH ALLERGY IMM, V103, P118, DOI 10.1159/000236617; DWYER JM, 1987, ARCH INTERN MED, V147, P513, DOI 10.1001/archinte.147.3.513; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; EWING EP, 1985, ARCH PATHOL LAB MED, V109, P977; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; FEINBERG MB, 1992, CURR OPIN IMMUNOL, V4, P466, DOI 10.1016/S0952-7915(06)80041-5; FIELDS BN, 1994, NATURE, V369, P95, DOI 10.1038/369095a0; FINKEL TH, 1994, CURR OPIN IMMUNOL, V6, P605, DOI 10.1016/0952-7915(94)90149-X; GALY A, 1993, J EXP MED, V178, P391, DOI 10.1084/jem.178.2.391; GORCZYCA W, 1993, LEUKEMIA, V7, P659; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Gougeon M L, 1993, Semin Immunol, V5, P187, DOI 10.1006/smim.1993.1022; GREENE WC, 1993, SCI AM, V269, P98, DOI 10.1038/scientificamerican0993-98; GRODY WW, 1985, AM J CLIN PATHOL, V84, P85, DOI 10.1093/ajcp/84.1.85; GROUX H, 1992, J EXP MED, V175, P331, DOI 10.1084/jem.175.2.331; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; HARRIS PJ, 1991, MED HYPOTHESES, V36, P379, DOI 10.1016/0306-9877(91)90015-Q; JAMIESON BD, 1994, J VIROL, V68, P3478, DOI 10.1128/JVI.68.6.3478-3485.1994; JOSHI VV, 1985, ARCH PATHOL LAB MED, V109, P142; KANESHIMA H, 1994, IN PRESS J VIROL; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; KRAFT DL, 1993, J EXP MED, V178, P265, DOI 10.1084/jem.178.1.265; KROWKA JF, 1991, J IMMUNOL, V146, P3751; LAURENTCRAWFORD AG, 1991, VIROLOGY, V185, P829, DOI 10.1016/0042-6822(91)90554-O; LAURENTCRAWFORD AG, 1993, AIDS RES HUM RETROV, V9, P761, DOI 10.1089/aid.1993.9.761; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; LIFSON JD, 1986, NATURE, V323, P725, DOI 10.1038/323725a0; LYERLY HK, 1987, P NATL ACAD SCI USA, V84, P4601, DOI 10.1073/pnas.84.13.4601; MCCUNE J, 1991, ANNU REV IMMUNOL, V9, P399, DOI 10.1146/annurev.iy.09.040191.002151; MCCUNE JM, 1990, SCIENCE, V247, P564, DOI 10.1126/science.2300816; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; MCCUNE JM, 1991, CELL, V64, P351, DOI 10.1016/0092-8674(91)90644-E; MEYAARD L, 1994, J CLIN INVEST, V93, P982, DOI 10.1172/JCI117105; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; MURPHY MF, 1987, BRIT J HAEMATOL, V66, P337, DOI 10.1111/j.1365-2141.1987.tb06920.x; NAJEAN Y, 1994, J LAB CLIN MED, V123, P415; NAMIKAWA R, 1988, SCIENCE, V242, P1684, DOI 10.1126/science.3201256; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PAPIERNIK M, 1992, PEDIATRICS, V89, P297; PATTERSON BK, 1993, SCIENCE, V260, P976, DOI 10.1126/science.8493534; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; ROSENZWEIG M, 1993, AIDS, V7, P1601, DOI 10.1097/00002030-199312000-00009; SAVINO W, 1986, AM J PATHOL, V122, P302; SCHNITTMAN SM, 1990, P NATL ACAD SCI USA, V87, P7727, DOI 10.1073/pnas.87.19.7727; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; SCHUURMAN HJ, 1989, AM J PATHOL, V134, P1329; SEEMAYER TA, 1984, HUM PATHOL, V15, P469, DOI 10.1016/S0046-8177(84)80082-9; SILICIANO RF, 1988, CELL, V54, P561, DOI 10.1016/0092-8674(88)90078-5; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; SPIVAK JL, 1983, JAMA-J AM MED ASSOC, V250, P3084, DOI 10.1001/jama.250.22.3084; STANLEY SK, 1993, J EXP MED, V178, P1151, DOI 10.1084/jem.178.4.1151; STRICKER RB, 1987, NATURE, V327, P710, DOI 10.1038/327710a0; TERAI C, 1991, J CLIN INVEST, V87, P1710, DOI 10.1172/JCI115188; TERSMETTE M, 1989, J VIROL, V63, P2118, DOI 10.1128/JVI.63.5.2118-2125.1989; TREMBLAY M, 1990, J ACQ IMMUN DEF SYND, V3, P356; VAISHNAV YN, 1991, ANNU REV BIOCHEM, V60, P577, DOI 10.1146/annurev.bi.60.070191.003045; VALENTIN H, 1994, J VIROL, V68, P3041, DOI 10.1128/JVI.68.5.3041-3050.1994; VANDEKERCKHOVE BAE, 1992, J EXP MED, V176, P1619, DOI 10.1084/jem.176.6.1619; VISCIDI RP, 1989, SCIENCE, V246, P1606, DOI 10.1126/science.2556795; WALLER EK, 1992, BLOOD, V80, P3144; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453; ZINKERNAGEL RM, 1994, IMMUNOL TODAY, V15, P262, DOI 10.1016/0167-5699(94)90005-1	88	199	200	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1995	2	1					25	36		10.1016/1074-7613(95)90076-4	http://dx.doi.org/10.1016/1074-7613(95)90076-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QC593	7600300	Bronze			2022-12-18	WOS:A1995QC59300003
J	Crinier, A; Milpied, P; Escaliere, B; Piperoglou, C; Galluso, J; Balsamo, A; Spinelli, L; Cervera-Marzal, I; Ebbo, M; Girard-Madoux, M; Jaeger, S; Bollon, E; Hamed, S; Hardwigsen, J; Ugolini, S; Vely, F; Narni-Mancinelli, E; Vivier, E				Crinier, Adeline; Milpied, Pierre; Escaliere, Bertrand; Piperoglou, Christelle; Galluso, Justine; Balsamo, Anais; Spinelli, Lionel; Cervera-Marzal, Inaki; Ebbo, Mikael; Girard-Madoux, Mathilde; Jaeger, Sebastien; Bollon, Emilie; Hamed, Sami; Hardwigsen, Jean; Ugolini, Sophie; Vely, Frederic; Narni-Mancinelli, Emilie; Vivier, Eric			High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; DEVELOPMENTAL-STAGES; ACTIVATION; MATURATION; HETEROGENEITY; TISSUES	Natural killer (NK) cells are innate lymphoid cells (ILCs) involved in antimicrobial and antitumoral responses. Several NK cell subsets have been reported in humans and mice, but their heterogeneity across organs and species remains poorly characterized. We assessed the diversity of human and mouse NK cells by single-cell RNA sequencing on thousands of individual cells isolated from spleen and blood. Unbiased transcriptional clustering revealed two distinct signatures differentiating between splenic and blood NK cells. This analysis at single-cell resolution identified three subpopulations in mouse spleen and four in human spleen, and two subsets each in mouse and human blood. A comparison of transcriptomic profiles within and between species highlighted the similarity of the two major subsets, NK1 and NK2, across organs and species. This unbiased approach provides insight into the biology of NK cells and establishes a rationale for the translation of mouse studies to human physiology and disease.	[Crinier, Adeline; Milpied, Pierre; Escaliere, Bertrand; Galluso, Justine; Balsamo, Anais; Spinelli, Lionel; Cervera-Marzal, Inaki; Ebbo, Mikael; Girard-Madoux, Mathilde; Jaeger, Sebastien; Ugolini, Sophie; Vely, Frederic; Narni-Mancinelli, Emilie; Vivier, Eric] Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM, CNRS, Marseille, France; [Piperoglou, Christelle; Ebbo, Mikael; Vely, Frederic; Vivier, Eric] Hop La Timone, AP HM, Marseille Immunopole, Immunol, Marseille, France; [Vivier, Eric] Innate Pharma, Innate Pharma Res Labs, Marseille, France; [Ebbo, Mikael] Hop La Timone, AP HM, Internal Med, Marseille, France; [Bollon, Emilie; Hamed, Sami; Hardwigsen, Jean] Hop La Timone, AP HM, Gen Surg & Liver Transplantat, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vivier, E (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM, CNRS, Marseille, France.; Vivier, E (corresponding author), Hop La Timone, AP HM, Marseille Immunopole, Immunol, Marseille, France.; Vivier, E (corresponding author), Innate Pharma, Innate Pharma Res Labs, Marseille, France.	vivier@ciml.univ-mrs.fr	Milpied, Pierre J/Q-1380-2015; Narni-Mancinelli, Emilie/X-1888-2018; Vély, Frédéric/HHM-3894-2022; Vivier, Eric/F-8939-2010	Milpied, Pierre J/0000-0003-1873-5358; Narni-Mancinelli, Emilie/0000-0002-7001-1026; Vivier, Eric/0000-0001-7022-8287; Ugolini, Sophie/0000-0003-4041-0103; CRINIER, ADELINE/0000-0001-9721-2568; Cervera-Marzal, Inaki/0000-0002-9341-2252; Girard-Madoux, Mathilde/0000-0002-8840-2623	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (TILC) [694502]; Agence Nationale de la Recherche [ANR-15-CE15-0016-01]; Equipe Labellisee "La Ligue''; Ligue Nationale contre le Cancer [EL2017.LNCC/ErV]; MSDAvenir [161204A50]; Innate Pharma [10406A20/V]; INSERM; CNRS; Aix-Marseille University	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (TILC)(European Research Council (ERC)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Equipe Labellisee "La Ligue''; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); MSDAvenir; Innate Pharma; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University	The E.V. laboratory is supported by funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (TILC, grant agreement no. 694502), the Agence Nationale de la Recherche (convention no. ANR-15-CE15-0016-01), Equipe Labellisee "La Ligue,'' Ligue Nationale contre le Cancer (convention no. EL2017.LNCC/ErV), MSDAvenir (convention no. 161204A50), Innate Pharma (convention no. 10406A20/V), and institutional grants to the CIML (INSERM, CNRS, and Aix-Marseille University) and to Marseille Immunopole. We thank S. Carpentier, S. Guia, C. Bernat, and the cytometry platform (CIML) for help and advice.	Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Chiossone L, 2018, NAT REV IMMUNOL, V18, P671, DOI 10.1038/s41577-018-0061-z; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Freud AG, 2017, IMMUNITY, V47, P820, DOI 10.1016/j.immuni.2017.10.008; Hammer Q, 2018, NAT IMMUNOL, V19, P453, DOI 10.1038/s41590-018-0082-6; Hanna J, 2004, J IMMUNOL, V173, P6547, DOI 10.4049/jimmunol.173.11.6547; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Lugthart G, 2016, J IMMUNOL, V197, P78, DOI 10.4049/jimmunol.1502603; Lysakova-Devine T, 2014, J LEUKOCYTE BIOL, V96, P981, DOI 10.1189/jlb.1RU0514-241R; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Scheiter M, 2013, MOL CELL PROTEOMICS, V12, P1099, DOI 10.1074/mcp.M112.024596; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Tomasello E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00344; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vossen MTM, 2008, J IMMUNOL, V180, P3739, DOI 10.4049/jimmunol.180.6.3739; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wilk AJ, 2018, J LEUKOCYTE BIOL, V103, P629, DOI 10.1002/JLB.6RI0917-390R; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	30	198	201	3	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					971	+		10.1016/j.immuni.2018.09.009	http://dx.doi.org/10.1016/j.immuni.2018.09.009			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30413361	Green Published, hybrid			2022-12-18	WOS:000450752200020
J	Obermoser, G; Presnell, S; Domico, K; Xu, H; Wang, YY; Anguiano, E; Thompson-Snipes, L; Ranganathan, R; Zeitner, B; Bjork, A; Anderson, D; Speake, C; Ruchaud, E; Skinner, J; Alsina, L; Sharma, M; Dutartre, H; Cepika, A; Israelsson, E; Nguyen, P; Nguyen, QA; Harrod, AC; Zurawski, SM; Pascual, V; Ueno, H; Nepom, GT; Quinn, C; Blankenship, D; Palucka, K; Banchereau, J; Chaussabel, D				Obermoser, Gerlinde; Presnell, Scott; Domico, Kelly; Xu, Hui; Wang, Yuanyuan; Anguiano, Esperanza; Thompson-Snipes, LuAnn; Ranganathan, Rajaram; Zeitner, Brad; Bjork, Anna; Anderson, David; Speake, Cate; Ruchaud, Emily; Skinner, Jason; Alsina, Laia; Sharma, Mamta; Dutartre, Helene; Cepika, Alma; Israelsson, Elisabeth; Phuong Nguyen; Quynh-Anh Nguyen; Harrod, A. Carson; Zurawski, Sandra M.; Pascual, Virginia; Ueno, Hideki; Nepom, Gerald T.; Quinn, Charlie; Blankenship, Derek; Palucka, Karolina; Banchereau, Jacques; Chaussabel, Damien			Systems Scale Interactive Exploration Reveals Quantitative and Qualitative Differences in Response to Influenza and Pneumococcal Vaccines	IMMUNITY			English	Article							YELLOW-FEVER VACCINE; LUPUS-ERYTHEMATOSUS; IMMUNE-RESPONSES; BLOOD; HUMANS; BIOLOGY; INTERFERON; IMMUNOLOGY; PATTERNS; CELLS	Systems immunology approaches were employed to investigate innate and adaptive immune responses to influenza and pneumococcal vaccines. These two non-live vaccines show different magnitudes of transcriptional responses at different time points after vaccination. Software solutions were developed to explore correlates of vaccine efficacy measured as antibody titers at day 28. These enabled a further dissection of transcriptional responses. Thus, the innate response, measured within hours in the peripheral blood, was dominated by an interferon transcriptional signature after influenza vaccination and by an inflammation signature after pneumococcal vaccination. Day 7 plasmablast responses induced by both vaccines was more pronounced after pneumococcal vaccination. Together, these results suggest that comparing global immune responses elicited by different vaccines will be critical to our understanding of the immune mechanisms underpinning successful vaccination.	[Obermoser, Gerlinde; Wang, Yuanyuan; Anguiano, Esperanza; Thompson-Snipes, LuAnn; Ranganathan, Rajaram; Ruchaud, Emily; Skinner, Jason; Alsina, Laia; Sharma, Mamta; Dutartre, Helene; Cepika, Alma; Phuong Nguyen; Quynh-Anh Nguyen; Harrod, A. Carson; Zurawski, Sandra M.; Pascual, Virginia; Ueno, Hideki; Quinn, Charlie; Palucka, Karolina; Banchereau, Jacques; Chaussabel, Damien] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Presnell, Scott; Domico, Kelly; Zeitner, Brad; Bjork, Anna; Anderson, David; Speake, Cate; Israelsson, Elisabeth; Nepom, Gerald T.; Quinn, Charlie; Chaussabel, Damien] Benaroya Res Inst, Seattle, WA 98101 USA; [Xu, Hui; Blankenship, Derek] Baylor Inst Hlth Care Res & Improvement, Dallas, TX 75206 USA	Baylor Scott & White Health; Baylor University Medical Center; Benaroya Research Institute	Palucka, K (corresponding author), Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA.	karolinp@baylorhealth.edu; dchaussabel@benaroyaresearch.org	Alsina, Laia/AID-4372-2022; Pascual, Virginia/ABD-3099-2020; Lv, Yuanjie/AER-0767-2022; Chaussabel, Damien/AAX-1909-2020; Ueno, Hideki/L-1237-2016; Sharma, Mamta/GSN-5871-2022; Dutartre, Helene/L-7463-2019; Alsina, Laia/GQI-3516-2022	Ueno, Hideki/0000-0001-7747-0738; Dutartre, Helene/0000-0002-2682-4302; Chaussabel, Damien/0000-0002-6131-7242; Cepika, Alma-Martina/0000-0003-2862-1901; Alsina, Laia/0000-0002-3559-0018; Skinner, Jason/0000-0002-2408-7695; Harrod, Albert/0000-0002-5035-5286; Nepom, Gerald/0000-0002-8063-1464	Baylor Health Care System Foundation; National Institutes of Health [U19 AI08998, U19 AI057234, U01 AI082110, N01-AI-15416, P01 CA084512]; Erwin Schrodinger Research Grant of the Austrian Science Fund; Medical Research Fund MFF Tirol; NATIONAL CANCER INSTITUTE [P01CA084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI008998, R01AI008998, U19AI057234, N01AI015416, U01AI082110, R37AI008998, U19AI089987] Funding Source: NIH RePORTER	Baylor Health Care System Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Erwin Schrodinger Research Grant of the Austrian Science Fund; Medical Research Fund MFF Tirol; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank our volunteer participants and all of the members of BIIR who assisted in this work. We thank I. Berthier, C. Boudreaux, A. Cobb, M. Hughes, B. Lemoine, I. Munagala, D. Nattamai, and colleagues for providing technical assistance with sample preparation, microarray processing, and flow cytometry. We thank A. Garcia-Sastre and R. Albrecht, Department of Microbiology, Mount Sinai School of Medicine, for advice and performing serological assays. We thank E. De Vol, N. Baldwin, and E. Whalen for advice and support in biostatistics and bioinformatics, G. Hayward for help depositing microarray data, M. Roy and O. Vargas for help with editing the wiki site, C. Samuelsen for organizational support, and R. Coffman for discussion of the manuscript. G. O. was supported by an Erwin Schrodinger Research Grant of the Austrian Science Fund and the Medical Research Fund MFF Tirol. The work of D. C., J. B., and K. P. are supported by the Baylor Health Care System Foundation and the National Institutes of Health (U19 AI08998, U19 AI057234, U01 AI082110, N01-AI-15416, and P01 CA084512). J. B., K. P., and D. C. designed the study; G. O., Y. W., E. A., L. T.-S., R. R., E. R, J. S., L. A., M. S., H. D., P. N., Q.-A. N., and S. M. Z. assisted in experiments; H. U. and V. P. supervised the experiments; A. C. H. recruited volunteers; G. O., H. X., Y. W., E. A., A. C., and D. B. analyzed the data; S. P., K. D., B. Z., A. B., D. A., C. S., E. I., G. T. N., and C. Q. provided bioinformatic tools and support, and G. O, K. P., and D. C prepared the manuscript.	Alakulppi N, 2008, TRANSPLANTATION, V86, P1222, DOI 10.1097/TP.0b013e3181883fb0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2009, NAT IMMUNOL, V10, P1225, DOI 10.1038/ni1209-1225; FDA, 2011, COMPL LIST VACC LIC; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Mallory RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013755; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Ovcharenko D, 2005, RNA, V11, P985, DOI 10.1261/rna.7288405; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; Whitley P., 2005, APPL BIOSYSTEMS TECH; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890	22	198	199	2	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					831	844		10.1016/j.immuni.2012.12.008	http://dx.doi.org/10.1016/j.immuni.2012.12.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23601689	Bronze, Green Accepted			2022-12-18	WOS:000330942100023
J	Matsumoto, M; Fujii, Y; Baba, A; Hikida, M; Kurosaki, T; Baba, Y				Matsumoto, Masanori; Fujii, Yoko; Baba, Akemi; Hikida, Masaki; Kurosaki, Tomohiro; Baba, Yoshihiro			The Calcium Sensors STIM1 and STIM2 Control B Cell Regulatory Function through Interleukin-10 Production	IMMUNITY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE ENCEPHALOMYELITIS; ENDOPLASMIC-RETICULUM; T-CELLS; ANTIGEN RECEPTOR; CHANNEL FUNCTION; IMMUNE CELLS; B10 CELLS; ACTIVATION; IL-10	A chief Ca(2+) entry pathway in immune cells is store-operated Ca(2+) (SOC) influx, which is triggered by depletion of Ca(2+) from the endoplasmic reticulum (ER). However, its physiological role in B cells remains elusive. Here, we show that ER calcium sensors STIM1- and STIM2-induced SOC influx is critical for B cell regulatory function. B cell-specific deletion of STIM1 and STIM2 in mice caused a profound defect in B cell receptor (BCR)-induced SOC influx and proliferation. However, B cell development and antibody responses were unaffected. Remarkably, B cells lacking both STIM proteins failed to produce the anti-inflammatory cytokine IL-10 because of defective activation of nuclear factor of activated T cells (NFAT) after BCR stimulation. This resulted in exacerbation of experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Our data establish STIM-dependent SOC influx as a key signal for B cell regulatory function required to limit autoimmunity.	[Matsumoto, Masanori; Baba, Akemi; Kurosaki, Tomohiro; Baba, Yoshihiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Suita, Osaka 5650871, Japan; [Matsumoto, Masanori; Fujii, Yoko; Kurosaki, Tomohiro; Baba, Yoshihiro] RIKEN Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Kanagawa 2300045, Japan; [Hikida, Masaki] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto 6068501, Japan	Osaka University; RIKEN; Kyoto University	Kurosaki, T (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kurosaki@ifrec.osaka-u.ac.jp; babay@ifrec.osaka-u.ac.jp	Kurosaki, Tomohiro/D-1306-2009; Matsumoto, Masanori/N-9971-2018	Kurosaki, Tomohiro/0000-0002-6352-304X; 				Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Baba Y, 2009, IMMUNOL REV, V231, P174, DOI 10.1111/j.1600-065X.2009.00813.x; Bettelli E, 1998, J IMMUNOL, V161, P3299; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Braun A, 2009, BLOOD, V113, P1097, DOI 10.1182/blood-2008-05-158477; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Ghosh S, 2010, P NATL ACAD SCI USA, V107, P15169, DOI 10.1073/pnas.1009193107; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Greenblatt MB, 2010, J EXP MED, V207, P923, DOI 10.1084/jem.20092531; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; KUCHROO VK, 1993, J IMMUNOL, V151, P4371; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Lampropoulou V, 2010, IMMUNOL REV, V233, P146, DOI 10.1111/j.0105-2896.2009.00855.x; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Lyons JA, 1999, EUR J IMMUNOL, V29, P3432, DOI 10.1002/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270	41	198	201	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 27	2011	34	5					703	714		10.1016/j.immuni.2011.03.016	http://dx.doi.org/10.1016/j.immuni.2011.03.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21530328	Bronze			2022-12-18	WOS:000291456500010
J	Liu, Y; Subrahmanyam, R; Chakraborty, T; Sen, R; Desiderio, S				Liu, Yun; Subrahmanyam, Ramesh; Chakraborty, Tirtha; Sen, Ranjan; Desiderio, Stephen			A plant homeodomain in Rag-2 that binds hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement	IMMUNITY			English	Article							V(D)J RECOMBINATION ACTIVITY; B-CELL; PHD FINGER; SIGNAL SEQUENCES; CHAIN GENE; C-TERMINUS; ACTIVE-SITE; PRE-B; PROTEINS; METHYLATION	V(D)J recombination is initiated by the recombination activating gene (RAG) proteins RAG-1 and RAG-2. The ability of antigen-receptorgene segments to undergo V(D)J recombination is correlated with spatially- and temporallyrestricted chromatin modifications. We have found that RAG-2 bound specifically to histone H3 and that this binding was absolutely dependent on dimethylation or trimethylation at lysine 4 (H3K4me2 or H3K4me3). The interaction required a noncanonical plant homeodomain (PHD) that had previously been described within the noncore region of RAG-2. Binding of the RAG-2 PHD finger to chromatin across the IgH D-J(H)-C locus showed a strong correlation with the distribution of trimethylated histone H3 K4. Mutation of a conserved tryptophan residue in the RAG-2 PHD finger abolished binding to H3K4me3 and greatly impaired recombination of extrachromosomal and endogenous immunoglobulin gene segments. Together, these findings are consistent with the interpretation that recognition of hypermethylated histone H3 K4 promotes efficient V(D)J recombination in vivo.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; NIA, Lab Cell & Mol Biol, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Desiderio, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	sdesider@jhmi.edu	Subrahmanyam, Ramesh/K-5503-2012; Liu, Yun/I-5755-2012	Liu, Yun/0000-0002-3917-0600; Liu, Yun/0000-0001-5753-1265	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA16519, P01 CA016519] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000383] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P1209, DOI 10.1073/pnas.0237043100; Akamatsu Y, 1998, MOL CELL BIOL, V18, P4670, DOI 10.1128/MCB.18.8.4670; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Baumann M, 2003, EMBO J, V22, P5197, DOI 10.1093/emboj/cdg487; Bergeron S, 2006, METHOD ENZYMOL, V408, P511, DOI 10.1016/S0076-6879(06)08032-3; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Callebaut I, 1998, CELL MOL LIFE SCI, V54, P880, DOI 10.1007/s000180050216; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; CUOMO CA, 1994, NUCLEIC ACIDS RES, V22, P1810, DOI 10.1093/nar/22.10.1810; Difilippantonio MJ, 1996, CELL, V87, P253, DOI 10.1016/S0092-8674(00)81343-4; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eastman QM, 1999, MOL CELL BIOL, V19, P3788; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Elkin SK, 2005, J BIOL CHEM, V280, P28701, DOI 10.1074/jbc.M504731200; Feeney AJ, 2000, IMMUNOL RES, V21, P195, DOI 10.1385/IR:21:2-3:195; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Gomez CA, 2000, MOL CELL BIOL, V20, P5653, DOI 10.1128/MCB.20.15.5653-5664.2000; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; Jiang H, 2004, J BIOL CHEM, V279, P8478, DOI 10.1074/jbc.M311219200; Jiang H, 2005, MOL CELL, V18, P699, DOI 10.1016/j.molcel.2005.05.011; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Kalkhoven E, 2002, MOL CELL BIOL, V22, P1961, DOI 10.1128/MCB.22.7.1961-1970.2002; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Kirch SA, 1998, EMBO J, V17, P4881, DOI 10.1093/emboj/17.16.4881; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; Lee J, 1999, IMMUNITY, V11, P771, DOI 10.1016/S1074-7613(00)80151-X; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; McMahan CJ, 1997, MOL CELL BIOL, V17, P4544, DOI 10.1128/MCB.17.8.4544; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Noordzij JG, 2002, BLOOD, V100, P2145; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perkins EJ, 2004, NUCLEIC ACIDS RES, V32, P1942, DOI 10.1093/nar/gkh523; Qiu JX, 2001, MOL CELL, V7, P77, DOI 10.1016/S1097-2765(01)00156-3; Ross AE, 2003, MOL CELL BIOL, V23, P5308, DOI 10.1128/MCB.23.15.5308-5319.2003; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Sekiguchi J, 2001, MOL CELL, V8, P1383, DOI 10.1016/S1097-2765(01)00423-3; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Steen SB, 1999, MOL CELL BIOL, V19, P3010; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Swanson PC, 1999, MOL CELL BIOL, V19, P3674; Swanson PC, 1998, IMMUNITY, V9, P115, DOI 10.1016/S1074-7613(00)80593-2; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; West KL, 2005, IMMUNITY, V23, P203, DOI 10.1016/j.immuni.2005.07.004; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	70	198	201	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2007	27	4					561	571		10.1016/j.immuni.2007.09.005	http://dx.doi.org/10.1016/j.immuni.2007.09.005			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17936034	Green Accepted, Bronze			2022-12-18	WOS:000250490700008
J	An, HZ; Zhao, W; Hou, J; Zhang, Y; Xie, Y; Zheng, YJ; Xu, HM; Qian, C; Zhou, J; Yu, YZ; Liu, SX; Feng, GS; Cao, XT				An, Huazhang; Zhao, Wei; Hou, Jin; Zhang, Yan; Xie, Yun; Zheng, Yuejuan; Xu, Hongmei; Qian, Cheng; Zhou, Jun; Yu, Yizhi; Liu, Shuxun; Feng, Gensheng; Cao, Xuetao			SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production	IMMUNITY			English	Article							NF-KAPPA-B; TYROSINE-PHOSPHATASE; INTERLEUKIN-1 RECEPTOR; SH2 DOMAIN; BETA; LIPOPOLYSACCHARIDE; ACTIVATION; FACTOR-3; KINASE; IDENTIFICATION	The Toll-like receptor 3 (TLR3) and TLR4-signaling pathway that involves the adaptor protein TRIF activates type I interferon (IFN) and proinflammatory cytokine expression. Little is known about how TRIF pathway-dependent gene expression is regulated. SH2-containing protein tyrosine phosphatase 2 (SHP-2) is a widely expressed cytoplasmic tyrosine phosphatase. Here we demonstrate that SHP-2 negatively regulated TLR4- and TLR3-activated IFN-beta production. SHP-2 inhibited TLR3-activated but not TLR2-, TLR7-, and TLR9-activated proinflammatory cytokine IL-6 and TNF-alpha production. SHP-2 inhibited poly(I:C)-induced cytokine production by a phosphatase activity-independent mechanism. C-terminal domain of SHP-2 directly bound TANK binding kinase (TBK1) by interacting with the kinase domain of TBK1. SHP-2 deficiency increased TBK1-activated IFN-beta and TNF-alpha expression. TBK1 knockdown inhibited poly(I:C)-induced IL-6 production in SHP-2-deficient cells. SHP-2 also inhibited poly(I:C)-induced activation of MAP kinase pathways. These results demonstrate that SHP-2 specifically negatively regulate TRIF-mediated gene expression in TLR signaling, partially through inhibiting TBK1-activated signal transduction.	Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; Tsinghua Univ, Sch Med, Inst Immunol, Beijing 100084, Peoples R China; Zhejiang Univ, Inst Immunol, Hangzhou 310031, Peoples R China; Burnham Inst Med Res, La Jolla, CA 92037 USA	Naval Medical University; Naval Medical University; Tsinghua University; Zhejiang University; Sanford Burnham Prebys Medical Discovery Institute	Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China.	caoxt@public3.sta.net.cn	yu, yizhi/ADP-7854-2022; ZHAO, WEI/C-9163-2011; xu, hong/GSD-8903-2022; Zheng, Yuejuan/AAF-5923-2020	Zhao, Wei/0000-0001-8440-2274				An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Qu CK, 2000, CELL RES, V10, P279, DOI 10.1038/sj.cr.7290055; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Shinobu N, 2002, FEBS LETT, V517, P251, DOI 10.1016/S0014-5793(02)02636-4; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Vogel W, 1996, CELL GROWTH DIFFER, V7, P1589; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yin TG, 1997, J BIOL CHEM, V272, P1032, DOI 10.1074/jbc.272.2.1032; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101	39	198	215	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					919	928		10.1016/j.immuni.2006.10.014	http://dx.doi.org/10.1016/j.immuni.2006.10.014			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17157040	Bronze			2022-12-18	WOS:000243087500011
J	Marsland, BJ; Battig, P; Bauer, M; Ruedl, C; Lassing, U; Beerli, RR; Dietmeier, K; Ivanova, L; Pfister, T; Vogt, L; Nakano, H; Nembrini, C; Saudan, P; Kopf, M; Bachmann, MF				Marsland, BJ; Battig, P; Bauer, M; Ruedl, C; Lassing, U; Beerli, RR; Dietmeier, K; Ivanova, L; Pfister, T; Vogt, L; Nakano, H; Nembrini, C; Saudan, P; Kopf, M; Bachmann, MF			CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; MHC CLASS-II; EFFECTOR FUNCTIONS; IMMUNE-RESPONSES; TRANSGENIC MICE; INNATE IMMUNITY; DOWN-REGULATION; T-LYMPHOCYTES; FAMILY-MEMBER; UP-REGULATION	Dendritic cells (DCs) are key instigators of adaptive immune responses. Using an alphaviral expression cloning technology, we have identified the chemokine CCL19 as a potent inducer of T cell proliferation in a DC-T cell coculture system. Subsequent studies showed that CCL19 enhanced T cell proliferation by inducing maturation of DCs, resulting in upregulation of costimulatory molecules and the production of proinflammatory cytokines. Moreover, CCL19 programmed DCs for the induction of T helper type (Th) 1 rather than Th2 responses. Importantly, only activated DCs that migrated from the periphery to draining lymph nodes, but not resting steady-state DCs residing within lymph nodes, expressed high levels of CCR7 in vivo and responded to CCL19 with the production of proinflammatory cytokines. Migrating DCs isolated from mice genetically deficient in CCL19 and CCL21 (plt/plt) presented an only partially mature phenotype, highlighting the importance of these chemokines for full DC maturation in vivo. Our findings indicate that CCL19 and CCL21 are potent natural adjuvants for terminal activation of DCs and suggest that chemokines not only orchestrate DC migration but also regulate their immunogenic potential for the induction of T cell responses.	Cytos Biotechnol AG, CH-8952 Zurich, Switzerland; Swiss Fed Inst Technol, Dept Environm Sci, CH-8092 Zurich, Switzerland; Duke Univ, Ctr Med, Dept Med, Durham, NC 27710 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Duke University	Bachmann, MF (corresponding author), Cytos Biotechnol AG, Wagistr 25, CH-8952 Zurich, Switzerland.	martin.bachmann@cytos.com	Ivanova, ludmila b./B-9280-2014; Ruedl, christiane/A-2219-2011; Kopf, Manfred/B-6907-2009	Ruedl, christiane/0000-0002-5599-6541; Kopf, Manfred/0000-0002-0628-7140				Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Bachmann MF, 2002, CURR OPIN IMMUNOL, V14, P413, DOI 10.1016/S0952-7915(02)00363-1; Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Beutler B, 2002, CURR OPIN HEMATOL, V9, P2, DOI 10.1097/00062752-200201000-00002; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; BREDENBEEK PJ, 1993, J VIROL, V67, P6439, DOI 10.1128/JVI.67.11.6439-6446.1993; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunzer M, 2001, SEMIN IMMUNOL, V13, P291, DOI 10.1006/smim.2001.0325; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hillinger S, 2003, J IMMUNOL, V171, P6457, DOI 10.4049/jimmunol.171.12.6457; Hoshino K, 1999, J IMMUNOL, V162, P3749; Junt T, 2002, J IMMUNOL, V168, P6032, DOI 10.4049/jimmunol.168.12.6032; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Koller D, 2001, NAT BIOTECHNOL, V19, P851, DOI 10.1038/nbt0901-851; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Lee J, 2003, J COMB OPTIM, V7, P169, DOI 10.1023/A:1024475030446; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Moutaftsi M, 2004, J VIROL, V78, P3046, DOI 10.1128/JVI.78.6.3046-3054.2004; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Ravkov EV, 2003, J IMMUNOL, V170, P2461, DOI 10.4049/jimmunol.170.5.2461; Rescigno M, 1999, IMMUNOL TODAY, V20, P200, DOI 10.1016/S0167-5699(98)01427-3; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Ruedl C, 1999, EUR J IMMUNOL, V29, P3762, DOI 10.1002/(SICI)1521-4141(199911)29:11<3762::AID-IMMU3762>3.0.CO;2-F; Ruedl C, 2000, EUR J IMMUNOL, V30, P2056, DOI 10.1002/1521-4141(200007)30:7<2056::AID-IMMU2056>3.0.CO;2-S; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Salomon B, 1998, J IMMUNOL, V160, P708; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Schneider-Schaulies S, 2003, CURR TOP MICROBIOL, V276, P77; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Timmerman JM, 1999, ANNU REV MED, V50, P507; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; Wong BR, 1999, J LEUKOCYTE BIOL, V65, P715, DOI 10.1002/jlb.65.6.715; Yanagawa Y, 2002, BLOOD, V100, P1948, DOI 10.1182/blood-2002-01-0260; Yanagawa Y, 2003, BLOOD, V101, P4923, DOI 10.1182/blood-2002-11-3474; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	61	198	219	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2005	22	4					493	505		10.1016/j.immuni.2005.02.010	http://dx.doi.org/10.1016/j.immuni.2005.02.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	923KU	15845453	Bronze			2022-12-18	WOS:000228909600010
J	Ramakrishnan, P; Wang, WX; Wallach, D				Ramakrishnan, P; Wang, WX; Wallach, D			Receptor-specific signaling for both the alternative and the canonical NF-kappa B activation pathways by NF-kappa B-inducing kinase	IMMUNITY			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; NECROSIS-FACTOR RECEPTOR; ALYMPHOPLASIA ALY MICE; NF-KAPPA-B2 P100; IKK-ALPHA; TRANSCRIPTIONAL ACTIVITY; TNF RECEPTOR; EXPRESSION; RELB; GENE	The NF-kappaB-inducing kinase (NIK) induces proteolytic processing of NF-kappaB2/p100 and, hence,the generation of NF-kappaB dimers such as p52:RelB but was suggested not to signal for the processing Of IkappaB. Here, we show that although the induction Of IKB degradation in lymphocytes by TNF is independent of NIK, its induction by CD70, CD40 ligand, and BLyS/BAFF, which all also induce NF-kappaB2/p100 processing, does depend on NIK function. Both CD70 and TNF induce recruitment of the IKK kinase complex to their receptors. In the case of CD70, but not TNF, this process is associated with NIK recruitment and is followed by prolonged receptor association of just IKK1 and NIK. Recruitment of the IKK complex to CD27, but not that of NIK, depends on NIK kinase function. Our findings indicate that NIK participates in a unique set of proximal signaling events initiated by specific inducers, which activate both canonical and noncanonical NF-kappaB dimers.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Wallach, D (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	d.wallach@weizmann.ac.il	Ramakrishnan, Parameswaran/AAB-9083-2020	Wang, Wang-Xia/0000-0002-8104-3779; Ramakrishnan, Parameswaran/0000-0002-1314-827X				Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; de Wit H, 1998, LEUKEMIA, V12, P363, DOI 10.1038/sj.leu.2400950; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Erlichman B, 1999, CYTOKINE, V11, P476, DOI 10.1006/cyto.1998.0449; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; FANSLOW WC, 1994, J IMMUNOL, V152, P4262; Garceau N, 2000, J EXP MED, V191, P381, DOI 10.1084/jem.191.2.381; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Karrer U, 2000, EUR J IMMUNOL, V30, P2799, DOI 10.1002/1521-4141(200010)30:10<2799::AID-IMMU2799>3.0.CO;2-2; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Leonardi A, 2002, ENDOCRINOLOGY, V143, P2169, DOI 10.1210/en.143.6.2169; LIN RT, 1995, J BIOL CHEM, V270, P3123, DOI 10.1074/jbc.270.7.3123; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Matsumoto M, 1999, J IMMUNOL, V163, P1584; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; PERKINS ND, 1992, P NATL ACAD SCI USA, V89, P1529, DOI 10.1073/pnas.89.5.1529; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Saito N, 2003, J BIOL CHEM, V278, P46565, DOI 10.1074/jbc.M302549200; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Smith C, 2001, J IMMUNOL, V167, P5895, DOI 10.4049/jimmunol.167.10.5895; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang YQ, 2002, NAT CELL BIOL, V4, P888, DOI 10.1038/ncb872; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	50	198	209	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2004	21	4					477	489		10.1016/j.immuni.2004.08.009	http://dx.doi.org/10.1016/j.immuni.2004.08.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485626	Bronze			2022-12-18	WOS:000224744400005
J	Usui, T; Nishikomori, R; Kitani, A; Strober, W				Usui, T; Nishikomori, R; Kitani, A; Strober, W			GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12R beta 2 chain or T-bet	IMMUNITY			English	Article							IFN-GAMMA PRODUCTION; TRANSCRIPTION FACTOR GATA-3; LINEAGE COMMITMENT; CYTOKINE RESPONSES; INTERFERON-GAMMA; GENE-EXPRESSION; TRANSGENIC MICE; CUTTING EDGE; CELLS; IL-4	To further understand the interaction among GATA-3, Stat4, and T-bet in helper T cell development, we first showed that retroviral expression of GATA-3 in developing Th1 cells suppresses Th1 development through downregulation of Stat4 rather through downregulation of the IL-12Rbeta2 chain. Correspondingly, Stat4 levels are greatly suppressed during physiological Th2 development. Then, using cells doubly infected with GFP- and YFP-expressing retroviruses, we showed that retroviral GATA-3 expression in developing Th1 cells does not block Th1 development in cells coexpressing Stat4 but does so in cells coexpressing T-bet. Finally, we showed that retroviral Stat4 expression could facilitate Th2-->Th1 conversion in cells bearing an IL-12Rbeta2 transgene, even in cells lacking T-bet. These findings reassert that Stat4 signaling is a central element of Th1/Th2 development.	NIAID, Mucosal Immun Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Strober, W (corresponding author), NIAID, Mucosal Immun Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA.	wstrober@niaid.nih.gov	Nishikomori, Ryuta/N-4039-2018; Nishikomori, Ryuta/AAM-5771-2020	Nishikomori, Ryuta/0000-0002-9407-6158; Nishikomori, Ryuta/0000-0002-9407-6158	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000872, ZIAAI000872] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Chtanova T, 2001, J IMMUNOL, V167, P3057, DOI 10.4049/jimmunol.167.6.3057; Ferber IA, 1999, CLIN IMMUNOL, V91, P134, DOI 10.1006/clim.1999.4718; Glimcher LH, 2000, GENE DEV, V14, P1693; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Heath VL, 2000, J IMMUNOL, V164, P2861, DOI 10.4049/jimmunol.164.6.2861; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nishikomori R, 2000, J EXP MED, V191, P847, DOI 10.1084/jem.191.5.847; Nishikomori R, 2001, J IMMUNOL, V166, P6776, DOI 10.4049/jimmunol.166.11.6776; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Usui T, 1997, J IMMUNOL, V158, P3197; Wirtz S, 1999, J IMMUNOL, V162, P1884; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	35	198	203	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2003	18	3					415	428		10.1016/S1074-7613(03)00057-8	http://dx.doi.org/10.1016/S1074-7613(03)00057-8			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	658GR	12648458	Bronze			2022-12-18	WOS:000181713700011
J	Gao, B; Adhikari, R; Howarth, M; Nakamura, K; Gold, MC; Hill, AB; Knee, R; Michalak, M; Elliott, T				Gao, B; Adhikari, R; Howarth, M; Nakamura, K; Gold, MC; Hill, AB; Knee, R; Michalak, M; Elliott, T			Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin	IMMUNITY			English	Article							COMPLEX CLASS-I; ENDOPLASMIC-RETICULUM; PEPTIDE-BINDING; CONFORMATIONAL CHANGE; ALPHA-2 DOMAIN; HEAVY-CHAIN; CALNEXIN; TAPASIN; PROTEINS; ERP57	MHC class I molecules expressed in a calreticulin-deficient cell line (K42) assembled with beta2-microglobulin (beta2-m) normally, but their subsequent loading with optimal peptides was defective. Suboptimally loaded class I molecules were released into the secretory pathway. This occurred despite the ability of newly synthesized class I to interact with the transporter associated with antigen processing (TAP) loading complex. The efficiency of peptide loading was reduced by 50%-80%, and impaired T cell recognition was observed for three out of four antigens tested. The peptide-loading function was specific to calreticulin, since the defect in K42 could be rectified by transfection with calreticulin but not a soluble form of calnexin, which shares its lectin-like activity.	Univ Oxford, Inst Mol Med, Nuffield Dept Clin Med, John Radcliffe Hosp, Oxford OX3 9DS, England; Univ Southampton, Southampton Gen Hosp, Sch Med, CRC Med Oncol Unit, Southampton SO16 6YD, Hants, England; Univ Southampton, Southampton Gen Hosp, Sch Med, Canc Sci Div, Southampton SO16 6YD, Hants, England; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Oregon Hlth Sci Univ, Portland, OR 97201 USA	University of Oxford; University of Southampton; University of Southampton; University of Alberta; Oregon Health & Science University	Elliott, T (corresponding author), Univ Oxford, Inst Mol Med, Nuffield Dept Clin Med, John Radcliffe Hosp, Oxford OX3 9DS, England.			, Kimitoshi/0000-0003-4903-2428; Slater, Marielle/0000-0003-2505-3291; Elliott, Tim/0000-0003-1097-0222				Androlewicz MJ, 1999, IMMUNOL RES, V20, P79, DOI 10.1007/BF02786464; Basu S, 1999, J EXP MED, V189, P797, DOI 10.1084/jem.189.5.797; CERUNDOLO V, 1991, EUR J IMMUNOL, V21, P2069, DOI 10.1002/eji.1830210915; Danilczyk UG, 2000, J BIOL CHEM, V275, P13089, DOI 10.1074/jbc.275.17.13089; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; ELLIOTT T, 1991, NATURE, V351, P402, DOI 10.1038/351402a0; Farmery MR, 2000, J BIOL CHEM, V275, P14933, DOI 10.1074/jbc.275.20.14933; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; Harris MR, 1998, J IMMUNOL, V160, P5404; HSU VW, 1991, NATURE, V352, P441, DOI 10.1038/352441a0; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kavanagh DG, 2001, J EXP MED, V194, P967, DOI 10.1084/jem.194.7.967; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Li SL, 1999, J BIOL CHEM, V274, P8649, DOI 10.1074/jbc.274.13.8649; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; Menoret A, 2001, J BIOL CHEM, V276, P33313, DOI 10.1074/jbc.M103383200; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; Nair S, 1999, J IMMUNOL, V162, P6426; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Pentcheva T, 2001, J IMMUNOL, V166, P6625, DOI 10.4049/jimmunol.166.11.6625; Rigney E, 1998, J BIOL CHEM, V273, P14200, DOI 10.1074/jbc.273.23.14200; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; SALTER RD, 1994, IMMUNOGENETICS, V39, P266; Spee P, 1997, EUR J IMMUNOL, V27, P2441, DOI 10.1002/eji.1830270944; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; TECTOR M, 1995, J BIOL CHEM, V270, P19638, DOI 10.1074/jbc.270.33.19638; TOWNSEND A, 1989, COLD SH Q B, V54, P299; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Wilson CM, 2000, J BIOL CHEM, V275, P21224, DOI 10.1074/jbc.M000567200; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Yu YYL, 1999, J IMMUNOL, V163, P4427; Zhang Q, 1998, J IMMUNOL, V160, P831	42	198	205	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2002	16	1					99	109		10.1016/S1074-7613(01)00260-6	http://dx.doi.org/10.1016/S1074-7613(01)00260-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825569	Bronze			2022-12-18	WOS:000173575700010
J	Wang, YF; Kelly, CG; Karttunen, JT; Whittall, T; Lehner, PJ; Duncan, L; MacAry, P; Younson, JS; Singh, M; Oehlmann, W; Cheng, GH; Bergmeier, L; Lehner, T				Wang, YF; Kelly, CG; Karttunen, JT; Whittall, T; Lehner, PJ; Duncan, L; MacAry, P; Younson, JS; Singh, M; Oehlmann, W; Cheng, GH; Bergmeier, L; Lehner, T			CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines	IMMUNITY			English	Article							NF-KAPPA-B; DENDRITIC CELLS; ESCHERICHIA-COLI; INNATE IMMUNITY; CUTTING EDGE; T-CELLS; ACTIVATION; HSP70; LIPOPOLYSACCHARIDE; ANTIGEN	The 70 kDa mycobacterial heat shock protein (Mtb HSP70) stimulates mononuclear cells to release CC-chemokines. We now show that this function of Mtb HSP70, but not human HSP70, is dependent on the cell surface expression of CD40. Deletion of the CD40 cytoplasmic tail abolished, and CD40 antibody inhibited, Mtb HSP70 stimulation of CC-chemokine release. Mtb HSP70 stimulated THP1, KG1 cells, and monocyte-derived dendritic cells to produce RANTES. Specific binding of CD40-transfected HEK 293 cells to Mtb HSP70 was demonstrated by surface plasmon resonance. Coimmunoprecipitation of Mtb HSP70 with CD40 indicates a physical association between these molecules. The results suggest that CD40 is critical in microbial HSP70 binding and stimulation of RANTES production.	KCL, Guys Kings & St Thomas Med Sch, Dept Oral Med, Peter Gorer Dept Immunobiol, London, England; KCL, Guys Kings & St Thomas Med Sch, Dept Oral Med, Immunol Unit, London, England; Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Pathol,Div Immunol, Cambridge CB2 2QQ, England; Lionex Diagnost & Therapeut GmbH, Braunschweig, Germany; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA	University of London; King's College London; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Lionex Diagnostics & Therapeutics GmbH; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Lehner, T (corresponding author), KCL, Guys Kings & St Thomas Med Sch, Dept Oral Med, Peter Gorer Dept Immunobiol, London, England.			Whittall, Trevor/0000-0002-2189-3675; Lehner, Paul Joseph/0000-0001-9383-1054; MacAry, Paul/0000-0002-1139-8996				Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Binder RJ, 2000, J IMMUNOL, V165, P2582, DOI 10.4049/jimmunol.165.5.2582; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; CLUPITU AMT, 1998, J EXP MED, V187, P685; Fujihara SM, 1999, EMBO J, V18, P411, DOI 10.1093/emboj/18.2.411; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Herold KC, 1997, J IMMUNOL, V159, P4150; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Huang Q, 2000, J EXP MED, V191, P403, DOI 10.1084/jem.191.2.403; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; KIENER PA, 1995, J IMMUNOL, V155, P4917; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; KOMBLUTH RS, 1998, P NATL ACAD SCI USA, V95, P5205; Lee HH, 1999, P NATL ACAD SCI USA, V96, P1421, DOI 10.1073/pnas.96.4.1421; Lehner T, 2000, EUR J IMMUNOL, V30, P594, DOI 10.1002/1521-4141(200002)30:2<594::AID-IMMU594>3.3.CO;2-T; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LUSSOW AR, 1991, EUR J IMMUNOL, V21, P2297, DOI 10.1002/eji.1830211002; McDyer JF, 1999, J IMMUNOL, V162, P3711; MCLEISH KR, 1989, INFLAMMATION, V13, P681, DOI 10.1007/BF00914312; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; PERRAUT R, 1993, CLIN EXP IMMUNOL, V93, P382, DOI 10.1111/j.1365-2249.1993.tb08189.x; Pilon M, 1999, CELL, V97, P679, DOI 10.1016/S0092-8674(00)80780-1; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Seo JK, 1997, J IMMUNOL, V158, P1895; SINGH M, 1992, GENE, V117, P53, DOI 10.1016/0378-1119(92)90489-C; St Louis DC, 1999, J IMMUNOL, V162, P3237; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Suzue K, 1996, J IMMUNOL, V156, P873; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; Verani A, 1997, J EXP MED, V185, P805, DOI 10.1084/jem.185.5.805; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang RB, 1999, J IMMUNOL, V163, P639; Young LS, 1998, IMMUNOL TODAY, V19, P502, DOI 10.1016/S0167-5699(98)01340-1; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	50	198	219	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2001	15	6					971	983		10.1016/S1074-7613(01)00242-4	http://dx.doi.org/10.1016/S1074-7613(01)00242-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754818	Bronze			2022-12-18	WOS:000172961400011
J	SUZUKI, H; PUNT, JA; GRANGER, LG; SINGER, A				SUZUKI, H; PUNT, JA; GRANGER, LG; SINGER, A			ASYMMETRIC SIGNALING REQUIREMENTS FOR THYMOCYTE COMMITMENT TO THE CD4(+) VERSUS CD8(+) T-CELL LINEAGES - A NEW PERSPECTIVE ON THYMIC COMMITMENT AND SELECTION	IMMUNITY			English	Article							CLASS-II MOLECULES; DEFICIENT MICE; INSTRUCTIVE MODEL; DIFFERENTIATION; EXPRESSION; RECEPTOR; BETA-2-MICROGLOBULIN; ASSOCIATION; LYMPHOCYTES; INDUCTION	Differentiation of immature CD4(+)CD8(+) thymocytes into mature CD4(+)CD8(-) and CD4(-)CD8(+) T cells requires that synthesis of one or the other coreceptor molecule be terminated, a process referred to as lineage commitment. The present study has utilized a novel coreceptor reexpression assay to identify lineage commitment in immature thymocytes and has found that the MHC recognition requirements for CD4 commitment and CD8 commitment fundamentally differ from one another. Remarkably, we found that thymocyte commitment to the CD8(+) lineage requires MHC class I-dependent instructional signals, whereas thymocyte commitment to the CD4(+) lineage is MHC independent and may occur by default. In addition, an unanticipated relationship between lineage commitment and surface phenotype has been identified. These results are incompatible with current concepts and require a new perspective on lineage commitment and positive selection, which we refer to as asymmetric commitment.			SUZUKI, H (corresponding author), NCI,EXPTL IMMUNOL BRANCH,BLDG 10,BETHESDA,MD 20892, USA.		Suzuki, Harumi/L-1271-2013	Suzuki, Harumi/0000-0003-3616-9361				ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; BARON A, 1994, EUR J IMMUNOL, V24, P1933, DOI 10.1002/eji.1830240834; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; CHAN HC, 1994, EMBO J, V13, P4482; CHAN IT, 1993, SCIENCE, V261, P1581, DOI 10.1126/science.8372352; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CHAN SH, 1993, IMMUNOL REV, V135, P119, DOI 10.1111/j.1600-065X.1993.tb00646.x; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; CROOKS MEC, 1994, IMMUNITY, V1, P277; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; DAVIS CB, 1994, CURR OPIN IMMUNOL, V6, P266, DOI 10.1016/0952-7915(94)90100-7; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; FUNGLEUNG WP, 1994, J EXP MED, V180, P959, DOI 10.1084/jem.180.3.959; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; ITANO A, 1994, P NATL ACAD SCI USA, V91, P220, DOI 10.1073/pnas.91.1.220; KARLSSON L, 1991, NATURE, V351, P485, DOI 10.1038/351485a0; KAVATHAS P, 1984, P NATL ACAD SCI-BIOL, V81, P7688, DOI 10.1073/pnas.81.24.7688; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KEARSE KP, 1995, J EXP MED, V181, P193, DOI 10.1084/jem.181.1.193; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KOLLER BH, 1990, SCIENCE, V248, P1127; KYEWSKI BA, 1993, EUR J IMMUNOL, V23, P1661; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; MCCARTHY SA, 1988, J IMMUNOL, V141, P3737; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; PUNT JA, 1994, J EXP MED, V180, P587, DOI 10.1084/jem.180.2.587; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; ROBEY E, 1994, J EXP MED, V179, P1997, DOI 10.1084/jem.179.6.1997; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; SEONG RH, 1992, NATURE, V356, P718, DOI 10.1038/356718a0; TAKAHAMA Y, 1994, NATURE, V371, P67, DOI 10.1038/371067a0; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; VONBOEHMER H, 1993, CELL, V73, P207, DOI 10.1016/0092-8674(93)90220-K; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; WILLIAMS DB, 1989, J IMMUNOL, V142, P2796; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	43	198	198	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1995	2	4					413	425		10.1016/1074-7613(95)90149-3	http://dx.doi.org/10.1016/1074-7613(95)90149-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU616	7719943	Bronze			2022-12-18	WOS:A1995QU61600011
J	McGovern, N; Schlitzer, A; Gunawan, M; Jardine, L; Shin, A; Poyner, E; Green, K; Dickinson, R; Wang, XN; Low, D; Best, K; Covins, S; Milne, P; Pagan, S; Aljefri, K; Windebank, M; Saavedra, DM; Larbi, A; Wasan, PS; Duan, K; Poidinger, M; Bigley, V; Ginhoux, F; Collin, M; Haniffa, M				McGovern, Naomi; Schlitzer, Andreas; Gunawan, Merry; Jardine, Laura; Shin, Amanda; Poyner, Elizabeth; Green, Kile; Dickinson, Rachel; Wang, Xiao-nong; Low, Donovan; Best, Katie; Covins, Samuel; Milne, Paul; Pagan, Sarah; Aljefri, Khadija; Windebank, Martin; Saavedra, Diego Miranda; Larbi, Anis; Wasan, Pavandip Singh; Duan, Kaibo; Poidinger, Michael; Bigley, Venetia; Ginhoux, Florent; Collin, Matthew; Haniffa, Muzlifah			Human Dermal CD14(+) Cells Are a Transient Population of Monocyte-Derived Macrophages	IMMUNITY			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; ANTIGEN-PRESENTING CELLS; STEADY-STATE; FUNCTIONAL SPECIALIZATION; TISSUE MACROPHAGES; LANGERHANS CELLS; MOUSE; SKIN; DIFFERENTIATION; REVEALS	Dendritic cells (DCs), monocytes, and macrophages are leukocytes with critical roles in immunity and tolerance. The DC network is evolutionarily conserved; the homologs of human tissue CD141(hi) XCR1(+)CLEC9A(+) DCs and CD1c(+) DCs are murine CD103(+) DCs and CD64(-)CD11b(+) DCs. In addition, human tissues also contain CD14(+) cells, currently designated as DCs, with an as-yet unknown murine counterpart. Here we have demonstrated that human dermal CD14(+) cells are a tissue-resident population of monocyte-derived macrophages with a short half-life of <6 days. The decline and reconstitution kinetics of human blood CD14(+) monocytes and dermal CD14(+) cells in vivo supported their precursor-progeny relationship. The murine homologs of human dermal CD14(+) cells are CD11b(+) CD64(+) monocyte-derived macrophages. Human and mouse monocytes and macrophages were defined by highly conserved gene transcripts, which were distinct from DCs. The demonstration of monocyte-derived macrophages in the steady state in human tissue supports a conserved organization of human and mouse mononuclear phagocyte system.	[McGovern, Naomi; Gunawan, Merry; Jardine, Laura; Poyner, Elizabeth; Green, Kile; Dickinson, Rachel; Wang, Xiao-nong; Best, Katie; Covins, Samuel; Milne, Paul; Pagan, Sarah; Aljefri, Khadija; Windebank, Martin; Saavedra, Diego Miranda; Wasan, Pavandip Singh; Bigley, Venetia; Collin, Matthew; Haniffa, Muzlifah] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [McGovern, Naomi; Schlitzer, Andreas; Shin, Amanda; Low, Donovan; Larbi, Anis; Duan, Kaibo; Poidinger, Michael; Ginhoux, Florent] ASTAR, Singapore Immunol Network, Singapore 138648, Singapore; [Poidinger, Michael] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Newcastle University - UK; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore	Collin, M (corresponding author), Newcastle Univ, Sch Med, Inst Cellular Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	matthew.collin@newcastle.ac.uk; m.a.haniffa@newcastle.ac.uk	Bigley, Venetia/AAU-9738-2020; Larbi, Anis/ABE-5868-2020; Schlitzer, Andreas/R-2237-2016	Bigley, Venetia/0000-0002-3017-2474; Schlitzer, Andreas/0000-0001-7662-3712; Green, Kile/0000-0002-4777-5458; McGovern, Naomi/0000-0001-5200-2698; Poidinger, Michael/0000-0002-1047-2277; Milne, Paul/0000-0002-8278-0463	Wellcome Trust, UK [WT088555MA]; British Skin Foundation; Singapore Immunology Network core grant; Leukaemia and Lymphoma Research UK; Histiocytosis Association and Histiocytosis Research Trust; AXA Research Fund; Wellcome Trust [101155/Z/13/Z] Funding Source: researchfish	Wellcome Trust, UK(Wellcome Trust); British Skin Foundation; Singapore Immunology Network core grant; Leukaemia and Lymphoma Research UK; Histiocytosis Association and Histiocytosis Research Trust; AXA Research Fund(AXA Research Fund); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by: The Wellcome Trust, UK (WT088555MA; M. H. and N.M.); British Skin Foundation (M. H. and M. G.); Singapore Immunology Network core grant (F. G.); Leukaemia and Lymphoma Research UK (S. P.); Histiocytosis Association and Histiocytosis Research Trust (M. C. and P. M.) and AXA Research Fund (M. C. and M. G.). We thank the following for assistance: D. McDonald and A. Fuller at the Flow Cytometry Core Facility of the Faculty of Medicine Newcastle University; T. Booth and A. Laude of the Bio-imaging Unit, Newcastle University; I. Low and N. Binte Shadan of the Flow Cytometry Core Service, Singapore Immunology Network and D. Lilic, and F. Ahmad, Newcastle University for reagents. We thank the Departments of Dermatology, Plastic Surgery and Haematology, Newcastle upon Tyne NHS Trust for clinical material.	Angel CE, 2006, J IMMUNOL, V176, P5730, DOI 10.4049/jimmunol.176.10.5730; Autissier P, 2010, J IMMUNOL METHODS, V360, P119, DOI 10.1016/j.jim.2010.06.017; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; de Gruijl TD, 2006, J IMMUNOL, V176, P7232, DOI 10.4049/jimmunol.176.12.7232; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Han B, 2002, AM J PATHOL, V161, P481, DOI 10.1016/S0002-9440(10)64204-6; Haniff M, 2009, J EXP MED, V206, P371, DOI 10.1084/jem.20081633; Haniffa M, 2013, ADV IMMUNOL, V120, P1, DOI 10.1016/B978-0-12-417028-5.00001-6; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jardine L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00495; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Morelli AE, 2005, J IMMUNOL, V175, P7905, DOI 10.4049/jimmunol.175.12.7905; NESTLE FO, 1993, J IMMUNOL, V151, P6535; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Penel-Sotirakis K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045680; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Stoitzner P, 1999, J LEUKOCYTE BIOL, V66, P462, DOI 10.1002/jlb.66.3.462; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wang XN, 2014, J INVEST DERMATOL, V134, P965, DOI 10.1038/jid.2013.481; Watchmaker PB, 2014, NAT IMMUNOL, V15, P98, DOI 10.1038/ni.2768; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	51	197	200	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					465	477		10.1016/j.immuni.2014.08.006	http://dx.doi.org/10.1016/j.immuni.2014.08.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25200712	hybrid, Green Published			2022-12-18	WOS:000342626500016
J	Di Meglio, P; Duarte, JH; Ahlfors, H; Owens, NDL; Li, Y; Villanova, F; Tosi, I; Hirota, K; Nestle, FO; Mrowietz, U; Gilchrist, MJ; Stockinger, B				Di Meglio, Paola; Duarte, Joao H.; Ahlfors, Helena; Owens, Nick D. L.; Li, Ying; Villanova, Federica; Tosi, Isabella; Hirota, Keiji; Nestle, Frank O.; Mrowietz, Ulrich; Gilchrist, Michael J.; Stockinger, Brigitta			Activation of the Aryl Hydrocarbon Receptor Dampens the Severity of Inflammatory Skin Conditions	IMMUNITY			English	Article							DELTA T-CELLS; PSORIASIS-VULGARIS LESIONS; PLAQUE-FORMATION; GENE-EXPRESSION; IN-VITRO; GAMMA; MICE; INSIGHTS; AXIS; 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN	Environmental stimuli are known to contribute to psoriasis pathogenesis and that of other autoimmune diseases, but the mechanisms are largely unknown. Here we show that the aryl hydrocarbon receptor (AhR), a transcription factor that senses environmental stimuli, modulates pathology in psoriasis. AhR-activating ligands reduced inflammation in the lesional skin of psoriasis patients, whereas AhR antagonists increased inflammation. Similarly, AhR signaling via the endogenous ligand FICZ reduced the inflammatory response in the imiquimod-induced model of skin inflammation and AhR-deficient mice exhibited a substantial exacerbation of the disease, compared to AhR-sufficient controls. Nonhematopoietic cells, in particular keratinocytes, were responsible for this hyperinflammatory response, which involved upregulation of AP-1 family members of transcription factors. Thus, our data suggest a critical role for AhR in the regulation of inflammatory responses and open the possibility for novel therapeutic strategies in chronic inflammatory disorders.	[Di Meglio, Paola; Duarte, Joao H.; Ahlfors, Helena; Li, Ying; Hirota, Keiji; Stockinger, Brigitta] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Owens, Nick D. L.; Gilchrist, Michael J.] Natl Inst Med Res, MRC, Div Syst Biol, London NW7 1AA, England; [Villanova, Federica; Tosi, Isabella; Nestle, Frank O.] Kings Coll London, St Johns Inst Dermatol, London SE1 9RT, England; [Villanova, Federica; Tosi, Isabella; Nestle, Frank O.] NIHR Biomed Res Ctr, London SE1 9RT, England; [Mrowietz, Ulrich] Univ Med Ctr Schleswig Holstein, Psoriasis Ctr, Dept Dermatol, D-24105 Kiel, Germany	MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of London; King's College London; University of Kiel; Schleswig Holstein University Hospital	Stockinger, B (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, Mill Hill, London NW7 1AA, England.	bstocki@nimr.mrc.ac.uk		Ahlfors, Helena/0000-0002-8183-0895; Stockinger, Brigitta/0000-0001-8781-336X; Di Meglio, Paola/0000-0002-2066-7780; Duarte, Joao H./0000-0001-7186-4947; Hirota, Keiji/0000-0002-4737-0661	ERC [232782]; Medical Research Council [U117597137]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's; St Thomas' NHS Foundation Trust; King's College London; MRC [MC_U117597137] Funding Source: UKRI; Medical Research Council [MC_U117597137] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's(National Institute for Health Research (NIHR)); St Thomas' NHS Foundation Trust; King's College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by ERC Advanced Investigator Grant 232782 to B.S. M.J.G. and N.D.L.O. are supported by the Medical Research Council (U117597137). F.O.N, F. V., and I. T. are supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. We would like to thank the Biological Services for breeding and maintenance of our mouse strains. We furthermore acknowledge technical support by the FACS facility, Histology facility, and High Throughput Sequencing Group at the NIMR. We are grateful to psoriatic patients and healthy volunteers for their participation. We thank S. K. Mrowietz for technical assistance, M. Jaskolski and L.-M. Philipp at the Psoriasis Center, University Medical Center Schleswig-Holstein, for help with psoriatic biopsy collection and processing, D. Pennino and H. Sreeneebus at St. John's Institute of Dermatology for provision of human primary keratinocytes and for healthy skin collection, respectively, and J. Krutmann at the Leibniz Research Institute for Environmental Medicine in Dusseldorf (Germany) for provision of AhR-silenced and EV-HaCaT cell lines.	Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Bata-Csorgo Z., 2012, EXPERT REV DERMATOL, V7, P473, DOI [10.1586/edm.12.48, DOI 10.1586/EDM.12.48]; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Di Meglio P, 2011, IMMUNITY, V35, P857, DOI 10.1016/j.immuni.2011.12.003; Duarte JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079819; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; GILLNER M, 1985, MOL PHARMACOL, V28, P357; Girardi M, 2006, J INVEST DERMATOL, V126, P808, DOI 10.1038/sj.jid.5700120; Gudjonsson JE, 2007, J INVEST DERMATOL, V127, P1292, DOI 10.1038/sj.jid.5700807; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Hahn ME, 2006, J EXP ZOOL PART A, V305A, P693, DOI 10.1002/jez.a.323; Haider AS, 2006, J INVEST DERMATOL, V126, P912, DOI 10.1038/sj.jid.5700183; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Johnson-Huang LM, 2012, J INVEST DERMATOL, V132, P1177, DOI 10.1038/jid.2011.458; Kadow S, 2011, J IMMUNOL, V187, P3104, DOI 10.4049/jimmunol.1100912; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Katiyar SK, 2000, J INVEST DERMATOL, V114, P328, DOI 10.1046/j.1523-1747.2000.00876.x; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Mitchell KA, 2009, BIOCHEM PHARMACOL, V77, P947, DOI 10.1016/j.bcp.2008.10.028; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rannug A, 2006, BIOL CHEM, V387, P1149, DOI 10.1515/BC.2006.143; Swindell WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-527; Swindell WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018266; Tagami H, 1997, CLIN DERMATOL, V15, P677, DOI 10.1016/S0738-081X(97)00024-2; Tauchi M, 2005, MOL CELL BIOL, V25, P9360, DOI 10.1128/MCB.25.21.9360-9368.2005; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Tseng HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057955; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van den Bogaard EH, 2013, J CLIN INVEST, V123, P917, DOI 10.1172/JCI65642; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Walter A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2566; Wang AY, 2013, CELL MICROBIOL, V15, P779, DOI 10.1111/cmi.12071; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110	50	197	204	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					989	1001		10.1016/j.immuni.2014.04.019	http://dx.doi.org/10.1016/j.immuni.2014.04.019			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24909886	hybrid, Green Published			2022-12-18	WOS:000341440200019
J	Lei, Y; Wen, HT; Yu, YB; Taxman, DJ; Zhang, L; Widman, DG; Swanson, KV; Wen, KW; Damania, B; Moore, CB; Giguere, PM; Siderovski, DP; Hiscott, J; Razani, B; Semenkovich, CF; Chen, X; Ting, JPY				Lei, Yu; Wen, Haitao; Yu, Yanbao; Taxman, Debra J.; Zhang, Lu; Widman, Douglas G.; Swanson, Karen V.; Wen, Kwun-Wah; Damania, Blossom; Moore, Chris B.; Giguere, Patrick M.; Siderovski, David P.; Hiscott, John; Razani, Babak; Semenkovich, Clay F.; Chen, Xian; Ting, Jenny P. -Y.			The Mitochondrial Proteins NLRX1 and TUFM Form a Complex that Regulates Type I Interferon and Autophagy	IMMUNITY			English	Article							ANTIVIRAL IMMUNE-RESPONSES; ELONGATION-FACTOR TU; LEUCINE-RICH REPEAT; HEPATITIS-C VIRUS; NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; NUCLEOTIDE-BINDING; INNATE IMMUNITY; RNA	The mitochondrial protein MAVS (also known as IPS-1, VISA, and CARDIF) interacts with RIG-I-like receptors (RLRs) to induce type I interferon (IFN-I). NLRX1 is a mitochondrial nucleotide-binding, leucine-rich repeats (NLR)-containing protein that attenuates MAVS-RLR signaling. Using Nlrx1(-/-) cells, we confirmed that NLRX1 attenuated IFN-I production, but additionally promoted autophagy during viral infection. This dual function of NLRX1 paralleled the previously described functions of the autophagy-related proteins Atg5-Atg12, but NLRX1 did not associate with Atg5-Atg12. High-throughput quantitative mass spectrometry and endogenous protein-protein interaction revealed an NLRX1-interacting partner, mitochondrial Tu translation elongation factor (TUFM). TUFM interacted with Atg5-Atg12 and Atg16L1 and has similar functions as NLRX1 by inhibiting RLR-induced IFN-I but promoting autophagy. In the absence of NLRX1, increased IFN-I and decreased autophagy provide an advantage for host defense against vesicular stomatitis virus. This study establishes a link between an NLR protein and the viral-induced autophagic machinery via an intermediary partner, TUFM.	[Lei, Yu; Wen, Haitao; Taxman, Debra J.; Zhang, Lu; Widman, Douglas G.; Swanson, Karen V.; Wen, Kwun-Wah; Damania, Blossom; Siderovski, David P.; Chen, Xian; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Yu, Yanbao; Chen, Xian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Taxman, Debra J.; Wen, Kwun-Wah; Damania, Blossom; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Giguere, Patrick M.; Siderovski, David P.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Moore, Chris B.] GlaxoSmithKline, Ctr Excellence Drug Discovery, Res Triangle Pk, NC 27709 USA; [Hiscott, John] VGTI Florida, Port St Lucie, FL 34987 USA; [Razani, Babak; Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63105 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline; Vaccine & Gene Therapy Institute of Florida; Washington University (WUSTL)	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jpyting@gmail.com	Lei, Yu Leo/ABF-1293-2020; Siderovski, David Peter/AAA-9603-2019; Yu, Yanbao/G-3035-2010; Wen, Haitao/AAJ-7621-2020; Zhang, Lu/P-6929-2015	Lei, Yu Leo/0000-0002-9868-9824; Siderovski, David Peter/0000-0002-0688-8210; Yu, Yanbao/0000-0003-2994-1974; Widman, Douglas/0000-0002-3585-6373; Semenkovich, Clay/0000-0003-1163-1871; Swanson, Karen V/0000-0003-3105-0599; Razani, Babak/0000-0002-7172-9240	NIH [U54-AI057157, U19AI077437, U19AI067798, CA156330, R01AI064806, 1U24CA160035, DE018281, F32-AI094941]; American Heart Association; Mid-Atlantic Affiliate; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA156330, U24CA160035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064806, U19AI077437, F32AI094941, U19AI067798, U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076729, R01DK088083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Mid-Atlantic Affiliate; Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants U54-AI057157 (SERCEB), U19AI077437, U19AI067798, and CA156330 awarded to J.P.-Y.T., NIH grants R01AI064806 and 1U24CA160035 awarded to X.C., NIH grant DE018281 awarded to J.P.-Y.T. and B.D., and NIH grant F32-AI094941 awarded to D.G.W. H.W. is supported by the Postdoctoral Fellowship of the American Heart Association, Mid-Atlantic Affiliate, and Postdoctoral Fellowship of the Cancer Research Institute. We thank H. Shu for providing MITA and ISRE reporter plasmids, N. Takeuchi for the TUFM expression plasmid, F. Takeshita for the Atg5 and Atg12 expression plasmids, N. Mizushima for mice with the floxed Atg5 locus, and D. Baltimore for the FG12 lentiviral vector plasmid.	Alirezaei M, 2012, CELL HOST MICROBE, V11, P298, DOI 10.1016/j.chom.2012.01.014; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Bhargava K, 2004, PROTEIN EXPRES PURIF, V37, P368, DOI 10.1016/j.pep.2004.06.030; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen X, 2000, ANAL CHEM, V72, P1134, DOI 10.1021/ac9911600; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Sanjuan MA, 2008, AUTOPHAGY, V4, P607, DOI 10.4161/auto.6397; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Suzuki H, 2007, J BIOL CHEM, V282, P4076, DOI 10.1074/jbc.M608187200; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; WELLS J, 1995, FEBS LETT, V358, P119, DOI 10.1016/0014-5793(94)01403-N; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; Zhang YN, 2011, AUTOPHAGY, V7, P613, DOI 10.4161/auto.7.6.15267; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008; Zhu HN, 2002, RAPID COMMUN MASS SP, V16, P2115, DOI 10.1002/rcm.831; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	50	197	212	2	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 29	2012	36	6					933	946		10.1016/j.immuni.2012.03.025	http://dx.doi.org/10.1016/j.immuni.2012.03.025			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22749352	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000306097100012
J	Yoneyama, M; Fujita, T				Yoneyama, Mitsutoshi; Fujita, Takashi			Structural mechanism of RNA recognition by the RIG-l-like receptors	IMMUNITY			English	Review							ANTIVIRAL INNATE IMMUNITY; DOUBLE-STRANDED-RNA; RESPONSES; HELICASE; DOMAIN; LGP2; VIRUSES; ACID; MDA5	Cytoplasmic nonself RNA, such as that generated by invading viruses, is recognized by a family of sensory molecules termed RIG-l-like Receptors (RLRs). Here, we discuss the mechanism of the RLRs' sensing of nonself RNA. Our findings define three functional domains of RLRs and provide insights into how RLRs function as a molecular switch through interactions with virus-specific RNA ligands.	[Yoneyama, Mitsutoshi; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Inst Virus Res, Mol Genet Lab, Kyoto 6068507, Japan; [Yoneyama, Mitsutoshi; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Mol Cell Biol Lab, Kyoto 6068507, Japan; [Yoneyama, Mitsutoshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Fujita, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Inst Virus Res, Mol Genet Lab, Kyoto 6068507, Japan.	tfujita@virus.kyoto-u.ac.jp	Yoneyama, Mitsutoshi/D-8244-2017	Yoneyama, Mitsutoshi/0000-0001-9512-0408				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Paul Aniko V., 2002, P227; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	19	197	214	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2008	29	2					178	181		10.1016/j.immuni.2008.07.009	http://dx.doi.org/10.1016/j.immuni.2008.07.009			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18701081	Bronze			2022-12-18	WOS:000258610800006
J	Lopez-Rodriguez, C; Aramburu, J; Jin, L; Rakeman, AS; Michino, M; Rao, A				Lopez-Rodriguez, C; Aramburu, J; Jin, L; Rakeman, AS; Michino, M; Rao, A			Bridging the NFAT and NF-kappa B families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress	IMMUNITY			English	Article							CHRONIC-RENAL-FAILURE; NECROSIS-FACTOR-ALPHA; T-CELL-ACTIVATION; CRYSTAL-STRUCTURE; TNF-ALPHA; RECEPTOR; PROTEIN; BINDING; IDENTIFICATION; HEMODIALYSIS	The transcription factor NFAT5/TonEBP is evolutionarily the oldest member of the NFAT/Rel family of transcription factors. We show that NFAT5 is uniquely related to NF-KB and is the only member of the Rel/NFAT family to be activated by osmotic stress. Like Rel/NF-kappaB proteins but unlike the calcium-regulated NFAT proteins, NFAT5 is constitutively dimeric, and dimerization is essential for DNA binding and transcriptional activity. Using dominant-negative proteins that inhibit NFAT5 dimerization, we show that NFAT5 regulates expression of the TNF alpha and lymphotoxin-beta genes in osmotically stressed T cells. Chromatin immunoprecipitation experiments confirm that NFAT5 binds to the TNF alpha promoter in vivo. We suggest that NFAT5 participates in specific aspects of host defense by upregulating TNF family genes and other target genes in T cells.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Pompeu Fabra, Dept Ciences Expt & Salut, Barcelona 08003, Spain; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Pompeu Fabra University; Harvard University	Rao, A (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, 200 Longwood Ave, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu	Lopez-Rodriguez, C/G-4482-2014; Aramburu, J/G-8991-2014	Lopez-Rodriguez, C/0000-0002-2311-2406; Aramburu, J/0000-0001-9279-9523	NATIONAL CANCER INSTITUTE [R37CA042471, R01CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040127] Funding Source: NIH RePORTER; NCI NIH HHS [CA42471] Funding Source: Medline; NIAID NIH HHS [AI40127] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bell CE, 2000, CELL, V101, P801, DOI 10.1016/S0092-8674(00)80891-0; Brauner A, 1996, AM J KIDNEY DIS, V27, P402, DOI 10.1016/S0272-6386(96)90364-9; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; CARUANA RJ, 1992, INT J ARTIF ORGANS, V15, P93, DOI 10.1177/039139889201500206; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chen L, 1999, COLD SPRING HARB SYM, V64, P527, DOI 10.1101/sqb.1999.64.527; Chen TT, 1999, MAR BIOTECHNOL, V1, P1; Chytil M, 1996, CURR OPIN STRUC BIOL, V6, P91, DOI 10.1016/S0959-440X(96)80100-X; DESCAMPSLATSCHA B, 1995, J IMMUNOL, V154, P882; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Haussinger D, 1996, BIOCHEM J, V313, P697; Hedin KE, 1997, J IMMUNOL, V159, P5431; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; INGLIS A, 1995, BURNS, V21, P212, DOI 10.1016/0305-4179(95)80012-D; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; JUNGER WG, 1994, CIRC SHOCK, V42, P190; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Ko BCB, 1997, J BIOL CHEM, V272, P16431, DOI 10.1074/jbc.272.26.16431; Kronfol N. O., 1994, HDB DIALYSIS, P301; Kuprash DV, 1996, J IMMUNOL, V156, P2465; KWON HM, 1995, CURR OPIN CELL BIOL, V7, P465, DOI 10.1016/0955-0674(95)80002-6; Lopez-Rodriguez C, 1999, COLD SPRING HARB SYM, V64, P517, DOI 10.1101/sqb.1999.64.517; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Macian F, 1999, MOL CELL BIOL, V19, P3645, DOI 10.1128/mcb.19.5.3645; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Meyers Alan, 1994, Current Opinion in Pediatrics, V6, P303, DOI 10.1097/00008480-199406000-00012; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; NAKANISHI I, 1994, NEPHROL DIAL TRANSPL, V9, P1435; Neilson J, 2001, CURR OPIN IMMUNOL, V13, P346, DOI 10.1016/S0952-7915(00)00225-9; Nishikawa S, 2000, CURR OPIN IMMUNOL, V12, P342, DOI 10.1016/S0952-7915(00)00097-2; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; PEREIRA BJG, 1994, KIDNEY INT, V45, P890, DOI 10.1038/ki.1994.117; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RYSECK RP, 1995, MOL CELL BIOL, V15, P3100; Screaton G, 2000, CURR OPIN IMMUNOL, V12, P316, DOI 10.1016/S0952-7915(00)00093-5; Sengchanthalangsy LL, 1999, J MOL BIOL, V289, P1029, DOI 10.1006/jmbi.1999.2823; Shapiro L, 1997, EXP CELL RES, V231, P354, DOI 10.1006/excr.1997.3476; Shapiro L, 1995, P NATL ACAD SCI USA, V92, P12230, DOI 10.1073/pnas.92.26.12230; Smolen JS, 1996, SCAND J RHEUMATOL, V25, P1; Takayama F, 1998, KIDNEY INT, V53, P1007, DOI 10.1046/j.1523-1755.1998.00819.x; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422; Zhou P, 1998, CELL, V92, P687, DOI 10.1016/S0092-8674(00)81136-8	55	197	200	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2001	15	1					47	58		10.1016/S1074-7613(01)00165-0	http://dx.doi.org/10.1016/S1074-7613(01)00165-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485737	Bronze			2022-12-18	WOS:000170153300006
J	Matechak, EO; Killeen, N; Hedrick, SM; Fowlkes, BJ				Matechak, EO; Killeen, N; Hedrick, SM; Fowlkes, BJ			MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent	IMMUNITY			English	Article							RECEPTOR TRANSGENIC MICE; ANTIGEN RECEPTOR; THYMOCYTE DEVELOPMENT; IMMATURE THYMOCYTES; NEGATIVE SELECTION; THYMIC SELECTION; DEFICIENT MICE; LYMPHOCYTES; EXPRESSION; MOLECULES	The generation of mature CD4 T cells from CD4(+)CD8(+) precursor thymocytes usually requires corecognition of class II MHC by a TCR and CD4, while the production of mature CD8 T cells requires corecognition of class I MHC by a TCR and CD8. To assess the role of the CD4 coreceptor in development and lineage commitment, we generated CD4-deficient mice expressing a transgenic class Ii-specific TCR. Surprisingly, in the absence of CD4 a large number of T cells mature, but these cells appear in the CD8 lineage. Thus, when CD4 is present, the majority of immature T cells with this class Ii-specific TCR choose the CD4 lineage but develop in the CD8 pathway when CD4 is absent. The results indicate that even for TCRs that are not dependent on coreceptor for MHC recognition, the coreceptor can influence the lineage choice. These findings are considered in terms of a quantitative signaling model for CD4/CD8 lineage commitment.	UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT IMMUNOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,CTR CANC,LA JOLLA,CA 92093	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego	Matechak, EO (corresponding author), NIAID,CELLULAR & MOLEC IMMUNOL LAB,NATL INST HLTH,BETHESDA,MD 20892, USA.		Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751				ARNOLD LW, 1983, J IMMUNOL, V131, P2064; BARON A, 1994, EUR J IMMUNOL, V24, P1933, DOI 10.1002/eji.1830240834; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; BRANDLE D, 1994, EUR J IMMUNOL, V24, P145, DOI 10.1002/eji.1830240122; BRUCE J, 1981, J IMMUNOL, V127, P2496; CHAN SH, 1994, EMBO J, V13, P4482, DOI 10.1002/j.1460-2075.1994.tb06770.x; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; Coligan J, 1995, CURRENT PROTOCOLS IM; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; DEGERMANN S, 1994, J IMMUNOL, V152, P3254; FOWLKES BJ, 1995, CURR OPIN IMMUNOL, V7, P188, DOI 10.1016/0952-7915(95)80003-4; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; ITANO A, 1994, P NATL ACAD SCI USA, V91, P220, DOI 10.1073/pnas.91.1.220; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; IWABUCHI K, 1992, P NATL ACAD SCI USA, V89, P9000, DOI 10.1073/pnas.89.19.9000; KAYE J, 1992, J IMMUNOL, V148, P3342; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KERSH GJ, 1995, J IMMUNOL, V154, P1057; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KILLEEN N, 1993, EMBO J, V12, P1547, DOI 10.1002/j.1460-2075.1993.tb05798.x; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; KISIELOW P, 1995, J EXP MED, V181, P1975, DOI 10.1084/jem.181.6.1975; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KOO GC, 1986, J IMMUNOL, V137, P3742; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; MARK C, 1982, IMMUNOGENETICS, V16, P95, DOI 10.1007/BF00364447; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; PATERSON RK, 1994, J IMMUNOL, V153, P3491; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RAHEMTULLA A, 1994, EUR J IMMUNOL, V24, P2213, DOI 10.1002/eji.1830240942; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; RAVICHANDRAN KS, 1994, J EXP MED, V179, P727, DOI 10.1084/jem.179.2.727; ROBEY E, 1994, J EXP MED, V179, P1997, DOI 10.1084/jem.179.6.1997; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VONBOEHMER H, 1986, IMMUNOL TODAY, V7, P333; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; YAGUE J, 1988, NUCLEIC ACIDS RES, V16, P11355, DOI 10.1093/nar/16.23.11355	53	197	198	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1996	4	4					337	347		10.1016/S1074-7613(00)80247-2	http://dx.doi.org/10.1016/S1074-7613(00)80247-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UH522	8612128	Bronze			2022-12-18	WOS:A1996UH52200002
J	Herz, J; Filiano, AJ; Smith, A; Yogev, N; Kipnis, J				Herz, Jasmin; Filiano, Anthony J.; Smith, Ashtyn; Yogev, Nir; Kipnis, Jonathan			Myeloid Cells in the Central Nervous System	IMMUNITY			English	Review							BLOOD-BRAIN-BARRIER; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TISSUE-RESIDENT MACROPHAGES; SPINAL-CORD-INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; AMYOTROPHIC-LATERAL-SCLEROSIS; MONOCYTE-DERIVED MACROPHAGES; PLASMACYTOID DENDRITIC CELLS; MYELIN BASIC-PROTEIN; REGULATORY T-CELLS	The central nervous system (CNS) and its meningeal coverings accommodate a diverse myeloid compartment that includes parenchymal microglia and perivascular macrophages, as well as choroid plexus and meningeal macrophages, dendritic cells, and granulocytes. These myeloid populations enjoy an intimate relationship with the CNS, where they play an essential role in both health and disease. Although the importance of these cells is clearly recognized, their exact function in the CNS continues to be explored. Here, we review the subsets of myeloid cells that inhabit the parenchyma, meninges, and choroid plexus and discuss their roles in CNS homeostasis. We also discuss the role of these cells in various neurological pathologies, such as autoimmunity, mechanical injury, neurodegeneration, and infection. Wehighlight the neuroprotective nature of certain myeloid cells by emphasizing their therapeutic potential for the treatment of neurological conditions.	[Herz, Jasmin; Filiano, Anthony J.; Smith, Ashtyn; Kipnis, Jonathan] Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA; [Yogev, Nir; Kipnis, Jonathan] Johannes Gutenberg Univ Mainz, Gutenberg Res Fellowship Grp Neuroimmunol, Focus Program Translat Neurosci & Immunotherapy, Rhine Main Neurosci,Network Univ Med Ctr, D-55131 Mainz, Germany	University of Virginia; Johannes Gutenberg University of Mainz	Filiano, AJ; Kipnis, J (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA.; Kipnis, J (corresponding author), Johannes Gutenberg Univ Mainz, Gutenberg Res Fellowship Grp Neuroimmunol, Focus Program Translat Neurosci & Immunotherapy, Rhine Main Neurosci,Network Univ Med Ctr, D-55131 Mainz, Germany.	anthony.filiano@duke.edu; kipnis@virginia.edu	Kipnis, Jonathan/AGG-9735-2022	Kipnis, Jonathan/0000-0002-3714-517X	National Institutes of Health [NS096967]; German Research Foundation (DFG) [CRC-TR-128]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank S. Smith for editing the manuscript and A. Impagliazzo for the artwork. We would also like to thank all members of the Kipnis lab for their valuable comments during multiple discussions of this work. This work was supported by a grant from the National Institutes of Health (NS096967 to J.K.) and the German Research Foundation (DFG) (CRC-TR-128, B11 to J.K.).	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; ALLEN DJ, 1975, J COMP NEUROL, V161, P197, DOI 10.1002/cne.901610205; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Appel S H, 2011, Acta Myol, V30, P4; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bauler TJ, 2017, AM J PATHOL, V187, P187, DOI 10.1016/j.ajpath.2016.09.002; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Benowitz L, 2008, EXP NEUROL, V209, P389, DOI 10.1016/j.expneurol.2007.05.025; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; BO L, 1991, J NEUROL SCI, V105, P135, DOI 10.1016/0022-510X(91)90136-U; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; Brendecke SM, 2015, SEMIN IMMUNOPATHOL, V37, P591, DOI 10.1007/s00281-015-0520-6; BRENNER T, 1994, J NEUROL SCI, V122, P210, DOI 10.1016/0022-510X(94)90300-X; Bruck W, 1996, IMMUNOBIOLOGY, V195, P588; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chikahisa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078434; Chinnery HR, 2010, J NEUROPATH EXP NEUR, V69, P896, DOI 10.1097/NEN.0b013e3181edbc1a; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Christy AL, 2013, J AUTOIMMUN, V42, P50, DOI 10.1016/j.jaut.2012.11.003; Clarkson BD, 2017, SCI REP-UK, V7, DOI 10.1038/srep42856; Cohen M, 2014, EMBO J, V33, P2906, DOI 10.15252/embj.201489293; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Cronk JC, 2015, IMMUNITY, V42, P679, DOI 10.1016/j.immuni.2015.03.013; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Derecki NC, 2011, BRAIN BEHAV IMMUN, V25, P379, DOI 10.1016/j.bbi.2010.11.009; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Dines KC, 1997, J NEUROPATH EXP NEUR, V56, P627; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Drevets DA, 2004, J IMMUNOL, V172, P4418, DOI 10.4049/jimmunol.172.7.4418; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Farfara D, 2011, ANN NEUROL, V69, P170, DOI 10.1002/ana.22191; Filiano AJ, 2013, J NEUROSCI, V33, P5352, DOI 10.1523/JNEUROSCI.6103-11.2013; Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012; Gadani SP, 2017, J EXP MED, V214, P285, DOI 10.1084/jem.20161982; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldman D, 2001, INFECT IMMUN, V69, P1808, DOI 10.1128/IAI.69.3.1808-1815.2001; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/208093; Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000; He HH, 2016, ARTERIOSCL THROM VAS, V36, P2203, DOI 10.1161/ATVBAHA.116.307592; Henderson APD, 2009, ANN NEUROL, V66, P739, DOI 10.1002/ana.21800; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Herz J, 2015, J EXP MED, V212, P1153, DOI 10.1084/jem.20142047; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hirata K, 1999, J NEUROCYTOL, V28, P685, DOI 10.1023/A:1007012916530; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; HOUGH LB, 1988, PROG NEUROBIOL, V30, P469, DOI 10.1016/0301-0082(88)90032-9; Isaksson M, 2012, EUR J IMMUNOL, V42, P2555, DOI 10.1002/eji.201142239; Jarvis JN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004754; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Ji QY, 2013, NAT IMMUNOL, V14, P254, DOI 10.1038/ni.2513; KAPPERS JA, 1958, Z ZELLFORSCH MIK ANA, V48, P617, DOI 10.1007/BF00398650; Karman J, 2004, IMMUNOL LETT, V92, P107, DOI 10.1016/j.imlet.2003.10.017; Keilhoff G, 2007, DEV NEUROBIOL, V67, P1382, DOI 10.1002/dneu.20384; Kierdorf K, 2015, SEMIN IMMUNOL, V27, P369, DOI 10.1016/j.smim.2016.03.017; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Klein RS, 2017, NAT IMMUNOL, V18, P132, DOI 10.1038/ni.3656; KNIGHT SC, 1983, P NATL ACAD SCI-BIOL, V80, P6032, DOI 10.1073/pnas.80.19.6032; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Konradt C, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.1, 10.1038/NMICROBIOL.2016.1]; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Lande R, 2008, J NEUROPATH EXP NEUR, V67, P388, DOI 10.1097/NEN.0b013e31816fc975; Lewis ND, 2014, J NEUROIMMUNOL, V277, P26, DOI 10.1016/j.jneuroim.2014.09.014; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Longhini ALF, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-2; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6; Mendes-Jorge L, 2009, INVEST OPHTH VIS SCI, V50, P5997, DOI 10.1167/iovs.09-3515; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mildner A, 2008, J IMMUNOL, V181, P2713, DOI 10.4049/jimmunol.181.4.2713; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naert G, 2011, J NEUROSCI, V31, P6208, DOI 10.1523/JNEUROSCI.0299-11.2011; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nautiyal KM, 2012, EUR J NEUROSCI, V36, P2347, DOI 10.1111/j.1460-9568.2012.08138.x; Nautiyal KM, 2008, P NATL ACAD SCI USA, V105, P18053, DOI 10.1073/pnas.0809479105; Nayak Debasis, 2012, Intravital, V1, P95, DOI 10.4161/intv.22823; Nelson LH, 2017, BEHAV BRAIN RES, V316, P279, DOI 10.1016/j.bbr.2016.09.006; Nigro A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00017; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Pesic M, 2013, J CLIN INVEST, V123, P1192, DOI 10.1172/JCI67233; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; Polfliet MMJ, 2001, J IMMUNOL, V167, P4644, DOI 10.4049/jimmunol.167.8.4644; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Popovich PG, 2014, EXP NEUROL, V258, P1, DOI 10.1016/j.expneurol.2014.05.001; Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prokop S, 2015, J EXP MED, V212, P1811, DOI 10.1084/jem.20150479; Prokop Stefan, 2013, Acta Neuropathol, V126, P461; Quintana E, 2015, GLIA, V63, P2231, DOI 10.1002/glia.22889; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Russi AE, 2015, TRANSL RES, V165, P255, DOI 10.1016/j.trsl.2014.08.005; Russo MV, 2015, TRENDS IMMUNOL, V36, P637, DOI 10.1016/j.it.2015.08.002; Sakka L, 2011, EUR ANN OTORHINOLARY, V128, P309, DOI 10.1016/j.anorl.2011.03.002; Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Serot JM, 1997, NEUROREPORT, V8, P1995, DOI 10.1097/00001756-199705260-00039; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Sie C, 2017, SEMIN IMMUNOPATHOL, V39, P99, DOI 10.1007/s00281-016-0608-7; Silverman AJ, 2002, PROG BRAIN RES, V141, P315; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Skaper SD, 2013, MOL NEUROBIOL, V48, P340, DOI 10.1007/s12035-013-8487-6; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; THEOHARIDES TC, 1990, LIFE SCI, V46, P607, DOI 10.1016/0024-3205(90)90129-F; Thewissen K, 2014, MULT SCLER J, V20, P548, DOI 10.1177/1352458513505352; TOMS R, 1990, J NEUROIMMUNOL, V30, P169, DOI 10.1016/0165-5728(90)90101-R; Tran EH, 1998, J IMMUNOL, V161, P3767; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; van Zwam M, 2009, J MOL MED, V87, P273, DOI 10.1007/s00109-008-0421-4; VanRyzin JW, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0297-16.2016; VENEZIE RD, 1995, J NEUROSCI RES, V40, P99, DOI 10.1002/jnr.490400111; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Walsh JT, 2011, TRENDS MOL MED, V17, P541, DOI 10.1016/j.molmed.2011.05.012; Wang X, 2016, J NEUROSCI, V36, P2827, DOI 10.1523/JNEUROSCI.3575-15.2016; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yillar Do, 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P1; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yogev N, 2012, IMMUNITY, V37, P264, DOI 10.1016/j.immuni.2012.05.025; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhang S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-154; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zhuang X, 1996, J NEUROBIOL, V31, P393, DOI 10.1002/(SICI)1097-4695(199612)31:4<393::AID-NEU1>3.0.CO;2-4	178	196	199	7	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					943	956		10.1016/j.immuni.2017.06.007	http://dx.doi.org/10.1016/j.immuni.2017.06.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636961	Bronze, Green Accepted			2022-12-18	WOS:000403665900004
J	Rauch, I; Deets, KA; Ji, DX; von Moltke, J; Tenthorey, JL; Lee, AY; Philip, NH; Ayres, JS; Brodsky, IE; Gronert, K; Vance, RE				Rauch, Isabella; Deets, Katherine A.; Ji, Daisy X.; von Moltke, Jakob; Tenthorey, Jeannette L.; Lee, Angus Y.; Philip, Naomi H.; Ayres, Janelle S.; Brodsky, Igor E.; Gronert, Karsten; Vance, Russell E.			NAIP-NLRC4 Inflammasomes Coordinate Intestinal Epithelial Cell Expulsion with Eicosanoid and IL-18 Release via Activation of Caspase-1 and-8	IMMUNITY			English	Article							NF-KAPPA-B; BACTERIAL LIGANDS; HOST-DEFENSE; NLRC4; SALMONELLA; MICE; IL-1-BETA; NLRP3; PYROPTOSIS; PROTECTION	Intestinal epithelial cells (IECs) form a critical barrier against pathogen invasion. By generation of mice in which inflammasome expression is restricted to IECs, we describe a coordinated epithelium-intrinsic inflammasome response in vivo. This response was sufficient to protect against Salmonella tissue invasion and involved a previously reported IEC expulsion that was coordinated with lipid mediator and cytokine production and lytic IEC death. Excessive inflammasome activation in IECs was sufficient to result in diarrhea and pathology. Experiments with IEC organoids demonstrated that IEC expulsion did not require other cell types. IEC expulsion was accompanied by a major actin rearrangement in neighboring cells that maintained epithelium integrity but did not absolutely require Caspase-1 or Gasdermin D. Analysis of Casp1(-/-)Casp8(-/-) mice revealed a functional Caspase-8 inflammasome in vivo. Thus, a coordinated IEC-intrinsic, Caspase-1 and -8 inflammasome response plays a key role in intestinal immune defense and pathology.	[Rauch, Isabella; Deets, Katherine A.; Ji, Daisy X.; von Moltke, Jakob; Tenthorey, Jeannette L.; Ayres, Janelle S.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Philip, Naomi H.; Brodsky, Igor E.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Gronert, Karsten] Univ Calif Berkeley, Sch Optometry, Vis Sci Program, Berkeley, CA 94720 USA; [Vance, Russell E.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Lee, Angus Y.; Vance, Russell E.] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Lee, Angus Y.; Vance, Russell E.] Univ Calif Berkeley, Immunotherapeut & Vaccine Res Initiat, Berkeley, CA 94720 USA; [von Moltke, Jakob] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA; [Ayres, Janelle S.] Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; University of Pennsylvania; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; Salk Institute	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA.; Vance, RE (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Vance, RE (corresponding author), Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA.; Vance, RE (corresponding author), Univ Calif Berkeley, Immunotherapeut & Vaccine Res Initiat, Berkeley, CA 94720 USA.	rvance@berkeley.edu	Rauch, Isabella/AAN-6495-2020	Rauch, Isabella/0000-0003-1897-5693; Ji, Daisy/0000-0002-9148-3620	HHMI; NIH [AI075039, AI063302, EY026082, 1S10RR026866-01]; Austrian Science Fund (FWF) (the Erwin Schrodinger Fellowship) [J3789-B22]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026866] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY026082, R01EY022208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, R01AI075039] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [J 3789] Funding Source: researchfish	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF) (the Erwin Schrodinger Fellowship); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We acknowledge the assistance of the UC Berkeley CRL Flow Cytometry Laboratory, Eric Chen, Peter Dietzen, Roberto Chavez, Jake Wu, and James Kang for technical support, the Vance and Barton Labs for discussions, and Greg Barton for comments on the manuscript. We thank Xiaodong Wang for Ripk3<SUP>-/-</SUP> mice and the Winoto Lab for backcrossing the mice to the C57BL/6 background. This work was supported by HHMI and NIH grants to R.E.V. (AI075039, AI063302) and NIH grant (EY026082) to K.G. R.E.V. was a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease and is an Investigator of the Howard Hughes Medical Institute. Research reported in this publication was supported in part by the NIH S10 program under award number 1S10RR026866-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. I.R. is supported by the Austrian Science Fund (FWF) (the Erwin Schrodinger Fellowship J3789-B22).	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Allam R, 2015, J EXP MED, V212, P369, DOI 10.1084/jem.20140474; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Ballard JD, 1996, P NATL ACAD SCI USA, V93, P12531, DOI 10.1073/pnas.93.22.12531; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Karki R, 2015, CELL HOST MICROBE, V17, P357, DOI 10.1016/j.chom.2015.01.006; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; LaRock CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003793; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Muller AA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005723; Nordlander S, 2014, MUCOSAL IMMUNOL, V7, P775, DOI 10.1038/mi.2013.95; Rauch I, 2016, J EXP MED, V213, P657, DOI 10.1084/jem.20151809; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sellin ME, 2015, TRENDS IMMUNOL, V36, P442, DOI 10.1016/j.it.2015.06.002; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	51	196	203	5	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					649	659		10.1016/j.immuni.2017.03.016	http://dx.doi.org/10.1016/j.immuni.2017.03.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28410991	Bronze, Green Accepted			2022-12-18	WOS:000399451100017
J	Seo, SU; Kamada, N; Munoz-Planillo, R; Kim, YG; Kim, D; Koizumi, Y; Hasegawa, M; Himpsl, SD; Browne, HP; Lawley, TD; Mobley, HLT; Inohara, N; Nunez, G				Seo, Sang-Uk; Kamada, Nobuhiko; Munoz-Planillo, Raul; Kim, Yun-Gi; Kim, Donghyun; Koizumi, Yukiko; Hasegawa, Mizuho; Himpsl, Stephanie D.; Browne, Hilary P.; Lawley, Trevor D.; Mobley, Harry L. T.; Inohara, Naohiro; Nunez, Gabriel			Distinct Commensals Induce Interleukin-1 beta via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to Injury	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; PROTEUS-MIRABILIS; DEXTRAN SULFATE; GUT MICROBIOTA; BOWEL-DISEASE; IMMUNE-SYSTEM; GERM-FREE; COLITIS; MACROPHAGES; MICE	The microbiota stimulates inflammation, but the signaling pathways and the members of the microbiota involved remain poorly understood. We found that the microbiota induces interleukin-1 beta (IL-1 beta) release upon intestinal injury and that this is mediated via the NLRP3 inflammasome. Enterobacteriaceae and in particular the pathobiont Proteus mirabilis, induced robust IL-1 beta release that was comparable to that induced by the pathogen Salmonella. Upon epithelial injury, production of IL-1 beta in the intestine was largely mediated by intestinal Ly6C(high) monocytes, required chemokine receptor CCR2 and was abolished by deletion of IL-1 beta in CCR2(+) blood monocytes. Furthermore, colonization with P. mirabilis promoted intestinal inflammation upon intestinal injury via the production of hemolysin, which required NLRP3 and IL-1 receptor signaling in vivo. Thus, upon intestinal injury, selective members of the microbiota stimulate newly recruited monocytes to induce NLRP3-dependent IL-1 beta release, which promotes inflammation in the intestine.	[Seo, Sang-Uk; Munoz-Planillo, Raul; Kim, Yun-Gi; Kim, Donghyun; Koizumi, Yukiko; Hasegawa, Mizuho; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Seo, Sang-Uk; Kamada, Nobuhiko; Munoz-Planillo, Raul; Kim, Yun-Gi; Kim, Donghyun; Koizumi, Yukiko; Hasegawa, Mizuho; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Kamada, Nobuhiko] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Himpsl, Stephanie D.; Mobley, Harry L. T.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Browne, Hilary P.; Lawley, Trevor D.] Wellcome Trust Sanger Inst, Bacterial Pathogenesis Lab, Hinxton CB10 1SA, Cambs, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wellcome Trust Sanger Institute	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	gabriel.nunez@umich.edu	Kim, Donghyun/J-3609-2019; Kamada, Nobuhiko/AAW-3299-2020; Nuñez, Gabriel/A-7160-2014	Kim, Donghyun/0000-0002-5137-2213; Kamada, Nobuhiko/0000-0002-1980-4178; Browne, Hilary/0000-0002-1305-2470; Mobley, Harry/0000-0001-9195-7665	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2013R1A6A3A03024348]; Crohn's and Colitis Foundation of America; Michigan Gastrointestinal Peptide Research Center NIDDK [5P30DK034933]; Wellcome Trust [098051, WT086418MA]; National Institutes of Health [DK091191, DK095782]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331, R01AI059722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095782, R01DK091191, P30DK034933] Funding Source: NIH RePORTER	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Crohn's and Colitis Foundation of America; Michigan Gastrointestinal Peptide Research Center NIDDK; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Grace Chen for critical review of the manuscript and Eric Pamer for proving mutant mice. We thank the University of Michigan Host Microbiome Initiative for support. This work is supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology 2013R1A6A3A03024348 (S.-U.S.), a Career Development award from the Crohn's and Colitis Foundation of America (N.K.), the Michigan Gastrointestinal Peptide Research Center NIDDK 5P30DK034933 (N.K.), grants 098051 and WT086418MA from the Wellcome Trust (T.D.L.) and DK091191 and DK095782 from the National Institutes of Health (G.N.).	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Alteri CJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003608; Armbruster CE, 2012, NAT REV MICROBIOL, V10, P743, DOI 10.1038/nrmicro2890; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bauer C, 2012, DIGEST DIS, V30, P82, DOI 10.1159/000341681; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; De la Fuente M, 2014, INT J MED MICROBIOL, V304, P384, DOI 10.1016/j.ijmm.2014.01.002; Drouet M, 2012, INFLAMM BOWEL DIS, V18, P1923, DOI 10.1002/ibd.22908; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hudcovic T, 2001, FOLIA MICROBIOL, V46, P565, DOI 10.1007/BF02818004; JONES BD, 1987, INFECT IMMUN, V55, P2198, DOI 10.1128/IAI.55.9.2198-2203.1987; Kamada A, 2005, INFLAMM BOWEL DIS, V11, P455, DOI 10.1097/01.MIB.0000158158.55955.de; Kamada N, 2014, GASTROENTEROLOGY, V146, P1477, DOI 10.1053/j.gastro.2014.01.060; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; LIGUMSKY M, 1990, GUT, V31, P686, DOI 10.1136/gut.31.6.686; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; SWIHART KG, 1990, INFECT IMMUN, V58, P1861, DOI 10.1128/IAI.58.6.1861-1869.1990; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Waddell A, 2011, J IMMUNOL, V186, P5993, DOI 10.4049/jimmunol.1003844; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	47	196	207	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					744	755		10.1016/j.immuni.2015.03.004	http://dx.doi.org/10.1016/j.immuni.2015.03.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25862092	Green Accepted, Bronze			2022-12-18	WOS:000353347500019
J	Pandiyan, P; Conti, HR; Zheng, LX; Peterson, AC; Mathern, DR; Hernandez-Santos, N; Edgerton, M; Gaffen, SL; Lenardo, MJ				Pandiyan, Pushpa; Conti, Heather R.; Zheng, Lixin; Peterson, Alanna C.; Mathern, Douglas R.; Hernandez-Santos, Nydiaris; Edgerton, Mira; Gaffen, Sarah L.; Lenardo, Michael J.			CD4(+)CD25(+)Foxp3(+) Regulatory T Cells Promote Th17 Cells In Vitro and Enhance Host Resistance in Mouse Candida albicans Th17 Cell Infection Model	IMMUNITY			English	Article							PROTECTIVE IMMUNITY; ORAL CANDIDIASIS; IL-17; INTERLEUKIN-2; AUTOIMMUNITY; GENERATION; RESPONSES; DEFENSE; HELPER	Th17 cells and CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells are thought to promote and suppress inflammatory responses, respectively. Here we explore why under Th17 cell polarizing conditions, Treg cells did not suppress, but rather upregulated, the expression of interleukin-17A (IL-17A), IL-17F, and IL-22 from responding CD4(+) T cells (Tresp cells). Upregulation of IL-17 cytokines in Tresp cells was dependent on consumption of IL-2 by Treg cells, especially at early time points both in vitro and in vivo. During an oral Candida albicans infection in mice, Treg cells induced IL-17 cytokines in Tresp cells, which markedly enhanced fungal clearance and recovery from infection. These findings show how Treg cells can promote acute Th17 cell responses to suppress mucosal fungus infections and reveal that Treg cells have a powerful capability to fight infections besides their role in maintaining tolerance or immune homeostasis.	[Pandiyan, Pushpa; Zheng, Lixin; Mathern, Douglas R.; Lenardo, Michael J.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Conti, Heather R.; Edgerton, Mira; Gaffen, Sarah L.] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA; [Peterson, Alanna C.; Hernandez-Santos, Nydiaris; Gaffen, Sarah L.] Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15261 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	lenardo@nih.gov		Altan-Bonnet, Gregoire/0000-0002-7283-3162	National Research Council (NRC); National Academy of Sciences; NIH [DE0188122]; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH);  [AR054389];  [DE007034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R43DE007034, R21DE018822, T32DE007034] Funding Source: NIH RePORTER	National Research Council (NRC); National Academy of Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank R. Germain, A. Singer, Y. Belkaid, P. Schwartzberg, and A. Snow for critically reading the manuscript and C. Trageser, J. Lee, and other members of the M.J.L. laboratory for valuable suggestions and help. We also thank O. Schwartz and L. Koo for their help in microscopy and J. Edwards for FAGS sorting. P.P. was supported by a fellowship from the National Research Council (NRC) and National Academy of Sciences; S.L.G. and M.E. were supported by NIH grant DE0188122; and S.L.G. was also supported by AR054389. H.R.C. was supported by a training grant (DE007034) to the Department of Oral Biology. This work was supported by the intramural research program of National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). P.P. designed the study, performed experiments, and analyzed data with the supervision of M.J.L. P.P. and M.J.L. wrote the manuscript; L.Z. measured the weight of the mice in blinded fashion and contributed to discussions; and D.R.M. helped P.P. in LPMC preparations in IBD experiments. S.L.G. and M.E. supported H.R.C. H.R.C. performed and helped P.P. in C. albicans infection experiments.	Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Coutinho A, 2008, J CLIN IMMUNOL, V28, pS4, DOI 10.1007/s10875-007-9167-y; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Farah CS, 2006, ORAL MICROBIOL IMMUN, V21, P252, DOI 10.1111/j.1399-302X.2006.00288.x; Gunnlaugsdottir B, 2005, INT IMMUNOL, V17, P35, DOI 10.1093/intimm/dxh183; Kamai Y, 2001, ANTIMICROB AGENTS CH, V45, P3195, DOI 10.1128/AAC.45.11.3195-3197.2001; Kekalainen E, 2007, J IMMUNOL, V178, P1208, DOI 10.4049/jimmunol.178.2.1208; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Maloy KJ, 2005, NAT IMMUNOL, V6, P1071, DOI 10.1038/ni1105-1071; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Montagnoli C, 2002, J IMMUNOL, V169, P6298, DOI 10.4049/jimmunol.169.11.6298; Ochs HD, 2007, IMMUNOL RES, V38, P112, DOI 10.1007/s12026-007-0022-2; Ochs HD, 2009, J ALLERGY CLIN IMMUN, V123, P977, DOI 10.1016/j.jaci.2009.03.030; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pandiyan P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-6; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Roifman CM, 2000, PEDIATR RES, V48, P6, DOI 10.1203/00006450-200007000-00004; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	30	196	213	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 25	2011	34	3					422	434		10.1016/j.immuni.2011.03.002	http://dx.doi.org/10.1016/j.immuni.2011.03.002			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21435589	Green Accepted, Bronze			2022-12-18	WOS:000289014500017
J	Tavares, RM; Turer, EE; Liu, CL; Advincula, R; Scapini, P; Rhee, L; Barrera, J; Lowel, CA; Utz, PJ; Malynn, BA; Ma, A				Tavares, Rita M.; Turer, Emre E.; Liu, Chih L.; Advincula, Rommel; Scapini, Patrizia; Rhee, Lesley; Barrera, Julio; Lowel, Clifford A.; Utz, Paul J.; Malynn, Barbara A.; Ma, Averil			The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity	IMMUNITY			English	Article							NF-KAPPA-B; ZINC-FINGER PROTEIN; GERMINAL-CENTER; LYMPHOCYTE DEVELOPMENT; TNFAIP3 A20; FAS; EXPRESSION; ACTIVATION; CENTERS; MUTATIONS	A20 is a ubiquitin modifying enzyme that restricts NF-kappa B signals and protects cells against tumor necrosis factor (TNF)-induced programmed cell death. Given recent data linking A20 (TNFAIP3) with human B cell lymphomas and systemic lupus erythematosus (SLE), we have generated mice bearing a floxed allele of Tnfaip3 to interrogate A20's roles in regulating B cell functions. A20-deficient B cells are hyperresponsive to multiple stimuli and display exaggerated NF-kappa B responses to CD40-induced signals. Mice expressing absent or hypomorphic amounts of A20 in B cells possess elevated numbers of germinal center B cells, autoantibodies, and glomerular immunoglobulin deposits. A20-deficient B cells are resistant to Fas-mediated cell death, probably due to increased expression of NF-kappa B-dependent antiapoptotic proteins such as Bcl-x. These findings show that A20 can restrict B cell survival, whereas A20 protects other cells from TNF-induced cell death. Our studies demonstrate how reduced A20 expression predisposes to autoimmunity.	[Tavares, Rita M.; Turer, Emre E.; Advincula, Rommel; Rhee, Lesley; Barrera, Julio; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Tavares, Rita M.] Inst Gulbenkian Ciencias, PhD Program Biomed, Oeiras, Portugal; [Liu, Chih L.; Utz, Paul J.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Scapini, Patrizia; Lowel, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Instituto Gulbenkian de Ciencia; Stanford University; University of California System; University of California San Francisco	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	barbara.malynn@ucsf.edu; averil.ma@ucsf.edu		Tavares, Rita/0000-0002-1654-4454	National Institutes of Health; Alliance for Lupus Research; Fundacao para a Ciencia e Tecnologia; UCSF-VAMC Pathology Core; Cancer Center Pathology Core, UCSF Liver Center Immunology and Pathology Cores; UCSF Transgenic and Targeted Mutagenesis Core Facility; Rainin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068150, P01AI078869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); UCSF-VAMC Pathology Core; Cancer Center Pathology Core, UCSF Liver Center Immunology and Pathology Cores; UCSF Transgenic and Targeted Mutagenesis Core Facility; Rainin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, the Alliance for Lupus Research (A.M.), the Fundacao para a Ciencia e Tecnologia (to R. T.), UCSF-VAMC Pathology Core, the Cancer Center Pathology Core, UCSF Liver Center Immunology and Pathology Cores, the UCSF Transgenic and Targeted Mutagenesis Core Facility, and the Rainin Foundation. We thank the skillful technical assistance of I. Hsieh (UCSF-VAMC Pathology) and J. Publicover (UCSF Liver Center), and helpful advice from J.P. Pereira and L. Reinhardt. We thank T. DeFranco and J. Cyster for critically reading the manuscript. R.M.T. planned and performed the experiments, analyzed the data, and assisted in writing the manuscript. E.E.T. made the conditional gene targeting construct, performed gene targeting in ESCs, and characterized the original Tnfaip3<SUP>f1</SUP> germline mice. R.A. performed mice breeding and genotyping, and assisted with mouse injections and bleeding. C.L.L. performed the antibody array experiments and statistical analyses, under the supervision of P.J.U. C.A.L., and P.J.U. edited the manuscript. P.S. assisted in the analysis of the autoantibody data and mouse histology and immunohistochemistry, under the supervision of C.A.L. L.R. performed some of the initial experiments with R.M.T. J.B. provided excellent technical assistance. B.A.M. and A.M. helped plan and supervise the experiments and data analysis and wrote the manuscript.	Arvelo MB, 2002, HEPATOLOGY, V35, P535, DOI 10.1053/jhep.2002.31309; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Fairhurst AM, 2006, ADV IMMUNOL, V92, P1, DOI 10.1016/S0065-2776(06)92001-X; Fukuyama H, 2002, EUR J IMMUNOL, V32, P223, DOI 10.1002/1521-4141(200201)32:1<223::AID-IMMU223>3.0.CO;2-4; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Homig-Holzel C, 2008, J EXP MED, V205, P1317, DOI 10.1084/jem.20080238; Jacobi AM, 2005, J EXP MED, V202, P341, DOI 10.1084/jem.20050221; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Mizuno T, 2003, APOPTOSIS, V8, P451, DOI 10.1023/A:1025534223168; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; SARMA V, 1995, J BIOL CHEM, V270, P12343, DOI 10.1074/jbc.270.21.12343; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Schram BR, 2003, J IMMUNOL, V170, P3118, DOI 10.4049/jimmunol.170.6.3118; Sen R, 2006, IMMUNITY, V25, P871, DOI 10.1016/j.immuni.2006.12.003; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; SMITH KGC, 1995, P NATL ACAD SCI USA, V92, P11628, DOI 10.1073/pnas.92.25.11628; Takahashi Y, 1999, J EXP MED, V190, P399, DOI 10.1084/jem.190.3.399; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Wang JY, 1996, EUR J IMMUNOL, V26, P92, DOI 10.1002/eji.1830260114; Watanabe D, 1995, INT IMMUNOL, V7, P1949, DOI 10.1093/intimm/7.12.1949; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Witte T, 2008, CLIN REV ALLERG IMMU, V34, P345, DOI 10.1007/s12016-007-8046-x; Yurasov S, 2007, CURR OPIN RHEUMATOL, V19, P421, DOI 10.1097/BOR.0b013e328277ef3b	46	196	208	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					181	191		10.1016/j.immuni.2010.07.017	http://dx.doi.org/10.1016/j.immuni.2010.07.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20705491	Green Accepted, Bronze			2022-12-18	WOS:000281654900008
J	Shulman, Z; Shinder, V; Klein, E; Grabovsky, V; Yeger, O; Geron, E; Montresor, A; Bolomini-Vittori, M; Feigelson, SW; Kirchhausen, T; Laudanna, C; Shakhar, G; Alon, R				Shulman, Ziv; Shinder, Vera; Klein, Eugenia; Grabovsky, Valentin; Yeger, Orna; Geron, Erez; Montresor, Alessio; Bolomini-Vittori, Matteo; Feigelson, Sara W.; Kirchhausen, Tomas; Laudanna, Carlo; Shakhar, Guy; Alon, Ronen			Lymphocyte Crawling and Transendothelial Migration Require Chemokine Triggering of High-Affinity LFA-1 Integrin	IMMUNITY			English	Article							VASCULAR ENDOTHELIUM; T-CELL; LEUKOCYTE TRANSMIGRATION; INFLAMMATORY RESPONSE; ADHERENT LEUKOCYTES; ADHESION RECEPTORS; BLOOD-VESSELS; ACTIVATION; ICAM-1; MOTILITY	Endothelial chemokines are instrumental for integrin-mediated lymphocyte adhesion and transendothelial migration (TEM). By dissecting how chemokines trigger lymphocyte integrins to support shear-resistant motility on and across cytokine-stimulated endothelial barriers, we found a critical role for high-affinity (HA) LFA-1 integrin in lymphocyte crawling on activated endothelium. Endothelial-presented chemokines triggered HA-LFA-1 and adhesive filopodia at numerous submicron dots scattered underneath crawling lymphocytes. Shear forces applied to endothelial-bound lymphocytes dramatically enhanced filopodia density underneath crawling lymphocytes. A fraction of the adhesive filopodia invaded the endothelial cells prior to and during TEM and extended large subluminal leading edge containing dots of HA-LFA-1 occupied by subluminal ICAM-1. Memory T cells generated more frequent invasive filopodia and transmigrated more rapidly than their naive counterparts. We propose that shear forces exerted on HA-LFA-1 trigger adhesive and invasive filopodia at apical endothelial surfaces and thereby promote lymphocyte crawling and probing for TEM sites.	[Shulman, Ziv; Grabovsky, Valentin; Geron, Erez; Feigelson, Sara W.; Shakhar, Guy; Alon, Ronen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Shinder, Vera; Klein, Eugenia; Yeger, Orna] Weizmann Inst Sci, Irving & Cherna Moskowitz Ctr Nano & Bio Nano Ima, IL-76100 Rehovot, Israel; [Montresor, Alessio; Bolomini-Vittori, Matteo; Laudanna, Carlo] Univ Verona, Div Gen Pathol, Dept Pathol, Sch Med, I-37134 Verona, Italy; [Montresor, Alessio; Bolomini-Vittori, Matteo; Laudanna, Carlo] Univ Verona, CBMC, I-37134 Verona, Italy; [Kirchhausen, Tomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kirchhausen, Tomas] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA	Weizmann Institute of Science; Weizmann Institute of Science; University of Verona; University of Verona; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il	Bolomini-Vittori, Matteo/Q-5659-2016; ALON, RONEN/GRX-6987-2022	Bolomini-Vittori, Matteo/0000-0002-5762-0791; Alon, Ronen/0000-0001-9161-6369	Israel Science Foundation; Minerva Foundation,; MAIN; EU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Minerva Foundation,; MAIN; EU(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Schwarzbaum for editorial assistance and O. Barreiro (University Autonoma, Madrid), P. Goichberg, and C. Luxenburg for helpful suggestions. We also thank Ishai Sher and the Weizmann Institute graphic department for graphic assistance. R.A. is the Incumbent of The Linda Jacobs Chair in Immune and Stem Cell Research. R.A. is supported by the Israel Science Foundation, by the Minerva Foundation, Germany, and by MAIN, the EU6 Program for Migration and Inflammation.	Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; ANDERSON AO, 1976, IMMUNOLOGY, V31, P731; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Beals CR, 2001, J IMMUNOL, V167, P6113, DOI 10.4049/jimmunol.167.11.6113; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2003, J IMMUNOL, V171, P6135, DOI 10.4049/jimmunol.171.11.6135; Cinamon G, 2004, J IMMUNOL, V173, P7282, DOI 10.4049/jimmunol.173.12.7282; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Cuvelier SL, 2001, J EXP MED, V194, P1699, DOI 10.1084/jem.194.12.1699; Evans BJ, 2006, BLOOD, V107, P3593, DOI 10.1182/blood-2005-09-3695; Ghandour H, 2007, BLOOD, V110, P3682, DOI 10.1182/blood-2007-03-077628; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Hordijk PL, 2003, CELL BIOCHEM BIOPHYS, V38, P305, DOI 10.1385/CBB:38:3:305; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Larrivee Bruno, 2005, Methods Mol Biol, V290, P315; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Shulman Z, 2006, BLOOD, V108, P2150, DOI 10.1182/blood-2006-04-017608; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yang W, 2006, J BIOL CHEM, V281, P37904, DOI 10.1074/jbc.M606888200	43	196	208	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					384	396		10.1016/j.immuni.2008.12.020	http://dx.doi.org/10.1016/j.immuni.2008.12.020			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19268609	Green Accepted, Bronze			2022-12-18	WOS:000264405500011
J	Kwon, K; Hutter, C; Sun, Q; Bilic, I; Cobaleda, C; Malin, S; Busslinger, M				Kwon, Kyongrim; Hutter, Caroline; Sun, Qiong; Bilic, Ivan; Cobaleda, Csar; Malin, Stephen; Busslinger, Meinrad			Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development	IMMUNITY			English	Article							LOOP-HELIX PROTEINS; GENE-EXPRESSION; INTRONIC ENHANCER; V(D)J RECOMBINASE; PAX5; EBF; DIFFERENTIATION; ACTIVATION; PROMOTES; E47	The transcription factor E2A controls the initiation of B lymphopoiesis, which is arrested at the pre-pro-B cell stage in E2A-deficient mice. Here, we demonstrate by conditional mutagenesis that E2A is essential for the development of pro-B, pre-B, and immature B cells in the bone marrow. E2A is, however, dispensable for the generation of mature B cells and plasma cells in peripheral lymphoid organs. In contrast, germinal center B cell development is impaired in the absence of E2A despite normal AID expression and class-switch recombination. Molecular analysis revealed that E2A is required not only for initiating but also for maintaining the expression of Ebf1, Pax5, and the B cell gene program in pro-B cells. Notably, precocious Pax5 transcription from the lkzf1 locus promotes pro-B cell development in E2A-deficient mice, demonstrating that ectopic Pax5 expression is sufficient to activate the B lymphoid transcription program in vivo in the absence of E2A.	[Kwon, Kyongrim; Hutter, Caroline; Sun, Qiong; Bilic, Ivan; Cobaleda, Csar; Malin, Stephen; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	busslinger@imp.ac.at	Hutter, Caroline/AAD-4426-2021; Busslinger, Meinrad J./J-1249-2016; Cobaleda, Cesar/D-4668-2011	Busslinger, Meinrad J./0000-0002-9111-9351; Cobaleda, Cesar/0000-0003-3807-9204; Hutter, Caroline/0000-0003-2059-4814				Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Becker-Herman S, 2002, J IMMUNOL, V168, P5507, DOI 10.4049/jimmunol.168.11.5507; Borghesi L, 2005, J EXP MED, V202, P1669, DOI 10.1084/jem.20051190; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Greenbaum S, 2004, J BIOL CHEM, V279, P45028, DOI 10.1074/jbc.M400061200; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Inlay MA, 2004, J EXP MED, V200, P1205, DOI 10.1084/jem.20041135; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; KONDO H, 1994, INT ARCH ALLERGY IMM, V105, P38, DOI 10.1159/000236801; Lazorchak AS, 2006, J IMMUNOL, V177, P2495, DOI 10.4049/jimmunol.177.4.2495; Lazorchak AS, 2006, MOL CELL BIOL, V26, P810, DOI 10.1128/MCB.26.3.810-821.2006; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Norton JD, 2000, J CELL SCI, V113, P3897; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Roberts EC, 2001, MOL CELL BIOL, V21, P524, DOI 10.1128/MCB.21.2.524-533.2001; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Schwenk F, 1998, NUCLEIC ACIDS RES, V26, P1427, DOI 10.1093/nar/26.6.1427; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Sugai M, 2003, NAT IMMUNOL, V4, P25, DOI 10.1038/ni874; Wikstrom I, 2006, J IMMUNOL, V177, P6723, DOI 10.4049/jimmunol.177.10.6723; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zhuang YA, 2004, MOL IMMUNOL, V40, P1165, DOI 10.1016/j.molimm.2003.11.031	47	196	198	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2008	28	6					751	762		10.1016/j.immuni.2008.04.014	http://dx.doi.org/10.1016/j.immuni.2008.04.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18538592	Bronze			2022-12-18	WOS:000256760200007
J	Gardam, S; Sierro, F; Basten, A; Mackay, F; Brink, R				Gardam, Sandra; Sierro, Frederic; Basten, Antony; Mackay, Fabienne; Brink, Robert			TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor	IMMUNITY			English	Article							NF-KAPPA-B; ACTIVATING FACTOR; MARGINAL ZONE; TNF; ALPHA; KINASE; FAMILY; PATHWAYS; MICE; HOMEOSTASIS	Tumor necrosis factor receptor-associated factors 2 and 3 (TRAF2 and TRAF3) were shown to function in a cooperative and nonredundant manner to suppress nuclear factor-kappa B2 (NF-kappa B2) activation, gene expression, and survival in mature B cells. In the absence of this suppressive activity, B cells developed independently of the obligatory B cell survival factor, BAFF (B cell-activating factor of the tumor necrosis factor family). However, deletion of either TRAF2 or TRAF3 from the T cell lineage did not promote T cell survival, despite causing extensive NF-kappa B2 activation. This constitutive, lineage-specific suppression of B cell survival by TRAF2 and TRAF3 determines the requirement for BAFF to sustain B cell development in vivo. Binding of BAFF to BAFF receptor reversed TRAF2-TRAF3-mediated suppression of B cell survival by triggering the depletion of TRAF3 protein. This process was TRAF2 dependent, revealing dual roles for TRAF2 in regulating B cell homeostasis.	[Gardam, Sandra; Sierro, Frederic; Basten, Antony; Mackay, Fabienne; Brink, Robert] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Gardam, Sandra; Basten, Antony; Brink, Robert] Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia; [Gardam, Sandra; Basten, Antony; Brink, Robert] Univ Sydney, Fac Med, Camperdown, NSW, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Sydney; Centenary Institute; University of Sydney	Brink, R (corresponding author), St Vincents Hosp, Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	r.brink@garvan.org.au	Mackay, Fabienne/B-7440-2008; Sierro, Frederic/B-9742-2009; Brink, Robert/B-7910-2010	Mackay, Fabienne/0000-0002-6074-2693; Sierro, Frederic/0000-0001-5004-8414; Brink, Robert/0000-0002-9586-3655				Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Grech A, 2000, MOL IMMUNOL, V37, P721, DOI 10.1016/S0161-5890(00)00098-5; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Miosge LA, 2002, J EXP MED, V196, P1113, DOI 10.1084/jem.20020959; Morrison MD, 2005, J BIOL CHEM, V280, P10018, DOI 10.1074/jbc.M413634200; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012; Xu LG, 2002, J IMMUNOL, V169, P6883, DOI 10.4049/jimmunol.169.12.6883; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790	43	196	197	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2008	28	3					391	401		10.1016/j.immuni.2008.01.009	http://dx.doi.org/10.1016/j.immuni.2008.01.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18313334	Bronze			2022-12-18	WOS:000254142500016
J	Nishida, N; Xie, C; Shimaoka, M; Cheng, YF; Walz, T; Springer, TA				Nishida, Noritaka; Xie, Can; Shimaoka, Motomu; Cheng, Yifan; Walz, Thomas; Springer, Timothy A.			Activation of leukocyte beta(2) integrins by conversion from bent to extended conformations	IMMUNITY			English	Article							I-LIKE DOMAIN; CRYSTAL-STRUCTURE; A-DOMAIN; INTEGRIN-BETA(2) SUBUNIT; EXTRACELLULAR SEGMENT; ELECTRON-MICROSCOPY; ALPHA-SUBUNIT; PSI DOMAIN; AFFINITY; ADHESION	We used negative stain electron microscopy (EM) to examine the conformational changes in the ectodomains required for activation of the leukocyte integrins alpha(X)beta(2) and alpha(L)beta(2). They transitioned between a bent conformation and two extended conformations in which the headpiece was in either a closed or an open state. Extended integrins exhibited marked flexibility at the alpha subunit genu and between integrin epidermal growth factor-like (I-EGF) domains 1 and 2. A clasp to mimic juxtamembrane association between the integrin alpha and beta subunits stabilized the bent conformation strongly for alpha(X)beta(2) and less so for alpha(L)beta(2). A small molecule allosteric antagonist induced the extended, open headpiece conformation. A Fab known to activate beta(2) integrins on leukocytes induced extension, and a Fab reporter of activation bound only after extension had been induced. The results establish an intimate relationship between extension of beta(2) integrins and their activation in immune responses and leukocyte trafficking.	Harvard Univ, Sch Med, CBR, Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, CBR, Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	springeroffice@cbr.med.harvard.edu	Nishida, Noritaka/E-7087-2010	Cheng, Yifan/0000-0001-9535-0369; Walz, Thomas/0000-0003-2606-2835; Xie, Can/0000-0002-7412-3236	NIAID NIH HHS [AI63421, AI72765] Funding Source: Medline; NIGMS NIH HHS [GM62580] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063421, R01AI072765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; CASASNOVAS JM, 1995, J BIOL CHEM, V270, P13216, DOI 10.1074/jbc.270.22.13216; DU XP, 1993, J BIOL CHEM, V268, P23087; Evangelista V, 1996, BLOOD, V88, P4183, DOI 10.1182/blood.V88.11.4183.bloodjournal88114183; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; PETRUZZELLI L, 1995, J IMMUNOL, V155, P854; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; Shi ML, 2005, J BIOL CHEM, V280, P30586, DOI 10.1074/jbc.M502525200; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2002, P NATL ACAD SCI USA, V99, P16737, DOI 10.1073/pnas.252633099; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STEVENS FJ, 1989, BIOPHYS J, V55, P1155, DOI 10.1016/S0006-3495(89)82912-1; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2001, P NATL ACAD SCI USA, V98, P11175, DOI 10.1073/pnas.201420198; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Takami M, 2001, AM J PHYSIOL-CELL PH, V280, pC1045, DOI 10.1152/ajpcell.2001.280.5.C1045; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; Welzenbach K, 2002, J BIOL CHEM, V277, P10590, DOI 10.1074/jbc.M110521200; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2004, P NATL ACAD SCI USA, V101, P15422, DOI 10.1073/pnas.0406680101; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200	48	196	199	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2006	25	4					583	594		10.1016/j.immuni.2006.07.016	http://dx.doi.org/10.1016/j.immuni.2006.07.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17045822	Bronze			2022-12-18	WOS:000241481500010
J	Kim, MY; Gaspal, FMC; Wiggett, HE; McConnell, FM; Gulbranson-Judge, A; Raykundalia, C; Walker, LSK; Goodall, MD; Lane, PJL				Kim, MY; Gaspal, FMC; Wiggett, HE; McConnell, FM; Gulbranson-Judge, A; Raykundalia, C; Walker, LSK; Goodall, MD; Lane, PJL			CD4(+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells	IMMUNITY			English	Article							GERMINAL CENTER FORMATION; DENDRITIC CELLS; CHEMOKINE RECEPTOR; LYMPH-NODES; IN-VIVO; AFFINITY MATURATION; MICE; EXPRESSION; LIGAND; POPULATIONS	In this report we identify an accessory cell that interacts with primed and memory T cells at sites where they collaborate with B cells. These cells are distinguished from conventional dendritic cells by their lack of response to FIt3 ligand and their inability to process antigen. Unlike dendritic cells, the CD4(+)CD3(-) cells have little CD80 or CD86 expression but do express high levels of the TNF ligands, OX40 ligand and CD30 ligand. We show that Th2-primed cells express the receptors for these TNF ligands and preferentially survive when cocultured with these cells. Furthermore, we show that the preferential survival of OX40(+) T cells and support of memory T cell help for B cells are linked to their association with CD4(+)CD3(-) cells in vivo.	Univ Birmingham, Sch Med, Med Res Council, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Birmingham	Lane, PJL (corresponding author), Univ Birmingham, Sch Med, Med Res Council, Ctr Immune Regulat, Vincent Dr, Birmingham B15 2TT, W Midlands, England.			Walker, Lucy/0000-0001-5986-5015	Wellcome Trust [WT065695] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; CROWE PD, 1995, J EXP MED, V181, P1205, DOI 10.1084/jem.181.3.1205; Ferguson SE, 1996, J IMMUNOL, V156, P4576; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; HO F, 1986, EUR J IMMUNOL, V16, P1297, DOI 10.1002/eji.1830161018; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; LANE P, 1994, J EXP MED, V179, P819, DOI 10.1084/jem.179.3.819; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MALLETT S, 1990, EMBO J, V9, P1063, DOI 10.1002/j.1460-2075.1990.tb08211.x; Malmstrom V, 2001, J IMMUNOL, V166, P6972, DOI 10.4049/jimmunol.166.11.6972; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Ohshima Y, 1998, BLOOD, V92, P3338, DOI 10.1182/blood.V92.9.3338.421k19_3338_3345; Ohshima Y, 1997, J IMMUNOL, V159, P3838; Pulendran B, 1997, J IMMUNOL, V159, P2222; Randolph DA, 1999, SCIENCE, V286, P2159, DOI 10.1126/science.286.5447.2159; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Secord EA, 1996, CELL IMMUNOL, V174, P173, DOI 10.1006/cimm.1996.0307; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115	35	196	202	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2003	18	5					643	654		10.1016/S1074-7613(03)00110-9	http://dx.doi.org/10.1016/S1074-7613(03)00110-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753741	Bronze			2022-12-18	WOS:000182962200009
J	Sun, L; Youn, HD; Loh, C; Stolow, M; He, WW; Liu, JO				Sun, L; Youn, HD; Loh, C; Stolow, M; He, WW; Liu, JO			Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes	IMMUNITY			English	Article							TRANSCRIPTION FACTOR NFAT1; CYTOSOLIC BINDING-PROTEIN; PEPTIDYL-PROLYL ISOMERASE; CYCLOSPORINE-A; PHOSPHATASE-ACTIVITY; IMMUNOSUPPRESSANT FK506; KINASE-C; IN-VIVO; ACTIVATION; CELLS	Calcineurin plays a pivotal role in the T cell receptor (TCR)-mediated signal transduction pathway and serves as a common target for the immunosuppressants FK506 and cyclosporin A. We report the identification of a novel endogenous calcineurin binding protein named Cabin 1 that inhibits calcineurin-mediated signal transduction. The interaction between Cabin 1 and calcineurin is dependent on PKC activation. Overexpression of Cabin 1 or its N-terminal truncation mutants inhibits the transcriptional activation of calcineurin-responsive elements in the interleukin-2 promoter and blocks dephosphorylation of NF-AT upon T cell activation. These results suggest a negative regulatory role for Cabin 1 in calcineurin signaling and provide a possible mechanism of feedback inhibition of TCR signaling through cross-talk between protein kinases and calcineurin.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Chem, Cambridge, MA 02139 USA; OriGene Technol Inc, Rockville, MD 20850 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Liu, JO (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.		Youn, Hong-Duk/J-2774-2012					AITKEN A, 1982, EUR J BIOCHEM, V126, P235, DOI 10.1111/j.1432-1033.1982.tb06771.x; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; CARDENAS ME, 1994, EMBO J, V13, P5944, DOI 10.1002/j.1460-2075.1994.tb06940.x; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; FRUMAN DA, 1995, MOL CELL BIOL, V15, P3857; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; FURUKAWA T, 1995, J NIH RES, V7, P52; GARDNER P, 1989, CELL, V59, P15, DOI 10.1016/0092-8674(89)90865-9; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HSU HL, 1994, P NATL ACAD SCI USA, V91, P3181, DOI 10.1073/pnas.91.8.3181; HUBBARD MJ, 1989, BIOCHEMISTRY-US, V28, P1868, DOI 10.1021/bi00430a066; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jiang HS, 1997, MOL IMMUNOL, V34, P663, DOI 10.1016/S0161-5890(97)00054-0; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU J, 1992, BIOCHEMISTRY-US, V31, P3896, DOI 10.1021/bi00131a002; Loh C, 1996, MOL CELL BIOL, V16, P3945; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; NELSON PA, 1993, J IMMUNOL, V150, P2139; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Sugimoto T, 1997, J BIOL CHEM, V272, P29415, DOI 10.1074/jbc.272.47.29415; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TORDAI A, 1989, IMMUNOL LETT, V20, P47, DOI 10.1016/0165-2478(89)90067-9; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Wesselborg S, 1996, J BIOL CHEM, V271, P1274, DOI 10.1074/jbc.271.3.1274	51	196	202	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1998	8	6					703	711		10.1016/S1074-7613(00)80575-0	http://dx.doi.org/10.1016/S1074-7613(00)80575-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655484	Bronze			2022-12-18	WOS:000074396300006
J	Kuraishy, A; Karin, M; Grivennikov, SI				Kuraishy, Ali; Karin, Michael; Grivennikov, Sergei I.			Tumor Promotion via Injury- and Death-Induced Inflammation	IMMUNITY			English	Review							NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; COLITIS-ASSOCIATED CANCER; SQUAMOUS-CELL CARCINOMA; NECROSIS-FACTOR-ALPHA; HEPATOCELLULAR-CARCINOMA; STEM-CELLS; TNF-ALPHA; COLORECTAL-CANCER; STAT3 ACTIVATION	Inhibition of programmed cell death is considered to be a major aspect of tumorigenesis. Indeed, several key oncogenic transcription factors, such as NF-kappa B and STAT3, exert their tumor-promoting activity at least in part through upregulation of survival genes. However, many cancers develop in response to chronic tissue injury, in which the resulting cell death increases the tumorigenic potential of the neighboring cells. In this review, we discuss a resolution to this paradox based on cell death-mediated induction of tumor promoting inflammatory cytokines, which enhance cell survival and trigger compensatory proliferation in response to tissue injury.	[Kuraishy, Ali; Karin, Michael; Grivennikov, Sergei I.] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Kuraishy, Ali; Karin, Michael; Grivennikov, Sergei I.] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Sch Med, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Grivennikov, Sergei/AAE-7365-2019	Grivennikov, Sergei/0000-0003-2987-0555	American Cancer Society; Crohn's and Colitis Foundation of America (CDA) [2693]; NIDDK NIH [1K99DK088589-01A1]; UCSD DDRDC [DK080506]; NIH; American Association for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA132586, R01CA127923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, K99DK088589] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Crohn's and Colitis Foundation of America (CDA); NIDDK NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UCSD DDRDC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.K. was supported by a postdoctoral fellowship from the American Cancer Society. S.G. was supported by Crohn's and Colitis Foundation of America (CDA #2693); K99 Pathway to Independence award from NIDDK NIH (1K99DK088589-01A1) and a UCSD DDRDC Pilot Grant (DK080506). M.K. is an American Cancer Society Research Professor and research in his lab is supported by the NIH and the American Association for Cancer Research.	Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bornstein S, 2009, J CLIN INVEST, V119, P3408, DOI 10.1172/JCI38854; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Caricchio R, 2003, J IMMUNOL, V171, P5778, DOI 10.4049/jimmunol.171.11.5778; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Chichlowski M, 2008, COMPARATIVE MED, V58, P534; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Daniel D, 2003, J EXP MED, V197, P1017, DOI 10.1084/jem.20021047; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Domingo DS, 2008, ADV EXP MED BIOL, V624, P187, DOI 10.1007/978-0-387-77574-6_15; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dursun B, 2006, AM J PHYSIOL-RENAL, V291, pF578, DOI 10.1152/ajprenal.00455.2005; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Fucikova J, 2011, CANCER RES, V71, P4821, DOI 10.1158/0008-5472.CAN-11-0950; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Gulley James, 2003, Clin Adv Hematol Oncol, V1, P49; Haddow A, 1972, Adv Cancer Res, V16, P181; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hecht SS, 2002, LANCET ONCOL, V3, P461, DOI 10.1016/S1470-2045(02)00815-X; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Karin M, 2005, NAT MED, V11, P20, DOI 10.1038/nm0105-20; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Kedinger V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-34; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Lewis JS, 2000, J PATHOL, V192, P150, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McKenzie S, 2006, J CELL BIOCHEM, V97, P18, DOI 10.1002/jcb.20634; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nickoloff BJ, 2005, J INVEST DERMATOL, V124, pX, DOI 10.1111/j.0022-202X.2005.23724.x; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Owens P, 2010, AM J PATHOL, V176, P122, DOI 10.2353/ajpath.2010.090081; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Qureshi Asif M, 2011, Genes Cancer, V2, P74, DOI 10.1177/1947601911402681; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rudolph R, 2004, PLAST RECONSTR SURG, V114, p82E, DOI 10.1097/01.PRS.0000138243.45735.8A; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schiechl G, 2011, J CLIN INVEST, V121, P1692, DOI 10.1172/JCI42540; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Schwartz M, 2007, NAT CLIN PRACT ONCOL, V4, P424, DOI 10.1038/ncponc0844; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma A, 2008, CANCER INVEST, V26, P843, DOI 10.1080/07357900801954210; SIEWEKE MH, 1990, SCIENCE, V248, P1656, DOI 10.1126/science.2163544; Smyth MJ, 2003, IMMUNITY, V18, P1, DOI 10.1016/S1074-7613(02)00502-2; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; UDONO H, 1994, J IMMUNOL, V152, P5398; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Wang H, 2011, AM J PATHOL, V179, P714, DOI 10.1016/j.ajpath.2011.05.005; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang JM, 2010, J CLIN INVEST, V120, P2563, DOI 10.1172/JCI42358; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666; Zhang L, 2010, NATURE, V464, P1058, DOI 10.1038/nature08871; Zhang WZ, 2010, P NATL ACAD SCI USA, V107, P18956, DOI 10.1073/pnas.1013420107; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	123	195	204	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					467	477		10.1016/j.immuni.2011.09.006	http://dx.doi.org/10.1016/j.immuni.2011.09.006			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22035839	Bronze, Green Accepted			2022-12-18	WOS:000296657700004
J	Petermann, F; Rothhammer, V; Claussen, MC; Haas, JD; Blanco, LR; Heink, S; Prinz, I; Hemmer, B; Kuchroo, VK; Oukka, M; Korn, T				Petermann, Franziska; Rothhammer, Veit; Claussen, Melte C.; Haas, Jan D.; Blanco, Lorena Riol; Heink, Sylvia; Prinz, Immo; Hemmer, Bernhard; Kuchroo, Vijay K.; Oukka, Mohamed; Korn, Thomas			gamma delta T Cells Enhance Autoimmunity by Restraining Regulatory T Cell Responses via an Interleukin-23-Dependent Mechanism	IMMUNITY			English	Article							IN-VIVO; TH17 CELLS; ANTIGEN-PRESENTATION; MULTIPLE-SCLEROSIS; INTERFERON-GAMMA; CUTTING EDGE; TGF-BETA; INFLAMMATION; IL-23; RECEPTOR	Mice that lack interleukin-23 (IL-23) are resistant to T cell-mediated autoimmunity. Although IL-23 is a maturation factor for T helper 17 (Th17) cells, a subset of gamma delta T cells expresses the IL-23 receptor (IL-23R) constitutively. Using IL-23R reporter mice, we showed that gamma delta T cells were the first cells to respond to IL-23 during experimental autoimmune encephalomyelitis (EAE). Although gamma delta T cells produced Th17 cell-associated cytokines in response to IL-23, their major function was to prevent the development of regulatory T (Treg) cell responses. IL-23-activated gamma delta T cells rendered alpha beta effector T cells refractory to the suppressive activity of Treg cells and also prevented the conversion of conventional T cells into Foxp3(+) Treg cells in vivo. Thus, IL-23, which by itself has no direct effect on Treg cells, is able to disarm Treg cell responses and promote antigen-specific effector T cell responses via activating gamma delta T cells.	[Oukka, Mohamed] Univ Washington, Sch Med, Seattle Childrens Hosp, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA; [Petermann, Franziska; Rothhammer, Veit; Claussen, Melte C.; Heink, Sylvia; Hemmer, Bernhard; Korn, Thomas] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, D-81675 Munich, Germany; [Haas, Jan D.; Prinz, Immo] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Blanco, Lorena Riol] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Technical University of Munich; Hannover Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Oukka, M (corresponding author), Univ Washington, Sch Med, Seattle Childrens Hosp, Ctr Immun & Immunotherapies, 1900 9th Ave,M-S C9S-7, Seattle, WA 98101 USA.	moukka@u.washington.edu; korn@lrz.tum.de	Hemmer, Bernhard/AAT-8388-2021; Hemmer, Bernhard/GPX-8451-2022; Korn, Thomas/AAE-6960-2019; Prinz, Immo/A-3026-2010	Hemmer, Bernhard/0000-0001-5985-6784; Korn, Thomas/0000-0002-3633-0955; Prinz, Immo/0000-0002-8789-9578; Heink, Sylvia/0000-0002-3276-6313	Gemeinnutzige Hertie-Stiftung; Technical University Munich; Deutsche Forschungsgemeinschaft [KO 2964/3-1, KO 2964/4-1, KO 2964/5-1]; National Institutes of Health [R01NS 30843, RO1AI 073542-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030843] Funding Source: NIH RePORTER	Gemeinnutzige Hertie-Stiftung; Technical University Munich; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank S. Woeste for skillful technical assistance. V.R. receives funding from the Gemeinnutzige Hertie-Stiftung. M.C.C. is funded by intramural grants from the Technical University Munich (KKF). T.K. is recipient of a Heisenberg grant and other grants from the Deutsche Forschungsgemeinschaft (KO 2964/3-1, KO 2964/4-1, and KO 2964/5-1). This work was also supported by grants from the National Institutes of Health (R01NS 30843 to V.K.K. and RO1AI 073542-03 to MO).	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Becher B, 2003, J CLIN INVEST, V112, P1186, DOI 10.1172/JCI200319079; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BIGBY M, 1993, J IMMUNOL, V151, P4465; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; CORREA I, 1992, P NATL ACAD SCI USA, V89, P653, DOI 10.1073/pnas.89.2.653; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Duhindan N, 1997, EUR J IMMUNOL, V27, P1704, DOI 10.1002/eji.1830270717; Gyulveszi G, 2009, EUR J IMMUNOL, V39, P1864, DOI 10.1002/eji.200939305; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; King DP, 1999, J IMMUNOL, V162, P5033; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Odyniec A, 2004, J IMMUNOL, V173, P682, DOI 10.4049/jimmunol.173.1.682; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Poggi A, 2007, CURR MED CHEM, V14, P3166, DOI 10.2174/092986707782793835; Rajan AJ, 1998, J IMMUNOL, V160, P5955; Rhodes KA, 2008, EUR J IMMUNOL, V38, P2274, DOI 10.1002/eji.200838354; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rinaldi L, 2006, BRAIN, V129, P1993, DOI 10.1093/brain/awl179; Riol-Blanco L, 2010, J IMMUNOL, V184, P1710, DOI 10.4049/jimmunol.0902796; SKEEN MJ, 1993, J EXP MED, V178, P971, DOI 10.1084/jem.178.3.971; Sonderegger I, 2008, EUR J IMMUNOL, V38, P1833, DOI 10.1002/eji.200838511; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Vincent MS, 1996, J EXP MED, V184, P2109, DOI 10.1084/jem.184.6.2109; Wen L, 1996, J EXP MED, V183, P2271, DOI 10.1084/jem.183.5.2271; Wohler JE, 2009, EUR J IMMUNOL, V39, P1516, DOI 10.1002/eji.200839176; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	58	195	211	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 24	2010	33	3					351	363		10.1016/j.immuni.2010.08.013	http://dx.doi.org/10.1016/j.immuni.2010.08.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20832339	Green Accepted, Bronze			2022-12-18	WOS:000282798500010
J	Macdonald, WA; Chen, ZJ; Gras, S; Archbold, JK; Tynan, FE; Clements, CS; Bharadwaj, M; Kjer-Nielsen, L; Saunders, PM; Wilce, MCJ; Crawford, F; Stadinsky, B; Jackson, D; Brooks, AG; Purcell, AW; Kappler, JW; Burrows, SR; Rossjohn, J; McCluskey, J				Macdonald, Whitney A.; Chen, Zhenjun; Gras, Stephanie; Archbold, Julia K.; Tynan, Fleur E.; Clements, Craig S.; Bharadwaj, Mandvi; Kjer-Nielsen, Lars; Saunders, Philippa M.; Wilce, Matthew C. J.; Crawford, Fran; Stadinsky, Brian; Jackson, David; Brooks, Andrew G.; Purcell, Anthony W.; Kappler, John W.; Burrows, Scott R.; Rossjohn, Jamie; McCluskey, James			T Cell Allorecognition via Molecular Mimicry	IMMUNITY			English	Article							VERSUS-HOST-DISEASE; EPSTEIN-BARR-VIRUS; STRUCTURAL BASIS; POSITIVE SELECTION; RECEPTOR RECOGNITION; ANTIGEN PRESENTATION; AUTOIMMUNE-DISEASE; CRYSTAL-STRUCTURE; LYMPHOCYTES CTL; MHC RESTRICTION	T cells often alloreact with foreign human leukocyte antigens (HLA). Here we showed the LC13 T cell receptor (TCR), selected for recognition on self-HLA-B*0801 bound to a viral peptide, alloreacts with B44 allotypes (HLA-B*4402 and HLA-13*4405) bound to two different allopeptides. Despite extensive polymorphism between HLA-B*0801, HLA-B*4402, and HLA-13*4405 and the disparate sequences of the viral and allopeptides, the LC13 TCR engaged these peptide-HLA (pHLA) complexes identically, accommodating mimicry of the viral peptide by the allopeptide. The viral and allopeptides adopted similar conformations only after TCR ligation, revealing an induced-fit mechanism of molecular mimicry. The LC13 T cells did not alloreact against HLA-13*4403, and the single residue polymorphism between HLA-13*4402 and HLA-13*4403 affected the plasticity of the allopeptide, revealing that molecular mimicry was associated with TCR specificity. Accordingly, molecular mimicry that is HLA and peptide dependent is a mechanism for human T cell alloreactivity between disparate cognate and allogeneic pHLA complexes.	[Macdonald, Whitney A.; Gras, Stephanie; Archbold, Julia K.; Tynan, Fleur E.; Clements, Craig S.; Wilce, Matthew C. J.; Rossjohn, Jamie] Monash Univ, Prot Crystallog Unit, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Chen, Zhenjun; Bharadwaj, Mandvi; Kjer-Nielsen, Lars; Saunders, Philippa M.; Jackson, David; Brooks, Andrew G.; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Purcell, Anthony W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Crawford, Fran; Stadinsky, Brian; Kappler, John W.] Natl Jewish Hlth, Howard Hughes Med Inst, Integrated Dept Immunol, Denver, CO 80206 USA; [Burrows, Scott R.] Queensland Inst Med Res, Cellular Immunol Lab, Brisbane, Qld 4029, Australia; [Burrows, Scott R.] Australian Ctr Vaccine Dev, Brisbane, Qld 4029, Australia	Monash University; University of Melbourne; University of Melbourne; University of Melbourne; Howard Hughes Medical Institute; National Jewish Health; QIMR Berghofer Medical Research Institute	Rossjohn, J (corresponding author), Monash Univ, Prot Crystallog Unit, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.		Purcell, Anthony/AAH-1942-2019; gras, stephanie/C-8307-2013; McCluskey, James/A-1291-2007; Archbold, Julia/N-2884-2013; Burrows, Scott/G-2050-2011; Rossjohn, Jamie/F-9032-2013; Bharadwaj, Mandvi/C-4446-2014	Purcell, Anthony/0000-0003-0532-8331; McCluskey, James/0000-0002-8597-815X; Archbold, Julia/0000-0002-7768-4784; Burrows, Scott/0000-0002-1430-0472; Rossjohn, Jamie/0000-0002-2020-7522; Brooks, Andrew/0000-0002-4085-9683; Jackson, David/0000-0001-7255-270X; gras, stephanie/0000-0001-7416-038X	ARC; NHMRC; Roche Organ Transplant Research Foundation	ARC(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Roche Organ Transplant Research Foundation	We thank the staff at the GMCA-CAT beamline (Chicago, Advanced Photon Source) and the PX1 Beamline at the Australian synchrotron for assistance with data collection We thank Hugh Reid and Kim R Jordan for technical advice J R is a Federation Fellow of the Australian Research Council, C S C is an ARC QEII fellow, W A M is a Peter Doherty Postdoctoral Fellow, F E T is a CJ Martin Fellow, and A.W P, M C J W., and S R B are Senior Research Fellows of the National Health and Medical Research Council Australia This work was supported by grants from the ARC, NHMRC, and Roche Organ Transplant Research Foundation	Afzali B, 2007, TISSUE ANTIGENS, V69, P545, DOI 10.1111/j.1399-0039.2007.00834.x; ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; Archbold JK, 2008, TRENDS IMMUNOL, V29, P220, DOI 10.1016/j.it.2008.02.005; Archbold JK, 2008, MOL IMMUNOL, V45, P583, DOI 10.1016/j.molimm.2006.05.018; Archbold JK, 2006, J BIOL CHEM, V281, P34324, DOI 10.1074/jbc.M606755200; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; BEVAN MJ, 1981, P NATL ACAD SCI-BIOL, V78, P1843, DOI 10.1073/pnas.78.3.1843; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Burrows SR, 1997, EUR J IMMUNOL, V27, P178, DOI 10.1002/eji.1830270126; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; CHARRON D, 1997, GENETIC DIVERSITY HL, V1; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Crawford F, 2006, IMMUNOL REV, V210, P156, DOI 10.1111/j.0105-2896.2006.00365.x; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Doxiadis IIN, 1996, LANCET, V348, P850, DOI 10.1016/S0140-6736(96)02296-9; DROGE W, 1979, Z IMMUNITATSFORSCH, V156, P2, DOI 10.1016/S0340-904X(79)80056-1; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; FINK PJ, 1995, ADV IMMUNOL, V59, P99, DOI 10.1016/S0065-2776(08)60630-6; FLEISCHHAUER K, 1990, NEW ENGL J MED, V323, P1818, DOI 10.1056/NEJM199012273232607; Garboczi DN, 1999, IMMUNITY, V10, P1, DOI 10.1016/S1074-7613(00)80001-1; Garcia K C, 1999, Rev Immunogenet, V1, P75; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Hausmann S, 1999, J IMMUNOL, V162, P338; HEATH WR, 1991, P NATL ACAD SCI USA, V88, P5101, DOI 10.1073/pnas.88.12.5101; HEATH WR, 1989, NATURE, V341, P749, DOI 10.1038/341749a0; Heemskerk MBA, 2007, BONE MARROW TRANSPL, V40, P193, DOI 10.1038/sj.bmt.1705721; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; KEEVER CA, 1994, BONE MARROW TRANSPL, V14, P137; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; LECHLER R, 1990, IMMUNOL RES, V9, P135, DOI 10.1007/BF02918204; LINDAHL KF, 1977, J EXP MED, V145, P500, DOI 10.1084/jem.145.3.500; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; MAN S, 1992, INT IMMUNOL, V4, P367, DOI 10.1093/intimm/4.3.367; MANUZZA RA, 1993, CURR OPIN IMMUNOL, V5, P50; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; Mifsud NA, 2008, AM J TRANSPLANT, V8, P121, DOI 10.1111/j.1600-6143.2007.02044.x; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; QUARATINO S, 1995, P NATL ACAD SCI USA, V92, P10398, DOI 10.1073/pnas.92.22.10398; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Rose NR, 2000, CELL MOL LIFE SCI, V57, P542, DOI 10.1007/PL00000716; Rossjohn J, 2007, CELL, V129, P19, DOI 10.1016/j.cell.2007.03.018; Rubtsova K, 2009, P NATL ACAD SCI USA, V106, P7951, DOI 10.1073/pnas.0902728106; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Smith KD, 1997, TRANSPLANTATION, V64, P351, DOI 10.1097/00007890-199707270-00030; Smith PA, 1997, J EXP MED, V185, P1023, DOI 10.1084/jem.185.6.1023; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; WILLIAMS RC, 1983, AM J MED, V75, P727, DOI 10.1016/0002-9343(83)90399-6; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; YAGI J, 1990, INT IMMUNOL, V2, P83, DOI 10.1093/intimm/2.1.83; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941; Zernich D, 2004, J EXP MED, V200, P13, DOI 10.1084/jem.20031680; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	68	195	198	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					897	908		10.1016/j.immuni.2009.09.025	http://dx.doi.org/10.1016/j.immuni.2009.09.025			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20064448	Bronze			2022-12-18	WOS:000273616400010
J	Lee, HK; Dunzendorfer, S; Soldau, K; Tobias, PS				Lee, HK; Dunzendorfer, S; Soldau, K; Tobias, PS			Double-stranded RNA-mediated TLR3 activation is enhanced by CD14	IMMUNITY			English	Article							LPS-BINDING-PROTEIN; TOLL-LIKE RECEPTOR-3; LIPOPOLYSACCHARIDE LPS; CPG-DNA; MEMBRANE CD14; SOLUBLE CD14; CELLS; LIPOPROTEINS; RECOGNITION; COMPONENTS	CD14 is a well-known pattern-recognition receptor in the innate immune system. Here, we show that CD14 enhances double-stranded RNA (dsRNA)-mediated Toll-like receptor 3 (TLR3) activation. Bone marrow-derived macrophages (BMDMs) from CD14(-/-) mice exhibited impaired responses to polyinosine-polycytidylic acid (plpC) and reduced production of inflammatory cytokines. CD14(-/-) mice injected with pIpC also showed impaired cytokine production. When tested with [P-32] labeled pIpC small fragments (pIpCsf) that maintain the inflammatory activity of crude pIpC, CD14 directly bound pIpCsf and mediated cellular uptake of pIpCsf. Our data show that TLR3 is intracellular and directly interacts with CD14. Internalized pIpCsf was localized in the lysosomes via the endosomes. In unstimulated cells, neither CD14 nor TLR3 was detected in the lysosomes. However, TLR3 was localized in the lysosomes as was CD14 once the cells took up pIpC. We also observed that internalized pIpCsf colocalized with CD14 and TLR3. Consequently, CD14 mediates pIpC uptake and enhances TLR3 signaling.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Lee, HK (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	tobias@scripps.edu			NIAID NIH HHS [AI59753] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059753] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; CARTER WA, 1974, SCIENCE, V186, P1172, DOI 10.1126/science.186.4170.1172; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Dunzendorfer S, 2004, FASEB J, V18, P1117, DOI 10.1096/fj.03-1263fje; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Dziarski R, 2000, CHEM IMMUNOL, V74, P83; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; GEGNER JA, 1995, J BIOL CHEM, V270, P5320, DOI 10.1074/jbc.270.10.5320; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; KIRKLAND TN, 1993, J BIOL CHEM, V268, P24818; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Luzio JP, 2001, BIOCHEM SOC T, V29, P476, DOI 10.1042/BST0290476; Majde JA, 2000, J INTERF CYTOK RES, V20, P259, DOI 10.1089/107999000312397; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Tapping RI, 1997, J BIOL CHEM, V272, P23157, DOI 10.1074/jbc.272.37.23157; TOBIAS PS, 1993, J IMMUNOL, V150, P3011; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vasselon T, 2004, J IMMUNOL, V173, P7401, DOI 10.4049/jimmunol.173.12.7401; Wang PY, 1999, J BIOL CHEM, V274, P23235, DOI 10.1074/jbc.274.33.23235; Wang PY, 1998, J BIOL CHEM, V273, P24309, DOI 10.1074/jbc.273.38.24309; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	37	195	207	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2006	24	2					153	163		10.1016/j.immuni.2005.12.012	http://dx.doi.org/10.1016/j.immuni.2005.12.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	014KN	16473828	Bronze			2022-12-18	WOS:000235479000007
J	Spiotto, MT; Yu, P; Rowley, DA; Nishimura, MI; Meredith, SC; Gajewski, TF; Fu, YX; Schreiber, H				Spiotto, MT; Yu, P; Rowley, DA; Nishimura, MI; Meredith, SC; Gajewski, TF; Fu, YX; Schreiber, H			Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells	IMMUNITY			English	Article							CYTOTOXIC T-CELLS; LYMPHOCYTES-T; IN-VIVO; ADOPTIVE TRANSFER; ALLOGENEIC-TUMOR; CANCER-CELLS; ACTIVATION; RECEPTOR; MICE; LOCALIZATION	To explain why solid cancers grow or are rejected, we examined how the tumor stroma affected the level of antigen expression necessary to induce an immune response. We applied a tamoxifen-regulated Cre-loxP system to induce a model SIYRYYGL antigen recognized by the 2C T cell receptor. Solid tumors expressing the antigen at lower levels grew, whereas solid tumors expressing antigen induced to 26-fold higher levels were rejected. In contrast, mice rejected cell suspensions expressing higher or lower levels of the antigen. The antigen was likely crosspresented because draining lymph node responses required bone marrow-derived cells in the tumor stroma. Thus, tumor antigens expressed at levels sufficient for crosspresentation by bone marrow-derived stromal cells may overcome immunological "ignorance" to solid tumors.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Spiotto, MT (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.		Spiotto, Michael/AAC-8331-2021	fu, yang-xin/0000-0001-8441-6617	NATIONAL CANCER INSTITUTE [P01CA097296, P30CA014599, R01CA022677] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA37516, CA-14599, P01-CA97296, R01-CA22677] Funding Source: Medline; NICHD NIH HHS [HD 07009] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Carbone FR, 1998, IMMUNOL TODAY, V19, P368, DOI 10.1016/S0167-5699(98)01301-2; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Cordaro TA, 2000, EUR J IMMUNOL, V30, P1297, DOI 10.1002/(SICI)1521-4141(200005)30:5<1297::AID-IMMU1297>3.0.CO;2-C; COTRAN RS, 1999, ROBBINS PATHOLOGIC B, P261; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; Dalyot-Herman N, 2000, J IMMUNOL, V165, P6731, DOI 10.4049/jimmunol.165.12.6731; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; GOODNOW C, 1999, IMMUNOBIOLOGY IMMUNE, P520; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Kedl RM, 1997, J IMMUNOL, V159, P650; KOEPPEN H, 1993, EUR J IMMUNOL, V23, P2770, DOI 10.1002/eji.1830231108; KRIPKE ML, 1974, J NATL CANCER I, V53, P1333, DOI 10.1093/jnci/53.5.1333; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; KUNDIG TM, 1993, J IMMUNOL, V150, P4450; Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703; Manning TC, 1997, J IMMUNOL, V159, P4665; MATSUDA M, 1995, INT J CANCER, V61, P765, DOI 10.1002/ijc.2910610605; MIZOGUCHI H, 1992, SCIENCE, V258, P1795, DOI 10.1126/science.1465616; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; Nguyen LT, 2002, J EXP MED, V195, P423, DOI 10.1084/jem.20010032; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; SCHREIBER H, 1999, TUMOR IMMUNOLOGY FUN, P1237; Schuler G, 1997, J EXP MED, V186, P1183, DOI 10.1084/jem.186.8.1183; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SINGH S, 1992, J EXP MED, V175, P139, DOI 10.1084/jem.175.1.139; Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; Udaka K, 1996, J IMMUNOL, V157, P670; WARD PL, 1989, J EXP MED, V170, P217, DOI 10.1084/jem.170.1.217; Wick M, 1997, J EXP MED, V186, P229, DOI 10.1084/jem.186.2.229; Wolf SS, 1995, MOL BIOTECHNOL, V4, P269, DOI 10.1007/BF02779020; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543; Zinkernagel RM, 2000, SEMIN IMMUNOL, V12, P163, DOI 10.1006/smim.2000.0253	38	195	202	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2002	17	6					737	747		10.1016/S1074-7613(02)00480-6	http://dx.doi.org/10.1016/S1074-7613(02)00480-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479820	Bronze			2022-12-18	WOS:000179985500006
J	McSorley, SJ; Asch, S; Costalonga, M; Reinhardt, RL; Jenkins, MK				McSorley, SJ; Asch, S; Costalonga, M; Reinhardt, RL; Jenkins, MK			Tracking Salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection	IMMUNITY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; HOST IMMUNE-RESPONSES; IN-VIVO; TOLERANCE INDUCTION; CLONAL EXPANSION; DENDRITIC CELLS; MICE; EXPRESSION; MIGRATION; INTESTINE	A novel adoptive transfer system was used to track the fate of naive Salmonella-specific CD4 T cells in vivo. These cells showed signs of activation in the Peyer's patches as early as 3 hr after oral infection. The activated CD4 T cells then produced IL-2 and proliferated in the T cell areas of these tissues before migrating into the B cell-rich follicles. In contrast, Salmonella-specific CD4 T cells were not activated in the spleen and very few of these cells migrated to the liver, despite the presence of bacteria in both organs. These results show that the T cell response to pathogenic Salmonella infection is localized to the gut-associated lymphoid tissue and does not extend efficiently to the major sites of late infection.	Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	McSorley, SJ (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Div Immunol, 263 Farmington Ave, Farmington, CT 06030 USA.		Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655; McSorley, Stephen/0000-0002-6363-3222; Asch, Sarah/0000-0002-4868-1226; Costalonga, Massimo/0000-0001-5922-3709	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035296, R37AI027998, R01AI039614, R01AI027998] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 35296, AI 39614, AI 27998] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Chen ZM, 1998, J IMMUNOL, V160, P3462; Chen ZM, 1999, INFECT IMMUN, V67, P2025; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Cookson BT, 1997, J IMMUNOL, V158, P4310; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; George A, 1996, INFECT IMMUN, V64, P4606, DOI 10.1128/IAI.64.11.4606-4611.1996; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hess J, 1996, J IMMUNOL, V156, P3321; Huleatt JW, 2001, J IMMUNOL, V166, P4065, DOI 10.4049/jimmunol.166.6.4065; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Iwasaki A, 1999, AM J PHYSIOL-GASTR L, V276, pG1074, DOI 10.1152/ajpgi.1999.276.5.G1074; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; JONES B, 1995, CURR OPIN IMMUNOL, V7, P474, DOI 10.1016/0952-7915(95)80091-3; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; KANTO S, 1991, J MOL BIOL, V219, P471, DOI 10.1016/0022-2836(91)90187-B; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; KOUSKOFF V, 1995, J IMMUNOL METHODS, V180, P273, DOI 10.1016/0022-1759(95)00002-R; Mackay CR, 1996, EUR J IMMUNOL, V26, P2433, DOI 10.1002/eji.1830261025; Maric I, 1996, J IMMUNOL, V156, P1408; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; McHeyzerWilliams MG, 1996, CURR OPIN IMMUNOL, V8, P278, DOI 10.1016/S0952-7915(96)80068-9; McSorley SJ, 2000, INFECT IMMUN, V68, P3344, DOI 10.1128/IAI.68.6.3344-3348.2000; McSorley SJ, 1997, INFECT IMMUN, V65, P171, DOI 10.1128/IAI.65.1.171-178.1997; McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Schaible U E, 1999, Adv Immunol, V71, P267; STOCKER BAD, 1959, J GEN MICROBIOL, V20, P423; VanCott JL, 1998, NAT MED, V4, P1247, DOI 10.1038/3227; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2	42	195	200	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2002	16	3					365	377		10.1016/S1074-7613(02)00289-3	http://dx.doi.org/10.1016/S1074-7613(02)00289-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911822	Bronze			2022-12-18	WOS:000174572800006
J	Horcher, M; Souabni, A; Busslinger, M				Horcher, M; Souabni, A; Busslinger, M			Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis	IMMUNITY			English	Article							TRANSCRIPTION FACTOR BSAP; NF-HB; ANTIGEN RECEPTOR; 3ALPHA ENHANCER; LYMPHOCYTES-B; PAX5 BSAP; IMMUNOGLOBULIN; EXPRESSION; PROTEIN; MICE	The a lineage commitment factor Pax5 (BSAP) is expressed throughout B cell development. To investigate its late function, we generated a mouse strain carrying a flexed Pax5 allele that was conditionally inactivated by CD19-cre or Mx-cre expression. Pax5 deletion resulted in the preferential loss of mature B cells, inefficient lymphoblast formation, and reduced serum IgG levels. Mature B cells radically changed their gene expression pattern in response to Pax5 inactivation. Most B cell antigens were downregulated on the cell surface, and the transcription of B cell-specific genes was decreased, whereas the expression of non-B lymphoid genes was activated in Pax5-deficient B cells. These data demonstrate that Pax5 is essential for maintaining the identity and function of B cells during late B lymphopoiesis.	Res Inst Mol Pathol, Vienna Bioctr, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Busslinger, M (corresponding author), Res Inst Mol Pathol, Vienna Bioctr, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	busslinger@nt.imp.univie.ac.at	Busslinger, Meinrad J./J-1249-2016	Busslinger, Meinrad J./0000-0002-9111-9351				ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Busslinger M, 1996, P NATL ACAD SCI USA, V93, P6129, DOI 10.1073/pnas.93.12.6129; Busslinger Meinrad, 1998, P83; CHENG HL, 1982, NATURE, V296, P410, DOI 10.1038/296410a0; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LIAO F, 1994, J IMMUNOL, V152, P2904; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; LUNDGREN M, 1995, EUR J IMMUNOL, V25, P2042, DOI 10.1002/eji.1830250736; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; MATHER EL, 1984, CELL, V36, P329, DOI 10.1016/0092-8674(84)90226-5; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; MONROE JG, 1983, EUR J IMMUNOL, V13, P208, DOI 10.1002/eji.1830130306; NEURATH MF, 1994, J IMMUNOL, V153, P730; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Oliver AM, 1997, J IMMUNOL, V158, P1108; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; Qiu G, 1998, J IMMUNOL, V161, P2906; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Roque MC, 1996, MOL CELL BIOL, V16, P3138; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Schwenk F, 1997, J IMMUNOL METHODS, V207, P203, DOI 10.1016/S0022-1759(97)00116-6; SINGH M, 1993, MOL CELL BIOL, V13, P3611, DOI 10.1128/MCB.13.6.3611; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Usui T, 1997, J IMMUNOL, V158, P3197; WAKATSUKI Y, 1994, J EXP MED, V179, P1099, DOI 10.1084/jem.179.4.1099; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Ying H, 1998, J IMMUNOL, V161, P4760	47	195	204	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2001	14	6					779	790		10.1016/S1074-7613(01)00153-4	http://dx.doi.org/10.1016/S1074-7613(01)00153-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420047	Bronze			2022-12-18	WOS:000169495100013
J	Nelson, PJ; Krensky, AM				Nelson, PJ; Krensky, AM			Chemokines, chemokine receptors, and allograft rejection	IMMUNITY			English	Review							TRANSPLANT REJECTION; IMMUNE-RESPONSES; MONOCYTE ARREST; T-LYMPHOCYTES; RANTES; EXPRESSION; CHEMOATTRACTANT; TISSUE; TRANSCRIPTION; HOMEOSTASIS		Univ Munich, Klinikum Innenstadt, Med Poliklin, D-80336 Munich, Germany; Stanford Univ, Dept Pediat, Div Immunol & Transplantat Biol, Stanford, CA 94305 USA	University of Munich; Stanford University	Nelson, PJ (corresponding author), Univ Munich, Klinikum Innenstadt, Med Poliklin, Schillerstr 42, D-80336 Munich, Germany.		Krensky, Alan/F-7956-2011					Ambrosio G, 1999, AM HEART J, V138, pS69, DOI 10.1016/S0002-8703(99)70323-6; Belperio JA, 2000, J IMMUNOL, V165, P461, DOI 10.4049/jimmunol.165.1.461; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Calo L., 2000, Clinical Nephrology, V53, P6; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; EISSNER A, 2000, TRANSPLANTATION, V70, P362; FISCHEREDER M, 2001, IN PRESS LANCET; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; Grone HJ, 1999, FASEB J, V13, P1371, DOI 10.1096/fasebj.13.11.1371; Hancock WW, 2000, CURR OPIN IMMUNOL, V12, P511, DOI 10.1016/S0952-7915(00)00130-8; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Hogaboam CM, 1999, GENE THER, V6, P573, DOI 10.1038/sj.gt.3300858; Horuk R, 2001, J BIOL CHEM, V276, P4199, DOI 10.1074/jbc.M007457200; Keane M P, 1999, Chem Immunol, V72, P86, DOI 10.1159/000058728; Koga S, 1999, J IMMUNOL, V163, P4878; Lakkis FG, 2000, NAT MED, V6, P686, DOI 10.1038/76267; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Murphy PM, 2000, PHARMACOL REV, V52, P145; NELSON PJ, 2001, IN PRESS IMUNOLOGIC; Ortiz BD, 1997, IMMUNOL TODAY, V18, P468, DOI 10.1016/S0167-5699(97)01128-6; PATTISON J, 1994, LANCET, V343, P209, DOI 10.1016/S0140-6736(94)90992-X; Robinson LA, 2000, J IMMUNOL, V165, P6067, DOI 10.4049/jimmunol.165.11.6067; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Song A, 2000, IMMUNOL REV, V177, P236, DOI 10.1034/j.1600-065X.2000.17610.x; Song A, 1999, IMMUNITY, V10, P93, DOI 10.1016/S1074-7613(00)80010-2; Sozzani S, 2000, J CLIN IMMUNOL, V20, P151, DOI 10.1023/A:1006659211340; Van Damme J, 1999, Chem Immunol, V72, P42, DOI 10.1159/000058725; VONHUNDELSHAUSE.P, 2001, IN PRESS CIRCULATION; Watarai Y, 2000, J IMMUNOL, V164, P6027, DOI 10.4049/jimmunol.164.11.6027; Weber C, 2001, BLOOD, V97, P1144, DOI 10.1182/blood.V97.4.1144; Weber KSC, 1999, EUR J IMMUNOL, V29, P700, DOI 10.1002/(SICI)1521-4141(199902)29:02<700::AID-IMMU700>3.3.CO;2-T; Yamaguchi Y, 1997, HEPATOLOGY, V26, P1546; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	40	195	207	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2001	14	4					377	386		10.1016/S1074-7613(01)00118-2	http://dx.doi.org/10.1016/S1074-7613(01)00118-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336683	Bronze			2022-12-18	WOS:000168246700005
J	Bakker, ABH; Hoek, RM; Cerwenka, A; Blom, B; Lucian, L; McNeil, T; Murray, R; Phillips, JH; Sedgwick, JD; Lanier, LL				Bakker, ABH; Hoek, RM; Cerwenka, A; Blom, B; Lucian, L; McNeil, T; Murray, R; Phillips, JH; Sedgwick, JD; Lanier, LL			DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CLASS-I MOLECULES; T-CELL; DENDRITIC CELLS; LY-49D RECEPTOR; CD40 LIGAND; NK CELLS; ACTIVATION; GENE	DAP12 is an ITAM-bearing membrane adaptor molecule implicated in the activation of NK and myeloid cells. In mice rendered DAP12 deficient by targeted gene disruption, lymphoid and myeloid development was apparently normal, although the activating Ly49 receptors on NK cells were downregulated and nonfunctional. To analyze the consequences of DAP12 deficiency in vivo, we examined the susceptibility of DAP12(-/-) mice to experimental autoimmune encephalomyelitis (EAE). DAP12-/- mice were resistant to EAE induced by immunization with myelin oligodendrocyte glycoprotein (MOG) peptide. Resistance was associated with a strongly diminished production of IFN gamma by myelin-reactive CD4(+) T cells due to inadequate T cell priming in vivo. These data suggest that DAP12 signaling may be required for optimal antigen-presenting cell (APC) function or inflammation.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA; Eos Biotechnol, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lanier@itsa.ucsf.edu	Bakker, Arnold B./F-8494-2010; Lanier, Lewis L/E-2139-2014	Bakker, Arnold B./0000-0003-1489-1847; Lanier, Lewis L/0000-0003-1308-3952; Cerwenka, Adelheid/0000-0001-6977-3536				Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025; Bakker ABH, 1998, J IMMUNOL, V160, P5239; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; Ferber IA, 1996, J IMMUNOL, V156, P5; FORD AL, 1995, J IMMUNOL, V154, P4309; GALLUCI S, 2000, NAT MED, V5, P1259; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; Korner H, 1997, J EXP MED, V186, P1585, DOI 10.1084/jem.186.9.1585; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Liu AG, 1999, J VAC SCI TECHNOL B, V17, P875, DOI 10.1116/1.590667; Mason LH, 1998, J IMMUNOL, V160, P4148; Mason LH, 1996, J EXP MED, V184, P2119, DOI 10.1084/jem.184.6.2119; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Nakamura MC, 1999, J IMMUNOL, V163, P4694; Ohshima Y, 1997, J IMMUNOL, V159, P3838; Olcese L, 1997, J IMMUNOL, V158, P5083; Oxenius A, 1996, J EXP MED, V183, P2209, DOI 10.1084/jem.183.5.2209; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; RACKE MK, 1995, J CLIN INVEST, V96, P2195, DOI 10.1172/JCI118274; Riminton DS, 1998, J EXP MED, V187, P1517, DOI 10.1084/jem.187.9.1517; Samoilova EB, 1998, J IMMUNOL, V161, P6480; SCOTT P, 1995, CURR OPIN IMMUNOL, V7, P34, DOI 10.1016/0952-7915(95)80026-3; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; Smith KM, 1998, J IMMUNOL, V161, P7; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Verloes A, 1997, J MED GENET, V34, P753, DOI 10.1136/jmg.34.9.753; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yanagihara S, 1998, J IMMUNOL, V161, P3096	45	195	209	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2000	13	3					345	353		10.1016/S1074-7613(00)00034-0	http://dx.doi.org/10.1016/S1074-7613(00)00034-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021532	Bronze			2022-12-18	WOS:000089616400007
J	Sharp, LL; Schwarz, DA; Bott, CM; Marshall, CJ; Hedrick, SM				Sharp, LL; Schwarz, DA; Bott, CM; Marshall, CJ; Hedrick, SM			The influence of the MAPK pathway on T cell lineage commitment	IMMUNITY			English	Article							PROTEIN-KINASE-C; ELEGANS VULVAR INDUCTION; RECEPTOR TYROSINE KINASE; CHAIN GENE REARRANGEMENT; OF-FUNCTION MUTATION; CAENORHABDITIS-ELEGANS; SIGNALING PATHWAYS; NEGATIVE SELECTION; ANTIGEN RECEPTOR; THYMOCYTE DEVELOPMENT	During development, progenitor thymocytes differentiate into either CD4 or CD8 T cells, and this fate decision depends on the specificity of the T cell antigen receptor (TCR) for MHC class II or class I molecules. Based on the mechanisms of fate specification known for simple metazoan organisms, we sought to determine whether the extracellular signal-related kinases (ERKs) play a role in T cell differentiation and lineage commitment. Using a dominant gain-of-function mutant of the erk2 gene, we show that differentiation into the CD4 lineage is favored. We also show that, conversely, the addition of a pharmacological inhibitor of the ERK pathway favors differentiation into the CD8 lineage. We present a quantitative selection model that incorporates these results as well as those of recent reports on the role of Notch in T cell lineage specification.	UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,CTR CANC,LA JOLLA,CA 92093; INST CANC RES,CHESTER BEATTY LABS,SECT CELL & MOL BIOL,LONDON SW3 6JB,ENGLAND	University of California System; University of California San Diego; University of California System; University of California San Diego; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK			Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751	NIAID NIH HHS [AI09208, AI21372-14] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021372, R37AI021372] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BOTT CM, 1994, FEBS LETT, V352, P201, DOI 10.1016/0014-5793(94)00958-9; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Chan S H, 1994, Semin Immunol, V6, P241, DOI 10.1006/smim.1994.1031; CHAN SH, 1994, EMBO J, V13, P4482, DOI 10.1002/j.1460-2075.1994.tb06770.x; CHANG HC, 1994, COLD SPRING HARB SYM, V59, P147, DOI 10.1101/SQB.1994.059.01.018; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; DAVIS CB, 1994, CURR OPIN IMMUNOL, V6, P266, DOI 10.1016/0952-7915(94)90100-7; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GRCETTRUP M, 1993, IMMUNOL TODAY, V14, P610; GREENWALD I, 1990, NATURE, V346, P197, DOI 10.1038/346197a0; HAFEN E, 1994, PROG NEUROBIOL, V42, P287, DOI 10.1016/0301-0082(94)90067-1; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; KAYE J, 1992, J IMMUNOL, V148, P3342; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KOGA M, 1995, DEVELOPMENT, V121, P2655; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LACKNER MR, 1994, GENE DEV, V8, P160, DOI 10.1101/gad.8.2.160; LAKE RA, 1990, EMBO J, V9, P3129, DOI 10.1002/j.1460-2075.1990.tb07510.x; Lerner A, 1996, EMBO J, V15, P5876, DOI 10.1002/j.1460-2075.1996.tb00974.x; MARQUARDT B, 1994, ONCOGENE, V9, P3213; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; QIU ZH, 1994, J BIOL CHEM, V269, P19480; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; STERNBERG PW, 1989, CELL, V58, P679, DOI 10.1016/0092-8674(89)90103-7; Sundaram M, 1996, BIOESSAYS, V18, P473, DOI 10.1002/bies.950180609; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	58	195	197	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1997	7	5					609	618		10.1016/S1074-7613(00)80382-9	http://dx.doi.org/10.1016/S1074-7613(00)80382-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390685	Bronze			2022-12-18	WOS:A1997YH55400004
J	Miragaia, RJ; Gomes, T; Chomka, A; Jardine, L; Riedel, A; Hegazy, AN; Whibley, N; Tucci, A; Chen, X; Lindeman, I; Emerton, G; Krausgruber, T; Shields, J; Haniffa, M; Powrie, F; Teichmann, SA				Miragaia, Ricardo J.; Gomes, Tomas; Chomka, Agnieszka; Jardine, Laura; Riedel, Angela; Hegazy, Ahmed N.; Whibley, Natasha; Tucci, Andrea; Chen, Xi; Lindeman, Ida; Emerton, Guy; Krausgruber, Thomas; Shields, Jacqueline; Haniffa, Muzlifah; Powrie, Fiona; Teichmann, Sarah A.			Single-Cell Transcriptomics of Regulatory T Cells Reveals Trajectories of Tissue Adaptation	IMMUNITY			English	Article							GENE-EXPRESSION; HELPER-CELLS; RNA-SEQ; LYMPHOCYTES; DIFFERENTIATION; MECHANISMS; INFERENCE; SUBSET; IRF4; FATE	Non-lymphoid tissues (NLTs) harbor a pool of adaptive immune cells with largely unexplored phenotype and development. We used single-cell RNA-seq to characterize 35,000 CD4(+) regulatory (Treg) and memory (Tmem) T cells in mouse skin and colon, their respective draining lymph nodes (LNs) and spleen. In these tissues, we identified Treg cell sub-populations with distinct degrees of NLT phenotype. Subpopulation pseudotime ordering and gene kinetics were consistent in recruitment to skin and colon, yet the initial NLT-priming in LNs and the final stages of NLT functional adaptation reflected tissue-specific differences. Predicted kinetics were recapitulated using an in vivo melanoma-induction model, validating key regulators and receptors. Finally, we profiled human blood and NLT Treg and Tmem cells, and identified cross-mammalian conserved tissue signatures. In summary, we describe the relationship between Treg cell heterogeneity and recruitment to NLTs through the combined use of computational prediction and in vivo validation.	[Miragaia, Ricardo J.; Gomes, Tomas; Chen, Xi; Lindeman, Ida; Emerton, Guy; Teichmann, Sarah A.] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England; [Miragaia, Ricardo J.] Univ Minho, Ctr Biol Engn, Braga, Portugal; [Chomka, Agnieszka; Hegazy, Ahmed N.; Whibley, Natasha; Tucci, Andrea; Krausgruber, Thomas; Powrie, Fiona] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Chomka, Agnieszka; Hegazy, Ahmed N.; Krausgruber, Thomas; Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Expt Med Div, Translat Gastroenterol Unit,Nuffield Dept Clin Me, Oxford, England; [Jardine, Laura; Haniffa, Muzlifah] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Riedel, Angela; Shields, Jacqueline] Univ Cambridge, MRC, Canc Unit, Cambridge, England; [Lindeman, Ida] Univ Oslo, Ctr Immune Regulat, N-0372 Oslo, Norway; [Lindeman, Ida] Univ Oslo, Dept Immunol, N-0372 Oslo, Norway; [Lindeman, Ida] Oslo Univ Hosp, N-0372 Oslo, Norway; [Teichmann, Sarah A.] Univ Cambridge, Dept Phys, Theory Condensed Matter, Cavendish Lab, Cambridge, England; [Teichmann, Sarah A.] EBI, EMBL, Wellcome Genome Campus, Hinxton, England; [Hegazy, Ahmed N.] Charite Univ Med Berlin, Berlin, Germany; [Hegazy, Ahmed N.] Free Univ Berlin, Berlin, Germany; [Hegazy, Ahmed N.] Humboldt Univ, Berlin, Germany; [Hegazy, Ahmed N.] Berlin Inst Hlth, Dept Gastroenterol Infect Dis & Rheumatol, Berlin, Germany; [Krausgruber, Thomas] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria	Wellcome Trust Sanger Institute; Universidade do Minho; University of Oxford; University of Oxford; Newcastle University - UK; University of Cambridge; University of Oslo; University of Oslo; University of Oslo; University of Cambridge; European Molecular Biology Laboratory (EMBL); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Teichmann, SA (corresponding author), Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England.; Teichmann, SA (corresponding author), Univ Cambridge, Dept Phys, Theory Condensed Matter, Cavendish Lab, Cambridge, England.; Teichmann, SA (corresponding author), EBI, EMBL, Wellcome Genome Campus, Hinxton, England.	st9@sanger.ac.uk	Krausgruber, Thomas/H-8490-2018; Riedel, Angela/ABC-7207-2020; Lindeman, Ida/T-4183-2019; Chen, Xi/F-2057-2019	Krausgruber, Thomas/0000-0002-1374-0329; Lindeman, Ida/0000-0001-8343-2842; Chen, Xi/0000-0003-2648-3146; Hegazy, Ahmed N./0000-0002-2946-8251	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/51950/2012]; European Union's H2020 research and innovation program "ENLIGHT-TEN'' under the Marie Sklodowska-Curie grant [675395]; ERC grant ThDEFINE; ERC grant ThSWITCH; EMBO long-term fellowship [ALTF 1161-2012]; Marie Curie fellowship [PIEF-GA-2012-330621]; MRC [MC_UU_12022/5] Funding Source: UKRI	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Union's H2020 research and innovation program "ENLIGHT-TEN'' under the Marie Sklodowska-Curie grant; ERC grant ThDEFINE; ERC grant ThSWITCH; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Marie Curie fellowship(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank V. Proserpio, M. Stubbington, T. Hagai, F.V. Braga, V. Svensson, and J. Henriksson for helpful discussions and advice; T. Hagai, R. Vento-Tormo, K. Meyer, and J. Park for critical reading of the manuscript; and B. Koppelman for editorial support. We thank WSI Single-cell Genomic Core Facility, WSI Sequencing Facility, WSI Flow Cytometry facilities, K. Polanski, and the Kennedy Institute Flow Cytometry Facility for expert technical advice and assistance. R. J. M. was supported by a PhD Fellowship from the Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BD/51950/2012) and T.G. by the European Union's H2020 research and innovation program "ENLIGHT-TEN'' under the Marie Sklodowska-Curie grant agreement 675395. This project was supported by ERC grants ThDEFINE and ThSWITCH. A.N.H. was supported by an EMBO long-term fellowship (ALTF 1161-2012) and a Marie Curie fellowship (PIEF-GA-2012-330621).	Adam M, 2017, DEVELOPMENT, V144, P3625, DOI 10.1242/dev.151142; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bollrath J, 2013, SEMIN IMMUNOL, V25, P352, DOI 10.1016/j.smim.2013.09.002; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Campbell KR, 2017, BIOINFORMATICS, V33, P1241, DOI 10.1093/bioinformatics/btw798; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chow Z, 2015, IMMUNOL CELL BIOL, V93, P355, DOI 10.1038/icb.2014.117; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Damianou A., 2012, MANIFOLD RELEVANCE D; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hu Zhi-Qing, 2015, Cell Mol Immunol, V12, P521, DOI 10.1038/cmi.2015.49; Ikebuchi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep35002; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; KIMPTON WG, 1995, INT IMMUNOL, V7, P1567, DOI 10.1093/intimm/7.10.1567; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Li CR, 2018, CELL, V174, P285, DOI 10.1016/j.cell.2018.05.004; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Lonnberg T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2192; Malhotra N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao6923; Malik BT, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6346; Matsushima H, 2010, J CLIN INVEST, V120, P653, DOI 10.1172/JCI42280; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Riedel A, 2016, NAT IMMUNOL, V17, P1118, DOI 10.1038/ni.3492; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Scialdone A, 2015, METHODS, V85, P54, DOI 10.1016/j.ymeth.2015.06.021; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Sherwood AM, 2013, CANCER IMMUNOL IMMUN, V62, P1453, DOI 10.1007/s00262-013-1446-2; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Thome JJC, 2016, NAT MED, V22, P72, DOI 10.1038/nm.4008; Titsias MK, 2010, P 13 INT C ARTIFICIA, V9, P844; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; Vasanthakumar A, 2017, CELL REP, V20, P2906, DOI 10.1016/j.celrep.2017.08.068; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wu YE, 2017, NEURON, V96, P313, DOI 10.1016/j.neuron.2017.09.026	50	194	199	6	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					493	+		10.1016/j.immuni.2019.01.001	http://dx.doi.org/10.1016/j.immuni.2019.01.001			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30737144	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-18	WOS:000459006700021
J	Mak, TW; Grusdat, M; Duncan, GS; Dostert, C; Nonnenmacher, Y; Cox, M; Binsfeld, C; Hao, ZY; Brustle, A; Itsumi, M; Jager, C; Chen, Y; Pinkenburg, O; Camara, B; Ollert, M; Bindslev-Jensen, C; Vasiliou, V; Gorrini, C; Lang, PA; Lohoff, M; Harris, IS; Hiller, K; Brenner, D				Mak, Tak W.; Grusdat, Melanie; Duncan, Gordon S.; Dostert, Catherine; Nonnenmacher, Yannic; Cox, Maureen; Binsfeld, Carole; Hao, Zhenyue; Bruestle, Anne; Itsumi, Momoe; Jaeger, Christian; Chen, Ying; Pinkenburg, Olaf; Camara, Baerbel; Ollert, Markus; Bindslev-Jensen, Carsten; Vasiliou, Vasilis; Gorrini, Chiara; Lang, Philipp A.; Lohoff, Michael; Harris, Isaac S.; Hiller, Karsten; Brenner, Dirk			Glutathione Primes T Cell Metabolism for Inflammation	IMMUNITY			English	Article							C-MYC; SIGNALING PATHWAY; LYMPHOCYTE ACTIVATION; GLUTAMINE REQUIREMENT; RECEPTOR STIMULATION; KINASE ACTIVATION; MAMMALIAN TARGET; INDUCED DEATH; CANCER-CELLS; COMPLEX 1	Activated T cells produce reactive oxygen species (ROS), which trigger the antioxidative glutathione (GSH) response necessary to buffer rising ROS and prevent cellular damage. We report that GSH is essential for T cell effector functions through its regulation of metabolic activity. Conditional gene targeting of the catalytic subunit of glutamate cysteine ligase (Gclc) blocked GSH production specifically in murine T cells. Gclc-deficient T cells initially underwent normal activation but could not meet their increased energy and biosynthetic requirements. GSH deficiency compromised the activation of mammalian target of rapamycin-1 (mTOR) and expression of NFAT and Myc transcription factors, abrogating the energy utilization and Myc-dependent metabolic reprogramming that allows activated T cells to switch to glycolysis and glutaminolysis. In vivo, T-cell-specific ablation of murine Gclc prevented autoimmune disease but blocked antiviral defense. The antioxidative GSH pathway thus plays an unexpected role in metabolic integration and reprogramming during inflammatory T cell responses.	[Mak, Tak W.; Duncan, Gordon S.; Cox, Maureen; Hao, Zhenyue; Gorrini, Chiara] Campbell Family Canc Res Inst, Toronto, ON M5G 2C1, Canada; [Mak, Tak W.; Duncan, Gordon S.; Cox, Maureen; Hao, Zhenyue; Gorrini, Chiara] Univ Hlth Network, Toronto, ON M5G 2C1, Canada; [Mak, Tak W.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Mak, Tak W.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; [Grusdat, Melanie; Dostert, Catherine; Binsfeld, Carole; Brenner, Dirk] Luxembourg Inst Hlth, Dept Infect & Immun Expt & Mol Immunol, L-4354 Esch Sur Alzette, Luxembourg; [Nonnenmacher, Yannic; Hiller, Karsten] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Integrated Ctr Syst Biol, D-38106 Braunschweig, Germany; [Nonnenmacher, Yannic; Bindslev-Jensen, Carsten; Hiller, Karsten] Univ Luxembourg, Luxembourg Ctr Syst Biomed, L-4367 Belvaux, Luxembourg; [Hao, Zhenyue] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S3E1, Canada; [Bruestle, Anne] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT 2601, Australia; [Itsumi, Momoe] Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo 1138510, Japan; [Chen, Ying; Vasiliou, Vasilis] Yale Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USA; [Pinkenburg, Olaf; Camara, Baerbel; Lohoff, Michael] Univ Marburg, Inst Med Microbiol, D-35032 Marburg, Germany; [Pinkenburg, Olaf; Camara, Baerbel; Lohoff, Michael] Univ Marburg, Hosp Hyg, D-35032 Marburg, Germany; [Ollert, Markus] Luxembourg Inst Hlth, Dept Infect & Immun Allergy & Clin Immunol, L-4354 Esch Sur Alzette, Luxembourg; [Ollert, Markus; Bindslev-Jensen, Carsten; Brenner, Dirk] Univ Southern Denmark, Dept Dermatol, Odense Res Ctr Anaphylaxis, DK-5000 Odense, Denmark; [Ollert, Markus; Bindslev-Jensen, Carsten; Brenner, Dirk] Univ Southern Denmark, Allergy Ctr, Odense Univ Hosp, DK-5000 Odense, Denmark; [Lang, Philipp A.] Univ Dusseldorf, Med Fac, Dept Mol Med 2, D-40225 Dusseldorf, Germany; [Harris, Isaac S.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Hiller, Karsten] Helmholtz Ctr Infect Res, Computat Biol Infect Res, D-38124 Braunschweig, Germany	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Luxembourg Institute of Health; Braunschweig University of Technology; University of Luxembourg; University of Toronto; Australian National University; John Curtin School of Medical Research; Tokyo Medical & Dental University (TMDU); Yale University; Philipps University Marburg; Philipps University Marburg; Luxembourg Institute of Health; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Heinrich Heine University Dusseldorf; Harvard University; Harvard Medical School; Helmholtz Association; Helmholtz-Center for Infection Research	Mak, TW (corresponding author), Campbell Family Canc Res Inst, Toronto, ON M5G 2C1, Canada.; Mak, TW (corresponding author), Univ Hlth Network, Toronto, ON M5G 2C1, Canada.; Mak, TW (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada.; Mak, TW (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada.; Brenner, D (corresponding author), Luxembourg Inst Hlth, Dept Infect & Immun Expt & Mol Immunol, L-4354 Esch Sur Alzette, Luxembourg.; Brenner, D (corresponding author), Univ Southern Denmark, Dept Dermatol, Odense Res Ctr Anaphylaxis, DK-5000 Odense, Denmark.; Brenner, D (corresponding author), Univ Southern Denmark, Allergy Ctr, Odense Univ Hosp, DK-5000 Odense, Denmark.	tmak@uhnresearch.ca; dirk.brenner@lih.lu	Duncan, Gordon/AIE-7011-2022; Dostert, Catherine/AAJ-5473-2020; Bindslev-Jensen, Carsten/H-1877-2011; Cox, Maureen/AAY-7685-2020	Bindslev-Jensen, Carsten/0000-0002-8940-038X; Cox, Maureen/0000-0001-8030-3340; Grusdat, Melanie/0000-0003-0708-0077; Brenner, Dirk/0000-0001-8979-1045; Gorrini, Chiara/0000-0002-5239-6671; Hiller, Karsten/0000-0001-9322-5820; Ollert, Markus W./0000-0002-8055-0103; Bruestle, Anne/0000-0002-3842-5683; Harris, Isaac/0000-0002-6855-2763	ATTRACT program; National Research Fund Luxembourg (FNR) [C15/BM/10355103]; NIH NIAAA [5R24AA022057-05]; German Research Council (DFG) [SFB974, LA-2558-5/1]; Deutsches Zentrum fur Infektionsforschung; University Hospital Giessen Marburg; National Multiple Sclerosis Society [RG 5035-A-2]; Canadian Institutes of Health Research [143268, MOP-123276]; Grants-in-Aid for Scientific Research [15K20095] Funding Source: KAKEN	ATTRACT program; National Research Fund Luxembourg (FNR)(Luxembourg National Research Fund); NIH NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); German Research Council (DFG)(German Research Foundation (DFG)); Deutsches Zentrum fur Infektionsforschung; University Hospital Giessen Marburg; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank L. Soriano Baguet and H. Kurniawan for assistance; L. Wybenga-Groot, C. Fladd, and the SPARC BioCentre in Toronto for Seahorse experiments; A. Elia for assistance with histology; and S. Storn and the Luxembourg Institute of Health's Animal Welfare Structure. We thank M. Saunders for scientific editing and to M. Brenner for general support. D.B. and K.H. are supported by the ATTRACT program and D.B. by a CORE grant (C15/BM/10355103) of the National Research Fund Luxembourg (FNR). V.V. holds a grant from the NIH NIAAA (5R24AA022057-05). This study was supported by the German Research Council (DFG, SFB974, LA-2558-5/1). M.L. and O.P. are funded by the Deutsches Zentrum fur Infektionsforschung and the University Hospital Giessen Marburg. T.W.M. holds grants from the National Multiple Sclerosis Society (RG 5035-A-2) and the Canadian Institutes of Health Research (143268, MOP-123276).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Babcock JT, 2013, J BIOL CHEM, V288, P15687, DOI 10.1074/jbc.M112.431056; Battello N, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0141-0; Brenner D, 2014, P NATL ACAD SCI USA, V111, P1060, DOI 10.1073/pnas.1323166111; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Brustle A, 2012, J CLIN INVEST, V122, P4698, DOI 10.1172/JCI63528; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200; Chen Y, 2007, HEPATOLOGY, V45, P1118, DOI 10.1002/hep.21635; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Douglas NC, 2001, NAT IMMUNOL, V2, P307, DOI 10.1038/86308; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gulow K, 2005, J IMMUNOL, V174, P5249, DOI 10.4049/jimmunol.174.9.5249; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; HORIG H, 1993, J CELL BIOCHEM, V53, P343, DOI 10.1002/jcb.240530412; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; Hwang NR, 2009, BIOCHEM J, V423, P253, DOI 10.1042/BJ20090854; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Namgaladze D, 2002, J BIOL CHEM, V277, P5962, DOI 10.1074/jbc.M111268200; NEWSHOLME EA, 1985, Q J EXP PHYSIOL CMS, V70, P473, DOI 10.1113/expphysiol.1985.sp002935; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Schmidt EV, 2009, CELL CYCLE, V8, P1344, DOI 10.4161/cc.8.9.8215; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Singh G, 2010, J BIOL CHEM, V285, P27241, DOI 10.1074/jbc.M110.100438; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yaqoob P, 1997, NUTRITION, V13, P646, DOI 10.1016/S0899-9007(97)83008-0; Yi JS, 2006, J IMMUNOL, V177, P852, DOI 10.4049/jimmunol.177.2.852	55	194	199	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					675	689		10.1016/j.immuni.2017.03.019	http://dx.doi.org/10.1016/j.immuni.2017.03.019			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423341	Bronze			2022-12-18	WOS:000399451100019
J	de Kleer, IM; Kool, M; de Bruijn, MJW; Willart, M; van Moorleghem, J; Schuijs, MJ; Plantinga, M; Beyaert, R; Hams, E; Fallon, PG; Hammad, H; Hendriks, RW; Lambrecht, BN				de Kleer, Isme M.; Kool, Mirjam; de Bruijn, Marjolein J. W.; Willart, Monique; van Moorleghem, Justine; Schuijs, Martijn J.; Plantinga, Maud; Beyaert, Rudi; Hams, Emily; Fallon, Padraic G.; Hammad, Hamida; Hendriks, Rudi W.; Lambrecht, Bart N.			Perinatal Activation of the Interleukin-33 Pathway Promotes Type 2 Immunity in the Developing Lung	IMMUNITY			English	Article							HOUSE-DUST MITE; INNATE LYMPHOID-CELLS; DENDRITIC CELLS; T-CELLS; AIRWAY INFLAMMATION; IMPAIRED RESPONSES; ALVEOLAR FORMATION; NEONATAL IMMUNITY; RESPIRATORY-TRACT; EPITHELIAL-CELLS	Allergic disease originates in early life and polymorphisms in interleukin-33 gene (IL33) and IL1RL1, coding for IL-33R and decoy receptor sST2, confer allergy risk. Early life T helper 2 (Th2) cell skewing and allergy susceptibility are often seen as remnants of feto-maternal symbiosis. Here we report that shortly after birth, innate lymphoid type 2 cells (ILC2s), eosinophils, basophils, and mast cells spontaneously accumulated in developing lungs in an IL-33-dependent manner. During the phase of postnatal lung alveolarization, house dust mite exposure further increased IL-33, which boosted cytokine production in ILC2s and activated CD11b(+) dendritic cells (DCs). IL-33 suppressed IL-12p35 and induced OX40L in neonatal DCs, thus promoting Th2 cell skewing. Decoy sST2 had a strong preventive effect on asthma in the neonatal period, less so in adulthood. Thus, enhanced neonatal Th2 cell skewing to inhaled allergens results from postnatal hyperactivity of the IL-33 axis during a period of maximal lung remodeling.	[de Kleer, Isme M.; de Bruijn, Marjolein J. W.; Hendriks, Rudi W.; Lambrecht, Bart N.] Erasmus Univ, Med Ctr Rotterdam, Dept Pulm Med, NL-3015 GJ Rotterdam, Netherlands; [de Kleer, Isme M.; Kool, Mirjam; Willart, Monique; van Moorleghem, Justine; Schuijs, Martijn J.; Plantinga, Maud; Hammad, Hamida; Lambrecht, Bart N.] VIB, Inflammat Res Ctr, Lab Immunoregulat & Mucosal Immunol, B-9050 Ghent, Belgium; [de Kleer, Isme M.; Kool, Mirjam; Willart, Monique; van Moorleghem, Justine; Schuijs, Martijn J.; Plantinga, Maud; Hammad, Hamida; Lambrecht, Bart N.] Univ Ghent, Dept Pulm Med, B-9000 Ghent, Belgium; [de Kleer, Isme M.] Erasmus Univ, Med Ctr Rotterdam, Sophias Childrens Hosp, Dept Pediat Pulmonol, NL-3015 GJ Rotterdam, Netherlands; [Plantinga, Maud] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Lab Cellular Immunol, NL-3584 EA Utrecht, Netherlands; [Beyaert, Rudi] VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, B-9050 Ghent, Belgium; [Hams, Emily; Fallon, Padraic G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Med, Dublin 2, Ireland	Erasmus University Rotterdam; Erasmus MC; Flanders Institute for Biotechnology (VIB); Ghent University; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Flanders Institute for Biotechnology (VIB); Trinity College Dublin	de Kleer, IM; Lambrecht, BN (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Pulm Med, NL-3015 GJ Rotterdam, Netherlands.; de Kleer, IM; Lambrecht, BN (corresponding author), VIB, Inflammat Res Ctr, Lab Immunoregulat & Mucosal Immunol, B-9050 Ghent, Belgium.; de Kleer, IM; Lambrecht, BN (corresponding author), Univ Ghent, Dept Pulm Med, B-9000 Ghent, Belgium.; de Kleer, IM (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Sophias Childrens Hosp, Dept Pediat Pulmonol, NL-3015 GJ Rotterdam, Netherlands.	i.dekleer@erasmusmc.nl; bart.lambrecht@ugent.be	Lambrecht, Bart N/K-2484-2014; Fallon, Padraic/Y-2711-2019; Beyaert, Rudi/B-2589-2009; Hammad, Hamida/J-9391-2015	Lambrecht, Bart N/0000-0003-4376-6834; Fallon, Padraic/0000-0002-8401-7293; Hammad, Hamida/0000-0003-3762-8603; Hams, Emily/0000-0002-9745-3246	VENI grant of the Dutch Scientific Organization (NWO); Long-term Fellowship grant European Respiratory Society - Marie Curie; Long-term Fellowship grant European Respiratory Society - Intra-European Fellowship Grant of Marie Curie (IEF-FP7); FWO project grant; ERC consolidator grant [261231]; University of Gent MRP grant (GROUP-ID consortium); FP7 (MedAll) grant; IMI (UBiopred) grant; Lung Foundation Netherlands [3.2.12.067, 5.1.14.020]	VENI grant of the Dutch Scientific Organization (NWO); Long-term Fellowship grant European Respiratory Society - Marie Curie; Long-term Fellowship grant European Respiratory Society - Intra-European Fellowship Grant of Marie Curie (IEF-FP7); FWO project grant; ERC consolidator grant; University of Gent MRP grant (GROUP-ID consortium); FP7 (MedAll) grant; IMI (UBiopred) grant; Lung Foundation Netherlands	This work was supported by a VENI grant of the Dutch Scientific Organization (NWO), a Long-term Fellowship grant of the European Respiratory Society cofunded by Marie Curie and a Intra-European Fellowship Grant of Marie Curie (IEF-FP7) to I.K., by a FWO project grant to H.H., and by an ERC consolidator grant (261231), a University of Gent MRP grant (GROUP-ID consortium), and FP7 (MedAll) and IMI (UBiopred) grants to B.N.L. These studies were partially supported by the Lung Foundation Netherlands (grants 3.2.12.067 and 5.1.14.020 to R.W.H.).	Belderbos M, 2009, CURR OPIN PEDIATR, V21, P762, DOI 10.1097/MOP.0b013e3283325e3a; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Bot A, 1998, Dev Immunol, V5, P197, DOI 10.1155/1998/50472; Burri PH, 2006, BIOL NEONATE, V89, P313, DOI 10.1159/000092868; Castanhinha S, 2015, J ALLERGY CLIN IMMUN, V136, P312, DOI 10.1016/j.jaci.2015.01.016; Celedon JC, 2007, J ALLERGY CLIN IMMUN, V120, P144, DOI 10.1016/j.jaci.2007.03.037; Coquet JM, 2015, IMMUNITY, V43, P318, DOI 10.1016/j.immuni.2015.07.015; De Kleer I, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00423; De Wit D, 2003, J AUTOIMMUN, V21, P277, DOI 10.1016/j.jaut.2003.08.003; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; Everts B, 2016, J EXP MED, V213, P35, DOI 10.1084/jem.20150235; Fock V, 2013, J IMMUNOL, V191, P3734, DOI 10.4049/jimmunol.1300490; Forsthuber T, 1996, SCIENCE, V271, P1728, DOI 10.1126/science.271.5256.1728; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Gordon ED, 2016, P NATL ACAD SCI USA, V113, P8765, DOI 10.1073/pnas.1601914113; Goriely S, 2001, J IMMUNOL, V166, P2141, DOI 10.4049/jimmunol.166.3.2141; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Grotenboer NS, 2013, J ALLERGY CLIN IMMUN, V131, P856, DOI 10.1016/j.jaci.2012.11.028; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guo LY, 2015, NAT IMMUNOL, V16, P1051, DOI 10.1038/ni.3244; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hung SL, 2002, J LEUKOCYTE BIOL, V72, P72; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jones CV, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-41; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lee HH, 2008, J EXP MED, V205, P2269, DOI 10.1084/jem.20071371; Li LQ, 2004, IMMUNITY, V20, P429, DOI 10.1016/S1074-7613(04)00072-X; Lodge CJ, 2011, J ALLERGY CLIN IMMUN, V128, P782, DOI 10.1016/j.jaci.2011.06.038; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Monticelli LA, 2012, CURR OPIN IMMUNOL, V24, P284, DOI 10.1016/j.coi.2012.03.012; NELSON DJ, 1995, J IMMUNOL, V155, P3517; NELSON DJ, 1994, J EXP MED, V179, P203, DOI 10.1084/jem.179.1.203; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Roediger B, 2015, J ALLERGY CLIN IMMUN, V136, P1653, DOI 10.1016/j.jaci.2015.03.043; Roux X, 2011, EUR J IMMUNOL, V41, P2852, DOI 10.1002/eji.201041224; Saglani S, 2013, J ALLERGY CLIN IMMUN, V132, P676, DOI 10.1016/j.jaci.2013.04.012; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Sarzotti M, 1996, SCIENCE, V271, P1726, DOI 10.1126/science.271.5256.1726; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Schittny JC, 2008, AM J PHYSIOL-LUNG C, V294, pL246, DOI 10.1152/ajplung.00296.2007; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sornasse T, 1996, J EXP MED, V184, P473, DOI 10.1084/jem.184.2.473; Tonon S, 2002, EUR J IMMUNOL, V32, P3118, DOI 10.1002/1521-4141(200211)32:11<3118::AID-IMMU3118>3.0.CO;2-B; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Traister RS, 2015, J ALLERGY CLIN IMMUN, V135, P92, DOI 10.1016/j.jaci.2014.06.023; Tschernig T, 2006, THORAX, V61, P986, DOI 10.1136/thx.2006.060335; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Vekemans J, 2002, CLIN EXP IMMUNOL, V127, P495, DOI 10.1046/j.1365-2249.2002.01788.x; Wahn U, 2001, J ALLERGY CLIN IMMUN, V107, P567, DOI 10.1067/mai.2001.112943; White GP, 2002, J IMMUNOL, V168, P2820, DOI 10.4049/jimmunol.168.6.2820; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018	68	194	195	2	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1285	1298		10.1016/j.immuni.2016.10.031	http://dx.doi.org/10.1016/j.immuni.2016.10.031			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	27939673	Green Published, Bronze			2022-12-18	WOS:000392918100014
J	Yu, AX; Zhu, LJ; Altman, NH; Malek, TR				Yu, Aixin; Zhu, Linjian; Altman, Norman H.; Malek, Thomas R.			A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells	IMMUNITY			English	Article							LETHAL AUTOIMMUNITY; STAT5 ACTIVATION; FOXP3 EXPRESSION; TGF-BETA; IL-2; RECEPTOR; MICE; INDUCTION; EXPANSION; CYTOKINE	Interleukin-2 receptor (IL-2R) signaling is essential for T regulatory (Treg) cell development and homeostasis. Here, we show that expression of IL-2R beta chains that lack tyrosine residues important for the association of the adaptor Shc and the transcription factor STAT5 in IL-2R beta-deficient mice resulted in production of a normal proportion of natural Treg cells that suppressed severe autoimmunity related with deficiency in IL-2 or IL-2R. These mutant IL-2R beta chains supported suboptimal and transient STAT5 activation that upregulate the transcription factor Foxp3 to normal amounts in natural, but not induced, Treg cells. Nevertheless, gene expression profiling revealed many targets in peripheral natural Treg cells that were IL-2 dependent and a substantial overlap between the Treg cell IL-2-dependent gene program and the Treg cell transcriptional signature. Collectively, these findings demonstrate that a critical, and perhaps minor, subset of IL-2-dependent targets is indexed to a low IL-2R signaling threshold and that a substantial proportion of the Treg cell gene program is regulated by IL-2.	[Yu, Aixin; Zhu, Linjian; Malek, Thomas R.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA; [Altman, Norman H.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33101 USA; [Malek, Thomas R.] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33101 USA	University of Miami; University of Miami; University of Miami	Malek, TR (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, POB 01960, Miami, FL 33101 USA.	tmalek@med.miami.edu			NIH [CA45957, A1040114, CA109094]; NATIONAL CANCER INSTITUTE [P01CA109094, R01CA045957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040114, R56AI040114, R01AI055815] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Barzana and B. Boyter for technical assistance, M. Inza, L. Romero and the Sylvester Comprehensive Cancer Center Transgenic Mouse Facility for production of the transgenic mice, and G. Cheng for comments on the manuscript. Our work is supported by grants CA45957, A1040114, and CA1 09094 from the NIH.	Ahmadzadeh M, 2007, J IMMUNOTHER, V30, P294, DOI 10.1097/CJI.0b013e3180336787; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; D'Souza WN, 2004, EUR J IMMUNOL, V34, P2977, DOI 10.1002/eji.200425485; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Di Santo JP, 2006, IMMUNOL REV, V214, P35, DOI 10.1111/j.1600-065X.2006.00461.x; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fujii H, 1998, EMBO J, V17, P6551, DOI 10.1093/emboj/17.22.6551; Fujitani Y, 1997, ONCOGENE, V14, P751, DOI 10.1038/sj.onc.1200907; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Jin HL, 2006, INT IMMUNOL, V18, P565, DOI 10.1093/intimm/dxh398; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Lockyer HM, 2007, J IMMUNOL, V179, P5301, DOI 10.4049/jimmunol.179.8.5301; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2000, J IMMUNOL, V164, P2905, DOI 10.4049/jimmunol.164.6.2905; Malek TR, 2001, J IMMUNOL, V166, P1675, DOI 10.4049/jimmunol.166.3.1675; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sharma R, 2006, J AUTOIMMUN, V27, P289, DOI 10.1016/j.jaut.2006.11.003; Snow JW, 2003, J IMMUNOL, V171, P5042, DOI 10.4049/jimmunol.171.10.5042; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Waldmann TA, 2007, ONCOGENE, V26, P3699, DOI 10.1038/sj.onc.1210368; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yang-Snyder J A, 1998, Dev Immunol, V5, P223, DOI 10.1155/1998/12421; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yu AX, 2006, J IMMUNOL, V177, P5115, DOI 10.4049/jimmunol.177.8.5115; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	46	194	206	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2009	30	2					204	217		10.1016/j.immuni.2008.11.014	http://dx.doi.org/10.1016/j.immuni.2008.11.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19185518	Green Accepted, Bronze			2022-12-18	WOS:000263710500008
J	Irla, M; Hugues, S; Gill, J; Nitta, T; Hikosaka, Y; Williams, IR; Hubert, FX; Scott, HS; Takahama, Y; Hollander, GA; Reith, W				Irla, Magali; Hugues, Stephanie; Gill, Jason; Nitta, Takeshi; Hikosaka, Yu; Williams, Ifor R.; Hubert, Francois-Xavier; Scott, Hamish S.; Takahama, Yousuke; Hollaender, Georg A.; Reith, Walter			Autoantigen-specific interactions with CD4(+) thymocytes control mature medullary thymic epithelial cell cellularity	IMMUNITY			English	Article							CLASS-II TRANSACTIVATOR; PROMISCUOUS GENE-EXPRESSION; T-CELLS; SELF-TOLERANCE; IN-VIVO; POSITIVE SELECTION; DENDRITIC CELLS; DEFICIENT MICE; PROMOTER-IV; MHC	Medullary thymic epithelial cells (mTECs) are specialized for inducing central immunological tolerance to self-antigens. To accomplish this, mTECs must adopt a mature phenotype characterized by expression of the autoimmune regulator Aire, which activates the transcription of numerous genes encoding tissue-restricted self-antigens. The mechanisms that control mature Aire(+) mTEC development in the postnatal thymus remain poorly understood. We demonstrate here that, although either CD4(+) or CD8(+) thymocytes are sufficient to sustain formation of a well-defined medulla, expansion of the mature mTEC population requires autoantigen-specific interactions between positively selected CD4(+) thymocytes bearing autoreactive T cell receptor (TCR) and mTECs displaying cognate self-peptide-MHC class II complexes. These interactions also involve the engagement of CD40 on mTECs by CD40L induced on the positively selected CD4(+) thymocytes. This antigen-specific TCR-MHC class II-mediated crosstalk between CD4(+) thymocytes and mTECs defines a unique checkpoint in thymic stromal development that is pivotal for generating a mature mTEC population competent for ensuring central T cell tolerance.	[Irla, Magali; Hugues, Stephanie; Reith, Walter] Univ Geneva, Sch Med, CMU, CH-1211 Geneva, Switzerland; [Gill, Jason; Hollaender, Georg A.] Univ Basel, Lab Pediat Immunol, Dept Biomed, CH-4058 Basel, Switzerland; [Gill, Jason; Hollaender, Georg A.] Univ Childrens Hosp Basel, CH-4058 Basel, Switzerland; [Nitta, Takeshi; Hikosaka, Yu; Takahama, Yousuke] Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan; [Williams, Ifor R.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Hubert, Francois-Xavier] Walter & Eliza Hall Inst Med Res, Div Mol Med, Melbourne, Vic 3050, Australia; [Hubert, Francois-Xavier] Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia; [Scott, Hamish S.] Univ Adelaide, Inst Med & Vet Sci, Div Mol Pathol, Adelaide, SA 5005, Australia; [Scott, Hamish S.] Univ Adelaide, Hanson Inst, Adelaide, SA 5005, Australia; [Scott, Hamish S.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia	University of Geneva; University of Basel; University of Basel; Tokushima University; Emory University; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Institute Medical & Veterinary Science Australia; University of Adelaide; Hanson Institute; University of Adelaide; University of Adelaide	Reith, W (corresponding author), Univ Geneva, Sch Med, CMU, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	walter.reith@medecine.unige.ch	Williams, Ifor R/D-3648-2011; Scott, Hamish/B-2122-2009; Takahama, Yousuke/A-5863-2010; IRLA, Magali/AAH-7941-2019	Williams, Ifor R/0000-0002-8810-2911; Scott, Hamish/0000-0002-5813-631X; Takahama, Yousuke/0000-0002-4992-9174; IRLA, Magali/0000-0001-8803-9708; Gill, Jason/0000-0003-0955-6470; hugues, stephanie/0000-0002-1031-5909; Hollander, Georg/0000-0002-8790-0874	Swiss National Science Foundation [3100AO-105895, 3100-68310.02]; Geneva Cancer League; Swiss Multiple Sclerosis Society; National Center of Competence in Research NCCR-NEURO; National Institutes of Health [ROI-A1057477-01]; Roche; Novartis; European Molecular Biology Organization; Institut National de la Sante et de la Recherche Medicale (INSERM)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Geneva Cancer League; Swiss Multiple Sclerosis Society; National Center of Competence in Research NCCR-NEURO(Swiss National Science Foundation (SNSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roche(Roche Holding); Novartis(Novartis); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	We thank C. Muller and B. Weber (Berne, Switzerland) for analysis of T cell infiltrates in the intestine and H.R. MacDonald (Lausanne, Switzerland), O. Lantz (Paris, France), M. Albert (Paris, France), R.M. Zinkernagel (Zurich, Switzerland), C. Kurts (Bonn, Germany), B. Huard (Geneva, Switzerland), S. Amigorena (Paris, France), and H. Acha-Orbea (Lausanne, Switzerland) for providing mice. Work in the laboratory of W. Reith was supported by the Swiss National Science Foundation (grant 3100AO-105895), Geneva Cancer League, Swiss Multiple Sclerosis Society, and National Center of Competence in Research NCCR-NEURO. Work in the laboratory of G. Hollander was supported by the Swiss National Science Foundation (grant 3100-68310.02), National Institutes of Health (grant ROI-A1057477-01), and European Community Integrated Project Euro-Thymaide. M.I. was supported by fellowships from Roche, Novartis, and the European Molecular Biology Organization, and S.H. was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM).	Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bochtler P, 2006, J IMMUNOL, V177, P8307, DOI 10.4049/jimmunol.177.12.8307; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Derbinski J, 2005, TRENDS IMMUNOL, V26, P503, DOI 10.1016/j.it.2005.07.006; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Dunn RJ, 1997, J HISTOCHEM CYTOCHEM, V45, P129, DOI 10.1177/002215549704500116; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kinoshita D, 2006, J IMMUNOL, V176, P3995, DOI 10.4049/jimmunol.176.7.3995; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; Lesley R, 2006, P NATL ACAD SCI USA, V103, P10717, DOI 10.1073/pnas.0601539103; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nasreen M, 2003, J IMMUNOL, V171, P3394, DOI 10.4049/jimmunol.171.7.3394; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; PALMER DB, 1993, DEV IMMUNOL, V3, P175, DOI 10.1155/1993/56290; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Ueno Tomoo, 2005, Methods Mol Biol, V290, P117; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; Waldburger JM, 2003, BLOOD, V101, P3550, DOI 10.1182/blood-2002-06-1855; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; White AJ, 2008, EUR J IMMUNOL, V38, P942, DOI 10.1002/eji.200738052	43	194	200	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 19	2008	29	3					451	463		10.1016/j.immuni.2008.08.007	http://dx.doi.org/10.1016/j.immuni.2008.08.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18799151	Bronze			2022-12-18	WOS:000259708900015
J	Samson, SI; Richard, O; Tavian, M; Ranson, T; Vosshenrich, CAJ; Colucci, F; Buer, J; Grosveld, F; Godin, I; Di Santo, JP				Samson, SI; Richard, O; Tavian, M; Ranson, T; Vosshenrich, CAJ; Colucci, F; Buer, J; Grosveld, F; Godin, I; Di Santo, JP			GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; TRANSCRIPTION FACTOR GATA-3; HELIX INHIBITOR ID2; T-CELLS; LINEAGE COMMITMENT; LYMPHOCYTE DEVELOPMENT; ANTIVIRAL DEFENSE; GENE-EXPRESSION; TH1 DEVELOPMENT; NERVOUS-SYSTEM	The GATA-3 transcription factor has a determinant role in T cell specification and is an essential mediator of T helper 2-type polarized immune responses. While both committed NK precursors and mature NK cells express GATA-3, a role of this transcription factor in murine NK cell differentiation is not known. We found that NK cells, in contrast to T cells, can be generated in the absence of GATA-3. However, while GATA-3 antagonizes IFN-gamma production in differentiating T cells, GATA-3-deficient NK cells paradoxically produced less IFN-gamma compared to control NK cells and failed to provide early protection in vivo against infection with Listeria monocytogenes. Surprisingly, GATA-3 was essential for NK cell homing to the liver. Our results suggest that GATA-3 promotes NK cell maturation and acts in this lineage to specify distinct effector phenotypes.	Inst Pasteur, INSERM, Equipe 101, Unite Cytokines & Dev Lymphoide, F-75724 Paris, France; Hop Paul Brousse, INSERM U506, F-94804 Villejuif, France; German Res Ctr Biotechnol, D-38124 Braunschweig, Germany; Erasmus Univ, Dept Dev Biol, NL-3000 DR Rotterdam, Netherlands; Inst Gustave Roussy, INSERM U362, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; Helmholtz-Center for Infection Research; Erasmus University Rotterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Di Santo, JP (corresponding author), Inst Pasteur, INSERM, Equipe 101, Unite Cytokines & Dev Lymphoide, F-75724 Paris, France.	disanto@pasteur.fr	Di Santo, James P/M-4298-2014; GOFF, odile RICHARD-LE/ABH-9553-2020; Colucci, Francesco/F-2844-2010; GODIN, Isabelle/K-5769-2013; Vosshenrich, Christian AJ/M-6523-2014; Tavian, Manuela/E-4210-2018; Tavian, Manuela/S-3201-2019	Di Santo, James P/0000-0002-7146-1862; Colucci, Francesco/0000-0001-5193-6376; GODIN, Isabelle/0000-0001-8577-8388; Vosshenrich, Christian AJ/0000-0002-4407-8649; Tavian, Manuela/0000-0003-4746-3240; Tavian, Manuela/0000-0003-4746-3240; Buer, Jan/0000-0002-7602-1698; richard-le goff, odile/0000-0002-6263-2375; samson, sandrine/0000-0001-8365-5093				Akashi K, 2000, CURR OPIN IMMUNOL, V12, P144, DOI 10.1016/S0952-7915(99)00064-3; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; BIASSONI R, 1993, EUR J IMMUNOL, V23, P1083, DOI 10.1002/eji.1830230516; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bregenholt S, 2001, J IMMUNOL, V166, P1871, DOI 10.4049/jimmunol.166.3.1871; Carlyle JR, 1997, J EXP MED, V186, P173, DOI 10.1084/jem.186.2.173; Colonna M, 2001, NAT IMMUNOL, V2, P899, DOI 10.1038/ni1001-899; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; Corral L, 2000, EUR J IMMUNOL, V30, P920, DOI 10.1002/1521-4141(200003)30:3<920::AID-IMMU920>3.0.CO;2-P; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Ferber IA, 1999, CLIN IMMUNOL, V91, P134, DOI 10.1006/clim.1999.4718; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Glimcher LH, 2000, GENE DEV, V14, P1693; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Hanke T, 1998, EUR J IMMUNOL, V28, P4409, DOI 10.1002/(SICI)1521-4141(199812)28:12<4409::AID-IMMU4409>3.0.CO;2-3; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Hoshino T, 1999, J IMMUNOL, V162, P5070; Ikawa T, 1999, J EXP MED, V190, P1617, DOI 10.1084/jem.190.11.1617; Ikawa T, 2001, P NATL ACAD SCI USA, V98, P5164, DOI 10.1073/pnas.091537598; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Loza MJ, 2001, NAT IMMUNOL, V2, P917, DOI 10.1038/ni1001-917; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Manaia A, 2000, DEVELOPMENT, V127, P643; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; ORKIN SH, 1992, BLOOD, V80, P575; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; RENARD V, 1995, P NATL ACAD SCI USA, V92, P7545, DOI 10.1073/pnas.92.16.7545; RODEWALD HR, 1995, CURR OPIN IMMUNOL, V7, P176, DOI 10.1016/0952-7915(95)80002-6; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Salazar-Mather TP, 2000, J CLIN INVEST, V105, P985, DOI 10.1172/JCI9232; Schaniel C, 2002, BLOOD, V99, P2760, DOI 10.1182/blood.V99.8.2760; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Unanue ER, 1997, IMMUNOL REV, V158, P11, DOI 10.1111/j.1600-065X.1997.tb00988.x; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Yamagata T, 2000, EMBO J, V19, P4676, DOI 10.1093/emboj/19.17.4676; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	60	194	200	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2003	19	5					701	711		10.1016/S1074-7613(03)00294-2	http://dx.doi.org/10.1016/S1074-7613(03)00294-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614857	Bronze			2022-12-18	WOS:000186672200010
J	Moser, M				Moser, M			Dendritic cells in immunity and tolerance - Do they display opposite functions?	IMMUNITY			English	Review							IN-VIVO; LYMPH-NODES; T-CELLS; ANTIGEN; LEADS; MICE	It was recently proposed that cells of the dendritic family not only control immunity but also maintain tolerance to self-antigens, two complementary functions that would ensure the integrity of the organism in an environment full of pathogens. As they express a variety of receptors that specifically recognize microbial products, DCs are able to discriminate between self and nonself and may therefore enable the immune system to mount potent effector activity to pathogens while silencing self-reactive lymphocytes.	Free Univ Brussels, Inst Biol & Med Mol, Physiol Anim Lab, B-6041 Gosselies, Belgium		Moser, M (corresponding author), Free Univ Brussels, Inst Biol & Med Mol, Physiol Anim Lab, B-6041 Gosselies, Belgium.							Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; LOHR J, 2003, IN PRESS NAT IMMUNOL; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; OLDENHOVE G, 2003, IN PRESS J EXP MED; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; YAMAZAKI S, 1923, IN PRESS J EXP MED	21	194	219	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2003	19	1					5	8		10.1016/S1074-7613(03)00182-1	http://dx.doi.org/10.1016/S1074-7613(03)00182-1			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871634	Bronze			2022-12-18	WOS:000184260400003
J	Rudd, CE				Rudd, CE			Upstream-downstream: CD28 cosignaling pathways and T cell function	IMMUNITY			English	Review							SIGNAL-TRANSDUCTION; ACTIVATION; RECEPTOR; COSTIMULATION; MOLECULES				Rudd, CE (corresponding author), HARVARD UNIV, SCH MED,DANA FARBER CANC INST,DEPT PATHOL, DIV TUMOR IMMUNOL, 44 BINNEY ST, BOSTON, MA 02115 USA.		Rudd, Christopher E/ABF-7259-2021; Rudd, Christopher E/GOH-2021-2022	Rudd, Christopher E/0000-0001-5295-9019				AUGUST A, 1994, INT IMMUNOL, V6, P769, DOI 10.1093/intimm/6.5.769; AUGUST A, 1994, BIOCHEM BIOPH RES CO, V199, P1466, DOI 10.1006/bbrc.1994.1396; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; BALDARI CT, 1993, J BIOL CHEM, V268, P2693; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; BOUCHER LM, 1995, J EXP MED, V181, P2059, DOI 10.1084/jem.181.6.2059; BRYAN RG, 1994, MOL CELL BIOL, V14, P7933, DOI 10.1128/MCB.14.12.7933; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; CEFAI D, 1996, IN PRESS INT IMMUNOL; CHAN G, 1995, EUR J IMMUNOL, V25, P1999, DOI 10.1002/eji.1830250730; CHATTA GS, 1994, J IMMUNOL, V153, P5393; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; CROOKS MEC, 1995, MOL CELL BIOL, V15, P6820; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; GENOT EM, 1995, J BIOL CHEM, V270, P9833, DOI 10.1074/jbc.270.17.9833; GhiottoRagueneau M, 1996, EUR J IMMUNOL, V26, P34, DOI 10.1002/eji.1830260106; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; HUTCHCROFT JE, 1994, P NATL ACAD SCI USA, V91, P3260, DOI 10.1073/pnas.91.8.3260; HUTCHCROFT JE, 1995, P NATL ACAD SCI USA, V92, P8808, DOI 10.1073/pnas.92.19.8808; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAI JH, 1994, J BIOL CHEM, V269, P30077; LAI JH, 1995, MOL CELL BIOL, V15, P4260; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; LINSLEY PS, 1995, J EXP MED, V182, P289, DOI 10.1084/jem.182.2.289; LU YL, 1995, EUR J IMMUNOL, V25, P533, DOI 10.1002/eji.1830250234; LU YL, 1994, EUR J IMMUNOL, V24, P2732, DOI 10.1002/eji.1830241124; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NUNES JA, 1994, J EXP MED, V180, P1067, DOI 10.1084/jem.180.3.1067; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; PAI SY, 1994, EUR J IMMUNOL, V24, P2364, DOI 10.1002/eji.1830241016; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; RAYTER SI, 1992, EMBO J, V11, P4549, DOI 10.1002/j.1460-2075.1992.tb05556.x; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; RUDD CE, 1994, IMMUNOL TODAY, V15, P225, DOI 10.1016/0167-5699(94)90248-8; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; THOMPSON CB, 1995, CELL, V81, P979, DOI 10.1016/S0092-8674(05)80001-7; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; TRUITT KE, 1995, J IMMUNOL, V155, P4702; UEDA Y, 1995, INT IMMUNOL, V7, P957, DOI 10.1093/intimm/7.6.957; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WANG J, 1995, J BIOL CHEM, V270, P12774, DOI 10.1074/jbc.270.21.12774; WARD SG, 1993, EUR J IMMUNOL, V23, P2572, DOI 10.1002/eji.1830231029; WARD SG, 1995, EUR J IMMUNOL, V25, P526, DOI 10.1002/eji.1830250233; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; ZETT T, 1996, J IMMUNOL, V156, P883; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	70	194	234	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1996	4	6					527	534		10.1016/S1074-7613(00)80479-3	http://dx.doi.org/10.1016/S1074-7613(00)80479-3			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UU443	8673699	Bronze			2022-12-18	WOS:A1996UU44300001
J	CLYNES, R; RAVETCH, JV				CLYNES, R; RAVETCH, JV			CYTOTOXIC ANTIBODIES TRIGGER INFLAMMATION THROUGH FC-RECEPTORS	IMMUNITY			English	Article							IMMUNE THROMBOCYTOPENIC PURPURA; AUTOIMMUNE HEMOLYTIC-ANEMIA; OP OP MOUSE; INTRAVENOUS IMMUNOGLOBULIN; GAMMA-RECEPTOR; NZB MICE; IGG FC; AUTOANTIBODIES; CLEARANCE; SUBUNIT	Pathogenic self-reactive antibodies are a significant cause of morbidity and mortality and contribute to both cytotoxic and immune complex-triggered inflammatory disorders, typified by rheumatic diseases, autoimmune hemolytic anemia, and thrombocytopenia. Roles have been proposed for Fc receptors, complement, and complement receptors in the pathogenesis of these disorders, although the contribution of each to autoimmune injury is unclear. gamma chain-deficient mice lacking Fc gamma RI and Fc gamma RIII are resistant to the development of experimental immune hemolytic anemia induced by polyclonal rabbit anti-mouse red blood cell IgG antibodies. This resistance is primarily a consequence of ineffective erythrophagocytosis, resulting from the lack of Fc gamma Rs on mononuclear phagocytes. Similarly, gamma chain-deficient mice are completely resistant to the development of experimental immune thrombocytopenia induced by mouse anti-platelet antibodies. These data suggest that Fc receptors play an integral role in the pathogenesis of type II hypersensitivity and suggest potential therapeutic benefits of Fc receptor blockade.			CLYNES, R (corresponding author), MEM SLOAN KETTERING CANC CTR,PROGRAM MOLEC BIOL,1275 YORK AVE,NEW YORK,NY 10021, USA.		Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041	NCI NIH HHS [CA-O9512] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009512] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLANCHETTE V, 1994, LANCET, V344, P703, DOI 10.1016/S0140-6736(94)92205-5; CECCHINI MG, 1994, DEVELOPMENT, V20, P1357; CLARKSON SB, 1986, NEW ENGL J MED, V314, P1236, DOI 10.1056/NEJM198605083141907; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; ERNST LK, 1993, P NATL ACAD SCI USA, V90, P6023, DOI 10.1073/pnas.90.13.6023; FELIX R, 1990, J BONE MINER RES, V5, P781; FLORES G, 1993, AM J HEMATOL, V44, P237, DOI 10.1002/ajh.2830440404; Gallin John I., 1993, P1015; Howie J B, 1968, Adv Immunol, V9, P215, DOI 10.1016/S0065-2776(08)60444-7; KURLANDER RJ, 1984, J IMMUNOL, V133, P855; KUROSAKI T, 1989, NATURE, V326, P292; LANIER LL, 1989, NATURE, V342, P803, DOI 10.1038/342803a0; MIZUTANI H, 1990, BLOOD, V75, P1809; MIZUTANI H, 1993, BLOOD, V82, P837; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; RAVETCH JV, 1994, CELL, V78, P553, DOI 10.1016/0092-8674(94)90521-5; REININGER L, 1990, EUR J IMMUNOL, V20, P771, DOI 10.1002/eji.1830200410; Roitt I. M., 1993, IMMUNOLOGY; SALAMA A, 1983, LANCET, V2, P193; SCHREIBER AD, 1972, J CLIN INVEST, V51, P575, DOI 10.1172/JCI106846; SHIBATA T, 1990, INT IMMUNOL, V2, P1133, DOI 10.1093/intimm/2.12.1133; Snyder Edward L., 1995, P2045; SOUBRANE C, 1993, BLOOD, V81, P15; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; UNKELESS JC, 1979, J EXP MED, V142, P580; VITALE B, 1967, TRANSFUSION, V7, P249, DOI 10.1111/j.1537-2995.1967.tb05513.x; WIKTORJEDRZEJCZ.W, 1990, P NATL ACAD SCI USA, V87, P4828; YOSHIDA H, 1990, NATURE, V45, P442	29	194	238	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1995	3	1					21	26		10.1016/1074-7613(95)90155-8	http://dx.doi.org/10.1016/1074-7613(95)90155-8			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7621075	Bronze			2022-12-18	WOS:A1995RK86800004
J	Teijeira, A; Garasa, S; Gato, M; Alfaro, C; Migueliz, I; Cirella, A; de Andrea, C; Ochoa, MC; Otano, I; Etxeberria, I; Andueza, MP; Nieto, CP; Resano, L; Azpilikueta, A; Allegretti, M; de Pizzol, M; Ponz-Sarvise, M; Rouzaut, A; Sanmamed, MF; Schalper, K; Carleton, M; Mellado, M; Rodriguez-Ruiz, ME; Berraondo, P; Perez-Gracia, JL; Melero, I				Teijeira, Alvaro; Garasa, Saray; Gato, Maria; Alfaro, Carlos; Migueliz, Itziar; Cirella, Assunta; de Andrea, Carlos; Carmen Ochoa, Maria; Otano, Itziar; Etxeberria, Inaki; Pilar Andueza, Maria; Nieto, Celia P.; Resano, Leyre; Azpilikueta, Arantza; Allegretti, Marcello; de Pizzol, Maria; Ponz-Sarvise, Mariano; Rouzaut, Ana; Sanmamed, Miguel F.; Schalper, Kurt; Carleton, Michael; Mellado, Mario; Rodriguez-Ruiz, Maria E.; Berraondo, Pedro; Perez-Gracia, Jose L.; Melero, Ignacio			CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity	IMMUNITY			English	Article							METASTATIC MELANOMA; PERIPHERAL-BLOOD; SUPPRESSOR-CELLS; DNA TRAPS; INHIBITION; INNATE; MOUSE; PAD4	Neutrophils are expanded and abundant in cancer-bearing hosts. Under the influence of CXCR1 and CXCR2 chemokine receptor agonists and other chemotactic factors produced by tumors, neutrophils, and granulocytic myeloid-derived suppressor cells (MDSCs) from cancer patients extrude their neutrophil extracellular traps (NETs). In our hands, CXCR1 and CXCR2 agonists proved to be the major mediators of cancer-promoted NETosis. NETs wrap and coat tumor cells and shield them from cytotoxicity, as mediated by CD8(+) T cells and natural killer (NK) cells, by obstructing contact between immune cells and the surrounding target cells. Tumor cells protected from cytotoxicity by NETs underlie successful cancer metastases in mice and the immunotherapeutic synergy of protein arginine deiminase 4 (PAD4) inhibitors, which curtail NETosis with immune checkpoint inhibitors. Intravital microscopy provides evidence of neutrophil NETs interfering cytolytic cytotoxic T lymphocytes (CTLs) and NK cell contacts with tumor cells.	[Teijeira, Alvaro; Garasa, Saray; Gato, Maria; Alfaro, Carlos; Migueliz, Itziar; Cirella, Assunta; Carmen Ochoa, Maria; Otano, Itziar; Etxeberria, Inaki; Nieto, Celia P.; Azpilikueta, Arantza; Rouzaut, Ana; Sanmamed, Miguel F.; Rodriguez-Ruiz, Maria E.; Berraondo, Pedro; Melero, Ignacio] Univ Navarra, Program Immunol, CIMA, Pamplona 31008, Spain; [Teijeira, Alvaro; Garasa, Saray; Gato, Maria; Alfaro, Carlos; Migueliz, Itziar; Cirella, Assunta; Carmen Ochoa, Maria; Otano, Itziar; Etxeberria, Inaki; Nieto, Celia P.; Azpilikueta, Arantza; Rouzaut, Ana; Sanmamed, Miguel F.; Rodriguez-Ruiz, Maria E.; Berraondo, Pedro; Melero, Ignacio] Univ Navarra, Immunotherapy Dept, CIMA, Pamplona 31008, Spain; [Teijeira, Alvaro; Alfaro, Carlos; de Andrea, Carlos; Carmen Ochoa, Maria; Azpilikueta, Arantza; Rouzaut, Ana; Sanmamed, Miguel F.; Rodriguez-Ruiz, Maria E.; Berraondo, Pedro; Melero, Ignacio] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Teijeira, Alvaro; Gato, Maria; de Andrea, Carlos; Carmen Ochoa, Maria; Otano, Itziar; Etxeberria, Inaki; Ponz-Sarvise, Mariano; Rouzaut, Ana; Sanmamed, Miguel F.; Rodriguez-Ruiz, Maria E.; Berraondo, Pedro; Melero, Ignacio] Navarra Inst Hlth Res IDISNA, Pamplona 31008, Spain; [de Andrea, Carlos; Pilar Andueza, Maria; Resano, Leyre; Ponz-Sarvise, Mariano; Perez-Gracia, Jose L.] Clin Univ Navarra, Dept Oncol, Pamplona 31008, Spain; [Allegretti, Marcello; de Pizzol, Maria] Dompe Farmaceut SpA, I-20122 Milan, Italy; [Schalper, Kurt] Yale Univ, Dept Pathol, Sch Med, New Haven, CT 06520 USA; [Carleton, Michael] Bristol Myers Squibb, Lawrence Township, NJ 08648 USA; [Mellado, Mario] Ctr Nacl Biotecnol CNB CSIC, Dept Immunol & Oncol, Chemokine Signaling Grp, Madrid 28049, Spain	University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Navarra; Dompe; Yale University; Bristol-Myers Squibb; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Teijeira, A; Melero, I (corresponding author), Univ Navarra, Program Immunol, CIMA, Pamplona 31008, Spain.; Teijeira, A; Melero, I (corresponding author), Univ Navarra, Immunotherapy Dept, CIMA, Pamplona 31008, Spain.; Teijeira, A; Melero, I (corresponding author), Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain.; Teijeira, A; Melero, I (corresponding author), Navarra Inst Hlth Res IDISNA, Pamplona 31008, Spain.	ateijeiras@unav.es; imelero@unav.es	Berraondo, Pedro/J-3154-2012; Perez-Gracia, Jose Luis/I-8372-2017; Melero, Ignacio/T-7600-2019; Otano, Itziar/N-1410-2016; Ochoa, Maria C./K-4508-2017; ETXEBERRIA, INAKI/I-3531-2017; Mellado, Mario/M-9893-2014; Ponz-Sarvise, Mariano/H-4104-2017; Migueliz, Itziar/H-4148-2017; Alfaro, Carlos/K-3566-2014; Rodriguez-Ruiz, Maria Esperanza/K-7227-2017; Andueza, María-Pilar/D-3884-2019; Mellado, Mario/Q-4752-2019; Garasa, Saray/J-6602-2017; F Sanmamed, Miguel/I-5572-2017	Berraondo, Pedro/0000-0001-7410-1865; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Melero, Ignacio/0000-0002-1360-348X; Otano, Itziar/0000-0002-1433-1711; Ochoa, Maria C./0000-0001-9920-2144; ETXEBERRIA, INAKI/0000-0003-2713-0836; Mellado, Mario/0000-0001-6325-1630; Ponz-Sarvise, Mariano/0000-0002-3240-729X; Migueliz, Itziar/0000-0002-7477-0935; Alfaro, Carlos/0000-0002-4812-7153; Rodriguez-Ruiz, Maria Esperanza/0000-0002-9765-2499; Andueza, María-Pilar/0000-0001-6558-1609; Mellado, Mario/0000-0001-6325-1630; Garasa, Saray/0000-0001-5192-2599; F Sanmamed, Miguel/0000-0002-7295-6074	MINECO [SAF2017-83267-C2-1-R]; immuno-oncology network of Bristol-Myers Squibb (I-ON); European Union [635122 -PROCROP]; Fundacion de la Asociacion Espanola Contra el Cancer (AECC); "la Caixa'' Banking Foundation [LCF/BQ/LR18/11640014]	MINECO(Spanish Government); immuno-oncology network of Bristol-Myers Squibb (I-ON)(Bristol-Myers Squibb); European Union(European Commission); Fundacion de la Asociacion Espanola Contra el Cancer (AECC); "la Caixa'' Banking Foundation(La Caixa Foundation)	This project was supported by MINECO SAF2017-83267-C2-1-R (AEI/FEDER, UE) (Ignacio Melero) and the immuno-oncology network of Bristol-Myers Squibb (I-ON). This project received funding from the European Union's Horizon 2020 research and innovation program (grant agreement 635122 -PROCROP) and Fundacion de la Asociacion Espanola Contra el Cancer (AECC). A.T. has received financial support through "la Caixa'' Banking Foundation (LCF/BQ/LR18/11640014).	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Alfaro C, 2016, CLIN CANCER RES, V22, P3924, DOI 10.1158/1078-0432.CCR-15-2463; Arelaki S., 2016, PLOS ONE, V11; Arina A, 2015, CURR OPIN IMMUNOL, V33, P120, DOI 10.1016/j.coi.2015.02.006; Bertini R, 2004, P NATL ACAD SCI USA, V101, P11791, DOI 10.1073/pnas.0402090101; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Castanheira FVS, 2019, BLOOD, V133, P2178, DOI 10.1182/blood-2018-11-844530; Cedervall J, 2015, CANCER RES, V75, P2653, DOI 10.1158/0008-5472.CAN-14-3299; Chao T, 2016, CANCER IMMUNOL RES, V4, P968, DOI 10.1158/2326-6066.CIR-16-0188; Chow MT, 2014, CANCER IMMUNOL RES, V2, P1125, DOI 10.1158/2326-6066.CIR-14-0160; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Condamine T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8943; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; da Silva RB, 2015, NAT IMMUNOL, V16, P850, DOI 10.1038/ni.3201; Demers M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1134073; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Etxeberria I, 2019, CANCER CELL, V36, P613, DOI 10.1016/j.ccell.2019.10.006; Ferrucci PF, 2016, ANN ONCOL, V27, P732, DOI 10.1093/annonc/mdw016; Finisguerra V, 2015, NATURE, V522, P349, DOI 10.1038/nature14407; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Galdiero MR, 2018, J LEUKOCYTE BIOL, V103, P457, DOI 10.1002/JLB.3MR0717-292R; Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Guglietta S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11037; Hemmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022043; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Hopkins AM, 2017, BRIT J CANCER, V117, P913, DOI 10.1038/bjc.2017.274; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kim K, 2014, P NATL ACAD SCI USA, V111, P11774, DOI 10.1073/pnas.1410626111; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Lee W, 2019, J EXP MED, V216, P176, DOI 10.1084/jem.20181170; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Li JL, 2016, J INVEST DERMATOL, V136, P416, DOI 10.1038/JID.2015.410; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Liao WT, 2019, CANCER CELL, V35, P559, DOI 10.1016/j.ccell.2019.02.008; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marques PE, 2015, NAT PROTOC, V10, P258, DOI 10.1038/nprot.2015.006; Munoz LM, 2009, J IMMUNOL, V183, P7337, DOI 10.4049/jimmunol.0901802; Matsumoto K, 2017, CANCER SCI, V108, P296, DOI 10.1111/cas.13156; Munoz LE, 2019, IMMUNITY, V51, P443, DOI 10.1016/j.immuni.2019.07.002; Najmeh S, 2015, JOVE-J VIS EXP, DOI 10.3791/52687; Neubert E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06263-5; Nie M, 2019, CLIN CANCER RES, V25, P1867, DOI 10.1158/1078-0432.CCR-18-1226; Ogata Takatsugu, 2018, Oncotarget, V9, P34520, DOI 10.18632/oncotarget.26145; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Park J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1711; Pio R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00774; Raghuwanshi SK, 2012, J IMMUNOL, V189, P2824, DOI 10.4049/jimmunol.1201114; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sanmamed MF, 2017, ANN ONCOL, V28, P1988, DOI 10.1093/annonc/mdx190; Sanmamed MF, 2014, CLIN CANCER RES, V20, P5697, DOI 10.1158/1078-0432.CCR-13-3203; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Shen MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098259; Spiegel A, 2016, CANCER DISCOV, V6, P630, DOI 10.1158/2159-8290.CD-15-1157; Stadtmann A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00263; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Weigelin B, 2015, P NATL ACAD SCI USA, V112, P7551, DOI 10.1073/pnas.1506357112; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96	69	193	201	13	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					856	+		10.1016/j.immuni.2020.03.001	http://dx.doi.org/10.1016/j.immuni.2020.03.001			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32289253	Bronze			2022-12-18	WOS:000535371100017
J	Thorsson, V; Gibbs, DL; Brown, SD; Wolf, D; Bortone, DS; Yang, THO; Porta-Pardo, E; Gao, GF; Plaisier, CL; Eddy, JA; Ziv, E; Culhane, AC; Paull, EO; Sivakumar, IKA; Gentles, AJ; Malhotra, R; Farshidfar, F; Colaprico, A; Parker, JS; Mose, LE; Vo, NS; Liu, J; Liu, Y; Rader, J; Dhankani, V; Reynolds, SM; Bowlby, R; Califano, A; Cherniack, AD; Anastassiou, D; Bedognetti, D; Mokrab, Y; Newman, AM; Rao, A; Chen, K; Krasnitz, A; Hu, H; Malta, TM; Noushmehr, H; Pedamallu, CS; Bullman, S; Ojesina, AI; Lamb, A; Zhou, W; Shen, H; Choueiri, TK; Weinstein, JN; Guinney, J; Saltz, J; Holt, RA; Rabkin, CS; Lazar, AJ; Serody, JS; Demicco, EG; Disis, ML; Vincent, BG; Shmulevich, I				Thorsson, Vesteinn; Gibbs, David L.; Brown, Scott D.; Wolf, Denise; Bortone, Dante S.; Yang, Tai-Hsien Ou; Porta-Pardo, Eduard; Gao, Galen F.; Plaisier, Christopher L.; Eddy, James A.; Ziv, Elad; Culhane, Aedin C.; Paull, Evan O.; Sivakumar, I. K. Ashok; Gentles, Andrew J.; Malhotra, Raunaq; Farshidfar, Farshad; Colaprico, Antonio; Parker, Joel S.; Mose, Lisle E.; Vo, Nam Sy; Liu, Jianfang; Liu, Yuexin; Rader, Janet; Dhankani, Varsha; Reynolds, Sheila M.; Bowlby, Reanne; Califano, Andrea; Cherniack, Andrew D.; Anastassiou, Dimitris; Bedognetti, Davide; Mokrab, Younes; Newman, Aaron M.; Rao, Arvind; Chen, Ken; Krasnitz, Alexander; Hu, Hai; Malta, Tathiane M.; Noushmehr, Houtan; Pedamallu, Chandra Sekhar; Bullman, Susan; Ojesina, Akinyemi I.; Lamb, Andrew; Zhou, Wanding; Shen, Hui; Choueiri, Toni K.; Weinstein, John N.; Guinney, Justin; Saltz, Joel; Holt, Robert A.; Rabkin, Charles S.; Lazar, Alexander J.; Serody, Jonathan S.; Demicco, Elizabeth G.; Disis, Mary L.; Vincent, Benjamin G.; Shmulevich, Ilya		Canc Genome Atlas Res Network	The Immune Landscape of Cancer (vol 48, pg 812, 2018)	IMMUNITY			English	Correction									[Thorsson, Vesteinn; Gibbs, David L.; Plaisier, Christopher L.; Dhankani, Varsha; Reynolds, Sheila M.; Shmulevich, Ilya] Inst Syst Biol, 401 Terry Ave N, Seattle, WA 98109 USA; [Brown, Scott D.; Bowlby, Reanne; Holt, Robert A.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Wolf, Denise] Univ Calif San Francisco, Box 0808,2340 Sutter St,S433, San Francisco, CA 94115 USA; [Bortone, Dante S.; Parker, Joel S.; Mose, Lisle E.; Vincent, Benjamin G.] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Lineberger Comprehens Canc Ctr, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Yang, Tai-Hsien Ou; Anastassiou, Dimitris] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Yang, Tai-Hsien Ou; Anastassiou, Dimitris] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Porta-Pardo, Eduard] Barcelona Supercomp Ctr, C Jordi Girona 29, Barcelona 08034, Spain; [Porta-Pardo, Eduard] SBP Med Discovery Inst, La Jolla, CA 92037 USA; [Gao, Galen F.; Cherniack, Andrew D.] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Gao, Galen F.; Cherniack, Andrew D.] Harvard Univ, Cambridge, MA 02142 USA; [Plaisier, Christopher L.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA; [Eddy, James A.; Lamb, Andrew; Guinney, Justin] Sage Bionetworks, 2901 Third Ave,Suite 330, Seattle, WA 98121 USA; [Ziv, Elad] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Inst Human Genet, Dept Med, 1450 3rd St, San Francisco, CA 94143 USA; [Culhane, Aedin C.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Paull, Evan O.; Califano, Andrea] Irving Canc Res Ctr, Room 913,1130 St Nicholas Ave, New York, NY 10032 USA; [Sivakumar, I. K. Ashok] Johns Hopkins Univ, Inst Computat Med, Dept Comp Sci, Baltimore, MD 21218 USA; [Gentles, Andrew J.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Gentles, Andrew J.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Malhotra, Raunaq] Seven Bridges Genom, Cambridge, MA 02142 USA; [Farshidfar, Farshad] Univ Calgary, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Colaprico, Antonio] ULB, Comp Sci Dept, Fac Sci, Blvd Triomphe CP212, B-1050 Brussels, Belgium; [Vo, Nam Sy; Liu, Yuexin; Rao, Arvind; Chen, Ken; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Liu, Jianfang; Hu, Hai] Chan Soon Shiong Inst Mol Med Windber, Windber, PA 15963 USA; [Rader, Janet] Med Coll Wisconsin, 9200 Wisconsin Ave, Milwaukee, WI 53226 USA; [Bedognetti, Davide; Mokrab, Younes] Sidra Med & Res Ctr, Res Branch, Div Translat Med, POB 26999, Doha, Qatar; [Krasnitz, Alexander] Cold Spring Harbor Lab, Simons Ctr Quantitat Biol, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA; [Malta, Tathiane M.; Noushmehr, Houtan] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Malta, Tathiane M.; Noushmehr, Houtan] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Sao Paulo, Brazil; [Pedamallu, Chandra Sekhar; Bullman, Susan; Choueiri, Toni K.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Ojesina, Akinyemi I.] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Zhou, Wanding; Shen, Hui] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA; [Saltz, Joel] Stony Brook Med, Dept Biomed Informat, 100 Nicolls Rd, Stony Brook, NY 11794 USA; [Rabkin, Charles S.] NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr, Bethesda, MD 20892 USA; [Lazar, Alexander J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, 1515 Holcombe Blvd,Unit 85, Houston, TX 77030 USA; [Lazar, Alexander J.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, 1515 Holcombe Blvd,Unit 85, Houston, TX 77030 USA; [Lazar, Alexander J.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, 1515 Holcombe Blvd,Unit 85, Houston, TX 77030 USA; [Serody, Jonathan S.] Dept Med & Microbiol, Chapel Hill, NC 27599 USA; [Serody, Jonathan S.] Lineberger Comprehens Canc Ctr, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Demicco, Elizabeth G.] Mt Sinai Hosp, Dept Pathol & Lab Med, 600 Univ Ave, Toronto, ON M5G 1X5, Canada; [Disis, Mary L.] Univ Washington, UW Med Canc Vaccine Inst, 850 Republican St,Brotman Bldg,2nd Floor,Room 221, Seattle, WA 98109 USA; [Newman, Aaron M.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Newman, Aaron M.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA	Institute for Systems Biology (ISB); British Columbia Cancer Agency; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Arizona State University; Arizona State University-Tempe; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Harvard University; Dana-Farber Cancer Institute; Johns Hopkins University; Stanford University; Stanford University; University of Calgary; Universite Libre de Bruxelles; University of Texas System; UTMD Anderson Cancer Center; Windber Research Institute; Medical College of Wisconsin; Sidra Medical & Research Center; Cold Spring Harbor Laboratory; Henry Ford Health System; Henry Ford Hospital; Universidade de Sao Paulo; Harvard University; Dana-Farber Cancer Institute; University of Alabama System; University of Alabama Birmingham; Van Andel Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Washington; University of Washington Seattle; Stanford University; Stanford University	Thorsson, V; Shmulevich, I (corresponding author), Inst Syst Biol, 401 Terry Ave N, Seattle, WA 98109 USA.; Vincent, BG (corresponding author), Univ N Carolina, Curriculum Bioinformat & Computat Biol, Lineberger Comprehens Canc Ctr, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA.	vesteinn.thorsson@systemsbiology.org; benjamin.vincent@unchealth.unc.edu; ilya.shmulevich@systemsbiology.org	Pedamallu, Chandra Sekhar/AAV-6723-2020; Carlotti, Carlos G/C-1608-2012; Tavobilov, Mikhail/AAE-9175-2022; Chen, Ken/AAU-1432-2021; Pollo, Bianca/K-5347-2018; Shabunin, Alexey/AFE-8506-2022; Scolyer, Richard/AAE-8511-2019; Parker, Joel/AAG-1108-2019; Barnholtz-Sloan, Jill/A-4817-2011; Shen, Hui/AAO-4387-2020; Khuri, Fadlo R./AAU-4942-2020; Porta-Pardo, Eduard/K-9162-2016; Longatto-Filho, Adhemar/N-3397-2019; Holt, Robert A/C-3303-2009; Bryce, Alan/W-1765-2019; Bedognetti, Davide/GLQ-9410-2022; mattei, luca/K-7709-2016; Van Den Berg, David J/G-8598-2017; Melamed, Jonathan/AAV-3769-2020; Culhane, Aedin/AAG-8490-2019; Cherniack, Andrew D./AAY-8132-2020; Choueiri, Toni/K-5238-2019; Pedamallu, Chandra Sekhar/AAV-6745-2020; Perin, Alessandro/AAC-1316-2019; Reis, Rui Manuel/B-1744-2018; Reis, Rui Manuel/AAD-6470-2020; Newman, Aaron M/ABE-1620-2021; Calatozzolo, Chiara/AAM-1153-2021; Moiseenko, Fedor/E-1775-2014; Fan, Huihui/AGB-0221-2022; Perou, Charles M/H-9934-2014; LAIRD, PETER W/G-8683-2012; Zhou, Wanding/K-3709-2016; von Deimling, Andreas/F-7774-2013; Dubina, Michael/E-1888-2014	Carlotti, Carlos G/0000-0002-7055-0564; Tavobilov, Mikhail/0000-0003-0335-1204; Chen, Ken/0000-0003-4013-5279; Pollo, Bianca/0000-0002-5523-4256; Shabunin, Alexey/0000-0002-4230-8033; Scolyer, Richard/0000-0002-8991-0013; Barnholtz-Sloan, Jill/0000-0001-6190-9304; Khuri, Fadlo R./0000-0002-8638-7618; Porta-Pardo, Eduard/0000-0001-7900-4239; Longatto-Filho, Adhemar/0000-0002-5779-9752; Holt, Robert A/0000-0002-7259-1247; Bryce, Alan/0000-0002-0206-3895; mattei, luca/0000-0002-7330-502X; Van Den Berg, David J/0000-0002-5404-5218; Melamed, Jonathan/0000-0003-2844-7990; Culhane, Aedin/0000-0002-1395-9734; Cherniack, Andrew D./0000-0003-0470-0111; Choueiri, Toni/0000-0002-9201-3217; Perin, Alessandro/0000-0002-6697-9835; Reis, Rui Manuel/0000-0002-9639-7940; Reis, Rui Manuel/0000-0002-9639-7940; Newman, Aaron M/0000-0002-1857-8172; Calatozzolo, Chiara/0000-0003-0165-3495; Moiseenko, Fedor/0000-0003-2544-9042; Fan, Huihui/0000-0003-4233-5389; Perou, Charles M/0000-0001-9827-2247; Chan, June/0000-0002-7620-569X; LAIRD, PETER W/0000-0001-9117-3641; Facciolo, Francesco/0000-0002-7137-8946; Lacombe, Louis/0000-0003-4811-0308; Zhou, Wanding/0000-0001-9126-1932; von Deimling, Andreas/0000-0002-5863-540X; Gibbs, David/0000-0003-1121-5114; Dubina, Michael/0000-0002-6606-3309; Shinbrot, Eve/0000-0002-8879-3150; Moncrieff, Marc/0000-0003-4492-235X; McCall, Shannon/0000-0003-3957-061X; Bergeron, Alain/0000-0002-2875-0773; Bullman, Susan/0000-0002-7713-0810; Tarnuzzer, Roy/0000-0002-3725-4173	NCI NIH HHS [U24 CA210969] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023	1	193	196	15	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					411	412		10.1016/j.immuni.2019.08.004	http://dx.doi.org/10.1016/j.immuni.2019.08.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31433971	Green Published, hybrid			2022-12-18	WOS:000482088500021
J	Hu, MM; Yang, Q; Xie, XQ; Liao, CY; Lin, H; Liu, TT; Yin, L; Shu, HB				Hu, Ming-Ming; Yang, Qing; Xie, Xue-Qin; Liao, Chen-Yang; Lin, Heng; Liu, Tian-Tian; Yin, Lei; Shu, Hong-Bing			Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus	IMMUNITY			English	Article							CYCLIC GMP-AMP; INNATE IMMUNE; ANTIVIRAL RESPONSE; CYTOSOLIC DNA; ACTIVATION; DEGRADATION; SYNTHASE; PATHWAY; IRF3; UBIQUITINATION	During viral infection, sensing of cytosolic DNA by the cyclic GMP-AMP synthase (cGAS) activates the adaptor protein STING and triggers an antiviral response. Little is known about the mechanisms that determine the kinetics of activation and deactivation of the cGAS-STING pathway, ensuring effective but controlled innate antiviral responses. Here we found that the ubiquitin ligase Trim38 targets cGas for sumoylation in uninfected cells and during the early phase of viral infection. Sumoylation of cGas prevented its polyubiquitination and degradation. Trim38 also sumoylated Sting during the early phase of viral infection, promoting both Sting activation and protein stability. In the late phase of infection, cGas and Sting were desumoylated by Senp2 and subsequently degraded via proteasomal and chaperone-mediated autophagy pathways, respectively. Our findings reveal an essential role for Trim38 in the innate immune response to DNA virus and provide insight into the mechanisms that ensure optimal activation and deactivation of the cGAS-STING pathway.	[Hu, Ming-Ming; Yang, Qing; Lin, Heng; Liu, Tian-Tian; Yin, Lei; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Hu, Ming-Ming; Yang, Qing; Xie, Xue-Qin; Liao, Chen-Yang; Liu, Tian-Tian; Shu, Hong-Bing] Wuhan Univ, Med Res Inst, Wuhan 430072, Peoples R China; [Shu, Hong-Bing] Wuhan Univ, Collaborat Innovat Ctr Viral Immunol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.; Shu, HB (corresponding author), Wuhan Univ, Med Res Inst, Wuhan 430072, Peoples R China.; Shu, HB (corresponding author), Wuhan Univ, Collaborat Innovat Ctr Viral Immunol, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn		yin, lei/0000-0001-5203-2766	Ministry of Science and Technology of China [2016YFA0502102, 2014CB910103, 2012CB910201]; National Natural Science Foundation of China [3163000013, 31521091, 91429304]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology of China (2016YFA0502102, 2014CB910103, 2012CB910201) and the National Natural Science Foundation of China (3163000013, 31521091, 91429304).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Bowie A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002919; Chen LT, 2016, J IMMUNOL, V197, P199, DOI 10.4049/jimmunol.1600039; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Hu MM, 2015, J IMMUNOL, V195, P4415, DOI 10.4049/jimmunol.1500859; Hu MM, 2014, P NATL ACAD SCI USA, V111, P1509, DOI 10.1073/pnas.1318227111; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liu TT, 2016, J IMMUNOL, V196, P5101, DOI 10.4049/jimmunol.1600212; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Ran Y, 2011, J MOL CELL BIOL, V3, P283, DOI 10.1093/jmcb/mjr020; Seo GJ, 2015, CELL REP, V13, P440, DOI 10.1016/j.celrep.2015.09.007; Shu HB, 2014, IMMUNITY, V41, P871, DOI 10.1016/j.immuni.2014.12.002; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008; Zhou Q, 2014, CELL HOST MICROBE, V16, P450, DOI 10.1016/j.chom.2014.09.006	29	193	202	4	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					555	569		10.1016/j.immuni.2016.08.014	http://dx.doi.org/10.1016/j.immuni.2016.08.014			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27637147	Bronze			2022-12-18	WOS:000388454300013
J	Larson-Casey, JL; Deshane, JS; Ryan, AJ; Thannickal, VJ; Carter, AB				Larson-Casey, Jennifer L.; Deshane, Jessy S.; Ryan, Alan J.; Thannickal, Victor J.; Carter, A. Brent			Macrophage Akt1 Kinase-Mediated Mitophagy Modulates Apoptosis Resistance and Pulmonary Fibrosis	IMMUNITY			English	Article							GROWTH-FACTOR; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; CYTOCHROME-C; LUNG; AUTOPHAGY; PROMOTES; INFLAMMATION; ACTIVATION; PARKIN	Idiopathic pulmonary fibrosis (IPF) is a devastating lung disorder with increasing incidence. Mitochondrial oxidative stress in alveolar macrophages is directly linked to pulmonary fibrosis. Mitophagy, the selective engulfment of dysfunctional mitochondria by autophagasomes, is important for cellular homeostasis and can be induced by mitochondrial oxidative stress. Here, we show Akt1 induced macrophage mitochondrial reactive oxygen species (ROS) and mitophagy. Mice harboring a conditional deletion of Akt1 in macrophages (Akt1(-/-)Lyz2-cre) and Park2(-/-) mice had impaired mitophagy and reduced active transforming growth factor-beta 1 (TGF-beta 1). Although Akt1 increased TGF-beta 1 expression, mitophagy inhibition in Akt1-overexpressing macrophages abrogated TGF-beta 1 expression and fibroblast differentiation. Importantly, conditional Akt1(-/-) Lyz2-cre mice and Park2(-/-) mice had increased macrophage apoptosis and were protected from pulmonary fibrosis. Moreover, IPF alveolar macrophages had evidence of increased mitophagy and displayed apoptosis resistance. These observations suggest that Akt1-mediated mitophagy contributes to alveolar macrophage apoptosis resistance and is required for pulmonary fibrosis development.	[Larson-Casey, Jennifer L.; Deshane, Jessy S.; Thannickal, Victor J.; Carter, A. Brent] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Ryan, Alan J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Thannickal, Victor J.; Carter, A. Brent] Birmingham Vet Adm Med Ctr, Birmingham, AL 35294 USA; [Carter, A. Brent] Univ Alabama Birmingham, Dept Med, 1918 Univ Blvd,404 MCLM, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Iowa; University of Alabama System; University of Alabama Birmingham	Carter, AB (corresponding author), Univ Alabama Birmingham, Dept Med, 1918 Univ Blvd,404 MCLM, Birmingham, AL 35294 USA.	bcarter1@uab.edu	Casey, Jennifer/N-8385-2019	Casey, Jennifer/0000-0001-7238-7986	National Institute of Health [2R01ES015981-08, 2T32HL105346-06]; Targeted Metabolomics and Proteonomics Laboratory [P30DK079337]; UAB Lung Health Center; UAB Center for Free Radical Biology; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and Biological Laboratory Research and Development [BX001135-03]; NATIONAL CANCER INSTITUTE [T32CA078586] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981, R01ES014871] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001135] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Targeted Metabolomics and Proteonomics Laboratory; UAB Lung Health Center; UAB Center for Free Radical Biology; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and Biological Laboratory Research and Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr. Stephen Barnes and Ray Moore II with the UAB Targeted Metabolomics & Proteomics Laboratory for assistance with GSH analysis by HPLC, Melissa Foley Chimento and the UAB High Resolution Imaging Facility for assistance with TEM, and M. Taaj Khan for assistance in generating the Tgfb1<SUP>-/-</SUP>Lyz2-cre mice. Research reported in this publication was supported in whole or in part, by National Institute of Health Grants 2R01ES015981-08 to A.B.C., 2T32HL105346-06 to the division of Pulmonary, Allergy, and Critical Care, and the Targeted Metabolomics and Proteonomics Laboratory supported by P30DK079337 (UAB O'Brien Acute Kidney Center), the UAB Lung Health Center, and the UAB Center for Free Radical Biology. This work was also supported by a Merit Review from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and Biological Laboratory Research and Development BX001135-03 to A.B.C.	Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012; BIRCHENALLROBERTS MC, 1990, MOL CELL BIOL, V10, P4978, DOI 10.1128/MCB.10.9.4978; BITTERMAN PB, 1982, J CLIN INVEST, V70, P806, DOI 10.1172/JCI110677; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Carter AB, 2001, J BIOL CHEM, V276, P33826, DOI 10.1074/jbc.M100209200; Chang AL, 2015, FREE RADICAL BIO MED, V78, P179, DOI 10.1016/j.freeradbiomed.2014.10.582; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Collard HR, 2015, ANN AM THORAC SOC, V12, P981, DOI 10.1513/AnnalsATS.201412-553OC; Collard Harold R, 2012, J Med Econ, V15, P829, DOI 10.3111/13696998.2012.680553; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Ghavami S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.36; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Jaffer OA, 2015, AM J RESP CELL MOL, V52, P106, DOI 10.1165/rcmb.2013-0519OC; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; Larson-Casey JL, 2014, J BIOL CHEM, V289, P36204, DOI 10.1074/jbc.M114.593285; Lee SJ, 2011, AM J RESP CELL MOL, V45, P867, DOI 10.1165/rcmb.2010-0352OC; LEMAIRE I, 1986, AM J PATHOL, V122, P205; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Malouf MA, 2011, RESPIROLOGY, V16, P776, DOI 10.1111/j.1440-1843.2011.01955.x; Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Osborn-Heaford HL, 2015, FREE RADICAL BIO MED, V86, P47, DOI 10.1016/j.freeradbiomed.2015.04.031; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Patel AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121246; Raghu G, 2004, BRIT J CANCER, V91, pS3, DOI 10.1038/sj.bjc.6602061; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Ricci A, 2013, J CELL PHYSIOL, V228, P1516, DOI 10.1002/jcp.24307; SCHWARTZ DA, 1994, AM J RESP CRIT CARE, V150, P1243, DOI 10.1164/ajrccm.150.5.7952547; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Weigert A, 2006, BLOOD, V108, P1635, DOI 10.1182/blood-2006-04-014852; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	50	193	206	4	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					582	596		10.1016/j.immuni.2016.01.001	http://dx.doi.org/10.1016/j.immuni.2016.01.001			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26921108	Green Accepted, Bronze			2022-12-18	WOS:000372784200016
J	Boyle, MJ; Reiling, L; Feng, GQ; Langer, C; Osier, FH; Aspeling-Jones, H; Cheng, YS; Stubbs, J; Tetteh, KKA; Conway, DJ; McCarthy, JS; Muller, I; Marsh, K; Anders, RF; Beeson, JG				Boyle, Michelle J.; Reiling, Linda; Feng, Gaoqian; Langer, Christine; Osier, Faith H.; Aspeling-Jones, Harvey; Cheng, Yik Sheng; Stubbs, Janine; Tetteh, Kevin K. A.; Conway, David J.; McCarthy, James S.; Muller, Ivo; Marsh, Kevin; Anders, Robin F.; Beeson, James G.			Human Antibodies Fix Complement to Inhibit Plasmodium falciparum Invasion of Erythrocytes and Are Associated with Protection against Malaria	IMMUNITY			English	Article							BLOOD-STAGE ANTIGENS; GROWTH-INHIBITION; IMMUNOGLOBULIN-G; IMMUNITY; VACCINE; PARASITEMIA; SPECIFICITY; RESPONSES; FRAGMENT; CHILDREN	Antibodies play major roles in immunity to malaria; however, a limited understanding of mechanisms mediating protection is a major barrier to vaccine development. We have demonstrated that acquired human anti-malarial antibodies promote complement deposition on the merozoite to mediate inhibition of erythrocyte invasion through C1q fixation and activation of the classical complement pathway. Antibody-mediated complement-dependent (Ab-C') inhibition was the predominant invasion-inhibitory activity of human antibodies; most antibodies were non-inhibitory without complement. Inhibitory activity was mediated predominately via C1q fixation, and merozoite surface proteins 1 and 2 were identified as major targets. Complement fixation by antibodies was very strongly associated with protection from both clinical malaria and high-density parasitemia in a prospective longitudinal study of children. Ab-C0 inhibitory activity could be induced by human immunization with a candidate merozoite surface-protein vaccine. Our findings demonstrate that human anti-malarial antibodies have evolved to function by fixing complement for potent invasion-inhibitory activity and protective immunity.	[Boyle, Michelle J.; Reiling, Linda; Feng, Gaoqian; Langer, Christine; Cheng, Yik Sheng; Stubbs, Janine; Beeson, James G.] Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia; [Boyle, Michelle J.; Cheng, Yik Sheng] Univ Melbourne, Dept Med Biol, Royal Parade, Melbourne, Vic 3010, Australia; [Osier, Faith H.; Marsh, Kevin] Kenya Govt Med Res Ctr, Ctr Geog Med Res, Coast, Kilifi 80108, Kenya; [Aspeling-Jones, Harvey; Tetteh, Kevin K. A.; Conway, David J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [McCarthy, James S.] Univ Queensland, QIMR Berghofer Med Res Inst, Herston, Qld 4006, Australia; [Muller, Ivo] Royal Parade, Walter & Eliza Hall Inst, Melbourne, Vic 3050, Australia; [Anders, Robin F.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Bundoora, Vic 3086, Australia; [Beeson, James G.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	Burnet Institute; University of Melbourne; Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; QIMR Berghofer Medical Research Institute; University of Queensland; La Trobe University; Monash University	Beeson, JG (corresponding author), Burnet Inst Med Res & Publ Hlth, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	beeson@burnet.edu.au	Boyle, Michelle/P-7297-2019; Boyle, Michelle/D-4223-2018; McCarthy, James S/C-1681-2009	Boyle, Michelle/0000-0002-0268-232X; Boyle, Michelle/0000-0002-0268-232X; McCarthy, James/0000-0001-6596-9718; Osier, Faith/0000-0001-7133-5375; Conway, David/0000-0002-8711-3037; Feng, Gaoqian/0000-0002-3605-038X; Anders, Robin/0000-0002-0693-4547	National Health and Medical Research Council of Australia; Australian Research Council; Victorian State Government; Queensland Government; Australian Government; University of Melbourne Department of Medicine, Dentistry, and Health Sciences; PATH Malaria Vaccine Initiative; Medical Research Council [1363954] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian State Government; Queensland Government; Australian Government(Australian GovernmentCGIAR); University of Melbourne Department of Medicine, Dentistry, and Health Sciences; PATH Malaria Vaccine Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	RBCs and serum for parasite culture were provided by the Australian Red Cross Blood Bank (Melbourne). We thank the following people for reagents: D. Drew and A. Hodder (AMA1 antibodies), R. Coppel and B. Cooke (MSP4 antigen and MSP4 antibodies), and B. Crabb and P. Gilson (MSP1-19 antibodies). Funding was provided by the National Health and Medical Research Council of Australia (program grant to J.G.B.; Infrastructure for Research Institutes Support Scheme grant and research fellowships to J.G.B. and J.S.M.), the Australian Research Council (Future Fellowship to J.G.B.), a Victorian State Government Operational Infrastructure Support grant, the Queensland Government (Medical Research Fellowship to J.S.M.), the Australian Government (PhD scholarship to M.J.B.), and the University of Melbourne Department of Medicine, Dentistry, and Health Sciences (PhD top-up award to M.J.B.). The MSP2 phase 1 vaccine trial was funded by PATH Malaria Vaccine Initiative. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank D. Wilson and P. Jagannathan for critical reading of the manuscript and Kristina Persson for helpful discussions. This paper is published with permission from the director of KEMRI.	Beeson J. G., 2014, MALARIA VACCINE DEV, P80; Biryukov S, 2014, TRENDS MOL MED, V20, P293, DOI 10.1016/j.molmed.2014.01.001; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Boyle MJ, 2014, INFECT IMMUN, V82, P924, DOI 10.1128/IAI.00866-13; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Courtin D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007590; Cowan GJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026616; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Dent AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003557; Dluzewski AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003085; Drew DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051023; Feng JQ, 2002, J VIROL, V76, P1369, DOI 10.1128/JVI.76.3.1369-1378.2002; Flueck C, 2009, VACCINE, V27, P2653, DOI 10.1016/j.vaccine.2009.02.081; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Galamo CD, 2009, J INFECT DIS, V199, P1151, DOI 10.1086/597426; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021914, 10.1371/journal.pone.0024413]; Mehlhop E, 2009, CELL HOST MICROBE, V6, P381, DOI 10.1016/j.chom.2009.09.003; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Ndungu FM, 2002, PARASITE IMMUNOL, V24, P77, DOI 10.1046/j.0141-9838.2001.00440.x; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; OEUVRAY C, 1994, BLOOD, V84, P1594; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Reiling L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045253; Reiling L, 2010, J IMMUNOL, V185, P6157, DOI 10.4049/jimmunol.1001555; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Silver KL, 2010, CELL MICROBIOL, V12, P1036, DOI 10.1111/j.1462-5822.2010.01492.x; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stubbs J, 2011, INFECT IMMUN, V79, P1143, DOI 10.1128/IAI.01034-10; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; Wilson DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027705; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152	45	193	196	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					580	590		10.1016/j.immuni.2015.02.012	http://dx.doi.org/10.1016/j.immuni.2015.02.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786180	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000351301900020
J	Chu, VT; Beller, A; Rausch, S; Strandmark, J; Zanker, M; Arbach, O; Kruglov, A; Berek, C				Chu, Van Trung; Beller, Alexander; Rausch, Sebastian; Strandmark, Julia; Zaenker, Michael; Arbach, Olga; Kruglov, Andrey; Berek, Claudia			Eosinophils Promote Generation and Maintenance of Immunoglobulin-A-Expressing Plasma Cells and Contribute to Gut Immune Homeostasis	IMMUNITY			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; PEYERS-PATCHES; LAMINA PROPRIA; TGF-BETA; GASTROINTESTINAL EOSINOPHILS; COMMENSAL BACTERIA; GERMINAL-CENTERS; IGA RESPONSES; BONE-MARROW	Although in normal lamina propria (LP) large numbers of eosinophils are present, little is known about their role in mucosal immunity at steady state. Here we show that eosinophils are needed to maintain immune homeostasis in gut-associated tissues. By using eosinophil-deficient Delta dblGATA-1 and PHIL mice or an eosinophil-specific depletion model, we found a reduction in immunoglobulin A(+) (IgA(+)) plasma cell numbers and in secreted IgA. Eosinophil-deficient mice also showed defects in the intestinal mucous shield and alterations in microbiota composition in the gut lumen. In addition, TGF-beta-dependent events including class switching to IgA in Peyer's patches (PP), the formation of CD103(+) T cells including Foxp3(+) regulatory (Treg), and also CD103(+) dendritic cells were disturbed. In vitro cultures showed that eosinophils produce factors that promote T-independent IgA class switching. Our findings show that eosinophils are important players for immune homeostasis in gut-associated tissues and add to data suggesting that eosinophils can promote tissue integrity.	[Chu, Van Trung; Beller, Alexander; Kruglov, Andrey; Berek, Claudia] Deutsches Rheuma Forschungszentrum Berlin, Leibniz Inst, D-10117 Berlin, Germany; [Rausch, Sebastian; Strandmark, Julia] Free Univ Berlin, Inst Immunol Vet Med, D-14163 Berlin, Germany; [Zaenker, Michael] Internal Med Immanuel Klinikum Bernau, D-16321 Bernau, Germany; [Arbach, Olga] Charite, Inst Transfus Med, D-10117 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Berek, C (corresponding author), Deutsches Rheuma Forschungszentrum Berlin, Leibniz Inst, D-10117 Berlin, Germany.	berek@drfz.de	Kruglov, Andrey/AAP-2023-2021; Kruglov, Andrey A/F-7543-2017	Kruglov, Andrey A/0000-0002-4597-2087; Chu, Van Trung/0000-0003-1327-8696	Deutsche Forschungsgemeinschaft [BE 1171/2]; Berlin Senate of Research and Education	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Berlin Senate of Research and Education	We thank N.A. Lee (Mayo Clinic) for providing PHIL mice, B. Raupach (Max Plank Institute for Infection Biology) for helping with MyD88 and TRIF double-deficient mice, the members of the Deutsches Rheuma Forschungszentrum, in particular G. Steinhauser and T. Kaiser for technical support, and R. S. Jack and S. Hartmann (Free University, Berlin) for critical reading of the manuscript. The work was supported by the Deutsche Forschungsgemeinschaft (BE 1171/2). The DRFZ, a Leibniz Institute, is supported by the Berlin Senate of Research and Education.	Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Barternes KR, 2005, J ALLERGY CLIN IMMUN, V116, P827, DOI 10.1016/j.jaci.2005.07.014; Bergqvist P, 2006, J IMMUNOL, V177, P7772, DOI 10.4049/jimmunol.177.11.7772; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Casola S, 2006, CURR TOP MICROBIOL, V308, P155; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Chu VT, 2012, EUR J IMMUNOL, V42, P130, DOI 10.1002/eji.201141953; Chu VT, 2007, J IMMUNOL, V179, P5947, DOI 10.4049/jimmunol.179.9.5947; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Dullaers M, 2009, IMMUNITY, V30, P120, DOI 10.1016/j.immuni.2008.11.008; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hogan SP, 2001, NAT IMMUNOL, V2, P353, DOI 10.1038/86365; KILSHAW PJ, 1990, EUR J IMMUNOL, V20, P2201, DOI 10.1002/eji.1830201008; Kuwahara M, 2012, NAT IMMUNOL, V13, P778, DOI 10.1038/ni.2362; Lee JJ, 2010, CLIN EXP ALLERGY, V40, P563, DOI 10.1111/j.1365-2222.2010.03484.x; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Nei Y, 2013, P NATL ACAD SCI USA, V110, P18620, DOI 10.1073/pnas.1311668110; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rothenberg ME, 2001, IMMUNOL REV, V179, P139, DOI 10.1034/j.1600-065X.2001.790114.x; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; STOKES CR, 1975, NATURE, V255, P745, DOI 10.1038/255745a0; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tezuka H, 2010, IMMUNOL REV, V234, P247, DOI 10.1111/j.0105-2896.2009.00872.x; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; van Ginkel FW, 1999, J IMMUNOL, V163, P1951; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; WELTZIN R, 1989, J CELL BIOL, V108, P1673, DOI 10.1083/jcb.108.5.1673; Wen T, 2012, J IMMUNOL, V188, P1075, DOI 10.4049/jimmunol.1102222; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	48	193	198	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					582	593		10.1016/j.immuni.2014.02.014	http://dx.doi.org/10.1016/j.immuni.2014.02.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24745334	Bronze			2022-12-18	WOS:000334849400015
J	Henao-Mejia, J; Williams, A; Goff, LA; Staron, M; Licona-Limon, P; Kaech, SM; Nakayama, M; Rinn, JL; Flavell, RA				Henao-Mejia, Jorge; Williams, Adam; Goff, Loyal A.; Staron, Matthew; Licona-Limon, Paula; Kaech, Susan M.; Nakayama, Maki; Rinn, John L.; Flavell, Richard A.			The MicroRNA miR-181 Is a Critical Cellular Metabolic Rheostat Essential for NKT Cell Ontogenesis and Lymphocyte Development and Homeostasis	IMMUNITY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; C-MYC; DEVELOPMENT REQUIRES; THYMOCYTE SURVIVAL; THYMIC DEVELOPMENT; T-CELLS; TRANSCRIPTION; KINASE; DIFFERENTIATION; EXPRESSION	Regulation of metabolic pathways in the immune system provides a mechanism to actively control cellular function, growth, proliferation, and survival. Here, we report that miR-181 is a nonredundant determinant of cellular metabolism and is essential for supporting the biosynthetic demands of early NKT cell development. As a result, miR-181-deficient mice showed a complete absence of mature NKT cells in the thymus and periphery. Mechanistically, miR-181 modulated expression of the phosphatase PTEN to control PI3K signaling, which was a primary stimulus for anabolic metabolism in immune cells. Thus miR-181-deficient mice also showed severe defects in lymphoid development and T cell homeostasis associated with impaired PI3K signaling. These results uncover miR-181 as essential for NKT cell development and establish this family of miRNAs as central regulators of PI3K signaling and global metabolic fitness during development and homeostasis.	[Henao-Mejia, Jorge; Williams, Adam; Staron, Matthew; Licona-Limon, Paula; Kaech, Susan M.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Goff, Loyal A.; Rinn, John L.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Goff, Loyal A.; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Goff, Loyal A.] MIT, Dept Elect Engn & Comp Sci, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02140 USA; [Nakayama, Maki] Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Kaech, Susan M.; Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu		Goff, Loyal/0000-0003-2875-451X	Leukemia and Lymphoma Society postdoctoral fellowship; PEW charitable trust: PEW Latin American Fellow Program in Biomedical Sciences; Howard Hughes Medical Institute;  [F32, 1F32AI096718-01A1];  [R00 DK080885]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI096718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK080885] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society postdoctoral fellowship(Leukemia and Lymphoma Society); PEW charitable trust: PEW Latin American Fellow Program in Biomedical Sciences; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Stephanie C. Eisenbarth, Jon Alderman, and Caroline Lieber for technical assistance and discussions. J.H.M. is supported by a Leukemia and Lymphoma Society postdoctoral fellowship. M. S. is supported by F32, 1F32AI096718-01A1. M.N. is supported by R00 DK080885. P. L-L. was supported by a post-doctoral fellowship from the PEW charitable trust: PEW Latin American Fellow Program in Biomedical Sciences. This work was supported in part by the Howard Hughes Medical Institute (S. M. K. and R.A.F.).	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Baracho GV, 2011, CURR OPIN IMMUNOL, V23, P178, DOI 10.1016/j.coi.2011.01.001; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; D'Cruz LM, 2010, NAT IMMUNOL, V11, P240, DOI 10.1038/ni.1845; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Dose M, 2009, P NATL ACAD SCI USA, V106, P8641, DOI 10.1073/pnas.0812255106; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Fayard E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000992; Fayard E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3135re5; Fedeli M, 2009, J IMMUNOL, V183, P2506, DOI 10.4049/jimmunol.0901361; Finlay DK, 2010, J IMMUNOL, V185, P5973, DOI 10.4049/jimmunol.1000827; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; Ji H, 2007, BLOOD, V110, P2940, DOI 10.1182/blood-2007-04-086751; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Juntilla MM, 2007, P NATL ACAD SCI USA, V104, P12105, DOI 10.1073/pnas.0705285104; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mycko MP, 2009, J IMMUNOL, V182, P4641, DOI 10.4049/jimmunol.0803394; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Pal A, 2012, NEW ENGL J MED, V367, P1002, DOI 10.1056/NEJMoa1113966; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swat W, 2006, BLOOD, V107, P2415, DOI 10.1182/blood-2005-08-3300; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang W, 1999, J IMMUNOL, V162, P314; Webb LMC, 2005, J IMMUNOL, V175, P2783, DOI 10.4049/jimmunol.175.5.2783; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Zheng QH, 2012, J IMMUNOL, V188, P2118, DOI 10.4049/jimmunol.1103342; Zilberman Y, 2004, CELL IMMUNOL, V227, P12, DOI 10.1016/j.cellimm.2004.01.005	52	193	206	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					984	997		10.1016/j.immuni.2013.02.021	http://dx.doi.org/10.1016/j.immuni.2013.02.021			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23623381	Green Accepted, Bronze			2022-12-18	WOS:000330942500016
J	Haring, JS; Badovinac, VP; Harty, JT				Haring, Jodie S.; Badovinac, Vladimir P.; Harty, John T.			Inflaming the CD8(+) T cell response	IMMUNITY			English	Review							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CHRONIC VIRAL-INFECTION; CUTTING EDGE; INTERFERON-GAMMA; CLONAL EXPANSION; IFN-GAMMA; PROTECTIVE IMMUNITY; IN-VIVO; LISTERIA-MONOCYTOGENES; SELECTIVE EXPRESSION	Although inflammatory cytokines induced by infection or vaccination with adjuvants have long been known to stimulate optimal antigen-presenting cell function, recent evidence indicates that some inflammatory cytokines also act directly on the responding T cells to control their response to infection. Here, we review the evidence that specific inflammatory cytokines act to control the magnitude of expansion, the degree of contraction, and the rate of memory cell development. These data may suggest new strategies for manipulating vaccine efficacy in the quest to protect against pathogenic microbes.	Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu	badovinac, Vladimir/O-7760-2015	Harty, John/0000-0001-7266-2802; Badovinac, Vladimir/0000-0003-3180-2439	NIAID NIH HHS [AI46653, AI059752, AI50073, AI42767] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046653, R01AI059752, R01AI050073, R21AI042767, R01AI042767, R37AI042767] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Badovinac VP, 2002, MICROBES INFECT, V4, P441, DOI 10.1016/S1286-4579(02)01558-7; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beadling C, 2005, BLOOD, V105, P1179, DOI 10.1182/blood-2004-07-2833; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Bertram EM, 2004, J IMMUNOL, V172, P981, DOI 10.4049/jimmunol.172.2.981; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Castagliuolo I, 2004, J GASTROINTEST SURG, V8, P24, DOI 10.1016/j.gassur.2003.10.004; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; Dalton DK, 2000, J EXP MED, V192, P117, DOI 10.1084/jem.192.1.117; Decrion AZ, 2005, CURR HIV RES, V3, P243, DOI 10.2174/1570162054368057; Hamilton SE, 2002, J IMMUNOL, V169, P4936, DOI 10.4049/jimmunol.169.9.4936; Haring JS, 2005, J IMMUNOL, V174, P6791, DOI 10.4049/jimmunol.174.11.6791; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kersh EN, 2003, J IMMUNOL, V170, P5455, DOI 10.4049/jimmunol.170.11.5455; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Krieg AM, 2003, NAT MED, V9, P831, DOI 10.1038/nm0703-831; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; Lanzavecchia A, 2001, NAT IMMUNOL, V2, P487, DOI 10.1038/88678; Leavey JK, 2003, J IMMUNOL, V170, P2264, DOI 10.4049/jimmunol.170.5.2264; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; Levine MM, 2004, NAT IMMUNOL, V5, P460, DOI 10.1038/ni0504-460; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Masopust D, 2004, IMMUNOL RES, V29, P151, DOI 10.1385/IR:29:1-3:151; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nguyen LT, 2000, EUR J IMMUNOL, V30, P683, DOI 10.1002/1521-4141(200002)30:2<683::AID-IMMU683>3.3.CO;2-X; Orange JS, 1996, J IMMUNOL, V156, P1138; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Palmer EM, 2001, J IMMUNOL, V167, P749, DOI 10.4049/jimmunol.167.2.749; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; POSTON RM, 1991, J IMMUNOL, V146, P4333; POSTON RM, 1992, J IMMUNOL, V149, P3040; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Reich A, 2000, EUR J IMMUNOL, V30, P678, DOI 10.1002/1521-4141(200002)30:2<678::AID-IMMU678>3.3.CO;2-H; Roberts AD, 2005, J EXP MED, V202, P123, DOI 10.1084/jem.20050137; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schmidt CS, 2002, J IMMUNOL, V168, P5521, DOI 10.4049/jimmunol.168.11.5521; Schmidt CS, 1999, J IMMUNOL, V163, P2561; Sercan O, 2006, J IMMUNOL, V176, P735, DOI 10.4049/jimmunol.176.2.735; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; Steinman RM, 2003, PATHOL BIOL, V51, P59, DOI 10.1016/S0369-8114(03)00096-8; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun Xing Cai, 2004, BMC Physiol, V4, P8, DOI 10.1186/1472-6793-4-8; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; THOMPSON LJ, 2006, IN PRESS J IMMUNOL, V177; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; Valenzuela JO, 2005, J IMMUNOL, V174, P600, DOI 10.4049/jimmunol.174.2.600; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; WELSH RM, 1978, J EXP MED, V148, P163, DOI 10.1084/jem.148.1.163; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Weninger W, 2002, IMMUNOL REV, V186, P221, DOI 10.1034/j.1600-065X.2002.18618.x; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Whitmire JK, 2005, J IMMUNOL, V175, P5624, DOI 10.4049/jimmunol.175.9.5624; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wong P, 2004, J IMMUNOL, V172, P7239, DOI 10.4049/jimmunol.172.12.7239; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045	95	193	196	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2006	25	1					19	29		10.1016/j.immuni.2006.07.001	http://dx.doi.org/10.1016/j.immuni.2006.07.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860754	Bronze			2022-12-18	WOS:000239713000007
J	Browning, JL; Allaire, N; Ngam-ek, A; Notidis, E; Hunt, J; Perrin, S; Fava, RA				Browning, JL; Allaire, N; Ngam-ek, A; Notidis, E; Hunt, J; Perrin, S; Fava, RA			Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function	IMMUNITY			English	Article							HIGH ENDOTHELIAL VENULES; TUMOR-NECROSIS-FACTOR; CORE-2 BRANCHING BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; DENDRITIC CELL PRECURSORS; PERIPHERAL NODE ADDRESSIN; LYMPH-NODES; L-SELECTIN; RESTRICTED SULFOTRANSFERASE; GENE-EXPRESSION; TISSUE	The lymphotoxin axis is important for the maintenance of several specialized lymphoid microenvironments in secondary lymphoid tissue. Lymphoid-tissue architecture is highly plastic and requires continual homeostatic signaling to maintain its basal functional state. The cellularity of lymph nodes in adult mice was reduced by systemic blockade of lymphotoxin-beta receptor (LT beta R) signaling with a soluble decoy receptor both in resting and reactive settings. This reduction in cellularity resulted from greatly impaired lymphocyte entry into lymph nodes due to decreased levels of peripheral lymph node addressin (PNAd) and MAdCAM on high endothelial venules (HEV). LT beta R signaling was required to maintain normal levels of RNA expression of MAdCAM, and also of PNAd by regulating the expression of key enzymes and scaffold proteins required for its assembly. Thus, the homeostatic maintenance of functional HEV status in adult mice relies largely on LT beta R signaling.	Biogen Idec Inc, Dept Immunobiol, Cambridge, MA 02142 USA; Biogen Idec Inc, Dept Transcript Profiling, Cambridge, MA 02142 USA; Dept Vet Affairs Med Ctr, Arthritis Res Lab, White River Jct, VT 05009 USA; Dartmouth Coll Sch Med, Dept Med, Hanover, NH 03755 USA	Biogen; Biogen; Dartmouth College	Browning, JL (corresponding author), Biogen Idec Inc, Dept Immunobiol, Cambridge, MA 02142 USA.	jeff.browning@biogenidec.com		Browning, Jeffrey/0000-0001-9168-5233				Bistrup A, 2004, AM J PATHOL, V164, P1635, DOI 10.1016/S0002-9440(10)63722-4; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Braun A, 2004, ARTHRITIS RHEUM-US, V50, P2140, DOI 10.1002/art.20356; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Carragher D, 2004, J IMMUNOL, V173, P2271, DOI 10.4049/jimmunol.173.4.2271; Cyster JG, 2000, IMMUNOL REV, V176, P181; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dohi T, 2001, J IMMUNOL, V167, P2781, DOI 10.4049/jimmunol.167.5.2781; Drayton DL, 2004, J IMMUNOL, V173, P6161, DOI 10.4049/jimmunol.173.10.6161; Drayton DL, 2003, J EXP MED, V197, P1153, DOI 10.1084/jem.20021761; DUIJVESTIJN AM, 1990, IMMUNOBIOLOGY, V180, P295, DOI 10.1016/S0171-2985(11)80293-7; Fava RA, 2003, J IMMUNOL, V171, P115, DOI 10.4049/jimmunol.171.1.115; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gauguet JM, 2004, BLOOD, V104, P4104, DOI 10.1182/blood-2004-05-1986; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Gommerman JL, 2002, J CLIN INVEST, V110, P1359, DOI 10.1172/JCI200215975; HENDRIKS HR, 1987, EUR J IMMUNOL, V17, P1691, DOI 10.1002/eji.1830171203; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; Hochman PS, 1996, J INFLAMM, V46, P220; HOKE D, 1995, CURR BIOL, V5, P670, DOI 10.1016/S0960-9822(95)00132-1; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; HUANG K, 1994, J NEUROIMMUNOL, V53, P133, DOI 10.1016/0165-5728(94)90023-X; Koni PA, 1998, J EXP MED, V187, P1977, DOI 10.1084/jem.187.12.1977; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Kraal G, 1997, ADV IMMUNOL, V65, P347, DOI 10.1016/S0065-2776(08)60746-4; Lane PJL, 2005, NAT REV IMMUNOL, V5, P655, DOI 10.1038/nri1665; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Ley K, 2003, J EXP MED, V198, P1285, DOI 10.1084/jem.20031664; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; Mackay F, 1998, GASTROENTEROLOGY, V115, P1464, DOI 10.1016/S0016-5085(98)70025-3; MEBIUS RE, 1993, J IMMUNOL, V151, P6769; MEBIUS RE, 1991, J CELL BIOL, V115, P85, DOI 10.1083/jcb.115.1.85; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Nakano H, 1997, EUR J IMMUNOL, V27, P215, DOI 10.1002/eji.1830270132; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Pasparakis M, 2000, CELL IMMUNOL, V201, P33, DOI 10.1006/cimm.2000.1636; Rennert PD, 1997, INT IMMUNOL, V9, P1627, DOI 10.1093/intimm/9.11.1627; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Rivera-Nieves J, 2005, J IMMUNOL, V174, P2343, DOI 10.4049/jimmunol.174.4.2343; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; STMARIE G, 1985, LAB INVEST, V52, P631; Stopfer P, 2004, CLIN EXP IMMUNOL, V136, P21, DOI 10.1111/j.1365-2249.2004.02402.x; Swarte VVR, 1998, EUR J IMMUNOL, V28, P3040, DOI 10.1002/(SICI)1521-4141(199810)28:10<3040::AID-IMMU3040>3.0.CO;2-5; van Zante A, 2003, J EXP MED, V198, P1289, DOI 10.1084/jem.20030057; VANDINTHERJANSSEN ACHM, 1990, J RHEUMATOL, V17, P11; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wang J, 2005, IMMUNOL REV, V204, P144, DOI 10.1111/j.0105-2896.2005.00218.x; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; WATSON SR, 1990, J CELL BIOL, V110, P2221, DOI 10.1083/jcb.110.6.2221; Weyand CM, 2001, AM J PATHOL, V159, P787, DOI 10.1016/S0002-9440(10)61751-8; Wolburg K, 1999, CELL TISSUE RES, V296, P259, DOI 10.1007/s004410051287; Ying XY, 2005, AM J PATHOL, V166, P135, DOI 10.1016/S0002-9440(10)62239-0; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35	57	193	193	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2005	23	5					539	550		10.1016/j.immuni.2005.10.002	http://dx.doi.org/10.1016/j.immuni.2005.10.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	989GK	16286021	Bronze			2022-12-18	WOS:000233660700010
J	Cannons, JL; Yu, LJ; Hill, B; Mijares, LA; Dombroski, D; Nichols, KE; Antonellis, A; Koretzky, GA; Gardner, K; Schwartzberg, PL				Cannons, JL; Yu, LJ; Hill, B; Mijares, LA; Dombroski, D; Nichols, KE; Antonellis, A; Koretzky, GA; Gardner, K; Schwartzberg, PL			SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappa B1	IMMUNITY			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; NF-KAPPA-B; CONTROLS T-CELL; KINASE-C-THETA; GENE-PRODUCT; SIGNAL-TRANSDUCTION; HUMORAL IMMUNITY; MICE DEFICIENT; ENCODING GENE; SH2 DOMAIN	XLP is caused by mutations affecting SAP, an adaptor that recruits Fyn to SLAM family receptors. SAP-deficient mice recapitulate features of XLP, including increased T cell activation and decreased humoral responses post-infection. SAP-deficient T cells also show increased TCR-induced IFN-gamma and decreased T(H)2 cytokine production. We demonstrate that the defect in IL-4 secretion in SAP-deficient T cells is independent of increased IFN-gamma production. SAP-deficient cells respond normally to polarizing cytokines, yet show impaired TCR-mediated induction of GATA-3 and IL-4. Examination of TCR signaling revealed normal Ca2+ mobilization and ERK activation in SAP-deficient cells, but decreased PKC-theta recruitment, Bcl-10 phosphorylation, IkappaB-alpha degradation, and nuclear NF-kappaB1/p50 levels. Similar defects were observed in Fyn-deficient cells. SLAM engagement amplified PKC-theta recruitment in wt but not SAP- or Fyn-deficient cells, arguing that a SAP/Fyn-mediated pathway enhances PKC-theta/NF-kappaB1 activation and suggesting a role for this pathway in T(H)2 regulation.	NHGRI, Natl Inst Hlth, Bethesda, MD 20892 USA; NCI, Natl Inst Hlth, Bethesda, MD 20892 USA; George Washington Univ, Inst Biomed Sci, Washington, DC 20052 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Abramson Family Canc Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Schwartzberg, PL (corresponding author), NHGRI, Natl Inst Hlth, Bethesda, MD 20892 USA.	pams@mail.nih.gov	Nichols, Kim/E-9353-2016; Koretzky, Gary/AAU-5381-2021; Nichols, Kim/AAP-8592-2020	Nichols, Kim/0000-0002-5581-6555; Nichols, Kim/0000-0002-5581-6555	DIVISION OF CLINICAL SCIENCES - NCI [Z01SC010056] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, Z01HG000123] Funding Source: NIH RePORTER	DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Artis D, 2002, J IMMUNOL, V169, P4481, DOI 10.4049/jimmunol.169.8.4481; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Filipp D, 2003, J EXP MED, V197, P1221, DOI 10.1084/jem.20022112; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Hehner SP, 2000, J IMMUNOL, V164, P3829, DOI 10.4049/jimmunol.164.7.3829; Howie D, 2002, BLOOD, V99, P957, DOI 10.1182/blood.V99.3.957; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Iwashima M, 2003, IMMUNOL REV, V191, P196, DOI 10.1034/j.1600-065X.2003.00024.x; Jankovic D, 2004, J IMMUNOL, V173, P2419, DOI 10.4049/jimmunol.173.4.2419; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li CJ, 2003, J BIOL CHEM, V278, P3852, DOI 10.1074/jbc.M206649200; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakamura H, 2001, J IMMUNOL, V167, P2657, DOI 10.4049/jimmunol.167.5.2657; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Sanzone S, 2003, J BIOL CHEM, V278, P29593, DOI 10.1074/jbc.M300565200; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; SEEMAYER TA, 1995, PEDIATR RES, V38, P471, DOI 10.1203/00006450-199510000-00001; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sylla BS, 2000, P NATL ACAD SCI USA, V97, P7470, DOI 10.1073/pnas.130193097; Tam WF, 2001, MOL CELL BIOL, V21, P4837, DOI 10.1128/MCB.21.14.4837-4846.2001; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; YASUDA N, 1991, CLIN EXP IMMUNOL, V83, P10; Yin L, 2003, J MED VIROL, V71, P446, DOI 10.1002/jmv.10504	43	193	200	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2004	21	5					693	706		10.1016/j.immuni.2004.09.012	http://dx.doi.org/10.1016/j.immuni.2004.09.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539155	Bronze			2022-12-18	WOS:000225365000010
J	Boulay, JL; O'Shea, JJ; Paul, WE				Boulay, JL; O'Shea, JJ; Paul, WE			Molecular phylogeny within type I cytokines and their cognate receptors	IMMUNITY			English	Review							GENOME SEQUENCE; GROWTH-HORMONE; EVOLUTION; GENE; PROTEIN; FAMILY	Type I helical cytokines are ligands for receptors structurally related by a common sequence signature. Here we analyze the 27 ligands and 34 human type I cytokine receptor encoded by the human genome. We compare these to ligands and receptors found in mouse and insects. We describe their structural relatedness to one another and discuss the evolution of these gene families.	Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	University of Basel; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Boulay, JL (corresponding author), Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland.	jean-louis.boulay@unibas.ch			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493, Z01AI000493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106, ZIAAR041106] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BARSH GS, 1983, NUCLEIC ACIDS RES, V11, P3939, DOI 10.1093/nar/11.12.3939; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BOULAY JL, 1992, CURR OPIN IMMUNOL, V4, P294, DOI 10.1016/0952-7915(92)90079-T; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Leonard W.J., 1999, FUNDAMENTAL IMMUNOLO, Vfourth, P741; Leonard WJ, 2002, NAT IMMUNOL, V3, P605, DOI 10.1038/ni0702-605; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; ONO M, 1990, P NATL ACAD SCI USA, V87, P4330, DOI 10.1073/pnas.87.11.4330; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vilcek J, 2003, NAT IMMUNOL, V4, P8, DOI 10.1038/ni0103-8; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482	19	193	204	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2003	19	2					159	163		10.1016/S1074-7613(03)00211-5	http://dx.doi.org/10.1016/S1074-7613(03)00211-5			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932349	Bronze			2022-12-18	WOS:000184929000003
J	Villalba, M; Coudronniere, N; Deckert, M; Teixeiro, E; Mas, P; Altman, A				Villalba, M; Coudronniere, N; Deckert, M; Teixeiro, E; Mas, P; Altman, A			A novel functional interaction between Vav and PKC theta is required for TCR-induced T cell activation	IMMUNITY			English	Article							PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTORS; IL-2 GENE; LYMPHOCYTES; FAMILY; THYMOCYTES; PROTOONCOGENE; SELECTION; CALCIUM	Vav and PKC theta play an early and important role in the TCR/CD28-induced stimulation of MAP kinases and activation of the IL-2 gene. Vav is also essential for actin cytoskeleton reorganization and TCR capping. Here, we report that PKC theta function was selectively required in a Vav signaling pathway that mediates the TCR/CD28-induced activation of JNK and the IL-2 gene and the upregulation of CD69 expression. Vav also promoted PKC theta translocation from the cytosol to the membrane and cytoskeleton and induced its enzymatic activation in a CD3/CD28-initiated pathway that was dependent on Rac and on actin cytoskeleton reorganization. These findings reveal that the Vav/Rac pathway promotes the recruitment of PKC theta to the T cell synapse and its activation, essential processes for T cell activation and IL-2 production.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA; Univ Complutense Madrid, Fdn Jimenez Diaz, Dept Immunol, E-28040 Madrid, Spain; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; Complutense University of Madrid; Scripps Research Institute	Altman, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA.		villalba, martin/AAG-2604-2020; Deckert, Marcel/T-3566-2019; villalba, martin/N-7123-2017; Deckert, Marcel/M-4998-2016; Mas, Paloma/B-8215-2016	villalba, martin/0000-0002-4385-4888; Deckert, Marcel/0000-0003-2094-559X; villalba, martin/0000-0002-4385-4888; Mas, Paloma/0000-0002-3780-8041	NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050819] Funding Source: NIH RePORTER; NCI NIH HHS [CA35299] Funding Source: Medline; NIGMS NIH HHS [GM50819] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIER G, 1993, J BIOL CHEM, V268, P4997; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Cantrell D, 1998, CURR BIOL, V8, pR535, DOI 10.1016/S0960-9822(07)00341-7; Chen CY, 1996, MOL CELL BIOL, V16, P6582; Collins TL, 1997, IMMUNOL TODAY, V18, P221; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; COUDRONNIERE N, 2000, IN PRESS P NATL ACAS; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Meller N, 1998, STEM CELLS, V16, P178, DOI 10.1002/stem.160178; Meller N, 1996, MOL CELL BIOL, V16, P5782; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; OHNO Y, 1989, P NATL ACAD SCI USA, V86, P3099; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Romero F, 1996, CELL SIGNAL, V8, P545, DOI 10.1016/S0898-6568(96)00118-0; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Villalba M, 1999, J IMMUNOL, V163, P5813; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; WU J, 1995, MOL CELL BIOL, V15, P4337; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Xavier R, 1999, CURR OPIN IMMUNOL, V11, P265, DOI 10.1016/S0952-7915(99)80043-0; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	39	193	198	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2000	12	2					151	160		10.1016/S1074-7613(00)80168-5	http://dx.doi.org/10.1016/S1074-7613(00)80168-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	289LA	10714681	Bronze			2022-12-18	WOS:000085621400005
J	Klickstein, LB; Barbashov, SF; Liu, T; Jack, RM; NicholsonWeller, A				Klickstein, LB; Barbashov, SF; Liu, T; Jack, RM; NicholsonWeller, A			Complement receptor type 1 (CR1, CD35) is a receptor for C1q	IMMUNITY			English	Article							HUMAN PERIPHERAL-BLOOD; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; SYSTEMIC LUPUS-ERYTHEMATOSUS; SURFACE-PLASMON RESONANCE; COLLAGEN-LIKE REGION; C3B/C4B RECEPTOR; IMMUNE-COMPLEXES; C3B RECEPTOR; HUMAN-NEUTROPHILS; BINDING-SITES	Molecular definition of the cellular receptor for the collagen domain of C1q has been elusive. We now report that C1q binds specifically to human CR1 (CD35), the leukocyte C3b/C4b receptor, and the receptor on erythrocytes for opsonized immune complexes. Biotinylated or radioiodinated C1q (*C1q) bound specifically to transfected K562 cells expressing cell surface CR1 and to immobilized recombinant soluble CR1 (rsCR1). *C1q binding to rsCR1 was completely inhibited by unlabeled C1q and the collagen domain of C1q and was partially inhibited by C3b dimers. Kinetic analysis in physiologic saline of the interaction of unlabeled C1q with immobilized rsCR1 using surface plasmon resonance yielded an apparent equilibrium dissociation constant (K-eq2) of 3.9 nM. Thus, CR1 is a cellular C1q receptor that recognizes al three complement opsonins, namely, C1q, C3b, and C4b.	BRIGHAM & WOMENS HOSP, DEPT MED, DIV RHEUMATOL IMMUNOL, BOSTON, MA 02215 USA; BETH ISRAEL DEACONESS MED CTR, DIV INFECT DIS, HARVARD THORNDIKE LAB, CHARLES A DANA RES INST, BOSTON, MA 02215 USA; LA JOLLA PHARMACEUT, SAN DIEGO, CA 92121 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; La Jolla Pharmaceutical Company	Klickstein, LB (corresponding author), HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02215 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034028] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK34028] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNAOUT MA, 1981, J IMMUNOL, V127, P1348; ATKINSON JP, 1986, SPRINGER SEMIN IMMUN, V9, P179, DOI 10.1007/BF02099021; BAKER CJ, 1982, J CLIN INVEST, V69, P394, DOI 10.1172/JCI110463; Bleackley R C, 1995, Curr Top Microbiol Immunol, V198, P145; BOWNESS P, 1994, Q J MED, V87, P455; BROWN EJ, 1989, J BIOL CHEM, V264, P6196; CHANGELIAN PS, 1985, J IMMUNOL, V134, P1851; CHEN A, 1994, J IMMUNOL, V153, P1430; CHEVALIER J, 1989, J IMMUNOL, V142, P2031; COLTEN HR, 1992, ANNU REV IMMUNOL, V10, P809, DOI 10.1146/annurev.iy.10.040192.004113; CULLEN DC, 1987, BIOSENSORS, V3, P211; DICKLER HB, 1972, J EXP MED, V136, P191, DOI 10.1084/jem.136.1.191; EDBERG JC, 1987, J IMMUNOL, V139, P3739; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; FEARON DT, 1983, ANNU REV IMMUNOL, V1, P243, DOI 10.1146/annurev.iy.01.040183.001331; FEARON DT, 1980, J EXP MED, V152, P20, DOI 10.1084/jem.152.1.20; Gertler A, 1996, J BIOL CHEM, V271, P24482, DOI 10.1074/jbc.271.40.24482; GHEBREHIWET B, 1984, J EXP MED, V160, P1375, DOI 10.1084/jem.160.5.1375; GHEBREHIWET B, 1988, J IMMUNOL METHODS, V110, P251, DOI 10.1016/0022-1759(88)90111-1; GHEBREHIWET B, 1982, J IMMUNOL, V129, P157; GHEBREHIWET B, 1992, J LEUKOCYTE BIOL, V51, P546, DOI 10.1002/jlb.51.6.546; Ghebrehiwet B, 1993, BEHRING I MITT, V93, P236; GROGER RK, 1989, GENE, V81, P285, DOI 10.1016/0378-1119(89)90189-3; GUAN E, 1991, J BIOL CHEM, V266, P20345; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; HEBERT LA, 1991, AM J KIDNEY DIS, V17, P352; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; JACK RM, 1986, J IMMUNOL, V137, P3996; JACK RM, 1994, J IMMUNOL, V153, P262; JIANG HX, 1991, J IMMUNOL, V146, P2324; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JOURNET A, 1986, BIOCHEM J, V240, P783, DOI 10.1042/bj2400783; Kishore U, 1997, BIOCHEM J, V322, P543, DOI 10.1042/bj3220543; KLICKSTEIN LB, 1988, J EXP MED, V168, P1699, DOI 10.1084/jem.168.5.1699; KLICKSTEIN LB, 1987, J EXP MED, V165, P1095, DOI 10.1084/jem.165.4.1095; Korb LC, 1997, J IMMUNOL, V158, P4525; KRYCH M, 1991, P NATL ACAD SCI USA, V88, P4353, DOI 10.1073/pnas.88.10.4353; LACHMANN PJ, 1984, PHILOS T ROY SOC B, V306, P419, DOI 10.1098/rstb.1984.0102; LEPOW IH, 1963, J EXP MED, V117, P983, DOI 10.1084/jem.117.6.983; LEYTUS SP, 1986, BIOCHEMISTRY-US, V25, P4855, DOI 10.1021/bi00365a020; LIBERTI PA, 1981, J IMMUNOL METHODS, V40, P243, DOI 10.1016/0022-1759(81)90071-5; LOZADA C, 1995, P NATL ACAD SCI USA, V92, P8378, DOI 10.1073/pnas.92.18.8378; MALHOTRA R, 1988, BIOCHEM SOC T, V16, P735, DOI 10.1042/bst0160735; MALHOTRA R, 1993, IMMUNOLOGY, V78, P341; MALHOTRA R, 1989, BIOCHEM J, V262, P625, DOI 10.1042/bj2620625; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; Nepomuceno RR, 1997, IMMUNITY, V6, P119, DOI 10.1016/S1074-7613(00)80419-7; PACCAUD JP, 1990, BIOCHEM BIOPH RES CO, V172, P1203, DOI 10.1016/0006-291X(90)91576-E; PACCAUD JP, 1988, J IMMUNOL, V141, P3889; PEERSCHKE EIB, 1993, J LEUKOCYTE BIOL, V53, P179, DOI 10.1002/jlb.53.2.179; Petry F, 1997, HUM GENET, V100, P51, DOI 10.1007/s004390050464; PETTY HR, 1980, P NATL ACAD SCI-BIOL, V77, P6587, DOI 10.1073/pnas.77.11.6587; REID KBM, 1976, BIOCHEM J, V155, P5, DOI 10.1042/bj1550005; REILLY BD, 1994, J BIOL CHEM, V269, P7696; SHAW S, 1995, LEUCOCYTE TYPING, V5, P87; SIEGEL RC, 1983, MOL IMMUNOL, V20, P53, DOI 10.1016/0161-5890(83)90105-0; Storm D, 1996, J IMMUNOL METHODS, V199, P87, DOI 10.1016/S0022-1759(96)00172-X; Stuart GR, 1996, FEBS LETT, V397, P245, DOI 10.1016/S0014-5793(96)01156-8; Tenner A. J., 1993, BEHRING I MITT, V93, P241; TENNER AJ, 1980, J IMMUNOL, V125, P1658; TENNER AJ, 1984, J IMMUNOL, V133, P886; TENNER AJ, 1981, J IMMUNOL, V126, P1174; TENNER AJ, 1981, J IMMUNOL, V127, P648; TERKELTAUB R, 1983, ARTHRITIS RHEUM, V26, P775, DOI 10.1002/art.1780260612; TOSI M, 1987, BIOCHEMISTRY-US, V26, P8516, DOI 10.1021/bi00400a004; Tseng Y, 1997, J IMMUNOL, V158, P937; TUVESON DA, 1991, J EXP MED, V173, P1083, DOI 10.1084/jem.173.5.1083; UWATOKO S, 1990, J IMMUNOL, V144, P3484; VANGURI P, 1982, P NATL ACAD SCI-BIOL, V79, P3290, DOI 10.1073/pnas.79.10.3290; WYSOCKI LJ, 1978, P NATL ACAD SCI USA, V75, P2844, DOI 10.1073/pnas.75.6.2844; YING SC, 1993, J IMMUNOL, V150, P169; YOON SH, 1985, J IMMUNOL, V134, P3332; ZHANG SC, 1986, TISSUE CELL, V18, P13, DOI 10.1016/0040-8166(86)90003-0	73	193	197	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1997	7	3					345	355		10.1016/S1074-7613(00)80356-8	http://dx.doi.org/10.1016/S1074-7613(00)80356-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830	9324355	hybrid			2022-12-18	WOS:A1997XY83000004
J	Gobin, SJP; Peijnenburg, A; Keijsers, V; vandenElsen, PJ				Gobin, SJP; Peijnenburg, A; Keijsers, V; vandenElsen, PJ			Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: The ISRE-mediated route and a novel pathway involving CIITA	IMMUNITY			English	Article							BARE-LYMPHOCYTE-SYNDROME; PROTEASOME-RELATED GENE; X-BOX REGION; ANTIGEN PRESENTATION; INTERFERON-GAMMA; HEAVY-CHAIN; HLA-DM; EXPRESSION; ACTIVATION; TRANSCRIPTION	The constitutive and cytokine-induced levels of major histocompatibility (MHC) class I expression are tightly controlled at the transcriptional level. In this study, it is shown that the cis-acting regulatory element site alpha of the MHC class I promoter is essential for the IFN gamma-induced transactivation of MHC class I gene expression through the ISRE. Moreover, it was discovered that the class II transactivator (CIITA), which is itself under the control of the IFN gamma induction pathway, strongly transactivates MHC class I gene expression and exerts its activity through site alpha. Therefore, site alpha is a crucial regulatory element, mediating the classic route of IFN gamma induction via the ISRE as well as a novel route of MHC class I transactivation involving CIITA.	LEIDEN UNIV HOSP, BLOOD BANK, NL-2333 ZA LEIDEN, NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC)	Gobin, SJP (corresponding author), LEIDEN UNIV HOSP, DEPT IMMUNOHAEMATOL, NL-2333 ZA LEIDEN, NETHERLANDS.							ANDERSSON G, 1990, J IMMUNOL, V145, P3456; ANDREWS PW, 1987, CANCER RES, V47, P740; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; BLANCHET O, 1991, INT J CANCER, P138; BLUYSSEN HAR, 1995, P NATL ACAD SCI USA, V92, P5645, DOI 10.1073/pnas.92.12.5645; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; CHANG CH, 1992, IMMUNOGENETICS, V35, P378; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN E, 1986, MOL CELL BIOL, V6, P1698, DOI 10.1128/MCB.6.5.1698; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; COX PM, 1992, NUCLEIC ACIDS RES, V20, P4881, DOI 10.1093/nar/20.18.4881; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DEY A, 1992, MOL CELL BIOL, V12, P3590, DOI 10.1128/MCB.12.8.3590; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; FUJITA T, 1989, P NATL ACAD SCI USA, V86, P9936, DOI 10.1073/pnas.86.24.9936; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GIRDLESTONE J, 1993, P NATL ACAD SCI USA, V90, P11568, DOI 10.1073/pnas.90.24.11568; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; GUSSOW D, 1987, J IMMUNOL, V139, P3132; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; ISRAEL A, 1989, EMBO J, V8, P3793, DOI 10.1002/j.1460-2075.1989.tb08556.x; JOHNSON DR, 1994, MOL CELL BIOL, V14, P1322, DOI 10.1128/MCB.14.2.1322; KELLY A, 1991, NATURE, V353, P667, DOI 10.1038/353667a0; KELLY AP, 1991, NATURE, V353, P571, DOI 10.1038/353571a0; KERN I, 1995, INT IMMUNOL, V7, P1295, DOI 10.1093/intimm/7.8.1295; KORBER B, 1988, SCIENCE, V239, P1302, DOI 10.1126/science.3125612; LEBOUTEILLER P, 1994, CRIT REV IMMUNOL, V14, P89, DOI 10.1615/CritRevImmunol.v14.i2.10; Lee YJ, 1996, J IMMUNOL, V157, P1559; Lehner PJ, 1996, CURR OPIN IMMUNOL, V8, P59, DOI 10.1016/S0952-7915(96)80106-3; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; MARCADET A, 1987, IMMUNOBIOLOGY HLA, P560; Marusina K, 1996, Curr Opin Hematol, V3, P19; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Min W, 1996, J IMMUNOL, V156, P3174; MORENO CS, 1995, J IMMUNOL, V155, P4313; NEEFJES JJ, 1988, EUR J IMMUNOL, V18, P801, DOI 10.1002/eji.1830180522; ONO SJ, 1991, P NATL ACAD SCI USA, V88, P4304, DOI 10.1073/pnas.88.10.4304; ONO SJ, 1991, P NATL ACAD SCI USA, V88, P4309, DOI 10.1073/pnas.88.10.4309; OSULLIVAN DM, 1986, P NATL ACAD SCI USA, V83, P4484, DOI 10.1073/pnas.83.12.4484; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SOOD AK, 1981, P NATL ACAD SCI-BIOL, V78, P616, DOI 10.1073/pnas.78.1.616; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; SUTHERLAND J, 1985, HUM IMMUNOL, V12, P65, DOI 10.1016/0198-8859(85)90344-1; TING JPY, 1993, CURR OPIN IMMUNOL, V5, P8, DOI 10.1016/0952-7915(93)90074-3; VERSTEEG R, 1988, EMBO J, V7, P1023, DOI 10.1002/j.1460-2075.1988.tb02909.x; WRIGHT KL, 1995, J EXP MED, V181, P1459, DOI 10.1084/jem.181.4.1459; YANG Y, 1992, P NATL ACAD SCI USA, V89, P4928, DOI 10.1073/pnas.89.11.4928; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9	62	193	193	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1997	6	5					601	611		10.1016/S1074-7613(00)80348-9	http://dx.doi.org/10.1016/S1074-7613(00)80348-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175838	Bronze			2022-12-18	WOS:A1997XB81900011
J	Ripperger, TJ; Uhrlaub, JL; Watanabe, M; Wong, R; Castaneda, Y; Pizzato, HA; Thompson, MR; Bradshaw, C; Weinkauf, CC; Bime, C; Erickson, HL; Knox, K; Bixby, B; Parthasarathy, S; Chaudhary, S; Natt, B; Cristan, E; El Aini, T; Rischard, F; Campion, J; Chopra, M; Insel, M; Sam, A; Knepler, JL; Capaldi, AP; Spier, CM; Dake, MD; Edwards, T; Kaplan, ME; Scott, SJ; Hypes, C; Mosier, J; Harris, DT; LaFleur, BJ; Sprissler, R; Nikolich-Zugich, J; Bhattacharya, D				Ripperger, Tyler J.; Uhrlaub, Jennifer L.; Watanabe, Makiko; Wong, Rachel; Castaneda, Yvonne; Pizzato, Hannah A.; Thompson, Mallory R.; Bradshaw, Christine; Weinkauf, Craig C.; Bime, Christian; Erickson, Heidi L.; Knox, Kenneth; Bixby, Billie; Parthasarathy, Sairam; Chaudhary, Sachin; Natt, Bhupinder; Cristan, Elaine; El Aini, Tammer; Rischard, Franz; Campion, Janet; Chopra, Madhav; Insel, Michael; Sam, Afshin; Knepler, James L.; Capaldi, Andrew P.; Spier, Catherine M.; Dake, Michael D.; Edwards, Taylor; Kaplan, Matthew E.; Scott, Serena Jain; Hypes, Cameron; Mosier, Jarrod; Harris, David T.; LaFleur, Bonnie J.; Sprissler, Ryan; Nikolich-Zugich, Janko; Bhattacharya, Deepta			Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity	IMMUNITY			English	Article							NEUTRALIZING ANTIBODY; PLASMA-CELLS; CORONAVIRUS; MEMORY; DURATION	We conducted a serological study to define correlates of immunity against SARS-CoV-2. Compared to those with mild coronavirus disease 2019 (COVID-19) cases, individuals with severe disease exhibited elevated virus-neutralizing titers and antibodies against the nucleocapsid (N) and the receptor binding domain (RBD) of the spike protein. Age and sex played lesser roles. All cases, including asymptomatic individuals, seroconverted by 2 weeks after PCR confirmation. Spike RBD and S2 and neutralizing antibodies remained detectable through 5-7 months after onset, whereas alpha-N titers diminished. Testing 5,882 members of the local community revealed only 1 sample with seroreactivity to both RBD and S2 that lacked neutralizing antibodies. This fidelity could not be achieved with either RBD or S2 alone. Thus, inclusion of multiple independent assays improved the accuracy of antibody tests in low-seroprevalence communities and revealed differences in antibody kinetics depending on the antigen, We conclude that neutralizing antibodies are stably produced for at least 5-7 months after SARS-CoV-2 infection.	[Ripperger, Tyler J.; Uhrlaub, Jennifer L.; Watanabe, Makiko; Wong, Rachel; Castaneda, Yvonne; Pizzato, Hannah A.; Bradshaw, Christine; Harris, David T.; Nikolich-Zugich, Janko; Bhattacharya, Deepta] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA; [Uhrlaub, Jennifer L.; Watanabe, Makiko; Castaneda, Yvonne; Bradshaw, Christine; Nikolich-Zugich, Janko] Univ Arizona, Ctr Aging, Coll Med, Tucson, AZ 85721 USA; [Wong, Rachel; Pizzato, Hannah A.] Washington Univ, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Thompson, Mallory R.; Weinkauf, Craig C.] Univ Arizona, Coll Med, Dept Surg, Tucson, AZ USA; [Thompson, Mallory R.] Univ Arizona, Coll Med, Dept Cellular & Mol Med, Tucson, AZ USA; [Bime, Christian; Erickson, Heidi L.; Knox, Kenneth; Bixby, Billie; Parthasarathy, Sairam; Chaudhary, Sachin; Natt, Bhupinder; Cristan, Elaine; El Aini, Tammer; Rischard, Franz; Campion, Janet; Chopra, Madhav; Insel, Michael; Sam, Afshin; Knepler, James L.; Hypes, Cameron; Mosier, Jarrod] Univ Arizona, Coll Med, Dept Med, Div Pulm Allergy Crit Care & Sleep Med, Tucson, AZ USA; [Knox, Kenneth] Univ Arizona, Dept Med, Phoenix, AZ USA; [Capaldi, Andrew P.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Capaldi, Andrew P.; Kaplan, Matthew E.] Univ Arizona, Funct Genom Core, Tucson, AZ USA; [Spier, Catherine M.] Univ Arizona, Coll Med, Dept Pathol, Tucson, AZ 85721 USA; [Dake, Michael D.] Univ Arizona, Off Senior Vice President Hlth Sci, Tucson, AZ USA; [Edwards, Taylor; Sprissler, Ryan] Univ Arizona, Univ Arizona Genom Core, Tucson, AZ USA; [Edwards, Taylor; Sprissler, Ryan] Univ Arizona, Arizona Res Labs, Univ Arizona Genet Core, Tucson, AZ USA; [Scott, Serena Jain] Univ Arizona, Dept Med, Coll Med, Div Geriatr Gen Med & Palliat Care, Tucson, AZ USA; [Hypes, Cameron; Mosier, Jarrod] Univ Arizona, Coll Med, Dept Emergency Med, Tucson, AZ USA; [Harris, David T.] Univ Arizona, Univ Arizona Hlth Sci Biobank, Tucson, AZ USA; [LaFleur, Bonnie J.; Sprissler, Ryan; Nikolich-Zugich, Janko; Bhattacharya, Deepta] Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; Washington University (WUSTL); University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona	Nikolich-Zugich, J; Bhattacharya, D (corresponding author), Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA.; Nikolich-Zugich, J (corresponding author), Univ Arizona, Ctr Aging, Coll Med, Tucson, AZ 85721 USA.; Nikolich-Zugich, J; Bhattacharya, D (corresponding author), Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA.	nikolich@arizona.edu; deeptab@arizona.edu	LaFleur, Bonnie J/GPJ-9592-2022	LaFleur, Bonnie J/0000-0002-4939-9337; Edwards, Taylor/0000-0002-7235-6175; Chopra, Madhav/0000-0002-2224-4730; Rischard, Franz/0000-0002-6861-8304	National Institutes of Health [AG020719, AG057701]; Centers for Disease Control and Prevention [75D30120C08379]; State of Arizona [CTR050053]; UArizona BIO5 Institute [R01AI099108, R01AI129945]; Bowman Endowment in Medical Sciences	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); State of Arizona; UArizona BIO5 Institute; Bowman Endowment in Medical Sciences	The authors are indebted to the nurses in the intensive care units of Banner University Medical Center-Tucson and South Campuses and research coordinators (Cathleen Wilson and Trina Hughes) for facilitating the collection of samples in critically ill hospitalized patients with COVID-19. We thank F. Krammer, V. Simon, M. Rao, and J. Jhang at Mt. Sinai Hospital and A. Ellebedy and D. Fremont at Washington University in St. Louis for reagents and protocols. This work was supported in part by National Institutes of Health awards AG020719 and AG057701 and Centers for Disease Control and Prevention award 75D30120C08379 to J.N.-Z., the contract CTR050053 from the State of Arizona to J.N.-Z. and D.B., R01AI099108 and R01AI129945 to D.B., by the COVID-19 Rapid Response Grant from the UArizona BIO5 Institute to C.C.W., D.B., and J.N.-Z., and the Bowman Endowment in Medical Sciences to J.N.-Z. The graphical abstract for this study was created on biorender.com.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Altman D, 2020, SARS COV 2 INFECT IN; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Atyeo C, 2020, IMMUNITY, V53, P524, DOI 10.1016/j.immuni.2020.07.020; Baumgarth N, 2020, J IMMUNOL, V205, P2342, DOI 10.4049/jimmunol.2000839; Bendavid E., 2020, MEDRXIV, P1, DOI [10.1101/2020.04.14.20062463, DOI 10.1101/2020.04.14.20062463]; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Bryan A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00941-20; Burbelo Peter D, 2020, medRxiv, DOI 10.1101/2020.04.20.20071423; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Cao WCC, 2007, NEW ENGL J MED, V357, P1162, DOI 10.1056/NEJMc070348; CDC, 2020, INF LAB COR COVID 19; Choe PG, 2020, EMERG INFECT DIS, V26, P2484, DOI 10.3201/eid2610.202211; Duan JZ, 2005, BIOCHEM BIOPH RES CO, V333, P186, DOI 10.1016/j.bbrc.2005.05.089; Galao R, 2020, LONGITUDINAL EVALUAT; Giroglou T, 2004, J VIROL, V78, P9007, DOI 10.1128/JVI.78.17.9007-9015.2004; Gorse GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1875, DOI 10.1128/CVI.00278-10; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Guo X., 2020, LONG TERM PERSISTENC; Hanson K.E., 2020, SEROLOGY 4; Hou HY, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1136; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Isho B., 2020, EVIDENCE SUSTAINED M; Iyer Anita S, 2020, medRxiv, DOI 10.1101/2020.07.18.20155374; Jash A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51860-z; Jash A, 2016, J IMMUNOL, V197, P1159, DOI 10.4049/jimmunol.1600882; Johnson Bryan A, 2020, bioRxiv, DOI 10.1101/2020.08.26.268854; Ko JH, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072268; Korea Central Disaster Control and Prevention (KCDC), 2020, FIND INV AN REP CAS; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Liu XQ, 2020, ANN HEMATOL, V99, P1421, DOI 10.1007/s00277-020-04103-5; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Olsson A, 2020, ROBUST T CELL IMMUNI; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Qu JX, 2020, CLIN INFECT DIS, V71, P2255, DOI 10.1093/cid/ciaa489; REED SE, 1984, J MED VIROL, V13, P179, DOI 10.1002/jmv.1890130208; Rosenberg E.S., 2020, ANN EPIDEMIOL, V48, P23, DOI [10.1016/j.annepidem.2020.06.004, DOI 10.1016/j.annepidem.2020.06.004]; Schmidt F, 2020, J EXP MED, V217, DOI 10.1084/jem.20201181; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Song G., 2020, CROSS REACTIVE SERUM; Srinivasan S, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040360; Steensels D, 2020, JAMA-J AM MED ASSOC, V324, P195, DOI 10.1001/jama.2020.11160; Sterlin D., 2020, IGA DOMINATES EARLY; Steyvers M, 2020, ESTIMATING COVID 19; Stringhini S, 2020, LANCET, V396, P313, DOI 10.1016/S0140-6736(20)31304-0; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Tan CW, 2020, NAT BIOTECHNOL, V38, P1073, DOI 10.1038/s41587-020-0631-z; To Kelvin Kai-Wang, 2021, Clin Infect Dis, V73, pe2946, DOI 10.1093/cid/ciaa1275; Uhrlaub JL, 2011, J IMMUNOL, V186, P3882, DOI 10.4049/jimmunol.1002799; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294; Weisblum Y, 2020, ELIFE, V9, DOI 10.7554/eLife.61312; Wong R, 2020, IMMUNITY, V53, P1078, DOI 10.1016/j.immuni.2020.09.001; Worobey M, 2020, SCIENCE, V370, P564, DOI 10.1126/science.abc8169; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Yang C., 2020, VIRAL RNA LEVEL SERU; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	67	192	194	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					925	+		10.1016/j.immuni.2020.10.004	http://dx.doi.org/10.1016/j.immuni.2020.10.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33129373	Green Published, Bronze			2022-12-18	WOS:000599348200007
J	Sariol, A; Perlman, S				Sariol, Alan; Perlman, Stanley			Lessons for COVID-19 Immunity from Other Coronavirus Infections	IMMUNITY			English	Review							ACUTE RESPIRATORY SYNDROME; CENTRAL-NERVOUS-SYSTEM; MOUSE HEPATITIS-VIRUS; T-CELL RESPONSES; TRANSMISSIBLE GASTROENTERITIS VIRUS; MONOCYTE-DERIVED MACROPHAGES; ANTIBODY-MEDIATED PROTECTION; SARS-CORONAVIRUS; MERS-COV; BRONCHITIS VIRUS	A key goal to controlling coronavirus disease 2019 (COVID-19) is developing an effective vaccine. Development of a vaccine requires knowledge of what constitutes a protective immune response and also features that might be pathogenic. Protective and pathogenic aspects of the response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not well understood, partly because the virus has infected humans for only 6 months. However, insight into coronavirus immunity can be informed by previous studies of immune responses to non-human coronaviruses, common cold coronaviruses, and SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV). Here, we review the literature describing these responses and discuss their relevance to the SARS-CoV-2 immune response.	[Sariol, Alan; Perlman, Stanley] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Perlman, Stanley] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Perlman, S (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.; Perlman, S (corresponding author), Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.	stanley-perlman@uiowa.edu	Lin, Chen/AFV-2163-2022	Perlman, Stanley/0000-0003-4213-2354; Sariol, Alan/0000-0002-3127-0543	NIH [PO1 AI060699, RO1 AI129269]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the NIH (grants PO1 AI060699 and RO1 AI129269).	Adams Emily R, 2020, Wellcome Open Res, V5, P139, DOI 10.12688/wellcomeopenres.15927.1; Akerstrom S, 2006, FEBS LETT, V580, P3799, DOI 10.1016/j.febslet.2006.06.002; Alsaad KO, 2018, HISTOPATHOLOGY, V72, P516, DOI 10.1111/his.13379; Anghelina D, 2009, VIROLOGY, V385, P358, DOI 10.1016/j.virol.2008.12.014; Anghelina D, 2006, AM J PATHOL, V169, P209, DOI 10.2353/ajpath.2006.051308; [Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2020, NATURE, DOI DOI 10.1038/s41586-020-2423-5; [Anonymous], 2020, SARS COV 2 RECEPTOR, DOI [10.1101/2020.04.10.036418, DOI 10.1101/2020.04.10.036418]; ANTON IM, 1995, VIROLOGY, V212, P746, DOI 10.1006/viro.1995.1535; Arabi YM, 2020, TRIALS, V21, DOI 10.1186/s13063-019-3846-x; Arabi YM, 2020, CLIN INFECT DIS, V70, P1837, DOI 10.1093/cid/ciz544; Arabi YM, 2017, NEW ENGL J MED, V376, P584, DOI 10.1056/NEJMsr1408795; Arashiro T, 2020, EMERG INFECT DIS, V26, P1346, DOI 10.3201/eid2606.200452; Athmer J, 2018, MBIO, V9, DOI 10.1128/mBio.00272-18; Bao L., 2020, NATURE, V2020, P7, DOI DOI 10.1016/S0140-6736(20)30183-5; BARTHOLD SW, 1984, ARCH VIROL, V81, P103, DOI 10.1007/BF01309300; Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343; Bergmann CC, 2004, J VIROL, V78, P1739, DOI 10.1128/JVI.78.4.1739-1750.2004; Bisht H, 2004, P NATL ACAD SCI USA, V101, P6641, DOI 10.1073/pnas.0401939101; Black JRM, 2020, LANCET, V395, P1418, DOI 10.1016/S0140-6736(20)30917-X; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; BRADBURNE AF, 1967, BMJ-BRIT MED J, V3, P767, DOI 10.1136/bmj.3.5568.767; BRIM TA, 1995, VET IMMUNOL IMMUNOP, V48, P35, DOI 10.1016/0165-2427(94)05416-P; Buchholz UJ, 2004, P NATL ACAD SCI USA, V101, P9804, DOI 10.1073/pnas.0403492101; Butler NS, 2007, J VIROL, V81, P13291, DOI 10.1128/JVI.01580-07; CALLEBAUT P, 1990, ADV EXP MED BIOL, V276, P421; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Cameron MJ, 2008, VIRUS RES, V133, P13, DOI 10.1016/j.virusres.2007.02.014; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; CASTRO RF, 1995, J VIROL, V69, P8127, DOI 10.1128/JVI.69.12.8127-8131.1995; Cavanagh D, 1997, AVIAN PATHOL, V26, P63, DOI 10.1080/03079459708419194; Cavanagh D, 2003, AVIAN PATHOL, V32, P567, DOI 10.1080/03079450310001621198; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Cervantes-Barragan L, 2012, J IMMUNOL, V188, P3678, DOI 10.4049/jimmunol.1102422; Cervantes-Barragan L, 2009, J IMMUNOL, V182, P1099, DOI 10.4049/jimmunol.182.2.1099; Chan JF, 2020, CLIN INFECT DIS; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Channappanavar R, 2019, J CLIN INVEST, V129, P3625, DOI 10.1172/JCI126363; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Chattha KS, 2015, ANNU REV ANIM BIOSCI, V3, P375, DOI 10.1146/annurev-animal-022114-111038; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen J, 2010, J VIROL, V84, P1289, DOI 10.1128/JVI.01281-09; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Cho KO, 2001, ARCH VIROL, V146, P2401, DOI 10.1007/s007050170011; Cho SY, 2016, LANCET, V388, P994, DOI 10.1016/S0140-6736(16)30623-7; Chu DKW, 2018, P NATL ACAD SCI USA, V115, P3144, DOI 10.1073/pnas.1718769115; Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380; Chu H, 2014, VIROLOGY, V454, P197, DOI 10.1016/j.virol.2014.02.018; Chua MM, 2004, J VIROL, V78, P1150, DOI 10.1128/JVI.78.3.1150-1159.2004; Cockrell AS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.226; Coleman C.M., 2016, J VIROL, V91; Collisson EW, 2000, DEV COMP IMMUNOL, V24, P187, DOI 10.1016/S0145-305X(99)00072-5; Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951; Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112; Dandekar AA, 2003, J VIROL, V77, P11867, DOI 10.1128/JVI.77.22.11867-11874.2003; de Wit E, 2013, P NATL ACAD SCI USA, V110, P16598, DOI 10.1073/pnas.1310744110; Deming D, 2006, PLOS MED, V3, P2359, DOI 10.1371/journal.pmed.0030525; Deng XF, 2017, P NATL ACAD SCI USA, V114, pE4251, DOI 10.1073/pnas.1618310114; Dijkman R, 2013, J VIROL, V87, P6081, DOI 10.1128/JVI.03368-12; Dinnon Kenneth H, 2020, bioRxiv, DOI 10.1101/2020.05.06.081497; Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858; Enkirch T, 2015, VIROLOGY, V479, P259, DOI 10.1016/j.virol.2015.03.017; Falzarano D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004250; Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362; Fan YY, 2009, ARCH VIROL, V154, P1093, DOI 10.1007/s00705-009-0409-6; Fehr AR, 2016, MBIO, V7, DOI 10.1128/mBio.01721-16; Fehr D, 1997, VACCINE, V15, P1101, DOI 10.1016/S0264-410X(97)00006-6; Folegatti PM, 2020, LANCET INFECT DIS, V20, P816, DOI 10.1016/S1473-3099(20)30160-2; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P6212, DOI 10.1073/pnas.0400762101; Frieman M, 2012, J VIROL, V86, P884, DOI 10.1128/JVI.05957-11; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Garcia-Sastre A, 2017, CELL HOST MICROBE, V22, P176, DOI 10.1016/j.chom.2017.07.012; GERBER JD, 1990, VACCINE, V8, P536, DOI 10.1016/0264-410X(90)90004-6; Gorse GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1875, DOI 10.1128/CVI.00278-10; Gretebeck LM, 2015, CURR OPIN VIROL, V13, P123, DOI 10.1016/j.coviro.2015.06.009; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Gu J, 2007, AM J PATHOL, V170, P1136, DOI 10.2353/ajpath.2007.061088; Guo X G Z, 2020, LONG TERM PERSISTENC, DOI 10.1101/2020.02.12.20021386; Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; He L, 2006, J PATHOL, V210, P288, DOI 10.1002/path.2067; He ZP, 2005, INT J INFECT DIS, V9, P323, DOI 10.1016/j.ijid.2004.07.014; HECKERT RA, 1990, VET MICROBIOL, V22, P187, DOI 10.1016/0378-1135(90)90106-6; HENDLEY JO, 1972, AM REV RESPIR DIS, V105, P805; HIGGINS PG, 1983, ANTIMICROB AGENTS CH, V24, P713, DOI 10.1128/AAC.24.5.713; Hsueh PR, 2004, CLIN MICROBIOL INFEC, V10, P1062, DOI 10.1111/j.1469-0691.2004.01009.x; Hu Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02143-16; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Ireland DDC, 2008, J VIROL, V82, P300, DOI 10.1128/JVI.01794-07; Iwata-Yoshikawa N, 2014, J VIROL, V88, P8597, DOI 10.1128/JVI.00983-14; Jackwood MW, 2012, AVIAN DIS, V56, P634, DOI 10.1637/10227-043012-Review.1; JACKWOOD MW, 2017, PLOS ONE, V12, pNIL_1113, DOI [DOI 10.1371/JOURNAL.PONE.0176709, DOI 10.1371/journal.pone.0176709]; JIA W, 1995, ARCH VIROL, V140, P259, DOI 10.1007/BF01309861; Jia WX, 2019, EMERG MICROBES INFEC, V8, P760, DOI 10.1080/22221751.2019.1620083; Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027; Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC; Josset L, 2013, MBIO, V4, DOI 10.1128/mBio.00165-13; Khanolkar A, 2009, J VIROL, V83, P9258, DOI 10.1128/JVI.00355-09; Kiambi S, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0193-z; Kim ES, 2016, J KOREAN MED SCI, V31, P1717, DOI 10.3346/jkms.2016.31.11.1717; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Kim MH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220196; Kim TS, 2005, J VIROL, V79, P7113, DOI 10.1128/JVI.79.11.7113-7120.2005; Kim YI, 2020, CELL HOST MICROBE, V27, P704, DOI 10.1016/j.chom.2020.03.023; Kindler E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006195; Kirkcaldy RD, 2020, JAMA; Koch T, 2020, LANCET INFECT DIS, V20, P827, DOI 10.1016/S1473-3099(20)30248-6; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Lee N, 2006, J CLIN VIROL, V35, P179, DOI 10.1016/j.jcv.2005.07.005; Lew TWK, 2003, JAMA-J AM MED ASSOC, V290, P374, DOI 10.1001/jama.290.3.374; Li CKF, 2008, J IMMUNOL, V181, P5490, DOI 10.4049/jimmunol.181.8.5490; Li K, 2017, P NATL ACAD SCI USA, V114, pE3119, DOI 10.1073/pnas.1619109114; Lin JT, 2007, ANTIVIR THER, V12, P1107; Lin MT, 1999, J IMMUNOL, V162, P7358; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Liu WJ, 2017, ANTIVIR RES, V137, P82, DOI 10.1016/j.antiviral.2016.11.006; Lokugamage K. G., 2020, SARS COV 2 IS SENSIT, DOI [10.1101/2020.03.07.982264, DOI 10.1101/2020.03.07.982264]; Long Q-X., 2020, NAT MED, V26, P845, DOI DOI 10.1093/biolre/ioaa050; Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; Matthews AE, 2001, J IMMUNOL, V167, P5254, DOI 10.4049/jimmunol.167.9.5254; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; MCINTOSH K, 1967, P NATL ACAD SCI USA, V57, P933, DOI 10.1073/pnas.57.4.933; Memish ZA, 2020, LANCET, V395, P1063, DOI 10.1016/S0140-6736(19)33221-0; Menachery VD, 2018, P NATL ACAD SCI USA, V115, pE1012, DOI 10.1073/pnas.1706928115; Menachery VD, 2014, J VIROL, V88, P4251, DOI 10.1128/JVI.03571-13; Min CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25359; Modjarrad K, 2019, LANCET INFECT DIS, V19, P1013, DOI 10.1016/S1473-3099(19)30266-X; MONTO AS, 1974, J INFECT DIS, V129, P271, DOI 10.1093/infdis/129.3.271; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; Ng DL, 2016, AM J PATHOL, V186, P652, DOI 10.1016/j.ajpath.2015.10.024; Ng OW, 2016, VACCINE, V34, P2008, DOI 10.1016/j.vaccine.2016.02.063; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Oh HLJ, 2011, J VIROL, V85, P10464, DOI 10.1128/JVI.05039-11; Omrani AS, 2014, LANCET INFECT DIS, V14, P1090, DOI 10.1016/S1473-3099(14)70920-X; Page C, 2012, J VIROL, V86, P13334, DOI 10.1128/JVI.01689-12; Park SK, 1998, AM J VET RES, V59, P1002; Park WB, 2015, EMERG INFECT DIS, V21, P2186, DOI 10.3201/eid2112.151421; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Perlman S., 2019, MANDELL DOUGLAS BENN, VNinth; Pewe L, 2002, J VIROL, V76, P7329, DOI 10.1128/JVI.76.14.7329-7333.2002; Pewe L, 2002, J IMMUNOL, V168, P1547, DOI 10.4049/jimmunol.168.4.1547; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]; Qiu MF, 2005, MICROBES INFECT, V7, P882, DOI 10.1016/j.micinf.2005.02.006; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Ramakrishna C, 2003, J VIROL, V77, P4670, DOI 10.1128/JVI.77.8.4670-4678.2003; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Roberts A, 2005, J VIROL, V79, P5833, DOI 10.1128/JVI.79.9.5833-5838.2005; Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005; Rockx B, 2020, SCIENCE, V368, P1012, DOI 10.1126/science.abb7314; Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08; Rottier PJM, 2005, J VIROL, V79, P14122, DOI 10.1128/JVI.79.22.14122-14130.2005; Saif L.J., 2019, CORONAVIRUSES DIS SW, P488; Saif LJ, 2010, VET CLIN N AM-FOOD A, V26, P349, DOI 10.1016/j.cvfa.2010.04.005; SAIF LJ, 1972, INFECT IMMUN, V6, P600, DOI 10.1128/IAI.6.4.600-609.1972; SANCHEZ CM, 1992, VIROLOGY, V190, P92, DOI 10.1016/0042-6822(92)91195-Z; Savarin C, 2008, J VIROL, V82, P12432, DOI 10.1128/JVI.01267-08; Scheuplein VA, 2015, J VIROL, V89, P3859, DOI 10.1128/JVI.03607-14; Schmidt O.W., 1986, RISES TITERS ANTIBOD; Schwegmann-Wessels C, 2006, DEUT TIERARZTL WOCH, V113, P157; Shaman J., 2020, MEDRXIV, DOI [10.1101/2020.01.30.20019612., DOI 10.1101/2020.01.30.20019612]; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Shin HS, 2019, CLIN INFECT DIS, V68, P984, DOI 10.1093/cid/ciy595; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Singleton R, 2003, J VIROL, V77, P11303, DOI 10.1128/JVI.77.21.11303-11311.2003; Smith EC, 2014, ANNU REV VIROL, V1, P111, DOI 10.1146/annurev-virology-031413-085507; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Sun Jing, 2020, CELL, V182, P734, DOI DOI 10.1016/j.cell.2020.06.010; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Tai WB, 2017, J VIROL, V91, DOI 10.1128/JVI.01651-16; Tang F, 2011, J IMMUNOL, V186, P7264, DOI 10.4049/jimmunol.0903490; Tang XC, 2014, P NATL ACAD SCI USA, V111, pE2018, DOI 10.1073/pnas.1402074111; Templeton SP, 2008, BRAIN PATHOL, V18, P40, DOI 10.1111/j.1750-3639.2007.00098.x; The World Health Organization, 2020, DRAFT LANDSC COVID 1; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Tseng CTK, 2007, J VIROL, V81, P1162, DOI 10.1128/JVI.01702-06; Tynell J, 2016, J GEN VIROL, V97, P344, DOI 10.1099/jgv.0.000351; TYRRELL DAJ, 1965, BMJ-BRIT MED J, V1, P1467, DOI 10.1136/bmj.1.5448.1467; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; VENNEMA H, 1990, J VIROL, V64, P1407, DOI 10.1128/JVI.64.3.1407-1409.1990; Vijay R, 2015, J EXP MED, V212, P1851, DOI 10.1084/jem.20150632; WANG FI, 1990, J NEUROIMMUNOL, V30, P31, DOI 10.1016/0165-5728(90)90050-W; Wang L, 2018, J VIROL, V92, DOI 10.1128/JVI.01060-18; WEISS RC, 1981, COMP IMMUNOL MICROB, V4, P175, DOI 10.1016/0147-9571(81)90003-5; Wesley R, 2002, J VET DIAGN INVEST, V14, P525, DOI 10.1177/104063870201400617; Wesley RD, 1996, AM J VET RES, V57, P157; WILLIAMSON JSP, 1990, J VIROL, V64, P4589, DOI 10.1128/JVI.64.9.4589-4592.1990; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Wu GF, 2000, J IMMUNOL, V165, P2278, DOI 10.4049/jimmunol.165.4.2278; Wu LP, 2007, EMERG INFECT DIS, V13, P1562, DOI 10.3201/eid1310.070576; XU ZJ, 2020, GEROSCIENCE 0611, DOI DOI 10.1126/SCIENCE.ABC1932; Yang PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07027; Yang Y, 2020, J ALLERGY CLIN IMMUN, V146, P119, DOI 10.1016/j.jaci.2020.04.027; Yen YT, 2006, J VIROL, V80, P2684, DOI 10.1128/JVI.80.6.2684-2693.2006; Yilla M, 2005, VIRUS RES, V107, P93, DOI 10.1016/j.virusres.2004.09.004; Yoshikawa T, 2009, J VIROL, V83, P3039, DOI 10.1128/JVI.01792-08; Yu S., CLIN CHARACTERISTICS, DOI DOI 10.1038/s41392-020-0148-4; Yu Xue-ying, 2003, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V25, P542; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang LQ, 2006, J MED VIROL, V78, P1, DOI 10.1002/jmv.20499; Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004; Zhang Y, 2010, VIRUS GENES, V41, P377, DOI 10.1007/s11262-010-0517-0; Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111; Zhao JC, 2012, J VIROL, V86, P11416, DOI 10.1128/JVI.01410-12; Zhao JC, 2011, J CLIN INVEST, V121, P4921, DOI 10.1172/JCI59777; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10; Zhao JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000636; Zhao JX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5393; Zhao JX, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004279; Zhao JX, 2011, J EXP MED, V208, P1571, DOI 10.1084/jem.20110236; Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011; Zheng J, 2019, EMERG INFECT DIS, V25, P2307, DOI 10.3201/eid2512.191169; Zhong XF, 2005, J VIROL, V79, P3401, DOI 10.1128/JVI.79.6.3401-3408.2005; Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]; Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	230	192	197	9	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					248	263		10.1016/j.immuni.2020.07.005	http://dx.doi.org/10.1016/j.immuni.2020.07.005			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32717182	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000561190600007
J	Pauthner, M; Havenar-Daughton, C; Sok, D; Nkolola, JP; Bastidas, R; Boopathy, AV; Carnathan, DG; Chandrashekar, A; Cirelli, KM; Cottrell, CA; Eroshkin, AM; Guenaga, J; Kaushik, K; Kulp, DW; Liu, JY; McCoy, LE; Oom, AL; Ozorowski, G; Post, KW; Sharma, SK; Steichen, JM; de Taeye, SW; Tokatlian, T; de la Pena, AT; Butera, ST; LaBranche, CC; Montefiori, DC; Silvestri, G; Wilson, IA; Irvine, DJ; Sanders, RW; Schief, WR; Ward, AB; Wyatt, RT; Barouch, DH; Crotty, S; Burton, DR				Pauthner, Matthias; Havenar-Daughton, Colin; Sok, Devin; Nkolola, Joseph P.; Bastidas, Raiza; Boopathy, Archana V.; Carnathan, Diane G.; Chandrashekar, Abishek; Cirelli, Kimberly M.; Cottrell, Christopher A.; Eroshkin, Alexey M.; Guenaga, Javier; Kaushik, Kirti; Kulp, Daniel W.; Liu, Jinyan; McCoy, Laura E.; Oom, Aaron L.; Ozorowski, Gabriel; Post, Kai W.; Sharma, Shailendra K.; Steichen, Jon M.; de Taeye, Steven W.; Tokatlian, Talar; de la Pena, Alba Torrents; Butera, Salvatore T.; LaBranche, Celia C.; Montefiori, David C.; Silvestri, Guido; Wilson, Ian A.; Irvine, Darrell J.; Sanders, Rogier W.; Schief, William R.; Ward, Andrew B.; Wyatt, Richard T.; Barouch, Dan H.; Crotty, Shane; Burton, Dennis R.			Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; STANDARDIZED ASSESSMENTS; GLYCOPROTEIN COMPLEX; ENV TRIMERS; TFH CELLS; DESIGN; ESCAPE; TARGET	The development of stabilized recombinant HIV envelope trimers that mimic the virion surface molecule has increased enthusiasm for a neutralizing antibody (nAb)-based HIV vaccine. However, there is limited experience with recombinant trimers as immunogens in nonhuman primates, which are typically used as a model for humans. Here, we tested multiple immunogens and immunization strategies head-to-head to determine their impact on the quantity, quality, and kinetics of autologous tier 2 nAb development. A bilateral, adjuvanted, subcutaneous immunization protocol induced reproducible tier 2 nAb responses after only two immunizations 8 weeks apart, and these were further enhanced by a third immunization with BG505 SOSIP trimer. We identified immunogens that minimized non-neutralizing V3 responses and demonstrated that continuous immunogen delivery could enhance nAb responses. nAb responses were strongly associated with germinal center reactions, as assessed by lymph node fine needle aspiration. This study provides a framework for preclinical and clinical vaccine studies targeting nAb elicitation.	[Pauthner, Matthias; Sok, Devin; Bastidas, Raiza; Guenaga, Javier; Kulp, Daniel W.; McCoy, Laura E.; Sharma, Shailendra K.; Steichen, Jon M.; Butera, Salvatore T.; Schief, William R.; Wyatt, Richard T.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Pauthner, Matthias; Havenar-Daughton, Colin; Sok, Devin; Nkolola, Joseph P.; Bastidas, Raiza; Carnathan, Diane G.; Cirelli, Kimberly M.; Cottrell, Christopher A.; Eroshkin, Alexey M.; Guenaga, Javier; Kaushik, Kirti; Kulp, Daniel W.; Liu, Jinyan; McCoy, Laura E.; Oom, Aaron L.; Ozorowski, Gabriel; Post, Kai W.; Sharma, Shailendra K.; Steichen, Jon M.; Tokatlian, Talar; Butera, Salvatore T.; Silvestri, Guido; Wilson, Ian A.; Irvine, Darrell J.; Schief, William R.; Ward, Andrew B.; Wyatt, Richard T.; Barouch, Dan H.; Crotty, Shane; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Pauthner, Matthias; Sok, Devin; Bastidas, Raiza; Cottrell, Christopher A.; Guenaga, Javier; Kulp, Daniel W.; McCoy, Laura E.; Ozorowski, Gabriel; Sharma, Shailendra K.; Steichen, Jon M.; Wilson, Ian A.; Schief, William R.; Ward, Andrew B.; Wyatt, Richard T.; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Pauthner, Matthias; Sok, Devin; Bastidas, Raiza; Cottrell, Christopher A.; Guenaga, Javier; Kulp, Daniel W.; McCoy, Laura E.; Ozorowski, Gabriel; Sharma, Shailendra K.; Steichen, Jon M.; Wilson, Ian A.; Schief, William R.; Ward, Andrew B.; Wyatt, Richard T.; Burton, Dennis R.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Havenar-Daughton, Colin; Cirelli, Kimberly M.; Kaushik, Kirti; Oom, Aaron L.; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Sok, Devin] Int AIDS Vaccine Initiat, New York, NY 10004 USA; [Nkolola, Joseph P.; Chandrashekar, Abishek; Liu, Jinyan; Barouch, Dan H.] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Cottrell, Christopher A.; Ozorowski, Gabriel; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Eroshkin, Alexey M.; Post, Kai W.] Sanford Burnham Prebys Med Discovery Inst, Bioinformat Core, La Jolla, CA 92037 USA; [Boopathy, Archana V.; Tokatlian, Talar; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [de Taeye, Steven W.; de la Pena, Alba Torrents; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Irvine, Darrell J.; Schief, William R.; Barouch, Dan H.; Burton, Dennis R.] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Irvine, Darrell J.; Schief, William R.; Barouch, Dan H.; Burton, Dennis R.] Harvard Univ, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Irvine, Darrell J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Crotty, Shane] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92037 USA; [Carnathan, Diane G.; Silvestri, Guido] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Carnathan, Diane G.; Silvestri, Guido] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [McCoy, Laura E.] UCL, Div Infect & Immun, London WC1E 6BT, England; [Oom, Aaron L.] Univ Calif San Diego, La Jolla, CA 92093 USA	Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; La Jolla Institute for Immunology; International AIDS Vaccine Initiative; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Cornell University; Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute; Massachusetts Institute of Technology (MIT); University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Duke University; Scripps Research Institute; University of California System; University of California San Diego; Emory University; Emory University; University of London; University College London; University of California System; University of California San Diego	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Crotty, S; Burton, DR (corresponding author), Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA.; Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Burton, DR (corresponding author), Harvard Univ, Cambridge, MA 02139 USA.; Crotty, S (corresponding author), Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92037 USA.	shane@lji.org; burton@scripps.edu	Ward, Andrew/ABD-7728-2021; Cottrell, Christopher A/P-3514-2015; Barouch, Dan/Y-3918-2019; Ozorowski, Gabriel/HCH-0634-2022; Chandrashekar, Abishek/P-2610-2019; Ward, Andrew B/F-9203-2014; Crotty, Shane/AAC-6703-2019; Schief, William/ABF-3645-2020; Crotty, Shane/AAE-8446-2019	Ward, Andrew/0000-0001-7153-3769; Cottrell, Christopher A/0000-0002-3364-3083; Chandrashekar, Abishek/0000-0001-7821-5552; Ward, Andrew B/0000-0001-7153-3769; Crotty, Shane/0000-0002-6484-6262; Schief, William/0000-0002-1120-0150; Oom, Aaron/0000-0003-3300-0333; Pauthner, Matthias G./0000-0001-9212-4307; McCoy, Laura/0000-0001-9503-7946; Post, Kai Wolfram/0000-0003-1002-3989	NIAID-NIH [HHSN27201100016C]; NIAID [UM1AI100663]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI104722, UM1AI124436, UM1AI100663] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U24OD011023, P51OD011132] Funding Source: NIH RePORTER	NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the staff at Beth Israel Deaconess Medical Center (Arshi Agarwal, Erica Borducchi, Amanda Brinkman, Crystal Cabral, Patricia Giglio, David Jetton, Jessica Jimenez, Shanell Mojta, Katherine Molloy, Jade Mondesir, and Lauren Peter) and the staff at Alphagenesis (William Rinaldi, Melissa Ferguson, Kimberly Schmidt, Brianne Hibl, Greg Westergaard, Tiffany Markel, and Hector Santiago) for work on nonhuman primates. We further thank Jennifer Wood and the Yerkes National Primate Research Center veterinarians. We thank the International Vaccine Initiative for the ISCOMATRIX adjuvant. We thank Richard Wilson, Shridhar Bale, and Karen Tran for technical support and Joan Allmaras for administrative support. Neutralization assays in the Montefiori laboratory at Duke University were conducted under NIAID-NIH contract number HHSN27201100016C. The funding for this study was provided by NIAID UM1AI100663 (Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery). The Bill and Melinda Gates Foundation and the International AIDS Vaccine Initiative helped support the design of some immunogens used in this study.	Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Chung NPY, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-33; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; de Taeye SW, 2016, TRENDS IMMUNOL, V37, P221, DOI 10.1016/j.it.2016.01.007; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Feng Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005767; Gonzalez-Figueroa P, 2017, TRENDS MOL MED, V23, P95, DOI 10.1016/j.molmed.2016.12.009; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Havenar-Daughton C, 2017, IMMUNOL REV, V275, P49, DOI 10.1111/imr.12512; Havenar-Daughton C, 2016, CELL REP, V17, P2195, DOI 10.1016/j.celrep.2016.10.085; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2016, J IMMUNOL, V196, P3064, DOI 10.4049/jimmunol.1500527; Hu JK, 2015, J VIROL, V89, P10383, DOI 10.1128/JVI.01653-15; Ingale J, 2016, CELL REP, V15, P1986, DOI 10.1016/j.celrep.2016.04.078; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Sok D, 2016, IMMUNITY, V45, P31, DOI 10.1016/j.immuni.2016.06.026; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Sun HX, 2009, VACCINE, V27, P4388, DOI 10.1016/j.vaccine.2009.05.032; Tam HH, 2016, P NATL ACAD SCI USA, V113, pE6639, DOI 10.1073/pnas.1606050113; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006	40	192	194	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					1073	+		10.1016/j.immuni.2017.05.007	http://dx.doi.org/10.1016/j.immuni.2017.05.007			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636956	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000403665900019
